PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ladhani, L; Pardon, G; Meeuws, H; van Wesenbeeck, L; Schmidt, K; Stuyver, L; van der Wijngaart, W				Ladhani, Laila; Pardon, Gaspard; Meeuws, Hanne; van Wesenbeeck, Liesbeth; Schmidt, Kristiane; Stuyver, Lieven; van der Wijngaart, Wouter			Sampling and detection of airborne influenza virus towards point-of-care applications	PLOS ONE			English	Article							ELECTROSTATIC PRECIPITATOR; EXHALED PARTICLES; COLLECTION; AEROSOLS	Airborne transmission of the influenza virus contributes significantly to the spread of this infectious pathogen, particularly over large distances when carried by aerosol droplets with long survival times. Efficient sampling of virus-loaded aerosol in combination with a low limit of detection of the collected virus could enable rapid and early detection of airborne influenza virus at the point-of-care setting. Here, we demonstrate a successful sampling and detection of airborne influenza virus using a system specifically developed for such applications. Our system consists of a custom-made electrostatic precipitation (ESP)-based bioaerosol sampler that is coupled with downstream quantitative polymerase chain reaction (qPCR) analysis. Aerosolized viruses are sampled directly into a miniaturized collector with liquid volume of 150 mu L, which constitutes a simple and direct interface with subsequent biological assays. This approach reduces sample dilution by at least one order of magnitude when compared to other liquid-based aerosol bio-samplers. Performance of our ESP-based sampler was evaluated using influenza virus-loaded sub-micron aerosols generated from both cultured and clinical samples. Despite the miniaturized collection volume, we demonstrate a collection efficiency of at least 10% and sensitive detection of a minimum of 3721 RNA copies. Furthermore, we show that an improved extraction protocol can allow viral recovery of down to 303 RNA copies and a maximum sampler collection efficiency of 47%. A device with such a performance would reduce sampling times dramatically, from a few hours with current sampling methods down to a couple of minutes with our ESP-based bioaerosol sampler.	[Ladhani, Laila; Pardon, Gaspard; van der Wijngaart, Wouter] KTH Royal Inst Technol, Dept Micro & Nanosyst, Stockholm, Sweden; [Meeuws, Hanne; van Wesenbeeck, Liesbeth; Schmidt, Kristiane; Stuyver, Lieven] Janssen Diagnost, Beerse, Belgium	Royal Institute of Technology	van der Wijngaart, W (corresponding author), KTH Royal Inst Technol, Dept Micro & Nanosyst, Stockholm, Sweden.	wouter@kth.se	van der Wijngaart, Wouter/O-2378-2019; Pardon, Gaspard/G-8304-2011	van der Wijngaart, Wouter/0000-0001-8248-6670; Pardon, Gaspard/0000-0001-9177-1174	European Union [115153]; European Federation of Pharmaceutical Industries and Associations (RAPP-ID project) [115153]	European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (RAPP-ID project)	The funder (jointly between Innovative Medicines Initiative (IMI), http//www.imi.europa.eu/content/rapp-id, a public-private partnership between the European Union, and the European Federation of Pharmaceutical Industries and Associations (RAPP-ID project, grant agreement, no. 115153) provided support in the form of salaries for authors: L.L., G.P., H.M., L.vW., KS., L.S. and W.vW; and materials. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agranovski IE, 2005, J AEROSOL SCI, V36, P609, DOI 10.1016/j.jaerosci.2004.11.014; Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brooke CB, 2014, FUTURE VIROL, V9, P41, DOI 10.2217/FVL.13.118; Brown JR, 2015, J HOSP INFECT, V91, P278, DOI 10.1016/j.jhin.2015.08.004; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Han T, 2010, AEROSOL SCI TECH, V44, P339, DOI 10.1080/02786821003649352; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; Kettleson EM, 2009, ENVIRON SCI TECHNOL, V43, P5940, DOI 10.1021/es803289w; Lemon SM, 2005, THREAT PANDEMIC INFL; Mainelis G, 2002, J AEROSOL SCI, V33, P1417, DOI 10.1016/S0021-8502(02)00091-5; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Nauwelaers D, 2009, J CLIN VIROL, V46, P238, DOI 10.1016/j.jcv.2009.08.013; Nikitin N, 2014, ADV VIROL, V2014, P1, DOI DOI 10.1155/2014/859090); Pardon G, 2015, SENSOR ACTUAT B-CHEM, V212, P344, DOI 10.1016/j.snb.2015.02.008; Richard M, 2016, FEMS MICROBIOL REV, V40, P68, DOI 10.1093/femsre/fuv039; Tan MM, 2011, AEROSOL SCI TECH, V45, P1154, DOI 10.1080/02786826.2011.582193; Tellier R., 2009, J R SOC INTERFACE; Van Wesenbeeck L, 2014, VIROL J, V11, P105; Van Wesenbeeck L, 2013, J CLIN MICROBIOL, V51, P2977, DOI 10.1128/JCM.00911-13; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zhao Y, 2014, ANN AGR ENV MED, V21, P464, DOI 10.5604/12321966.1120585	24	30	30	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174314	10.1371/journal.pone.0174314	http://dx.doi.org/10.1371/journal.pone.0174314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350811	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174400024
J	Kim, C; Park, SH; Oh, SY; Kim, SS; Jo, KW; Shim, TS; Kim, MY				Kim, Cherry; Park, So Hee; Oh, Sang Young; Kim, Sung-Soo; Jo, Kyung-Wook; Shim, Tae Sun; Kim, Mi Young			Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities	PLOS ONE			English	Article							SMEAR-POSITIVE SPUTUM; PULMONARY TUBERCULOSIS; COMPUTED-TOMOGRAPHY; SOUTH-KOREA; INFECTION; MANIFESTATIONS; COMPLEX; KANSASII; SPECTRUM; FEATURES	Objectives This article focuses on the differences between CT findings of HIV-negative patients who have cavities with nontuberculous mycobacteria (NTM) disease and those with Mycobacterium tuberculosis infections (TB). Methods We retrospectively reviewed 128 NTM disease patients (79 males and 49 females) with cavities in chest CT, matched for age and gender with 128 TB patients in the same period. Sputum cultures of all patients were positive for pathogens. Two independent chest radiologists evaluated the characteristics of the largest cavity and related factors. Results Interobserver agreement was excellent (kappa value, 0.853-0.938). Cavity walls in NTM disease were significantly thinner (6.9 +/- 4 mm vs 10.9 +/- 6 mm, P<0.001) and more even (the ratio of thickness, 2.6 +/- 1 vs 3.7 +/- 2, P<0.001) than those in TB. The thickening of adjacent pleura next to the cavity was also significantly thicker in NTM than TB (P<0.001). However, in the multivariate analysis, thickening of adjacent pleura was the only significant factor among the representative cavity findings (Odds ratio [ OR], 6.49; P<0.001). In addition, ill-defined tree-in- bud nodules (OR, 8.82; P<0.001), number of non-cavitary nodules (>= 10mm) (OR, 0.72; P = 0.003), and bronchiectasis in the RUL (OR, 5.3; P = 0.002) were significantly associated ancillary findings with NTM disease in the multivariate analysis. Conclusions The major cavities in NTM disease generally have thinner and more even walls than those in TB. When cavities are associated with adjacent pleural thickening, ill-defined satellite tree-in-bud nodules, or fewer non-cavitary nodules >= 10 mm, these CT findings are highly suggestive of NTM disease rather than TB.	[Kim, Cherry; Oh, Sang Young; Kim, Mi Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Cherry; Oh, Sang Young; Kim, Mi Young] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Cherry] Korea Univ, Coll Med, Ansan Hosp, Dept Radiol, Ansan, Gyeonggi, South Korea; [Park, So Hee] Kyung Hee Univ Hosp Gangdong, Pulm & Crit Care Med, Seoul, South Korea; [Oh, Sang Young] Cheongju Univ, Dept Healthcare Management, Cheongju, South Korea; [Jo, Kyung-Wook; Shim, Tae Sun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulm & Crit Care Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Kyung Hee University Hospital; Cheongju University; University of Ulsan; Asan Medical Center	Kim, MY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, MY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	mimowdr@amc.seoul.kr	Kim, Sung-Soo/AFP-2188-2022	Kim, Sung-Soo/0000-0002-7205-0758; Kim, Mi Young/0000-0003-0691-5546				ALBELDA SM, 1985, RADIOLOGY, V157, P289, DOI 10.1148/radiology.157.2.4048433; AlJarad N, 1996, THORAX, V51, P137, DOI 10.1136/thx.51.2.137; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Chiang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093397; CHRISTENSEN EE, 1978, AM J ROENTGENOL, V131, P985, DOI 10.2214/ajr.131.6.985; CHRISTENSEN EE, 1981, CHEST, V80, P132, DOI 10.1378/chest.80.2.132; Goo JM, 2002, RADIOL CLIN N AM, V40, P73, DOI 10.1016/S0033-8389(03)00110-6; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; HARTMAN TE, 1993, RADIOLOGY, V187, P23, DOI 10.1148/radiology.187.1.8451419; HOSKER HSR, 1995, RESP MED, V89, P3, DOI 10.1016/0954-6111(95)90063-2; IM JG, 1995, SEMIN ULTRASOUND CT, V16, P420, DOI 10.1016/0887-2171(95)90029-2; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; IM JG, 1995, CRIT REV DIAGN IMAG, V36, P227; Jeon K, 2005, INT J TUBERC LUNG D, V9, P1046; Kendall BA, 2011, EMERG INFECT DIS, V17, P506, DOI 10.3201/eid1703.101164; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Kim TS, 2005, AM J ROENTGENOL, V184, P1247, DOI 10.2214/ajr.184.4.01841247; Kim YK, 2014, INT J TUBERC LUNG D, V18, P725, DOI 10.5588/ijtld.13.0871; Koh WJ, 2006, INT J TUBERC LUNG D, V10, P1001; Koh WJ, 2002, KOREAN J RADIOL, V3, P145, DOI 10.3348/kjr.2002.3.3.145; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; LYNCH DA, 1995, J COMPUT ASSIST TOMO, V19, P353, DOI 10.1097/00004728-199505000-00003; Maekawa K, 2013, INT J TUBERC LUNG D, V17, P829, DOI 10.5588/ijtld.12.0672; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Marras TK, 2013, RESPIROLOGY, V18, P92, DOI 10.1111/j.1440-1843.2012.02277.x; MILLER WT, 1994, RADIOLOGY, V191, P343, DOI 10.1148/radiology.191.2.8153304; MOORE EH, 1993, RADIOLOGY, V187, P777, DOI 10.1148/radiology.187.3.8497629; Namkoong H, 2016, EMERG INFECT DIS, V22, P1116, DOI 10.3201/eid2206.151086; O'Connell ML, 2012, CHEST, V141, P1203, DOI 10.1378/chest.11-0425; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; PATZ EF, 1995, RADIOL CLIN N AM, V33, P719; Singanayagam A, 2016, INT J TUBERC LUNG D, V20, P1653, DOI 10.5588/ijtld.16.0159; Taiwo B, 2010, INFECT DIS CLIN N AM, V24, P769, DOI 10.1016/j.idc.2010.04.008; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Yoon YS, 2016, THORAX	36	15	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174240	10.1371/journal.pone.0174240	http://dx.doi.org/10.1371/journal.pone.0174240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346488	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300035
J	Deave, T; Hawkins, A; Kumar, A; Hayes, M; Cooper, N; Watson, M; Ablewhite, J; Coupland, C; Sutton, A; Majsak-Newman, G; McDaid, L; Goodenough, T; Beckett, K; McColl, E; Reading, R; Kendrick, D				Deave, Toity; Hawkins, Adrian; Kumar, Arun; Hayes, Mike; Cooper, Nicola; Watson, Michael; Ablewhite, Joanne; Coupland, Carol; Sutton, Alex; Majsak-Newman, Gosia; McDaid, Lisa; Goodenough, Trudy; Beckett, Kate; McColl, Elaine; Reading, Richard; Kendrick, Denise			Evaluating implementation of a fire-prevention injury prevention briefing in children's centres: Cluster randomised controlled trial	PLOS ONE			English	Article							HEALTH-CARE; OUTCOMES	Background Many developed countries have high mortality rates for fire-related deaths in children aged 0-14 years with steep social gradients. Evidence-based interventions to promote fire safety practices exist, but the impact of implementing a range of these interventions in children's services has not been assessed. We developed an Injury Prevention Briefing (IPB), which brought together evidence about effective fire safety interventions and good practice in delivering interventions; plus training and facilitation to support its use and evaluated its implementation. Methods We conducted a cluster randomised controlled trial, with integrated qualitative and cost-effectiveness nested studies, across four study sites in England involving children's centres in disadvantaged areas; participants were staff and families attending those centres. Centres were stratified by study site and randomised within strata to one of three arms: IPB plus facilitation (IPB+), IPB only, usual care. IPB+ centres received initial training and facilitation at months 1, 3, and 8. Baseline data from children's centres were collected between August 2011 and January 2012 and follow-up data were collected between June 2012 and June 2013. Parent baseline data were collected between January 2012 and May 2012 and followup data between May 2013 and September 2013. Data comprised baseline and 12 month parent-and staff-completed questionnaires, facilitation contact data, activity logs and staff interviews. The primary outcome was whether families had a plan for escaping from a house fire. Treatment arms were compared using multilevel models to account for clustering by children's centre. Results 1112 parents at 36 children's centres participated. There was no significant effect of the intervention on families' possession of plans for escaping from a house fire (adjusted odds ratio (AOR) IPB only vs. usual care: 0.93, 95%Cl 0.58, 1.49; AOR IPB+ vs. usual care 1.41, 95%Cl 0.91, 2.20). However, significantly more families in the intervention arms reported more behaviours for escaping from house fires (AOR IPB only vs. usual care: 2.56, 95%Cl 01.38, 4.76; AOR IPB+ vs. usual care 1.78, 95%Cl 1.01, 3.15). Conclusion Our study demonstrated that children's centres can deliver an injury prevention intervention to families in disadvantaged communities and achieve changes in home safety behaviours.	[Deave, Toity; Goodenough, Trudy] Univ West England Bristol, Ctr Child & Adolescent Hlth, Hlth & Appl Sci, Bristol, Avon, England; [Hawkins, Adrian; McColl, Elaine] Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Kumar, Arun; Ablewhite, Joanne; Coupland, Carol; Kendrick, Denise] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England; [Hayes, Mike] Child Accid Prevent Trust, London, England; [Cooper, Nicola; Sutton, Alex] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Watson, Michael] Univ Nottingham, Sch Hlth Sci, Fac Med & Hlth Sci, Nottingham, England; [Majsak-Newman, Gosia] Norfolk & Suffolk Primary & Community Care Res Of, South Norfolk CCG, Norwich, Norfolk, England; [McDaid, Lisa] Univ East Anglia, Norfolk & Norwich Univ Hosp, Norwich Med Sch, NHS Clin Res & Trials Unit, Norwich, Norfolk, England; [Beckett, Kate] Univ West England, Univ Hosp Bristol NHS Fdn Trust, Res & Innovat, Educ Ctr, Bristol, Avon, England; [McColl, Elaine] Newcastle Univ, Newcastle Clin Trials Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Reading, Richard] Norfolk & Norwich Univ Hosp, Jenny Lind Paediat Dept, Norwich, Norfolk, England	University of Bristol; Newcastle University - UK; University of Nottingham; University of Leicester; University of Nottingham; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of East Anglia; University of Bristol; University of West England; Newcastle University - UK; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Kendrick, D (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England.	denise.kendrick@nottingham.ac.uk	McColl, Elaine/V-9906-2019; Watson, Michael Craig/B-9331-2008; Deave, Toity/AAB-1559-2020	McColl, Elaine/0000-0001-8300-3204; Deave, Toity/0000-0001-9966-8948; Watson, Michael Craig/0000-0003-1628-2746; Kendrick, Denise/0000-0003-3603-6542; Sutton, Alexander/0000-0002-8934-9940; McDaid, Lisa/0000-0001-5032-2380; Coupland, Carol/0000-0002-2327-3306	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-040710231]; National Institute for Health Research [RP-PG-0407-10231] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-040710231). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The institutions of the authors therefore received funds for us to carry out the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DEV EVALUATING COMPL; Beckett K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1256; Branche C., 2008, WORLD REPORT CHILD I; Brussoni M, 2006, INJURY PREV, V12, P373, DOI 10.1136/ip.2005.011403; Deave T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-69; Deave T, 2013, ARCH DIS CHILD, V98, P485, DOI 10.1136/archdischild-2012-302901; Department for Communities and Local Government, 2010, ENGL IND DEPR; Department for Education, 2010, SUR START CHILDR CEN; Department for Education, 2012, COR PURP SUR START C; DiGuiseppi C, 2001, COCHRANE DB SYST REV, V2; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Eldridge S, 2012, PRACTICAL GUIDE CLUS, P141; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gielen A, 2006, INJ VIOL PREV BEHA S; Goff J., 2013, EVALUATION CHILDRENS; Gomes M, 2012, HEALTH ECON, V21, P1101, DOI 10.1002/hec.2812; Greenhalgh T, 2004, SPREAD GOOD ID SYST; Grieve R, 2010, MED DECIS MAKING, V30, P163, DOI 10.1177/0272989X09341752; Hayes M, 2014, INJ PREV BRIEF PREV; Hindmarch P, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0578-4; Ingram JC, 2012, HEALTH EDUC RES, V27, P258, DOI 10.1093/her/cyr066; Johnston B D, 2000, Inj Prev, V6, P305, DOI 10.1136/ip.6.4.305; Kelly MP, 2004, EVID PRACT METH 1 PR; Kendrick D, 2012, COCHRANE DB SYST REV, V9; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maisey R, 2013, EV CHILDR CENTR ENG; Marshall SW, 1998, JAMA-J AM MED ASSOC, V279, P1633, DOI 10.1001/jama.279.20.1633; National Center for Injury Prevention and Control, 2012, NAT ACT PLAN CHILD I; NESS Research team, 2008, IMP SUR START LOC PR; NESS Research Team, 2010, IMPACT SUR START LOC; Ploubidis G B, 2015, BMC Res Notes, V8, P789, DOI 10.1186/s13104-015-1769-5; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ramey SL, 2000, HEAD START CHILDR EN; Rubin D. B., 2004, MULTIPLE IMPUTATION; RUNYAN CW, 1992, NEW ENGL J MED, V327, P859, DOI 10.1056/NEJM199209173271207; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sethi D, 2008, EUR REP CHILD INJ PR; Stith Sandra, 2006, J Prim Prev, V27, P599, DOI 10.1007/s10935-006-0062-8; Tarullo LB, 1995, HEAD START PROGR PER; Whiteside-Mansell L, 2010, EARLY CHILD EDUC J, V38, P33, DOI 10.1007/s10643-010-0380-6	43	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0172584	10.1371/journal.pone.0172584	http://dx.doi.org/10.1371/journal.pone.0172584			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339460	Green Published, gold, Green Accepted			2022-12-27	WOS:000399116700003
J	Heng, S; Sluydts, V; Durnez, L; Mean, V; Polo, K; Tho, S; Coosemans, M; van Griensven, J				Heng, Somony; Sluydts, Vincent; Durnez, Lies; Mean, Vanna; Polo, Koh; Tho, Sochantha; Coosemans, Marc; van Griensven, Johan			Safety of a topical insect repellent (picaridin) during community mass use for malaria control in rural Cambodia	PLOS ONE			English	Article							EFFICACY; DEET; TOXICITY; NETS	Background While community distribution of topical repellents has been proposed as an additional malaria control intervention, the safety of this intervention at the population level remains poorly evaluated. We describe the safety of mass distribution of the picaridin repellent during a cluster-randomised trial in rural Cambodia in 2012-2013. Methods The repellent was distributed among 57 intervention villages with around 25,000 inhabitants by a team of village distributors. Information on individual adverse events, reported by phone by the village distributors, was obtained through home visits. Information on perceived side effects, reported at the family level, was obtained during two-weekly bottle exchange. Adverse events were classified as adverse reactions (events likely linked to the repellent), cases of repellent abuse and events not related to the repellent use, and classified as per Common Terminology Criteria for Adverse Events. Findings Of the 41 adverse events notified by phone by the village distributors, there were 22 adverse reactions, 11 cases of repellent abuse (6 accidental, 5 suicide attempts) and 8 non-related events. All adverse reactions were mild, occurred in the first few months of use, and mainly manifested as skin conditions. Of the 11 cases of abuse, 2 were moderate and 2 life-threatening. All cases with adverse reactions and repellent abuse recovered completely. 20% of families reported perceived side effects, mainly itching, headache, dizziness and bad smell, but few discontinued repellent use. Conclusions Adverse reactions and abuse during mass use of picaridin were uncommon and generally mild, supporting the safety of the picaridin repellent for malaria control.	[Heng, Somony; Mean, Vanna; Tho, Sochantha] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Heng, Somony; Sluydts, Vincent; Durnez, Lies; Coosemans, Marc; van Griensven, Johan] Inst Trop Med, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Polo, Koh] Banlong Referral Hosp, Ban Lung City, Ratanakiri Prov, Cambodia; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	National Center Parasitology, Entomology & Malaria Control; Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp	van Griensven, J (corresponding author), Inst Trop Med, Antwerp, Belgium.	jvangriensven@itg.be	Sluydts, Vincent/AAU-8776-2020	Sluydts, Vincent/0000-0001-5213-851X	Bill & Melinda Gates Foundation [OPP1032354]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This project was funded by the Bill & Melinda Gates Foundation (grant OPP1032354). All of the repellents used during this study were provided as material support from the company, S. C. Johnson. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Dadzie S, 2013, AM J TROP MED HYG, V88, P309, DOI 10.4269/ajtmh.2012.12-0370; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Frances S.P., 2007, INSECT REPELLENTS PR, P337; Frances S. P., 2007, INSECT REPELLENTS PR, P311; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Jegannathan B, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-47; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; Osimitz TG, 2010, REGUL TOXICOL PHARM, V56, P93, DOI 10.1016/j.yrtph.2009.09.004; ROBBINS PJ, 1986, J TOXICOL ENV HEALTH, V18, P503, DOI 10.1080/15287398609530891; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Somony H, 2015, MALAR J IN PRESS; Strickman D, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P231; Tomenson JA, 2009, INT ARCH OCC ENV HEA, V82, P935, DOI 10.1007/s00420-009-0399-4; Van Roey K, 2014, PLOS NEGLECT TROP D, P8; WHO/HQ GENEVA, 2001, REP 4 WHOP WORK GROU; Wiles D, 2014, J ANAL TOXICOL, V38, P696, DOI 10.1093/jat/bku082; World Health Organization, 2014, COMP HDB WHO GUID PR, V11, P1; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135; Yap HH, 1998, J VECTOR ECOL, V23, P62	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0172566	10.1371/journal.pone.0172566	http://dx.doi.org/10.1371/journal.pone.0172566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339462	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700002
J	Li, JS; Tsai, TY; Felson, DT; Li, GA; Lewis, CL				Li, Jing-Sheng; Tsai, Tsung-Yuan; Felson, David T.; Li, Guoan; Lewis, Cara L.			Six degree-of-freedom knee joint kinematics in obese individuals with knee pain during gait	PLOS ONE			English	Article							GEOMETRIC IMAGE DISTORTION; OSTEOARTHRITIS; WALKING; ADULTS; BIOMECHANICS; ARTIFACTS; MUSCLE; MOTION; CHAIN	Knee joint pain is a common symptom in obese individuals and walking is often prescribed as part of management programs. Past studies in obese individuals have focused on standing alignment and kinematics in the sagittal and coronal planes. Investigation of 6 degree-of-freedom (6DOF) knee joint kinematics during standing and gait is important to thoroughly understand knee function in obese individuals with knee pain. This study aimed to investigate the 6DOF knee joint kinematics in standing and during gait in obese patients using a validated fluoroscopic imaging system. Ten individuals with obesity and knee pain were recruited. While standing, the knee was in 7.4 +/- 6.3 degrees of hyperextension, 2.8 +/- 3.3 degrees of abduction and 5.6 +/- 7.3 degrees of external rotation. The femoral center was located 0.7 +/- 3.1mm anterior and 5.1 +/- 1.5mm medial to the tibial center. During treadmill gait, the sagittal plane motion, i.e., flexion/extension and anterior-posterior translation, showed a clear pattern. Specifically, obese individuals with knee pain maintained the knee in more flexion and more anterior tibial translation during most of the stance phase of the gait cycle and had a reduced total range of knee flexion when compared to a healthy non-obese group. In conclusion, obese individuals with knee pain used hyperextension knee posture while standing, but maintained the knee in more flexion during gait with reduced overall range of motion in the 6DOF analysis.	[Li, Jing-Sheng; Tsai, Tsung-Yuan; Li, Guoan] Harvard Med Sch, Massachusetts Gen Hosp, Dept Orthopaed Surg, Bioengn Lab, Boston, MA USA; [Li, Jing-Sheng; Lewis, Cara L.] Boston Univ, Sargent Coll, Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; [Felson, David T.; Lewis, Cara L.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Felson, David T.] Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Boston University; University of Manchester	Lewis, CL (corresponding author), Boston Univ, Sargent Coll, Coll Hlth & Rehabil Sci, Boston, MA 02215 USA.; Lewis, CL (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA.	lewisc@bu.edu		Tsai, Tsung-Yuan/0000-0003-1522-2987	National Institutes of Health [P60AR47785, AR063235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR063235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health, P60AR47785, to David T Felson and the National Institutes of Health, AR063235, to Cara L Lewis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani KS, 2002, DISABIL REHABIL, V24, P275, DOI 10.1080/09638280110087098; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Blaszczyk JW, 2011, ACTA NEUROBIOL EXP, V71, P528; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Bytyqi D, 2014, INT ORTHOP, V38, P1191, DOI 10.1007/s00264-014-2312-3; Cappozzo A, 1996, CLIN BIOMECH, V11, P90, DOI 10.1016/0268-0033(95)00046-1; de Souza SAF, 2005, OBES SURG, V15, P1238, DOI 10.1381/096089205774512627; Duffell LD, 2014, GAIT POSTURE, V39, P1057, DOI 10.1016/j.gaitpost.2014.01.005; Fryar C.D., 2014, PREVALENCE OVERWEIGH; Gronenschild E, 1997, MED PHYS, V24, P1875, DOI 10.1118/1.598101; Gronenschild E, 1999, MED PHYS, V26, P2602, DOI 10.1118/1.598800; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Haight DJ, 2014, J ORTHOP RES, V32, P324, DOI 10.1002/jor.22497; Henriksen M, 2010, ARTHRIT CARE RES, V62, P501, DOI 10.1002/acr.20033; Jalai CM, 2016, SPINE J OFFICIAL J N; Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; Kozanek M, 2009, J BIOMECH, V42, P1877, DOI 10.1016/j.jbiomech.2009.05.003; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Lerner ZF, 2014, MED SCI SPORT EXER, V46, P1261, DOI 10.1249/MSS.0000000000000218; Li GA, 2008, J BIOMECH, V41, P1616, DOI 10.1016/j.jbiomech.2008.01.034; Li Jing-ji, 2013, J CONTROL SCI ENG, V2013, P4, DOI DOI 10.1155/2013/657182.74; Loudon JK, 1998, J ORTHOP SPORT PHYS, V27, P361, DOI 10.2519/jospt.1998.27.5.361; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; McMillan AG, 2010, GAIT POSTURE, V32, P263, DOI 10.1016/j.gaitpost.2010.05.008; Messier SP, 2010, CLIN GERIATR MED, V26, P461, DOI 10.1016/j.cger.2010.05.001; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Peters A, 2010, GAIT POSTURE, V31, P1, DOI 10.1016/j.gaitpost.2009.09.004; Poirier Paul, 2001, Cardiology Clinics, V19, P459, DOI 10.1016/S0733-8651(05)70229-0; Sheehan KJ, 2013, CLIN BIOMECH, V28, P337, DOI 10.1016/j.clinbiomech.2013.01.007; Sturmer T, 2000, J CLIN EPIDEMIOL, V53, P307, DOI 10.1016/S0895-4356(99)00162-6; Tsai TY, 2013, J BIOMECH, V46, P1300, DOI 10.1016/j.jbiomech.2013.02.010; Tsai TY, 2011, J BIOMECH, V44, P1182, DOI 10.1016/j.jbiomech.2011.01.009; Vismara L, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-14; World Health Organization, WORLD HLTH STAT REP	36	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174663	10.1371/journal.pone.0174663	http://dx.doi.org/10.1371/journal.pone.0174663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339477	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700035
J	Maraux, B; Lissouba, P; Rain-Taljaard, R; Taljaard, D; Bouscaillou, J; Lewis, D; Puren, A; Auvert, B				Maraux, Barbara; Lissouba, Pascale; Rain-Taljaard, Reathe; Taljaard, Dirk; Bouscaillou, Julie; Lewis, David; Puren, Adrian; Auvert, Bertran			Women's knowledge and perception of male circumcision before and after its roll-out in the South African township of Orange Farm from community-based cross-sectional surveys	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HIV PREVENTION; RANDOMIZED-TRIAL; MEN; INTERVENTION; KISUMU; UGANDA; KENYA; RAKAI; RISK	The roll-out of medical male circumcision (MC) is progressing in Southern and Eastern Africa. Little is known about the effect of this roll-out on women. The objective of this study was to assess the knowledge and perceptions of women regarding MC in a setting before and after the roll-out. This study was conducted in the South African township of Orange Farm where MC prevalence among men increased from 17% to 53% in the period 2008-2010. Data from three community-based cross sectional surveys conducted in 2007, 2010 and 2012 among 1258, 1197 and 2583 adult women, respectively were studied. In 2012, among 2583 women, 73.7% reported a preference for circumcised partners, and 87.9% knew that circumcised men could become infected with HIV. A total of 95.8% preferred to have their male children circumcised. These three proportions increased significantly during the roll-out. In 2007, the corresponding values were 64.4%, 82.9% and 80.4%, respectively. Among 2581 women having had sexual intercourse with circumcised and uncircumcised men, a majority (55.8%, 1440/2581) agreed that it was easier for a circumcised man to use a condom, 20.5% (530/2581) disagreed; and 23.07 (611/2581) did not know. However, some women incorrectly stated that they were fully (32/2579; 1.2%; 95%)CI: 0.9% to 1.7%) or partially (233/2579; 9.0%; 95%CI: 8.0% to 10.2%) protected when having unprotected sex with a circumcised HIV-positive partner. This study shows that the favorable perception of women and relatively correct knowledge regarding VMMC had increased during the rollout of VMMC. When possible, women should participate in the promotion of VMMC although further effort should be made to improve their knowledge.	[Maraux, Barbara; Auvert, Bertran] INSERM U1018, Villejuif, France; [Lissouba, Pascale] Med Sans Frontieres, Paris, France; [Rain-Taljaard, Reathe] Progressus Res & Dev, Johannesburg, South Africa; [Taljaard, Dirk] CHAPS, Johannesburg, South Africa; [Bouscaillou, Julie] Med Monde, Paris, France; [Lewis, David] Western Sydney Sexual Hlth Ctr, Parramatta, Australia; [Lewis, David] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Lewis, David] Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW, Australia; [Puren, Adrian] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Auvert, Bertran] Hop Ambroise Pare, AP HP, Boulogne, France; [Auvert, Bertran] Univ Versailles St Quentin, Versailles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Doctors Without Borders; University of Sydney; University of Sydney; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Auvert, B (corresponding author), INSERM U1018, Villejuif, France.; Auvert, B (corresponding author), Hop Ambroise Pare, AP HP, Boulogne, France.; Auvert, B (corresponding author), Univ Versailles St Quentin, Versailles, France.	bertran.auvert@uvsq.fr	Lissouba, Pascale/ABB-8815-2021; Puren, Adrian/W-1679-2018; Puren, Adrian/AAC-2065-2020	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Lewis, David/0000-0002-5534-8392; Lissouba, Pascale/0000-0002-4751-6894	ANRS France [12126, 12285]; Sidaction France [AP-FPB-2011/01]	ANRS France(ANRS); Sidaction France	This work was supported by ANRS France (grants 12126 and 12285), Sidaction France (grant AP-FPB-2011/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STUD METH SER F, V98, P113; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kigozi G, 2009, BJU INT, V104, P1698, DOI 10.1111/j.1464-410X.2009.08683.x; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Lissouba P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-253; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Mantell JE, 2013, SEX HEALTH, V10, P112, DOI 10.1071/SH12067; National Department of Health P, 2011, 2010 NAT ANT SENT HI, P50; Team RDC, 2005, R LANG ENV STAT COMP; Thomas AG, 2012, J ACQ IMMUN DEF SYND, V60, P88; Umar E, 2013, MALAWI MED J, V25, P72; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 1998, LOOK DEEP HIV EP QUE, P1; UNAIDS-WHO, 2008, OP GUID SCAL MAL CIR; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2006, ACCEPTABILITY MALE C; WHO-UNAIDS, 2007, TECH CONS MAL CIRC H	24	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173595	10.1371/journal.pone.0173595	http://dx.doi.org/10.1371/journal.pone.0173595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339497	Green Published, gold			2022-12-27	WOS:000399116700007
J	Eyler, DE; Burnham, KA; Wilson, TE; O'Brien, PJ				Eyler, Daniel E.; Burnham, Kylie A.; Wilson, Thomas E.; O'Brien, Patrick J.			Mechanisms of glycosylase induced genomic instability	PLOS ONE			English	Article							BASE EXCISION-REPAIR; 3-METHYLADENINE DNA GLYCOSYLASE; MISMATCH REPAIR; MICROSATELLITE INSTABILITY; MUTATION-RATE; ABASIC SITES; SUBSTRATE-SPECIFICITY; POLYMERASE-DELTA; YEAST; PREVENT	Human alkyladenine DNA glycosylase (AAG) initiates base excision repair (BER) to guard against mutations by excising alkylated and deaminated purines. Counterintuitively, increased expression of AAG has been implicated in increased rates of spontaneous mutation in microsatellite repeats. This microsatellite mutator phenotype is consistent with a model in which AAG excises bulged (unpaired) bases, altering repeat length. To directly test the role of base excision in AAG-induced mutagenesis, we conducted mutation accumulation experiments in yeast overexpressing different variants of AAG and detected mutations via high-depth genome resequencing. We also developed a new software tool, hp_caller, to perform accurate genotyping at homopolymeric repeat loci. Overexpression of wild-type AAG elevated indel mutations in homopolymeric sequences distributed throughout the genome. However, catalytically inactive variants (E125Q/E125A) caused equal or greater increases in frameshift mutations. These results disprove the hypothesis that base excision is the key step in mutagenesis by overexpressed wild-type AAG. Instead, our results provide additional support for the previously published model wherein overexpressed AAG interferes with the mismatch repair (MMR) pathway. In addition to the above results, we observed a dramatic mutator phenotype for N169S AAG, which has increased rates of excision of undamaged purines. This mutant caused a 10-fold increase in point mutations at G:C base pairs and a 50-fold increase in frameshifts in A:T homopolymers. These results demonstrate that it is necessary to consider the relative activities and abundance of many DNA replication and repair proteins when considering mutator phenotypes, as they are relevant to the development of cancer and its resistance to treatment.	[Eyler, Daniel E.; Burnham, Kylie A.; O'Brien, Patrick J.] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wilson, Thomas E.] Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI 48109 USA; [Wilson, Thomas E.] Univ Michigan, Med Sch, Dept Human Genet, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu		Eyler, Daniel/0000-0002-6425-9770	American Cancer Society [RSG-11-148-01-DMC]; National Institutes of Health [R01 GM108022]; National Cancer Institute of the National Institutes of Health [P30CA046592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108022] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the American Cancer Society (RSG-11-148-01-DMC) and the National Institutes of Health (R01 GM108022). The University of Michigan DNA sequencing core receives support from the National Cancer Institute of the National Institutes of Health (P30CA046592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner CW, 2001, J BIOL CHEM, V276, P13379, DOI 10.1074/jbc.M010641200; Auerbach P, 2005, PNAS, V102, P17771; Auerbach PA, 2010, MUTAGENESIS, V25, P63, DOI 10.1093/mutage/gep045; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Boland CR, 2013, HIST LYNCH SYNDROME; Branum ME, 2001, J BIOL CHEM, V276, P25421, DOI 10.1074/jbc.M101032200; Calvo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003413; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Cerda SR, 1998, FEBS LETT, V431, P12, DOI 10.1016/S0014-5793(98)00697-8; Chan K, 2013, DNA REPAIR, V12, P878, DOI 10.1016/j.dnarep.2013.07.008; Chan K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003149; Connor EE, 2005, CHEM RES TOXICOL, V18, P87, DOI 10.1021/tx049822q; Connor EE, 2002, CHEM BIOL, V9, P1033, DOI 10.1016/S1074-5521(02)00215-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Fox EJ, 2013, CANCER METAST REV, V32, P353, DOI 10.1007/s10555-013-9426-8; Galick HA, 2013, P NATL ACAD SCI USA, V110, P14314, DOI 10.1073/pnas.1306752110; GIBBS PEM, 1995, J MOL BIOL, V251, P229, DOI 10.1006/jmbi.1995.0430; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Gragg H, 2002, MOL CELL BIOL, V22, P8756, DOI 10.1128/MCB.22.24.8756-8762.2002; Greene C, 1997, MOL CELL BIOL, V17; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hendershot JM, 2014, NUCLEIC ACIDS RES, V42, P12681, DOI 10.1093/nar/gku919; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Lang GI, 2013, MUTATION RATES SPECT; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Li H, 2011, BIOINFORMATICS, P1; LOEB LA, 1994, CANCER RES, V54, P5059; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Lujan SA, 2015, NUCLEIC ACIDS RES, V43, P4067, DOI 10.1093/nar/gkv271; Lujan SA, 2014, GENOME RES, V24, P1751, DOI 10.1101/gr.178335.114; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lyons DM, 2010, J BIOL CHEM, V285, P25203, DOI 10.1074/jbc.M110.118596; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Ma W, 2011, PLOS GENET, V7; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Ma WJ, 2009, MOL CELL BIOL, V29, P1212, DOI 10.1128/MCB.01499-08; Madhukar NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117131; Maiti A, 2012, P NATL ACAD SCI USA, V109, P8091, DOI 10.1073/pnas.1201010109; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; Nishant KT, 2009, BIOESSAYS, V31, P912, DOI 10.1002/bies.200900017; O'Brien PJ, 2006, CHEM REV, V106, P720, DOI 10.1021/cr040481v; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Serero A, 2014, P NATL ACAD SCI, V111; Sjolund A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004753; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tran HT, 1999, GENETICS, V152, P47; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; VICKERS MA, 1993, P NATL ACAD SCI USA, V90, P3437, DOI 10.1073/pnas.90.8.3437; Xiao W, 2001, MUTAT RES-DNA REPAIR, V487, P137, DOI 10.1016/S0921-8777(01)00113-6; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Zhai J, 2010, P NATL ACAD SCI USA, V107, P680, DOI 10.1073/pnas.0908302107; Zhang YR, 2015, ACS CHEM BIOL, V10, P2606, DOI 10.1021/acschembio.5b00409; Zhu YO, 2014, P NATL ACAD SCI USA, V111, pE2310, DOI 10.1073/pnas.1323011111	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174041	10.1371/journal.pone.0174041	http://dx.doi.org/10.1371/journal.pone.0174041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333944	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200039
J	Haavik, LJ; Dodds, KJ; Allison, JD				Haavik, Laurel J.; Dodds, Kevin J.; Allison, Jeremy D.			Suitability of eastern pines for oviposition and survival of Sirex noctilio F	PLOS ONE			English	Article							WOODWASPS HYMENOPTERA-SIRICIDAE; PINUS-RADIATA; BIOLOGICAL-CONTROL; PREFERENCE; PERFORMANCE; COLEOPTERA; BEHAVIOR; ECOLOGY; LARVAL; PARASITOIDS	The European woodwasp, Sirex noctilio F., is a pest of pines in many areas around the world. Since its introduction to North America, the distribution of S. noctilio overlaps with a known host (Pinus sylvestris) and hosts native to North America. Direct comparisons of suitability for oviposition and larval survival among these pines have not been made. We tested the relative suitability of four common pine species in northeastern North America (P. sylvestris, P. resinosa, P. banksiana, and P. strobus) as hosts for S. noctilio in a controlled, but in situ experiment. In a mixed pine forest in northern Ontario, we caged S. noctilio mating pairs on 10 freshly cut pine logs of each species, and estimated oviposition, counted adult S. noctilio (F1 generation) that emerged from logs, and calculated survivorship from egg to adult. Pinus sylvestris and P. resinosa were optimal hosts according to all three metrics of S. noctilio performance. Pinus strobus was a suitable larval host, but was not perceived as such by females, as evidenced by lower oviposition. Pinus banksiana was perceived as a suitable host by females, but was the least suitable larval host. Our results suggest that P. sylvestris and P. resinosa are more suitable hosts, at least in cut logs, than P. strobus and P. banksiana for S. noctilio in eastern North America.	[Haavik, Laurel J.; Allison, Jeremy D.] Nat Resources Canada, Great Lakes Forestry Ctr, Canadian Forest Serv, Sault Ste Marie, Sault Ste Marie, ON, Canada; [Dodds, Kevin J.] USDA, Forest Serv, Forest Hlth Protect, Durham, NH USA	Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; United States Department of Agriculture (USDA); United States Forest Service	Haavik, LJ (corresponding author), Nat Resources Canada, Great Lakes Forestry Ctr, Canadian Forest Serv, Sault Ste Marie, Sault Ste Marie, ON, Canada.	lhaavik@fs.fed.us	Allison, Jeremy/AAQ-1461-2020	Allison, Jeremy/0000-0002-0765-3149	Natural Resources Canada; Ontario Ministry of Natural Resources; USDA Forest Service-Forest Health Protection; USDA Forest Service	Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Ontario Ministry of Natural Resources; USDA Forest Service-Forest Health Protection(United States Department of Agriculture (USDA)United States Forest Service); USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	Authors thank Sarah Drabble, Reg Nott, Nick Boyonoski, Sarah Crispell, Katelyn Kotska, Chanel Fall, Cydney Mihell, Brett Marshall, and Shannon Escasa for field and lab assistance and Al Foley for access to the Ontario Tree Seed Facility. This work was funded in part by Natural Resources Canada, The Ontario Ministry of Natural Resources, and the USDA Forest Service-Forest Health Protection.r This work was supported by the Natural Resources Canada, Ontario Ministry of Natural Resources and the USDA Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ayres MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090321; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; Boroczky K, 2012, J CHEM ECOL, V38, P213, DOI 10.1007/s10886-012-0077-y; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Corley JC, 2010, J INSECT BEHAV, V23, P431, DOI 10.1007/s10905-010-9226-8; COUTTS M P, 1969, Australian Forest Research, V4, P29; COUTTS MP, 1969, AUST J BIOL SCI, V22, P915, DOI 10.1071/BI9690915; COUTTS MP, 1969, FOREST SCI, V15, P412; Coutts MP, 1966, POLYPHENOLS RESIN RE; Coyle DR, 2012, ENVIRON ENTOMOL, V41, P731, DOI 10.1603/EN11280; Coyle DR, 2012, ENVIRON ENTOMOL, V41, P91, DOI 10.1603/EN11192; de Groot Peter, 2006, Great Lakes Entomologist, V39, P49; Dodds KJ, 2010, CAN J FOREST RES, V40, P212, DOI 10.1139/X09-181; DONLEY DE, 1978, ANN ENTOMOL SOC AM, V71, P496, DOI 10.1093/aesa/71.4.496; Eager PT, 2011, ENVIRON ENTOMOL, V40, P1266, DOI 10.1603/EN10322; Erbilgin N, 2017, J CHEM ECOL IN PRESS; Fischbein D, 2012, ECOL ENTOMOL, V37, P161, DOI 10.1111/j.1365-2311.2012.01350.x; Flaherty L, 2013, ECOL ENTOMOL, V38, P546, DOI 10.1111/een.12045; Foelker CJ, 2016, ECOL ENTOMOL, V41, P676, DOI 10.1111/een.12342; Foelker CJ, 2016, CAN ENTOMOL, V148, P532, DOI 10.4039/tce.2016.6; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Haavik LJ, 2016, AGR FOREST ENTOMOL, V18, P357, DOI 10.1111/afe.12167; Haavik LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138516; HANKS LM, 1993, OECOLOGIA, V95, P22, DOI 10.1007/BF00649502; HILLIS WE, 1968, PHYTOCHEMISTRY, V7, P13, DOI 10.1016/S0031-9422(00)88199-6; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Hurley BP, 2007, AGR FOREST ENTOMOL, V9, P159, DOI 10.1111/j.1461-9563.2007.00340.x; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Lombardero MJ, 2016, B ENTOMOL RES, V106, P569, DOI 10.1017/S0007485316000043; Madden J.L., 1988, P407; MADDEN JL, 1974, AUST J ZOOL, V22, P341, DOI 10.1071/ZO9740341; MADDEN JL, 1971, B ENTOMOL RES, V60, P467, DOI 10.1017/S0007485300040414; Madden JL, 1979, INSECT FUNGUS SYMBIO, P288; Marshall JM, 2013, AM MIDL NAT, V169, P179, DOI 10.1674/0003-0031-169.1.179; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; Morewood WD, 2003, ENVIRON ENTOMOL, V32, P1028, DOI 10.1603/0046-225X-32.5.1028; Nahrung HF, 2016, FORESTRY, V89, P310, DOI 10.1093/forestry/cpv039; RAWLINGS G. B., 1949, NEW ZEALAND JOUR FOREST, V6, P20; Rawlings G. B., 1948, New Zealand Journal of Forestry, V5, P411; Rigsby CM, 2014, ANN ENTOMOL SOC AM, V107, P773, DOI 10.1603/AN13185; Ryan K, 2012, ENVIRON ENTOMOL, V41, P289, DOI 10.1603/EN11275; Ryan K, 2013, CAN ENTOMOL, V145, P117, DOI 10.4039/tce.2012.96; Ryan K, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P15, DOI 10.1007/978-94-007-1960-6_2; SIMPSON RF, 1976, ENTOMOL EXP APPL, V19, P205, DOI 10.1007/BF00302055; SIMPSON RF, 1976, ENTOMOL EXP APPL, V19, P11, DOI 10.1007/BF00304482; Skilling DD, 1990, USDA FOREST SERVICE, V654, P1383; SPRADBERY JP, 1978, B ENTOMOL RES, V68, P341, DOI 10.1017/S0007485300009330; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; TAYLOR KL, 1978, OECOLOGIA, V32, P1, DOI 10.1007/BF00344686; Thompson BM, 2014, ANN ENTOMOL SOC AM, V107, P453, DOI 10.1603/AN13128; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zylstra KE, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.8301	55	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174532	10.1371/journal.pone.0174532	http://dx.doi.org/10.1371/journal.pone.0174532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334011	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200109
J	Verspyck, E; de Vienne, C; Muszynski, C; Bubenheim, M; Chanavaz-Lacheray, I; Dreyfus, M; Deruelle, P; Benichou, J				Verspyck, Eric; de Vienne, Claire; Muszynski, Charles; Bubenheim, Michael; Chanavaz-Lacheray, Isabella; Dreyfus, Michel; Deruelle, Philippe; Benichou, Jacques			Maintenance nifedipine therapy for preterm symptomatic placenta previa: A randomized, multicenter, double-blind, placebo-controlled trial	PLOS ONE			English	Article							EXPECTANT MANAGEMENT; TOCOLYTIC THERAPY; 3RD TRIMESTER; UNITED-STATES; DELIVERY; ACCRETA; LABOR	Objective To assess the impact of maintenance nifedipine therapy on pregnancy duration in women with preterm placenta previa bleeding. Methods PPADAL was a randomized, double-blind, placebo-controlled trial conducted between 05/2008 and 05/2012 in five French hospitals. The trial included 109 women, aged >= 18 years, with at least one episode of placenta previa bleeding, intact membranes and no other pregnancy complication, at gestational age 24 to 34 weeks and after 48 hours of complete acute tocolysis. Women were randomly allocated to receive either 20 mg of slow-release nifedipine three times daily (n = 54) or placebo (n = 55) until 36 + 6 weeks of gestation. The primary outcome for the trial was length of pregnancy measured in days after enrolment. Main secondary outcomes were rates of recurrent bleeding, cesarean delivery due to hemorrhage, blood transfusion, maternal side effects, gestational age at delivery and adverse perinatal outcomes (perinatal death, chronic lung disease, neonatal sepsis, intraventricular hemorrhage > grade 2, perventricular leukomalacia > grade 1, or necrotizing enterocolitis). Analysis was by intention to treat. Results Mean (SD) prolongation of pregnancy was not different between the nifedipine (n = 54) and the placebo (n = 55) group; 42.5 days +/- 23.8 versus 44.2 days +/- 24.5, p = 0.70. Cesarean due to hemorrhage performed before 37 weeks occurred more frequently in the nifedipine group in comparison with the placebo group (RR, 1.66; 95% confidence interval, 1.05 - 2.72). Adverse perinatal outcomes were comparable between groups; 3.8% for nifedipine versus 5.5% for placebo (relative risk, 0.52; 95% confidence interval 0.10 - 2.61). No maternal mortality or perinatal death occurred. Conclusion Maintenance oral nifedipine neither prolongs duration of pregnancy nor improves maternal or perinatal outcomes.	[Verspyck, Eric] Rouen Univ Hosp, Dept Obstet & Gynecol, Rouen, France; [de Vienne, Claire; Dreyfus, Michel] Caen Univ Hosp, Dept Obstet & Gynecol, Caen, France; [Muszynski, Charles] Amiens Univ Hosp, Dept Obstet & Gynecol, Amiens, France; [Bubenheim, Michael] Rouen Univ Hosp, Dept Biostat, Rouen, France; [Chanavaz-Lacheray, Isabella] Belvedere Hosp, Dept Obstet & Gynecol, Mont St Aignan, France; [Deruelle, Philippe] Lille Univ, Dept Obstet & Gynecol, EA Environm Perinatal & Sante 4489, Lille, France; [Benichou, Jacques] Univ Rouen & Biostat, INSERM, U657, Rouen, France	CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Rouen; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Verspyck, E (corresponding author), Rouen Univ Hosp, Dept Obstet & Gynecol, Rouen, France.	eric.verspyck@chu-rouen.fr			clinical research program for hospitals (PHRC) of the French Health Ministry	clinical research program for hospitals (PHRC) of the French Health Ministry	This study was only funded by the clinical research program for hospitals (PHRC) of the French Health Ministry. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also confirm that no authors received a salary from the funders.	Ananth CV, 2003, AM J OBSTET GYNECOL, V188, P1299, DOI 10.1067/mob.2003.76; BESINGER RE, 1995, AM J OBSTET GYNECOL, V172, P1770, DOI 10.1016/0002-9378(95)91410-2; Bhide A, 2003, BJOG-INT J OBSTET GY, V110, P860, DOI 10.1111/j.1471-0528.2003.02491.x; Bose DA, 2011, AM J PERINAT, V28, P45, DOI 10.1055/s-0030-1262510; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; IYASU S, 1993, AM J OBSTET GYNECOL, V168, P1424, DOI 10.1016/S0002-9378(11)90776-5; Kayem G, 2014, J GYNECOL OBST BIO R, V43, P1142, DOI 10.1016/j.jgyn.2014.10.007; Kayem G, 2004, OBSTET GYNECOL, V104, P531, DOI 10.1097/01.AOG.0000136086.78099.0f; King JF, 2007, COCHRANE DB SYST REV; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Love CDB, 1996, BRIT J OBSTET GYNAEC, V103, P864, DOI 10.1111/j.1471-0528.1996.tb09903.x; MAGANN EF, 1993, AUST NZ J OBSTET GYN, V33, P22, DOI 10.1111/j.1479-828X.1993.tb02045.x; Oppenheimer LW, 2009, AM J OBSTET GYNECOL, V201, P227, DOI 10.1016/j.ajog.2009.06.010; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Predanic M, 2005, J ULTRAS MED, V24, P773, DOI 10.7863/jum.2005.24.6.773; Roos C, 2013, JAMA-J AM MED ASSOC, V309, P41, DOI 10.1001/jama.2012.153817; Royal College of Obstetricians and Gynecologists, 2011, PLAC PRAEV PLAC PRAE; Sayin NC, 2004, J PERINAT MED, V32, P220, DOI 10.1515/JPM.2004.041; Sharma A, 2004, INT J GYNECOL OBSTET, V84, P109, DOI 10.1016/S0020-7292(03)00198-X; SILVER R, 1984, AM J OBSTET GYNECOL, V150, P15, DOI 10.1016/S0002-9378(84)80102-7; Wing DA, 1996, AM J OBSTET GYNECOL, V175, P806, DOI 10.1016/S0002-9378(96)80003-2; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074	22	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173717	10.1371/journal.pone.0173717	http://dx.doi.org/10.1371/journal.pone.0173717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333939	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200023
J	Yanez, AM; Leiva, A; Estela, A; Cukic, I				Yanez, Aina M.; Leiva, Alfonso; Estela, Andreu; Cukic, Iva			The associations of personality traits and parental education with smoking behaviour among adolescents	PLOS ONE			English	Article							MAJOR RISK-FACTORS; SOCIOECONOMIC-STATUS; HEALTH BEHAVIORS; MULTILEVEL ANALYSIS; 5-FACTOR MODEL; INEQUALITIES; QUESTIONNAIRE; CONTRIBUTORS; MORTALITY; FAMILY	We examined whether personality traits and parental education are associated with smoking initiation in a sample of Spanish secondary school students. Participants, taken from the ITACA study (842 adolescents aged 14 - 15 years), completed a questionnaire assessing personality traits of the Five Factor Model, smoking behaviours and parental education. Multinomial logistic regression models controlling for age and sex were used to determine the independent associations and interactions of personality traits and parental education with risk of ever trying smoking, as well as with being a regular smoker in adolescence. Higher conscientiousness was related to a lower chance of trying smoking at least once (OR = 0.57, 95% CIs = 0.46, 0.71) as well as being a regular smoker (OR = 0.39, 95% CIs = 0.27, 0.55). Higher emotional instability (neuroticism) was associated with higher risk of being in either smoking category (OR = 1.33, 95% CIs = 1.10, 1.60 and OR = 1.76, 95% CIs = 1.31, 2.35, respectively). Higher extraversion was also associated with a higher risk of both types of smoking behaviour (OR = 1.38, 95% CIs = 1.12, 1.70 and OR = 2.43 (1.67, 3.55, respectively). Higher parental education was significantly related to lower risk of being a regular smoker (OR = 0.70, 95% CIs = 0.54, 0.89), but not with trying smoking in the past. Finally, we found no evidence of the interactions between adolescents' personality and parental education in predicting adolescent smoking behaviours. We conclude that personality factors and parental education are important and independent factors associated with smoking behaviour in adolescents.	[Yanez, Aina M.; Leiva, Alfonso] Inst Invest Sanitaria Palma IdISPa, Mallorca, Spain; [Yanez, Aina M.] Univ Illes Balears, Res Grp Evidence Lifestyles & Hlth, Mallorca, Spain; [Leiva, Alfonso] Baleares Hlth Serv IbSalut, Primary Care Res Unit Mallorca, Mallorca, Spain; [Estela, Andreu] Baleares Hlth Serv IbSalut, Dalt St Joan Hlth Ctr, Menorca, Spain; [Cukic, Iva] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Cukic, Iva] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland	Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; Atencio Primaria de Mallorca; Atencio Primaria de Menorca; University of Edinburgh; University of Edinburgh	Cukic, I (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.; Cukic, I (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.	iva.cukic@ed.ac.uk	Cukic, Iva/HGE-8252-2022; Yañez, Aina M/AAF-7087-2021; Leiva, Alfonso/ABF-1361-2020	Yañez, Aina M/0000-0001-8527-3937; leiva, Alfonso/0000-0001-5306-8533; Cukic, Iva/0000-0002-2010-1648	Health Research Funds of the "Instituto de Salud Carlos III" from Spanish Government [P10/00517]; European Union ERDF funds; Health Promotion and Preventive Activities-Primary Health Care Network [ISCIII-RETCI G03/170, RD06/0018]	Health Research Funds of the "Instituto de Salud Carlos III" from Spanish Government; European Union ERDF funds(European Commission); Health Promotion and Preventive Activities-Primary Health Care Network	This project was funded by Health Research Funds of the "Instituto de Salud Carlos III" from Spanish Government (P10/00517) co-financed with European Union ERDF funds. The work is also being supported by the Health Promotion and Preventive Activities-Primary Health Care Network, which is sustained by the Ministry of Health of Spain (ISCIII-RETCI G03/170 and RD06/0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the participants, schools, and all those involved in the "ITACA" study. This Project was funded by a Health Research Funds of the "Instituto de Salud Carlos III" from Spanish Government (P10/00517) co-financed with European Union ERDF funds. The work is also being supported by the Health Promotion and Preventive Activities-Primary Health Care Network, which is sustained by the Ministry of Health of Spain (ISCIII-RETCI G03/170 and RD06/0018).	[Anonymous], 2012, DEL GOB PLAN NAC DRO; [Anonymous], 2015, WHO REP GLOB TOB EP; Barbaranelli C, 2003, PERS INDIV DIFFER, V34, P645, DOI 10.1016/S0191-8869(02)00051-X; Barbaranelli C, 2008, PERS INDIV DIFFER, V44, P876, DOI 10.1016/j.paid.2007.10.014; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Chapman B, 2009, ANN BEHAV MED, V38, P237, DOI 10.1007/s12160-009-9142-3; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; Conner M, 2009, PSYCHOL HEALTH, V24, P1085, DOI 10.1080/08870440802239192; de Leeuw RNH, 2010, J FAM PSYCHOL, V24, P68, DOI 10.1037/a0018182; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Doku D, 2010, J ADOLESCENT HEALTH, V47, P479, DOI 10.1016/j.jadohealth.2010.03.012; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Jonassaint CR, 2011, INT J BEHAV MED, V18, P13, DOI 10.1007/s12529-009-9069-x; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kendler KS, 2013, AM J PSYCHIAT, V170, P408, DOI 10.1176/appi.ajp.2012.12030321; Lantz PM, 2003, TOB CONTROL, V12, pI60, DOI 10.1136/tc.12.suppl_1.i60; Leiva A, 2014, BMC PUBLIC HEALTH, V14, P1; Lopez-Gonzalez AA, 2015, GAC SANIT, V29, P27, DOI 10.1016/j.gaceta.2014.08.004; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Mercado A, 2016, INT J MENT HEALTH AD, V14, P907, DOI 10.1007/s11469-016-9639-5; Ministerio de Sanidad y Consumo, 2015, ENC NAC SAL; Moor I, 2015, EUR J PUBLIC HEALTH, V25, P457, DOI 10.1093/eurpub/cku244; Moore GF, 2015, J SCHOOL HEALTH, V85, P267, DOI 10.1111/josh.12242; Muris P, 2005, PERS INDIV DIFFER, V38, P1757, DOI 10.1016/j.paid.2004.11.018; Nandi A, 2014, EPIDEMIOLOGY, V25, P170, DOI 10.1097/EDE.0000000000000038; Ortiz MAC, 2005, PSICOTHEMA, V17, P286; Otten R, 2008, SUBST USE MISUSE, V43, P341, DOI 10.1080/10826080701202833; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Turiano NA, 2015, HEALTH PSYCHOL, V34, P51, DOI 10.1037/hea0000038; Valdivieso E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-665; Zvolensky MJ, 2015, J PSYCHIATR RES, V63, P91, DOI 10.1016/j.jpsychires.2015.02.008	37	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174211	10.1371/journal.pone.0174211	http://dx.doi.org/10.1371/journal.pone.0174211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333969	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200063
J	Bernard, A; Rowe, F; Bell, M; Ueffing, P; Charles-Edwards, E				Bernard, Aude; Rowe, Francisco; Bell, Martin; Ueffing, Philipp; Charles-Edwards, Elin			Comparing internal migration across the countries of Latin America: A multidimensional approach	PLOS ONE			English	Article							POPULATION-DISTRIBUTION; AGE PROFILES; ISSUES	While considerable progress has been made in understanding the way particular aspects of internal migration, such as its intensity, age profile and spatial impact, vary between countries around the world, little attention to date has been given to establishing how these dimensions of migration interact in different national settings. We use recently developed measures of internal migration that are scale-independent to compare the overall intensity, age composition, spatial impact, and distance profile of internal migration in 19 Latin American countries. Comparisons reveal substantial cross-national variation but cluster analysis suggests the different dimensions of migration evolve systematically to form a broad sequence characterised by low intensities, young ages at migration, unbalanced flows and high friction of distance at lower levels of development, trending to high intensities, an older age profile of migration, more closely balanced flows and lower friction of distance at later stages of development. However, the transition is not linear and local contingencies, such as international migration and political control, often distort the migration-development nexus, leading to unique migration patterns in individual national contexts.	[Bernard, Aude; Bell, Martin; Charles-Edwards, Elin] Univ Queensland, Brisbane, Qld, Australia; [Rowe, Francisco] Univ Liverpool, Liverpool, Merseyside, England; [Ueffing, Philipp] United Nations Populat Div, New York, NY USA	University of Queensland; University of Liverpool	Bernard, A (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	a.bernard@uq.edu.au	Bernard, Aude/GWV-0498-2022; Rowe, Francisco/Q-7011-2019	Bernard, Aude/0000-0001-7388-4562; Rowe, Francisco/0000-0003-4137-0246; Ueffing, Philipp/0000-0002-3847-0951; Charles-Edwards, Elin/0000-0003-2580-207X	Australian Research Council under ARCD is covery Project [DP110101363]	Australian Research Council under ARCD is covery Project(Australian Research Council)	The work reported in this article forms part of the IMAGE project support by the Australian Research Council under ARCD is covery Project (DP110101363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amaral E. F. L., 2013, ENCY GLOBAL HUMAN MI; Aroca P, 2005, WORLD BANK ECON REV, V19, P449, DOI 10.1093/wber/lhi017; Aroca P, 2013, ADV SPAT SCI, P341, DOI 10.1007/978-3-642-39674-8_15; Bell M, 2002, J R STAT SOC A STAT, V165, P435, DOI 10.1111/1467-985X.t01-1-00247; Bell M, 2015, IMAGE INVENTORY USER; Bell M., 2014, IMAGE REPOSITORY USE; Bell M., 2009, HUMAN DEV RES PAPER, V30; Bell M, 2015, POPUL DEV REV, V41, P33, DOI 10.1111/j.1728-4457.2015.00025.x; Bell M, 2015, POPUL SPACE PLACE, V21, P1, DOI 10.1002/psp.1848; Bernard A, 2014, EUR POP C 25 28 JUN; Bernard A, 2015, DEMOGR RES, V32, P915, DOI 10.4054/DemRes.2015.32.33; Bernard A, 2014, POPUL DEV REV, V40, P213, DOI 10.1111/j.1728-4457.2014.00671.x; Bernard A, 2014, POP STUD-J DEMOG, V68, P179, DOI 10.1080/00324728.2014.890243; Busso G, 2007, SEM INT MIGR DES CAS, P1; Cassinelli P, 1983, POBLACION POLITICAS; CELADE Latin American and Caribbean Demographic Center, 2010, INT MIGR; CELADE Latin American and Caribbean Demographic Center, 2002, MAN DAT PROC MOD RED; Cerrutti M., 2003, URBANIZATION INTERNA; Chavez AM, 2004, PROCESOS METROPOLITA, P147; Cooke TJ, 2013, PROF GEOGR, V65, P664, DOI 10.1080/00330124.2012.724343; COURGEAU D, 1973, POPULATION, V28, P511, DOI 10.2307/1530704; Courgeau D, 2013, POPULATION, V67, P631, DOI DOI 10.3917/P0PE.1204.0631; Da Cunha JMP, 2003, URBANIZACION REDISTR; Daras K, 2014, IMAGE STUDIO 1 1 USE; Elizaga JC, 1970, MIGRACIONES AREAS ME; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; Gilbert A., 2013, OXFORD HDB CITIES HI, P483; Hering L, 2015, WORLD BANK EC REV; Herrick B.H, 1966, URBAN MIGRATION EC D, V1; Inglehart R, 1997, PS, V30, P34, DOI 10.2307/420668; Jordan R., 1982, EURE, V9, P7; Lattes A, 1975, POBLACION ARGENTINA; Lattes A. E., 2001, CIUDAD CONSTRUIDA UR, P49; Liu Y, 2014, APPL SPAT ANAL POLIC, V7, P47, DOI 10.1007/s12061-014-9102-6; LONG L, 1991, INT REGIONAL SCI REV, V14, P133, DOI 10.1177/016001769101400202; Long L, 1990, COMP MIGRATION MEASU; Mattar J, 2013, ADV SPAT SCI, P43, DOI 10.1007/978-3-642-39674-8_3; Minnesota Population Center, 2011, INT PUBL US MICR SER; Molloy R., 2011, INTERNAL MIGRATION U; ONE Oficina Nacional de Estadisticas, 2010, MIGR INT CUB; Perez M, 2016, NOVED POBLAC, V12, P97; Rees P, 2016, IMPACT INTERNAL MIGR; Rodriguez J, 2006, REV GEOGR NORTE GD, P7; Rodriguez J, 2008, UN EXP GROUP M POP D, P21; Rodriguez J, 2011, MIGRACION INTERNA SI; Rodriguez J, 2009, MIGRACION INTERNA DE; Rodriguez Jorge, 2004, MIGRACION INTERNA AM; Rodriguez Vignoli J., 2013, NOTAS POBLACION, V96, P53, DOI [10.18356/4e1f4196-es, DOI 10.18356/4E1F4196-ES]; Rogers A., 1981, MODEL MIGRATION SCHE; Rowe F, 2013, SPATIAL LABOUR MOBIL, P43; Rueda R., 1974, POBLACION COLOMBIA; SAHOTA GS, 1968, J POLIT ECON, V76, P218, DOI 10.1086/259395; Skeldon R., 1997, MIGRATION DEV GLOBAL; Sridhar K.S., 2007, APPL ECONOMETRICS IN, V7; Stillwell J, 2016, ENV PLANNING A; Stillwell J, 2014, APPL SPAT ANAL POLIC, V7, P5, DOI 10.1007/s12061-014-9104-4; UN UNDP, 2009, HUM DEV REP 2009 OV; United Nations, 2013, TECHNICAL PAPER NO 2; Villa M, 1980, REDISTRIBUCION ESPAC; Villarraga Orjuela HG, 2015, MIGRACION INTERNA MO; Wrigley N, 1996, SPATIAL ANAL MODELLI, P23; ZELINSKY W, 1971, GEOGR REV, V61, P219, DOI 10.2307/213996; ZLOTNIK H, 1994, INT MIGR REV, V28, P171, DOI 10.2307/2547032	63	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173895	10.1371/journal.pone.0173895	http://dx.doi.org/10.1371/journal.pone.0173895			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328932	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700037
J	Chance, T; Chua, J; Toothman, RG; Ladner, JT; Nuss, JE; Raymond, JL; Biot, FV; Demons, S; Miller, L; Halasohoris, S; Mou, S; Koroleva, G; Lovett, S; Palacios, G; Vietri, NJ; Worsham, PL; Cote, CK; Kijek, TM; Bozue, JA				Chance, Taylor; Chua, Jennifer; Toothman, Ronald G.; Ladner, Jason T.; Nuss, Jonathan E.; Raymond, Jo Lynne; Biot, Fabrice V.; Demons, Samandra; Miller, Lynda; Halasohoris, Stephanie; Mou, Sherry; Koroleva, Galina; Lovett, Sean; Palacios, Gustavo; Vietri, Nicholas J.; Worsham, Patricia L.; Cote, Christopher K.; Kijek, Todd M.; Bozue, Joel A.			A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia	PLOS ONE			English	Article							LIVE VACCINE STRAIN; O-ANTIGEN; IN-VITRO; LIPID-A; VIRULENCE DETERMINANTS; ACQUIRED TULAREMIA; ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; MUTANT; IDENTIFICATION	Francisella tularensis, a gram-negative facultative intracellular bacterial pathogen, is the causative agent of tularemia and able to infect many mammalian species, including humans. Because of its ability to cause a lethal infection, low infectious dose, and aerosolizable nature, F. tularensis subspecies tularensis is considered a potential biowarfare agent. Due to its in vitro efficacy, ciprofloxacin is one of the antibiotics recommended for post-exposure prophylaxis of tularemia. In order to identify therapeutics that will be efficacious against infections caused by drug resistant select-agents and to better understand the threat, we sought to characterize an existing ciprofloxacin resistant (CipR) mutant in the Schu S4 strain of F. tularensis by determining its phenotypic characteristics and sequencing the chromosome to identify additional genetic alterations that may have occurred during the selection process. In addition to the previously described genetic alterations, the sequence of the CipR mutant strain revealed several additional mutations. Of particular interest was a frame-shift mutation within kdsD which encodes for an enzyme necessary for the production of 3-Deoxy-D-manno-Octulosonic Acid (KDO), an integral component of the lipopolysaccharide (LPS). A kdsD mutant was constructed in the Schu S4 strain. Although it was not resistant to ciprofloxacin, the kdsD mutant shared many phenotypic characteristics with the CipR mutant, including growth defects under different conditions, sensitivity to hydrophobic agents, altered LPS profiles, and attenuation in multiple models of murine tularemia. This study demonstrates that the KdsD enzyme is essential for Francisella virulence and may be an attractive therapeutic target for developing novel medical countermeasures.	[Chance, Taylor; Raymond, Jo Lynne] US Army Med Res Inst Infect Dis, Div Pathol, Frederick, MD USA; [Chua, Jennifer; Toothman, Ronald G.; Demons, Samandra; Miller, Lynda; Halasohoris, Stephanie; Mou, Sherry; Vietri, Nicholas J.; Worsham, Patricia L.; Cote, Christopher K.; Bozue, Joel A.] USAMRIID, Bacteriol Div, Frederick, MD 21702 USA; [Ladner, Jason T.; Koroleva, Galina; Lovett, Sean; Palacios, Gustavo] USAMRIID, Ctr Genome Sci, Frederick, MD USA; [Nuss, Jonathan E.; Kijek, Todd M.] USAMRIID, Dept Mol & Translat Sci, Frederick, MD USA; [Biot, Fabrice V.] Inst Rech Biomed Armees, Dept Biol Agents Transmissibles, Unite Bacteriol, UMR MD1, BP 73, Bretigny Sur Orge, France; [Chance, Taylor] Vet Pathol Serv, Joint Pathol Ctr, Silver Spring, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; UDICE-French Research Universities; Aix-Marseille Universite	Bozue, JA (corresponding author), USAMRIID, Bacteriol Div, Frederick, MD 21702 USA.	joel.a.bozue.civ@mail.mil	Palacios, Gustavo/I-7773-2015; Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022; Ladner, Jason/G-3486-2011	Palacios, Gustavo/0000-0001-5062-1938; Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176; Ladner, Jason/0000-0001-7751-4366; Chua, Jennifer/0000-0001-8156-5174; BIOT, Fabrice/0000-0002-3632-2146	Defense Threat Reduction Agency JSTO-CBD (project) [923698, CB10246]	Defense Threat Reduction Agency JSTO-CBD (project)(United States Department of DefenseDefense Threat Reduction Agency)	The research described herein was sponsored by the Defense Threat Reduction Agency JSTO-CBD (project numbers 923698 and CB10246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Arav-Boger R, 2000, PEDIATR INFECT DIS J, V19, P583, DOI 10.1097/00006454-200006000-00024; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Berger JM, 1998, CURR OPIN STRUC BIOL, V8, P26, DOI 10.1016/S0959-440X(98)80006-7; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Case ED, 2014, CELL MICROBIOL, V16, P862, DOI 10.1111/cmi.12246; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; ENDERLIN G, 1994, CLIN INFECT DIS, V19, P42, DOI 10.1093/clinids/19.1.42; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Faith SA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00126; Fritz DL, 2014, COMPARATIVE MED, V64, P341; FULOP M, 1993, MICROBIOLOGICA, V16, P141; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gestin B, 2010, J ANTIMICROB CHEMOTH, V65, P2359, DOI 10.1093/jac/dkq315; Goethert HK, 2004, J CLIN MICROBIOL, V42, P4968, DOI 10.1128/JCM.42.11.4968-4973.2004; Gourley LJ, 2010, PROTEIN SCI, V19, P2430, DOI 10.1002/pro.525; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; HARRIS S, 1992, ANN NY ACAD SCI, V666, P21, DOI 10.1111/j.1749-6632.1992.tb38021.x; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Heine HS, 2016, ANTIMICROB AGENTS CH, V60, P1834, DOI 10.1128/AAC.02887-15; Hepburn MJ, 2008, EXPERT REV ANTI-INFE, V6, P231, DOI 10.1586/14787210.6.2.231; HOOPER DC, 1987, AM J MED, V82, P12; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; JELLISON WL, 1950, PUBLIC HEALTH REP, V65, P1321, DOI 10.2307/4587498; Johansson A, 2000, PEDIATR INFECT DIS J, V19, P449, DOI 10.1097/00006454-200005000-00011; Johansson A, 2001, CLIN INFECT DIS, V33, P267, DOI 10.1086/321825; Jones BD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00032; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Kanistanon D, 2012, INFECT IMMUN, V80, P943, DOI 10.1128/IAI.06109-11; Kilar A, 2013, MASS SPECTROM REV, V32, P90, DOI 10.1002/mas.21352; Kim TH, 2012, J INFECT DIS, V205, P1056, DOI 10.1093/infdis/jir620; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leo E, 2005, J BIOL CHEM, V280, P14252, DOI 10.1074/jbc.M500156200; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Limaye AP, 1999, CLIN INFECT DIS, V29, P922, DOI 10.1086/520458; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Llewellyn AC, 2012, MOL MICROBIOL, V86, P611, DOI 10.1111/mmi.12004; Loveless BM, 2010, MOL CELL PROBE, V24, P154, DOI 10.1016/j.mcp.2010.01.003; LoVullo ED, 2009, FEMS MICROBIOL LETT, V291, P95, DOI 10.1111/j.1574-6968.2008.01440.x; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; MARKOWITZ LE, 1985, JAMA-J AM MED ASSOC, V254, P2922, DOI 10.1001/jama.254.20.2922; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meredith TC, 2005, J BACTERIOL, V187, P6936, DOI 10.1128/JB.187.20.6936-6942.2005; Meredith TC, 2003, J BIOL CHEM, V278, P32771, DOI 10.1074/jbc.M303661200; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; NUTTER JE, 1966, J BACTERIOL, V92, P645, DOI 10.1128/JB.92.3.645-651.1966; Okan NA, 2013, MBIO, V4, DOI 10.1128/mBio.00638-12; OVERHOLT EL, 1961, AM J MED, V30, P785, DOI 10.1016/0002-9343(61)90214-5; Ozanic M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005208; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Perez-Castrillon JL, 2001, CLIN INFECT DIS, V33, P573, DOI 10.1086/322601; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Rasmussen JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00338; Rasmussen JA, 2014, INFECT IMMUN, V82, P1523, DOI 10.1128/IAI.01640-13; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; Roberts LM, 2014, INFECT IMMUN, V82, P2504, DOI 10.1128/IAI.01654-13; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SANDSTROM G, 1992, FEMS MICROBIOL IMMUN, V105, P201, DOI 10.1111/j.1574-6968.1992.tb05902.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; SAWYER WD, 1966, BACTERIOL REV, V30, P542, DOI 10.1128/MMBR.30.3.542-550.1966; SCHEEL O, 1992, EUR J CLIN MICROBIOL, V11, P447, DOI 10.1007/BF01961860; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Sommaruga S, 2009, BIOCHEM BIOPH RES CO, V388, P222, DOI 10.1016/j.bbrc.2009.07.154; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Su JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00083; Sutera V, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00036; Sutera V, 2014, J ANTIMICROB CHEMOTH, V69, P101, DOI 10.1093/jac/dkt321; SYRJALA H, 1991, EUR J CLIN MICROBIOL, V10, P68, DOI 10.1007/BF01964409; Tatusova T., 2013, NCBI HDB; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Twenhafel NA, 2009, VET PATHOL, V46, P698, DOI 10.1354/vp.08-VP-0302-T-AM; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Wen L, 2009, PROTEIN EXPRES PURIF, V65, P83, DOI 10.1016/j.pep.2008.11.011; WOLFSON JS, 1989, CLIN MICROBIOL REV, V2, P378, DOI 10.1128/CMR.2.4.378-424.1989; Yep A, 2011, BIOORG MED CHEM LETT, V21, P2679, DOI 10.1016/j.bmcl.2010.12.066; Zhou P, 2010, APPL ENVIRON MICROB, V76, P3437, DOI 10.1128/AEM.03082-09; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	104	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174106	10.1371/journal.pone.0174106	http://dx.doi.org/10.1371/journal.pone.0174106			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328947	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700054
J	Chen, YWR; Chen, V; Hollander, Z; Leipsic, JA; Hague, CJ; DeMarco, ML; FitzGerald, JM; McManus, BM; Ng, RT; Sin, DD				Chen, Yu-wei Roy; Chen, Virginia; Hollander, Zsuzsanna; Leipsic, Jonathon A.; Hague, Cameron J.; DeMarco, Mari L.; FitzGerald, J. Mark; McManus, Bruce M.; Ng, Raymond T.; Sin, Don D.			C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HEART-FAILURE; EMERGENCY-DEPARTMENT; RENAL-FUNCTION; METAANALYSIS; INFLAMMATION; ASSOCIATION; DYSFUNCTION; DIAGNOSIS; MARKERS	There are currently no accepted and validated blood tests available for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). In this study, we sought to determine the discriminatory power of blood C-reactive protein (CRP) and N-terminal prohormone brain natriuretic peptide (NT-proBNP) in the diagnosis of AECOPD requiring hospitalizations. The study cohort consisted of 468 patients recruited in the COPD Rapid Transition Program who were hospitalized with a primary diagnosis of AECOPD, and 110 stable COPD patients who served as controls. Logistic regression was used to build a classification model to separate AECOPD from convalescent or stable COPD patients. Performance was assessed using an independent validation set of patients who were not included in the discovery set. Serum CRP and whole blood NT-proBNP concentrations were highest at the time of hospitalization and progressively decreased over time. Of the 3 classification models, the one with both CRP and NT-proBNP had the highest AUC in discriminating AECOPD (cross-validated AUC of 0.80). These data were replicated in a validation cohort with an AUC of 0.88. A combination of CRP and NT-proBNP can reasonably discriminate AECOPD requiring hospitalization versus clinical stability and can be used to rapidly diagnose patients requiring hospitalization for AECOPD.	[Chen, Yu-wei Roy; Chen, Virginia; Hollander, Zsuzsanna; McManus, Bruce M.; Sin, Don D.] St Pauls Hosp, Ctr Heart Lung Innovat, James Hogg Res Ctr, Vancouver, BC, Canada; [Chen, Virginia; Hollander, Zsuzsanna; McManus, Bruce M.; Sin, Don D.] St Pauls Hosp, Inst Heart Lung Hlth, Vancouver, BC, Canada; [Chen, Virginia; Hollander, Zsuzsanna; McManus, Bruce M.; Ng, Raymond T.] PROOF Ctr Excellence, Vancouver, BC, Canada; [Leipsic, Jonathon A.; Hague, Cameron J.] St Pauls Hosp, Dept Radiol, Vancouver, BC, Canada; [DeMarco, Mari L.; McManus, Bruce M.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [FitzGerald, J. Mark; Sin, Don D.] Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC, Canada; [FitzGerald, J. Mark] Vancouver Gen Hosp, Lung Ctr, Vancouver, BC, Canada; [Ng, Raymond T.] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada	St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Sin, DD (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, James Hogg Res Ctr, Vancouver, BC, Canada.; Sin, DD (corresponding author), St Pauls Hosp, Inst Heart Lung Hlth, Vancouver, BC, Canada.; Sin, DD (corresponding author), Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC, Canada.	Don.Sin@hli.ubc.ca	Leipsic, Jonathon/ABE-6194-2020; Sin, Don/AAC-2219-2021	DeMarco, Mari/0000-0001-9281-9547	Genome Canada; Genome British Columbia; Genome Quebec; Canadian Institutes of Health Research; PROOF Centre of Excellence; St. Paul's Foundation; Providence Health Care Research Institute; Canadian Respiratory Research Network; National Heart, Lung, and Blood Institute's COPD Clinical Research Network [U10 HL074441, U10 HL074418, U10 HL074428, U10 HL074409, U10 HL074407, U10 HL074422, U10 HL074416, U10 HL074408, U10 HL074439, U10 HL0744231, U10 HL074424]	Genome Canada(Genome Canada); Genome British Columbia; Genome Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PROOF Centre of Excellence; St. Paul's Foundation; Providence Health Care Research Institute; Canadian Respiratory Research Network; National Heart, Lung, and Blood Institute's COPD Clinical Research Network	Funding was provided by Genome Canada, Genome British Columbia, Genome Quebec, the Canadian Institutes of Health Research, PROOF Centre of Excellence, St. Paul's Foundation, Providence Health Care Research Institute, the Canadian Respiratory Research Network, and the National Heart, Lung, and Blood Institute's COPD Clinical Research Network (Grants U10 HL074441, U10 HL074418, U10 HL074428, U10 HL074409, U10 HL074407, U10 HL074422, U10 HL074416, U10 HL074408, U10 HL074439, U10 HL0744231, and U10 HL074424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Abroug F, 2006, AM J RESP CRIT CARE, V174, P990, DOI 10.1164/rccm.200603-380OC; Anwaruddin S, 2006, J AM COLL CARDIOL, V47, P91, DOI 10.1016/j.jacc.2005.08.051; Bozkanat E, 2005, J INT MED RES, V33, P537, DOI 10.1177/147323000503300509; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Calzetta L, 2016, INT J CARDIOL, V221, P1031, DOI 10.1016/j.ijcard.2016.07.109; Chen YR, 2016, AM THOR SOC INT C, V301, pA1024; Chen YR, 2015, AM THOR SOC INT C, V257, pA2928; Crisafulli E, 2015, COPD, P1; El Mallawany H, 2014, EGYPT J CHEST DIS TU, V63, P57, DOI 10.1016/j.ejcdt.2013.10.016; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gumus A, 2015, INT J CHRONIC OBSTR, V10, P357, DOI 10.2147/COPD.S77654; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Helmy TA, 2014, EGYPT J CHEST DIS TU, V63, P838, DOI 10.1016/j.ejcdt.2014.06.003; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Kim HN, 2011, CIRCULATION, V123, P2015, DOI 10.1161/CIRCULATIONAHA.110.979500; Leuppi JD, 2013, JAMA-J AM MED ASSOC, V309, P2223, DOI 10.1001/jama.2013.5023; MacDonald MI, 2016, LANCET RESP MED, V4, P138, DOI 10.1016/S2213-2600(15)00509-3; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Man SFP, 2006, THORAX, V61, P849, DOI 10.1136/thx.2006.059808; McCullough PA, 2003, ACAD EMERG MED, V10, P198, DOI 10.1197/aemj.10.3.198; McCullough PA, 2003, AM J KIDNEY DIS, V41, P571, DOI 10.1053/ajkd.2003.50118; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mueller C, 2007, SWISS MED WKLY, V137, P4; Nishimura K, 2014, INT J CHRONIC OBSTR, V9, P155, DOI 10.2147/COPD.S55143; Parker CM, 2005, EUR RESPIR J, V26, P420, DOI 10.1183/09031936.05.00136304; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Quon BS, 2008, CHEST, V133, P756, DOI 10.1378/chest.07-1207; Reitz D, 2015, J CLIN PATHOL, V68, P427, DOI 10.1136/jclinpath-2014-202451; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Segreti A, 2013, PULM PHARMACOL THER, V26, P630, DOI 10.1016/j.pupt.2013.03.020; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Sin DD, 2015, AM J RESP CRIT CARE, V192, P1162, DOI 10.1164/rccm.201505-0871PP; Suda K, 2011, AM J RESP CELL MOL, V45, P510, DOI 10.1165/rcmb.2010-0169OC; Takahashi T, 2014, INT J CHRONIC OBSTR, V9, P303, DOI 10.2147/COPD.S38931; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Tommelein E, 2014, BRIT J CLIN PHARMACO, V77, P756, DOI 10.1111/bcp.12242; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030	40	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174063	10.1371/journal.pone.0174063	http://dx.doi.org/10.1371/journal.pone.0174063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328968	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700046
J	Park, H; Park, YH; Cha, J; Seo, SW; Na, DL; Lee, JM				Park, Hyunjin; Park, Yeong-Hun; Cha, Jungho; Seo, Sang Won; Na, Duk L.; Lee, Jong-Min			Agreement between functional connectivity and cortical thickness-driven correlation maps of the medial frontal cortex	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; AUTOMATED 3-D EXTRACTION; CEREBRAL-CORTEX; PARCELLATION; VOLUME; FMRI; NETWORKS; SURFACES; INNER	Parcellation of the human cortex has important implications in neuroscience. Parcellation is often a crucial requirement before meaningful regional analysis can occur. The human cortex can be parcellated into distinct regions based on structural features, such as gyri and sulci. Brain network patterns in a given region with respect to its neighbors, known as connectional fingerprints, can be used to parcellate the cortex. Distinct imaging modalities might provide complementary information for brain parcellation. Here, we established functional connectivity with time series data from functional MRI (fMRI) combined with a correlation map of cortical thickness obtained from T1-weighted MRI. We aimed to extend the previous study, which parcellated the medial frontal cortex (MFC) using functional connectivity, and to test the value of additional information regarding cortical thickness. Two types of network information were used to parcellate the MFC into two sub-regions with spectral and Ward's clustering approaches. The MFC region was defined using manual delineation based on in-house data (n= 12). Parcellation was applied to independent large-scale data obtained from the Human Connectome Project (HCP, n = 248). Agreement between parcellation using fMRI-and thickness-driven connectivity yielded dice coefficient overlaps of 0.74 (Ward's clustering) and 0.54 (spectral clustering). We also explored whole brain connectivity using the MFC sub-regions as seed regions based on these two types of information. The results of whole brain connectivity analyses were also consistent for both types of information. We observed that an inter-regional correlation map derived from cortical thickness strongly reflected the underlying functional connectivity of MFC region.	[Park, Hyunjin] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea; [Park, Hyunjin] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Park, Yeong-Hun; Cha, Jungho; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Seo, Sang Won; Na, Duk L.] Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS); Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JM (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul, South Korea.	ljm@hanyang.ac.kr	Lang, Steven/AAE-8102-2021; Park, Hyunjin/A-1164-2007	Lang, Steven/0000-0003-1669-9146; Park, Hyunjin/0000-0001-5681-8918; Cha, Jungho/0000-0003-1189-2051; Lee, Jong-Min/0000-0002-3598-376X	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016R1A2B3016609]; 16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University	National Research Foundation of Korea (NRF) - Korea government (MSIP); 16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); McDonnell Center for Systems Neuroscience at Washington University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2B3016609).; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2B3016609). Data were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research and by the McDonnell Center for Systems Neuroscience at Washington University.	Arslan S, 2015, LECT NOTES COMPUT SC, V9351, P47, DOI 10.1007/978-3-319-24574-4_6; Boisgueheneuc F., 2006, BRAIN, V129, p[12, 3315], DOI DOI 10.1093/BRAIN/AWL244; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Eickhoff SB, 2015, HUM BRAIN MAPP, V36, P4771, DOI 10.1002/hbm.22933; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fisher RA, 1914, BIOMETRIKA, V10, P507; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Japee S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00023; Jo HJ, 2008, NEUROIMAGE, V40, P1077, DOI 10.1016/j.neuroimage.2007.12.036; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kim H.T., 2013, THESIS; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Luo GH, 2016, SCI REP-UK, V6, P1, DOI [10.1038/srep35231, 10.1038/s41598-016-0027-y]; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Marsden CD, 1996, ADV NEUROL, V70, P477; Moreno-Dominguez D, 2014, HUM BRAIN MAPP, V35, P5000, DOI 10.1002/hbm.22528; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Ng AY, 2002, ADV NEUR IN, V14, P849; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; SANTOSH CG, 1995, BRIT J RADIOL, V68, P369, DOI 10.1259/0007-1285-68-808-369; Segall JM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00010; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; VanOostende S, 1997, NEUROIMAGE, V6, P181, DOI 10.1006/nimg.1997.0287; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0171803	10.1371/journal.pone.0171803	http://dx.doi.org/10.1371/journal.pone.0171803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328993	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700003
J	Thongprayoon, C; Cheungpasitporn, W; Cheng, Z; Qian, Q				Thongprayoon, Charat; Cheungpasitporn, Wisit; Cheng, Zhen; Qian, Qi			Chloride alterations in hospitalized patients: Prevalence and outcome significance	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE KIDNEY INJURY; SEVERE SEPSIS; ANION GAP; HYPERCHLOREMIA; MORTALITY; RESUSCITATION; METAANALYSIS; ASSOCIATION; MORBIDITY	Serum Cl (sCl) alterations in hospitalized patients have not been comprehensively studied in recent years. The aim of this study is to investigate the prevalence and outcome significance of (1) sCl alterations on hospital admission, and (2) sCl evolution within the first 48 hr of hospital admission. We conducted a retrospective study of all hospital admissions in the years 2011-2013 at Mayo Clinic Rochester, a 2000-bed tertiary medical center. Outcome measures included hospital mortality, length of hospital stay and discharge disposition. 76,719 unique admissions (>= 18 years old) were studied. Based on hospital mortality, sCl in the range of 105-108 mmol/L was found to be optimal. sCl < 100 (n = 13,611) and >108 (n = 11,395) mmol/L independently predicted a higher risk of hospital mortality, longer hospital stay and being discharged to a care facility. 13,089 patients (17.1%) had serum anion gap >12 mmol/L; their hospital mortality, when compared to 63,630 patients (82.9%) with anion gap <= 12 mmol/L, was worse. Notably, patients with elevated anion gap displayed a progressively worsening mortality with rising sCl. sCl elevation within 48 hr of admission was associated with a higher proportion of 0.9% saline administration and was an independent predictor for hospital mortality. Moreover, the magnitude of sCl rise was inversely correlated to the days of patient survival. In conclusion, serum Cl alterations on admission predict poor clinical outcomes. Post-admission sCl increase, due to Cl-rich fluid infusion, independently predicts hospital mortality. These results raise a critical question of whether iatrogenic cause of hyperchloremia should be avoided, a question to be addressed by future prospective studies.	[Thongprayoon, Charat; Cheungpasitporn, Wisit; Cheng, Zhen; Qian, Qi] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Thongprayoon, Charat] Mayo Clin, Dept Anesthesiol, Rochester, MN USA; [Cheng, Zhen] Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Mayo Clinic; Mayo Clinic; Nanjing University	Qian, Q (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	qian.qi@mayo.edu	Thongprayoon, Charat/J-4184-2019; Cheungpasitporn, Wisit/H-8194-2019	Thongprayoon, Charat/0000-0002-8313-3604; Cheungpasitporn, Wisit/0000-0001-9954-9711				ANDERSON LE, 1987, SOUTHERN MED J, V80, P729, DOI 10.1097/00007611-198706000-00016; [Anonymous], 2015, RMS REGRESSION MODEL; Barriere DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070690; Boniatti MM, 2011, J CRIT CARE, V26, P175, DOI 10.1016/j.jcrc.2010.04.013; Brugts JJ, 2007, J AM COLL CARDIOL, V50, P2148, DOI 10.1016/j.jacc.2007.08.029; BULLIVANT EMA, 1989, AM J PHYSIOL, V256, pF152, DOI 10.1152/ajprenal.1989.256.1.F152; Burdett E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004089.pub2; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Constable PD, 1998, AM J VET RES, V59, P881; Ferreira JP, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003500; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; GILFIX BM, 1993, J CRIT CARE, V8, P187, DOI 10.1016/0883-9441(93)90001-2; Gunnerson KJ, 2005, CRIT CARE, V9, P508, DOI 10.1186/cc3796; Havel C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub3; Henry L, 2012, ANN THORAC SURG, V94, P744, DOI 10.1016/j.athoracsur.2012.04.073; Hollenberg SM, 2004, CRITICAL CARE MED, V32; Kellum JA, 1998, SHOCK, V9, P364, DOI 10.1097/00024382-199805000-00009; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; KOTCHEN TA, 1983, ANN INTERN MED, V98, P817, DOI 10.7326/0003-4819-98-5-817; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lilly CM, 2014, NEW ENGL J MED, V370, P1750, DOI 10.1056/NEJMe1402564; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e; Nagaoka D, 2010, J CRIT CARE, V25, P525, DOI 10.1016/j.jcrc.2010.02.003; Neyra JA, 2015, CRIT CARE MED, V43, P1938, DOI 10.1097/CCM.0000000000001161; OH MS, 1977, NEW ENGL J MED, V297, P814, DOI 10.1056/NEJM197710132971507; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rastegar A, 2007, J AM SOC NEPHROL, V18, P2429, DOI 10.1681/ASN.2006121408; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Szrama J, 2016, ANAESTH INTENSIVE TH, V48, P180, DOI 10.5603/AIT.a2016.0020; Tani M, 2012, SCI WORLD J, DOI 10.1100/2012/474185; Veizis IE, 2007, PEDIATR NEPHROL, V22, P770, DOI 10.1007/s00467-006-0355-4; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Williams RN, 2006, J ORGAN DYSFUNCTION, V2, P166; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052	42	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174430	10.1371/journal.pone.0174430	http://dx.doi.org/10.1371/journal.pone.0174430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328963	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700091
J	Wang, Y; Luo, X; Mao, XM; Tao, YC; Ran, XJ; Zhao, HX; Xiong, JH; Li, LL				Wang, Ye; Luo, Xin; Mao, Xinmin; Tao, Yicun; Ran, Xinjian; Zhao, Haixia; Xiong, Jianhui; Li, Linlin			Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PREVALENCE; BACTERIA	The gut microbiome may have an important influence on the development of diabetes mellitus type 2 (DM2). To better understand the DM2 pandemic in ethnic minority groups in China, we investigated and compared the composition and richness of the gut microbiota of healthy, normal glucose tolerant (NGT) individuals and DM2 patients from two ethnic minority groups in Xinjiang, northwest China, the Uygurs and Kazaks. The conserved V6 region of the 16S rRNA gene was amplified by PCR from the isolated DNA. The amplified DNA was sequenced and analyzed. An average of 4047 high quality reads of unique tag sequences were obtained from the 40 Uygurs and Kazaks. The 3 most dominant bacterial families among all participants, both healthy and DM2 patients, were the Ruminococcaceae, Lachnospiraceae, and Enterobacteriaceae. Significant differences in intestinal microbiota were found between the NGT individuals and DM2 patients, as well as between the two ethnic groups. Our findings shed new light on the gut microbiome in relation to DM2. The differentiated microbiota data may be used for potential biomarkers for DM2 diagnosis and prevention.	[Wang, Ye; Luo, Xin; Mao, Xinmin; Tao, Yicun; Ran, Xinjian; Xiong, Jianhui; Li, Linlin] Xinjiang Med Univ, Dept Pharmacol, Basic Med Coll, Urumqi, Xinjiang, Peoples R China; [Zhao, Haixia] Xinjiang Med Univ, Affiliated Hosp 1, Pharmaceut Preparat Dept, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Li, LL (corresponding author), Xinjiang Med Univ, Dept Pharmacol, Basic Med Coll, Urumqi, Xinjiang, Peoples R China.	Lilinlin01@xjmu.edu.cn			National Natural Science Foundation of China (NSFC)-Xinjiang Joint Fund for Special Training of Local Young Talents [U1403322]	National Natural Science Foundation of China (NSFC)-Xinjiang Joint Fund for Special Training of Local Young Talents(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC)-Xinjiang Joint Fund for Special Training of Local Young Talents (grant number: U1403322). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Al-Otaibi Fawzia Eida, 2014, J Med Case Rep, V8, P365, DOI 10.1186/1752-1947-8-365; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Chatenoud L, 2015, EUR J IMMUNOL, V45, P2968, DOI 10.1002/eji.201570114; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Heggendorn FL, 2013, ACTA ODONTOL SCAND, V71, P1458, DOI 10.3109/00016357.2013.770163; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9; Obi CL, 2007, J HEALTH POPUL NUTR, V25, P428; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Qin J, 2010, NATURE, V490, P55; Sharma Rohit, 2015, Ayu, V36, P10, DOI 10.4103/0974-8520.169014; Tsai YH, 2009, CLIN ORTHOP RELAT R, V467, P846, DOI 10.1007/s11999-008-0504-0; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang LF, 2010, J CLIN HYPERTENS, V12, P741, DOI 10.1111/j.1751-7176.2010.00349.x; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007	21	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172774	10.1371/journal.pone.0172774	http://dx.doi.org/10.1371/journal.pone.0172774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328990	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700009
J	Lee, CC; Chen, PH; Ho, KH; Shih, CM; Cheng, CH; Lin, CW; Cheng, KT; Liu, AJ; Chen, KC				Lee, Chin-Cheng; Chen, Peng-Hsu; Ho, Kuo-Hao; Shih, Chwen-Ming; Cheng, Chia-Hsiung; Lin, Cheng-Wei; Cheng, Kur-Ta; Liu, Ann-Jeng; Chen, Ku-Chung			The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NFIA; CARCINOMA; MIR-302B; PROLIFERATION; TEMOZOLOMIDE; SENSITIVITY; METASTASIS; EXPRESSION; EXPANSION	MicroRNAs are small noncoding RNAs that post-transcriptionally control the expression of genes involved in glioblastoma multiforme (GBM) development. Although miR-302b functions as a tumor suppressor, its role in GBM is still unclear. Therefore, this study comprehensively explored the roles of miR-302b-mediated gene networks in GBM cell death. We found that miR-302b levels were significantly higher in primary astrocytes than in GBM cell lines. miR-302b overexpression dose dependently reduced U87-MG cell viability and induced apoptosis through caspase-3 activation and poly(ADP ribose) polymerase degradation. A transcriptome microarray revealed 150 downregulated genes and 380 upregulated genes in miR-302b-overexpressing cells. Nuclear factor IA (NFIA), higher levels of which were significantly related to poor survival, was identified as a direct target gene of miR- 302b and was involved in miR-302b-induced glioma cell death. Higher NFIA levels were observed in GBM cell lines and human tumor sections compared with astrocytes and non-tumor tissues, respectively. NFIA knockdown significantly enhanced apoptosis. We found high levels of insulin-like growth factor-binding protein 2 (IGFBP2), another miR-302b- downregulated gene, in patients with poor survival. We verified that NFIA binds to the IGFBP2 promoter and transcriptionally enhances IGFBP2 expression levels. We identified that NFIA-mediated IGFBP2 signaling pathways are involved in miR- 302b- induced glioma cell death. The identification of a regulatory loop whereby miR- 302b inhibits NFIA, leading to a decrease in expression of IGFBP-2, may provide novel directions for developing therapies to target glioblastoma tumorigenesis.	[Lee, Chin-Cheng] Shin Kong Wu Ho Su Mem Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Chen, Peng-Hsu; Shih, Chwen-Ming; Cheng, Chia-Hsiung; Lin, Cheng-Wei; Cheng, Kur-Ta; Chen, Ku-Chung] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Ho, Kuo-Hao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Shih, Chwen-Ming; Cheng, Chia-Hsiung; Lin, Cheng-Wei; Cheng, Kur-Ta; Chen, Ku-Chung] Taipei Med Univ, Sch Med, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan; [Liu, Ann-Jeng] Taipei City Hosp, Ren Ai Branch, Dept Neurosurg, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei City Hospital	Chen, KC (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.; Chen, KC (corresponding author), Taipei Med Univ, Sch Med, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan.	kuchung@tmu.edu.tw	Cheng, Chia-Hsiung/A-6044-2019	Cheng, Chia-Hsiung/0000-0003-0307-9650	Ministry of Science and Technology, Taiwan [MOST 104-2320-B-038-046, MOST 105-2320-B-038-019]; Shin Kong Wu Ho-Su Memorial Hospital, Taiwan [SKH-8302-105-DR-26]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taiwan	This work was supported by the Ministry of Science and Technology, Taiwan [MOST 104-2320-B-038-046 and MOST 105-2320-B-038-019] and Shin Kong Wu Ho-Su Memorial Hospital, Taiwan (intramural grant no. SKH-8302-105-DR-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Technology, Taiwan [MOST 104-2320-B-038-046 and MOST 105-2320-B-038-019] and Shin Kong Wu Ho-Su Memorial Hospital, Taiwan (intramural grant no. SKH-8302-105-DR-26).	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Brahmkhatri VP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538019; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Cai DH, 2015, INT J MOL SCI, V16, P23668, DOI 10.3390/ijms161023668; Cataldo A, 2016, ONCOTARGET, V7, P786, DOI 10.18632/oncotarget.6381; Chen PH, 2014, J NEUROCHEM, V131, P731, DOI 10.1111/jnc.12820; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Fukushima T, 2007, ANTICANCER RES, V27, P3685; Ge TT, 2014, CELL PHYSIOL BIOCHEM, V34, P2209, DOI 10.1159/000369664; Glasgow SM, 2014, NAT NEUROSCI, V17, P1322, DOI 10.1038/nn.3790; Glasgow SM, 2013, J NEUROSCI, V33, P13560, DOI 10.1523/JNEUROSCI.0321-13.2013; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Han S, 2014, BRIT J CANCER, V111, P1400, DOI 10.1038/bjc.2014.435; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Lee JS, 2014, NEURO-ONCOLOGY, V16, P191, DOI 10.1093/neuonc/not167; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2016, CELL PHYSIOL BIOCHEM, V38, P1715, DOI 10.1159/000443111; Liu C, 2015, ONCOL LETT, V9, P96, DOI 10.3892/ol.2014.2678; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Phillips LM, 2016, J PATHOL, V239, P355, DOI 10.1002/path.4734; QIAN F, 1995, GENOMICS, V28, P66, DOI 10.1006/geno.1995.1107; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shea A, 2016, CANCER MED-US, V5, P1917, DOI 10.1002/cam4.775; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Trojan J, 2007, NEUROSCIENCE, V145, P795, DOI 10.1016/j.neuroscience.2007.01.021; Tsuyama J, 2015, STEM CELL REP, V5, P365, DOI 10.1016/j.stemcr.2015.06.006; Wang LM, 2016, TUMOR BIOL, V37, P847, DOI 10.1007/s13277-015-3330-5; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zhang MX, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-10; Zhao L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0300-8	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173890	10.1371/journal.pone.0173890	http://dx.doi.org/10.1371/journal.pone.0173890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323865	Green Submitted, gold, Green Published			2022-12-27	WOS:000399089000042
J	Shott, MJ				Shott, Michael J.			Stage and continuum approaches in prehistoric biface production: A North American perspective	PLOS ONE			English	Article							REDUCTION; QUARRY; HEAVY; FORM	North American lithic analysis often assigns biface preforms to discrete, successive stages defined in Callahan's influential study. Yet recent research questions the stage concept, emphasizing instead a continuous view of the reduction process. To compare stage and continuum approaches, their assumptions are tested in experimental replicas, including Callahan's, and empirical Paleoindian preform assemblages. In these samples, biface reduction is a process that can be tracked and measured by continuous measures of size and reduction allometry. The process is characterized by continuous variation in the rate at which preform weight declines with preform volume. That is, weight declines at an ever-declining rate through the production process. Reduction is complex, but understood better as an allometric process than as a sequence of technological stages. "Stage" may be a useful heuristic or summary device, but preform assemblages should be analyzed in detail to reveal the continuous allometric processes that govern biface production.	[Shott, Michael J.] Univ Akron, Dept Anthropol & Class Studies, Akron, OH 44325 USA	University System of Ohio; University of Akron	Shott, MJ (corresponding author), Univ Akron, Dept Anthropol & Class Studies, Akron, OH 44325 USA.	shott@uakron.edu						Amick D. S., 1985, TENNESSEE SE ARCHAEO, V4, P134; Andrefsky W., 1998, LITHICS MACROSCOPIC; Andrefsky W, 2006, AM ANTIQUITY, V71, P743, DOI 10.2307/40035887; [Anonymous], 1985, CONCORDANCE ARCHAEOL; Apel J., 2001, DAGGERS KNOWLEDGE PO; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Bamforth DouglasB., 2014, CLOVIS CACHES RECENT, P39; Beck C, 2002, J ANTHROPOL ARCHAEOL, V21, P481, DOI 10.1016/S0278-4165(02)00007-7; Bement LelandC., 2014, CLOVIS CACHES RECENT, P61; Bennett G, 2014, THESIS; Bleed P, 2002, J ANTHROPOL ARCHAEOL, V21, P329, DOI 10.1016/S0278-4165(02)00001-6; Bradbury AP, 2014, LITHIC TECHNOL, V39, P20, DOI 10.1179/0197726113Z.00000000030; Bradbury AP, 1999, J ARCHAEOL SCI, V26, P105, DOI 10.1006/jasc.1998.0309; Bradley B.A., 2009, HELL GAP STRATIFIED, P259; Bradley BA., 2010, CLOVIS TECHNOLOGY AR; Buchanan B, 2006, J ARCHAEOL SCI, V33, P185, DOI 10.1016/j.jas.2005.07.008; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Callahan E, 1996, B PRIMITIVE TECHNOLO, V11, P56; Carper RG, 2005, LITHIC TECHNOL, V30, P127, DOI 10.1080/01977261.2005.11721030; Clarkson C, 2014, J ARCHAEOL SCI, V49, P361, DOI 10.1016/j.jas.2014.05.031; Collins M. B., 1975, LITHIC TECHNOLOGY MA, P15; Crabtree D.E., 1972, OCCASIONAL PAPERS ID; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Davis L, 2015, LITHIC TECHNOLOGY, P40; Dickens WA, 2005, THESIS; Douglass MJ, 2008, AM ANTIQUITY, V73, P513, DOI 10.2307/25470502; ELSTON RG, 1992, ARCHAEOLOGICAL INVES, V1, P31; Hill PJ, 2010, EXPT INTERPRETATION, P511; Holmes W. H., 1894, MEMOIRS INT C ANTHR, P120; Holmes WH, 1892, P AM ASS ADV SCI 41, P239; Huckell B.B., 2007, MURRAY SPRINGS CLOVI, P170; Huckell BB., 2014, CLOVIS CACHES RECENT, P133; Ingbar E., 1989, INT SERIES, V528, P117; Jennings TA, 2013, J ARCHAEOL SCI, V40, P649, DOI 10.1016/j.jas.2012.07.016; JOHNSON JK, 1993, PLAINS ANTHROPOL, V38, P151; Johnson JK, 1981, TENNESSEE VALLEY AUT, V28; Jones J.Scott., 1996, THESIS OREGON STATE; Julig PJ, 1994, ONTARIO HERITAGE FDN; Kilby J. D., 2008, THESIS; Kuhn SL, 2015, LITHIC TECHNOLOGICAL SYSTEMS AND EVOLUTIONARY THEORY, P172; Lerner Harry., 2015, WORKS STONE CONT PER, P143; Li H, 2015, PLOS ONE, V19; Lindly JM, 2011, PALEOANTHROPOLOGY, V2011, P320, DOI DOI 10.4207/PA.2011.ART62; McCoy P.C., 2014, RAPA NUI J, V28, P5; Miller D. S, 2014, THESIS; Miller D. Shane, 2012, CONT LITHIC ANAL SE, P28; Morrow JE., 2006, PALEOINDIAN ARCHAEOL, P123; Morrow JE, 1996, THESIS; Muniz MarkP., 2014, CLOVIS CACHES RECENT, P107; Muto Guy R., 1971, GREAT BASIN ANTHR C, V1, P109; Nami H. G., 2010, EXPT INTERPRETATION, P203; Odell G. H., 2012, LITHIC ANAL; Pelegrin J., 1993, LAT AM ANTIQ, V4, P367, DOI [10.2307/972073, DOI 10.2307/972073, https://doi.org/10.2307/972073]; Prasciunas M, 2004, THESIS; Richardson E., 2013, ARCHAEOLOGY DIGITAL, P83; Sanders TN, 1983, THESIS; Santarone P, 2014, CLOVIS CACHES RECENT, P11; Selden RZ, 2016, J TEXAS ARCHEOLOGY H, V3, P19; Sharrock FW, 1966, U UTAH ANTHR PAPERS; Shipton C, 2011, AFR ARCHAEOL REV, V28, P141, DOI 10.1007/s10437-011-9089-1; Shott M., 2004, AGGREGATE ANAL CHIPP, P211; Shott M. J., 2012, SAA ARCHAEOLOGICAL R, V12, P12; Shott MJ, 2007, LITHIC TECHNOL, V32, P203; Shott MJ, 2007, AM ANTIQUITY, V72, P153, DOI 10.2307/40035302; Shott MJ, 2015, AM ANTIQUITY, V80, P548, DOI 10.7183/0002-7316.80.3.548; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Shott MJ., 1996, LITHIC TECHNOL, V21, P6, DOI [10.1080/01977261.1996.11754381, DOI 10.1080/01977261.1996.11754381]; Smallwood AM, 2011, THESIS; Smallwood AM, 2012, AM ANTIQUITY, V77, P689, DOI 10.7183/0002-7316.77.4.689; Statistical Consulting Group, 2013, COMP REGR COEFF GROU; Surovell T., 2009, BEHAV ECOLOGY LITHIC; Thomsen K., 2004, NUMERICANA; Verrey RA, 1983, 48 ANN M SOC AM ARCH; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Waters M.R., 2011, CLOVIS LITHIC TECHNO; Wilke P. J., 1991, J CALIFORNIA GREAT B, V13, P242; Wilson J, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P86, DOI 10.1017/CBO9780511499661.005	77	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0170947	10.1371/journal.pone.0170947	http://dx.doi.org/10.1371/journal.pone.0170947			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ER8RG	28323895	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000011
J	Souza, RFS; Jardin, J; Cauty, C; Rault, L; Bouchard, DS; Bermudez-Humaran, LG; Langella, P; Monedero, V; Seyffert, N; Azevedo, V; Le Loir, Y; Even, S				Souza, Renata F. S.; Jardin, Julien; Cauty, Chantal; Rault, Lucie; Bouchard, Damien S.; Bermudez-Humaran, Luis G.; Langella, Philippe; Monedero, Vicente; Seyffert, Nubia; Azevedo, Vasco; Le Loir, Yves; Even, Sergine			Contribution of sortase SrtA2 to Lactobacillus casei BL23 inhibition of Staphylococcus aureus internalization into bovine mammary epithelial cells	PLOS ONE			English	Article							PROPIONIBACTERIUM-FREUDENREICHII; MOONLIGHTING PROTEINS; INTRAMAMMARY INFUSION; SURFACE-PROTEINS; GENOME SEQUENCE; LIVE CULTURE; MASTITIS; BIOSYNTHESIS; CASEI; POLYSACCHARIDE	Probiotics have been considered as a promising strategy to prevent various diseases in both humans and animals. This approach has gained interest in recent years as a potential means to control bovine mastitis. In a previous study, we found that several L. casei strains, including BL23, were able to inhibit the internalization of S. aureus, a major etiologic agent of mastitis, into bovine mammary epithelial cells (bMEC). This antagonism required a direct contact between L. casei and bMEC or S. aureus, suggesting the inhibition relied on interactions between L. casei cell surface components and bMEC. In this study, we have investigated the impact of some candidates which likely influence bacteria host cell interactions. We have shown that L. casei BL23 fbpA retained its inhibitory potential, indicating that L. casei BL23 antagonism did not rely (solely) on competition between S. aureus and L. casei fibronectin-binding proteins for adhesion to bMEC. We have then investigated the impact of four sortase mutants, srtA1, srtA2, srtC1 and srtC2, and a double mutant (srtA1-srtA2) on L. casei BL23 inhibitory potential. Sortases are responsible for the anchoring on the bacterial cell wall of LPXTG-proteins, which reportedly play an important role in bacteria-host cell interaction. All the srt mutants tested presented a reduced inhibition capacity, the most pronounced effect being observed with the srtA2 mutant. A lower internalization capacity of L. casei srtA2 into bMEC was also observed. This was associated with several changes at the surface of L. casei BL23 srtA2 compared to the wild type (wt) strain, including altered abundance of some LPXTG-and moonlighting proteins, and modifications of cell wall structure. These results strongly support the role of sortase A2 in L. casei BL23 inhibition against S. aureus internalization. Deciphering the contribution of the cell surface components altered in srtA2 strain in the inhibition will require further investigation.	[Souza, Renata F. S.; Jardin, Julien; Cauty, Chantal; Rault, Lucie; Bouchard, Damien S.; Le Loir, Yves; Even, Sergine] INRA, STLO, UMR 1253, Rennes, France; [Souza, Renata F. S.; Jardin, Julien; Cauty, Chantal; Rault, Lucie; Bouchard, Damien S.; Le Loir, Yves; Even, Sergine] Agrocampus Ouest, STLO, UMR1253, Rennes, France; [Souza, Renata F. S.; Seyffert, Nubia; Azevedo, Vasco] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Bermudez-Humaran, Luis G.; Langella, Philippe] Paris Saclay Univ, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France; [Monedero, Vicente] Inst Agroquim & Tecnol Alimentos CSIC, Paterna, Spain; [Bouchard, Damien S.] ANSES ANMV, Fougeres, France	INRAE; Institut Agro; Agrocampus Ouest; Universidade Federal de Minas Gerais; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC)	Even, S (corresponding author), INRA, STLO, UMR 1253, Rennes, France.; Even, S (corresponding author), Agrocampus Ouest, STLO, UMR1253, Rennes, France.	sergine.even@inra.fr	Azevedo, Vasco/B-1556-2019; LE LOIR, Yves/AAD-1879-2021; Humaran, Luis G. Bermudez/ABH-4168-2020; Azevedo, Vasco A.C/F-4315-2011; JARDIN, Julien/A-3241-2012; BERMUDEZ, Luis/AAE-8917-2021; Seyffert, Nubia/N-6410-2014; Langella, Philippe/N-8368-2017; Monedero, Vicente/H-3876-2012	Azevedo, Vasco/0000-0002-4775-2280; Humaran, Luis G. Bermudez/0000-0001-7525-3131; Azevedo, Vasco A.C/0000-0002-4775-2280; JARDIN, Julien/0000-0003-0520-9391; Seyffert, Nubia/0000-0002-2193-6508; Langella, Philippe/0000-0001-5960-4341; Monedero, Vicente/0000-0001-7461-8047; Le Loir, Yves/0000-0002-0355-1065	Institut National de la Recherche Agronomique (INRA/France); Coordenacao de Aperfeicoamento de PessoaldeEnsinoSuperior (CAPES/Brazil); PhD fellowship from Coordenacao de Aperfeicoamento de Pessoalde Ensino Superior (CAPES-COFECUB/Brazil); INRA-funded GISA project (Ruminflame)	Institut National de la Recherche Agronomique (INRA/France); Coordenacao de Aperfeicoamento de PessoaldeEnsinoSuperior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PhD fellowship from Coordenacao de Aperfeicoamento de Pessoalde Ensino Superior (CAPES-COFECUB/Brazil); INRA-funded GISA project (Ruminflame)	The work was supported by Institut National de la Recherche Agronomique (INRA/France) and Coordenacao de Aperfeicoamento de PessoaldeEnsinoSuperior (CAPES/Brazil) and RS was the recipient of a PhD fellowship from Coordenacao de Aperfeicoamento de Pessoalde Ensino Superior (CAPES-COFECUB/Brazil). Part of this work was financially supported by the INRA-funded GISA project (Ruminflame). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin AA, 2008, J CROHNS COLITIS, V2, P296, DOI 10.1016/j.crohns.2008.04.002; Allignet J, 2002, FEMS MICROBIOL LETT, V213, P193, DOI 10.1016/S0378-1097(02)00813-3; Amara AA, 2015, SAUDI PHARM J, V23, P107, DOI 10.1016/j.jsps.2013.07.001; Baron F, 2006, LAIT, V86, P251, DOI 10.1051/lait:2006005; Bidart GN, 2016, APPL ENVIRON MICROB, V82, P570, DOI 10.1128/AEM.02888-15; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Blein-Nicolas M, 2015, MOL CELL PROTEOMICS, V14, P2056, DOI 10.1074/mcp.M115.048058; Bouchard DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144831; Bouchard DS, 2013, APPL ENVIRON MICROB, V79, P877, DOI 10.1128/AEM.03323-12; Bron PA, 2007, J APPL MICROBIOL, V103, P1424, DOI 10.1111/j.1365-2672.2007.03376.x; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Cousin FJ, 2012, J AGR FOOD CHEM, V60, P7917, DOI 10.1021/jf302245m; Crispie F, 2008, J DAIRY RES, V75, P374, DOI 10.1017/S0022029908003385; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Nader-Macias MEF, 2008, J IND MICROBIOL BIOT, V35, P1387, DOI 10.1007/s10295-008-0438-2; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Frola ID, 2012, J DAIRY RES, V79, P84, DOI 10.1017/S0022029911000835; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Goh YJ, 2013, MOL MICROBIOL, V89, P1187, DOI 10.1111/mmi.12338; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Khani Soghra, 2012, Inflammation & Allergy Drug Targets, V11, P79; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Klostermann K, 2008, J DAIRY RES, V75, P365, DOI 10.1017/S0022029908003373; Kumar S, 2013, PLOS ONE; Langella O, 2017, J PROTEOME RES, V16, P494, DOI 10.1021/acs.jproteome.6b00632; Le Marechal C, 2015, J PROTEOMICS, V113, P447, DOI 10.1016/j.jprot.2014.07.018; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Leisner JJ, 2012, INT J FOOD MICROBIOL, V152, P107, DOI 10.1016/j.ijfoodmicro.2011.05.012; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Mariscotti JF, 2014, INT J MED MICROBIOL, V304, P393, DOI 10.1016/j.ijmm.2014.01.003; Martinez RCR, 2009, LETT APPL MICROBIOL, V48, P269, DOI 10.1111/j.1472-765X.2008.02477.x; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Miyoshi Anderson, 2003, Genet Mol Res, V2, P348; Motulsky H., 2007, GRAPHPAD SOFTW, V31, P39; Munoz-Provencio D, 2012, APPL ENVIRON MICROB, V78, P8684, DOI 10.1128/AEM.02287-12; Ocana VS, BR J BIOMED SCI; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Peton V, 2014, VET RES, V45, DOI 10.1186/s13567-014-0106-7; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Provencio D, 2010, J APPL MICROBIOL, V108, P1050; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Raz A, 2015, PLOS ONE; Reid G, 2002, MICROBES INFECT, V4, P319, DOI 10.1016/S1286-4579(02)01544-7; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Sankova A R, 2011, CELL MOL IMMUNOL, V8, P110; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wang LL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12731; Wang WF, 2016, MOL BIOSYST, V12, P1420, DOI 10.1039/c5mb00550g; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	59	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174060	10.1371/journal.pone.0174060	http://dx.doi.org/10.1371/journal.pone.0174060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323870	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000056
J	Stratigopoulou, P; Paul, A; Hoyer, DP; Kykalos, S; Saner, FH; Sotiropoulos, GC				Stratigopoulou, Panagiota; Paul, Andreas; Hoyer, Dieter P.; Kykalos, Stylianos; Saner, Fuat H.; Sotiropoulos, Georgios C.			High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome	PLOS ONE			English	Article							LENGTH-OF-STAY; DONOR RISK INDEX; DISEASE MELD; ECONOMIC-IMPACT; MODEL; RECIPIENTS; ALLOCATION; SURVIVAL; CARE; MORTALITY	Background The aim of the present study is to determine the incidence of a prolonged (>3 days) initial ICU-stay after liver transplantation (LT) and to identify risk factors for it. Patients and methods We retrospectively analyzed data of adult recipients who underwent deceased donor first LT at the University Hospital Essen between 11/2003 and 07/2012 and showed a primary graft function. Results Of the 374 recipients, 225 (60.16%) had prolonged ICU-stay. On univariate analysis, donor INR, high doses of vasopressors, "rescue-offer" grafts, being hospitalized at transplant, high urgency cases, IabMELD, alcoholic cirrhosis, being on renal dialysis and length of surgery were associated with prolonged ICU-stay. After multivariate analysis, only the IabMELD and the operation's length were independently correlated with prolonged ICU-stay. Cut-off values for these variables were 19 and 293.5 min, respectively. Hospital stay was longer for patients with a prolonged initial ICU-stay (p<0.001). Survival rates differed significantly between the two groups at 3 months, 1-year and 5-years after LT (p<0.001). Conclusions LabMELD and duration of LT were identified as independent predictors for prolonged ICU-stay after LT. Identification of recipients in need of longer ICU-stay could contribute to a more evidenced-based and cost-effective use of ICU facilities in transplant centers.	[Stratigopoulou, Panagiota; Paul, Andreas; Hoyer, Dieter P.; Kykalos, Stylianos; Saner, Fuat H.; Sotiropoulos, Georgios C.] Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany	University of Duisburg Essen	Kykalos, S (corresponding author), Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany.	kykalos@gmail.com	Saner, Fuat H/W-8024-2019; Kykalos, Stylianos/ABF-1966-2021					Axelrod DA, 2007, AM J TRANSPLANT, V7, P990, DOI 10.1111/j.1600-6143.2006.01724.x; Axelrod DA, 2005, AM J TRANSPLANT, V5, P2297, DOI 10.1111/j.1600-6143.2005.01025.x; Biancofiore G, 2005, LIVER TRANSPLANT, V11, P967, DOI 10.1002/lt.20515; Bruns H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098782; Buchanan P, 2009, LIVER TRANSPLANT, V15, P1270, DOI 10.1002/lt.21802; CARTON EG, 1994, ANESTH ANALG, V78, P382, DOI 10.1213/00000539-199402000-00031; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Dutkowski P, 2011, LIVER TRANSPLANT, V17, P674, DOI 10.1002/lt.22228; Earl TM, 2008, TRANSPLANTATION, V86, P238, DOI 10.1097/TP.0b013e3181778d54; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Foxton MR, 2010, LIVER TRANSPLANT, V16, P668, DOI 10.1002/lt.22027; Gastaca M, 2012, TRANSPL P, V44, P1554, DOI [10.1016/j.transproceed.2012.05.025, 10.1016/j.transproceed.2012.05.008]; Hong JC, 2011, ANN SURG, V254, P444, DOI 10.1097/SLA.0b013e31822c5878; Hoyer DP, 2015, LIVER INT, V35, P156, DOI 10.1111/liv.12443; Mandell MS, 2007, LIVER TRANSPLANT, V13, P1557, DOI 10.1002/lt.21263; Oberkofler CE, 2010, CRIT CARE, V14, DOI 10.1186/cc9068; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x; Razonable RR, 2011, LIVER TRANSPLANT, V17, P511, DOI 10.1002/lt.22291; Salvalaggio PR, 2011, LIVER TRANSPLANT, V17, P233, DOI 10.1002/lt.22230; Smith JO, 2009, LIVER TRANSPLANT, V15, P273, DOI 10.1002/lt.21731; Taner CB, 2012, LIVER TRANSPLANT, V18, P361, DOI 10.1002/lt.22459; Washburn WK, 2006, AM J TRANSPLANT, V6, P2449, DOI 10.1111/j.1600-6143.2006.01490.x; Washburn WK, 2009, LIVER TRANSPLANT, V15, P1570, DOI 10.1002/lt.21858; Weismuller TJ, 2011, TRANSPL INT, V24, P91, DOI 10.1111/j.1432-2277.2010.01161.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wong CS, 2010, LIVER TRANSPLANT, V16, P138, DOI 10.1002/lt.21969; Xia VW, 2008, CURR OPIN ORGAN TRAN, V13, P280, DOI 10.1097/MOT.0b013e328300a070; Xia VW, 2006, LIVER TRANSPLANT, V12, P614, DOI 10.1002/lt.20679	29	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174173	10.1371/journal.pone.0174173	http://dx.doi.org/10.1371/journal.pone.0174173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319169	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800056
J	Molla, AA; Gelagay, AA				Molla, Abiyot Abeje; Gelagay, Abebaw Addis			Risky sexual practice and associated factors among HIV positive adults attending anti-retroviral treatment clinic at Gondar University Referral Hospital, Northwest Ethiopia	PLOS ONE			English	Article							THERAPY; BEHAVIORS	Introduction Risky sexual practice among people living with HIV/AIDS is a public health concern because of the risk of transmission of the virus to sero-discordant partner/s. There is also the risk of re-infection with new, drug resistant viral strains between sero-concordant partners. However, there is lack of information on risky sexual practices among HIV positive adults. Therefore, this study aimed to assess risky sexual practice and associated factors among adult HIV positive clients at Gondar University Referral Hospital, Northwest Ethiopia, 2015. Methods An institution based cross sectional study was conducted at Gondar University Referral Hospital from May to June 2015. A pretested structured questionnaire was used to collect the data. Using systematic random sampling technique, a total of 513 respondents were participated in this study. The data were entered into EPI info version 3.5.3 and transferred to SPSS version 20 for analysis. Descriptive, bivariate and multivariate analyses were done. A P-value <0.05 was considered to determine the statistical significance of the association between factors (independent variables) and risky sexual practice. The Odds ratio was also used to determine the presence and the degree of association between the dependent and independent variables. Results A total of 513 respondents were participated in this study. The prevalence of risky sexual practices in the past three months was 38% (95% CI: 33.3%, 42.3%). Being in the age range of 18-29 years (AOR = 2.63, 95% CI: 1.55, 4.47) and 30-39 years (AOR = 2.29, 95% CI: 1.48, 3.53), being single (AOR = 6.32, 95%CI: 2.43, 16.44),being married (AOR = 6.06,95% CI: 2.81, 13.07), having no child (AOR = 2.58, 95% CI: 1.17, 5.72), and a CD4 count of greater than 500/mm(3) were factors significantly associated with risky sexual practices. Conclusions A considerable number of HIV positive clients had risky sexual practices. It is strongly recommended that the Regional Health Bureau and health service providers working at Gondar University Hospital especially in the ART Clinic need to work hard on behavioral change communication.	[Molla, Abiyot Abeje] Univ Gondar Hosp, Gondar, Ethiopia; [Gelagay, Abebaw Addis] Univ Gondar, Dept Reprod Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Gelagay, AA (corresponding author), Univ Gondar, Dept Reprod Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	abebaw.addis@gmail.com						Allen C, 2011, CULT HEALTH SEX, V13, P529, DOI 10.1080/13691058.2011.558593; Bajunirwe F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-430; Demissie K, 2015, HIV AIDS-RES PALLIAT, V7, P183, DOI 10.2147/HIV.S78300; Dessie Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-422; Engedashet E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-56; Federal Democratic Republic of Ethiopia, 2014, COUNTR PROGR REP HIV; Fu TC, 2012, AIDS, V26, P2383, DOI 10.1097/QAD.0b013e32835ad438; Gerbi GB, 2009, J SUBST USE, V14, P90, DOI 10.1080/14659890802624261; Ikechebelu JI, 2009, NIGER J CLIN PRACT, V12, P416; Madiba S., 2014, WORLD J AIDS, V2014, P43584, DOI [10.4236/wja.2014.41008, DOI 10.4236/WJA.2014.41008]; Mhalu A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17342; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Ncube N M, 2012, Ghana Med J, V46, P27; Ragnarsson A, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-20; Thanh DC, 2009, AIDS BEHAV, V13, P1151, DOI 10.1007/s10461-008-9451-8; UNAI DS, 2014, FACT SHEET GLOBAL ST; UNAI DS, 2015, AIDS NUMB WORLD AIDS; Yalew E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-308; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-636	19	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174267	10.1371/journal.pone.0174267	http://dx.doi.org/10.1371/journal.pone.0174267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350810	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174400021
J	Chen, GJ; Zhang, ZJ; Adebamowo, SN; Liu, GZ; Adeyemo, A; Zhou, YX; Doumatey, AP; Wang, CT; Zhou, J; Yan, WQ; Shriner, D; Tekola-Ayele, F; Bentley, AR; Jiang, CQ; Rotimi, CN				Chen, Guanjie; Zhang, Zhenjian; Adebamowo, Sally N.; Liu, Guozheng; Adeyemo, Adebowale; Zhou, Yanxun; Doumatey, Ayo P.; Wang, Chuntao; Zhou, Jie; Yan, Wenqiang; Shriner, Daniel; Tekola-Ayele, Fasil; Bentley, Amy R.; Jiang, Congqing; Rotimi, Charles N.			Common and rare exonic MUC5B variants associated with type 2 diabetes in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-I; SUSCEPTIBILITY LOCI; P38 MAPK; PROMOTER POLYMORPHISM; GENETIC ARCHITECTURE; RISK LOCI; INSULIN; METAANALYSIS; POPULATION	Genome-wide association studies have identified over one hundred common genetic risk variants associated with type 2 diabetes (T2D). However, most of the heritability of T2D has not been accounted for. In this study, we investigated the contribution of rare and common variants to T2D susceptibility by analyzing exome array data in 1,908 Han Chinese genotyped with Affymetrix Axiom Exome Genotyping Arrays. Based on the joint common and rare variants analysis of 57,704 autosomal SNPs within 12,244 genes using Sequence Kernel Association Tests (SKAT), we identified significant associations between T2D and 25 variants (9 rare and 16 common) in MUC5B, p-value 1.01 x 10(-14). This finding was replicated (p = 0.0463) in an independent sample that included 10,401 unrelated individuals. Sixty-six of 1,553 possible haplotypes based on 25 SNPs within MUC5B showed significant association with T2D (Bonferroni corrected p values < 3.2x10(-5)). The expression level of MUC5B is significantly higher in pancreatic tissues of persons with T2D compared to those without T2D (p-value = 5x10(-5)). Our findings suggest that dysregulated MUC5B expression may be involved in the pathogenesis of T2D. As a strong candidate gene for T2D, MUC5B may play an important role in the mechanisms underlying T2D etiology and its complications.	[Chen, Guanjie; Adebamowo, Sally N.; Adeyemo, Adebowale; Doumatey, Ayo P.; Zhou, Jie; Shriner, Daniel; Tekola-Ayele, Fasil; Bentley, Amy R.; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Zhang, Zhenjian; Liu, Guozheng; Zhou, Yanxun; Wang, Chuntao; Yan, Wenqiang; Jiang, Congqing] Suizhou Cent Hosp, Suizhou, Hubei, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chen, GJ; Rotimi, CN (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	chengu@mail.nih.gov; rotimic@mail.nih.gov		Tekola-Ayele, Fasil/0000-0003-4194-9370; Adeyemo, Adebowale/0000-0002-3105-3231; Shriner, Daniel/0000-0003-1928-5520	Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology; Office of the Director at the National Institutes of Health [Z01HG200362]; National Institutes of Health [Z01HG200362]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Human Genome Research Institute [U01HG004402]; NHLBI [R01 HL46380, N01-HC-65226, N02-HL-64278]; Jackson State University [HHSN268201300049C, HHSN268201300050C]; Tougaloo College [HHSN268201300048C]; University of Mississippi Medical Center [HHSN268201300046C, HHSN268201300047C]; National Heart, Lung, and Blood Institute (NHLBI); National Institute for Minority Health and Health Disparities (NIMHD); MESA [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC -95168, N01-HC-95169]; CTSA [UL1-RR-024156]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); Office of the Director at the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jackson State University; Tougaloo College; University of Mississippi Medical Center; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); MESA; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is supported by the National Human Genome Research Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Center for Information Technology, and the Office of the Director at the National Institutes of Health (Z01HG200362). National Institutes of Health (US), Z01HG200362, Dr. Charles N Rotimi. The Atherosclerosis Risk in Communities Study (ARIC) is a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). GENEVA was provided by National Human Genome Research Institute grant U01HG004402, E. Boerwinkle. The Cleveland Family Study is supported by NHLBI grant number R01 HL46380, and genotyping was supported by NHLBI Contract N01-HC-65226. The Jackson Heart Study is supported and conducted in collaboration with Jackson State University (HHSN268201300049C and HHSN268201300050C), Tougaloo College (HHSN268201300048C), and the University of Mississippi Medical Center (HHSN268201300046C and HHSN268201300047C) contracts from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute for Minority Health and Health Disparities (NIMHD). CARe genotyping was provided by NHLBI Contract N01-HC-65226. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. MESA is supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and CTSA UL1-RR-024156. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Adeyemo AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00335; Ardigo Diego, 2004, Current Drug Targets - Inflammation and Allergy, V3, P455, DOI 10.2174/1568010042634488; Bae CH, 2013, BIOCHEM BIOPH RES CO, V430, P683, DOI 10.1016/j.bbrc.2012.11.091; Bahamondes V, 2011, ARTHRITIS RHEUM-US, V63, P3126, DOI 10.1002/art.30500; Bao W, 2007, J CARDIOVASC PHARM, V49, P362, DOI 10.1097/FJC.0b013e318046f34a; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Clauson PG, 1998, SCAND J CLIN LAB INV, V58, P353, DOI 10.1080/00365519850186544; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; da Costa SR, 2006, EXP EYE RES, V82, P33, DOI 10.1016/j.exer.2005.04.019; Dean DA, 2016, SLEEP, V39, P1151, DOI 10.5665/sleep.5774; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Federation ID, 2015, IDF DIAB ATL UPD POS; Fox ER, 2011, DIABETES CARE, V34, P507, DOI 10.2337/dc10-0838; Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E; Goldman MD, 2003, DIABETES CARE, V26, P1915, DOI 10.2337/diacare.26.6.1915; GUM JR, 1992, J BIOL CHEM, V267, P21375; Hanson RL, 2014, DIABETES, V63, P369, DOI 10.2337/db13-0416; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Kaparianos A, 2008, Chron Respir Dis, V5, P101, DOI 10.1177/1479972307086313; Kessler L, 1998, DIABETES METAB, V24, P327; Lal AS, 1999, BIOCHEM BIOPH RES CO, P259; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Ma RCW, 2014, LANCET DIABETES ENDO, V2, P980, DOI 10.1016/S2213-8587(14)70145-7; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marvisi Maurizio, 1996, Recenti Progressi in Medicina, V87, P623; Mathai SK, 2016, THORAX; Moehle C, 2006, J MOL MED, V84, P1055, DOI 10.1007/s00109-006-0100-2; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Nicolaie T, 2003, Rom J Intern Med, V41, P365; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; SANDLER M, 1990, ARCH INTERN MED, V150, P1385, DOI 10.1001/archinte.150.7.1385; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yoo BK, 2008, NEUROCHEM INT, V52, P1188, DOI 10.1016/j.neuint.2007.12.009; Yu B, 2013, GENET EPIDEMIOL, V37, P840, DOI 10.1002/gepi.21752; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhu QQ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001901	67	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173784	10.1371/journal.pone.0173784	http://dx.doi.org/10.1371/journal.pone.0173784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346466	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300012
J	Hinton, BJ; Fan, B; Ng, BK; Shepherd, JA				Hinton, Benjamin J.; Fan, Bo; Ng, Bennett K.; Shepherd, John A.			Dual energy X-ray absorptiometry body composition reference values of limbs and trunk from NHANES 1999-2004 with additional visualization methods	PLOS ONE			English	Article							LEG LEAN MASS; FAT MASS; LMS METHOD; BMI; SARCOPENIA; INDEX; ASSOCIATION; PERCENTILES; DEFINITION; MORTALITY	Body Mass Index has traditionally been used as a measure of health, but Fat Mass Index (FMI) and Lean Mass Index (LMI) have been shown to be more predictive of mortality and health risk. Total body FMI and LMI reference curves have particularly been useful in quantifying sarcopenia and sarcopenic obesity. Research has shown regional composition has significant associations to health outcomes. We derived FMI and LMI reference curves of the regions of the body (leg, arm, and trunk) for 15,908 individuals in the 1999-2004 National Health and Nutrition Examination Survey data for each sex and ethnicity using the Lambda -Mu -Sigma (LMS) method and developed software to visualize this regional composition. These reference curves displayed differentiation between males and females during puberty and sharper limb LMI declines during late adulthood for males. For adults ages 3050, females had 39%, 83%, and 47% larger arm, leg, and trunk FMI values than males, respectively. Males had 49%, 20%, and 15% higher regional LMI values than females for the arms, legs, and trunk respectively. The leg FMI and LMI of black females were 14% and 15% higher respectively than those of Hispanic and white females. White and Hispanic males had 37% higher trunk FMI values than black males. Hispanic females had 20% higher trunk FMI than white and black females. These data underscore the importance of accounting for sex and ethnicity in studies of regional composition. This study is the first to produce regional LMI and FMI reference tables and curves from the NHANES dataset. These reference curves provide a framework useful in studies and research involving sarcopenia, obesity, sarcopenic obesity, and other studies of compositional phenotypes. Further, the software tool we provide for visualizing regional composition will prove useful in monitoring progress in physical therapy, diets, or other attempts to attain healthier compositions.	[Hinton, Benjamin J.; Fan, Bo; Ng, Bennett K.; Shepherd, John A.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Hinton, Benjamin J.; Ng, Bennett K.; Shepherd, John A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Hinton, Benjamin J.; Ng, Bennett K.; Shepherd, John A.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Hinton, BJ (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Hinton, BJ (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Hinton, BJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	bhinton@berkeley.edu	Shepherd, John/S-3146-2018	Shepherd, John/0000-0003-2280-2541; Ng, Bennett/0000-0003-4625-3161	Public Health Service Centers for Disease Control [200-2015-61352 MA, 200-201138445, 200-2011-38445T01, 200-2005-11219, 200-1999-07002, 200-2011-38445-T03]; National Science Foundation Graduate Research Fellowship Program [1144247]; National Institutes of Health Training [T32GM008155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109008] Funding Source: NIH RePORTER	Public Health Service Centers for Disease Control; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Centers for Disease Control (http://www.cdc.gov/) #200-2015-61352 MA, 200-201138445, 200-2011-38445T01, 200-2005-11219, 200-1999-07002, 200-2011-38445-T03 (Received by JAS); National Science Foundation Graduate Research Fellowship Program #1144247 (https://www.nsfgrfp.org/) (http://www.nst.gov/)(Received by BJH); and National Institutes of Health Training Grant #T32GM008155 (https://www.nih.gov/) (Received by BJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Centers for Disease Control and Prevention (CDC), 2015, NAT HLTH NUTR EX SUR; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; Fan B, 2014, J CLIN DENSITOM, V17, P344, DOI 10.1016/j.jocd.2013.08.019; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hart NH, 2014, J SPORT SCI MED, V13, P157; He Q, 2002, CIRCULATION, V105, P1093, DOI 10.1161/hc0902.104706; Jordan MJ, 2015, SCAND J MED SCI SPOR, V25, pe301, DOI 10.1111/sms.12314; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kranz S, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-38; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; MARTIN ML, 1991, J CLIN INVEST, V88, P609, DOI 10.1172/JCI115345; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Muller MJ, 2013, EUR J CLIN NUTR, V67, P1119, DOI 10.1038/ejcn.2013.174; Nussey S, 2001, ENDOCRINOLOGY INTEGR; Oyhenart EE, 2015, ANN HUM BIOL, V42, P439, DOI 10.3109/03014460.2014.968207; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Pang MYC, 2005, OSTEOPOROSIS INT, V16, P1769, DOI 10.1007/s00198-005-1925-1; Prado CMM, 2014, AM J CLIN NUTR, V99, P1369, DOI 10.3945/ajcn.113.078576; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Sakai Y, 2005, J INTERN MED, V257, P194, DOI 10.1111/j.1365-2796.2004.01432.x; Sanchis-Moysi J, 2010, EUR J APPL PHYSIOL, V110, P83, DOI 10.1007/s00421-010-1470-2; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Sood A, 2011, EUR RESPIR J, V37, P65, DOI 10.1183/09031936.00193709; Toth MJ, 2000, ANN NY ACAD SCI, V904, P502; Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001; Villaca DS, 2008, BR J NUTR, V100; Visser M, 2009, J NUTR HEALTH AGING, V13, P713, DOI 10.1007/s12603-009-0202-y; Weber DR, 2013, AM J CLIN NUTR, V98, P49, DOI 10.3945/ajcn.112.053611; Wells JCK, 2012, AM J CLIN NUTR, V96, P1316, DOI 10.3945/ajcn.112.036970; Williams MJ, 1997, AM J CLIN NUTR, V65, P855, DOI 10.1093/ajcn/65.3.855; Wilson JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068716	42	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174180	10.1371/journal.pone.0174180	http://dx.doi.org/10.1371/journal.pone.0174180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346492	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300028
J	Li, G; Lu, SG; Shen, MY; Le, S; Shen, W; Tan, YL; Wang, J; Zhao, X; Zhao, Y; Gong, YL; Yang, YH; Zhu, HB; Hu, FQ; Li, M				Li, Gang; Lu, Shuguang; Shen, Mengyu; Le, Shuai; Shen, Wei; Tan, Yinling; Wang, Jing; Zhao, Xia; Zhao, Yan; Gong, Yali; Yang, Yuhui; Zhu, Hongbin; Hu, Fuquan; Li, Ming			Characterization and interstrain transfer of prophage pp3 of Pseudomonas aeruginosa	PLOS ONE			English	Article							LYSOGENIC CONVERSION; BACTERIOPHAGE D3; PHAGE; GENOME; STREPTOCOCCUS; TOXIN; GENE; CHROMOSOMES; PATHOGEN; SEQUENCE	Prophages are major contributors to horizontal gene transfer and drive the evolution and diversification of bacteria. Here, we describe the characterization of a prophage element designated pp3 in the clinical Pseudomonas aeruginosa isolate PA1. pp3 spontaneously excises from the PA1 genome and circularizes at a very high frequency of 25%. pp3 is likely to be a defective prophage due to its inability to form plaques on P. aeruginosa indicator strains, and no phage particles could be detected in PA1 supernatants. The pp3-encoded integrase is essential for excision by mediating site-specific recombination at the 26-bp attachment sequence. Using a filter mating experiment, we demonstrated that pp3 can transfer into P. aeruginosa recipient strains that do not possess this element naturally. Upon transfer, pp3 integrates into the same attachment site as in PA1 and maintains the ability to excise and circularize. Furthermore, pp3 significantly promotes biofilm formation in the recipient. Sequence alignment reveals that the 26-bp attachment site recognized by pp3 is conserved in all P. aeruginosa strains sequenced to date, making it possible that pp3 could be extensively disseminated in P. aeruginosa. This work improves our understanding of the ways in which prophages influence bacterial behavior and evolution.	[Li, Gang; Lu, Shuguang; Shen, Mengyu; Le, Shuai; Shen, Wei; Tan, Yinling; Wang, Jing; Zhao, Xia; Zhao, Yan; Gong, Yali; Yang, Yuhui; Zhu, Hongbin; Hu, Fuquan; Li, Ming] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China	Army Medical University	Hu, FQ; Li, M (corresponding author), Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China.	hufuquan2009@aliyun.com; sotx7080@163.com		Le, Shuai/0000-0003-3748-5454	National Natural Science Foundation of China [31570173, 31370169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31570173) (FQH), and the National Natural Science Foundation of China (31370169) (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Davies EV, 2016, ISME J, V10, P2553, DOI 10.1038/ismej.2016.51; DeBardeleben HK, 2014, J BACTERIOL, V196, P2670, DOI 10.1128/JB.01556-14; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; FREEMAN VJ, 1951, J BACTERIOL, V61, P675, DOI 10.1128/JB.61.6.675-688.1951; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; James CE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-216; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Li G, 2016, TOXINS, V8, DOI 10.3390/toxins8040113; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Lu S, 2015, GENOME ANNOUNC, V3; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; Masak J, 2014, FEMS MICROBIOL ECOL, V89, P1, DOI 10.1111/1574-6941.12344; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Nanda AM, 2015, J BACTERIOL, V197, P410, DOI 10.1128/JB.02230-14; Newton GJ, 2001, MOL MICROBIOL, V39, P1237, DOI 10.1046/j.1365-2958.2001.02311.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Rabinovich L, 2012, CELL, V150, P792, DOI 10.1016/j.cell.2012.06.036; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; Scott J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00317; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wang XX, 2016, DRUG RESIST UPDATE, V27, P30, DOI 10.1016/j.drup.2016.06.001; Wang XM, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/465915; Wegrzyn G, 2012, ADV VIRUS RES, V82, P155, DOI 10.1016/B978-0-12-394621-8.00016-9; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Yang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38795; Zeng Z, 2016, ISME J; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	44	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174429	10.1371/journal.pone.0174429	http://dx.doi.org/10.1371/journal.pone.0174429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346467	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300045
J	Liehr, M; Mereu, A; Pastor, JJ; Quintela, JC; Staats, S; Rimbach, G; Ipharraguerre, IR				Liehr, Martin; Mereu, Alessandro; Javier Pastor, Jose; Carlos Quintela, Jose; Staats, Stefanie; Rimbach, Gerald; Rodolfo Ipharraguerre, Ignacio			Olive oil bioactives protect pigs against experimentally-induced chronic inflammation independently of alterations in gut microbiota	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC INTESTINAL INFLAMMATION; TUMOR-NECROSIS-FACTOR; CELL-LINE CACO-2; BARRIER FUNCTION; EPITHELIAL BARRIER; ANIMAL-MODELS; TNF-ALPHA; PERMEABILITY; POLYPHENOLS	Subclinical chronic inflammation (SCI) is associated with impaired animal growth. Previous work has demonstrated that olive-derived plant bioactives exhibit anti-inflammatory properties that could possibly counteract the growth-depressing effects of SCI. To test this hypothesis and define the underlying mechanism, we conducted a 30-day study in which piglets fed an olive-oil bioactive extract (OBE) and their control counterparts (C+) were injected repeatedly during the last 10 days of the study with increasing doses of Escherichia coli lipopolysaccharides (LPS) to induce SCI. A third group of piglets remained untreated throughout the study and served as a negative control (C-). In C+ pigs, SCI increased the circulating concentration of interleukin 1 beta (p < 0.001) and decreased feed ingestion (p < 0.05) and weight gain (p < 0.05). These responses were not observed in OBE animals. Although intestinal inflammation and colonic microbial ecology was not altered by treatments, OBE enhanced ileal mRNA abundance of tight and adherens junctional proteins (p < 0.05) and plasma recovery of mannitol (p < 0.05) compared with C+ and C-. In line with these findings, OBE improved transepithelial electrical resistance (p < 0.01) in TNF-alpha-challenged Caco-2/TC-7 cells, and repressed the production of inflammatory cytokines (p < 0.05) in LPS-stimulated macrophages. In summary, this work demonstrates that OBE attenuates the suppressing effect of SCI on animal growth through a mechanism that appears to involve improvements in intestinal integrity unrelated to alterations in gut microbial ecology and function.	[Liehr, Martin; Staats, Stefanie; Rimbach, Gerald; Rodolfo Ipharraguerre, Ignacio] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [Mereu, Alessandro; Javier Pastor, Jose; Rodolfo Ipharraguerre, Ignacio] Lucta SA, Barcelona, Spain; [Carlos Quintela, Jose] ProNutra Solut SL, Madrid, Spain; [Mereu, Alessandro] Yara Int, Oslo, Norway	University of Kiel	Ipharraguerre, IR (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany.; Ipharraguerre, IR (corresponding author), Lucta SA, Barcelona, Spain.	ipharraguerre@foodsci.uni-kiel.de	Rimbach, Gerald/A-7178-2011; Pastor, Jose J./S-1931-2016; Ipharraguerre, Ignacio R/X-3196-2019	Rimbach, Gerald/0000-0001-7888-4684; Pastor, Jose J./0000-0003-2448-2334; Ipharraguerre, Ignacio R/0000-0003-1105-6600	Kiel University (Kiel, Germany); Lucta S.A. (Barcelona, Spain); ProNutra Solutions S.L. (Madrid, Spain); Lucta S.A.	Kiel University (Kiel, Germany); Lucta S.A. (Barcelona, Spain); ProNutra Solutions S.L. (Madrid, Spain); Lucta S.A.	This work was funded by Kiel University (Kiel, Germany), Lucta S.A. (Barcelona, Spain) and ProNutra Solutions S.L. (Madrid, Spain). Funders provided support in the form of salaries for authors [ML, AM, JJP, JCQ, SS, GR and IRI]. In addition, Lucta S.A. provided partial funding support and research material (olive-oil bioactive extract). Funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the indicated forms. The specific roles of the authors are articulated in the 'author contributions' section.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Martin MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159; Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Bayram B, 2013, FOOD CHEM, V138, P1663, DOI 10.1016/j.foodchem.2012.11.122; Bayram B, 2012, PLANT FOOD HUM NUTR, V67, P326, DOI 10.1007/s11130-012-0315-z; Benavente-Garcia O, 2000, FOOD CHEM, V68, P457, DOI 10.1016/S0308-8146(99)00221-6; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; BORENFREUND E, 1985, XENOBIOTICA, V15, P705, DOI 10.3109/00498258509047431; BRETDIBAT JL, 1995, BRAIN BEHAV IMMUN, V9, P242, DOI 10.1006/brbi.1995.1023; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cani PD, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03866.x; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caramia G, 2012, EUR J LIPID SCI TECH, V114, P375, DOI 10.1002/ejlt.201100164; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Catalan U, 2015, MOL NUTR FOOD RES, V59, P2523, DOI 10.1002/mnfr.201500361; CHANTRET I, 1994, J CELL SCI, V107, P213; Chen YL, 2016, EXP THER MED, V11, P1116, DOI 10.3892/etm.2015.2963; Corona G, 2007, BIOCHEM BIOPH RES CO, V362, P606, DOI 10.1016/j.bbrc.2007.08.049; Cray C, 2009, COMPARATIVE MED, V59, P517; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; El SN, 2009, NUTR REV, V67, P632, DOI 10.1111/j.1753-4887.2009.00248.x; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Gessner D.K., 2016, J ANIM PHYSL ANIM NU; Ghanbari R, 2012, INT J MOL SCI, V13, P3291, DOI 10.3390/ijms13033291; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hwang Joon-Ho, 2014, Prev Nutr Food Sci, V19, P89, DOI 10.3746/pnf.2014.19.2.089; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Jiminez JA, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0076-y; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Mantovani G., 2006, CACHEXIA WASTING MOD; Marin L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/905215; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Mereu A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0588-1; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Mulinacci N, 2001, J AGR FOOD CHEM, V49, P3509, DOI 10.1021/jf000972q; Murakami M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00323; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Pastor A, 2016, J CHROMATOGR A, V1437, P183, DOI 10.1016/j.chroma.2016.02.016; Pastorelli H, 2012, ANIMAL, V6, P952, DOI 10.1017/S175173111100228X; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Pereira AP, 2007, MOLECULES, V12, P1153, DOI 10.3390/12051153; Piegholdt S, 2014, FREE RADICAL BIO MED, V70, P255, DOI 10.1016/j.freeradbiomed.2014.02.025; Piroddi M, 2016, BIOFACTORS; PLATASALAMAN CR, 1991, NEUROSCI BIOBEHAV R, V15, P185, DOI 10.1016/S0149-7634(05)80001-6; PLATASALAMAN CR, 1988, BRAIN RES, V448, P106, DOI 10.1016/0006-8993(88)91106-7; Pomorska-Mol M, 2014, INFLUENZA OTHER RESP, V8, P228, DOI 10.1111/irv.12186; Rakhshandeh A, 2012, ANIMAL, V6, P305, DOI 10.1017/S1751731111001522; Rakhshandeh A, 2010, LIVEST SCI, V134, P21, DOI 10.1016/j.livsci.2010.06.085; RALPH P, 1977, J IMMUNOL, V119, P950; Rodriguez-Rodriguez R, 2015, CURR MED CHEM, V22, P1414, DOI 10.2174/0929867322666141212122921; Romero C, 2010, FOOD CHEM, V118, P670, DOI 10.1016/j.foodchem.2009.05.037; Sanchez P, Edible olive pomace oil concentrated in triterpenic acids, procedure of physical refining utilised for obtainment thereof and recovery of functional compo-nents present in the crude oil. US Patent No, Patent No. [US8361518B2, 8361518B2]; Sanchez-Quesada C, 2013, J AGR FOOD CHEM, V61, P12173, DOI 10.1021/jf403154e; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; SUTO G, 1994, GASTROENTEROLOGY, V106, P1568; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Suzuki T, 2011, J NUTR BIOCHEM, V22, P401, DOI 10.1016/j.jnutbio.2010.08.001; Swiergiel AH, 1999, BRAIN BEHAV IMMUN, V13, P252, DOI 10.1006/brbi.1999.0565; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; UDEN P, 1980, J SCI FOOD AGR, V31, P625, DOI 10.1002/jsfa.2740310702; VANHEUGTEN E, 1994, J ANIM SCI, V72, P2661, DOI 10.2527/1994.72102661x; Visioli F, 2002, CRIT REV FOOD SCI, V42, P209, DOI 10.1080/10408690290825529; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang M, 2015, ILAR J, V56, P63, DOI 10.1093/ilar/ilv006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wells CL, 1999, J NUTR, V129, P634, DOI 10.1093/jn/129.3.634; Wyns H, 2015, VET IMMUNOL IMMUNOP, V166, P58, DOI 10.1016/j.vetimm.2015.06.001; Yap WH, 2015, BIOCHEM RES INT, V2015, DOI 10.1155/2015/279356	84	27	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174239	10.1371/journal.pone.0174239	http://dx.doi.org/10.1371/journal.pone.0174239			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346507	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174300034
J	Somogyi, B; Palffy, K; Balogh, KV; Botta-Dukat, Z; Voros, L				Somogyi, Boglarka; Palffy, Karoly; Balogh, Katalin V.; Botta-Dukat, Zoltan; Voros, Lajos			Unusual behaviour of phototrophic picoplankton in turbid waters	PLOS ONE			English	Article							AUTOTROPHIC PICOPLANKTON; SHALLOW LAKES; PHYTOPLANKTON SIZE; SUSPENDED CLAY; LIGHT QUALITY; BOTTOM-UP; TOP-DOWN; PICOPHYTOPLANKTON; MARINE; ECOSYSTEMS	Autotrophic picoplankton (APP) abundance and contribution to phytoplankton biomass was studied in Hungarian shallow lakes to test the effect of inorganic turbidity determining the size distribution of the phytoplankton. The studied lakes displayed wide turbidity (TSS: 4-2250 mg l(-1)) and phytoplankton biomass (chlorophyll a: 1-460 mu g l(-1)) range, as well as APP abundance (0 and 100 million cells ml(-1)) and contribution (0-100%) to total phytoplankton biomass. Inorganic turbidity had a significant effect on the abundance and contribution of APP, resulting in higher values compared to other freshwater lakes with the same phytoplankton biomass. Our analysis has provided empirical evidence for a switching point (50 mg l(-1) inorganic turbidity), above which turbidity is the key factor causing APP predominance regardless of phytoplankton biomass in shallow turbid lakes. Our results have shown that turbid shallow lakes are unique waters, where the formerly and widely accepted model (decreasing APP contribution with increasing phytoplankton biomass) is not applicable. We hypothesize that this unusual behaviour of APP in turbid waters is a result of either diminished underwater light intensity or a reduced grazing pressure due to high inorganic turbidity.	[Somogyi, Boglarka; Palffy, Karoly; Balogh, Katalin V.; Voros, Lajos] MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrobot, Tihany, Hungary; [Botta-Dukat, Zoltan] MTA Ctr Ecol Res, Inst Ecol & Bot, Dept Terr Ecol, Vacratot, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Somogyi, B (corresponding author), MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrobot, Tihany, Hungary.	somogyi.boglarka@okologia.mta.hu	Botta-Dukat, Zoltan/B-2911-2015	Botta-Dukat, Zoltan/0000-0002-9544-3474; Palffy, Karoly/0000-0003-2015-7972; Somogyi, Boglarka/0000-0003-0900-3315	European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0038]; Hungarian Scientific Research Fund [OTKA PD112449]; Bolyai Janos Research Grant (Hungarian Academy of Sciences)	European Social Fund(European Social Fund (ESF)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos Research Grant (Hungarian Academy of Sciences)	This work was supported by the European Social Fund in the framework of TAMOP-4.2.2.A-11/1/KONV-2012-0038 and by the Hungarian Scientific Research Fund (OTKA PD112449). BS was supported by the Bolyai Janos Research Grant (Hungarian Academy of Sciences).	Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; [Anonymous], 2014, R LANG ENV STAT COMP; Balogh K. V.-, 2009, HYDROBIOLOGIA, V632, P91, DOI DOI 10.1007/S10750-009-9830-9; Balogh K V, 2010, ACTA BIOL DEBR OECOL, V22, P75; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Boenigk J, 2004, AQUAT MICROB ECOL, V34, P181, DOI 10.3354/ame034181; Boros E, 2013, HORTOBAGY TERMESZETV; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Callieri C, 2007, AQUAT ECOL, V41, P511, DOI 10.1007/s10452-007-9125-z; Callieri Cristiana, 2002, Journal of Limnology, V61, P1; Callieri Cristiana, 2008, Freshwater Reviews, V1, P1, DOI 10.1608/FRJ-1.1.1; Carrick HJ, 1997, LIMNOL OCEANOGR, V42, P1613, DOI 10.4319/lo.1997.42.7.1613; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Craig SR, 1984, VERH INT VEREIN LIMN, V22, P351; Cronberg G., 1981, ALGOL STUD, V27, P101, DOI [10.1127/algol_stud/27/1981/101, DOI 10.1127/ALGOL_STUD/27/1981/101]; Crosbie ND, 2003, AQUAT MICROB ECOL, V33, P53, DOI 10.3354/ame033053; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Eaton AD, 1995, STAND METH CLIN CHEM; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; FOGG GE, 1995, AQUAT MICROB ECOL, V9, P33, DOI 10.3354/ame009033; Gervais F, 1997, J PLANKTON RES, V19, P771, DOI 10.1093/plankt/19.6.771; GLOVER HE, 1986, NATURE, V319, P142, DOI 10.1038/319142a0; Greisberger S, 2008, AQUAT ECOL, V42, P379, DOI 10.1007/s10452-007-9095-1; GROBBELAAR JU, 1985, J PLANKTON RES, V7, P653, DOI 10.1093/plankt/7.5.653; HART RC, 1988, FRESHWATER BIOL, V19, P123, DOI 10.1111/j.1365-2427.1988.tb00334.x; Hepperle D, 2001, INT REV HYDROBIOL, V86, P269, DOI 10.1002/1522-2632(200106)86:3<269::AID-IROH269>3.0.CO;2-7; Horn H, 2008, LIMNOLOGICA, V38, P302, DOI 10.1016/j.limno.2008.05.007; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; JACK JD, 1993, FRESHWATER BIOL, V29, P385, DOI 10.1111/j.1365-2427.1993.tb00773.x; JOHNSON PW, 1979, LIMNOL OCEANOGR, V24, P928, DOI 10.4319/lo.1979.24.5.0928; Kirk J.T.O, 1996, LIGHT PHOTOSYNTHESIS; KIRK KL, 1991, ECOLOGY, V72, P915, DOI 10.2307/1940593; Kuipers B, 2003, J SEA RES, V50, P1, DOI 10.1016/S1385-1101(03)00043-1; Loffler H., 1979, AQUAT BOT; MacIsaac EA, 1993, HDB METHODS AQUATIC, V30, P187; Malinsky-Rushansky N, 2002, J PLANKTON RES, V24, P1173, DOI 10.1093/plankt/24.11.1173; Miquelis A, 1998, HYDROBIOLOGIA, V386, P203, DOI 10.1023/A:1003540715749; MORRIS I, 1981, LIMNOL OCEANOGR, V26, P957, DOI 10.4319/lo.1981.26.5.0957; Moser M, 2009, J PLANKTON RES, V31, P349, DOI 10.1093/plankt/fbn123; Motwani NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079230; Palffy K, 2014, EXTREMOPHILES, V18, P111, DOI 10.1007/s00792-013-0602-0; Pfandl K, 2006, AQUAT MICROB ECOL, V45, P89, DOI 10.3354/ame045089; PLATT T, 1983, NATURE, V301, P702, DOI 10.1038/301702a0; PUTT M, 1985, J PLANKTON RES, V7, P779, DOI 10.1093/plankt/7.6.779; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Schagerl M, 2003, HYDROBIOLOGIA, V506, P297, DOI 10.1023/B:HYDR.0000008562.97458.d1; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Somogyi B, 2016, J GREAT LAKES RES; Somogyi B, 2010, ANN LIMNOL-INT J LIM, V46, P9, DOI 10.1051/limn/2010001; Somogyi B, 2009, AQUAT ECOL, V43, P735, DOI 10.1007/s10452-009-9269-0; STOCKNER JG, 1991, INT REV GES HYDROBIO, V76, P483, DOI 10.1002/iroh.19910760402; STOCKNER JG, 1986, CAN J FISH AQUAT SCI, V43, P2472, DOI 10.1139/f86-307; SzelagWasielewska E, 1997, HYDROBIOLOGIA, V342, P79, DOI 10.1023/A:1017005021243; Talling JF, 1971, VERH INT VER THEOR A, V19, P214; TOTH LG, 1986, ARCH HYDROBIOL, V106, P45; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Voros L, 2008, ACTA ZOOL ACAD SCI H, V54, P23; VOROS L, 1991, INT REV GES HYDROBIO, V76, P617, DOI 10.1002/iroh.19910760412; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P120; WATSON S, 1988, CAN J FISH AQUAT SCI, V45, P915, DOI 10.1139/f88-112; Weisse Thomas, 1993, Advances in Microbial Ecology, V13, P327; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Zelleis A, 2008, J COMPUT GRAPH STAT, V17, P492, DOI 10.1198/106186008X319331	66	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174316	10.1371/journal.pone.0174316	http://dx.doi.org/10.1371/journal.pone.0174316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346542	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000399174300038
J	Stankevicins, L; Barat, A; Dessen, P; Vassetzky, Y; Gallo, CVD				Stankevicins, L.; Barat, A.; Dessen, P.; Vassetzky, Y.; Gallo, C. V. de Moura			The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model	PLOS ONE			English	Article							TUMOR PROGRESSION; FOLLOW-UP; IN-VITRO; EXPRESSION; MIR-205; CELLS; CLASSIFICATION; PROLIFERATION; CARCINOMA; PROTEIN	MicroRNA is a class of noncoding RNAs able to base pair with complementary messenger RNA sequences, inhibiting their expression. These regulatory molecules play important roles in key cellular processes including cell proliferation, differentiation and response to DNA damage; changes in miRNA expression are a common feature of human cancers. To gain insights into the mechanisms involved in breast cancer progression we conducted a microRNA global expression analysis on a 21T series of cell lines obtained from the same patient during different stages of breast cancer progression. These stages are represented by cell lines derived from normal epithelial (H16N2), atypical ductal hyperplasia (21 PT), primary in situ ductal carcinoma (21NT) and pleural effusion of a lung metastasis (21 MT-1 and 21 MT-2). In a global microRNA expression analysis, miR-205-5p was the only miRNA to display an important downregulation in the metastatic cell lines (21MT-1; 21MT-2) when compared to the non-invasive cells (21 PT and 21 NT). The lower amounts of miR-205-5p found also correlated with high histological grades biopsies and with higher invasion rates in a Boyden chamber assay. This work pinpoints miR-205-5p as a potential player in breast tumor invasiveness.	[Stankevicins, L.; Gallo, C. V. de Moura] Univ Estado Rio de Janeiro, Dept Genet, Inst Biol Roberto Alcantara Gomes, Rio De Janeiro, Brazil; [Stankevicins, L.; Barat, A.; Vassetzky, Y.] Univ Paris Sud, Inst Cancerol Gustave Roussy, CNRS, UMR Signalisat Noyaux & Innovat Cancerol 8126, Villejuif, France; [Dessen, P.] Inst Cancerol Gustave Roussy, Funct Genom Unit, Villejuif, France; [Vassetzky, Y.] NK Koltzov Inst Dev Biol RAS, Moscow, Russia; [Stankevicins, L.] Saarland Univ, Dept Phys, Saarbrucken, Germany	Universidade do Estado do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Saarland University	Gallo, CVD (corresponding author), Univ Estado Rio de Janeiro, Dept Genet, Inst Biol Roberto Alcantara Gomes, Rio De Janeiro, Brazil.	claudia.gallo@pq.cnpq.br	Vassetzky, Yegor S/C-6447-2008	Vassetzky, Yegor S/0000-0003-3101-7043	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (Capes)-Programa CAPES-COFECUB [287/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474506/20096]; Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/111.310/2011]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (Capes)-Programa CAPES-COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funded by 1 - Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (Capes)-Programa CAPES-COFECUB, no 287/2008 Scientific missions and fellowship www.capes.gov. br. 2- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), no 474506/20096 reagents WWW.cnpq.br. 3- Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), no E-26/111.310/2011 reagents www.faperj.br.	Adachi R, 2011, BIOCHEM BIOPH RES CO, V411, P804, DOI 10.1016/j.bbrc.2011.07.033; BAND V, 1990, CANCER RES, V50, P7351; Bray F, 2015, INT J CANCER, V137, P2060, DOI 10.1002/ijc.29670; Chao CH, 2014, J CLIN INVEST, V124, P3093, DOI 10.1172/JCI73351; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gong C, 2015, ONCOGENE, V34, P84, DOI 10.1038/onc.2013.525; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Huo D, 2016, ONCOTARGET; Huo L, 2016, MODERN PATHOL, V29, P330, DOI 10.1038/modpathol.2016.38; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Kim MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33899; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; LIU XL, 1994, CARCINOGENESIS, V15, P1969, DOI 10.1093/carcin/15.9.1969; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhavan D, 2016, CARCINOGENESIS, V37, P461, DOI 10.1093/carcin/bgw008; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Mei ZF, 2014, FEBS LETT, V588, P3055, DOI 10.1016/j.febslet.2014.06.020; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muhammad N, 2016, ONCOTARGET; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Santos GC, 2015, J CELL BIOCHEM, V116, P533, DOI 10.1002/jcb.25003; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Song HM, 2015, INT J CLIN EXP PATHO, V8, P9889; Souter LH, 2010, LAB INVEST, V90, P1247, DOI 10.1038/labinvest.2010.97; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Wu ZY, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0235-8; Yang GJ, 2016, EXP MOL PATHOL, V100, P160, DOI 10.1016/j.yexmp.2015.12.010; Zhang WC, 2014, TUMOR BIOL, V35, P6235, DOI 10.1007/s13277-014-2202-8	38	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173756	10.1371/journal.pone.0173756	http://dx.doi.org/10.1371/journal.pone.0173756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346474	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174300011
J	Hakim, CH; Mijailovic, A; Lessa, TB; Coates, JR; Shin, C; Rutkove, SB; Duan, D				Hakim, Chady H.; Mijailovic, Alex; Lessa, Thais B.; Coates, Joan R.; Shin, Carmen; Rutkove, Seward B.; Duan, Dongsheng			Non-invasive evaluation of muscle disease in the canine model of Duchenne muscular dystrophy by electrical impedance myography	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRIAL; AGE; TRANSDUCTION; ANESTHESIA; BIOMARKER; DESIGN; DOGS	Dystrophin-deficient dogs are by far the best available large animal models for Duchenne muscular dystrophy (DMD), the most common lethal childhood muscle degenerative disease. The use of the canine DMD model in basic disease mechanism research and translational studies will be greatly enhanced with the development of reliable outcome measures. Electrical impedance myography (EIM) is a non-invasive painless procedure that provides quantitative data relating to muscle composition and histology. EIM has been extensively used in neuromuscular disease research in both human patients and rodent models. Recent studies suggest that EIM may represent a highly reliable and convenient outcome measure in DMD patients and the mdx mouse model of DMD. To determine whether EIM can be used as a biomarker of disease severity in the canine model, we performed the assay in fourteen young (similar to 6.6-m-old; 6 normal and 8 affected) and ten mature (similar to 16.9-m-old; 4 normal and 6 affected) dogs of mixed background breeds. EIM was well tolerated with good inter-rater reliability. Affected dogs showed higher resistance, lower reactance and phase. The difference became more straightforward in mature dogs. Importantly, we observed a statistically significant correlation between the EIM data and muscle fibrosis. Our results suggest that EIM is a valuable objective measurement in the canine DMD model.	[Hakim, Chady H.; Lessa, Thais B.; Duan, Dongsheng] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Mijailovic, Alex; Shin, Carmen; Rutkove, Seward B.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Coates, Joan R.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Duan, Dongsheng] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Duan, Dongsheng] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA; [Duan, Dongsheng] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA; [Hakim, Chady H.] NCATS, Bethesda, MD USA	University of Missouri System; University of Missouri Columbia; Harvard University; Beth Israel Deaconess Medical Center; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Duan, D (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.; Rutkove, SB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.; Duan, D (corresponding author), Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA.; Duan, D (corresponding author), Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA.; Duan, D (corresponding author), Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.	srutkove@bidmc.harvard.edu; duand@missouri.edu		Rutkove, Seward/0000-0002-6375-3312; Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [NS-90634, AR-70517, NS-055099]; Department of Defense , Jesse's Journey-The Foundation for Gene and Cell Therapy and Hope for Javier [MD130014]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense , Jesse's Journey-The Foundation for Gene and Cell Therapy and Hope for Javier; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NS-90634 and AR-70517 to DD; NS-055099 to SBR), Department of Defense (MD130014 to DD), Jesse's Journey-The Foundation for Gene and Cell Therapy (to DD) and Hope for Javier (to DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron R, 2006, PHYSIOL MEAS, V27, P953, DOI 10.1088/0967-3334/27/10/002; Ahad MA, 2009, CLIN NEUROPHYSIOL, V120, P1534, DOI 10.1016/j.clinph.2009.05.017; Birmingham K, 1997, NAT MED, V3, P1058, DOI 10.1038/nm1097-1058a; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; Duan DS, 2015, HUM GENE THER CL DEV, V26, P57, DOI 10.1089/humc.2015.006; Duan D, 2011, RES REP BIOL, V2, P31, DOI 10.2147/RRB.S13463; Esper GJ, 2006, MUSCLE NERVE, V34, P595, DOI 10.1002/mus.20626; Fine DM, 2011, NEUROMUSCULAR DISORD, V21, P453, DOI 10.1016/j.nmd.2011.03.010; Geisbush TR, 2015, CLIN NEUROPHYSIOL, V126, P1790, DOI 10.1016/j.clinph.2014.11.017; Hakim Chady H, 2015, J Neuromuscul Dis, V2, P397; Hakim CH, 2011, J APPL PHYSIOL, V110, P1656, DOI 10.1152/japplphysiol.01425.2010; Hayes J, 2008, PEDIATR ANESTH, V18, P100, DOI 10.1111/j.1460-9592.2007.02302.x; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Kortman HGJ, 2013, PHYSIOL MEAS, V34, P1611, DOI 10.1088/0967-3334/34/12/1611; Li JF, 2014, MATER CORROS, V65, P1062, DOI 10.1002/maco.201307020; Li J, 2016, AMYOTROPH LAT SCL FR, V17, P397, DOI 10.3109/21678421.2016.1165258; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151415; Li JY, 2013, INT CONF MEAS, P1, DOI 10.1109/ICMTMA.2013.11; Li John Zenghong, 2012, ISRN Otolaryngol, V2012, P708974, DOI 10.5402/2012/708974; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Mcllduff CE, 2016, MUSCLE NERVE; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; MENDELL JR, 1987, ARCH NEUROL-CHICAGO, V44, P808, DOI 10.1001/archneur.1987.00520200012009; Merlini L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0408-z; Narayanaswami P, 2012, MUSCLE NERVE, V46, P257, DOI 10.1002/mus.23307; Romitti P. A., 2015, PEDIATRICS; Rutkove SB, 2006, CLIN NEUROPHYSIOL, V117, P1244, DOI 10.1016/j.clinph.2005.12.029; Rutkove SB, 2005, MUSCLE NERVE, V32, P335, DOI 10.1002/mus.20377; Rutkove S, 2009, LANCET NEUROL, V8, P226, DOI 10.1016/S1474-4422(09)70030-4; Rutkove SB, 2007, CLIN NEUROPHYSIOL, V118, P2413, DOI 10.1016/j.clinph.2007.08.004; Rutkove SB, 2014, PEDIATR NEUROL, V51, P88, DOI 10.1016/j.pediatrneurol.2014.02.015; Rutkove SB, 2014, MUSCLE NERVE, V49, P441, DOI 10.1002/mus.24128; Rutkove SB, 2012, AMYOTROPH LATERAL SC, V13, P439, DOI 10.3109/17482968.2012.688837; Rutkove SB, 2012, MUSCLE NERVE, V45, P642, DOI 10.1002/mus.23233; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Sanchez B, 2016, SCI REP-UK, V6, DOI 10.1038/srep32615; Schwartz DP, 2016, MUSCLE NERVE, V53, P402, DOI 10.1002/mus.24770; Schwartz S, 2015, CLIN NEUROPHYSIOL, V126, P202, DOI 10.1016/j.clinph.2014.05.007; Segura LG, 2013, PEDIATR ANESTH, V23, P855, DOI 10.1111/pan.12248; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Shiffman CA, 2013, PHYSIOL MEAS, V34, P223, DOI 10.1088/0967-3334/34/2/223; Shiffman CA, 2013, PHYSIOL MEAS, V34, P203, DOI 10.1088/0967-3334/34/2/203; Shin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059875; Shklyar I, 2015, PEDIATR NEUROL, V52, P202, DOI 10.1016/j.pediatrneurol.2014.09.014; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith BF, 2011, LAB INVEST, V91, P216, DOI 10.1038/labinvest.2010.146; Statland JM, 2016, MUSCLE NERVE, V54, P696, DOI 10.1002/mus.25065; Tarulli A, 2005, NEUROLOGY, V65, P451, DOI 10.1212/01.wnl.0000172338.95064.cb; Tarulli AW, 2006, PHYSIOL MEAS, V27, P1269, DOI 10.1088/0967-3334/27/12/002; Tarulli AW, 2009, ARCH PHYS MED REHAB, V90, P1806, DOI 10.1016/j.apmr.2009.04.007; VALENTINE BA, 1992, AM J MED GENET, V42, P352, DOI 10.1002/ajmg.1320420320; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wu JS, 2015, MUSCLE NERVE, V52, P598, DOI 10.1002/mus.24573; Yang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044438; Yue YP, 2015, HUM MOL GENET, V24, P5880, DOI 10.1093/hmg/ddv310; Yue YP, 2011, METHODS MOL BIOL, V709, P313, DOI 10.1007/978-1-61737-982-6_21; Zaidman CM, 2015, MUSCLE NERVE, V52, P592, DOI 10.1002/mus.24611	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173557	10.1371/journal.pone.0173557	http://dx.doi.org/10.1371/journal.pone.0173557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339469	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700006
J	Eirin, A; Zhu, XY; Puranik, AS; Woollard, JR; Tang, H; Dasari, S; Lerman, A; van Wijnen, AJ; Lerman, LO				Eirin, Alfonso; Zhu, Xiang-Yang; Puranik, Amrutesh S.; Woollard, John R.; Tang, Hui; Dasari, Surendra; Lerman, Amir; van Wijnen, Andre J.; Lerman, Lilach O.			Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells	PLOS ONE			English	Article							RENAL-ARTERY STENOSIS; LARGE GENE LISTS; ANALYSIS PIPELINE; EXOSOMES; DIFFERENTIATION; EXPRESSION; DISEASE; PROLIFERATION; MECHANISMS; MICRORNA	Background Mesenchymal stromal/stem cell (MSC) transplantation is a promising therapy for tissue regeneration. Extracellular vesicles (EVs) released by MSCs act as their paracrine effectors by delivering proteins and genetic material to recipient cells. To assess how their cargo mediates biological processes that drive their therapeutic effects, we integrated miRNA, mRNA, and protein expression data of EVs from porcine adipose tissue-derived MSCs. Methods Simultaneous expression profiles of miRNAs, mRNAs, and proteins were obtained by highthroughput sequencing and LC-MS/MS proteomic analysis in porcine MSCs and their daughter EVs (n = 3 each). TargetScan and ComiR were used to predict miRNA target genes. Functional annotation analysis was performed using DAVID 6.7 database to rank primary gene ontology categories for the enriched mRNAs, miRNA target genes, and proteins. STRING was used to predict associations between mRNA and miRNA target genes. Results Differential expression analysis revealed 4 miRNAs, 255 mRNAs, and 277 proteins enriched in EVs versus MSCs (fold change > 2, p< 0.05). EV-enriched miRNAs target transcription factors (TFs) and EV-enriched mRNAs encode TFs, but TF proteins are not enriched in EVs. Rather, EVs are enriched for proteins that support extracellular matrix remodeling, blood coagulation, inflammation, and angiogenesis. Conclusions Porcine MSC-derived EVs contain a genetic cargo of miRNAs and mRNAs that collectively control TF activity in EVs and recipient cells, as well as proteins capable of modulating cellular pathways linked to tissue repair. These properties provide the fundamental basis for considering therapeutic use of EVs in tissue regeneration.	[Eirin, Alfonso; Zhu, Xiang-Yang; Puranik, Amrutesh S.; Woollard, John R.; Tang, Hui; Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Dasari, Surendra] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Lerman, Amir; Lerman, Lilach O.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA; [van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Lerman, LO (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Lerman, LO (corresponding author), Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	Lerman.Lilach@Mayo.Edu	Puranik, Amrutesh S./C-1365-2009; Lerman, Lilach/M-4962-2017; van Wijnen, Andre J./AAG-3578-2019	Puranik, Amrutesh S./0000-0001-7249-5602; van Wijnen, Andre J./0000-0002-4458-0946; Eirin, Alfonso/0000-0002-3864-9644	NIH [DK73608, DK104273, HL123160, DK102325, DK106427]; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Foundation: Mary Kathryn and Michael B. Panitch Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK106427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Foundation: Mary Kathryn and Michael B. Panitch Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by the NIH grant numbers DK73608, DK104273, HL123160, and DK102325, DK106427, the Mayo Clinic Center for Regenerative Medicine, and the Mayo Clinic Foundation: Mary Kathryn and Michael B. Panitch Career Development Award.	Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Baglio SR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0116-z; Chen PM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-49; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dudakovic A, 2014, J CELL PHYSL; Dudakovic A, 2014, J CELL BIOCH; Ebrahimi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067474; Eirin A, 2016, SCI REP IN PRESS; Eirin A, 2017, KIDNEY INT; Eirin A, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt541; Eirin A, 2015, CELL TRANSPLANT, V24, P2041, DOI 10.3727/096368914X685582; Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041; Eirin A, 2014, NEPHROL DIAL TRANSPL, V29, P274, DOI 10.1093/ndt/gft305; Eirin A, 2012, STEM CELLS, V30, P1030, DOI 10.1002/stem.1047; Hallenborg P, 2012, CELL DEATH DIFFER, V19, P1381, DOI 10.1038/cdd.2012.15; Hogan MC, 2015, J AM SOC NEPHROL, V26, P1661, DOI 10.1681/ASN.2014040354; Hogan MC, 2014, KIDNEY INT, V85, P1225, DOI 10.1038/ki.2013.422; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang S, 2014, FEBS LETT, V588, P2957, DOI 10.1016/j.febslet.2014.05.048; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lambeth LS, 2009, J GEN VIROL, V90, P1164, DOI 10.1099/vir.0.007831-0; Li SJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5896061; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mahaira LG, 2014, STEM CELLS DEV, V23, P2501, DOI 10.1089/scd.2013.0604; Martin SK, 2015, STEM CELLS, V33, P1359, DOI 10.1002/stem.1931; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Poitz DM, 2013, BBA-MOL CELL RES, V1833, P3396, DOI 10.1016/j.bbamcr.2013.10.003; Price JD, 2015, DIABETES, V64, P3521, DOI 10.2337/db14-1880; Quesenberry PJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0150-x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Tsai CC, 2012, CELL CYCLE, V11, P3711, DOI 10.4161/cc.22048; Wang SS, 2013, FEBS J, V280, P2644, DOI 10.1111/febs.12256; Wu YH, 2012, LASER MED SCI, V27, P509, DOI 10.1007/s10103-011-0995-x; Xing Y, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt520; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Zhu XY, 2013, STEM CELLS, V31, P117, DOI 10.1002/stem.1263	43	68	74	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174303	10.1371/journal.pone.0174303	http://dx.doi.org/10.1371/journal.pone.0174303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333993	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200077
J	Ghorbani, S; Talebi, F; Ghasemi, S; Abad, AJJ; Vojgani, M; Noorbakhsh, F				Ghorbani, Samira; Talebi, Farideh; Ghasemi, Sedigheh; Abad, Ali Jahanbazi Jahan; Vojgani, Mohammed; Noorbakhsh, Farshid			miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death	PLOS ONE			English	Article							NECROSIS-FACTOR TNF; ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; MICRORNA TARGETS; GENE-EXPRESSION; FACTOR RECEPTOR; FACTOR-ALPHA; IG20 GENE; TUMOR; APOPTOSIS	MicroRNAs are small noncoding RNAs, which regulate the expression of protein coding transcripts through mRNA degradation or translational inhibition. Numerous reports have highlighted the role of miRNAs in regulating cell death pathways including the expression of genes involved in the induction of apoptosis. Tumor necrosis factor alpha (TNF-alpha) is a proinflammatory cytokine which can send pro-death signals through its receptor TNFR1. Diverse adaptor molecules including DENN/MADD adaptor protein have been shown to modulate TNF-alpha pro-death signaling via recruitment of MAP kinases to TNFR1 and activation of pro-survival NF kappa B signaling. Herein, we investigated the role of microRNA-181 (miR-181) in regulating DENN/MADD expression levels and its subsequent effects on TNF-alpha-induced cell death. Using bioinformatics analyses followed by luciferase reporter assays we showed that miR-181 interacts with the 3' UTR of DENN/MADD transcripts. miR-181 overexpression also led to decreased endogenous DENN/MADD mRNA levels in L929 murine fibroblasts. Flow cytometric analysis of miR-181 transfected cells showed this miRNA accentuates mitochondrial membrane potential loss caused by TNF-alpha. These findings were associated with enhanced apoptosis of L929 cells following TNF-alpha treatment. Overall, these data point to the potential role of miR-181 in regulating TNF-alpha pro-death signaling, which could be of importance from pathogenesis and therapeutic perspectives in inflammatory disorders associated with tissue degeneration and cell death.	[Ghorbani, Samira; Talebi, Farideh; Vojgani, Mohammed; Noorbakhsh, Farshid] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran; [Ghorbani, Samira; Ghasemi, Sedigheh; Abad, Ali Jahanbazi Jahan] Khatam AI Anbia Hosp, Shefa Neurosci Res Inst, Tehran, Iran; [Noorbakhsh, Farshid] Iran Univ Med Sci, Razi Drug Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Iran University of Medical Sciences	Noorbakhsh, F (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.; Noorbakhsh, F (corresponding author), Iran Univ Med Sci, Razi Drug Res Ctr, Tehran, Iran.	f-noorbakhsh@sina.tums.ac.ir	Talebi, Farideh/ABF-3494-2021	Ghorbani, Samira/0000-0003-3268-5369; Jahanbazi Jahanabad, Ali/0000-0001-8629-7762; Talebi, Farideh/0000-0003-2178-5639	Razi Drug Research Center, Iran University of Medical Sciences [90-03-118-15289]; Tehran University of Medical Sciences [90-04-30-15983]	Razi Drug Research Center, Iran University of Medical Sciences; Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This research was supported by grants from Razi Drug Research Center, Iran University of Medical Sciences (90-03-118-15289) and Tehran University of Medical Sciences (90-04-30-15983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Brinkman BMN, 1999, J BIOL CHEM, V274, P30882, DOI 10.1074/jbc.274.43.30882; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Flusberg DA, 2015, TRENDS CELL BIOL, V25, P446, DOI 10.1016/j.tcb.2015.03.003; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Ko S, 2001, BIOL SIGNAL RECEPT, V10, P326; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Lim KM, 2004, INT J CANCER, V109, P24, DOI 10.1002/ijc.11660; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Polla BS, 1996, FREE RADICAL RES, V25, P125, DOI 10.3109/10715769609149917; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Subramanian M, 2009, J CLIN ENDOCR METAB, V94, P1467, DOI 10.1210/jc.2008-2378; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang Y, 2013, LAB INVEST, V93, P1024, DOI 10.1038/labinvest.2013.89; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174368	10.1371/journal.pone.0174368	http://dx.doi.org/10.1371/journal.pone.0174368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323882	gold, Green Submitted, Green Published			2022-12-27	WOS:000399089000090
J	Koistinen, NA; Edlund, AK; Menon, PK; Ivanova, EV; Bacanu, S; Iverfeldt, K				Koistinen, Niina A.; Edlund, Anna K.; Menon, Preeti K.; Ivanova, Elena V.; Bacanu, Smaranda; Iverfeldt, Kerstin			Nuclear localization of amyloid-beta precursor protein-binding protein Fe65 is dependent on regulated intramembrane proteolysis	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; ADAPTER PROTEIN; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; PHOSPHORYLATION; SECRETASE; APP; TRANSCRIPTION; COMPLEX	Fe65 is an adaptor protein involved in both processing and signaling of the Alzheimer-associated amyloid-beta precursor protein, APP. Here, the subcellular localization was further investigated using TAP-tagged Fe65 constructs expressed in human neuroblastoma cells. Our results indicate that PTB2 rather than theWWdomain is important for the nuclear localization of Fe65. Electrophoretic mobility shift of Fe65 caused by phosphorylation was not detected in the nuclear fraction, suggesting that phosphorylation could restrict nuclear localization of Fe65. Furthermore, both ADAM10 and gamma-secretase inhibitors decreased nuclear Fe65 in a similar way indicating an important role also of alpha-secretase in regulating nuclear translocation.	[Koistinen, Niina A.; Edlund, Anna K.; Menon, Preeti K.; Ivanova, Elena V.; Bacanu, Smaranda; Iverfeldt, Kerstin] Stockholm Univ, Dept Neurochem, Stockholm, Sweden	Stockholm University	Iverfeldt, K (corresponding author), Stockholm Univ, Dept Neurochem, Stockholm, Sweden.	kerstin@neurochem.su.se		Bacanu, Silviu-Alin/0000-0002-4364-1583	Swedish Research Couuncil [521-2012-2367]; Foundation Olle Enkvist Byggmastare	Swedish Research Couuncil; Foundation Olle Enkvist Byggmastare	This work was supported by the Swedish Research Couuncil (to K.I.; 521-2012-2367), and by the Foundation Olle Enkvist Byggmastare (to N.A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Swedish Research Council (to K.I.; 521-2012-2367), and by the Foundation Olle Enkvist Byggmastare (to N.A.K.).	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Beckman M, 1997, NEUROSCI LETT, V221, P73, DOI 10.1016/S0304-3940(96)13292-4; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Cool BH, 2010, J NEUROCHEM, V112, P410, DOI 10.1111/j.1471-4159.2009.06456.x; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hu QB, 2002, HUM MOL GENET, V11, P465, DOI 10.1093/hmg/11.4.465; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; Jowsey PA, 2015, BIOCHEM J, V465, P413, DOI 10.1042/BJ20140656; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Koistinen NA, 2016, NEUROSCI LETT, V613, P54, DOI 10.1016/j.neulet.2015.12.050; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lee EJ, 2008, BMB REP, V41, P41, DOI 10.5483/BMBRep.2008.41.1.041; Meiyappan M, 2007, J MOL BIOL, V372, P970, DOI 10.1016/j.jmb.2007.06.064; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Radzimanowski J, 2008, J BIOL CHEM, V283, P23113, DOI 10.1074/jbc.M800861200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sen A, 2015, J NEUROSCI, V35, P7538, DOI 10.1523/JNEUROSCI.0260-15.2015; SILVA OABDE, 1993, NEUROSCIENCE, V57, P873, DOI 10.1016/0306-4522(93)90031-A; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173888	10.1371/journal.pone.0173888	http://dx.doi.org/10.1371/journal.pone.0173888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323844	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000040
J	Liu, N; Wang, BYJ; Broughton, KM; Alvarez, R; Siddiqi, S; Loaiza, R; Nguyen, N; Quijada, P; Gude, N; Sussman, MA				Liu, Nan; Wang, Bingyan J.; Broughton, Kathleen M.; Alvarez, Roberto; Siddiqi, Sailay; Loaiza, Rebeca; Nguyen, Nicky; Quijada, Pearl; Gude, Natalie; Sussman, Mark A.			PIM1-minicircle as a therapeutic treatment for myocardial infarction	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CARDIAC STEM-CELLS; VIVO GENE-TRANSFER; PLASMID DNA; IN-VIVO; MOUSE HEART; T-CELL; EXPRESSION; MINICIRCLE; MUSCLE	PIM1, a pro-survival gene encoding a serine/threonine kinase, influences cell proliferation and survival. Modification of cardiac progenitor cells (CPCs) or cardiomyocytes with PIM1 using a lentivirus-based delivery method showed long-term improved cardiac function after myocardial infarction (MI). However, lentivirus based delivery methods have stringent FDA regulation with respect to clinical trials. To provide an alternative and low risk PIM1 delivery method, this study examined the use of a non-viral modified plasmid-minicircle (MC) as a vehicle to deliver PIM1 into mouse CPCs (mCPCs) in vitro and the myocardium in vivo. MC containing a turbo gfp reporter gene (gfp-MC) was used as a transfection and injection control. PIM1 was subcloned into gfp-MC (PIM1-MC) and then transfected into mCPCs at an efficiency of 29.4 +/- 3.7%. PIM1-MC engineered mCPCs (PIM1-mCPCs) exhibit significantly (P<0.05) better survival rate under oxidative treatment. PIM1-mCPCs also exhibit 1.9 +/- 0.1 and 2.2 +/- 0.2 fold higher cell proliferation at 3 and 5 days post plating, respectively, as compared to gfp-MC transfected mCPCs control. PIM1-MC was injected directly into ten-week old adult FVB female mice hearts in the border zone immediately after MI. Delivery of PIM1 into myocardium was confirmed by GFP(+) cardiomyocytes. Mice with PIM1-MC injection showed increased protection compared to gfp-MC injection groups measured by ejection fraction at 3 and 7 days post injury (P = 0.0379 and P = 0.0262 by t-test, respectively). Success of PIM1 delivery and integration into mCPCs in vitro and cardiomyocytes in vivo by MC highlights the possibility of a non-cell based therapeutic approach for treatment of ischemic heart disease and MI.	[Liu, Nan; Wang, Bingyan J.; Broughton, Kathleen M.; Alvarez, Roberto; Siddiqi, Sailay; Loaiza, Rebeca; Nguyen, Nicky; Quijada, Pearl; Gude, Natalie; Sussman, Mark A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Sussman, MA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	heartman4ever@icloud.com	Wang, Bingyan/AAB-3883-2019; Sussman, Mark/H-2284-2014	Wang, Bingyan/0000-0002-3522-2848; Sussman, Mark/0000-0002-0104-4799	National Institutes of Health [R01HL067245, R37HL091102, R01HL105759, R01HL113647, R01HL117163, P01HL085577, R01HL122525]; Fondation Leducq [G00010319]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation)	M.A Sussman is supported by National Institutes of Health grants:R01HL067245, R37HL091102, R01HL105759, R01HL113647, R01HL117163, P01HL085577, R01HL122525, https://www.nih.gov/; Fondation Leducq G00010319, https://www.fondationleducg.org/. The funders had no role in study design, data collection ana analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2013, NAT REV CARDIOL, V10, P98, DOI 10.1038/nrcardio.2012.178; [Anonymous], 2011, CPD CURRENT PHARM DE, V17, P3252; [Anonymous], 2015, STEM CELL TRANSLATIO; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Darquet AM, 1999, GENE THER, V6, P209, DOI 10.1038/sj.gt.3300816; Daviglus Martha L, 2006, Am J Cardiovasc Drugs, V6, P87, DOI 10.2165/00129784-200606020-00003; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Ferreira-Gonzalez I, 2014, REV ESP CARDIOL, V67, P139, DOI [10.1016/j.rec.2013.10.002, 10.1016/j.recesp.2013.10.003]; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hengge UR, 1996, J CLIN INVEST, V97, P2911, DOI 10.1172/JCI118750; Hu KJ, 2014, STEM CELLS DEV, V23, P1301, DOI 10.1089/scd.2013.0621; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Jechlinger W, 2006, EXPERT REV VACCINES, V5, P803, DOI 10.1586/14760584.5.6.803; Katakami N, 2004, J BIOL CHEM, V279, P54742, DOI 10.1074/jbc.M409140200; Kulandavelu S, 2016, J AM COLL C IN PRESS; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li K, 1997, J MOL CELL CARDIOL, V29, P1499, DOI 10.1006/jmcc.1997.0389; Li SH, 2013, EUR HEART J, V34, P1157, DOI 10.1093/eurheartj/ehs072; Ludke A, 2014, CAN J CARDIOL, V30, P1299, DOI 10.1016/j.cjca.2014.03.021; MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; McTaggart Ryan A, 2004, Hepatology, V39, P1143, DOI 10.1002/hep.20192; Mohsin S, 2012, J AM COLL CARDIOL, V60, P1278, DOI 10.1016/j.jacc.2012.04.047; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; National Heart Lung and Blood Institute (NHLBI), NHLBI FACT BOOK; Roger VL, 2011, CIRCULATION, P125; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; SIKES ML, 1994, HUM GENE THER, V5, P837, DOI 10.1089/hum.1994.5.7-837; Srivastava D, 2006, NATURE, V444, P512, DOI 10.1038/nature05423; Stenler S, 2009, J CARDIOVASC PHARM, V53, P18, DOI 10.1097/FJC.0b013e318194234e; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Walter I, 2000, HISTOCHEM J, V32, P99, DOI 10.1023/A:1004014211408; Wang Z, 2001, J Vet Sci, V2, P167; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	44	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173963	10.1371/journal.pone.0173963	http://dx.doi.org/10.1371/journal.pone.0173963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323876	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000049
J	Salisbury, PA; Fripp, YJ; Gurung, AM; Williams, WM				Salisbury, Phillip A.; Fripp, Yvonne J.; Gurung, Allison M.; Williams, Warren M.			Is floral structure a reliable indicator of breeding system in the Brassicaceae?	PLOS ONE			English	Article							POLLEN-OVULE RATIOS; SELF-INCOMPATIBILITY; FLOWERING PLANTS; BRUSSELS-SPROUTS; GENUS CAPSELLA; CRUCIFERAE; STERILITY; GENETICS; SIZE	This study investigated the usefulness of floral characters as a potential indicator of breeding system in the Brassicaceae. Initially, pod set, seed set and pollen tube growth experiments were carried out to confirm the breeding systems of 53 lines representing 25 different cultivated and weedy species from the Brassicaceae. The results of the pod set tests clearly differentiated between self-compatible and self-incompatible species. Floral characters were then evaluated on one or more lines of each of the 25 species. Fourteen floral characters were evaluated including, flower diameter, Cruden's outcrossing index, timing and direction of dehiscence and pollen-ovule ratio. Significant differences between species were evident in all of the floral characteristics evaluated. Flower diameter was generally larger in self-incompatible species than self-compatible species and pollen/ovule ratio was generally higher in self-incompatible species than self-compatible species. However, none of the floral characteristics was able to clearly differentiate the self-compatible and self-incompatible species and allow prediction of the breeding system with absolute confidence. The floral characteristic which was most effective at differentiating the two groups was anther direction at dehiscence.	[Salisbury, Phillip A.; Gurung, Allison M.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Salisbury, Phillip A.] AgriBio, Ctr AgriBiosci, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic, Australia; [Fripp, Yvonne J.] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia; [Williams, Warren M.] AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand	University of Melbourne; La Trobe University; La Trobe University; AgResearch - New Zealand	Salisbury, PA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia.; Salisbury, PA (corresponding author), AgriBio, Ctr AgriBiosci, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic, Australia.	p.salisbury@unimelb.edu.au			AgriBio; AgResearch	AgriBio; AgResearch	WW was provided support in the form of a salary from AgriBio & AgResearch, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bateman A. J., 1955, CRUCIFERAE HEREDITY, V9, P53, DOI DOI 10.1038/HDY.1955.2; BATEMAN AJ, 1954, HEREDITY, V8, P305, DOI 10.1038/hdy.1954.36; CRUDEN RW, 1981, EVOLUTION, V35, P964, DOI 10.1111/j.1558-5646.1981.tb04962.x; CRUDEN RW, 1985, BOT GAZ, V146, P143, DOI 10.1086/337509; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Downey RK, 1980, HYBRIDIZATION CROP P, P495; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; EL MURABAA A. I. M., 1957, EUPHYTICA, V6, P268, DOI 10.1007/BF00042312; FRYXELL PA, 1957, BOT REV, V23, P135, DOI 10.1007/BF02869758; Hinata K., 1980, Brassica crops and wild allies. [II]., P223; Hinata K., 1974, Tohoku Journal of Agricultural Research, V25, P58; HINATA K, 1975, Tohoku Journal of Agricultural Research, V26, P117; JOHNSON AG, 1971, EUPHYTICA, V20, P561; LLOYD DAVID G., 1965, CONTRIB GRAY HERB HARVARD UNIV, V195, P3; LYONS EE, 1991, AM J BOT, V78, P270, DOI 10.2307/2445250; Neuffer B, 2013, FLORA, V208, P626, DOI 10.1016/j.flora.2013.09.007; PRESTON RE, 1986, AM J BOT, V73, P1732, DOI 10.2307/2444239; Rajan SS, 1966, INDIAN COUNCIL AGR R; RICHARDS RA, 1973, GENETICA, V44, P439, DOI 10.1007/BF00161316; Riley HP, 1936, GENETICS, V21, P24; Salisbury P. A., 1991, THESIS; Salisbury PA, 1989, GENET LIFE SCI ADV, V8, P65; Sears ER, 1937, GENETICS, V22, P130; Sicard A, 2011, ANN BOT-LONDON, V107, P1433, DOI 10.1093/aob/mcr023; Stout AB, 1931, AM J BOT, V18, P686, DOI 10.2307/2435680; Takahata Y., 1980, Brassica crops and wild allies. [I]., P33; Takahata Y, 2008, BREEDING SCI, V58, P385, DOI 10.1270/jsbbs.58.385; VISSER DL, 1977, EUPHYTICA, V26, P273, DOI 10.1007/BF00026988; Voillemot M, 2016, ANN BOT, V119, P177; Warwick SI, 2011, PLANT GENET GENOMICS, V9, P33, DOI 10.1007/978-1-4419-7118-0_2	30	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174176	10.1371/journal.pone.0174176	http://dx.doi.org/10.1371/journal.pone.0174176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323862	gold, Green Submitted, Green Published			2022-12-27	WOS:000399089000072
J	Zhang, ZK; Lai, SJ; Yu, JX; Geng, QB; Yang, WQ; Chen, Y; Wu, JG; Jing, HQ; Yang, WZ; Li, ZJ				Zhang, Zike; Lai, Shengjie; Yu, Jianxing; Geng, Qibin; Yang, Wanqi; Chen, Yu; Wu, Jianguo; Jing, Huaiqi; Yang, Weizhong; Li, Zhongjie			Etiology of acute diarrhea in the elderly in China: A six-year observational study	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; NOROVIRUS; CHILDREN; INFECTION; ENTEROPATHOGENS; EPIDEMIOLOGY; MULTICENTER; GI	Acute diarrhea leads to a substantial disease burden among the elderly worldwide. However, in the context of increasingly aging trend in China, the prevalence of etiological agents among elderly diarrheal patients was undetermined. This study aimed to explore the major enteropathogens of acute diarrhea among outpatients older than 65 years in China, and also the epidemiological features of the pathogens. Demographic and clinical data for acute diarrhea among outpatients older than 65 years were collected from 213 participating hospitals from 2009 to 2014. Stool specimens were collected and tested for 13 enteric viruses and bacteria. The proportion of outpatients positive for targeted pathogens was analyzed by residential areas and seasonal patterns. Among the 7,725 patients enrolled, 1,617 (20.9%) were positive for any one of the 13 study pathogens. The predominant pathogen was norovirus (9.0%), followed by diarrheagenic Escherichia coli (DEC) (5.5%), rotavirus (3.9%), nontyphoidal Salmonella (NTS) (2.9%), and Shigella spp. (2.5%). The prevalence of Shigella spp. among rural patients (6.9%) was higher than that among urban patients (1.6%) (p < 0.001), with opposite trend for DEC (3.6% versus 5.9%, p = 0.007). An obvious seasonal pattern was observed for major pathogens, with peak for norovirus in autumn, rotavirus in winter and DEC, NTS, and Shigella spp. in summer. A wide variety of enteropathogens were detected among the elderly with acute diarrhea in China, with norovirus and DEC being the most commonly isolated pathogens. A strong seasonal pattern was observed for major pathogens of acute diarrhea among the elderly.	[Zhang, Zike; Chen, Yu] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zike; Chen, Yu] Key Lab Clin In Vitro Diagnost Tech Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zike; Lai, Shengjie; Yu, Jianxing; Geng, Qibin; Yang, Wanqi; Yang, Weizhong; Li, Zhongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Lai, Shengjie] Univ Southampton, Dept Geog & Environm, Worldpop, Southampton, Hants, England; [Yu, Jianxing] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing, Peoples R China; [Yu, Jianxing] Peking Union Med Coll, Beijing, Peoples R China; [Geng, Qibin; Yang, Wanqi; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Jing, Huaiqi] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Zhejiang University; Chinese Center for Disease Control & Prevention; University of Southampton; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wuhan University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Yang, WZ; Li, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yangwz@chinacdc.cn; lizj@chinacdc.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	Lai, Shengjie/0000-0001-9781-8148; Wu, Jianguo/0000-0002-8326-2895; YU, Jianxing/0000-0002-9696-2460	National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China [2009ZX10004-201, 2012ZX10004-201]; Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC	National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China; Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC	This work was supported by the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China [2009ZX10004-201, 2012ZX10004-201]; and the Grant from Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of 302 the manuscript.	[Anonymous], 2016, ANN REPORT URBAN DEV; Bisi-Johnson MA, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-9; Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Chen Y, 2013, PEDIATR INFECT DIS J, V32, pE285, DOI 10.1097/INF.0b013e31828c3de4; DuPont HL, 2014, NEW ENGL J MED, V370, P1532, DOI 10.1056/NEJMra1301069; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Okame M, 2006, J MED VIROL, V78, P1318, DOI 10.1002/jmv.20696; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Patel P. K., 2008, Eastern Mediterranean Health Journal, V14, P571; Phan TG, 2005, CLIN LAB, V51, P429; Podkolzin AT, 2009, J INFECT DIS S, P228; Qu Mei, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P1123; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Souza TB, 2009, J INFECTION, V59, P247, DOI 10.1016/j.jinf.2009.08.007; Spina A, 2015, CLIN MICROBIOL INFEC, V21, P719, DOI 10.1016/j.cmi.2015.04.007; Svenungsson B, 2000, CLIN INFECT DIS, V30, P770, DOI 10.1086/313770; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Walker CLF, 2010, EPIDEMIOL INFECT, V138, P1215, DOI 10.1017/S0950268810000592; Wang X, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131771, 10.1371/journal.pone.0142136]; Wang YH, 2012, ARCH VIROL, V157, P2417, DOI 10.1007/s00705-012-1437-1; Xue Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0922-z; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001; Zhu Min, 2008, Wei Sheng Yan Jiu, V37, P126	32	17	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173881	10.1371/journal.pone.0173881	http://dx.doi.org/10.1371/journal.pone.0173881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323855	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000038
J	Asatryan, B; Vital, C; Kellerhals, C; Medeiros-Domingo, A; Grani, C; Trachsel, LD; Schmied, CM; Saguner, AM; Eser, P; Herzig, D; Bolliger, S; Michaud, K; Wilhelm, M				Asatryan, Babken; Vital, Cristina; Kellerhals, Christoph; Medeiros-Domingo, Argelia; Grani, Christoph; Trachsel, Lukas D.; Schmied, Christian M.; Saguner, Ardan M.; Eser, Prisca; Herzig, David; Bolliger, Stephan; Michaud, Katarzyna; Wilhelm, Matthias			Sports-related sudden cardiadc deaths in the young population of Switzerlan	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; OF-CARDIOLOGY; WORKING GROUP; COLLEGE; REHABILITATION; PREVENTION; NATIONWIDE	Background In Switzerland, ECG screening was first recommended for national squad athletes in 1998. Since 2001 it has become mandatory in selected high-risk professional sports. Its impact on the rates of sports-related sudden cardiac death (SCD) is unknown. Objective We aimed to study the incidence, causes and time trends of sports-related SCD in comparison to SCD unrelated to exercise in Switzerland. Methods We reviewed all forensic reports of SCDs of the German-speaking region of Switzerland in the age group of 10 to 39 years, occurring between 1999 and 2010. Cases were classified into three categories based on whether or not deaths were associated with sports: no sports (NONE), recreational sports (REC), and competitive sports (COMP). Results Over the 12-year study period, 349 SCD cases were recorded (mean age 30 +/- 7 years, 76.5% male); 297 cases were categorized as NONE, 31 as REC, and 21 as COMP. Incidences of SCD per 100,000 person-years [mean (95% CI)] were the lowest in REC [0.43 (0.35-0.56)], followed by COMP [1.19 (0.89-1.60)] and NONE [2.46 (2.27-2.66)]. In all three categories, coronary artery disease (CAD) with or without acute myocardial infarction (MI) was the most common cause of SCD. Three professional athletes were identified in COMP category which all had SCD due to acute MI. There were no time trends, neither in overall, nor in cause-specific incidences of SCD. Conclusions The incidence of SCD in young individuals in Switzerland is low, both related and unrelated to sports. In regions, like Switzerland, where CAD is the leading cause of SCD associated with competitions, screening for cardiovascular risk factors in addition to the current PPS recommendations might be indicated to improve detection of silent CAD and further decrease the incidence of SCD.	[Asatryan, Babken; Vital, Cristina; Kellerhals, Christoph; Medeiros-Domingo, Argelia; Trachsel, Lukas D.; Eser, Prisca; Herzig, David; Wilhelm, Matthias] Univ Bern, Univ Clin Cardiol, Univ Hosp Bern, Nselspital, Bern, Switzerland; [Grani, Christoph; Schmied, Christian M.; Saguner, Ardan M.] Univ Heart Ctr, Zurich, Switzerland; [Bolliger, Stephan] Univ Zurich, Inst Forens Med, Zurich, Switzerland; [Michaud, Katarzyna] Univ Ctr Legal Med, Unit Forens Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Zurich	Wilhelm, M (corresponding author), Univ Bern, Univ Clin Cardiol, Univ Hosp Bern, Nselspital, Bern, Switzerland.	matthias.wilhelm@insel.ch	Wilhelm, Matthias/AAS-9456-2020; Eser, Prisca/AAE-3758-2021; Saguner, Ardan M./AAV-3624-2020; Asatryan, Babken/K-6966-2015	Wilhelm, Matthias/0000-0003-4541-3995; Asatryan, Babken/0000-0002-0050-5717; Test, Tom/0000-0002-4998-5635; Grani, Christoph/0000-0001-6029-0597; Medeiros-Domingo, Argelia/0000-0001-5586-3418	Swiss Heart Foundation	Swiss Heart Foundation	The work was supported by an unrestricted grant from the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso C, 2008, VIRCHOWS ARCH, V452, P11, DOI 10.1007/s00428-007-0505-5; Bohm P, 2016, EUR J PREV CARDIOL, V23, P649, DOI 10.1177/2047487315594087; Chappex N, 2015, J FORENSIC LEG MED, V35, P62, DOI 10.1016/j.jflm.2015.07.004; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Harmon KG, 2014, HEART, V100, P1185, DOI 10.1136/heartjnl-2014-093872.rep; Harmon KG, 2014, CIRC-ARRHYTHMIA ELEC, V7, P198, DOI 10.1161/CIRCEP.113.001376; Hofer F, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-140; Kaltman JR, 2011, CIRCULATION, V123, P1911, DOI 10.1161/CIRCULATIONAHA.110.017228; Kasanuki H, 1997, CIRCULATION, V95, P2277, DOI 10.1161/01.CIR.95.9.2277; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Maron BJ, 2015, CIRCULATION, V132, pE267, DOI 10.1161/CIR.0000000000000238; Maron BJ, 2014, J AM COLL CARDIOL, V63, P1636, DOI 10.1016/j.jacc.2014.01.041; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Mehra R, 2007, J ELECTROCARDIOL, V40, pS118, DOI 10.1016/j.jelectrocard.2007.06.023; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Quigley F, 2000, BRIT J SPORT MED, V34, P258, DOI 10.1136/bjsm.34.4.258; Risgaard B, 2014, HEART RHYTHM, V11, P1673, DOI 10.1016/j.hrthm.2014.05.026; Schmied C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13575; Schwartz PJ, 2001, CIRCULATION, V103, P89; Solberg EE, 2016, EUR J PREV CARDIOL, V23, P657, DOI 10.1177/2047487315599891; Solberg EE, 2010, EUR J CARDIOV PREV R, V17, P337, DOI 10.1097/HJR.0b013e328332f8f7; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wilhelm M, 2011, SCHWEIZ Z SPORTSMED, V59, P96; Wilhelm M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14129	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							E0174434	10.1371/journal.pone.0174434	http://dx.doi.org/10.1371/journal.pone.0174434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350812	gold, Green Published, Green Accepted			2022-12-27	WOS:000399174400043
J	Proville, J; Zavala-Araiza, D; Wagner, G				Proville, Jeremy; Zavala-Araiza, Daniel; Wagner, Gernot			Night-time lights: A global, long term look at links to socio-economic trends	PLOS ONE			English	Article							SATELLITE IMAGERY; POWER CONSUMPTION; ECONOMIC-ACTIVITY; POPULATION; ELECTRIFICATION; SCALES; CHINA	We use a parallelized spatial analytics platform to process the twenty-one year totality of the longest-running time series of night-time lights data D the Defense Meteorological Satellite Program (DMSP) dataset D surpassing the narrower scope of prior studies to assess changes in area lit of countries globally. Doing so allows a retrospective look at the global, long-term relationships between night-time lights and a series of socio-economic indicators. We find the strongest correlations with electricity consumption, CO2 emissions, and GDP, followed by population, CH4 emissions, N2O emissions, poverty (inverse) and F-gas emissions. Relating area lit to electricity consumption shows that while a basic linear model provides a good statistical fit, regional and temporal trends are found to have a significant impact.	[Proville, Jeremy] Environm Def Fund, Off Econ Policy & Anal, New York, NY 10010 USA; [Zavala-Araiza, Daniel] Environm Def Fund, Climate & Energy Program, Austin, TX USA; [Wagner, Gernot] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wagner, Gernot] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Environmental Defense Fund; Environmental Defense Fund; Harvard University; Harvard University	Proville, J (corresponding author), Environm Def Fund, Off Econ Policy & Anal, New York, NY 10010 USA.	jproville@edf.org		Wagner, Gernot/0000-0001-6059-0688				Amaral S., 2005, COMPUT ENVIRON URBAN, V29, P179, DOI [10.1016/j.compenvurbsys.2003.09.004, DOI 10.1016/J.COMPENVURBSYS.2003.09.004]; Asefi-Najafabady S, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD021296; Bennie J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03789; Boden T. A., 2015, GLOBAL REGIONAL NATL; Chand TRK, 2009, INT J REMOTE SENS, V30, P647, DOI 10.1080/01431160802345685; Chen X, 2011, P NATL ACAD SCI USA, V108, P8589, DOI 10.1073/pnas.1017031108; Coscieme L, 2014, AMBIO, V43, P969, DOI 10.1007/s13280-013-0468-5; Doll CNH, 2006, ECOL ECON, V57, P75, DOI 10.1016/j.ecolecon.2005.03.007; Doll CNH, 2000, AMBIO, V29, P157, DOI 10.1639/0044-7447(2000)029[0157:NTIAAT]2.0.CO;2; EIA, US EN INF ADM EIA IN; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Elvidge CD, 2001, ISPRS J PHOTOGRAMM, V56, P81, DOI 10.1016/S0924-2716(01)00040-5; Elvidge CD, 2009, ENERGIES, V2, P595, DOI 10.3390/en20300595; Elvidge CD, 2009, COMPUT GEOSCI-UK, V35, P1652, DOI 10.1016/j.cageo.2009.01.009; Emissions Database for Global Atmospheric Research (EDGAR), GHG CO2 CH4 N2O F GA; Ghosh T, 2010, OPEN GEOGRAPHY J, V3, P93; Ghosh T, 2012, SOCIAL GEOGRAPHY, V7, P23, DOI [10.5194/sg-7-23-2012, DOI 10.5194/SG-7-23-2012]; Ghosh T, 2009, 2009 JOINT URBAN REMOTE SENSING EVENT, VOLS 1-3, P1675; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; Hooke RL, 2012, GSA TODAY, V22, P4, DOI DOI 10.1130/GSAT151A.1; Hsu, 2013, P ASIA PACIFIC ADV N, V35, P62, DOI [DOI 10.7125/APAN.35.7, 10.7125/APAN.35.7]; Imhoff ML, 1997, REMOTE SENS ENVIRON, V61, P361; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Letu H, 2012, IEEE T GEOSCI REMOTE, V50, P389, DOI 10.1109/TGRS.2011.2178031; Letu H, 2010, INT J REMOTE SENS, V31, P4443, DOI 10.1080/01431160903277464; Li X, 2013, REMOTE SENS-BASEL, V5, P3057, DOI 10.3390/rs5063057; Ma T, 2014, REMOTE SENS LETT, V5, P165, DOI 10.1080/2150704X.2014.890758; Mellander C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139779; Mertes CM, 2015, REMOTE SENS ENVIRON, V158, P331, DOI 10.1016/j.rse.2014.09.023; Miller SD, 2012, P NATL ACAD SCI USA, V109, P15706, DOI 10.1073/pnas.1207034109; Min B, 2014, REMOTE SENS-BASEL, V6, P9511, DOI 10.3390/rs6109511; Min B, 2013, INT J REMOTE SENS, V34, P8118, DOI 10.1080/01431161.2013.833358; National Oceanic and Atmospheric Administration (NOAA) National Centers for Environmental Information, DEF MET SAT PROGR DM; Ou JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138310; Pandey B, 2013, INT J APPL EARTH OBS, V23, P49, DOI 10.1016/j.jag.2012.11.005; Patel NN, 2015, INT J APPL EARTH OBS, V35, P199, DOI 10.1016/j.jag.2014.09.005; Proville J, NIGHT TIME LIGHTS GL; Sandvik B., 2009, WORLD BORDERS DATASE; Shi KF, 2014, REMOTE SENS-BASEL, V6, P1705, DOI 10.3390/rs6021705; Shi KF, 2014, REMOTE SENS LETT, V5, P358, DOI 10.1080/2150704X.2014.905728; Sutton P., 1997, Computers, Environment and Urban Systems, V21, P227, DOI 10.1016/S0198-9715(97)01005-3; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Sutton P., 2007, INT J ECOL EC STAT, V8, P5; Sutton PC, 2012, ECOL INDIC, V16, P11, DOI 10.1016/j.ecolind.2011.03.008; Sutton PC, 2002, ECOL ECON, V41, P509, DOI 10.1016/S0921-8009(02)00097-6; Townsend AC, 2010, INT J REMOTE SENS, V31, P4459, DOI 10.1080/01431160903261005; World Bank, WORLD DEV IND; Zhang QL, 2015, REMOTE SENS-BASEL, V7, P11887, DOI 10.3390/rs70911887; Ziskin D, 2010, P 30 M AS PAC ADV NE, V30, P131, DOI DOI 10.7125/APAN.30.18	50	56	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174610	10.1371/journal.pone.0174610	http://dx.doi.org/10.1371/journal.pone.0174610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346500	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300060
J	Timman, R; Gopie, JP; Brinkman, JN; Kleijne, A; Seynaeve, C; Menke-Pluymers, MBE; ter Kuile, MM; Tibben, A; Mureau, MAM				Timman, Reinier; Gopie, Jessica P.; Brinkman, J. Nick; Kleijne, Annelies; Seynaeve, Caroline; Menke-Pluymers, Marian B. E.; ter Kuile, Moniek M.; Tibben, Aad; Mureau, Marc A. M.			Most women recover from psychological distress after postoperative complications following implant or DIEP flap breast reconstruction: A prospective long-term follow-up study	PLOS ONE			English	Article							EPIGASTRIC PERFORATOR FLAP; QUALITY-OF-LIFE; PATIENT SATISFACTION; EVENT SCALE; PSYCHOSOCIAL OUTCOMES; DEPRESSION SCALE; HOSPITAL ANXIETY; IMPACT; EXPERIENCE; IMMEDIATE	Background Substantial complication rates after postmastectomy breast reconstruction (BR) in breast cancer patients have been reported. Few studies have reported on the resulting psychological distress (PD) and satisfaction with the aesthetic result in relation to postoperative complications after completion of implant or DIEP flap BR. The present study investigated whether women were able to recover from complication related distress in the long term. Methods PD was prospectively measured using questionnaires regarding anxiety, depression and cancer distress. Eligible patients completed questionnaires before BR (T0, n = 144), after one month (T1, n = 139) and after completion of BR, approximately 21 months after initial reconstructive surgery (T2, n = 119). Satisfaction with the aesthetic result was assessed 21 months after BR. Data concerning complications, subsequent additional surgery and total reconstruction failure up to T2 were collected from the medical records. Analyses were performed using multi-level regression analyses correcting for age. Results One or more complications occurred in 61 patients (42%) and 50 women required subsequent surgery (35%). In time, mean PD significantly declined towards baseline scoresindependent of complications. However, a total reconstruction failure (n = 10) was significantly associated with a large temporary increase in depression scores. After additional surgery due to complications patients were less satisfied with aesthetic outcome, although patient satisfaction was independent of PD. Conclusions PD outcomes generally declined to normal levels after completion of the entire BR course. Patients experiencing a total reconstruction failure reported more depression after this loss, but in the long term recovered to the same level as women without complications. These findings indicate that women generally can cope efficiently with these serious adverse events, even if they were less satisfied with the aesthetic result.	[Timman, Reinier] Erasmus MC, Univ Med Ctr Rotterdam, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Gopie, Jessica P.; Kleijne, Annelies; Tibben, Aad] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Brinkman, J. Nick; Mureau, Marc A. M.] Erasmus MC Canc Inst, Univ Med Ctr Rotterdam, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands; [Seynaeve, Caroline] Erasmus MC Canc Inst, Univ Med Ctr Rotterdam, Dept Med Oncol, Rotterdam, Netherlands; [Menke-Pluymers, Marian B. E.] Erasmus MC Canc Inst, Univ Med Ctr Rotterdam, Dept Surg Oncol, Rotterdam, Netherlands; [Menke-Pluymers, Marian B. E.] Albert Schweitzer Hosp, Breast Clin, Rotterdam, Netherlands; [ter Kuile, Moniek M.] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Albert Schweitzer Ziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Timman, R (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands.	r.timman@erasmusmc.nl	Mureau, Marc/HHN-5563-2022		Dutch Cancer Society [KWF-UL 2007-3726]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was supported by the Dutch Cancer Society (KWF-UL 2007-3726), www.kwf.nl, received by AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Nab Z, 2007, PATIENT EDUC COUNS, V66, P243, DOI 10.1016/j.pec.2006.12.008; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Atisha D, 2008, ANN SURG, V247, P1019, DOI 10.1097/SLA.0b013e3181728a5c; Berry T, 2010, ANN SURG ONCOL, V17, pS202, DOI 10.1245/s10434-010-1261-3; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blondeel PN, 1999, BRIT J PLAST SURG, V52, P104, DOI 10.1054/bjps.1998.3033; Chen CM, 2007, PLAST RECONSTR SURG, V120, P1477, DOI 10.1097/01.prs.0000288014.76151.f7; Colakoglu S, 2011, PLAST RECONSTR SURG, V127, P1428, DOI 10.1097/PRS.0b013e318208d0d4; Damen THC, 2009, J PLAST RECONSTR AES, V62, P71, DOI 10.1016/j.bjps.2007.09.045; Damen THC, 2010, J PLAST RECONSTR AES, V63, P93, DOI 10.1016/j.bjps.2008.08.019; Fallbjork U, 2012, EUR J ONCOL NURS, V16, P220, DOI 10.1016/j.ejon.2011.05.005; Fang SY, 2010, CANCER NURS, V33, pE1, DOI 10.1097/NCC.0b013e3181d1c853; Gopie JP, 2014, PSYCHO-ONCOLOGY, V23, P100, DOI 10.1002/pon.3377; Gopie JP, 2013, PSYCHO-ONCOLOGY, V22, P290, DOI 10.1002/pon.2089; Gopie JP, 2011, J PLAST RECONSTR AES, V64, P1167, DOI 10.1016/j.bjps.2011.03.034; Hamdi M, 1999, PLAST RECONSTR SURG, V103, P86, DOI 10.1097/00006534-199901000-00015; Ho AL, 2013, PLAST RECONSTR SURG, V132, p212E, DOI 10.1097/PRS.0b013e31829586fa; Hofer SOP, 2007, ANN PLAS SURG, V59, P137, DOI 10.1097/01.sap.0000253326.85829.45; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Horowitz M.J., 1982, HDB STRESS THEORETIC, DOI DOI 10.1007/978-1-4615-2820-3_4; Joseph S, 2000, J TRAUMA STRESS, V13, P101, DOI 10.1023/A:1007777032063; Lee CN, 2010, ANN PLAS SURG, V64, P567, DOI 10.1097/SAP.0b013e3181bffc9b; Little R. J. A., 1987, STAT ANAL MISSING DA; Lu SM, 2014, J PLAST RECONSTR AES, V67, P682, DOI 10.1016/j.bjps.2014.01.017; McCarthy CM, 2008, PLAST RECONSTR SURG, V121, P1886, DOI 10.1097/PRS.0b013e31817151c4; Potter S, 2009, BRIT J SURG, V96, P613, DOI 10.1002/bjs.6605; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spector DJ, 2011, J PSYCHOSOC ONCOL, V29, P664, DOI 10.1080/07347332.2011.615384; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sullivan SR, 2008, PLAST RECONSTR SURG, V122, P19, DOI 10.1097/PRS.0b013e3181774267; Tonseth KA, 2008, J PLAST RECONSTR AES, V61, P1188, DOI 10.1016/j.bjps.2007.05.006; Tsoi B, 2014, J AM COLL SURGEONS, V218, P1038, DOI 10.1016/j.jamcollsurg.2014.02.011; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Verbeke G, 2000, LINEAR MIXED MODELS; Wilkins EG, 2000, PLAST RECONSTR SURG, V106, P1014, DOI 10.1097/00006534-200010000-00010; Woerdeman LAE, 2007, PLAST RECONSTR SURG, V119, P455, DOI 10.1097/01.prs.0000246379.99318.74; Yang BL, 2015, PLOS ONE, V10; Yueh JH, 2010, PLAST RECONSTR SURG, V125, P1585, DOI 10.1097/PRS.0b013e3181cb6351; Zhang Y., 2015, PLOS ONE, V10; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174455	10.1371/journal.pone.0174455	http://dx.doi.org/10.1371/journal.pone.0174455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346508	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300050
J	Choi, JA; Kim, HW; Kwon, JW; Shim, YS; Jee, DH; Yun, JS; Ahn, YB; Park, CK; Ko, SH				Choi, Jin A.; Kim, Hyo Won; Kwon, Jin-Woo; Shim, Yun-Sub; Jee, Dong Hyun; Yun, Jae-Seung; Ahn, Yu-Bae; Park, Chan Kee; Ko, Seung-Hyun			Early inner retinal thinning and cardiovascular autonomic dysfunction in type 2 diabetes	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; MACULAR GANGLION-CELL; SPECTRAL-DOMAIN; DEFECTS; THICKNESS; DISEASE; ASSOCIATION; RETINOPATHY; MELLITUS	Background To investigate changes in the neural retina according to the presence of retinal nerve fiber layer (RNFL) defects in type 2 diabetes, and to determine the association between inner retina thickness and the severity of diabetic complications. Methods We studied non-glaucomatous patients with type 2 diabetes and control subjects Circumpapillary RNFL and macula ganglion cell-inner plexiform layer (GCIPL) thicknesses were measured by spectral-domain optical coherence tomography. In patients with type 2 diabetes, a cardiovascular autonomic function test (AFT) was performed, which included the heart rate parameter of beat-beat variation-with deep breathing, in response to the Valsalva maneuver, and on postural change from lying to standing. The results of each test were scored as 0 for normal and 1 for abnormal. A total AFT score of 1 was defined as early cardiovascular autonomic neuropathy (CAN), and an AFT score >= 2 as definite CAN. Results We compared control eyes (n = 70), diabetic eyes with RNFL defects (n = 47), and eyes without RNFL defects (n = 30). The average RNFL and GCIPL thicknesses were significantly different among groups (all, P<0.05). On post-hoc testing, diabetic eyes with RNFL defects had a significantly thinner average GCIPL thickness than those without RNFL defects. On multivariate analyses, significantly thinner average GCIPL was seen in early CAN staging (B = -4.32, P = 0.016) and in definite CAN staging (B = -10.33, P<0.001), compared with no CAN involvement, after adjusting for confounding parameters. Conclusions Cardiovascular autonomic dysfunction was associated with early neurodegenerative changes in type 2 diabetes.	[Choi, Jin A.; Kim, Hyo Won; Kwon, Jin-Woo; Shim, Yun-Sub; Jee, Dong Hyun] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, St Vincents Hosp, Coll Med, Seoul, South Korea; [Yun, Jae-Seung; Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincents Hosp,Coll Med, Seoul, South Korea; [Park, Chan Kee] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Ko, SH (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincents Hosp,Coll Med, Seoul, South Korea.; Park, CK (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	kosh@catholic.ac.kr; ckpark@catholic.ac.kr		Kwon, Jin-woo/0000-0003-2093-4284	St.Vincent's hospital, research institute of medical science (SVHR); National Research Foundation of Korea Grant - Korean government (MSIP) [NRF-2016R1C1B1011287]	St.Vincent's hospital, research institute of medical science (SVHR); National Research Foundation of Korea Grant - Korean government (MSIP)	The authors wish to acknowledge the financial support of the St.Vincent's hospital, research institute of medical science (SVHR-2015-14) and the National Research Foundation of Korea Grant funded by the Korean government (MSIP) (No. NRF-2016R1C1B1011287). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; BANGSTAD HJ, 1994, ACTA OPHTHALMOL, V72, P668; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Chhablani J, 2015, INVEST OPHTH VIS SCI, V56, P6333, DOI 10.1167/iovs.15-17334; Chhablani J, 2014, SAUDI J OPHTHALMOL, V28, P81, DOI 10.1016/j.sjopt.2014.02.010; CHIHARA E, 1993, OPHTHALMOLOGY, V100, P1147; Choi JA, 2015, OPHTHALMOLOGY, V122, P976, DOI 10.1016/j.ophtha.2015.01.001; De Clerck EEB, 2015, LANCET DIABETES ENDO, V3, P653, DOI 10.1016/S2213-8587(15)00136-9; El-Menyar AA, 2006, J CARDIOVASC MED, V7, P580, DOI 10.2459/01.JCM.0000237904.95882.c8; EWING DJ, 1974, CLIN SCI MOL MED, V46, P295, DOI 10.1042/cs0460295; Fernyhough P, 1999, DIABETES, V48, P881, DOI 10.2337/diabetes.48.4.881; Geitzenauer W, 2010, RETINA-J RET VIT DIS, V30, P596, DOI 10.1097/IAE.0b013e3181c10711; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; Jie R, 2015, INVEST OPHTH VIS SCI, V56, P5118, DOI 10.1167/iovs.15-16682; JONAS JB, 1993, GRAEF ARCH CLIN EXP, V231, P207, DOI 10.1007/BF00918842; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P285, DOI 10.1136/bjo.78.4.285; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Kim KE, 2015, OPHTHALMOLOGY, V122, P502, DOI 10.1016/j.ophtha.2014.09.031; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lieth E, 2000, EXP EYE RES, V70, P723, DOI 10.1006/exer.2000.0840; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Niessen AGJE, 1998, ACTA OPHTHALMOL SCAN, V76, P278, DOI 10.1034/j.1600-0420.1998.760305.x; NIESSEN AGJE, 1995, AM J OPHTHALMOL, V120, P577, DOI 10.1016/S0002-9394(14)72204-4; Park HL, 2016, DIABETES CARE; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Pedro-Botet J, 2015, J GERIATR CARDIOL, V12, P431, DOI 10.11909/j.issn.1671-5411.2015.04.016; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Santiago AR, 2007, NEUROBIOL DIS, V25, P464, DOI 10.1016/j.nbd.2006.10.023; Sasaki M, 2014, INVEST OPHTH VIS SCI, V55, P1749, DOI 10.1167/iovs.13-13035; Simo R, 2015, PROG RETIN EYE RES, V48, P160, DOI 10.1016/j.preteyeres.2015.04.003; Srinivasan S, 2016, OPHTHAL PHYSL OPT, V36, P158, DOI 10.1111/opo.12263; Sukla Pradeep, 2016, Avicenna J Med, V6, P81, DOI 10.4103/2231-0770.184067; Tiftikcioglu BI, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003340; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Wang DD, 2014, STROKE, V45, P1651, DOI 10.1161/STROKEAHA.113.004629; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yoo YC, 2013, J GLAUCOMA, V22, P559, DOI 10.1097/IJG.0b013e31824484b9; Yun JS, 2015, DIABETES METAB J, V39, P498, DOI 10.4093/dmj.2015.39.6.498; Yun JS, 2015, DIABETES RES CLIN PR, V108, P31, DOI 10.1016/j.diabres.2015.01.031; Yun JS, 2014, DIABETES CARE, V37, P235, DOI 10.2337/dc13-1164	43	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174377	10.1371/journal.pone.0174377	http://dx.doi.org/10.1371/journal.pone.0174377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334035	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200089
J	Nogueira, M				Nogueira, Miguel			Exploring the link between multiscale entropy and fractal scaling behavior in near-surface wind	PLOS ONE			English	Article							PHYSIOLOGICAL TIME-SERIES; ENERGY-CONTAINING SCALES; APPROXIMATE ENTROPY; COMPLEXITY; PRECIPITATION; TEMPERATURE; VELOCITY; RAINFALL	The equivalency between the power law behavior of Multiscale Entropy (MSE) and of power spectra opens a promising path for interpretation of complex time-series, which is explored here for the first time for atmospheric fields. Additionally, the present manuscript represents a new independent empirical validation of such relationship, the first one for the atmosphere. The MSE-fractal relationship is verified for synthetic fractal time-series covering the full range of exponents typically observed in the atmosphere. It is also verified for near-surface wind observations from anemometers and CFSR re-analysis product. The results show a ubiquitous beta approximate to 5/3 behavior inside the inertial range. A scaling break emerges at scales around a few seconds, with a tendency towards 1/f noise. The presence, extension and fractal exponent of this intermediate range are dependent on the particular surface forcing and atmospheric conditions. MSE shows an identical picture which is consistent with the turbulent energy cascade model: viscous dissipation at the small-scale end of the inertial range works as an information sink, while at the larger (energy-containing) scales the multiple forcings in the boundary layer act as widespread information sources. Another scaling transition occurs at scales around 1-10 days, with an abrupt flattening of the spectrum. MSE shows that this transition corresponds to a maximum of the new information introduced, occurring at the time-scales of the synoptic features that dominate weather patterns. At larger scales, a scaling regime with flatter slopes emerges extending to scales larger than 1 year. MSE analysis shows that the amount of new information created decreases with increasing scale in this low-frequency regime. Additionally, in this region the energy injection is concentrated in two large energy peaks: daily and yearly time-scales. The results demonstrate that the superposition of these periodic signals does not destroy the underlying scaling behavior, with both periodic and fractal terms playing an important role in the observed wind time-series.	[Nogueira, Miguel] Univ Lisbon, Fac Ciencias, Inst Dom Luiz, Campo Grande, Lisbon, Portugal	Universidade de Lisboa	Nogueira, M (corresponding author), Univ Lisbon, Fac Ciencias, Inst Dom Luiz, Campo Grande, Lisbon, Portugal.	mdnogueira@fc.ul.pt	Nogueira, Miguel/Z-1910-2019; Nogueira, Miguel/L-3164-2015	Nogueira, Miguel/0000-0003-4587-875X; Nogueira, Miguel/0000-0003-4587-875X	Portuguese Science Foundation (FCT) [UID/GEO/50019/2013, RECI/GEO-MET/0380/2012]	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology)	This study was funded by the Portuguese Science Foundation (FCT), under grants UID/GEO/50019/2013, as part of research project RECI/GEO-MET/0380/2012. These grants supported the computational resources used in the present manuscript, developed and Instituto Dom Luiz at the Faculty of Sciences of the Universidade of Lisbon. Grant UID/GEO/50019/2013 is supporting any publication costs. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Portuguese Science Foundation (FCT), under grants UID/GEO/50019/2013, as part of research project RECI/GEO-MET/0380/2012.	Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; Balzter H, 2015, CLIMATE, V3, P227, DOI 10.3390/cli3010227; Barros AP, 2004, NAT HAZARD EARTH SYS, V4, P29, DOI 10.5194/nhess-4-29-2004; Bindlish R, 1996, COMPUT GEOSCI, V22, P907, DOI 10.1016/S0098-3004(96)00049-0; Bindlish R, 2000, GLOBAL PLANET CHANGE, V25, P111, DOI 10.1016/S0921-8181(00)00024-2; Calif R, 2014, NONLINEAR PROC GEOPH, V21, P379, DOI 10.5194/npg-21-379-2014; Calif R, 2012, J WIND ENG IND AEROD, V109, P1, DOI 10.1016/j.jweia.2012.06.002; Chou CM, 2012, ENTROPY-SWITZ, V14, P945, DOI 10.3390/e14050945; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Courtiol J, 2016, J NEUROSCI METH, V273, P175, DOI 10.1016/j.jneumeth.2016.09.004; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; Fu ZT, 2014, COMMUN NONLINEAR SCI, V19, P83, DOI 10.1016/j.cnsns.2013.06.026; Gao JB, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00064; Huixia Li, 2011, 2011 International Conference on Electrical and Control Engineering, P4579, DOI 10.1109/ICECENG.2011.6057295; Humeau-Heurtier A, 2015, ENTROPY-SWITZ, V17, P3110, DOI 10.3390/e17053110; Huybers P, 2006, NATURE, V441, P329, DOI 10.1038/nature04745; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Katul G, 1998, BOUND-LAY METEOROL, V86, P279, DOI 10.1023/A:1000657014845; Katul G, PHYS REV E, V86; KATUL GG, 1995, J GEOPHYS RES-ATMOS, V100, P14243, DOI 10.1029/94JD02616; Kirkby MJ, 1982, FRACTAL GEOMETRY NAT, P460; Kolmogorov A.N., 1941, DOKL AKAD NAUK SSSR, V30, P299, DOI DOI 10.1098/RSPA.1991.0075; Lauren MK, 1999, BOUND-LAY METEOROL, V90, P21, DOI 10.1023/A:1001749126625; Li Z, 2008, STOCH ENV RES RISK A, V22; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Lovejoy S, 2010, ATMOS RES, V96, P1, DOI 10.1016/j.atmosres.2010.01.004; Lovejoy S, 2012, EXTREME EVENTS NATUR; Lovejoy S., 2013, The Weather and Climate: Emergent Laws and Multifractal Cascades; Muzy JF, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056308; Nogueira M, 2015, J HYDROL, V529, P1407, DOI 10.1016/j.jhydrol.2015.08.041; Nogueira M, 2014, J GEOPHYS RES-ATMOS, V119, P13771, DOI 10.1002/2014JD022548; Nogueira M, 2013, NONLINEAR PROC GEOPH, V20, P605, DOI 10.5194/npg-20-605-2013; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Poulos GS, 2002, B AM METEOROL SOC, V83, P555, DOI 10.1175/1520-0477(2002)083<0555:CACIOT>2.3.CO;2; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; SCHERTZER D, 1987, J GEOPHYS RES-ATMOS, V92, P9693, DOI 10.1029/JD092iD08p09693; Schmitt F, 1994, NONLINEAR PROC GEOPH, V1, P95, DOI 10.5194/npg-1-95-1994; Schmitt F, 1993, FRACTALS, V1, P568, DOI 10.1142/S0218348X93000599; Schmitt FG, 2007, WIND ENERGY, P73, DOI 10.1007/978-3-540-33866-6_13; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SINAI I, 1959, DOKL AKAD NAUK SSSR+, V124, P768; Skamarock WC, 2004, MON WEATHER REV, V132, P3019, DOI 10.1175/MWR2830.1; Tchiguirinskaia I, 2007, WIND ENERGY, P99, DOI 10.1007/978-3-540-33866-6_17; Tuck AF, 2010, Q J ROY METEOR SOC, V136, P1125, DOI 10.1002/qj.644; Valencia JF, 2009, IEEE ENG MED BIOL, V28, P72, DOI 10.1109/MEMB.2009.934621; Veneziano D, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004716; ZHANG YC, 1991, J PHYS I, V1, P971, DOI 10.1051/jp1:1991180; Zhou Y, 2012, HYDROL PROCESS, V26, P3253, DOI 10.1002/hyp.8406	50	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173994	10.1371/journal.pone.0173994	http://dx.doi.org/10.1371/journal.pone.0173994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334026	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200035
J	Shen, CJ; Kuo, YL; Chen, CC; Chen, MJ; Cheng, YM				Shen, Ching-Ju; Kuo, Yu-Ling; Chen, Chien-Chung; Chen, Ming-Jenn; Cheng, Ya-Min			MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; CELLS; OVEREXPRESSION; CONTRIBUTES; METASTASIS; INHIBITION; PROGNOSIS; CARCINOMA	High matrix metalloproteinase 1 (MMP1) expression is associated with enhanced breast cancer growth and metastasis and also might predict poor prognosis. In this study, we further investigated the functional role of MMP1 and how it is upregulated in multi-drug resistant (MDR) breast cancer cells. By retrieving microarray data in GEO datasets and the survival data in the Kaplan Meier plotter, we observed that MMP1 is significantly upregulated in MCF-7/ADR cells compared to the parental MCF-7 cells, while high MMP1 expression is associated with worse overall survival (OS) and recurrence free survival (RFS) in breast cancer patients after systematic therapy. Functional studies showed that MMP1 overexpression significantly reduced the drug sensitivity in MCF-7 cells, while MMP1 knockdown substantially enhanced the sensitivity in MCF-7/ADR cells. By performing western blotting and immunofluorescent staining, we confirmed that MCF-7/ADR cells had enhanced mesenchymal properties than MCF-7 cells. In MCF-7 cells, enforced Slug expression resulted in significant MMP1 upregulation, while in MCF-7/ADR cells, Slug knockdown led to reduced MMP1 expression. By performing bioinformatic analysis, we observed that the promoter of MMP1 has three putative Slug binding sites. The following dual luciferase assay and ChIP-qPCR verified these three binding sites. Therefore, we infer that Slug enhances MMP1 transcription via directly binding to the promoter region in breast cancer cells, which is a previously unrecognized mechanism in the development of MDR.	[Shen, Ching-Ju; Kuo, Yu-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Shen, Ching-Ju; Kuo, Yu-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Gynecol & Obstet, Kaohsiung, Taiwan; [Chen, Chien-Chung] E Da Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Chen, Ming-Jenn] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Chen, Ming-Jenn] Chia Nan Univ Pharm & Sci, Dept Sports Management, Coll Leisure & Recreat Management, Tainan, Taiwan; [Cheng, Ya-Min] Natl Cheng Kung Univ, Inst Clin Med, Dept Obstet & Gynecol, Coll Med, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; E-Da Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University	Cheng, YM (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Dept Obstet & Gynecol, Coll Med, Tainan, Taiwan.	chenmed.tw@yahoo.com.tw						Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Cao WH, 2016, EUR REV MED PHARMACO, V20, P1115; Chen SJ, 2012, MOL BIOL REP, V39, P5465, DOI 10.1007/s11033-011-1347-4; Cheng S, 2008, J SURG RES, V146, P104, DOI 10.1016/j.jss.2007.05.032; Nguyen CH, 2015, ONCOTARGET, V6, P39262, DOI 10.18632/oncotarget.5741; Cierna Z, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-472; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; Feng XL, 2011, MOL CELL BIOL, V31, P3457, DOI 10.1128/MCB.05523-11; Geng C, 2016, BIOCHEM BIOPH RES CO, V473, P147, DOI 10.1016/j.bbrc.2016.03.067; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jezequel P, 2012, BREAST CANCER RES TR, V131, P765, DOI 10.1007/s10549-011-1457-7; Joannes A, 2014, MOL CANCER RES, V12, P775, DOI 10.1158/1541-7786.MCR-13-0386-T; Li YY, 2014, IUBMB LIFE, V66, P507, DOI 10.1002/iub.1285; Li YP, 2015, AM J TRANSL RES, V7, P120; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu SN, 2016, BIOL PLANTARUM, V60, P401, DOI 10.1007/s10535-016-0614-6; Lukyanova N. Yu., 2009, Experimental Oncology, V31, P87; Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Przybyla LM, 2013, STEM CELLS, V31, P1097, DOI 10.1002/stem.1360; Saeki T, 2005, CANCER CHEMOTH PHARM, V56, pS84, DOI 10.1007/s00280-005-0106-4; Santilli Guido, 2011, Cancers (Basel), V3, P1405, DOI 10.3390/cancers3011405; Sun WL, 2015, NEOPLASMA, V62, P199, DOI 10.4149/neo_2015_025; Szasz AM, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10337; Xiao C, 2016, EUR REV MED PHARMACO, V20, P2819; Yang JM, 2003, MOL CANCER RES, V1, P420; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	30	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174487	10.1371/journal.pone.0174487	http://dx.doi.org/10.1371/journal.pone.0174487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334049	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200106
J	Van Opstal, AJ; Vliegen, J; Van Esch, T				Van Opstal, A. John; Vliegen, Joyce; Van Esch, Thamar			Reconstructing spectral cues for sound localization from responses to rippled noise stimuli	PLOS ONE			English	Article							HEADPHONE SIMULATION; FREQUENCY; LINKAGE; LEVEL	Human sound localization in the mid-saggital plane (elevation) relies on an analysis of the idiosyncratic spectral shape cues provided by the head and pinnae. However, because the actual free-field stimulus spectrum is a-priori unknown to the auditory system, the problem of extracting the elevation angle from the sensory spectrum is ill-posed. Here we test different spectral localization models by eliciting head movements toward broad-band noise stimuli with randomly shaped, rippled amplitude spectra emanating from a speaker at a fixed location, while varying the ripple bandwidth between 1.5 and 5.0 cycles/octave. Six listeners participated in the experiments. From the distributions of localization responses toward the individual stimuli, we estimated the listeners' spectral-shape cues underlying their elevation percepts, by applying maximum-likelihood estimation. The reconstructed spectral cues resulted to be invariant to the considerable variation in ripple bandwidth, and for each listener they had a remarkable resemblance to the idiosyncratic head-related transfer functions (HRTFs). These results are not in line with models that rely on the detection of a single peak or notch in the amplitude spectrum, nor with a local analysis of first-and second-order spectral derivatives. Instead, our data support a model in which the auditory system performs a cross-correlation between the sensory input at the eardrum-auditory nerve, and stored representations of HRTF spectral shapes, to extract the perceived elevation angle.	[Van Opstal, A. John; Vliegen, Joyce; Van Esch, Thamar] Radboud Univ Nijmegen, Dept Biophys, Donders Ctr Neurosci, HG00-831,Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen	Van Opstal, AJ (corresponding author), Radboud Univ Nijmegen, Dept Biophys, Donders Ctr Neurosci, HG00-831,Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	j.vanopstal@donders.ru.nl	van Opstal, John/D-1907-2010	van Opstal, John/0000-0001-5957-5712	Radboud University Nijmegen; Netherlands Organization for Scientific Research (NWO - section Maatschappij en Geesteswetenschappen, MaGW) [410-20-301]; European Union, Horizon-2020, ERC Advanced Grant [693400]	Radboud University Nijmegen; Netherlands Organization for Scientific Research (NWO - section Maatschappij en Geesteswetenschappen, MaGW)(Netherlands Organization for Scientific Research (NWO)); European Union, Horizon-2020, ERC Advanced Grant	This research was supported by the Radboud University Nijmegen (TVE), the Netherlands Organization for Scientific Research (NWO - section Maatschappij en Geesteswetenschappen, MaGW, project nr. 410-20-301; JV; Web:www.nwo.nl), and the European Union, Horizon-2020, ERC Advanced Grant 2016 (nr. 693400, ORIENT, AJVO; Web: https://ec. europa.eu/research/participants/portal/desktop/en/ opportunities/h2020/calls/erc-2016-adg.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Paul Hofman for his excellent stimulus generation and data analysis software, and to Gunther Windau, Ger van Lingen, Ton van Dreumel and Hans Kleijnen for their indispensible technical support. This research was supported by the Radboud University (TVE), the Netherlands Organization for Scientific Research (NWO-section Maatschappij en Geesteswetenschappen, MaGW, project nr. 410-20-301; JV), and the European Union, Horizon-2020 ERC Advanced Grant (nr. 693400, ORIENT, AJVO).	Algazi VR, 2001, J ACOUST SOC AM, V109, P1110, DOI 10.1121/1.1349185; Blauert J., 1997, SPATIAL HEARING PSYC; Bremen P, 2010, J NEUROSCI, V30, P194, DOI 10.1523/JNEUROSCI.2982-09.2010; BUTLER RA, 1993, HEARING RES, V67, P220, DOI 10.1016/0378-5955(93)90250-5; BUTLER RA, 1987, PERCEPT PSYCHOPHYS, V41, P1, DOI 10.3758/BF03208206; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; Good MD, 1996, J ACOUST SOC AM, V99, P1108, DOI 10.1121/1.415233; HARTMANN WM, 1993, J ACOUST SOC AM, V94, P2083, DOI 10.1121/1.407481; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Hofman PM, 2002, BIOL CYBERN, V86, P305, DOI 10.1007/s00422-001-0294-x; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; Macpherson EA, 2000, J ACOUST SOC AM, V108, P1834, DOI 10.1121/1.1310196; MAKOUS JC, 1990, J ACOUST SOC AM, V87, P2188, DOI 10.1121/1.399186; MIDDLEBROOKS JC, 1992, J ACOUST SOC AM, V92, P2607, DOI 10.1121/1.404400; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MUSICANT AD, 1984, HEARING RES, V14, P185, DOI 10.1016/0378-5955(84)90017-0; Otte RJ, 2013, JARO-J ASSOC RES OTO, V14, P261, DOI 10.1007/s10162-012-0367-7; ROGERS ME, 1992, PERCEPT PSYCHOPHYS, V52, P536, DOI 10.3758/BF03206715; SCHROEDER MR, 1970, IEEE T INFORM THEORY, V16, P85, DOI 10.1109/TIT.1970.1054411; Takemoto H, 2012, J ACOUST SOC AM, V132, P3832, DOI 10.1121/1.4765083; Van Barneveld DCPBM, 2011, EXP BRAIN RES, V213, P235, DOI 10.1007/s00221-011-2741-9; Van Opstal AJ, 2016, AUDITORY SYSTEM HUMA; Van Wanrooij MM, 2005, J NEUROSCI, V25, P5413, DOI 10.1523/JNEUROSCI.0850-05.2005; Vliegen J, 2004, J ACOUST SOC AM, V115, P1705, DOI 10.1121/1.1687423; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; ZAKARAUSKAS P, 1993, J ACOUST SOC AM, V94, P1323, DOI 10.1121/1.408160; Zwiers MP, 2003, NAT NEUROSCI, V6, P175, DOI 10.1038/nn999; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	30	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174185	10.1371/journal.pone.0174185	http://dx.doi.org/10.1371/journal.pone.0174185			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333967	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200059
J	Gardinali, NR; Guimaraes, JR; Melgaco, JG; Kevorkian, YB; Bottino, FD; Vieira, YR; da Silva, ACD; Pinto, DP; da Fonseca, LB; Vilhena, LS; Uiechi, E; da Silva, MCC; Moran, J; Marchevsky, RS; Cruz, OG; Otonel, RAA; Alfieri, AA; de Oliveira, JM; Gaspar, AMC; Pinto, MA				Gardinali, Noemi Rovaris; Guimaraes, Juliana Rodrigues; Melgaco, Juliana Gil; Kevorkian, Yohan Britto; Bottino, Fernanda de Oliveira; Vieira, Yasmine Rangel; de Azevedo da Silva, Aline Campos; Pinto, Douglas Pereira; da Fonseca, Lais Bastos; Vilhena, Leandro Schiavo; Uiechi, Edilson; Carlan da Silva, Maria Cristina; Moran, Julio; Marchevsky, Renato Sergio; Cruz, Oswaldo Goncalves; Arellano Otonel, Rodrigo Alejandro; Alfieri, Amauri Alcindo; de Oliveira, Jaqueline Mendes; Coimbra Gaspar, Ana Maria; Pinto, Marcelo Alves			Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy	PLOS ONE			English	Article							CALCINEURIN INHIBITORS; TRANSPLANT RECIPIENTS; ENTERIC VIRUSES; 1ST REPORT; THROMBOCYTOPENIA; TACROLIMUS; REPLICATION; TRANSFUSION; PATIENT; MACAQUE	Epidemiological studies found that hepatitis E virus genotype 3 (HEV-3) infection was associated with chronic hepatitis and cirrhosis in immunocompromised patients. Our study aimed to investigate the relationship between the host immunosuppressive status and the occurrence of HEV-related chronic hepatitis. Here we describe a successful experimental study, using cynomolgus monkeys previously treated with tacrolimus, a potent calcineurin inhibitor immunosuppressant, and infected with a Brazilian HEV-3 strain isolated from naturally infected pigs. HEV infected monkeys were followed up during 160 days post infection (dpi) by clinical signs; virological, biochemical and haematological parameters; and liver histopathology. The tacrolimus blood levels were monitored throughout the experiment. Immunosuppression was confirmed by clinical and laboratorial findings, such as: moderate weight loss, alopecia, and herpes virus opportunistic infection. In this study, chronic HEV infection was characterized by the mild increase of liver enzymes serum levels; persistent RNA viremia and viral faecal shedding; and liver histopathology. Three out of four immunosuppressed monkeys showed recurrent HEV RNA detection in liver samples, evident hepatocellular ballooning degeneration, mild to severe macro and microvesicular steatosis (zone 1), scattered hepatocellular apoptosis, and lobular focal inflammation. At 69 dpi, liver biopsies of all infected monkeys revealed evident ballooning degeneration (zone 3), discretehepatocellular apoptosis, and at most mild portal and intra-acinar focal inflammation. At 160 dpi, the three chronically HEV infected monkeys showed microscopic features (piecemeal necrosis) corresponding to chronic hepatitis in absence of fibrosis and cirrhosis in liver parenchyma. Within 4-months follow up, the tacrolimus-immunosuppressed cynomolgus monkeys infected with a Brazilian swine HEV-3 strain exhibited more severe hepatic lesions progressing to chronic hepatitis without liver fibrosis, similarly as shown in tacrolimus-immunosuppressed solid organ transplant (SOT) recipients. The cause-effect relationship between HEV infection and tacrolimus treatment was confirmed in this experiment.	[Gardinali, Noemi Rovaris; Guimaraes, Juliana Rodrigues; Melgaco, Juliana Gil; Kevorkian, Yohan Britto; Bottino, Fernanda de Oliveira; Vieira, Yasmine Rangel; de Oliveira, Jaqueline Mendes; Coimbra Gaspar, Ana Maria; Pinto, Marcelo Alves] Fundacao Oswaldo Cruz, Lab Desenvolvimento Tecnol Virol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [de Azevedo da Silva, Aline Campos; Pinto, Douglas Pereira; da Fonseca, Lais Bastos; Vilhena, Leandro Schiavo] Fundacao Oswaldo Cruz, Serv Equivalencia & Farmacocinet SEFAR, VPPIS, Rio De Janeiro, Brazil; [Uiechi, Edilson] Libbs Ind Farmaceut, Sao Paulo, Brazil; [Carlan da Silva, Maria Cristina] UFABC, Lab Biol Mol Patogenos Virol Mol, CCNH, Sao Paulo, Brazil; [Moran, Julio] Dr Julio Moran Labs, Zurich, Switzerland; [Marchevsky, Renato Sergio] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol Biomanguinhos, Lab Neurovirulencia, Rio De Janeiro, Brazil; [Cruz, Oswaldo Goncalves] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Arellano Otonel, Rodrigo Alejandro; Alfieri, Amauri Alcindo] Univ Estadual Londrina, Dept Med Vet Prevent, Lab Virol Anim, Londrina, Parana, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do ABC (UFABC); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Estadual de Londrina	Gardinali, NR (corresponding author), Fundacao Oswaldo Cruz, Lab Desenvolvimento Tecnol Virol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.	no_rovaris@yahoo.com.br	Melgaço, Juliana/AAQ-6084-2020; da silva, maria cristina carlan/E-2669-2013; Pinto, Marcelo/G-7503-2012; Alfieri, A./J-3408-2019; Pinto, Marcelo Alves/ABA-3312-2020	Melgaço, Juliana/0000-0003-0087-6531; da silva, maria cristina carlan/0000-0003-4081-8272; Pinto, Marcelo/0000-0003-3462-7277; Alfieri, A./0000-0002-7024-4487; Schiavo Vilhena, Leandro/0000-0002-5451-3691; Marchevsky, Renato/0000-0003-1174-3902; Kevorkian, Yohan/0000-0003-1602-4974; de Oliveira Bottino, Fernanda/0000-0002-6682-9845	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.848/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FIOCRUZ PASTEUR Program; Libbs Industria Farmaceutica	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ PASTEUR Program; Libbs Industria Farmaceutica	Support was provided by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), grants awarded to AMCG (E-26/110.848/2013); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grants awarded to MAP; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), fellowship awarded to NRG; and FIOCRUZ PASTEUR Program, budget awarded to MAP within the framework of the call 2013/2015. Libbs Industria Farmaceutica provided, as a donation, the tacrolimus medicine, the immunosuppressive used in the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Libbs Industria Farmaceutica provided support in the form of salaries for author EU, and Dr. Julio Moran Laboratories for author JM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; Arai Keisuke, 2016, Kobe J Med Sci, V62, pE9; Bloom RD, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000012382.97168.E0; Chin JL, 2016, CLIN APPL THROMB-HEM, V22, P351, DOI 10.1177/1076029614559771; Ciftci HS, 2013, INDIAN J CLIN BIOCHE, V28, P164, DOI 10.1007/s12291-012-0251-6; Colson P, 2008, J CLIN MICROBIOL, V46, P2450, DOI 10.1128/JCM.02295-07; Dalton HR, 2016, DIGEST DIS, V34, P308, DOI 10.1159/000444468; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; de Carvalho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-495; Diaz GC, 2008, LIVER TRANSPLANT, V14, P1803, DOI 10.1002/lt.21539; Du LY, 2016, SAUDI MED J, V37, P483, DOI 10.15537/smj.2016.5.14178; Fourquet E, 2010, J CLIN VIROL, V48, P73, DOI 10.1016/j.jcv.2010.02.016; Gardinali NR, 2012, RES VET SCI, V93, P1515, DOI 10.1016/j.rvsc.2012.06.003; Geng YS, 2016, J HEPATOL, V64, P37, DOI 10.1016/j.jhep.2015.08.034; Griffin SP, 2016, PROG TRANSPLANT; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Haagsma EB, 2009, LIVER TRANSPLANT, V15, P1225, DOI 10.1002/lt.21819; Han J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099861; Haustein SV, 2008, ILAR J, V49, P209, DOI 10.1093/ilar.49.2.209; Heldt FH, 2016, FOOD ENV VIROL; Hering T, 2014, J MED VIROL, V86, P948, DOI 10.1002/jmv.23915; Huang F, 2016, J HEPATOL; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; JUSKO WJ, 1995, THER DRUG MONIT, V17, P606, DOI 10.1097/00007691-199512000-00011; Kamar N, 2013, AM J TRANSPLANT, V13, P1935, DOI 10.1111/ajt.12253; Kamar N, 2010, AM J TRANSPLANT, V10, P1321, DOI 10.1111/j.1600-6143.2010.03068.x; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2016, LIVER INT, V36, P467, DOI 10.1111/liv.13037; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kamar N, 2010, TRANSPLANTATION, V89, P353, DOI 10.1097/TP.0b013e3181c4096c; Khuroo MS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090253; Kinugasa F, 2008, J PHARMACOL SCI, V108, P529, DOI 10.1254/jphs.08142FP; Kisu I, 2014, J OBSTET GYNAECOL RE, V40, P907, DOI 10.1111/jog.12302; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kokkinos P, 2012, FOOD ENVIRON VIROL, V4, P179, DOI 10.1007/s12560-012-9087-8; KROGSGAARD K, 1991, SCAND J GASTROENTERO, V26, P275, DOI 10.3109/00365529109025042; Legrand-Abravanel F, 2010, J INFECT DIS, V202, P835, DOI 10.1086/655899; Lhomme S, 2012, J VIROL, V86, P10006, DOI 10.1128/JVI.01003-12; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; LONGER CF, 1993, J INFECT DIS, V168, P602, DOI 10.1093/infdis/168.3.602; dos Santos DRL, 2011, VET MICROBIOL, V149, P236, DOI 10.1016/j.vetmic.2010.10.024; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; Mahalingam R, 2010, J NEUROVIROL, V16, P342, DOI 10.3109/13550284.2010.513031; Marchetti P, 2000, J ENDOCRINOL INVEST, V23, P482, DOI 10.1007/BF03343761; Matthews KA, 2015, COMPARATIVE MED, V65, P352; Maunula L, 2013, INT J FOOD MICROBIOL, V167, P177, DOI 10.1016/j.ijfoodmicro.2013.09.003; Muduma G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160421; Passos AM, 2013, J MED VIROL, V85, P615, DOI 10.1002/jmv.23494; Passos-Castilho AM, 2014, J CLIN MICROBIOL, V52, P4425, DOI 10.1128/JCM.02286-14; Pischke S, 2012, AM J TRANSPLANT, V12, P3128, DOI 10.1111/j.1600-6143.2012.04200.x; Pischke S, 2010, LIVER TRANSPLANT, V16, P74, DOI 10.1002/lt.21958; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Suneetha PV, 2012, HEPATOLOGY, V55, P695, DOI 10.1002/hep.24738; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; TSAREV SA, 1993, J INFECT DIS, V167, P1302, DOI 10.1093/infdis/167.6.1302; Wang YC, 1999, J GEN VIROL, V80, P169, DOI 10.1099/0022-1317-80-1-169; Wang YJ, 2014, GASTROENTEROLOGY, V146, P1775, DOI 10.1053/j.gastro.2014.02.036; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	62	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174070	10.1371/journal.pone.0174070	http://dx.doi.org/10.1371/journal.pone.0174070			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328941	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700047
J	Guayasamin, JM; Hutter, CR; Tapia, EE; Culebras, J; Penafiel, N; Pyron, RA; Morochz, C; Funk, WC; Arteaga, A				Guayasamin, Juan M.; Hutter, Carl R.; Tapia, Elicio E.; Culebras, Jaime; Penafiel, Nicolas; Pyron, R. Alexander; Morochz, Carlos; Funk, W. Chris; Arteaga, Alejandro			Diversification of the rainfrog Pristimantis ornatissimus in the lowlands and Andean foothills of Ecuador	PLOS ONE			English	Article							GENETIC-STRUCTURE; NICHE EVOLUTION; MOUNTAIN PASSES; FROG; DISPERSAL; DIVERGENCE; LANDSCAPE; DIVERSITY; ANURA; DISTRIBUTIONS	Geographic barriers and elevational gradients have long been recognized as important in species diversification. Here, we illustrate an example where both mechanisms have shaped the genetic structure of the Neotropical rainfrog, Pristimantis ornatissimus, which has also resulted in speciation. This species was thought to be a single evolutionary lineage distributed throughout the Ecuadorian Choco A and the adjacent foothills of the Andes. Based on recent sampling of P. ornatissimus sensu lato, we provide molecular and morphological evidence that support the validity of a new species, which we name Pristimantis ecuadorensis sp. nov. The sister species are elevational replacements of each other; the distribution of Pristimantis ornatissimus sensu stricto is limited to the Ecuadorian Choco A ecoregion (< 1100 m), whereas the new species has only been found at Andean localities between 1450-1480 m. Given the results of the Multiple Matrix Regression with Randomization analysis, the genetic difference between P. ecuadorensis and P. ornatissimus is not explained by geographic distance nor environment, although environmental variables at a finer scale need to be tested. Therefore this speciation event might be the byproduct of stochastic historic extinction of connected populations or biogeographic events caused by barriers to dispersal such as rivers. Within P. ornatissimus sensu stricto, morphological patterns and genetic structure seem to be related to geographic isolation (e.g., rivers). Finally, we provide an updated phylogeny for the genus, including the new species, as well as other Ecuadorian Pristimantis.	[Guayasamin, Juan M.] USFQ, Colegio Ciencias Biol & Ambientales COCIBA, Inst Invest Biol & Ambientales BIOSFERA, Lab Biol Evolut, Quito, Ecuador; [Guayasamin, Juan M.; Culebras, Jaime; Penafiel, Nicolas] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Ingn Biodiversidad & Cambio Climat, Fac Med Ambiente, Quito, Ecuador; [Hutter, Carl R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Biodivers Inst, Lawrence, KS 66045 USA; [Tapia, Elicio E.] Fdn Otonga, Ctr Jambatu Invest & Conservac Anfibios, San Rafael, Quito, Ecuador; [Pyron, R. Alexander] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Morochz, Carlos] Reserva Biodiversidad Mashpi, Quito, Ecuador; [Funk, W. Chris] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Arteaga, Alejandro] Trop Herping, Torres Santa Fe, Quito, Ecuador	University of Kansas; George Washington University; Colorado State University	Guayasamin, JM (corresponding author), USFQ, Colegio Ciencias Biol & Ambientales COCIBA, Inst Invest Biol & Ambientales BIOSFERA, Lab Biol Evolut, Campus Cumbaya, Quito, Ecuador.	jmguayasamin@usfq.edu.ec	Arteaga, Alejandro/AAL-3432-2020; Hutter, Carl R/A-7380-2015; Pyron, Robert/F-1681-2014	Arteaga, Alejandro/0000-0002-0014-3728; Pyron, Robert/0000-0003-2524-1794; Culebras, Jaime/0000-0003-2211-6605; Hutter, Carl/0000-0001-6381-6339; Guayasamin, Juan/0000-0003-0098-978X; Funk, W. Chris/0000-0002-6466-3618	Universidad Tecnologica Indoamerica Biodiversity Program; Universidad San Francisco de Quito [11019]; U.S. National Science Foundation (Dimensions of Biodiversity grant) [DEB-1046408, DEB-1045960, DEB-1045991, DBI-0905765, DEB-1441719]; George Washington University; Ministerio de Ambiente del Ecuador [MAE-DNB-CM-2015-0017, 005-15 IC-FAU-DNB/MA]	Universidad Tecnologica Indoamerica Biodiversity Program; Universidad San Francisco de Quito; U.S. National Science Foundation (Dimensions of Biodiversity grant)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); George Washington University; Ministerio de Ambiente del Ecuador	This study was funded by the Universidad Tecnologica Indoamerica Biodiversity Program, Universidad San Francisco de Quito (Collaboration Grant 11019 to J MG), and the U.S. National Science Foundation (Dimensions of Biodiversity grant, awards DEB-1046408, DEB-1045960, and DEB-1045991 to WCF and JMG, and DBI-0905765 and DEB-1441719 to RAP), and The George Washington University. The funders provided support in the form of salaries for authors [JMG, AA, NP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This article was greatly improved by comments of Igor Kaefer and an anonymous reviewer. We are grateful to personnel of Reserva de Biodiversidad Mashpi for their hospitality and support during fieldwork. Research permits were issued by the Ministerio de Ambiente del Ecuador (MAE-DNB-CM-2015-0017, granted to Universidad Tecnologica Indoamerica; No 005-15 IC-FAU-DNB/MA, granted to Centro Jambatu de Investigacion y ConservaciOn de Anfibios; CJ). Luis A. Coloma provided access to specimens and photographs housed at CJ.	AmphibiaWeb, 2016, AMPH INF AMPH BIOL C; [Anonymous], 1877, DIFFERENT FORMS FLOW; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arteaga A, 2013, AMPHIBIANS REPTILES; Arteaga A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151746; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Blair ME, 2013, J EVOLUTION BIOL, V26, P1790, DOI 10.1111/jeb.12179; Burbrink FT, 1998, BIOL CONSERV, V86, P107, DOI 10.1016/S0006-3207(98)00054-8; Cadena CD, 2013, P ROY SOC LOND B BIO, V279, P194; Castroviejo-Fisher S, 2014, J BIOGEOGR, V41, P66, DOI 10.1111/jbi.12208; Coyne J.A., 2004, SPECIATION; Crawford AJ, 2003, J MOL EVOL, V57, P636, DOI 10.1007/s00239-003-2513-7; Crawford AJ, 2007, MOL ECOL, V16, P4789, DOI 10.1111/j.1365-294X.2007.03524.x; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Darwin C., 1858, J LINNEAN SOC ZOOLOG, V3, P45, DOI DOI 10.1111/J.1096-3642.1858.TB02500.X; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Despax MR, 1911, B MUS HIST NAT PARIS, V17, P90; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2015, J TROP ECOL, V31, P361, DOI 10.1017/S0266467415000206; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Frost DR, AMPHIBIAN SPECIES WO; GARCIAR JC, 2012, PLOS ONE, V0007; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Guayasamin JM, 2004, HERPETOLOGICA, V60, P103, DOI 10.1655/02-106; Guayasamin JM, 2015, ZOOL J LINN SOC-LOND, V173, P913, DOI 10.1111/zoj.12222; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Hijmans R.J., **DATA OBJECT**; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillman SS, 2014, PHYSIOL BIOCHEM ZOOL, V87, P105, DOI 10.1086/671109; Huffer CR, 2012, ECUADOR ZOOTAXA, V3257, P1; Hutter Carl R., 2015, Neotropical Biodiversity, V1, P36, DOI 10.1080/23766808.2015.1100376; Hutter CR, 2013, ECOL LETT, V16, P1135, DOI 10.1111/ele.12148; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; JimUnez de la Espada M., 1870, J SCI MATH PHYS NATU, V3, P57; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koecke AV, 2013, AM J BOT, V100, P1800, DOI 10.3732/ajb.1300059; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Lessmann Janeth, 2016, Neotropical Biodiversity, V2, P99; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Martin-Torrijos Laura, 2016, Neotropical Biodiversity, V2, P26; Mayr E., 1982, Progress in Clinical and Biological Research, V96, P1; Mayr E., 1954, EVOLUTION PROCESS, P157; Mayr E, 1942, SYSTEMATICS ORIGIN S; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2015, MOL ECOL, V24, P3723, DOI 10.1111/mec.13275; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rodriguez A, 2015, EVOL ECOL, V29, P765, DOI 10.1007/s10682-015-9774-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Torres-Carvajal O, 2014, ZOOKEYS, P105, DOI 10.3897/zookeys.410.7401; Valero KCW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00155; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Vos CC, 2001, HEREDITY, V86, P598, DOI 10.1046/j.1365-2540.2001.00865.x; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; Wang IJ, 2010, MOL ECOL, V19, P447, DOI 10.1111/j.1365-294X.2009.04465.x; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whitlock MC, 2003, GENETICS, V164, P767; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 2013, EVOLUTION, V67, P1715, DOI 10.1111/evo.12053; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zwickl DJ., 2006, GENETIC ALGORITHM AP	77	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172615	10.1371/journal.pone.0172615	http://dx.doi.org/10.1371/journal.pone.0172615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329011	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700004
J	Hunter, BM; Harrison, S; Portela, A; Bick, D				Hunter, Benjamin M.; Harrison, Sean; Portela, Anayda; Bick, Debra			The effects of cash transfers and vouchers on the use and quality of maternity care services: A systematic review	PLOS ONE			English	Review							MIDDLE-INCOME COUNTRIES; NATIONAL INCENTIVE PROGRAM; PROMOTE SAFE DELIVERY; PRIMARY-HEALTH-CARE; INFANT-MORTALITY; INSTITUTIONAL DELIVERIES; FINANCIAL INCENTIVES; IMPACT; DEMAND; MEXICO	Background Cash transfers and vouchers are forms of 'demand-side financing' that have been widely used to promote maternal and newborn health in low- and middle-income countries during the last 15 years. Methods This systematic review consolidates evidence from seven published systematic reviews on the effects of different types of cash transfers and vouchers on the use and quality of maternity care services, and updates the systematic searches to June 2015 using the Joanna Briggs Institute approach for systematic reviewing. The review protocol for this update was registered with PROSPERO (CRD42015020637). Results Data from 51 studies (15 more than previous reviews) and 22 cash transfer and voucher programmes suggest that approaches tied to service use (either via payment conditionalities or vouchers for selected services) can increase use of antenatal care, use of a skilled attendant at birth and in the case of vouchers, postnatal care too. The strongest evidence of positive effect was for conditional cash transfers and uptake of antenatal care, and for vouchers for maternity care services and birth with a skilled birth attendant. However, effects appear to be shaped by a complex set of social and healthcare system barriers and facilitators. Studies have typically focused on an initial programme period, usually two or three years after initiation, and many lack a counterfactual comparison with supply-side investment. There are few studies to indicate that programmes have led to improvements in quality of maternity care or maternal and newborn health outcomes. Conclusion Future research should use multiple intervention arms to compare cost-effectiveness with similar investment in public services, and should look beyond short-to medium-term service utilisation by examining programme costs, longer-term effects on service utilisation and health outcomes, and the equity of those effects.	[Hunter, Benjamin M.] Kings Coll London, Dept Int Dev, London, England; [Harrison, Sean] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Portela, Anayda] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Bick, Debra] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, London, England	University of London; King's College London; University of Bristol; World Health Organization; University of London; King's College London	Hunter, BM (corresponding author), Kings Coll London, Dept Int Dev, London, England.	benjamin.hunter@kcl.ac.uk	Bick, Debra/P-9575-2018	Bick, Debra/0000-0002-8557-7276; Hunter, Benjamin/0000-0002-5848-5245; Portela, Anayda/0000-0001-6368-1585; Harrison, Sean/0000-0002-7966-0700	King's College London; World Health Organization's Department of Maternal, Newborn, Child and Adolescent Health; Norway Agency for Development Cooperation (NORAD); Australian Agency for International Development; National Institute for Health Research (NIHR); Leadership in Applied Health Research and Care South London	King's College London; World Health Organization's Department of Maternal, Newborn, Child and Adolescent Health; Norway Agency for Development Cooperation (NORAD); Australian Agency for International Development; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Leadership in Applied Health Research and Care South London	This systematic review update was funded by the World Health Organization's Department of Maternal, Newborn, Child and Adolescent Health, through funding received from the Norway Agency for Development Cooperation (NORAD). The original systematic review was commissioned and funded by the Australian Agency for International Development. DB is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. AP is a staff member of the World Health Organization. She alone is responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2011, INT J EQUITY HEALTH, P10; Agha S., 2011, REPROD HLTH, V8; Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; Alatas V., 2011, PROGRAM KELUARGA HAR; Alfonso YN, 2015, HLTH POLICY PLANNING; Amarante V, 2011, DO CASH TRANSFERS IM; Amendah DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080582; Amudhan S, 2013, INT J EPIDEMIOL, V42, P769, DOI 10.1093/ije/dyt071; Baird S, 2011, Q J ECON, V126, P1709, DOI 10.1093/qje/qjr032; Barber SL, 2008, TROP MED INT HEALTH, V13, P1405, DOI 10.1111/j.1365-3156.2008.02157.x; Barber SL, 2010, EUR J PUBLIC HEALTH, V20, P383, DOI 10.1093/eurpub/ckp184; Barber SL, 2009, HEALTH POLICY PLANN, V24, P18, DOI 10.1093/heapol/czn039; Barham T, 2011, J DEV ECON, V94, P74, DOI 10.1016/j.jdeveco.2010.01.003; Bellows B, 2012, HLTH POLICY PLAN; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Benhassine N., 2013, TURNING SHOVE NUDGE; Bhat R, 2009, J HEALTH POPUL NUTR, V27, P249, DOI 10.3329/jhpn.v27i2.3367; Bhatia M. R., 2007, Journal of International Development, V19, P975, DOI 10.1002/jid.1361; Brody CM, 2013, GLOB PUBLIC HEALTH, V8, P363, DOI 10.1080/17441692.2012.759254; Caldes N, 2005, COST POVERTY ALLEVIA; Carvalho N., 2014, PLOS ONE, V9; Coady D, 2004, WORLD BANK RES OBSER, V19, P61, DOI 10.1093/wbro/lkh016; Davis, 2016, EVIDENCE ACTION STOR; De Brauw A., 2011, CAN CONDITIONAL CASH; De Costa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095704; Fiszbein A, 2009, CONDITIONAL CASH TRA; Glassman A, 2013, J HEALTH POPUL NUTR, V31, P48; Gopalan SS, 2014, SOC SCI MED, V100, P72, DOI 10.1016/j.socscimed.2013.10.030; Guanais FC, 2013, AM J PUBLIC HEALTH, V103, P2000, DOI 10.2105/AJPH.2013.301452; Gutierrez J. P, 2011, EVALUACION EXTERNA I; Handa S, 2015, HLTH EC; Handa S, 2012, J DEV EFFECT, V4, P78, DOI 10.1080/19439342.2011.641994; Hanson K, 2009, BMJ-BRIT MED J, V339, P93; Harrison S, 2017, RES SYNTH METHODS, DOI [10.1002/irsm.1239, DOI 10.1002/IRSM.1239]; Hatt L., 2010, EC EVALUATION DEMAND; Hemminki E, 2013, MATERN CHILD HLTH J, V17, P208, DOI 10.1007/s10995-012-0962-6; Hernandez Prado B, 2004, EVALUACION EXTERNA I; HERNANDEZPRADO B, 2004, IMPACT OPORTUNIDADES; Hunter B, 2017, IN PRESS; IFPS Technical Assistance Project (ITAP), 2012, SAMBH VOUCH MAK HIGH; Joanna Briggs Institute, 2015, JOANN BRIGGS I JBI S; Joshi S, 2014, WORLD DEV, V64, P434, DOI 10.1016/j.worlddev.2014.06.004; Krishna A., 2010, ONE ILLNESS AWAY WHY; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mayora C, 2014, COST EFFECT RESOUR A, V12, DOI 10.1186/1478-7547-12-14; Mazumdar S, 2012, FINANCIAL INCENTIVES; Meyer C, 2011, IMPACT VOUCHERS USE; Mohanan M, 2014, B WORLD HEALTH ORGAN, V92, P187, DOI 10.2471/BLT.13.124644; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32; Murray Susan F, 2012, JBI Libr Syst Rev, V10, P4165; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; Nguyen HTH, 2012, SOC SCI MED, V74, P989, DOI 10.1016/j.socscimed.2011.11.030; Obare F, 2012, HLTH POLICY PLAN; Obare F, 2014, SOC SCI MED, V102, P183, DOI 10.1016/j.socscimed.2013.12.007; Okoli U, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0408-9; Powell-Jackson T, 2009, ADV HEALTH ECON HEAL, V21, P221, DOI 10.1108/S0731-2199(2009)0000021012; Powell-Jackson T, 2012, J HEALTH ECON, V31, P271, DOI 10.1016/j.jhealeco.2011.10.010; Powell-Jackson T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-97; Purohit N, 2014, J HEALTH MANAG, V16, P289, DOI 10.1177/0972063414526116; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Reproductive Health Vouchers Evaluation Team, 2012, REPR HLTH VOUCH PROG; Rob U, 2010, INT Q COMMUNITY HEAL, V30, P293, DOI 10.2190/IQ.30.4.b; Santhya KG, 2011, EFFECTS JANANI SURAK; Shei A, 2013, HEALTH AFFAIR, V32, P1274, DOI 10.1377/hlthaff.2012.0827; Sosa-Rubi SG, 2011, HEALTH POLICY PLANN, V26, P496, DOI 10.1093/heapol/czq085; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Triyana M, 2014, DO HLTH CARE PROVIDE; Urquieta J, 2009, ECON DEV CULT CHANGE, V57, P539, DOI 10.1086/596598; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Vora KS, 2012, IMPLEMENTATION JANAN; Watt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122828; World Bank, 2005, GUID COMP VOUCH HLTH	76	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173068	10.1371/journal.pone.0173068	http://dx.doi.org/10.1371/journal.pone.0173068			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328940	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000399094700016
J	Lu, X; Luan, S; Cao, BX; Meng, XH; Sui, J; Dai, P; Luo, K; Shi, XL; Hao, DC; Han, GM; Kong, J				Lu, Xia; Luan, Sheng; Cao, Baoxiang; Meng, Xianhong; Sui, Juan; Dai, Ping; Luo, Kun; Shi, Xiaoli; Hao, Dengchun; Han, Guomin; Kong, Jie			Estimation of genetic parameters and genotype-by-environment interactions related to acute ammonia stress in Pacific white shrimp (Litopenaeus vannamei) juveniles at two different salinity levels	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; ACUTE TOXICITY; BODY-WEIGHT; IMMUNE-RESPONSE; RAINBOW-TROUT; VIBRIO-PARAHAEMOLYTICUS; OREOCHROMIS-NILOTICUS; PENAEUS-VANNAMEI; LIFE STAGES; GROWTH	Regarding the practical farming of Litopenaeus vannamei, the deterioration of water quality from intensive culture systems and environmental pollution is a common but troublesome problem in the cultivation of this species. The toxicities that result from deteriorating water quality, such as that from ammonia stress, have lethal effects on juvenile shrimp and can increase their susceptibility to pathogens. The toxicity of ammonia plays an important role in the frequently high mortality during the early stage on shrimp farms. However, little information is available regarding the genetic parameters of the ammonia tolerance of juveniles in the early stage, but this information is necessary to understand the potential for the genetic improvement of this trait. Considering the euryhalinity of L. vannamei and the fact that low salinity can increase the toxicity of ammonia stress, we estimated the heritability of ammonia tolerance in juveniles in 30 parts per thousand (normal) and 5 parts per thousand (low) salinity in this study using the survival time (ST) at individual level and the survival status at the half-lethal time (SS50) at the family level. In the normal and low salinity conditions and for the merged data, the heritability estimates of the ST (0.784 +/- 0.070, 0.575 +/- 0.068, and 0.517 +/- 0.058, respectively) and SS50 (0.402 +/- 0.061, 0.216 +/- 0.050, and 0.264 +/- 0.050, respectively) were all significantly greater than zero, which indicates that the ammonia-tolerance of shrimp can be greatly improved. So it might provide an alternative method to reduce mortality, help to enhance resistance to pathogens and reduce the occurrence of infectious diseases. The significant positive genetic correlation between ST and body length suggested that ammonia is more toxic to shrimp in the early stage. The medium-strength genetic correlations of the ST and SS50 between the two environments (0.394 +/- 0.097 and 0.377 +/- 0.098, respectively) indicate a strong genotype-by-environment (GxE) interaction for ammonia tolerance between the different salinity levels. Therefore, salinity-specific breeding programs for ammonia tolerance in shrimp should be purposefully implemented.	[Lu, Xia; Luan, Sheng; Cao, Baoxiang; Meng, Xianhong; Sui, Juan; Dai, Ping; Luo, Kun; Shi, Xiaoli; Hao, Dengchun; Kong, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Peoples R China; [Lu, Xia; Luan, Sheng; Cao, Baoxiang; Meng, Xianhong; Sui, Juan; Dai, Ping; Luo, Kun; Shi, Xiaoli; Hao, Dengchun; Kong, Jie] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Hao, Dengchun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Han, Guomin] Agr Univ Hebei, Coll Ocean, Huanghua, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Hebei Agricultural University	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Peoples R China.; Kong, J (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	kongjie@ysfri.ac.cn			Central Public-interest Scientific Institution Basal Research Fund, CAFS [2016HY-ZD04]; National Natural Science Foundation of China [31302179]; Taishan scholar program for seed industry; Introduction of International Advanced Agricultural Science and Technology Plan [2016-X39]; China Postdoctoral Science Foundation [2015M572095]	Central Public-interest Scientific Institution Basal Research Fund, CAFS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan scholar program for seed industry; Introduction of International Advanced Agricultural Science and Technology Plan; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Central Public-interest Scientific Institution Basal Research Fund, CAFS (No. 2016HY-ZD04), the National Natural Science Foundation of China (No. 31302179), the Taishan scholar program for seed industry, the Introduction of International Advanced Agricultural Science and Technology Plan (No. 2016-X39), and the China Postdoctoral Science Foundation (No. 2015M572095).	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Alagappan KM, 2010, CURR MICROBIOL, V61, P235, DOI 10.1007/s00284-010-9599-0; Andriantahina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075206; [Anonymous], [No title captured]; [Anonymous], THESIS; Argue BJ, 2002, AQUACULTURE, V204, P447, DOI 10.1016/S0044-8486(01)00830-4; Barajas FJM, 2006, AQUAC RES, V37, P492, DOI 10.1111/j.1365-2109.2006.01455.x; Barajas FM, 2006, AQUAC RES, V37, P1406, DOI 10.1111/j.1365-2109.2006.01573.x; Bentsen HB, 2012, AQUACULTURE, V338, P56, DOI 10.1016/j.aquaculture.2012.01.027; BOWER CE, 1978, J FISH RES BOARD CAN, V35, P1012, DOI 10.1139/f78-165; Calus P.M., 2006, THESIS; Castillo-Juarez H, 2007, AQUACULTURE, V273, P42, DOI 10.1016/j.aquaculture.2007.09.023; CHEN J-C, 1990, Journal of the World Aquaculture Society, V21, P300, DOI 10.1111/j.1749-7345.1990.tb00543.x; CHEN JC, 1990, MAR BIOL, V107, P427, DOI 10.1007/BF01313424; CHEN JC, 1992, COMP BIOCHEM PHYS C, V101, P449, DOI 10.1016/0742-8413(92)90068-I; CHEN JC, 1992, AQUACULTURE, V104, P249, DOI 10.1016/0044-8486(92)90207-2; CHEN JC, 1992, COMP BIOCHEM PHYS C, V101, P443, DOI 10.1016/0742-8413(92)90067-H; CHEN JC, 1992, J EXP MAR BIOL ECOL, V156, P139, DOI 10.1016/0022-0981(92)90021-2; CHEN JC, 1994, MAR ECOL PROG SER, V110, P85, DOI 10.3354/meps110085; CHEN JC, 1991, COMP BIOCHEM PHYS C, V100, P477; CHEN JC, 1990, AQUACULTURE, V89, P127, DOI 10.1016/0044-8486(90)90305-7; Cheng W, 2004, FISH SHELLFISH IMMUN, V17, P193, DOI 10.1016/j.fsi.2004.03.004; CHIEN YH, 1992, PROCEEDINGS OF THE SPECIAL SESSION ON SHRIMP FARMING, P144; Colt J. E., 1981, Proceedings of the Bio-Engineering Symposium for Fish Culture, P34; Cuzon G, 2004, AQUACULTURE, V235, P513, DOI 10.1016/j.aquaculture.2003.12.022; Cobo MD, 2014, AQUAC RES, V45, P470, DOI 10.1111/j.1365-2109.2012.03248.x; Eknath AE, 2007, AQUACULTURE, V273, P1, DOI 10.1016/j.aquaculture.2007.09.015; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; FAO, 2015, FAO YB; Foss A, 2003, AQUACULTURE, V224, P105, DOI 10.1016/S0044-8486(03)00209-6; Frias-Espericueta MG, 1999, B ENVIRON CONTAM TOX, V62, P646, DOI 10.1007/s001289900923; Gallardo JA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-19; Gilmour AR, 2009, ASREML USER GUIDE RE; Gitterle T, 2005, AQUACULTURE, V246, P139, DOI 10.1016/j.aquaculture.2005.02.011; Guan JT, 2016, AQUACULTURE, V450, P321, DOI 10.1016/j.aquaculture.2015.08.014; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hurvitz A, 1997, FISH SHELLFISH IMMUN, V7, P45, DOI 10.1006/fsim.1996.0062; Ibarra AM, 2007, AQUAC RES, V38, P838, DOI 10.1111/j.1365-2109.2007.01734.x; Ibarra AM, 2009, AQUACULTURE, V297, P64, DOI 10.1016/j.aquaculture.2009.09.015; James JW, 2009, ADAPTATION AND FITNESS IN ANIMAL POPULATIONS, P151, DOI 10.1007/978-1-4020-9005-9_10; KOU Y-Z, 1991, Aquaculture and Fisheries Management, V22, P259; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; LEWIS WM, 1986, T AM FISH SOC, V115, P183, DOI 10.1577/1548-8659(1986)115<183:TONTF>2.0.CO;2; Li WJ, 2016, CHIN J OCEANOL LIMN, V34, P1025, DOI 10.1007/s00343-016-5034-0; LIN HP, 1993, MAR BIOL, V117, P591, DOI 10.1007/BF00349770; Lin YC, 2001, J EXP MAR BIOL ECOL, V259, P109, DOI 10.1016/S0022-0981(01)00227-1; Liu CH, 2004, FISH SHELLFISH IMMUN, V16, P321, DOI 10.1016/S1050-4648(03)00113-X; Lu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164396; Luan S, 2015, AQUAC RES, V46, P1345, DOI 10.1111/are.12287; Mulder HA, 2006, J DAIRY SCI, V89, P1740, DOI 10.3168/jds.S0022-0302(06)72242-1; Mulder HA, 2005, J ANIM SCI, V83, P49; NAN F-H, 1991, Journal of the Fisheries Society of Taiwan, V18, P41; Nguyen NH, 2007, AQUACULTURE, V272, pS38, DOI 10.1016/j.aquaculture.2007.08.013; OSTRENSKY A, 1995, AQUACULTURE, V132, P339, DOI 10.1016/0044-8486(94)00343-M; Paaby AB, 2014, NATURE REV GENETICS; Pante MJR, 2002, AQUACULTURE, V204, P383, DOI 10.1016/S0044-8486(01)00825-0; Qiu De-Quan, 2008, Acta Hydrobiologica Sinica, V32, P455, DOI 10.3724/SP.J.1035.2008.00455; Racotta IS, 2000, COMP BIOCHEM PHYS A, V125, P437, DOI 10.1016/S1095-6433(00)00171-9; ROBERTSON A, 1949, GENETICS, V34, P395; Rovira J., 1987, MEJORAMIENTO GENETIC; Sae-Lim P, 2013, J ANIM SCI, V91, P5572, DOI 10.2527/jas.2012-5949; Sae-Lim P, 2016, REV AQUACULT, V8, P369, DOI 10.1111/raq.12098; Sae-Lim P, 2010, AQUACULTURE, V310, P66, DOI 10.1016/j.aquaculture.2010.10.020; SAS Institute Inc, 2005, SAS STAT SOFTW VERS; Sun GM, 2002, J AGUACULTURE, V1, P22; WAJSBROT N, 1990, ENVIRON TOXICOL CHEM, V9, P497, DOI 10.1002/etc.5620090413; WINKELMAN AM, 1994, AQUACULTURE, V125, P17, DOI 10.1016/0044-8486(94)90278-X; YOUNGLAI WW, 1991, MAR BIOL, V110, P293, DOI 10.1007/BF01313716; Zhao JH, 1997, AQUAC RES, V28, P517	69	21	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173835	10.1371/journal.pone.0173835	http://dx.doi.org/10.1371/journal.pone.0173835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328986	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700031
J	Garnaes, KK; Nyrnes, SA; Salvesen, KA; Salvesen, O; Morkved, S; Moholdt, T				Garnaes, Kirsti Krohn; Nyrnes, Siri Ann; Salvesen, Kjell Asmund; Salvesen, Oyvind; Morkved, Siv; Moholdt, Trine			Effect of supervised exercise training during pregnancy on neonatal and maternal outcomes among overweight and obese women. Secondary analyses of the ETIP trial: A randomised controlled trial	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; BIRTH-WEIGHT; ANTENATAL EXERCISE; LIFE-STYLE; RISK; HEALTH; FETAL; INTERVENTIONS; ASSOCIATIONS; METAANALYSIS	Background Maternal obesity associates with complications during pregnancy and childbirth. Our aim was to investigate if exercise during pregnancy in overweight/obese women could influence birth weight or other neonatal and maternal outcomes at delivery. Material and methods This is a secondary analysis of a randomised controlled trial of exercise training in pregnancy for women with body mass index (BMI) >= 28 kg/m(2). Ninety-one women (31.3 +/- 4.3 years, BMI 34.5 +/- 4.2 kg/m(2)) were allocated 1: 1 to supervised exercise during pregnancy or to standard care. The exercise group was offered three weekly training sessions consisting of 35 minutes of moderate intensity walking/running followed by 25 minutes of strength training. Data from 74 women (exercise 38, control 36) were analysed at delivery. Results Birth weight was 3719 +/- 695 g in the exercise group and 3912 +/- 413 g in the control group (CI - 460.96, 74.89, p = 0.16). Birth weight > 4000 g was 35% in the exercise group and 52% in the control group (p = 0.16). Mean gestational age at delivery was 39.1 weeks in the exercise group and 39.5 weeks in the control group (CI -1.33, 0.43, p = 0.31). No significant betweengroup differences were found in neonatal body size, skinfold thickness, placental weight ratio, or Apgar score. The prevalence of caesarean section was 24% in the exercise group and 17% in the control group (CI 0.20, 2.05, p = 0.57). Mean length of hospital stay was 4.8 days in the exercise group and 4.5 days in the control group (CI -0.45, 1.00, p = 0.45). Conclusions Offering supervised exercise during pregnancy for overweight and obese women did not influence birth weight or other neonatal and maternal outcomes at delivery. However our trial was limited by low sample size and poor adherence to the exercise protocol, and further research is needed.	[Garnaes, Kirsti Krohn; Nyrnes, Siri Ann; Moholdt, Trine] Norwegian Univ Sci & Technol, NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Nyrnes, Siri Ann] Univ Trondheim Hosp, St Olavs Hosp, Dept Paediat, Trondheim, Norway; [Salvesen, Kjell Asmund; Moholdt, Trine] Univ Trondheim Hosp, St Olavs Hosp, Dept Obstet & Gynaecol, Trondheim, Norway; [Salvesen, Kjell Asmund] Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Trondheim, Norway; [Salvesen, Kjell Asmund; Salvesen, Oyvind] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Morkved, Siv] Univ Trondheim Hosp, St Olavs Hosp, Clin Serv, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moholdt, T (corresponding author), Norwegian Univ Sci & Technol, NTNU, Dept Circulat & Med Imaging, Trondheim, Norway.; Moholdt, T (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Obstet & Gynaecol, Trondheim, Norway.	trine.moholdt@ntnu.no	Nyrnes, Siri Ann Ann/AAW-5601-2021; Moholdt, Trine/ABC-8674-2021; Moholdt, Trine/J-5884-2014	Moholdt, Trine/0000-0003-1024-8088; 	Central Norway Regional Health Authority (RHA) [46056728]; Norwegian University of Science and Technology (NTNU); Norwegian Fund for Post Graduate Training in Physiotherapy [7-370-00/08A]	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Norwegian Fund for Post Graduate Training in Physiotherapy	The present trial was supported by grants from The Liaison Committee between the Central Norway Regional Health Authority (RHA) (To author KKG, grant number: 46056728) and the Norwegian University of Science and Technology (NTNU), and The Norwegian Fund for Post Graduate Training in Physiotherapy (To author SM, grant number: 7-370-00/08A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2002, OBSTET GYNECOL, V99, P171; Artal R, 2003, CLIN OBSTET GYNECOL, V46, P479, DOI 10.1097/00003081-200306000-00026; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Barakat R, 2008, BRIT J SPORT MED, V42, P674, DOI 10.1136/bjsm.2008.047837; Barakat R, 2015, J OBSTET GYNECOL; Barakat R, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.039; Barakat R, 2014, AM J HEALTH PROMOT, V29, P2, DOI 10.4278/ajhp.130131-QUAN-56; Barakat R, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.043; Barakat R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.004; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Borg G, 1970, Lakartidningen, V67, P4548; Boulet S L, 2004, J Obstet Gynaecol, V24, P622; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Choi J, 2013, PREV MED, V56, P351, DOI 10.1016/j.ypmed.2013.02.021; Christiansen T, 2010, AM J PHYSIOL-ENDOC M, V298, pE824, DOI 10.1152/ajpendo.00574.2009; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Di Mascio D, 2016, AM J OBSTET GYNECOL, V215, P561, DOI 10.1016/j.ajog.2016.06.014; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Ehrenstein Vera, 2009, Clin Epidemiol, V1, P45; Finlayson G, 2009, PHYSIOL BEHAV, V97, P62, DOI 10.1016/j.physbeh.2009.02.002; Frias AE, 2012, SEMIN REPROD MED, V30, P472, DOI 10.1055/s-0032-1328875; Garns KK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002079; Gaudet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/640291; Haakstad LAH, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-66; Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028; Hemachandra AH, 2007, PEDIATRICS, V119, pE1264, DOI 10.1542/peds.2005-2486; Hopkins SA, 2011, CLIN ENDOCRINOL, V74, P495, DOI 10.1111/j.1365-2265.2010.03964.x; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; Kim SS, 2016, OBSTET GYNECOL, V128, P104, DOI 10.1097/AOG.0000000000001465; Lau C, 2011, OBSTET GYNECOL, V117, P978, DOI 10.1097/AOG.0b013e318212140e; Lutsiv O, 2015, OBES REV, V16, P531, DOI 10.1111/obr.12283; Moholdt TT, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-154; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Nascimento SL, 2011, BJOG-INT J OBSTET GY, V118, P1455, DOI 10.1111/j.1471-0528.2011.03084.x; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101; Oteng-Ntim E, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-47; Perales M, 2016, EARLY HUM DEV, V94, P43, DOI 10.1016/j.earlhumdev.2016.01.004; Poyatos-Leon R, 2015, ACTA OBSTET GYN SCAN, V94, P1039, DOI 10.1111/aogs.12675; Rasmussen KM, 2010, OBSTET GYNECOL, V116, P1191, DOI 10.1097/AOG.0b013e3181f60da7; Risnes KR, 2009, AM J EPIDEMIOL, V170, P622, DOI 10.1093/aje/kwp182; Seneviratne SN, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-148; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Stafne SN, 2012, OBSTET GYNECOL, V119, P29, DOI 10.1097/AOG.0b013e3182393f86; Sui ZX, 2012, ACTA OBSTET GYN SCAN, V91, P538, DOI 10.1111/j.1600-0412.2012.01357.x; Tan HC, 2015, PEDIATR DIABETES, V16, P419, DOI 10.1111/pedi.12273; Tanvig M, 2015, J CLIN ENDOCR METAB, V100, P175, DOI 10.1210/jc.2014-2675; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thangaratinam S, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16310; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Watterberg KL, 2015, PEDIATRICS, V136, P819, DOI 10.1542/peds.2015-2651; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Wiebe HW, 2015, OBSTET GYNECOL, V125, P1185, DOI 10.1097/AOG.0000000000000801; WOLFE LA, 1989, SPORTS MED, V8, P273, DOI 10.2165/00007256-198908050-00003; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710; World Health Organization, 2018, OB OV FACT SHEET 311	60	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173937	10.1371/journal.pone.0173937	http://dx.doi.org/10.1371/journal.pone.0173937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323893	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000044
J	Harris, MC; Cislo, D; Lenz, JS; Umbach, C; Lindau, M				Harris, Mark C.; Cislo, Dillon; Lenz, Joan S.; Umbach, Christopher; Lindau, Manfred			AFM/TIRF force clamp measurements of neurosecretory vesicle tethers reveal characteristic unfolding steps	PLOS ONE			English	Article							PLASMA-MEMBRANE; SECRETORY VESICLES; EXOCYST COMPLEX; CRYOELECTRON TOMOGRAPHY; REGULATED EXOCYTOSIS; MAMMALIAN EXOCYST; TRANSPORT-VESICLE; CRYSTAL-STRUCTURE; FUSION; CELLS	Although several proteins have been implicated in secretory vesicle tethering, the identity and mechanical properties of the components forming the physical vesicle-plasma membrane link remain unknown. Here we present the first experimental measurements of nanomechanical properties of secretory vesicle-plasma membrane tethers using combined AFM force clamp and TIRF microscopy on membrane sheets from PC12 cells expressing the vesicle marker ANF-eGFP. Application of pulling forces generated tether extensions composed of multiple steps with variable length. The frequency of short (<10 nm) tether extension events was markedly higher when a fluorescent vesicle was present at the cantilever tip and increased in the presence of GTP.S, indicating that these events reflect specifically the properties of vesicle-plasma membrane tethers. The magnitude of the short tether extension events is consistent with extension lengths expected from progressive unfolding of individual helices of the exocyst complex, supporting its direct role in forming the physical vesicle-plasma membrane link.	[Harris, Mark C.; Cislo, Dillon; Lenz, Joan S.; Lindau, Manfred] Cornell Univ, Sch Appl & Engn Phys, Engn, Ithaca, NY 14853 USA; [Umbach, Christopher] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Lindau, Manfred] Max Planck Inst Biophys Chem, Lab Nanoscale Cell Biol, Gottingen, Germany; [Cislo, Dillon] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Cornell University; Cornell University; Max Planck Society; University of California System; University of California Santa Barbara	Lindau, M (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Engn, Ithaca, NY 14853 USA.; Lindau, M (corresponding author), Max Planck Inst Biophys Chem, Lab Nanoscale Cell Biol, Gottingen, Germany.	ML95@cornell.edu	Lindau, Manfred/ABD-3449-2021	Lindau, Manfred/0000-0002-5722-9557; Cislo, Dillon/0000-0002-6996-572X	National Institutes of Health (NIH) [R21NS072577, T32GM008267]; National Science Foundation [DGE-0654112]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants R21NS072577, and T32GM008267, and National Science Foundation Agreement No. DGE-0654112 (IGERT program) administered by the Nanobiotechnology Center at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bujalowski PJ, 2013, METHODS, V60, P151, DOI 10.1016/j.ymeth.2013.03.010; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fernandez-Busnadiego R, 2013, J CELL BIOL, V201, P725, DOI 10.1083/jcb.201206063; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Gutkowska J, 1997, PHYSIOL REV, V77, P465, DOI 10.1152/physrev.1997.77.2.465; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Lang Thorsten, 2008, V440, P51, DOI 10.1007/978-1-59745-178-9_4; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Pfeffer S, 2001, MOL CELL, V8, P729, DOI 10.1016/S1097-2765(01)00371-9; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; van Weering JRT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000616; Vasan N, 2010, P NATL ACAD SCI USA, V107, P14176, DOI 10.1073/pnas.1009419107; Vik-Mo EO, 2003, NEUROSCIENCE, V119, P73, DOI 10.1016/S0306-4522(03)00065-4; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu Y, 2009, BIOPHYS J, V97, P101, DOI 10.1016/j.bpj.2009.04.028; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	44	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173993	10.1371/journal.pone.0173993	http://dx.doi.org/10.1371/journal.pone.0173993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323853	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000054
J	Yu, JH; Chung, BH; Yang, CW				Yu, Ji Hyun; Chung, Byung Ha; Yang, Chul Woo		Korean Organ Transplantat Registry	Impact of ABO incompatible kidney transplantation on living donor transplantation	PLOS ONE			English	Article							SINGLE-CENTER EXPERIENCE; INFECTIOUS COMPLICATIONS; RECIPIENTS; RITUXIMAB; OUTCOMES; SPOUSAL; KOREA	Background ABO incompatible kidney transplantation (ABOi-KT) is an important approach for overcoming donor shortages. We evaluated the effect of ABOi-KT on living donor KT. Methods Two nationwide transplantation databases were used. We evaluated the impact of ABOi-KT on overall living donor transplant activity and spousal donation as subgroup analysis. In addition, we compared the clinical outcome between ABOi-KT and ABO compatible KT (ABOc-KT) from spousal donor, and performed a Cox proportional hazards regression analysis to define the risk factors affecting the allograft outcomes. Result The introduction of ABOi-KT increased overall living donor KT by 12.2% and its portion was increased from 0.3% to 21.7% during study period. The ABOi-KT in living unrelated KT was two times higher than that of living related donor KT (17.8 vs. 9.8%). Spousal donor was a major portion of living unrelated KT (77.6%) and ABOi- KT increased spousal donation from 10% to 31.5% in living donor KT. In addition, increasing rate ABOi-KT from spousal donor was 10 times higher than that of living related donor. The clinical outcome (incidence of acute rejection, allograft function, and allograft and patient survival rates) of ABOi-KT from spousal donor was comparable to that of ABOc-KT. Neither ABO incompatibility nor spousal donor was associated with acute rejection or allograft failure on multivariate analysis. Conclusions ABOi- KT increased overall living donor KT, and ABOi- KT from spousal donor is rapidly increasing with favorable clinical outcomes.	[Yu, Ji Hyun; Chung, Byung Ha; Yang, Chul Woo; Korean Organ Transplantat Registry] Catholic Univ Korea, Transplantat Res Ctr, Div Nephrol, Dept Internal Med,Seoul St Marys Hosp,Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Transplantat Res Ctr, Div Nephrol, Dept Internal Med,Seoul St Marys Hosp,Coll Med, Seoul, South Korea.	yangch@catholic.ac.kr		Yang, Jeaseok/0000-0002-5378-7797	Korean Society for Transplantation; Research of Korea Centers for Disease Control and Prevention [2014ER630101]; Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea [HI14C3417]	Korean Society for Transplantation; Research of Korea Centers for Disease Control and Prevention; Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea	This study was supported by the Korean Society for Transplantation and by a fund (2014ER630101) from the Research of Korea Centers for Disease Control and Prevention and also it was supported by a grant (HI14C3417) from the Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C, 2014, TRANSPL P, V46, P425, DOI 10.1016/j.transproceed.2013.11.083; Barnett ANR, 2014, TRANSPL INT, V27, P187, DOI 10.1111/tri.12234; Choi BH, 2015, TRANSPL P, V47, P653, DOI 10.1016/j.transproceed.2014.11.049; Chung BH, 2013, TRANSPL INFECT DIS, V15, P559, DOI 10.1111/tid.12135; Chung BH, 2012, RENAL FAILURE, V34, P974, DOI 10.3109/0886022X.2012.700892; Chung Byung Ha, 2010, Korean Journal of Internal Medicine, V25, P288, DOI 10.3904/kjim.2010.25.3.288; Habicht A, 2011, NEPHROL DIAL TRANSPL, V26, P4124, DOI 10.1093/ndt/gfr215; Hwang JK, 2013, TRANSPL P, V45, P2931, DOI 10.1016/j.transproceed.2013.08.038; Kim BS, 2007, J AM SOC NEPHROL, V18, P1000, DOI 10.1681/ASN.2006101071; Kim YS, 2001, LANCET, V357, P1180, DOI 10.1016/S0140-6736(00)04377-4; Kong JM, 2013, CLIN TRANSPLANT, V27, P875, DOI 10.1111/ctr.12249; Korean Network for Organ Sharing, KONOS ANN REP; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Opelz G, 2015, TRANSPLANTATION, V99, P400, DOI 10.1097/TP.0000000000000312; Roozbeh J, 2006, TRANSPL P, V38, P562, DOI 10.1016/j.transproceed.2005.12.058; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Toki D, 2009, TRANSPL INT, V22, P447, DOI 10.1111/j.1432-2277.2008.00821.x; Yoon HE, 2009, NEPHRON CLIN PRACT, V113, pC241, DOI 10.1159/000235248	20	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173878	10.1371/journal.pone.0173878	http://dx.doi.org/10.1371/journal.pone.0173878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323892	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000037
J	Anandakrishnan, R; Zuckerman, DM				Anandakrishnan, Ramu; Zuckerman, Daniel M.			Biophysical comparison of ATP-driven proton pumping mechanisms suggests a kinetic advantage for the rotary process depending on coupling ratio	PLOS ONE			English	Article							H+-ATPASE; ROTOR RING; V-ATPASE; STOICHIOMETRY; TONOPLAST; ROTATION; SYNTHASE; PH	ATP-driven proton pumps, which are critical to the operation of a cell, maintain cytosolic and organellar pH levels within a narrow functional range. These pumps employ two very different mechanisms: an elaborate rotary mechanism used by V-ATPase H+ pumps, and a simpler alternating access mechanism used by P-ATPase H+ pumps. Why are two different mechanisms used to perform the same function? Systematic analysis, without parameter fitting, of kinetic models of the rotary, alternating access and other possible mechanisms suggest that, when the ratio of protons transported per ATP hydrolyzed exceeds one, the oneat- a-time proton transport by the rotary mechanism is faster than other possible mechanisms across a wide range of driving conditions. When the ratio is one, there is no intrinsic difference in the free energy landscape between mechanisms, and therefore all mechanisms can exhibit the same kinetic performance. To our knowledge all known rotary pumps have an H+: ATP ratio greater than one, and all known alternating access ATP-driven proton pumps have a ratio of one. Our analysis suggests a possible explanation for this apparent relationship between coupling ratio and mechanism. When the conditions under which the pump must operate permit a coupling ratio greater than one, the rotary mechanism may have been selected for its kinetic advantage. On the other hand, when conditions require a coupling ratio of one or less, the alternating access mechanism may have been selected for other possible advantages resulting from its structural and functional simplicity.	[Anandakrishnan, Ramu; Zuckerman, Daniel M.] Univ Pittsburgh, Dept Computat & Syst Biol, Sch Med, Pittsburgh, PA 15260 USA; [Anandakrishnan, Ramu] Edward Via Coll Osteopath Med, Div Biomed, Blacksburg, VA 24060 USA; [Zuckerman, Daniel M.] Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Portland, OR 97201 USA; [Zuckerman, Daniel M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Oregon Health & Science University	Anandakrishnan, R; Zuckerman, DM (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Sch Med, Pittsburgh, PA 15260 USA.; Anandakrishnan, R (corresponding author), Edward Via Coll Osteopath Med, Div Biomed, Blacksburg, VA 24060 USA.; Zuckerman, DM (corresponding author), Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Portland, OR 97201 USA.; Zuckerman, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	ramu@vt.edu; zuckermd@ohsu.edu	Anandakrishnan, Ramu/AAB-9040-2020	Anandakrishnan, Ramu/0000-0003-0422-3984	National Institutes of Health [P41-GM103712]; DMZ; National Science Foundation [MCB-1119091]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DMZ; National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institutes of Health Grant No. P41-GM103712, DMZ, and National Science Foundation Grant No. MCB-1119091, DMZ. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Anandakrishnana R, 2016, P NATL ACAD SCI USA, V113, P11220, DOI 10.1073/pnas.1608533113; BENNETT AB, 1984, PLANT PHYSIOL, V74, P545, DOI 10.1104/pp.74.3.545; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bhatt D, 2011, J CHEM THEORY COMPUT, V7, P2520, DOI 10.1021/ct200086k; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Castillo JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8622; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Fisher ME, 1999, P NATL ACAD SCI USA, V96, P6597, DOI 10.1073/pnas.96.12.6597; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; GRABER P, 1994, BBA-BIOENERGETICS, V1187, P171, DOI 10.1016/0005-2728(94)90105-8; Gruber G, 2014, BBA-BIOENERGETICS, V1837, P940, DOI 10.1016/j.bbabio.2014.03.004; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P2922, DOI 10.1073/pnas.80.10.2922; Hill TL, 2004, FREE ENERGY TRANSDUC; Kettner C, 2003, BIOPHYS J, V85, P3730, DOI 10.1016/S0006-3495(03)74789-4; Kuhlbrandt W, 2016, TRENDS BIOCHEM SCI, V41, P106, DOI 10.1016/j.tibs.2015.10.006; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; Miranda M, 2011, BBA-BIOMEMBRANES, V1808, P1781, DOI 10.1016/j.bbamem.2010.11.034; Morales-Rios E, 2015, P NATL ACAD SCI US; Morsomme P, 2000, BBA-BIOMEMBRANES, V1465, P1, DOI 10.1016/S0005-2736(00)00128-0; Muller ML, 2002, J MEMBRANE BIOL, V185, P209, DOI 10.1007/s00232-001-0124-z; Muller ML, 1999, J BIOL CHEM, V274, P10706, DOI 10.1074/jbc.274.16.10706; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orij R, 2011, BBA-GEN SUBJECTS, V1810, P933, DOI 10.1016/j.bbagen.2011.03.011; Panke O, 1996, FEBS LETT, V383, P196, DOI 10.1016/0014-5793(96)00246-3; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PERLIN DS, 1986, ARCH BIOCHEM BIOPHYS, V248, P53, DOI 10.1016/0003-9861(86)90400-5; Pittman JK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00011; Pogoryelov D, 2012, P NATL ACAD SCI USA, V109, pE1599, DOI 10.1073/pnas.1120027109; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Savir Y, 2013, CELL, V153, P471, DOI 10.1016/j.cell.2013.03.032; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Schep DG, 2016, P NATL ACAD SCI USA, V113, P3245, DOI 10.1073/pnas.1521990113; SCHJAERJACOBSEN H, 1979, IEEE T CIRCUITS SYST, V26, P775, DOI 10.1109/TCS.1979.1084700; SCHMIDT AL, 1993, ARCH BIOCHEM BIOPHYS, V306, P407, DOI 10.1006/abbi.1993.1530; Schulz S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001596; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Silverstein TP, 2014, J BIOENERG BIOMEMBR, V46, P229, DOI 10.1007/s10863-014-9547-y; STEIN WD, 1990, BIOPHYS J, V57, P255, DOI 10.1016/S0006-3495(90)82528-5; Sugawa M, 2016, P NATL ACAD SCI USA, V113, pE2916, DOI 10.1073/pnas.1524720113; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Tomashek JJ, 2000, J BIOENERG BIOMEMBR, V32, P493, DOI 10.1023/A:1005617024904; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	50	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173500	10.1371/journal.pone.0173500	http://dx.doi.org/10.1371/journal.pone.0173500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319179	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800017
J	Wen, M; Zhou, B; Chen, YH; Ma, ZL; Gou, Y; Zhang, CL; Yu, WF; Jiao, L				Wen, Min; Zhou, Bo; Chen, Yun-Hua; Ma, Zhao-Lei; Gou, Yun; Zhang, Chun-Lin; Yu, Wen-Feng; Jiao, Ling			Serum uric acid levels in patients with Parkinson's disease: A meta-analysis	PLOS ONE			English	Article							OXIDATIVE STRESS; URATE; RISK; ASSOCIATION; PROGRESSION	Background Lower serum uric acid (UA) levels have been reported as a risk factor in Parkinson's disease (PD). However, the results have been inconsistent so far. Objectives The aim of the present study was to clarify the potential relationship of uric acid with PD. Methods Comprehensive electronic search in pubmed, web of science, and the Cochrane Library database to find original articles about the association between PD and serum uric acid levels published before Dec 2015. Literature quality assessment was performed with the Newcastle-Ottawa Scale. Random-effects model was used to estimate the standardized mean differences (SMDs) with 95% confidence intervals (CIs). Heterogeneity across studies was assessed using I-2 and H-2 statistics. Sensitivity analyses to assess the influence of individual studies on the pooled estimate. Publication bias was investigated using funnel plots and Egger's regression test. Analyses were performed by using Review Manager 5.3 and Stata 11.0. Results Thirteen studies with a total of 4646 participants (2379 PD patients and 2267 controls) were included in this meta-analysis. The current results showed that the serum UA levels in PD patients were significantly lower compared to sex and age-matched healthy controls (SMD: -0.49, 95% CI: [-0.67, -0.30], Z = 5.20, P < 0.001) and these results showed no geographic regional (Asia: SMD = -0.65, 95% CI [-0.84, -0.46], Z = 6.75, p < 0.001; Non-Asia: SMD = -0.25, 95% CI [-0.43, -0.07], Z = 2.70, p = 0.007) and sex differences (women: SMD = -0.53, 95% CI [-0.70, -0.35], z = 5.98, p < 0.001; men: SMD = -0.66, 95% CI [-0.87,- 0.44], z = 6.03, p < 0.001). Serum UA levels in middle- late stage PD patients with higher H& Y scales were significantly lower than early stage PD patients with lower H& Y scales ( SMD = 0.63, 95% CI [ 0.36,0.89], z = 4.64, p < 0.001). Conclusions Our study showed that the serum UA levels are significantly lower in PD and the level is further decreased as the disease progresses. Thus it might be a potential biomarker to indicate the risk and progression of PD.	[Wen, Min; Chen, Yun-Hua; Gou, Yun] Guizhou Med Univ, Dept Anat, Guiyang, Peoples R China; [Zhou, Bo; Zhang, Chun-Lin] Guizhou Med Univ, Dept Biol, Guiyang, Peoples R China; [Ma, Zhao-Lei] Guizhou Med Univ, BaiYun Hosp, Dept Neurol, Guiyang, Peoples R China; [Yu, Wen-Feng] Minist Educ, Key Lab Endem & Ethn Dis, Guiyang, Guizhou Prov, Peoples R China; [Yu, Wen-Feng] Guizhou Med Univ, Key Lab Med Mol Biol, Guiyang, Guizhou Prov, Peoples R China; [Jiao, Ling] Guizhou Med Univ, Affiliated Hosp, Dept Neurol, Guiyang, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University; Guizhou Medical University; Guizhou Medical University	Yu, WF (corresponding author), Minist Educ, Key Lab Endem & Ethn Dis, Guiyang, Guizhou Prov, Peoples R China.; Yu, WF (corresponding author), Guizhou Med Univ, Key Lab Med Mol Biol, Guiyang, Guizhou Prov, Peoples R China.; Jiao, L (corresponding author), Guizhou Med Univ, Affiliated Hosp, Dept Neurol, Guiyang, Peoples R China.	wenfengyu2013@126.com; jiaoling5151@sina.com	zhou, bo/AGF-4774-2022		Natural Science Foundation of Guizhou Province of China [LG[2012]021, LG[2011]023]	Natural Science Foundation of Guizhou Province of China	This study was supported by the Natural Science Foundation of Guizhou Province of China (LG[2012]021 and LG[2011]023).	AHLSKOG JE, 1995, MOVEMENT DISORD, V10, P566, DOI 10.1002/mds.870100507; Andreadou E, 2009, CLIN NEUROL NEUROSUR, V111, P724, DOI 10.1016/j.clineuro.2009.06.012; Annanmaki T, 2007, MOVEMENT DISORD, V22, P1133, DOI 10.1002/mds.21502; Annanmaki T, 2011, PARKINSONISM RELAT D, V17, P333, DOI 10.1016/j.parkreldis.2011.01.013; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; Borenstein M., 2009, INTRO METAANALYSIS; Bowman GL, 2010, J ALZHEIMERS DIS, V19, P1331, DOI 10.3233/JAD-2010-1330; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Cipriani S, 2010, BIOMARK MED, V4, P701, DOI 10.2217/BMM.10.94; Constantinescu R, 2013, ACTA NEUROL SCAND, V127, pe8, DOI 10.1111/ane.12012; Constantinescu R, 2011, DRUG TODAY, V47, P369, DOI 10.1358/dot.2011.47.5.1591834; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Facheris MF, 2011, J MOL NEUROSCI, V43, P246, DOI 10.1007/s12031-010-9409-y; Floor E, 1998, J NEUROCHEM, V70, P268; GHIO AJ, 1994, ARCH BIOCHEM BIOPHYS, V313, P215, DOI 10.1006/abbi.1994.1379; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Gonzalez-Aramburu I, 2013, MOVEMENT DISORD, V28, P1737, DOI 10.1002/mds.25507; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Ikeda K, 2011, NEURODEGENER DIS, V8, P252, DOI 10.1159/000323265; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jesus S, 2013, EUR J NEUROL, V20, P208, DOI 10.1111/j.1468-1331.2012.03745.x; Kim TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112512; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Lolekha P, 2015, J CLIN NEUROSCI, V22, P1264, DOI 10.1016/j.jocn.2015.02.015; Maetzler W, 2011, J ALZHEIMERS DIS, V27, P119, DOI 10.3233/JAD-2011-110587; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ozsoy O, 2015, FREE RADICAL RES, V49, P1004, DOI 10.3109/10715762.2015.1027198; Palmer T.M., 2016, METAANALYSIS STATA U; Qin XL, 2015, CELL BIOCHEM BIOPHYS, V72, P49, DOI 10.1007/s12013-014-0402-x; Schlesinger I, 2008, MOVEMENT DISORD, V23, P1653, DOI 10.1002/mds.22139; Shen L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003620; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sun CC, 2012, CHINESE MED J-PEKING, V125, P583, DOI 10.3760/cma.j.issn.0366-6999.2012.04.005; Yue HY, 2014, ACS NANO, V8, P1639, DOI 10.1021/nn405961p; Zhang HN, 2012, NEUROSCI LETT, V514, P152, DOI 10.1016/j.neulet.2012.02.077; Zhaolei MA, 2015, OURNAL GUIZHOU MED U, V4, P867; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	43	59	64	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173731	10.1371/journal.pone.0173731	http://dx.doi.org/10.1371/journal.pone.0173731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319195	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800027
J	Loncoman, CA; Hartley, CA; Coppo, MJC; Vaz, PK; Diaz-Mendez, A; Browning, GF; Lee, SW; Devlin, JM				Loncoman, Carlos A.; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Diaz-Mendez, Andres; Browning, Glenn F.; Lee, Sang-won; Devlin, Joanne M.			Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host	PLOS ONE			English	Article							GALLID-1 HERPESVIRUS-INFECTION; GLYCOPROTEIN-G; IN-VIVO; CHICKEN; POLYMERASE; ALPHAHERPESVIRUSES; ESTABLISHMENT; DEFICIENT; AUSTRALIA; STRAINS	To date, recombination between different strains of the avian alphaherpesvirus infectious laryngotracheitis virus (ILTV) has only been detected in field samples using full genome sequencing and sequence analysis. These previous studies have revealed that natural recombination is widespread in ILTV and have demonstrated that recombination between two attenuated ILTV vaccine strains generated highly virulent viruses that produced widespread disease within poultry flocks in Australia. In order to better understand ILTV recombination, this study developed a TaqMan single nucleotide polymorphism (SNP) genotyping assay to detect recombination between two field strains of ILTV (CSW-1 and V1-99 ILTV) under experimental conditions. Following in vivo co-inoculation of these two ILTV strains in specific pathogen free (SPF) chickens, recovered viruses were plaque purified and subjected to the SNP genotyping assay. This assay revealed ILTV recombinants in all co-inoculated chickens. In total 64/87 (74%) of the recovered viruses were recombinants and 23 different recombination patterns were detected, with some of them occurring more frequently than others. The results from this study demonstrate that the TaqMan SNP genotyping assay is a useful tool to study recombination in ILTV and also show that recombination occurs frequently during experimental co-infection with ILTV in SPF chickens. This tool, when used to assess ILTV recombination in the natural host, has the potential to greatly contribute to our understanding of alphaherpesvirus recombination.	[Loncoman, Carlos A.; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Diaz-Mendez, Andres; Browning, Glenn F.; Lee, Sang-won; Devlin, Joanne M.] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet & Agr Sci, Melbourne, Vic, Australia	University of Melbourne	Loncoman, CA (corresponding author), Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet & Agr Sci, Melbourne, Vic, Australia.	cloncoman@student.unimelb.edu.au	Browning, Glenn Francis/P-4459-2014; Loncoman, Carlos/AAE-6481-2020; Vaz, Paola K./D-8713-2015	Browning, Glenn Francis/0000-0002-0903-2469; Loncoman, Carlos/0000-0002-4321-8873; Vaz, Paola K./0000-0001-6877-7383; Hartley, Carol/0000-0001-6174-7341; Diaz-Mendez, Andres/0000-0003-3004-8518; Coppo, Mauricio/0000-0002-4344-9532; Devlin, Joanne/0000-0003-0400-9670	Australian Research Council [FT140101287]; Becas Chile, CONICYT, Gobierno de Chile	Australian Research Council(Australian Research Council); Becas Chile, CONICYT, Gobierno de Chile	This work was supported by the Australian Research Council (FT140101287). Carlos Loncoman is supported by Becas Chile, CONICYT, Gobierno de Chile.; We gratefully acknowledge Mahathi Nadimpalli, Nino Ficorilli and Mesula Korsa for their help with cell culture, Jose Quinteros, June Daly, Jenece Wheeler and Cheryl Colson for their help with the in vivo studies, and Zelalem Mekuria and Alistair Legione for their help with the Geneious software. This work was supported by the Australian Research Council (FT140101287). Carlos Loncoman is supported by Becas Chile, CONICYT, Gobierno de Chile.	Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; BAGUST TJ, 1986, AVIAN DIS, V30, P179, DOI 10.2307/1590631; BAGUST TJ, 1986, AVIAN PATHOL, V15, P581, DOI 10.1080/03079458608436317; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2006, ARCH VIROL, V151, P1281, DOI 10.1007/s00705-005-0721-8; Drake JW, 2005, GENETICS, V170, P969, DOI 10.1534/genetics.104.040410; FAHEY KJ, 1983, AVIAN PATHOL, V12, P505, DOI 10.1080/03079458308436195; Garcia M, 2013, DIS POULTRY, P137; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120358; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Kolb AW, 2015, J VIROL, V89, P6427, DOI 10.1128/JVI.00416-15; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Loncoman CA, 2017, INFECT GENET EVOL, V49, P174, DOI 10.1016/j.meegid.2016.12.022; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Muylkens B, 2009, J VIROL, V83, P3127, DOI 10.1128/JVI.02474-08; Norberg P., 2015, J VIROL; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Vaz PK, 2016, J GEN VIROL, V97, P747, DOI 10.1099/jgv.0.000378	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174590	10.1371/journal.pone.0174590	http://dx.doi.org/10.1371/journal.pone.0174590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350819	gold, Green Published			2022-12-27	WOS:000399174400063
J	Kawahara, T; Makizaki, Y; Oikawa, Y; Tanaka, Y; Maeda, A; Shimakawa, M; Komoto, S; Moriguchi, K; Ohno, H; Taniguchi, K				Kawahara, Tomohiro; Makizaki, Yutaka; Oikawa, Yosuke; Tanaka, Yoshiki; Maeda, Ayako; Shimakawa, Masaki; Komoto, Satoshi; Moriguchi, Kyoko; Ohno, Hiroshi; Taniguchi, Koki			Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors	PLOS ONE			English	Article							NEONATAL MOUSE MODEL; DEVELOPING-COUNTRIES; MURINE ROTAVIRUS; GENE-EXPRESSION; SUCKLING MICE; INFECTION; DIARRHEA; OSTEOPONTIN; SYSTEM; CELLS	Human rotavirus (RV) infection is a leading cause of dehydrating diarrhea in infants and young children worldwide. Since therapeutic approaches to RV gastroenteritis are limited to alleviation of dehydration with oral rehydration solutions, more direct approaches to palliate symptoms of RV gastroenteritis are required. Treatments with probiotics have been increasingly recognized as alternative safe and low cost treatments for moderate infectious diarrhea. In this study, Bifidobacterium bifidum G9-1 (BBG9-1), which has been used as an intestinal drug for several decades, was shown to have a remarkable protective effect against RV gastroenteritis in a suckling mice model. As well as prophylactic oral administration of BBG9-1 from 2 days before RV infection, therapeutic oral administration of BBG9-1 from 1 day after RV infection significantly alleviated RV-induced diarrhea. Therapeutic administration of BBG9-1 reduced various types of damage in the small intestine, such as epithelial vacuolization and villous shortening, and significantly diminished the infectious RV titer in mixtures of cecal contents and feces. It was also shown that therapeutic administration of BBG9-1 significantly increased the number of acidic mucin-positive goblet cells and the gene expression of mucosal protective factors including MUC2, MUC3, MUC4, TG931 and TFF3 in the small intestine. This led to alleviation of low gut permeability shown as decreased gene expression levels of occludin, claudin-1 and villin-1 after RV infection. Furthermore, in the small intestine, therapeutic administration of BBG9-1 significantly palliated the decreased gene expression of SGLT-1, which plays an important role in water absorption. In the large intestine, administered BBG9-1 was shown to replicate to assimilate undigested nutrients, resulting in normalization of the abnormally high osmotic pressure. These results suggested that water malabsorption caused by RV infection was alleviated in mice administered BBG9-1. Thus, the present study showed that oral administration of BBG9-1 palliated diarrhea partly through protection against RV-induced lesions by inducing mucosal protective factors. Oral administration of BBG9-1 is thought to be an efficient method for management of an RV epidemic for both prophylactic and therapeutic purposes.	[Kawahara, Tomohiro; Makizaki, Yutaka; Oikawa, Yosuke; Tanaka, Yoshiki; Maeda, Ayako; Shimakawa, Masaki; Ohno, Hiroshi] Biofermin Pharmaceut Co Ltd, R&D Ctr, Kobe, Hyogo, Japan; [Komoto, Satoshi; Moriguchi, Kyoko; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi, Japan	Fujita Health University	Kawahara, T (corresponding author), Biofermin Pharmaceut Co Ltd, R&D Ctr, Kobe, Hyogo, Japan.	kawahara_tomohiro@biofermin.co.jp		Tanaka, Yoshiki/0000-0003-0050-587X	Biofermin Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [26461516] Funding Source: KAKEN	Biofermin Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Biofermin Pharmaceutical Co., Ltd. Authors [TK, YM, YO, YT, AM, MS and HO] are employees of Biofermin Pharmaceutical Co., Ltd. Author [KT] received a Grant-in-Aid from Biofermin Pharmaceutical Co., Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ahmadi E, 2015, CASP J INTERN MED, V6, P187; Azevedo MSP, 2012, BENEF MICROBES, V3, P33, DOI 10.3920/BM2011.0041; Babji S, 2012, CURR OPIN VIROL, V2, P443, DOI 10.1016/j.coviro.2012.05.005; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Chang RM, 2013, WORLD J EMERG MED, V4, P223, DOI [10.5847/wjem.j.1920-8642.2013.03.012, 10.5847/wjem.j.issn.1920-8642.2013.03.012]; CHEN CC, 1993, GASTROENTEROLOGY, V105, P84, DOI 10.1016/0016-5085(93)90013-3; Chenoll E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00655; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DUFFY LC, 1994, PEDIATR RES, V35, P690, DOI 10.1203/00006450-199406000-00014; FAO/WHO Expert Consultation, 2005, JOINT FAO WHO EXP CO, P341; Gillespie D, 2015, AGE AGEING, V44, P853, DOI 10.1093/ageing/afv072; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Guerin-Danan C, 2001, J NUTR, V131, P111, DOI 10.1093/jn/131.1.111; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Ho SB, 2006, GASTROENTEROLOGY, V131, P1501, DOI 10.1053/j.gastro.2006.09.006; Kang JY, 2015, J MICROBIOL, V53, P796, DOI 10.1007/s12275-015-5302-2; Kawahara T, 2015, MICROBIOL IMMUNOL, V59, P1, DOI 10.1111/1348-0421.12210; Khatri IA, 2001, AM J PHYSIOL-GASTR L, V280, pG1321, DOI 10.1152/ajpgi.2001.280.6.G1321; Knipping K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-109; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Lee DK, 2015, CLIN RES HEPATOL GAS, V39, P237, DOI 10.1016/j.clinre.2014.09.006; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Maeno Y, 2009, VIRAL IMMUNOL, V22, P139, DOI 10.1089/vim.2008.0054; Mao XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146312; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Mikkelsen KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142352; More MI, 2015, CLIN EXP GASTROENTER, V8, P237, DOI 10.2147/CEG.S85574; Morris AP, 2001, AM J PHYSIOL-GASTR L, V281, pG303, DOI 10.1152/ajpgi.2001.281.2.G303; O'Ryan ML, 2010, PEDIATR INFECT DIS J, V29, P855, DOI 10.1097/INF.0b013e3181e8b346; Ohno H, 2005, BIOL PHARM BULL, V28, P1462, DOI 10.1248/bpb.28.1462; Parashar UD, 2016, CLIN INFECT DIS, V62, pS91, DOI 10.1093/cid/civ1015; Qiao HP, 2002, PEDIATR RES, V51, P750, DOI 10.1203/01.PDR.0000017481.64723.1F; RIEPENHOFFTALTY M, 1985, PEDIATR RES, V19, P1250, DOI 10.1203/00006450-198512000-00005; Rollo EE, 2005, J VIROL, V79, P3509, DOI 10.1128/JVI.79.6.3509-3516.2005; Tate JE, 2012, VACCINE, V30, pA179, DOI 10.1016/j.vaccine.2011.08.110; Tsunemine S, 2015, MICROBIOL IMMUNOL, V59, P690, DOI 10.1111/1348-0421.12324; Tsunemine Satoru, 2011, Biosci Microflora, V30, P1, DOI 10.12938/bifidus.30.1; Ubelmann F, 2013, P NATL ACAD SCI USA, V110, pE1380, DOI 10.1073/pnas.1218446110; Vandenplas Y, 2013, CURR INFECT DIS REP, V15, P251, DOI 10.1007/s11908-013-0334-4; Vandenplas Y, 2016, BEST PRACT RES CL GA, V30, P49, DOI 10.1016/j.bpg.2015.12.002; WILLOUGHBY RE, 1993, GLYCOBIOLOGY, V3, P437, DOI 10.1093/glycob/3.5.437; Wolber FM, 2005, J NUTR, V135, P1470, DOI 10.1093/jn/135.6.1470; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Zhang Z, 2013, PATHOG DIS, V67, P184, DOI 10.1111/2049-632X.12030	50	29	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173979	10.1371/journal.pone.0173979	http://dx.doi.org/10.1371/journal.pone.0173979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346473	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300017
J	Modi, BP; Teves, ME; Pearson, LN; Parikh, HI; Chaemsaithong, P; Sheth, NU; York, TP; Romero, R; Strauss, JF				Modi, Bhavi P.; Teves, Maria E.; Pearson, Laurel N.; Parikh, Hardik I.; Chaemsaithong, Piya; Sheth, Nihar U.; York, Timothy P.; Romero, Roberto; Strauss, Jerome F., III			Rare mutations and potentially damaging missense variants in genes encoding fibrillar collagens and proteins involved in their production are candidates for risk for preterm premature rupture of membranes	PLOS ONE			English	Article							OSTEOGENESIS IMPERFECTA; ASSOCIATION; FETAL; BIRTH; ADMIXTURE; PROMOTER; DISEASE; GENETICS; POLYMORPHISM; DISCOVERY	Preterm premature rupture of membranes (PPROM) is the leading identifiable cause of preterm birth with similar to 40% of preterm births being associated with PPROM and occurs in 1% 2% of all pregnancies. We hypothesized that multiple rare variants in fetal genes involved in extracellular matrix synthesis would associate with PPROM, based on the assumption that impaired elaboration of matrix proteins would reduce fetal membrane tensile strength, predisposing to unscheduled rupture. We performed whole exome sequencing (WES) on neonatal DNA derived from pregnancies complicated by PPROM (49 cases) and healthy term deliveries (20 controls) to identify candidate mutations/variants. Genotyping for selected variants from the WES study was carried out on an additional 188 PPROM cases and 175 controls. All mothers were self-reported African Americans, and a panel of ancestry informative markers was used to control for genetic ancestry in all genetic association tests. In support of the primary hypothesis, a statistically significant genetic burden (all samples combined, SKAT-O p-value = 0.0225) of damaging/potentially damaging rare variants was identified in the genes of interest-fibrillar collagen genes, which contribute to fetal membrane strength and integrity. These findings suggest that the fetal contribution to PPROM is polygenic, and driven by an increased burden of rare variants that may also contribute to the disparities in rates of preterm birth among African Americans.	[Modi, Bhavi P.; York, Timothy P.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Teves, Maria E.; York, Timothy P.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Pearson, Laurel N.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Parikh, Hardik I.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Chaemsaithong, Piya; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Bethesda, MD USA; [Chaemsaithong, Piya; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Detroit, MI USA; [Sheth, Nihar U.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA	Virginia Commonwealth University; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Virginia Commonwealth University; University of Michigan System; University of Michigan; Michigan State University; Wayne State University	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	jerome.strauss@vcuhealth.org	Teves, Maria/AAJ-9523-2020; Parikh, Hardik/AAG-4963-2021; Romero, Roberto/A-5268-2019	Teves, Maria/0000-0001-7035-2202; Modi, Bhavi/0000-0003-1510-5916; Parikh, Hardik/0000-0002-5621-7343; chaemsaithong, piya/0000-0003-1750-9834; Romero, Roberto/0000-0002-4448-5121; Chaemsaithong, piya/0000-0002-5398-6868	National Institutes of Health [R01 HD073555, P60 MD002256]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH [HSN275201300006C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073555, ZIAHD002400] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was funded by National Institutes of Health Grants R01 HD073555 and P60 MD002256. This research was also supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HSN275201300006C (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Sonya Washington for enrolling subjects for the study at MCV Hospitals, Richmond VA. We also thank Dr. Barbara Boyan, Virginia Commonwealth University, for providing primary culture of human ear chondrocytes. This research was funded by National Institutes of Health Grants R01 HD073555 and P60 MD002256. This research was also supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HSN275201300006C.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2021, LANG ENV STAT COMP; Anum EA, 2009, PLACENTA, V30, P207, DOI 10.1016/j.placenta.2008.12.007; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Brusin Joyce Helena, 2008, Radiol Technol, V79, P535; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Capece A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108578; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz-Prado S, 2011, DIFFERENTIATION, V81, P162, DOI 10.1016/j.diff.2011.01.005; Diaz-Prado S, 2010, CELL TISSUE BANK, V11, P183, DOI 10.1007/s10561-009-9144-1; Dolan SM, 2010, PUBLIC HEALTH GENOM, V13, P514, DOI 10.1159/000294202; Ferrand PE, 2002, MOL HUM REPROD, V8, P494, DOI 10.1093/molehr/8.5.494; Fujimoto T, 2002, J BIOL CHEM, V277, P6296, DOI 10.1074/jbc.M107865200; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hampson V, 1997, BRIT J OBSTET GYNAEC, V104, P1087, DOI 10.1111/j.1471-0528.1997.tb12073.x; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houari MB, 2015, HUM MUTAT, V23, P1; Hurst BS, 2014, OBSTET GYNECOL, V123, P506, DOI 10.1097/AOG.0000000000000123; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; KANAYAMA N, 1985, AM J OBSTET GYNECOL, V153, P899, DOI 10.1016/0002-9378(85)90703-3; KEY TC, 1978, OBSTET GYNECOL, V51, P67; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lind J, 2002, ACTA OBSTET GYN SCAN, V81, P293, DOI 10.1034/j.1600-0412.2002.810403.x; Liu YS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-1; Malfait F, 2005, AM J MED GENET C, V139C, P17, DOI 10.1002/ajmg.c.30070; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002; Myking S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061781; Myking S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-174; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Romero R, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.026; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Shen Tammy T, 2008, BMC Pregnancy Childbirth, V8, P43, DOI 10.1186/1471-2393-8-43; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SKINNER SJM, 1981, OBSTET GYNECOL, V57, P487; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454; Taksande A, 2008, IRAN J PEDIATR, V18, P175, DOI 10.4103/0971-3026.40306; Wang H, 2004, HUM MOL GENET, V13, P2659, DOI 10.1093/hmg/ddh287; Wang HY, 2006, P NATL ACAD SCI USA, V103, P13463, DOI 10.1073/pnas.0603676103; Weinberg CR, 2009, AM J EPIDEMIOL, V170, P1373, DOI 10.1093/aje/kwp325; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Wesche WA, 2001, J CUTAN PATHOL, V28, P211, DOI 10.1034/j.1600-0560.2001.028004211.x; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; York TP, 2014, AM J OBSTET GYNECOL, V210, P398, DOI 10.1016/j.ajog.2013.10.001; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	58	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174356	10.1371/journal.pone.0174356	http://dx.doi.org/10.1371/journal.pone.0174356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346524	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300041
J	Wei, LK; Huang, XX				Wei, Likun; Huang, Xuxiong			Long-duration effect of multi-factor stresses on the cellular biochemistry, oil-yielding performance and morphology of Nannochloropsis oculata	PLOS ONE			English	Article							TETRASELMIS-SUBCORDIFORMIS; NITROGEN STARVATION; LIPID-ACCUMULATION; CHLAMYDOMONAS; GROWTH; METABOLISM; MICROALGAE; LIGHT; PROFILES; BIOFUELS	Microalga Nannochloropsis oculata is a promising alternative feedstock for biodiesel. Elevating its oil-yielding capacity is conducive to cost-saving biodiesel production. However, the regulatory processes of multi-factor collaborative stresses (MFCS) on the oil-yielding performance of N. oculata are unclear. The duration effects of MFCS (high irradiation, nitrogen deficiency and elevated iron supplementation) on N. oculata were investigated in an 18-d batch culture. Despite the reduction in cell division, the biomass concentration increased, resulting from the large accumulation of the carbon/energy-reservoir. However, different storage forms were found in different cellular storage compounds, and both the protein content and pigment composition swiftly and drastically changed. The analysis of four biodiesel properties using pertinent empirical equations indicated their progressive effective improvement in lipid classes and fatty acid composition. The variation curve of neutral lipid productivity was monitored with fluorescent Nile red and was closely correlated to the results from conventional methods. In addition, a series of changes in the organelles (e.g., chloroplast, lipid body and vacuole) and cell shape, dependent on the stress duration, were observed by TEM and LSCM. These changes presumably played an important role in the acclimation of N. oculata to MFCS and accordingly improved its oil-yielding performance.	[Wei, Likun; Huang, Xuxiong] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Key Lab Genet Resources Freshwater Aquaculture &, Shanghai, Peoples R China; [Huang, Xuxiong] Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Huang, Xuxiong] Shanghai Ocean Univ, Aquat Anim Breeding Ctr ZF1206, Shanghai Univ Knowledge Serv Platform, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Huang, XX (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Key Lab Genet Resources Freshwater Aquaculture &, Shanghai, Peoples R China.; Huang, XX (corresponding author), Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China.; Huang, XX (corresponding author), Shanghai Ocean Univ, Aquat Anim Breeding Ctr ZF1206, Shanghai Univ Knowledge Serv Platform, Shanghai, Peoples R China.	xxhuang@shou.edu.cn			Project of the State Oceanic Administration of China [SHME2011SW02]; Shanghai Municipal Agricultural Commission [2-1, 1-2]	Project of the State Oceanic Administration of China; Shanghai Municipal Agricultural Commission(Shanghai Municipal Education Commission (SHMEC))	This research was financially supported by a Project of the State Oceanic Administration of China (SHME2011SW02) and the Projects of the Shanghai Municipal Agricultural Commission (2013 No. 2-1 and 2015 No.1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2015, PLANT BIOTECHNOL J, V13, P540, DOI 10.1111/pbi.12278; Alboresi  A., 2016, PLANT PHYSIOL; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bhandari R, 2006, PHOTOCHEM PHOTOBIOL, V82, P702, DOI 10.1562/2005-09-20-RA-690; Blaby IK, 2013, PLANT CELL, V25, P4305, DOI 10.1105/tpc.113.117580; Concas A, 2014, BIORESOURCE TECHNOL, V153, P340, DOI 10.1016/j.biortech.2013.11.085; Dong HP, 2013, PLANT PHYSIOL, V162, P1110, DOI 10.1104/pp.113.214320; Duan M., 2011, OPTIMIZATION BIODIES; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gimpel JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01376; Goold H.D., 2016, PLANT PHYSIOL, P718; Goold H, 2015, PLANT CELL REP, V34, P545, DOI 10.1007/s00299-014-1711-7; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Griffiths MJ, 2010, LIPIDS, V45, P1053, DOI 10.1007/s11745-010-3468-2; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Huang NL, 2013, PLANT PHYSIOL, V161, P1862, DOI 10.1104/pp.112.212514; Huang XX, 2014, J APPL PHYCOL, V26, P105, DOI 10.1007/s10811-013-0056-x; Huang XX, 2013, J APPL PHYCOL, V25, P129, DOI 10.1007/s10811-012-9846-9; Iwai M, 2014, PLANT BIOTECHNOL J, V12, P808, DOI 10.1111/pbi.12210; Ramos MJ, 2009, BIORESOURCE TECHNOL, V100, P261, DOI 10.1016/j.biortech.2008.06.039; Jiang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087416; Kalayasiri P, 1996, J AM OIL CHEM SOC, V73, P471, DOI 10.1007/BF02523921; Kaye Y, 2015, ALGAL RES, V11, P387, DOI 10.1016/j.algal.2015.05.003; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Knothe G, 2014, FUEL, V119, P6, DOI 10.1016/j.fuel.2013.11.020; KRISNANGKURA K, 1986, J AM OIL CHEM SOC, V63, P552, DOI 10.1007/BF02645752; Levering J, 2015, CURR OPIN BIOTECH, V36, P32, DOI 10.1016/j.copbio.2015.08.001; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Lubian LM, 2000, J APPL PHYCOL, V12, P249, DOI 10.1023/A:1008170915932; Matthijs M, 2016, PLANT PHYSIOL, V170, P489, DOI 10.1104/pp.15.01300; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Peers G, 2014, TRENDS BIOTECHNOL, V32, P551, DOI 10.1016/j.tibtech.2014.09.007; Pfeil BE, 2014, CELL MOL LIFE SCI, V71, P979, DOI 10.1007/s00018-013-1412-3; Pruvost J, 2011, BIORESOURCE TECHNOL, V102, P150, DOI 10.1016/j.biortech.2010.06.153; Recht L, 2012, APPL MICROBIOL BIOT, V94, P1495, DOI 10.1007/s00253-012-3940-4; Rosenberg JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092460; Rumin J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0220-4; Schulze PSC, 2016, ALGAL RES, V16, P387, DOI 10.1016/j.algal.2016.03.034; Shtaida N, 2014, J EXP BOT, V65, P6563, DOI 10.1093/jxb/eru374; Stansell G R, 2012, J APPL PHYCOL, V24, P1; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wei LK, 2013, BIORESOURCE TECHNOL, V147, P534, DOI 10.1016/j.biortech.2013.08.079; Westbrook CK, 2013, ANNU REV PHYS CHEM, V64, P201, DOI 10.1146/annurev-physchem-040412-110009; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Malcata FX, 2011, TRENDS BIOTECHNOL, V29, P542, DOI 10.1016/j.tibtech.2011.05.005; Xie B, 2014, PLANT BIOTECHNOL J, V12, P872, DOI 10.1111/pbi.12190; Yang ZK, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-67; Yao L, 2016, PLANT BIOTECHNOLOGY	51	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174646	10.1371/journal.pone.0174646	http://dx.doi.org/10.1371/journal.pone.0174646			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346505	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300066
J	Eros, K; Magyar, K; Deres, L; Skazel, A; Riba, A; Vamos, Z; Kalai, T; Gallyas, F; Sumegi, B; Toth, K; Halmosi, R				Eros, Krisztian; Magyar, Klara; Deres, Laszlo; Skazel, Arpad; Riba, Adam; Vamos, Zoltan; Kalai, Tamas; Gallyas, Ferenc, Jr.; Sumegi, Balazs; Toth, Kalman; Halmosi, Robert			Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats	PLOS ONE			English	Article							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE ACTIVATION; BLOOD-BRAIN-BARRIER; ENDOTHELIAL DYSFUNCTION; ALZHEIMERS-DISEASE; ANGIOTENSIN-II; PROTEIN-KINASE; HEART-FAILURE; CELL-DEATH; NEURODEGENERATIVE DISORDERS	Vascular remodeling during chronic hypertension may impair the supply of tissues with oxygen, glucose and other compounds, potentially unleashing deleterious effects. In this study, we used Spontaneously Hypertensive Rats and normotensive Wistar-Kyoto rats with or without pharmacological inhibition of poly(ADP-ribose) polymerase-1 by an experimental compound L-2286, to evaluate carotid artery remodeling and consequent damage of neuronal tissue during hypertension. We observed elevated oxidative stress and profound thickening of the vascular wall with fibrotic tissue accumulation induced by elevated blood pressure. 32 weeks of L-2286 treatment attenuated these processes by modulating mitogen activated protein kinase phosphatase-1 cellular levels in carotid arteries. In hypertensive animals, vascular inflammation and endothelial dysfunction was observed by NF-kappa B nuclear accumulation and impaired vasodilation to acetylcholine, respectively. Pharmacological poly(ADP-ribose) polymerase-1 inhibition interfered in these processes and mitigated Apoptosis Inducing Factor dependent cell death events, thus improved structural and functional alterations of carotid arteries, without affecting blood pressure. Chronic poly(ADP-ribose) polymerase-1 inhibition protected neuronal tissue against oxidative damage, assessed by nitrotyrosine, 4-hydroxinonenal and 8-oxoguanosine immunohistochemistry in the area of Cornu ammonis 1 of the dorsal hippocampus in hypertensive rats. In this area, extensive pyramidal cell loss was also attenuated by treatment with lowered poly(ADP-ribose) polymer formation. It also preserved the structure of fissural arteries and attenuated perivascular white matter lesions and reactive astrogliosis in hypertensive rats. These data support the premise in which chronic poly(ADP-ribose) polymerase-1 inhibition has beneficial effects on hypertension related tissue damage both in vascular tissue and in the hippocampus by	[Eros, Krisztian; Magyar, Klara; Deres, Laszlo; Skazel, Arpad; Riba, Adam; Toth, Kalman; Halmosi, Robert] Univ Pecs, Ctr Clin, Dept Med 1, Pecs, Baranya, Hungary; [Eros, Krisztian; Deres, Laszlo; Riba, Adam; Vamos, Zoltan; Gallyas, Ferenc, Jr.; Sumegi, Balazs; Toth, Kalman; Halmosi, Robert] Univ Pecs, Szentagothai Res Ctr, Pecs, Baranya, Hungary; [Eros, Krisztian; Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Baranya, Hungary; [Vamos, Zoltan] Univ Pecs, Sch Med, Dept Pathophysiol & Gerontol, Pecs, Baranya, Hungary; [Kalai, Tamas] Univ Pecs, Sch Med, Dept Organ & Pharmacol Chem, Pecs, Baranya, Hungary; [Sumegi, Balazs; Toth, Kalman] Univ Pecs, MTA PTE Nucl & Mitochondrial Interact Res Grp, Pecs, Baranya, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Halmosi, R (corresponding author), Univ Pecs, Ctr Clin, Dept Med 1, Pecs, Baranya, Hungary.; Halmosi, R (corresponding author), Univ Pecs, Szentagothai Res Ctr, Pecs, Baranya, Hungary.	halmosi.robert@pte.hu	Gallyas, Ferenc/AAY-5343-2020; Halmosi, Róbert/AAK-1880-2020; Gallyas, Ferenc/C-2272-2012	Halmosi, Robert/0000-0002-6965-7743	Hungarian Science Research Fund [OTKA K-104220, OTKA NN- 109841, PTE-AOK-KA-2015-05, GINOP-2.3.2-15-2016-00048, GINOP-2.3.2-15-2016-00049, GINOP-2.3.3-15-2016-00025]	Hungarian Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Science Research Fund (OTKA K-104220, OTKA NN- 109841), PTE-AOK-KA-2015-05 and GINOP-2.3.2-15-2016-00048, GINOP-2.3.2-15-2016-00049, GINOP-2.3.3-15-2016-00025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Amenta Francesco, 2010, Italian Journal of Anatomy and Embryology, V115, P13; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; Bartha E, 2008, J CARDIOVASC PHARM, V52, P253, DOI 10.1097/FJC.0b013e3181855cef; Bartha E, 2011, J CARDIOVASC PHARM, V58, P380, DOI 10.1097/FJC.0b013e318225c21e; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Daulatzai MA, 2013, NEUROTOX RES, V24, P407, DOI 10.1007/s12640-013-9407-2; Deres L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102148; Douglas DL, 2014, J CELL SCI, V127, P4134, DOI 10.1242/jcs.128009; Duron E, 2008, ARCH CARDIOVASC DIS, V101, P181, DOI 10.1016/S1875-2136(08)71801-1; Fortuno A, 2004, J HYPERTENS, V22, P2169, DOI 10.1097/00004872-200411000-00020; Francis J, 2014, ANTIOXID REDOX SIGN, V20, P69, DOI 10.1089/ars.2013.5591; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gonzalez J, 2014, WORLD J CARDIOL, V6, P353, DOI 10.4330/wjc.v6.i6.353; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Harraz MM, 2008, STROKE, V39, P286, DOI 10.1161/STROKEAHA.107.511857; Harrison DG, 2007, J AM SOC HYPERTENS, V1, P30, DOI 10.1016/j.jash.2006.11.006; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang A, 1997, HYPERTENSION, V30, P1210, DOI 10.1161/01.HYP.30.5.1210; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Kaiser D, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0169-8; Kazama K, 2014, BIOCHEM BIOPH RES CO, V452, P142, DOI 10.1016/j.bbrc.2014.08.070; Kim JY, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00352; Kiss T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104890; Kubota Y, 2006, BIOL PHARM BULL, V29, P1756, DOI 10.1248/bpb.29.1756; Kulcsar G, 2003, ARKIVOC, P121, DOI 10.3998/ark.5550190.0004.512; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Li YL, 2016, MOL MED REP, V13, P2552, DOI 10.3892/mmr.2016.4853; Li Y, 2015, INT J CLIN EXP PATHO, V8, P14099; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Magyar K, 2014, BBA-MOL BASIS DIS, V1842, P935, DOI 10.1016/j.bbadis.2014.03.008; Majzunova M, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-69; Nabha L, 2005, CLIN EXP HYPERTENS, V27, P71, DOI 10.1081/CEH-200044267; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Pacher P, 2002, BRIT J PHARMACOL, V135, P1347, DOI 10.1038/sj.bjp.0704627; Pacher P, 2002, INT J MOL MED, V9, P659; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Palfi A, 2006, J MOL CELL CARDIOL, V41, P149, DOI 10.1016/j.yjmcc.2006.03.427; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406; Perluigi M, 2009, PROTEOM CLIN APPL, V3, P682, DOI 10.1002/prca.200800161; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Radovits T, 2007, EXP GERONTOL, V42, P676, DOI 10.1016/j.exger.2007.01.013; Renna Nicolas F, 2013, Int J Hypertens, V2013, P808353, DOI 10.1155/2013/808353; RITTER S, 1988, BRAIN RES, V450, P354, DOI 10.1016/0006-8993(88)91574-0; Ritz MF, 2012, CURR NEUROVASC RES, V9, P10, DOI 10.2174/156720212799297074; Rom S, 2015, J CEREBR BLOOD F MET, V35, P28, DOI 10.1038/jcbfm.2014.167; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sabbatini M, 2002, MECH AGEING DEV, V123, P547, DOI 10.1016/S0047-6374(01)00362-1; Schriewer JM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000159; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Shen XZ, 2015, HYPERTENSION, V66, P309, DOI 10.1161/HYPERTENSIONAHA.115.05333; Sriramula S, 2015, HYPERTENSION, V65, P577, DOI 10.1161/HYPERTENSIONAHA.114.04691; Szabo C, 2004, MOL MED, V10, P28, DOI 10.2119/2004-00001.Szabo; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Touyz RM, 2001, HYPERTENSION, V37, P574, DOI 10.1161/01.HYP.37.2.574; Turlejski T, 2016, BRAIN RES, V1650, P178, DOI 10.1016/j.brainres.2016.09.012; ul Islam B, 2015, INDIAN J CLIN BIOCHE, V30, P368, DOI 10.1007/s12291-014-0475-8; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; von Lukowicz T, 2008, CARDIOVASC RES, V78, P158, DOI 10.1093/cvr/cvm110; Walsh SK, 2012, BRIT J PHARMACOL, V166, P2109, DOI 10.1111/j.1476-5381.2012.01906.x; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Xu JY, 2014, BBA-MOL BASIS DIS, V1842, P2106, DOI 10.1016/j.bbadis.2014.07.008; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zheng L, 2016, MOL NEUROBIOLOGY	84	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174401	10.1371/journal.pone.0174401	http://dx.doi.org/10.1371/journal.pone.0174401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339485	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700029
J	Liu, H; Hou, Y; Zhu, QL; Xu, D; Wang, L; Li, JC; Jiang, YX; Wang, Q; Li, MT; Zhang, FC; Zeng, XF				Liu, He; Hou, Yong; Zhu, Qing-li; Xu, Dong; Wang, Liang; Li, Jian-chu; Jiang, Yu-xin; Wang, Qian; Li, Meng-tao; Zhang, Feng-chun; Zeng, Xiao-feng			A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: Does skin echogenicity matter?	PLOS ONE			English	Article							HIGH-FREQUENCY ULTRASOUND; OUTCOME MEASURE; SCLERODERMA; THICKNESS; INVOLVEMENT; DISEASE	Objective To evaluate the usefulness of skin ultrasound and acoustic radiation force impulse (ARFI) quantification in diffuse cutaneous systemic sclerosis (dcSSc). Patients and methods 28 patients with dcSSc, and 15 age gender matched normal controls were recruited. Skin echogenicity, thickness, and ARFI quantification were measured by ultrasound at 17 sites corresponding to the modified Rodnan skin score (mRSS) in each participant. Compared with controls, skin echogenicity of dcSSc patients was classified into isoechoic, hypoechoic, and hyperechoic. The skin thickness, ARFI quantification and mRSS were compared between isoechoic, hypoechoic, hyperechoic and controls. Results In patients with dcSSc, the skin thickness increased as the echogenicity changed on the order of isoechoic, hypoechoic and hyperechoic. ARFI quantification was significantly higher in hyperechoic than isoechoic (p<0.001). The mRSS were significantly higher in hyperechoic and/or hypoechoic than isoechoic. For isoechoic patients and healthy controls, the skin echogenicity or thickness was no significant different, however, the ARFI quantification was significantly higher in isoechoic than controls. Conclusion Skin ultrasound is feasible for assessing the skin involvement in dcSSc. Skin echogenicity correlates with skin thickness, stiffness, and mRSS. ARFI quantification may be more sensitive to detect skin changes, compared with skin echogenicity and thickness.	[Liu, He; Zhu, Qing-li; Wang, Liang; Li, Jian-chu; Jiang, Yu-xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ultrasound, Beijing, Peoples R China; [Liu, He; Hou, Yong; Zhu, Qing-li; Xu, Dong; Wang, Liang; Li, Jian-chu; Jiang, Yu-xin; Wang, Qian; Li, Meng-tao; Zhang, Feng-chun; Zeng, Xiao-feng] Peking Union Med Coll, Beijing, Peoples R China; [Hou, Yong; Xu, Dong; Wang, Qian; Li, Meng-tao; Zhang, Feng-chun; Zeng, Xiao-feng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Jiang, YX (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ultrasound, Beijing, Peoples R China.; Jiang, YX; Zeng, XF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Zeng, XF (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.	jiangyuxinxhbj@126.com; xiaofeng.zeng@cstar.org.cn	meng, li/GVT-2063-2022	Jiang, Yuxin/0000-0002-8388-7262	National Natural Science of China [81671614]	National Natural Science of China(National Natural Science Foundation of China (NSFC))	YH received the funding, the National Natural Science of China (81671614), the website: www.nsfc.gov.cn/. YH contributed in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abignano G, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0404-5; AKESSON A, 1986, ACTA RADIOL, V27, P91, DOI 10.1177/028418518602700117; Akesson A, 2004, ANN RHEUM DIS, V63, P791, DOI 10.1136/ard.2003.012146; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; CLAMAN HN, 1991, ARTHRITIS RHEUM, V34, P1495; Clements PJ, 2000, ARTHRITIS RHEUM-US, V43, P2445, DOI 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q; DERIGAL J, 1989, J INVEST DERMATOL, V93, P621, DOI 10.1111/1523-1747.ep12319741; Hesselstrand R, 2008, RHEUMATOLOGY, V47, P84, DOI 10.1093/rheumatology/kem307; Hou Y, 2015, J RHEUMATOL, V42, P449, DOI 10.3899/jrheum.140873; Kaloudi O, 2010, ANN RHEUM DIS, V69, P1140, DOI 10.1136/ard.2009.114843; Kissin EY, 2006, ARTHRIT RHEUM-ARTHR, V55, P603, DOI 10.1002/art.22093; lagnocco A, 2010, J RHEUMATOL, V37, P1688, DOI DOI 10.3899/(RHEUM.090974; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lupsor M, 2009, J GASTROINTEST LIVER, V18, P303; Merkel PA, 2003, J RHEUMATOL, V30, P1630; Moore TL, 2003, RHEUMATOLOGY, V42, P1559, DOI 10.1093/rheumatology/keg435; Nezafati KA, 2011, ARCH DERMATOL, V147, P1112, DOI 10.1001/archdermatol.2011.243; Santiago T, 2016, CLIN EXP RHEUMATOL, V34, pS137; Sedky MM, 2013, SKIN RES TECHNOL, V19, pE78, DOI 10.1111/j.1600-0846.2012.00612.x; Seidenari S, 1996, ACTA DERM-VENEREOL, V76, P361; Steen VD, 2001, ARTHRITIS RHEUM, V44, P2828, DOI 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]	22	19	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174481	10.1371/journal.pone.0174481	http://dx.doi.org/10.1371/journal.pone.0174481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339492	gold, Green Published, Green Submitted			2022-12-27	WOS:000399116700031
J	Qin, YL; Djabou, ASM; An, FF; Li, KM; Li, ZG; Yang, L; Wang, XJ; Chen, SB				Qin, Yuling; Djabou, Astride Stephanie Mouafi; An, Feifei; Li, Kaimian; Li, Zhaogui; Yang, Long; Wang, Xiaojing; Chen, Songbi			Proteomic analysis of injured storage roots in cassava (Manihot esculenta Crantz) under postharvest physiological deterioration	PLOS ONE			English	Article							OXIDATIVE STRESS RESPONSES; ASCORBATE PEROXIDASE; SUPEROXIDE-DISMUTASE; QUANTITATIVE PROTEOMICS; GUAIACOL PEROXIDASE; DEFENSE RESPONSES; SHELF-LIFE; TOLERANCE; PROTEINS; CATALASE	Postharvest physiological deterioration (PPD) is a global challenge in the improvement of cassava value chain. However, how to reduce cassava spoilage and reveal the mechanism of injured cassava storage roots in response to PPD were poorly understood. In the present study, we investigated the activities of antioxidant enzymes of cassava injured storage roots in PPD-susceptible (SC9) and PPD-tolerant (QZ1) genotypes at the time-points from 0h to 120h, and further analyzed their proteomic changes using two-dimensional electrophoresis (2-DE) in combination with MALDI-TOF-MS/MS. Ninety-nine differentially expressed proteins were identified from SC9 and QZ1 genotypes in the pairwise comparison of 24h/0h, 48h/0h, 72h/0h and 96h/0h. Of those proteins were associated with 13 biological functions, in which carbohydrate and energy metabolism related proteins were the biggest amount differential proteins in both genotypes, followed by chaperones, DNA and RNA metabolism, and defense system. We speculated that SOD in combination with CAT activities would be the first line of defense against PPD to support PPD-tolerant cassava varieties. The four hub proteins including CPN60B, LOS2, HSC70-1 and CPN20B, produced from the network of protein-protein interaction, will be the candidate key proteins linked with PPD. This study provides a new clue to improve cassava PPD-tolerant varieties and would be helpful to much better understand the molecular mechanism of PPD of cassava injured storage roots.	[Qin, Yuling; Wang, Xiaojing] South China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Qin, Yuling; An, Feifei; Li, Kaimian; Chen, Songbi] Chinese Acad Trop Agr Sci, Key Lab, Trop Crops Genet Resources Inst, Minist Agr Germplasm Resources Conservat & Utiliz, Danzhou, Peoples R China; [Djabou, Astride Stephanie Mouafi] Univ Yaounde I, Higher Teachers Training Coll, Dept Biol Sci, Lab Plant Physiol, Yaounde, Cameroon; [Li, Zhaogui] Agr Bur Wuming Cty, Wuming, Peoples R China; [Yang, Long] Guizhou Prov Acad Agr Sci, Subtrop Crops Res Inst, Xingyi, Peoples R China	South China Normal University; Chinese Academy of Tropical Agricultural Sciences; University of Yaounde I; Guizhou Academy of Agricultural Sciences	Chen, SB (corresponding author), Chinese Acad Trop Agr Sci, Key Lab, Trop Crops Genet Resources Inst, Minist Agr Germplasm Resources Conservat & Utiliz, Danzhou, Peoples R China.	songbichen@catas.cn		Chen, Songbi/0000-0002-8809-4456	NSFC-CGIAR International (Regional) Cooperation and Exchange Programs [31361140366]; National Science and Technology Infrastructure Program [2015BAD15601]; National Natural Science Foundation of China [31271776]; National Nonprofit Institute Research Grant of CATASTCGRI [1630032014051]; Initial Fund of High-level Creative Talents in Hainan Province	NSFC-CGIAR International (Regional) Cooperation and Exchange Programs; National Science and Technology Infrastructure Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nonprofit Institute Research Grant of CATASTCGRI; Initial Fund of High-level Creative Talents in Hainan Province	This work was supported by NSFC-CGIAR International (Regional) Cooperation and Exchange Programs (31361140366), National Science and Technology Infrastructure Program (2015BAD15601), National Natural Science Foundation of China (31271776), National Nonprofit Institute Research Grant of CATASTCGRI (1630032014051), and the Initial Fund of High-level Creative Talents in Hainan Province (2012-Chen Songbi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2014, J PLANT INTERACT, V9, P1, DOI 10.1080/17429145.2012.747629; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; An FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152154; An FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085991; Ansari MW, 2015, PROTOPLASMA, V252, P21, DOI 10.1007/s00709-014-0678-0; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; Bayoumi SAL, 2010, PHYTOCHEMISTRY, V71, P598, DOI 10.1016/j.phytochem.2009.10.012; Beeching JR, 1998, RECENT ADV PHYTOCHEM, V32, P231; Beneloujaephajri E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-160; Blagbrough IS, 2010, PHYTOCHEMISTRY, V71, P1940, DOI 10.1016/j.phytochem.2010.09.001; Boone CHT, 2016, PROTEOMICS, V16, P1889, DOI 10.1002/pmic.201500546; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Buschmann H, 2000, J AGR FOOD CHEM, V48, P5522, DOI 10.1021/jf000513p; Carvalho LMJ, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.15788; Carvalho Luiz Joaquim Castelo Branco, 2012, Open Biochem J, V6, P116, DOI 10.2174/1874091X01206010116; Chavez A. L., 2000, Food and Nutrition Bulletin, V21, P410; Chen SB, 2009, J EXP BOT, V60, P2005, DOI 10.1093/jxb/erp075; Gnonlonfin GJB, 2012, CRIT REV PLANT SCI, V31, P47, DOI 10.1080/07352689.2011.616039; Gu B, 2013, STARCH-STARKE, V65, P253, DOI 10.1002/star.201200028; Han YH, 2001, EUPHYTICA, V120, P59, DOI 10.1023/A:1017547419332; Hu W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00736; Huang J, 2001, EUPHYTICA, V120, P85, DOI 10.1023/A:1017555605219; Isamah GK, 2003, INT BIODETER BIODEGR, V52, P129, DOI 10.1016/S0964-8305(02)00168-3; Iyer S., 2010, Tropical Plant Biology, V3, P151, DOI 10.1007/s12042-010-9052-3; Jian C, 2013, THESIS; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liang Wenyu, 2014, Plant Omics, V7, P205; Liu J, 2011, J INTEGR PLANT BIOL, V53, P552, DOI 10.1111/j.1744-7909.2011.01048.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QX, 2016, J PINEAL RES, V60, P424, DOI 10.1111/jpi.12325; Manaa A, 2011, J EXP BOT, V62, P2797, DOI 10.1093/jxb/erq460; Morante N, 2010, CROP SCI, V50, P1333, DOI 10.2135/cropsci2009.11.0666; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rasool S, 2013, ACTA PHYSIOL PLANT, V35, P1039, DOI 10.1007/s11738-012-1142-4; Reilly K, 2004, PLANT MOL BIOL, V56, P625, DOI 10.1007/s11103-005-2271-6; Reilly K, 2003, PLANT MOL BIOL, V53, P669, DOI 10.1023/B:PLAN.0000019076.76614.88; Reilly K, 2001, BBA-GENE STRUCT EXPR, V1518, P317, DOI 10.1016/S0167-4781(01)00195-6; Reilly K, 2007, PLANT MOL BIOL, V64, P187, DOI 10.1007/s11103-007-9144-0; Rudi N, 2010, AFR J AGRIC RESOUR E, V4, P110; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Sanchez T, 2006, J SCI FOOD AGR, V86, P634, DOI 10.1002/jsfa.2371; Sanchez T, 2013, POSTHARVEST BIOL TEC, V86, P520, DOI 10.1016/j.postharvbio.2013.07.014; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Szklarczyk D, 2015, METHODS MOL BIOL, V1278, P39, DOI 10.1007/978-1-4939-2425-7_3; Timabud T, 2016, J PROTEOMICS, V133, P1, DOI 10.1016/j.jprot.2015.12.003; Uarrota Virgilio Gavicho, 2015, BMC Res Notes, V8, P648, DOI 10.1186/s13104-015-1580-3; Uarrota VG, 2014, FOOD CHEM, V161, P67, DOI 10.1016/j.foodchem.2014.03.110; Uarrota VG, 2016, FOOD CHEM, V197, P737, DOI 10.1016/j.foodchem.2015.11.025; van Doorn WG, 2014, POSTHARVEST BIOL TEC, V95, P64, DOI 10.1016/j.postharvbio.2014.04.002; van Oirschot QEA, 2000, J SCI FOOD AGR, V80, P1866, DOI 10.1002/1097-0010(200010)80:13&lt;1866::AID-JSFA718&gt;3.0.CO;2-H; Vanderschuren H, 2014, PLANT CELL, V26, P1913, DOI 10.1105/tpc.114.123927; Wang W, 2004, TRENDS PLANT SCI, V9, P1360; Wang WQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6110; Xu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0208-4; Xu J, 2013, PLANT PHYSIOL, V161, P1517, DOI 10.1104/pp.112.212803; Yang L, 2015, CHIN J TROP AGR, V35, P67; Yin XJ, 2016, J PROTEOME RES, V15, P2008, DOI 10.1021/acs.jproteome.6b00196; Zare S., 2012, International Journal of Agriculture and Crop Sciences (IJACS), V4, P398; Zidenga T, 2012, PLANT PHYSIOL, V159, P1396, DOI 10.1104/pp.112.200345	66	12	17	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174238	10.1371/journal.pone.0174238	http://dx.doi.org/10.1371/journal.pone.0174238			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339481	gold, Green Published, Green Submitted			2022-12-27	WOS:000399116700025
J	Abdissa, D; Geleta, G; Bacha, K; Abdissa, N				Abdissa, Dele; Geleta, Girma; Bacha, Ketema; Abdissa, Negera			Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities	PLOS ONE			English	Article							ANTHRAQUINONES	Medicinal plants with documented traditional uses remain an important source for the treatment of a wide range of ailments. Evidence shows that majority of the Ethiopian population are still dependent on traditional medicine. Aloe pulcherrima Gilbert & Sebsebe is one of the endemic Aloe species traditionally used for the treatment of malaria and wound healing in central, Southern and Northern part of Ethiopia. The aim of the current study was, therefore, to isolate active compounds from roots of A. pulcherrima and evaluate for their antibacterial and antiplasmodial activities using standard test strains. Bioassay-guided sequential extraction and column chrom-atographic separation were employed for the isolation of bioactive pure compounds. The structures of the compounds were determined by 1D and 2D NMR spectro-scopic techniques. Disk diffusion method was employed to evaluate the antibacterial activities of the isolated compounds against four bacterial strains specifically (Staphylococcus aureus ATCC 25923, Bacillus subtilis ATCC 6633, Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853). The malaria SYBR Green I-based in vitro assay technique was used for in vitro antiplasmodial activity evaluation of the compounds against chloroquine resistant (D6) and -sensitive (W2) strains of P. falciparum. Three compounds, chrysophanol, aloesaponarin I and aloesaponarin II were isolated from the acetone extracts of roots of A. pulcherrima. Evaluation of antibacterial activities revealed that aloesaponarin I and aloesaponarin II had significant activities against all the bacterial strains with inhibition zone diameters ranging from 18-27 mm as compared to the reference drug (gentamicin), which displayed inhibition zone diameter ranging between 20 mm (B. subtilis) and 25 mm (P. aeruginosa). The isolated compounds showed moderate in vitro antiplasmodial activity against both chloroquine resistant (W2) -sensitive (D6) strains. Isolation of chrysophanol, aloesaponarin I and aloesaponarin II from roots of A. pulcherrima is the first report of its kind. The finding could be used for further comprehensive evaluation of the isolated compounds for their antibacterial and antimalarial activities besides consideration of the same for potent drug development.	[Abdissa, Dele; Abdissa, Negera] Jimma Univ, Coll Nat Sci, Dept Chem, Jimma, Ethiopia; [Geleta, Girma; Bacha, Ketema] Jimma Univ, Coll Nat Sci, Dept Biol, Jimma, Ethiopia	Jimma University; Jimma University	Bacha, K (corresponding author), Jimma Univ, Coll Nat Sci, Dept Biol, Jimma, Ethiopia.	ketemabacha2002@yahoo.com	Abdissa, Negera/L-3144-2019	Abdissa, Negera/0000-0002-9899-0262; /0000-0002-6286-5689				Bacha K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0765-9; Begashaw T, 2016, AFR J MICROBIOL RES, V10, p1961 ; Cheloti M.W., 2010, THESIS U NAIROBI NAI; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Cui HX, 2006, WORLD J MICROB BIOT, V22, P1377, DOI 10.1007/s11274-006-9197-2; Dagne E, 2000, CURR ORG CHEM, V4, P1055, DOI 10.2174/1385272003375932; Demissew S, 2010, ALOES LILIES ETHIOPI, P113; Deressa T, 2010, ETHIOP J HEALTH DEV, V24, P25; Dewick P. M., 2002, MED NATURAL PRODUCTS, P35; Harvey A., 2001, GIT LAB J, V5, P284; Ivana BS, 2006, J INFECT DIS, V10, p400 ; Jayaweera DMA, 1982, MED PLANTS INDIGEN 4, p52 ; Juma WP, 2011, PHYTOCHEM LETT, V4, P176, DOI 10.1016/j.phytol.2011.02.010; Karunamoorthi K, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-22; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Mulat M., 2015, J PHARM SCI REV RES, V32, P45; Mwitari PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065619; Nejatzadeh-Barandozi Fatemeh, 2013, Org Med Chem Lett, V3, P5, DOI 10.1186/2191-2858-3-5; Satyajit DS, 2012, NATURAL PRODUCTS ISO, V864, P619; Schripsema J, 1996, PHYTOCHEMISTRY, V42, P177, DOI 10.1016/0031-9422(95)00885-3; Sebsebe D., 1997, FLORA ETHIOPIA ERITR, V6, P117; SMITH GF, 1995, TAXON, V44, P513, DOI 10.2307/1223496; TAKEDA N, 1973, TETRAHEDRON, V29, P3703, DOI 10.1016/S0040-4020(01)93536-7; Teka T., 2014, INT J PHYTOPHARM, V5, P261, DOI [DOI 10.3390/MOLECULES21111415, 10.3390/molecules21111415]; VANWYK BE, 1995, BIOCHEM SYST ECOL, V23, P267, DOI 10.1016/0305-1978(94)00094-W; Wink Michael, 2015, Medicines (Basel), V2, P251, DOI 10.3390/medicines2030251; YAGI A, 1974, CHEM PHARM BULL, V22, P1159; Yineger H, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-11	28	29	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173882	10.1371/journal.pone.0173882	http://dx.doi.org/10.1371/journal.pone.0173882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333961	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200026
J	Hossain, MF; Park, JY				Hossain, Md Faruk; Park, Jae Y.			Fabrication of sensitive enzymatic biosensor based on multi-layered reduced graphene oxide added PtAu nanoparticles-modified hybrid electrode	PLOS ONE			English	Article							GLUCOSE-OXIDASE; CARBON NANOTUBES; DIRECT ELECTROCHEMISTRY; PALLADIUM NANOPARTICLES; BIOFUEL CELL; SENSOR; FILMS; IMMOBILIZATION; GROWTH; LAYER	A highly sensitive amperometric glucose sensor was developed by immobilization of glucose oxidase (GOx) onto multi-layer reduced graphene oxide (MRGO) sheets decorated with platinum and gold flower-like nanoparticles (PtAuNPs) modified Au substrate electrode. The fabricated MRGO/PtAuNPs modified hybrid electrode demonstrated high electrocatalytic activities toward oxidation of H2O2, to which it had a wide linear response that ranged from 0.5 to 8 mM (R-2 = 0.997), and high sensitivity of 506.25 mu A/mMcm(2). Furthermore, glucose oxidase-chitosan composite and cationic polydiallyldimethylammonium chloride (PDDA) were assembled by a casting method on the surface of MRGO/PtAuNPs modified electrode. This as-fabricated hybrid biosensor electrode exhibited high electrocatalytic activity for the detection of glucose in PBS. It demonstrated good analytical properties in terms of a low detection limit of 1 mu M (signal-to-noise ratio of 3), short response time (3 s), high sensitivity (17.85 mu A/mMcm(2)), and a wide linear range (0.01 - 8 mM) for glucose sensing. These results reveal that the newly developed sensing electrode offers great promise for new type enzymatic biosensor applications.	[Hossain, Md Faruk; Park, Jae Y.] Kwangwoon Univ, Dept Elect Engn, Seoul, South Korea	Kwangwoon University	Hossain, MF; Park, JY (corresponding author), Kwangwoon Univ, Dept Elect Engn, Seoul, South Korea.	faruk.kwu@hotmail.com; jaepark@kw.ac.kr	Hossain, Faruk/AAX-1314-2020	Hossain, Md. Faruk/0000-0003-3214-3068	ICT RAMP;D program of MSIP/IITP, Implantable Biosensor and Automatic Physiological Function Monitor System for Chronic Disease Management [R0101-16-0147]; Technological Innovation RAMP;D Program - Small and Medium Business Administration (SMBA), Korea; Research Grant of Kwang woon University	ICT RAMP;D program of MSIP/IITP, Implantable Biosensor and Automatic Physiological Function Monitor System for Chronic Disease Management; Technological Innovation RAMP;D Program - Small and Medium Business Administration (SMBA), Korea; Research Grant of Kwang woon University	MFH and JYP received support from ICT R&D program of MSIP/IITP, Implantable Biosensor and Automatic Physiological Function Monitor System for Chronic Disease Management, under award number 2016 (R0101-16-0147). This research was also supported by the Technological Innovation R&D Program funded by the Small and Medium Business Administration (SMBA), Korea, and by a Research Grant of Kwang woon University in 2015. The Min DaP group provided technical support. The funders had norole in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammam M, 2011, SENSOR ACTUAT B-CHEM, V155, P340, DOI 10.1016/j.snb.2011.04.016; Badhulika S, 2014, ELECTROANAL, V26, P103, DOI 10.1002/elan.201300286; Calizo I, 2007, NANO LETT, V7, P2645, DOI 10.1021/nl071033g; Cash KJ, 2010, TRENDS MOL MED, V16, P584, DOI 10.1016/j.molmed.2010.08.002; Chen LY, 2011, ELECTROCHEM COMMUN, V13, P133, DOI 10.1016/j.elecom.2010.11.033; Chen X, 2003, ELECTROANAL, V15, P608, DOI 10.1002/elan.200390076; Chen XM, 2010, BIOSENS BIOELECTRON, V25, P1803, DOI 10.1016/j.bios.2009.12.035; Cheng N., 2012, AM J ANAL CHEM, V3, P312, DOI DOI 10.4236/AJAC.2012.34043; Compton OC, 2011, ACS NANO, V5, P4380, DOI 10.1021/nn1030725; Dai H, 2009, ELECTROCHIM ACTA, V54, P4582, DOI 10.1016/j.electacta.2009.03.042; Feng CX, 2014, J ELECTROCHEM SOC, V161, pB1, DOI 10.1149/2.025401jes; Fu CJ, 2013, INT J ELECTROCHEM SC, V8, P6269; Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033; Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017; Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; Guo HL, 2009, ACS NANO, V3, P2653, DOI 10.1021/nn900227d; Habrioux A, 2009, ELECTROCHEM COMMUN, V11, P111, DOI 10.1016/j.elecom.2008.10.047; Hossain MF, 2013, RSC ADV, V3, P16109, DOI 10.1039/c3ra41235k; Javid A, 2017, PHYS CHEM CHEM PHYS, V19, P237, DOI 10.1039/c6cp06955j; Jeong HK, 2009, CHEM PHYS LETT, V470, P255, DOI 10.1016/j.cplett.2009.01.050; Jo H, 2013, J ELECTROCHEM SCI TE, V4, P41, DOI 10.5229/JECST.2013.4.1.41; Kang XH, 2007, ANAL BIOCHEM, V369, P71, DOI 10.1016/j.ab.2007.07.005; Karlicky F, 2013, ACS NANO, V7, P6434, DOI 10.1021/nn4024027; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Kumar M, 2016, ARCH BIOCHEM BIOPHYS, V605, P41, DOI 10.1016/j.abb.2016.03.026; Liu SQ, 2003, BIOSENS BIOELECTRON, V19, P177, DOI 10.1016/S0956-5663(03)00172-6; Manesh KM, 2008, BIOSENS BIOELECTRON, V23, P771, DOI 10.1016/j.bios.2007.08.016; Markovic NM, 2002, SURF SCI REP, V45, P121, DOI 10.1016/S0167-5729(01)00022-X; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pajor-Swierzy A, 2014, COLLOID INTERFAC SCI, V1, P6, DOI 10.1016/j.colcom.2014.05.001; Pandolfo AG, 2006, J POWER SOURCES, V157, P11, DOI 10.1016/j.jpowsour.2006.02.065; Parlak O, 2014, ADV MATER, V26, P482, DOI 10.1002/adma.201303075; Parlak O, 2013, BIOSENS BIOELECTRON, V49, P53, DOI 10.1016/j.bios.2013.04.004; Ryu J, 2010, BIOSENS BIOELECTRON, V25, P1603, DOI 10.1016/j.bios.2009.11.019; Shao Y, 2010, ELECTROANAL, V21, P139; Shi HB, 2005, SENSOR ACTUAT B-CHEM, V109, P341, DOI 10.1016/j.snb.2004.12.068; Sprinkle M, 2010, NAT NANOTECHNOL, V5, P727, DOI 10.1038/nnano.2010.192; Sugawara K, 2006, ELECTROANAL, V18, P1001, DOI 10.1002/elan.200603491; Tian K, 2015, MAT SCI ENG C-MATER, V46, P548, DOI 10.1016/j.msec.2014.10.064; Tian K, 2014, MAT SCI ENG C-MATER, V41, P100, DOI 10.1016/j.msec.2014.04.013; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wang K, 2011, BIOSENS BIOELECTRON, V26, P2252, DOI 10.1016/j.bios.2010.09.043; Wang YJ, 2011, NANOSCALE RES LETT, V6, DOI [10.1186/1556-276X-6-297, 10.1186/1556-276X-6-241]; Wang YQ, 2013, J SOLID STATE ELECTR, V17, P881, DOI 10.1007/s10008-012-1939-5; Xu WL, 2015, J ELECTROANAL CHEM, V741, P8, DOI 10.1016/j.jelechem.2015.01.004; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; Yan XB, 2007, ELECTROCHEM COMMUN, V9, P1269, DOI 10.1016/j.elecom.2006.12.022; Yang MH, 2011, ELECTROANAL, V23, P850, DOI 10.1002/elan.201000645; Yang X, 2012, J MATER CHEM, V22, P8057, DOI 10.1039/c2jm16916a; Yao YL, 2008, ELECTROANAL, V20, P1542, DOI 10.1002/elan.200804209; You CP, 2009, MICROCHIM ACTA, V167, P109, DOI 10.1007/s00604-009-0228-1	51	43	43	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173553	10.1371/journal.pone.0173553	http://dx.doi.org/10.1371/journal.pone.0173553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333943	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200017
J	Kochat, V; Equbal, Z; Baligar, P; Kumar, V; Srivastava, M; Mukhopadhyay, A				Kochat, Veena; Equbal, Zaffar; Baligar, Prakash; Kumar, Vikash; Srivastava, Madhulika; Mukhopadhyay, Asok			JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors	PLOS ONE			English	Article							EMBRYONIC-STEM-CELLS; GENE-EXPRESSION; FUNCTIONAL HEPATOCYTES; IN-VIVO; DIFFERENTIATION; FUSION; MOUSE; LIVER; FIBROBLASTS; LINEAGE	The strictly regulated unidirectional differentiation program in some somatic stem/progenitor cells has been found to be modified in the ectopic site (tissue) undergoing regeneration. In these cases, the lineage barrier is crossed by either heterotypic cell fusion or direct differentiation. Though studies have shown the role of coordinated genetic and epigenetic mechanisms in cellular development and differentiation, how the lineage fate of adult bone marrow progenitor cells (BMPCs) is reprogrammed during liver regeneration and whether this lineage switch is stably maintained are not clearly understood. In the present study, we wanted to decipher genetic and epigenetic mechanisms that involve in lineage reprogramming of BMPCs into hepatocyte-like cells. Here we report dynamic transcriptional change during cellular reprogramming of BMPCs to hepatocytes and dissect the epigenetic switch mechanism of BM cell-mediated liver regeneration after acute injury. Genome-wide gene expression analysis in BM-derived hepatocytes, isolated after 1 month and 5 months of transplantation, showed induction of hepatic transcriptional program and diminishing of donor signatures over the time. The transcriptional reprogramming of BM-derived cells was found to be the result of enrichment of activating marks (H3K4me3 and H3K9Ac) and loss of repressive marks (H3K27me3 and H3K9me3) at the promoters of hepatic transcription factors (HTFs). Further analyses showed that BMPCs possess bivalent histone marks (H3K4me3 and H3K27me3) at the promoters of crucial HTFs. H3K27 methylation dynamics at the HTFs was antagonistically regulated by EZH2 and JMJD3. Preliminary evidence suggests a role of JMJD3 in removal of H3K27me3 mark from promoters of HTFs, thus activating epigenetically poised hepatic genes in BMPCs prior to partial nuclear reprogramming. The importance of JMJD3 in reprogramming of BMPCs to hepatic phenotype was confirmed by inhibiting catalytic function of the enzyme using small molecule GSK-J4. Our results propose a potential role of JMJD3 in lineage conversion of BM cells into hepatic lineage.	[Kochat, Veena; Equbal, Zaffar; Baligar, Prakash; Kumar, Vikash; Mukhopadhyay, Asok] Natl Inst Immunol, Stem Cell Biol Lab, New Delhi, India; [Srivastava, Madhulika] Natl Inst Immunol, Epigenet Regulat Res Lab, New Delhi, India; [Kochat, Veena] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Baligar, Prakash] Amity Univ, Amity Inst Mol Med & Stem Cell Res, Noida, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Texas System; UTMD Anderson Cancer Center; Amity University Noida	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Stem Cell Biol Lab, New Delhi, India.	ashok@nii.ac.in	BALIGAR, PRAKASH/AAB-7404-2021; Srivastava, Madhulika/M-8941-2019	BALIGAR, PRAKASH/0000-0002-0553-4090; Srivastava, Madhulika/0000-0002-0997-013X; Equbal, Zaffar/0000-0001-7791-1804	NII	NII(Department of Biotechnology (DBT) India)	This study was supported by Director, NII. The funders had no role in study design, data collection and analysis, decisiontopublish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Catacchio I, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/589139; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; Eisenberg CA, 2006, STEM CELLS, V24, P1236, DOI 10.1634/stemcells.2005-0128; Fagoonee S, 2010, STEM CELLS DEV, V19, P1183, DOI 10.1089/scd.2009.0496; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Jozefczuk J, 2011, STEM CELLS DEV, V20, P1259, DOI 10.1089/scd.2010.0361; Kochat V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0119-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Li QT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004524; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Novik EI, 2006, TISSUE ENG, V12, P1515, DOI 10.1089/ten.2006.12.1515; Pasque V, 2010, COLD SH Q B, V75, P189, DOI 10.1101/sqb.2010.75.002; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Quintana-Bustamante O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033945; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yadav N, 2009, BLOOD, V114, P4552, DOI 10.1182/blood-2009-02-202788; Yamamoto Y, 2005, HEPATOLOGY, V42, P558, DOI 10.1002/hep.20825; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	38	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173977	10.1371/journal.pone.0173977	http://dx.doi.org/10.1371/journal.pone.0173977			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328977	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700040
J	Prasad, SVN; Gupta, MK; Duan, ZH; Surampudi, VSK; Liu, CG; Kotwal, A; Moravec, CS; Starling, RC; Perez, DM; Sen, S; Wu, QY; Plow, EF; Karnik, S				Prasad, Sathyamangla V. Naga; Gupta, Manveen K.; Duan, Zhong-Hui; Surampudi, Venkata Suresh K.; Liu, Chang-Gong; Kotwal, Ashwin; Moravec, Christine S.; Starling, Randall C.; Perez, Dianne M.; Sen, Subha; Wu, Qingyu; Plow, Edward F.; Karnik, Sadashiva			A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks	PLOS ONE			English	Article							NF-KAPPA-B; DILATED CARDIOMYOPATHY; EXPRESSION; INHIBITION; TARGET; GROWTH; ACTIVATION; DISEASE; RNAS	It is well established that the gene expression patterns are substantially altered in cardiac hypertrophy and heart failure, however, less is known about the reasons behind such global differences. MicroRNAs (miRNAs) are short non-coding RNAs that can target multiple molecules to regulate wide array of proteins in diverse pathways. The goal of the study was to profile alterations in miRNA expression using end-stage human heart failure samples with an aim to build signaling network pathways using predicted targets for the altered miRNA and to determine nodal molecules regulating individual networks. Profiling of miRNAs using custom designed microarray and validation with an independent set of samples identified eight miRNAs that are altered in human heart failure including one novel miRNA yet to be implicated in cardiac pathology. To gain an unbiased perspective on global regulation by top eight altered miRNAs, functional relationship of predicted targets for these eight miRNAs were examined by network analysis. Ingenuity Pathways Analysis network algorithm was used to build global signaling networks based on the targets of altered miRNAs which allowed us to identify participating networks and nodal molecules that could contribute to cardiac pathophysiology. Majority of the nodal molecules identified in our analysis are targets of altered miRNAs and known regulators of cardiovascular signaling. Cardio-genomics heart failure gene expression public data base was used to analyze trends in expression pattern for target nodal molecules and indeed changes in expression of nodal molecules inversely correlated to miRNA alterations. We have used NF kappa B network as an example to show that targeting other molecules in the network could alter the nodal NF kappa B despite not being a miRNA target suggesting an integrated network response. Thus, using network analysis we show that altering key functional target proteins may regulate expression of the myriad signaling pathways underlying the cardiac pathology.	[Prasad, Sathyamangla V. Naga; Gupta, Manveen K.; Surampudi, Venkata Suresh K.; Kotwal, Ashwin; Perez, Dianne M.; Sen, Subha; Wu, Qingyu; Plow, Edward F.; Karnik, Sadashiva] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA; [Liu, Chang-Gong] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Liu, Chang-Gong] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Moravec, Christine S.; Starling, Randall C.] Cleveland Clin, Heart & Vasc Res Inst, Dept Cardiovasc Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University System of Ohio; University of Akron; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation	Karnik, S (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	prasads2@ccf.org; karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Wu, Qingyu/0000-0003-0561-9315	Cleveland Clinic Start up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115964] Funding Source: NIH RePORTER	Cleveland Clinic Start up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Cleveland Clinic Start up funds to S.V.N.P. The funders had no role in study design, data collection and analysis to publish, or preparation of the manuscript.	Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Connerty P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010031; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Duffy JY, 2009, CRIT CARE MED, V37, P577, DOI 10.1097/CCM.0b013e318194ab65; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grzeskowiak R, 2003, CARDIOVASC RES, V59, P400, DOI 10.1016/S0008-6363(03)00426-7; Gurha P, 2016, CURR OPIN CARDIOL, V31, P249, DOI 10.1097/HCO.0000000000000280; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jens M, 2015, NAT REV GENET, V16, P113, DOI 10.1038/nrg3853; Kunz M, 2015, J MOL CELL CARDIOL, V89, P3, DOI 10.1016/j.yjmcc.2014.11.027; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao Y, 2016, CELL REP, V16, P1456, DOI 10.1016/j.celrep.2016.06.084; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Perrino C, 2007, CIRCULATION, V116, P2571, DOI 10.1161/CIRCULATIONAHA.107.706515; Piek A, 2016, HEART FAIL REV, V21, P199, DOI 10.1007/s10741-016-9536-9; Ferreira LRP, 2014, INT J CARDIOL, V175, P409, DOI 10.1016/j.ijcard.2014.05.019; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Sysa-Shah P, 2016, CARDIOVASC RES, V109, P358, DOI 10.1093/cvr/cvv274; Sysa-Shah P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042805; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Thomas CM, 2014, AM J PHYSIOL-HEART C, V307, pH1036, DOI 10.1152/ajpheart.00340.2014; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Xu HF, 2014, MOL MED REP, V10, P161, DOI 10.3892/mmr.2014.2205; Young D, 2008, J MOL BIOL, V381, P559, DOI 10.1016/j.jmb.2008.05.076	45	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0170456	10.1371/journal.pone.0170456	http://dx.doi.org/10.1371/journal.pone.0170456			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329018	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700001
J	Kuznetsov, NA; Rhea, CK				Kuznetsov, Nikita A.; Rhea, Christopher K.			Power considerations for the application of detrended fluctuation analysis in gait variability studies	PLOS ONE			English	Article							RELIABILITY; DYNAMICS; WALKING	The assessment of gait variability using stochastic signal processing techniques such as detrended fluctuation analysis (DFA) has been shown to be a sensitive tool for evaluation of gait alterations due to aging and neuromuscular disease. However, previous studies have suggested that the application of DFA requires relatively long recordings (600 strides), which is difficult when working with clinical populations or older adults. In this paper we propose a model for predicting DFA variance in experimental data and conduct a Monte Carlo simulation to estimate the sample size and number of trials required to detect a change in DFA scaling exponent. We illustrate the model in a simulation to detect a difference of 0.1 (medium effect) between two groups of subjects when using short gait time series (100 to 200 strides) in the context of between-and within-subject designs. We assumed that the variance of DFA scaling exponent arises due to individual differences, time series length, and experimental error. Results showed that sample sizes required to achieve acceptable power of 80% are practically feasible, especially when using within-subject designs. For example, to detect a group difference in the DFA scaling exponent of 0.1, it would require either 25 subjects and 2 trials per subject or 12 subjects and 4 trials per subject using a within-subject design. We then compared plausibility of such power predictions to the empirically observed power from a study that required subjects to synchronize with a persistent fractal metronome. The results showed that the model adequately predicted the empirical pattern of results. Our power simulations could be used in conjunction with previous design guidelines in the literature when planning new gait variability experiments.	[Kuznetsov, Nikita A.; Rhea, Christopher K.] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Kuznetsov, NA (corresponding author), Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC 27412 USA.	nikita@uncg.edu	Kuznetsov, Nikita/AFU-9897-2022; Kuznetsov, Nikita/CAA-3889-2022	Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X	Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0094]	Office of the Assistant Secretary of Defense for Health Affairs	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. (W81XWH-15-1-0094) to Christopher K. Rhea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. (W81XWH-15-1-0094) to Christopher K. Rhea.	Ahn J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119596; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; Ashkenazy Y, 2001, PHYS REV LETT, V86, P1900, DOI 10.1103/PhysRevLett.86.1900; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Chen Z, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011104; Choi JS, 2015, J BIOMECH, V48, P1336, DOI 10.1016/j.jbiomech.2015.02.047; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Coronado AV, 2005, J BIOL PHYS, V31, P121, DOI 10.1007/s10867-005-3126-8; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; DAVIES RB, 1987, BIOMETRIKA, V74, P95, DOI 10.2307/2336024; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Delignieres D, 2013, ADV EXP MED BIOL, V782, P127, DOI 10.1007/978-1-4614-5465-6_7; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hipel KW, 1994, TIME SERIES MODELLIN; Holl M, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60143-1; Hoenig JM, 2012, THE ABUSE OF POWER; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Kirchner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085787; Kuznetsov N, 2013, ANN BIOMED ENG, V41, P1646, DOI 10.1007/s10439-012-0646-9; Ma QDY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031101; Marmelat V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091949; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Pierrynowski MR, 2005, GAIT POSTURE, V22, P46, DOI 10.1016/j.gaitpost.2004.06.007; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Torre K, 2011, PSYCHON B REV, V18, P339, DOI 10.3758/s13423-011-0049-1; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Xu YL, 2011, PHYSICA A, V390, P4057, DOI 10.1016/j.physa.2011.05.015; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	38	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174144	10.1371/journal.pone.0174144	http://dx.doi.org/10.1371/journal.pone.0174144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323871	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000066
J	Mohan, GC; Zhang, HY; Bao, L; Many, B; Chan, LS				Mohan, Girish C.; Zhang, Huayi; Bao, Lei; Many, Benjamin; Chan, Lawrence S.			Diacerein inhibits the pro-atherogenic & proinflammatory effects of IL-1 on human keratinocytes & endothelial cells	PLOS ONE			English	Article							SPLEEN TYROSINE KINASE; NECROSIS-FACTOR-ALPHA; PROMOTES ATHEROSCLEROSIS; ADHESION MOLECULES; OXIDATIVE STRESS; SERUM-LEVELS; PSORIASIS; INFLAMMATION; ACTIVATION; EXPRESSION	We investigated IL-1-induced regulation of genes related to inflammation and atherogenesis in human keratinocytes and endothelial cells, and if 'diacerein', an oral IL-1 inhibiting drug currently approved for use in osteoarthritis, would reverse IL-1's effects on these cells. Primary human keratinocytes and coronary artery endothelial cells were treated with either IL1a or IL-1 beta, with and without diacerein. Using PCR-array, we assessed differential gene-expression regulated by IL-1 and diacerein. We identified 34 pro-atherogenic genes in endothelial cells and 68 pro-inflammatory genes in keratinocytes significantly (p< 0.05) regulated at least 2-fold by IL-1, in comparison to control. Diacerein completely or partially reversed this regulation on almost all genes. Using ELISA, we confirmed diacerein's ability to reverse IL-1-driven gene-regulation of 11 selected factors, at the protein level. The results support a novel idea that diacerein acts as an inhibitor of the pro-atherogenic and pro-inflammatory effects of IL-1. Diacerein may have therapeutic applications to diminish IL-1-induced skin inflammation in psoriasis and attenuate IL-1-induced development of atherosclerosis. Further investigation into diacerein's effect on skin inflammation, atherogenesis and cardiovascular risk in animal models or humans is warranted.	[Mohan, Girish C.; Zhang, Huayi; Bao, Lei; Many, Benjamin; Chan, Lawrence S.] Univ Illinois Chicago UIC, Coll Med, Dept Dermatol, Chicago, IL 60607 USA; [Chan, Lawrence S.] Jesse Brown Vet Affairs Hosp, Dept Med, Chicago, IL 60612 USA; [Chan, Lawrence S.] Capt James Lovell FHCC, Dept Med, N Chicago, IL 60064 USA	University of Illinois System; University of Illinois Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Chan, LS (corresponding author), Univ Illinois Chicago UIC, Coll Med, Dept Dermatol, Chicago, IL 60607 USA.; Chan, LS (corresponding author), Jesse Brown Vet Affairs Hosp, Dept Med, Chicago, IL 60612 USA.; Chan, LS (corresponding author), Capt James Lovell FHCC, Dept Med, N Chicago, IL 60064 USA.	larrycha@uic.edu		Many, Benjamin/0000-0002-0544-591X	Orville J. Stone Endowed Professorship; Albert H. and Mary-Jane Slepyan Endowed Fellowship; University of Illinois Tanja Andric Memorial Endowment Fund	Orville J. Stone Endowed Professorship; Albert H. and Mary-Jane Slepyan Endowed Fellowship; University of Illinois Tanja Andric Memorial Endowment Fund	This work was supported by Orville J. Stone Endowed Professorship (L.S.Chan); Albert H. and Mary-Jane Slepyan Endowed Fellowship (L. Bao); University of Illinois Tanja Andric Memorial Endowment Fund (G.C. Mohan).	Ahlehoff O, 2014, J INTERNAL MED; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Balato A, 2013, ARCH DERMATOL RES, V305, P255, DOI 10.1007/s00403-013-1327-8; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Beaulieu LM, 2014, ARTERIOSCL THROM VAS, V34, P552, DOI 10.1161/ATVBAHA.113.302700; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Bharti R, 2016, ONCOGENE, V35, P3965, DOI 10.1038/onc.2015.466; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Butcher M, 2014, J IMMUNOLOGY S, V192; Cataisson C, 2006, J CLIN INVEST, V116, P2757, DOI 10.1172/JCI27514; Chang CH, 2003, CELL IMMUNOL, V221, P37, DOI 10.1016/S0008-8749(03)00058-3; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088405; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; David A, 2012, CLIN BIOCHEM, V45, P275, DOI 10.1016/j.clinbiochem.2011.12.010; de Castro CP, 2012, J IMMUNOL, V189, P4144, DOI 10.4049/jimmunol.1201946; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Dowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131; Etter H, 1998, CYTOKINE, V10, P395, DOI 10.1006/cyto.1997.0308; Fonsatti E, 1997, BRIT J CANCER, V76, P1255, DOI 10.1038/bjc.1997.545; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gibbs A, 2005, ARTHRITIS RES THER, V7, pS27, DOI 10.1186/ar1589; Golledge J, 2011, CARDIOVASC RES, V92, P19, DOI 10.1093/cvr/cvr183; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Guilloteau K, 2010, J IMMUNOLOGY; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; Hilgendorf I, 2011, ARTERIOSCL THROM VAS, V31, P1991, DOI 10.1161/ATVBAHA.111.230847; Hu ZH, 2013, INT J MOL SCI, V14, P4805, DOI 10.3390/ijms14034805; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Kaplan MJ, 2008, VASC HEALTH RISK MAN, V4, P1229, DOI 10.2147/VHRM.S3461; Kim WJ, 2006, IMMUNOLOGY, V119, P421, DOI 10.1111/j.1365-2567.2006.02453.x; Kim YJ, 2012, FEBS LETT, V586, P818, DOI 10.1016/j.febslet.2012.01.055; Kitagawa K, 2002, ATHEROSCLEROSIS, V160, P305, DOI 10.1016/S0021-9150(01)00587-1; Legendre F, 2009, SCAND J RHEUMATOL, V38, P104, DOI 10.1080/03009740802421996; Lehrke M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-50; Levula M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033787; Li H, 2011, MED HYPOTHESES, V77, P1105, DOI 10.1016/j.mehy.2011.09.013; Li JJ, 2005, MED HYPOTHESES, V64, P925, DOI 10.1016/j.mehy.2004.10.016; Li ZF, 2015, INFLAMMATION, V38, P1563, DOI 10.1007/s10753-015-0131-3; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Liu L, 2012, CARDIOVASC RES, V94, P3, DOI 10.1093/cvr/cvs108; Lohberger B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1915-4; MORAN CS, 1994, ARTERIOSCLER THROMB, V14, P1356, DOI 10.1161/01.ATV.14.8.1356; Muhr P, 2010, EXP DERMATOL, V19, P1105, DOI 10.1111/j.1600-0625.2010.01134.x; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Pirillo A, 2013, DIS MARKERS, V2013, P413, DOI 10.1155/2013/716325; Ranta V, 1999, CRIT CARE MED, V27, P2184, DOI 10.1097/00003246-199910000-00019; Rolfe BE, 2003, CARDIOVASC RES, V58, P222, DOI 10.1016/S0008-6363(02)00832-5; Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427; Son SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033063; Swindell WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079253; Tregouet DA, 2003, ANN HUM GENET, V67, P504, DOI 10.1046/j.1529-8817.2003.00053.x; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; WONG D, 1995, MICROVASC RES, V49, P325, DOI 10.1006/mvre.1995.1028; Xie W, 2014, HYPERTENSION RES OFF; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zhong XF, 2012, MOL MED REP, V5, P1261, DOI 10.3892/mmr.2012.793; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003	69	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173981	10.1371/journal.pone.0173981	http://dx.doi.org/10.1371/journal.pone.0173981			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323859	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000053
J	Stafuzza, NB; Zerlotini, A; Lobo, FP; Yamagishi, MEB; Chud, TCS; Caetano, AR; Munari, DP; Garrick, DJ; Machado, MA; Martins, MF; Carvalho, MR; Cole, JB; da Silva, MVGB				Stafuzza, Nedenia Bonvino; Zerlotini, Adhemar; Lobo, Francisco Pereira; Beleza Yamagishi, Michel Eduardo; Seleguim Chud, Tatiane Cristina; Caetano, Alexandre Rodrigues; Munari, Danisio Prado; Garrick, Dorian J.; Machado, Marco Antonio; Martins, Marta Fonseca; Carvalho, Maria Raquel; Cole, John Bruce; Gualberto Barbosa da Silva, Marcos Vinicius			Single nucleotide variants and InDels identified from whole-genome re-sequencing of Guzerat, Gyr, Girolando and Holstein cattle breeds	PLOS ONE			English	Article							LARGE GENE LISTS; SMALL INSERTIONS; MUTATION-RATE; SNP; SYSTEMS; DISCOVERY; DELETIONS; TRAITS; HUMANS; USHI	Whole-genome re-sequencing, alignment and annotation analyses were undertaken for 12 sires representing four important cattle breeds in Brazil: Guzerat (multi-purpose), Gyr, Girolando and Holstein (dairy production). A total of approximately 4.3 billion reads from an Illumina HiSeq 2000 sequencer generated for each animal 10.7 to 16.4-fold genome coverage. A total of 27,441,279 single nucleotide variations (SNVs) and 3,828,041 insertions/deletions (InDels) were detected in the samples, of which 2,557,670 SNVs and 883,219 InDels were novel. The submission of these genetic variants to the dbSNP database significantly increased the number of known variants, particularly for the indicine genome. The concordance rate between genotypes obtained using the Bovine HD BeadChip array and the same variants identified by sequencing was about 99.05%. The annotation of variants identified numerous non-synonymous SNVs and frameshift InDels which could affect phenotypic variation. Functional enrichment analysis was performed and revealed that variants in the olfactory transduction pathway was over represented in all four cattle breeds, while the ECM-receptor interaction pathway was over represented in Girolando and Guzerat breeds, the ABC transporters pathway was over represented only in Holstein breed, and the metabolic pathways was over represented only in Gyr breed. The genetic variants discovered here provide a rich resource to help identify potential genomic markers and their associated molecular mechanisms that impact economically important traits for Gyr, Girolando, Guzerat and Holstein breeding programs.	[Stafuzza, Nedenia Bonvino; Seleguim Chud, Tatiane Cristina; Munari, Danisio Prado] Univ Estadual Paulista, Dept Ciencias Exatas, Fac Ciencias Agrarias & Vet, Sao Paulo, Brazil; [Zerlotini, Adhemar; Lobo, Francisco Pereira; Beleza Yamagishi, Michel Eduardo] Embrapa Informat Agr, Campinas, SP, Brazil; [Caetano, Alexandre Rodrigues] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Garrick, Dorian J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Machado, Marco Antonio; Martins, Marta Fonseca; Gualberto Barbosa da Silva, Marcos Vinicius] Embrapa Gado Leite, Juiz De Fora, MG, Brazil; [Carvalho, Maria Raquel] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Cole, John Bruce] ARS, USDA, Anim Genom & Improvement Lab, Beltsville, MD USA	Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Iowa State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais; United States Department of Agriculture (USDA)	da Silva, MVGB (corresponding author), Embrapa Gado Leite, Juiz De Fora, MG, Brazil.	marcos.vb.silva@embrapa.br	Lobo, Francisco Pereira/AAG-3118-2021; Garrick, Dorian/Q-3239-2019; Yamagishi, Michel Eduardo Beleza/B-7902-2012; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020; Garrick, Dorian/P-9628-2019; Stafuzza, Nedenia B./C-4419-2013; Stafuzza, Nedenia Bonvino/M-9224-2019; Zerlotini, Adhemar/E-6533-2012; Carvalho, Maria Raquel Santos/HHN-1690-2022; Munari, Danisio P/C-6384-2012; Martins, Marta Fonseca/H-1672-2012; Carvalho, Maria Raquel/C-7310-2016	Lobo, Francisco Pereira/0000-0002-9671-9313; Yamagishi, Michel Eduardo Beleza/0000-0001-7109-3038; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; Garrick, Dorian/0000-0001-8640-5372; Stafuzza, Nedenia B./0000-0001-6432-2330; Stafuzza, Nedenia Bonvino/0000-0001-6432-2330; Zerlotini, Adhemar/0000-0002-7739-0284; Carvalho, Maria Raquel Santos/0000-0002-1744-448X; Munari, Danisio P/0000-0001-6915-038X; Martins, Marta Fonseca/0000-0002-4260-5329; Carvalho, Maria Raquel/0000-0002-1744-448X	Embrapa (Brazil) "Genomic Selection in Dairy Cattle in Brazil" [SEG 02.09.07.008.00.00]; Embrapa (Brazil) "National network for development of innovative genomic strategies applied to animal breeding, conservation and production" (PI - ARC) [SEG 01.11.07.002.00.00]; CNPq "Genomic Selection in Dairy Gyr and Girolando Breeds" [PVE 407246/2013-4]; FAPEMIG "Genomic Selection in Brazilian Dairy Breeds" [CVZ PPM 00395/14]; postdoctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); Sao Paulo Research Foundation (FAPESP) [15/08939-0]; productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq)	Embrapa (Brazil) "Genomic Selection in Dairy Cattle in Brazil"; Embrapa (Brazil) "National network for development of innovative genomic strategies applied to animal breeding, conservation and production" (PI - ARC); CNPq "Genomic Selection in Dairy Gyr and Girolando Breeds"; FAPEMIG "Genomic Selection in Brazilian Dairy Breeds"; postdoctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq)	MVGBS was supported by Embrapa (Brazil) SEG 02.09.07.008.00.00 "Genomic Selection in Dairy Cattle in Brazil", Embrapa (Brazil) SEG 01.11.07.002.00.00 "National network for development of innovative genomic strategies applied to animal breeding, conservation and production" (PI - ARC), CNPq PVE 407246/2013-4 "Genomic Selection in Dairy Gyr and Girolando Breeds", and FAPEMIG CVZ PPM 00395/14 "Genomic Selection in Brazilian Dairy Breeds" appropriated projects. NBS was supported by postdoctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD). TCSC received a fellowship from Sao Paulo Research Foundation (FAPESP 15/08939-0). ARC, MAM, DPM, MFM, MRC, and MVGBS were supported by productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq). We would like to thank the EMBRAPA Multiuser Bioinformatics Laboratory (Laboratorio Multiusuario de Bioinformatica da Embrapa) for providing highperformance computational infrastructure.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bovine HAPMAP Consortium, 2009, SCIENCE, V324, P529, DOI [10.1126/science.1167936, DOI 10.1126/SCIENCE.1167936]; Brayden DJ, 2010, HANDB EXP PHARMACOL, V199, P79, DOI 10.1007/978-3-642-10324-7_4; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Das A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2249-y; Dhanoa JK, 2016, VET WORLD, V9, P783, DOI 10.14202/vetworld.2016.783-791; Do DN, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00307; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Empresa Brasileira de Pesquisa Agropecuaria de Rondonia [Embrapa-RO], 2005, SIST PROD LEIT COM R, P7; *FAO, 1995, WORLD WATCH LIST DOM; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052589; Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jansen S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-446; Jiang L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1105; Koks S, 2014, MAMM GENOME, V25, P363, DOI 10.1007/s00335-014-9511-5; Lee HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084272; Lee K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-596; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XP, 2013, GENOME, V56, P592, DOI 10.1139/gen-2013-0082; Ma MH, 2007, CRIT REV BIOCHEM MOL, V42, P463, DOI 10.1080/10409230701693359; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nachman MW, 2000, GENETICS, V156, P297; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; O'Brien AMP, 2014, LIVEST SCI, V166, P121, DOI 10.1016/j.livsci.2014.05.007; Panetto JCC, 2016, EMBRAPA GADO LEITE D, V187; Peixoto MGCD, 2016, EMBRAPA GADO LEITE D, V188; Schrickx JA, 2008, EUR J PHARMACOL, V585, P510, DOI 10.1016/j.ejphar.2008.03.014; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Ferraz JBS, 2010, MEAT SCI, V84, P238, DOI 10.1016/j.meatsci.2009.06.006; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Tsuda K, 2013, GENOMICS, V102, P372, DOI 10.1016/j.ygeno.2013.08.002; Utsunomiya YT, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-47; Zhan BJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-557	44	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173954	10.1371/journal.pone.0173954	http://dx.doi.org/10.1371/journal.pone.0173954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323836	Green Published, gold			2022-12-27	WOS:000399089000048
J	Wang, W; Yan, HJ; Yu, JQ; Yi, J; Qu, Y; Fu, MZ; Chen, A; Tang, H; Niu, LL				Wang, Wei; Yan, Huijuan; Yu, Jianqiu; Yi, Jun; Qu, Yu; Fu, Maozhong; Chen, Ang; Tang, Hui; Niu, Lili			Discovery of genome-wideSN Ps by RAD-seqand the genetic diversity of captive hog deer (Axis porcinus)	PLOS ONE			English	Article							NOVO; LOCI; STACKS	The hog deer (Axis porcinus) is a small deer whose natural habitat is the wet or moist tall grasslands in South and Southeast Asia. Wild populations have dramatically decreased in recent decades. While wild hog deer were recently acknowledged to be extinct in China, a few captive populations have been maintained. In the present study, we successfully employed the restriction-site-associated DNA sequencing (RAD-seq) technique to generate a genome-wide profile of single-nucleotide polymorphisms (SNPs) in the captive population of hog deer from Chengdu Zoo, China (N = 11). Up to 4.7 million clean reads per sample were sequenced, and 11,155 SNPs and 8,247 haplotypes were simultaneously observed within more than 80% of sequenced individuals. In this population, the mean frequency of major alleles at each polymorphism site was 0.7903 +/- 0.0014, and the average nucleotide diversity (Pi) and inbreeding coefficient (F-IS) were 0.3031 +/- 0.0015 and-0.0302 +/- 0.0062, respectively. Additionally, the Euclidean distance-based multidimensional scaling method revealed that the pairwise genetic relatedness was evenly distributed. However, the results of homologous searching by short reads did not provide any meaningful explanation of the phylogenetic relationship of hog deer, which should be further investigated. In conclusion, our results revealed current state of genetic diversity in this captive population of hog deer. Furthermore, these genome-wide SNPs would be useful for guiding the mating schedule to avoid sharp increase of inbreeding coefficient.	[Wang, Wei; Yi, Jun; Fu, Maozhong; Tang, Hui] Sichuan Anim Sci Acad, Chengdu, Peoples R China; [Yan, Huijuan; Yu, Jianqiu; Qu, Yu; Chen, Ang; Niu, Lili] Chengdu Zoo, Chengdu, Peoples R China		Yan, HJ (corresponding author), Chengdu Zoo, Chengdu, Peoples R China.	240190769@qq.com			Garden Project Level Of Chengdu Zoo	Garden Project Level Of Chengdu Zoo	This study was financially supported by The Garden Project Level Of Chengdu Zoo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Biswas Tanushree, 2000, Indian Forester, V126, P1068; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deng JB, 2010, SICHUAN J ZOOLOGY, V29, P430; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Lian H, 2009, CONSERV GENET, V10, P681, DOI 10.1007/s10592-008-9614-1; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Smith Andrew T., 2008, P1; Timmins R, 2015, IUCN RED LIST THREAT; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang S., 1998, CHINA RED DATA BOOK; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; [余建秋 YU Jian-qiu], 2009, [四川动物, Sichuan Journal of Zoology], V28, P428; Yu Jianqiu, 2010, Acta Theriologica Sinica, V30, P200; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	21	5	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174299	10.1371/journal.pone.0174299	http://dx.doi.org/10.1371/journal.pone.0174299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323863	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000083
J	Dickinson, DL; Drummond, SPA; McElroy, T				Dickinson, David L.; Drummond, Sean P. A.; McElroy, Todd			The viability of an ecologically valid chronic sleep restriction and circadian timing protocol: An examination of sample attrition, compliance, and effectiveness at impacting sleepiness and mood	PLOS ONE			English	Article							DOSE-RESPONSE; PERFORMANCE DECREMENTS; SHIFT WORK; NIGHT; CHILDREN; ALCOHOL; QUESTIONNAIRE; DEPRIVATION; IMPAIRMENT; PERCEPTION	Chronic sleep restriction (SR) increases sleepiness, negatively impacts mood, and impairs a variety of cognitive performance measures. The vast majority of work establishing these effects are tightly controlled in-lab experimental studies. Examining commonly-experienced levels of SR in naturalistic settings is more difficult and generally involves observational methods, rather than active manipulations of sleep. The same is true for analyzing behavioral and cognitive outcomes at circadian unfavorable times. The current study tested the ability of an at-home protocol to manipulate sleep schedules (i.e., impose SR), as well as create a mismatch between a subject's circadian preference and time of testing. Viability of the protocol was assessed via completion, compliance with the SR, and success at manipulating sleepiness and mood. An online survey was completed by 3630 individuals to assess initial eligibility, 256 agreed via email response to participate in the 3-week study, 221 showed for the initial in-person session, and 184 completed the protocol (175 with complete data). The protocol consisted of 1 week at-home SR (5-6 hours in bed/night), 1 week washout, and 1 week well-rested (WR: 8-9 hours in bed/night). Sleep was monitored with actigraphy, diary, and call-ins. Risk management strategies were implemented for subject safety. At the end of each experimental week, subjects reported sleepiness and mood ratings. Protocol completion was 83%, with lower depression scores, higher anxiety scores, and morning session assignment predicting completion. Compliance with the sleep schedule was also very good. Subjects spent approximately 2 hours less time in bed/night and obtained an average of 1.5 hours less nightly sleep during SR, relative to WR, with 82% of subjects obtaining at least 60 minutes less average nightly sleep. Sleepiness and mood were impacted as expected by SR. These findings show the viability of studying experimental chronic sleep restriction outside the laboratory, assuming appropriate safety precautions are taken, thus allowing investigators to significantly increase ecological validity over strictly controlled in-lab studies.	[Dickinson, David L.] Appalachian State Univ, Dept Econ, Boone, NC 28608 USA; [Dickinson, David L.] Appalachian State Univ, Ctr Econ Res & Policy Anal, Boone, NC 28608 USA; [Dickinson, David L.] IZA Inst Study Labor, Bonn, Germany; [Dickinson, David L.] Chapman Univ, ESI, Orange, CA 92866 USA; [Drummond, Sean P. A.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Melbourne, Vic, Australia; [McElroy, Todd] Florida Gulf Coast Univ, Dept Psychol, Ft Myers, FL USA	University of North Carolina; Appalachian State University; University of North Carolina; Appalachian State University; IZA Institute Labor Economics; Chapman University System; Chapman University; Monash University; State University System of Florida; Florida Gulf Coast University	Dickinson, DL (corresponding author), Appalachian State Univ, Dept Econ, Boone, NC 28608 USA.; Dickinson, DL (corresponding author), Appalachian State Univ, Ctr Econ Res & Policy Anal, Boone, NC 28608 USA.; Dickinson, DL (corresponding author), IZA Inst Study Labor, Bonn, Germany.; Dickinson, DL (corresponding author), Chapman Univ, ESI, Orange, CA 92866 USA.	dickinsondl@appstate.edu		Drummond, Sean/0000-0002-9815-626X	National Science Foundation Behavioral and Cognitive Science [BCS1229067]	National Science Foundation Behavioral and Cognitive Science	Funded by National Science Foundation Behavioral and Cognitive Science award BCS1229067 awarded to DLD and TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Akerstedt T, 2008, CHRONOBIOL INT, V25, P271, DOI 10.1080/07420520802110589; Anderson C, 2006, HUM PSYCHOPHARM CLIN, V21, P299, DOI 10.1002/hup.769; Anderson C, 2013, INTERN MED J, V43, P717, DOI 10.1111/imj.12159; Anderson C, 2008, HUM PSYCHOPHARM CLIN, V23, P333, DOI 10.1002/hup.931; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Barrett PR, 2005, HUM PSYCHOPHARM CLIN, V20, P287, DOI 10.1002/hup.691; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BODENHAUSEN GV, 1990, PSYCHOL SCI, V1, P319, DOI 10.1111/j.1467-9280.1990.tb00226.x; Cajochen C, 1999, AM J PHYSIOL-REG I, V277, pR640, DOI 10.1152/ajpregu.1999.277.3.R640; Castillo M, 2016, THEORY IN PRESS  DEC; Chelminski I, 2000, PERS INDIV DIFFER, V29, P469, DOI 10.1016/S0191-8869(99)00208-1; Dickinson DL, 2016, BEHAV SLEEP MED, V14, P501, DOI 10.1080/15402002.2015.1028064; Dickinson DL, 2012, EXP ECON, V15, P444, DOI 10.1007/s10683-011-9307-3; Dinges DF, 1997, SLEEP, V20, P267; Drummond SPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035653; Fallone G, 2005, SLEEP, V28, P1561, DOI 10.1093/sleep/28.12.1561; Fallone G, 2002, SLEEP, V25, P739, DOI 10.1093/sleep/25.7.739; Ftouni S, 2013, J SLEEP RES, V22, P58, DOI 10.1111/j.1365-2869.2012.01038.x; Hershner SD, 2014, NAT SCI SLEEP, V6, P73, DOI 10.2147/NSS.S62907; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kruglanski AW, 2008, PSYCHOL SCI, V19, P296, DOI 10.1111/j.1467-9280.2008.02083.x; Lee J, 2015, SLEEP, V38, P765, DOI 10.5665/sleep.4672; Magee M, 2016, SCAND J WORK ENV HEA, V42, P217, DOI 10.5271/sjweh.3560; Marquie JC, 2015, OCCUP ENVIRON MED, V72, P258, DOI 10.1136/oemed-2013-101993; Rajaratnam SMW, 2013, MED J AUSTRALIA, V199, pS11, DOI 10.5694/mja13.10561; Raslear TG, 2011, PROG BRAIN RES, V190, P155, DOI 10.1016/B978-0-444-53817-8.00010-4; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sadeh A, 2011, SLEEP MED, V12, P257, DOI 10.1016/j.sleep.2010.02.001; Schoenborn Charlotte A, 2010, Vital Health Stat 10, P1; Sletten TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128273; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Vakulin A, 2007, SLEEP, V30, P1327, DOI 10.1093/sleep/30.10.1327; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174367	10.1371/journal.pone.0174367	http://dx.doi.org/10.1371/journal.pone.0174367			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319182	gold, Green Published			2022-12-27	WOS:000398945800072
J	Zhou, JZ; Li, SY; Wang, YP; Lei, Y; Foreman, RD; Yin, JY; Chen, JDZ				Zhou, Jingzhu; Li, Shiying; Wang, Yinping; Lei, Yong; Foreman, Robert D.; Yin, Jieyun; Chen, Jiande D. Z.			Effects and mechanisms of auricular electroacupuncture on gastric hypersensitivity in a rodent model of functional dyspepsia	PLOS ONE			English	Article							VISCERAL HYPERSENSITIVITY; ELECTRICAL-STIMULATION; RECTAL DISTENSION; AUTONOMIC FUNCTION; ACUPUNCTURE; MOTILITY; MANAGEMENT; SYMPTOMS; MIGRAINE; STRESS	Background Functional dyspepsia (FD) is a common functional gastrointestinal disease, and abdominal pain is one of the main symptoms. The aim of this study was to explore the effects and mechanisms of auricular electro-acupuncture (AEA) on gastric hypersensitivity in a rodent model of FD. Methods Ten-day-old pups were gavaged with 0.2 ml of 0.1% iodoacetamide daily for 6 days. AEA at the "stomach" point with different parameters or sham-EA was performed on 8-week-old animals. Gastric sensitivity to gastric distention was measured under different conditions. Autonomic functions were assessed from the spectral analysis of heart rate variability (HRV) derived from the electrocardiogram. Naloxone was injected intraperitoneally before AEA to explore the opioid mechanism. Gastric emptying was measured at the end of the study. Results 1) Gastric sensitivity to gastric distention was higher in the FD rats. AEA with parameters of 0.1s on, 0.4s off, 100Hz, 0.3ms and 0.4-0.5mA, but not other parameters or sham- EA, decreased gastric hypersensitivity in the FD rats. Naloxone did not block the effect of AEA. 2) Lower vagal activity and higher sympathovagal ratio were noted in the FD rats, compared with the controls. AEA increased vagal activity and improved sympathovagal imbalance. Conclusions AEA ameliorates gastric hypersensitivity in FD rats and this effect may be attributed to the improvement of sympathovagal balance.	[Zhou, Jingzhu; Li, Shiying; Lei, Yong; Yin, Jieyun; Chen, Jiande D. Z.] VA Med Ctr, Vet Res & Educ Fdn, Oklahoma City, OK 73104 USA; [Zhou, Jingzhu; Foreman, Robert D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Zhou, Jingzhu; Wang, Yinping] Nanjing Med Univ, Affiliated Hosp 1, Dept Acupuncture & Moxibust, Nanjing, Jiangsu, Peoples R China; [Chen, Jiande D. Z.] Ningbo Pace Translat Med Res Ctr, Ningbo, Zhejiang, Peoples R China; [Chen, Jiande D. Z.] Johns Hopkins Univ, Ctr Neurogastroenterol, Baltimore, MD 21218 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Nanjing Medical University; Johns Hopkins University	Chen, JDZ (corresponding author), VA Med Ctr, Vet Res & Educ Fdn, Oklahoma City, OK 73104 USA.; Chen, JDZ (corresponding author), Ningbo Pace Translat Med Res Ctr, Ningbo, Zhejiang, Peoples R China.; Chen, JDZ (corresponding author), Johns Hopkins Univ, Ctr Neurogastroenterol, Baltimore, MD 21218 USA.	JiandeDZChen@gmail.com	Wang, Yin/HCI-9352-2022					Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Arai YCP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/945063; Camilleri M, 2013, NAT REV GASTRO HEPAT, V10, P187, DOI 10.1038/nrgastro.2013.11; Carbone F, 2014, DIGEST DIS, V32, P222, DOI 10.1159/000357854; Ceccherelli F, 2012, ACUPUNCTURE ELECTRO, V37, P277; Chen Jian-yong, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P880; Chen J, 2008, AM J PHYSIOL-GASTR L, V295, pG614, DOI 10.1152/ajpgi.90322.2008; Dai F, 2013, AM J PHYSIOL-GASTR L, V305, pG333, DOI 10.1152/ajpgi.00224.2012; Gao XY, 2008, AUTON NEUROSCI-BASIC, V138, P50, DOI 10.1016/j.autneu.2007.10.003; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; HAUSKEN T, 1993, PSYCHOSOM MED, V55, P12, DOI 10.1097/00006842-199301000-00004; He BJ, 2013, PAIN MED, V14, P1608, DOI 10.1111/pme.12197; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786839; Hveem K, 1998, SCAND J GASTROENTERO, V33, P123; Jia CS, 2009, J TRADIT CHIN MED, V29, P43, DOI 10.1016/S0254-6272(09)60030-3; KAMETANI H, 1979, J PHYSIOL-LONDON, V294, P407, DOI 10.1113/jphysiol.1979.sp012937; Kienbaum P, 2001, CIRCULATION, V103, P850, DOI 10.1161/01.CIR.103.6.850; Kim SE, 2013, J NEUROGASTROENTEROL, V19, P233, DOI 10.5056/jnm.2013.19.2.233; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Lacy BE, 2013, ALIMENT PHARM THER, V38, P170, DOI 10.1111/apt.12355; Lacy BE, 2012, ALIMENT PHARM THER, V36, P3, DOI 10.1111/j.1365-2036.2012.05128.x; Lee KJ, 2004, BEST PRACT RES CL GA, V18, P707, DOI 10.1016/j.bpg.2004.04.007; Li H, 2013, ACUPUNCT MED, V31, P57, DOI 10.1136/acupmed-2012-010173; Lin Yuan, 2011, J ACUPUNC TUINA SCI, V9, P39; Liu JS, 2012, AM J PHYSIOL-REG I, V303, pR209, DOI 10.1152/ajpregu.00301.2010; Liu JS, 2004, DIGEST DIS SCI, V49, P729, DOI 10.1023/B:DDAS.0000030081.91006.86; Liu LS, 2008, GASTROENTEROLOGY, V134, P2070, DOI 10.1053/j.gastro.2008.02.093; Liu Yue-dong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P887; Lorena SLS, 2002, DIGEST DIS SCI, V47, P27; Ma TT, 2012, ALIMENT PHARM THER, V35, P552, DOI 10.1111/j.1365-2036.2011.04979.x; Mahadeva S, 2006, WORLD J GASTROENTERO, V12, P2661, DOI 10.3748/wjg.v12.i17.2661; Nogier P., 1981, ACURICULOTHERAPY AUR AURICULOTHERAPY AURI; Peuker ET, 2002, CLIN ANAT, V15, P35, DOI 10.1002/ca.1089; Samsom M, 1999, GASTROENTEROLOGY, V116, P515, DOI 10.1016/S0016-5085(99)70171-X; Sator-Katzenschlager SM, 2007, EXPERT REV MED DEVIC, V4, P23, DOI 10.1586/17434440.4.1.23; Song J, 2013, NEUROGASTROENT MOTIL, V25, P807, DOI 10.1111/nmo.12183; Sun Y, 2014, NEUROGASTROENT MOTIL, V26, P176, DOI 10.1111/nmo.12248; Takahashi T, 2011, NEUROMODULATION, V14, P8, DOI 10.1111/j.1525-1403.2010.00295.x; Wang Y, 2013, EUR J PAIN, V17, P1447, DOI 10.1002/j.1532-2149.2013.00325.x; Wang Yan-Gang, 2007, Zhongguo Zhen Jiu, V27, P245; Wong TM, 2001, J BIOMED SCI, V8, P299, DOI 10.1159/000054047; Wu SJ, 2011, J RES MED SCI, V16, P39; Xu SP, 2006, DIGEST DIS SCI, V51, P2154, DOI 10.1007/s10620-006-9412-x; Yin JY, 2011, AM J PHYSIOL-REG I, V301, pR465, DOI 10.1152/ajpregu.00271.2010; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009; Zhang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114226; Zhou YY, 2012, WORLD J GASTROENTERO, V18, P7201, DOI 10.3748/wjg.v18.i48.7201	47	21	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174568	10.1371/journal.pone.0174568	http://dx.doi.org/10.1371/journal.pone.0174568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350818	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174400058
J	Li, TZ; Liu, TT; Zheng, CY; Kang, CS; Yang, ZC; Yao, XT; Song, FB; Zhang, RZ; Wang, XR; Xu, N; Zhang, CY; Li, W; Li, SM				Li, Tianzhu; Liu, Tongtong; Zheng, Chengyu; Kang, Chunsheng; Yang, Zichao; Yao, Xiaotong; Song, Fengbin; Zhang, Runzhi; Wang, Xuerong; Xu, Ning; Zhang, Chunyi; Li, Wei; Li, Shumin			Changes in soil bacterial community structure as a result of incorporation of Brassica plants compared with continuous planting eggplant and chemical disinfection in greenhouses	PLOS ONE			English	Article							SOLANUM-MELONGENA L.; MICROBIAL COMMUNITY; FERTILIZED SOILS; CROPPING SYSTEMS; RHIZOSPHERE; MANAGEMENT; DIVERSITY; FLAVOBACTERIUM; BIOREMEDIATION; BIOFUMIGATION	Greenhouse eggplant monocropping in China has contributed to the aggravation of soil borne diseases, reductions in crop quality and yield, and the degradation of physical and chemical soil properties. Crop rotation is one effective way of alleviating the problems of continuous cropping worldwide; however, few studies have reported changes in soil bacterial community structures and physical and chemical soil properties after Brassica vegetables had been rotated with eggplant in greenhouses. In this experiment, mustard-eggplant (BFN) and oilseed rape-eggplant (BFC) rotations were studied to identify changes in the physicochemical properties and bacterial community structure in soil that was previously subject to monocropping. Samples were taken after two types of Brassica plants incorporated into soil for 15 days to compare with continually planted eggplant (control, CN) and chemical disinfection of soil (CF) in greenhouses. MiSeq pyrosequencing was used to analyze soil bacterial diversity and structure in the four different treatments. A total of 55,129 reads were identified, and rarefaction analysis showed that the soil treatments were equally sampled. The bacterial richness of the BFC treatment and the diversity of the BFN treatment were significantly higher than those of the other treatments. Further comparison showed that the bacterial community structures of BFC and BFN treatments were also different from CN and CF treatments. The relative abundance of several dominant bacterial genera in the BFC and BFN treatments (such as Flavobacteria, Stenotrophomonas, Massilia and Cellvibrio, which played different roles in improving soil fertility and advancing plant growth) was distinctly higher than the CN or CF treatments. Additionally, the total organic matter and Olsen-P content of the BFC and BFN treatments were significantly greater than the CN treatment. We conclude that Brassica vegetables-eggplant crop rotations could provide a more effective means of solving the problems of greenhouse eggplant monocultures.	[Li, Tianzhu; Liu, Tongtong; Zheng, Chengyu; Yang, Zichao; Yao, Xiaotong; Song, Fengbin; Zhang, Runzhi; Wang, Xuerong; Xu, Ning; Zhang, Chunyi; Li, Wei; Li, Shumin] Northeast Agr Univ, Resource & Environm Coll, Harbin, Peoples R China; [Kang, Chunsheng] Res Dev & Evaluat Ctr Lab, Harbin, Peoples R China	Northeast Agricultural University - China	Li, W; Li, SM (corresponding author), Northeast Agr Univ, Resource & Environm Coll, Harbin, Peoples R China.	botany@163.com; lishumin113@126.com	Kang, Chunsheng/AAM-5979-2021	Kang, Chunsheng/0000-0002-3255-3369	Special Fund for Agro-scientific Research in the Public Interest, China [201503109]; Heilongjiang Natural Science Foundation, China [C2015016]	Special Fund for Agro-scientific Research in the Public Interest, China; Heilongjiang Natural Science Foundation, China(Natural Science Foundation of Heilongjiang Province)	This work was financially supported by the Special Fund for Agro-scientific Research in the Public Interest, China (201503109), and Heilongjiang Natural Science Foundation, China (C2015016).	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Bai L, 2015, MICROBIOL RES, V180, P49, DOI 10.1016/j.micres.2015.07.007; Blanco H, 2008, CANQUI, V9, P199; Bonanomi G, 2010, SOIL BIOL BIOCHEM, V42, P136, DOI 10.1016/j.soilbio.2009.10.012; Boostani H. R., 2014, Scientific Journal of Biological Sciences, V3, P98; Canali S, 2013, EUR J AGRON, V50, P11, DOI 10.1016/j.eja.2013.05.001; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Cohen MF, 2005, SOIL BIOL BIOCHEM, V37, P1215, DOI 10.1016/j.soilbio.2004.11.027; CRAWFORD RL, 1985, ENZYME MICROB TECH, V7, P617, DOI 10.1016/0141-0229(85)90031-6; Deng SY, 2015, J HAZARD MATER, V297, P17, DOI 10.1016/j.jhazmat.2015.04.052; Dubey KK, 2012, WORLD J MICROB BIOT, V28, P1715, DOI 10.1007/s11274-011-0982-1; Etesami H, 2016, BIOL CONTROL, V94, P11, DOI 10.1016/j.biocontrol.2015.12.003; Ge SM, 2015, J ENVIRON MANAGE, V157, P54, DOI 10.1016/j.jenvman.2015.04.011; Ghosh A, 2016, INSIGHTS BACTERIOPLA; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Jiang YJ, 2016, SOIL BIOL BIOCHEM, V95, P250, DOI 10.1016/j.soilbio.2016.01.007; Johan L, 2012, J BIOL CHEM, V287, P43288; Johan L, 2011, BIOCHEM J, V436, P567; Kintche K, 2015, FIELD CROP RES, V184, P192, DOI 10.1016/j.fcr.2015.04.019; Kramer SB, 2006, P NATL ACAD SCI USA, V103, P4522, DOI 10.1073/pnas.0600359103; Larkin RP, 2007, CROP PROT, V26, P1067, DOI 10.1016/j.cropro.2006.10.004; Liu J, 2010, AGR SCI CHINA, V9, P266, DOI 10.1016/S1671-2927(09)60092-4; Liu K, 2015, PHYTOPATHOLOGY, V105; Liu XM, 2015, CHEMOSPHERE, V139, P379, DOI 10.1016/j.chemosphere.2015.07.034; Lou J, 2016, J BIOTECHNOL, V218, P49, DOI 10.1016/j.jbiotec.2015.11.026; Lacasa CM, 2015, SCI HORTIC-AMSTERDAM, V197, P607, DOI 10.1016/j.scienta.2015.10.024; da Costa CHM, 2016, EUR J AGRON, V74, P119, DOI 10.1016/j.eja.2015.12.001; Maya O, 2012, PLOS ONE, V7; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mengyi W, 2014, PLOS ONE, V9; Oda M., 2004, B NAT, V807, P619; Omirou M, 2011, MICROB ECOL, V61, P201, DOI 10.1007/s00248-010-9740-4; Pan M, 2016, ECOTOX ENVIRON SAFE, V126, P228, DOI 10.1016/j.ecoenv.2015.12.027; Pedras MSC, 2011, PHYTOCHEMISTRY, V72, P2308, DOI 10.1016/j.phytochem.2011.08.018; Peralta KD, 2012, WORLD J MICROB BIOT, V28, P2003, DOI 10.1007/s11274-012-1003-8; PICHINOTY F, 1976, A VAN LEEUW J MICROB, V42, P349, DOI 10.1007/BF00394134; Radicetti E, 2016, SCI HORTIC-AMSTERDAM, V204, P161, DOI 10.1016/j.scienta.2016.04.005; Radicetti E, 2016, SOIL TILL RES, V155, P329, DOI 10.1016/j.still.2015.09.004; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Ren T, 2015, CROP J, V3, P396, DOI 10.1016/j.cj.2015.04.007; Rosario MMT, 2008, PHYTOCHEMISTRY, V69, P464, DOI 10.1016/j.phytochem.2007.08.011; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shiomi Y, 1999, APPL ENVIRON MICROB, V65, P3996; Srinivasarao C, 2013, ADV AGRON, V121, P253, DOI 10.1016/B978-0-12-407685-3.00005-0; Sun FL, 2016, CHEMOSPHERE, V156, P212, DOI 10.1016/j.chemosphere.2016.04.117; Tago K, 2014, MICROBES ENVIRON, V29, P434, DOI 10.1264/jsme2.ME14122; Tian YQ, 2016, SCI TOTAL ENVIRON, V544, P251, DOI 10.1016/j.scitotenv.2015.11.091; Tian YQ, 2009, SCI HORTIC-AMSTERDAM, V123, P139, DOI 10.1016/j.scienta.2009.08.010; Tong Y, 2015, ENVIRON EXP BOT, V109, P288, DOI 10.1016/j.envexpbot.2014.06.008; Wang MY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00262; Wang QJ, 2014, EUR J SOIL BIOL, V61, P58, DOI 10.1016/j.ejsobi.2013.12.004; Wei Z, 2015, J HAZARDOUS MAT, V301; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Wu H., 2016, APPL MICROBIOL BIOT, P1; Zhang N, 2011, PLANT SOIL, V344, P87, DOI 10.1007/s11104-011-0729-7; Zhang XH, 2015, CHIN HERB MED, V7, P88, DOI 10.1016/S1674-6384(15)60025-9; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204; Zhao J, 2014, MICROB ECOL, V67, P443, DOI 10.1007/s00248-013-0322-0; Zheng BH, 2014, MICROBIOL RES, V169, P585, DOI 10.1016/j.micres.2013.09.019	59	37	41	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173923	10.1371/journal.pone.0173923	http://dx.doi.org/10.1371/journal.pone.0173923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346463	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300014
J	Shyu, HY; Chen, MH; Hsieh, YH; Shieh, JC; Yen, LR; Wang, HW; Cheng, CW				Shyu, Hann-Yeh; Chen, Ming-Hua; Hsieh, Yi-Hsien; Shieh, Jia-Ching; Yen, Ling-Rong; Wang, Hsiao-Wei; Cheng, Chun-Wen			Association of eNOS and Cav-1 gene polymorphisms with susceptibility risk of large artery atherosclerotic stroke	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARDIOVASCULAR-DISEASES; CAVEOLIN-1 GENE; ISCHEMIC-STROKE; EXPRESSION; GLU298ASP; VARIANTS; SUBTYPE	Endothelial nitric oxide synthase (eNOS) is localized in caveole and has important effects on caveolar coordination through its interaction with caveolin-1 (Cav-1), which supports normal functioning of vascular endothelial cells. However, the relationship between genotypic polymorphisms of e-NOS and Cav-1 genes and ischemic stroke (IS) remains lesser reported. This hospital-based case-control study aimed to determine the genetic polymorphisms of the eNOS (GIu298Asp) and Cav-1 (G14713A and T29107A) genes in association with susceptibility risk in patients who had suffered from a large artery atherosclerotic (LAA) stroke. Genotyping determination for these variant alleles was performed using the TaqMan assay. The distributions of observed allelic and genotypic frequencies for the polymorphisms were in Hardy-Weinberg equilibrium in healthy controls. The risk for an LAA stroke in the Asp298 variant was 1.72 (95% CI = 1.09-2.75) versus G1u298 of the eNOS. In the GA/AA (rs3807987) variant, it was 1.79 (95% CI = 1.16-2.74) versus GG and in TA/AA (rs7804372) was 1.61 (95% CI = 1.06-2.43) versus TTof the Cav-1, respectively. A tendency toward an increased LAA stroke risk was significant in carriers with the eNOS GIu298Asp variant in conjunction with the G14713 A and T29107A polymorphisms of the Cav-1 (aOR = 2.03, P- "trend = 0.002). A synergistic effect between eNOS and Cav-1 polymorphisms on IS risk elevation was significantly influenced by alcohol drinking, heavy cigarette smoking (P "trend<0.01), and hypercholesterolemia (P "trend < 0.001). In conclusion, genotypic polymorphisms of the eNOS GIu298Asp and Cav-1 14713A/29107A polymorphisms are associated with the elevated risk of LAA stroke among Han Chinese in Taiwan.	[Shyu, Hann-Yeh; Chen, Ming-Hua; Yen, Ling-Rong] Armed Forces Taoyuan Gen Hosp, Dept Internal Med, Neurol Sect, Taoyuan, Taiwan; [Shyu, Hann-Yeh] Natl Def Med Ctr, Inst Biol & Anat, Taipei, Taiwan; [Chen, Ming-Hua] Natl Def Med Ctr, Triservice Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsieh, Yi-Hsien; Wang, Hsiao-Wei; Cheng, Chun-Wen] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Shieh, Jia-Ching] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Wang, Hsiao-Wei; Cheng, Chun-Wen] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	National Defense Medical Center; National Defense Medical Center; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Cheng, CW (corresponding author), Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.; Cheng, CW (corresponding author), Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan.	cwcheng@csmu.edu.tw	Chen, Ming/GVU-8412-2022		Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan [10207]	Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan	This study was supported by the research grant 10207 from the Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; [Anonymous], 1988, ARCH INTERN MED, V148, P1023; Balakumar P, 2012, J MOL CELL CARDIOL, V52, P83, DOI 10.1016/j.yjmcc.2011.09.014; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Cam SF, 2005, THROMB RES, V116, P287, DOI 10.1016/j.thromres.2004.12.002; Chai Q, 2013, CARDIOVASC RES, V100, P151, DOI 10.1093/cvr/cvt157; Chen SS, 2016, ATHEROSCLEROSIS, V246, P148, DOI 10.1016/j.atherosclerosis.2016.01.008; Chen SS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001980; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fujita T, 2001, CARDIOVASC RES, V51, P709, DOI 10.1016/S0008-6363(01)00348-0; Goligorsky MS, 2002, AM J PHYSIOL-RENAL, V283, pF1, DOI 10.1152/ajprenal.00377.2001; Gorressen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120961; Grant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Hassan A, 2004, STROKE, V35, P654, DOI 10.1161/01.STR.0000117238.75736.53; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Hu CJ, 2007, CLIN CHEM LAB MED, V45, P20, DOI 10.1515/CCLM.2007.014; Kuklina EV, 2012, EXPERT REV NEUROTHER, V12, P199, DOI [10.1586/ern.11.99, 10.1586/ERN.11.99]; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Li G, 2014, ADV MECH ENG, DOI 10.1155/2014/251591; Lin NT, 2008, CHINESE J PHYSIOL, V51, P42; Luo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145399; MADDEN KP, 1995, NEUROLOGY, V45, P1975, DOI 10.1212/WNL.45.11.1975; Martin RIR, 2015, J MOL CELL CARDIOL, V85, P207, DOI 10.1016/j.yjmcc.2015.06.005; Men C, 2011, INDIAN J BIOCHEM BIO, V48, P154; Mineo C, 2012, ADV EXP MED BIOL, V729, P51, DOI 10.1007/978-1-4614-1222-9_4; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Park KW, 2004, HEART, V90, P282, DOI 10.1136/hrt.2002.003616; Pojoga LH, 2011, J CLIN ENDOCR METAB, V96, pE1288, DOI 10.1210/jc.2010-2738; Qin L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030429; Rubattu S, 2000, AM J HYPERTENS, V13, P1139, DOI 10.1016/S0895-7061(00)01249-8; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Shyu HY, 2012, J ATHEROSCLER THROMB, V19, P316, DOI 10.5551/jat.10967; Sonveaux P, 2004, CIRC RES, V95, P154, DOI 10.1161/01.RES.0000136344.27825.72; Srivastava K, 2005, COMMUNITY GENET, V8, P180, DOI 10.1159/000086761; Szabo GV, 2013, INTERV MED APPL SCI, V5, P46, DOI 10.1556/IMAS.5.2013.1.10; Testa A, 2012, AM J HYPERTENS, V25, P103, DOI 10.1038/ajh.2011.178; Torpy Janet M, 2009, JAMA, V302, P2388, DOI 10.1001/jama.302.21.2388; Ueki M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-72; Vecoli C, 2014, VITAM HORM, V96, P387, DOI 10.1016/B978-0-12-800254-4.00015-5; von Sarnowski B, 2013, STROKE, V44, P119, DOI 10.1161/STROKEAHA.112.665190; Yang BH, 2013, CELL MOL BIOENG, V6, P346, DOI 10.1007/s12195-013-0276-9; Yao YS, 2013, GENE, V528, P84, DOI 10.1016/j.gene.2013.06.047	48	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174110	10.1371/journal.pone.0174110	http://dx.doi.org/10.1371/journal.pone.0174110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346478	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300024
J	Sun, MY; Taylor, A; Zorumski, CF; Mennerick, S				Sun, Min-Yu; Taylor, Amanda; Zorumski, Charles F.; Mennerick, Steven			24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; CHOLESTEROL 24-HYDROXYLASE; BRAIN; OXYSTEROLS; 24(S)-HYDROXYCHOLESTEROL; METABOLISM; NECROPTOSIS; TURNOVER; PROTEINS; KNOCKOUT	N-methyl-D-aspartate receptors (NMDARs), a major subtype of glutamate receptor mediating excitatory transmission throughout the CNS, participate in ischemia-induced neuronal death. Unfortunately, undesired side effects have limited the strategy of inhibiting/blocking NMDARs as therapy. Targeting endogenous positive allosteric modulators of NMDAR function may offer a strategy with fewer downsides. Here, we explored whether 24S-hydroxycholesterol (24S-HC), an endogenous positive NMDAR modulator characterized recently by our group, participates in NMDAR-mediated excitotoxicity following oxygen-glucose deprivation (OGD) in primary neuron cultures. 24S-HC is the major brain cholesterol metabolite produced exclusively in neurons near sites of glutamate transmission. By selectively potentiating NMDAR current, 24S-HC may participate in NMDAR-mediated excitotoxicity following energy failure, thus impacting recovery after stroke. In support of this hypothesis, our findings indicate that exogenous application of 24S-HC exacerbates NMDAR-dependent excitotoxicity in primary neuron culture following OGD, an ischemic-like challenge. Similarly, enhancement of endogenous 24S-HC synthesis reduced survival rate. On the other hand, reducing endogenous 24S-HC synthesis alleviated OGD-induced cell death. We found that 25-HC, another oxysterol that antagonizes 24S-HC potentiation, partially rescued OGD-mediated cell death in the presence or absence of exogenous 24S-HC application, and 25HC exhibited NMDAR-dependent/24S-HC-dependent neuroprotection, as well as NMDARindependent neuroprotection in rat tissue but not mouse tissue. Our findings suggest that both endogenous and exogenous 24S-HC exacerbate OGD-induced damage via NMDAR activation, while 25-HC exhibits species dependent neuroprotection through both NMDAR-dependent and independent mechanisms.	[Sun, Min-Yu; Taylor, Amanda; Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.; Mennerick, S (corresponding author), Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA.	menneris@wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664	Bantly Foundation; National Institutes of Health [AA017413, MH077791, MH078823, MH101874, MH104506]; Washington University in St. Louis McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101874] Funding Source: NIH RePORTER	Bantly Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University in St. Louis McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Bantly Foundation and by National Institutes of Health (https://www.nih.gov/) grants AA017413, MH077791, MH078823, MH101874, and MH104506 (S.M.), and by Washington University in St. Louis McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship (M-Y. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Bjorkhem I, 2013, NEUROSCI LETT, V555, P102, DOI 10.1016/j.neulet.2013.09.003; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Emnett CM, 2013, MOL PHARMACOL, V84, P935, DOI 10.1124/mol.113.089334; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; KAKU DA, 1991, BRAIN RES, V554, P344, DOI 10.1016/0006-8993(91)90214-G; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leoni V, 2014, BIOCHEM BIOPH RES CO, V446, P697, DOI 10.1016/j.bbrc.2014.01.188; Linsenbardt AJ, 2014, NEUROPHARMACOLOGY, V85, P232, DOI 10.1016/j.neuropharm.2014.05.027; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Meljon A, 2014, BIOCHEM BIOPH RES CO, V446, P768, DOI 10.1016/j.bbrc.2014.01.153; Meljon A, 2012, J LIPID RES, V53, P2469, DOI 10.1194/jlr.D028233; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; ROTHMAN SM, 1987, NEUROSCIENCE, V21, P673, DOI 10.1016/0306-4522(87)90028-5; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; SMITH LL, 1972, J NEUROCHEM, V19, P899, DOI 10.1111/j.1471-4159.1972.tb01406.x; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x; Soderoa AO, 2011, NEUROBIOL AGING, V32, P1043, DOI 10.1016/j.neurobiolaging.2010.06.001; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Sun M.Y., 2015, NEUROSCIENTIST; Sun MY, 2015, J NEUROPHYSIOL; Weilinger NL, 2013, ACTA PHARMACOL SIN, V34, P39, DOI 10.1038/aps.2012.95; Yamanaka K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.524; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Zar JH, 1999, BIOSTATISTICAL ANAL	33	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174416	10.1371/journal.pone.0174416	http://dx.doi.org/10.1371/journal.pone.0174416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346482	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300044
J	Tan, HH; Xu, J; Teoh, HL; Chan, BPL; Seet, RCS; Venketasubramanian, N; Sharma, VK; Chen, CLH; Dong, Y				Tan, Hui Hui; Xu, Jing; Teoh, Hock Luen; Chan, Bernard Poon-Lap; Seet, Raymond Chee Seong; Venketasubramanian, Narayanaswarmy; Sharma, Vijay Kumar; Chen, Christopher Li-Hsian; Dong, YanHong			Decline in changing Montreal Cognitive Assessment (MoCA) scores is associated with post-stroke cognitive decline determined by a formal neuropsychological evaluation	PLOS ONE			English	Article							MINI-MENTAL-STATE; STROKE; IMPAIRMENT; SUPERIOR; DEMENTIA; VALIDITY; DISEASE	Objectives We aimed to examine changes in the Montreal Cognitive Assessment (MoCA) and MiniMental State Examination (MMSE) scores within a one-year period after stroke/transient ischemic attack (TIA) in associating cognitive decline determined by a formal neuropsychological test battery. Methods Patients with ischemic stroke/TIA received MoCA and MMSE at baseline within 14 days after stroke/TIA, at 3-6 months and 1-year follow-ups. The scores of MoCA and MMSE were considered to have declined if there were a reduction of >= 2 points in the respective scores measured across two time points. The decline in neuropsychological diagnosis transitional status was defined by a category transition from no cognitive impairment or any cognitive impairment to a more severe cognitive impairment or dementia. Results 275 patients with a mean age of 59.8 +/- 11.6 years, and education of 7.7 +/- 4.3 years completed all the assessments at baseline, 3-6 months and 1-year follow-ups. A decline in MoCA scores from 3-6 months to 1 year was associated with higher risk of decline in diagnosis transitional status (odd ratio = 3.21, p = 0.004) in the same time period whereas there was no association with a decline in MMSE scores. Conclusions The decline in MoCA scores from 3-6 months to 1 year after stroke/TIA has three times higher risk for decline in the diagnosis transitional status. The decline of MoCA scores (reduction >= 2points) is associated with the decline in neuropsychological diagnosis transitional status.	[Tan, Hui Hui; Teoh, Hock Luen; Chan, Bernard Poon-Lap; Seet, Raymond Chee Seong; Sharma, Vijay Kumar; Dong, YanHong] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Div Neurol, Singapore, Singapore; [Xu, Jing] Singapore Clin Res Inst, Singapore, Singapore; [Venketasubramanian, Narayanaswarmy; Chen, Christopher Li-Hsian] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Memory Ageing & Cognit Ctr, Singapore, Singapore; [Venketasubramanian, Narayanaswarmy] Raffles Hosp, Neurosci Ctr, Singapore, Singapore; [Dong, YanHong] Univ New South Wales, Ctr Healthy Brain Ageing CHeBA, Sydney, NSW, Australia; [Dong, YanHong] Univ New South Wales, Dementia Collaborat Res Ctr Assessment & Better C, Sch Psychiat, UNSW Med, Sydney, NSW, Australia	National University of Singapore; Singapore Clinical Research Institute; National University of Singapore; Raffles Hospital; University of New South Wales Sydney; University of New South Wales Sydney	Dong, Y (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Div Neurol, Singapore, Singapore.; Dong, Y (corresponding author), Univ New South Wales, Ctr Healthy Brain Ageing CHeBA, Sydney, NSW, Australia.; Dong, Y (corresponding author), Univ New South Wales, Dementia Collaborat Res Ctr Assessment & Better C, Sch Psychiat, UNSW Med, Sydney, NSW, Australia.	mdcdy@nus.edu.sg	Venketasubramanian, Narayanaswamy/GPP-5948-2022; Chen, Christopher/E-7023-2013; sharma, Vijay/T-5286-2019	Chen, Christopher/0000-0002-1047-9225; sharma, Vijay/0000-0002-8976-5696; Seet, Raymond/0000-0001-8946-3578; /0000-0002-4763-6984	National Medical Research Council [NMRC/CG/NUHS/2010]; NUHS National Clinician Scientist Program award	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NUHS National Clinician Scientist Program award	This study is funded by a Center Grant (NMRC/CG/NUHS/2010) from the National Medical Research Council (http://www.nmrc.gov.sg/). Y. Dong was a recipient of the NUHS National Clinician Scientist Program award during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by a Center Grant from the National Medical Research Council (NMRC/CG/NUHS/2010). Y. Dong was a recipient of the NUHS National Clinician Scientist Program award during this study. The authors thank all participants for their involvement, the research team from NUHS Memory Ageing and Cognition Centre for data collection.	Dong YH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0570-y; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kalmijn S, 1996, STROKE, V27, P2230, DOI 10.1161/01.STR.27.12.2230; Krishnan K, 2016, CHANGES MONTREAL COG; Narasimhalu K, 2009, NEUROLOGY, V73, P1866, DOI 10.1212/WNL.0b013e3181c3fcb7; Narasimhalu K, 2008, DEMENT GERIATR COGN, V25, P17, DOI 10.1159/000111128; Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Salvadori E, 2013, J NEUROL, V260, P2220, DOI 10.1007/s00415-013-6962-7; Sivakumar L, 2014, STROKE, V45, P1709, DOI 10.1161/STROKEAHA.114.004726; Van Heugten CM, 2015, CLIN REHABIL, V29, P694, DOI 10.1177/0269215514553012; Yeo D, 1997, NEUROLOGICAL J S E A, V2	18	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173291	10.1371/journal.pone.0173291	http://dx.doi.org/10.1371/journal.pone.0173291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346532	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300004
J	Besheli, LD; Tan, CO; Bell, DL; Hirsch, JA; Gupta, R				Besheli, Laleh Daftari; Tan, Can Ozan; Bell, Donnie L.; Hirsch, Joshua A.; Gupta, Rajiv			Temporal evolution of vasospasm and clinical outcome after intra-arterial vasodilator therapy in patients with aneurysmal subarachnoid hemorrhage	PLOS ONE			English	Article							PROLONGED-RELEASE IMPLANTS; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; DELAYED CEREBRAL-ISCHEMIA; DOUBLE-BLIND; NICARDIPINE; MANAGEMENT; METAANALYSIS; EXPERIENCE; INFARCTION; DIAGNOSIS	Intra-arterial (IA) vasodilator therapy is one of the recommended treatments to minimize the impact of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm refractory to standard management. However, its usefulness and efficacy is not well established. We evaluated the effect IA vasodilator therapy on middle cerebral artery blood flow and on discharge outcome. We reviewed records for 115 adults admitted to Neurointensive Care Unit to test whether there was a difference in clinical outcome (discharge mRS) in those who received IA infusions. In a subset of 19 patients (33 vessels) treated using IA therapy, we tested whether therapy was effective in reversing the trends in blood flow. All measures of MCA blood flow increased from day -2 to -1 before infusion (maximum Peak Systolic Velocity (PSV) 232.2 +/- 9.4 to 262.4 +/- 12.5 cm/s [p = 0.02]; average PSV 202.1 +/- 8.5 to 229.9 +/- 10.9 [p = 0.02]; highest Mean Flow Velocity (MFV) 154.3 +/- 8.3 to 172.9 +/- 10.5 [p = 0.10]; average MFV 125.5 +/- 6.3 to 147.8 +/- 9.5 cm/s, [p = 0.02]) but not post-infusion (maximum PSV 261.2 +/- 14.6 cm/s [p =.89]; average PSV 223.4 +/- 11.4 [p = 0.56]; highest MFV 182.9 +/- 12.4 cm/s [p = 0.38]; average MFV 153.0 +/- 10.2 cm/s [p = 0.54]). After IA therapy, flow velocities were consistently reduced (day X infusion interaction p< 0.01 for all measures). However, discharge mRS was higher in IA infusion group, even after adjusting for sex, age, and admission grades. Thus, while IA vasodilator therapy was effective in reversing the vasospasm-mediated deterioration in blood flow, clinical outcomes in the treated group were worse than the untreated group. There is need for a prospective randomized controlled trial to avoid potential confounding effect of selection bias.	[Besheli, Laleh Daftari; Tan, Can Ozan; Bell, Donnie L.; Hirsch, Joshua A.; Gupta, Rajiv] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Besheli, Laleh Daftari; Tan, Can Ozan; Bell, Donnie L.; Hirsch, Joshua A.; Gupta, Rajiv] Harvard Med Sch, Boston, MA 02115 USA; [Tan, Can Ozan] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Cerebrovasc Res Lab, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Spaulding Rehabilitation Hospital	Tan, CO (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Tan, CO (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Tan, CO (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Cerebrovasc Res Lab, Boston, MA 02129 USA.	cotan@mgh.harvard.edu	Tan, Can Ozan/E-2598-2016	Tan, Can Ozan/0000-0001-9673-9907				Badjatia N, 2004, AM J NEURORADIOL, V25, P819; Baggott CD, 2014, NEUROSURG CLIN N AM, V25, P497, DOI 10.1016/j.nec.2014.04.008; Barth M, 2007, STROKE, V38, P330, DOI 10.1161/01.STR.0000254601.74596.0f; Bauer AM, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00072; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brown RJ, 2013, NEUROSURGERY, V72, P702, DOI 10.1227/NEU.0b013e318285c3db; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; Huang RQ, 2013, ACTA NEUROL BELG, V113, P3, DOI 10.1007/s13760-012-0142-x; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Kasuya H, 2005, NEUROSURGERY, V56, P895; Keuwamp J, 2008, J NEUROSURG, V108, P458, DOI 10.3171/JNS/2008/108/3/0458; Krischek B, 2007, NEUROL MED-CHIR, V47, P389, DOI 10.2176/nmc.47.389; Lu N, 2012, NEUROCRIT CARE, V16, P368, DOI 10.1007/s12028-011-9659-8; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Marshall SA, 2010, NEUROSURG CLIN N AM, V21, P291, DOI 10.1016/j.nec.2009.10.010; Miller JC, 2010, J AM COLL RADIOL, V7, P73, DOI 10.1016/j.jacr.2009.06.015; Nogueira RG, 2009, AM J NEURORADIOL, V30, P160, DOI 10.3174/ajnr.A1275; Pierot L, 2010, CURR OPIN CRIT CARE, V16, P110, DOI 10.1097/MCC.0b013e3283372ef2; Polin RS, 1998, NEUROSURGERY, V42, P1256, DOI 10.1097/00006123-199806000-00031; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Santos GA, 2016, NEUROLOGY IN PRESS; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Suarez JI, 2002, CRIT CARE MED, V30, P1348, DOI 10.1097/00003246-200206000-00035; Tejada JG, 2007, AM J NEURORADIOL, V28, P844; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174676	10.1371/journal.pone.0174676	http://dx.doi.org/10.1371/journal.pone.0174676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339483	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700036
J	Qin, LJ; Zhang, F; Wang, WX; Song, WX				Qin, Lijuan; Zhang, Feng; Wang, Wanxiong; Song, Weixin			Interaction between Allee effects caused by organism-environment feedback and by other ecological mechanisms	PLOS ONE			English	Article							DISTRIBUTION PATTERNS; COMPETITIVE DYNAMICS; DENSITY-DEPENDENCE; TIME-DELAY; HABITAT; SUBJECT; POPULATIONS; COEXISTENCE; STABILITY; EPIDEMIC	Understanding Allee effect has crucial importance for ecological conservation and management because it is strongly related to population extinction. Due to various ecological mechanisms accounting for Allee effect, it is necessary to study the influence of multiple Allee effects on the dynamics and persistence of population. We here focus on organism-environment feedback which can incur strong, weak, and fatal Allee effect (AE-by-OEF), and further examine their interaction with the Allee effects caused by other ecological mechanisms (AE-by-OM). The results show that multiple Allee effects largely increase the extinction risk of population either due to the enlargement of Allee threshold or the change of inherent characteristic of Allee effect, and such an increase will be enhanced dramatically with increasing the strength of individual Allee effects. Our simulations explicitly considering spatial structure also demonstrate that local interaction among habitat patches can greatly mitigate such superimposed Allee effects as well as individual Allee effect. This implies that spatially structurized habitat could play an important role in ecological conservation and management.	[Qin, Lijuan; Wang, Wanxiong] Gansu Agr Univ, Coll Resources & Environm Sci, Lanzhou, Peoples R China; [Qin, Lijuan; Zhang, Feng; Wang, Wanxiong; Song, Weixin] Gansu Agr Univ, Coll Sci, Ctr Quantitat Biol, Lanzhou, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Wang, WX (corresponding author), Gansu Agr Univ, Coll Resources & Environm Sci, Lanzhou, Peoples R China.; Zhang, F; Wang, WX (corresponding author), Gansu Agr Univ, Coll Sci, Ctr Quantitat Biol, Lanzhou, Peoples R China.	fzhang188@163.com; wangwx@gsau.edu.cn			National Natural Science Foundation of China [31360104]; Supportive Plan of China [2007BAD88B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supportive Plan of China	This study was supported by the National Natural Science Foundation of China (No. 31360104) and the Supportive Plan of China (No. 2007BAD88B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Amarasekare P, 1998, AM NAT, V152, P298, DOI 10.1086/286169; Begon M., 1996, ECOLOGY; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Berryman AA, 2003, OIKOS, V103, P695, DOI 10.1034/j.1600-0706.2003.12810.x; BIRKHEAD TR, 1977, J ANIM ECOL, V46, P751, DOI 10.2307/3638; Brandt AJ, 2012, ECOLOGY, V93, P1451, DOI 10.1890/11-0579.1; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dennis B., 1989, Natural Resource Modeling, V3, P481; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Eskola HTM, 2007, THEOR POPUL BIOL, V72, P41, DOI 10.1016/j.tpb.2007.03.004; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gascoigne J, 2005, THEOR POPUL BIOL, V68, P237, DOI 10.1016/j.tpb.2005.02.005; Gascoigne JC, 2005, OECOLOGIA, V145, P371, DOI 10.1007/s00442-005-0137-x; HAMMOND DS, 1995, J TROP ECOL, V11, P295, DOI 10.1017/S0266467400008762; Hanert E, 2011, J THEOR BIOL, V279, P9, DOI 10.1016/j.jtbi.2011.03.012; Hanski I., 1999, METAPOPULATION ECOLO; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Hui C, 2004, POPUL ECOL, V46, P55, DOI 10.1007/s10144-004-0171-2; Hui C, 2004, ECOL MODEL, V177, P107, DOI 10.1016/j.ecolmodel.2003.11.016; Hui C, 2003, ECOL MODEL, V164, P201, DOI 10.1016/S0304-3800(03)00025-5; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Killingback T, 2006, J THEOR BIOL, V241, P745, DOI 10.1016/j.jtbi.2006.01.010; Kot M, 2001, ELEMENTS MATH ECOLOG, DOI 10.1017/CBO9780511608520; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Lande R., 2003, OXFORD SERIES ECOLOG; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2012, NONLINEAR DYNAM, V67, P1737, DOI 10.1007/s11071-011-0101-8; Liermann M, 2001, FISH FISH, V2, P33, DOI 10.1046/j.1467-2979.2001.00029.x; McVinish R, 2013, ECOL MODEL, V249, P84, DOI 10.1016/j.ecolmodel.2012.07.001; Molnar PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085410; Murray JD, 2003, MATH BILOLGY; Murrell DJ, 2010, ECOLOGY, V91, P1605, DOI 10.1890/09-0832.1; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Petrovskii S. V., 2006, EXACTLY SOLVABLE MOD; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Rass L, 2005, MATH BIOSCI, V195, P194, DOI 10.1016/j.mbs.2005.02.005; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Savill NJ, 1998, P ROY SOC B-BIOL SCI, V265, P25, DOI 10.1098/rspb.1998.0259; Seto M, 2011, J THEOR BIOL, V269, P297, DOI 10.1016/j.jtbi.2010.10.035; Shaw MW, 2014, EUR J PLANT PATHOL, V138, P487, DOI 10.1007/s10658-013-0339-8; Snyder RE, 2007, THEOR POPUL BIOL, V72, P7, DOI 10.1016/j.tpb.2007.03.009; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Stephens PA, 2008, CONSERV BIOL, V22, P1662; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun GQ, 2009, J BIOL PHYS, V35, P185, DOI 10.1007/s10867-009-9139-y; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tuckwell HC, 2007, BIOSYSTEMS, V90, P546, DOI 10.1016/j.biosystems.2006.12.006; Wang G, 1999, ECOL MODEL, V124, P183, DOI 10.1016/S0304-3800(99)00160-X; Wertheim B, 2002, ECOL ENTOMOL, V27, P608, DOI 10.1046/j.1365-2311.2002.00449.x; Yue DX, 2004, ISR J PLANT SCI, V52, P235, DOI 10.1560/XBQW-L1WH-1Q3X-DJHR; Zarnetske PL, 2012, ECOLOGY, V93, P1439, DOI 10.1890/11-1112.1; Zhang F, 2006, ECOL MODEL, V193, P721, DOI 10.1016/j.ecolmodel.2005.09.009; Zhang F, 2005, ECOL RES, V20, P461, DOI 10.1007/s11284-005-0072-7; Zhang F, 2012, MATH BIOSCI, V240, P260, DOI 10.1016/j.mbs.2012.08.006; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027523; Zhou SR, 2005, THEOR POPUL BIOL, V67, P23, DOI 10.1016/j.tpb.2004.06.007; Zhou SR, 2004, MATH BIOSCI, V189, P103, DOI 10.1016/j.mbs.2003.06.001; Zhou SR, 2004, THEOR POPUL BIOL, V65, P29, DOI 10.1016/j.tpb.2003.08.002; Zu JA, 2010, APPL MATH COMPUT, V217, P3542, DOI 10.1016/j.amc.2010.09.029	73	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174141	10.1371/journal.pone.0174141	http://dx.doi.org/10.1371/journal.pone.0174141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333974	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200054
J	Simiczyjew, A; Mazur, AJ; Dratkiewicz, E; Nowak, D				Simiczyjew, Aleksandra; Mazur, Antonina Joanna; Dratkiewicz, Ewelina; Nowak, Dorota			Involvement of beta- and gamma-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells	PLOS ONE			English	Article							MESSENGER-RNA; CYTOPLASMIC ACTINS; PLASMA-MEMBRANE; GENE-EXPRESSION; INVASION; PROTEINS; PLASTICITY; MOVEMENT; MOTILITY; TISSUES	Amoeboid movement is characteristic for rounded cells, which do not form strong adhesion contacts with the ECM and use blebs as migratory protrusions. It is well known that actin is the main component of mature forms of these structures, but the exact role fulfilled by nonmuscle actin isoforms alpha- and gamma-in bleb formation and migration of these cells is still not fully understood. The aim of this study was to establish the role of alpha- and gamma-actin in migration of bleb-forming cancer cells using isoform-specific antibodies and expression of fluorescently tagged actin isoforms. We observed, after staining with monoclonal antibodies, that both actins are present in these cells in the form of a cortical ring as well as in the area of blebs. Additionally, using simultaneous expression of differentially tagged alpha- and gamma-actin in cells, we observed that the actin isoforms are present together in a single bleb. They were involved during bleb expansion as well as retraction. Also present in the area of these protrusions formed by both isoforms were the bleb markers-ezrin and myosin II. The overexpression of alpha- or gamma-actin led to actin cytoskeletal rearrangement followed by the growth of migration and invasion abilities of examined human colon cancer cells, LS174T line. In summary these data prove that both actin isoforms have an impact on motility of bleb-forming cancer cells. Moreover, we conclude that monoclonal antibodies directed against actin isoforms in combination with the tagged actins are good tools to study their role in important biological processes.	[Simiczyjew, Aleksandra; Mazur, Antonina Joanna; Dratkiewicz, Ewelina; Nowak, Dorota] Univ Wroclaw, Fac Biotechnol, Dept Cell Pathol, Joliot Curie 14A, Wroclaw, Poland	University of Wroclaw	Simiczyjew, A (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Cell Pathol, Joliot Curie 14A, Wroclaw, Poland.	aleksandra.simiczyjew@uwr.edu.pl	Mazur, Antonina/L-6504-2019	Mazur, Antonina/0000-0002-7561-9030; Nowak, Dorota/0000-0002-6426-1686; Dratkiewicz, Ewelina/0000-0002-2389-3513; Simiczyjew, Aleksandra/0000-0002-6060-2375	Ministry of Science and Higher Education, Poland [N N303337535]; National Center for Science [DEC-2014/12/T/NZ3/00503]; Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW)	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Center for Science(National Science Centre, Poland); Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW)	Dorota Nowak would like to thank the Ministry of Science and Higher Education, Poland, for Grant No. N N303337535. Aleksandra Simiczyjew would like to thank the National Center for Science for funds for doctoral thesis realization on the basis of the decision number: DEC-2014/12/T/NZ3/00503. Publication costs were supported by Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW) for 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2014, BIOCHEMISTRY-MOSCOW+, V79, P947, DOI 10.1134/S0006297914090107; Baranwal S, 2012, MOL BIOL CELL, V23, P3542, DOI 10.1091/mbc.E12-02-0162; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Bolte S, 2006, J MICROSC-OXFORD, V224, P13, DOI DOI 10.1111/J.1365-2818.2006.01706.X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brault V, 1999, J CELL SCI, V112, P3627; Brittingham J, 1997, PATHOBIOLOGY, V65, P113, DOI 10.1159/000164112; Brockmann C, 2011, BIOL REPROD, V85, P1025, DOI 10.1095/biolreprod.111.091736; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Bunnell TM, 2010, CYTOSKELETON, V67, P564, DOI 10.1002/cm.20467; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Condeelis J, 2005, BIOL CELL, V97, P97; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Dugina V, 2015, ONCOTARGET, V6, P14556, DOI 10.18632/oncotarget.3989; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GABBIANI G, 1984, J CLIN INVEST, V73, P148, DOI 10.1172/JCI111185; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Harborth J, 2001, J CELL SCI, V114, P4557; HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Khaitlina SY, 2007, CELL TISSUE BIOL, V1, P293, DOI DOI 10.1134/S1990519X07040025; Kieda C, 2002, ENDOTHELIUM-J ENDOTH, V9, P247, DOI 10.1080/10623320214736; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Krakhmal NV, 2015, ACTA NATURAE, V7, P17, DOI 10.32607/20758251-2015-7-2-17-28; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laser-Azogui A, 2014, ONCOGENE, V33, P1788, DOI 10.1038/onc.2013.138; Le PU, 1998, INCREASED ACTIN EXPR, P1631; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; MacGrath SM, 2011, CURR BIOL, V21, pR280, DOI 10.1016/j.cub.2011.03.035; Malicka- Blaszkiewicz M, 2014, HISTOCHEM CELL BIOL, V142, P307; MALICKABLASZKIEWICZ M, 1981, BIOCHEM BIOPH RES CO, V102, P594, DOI 10.1016/S0006-291X(81)80173-8; MALICKABLASZKIEWICZ M, 1986, COMP BIOCHEM PHYS B, V84, P207, DOI 10.1016/0305-0491(86)90207-5; Mannherz HG, 2010, EUR J HISTOCHEM, V54, pe14; Morley S, 2014, ASIAN J ANDROL, V16, P530, DOI 10.4103/1008-682X.122877; Muller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070636; Nagata K., 1984, Cell and Muscle Motility, V5, P171; Nowak D, 2005, ACTA BIOCHIM POL, V52, P461; Nowak D, 2002, ACTA BIOCHIM POL, V49, P823; Opolski A, 1998, FOLIA MICROBIOL, V43, P507, DOI 10.1007/BF02820806; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Pasquier E, 2015, VASC CELL, V7, DOI 10.1186/s13221-014-0027-2; Peckham M, 2001, J CELL SCI, V114, P1367; Perrin BJ, 2010, CYTOSKELETON, V67, P630, DOI 10.1002/cm.20475; Pinner S, 2008, J MICROSC-OXFORD, V231, P441, DOI 10.1111/j.1365-2818.2008.02056.x; Popow-Wozniak A, 2012, HISTOCHEM CELL BIOL, V138, P725, DOI 10.1007/s00418-012-0988-2; Radwanska A, 2012, EXP CELL RES, V318, P2312, DOI 10.1016/j.yexcr.2012.07.005; RINTOUL Robert C., 2009, INT J RADIAT BIOL, V83, P733; Rommelaere Heidi, 2004, Biol Proced Online, V6, P235, DOI 10.1251/bpo94; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rossy J, 2007, EXP CELL RES, V313, P1106, DOI 10.1016/j.yexcr.2006.12.023; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; Shagieva GS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1266, DOI 10.1134/S0006297912110053; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Simiczyjew A, 2015, EXP CELL RES, V339, P206, DOI 10.1016/j.yexcr.2015.11.003; Simiczyjew Aleksandra, 2013, Postepy Biochem, V59, P285; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sroka J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149133; Stournaras C, 1996, BIOCHEM PHARMACOL, V52, P1339, DOI 10.1016/S0006-2952(96)00389-9; Sugiyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137032; TOH BH, 1977, CANCER RES, V37, P4280; Tondeleir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085608; Tondeleir D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067855; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Watanabe H, 1998, J CELL SCI, V111, P1287; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	84	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173709	10.1371/journal.pone.0173709	http://dx.doi.org/10.1371/journal.pone.0173709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333953	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200022
J	Son, SJ; Kim, J; Park, H				Son, Seong-Jin; Kim, Jonghoon; Park, Hyunjin			Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients	PLOS ONE			English	Article							LEWY BODIES; DEMENTIA; ATROPHY; STATE; MRI; PET; NETWORKS; THALAMUS; FDG	Regional volume atrophy and functional degeneration are key imaging hallmarks of Alzheimer's disease (AD) in structural and functional magnetic resonance imaging (MRI), respectively. We jointly explored regional volume atrophy and functional connectivity to better characterize neuroimaging data of AD and mild cognitive impairment (MCI). All data were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We compared regional volume atrophy and functional connectivity in 10 subcortical regions using structural MRI and resting-state functional MRI (rs-fMRI). Neuroimaging data of normal controls (NC) (n = 35), MCI (n = 40), and AD (n = 30) were compared. Significant differences of regional volumes and functional connectivity measures between groups were assessed using permutation tests in 10 regions. The regional volume atrophy and functional connectivity of identified regions were used as features for the random forest classifier to distinguish among three groups. The features of the identified regions were also regarded as connectional fingerprints that could distinctively separate a given group from the others. We identified a few regions with distinctive regional atrophy and functional connectivity patterns for NC, MCI, and AD groups. A three label classifier using the information of regional volume atrophy and functional connectivity of identified regions achieved classification accuracy of 53.33% to distinguish among NC, MCI, and AD. We identified distinctive regional atrophy and functional connectivity patterns that could be regarded as a connectional fingerprint.	[Son, Seong-Jin; Kim, Jonghoon] Sungkyunkwan Univ, Dept Elect Elect & Comp Engn, Suwon, South Korea; [Son, Seong-Jin; Kim, Jonghoon; Park, Hyunjin] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Park, Hyunjin] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea	Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU)	Park, H (corresponding author), Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea.; Park, H (corresponding author), Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea.	hyunjinp@skku.edu	Park, Hyunjin/A-1164-2007	Park, Hyunjin/0000-0001-5681-8918	Institute for Basic Science [IBS-R015-D1]; National Research Foundation of Korea [NRF-2016R1A2B4008545]; NIH grant [U01AG024904, P30AG010129, K01AG030514]; Dana Foundation; National Institutes of Health grant [U01 AG024904]	Institute for Basic Science; National Research Foundation of Korea(National Research Foundation of Korea); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Institute for Basic Science (IBS-R015-D1, http://www.ibs.re.kr/, recipient:HP). This work was also supported by the National Research Foundation of Korea (NRF-2016R1A2B4008545, http//www.nrt.re.krl, recipient:HP). Image data collection was supported by NIH grants U01AG024904, P30AG010129, K01AG030514 and the Dana Foundation. The authors appreciate the ADNI database (http://www.adni-info.org, funded by National Institutes of Health grant U01 AG024904) for providing neuroimaging data for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Institute for Basic Science (grant number IBS-R015-D1). This work was also supported by the National Research Foundation (NRF) of Korea (grant number NRF-2016R1A2B4008545). Image data collection was supported by NIH grants U01AG024904, P30AG010129, K01AG030514 and the Dana Foundation. The authors appreciate the ADNI wdatabase (http://www.adni-info.org, funded by National Institutes of Health grant U01 AG024904) for providing neuroimaging data for this study. The principle investigator (lead author) of ADNI is Michael W. Weiner, MD, University of California, San Francisco (adnio@ loni.usc.edu). A complete listing of ADNI investigators can be found at S3 File.	Afshari S, 2016, IEEE J BIOMED HEALTH; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Berchtold NC, 1998, NEUROBIOL AGING, V19, P173, DOI 10.1016/S0197-4580(98)00052-9; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; Bron EE, 2015, NEUROIMAGE, V111, P562, DOI 10.1016/j.neuroimage.2015.01.048; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carrillo MC, 2012, ALZHEIMERS DEMENT, V8, P337, DOI 10.1016/j.jalz.2012.04.007; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt106; de Jong D, 2007, CLIN CHEM LAB MED, V45, P1421, DOI 10.1515/CCLM.2007.320; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Edwin Thanarajah S, 2016, FRONT PSYCHIATRY, V7, P1; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hafkemeijer A, 2013, BRAIN CONNECT, V3, P353, DOI 10.1089/brain.2013.0144; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hoffstaedter F, 2015, BRAIN STRUCT FUNCT, V220, P999, DOI 10.1007/s00429-013-0696-2; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Kenny ER, 2013, BRIT J PSYCHIAT, V203, P209, DOI 10.1192/bjp.bp.112.108464; Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Mak E, 2015, NEUROBIOL AGING, V36, P1743, DOI 10.1016/j.neurobiolaging.2014.12.038; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Moisa M, 2012, J NEUROSCI, V32, P7244, DOI 10.1523/JNEUROSCI.2757-11.2012; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; Nir TM, 2015, NEUROBIOL AGING, V36, pS113, DOI 10.1016/j.neurobiolaging.2014.04.038; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Son SJ, 2015, NEUROSCI RES, V98, P50, DOI 10.1016/j.neures.2015.04.002; Stam Cornelius J., 2007, NONLINEAR BIOMEDICAL, V1, P1, DOI DOI 10.1186/1753-4631-1-3; Stepan-Buksakowska I, 2013, ALZ DIS ASSOC DIS, P1; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wachinger C, 2016, NEUROIMAGE, V139, P470, DOI 10.1016/j.neuroimage.2016.05.053; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang XY, 2015, J NEUROSCI, V35, P12545, DOI 10.1523/JNEUROSCI.3914-14.2015; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Xia Jing, 2014, Int J Alzheimers Dis, V2014, P721453, DOI 10.1155/2014/721453; Yao HX, 2013, EUR J RADIOL, V82, P1531, DOI 10.1016/j.ejrad.2013.03.019; Zhao HF, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0531-4; Zhou B, 2013, CURR ALZHEIMER RES, V10, P754, DOI 10.2174/15672050113109990146; Zhou Yongxia, 2013, ISRN Geriatr, V2013; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	61	21	21	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173426	10.1371/journal.pone.0173426	http://dx.doi.org/10.1371/journal.pone.0173426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333946	Green Published, gold			2022-12-27	WOS:000399102200013
J	Tsai, YC; Chiu, YW; Kuo, HT; Lee, JJ; Lee, SC; Chen, TH; Lin, MY; Hwang, SJ; Kuo, MC; Hsu, YL; Chen, HC				Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Jia-Jung; Lee, Su-Chu; Chen, Tzu-Hui; Lin, Ming-Yen; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Hsu, Ya-Ling; Chen, Hung-Chun			The interaction between fluid status and angiopoietin-2 in adverse renal outcomes of chronic kidney disease	PLOS ONE			English	Article							LEVELS PREDICT MORTALITY; SPECTROSCOPY; INFLAMMATION; MECHANISMS; OVERLOAD	Background Fluid overload is not only the characteristic but also an important complication in chronic kidney disease (CKD) patients. Angiopoietin-2 (Angpt2) disturbs endothelium and vessel permeability, which may induce fluid overload. The aim of this study is to examine the interaction between fluid status and Angpt2 in adverse renal outcomes of CKD. Methods This cohort study enrolled 290 patients with CKD stages 3-5 from January 2011 to December 2011 and followed up until December 2015. Fluid status was presented as overhydration (OH) value measured by body composition monitor, while OH>1.1L was defined as fluid overload. Renal outcomes were defined as commencing dialysis and rapid renal function decline (the slope of estimated glomerular filtration rate < -5 ml/min/1.73m(2)/y). Results During a mean follow-up of 38.6 +/- 18.3 months, 125 (43.1%) patients progressed to commencing dialysis and 99(34.7%) patients presented rapid renal function decline. All patients were stratified by OH of 1.1L and the median of circulating Angpt2. These patients with both OH <= 1.1L and high circulating Angpt2 were more likely to reach commencing dialysis compared to other groups. The risks for commencing dialysis and rapid renal function decline were significantly higher in patients with OH> 1.1L and high circulating Angpt2 level compared to those with OH. 1.1L and low circulating Angpt2 (2.14, 1.21-3.78, P = 0.009; 4.96, 1.45-16.97, P = 0.01). There was a significant interaction between OH level and circulating Angpt2 in entering dialysis (P-interaction = 0.02). Conclusions Fluid overload and Angpt2 might have a synergistic effect on adverse renal outcomes in CKD patients.	[Tsai, Yi-Chun; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Jia-Jung; Lee, Su-Chu; Lin, Ming-Yen; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Jia-Jung; Lin, Ming-Yen; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Chen, Tzu-Hui] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Hsu, Ya-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Kuo, MC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.; Kuo, MC (corresponding author), Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan.; Hsu, YL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw; yainghsu@cc.kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; lee, su-chu/0000-0002-8587-7324; Kuo, Hung-Tien/0000-0002-9931-4354				Ando M, 2016, RESP MED, V117, P27, DOI 10.1016/j.rmed.2016.05.012; [Anonymous], 2005, BLOOD, V105, p1523 ; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; Ebah LM, 2013, KIDNEY INT, V84, P980, DOI 10.1038/ki.2013.208; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Linares PM, 2014, J CROHNS COLITIS, V8, P183, DOI 10.1016/j.crohns.2013.06.013; Lymperopoulou K, 2015, CYTOKINE, V73, P163, DOI 10.1016/j.cyto.2015.01.022; Makowska JS, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0112-6; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Molnar MZ, 2014, TRANSPL INT, V27, P541, DOI 10.1111/tri.12293; Nemcsik J, 2017, J HYPERTENS; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Sporek M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5780903; Tsai YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135181; Tsai YC, 2015, CLIN J AM SOC NEPHRO, V10, P39, DOI 10.2215/CJN.03610414; Tsai YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108862; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wieskotten S, 2008, PHYSIOL MEAS, V29, P639, DOI 10.1088/0967-3334/29/5/009; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Wizemann V, 2008, CONTRIB NEPHROL, V161, P115, DOI 10.1159/000130423; Yan ZX, 2011, AM J PHYSIOL-HEART C, V302, p215 	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173906	10.1371/journal.pone.0173906	http://dx.doi.org/10.1371/journal.pone.0173906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333979	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200029
J	Couto, I; Victoria, M; Veloso, VG; Rodrigues, L; Grinsztejn, B; Lacerda, M; Victoria, F; Perazzo, H				Couto, Ingrid; Victoria, Marilu; Veloso, Valdilea G.; Rodrigues, Lorena; Grinsztejn, Beatriz; Lacerda, Marcus; Victoria, Flamir; Perazzo, Hugo			Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection	PLOS ONE			English	Article							SPLEEN TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; ESOPHAGEAL-VARICES; FIBROSIS; STIFFNESS; CIRRHOSIS; BIOPSY; COINFECTION; VARIABILITY; FIBROTEST	Objective The study aimed to evaluate the prevalence and predictor factors for compensated advanced chronic liver disease (c-ACLD) in patients with hepatitis Delta virus (HDV) infection. Methods This cross-sectional study included consecutive HDV-infected patients defined by positive anti-HDV. Patients with hepatitis C coinfection, liver transplantation or presence of conditions that limit liver (LSM) or spleen stiffness measurement (SSM) were excluded. Blood tests, abdominal ultrasound, SSM and LSM by transient elastography (FibroScan (R)) were performed at the same day. Alcohol consumption was quantified using the AUDIT score and c-ACLD was defined by LSM >= 15 kPa performed by an experimented operator blinded for clinical and laboratory data. Results 101 patients were eligible and few patients were excluded due to negative anti-HDV (n = 7), hepatitis C coinfection (n = 2), liver transplantation (n = 10) and limitation for LSM or SSM (n = 5). Therefore, 77 patients [61% male, age = 43 (IQR,36-52) years] were included. The prevalence of c-ACLD was 57% (n = 44/77). Patients with c-ACLD had a higher rate of detectable HBV viral load (p = 0.039), higher levels of transaminases, GGT, alkaline phosphatases, total bilirubin and INR (p<0.001 for all), as well as lower platelet count and albumin levels (p>0.001 for both) compared to those without c-ACLD. Patients with c-ACLD had higher SSM [65.2 (IQR,33.8-75.0) vs 21.8 (16.5-32.0) kPa; p<0.001] and higher splenic volume [475 (IQR,311-746) vs 154 (112-283) cm(3); p<0.001] compared to those without. Detectable HBV viral load (>10 UI/ml), alkaline phosphatase (per IU/L) and GGT levels (per IU/L) were independently associated with c-ACLD in all multivariate models. Splenic volume [per cm(3),OR = 1.01 (95%Cl,1.01 -1.02);p = 0.002], SSM [per kPa, OR = 1.04 (1.01-1.07); p = 0.012] and splenomegaly [yes vs no,OR = 28.45 (4.42-182.95);p<0.001] were independently associated with c-ACLD. Conclusions The prevalence of c-ACLD was high in patients with chronic HDV infection in western Amazon basin. HBV viral load, liver enzymes and splenic features can be used to predict severe liver disease in HDV-infected patients.	[Couto, Ingrid; Victoria, Marilu; Rodrigues, Lorena; Victoria, Flamir] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil; [Veloso, Valdilea G.; Grinsztejn, Beatriz; Perazzo, Hugo] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST AIDS LAPCLIN AIDS, Rio De Janeiro, Brazil; [Lacerda, Marcus] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Lacerda, Marcus] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Perazzo, H (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST AIDS LAPCLIN AIDS, Rio De Janeiro, Brazil.	perazzohugo@gmail.com		Perazzo, Hugo/0000-0003-0931-6418	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.268/2014]; Fundacao para o Desenvolvimento Cientffico e Tecnologico em Saiide (FIOTEC); Rio de Janeiro, Brazil; Brazilian Ministry of Health through the Interfederative Cooperation for AIDS and Viral Hepatitis control; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476] Funding Source: NIH RePORTER	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao para o Desenvolvimento Cientffico e Tecnologico em Saiide (FIOTEC); Rio de Janeiro, Brazil; Brazilian Ministry of Health through the Interfederative Cooperation for AIDS and Viral Hepatitis control; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) under grant E-26/110.268/2014 (VGV) and Fundacao para o Desenvolvimento Cientffico e Tecnologico em Saiide (FIOTEC), Rio de Janeiro, Brazil (VGV). ML and BG are productivity fellows from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). BG and VGV are research fellows from Fundagao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). The study was also supported by the Brazilian Ministry of Health through the Interfederative Cooperation for AIDS and Viral Hepatitis control (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Cassinotto C, 2015, DIGEST LIVER DIS, V47, P695, DOI 10.1016/j.dld.2015.04.008; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Ledinghen V, 2008, GASTROEN CLIN BIOL, V32, P58, DOI 10.1016/S0399-8320(08)73994-0; De Odorico I, 1999, J ULTRAS MED, V18, P231, DOI 10.7863/jum.1999.18.3.231; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2016, J Hepatol, V64, P433, DOI 10.1016/j.jhep.2015.10.006; Fraquelli M, 2014, J VIRAL HEPATITIS, V21, P90, DOI 10.1111/jvh.12119; Gheorghe L, 2015, J GASTROINTEST LIVER, V24, P413, DOI 10.15403/jgld.2014.1121.244.dtv; Heidrich B, 2014, HEPATOLOGY, V60, P87, DOI 10.1002/hep.27102; Kay A, 2014, J VIRAL HEPATITIS, V21, P921, DOI 10.1111/jvh.12267; Le Gal F, 2016, HEPATOLOGY, V64, P1483, DOI 10.1002/hep.28772; Li Y, 2016, ALIMENT PHARM THER, V43, P458, DOI 10.1111/apt.13488; Lutterkort GL, 2017, LIVER INT, V37, P196, DOI 10.1111/liv.13205; Braga WSM, 2014, J HEPATOL, V61, P1205, DOI 10.1016/j.jhep.2014.05.041; Perazzo H, 2015, LIVER INT, V35, P1533, DOI 10.1111/liv.12551; Poynard T, 2012, CLIN GASTROENTEROL H, V10, P657, DOI 10.1016/j.cgh.2012.01.023; Poynard T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003857; Rizzetto M, 2016, LIVER INT, V36, P135, DOI 10.1111/liv.13018; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Serrano BC, 2014, J VIRAL HEPATITIS, V21, pE154, DOI 10.1111/jvh.12251; Stroffolini T, 2016, INFECTION; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Wong GLH, 2016, J DIGEST DIS, V17, P538, DOI 10.1111/1751-2980.12359; Wranke A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101002; Zykus R, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0414-z	32	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174453	10.1371/journal.pone.0174453	http://dx.doi.org/10.1371/journal.pone.0174453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329027	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700094
J	Dusek, A; Bartos, L; Sedlacek, F				Dusek, Adam; Bartos, Ludek; Sedlacek, Frantisek			Pre-breeding food restriction promotes the optimization of parental investment in house mice, Mus musculus	PLOS ONE			English	Article							DEPENDENT LIFE-HISTORIES; OPTIMAL CLUTCH SIZE; REPRODUCTIVE EFFORT; LITTER-SIZE; NATURAL-SELECTION; MATERNAL-CARE; EVOLUTION; ALLOCATION; RESOURCES; QUALITY	Litter size is one of the most reliable state-dependent life-history traits that indicate parental investment in polytocous (litter-bearing) mammals. The tendency to optimize litter size typically increases with decreasing availability of resources during the period of parental investment. To determine whether this tactic is also influenced by resource limitations prior to reproduction, we examined the effect of experimental, pre-breeding food restriction on the optimization of parental investment in lactating mice. First, we investigated the optimization of litter size in 65 experimental and 72 control families (mothers and their dependent offspring). Further, we evaluated pre-weaning offspring mortality, and the relationships between maternal and offspring condition (body weight), as well as offspring mortality, in 24 experimental and 19 control families with litter reduction (the death of one or more offspring). Assuming that pre-breeding food restriction would signal unpredictable food availability, we hypothesized that the optimization of parental investment would be more effective in the experimental rather than in the control mice. In comparison to the controls, the experimental mice produced larger litters and had a more selective (size-dependent) offspring mortality and thus lower litter reduction (the proportion of offspring deaths). Selective litter reduction helped the experimental mothers to maintain their own optimum condition, thereby improving the condition and, indirectly, the survival of their remaining offspring. Hence, pre-breeding resource limitations may have facilitated the mice to optimize their inclusive fitness. On the other hand, in the control females, the absence of environmental cues indicating a risky environment led to "maternal optimism"(overemphasizing good conditions at the time of breeding), which resulted in the production of litters of super-optimal size and consequently higher reproductive costs during lactation, including higher offspring mortality. Our study therefore provides the first evidence that pre-breeding food restriction promotes the optimization of parental investment, including offspring number and developmental success.	[Dusek, Adam; Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Sedlacek, Frantisek] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic	Czech Research Institute of Animal Science; University of South Bohemia Ceske Budejovice	Dusek, A (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	adamdusek@yahoo.com	Dusek, Adam/B-5407-2008; Sedlacek, Frantisek/D-9159-2016	Dusek, Adam/0000-0001-8552-4089; Sedlacek, Frantisek/0000-0003-4346-2638	Ministry of Agriculture of the Czech Republic [MZeRo 0716]; University of South Bohemia; Faculty of Science [SGA2001, SGA2002]; Grant Agency of the University of South Bohemia [159/2013/P, 04-151/2016/P]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); University of South Bohemia; Faculty of Science; Grant Agency of the University of South Bohemia	This study was supported by the Ministry of Agriculture of the Czech Republic (http://eagri. cz/public/web/en/mze/ grant No. MZeRo 0716), by the University of South Bohemia, the Faculty of Science (http://www.prf.jcu.cz/en.html; grant No. SGA2001 and SGA2002), and by the Grant Agency of the University of South Bohemia (https://www.jcu.cz/science-and-research; grant No. 159/2013/P and 04-151/2016/P).	[Anonymous], 2006, SAS MIXED MODELS; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; BRONSON FH, 1984, SCI AM, V250, P116, DOI 10.1038/scientificamerican0384-116; BRONSON FH, 1979, Q REV BIOL, V54, P265, DOI 10.1086/411295; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Charnov EL, 2001, EVOL ECOL RES, V3, P521; Charnov EL, 2007, AM NAT, V170, pE129, DOI 10.1086/522840; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Drummond H, 2000, ETHOLOGY, V106, P511, DOI 10.1046/j.1439-0310.2000.00554.x; Dusek A, 2011, BEHAV ECOL SOCIOBIOL, V65, P2209, DOI 10.1007/s00265-011-1229-8; French SS, 2009, P ROY SOC B-BIOL SCI, V276, P4003, DOI 10.1098/rspb.2009.1199; FUCHS S, 1982, BEHAV ECOL SOCIOBIOL, V10, P39, DOI 10.1007/BF00296394; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; GANDELMAN R, 1978, DEV PSYCHOBIOL, V11, P235, DOI 10.1002/dev.420110307; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAMMOND KA, 1992, PHYSIOL ZOOL, V65, P952, DOI 10.1086/physzool.65.5.30158552; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Johnson MS, 2001, J EXP BIOL, V204, P1925; Johnston SL, 2006, P ROY SOC B-BIOL SCI, V273, P1369, DOI 10.1098/rspb.2005.3456; King EDA, 2013, ECOL EVOL, V3, P4161, DOI 10.1002/ece3.786; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; KONIG B, 1987, BEHAV ECOL SOCIOBIOL, V20, P1, DOI 10.1007/BF00292161; KONIG B, 1988, J ZOOL, V216, P195; LACK D, 1948, J ANIM ECOL, V17, P45, DOI 10.2307/1608; Lane M, 2014, SCIENCE, V345, P756, DOI 10.1126/science.1254400; Lessells CM, 2002, PHILOS T R SOC B, V357, P381, DOI 10.1098/rstb.2001.0928; Mappes T, 1997, EVOL ECOL, V11, P591, DOI 10.1007/s10682-997-1514-1; Martin JGA, 2010, AM NAT, V176, P414, DOI 10.1086/656267; MCNAMARA JM, 1992, EVOL ECOL, V6, P170, DOI 10.1007/BF02270710; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; McNamara JM, 2011, ECOL LETT, V14, P58, DOI 10.1111/j.1461-0248.2010.01556.x; Meikle DB, 1995, J REPROD FERTIL, V105, P193, DOI 10.1530/jrf.0.1050193; Mercer JG, 2001, NEUROSCI BIOBEHAV R, V25, P101, DOI 10.1016/S0149-7634(00)00053-1; Mock D. W., 1997, EVOLUTION SIBLING RI; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Morris DW, 1998, OIKOS, V83, P518, DOI 10.2307/3546679; Morris DW, 1996, J ANIM ECOL, V65, P43, DOI 10.2307/5698; MORRIS DW, 1987, OIKOS, V49, P332, DOI 10.2307/3565769; MORRIS DW, 1985, OIKOS, V45, P290, DOI 10.2307/3565719; MOUNTFORD MD, 1968, J ANIM ECOL, V37, P363, DOI 10.2307/2953; MYERS JH, 1978, AM NAT, V112, P381, DOI 10.1086/283280; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; Painter RC, 2008, HUM REPROD, V23, P2591, DOI 10.1093/humrep/den274; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; PERRIGO G, 1987, ANIM BEHAV, V35, P1298, DOI 10.1016/S0003-3472(87)80002-7; PETTIFOR RA, 1988, NATURE, V336, P160, DOI 10.1038/336160a0; PIANKA ER, 1976, AM ZOOL, V16, P775; Rauw WM, 1999, LIVEST PROD SCI, V60, P329, DOI 10.1016/S0301-6226(99)00104-9; ROFF DA, 2001, LIFE HIST EVOLUTION; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Schroderus E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-44; Schubert KA, 2009, AM NAT, V173, P831, DOI 10.1086/598495; Selesniemi K, 2008, AGING CELL, V7, P622, DOI 10.1111/j.1474-9726.2008.00409.x; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Simons AM, 2007, J EVOLUTION BIOL, V20, P813, DOI 10.1111/j.1420-9101.2006.01270.x; Skjervold H, 1977, J ANIM BREED GENET, V94, P66; Smiseth PT, 2012, EVOLUTION OF PARENTAL CARE, P1; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stockley P, 2002, P NATL ACAD SCI USA, V99, P12932, DOI 10.1073/pnas.192125999; Tannerfeldt M, 1998, OIKOS, V83, P545, DOI 10.2307/3546681; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1974, AM ZOOL, V14, P249; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006	67	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173985	10.1371/journal.pone.0173985	http://dx.doi.org/10.1371/journal.pone.0173985			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328991	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700041
J	Sirois-Leclerc, G; Remaud, A; Bilodeau, M				Sirois-Leclerc, Genevieve; Remaud, Anthony; Bilodeau, Martin			Dynamic postural control and associated attentional demands in contemporary dancers versus non-dancers	PLOS ONE			English	Article							BALLET DANCERS; BALANCE CONTROL; TASK; PERFORMANCE; EXPERTISE; STABILITY; ADULTS; SKILL; GAIT; SWAY	Postural control is not a fully automatic process, but requires a certain level of attention, particularly as the difficulty of the postural task increases. This study aimed at testing whether experienced contemporary dancers, because of their specialized training involving the control of posture/balance, would present with a dual-task performance suggesting lesser attentional demands associated with dynamic postural control compared with non-dancers. Twenty dancers and 16 non-dancers performed a dynamic postural tracking task in both antero-posterior and side-to-side directions, while standing on a force platform. The postural task was performed, in turn, 1) as a stand-alone task, and concurrently with both 2) a simple reaction time task and 3) a choice reaction time task. Postural control performance was estimated through variables calculated from centre of pressure movements. Although no overall group difference was found in reaction time values, we found a better ability to control the side to side movements of the centre of pressure during the tracking task in dancers compared with non-dancers, which was dependent on the secondary task. This suggests that such increased ability is influenced by available attentional resources.	[Sirois-Leclerc, Genevieve; Bilodeau, Martin] Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, Ottawa, ON, Canada; [Sirois-Leclerc, Genevieve] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Fac Hlth Sci, Ottawa, ON, Canada; [Remaud, Anthony; Bilodeau, Martin] Bruyere Res Inst, Ottawa, ON, Canada; [Bilodeau, Martin] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Bilodeau, M (corresponding author), Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, Ottawa, ON, Canada.; Bilodeau, M (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.; Bilodeau, M (corresponding author), Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada.	martin.bilodeau@uottawa.ca	Bilodeau, Martin/L-8588-2014	Bilodeau, Martin/0000-0002-8464-8837	Natural Sciences and Engineering Research Council of Canada (NSERC) [312041-2008]; Leaders Opportunity Fund Award from the Canada Foundation for Innovation; Canada Foundation for Innovation (Leaders Opportunities Fund)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leaders Opportunity Fund Award from the Canada Foundation for Innovation; Canada Foundation for Innovation (Leaders Opportunities Fund)	This work was supported in part through grants from the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Award #312041-2008 to MB; http://www.nserccrsng.gc.ca/) and the Canada Foundation for Innovation (Leaders Opportunities Fund to MB; https://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part through a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Award #312041-2008 (MB)) and a Leaders Opportunity Fund Award from the Canada Foundation for Innovation (MB). None of the authors had financial interest or benefits arising from this research.	Boisgontier M, 2011, MOV SPORT SCI, V3, P53; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Bruyneel AV, 2010, NEUROSCI LETT, V485, P228, DOI 10.1016/j.neulet.2010.09.017; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Gray R, 2004, J EXP PSYCHOL-APPL, V10, P42, DOI 10.1037/1076-898X.10.1.42; Hamacher D, 2015, J AGING PHYS ACTIV, V23, P647, DOI 10.1123/japa.2014-0067; Hugel F, 1999, INT J SPORTS MED, V20, P86, DOI 10.1055/s-1999-970270; Kahneman D., 1973, ATTENTION EFFORT; Lajoie Y, 1996, EXP AGING RES, V22, P185, DOI 10.1080/03610739608254006; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Negahban H, 2013, GAIT POSTURE, V38, P226, DOI 10.1016/j.gaitpost.2012.11.016; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Rein S, 2011, CLIN NEUROPHYSIOL, V122, P1602, DOI 10.1016/j.clinph.2011.01.004; Remaud A, 2013, EXP BRAIN RES, V231, P219, DOI 10.1007/s00221-013-3684-0; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Roerdink M, 2011, HUM MOVEMENT SCI, V30, P203, DOI 10.1016/j.humov.2010.04.005; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Simmons RW, 2005, INT J NEUROSCI, V115, P87, DOI 10.1080/00207450490512678; SMITH MD, 1992, PERCEPT MOTOR SKILL, V75, P955, DOI 10.2466/PMS.75.7.955-961; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; Vuillerme N, 2004, BRAIN RES BULL, V63, P161, DOI 10.1016/j.brainresbull.2004.02.006; Wickens C.D, 1989, HUMAN SKILLS, P71; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173795	10.1371/journal.pone.0173795	http://dx.doi.org/10.1371/journal.pone.0173795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323843	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000032
J	Hassel, E; Stensvold, D; Halvorsen, T; Wisloff, U; Langhammer, A; Steinshamn, S				Hassel, Erlend; Stensvold, Dorthe; Halvorsen, Thomas; Wisloff, Ulrik; Langhammer, Arnulf; Steinshamn, Sigurd			Lung function parameters improve prediction of VO2peak in an elderly population: The Generation 100 study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; PHYSICAL-ACTIVITY; OLDER-ADULTS; MEN; STANDARDIZATION; ASSOCIATION; SPIROMETRY; VO2MAX; WOMEN	Peak oxygen uptake (VO2peak) is an indicator of cardiovascular health and a useful tool for risk stratification. Direct measurement of VO2peak is resource-demanding and may be contraindicated. There exist several non-exercise models to estimate VO2peak that utilize easily obtainable health parameters, but none of them includes lung function measures or hemoglobin concentrations. We aimed to test whether addition of these parameters could improve prediction of VO2peak compared to an established model that includes age, waist circumference, self-reported physical activity and resting heart rate. We included 1431 subjects aged 69-77 years that completed a laboratory test of VO2peak, spirometry, and a gas diffusion test. Prediction models for VO2peak were developed with multiple linear regression, and goodness of fit was evaluated. Forced expiratory volume in one second (FEV1), diffusing capacity of the lung for carbon monoxide and blood hemoglobin concentration significantly improved the ability of the established model to predict VO2peak. The explained variance of the model increased from 31% to 48% for men and from 32% to 38% for women (p<0.001). FEV1, diffusing capacity of the lungs for carbon monoxide and hemoglobin concentration substantially improved the accuracy of VO2peak prediction when added to an established model in an elderly population.	[Hassel, Erlend; Stensvold, Dorthe; Wisloff, Ulrik; Steinshamn, Sigurd] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Hassel, Erlend; Steinshamn, Sigurd] Univ Trondheim Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, Trondheim, Norway; [Halvorsen, Thomas] SINTEF Technol & Soc, Dept Hlth Res, Trondheim, Norway; [Langhammer, Arnulf] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); SINTEF; Norwegian University of Science & Technology (NTNU)	Hassel, E (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway.; Hassel, E (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, Trondheim, Norway.	Erlend.Hassel@ntnu.no	Stensvold, Dorthe/HGE-7694-2022	stensvold, dorthe/0000-0002-8942-1316; Hassel, Erlend/0000-0003-3282-8921	Norwegi an Health Association; Kristian Gerhard Jebsen Foundation	Norwegi an Health Association; Kristian Gerhard Jebsen Foundation	Erlend Hassel received a Ph.D.-grant from Norwegi an Health Association (www. nasjonalfore ningen.no , grant number N/A).K.G. Jebsen Center for Exercise in Medicine wa funded by The Kristian Gerhard Jebsen Foundation (www.stiftkgj.no ,grant number N/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Garcia-Rio F, 2012, CHEST, V142, P175, DOI 10.1378/chest.11-2021; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Hassel E, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0317-0; JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Langhammer A, 2001, EUR RESPIR J, V18, P770, DOI 10.1183/09031936.01.00255301; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Loewen GM, 2007, J THORAC ONCOL, V2, P619, DOI 10.1097/JTO.0b013e318074bba7; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mailey EL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-59; Matthews CE, 1999, MED SCI SPORT EXER, V31, P486, DOI 10.1097/00005768-199903000-00019; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morey MC, 1998, MED SCI SPORT EXER, V30, P715, DOI 10.1097/00005768-199805000-00012; Nes BM, 2014, MED SCI SPORT EXER, V46, P1159, DOI 10.1249/MSS.0000000000000219; Nes BM, 2011, MED SCI SPORT EXER, V43, P2024, DOI 10.1249/MSS.0b013e31821d3f6f; Stamatakis E, 2013, EUR HEART J, V34, P750, DOI 10.1093/eurheartj/ehs097; Stensvold D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007519; Struthers R, 2008, BRIT J ANAESTH, V101, P774, DOI 10.1093/bja/aen310; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wasserman K, 2012, EXERCISE TESTING INT, P165; Wier LT, 2006, MED SCI SPORT EXER, V38, P555, DOI 10.1249/01.mss.0000193561.64152	24	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174058	10.1371/journal.pone.0174058	http://dx.doi.org/10.1371/journal.pone.0174058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319189	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800046
J	Gonzalez, R; De la Rosa, AJ; Rufini, A; Rodriguez-Hernandez, MA; Navarro-Villaran, E; Marchal, T; Pereira, S; De la Mata, M; Muller-Schilling, M; Pascasio-Acevedo, JM; Ferrer-Rios, MT; Gomez-Bravo, MA; Padillo, FJ; Muntane, J				Gonzalez, Raul; De la Rosa, Angel J.; Rufini, Alessandro; Rodriguez-Hernandez, Maria A.; Navarro-Villaran, Elena; Marchal, Trinidad; Pereira, Sheila; De la Mata, Manuel; Mueller-Schilling, Martina; Pascasio-Acevedo, Juan M.; Ferrer-Rios, Maria T.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Muntane, Jordi			Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation	PLOS ONE			English	Article							P53 FAMILY; EXPRESSION; APOPTOSIS; PROTEINS; FLIP; CASPASE-8; PATHWAY; BINDING; GENE	Background & Aims Patients with hepatocellular carcinoma (HCC) submitted to orthotopic liver transplantation (OLT) have a variable 5-year survival rate limited mostly by tumor recurrence. The etiology, age, sex, alcohol, Child-Pugh, and the immunesuppressor have been associated with tumour recurrence. The expression of Delta Np73 is related to the reduced survival of patients with HCC. The study evaluated the expression of p63 and p73 isoforms and cell death receptors, and their relation to tumour recurrence and survival. The results were in vitro validated in HCC cell lines. Methods HCC sections from patients submitted to OLT were used. The in vitro study was done in differentiated hepatitis B virus (HBV)-expressing Hep3B and control HepG2 cells. The expression of cell death receptors and cFLIPS/L, caspase-8 and-3 activities, and cell proliferation were determined in control and p63 and p73 overexpressing HCC cells. Results The reduced tumor expression of cell death receptors and TAp63 and TAp73, and increased Delta Np63 and ANp73 expression were associated with tumor recurrence and reduced survival. The in vitro study demonstrated that HBV-expressing Hep3B vs HepG2 cells showed reduced expression of p63 and p73, cell death receptors and caspase activation, and increased cFLIP(L)/cFLIP(S) ratio. The overexpression of TAp63 and TAp73 exerted a more potent pro-apoptotic and anti-proliferative effects in Hep3B than HepG2-transfected cells which was related to cFLIP(L) upregulation. Conclusions The reduction of TAp63 and TAp73 isoforms, rather than alteration of Delta N isoform expression, exerted a significant functional repercussion on cell death and proliferation in HBV-expressing HepB cells.	[Gonzalez, Raul; De la Rosa, Angel J.; Rodriguez-Hernandez, Maria A.; Navarro-Villaran, Elena; Pereira, Sheila] Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Inst Biomed Seville IBiS,CSIC, Seville, Spain; [Rufini, Alessandro] CRUK Leicester Canc, Dept Canc Studies, Leicester, Leics, England; [Marchal, Trinidad] Hosp Univ Reina Sofia, IMIBIC, Dept Pathol, Cordoba, Spain; [De la Mata, Manuel] Hosp Univ Reina Sofia, IMIBIC, Dept Gastroenterol, Cordoba, Spain; [De la Mata, Manuel; Pascasio-Acevedo, Juan M.; Ferrer-Rios, Maria T.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Muntane, Jordi] CIBERehd, Madrid, Spain; [Mueller-Schilling, Martina] Univ Hosp Heidelberg, Gastroenterol & Hepatol Dept Internal Med 4, Heidelberg, Germany; [Pascasio-Acevedo, Juan M.; Ferrer-Rios, Maria T.] Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Dept Gastroenterol,CSIC, Seville, Spain; [Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Muntane, Jordi] Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Dept Gen Surg,CSIC, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Muntane, J (corresponding author), CIBERehd, Madrid, Spain.; Muntane, J (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Dept Gen Surg,CSIC, Seville, Spain.	jmuntane-ibis@us.es	Navarro-Villarán, Elena/F-4699-2018; Padillo-Ruiz, Javier/AAF-9792-2021; Rodríguez-Hernández, Ángeles/K-9717-2015	Navarro-Villarán, Elena/0000-0003-0765-9089; Padillo-Ruiz, Javier/0000-0002-1220-0822; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; GOMEZ BRAVO, MIGUEL ANGEL/0000-0002-5155-3508	Institute de Salud Carlos III [PI13/00021]; Consejeria de Economia, Innovacion, Ciencia y Empleo [CTS-6264]; Consejeria de Salud [PI13/00025]; ERDF	Institute de Salud Carlos III(Instituto de Salud Carlos III); Consejeria de Economia, Innovacion, Ciencia y Empleo; Consejeria de Salud; ERDF(European Commission)	Institute de Salud Carlos III (PI13/00021), Consejeria de Economia, Innovacion, Ciencia y Empleo (CTS-6264) and Consejeria de Salud (PI13/00025). CIBERehd founded by Institute de Salud Carlos III and co-financed by European Development Regional Fund "A way to achieve Europe" ERDF for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Castillo J, 2009, GASTROENTEROLOGY, V137, P1805, DOI 10.1053/j.gastro.2009.07.065; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Courtois S, 2004, ONCOGENE, V23, P631, DOI 10.1038/sj.onc.1206929; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gonzalez R, 2013, ANTIOXID REDOX SIGN, V18, P491, DOI 10.1089/ars.2011.4476; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Irwin MS, 2001, APOPTOSIS, V6, P17, DOI 10.1023/A:1009663809458; Kinoshita H, 2000, INT J CANCER, V88, P986, DOI 10.1002/1097-0215(20001215)88:6<986::AID-IJC23>3.0.CO;2-B; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lee H, 2006, BIOCHEM BIOPH RES CO, V344, P166, DOI 10.1016/j.bbrc.2006.03.128; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Mundt HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/j.bbrc.2010.04.093; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Park BJ, 2000, CANCER RES, V60, P3370; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Ramalho FS, 2006, J GASTROEN HEPATOL, V21, P1276, DOI 10.1111/j.1440-1746.2006.04309.x; Rodriguez-Hernandez A, 2015, REDOX BIOL, V6, P174, DOI 10.1016/j.redox.2015.07.010; Sayan AE, 2001, ONCOGENE, V20, P5111, DOI 10.1038/sj.onc.1204669; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seitz SJ, 2010, INT J CANCER, V126, P2049, DOI 10.1002/ijc.24861; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Zaika AI, 2006, CELL DEATH DIFFER, V13, P935, DOI 10.1038/sj.cdd.4401897; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174326	10.1371/journal.pone.0174326	http://dx.doi.org/10.1371/journal.pone.0174326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350813	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174400025
J	Cui, Y; Zeng, WJ; Yu, J; Lu, J; Hu, YN; Diao, N; Liang, B; Han, P; Shi, HS				Cui, Yue; Zeng, Wenjuan; Yu, Jie; Lu, Jing; Hu, Yuannan; Diao, Nan; Liang, Bo; Han, Ping; Shi, Heshui			Quantification of left coronary bifurcation angles and plaques by coronary computed tomography angiography for prediction of significant coronary stenosis: A preliminary study with dual-source CT	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; INTRAVASCULAR ULTRASOUND; ARTERY BIFURCATION; SHEAR-STRESS; ATHEROSCLEROTIC PLAQUES; LESIONS; CONSENSUS; DISEASE	Purpose To evaluate the diagnostic performance of left coronary bifurcation angles and plaque characteristics for prediction of coronary stenosis by dual-source CT. Methods 106 patients suspected of coronary artery disease undergoing both coronary computed tomography angiography (CCTA) and invasive coronary angiography (CAG) within three months were included. Left coronary bifurcation angles including the angles between the left anterior descending artery and left circumflex artery (LAD-LCx), left main coronary artery and left anterior descending artery (LM-LAD), left main coronary artery and left circumflex artery (LM-LCx) were measured on CT images. CCTA plaque parameters were calculated by plaque analysis software. Coronary stenosis >= 50% by CAG was defined as significant. Results 106 patients with 318 left coronary bifurcation angles and 126 vessels were analyzed. The bifurcation angle of LAD-LCx was significantly larger in left coronary stenosis >= 50% than stenosis < 50%, and significantly wider in the non-calcified plaque group than calcified. Multivariable analyses showed the bifurcation angle of LAD-LCx was an independent predictor for significant left coronary stenosis (OR = 1.423, P = 0.002). In ROC curve analysis, LAD-LCx predicted significant left coronary stenosis with a sensitivity of 66.7%, specificity of 78.4%, positive predictive value of 85.2% and negative predictive value of 55.8%. The lipid plaque volume improved the diagnostic performance of CCTA diameter stenosis (AUC: 0.854 vs. 0.900, P = 0.045) in significant coronary stenosis. Conclusions The bifurcation angle of LAD-LCx could predict significant left coronary stenosis. Wider LAD-LCx is related to non-calcified lesions. Lipid plaque volume could improve the diagnostic performance of CCTA for coronary stenosis prediction.	[Cui, Yue; Yu, Jie; Hu, Yuannan; Diao, Nan; Liang, Bo; Han, Ping; Shi, Heshui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan, Peoples R China; [Zeng, Wenjuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Clin Lab, Wuhan, Peoples R China; [Lu, Jing] Xiamen Univ, Zhongshan Hosp, Dept Nucl Med, Xiamen, Fujian, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Xiamen University	Shi, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan, Peoples R China.	shiheshui2014@163.com	Yu, Jie/ABB-4105-2021; Zeng, Wen/GPS-8058-2022		National Natural Science Foundation of China [81271570]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (Grant No. 81271570).	Achenbach S, 2004, J AM COLL CARDIOL, V43, P842, DOI 10.1016/j.jacc.2003.09.053; Achenbach S, 2008, JACC-CARDIOVASC IMAG, V1, P177, DOI 10.1016/j.jcmg.2007.11.006; Chaichana T, 2011, J BIOMECH, V44, P1869, DOI 10.1016/j.jbiomech.2011.04.033; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Dey D, 2010, RADIOLOGY, V257, P516, DOI 10.1148/radiol.10100681; Diaz-Zamudio M, 2015, RADIOLOGY, V276, P408, DOI 10.1148/radiol.2015141648; Gaur S, 2016, EUR HEART J, V37, P1220, DOI 10.1093/eurheartj/ehv690; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Maurovich-Horvat P, 2014, NAT REV CARDIOL, V11, P390, DOI 10.1038/nrcardio.2014.60; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Murasato Y, 2007, CATHETER CARDIO INTE, V69, P248, DOI 10.1002/ccd.20916; Nadjiri J, 2016, J CARDIOVASC COMPUT, V10, P97, DOI 10.1016/j.jcct.2016.01.007; Opolski MP, 2014, EUR J RADIOL, V83, P135, DOI 10.1016/j.ejrad.2013.10.005; Papadopoulou SL, 2012, EUR HEART J-CARD IMG, V13, P635, DOI 10.1093/ehjci/jes083; Papadopoulou SL, 2011, ATHEROSCLEROSIS, V219, P163, DOI 10.1016/j.atherosclerosis.2011.07.005; Papafaklis MI, 2007, INT J CARDIOL, V115, P276, DOI 10.1016/j.ijcard.2006.04.030; Papafaklis MI, 2015, ATHEROSCLEROSIS, V240, P205, DOI 10.1016/j.atherosclerosis.2015.03.017; Pflederer T, 2006, INVEST RADIOL, V41, P793, DOI 10.1097/01.rli.0000239318.88270.9f; Salavati A, 2012, J CARDIOVASC COMPUT, V6, P78, DOI 10.1016/j.jcct.2011.10.018; Saremi F, 2015, AM J ROENTGENOL, V204, pW249, DOI 10.2214/AJR.14.13760; Stankovic G, 2013, EUROINTERVENTION, V9, P36, DOI 10.4244/EIJV9I1A7; Sun JY, 2008, AM J ROENTGENOL, V190, P748, DOI 10.2214/AJR.07.2763; Tesche C, 2016, J CARDIOVASC COMPUT, V10, P199, DOI 10.1016/j.jcct.2016.03.002	25	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174352	10.1371/journal.pone.0174352	http://dx.doi.org/10.1371/journal.pone.0174352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346530	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300040
J	Wubante, AA				Wubante, Amarech Asratie			Determinants of infant nutritional status in Dabat district, North Gondar, Ethiopia: A case control study	PLOS ONE			English	Article								Background Malnutrition is the top cause of global burden of disease, disability and mortality among infants. Over two-thirds of deaths of children globally occur during the first year of life (infancy). Malnutrition among infants is substantially high in Ethiopia. Therefore, this study is aimed to assess determinants of infant nutritional status. Methods A community based nested case-control study was conducted from February to June 2013 in Dabat district. A total of 80 cases and 320 controls (1: 4 ratios) were studied. Relevant data was extracted from the community based survey data set. Anthroplus software was used to identify cases and controls. Determinants of infant nutritional status were identified using multivariate analysis. Results Among the total of 80 cases and 320 controls, more than half (52.5%) of the cases and the controls (53.8%) were males and females, respectively. Breast Feeding (BF) was started immediately after birth in only 43.8% of the cases. Nearly 94% of the mothers of the cases had no breast feeding information as part of Ante Natal Care (ANC) follow up. Maternal age (AOR: 0.29; 95% CI: 0.11-0.76), having radio (AOR: 0.43; 95% CI: 0.22-0.82), lack of toilet facility (AOR: 2.24; 95% CI: 1.16-4.33), deprivation of colostrum (AOR: 1.76; 95% CI: 1.01-1.06) and method of complementary feeding (AOR: 2.82; 95% CI: 1.33-5.99) were associated with wasting. Conclusions This study has found that inappropriate infant feeding; nutritional information gap and lack of toilet facility as significant predictors of malnutrition. Hence, joint interventions, including counseling of mothers about benefits of colostrum feeding and use of appropriate feeding method, toilet utilization and mass media such as radio possession, are needed to address the problem in Dabat district.	[Wubante, Amarech Asratie] West Gojjam Zonal Hlth Dept, Finoteselam, Ethiopia		Wubante, AA (corresponding author), West Gojjam Zonal Hlth Dept, Finoteselam, Ethiopia.	asratama19@yahoo.com						[Anonymous], 2012, ETH DEM HLTH SURV 20; Assis AMO, 2005, EUR J CLIN NUTR, V59, P1317, DOI 10.1038/sj.ejcn.1602245; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Central Statistical Agency, 2007, POP HOUS CENS ETH 20; Chicci AHM, 1998, J NUTR EDUC, V14, P99; Emond A, 2007, ARCH DIS CHILD, V92, P115, DOI 10.1136/adc.2005.091496; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, ETH HLTH SECT DEV PR; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Galler JR, 2012, J NUTR, V142, P788, DOI 10.3945/jn.111.145441; Kumar Dinesh, 2006, Indian Journal of Pediatrics, V73, P417, DOI 10.1007/BF02758565; Panigrahi A, 2014, SCI WORLD J; Priyatama P., 2015, JIPBS, V2, P252; Sachdeva Sandeep, 2010, Indian J Community Med, V35, P353, DOI 10.4103/0970-0218.66889; Servili C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-693; Shiratori S, 2011, MEDIA IMPACT NUTR IN; Solomon Amsalu, 2008, Ethiopian Journal of Health Development, V22, P21; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; UNICEF WHO World Bank, 2013, JOINT CHILD MALN EST; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, POOR SAN THREAT PUBL; World Health Organization, 2006, WHO CHILD GROWTH STA	22	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174624	10.1371/journal.pone.0174624	http://dx.doi.org/10.1371/journal.pone.0174624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346497	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300063
J	Le-Trilling, VTK; Trilling, M				Vu Thuy Khanh Le-Trilling; Trilling, Mirko			Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system	PLOS ONE			English	Article							MURINE CYTOMEGALOVIRUS; VACCINIA VIRUS; EXPRESSION; PROTEIN; GENE; RATS	Mammalian cell culture is indispensable for most aspects of current biomedical research. Immortalized cell lines are very convenient, but transforming principles (e.g. oncogenic viruses or their oncogenes) can heavily influence the experimental outcome. Primary cells do not share this apparent disadvantage but are more laborious to generate. Certain viruses (e.g. mouse cytomegalovirus) do not replicate efficiently in most transformed cell lines. In the past, such viruses have been routinely propagated on primary mouse embryonic fibroblasts (MEF) established around day 17 (d17) of gestation. According to new regulations of the European Union, experiments using gravid mammals and/or their embryos in the last trimester (>d14 in the case of mice) of gestation do require explicit permission of the local authorities responsible for animal care and use. Applying for such permission is time-consuming and often inflexible. Embryonic fibroblasts could also be produced at earlier time points of pregnancy from younger and smaller embryos. Obviously, this approach consumes more pregnant mice and embryos. Newborn mice are larger thus yielding more cells per sacrificed animal and the new Directive (2010/63/EU) excludes the killing of animals solely for the use of their organs or tissues. We established a convenient protocol to generate adherent mouse newborn cells (MNC). A direct comparison of MNC with MEF revealed that MNC fully recapitulate all tested aspects of a broad panel of virological parameters (plaque size, final titers, viral replication kinetics, viral gene expression, drug and interferon susceptibility as well as species specificity). The herein described approach allows researchers the legal use of primary cells and contributes to the 3R (replace, reduce, refine) guiding principles D especially the 'reduce' aspect D for the use of animals in scientific research. Additionally, it offers the option to directly compare in vitro and in vivo experiments when MNC are generated from littermates of animals included in the in vivo experiments.	[Vu Thuy Khanh Le-Trilling; Trilling, Mirko] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany	University of Duisburg Essen	Le-Trilling, VTK; Trilling, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	Khanh.Le@uk-essen.de; Mirko.Trilling@uk-essen.de	Trilling, Mirko/AAL-3533-2021; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020	Trilling, Mirko/0000-0003-3659-3541; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732	Deutsche Forschungsgemeinschaft (DFG) [TRR60, GRK1949]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	VTKL-T and MT received funding from the Deutsche Forschungsgemeinschaft (DFG) through TRR60 project A7N and GRK1949 project 13. MT also received intramural support (IF0RES Sonderprogramm fur innovative Forschung) from the Medical Faculty of the University Hospital Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, EVOLUTIONARY THEORY, V10, P71; BRUGGEMAN CA, 1982, ARCH VIROL, V73, P231, DOI 10.1007/BF01318077; Brune W, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1907s43; Dekhtiarenko I, 2013, J IMMUNOL, V190, P3399, DOI 10.4049/jimmunol.1203173; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; KEIL GM, 1985, J VIROL, V54, P422, DOI 10.1128/JVI.54.2.422-428.1985; Le-Trilling VTK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19977; Lembo D, 2004, J VIROL, V78, P4278, DOI 10.1128/JVI.78.8.4278-4288.2004; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; RAPP M, 1992, J VIROL, V66, P4399, DOI 10.1128/JVI.66.7.4399-4406.1992; SMITH CB, 1986, ARCH VIROL, V90, P313, DOI 10.1007/BF01317379; Trilling M, 2014, J IMMUNOL, V192, P447, DOI 10.4049/jimmunol.1203516; Trilling M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002069; Trilling M, 2009, J VIROL, V83, P3684, DOI 10.1128/JVI.02042-08; Tripathy SK, 2006, J VIROL, V80, P545, DOI 10.1128/JVI.80.1.545-550.2006; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	16	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174695	10.1371/journal.pone.0174695	http://dx.doi.org/10.1371/journal.pone.0174695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339479	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700037
J	Cimini, M; Cannata, A; Pasquinelli, G; Rota, M; Goichberg, P				Cimini, Maria; Cannata, Antonio; Pasquinelli, Gianandrea; Rota, Marcello; Goichberg, Polina			Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium	PLOS ONE			English	Article							REMODELING FOLLOWING INFARCTION; ENDOTHELIAL PROGENITOR CELLS; TERMINAL HEART-FAILURE; INFLAMMATORY LYMPHANGIOGENESIS; VASCULAR DEVELOPMENT; CARDIAC-FUNCTION; MOUSE MODEL; FIBROSIS; PLASTICITY; NEOVASCULARIZATION	Cardiac lymphatic vasculature undergoes substantial expansion in response to myocardial infarction (MI). However, there is limited information on the cellular mechanisms mediating post-MI lymphangiogenesis and accompanying fibrosis in the infarcted adult heart. Using a mouse model of permanent coronary artery ligation, we examined spatiotemporal changes in the expression of lymphendothelial and mesenchymal markers in the acutely and chronically infarcted myocardium. We found that at the time of wound granulation, a three-fold increase in the frequency of podoplanin-labeled cells occurred in the infarcted hearts compared to non-operated and sham-operated counterparts. Podoplanin immunoreactivity detected LYVE-1-positive lymphatic vessels, as well as masses of LYVE-1-negative cells dispersed between myocytes, predominantly in the vicinity of the infarcted region. Podoplanin-carrying populations displayed a mesenchymal progenitor marker PDGFR alpha, and intermittently expressed Prox-1, a master regulator of the lymphatic endothelial fate. At the stages of scar formation and maturation, concomitantly with the enlargement of lymphatic network in the injured myocardium, the podoplanin-rich LYVE-1-negative multicellular assemblies were apparent in the fibrotic area, aligned with extracellular matrix deposits, or located in immediate proximity to activated blood vessels with high VEGFR-2 content. Of note, these podoplanin-containing cells acquired the expression of PDGFR beta or a hematoendothelial epitope CD34. Although Prox-1 labeling was abundant in the area affected by MI, the podoplanin-presenting cells were not consistently Prox-1-positive. The concordance of podoplanin with VEGFR-3 similarly varied. Thus, our data reveal previously unknown phenotypic and structural heterogeneity within the podoplanin-positive cell compartment in the infarcted heart, and suggest an alternate ability of podoplanin-presenting cardiac cells to generate lymphatic endothelium and pro-fibrotic cells, contributing to scar development.	[Cimini, Maria; Cannata, Antonio; Rota, Marcello; Goichberg, Polina] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Pasquinelli, Gianandrea] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, S Orsola Malpighi Hosp, Unit Surg Pathol, Bologna, Italy; [Rota, Marcello] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; New York Medical College	Goichberg, P (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	polina.goihberg@pfizer.com	Cannata, Antonio/O-6344-2015; Pasquinelli, Gianandrea/I-7088-2012	Cannata, Antonio/0000-0001-7609-6297; Pasquinelli, Gianandrea/0000-0003-1506-1829	American Heart Association [14GRNT20130013]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association grant: 14GRNT20130013 (PG) (http://professional.heart.org/professional/ResearchPrograms/ApplicationInformation/ScientistPrincipalinvestigators/UCM_ 316962_For-Scientists.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the American Heart Association grant (14GRNT20130013) ( PG). The authors thank Mr. Bonna Ith from the Pulmonary Division, Department of Medicine, Brigham and Women's Hospital for the excellent technical assistance, and Drs. Annarosa Leri and Piero Anversa from the Center for Regenerative Medicine, Brigham and Women's Hospital, Harvard Medical School for sharing their research facilities and valuable insight on the study design.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Aspelund A, 2016, CIRC RES, V118, P515, DOI 10.1161/CIRCRESAHA.115.306544; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bianchi R, 2016, ARTERIOSCLER THROMB; Braun N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053382; Cairns LA, 2003, BLOOD, V102, P3954, DOI 10.1182/blood-2003-04-1296; Cavasin MA, 2004, LIFE SCI, V75, P2181, DOI 10.1016/j.lfs.2004.04.024; Chen WS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11302; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Cui Y, 2010, THORAC CARDIOV SURG, V58, P1, DOI 10.1055/s-0029-1240553; Dashkevich A, 2010, LYMPHOLOGY, V43, P110; Dashkevich A, 2016, MICROCIRCULATION, V23, P5, DOI 10.1111/micc.12220; Dashkevich Alexey, 2009, Lymphatic Research and Biology, V7, P21, DOI 10.1089/lrb.2008.1010; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Eckert C, 2016, AM J PHYSIOL-GASTR L, V310, pG1, DOI 10.1152/ajpgi.00344.2015; Fatima A, 2016, J CLIN INVEST, V126, P2437, DOI 10.1172/JCI80465; Fiedler U, 2006, AM J PATHOL, V168, P1045, DOI 10.2353/ajpath.2006.050554; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Geissler HJ, 2003, THORAC CARDIOV SURG, V51, P244; Goichberg P, 2016, J THORAC DIS, V8, P1904, DOI 10.21037/jtd.2016.07.34; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Harvey NL, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-15; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Ishikawa Y, 2007, HISTOPATHOLOGY, V51, P345, DOI 10.1111/j.1365-2559.2007.02785.x; Iwayama T, 2015, GENE DEV, V29, P1106, DOI 10.1101/gad.260554.115; Kasten P, 2007, DEV DYNAM, V236, P2952, DOI 10.1002/dvdy.21298; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kerjaschki D, 2014, J CLIN INVEST, V124, P874, DOI 10.1172/JCI74854; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; KLINE IK, 1964, AM HEART J, V68, P515, DOI 10.1016/0002-8703(64)90153-X; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Lee S, 2010, SEMIN THROMB HEMOST, V36, P352, DOI 10.1055/s-0030-1253457; Liu C, 2014, MOL CELL BIOCHEM, V397, P295, DOI 10.1007/s11010-014-2197-x; Loukas M, 2011, CLIN ANAT, V24, P684, DOI 10.1002/ca.21104; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Maruyama Y, 2014, INVEST OPHTH VIS SCI, V55, P4813, DOI 10.1167/iovs.13-13711; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Nakamura K, 2008, INT J CARDIOL, V129, P309, DOI 10.1016/j.ijcard.2008.02.007; Nazari B, 2016, AM J PATHOL, V186, P2650, DOI 10.1016/j.ajpath.2016.06.020; Oliver G, 2010, DEVELOPMENT, V137, P363, DOI 10.1242/dev.035360; Pan YF, 2015, FRONT MED-PRC, V9, P421, DOI 10.1007/s11684-015-0424-9; Park C, 2011, TRENDS CARDIOVAS MED, V21, P135, DOI 10.1016/j.tcm.2012.04.002; Park JH, 2011, EXP MOL MED, V43, P479, DOI 10.3858/emm.2011.43.8.054; Pessina P, 2015, STEM CELL REP, V4, P1046, DOI 10.1016/j.stemcr.2015.04.007; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Planas-Paz L, 2012, EMBO J, V31, P788, DOI 10.1038/emboj.2011.456; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Ratajska A, 2014, SCI WORLD J, DOI 10.1155/2014/183170; Ren GF, 2002, J HISTOCHEM CYTOCHEM, V50, P71, DOI 10.1177/002215540205000108; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Secker GA, 2015, DEV DYNAM, V244, P323, DOI 10.1002/dvdy.24227; Seeger H, 2014, NEPHRON CLIN PRACT, V128, P178, DOI 10.1159/000368241; Signore S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9803; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Sun QN, 2012, LYMPHOLOGY, V45, P80; Tan KW, 2014, ANGIOGENESIS, V17, P373, DOI 10.1007/s10456-014-9419-4; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Ugorski M, 2016, AM J CANCER RES, V6, P370; Yamashita Masahiro, 2013, Ann Am Thorac Soc, V10, P90, DOI 10.1513/AnnalsATS.201209-078OC; Yang Y, 2014, ADV ANAT EMBRYOL CEL, V214, P5, DOI 10.1007/978-3-7091-1646-3_2; Zhao TQ, 2013, INT J CARDIOL, V167, P2638, DOI 10.1016/j.ijcard.2012.06.127; Zhao WY, 2011, J MOL CELL CARDIOL, V51, P830, DOI 10.1016/j.yjmcc.2011.06.023; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603; Zymek P, 2006, J AM COLL CARDIOL, V48, P2315, DOI 10.1016/j.jacc.2006.07.060	72	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173927	10.1371/journal.pone.0173927	http://dx.doi.org/10.1371/journal.pone.0173927			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333941	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200030
J	Crowson, CS; Rollefstad, S; Kitas, GD; van Riel, PLCM; Gabriel, SE; Semb, AG				Crowson, Cynthia S.; Rollefstad, Silvia; Kitas, George D.; van Riel, Piet L. C. M.; Gabriel, Sherine E.; Semb, Anne Grete		Trans-Atlantic Cardiovasc Risk	Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis	PLOS ONE			English	Article							NET RECLASSIFICATION IMPROVEMENT; DISEASE; EVENTS; VALIDATION; MODELS; PREVALENCE; THERAPY; SCORES; HYPERTENSION; ASSOCIATION	Objective Cardiovascular disease (CVD) risk calculators designed for use in the general population do not accurately predict the risk of CVD among patients with rheumatoid arthritis (RA), who are at increased risk of CVD. The process of developing risk prediction models involves numerous issues. Our goal was to develop a CVD risk calculator for patients with RA. Methods Thirteen cohorts of patients with RA originating from 10 different countries (UK, Norway, Netherlands, USA, Sweden, Greece, South Africa, Spain, Canada and Mexico) were combined. CVD risk factors and RA characteristics at baseline, in addition to information on CVD outcomes were collected. Cox models were used to develop a CVD risk calculator, considering traditional CVD risk factors and RA characteristics. Model performance was assessed using measures of discrimination and calibration with 10-fold cross-validation. Results A total of 5638 RA patients without prior CVD were included (mean age: 55 [SD: 14] years, 76% female). During a mean follow-up of 5.8 years (30139 person years), 389 patients developed a CVD event. Event rates varied between cohorts, necessitating inclusion of high and low risk strata in the models. The multivariable analyses revealed 2 risk prediction models including either a disease activity score including a 28 joint count and erythrocyte sedimentation rate (DAS28ESR) or a health assessment questionnaire (HAQ) along with age, sex, presence of hypertension, current smoking and ratio of total cholesterol to high-densitylipoprotein cholesterol. Unfortunately, performance of these models was similar to general population CVD risk calculators. Conclusion Efforts to develop a specific CVD risk calculator for patients with RA yielded 2 potential models including RA disease characteristics, but neither demonstrated improved performance compared to risk calculators designed for use in the general population. Challenges encountered and lessons learned are discussed in detail.	[Crowson, Cynthia S.; Gabriel, Sherine E.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Crowson, Cynthia S.; Gabriel, Sherine E.] Mayo Clin, Div Rheumatol, Dept Med, Rochester, MN 55905 USA; [Rollefstad, Silvia; Semb, Anne Grete] Diakonhjemmet Hosp, Dept Rheumatol, Prevent Cardiorheuma Clin, Oslo, Norway; [Kitas, George D.] Dudley Grp NHS Fdn Trust, Dudley, W Midlands, England; [van Riel, Piet L. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumat Dis, Nijmegen, Netherlands	Mayo Clinic; Mayo Clinic; Diakonhjemmet Hospital; Radboud University Nijmegen	Crowson, CS (corresponding author), Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.; Crowson, CS (corresponding author), Mayo Clin, Div Rheumatol, Dept Med, Rochester, MN 55905 USA.	crowson@mayo.edu	Kitas, George/AAO-6396-2020; van Riel, P.L.C.M./H-8082-2014		National Institutes of Health, NIAMS [R01AR46849]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046849] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a collaborative agreement for independent research from Eli Lilly and a grant from the National Institutes of Health, NIAMS (R01AR46849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alemao E, 2017, RHEUMATOLOGY OXFORD; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Arts EEA, 2015, ANN RHEUM DIS, V74, P668, DOI 10.1136/annrheumdis-2013-204024; Barnabe C, 2011, ARTHRIT CARE RES, V63, P522, DOI 10.1002/acr.20371; Bruce B, 2003, J RHEUMATOL, V30, P167; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Contreras-Yanez I, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0697-z; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Corrales A, 2014, ANN RHEUM DIS, V73, P722, DOI 10.1136/annrheumdis-2012-203101; Crowson CS, 2016, STAT METHODS MED RES, V25, P1692, DOI 10.1177/0962280213497434; Crowson CS, 2012, AM J CARDIOL, V110, P420, DOI 10.1016/j.amjcard.2012.03.044; Cutolo M, 2014, SEMIN ARTHRITIS RHEU, V43, P479, DOI 10.1016/j.semarthrit.2013.08.004; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davis JM, 2007, ARTHRITIS RHEUM-US, V56, P820, DOI 10.1002/art.22418; Dessein PH, 2014, J RHEUMATOL, V41, P1746, DOI 10.3899/jrheum.140122; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris JA, 2013, J RHEUMATOL, V40, P1823, DOI 10.3899/jrheum.121316; Hilden J, 2014, STAT MED, V33, P3405, DOI 10.1002/sim.5804; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Innala L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3442; Karpouzas GA, 2014, ANN RHEUM DIS, V73, P1797, DOI 10.1136/annrheumdis-2013-203617; Leening MJG, 2014, STAT MED, V33, P3415, DOI 10.1002/sim.6133; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Meek IL, 2013, RHEUMATOLOGY, V52, P210, DOI 10.1093/rheumatology/kes194; Mjaavatten MD, 2014, J RHEUMATOL, V41, P2370, DOI 10.3899/jrheum.140306; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Morris TP, 2014, STAT MED, V33, P88, DOI 10.1002/sim.5935; Myasoedova E, 2016, ANN RHEUM DIS, V75, P560, DOI 10.1136/annrheumdis-2014-206411; Myasoedova E, 2011, ANN RHEUM DIS, V70, P482, DOI 10.1136/ard.2010.135871; Panoulas VF, 2007, RHEUMATOLOGY, V46, P1477, DOI 10.1093/rheumatology/kem169; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Protogerou AD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4324; Putrik P, 2016, ANN RHEUM DIS, V75, P715, DOI 10.1136/annrheumdis-2015-207738; Putrik P, 2016, ANN RHEUM DIS, V75, P540, DOI 10.1136/annrheumdis-2014-206737; Putrik P, 2012, BEST PRACT RES CL RH, V26, P705, DOI 10.1016/j.berh.2012.07.011; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rollefstad S, 2013, ANN RHEUM DIS, V72, P1968, DOI 10.1136/annrheumdis-2012-202789; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Semb AG, 2012, ARTHRITIS RHEUM-US, V64, P2836, DOI 10.1002/art.34524; Sniderman AD, 2015, CURR OPIN LIPIDOL, V26, P210, DOI 10.1097/MOL.0000000000000181; Solomon DH, 2015, ARTHRITIS RHEUMATOL, V67, P1995, DOI 10.1002/art.39195; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Symmons DPM, 2015, ARTHRITIS RHEUMATOL, V67, P1990, DOI 10.1002/art.39199; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Yoon SS, 2016, AM J PREV MED	52	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174656	10.1371/journal.pone.0174656	http://dx.doi.org/10.1371/journal.pone.0174656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334012	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200114
J	El Khatib, M; Tran, QT; Nasrallah, C; Lopes, J; Bolla, JM; Vivaudou, M; Pages, JM; Colletier, JP				El Khatib, Mariam; Tran, Que-Tien; Nasrallah, Chady; Lopes, Julie; Bolla, Jean-Michel; Vivaudou, Michel; Pages, Jean-Marie; Colletier, Jacques-Philippe			Providencia stuartii form biofilms and floating communities of cells that display high resistance to environmental insults	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; URINARY CATHETERS; COMMON-CAUSE; INFECTIONS; BACTEREMIA; PORINS	Biofilms are organized communities of bacterial cells that are responsible for the majority of human chronic bacterial infections. Providencia stuartii is a Gram-negative biofilm-forming bacterium involved in high incidence of urinary tract infections in catheterized patients. Yet, the structuration of these biofilms, and their resistance to environmental insults remain poorly understood. Here, we report on planktonic cell growth and biofilm formation by P. stuartii, in conditions that mimic its most common pathophysiological habitat in humans, i.e. the urinary tract. We observed that, in the planktonic state, P. stuartii forms floating communities of cells, prior to attachment to a surface and subsequent adoption of the biofilm phenotype. P. stuartii planktonic and biofilm cells are remarkably resistant to calcium, magnesium and to high concentrations of urea, and show the ability to grow over a wide range of pHs. Experiments conducted on a P. stuartii strain knocked-out for the Omp-Pst2 porin sheds light on the role it plays in the early stages of growth, as well as in the adaptation to high concentration of urea and to varying pH.	[El Khatib, Mariam; Nasrallah, Chady; Lopes, Julie; Vivaudou, Michel; Colletier, Jacques-Philippe] Univ Grenoble Alpes, Commissariat Energie Atom, CNRS, Inst Biol Struct, Grenoble, France; [Tran, Que-Tien] Jacobs Univ Bremen, Sch Biophys, Bremen, Germany; [Bolla, Jean-Michel; Pages, Jean-Marie] Univ Aix Marseille, Inst Rech Biomed Armees, Equipe Transporteurs Membranaires Chimioresistanc, Marseille, France; [Nasrallah, Chady] Inst Genom Fonct, Dept Neurosci, Montpellier, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Jacobs University; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier	Colletier, JP (corresponding author), Univ Grenoble Alpes, Commissariat Energie Atom, CNRS, Inst Biol Struct, Grenoble, France.	colletier@ibs.fr	Bolla, Jean Michel/D-3885-2014; PAGES, jean-marie/F-2555-2013; Vivaudou, Michel/C-5338-2008	Bolla, Jean Michel/0000-0003-3892-4340; PAGES, jean-marie/0000-0001-7092-7977; Vivaudou, Michel/0000-0002-9777-3127; Lopes, Julie/0000-0002-8399-9475; Colletier, Jacques-Philippe/0000-0003-1819-4686	GRAL within the Grenoble Partnership for Structural Biology [ANR-10-LABX-49-01]; Agence Nationale de la Recherche [ANR-15-CE18-0005-02]; joint CEA-GRAL doctoral fellowship; CEA; CNRS; University Grenoble Alpes	GRAL within the Grenoble Partnership for Structural Biology; Agence Nationale de la Recherche(French National Research Agency (ANR)); joint CEA-GRAL doctoral fellowship; CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Grenoble Alpes	This work used the platforms of the Grenoble Instruct Center (ISBG: UMS 3518 CNRS-CEA-UGA-EMBL; http://www.isbg.fr) with support from GRAL (ANR-10-LABX-49-01; http://www.labex-gral.fr) within the Grenoble Partnership for Structural Biology (PSB). Financial support by the Agence Nationale de la Recherche (ANR-15-CE18-0005-02; http://www.agence-nationale-recherche.fr) is acknowledged, as well as from the CEA (www.cea.fr), the CNRS (www.cnrs.fr) and the University Grenoble Alpes (http://www.univ-grenoble-alpes.fr). M.E.K. is supported by a joint CEA-GRAL (http://www.labex-gral.fr) doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster CE, 2014, J INFECT DIS, V209, P1524, DOI 10.1093/infdis/jit663; Aubert D, 2005, ANTIMICROB AGENTS CH, V49, P3590, DOI 10.1128/AAC.49.8.3590-3592.2005; Bajaj H, 2012, BIOCHEMISTRY-US, V51, P10244, DOI 10.1021/bi301398j; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Bret L, 2004, CHEMOTHERAPY, V50, P255, DOI 10.1159/000081947; Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0; Chapman CMC, 2014, ANAEROBE, V27, P71, DOI 10.1016/j.anaerobe.2014.02.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; De Vecchi E, 2013, J MED MICROBIOL, V62, P859, DOI 10.1099/jmm.0.056945-0; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Frey K. G., 2014, GENOME ANNOUNC, V2; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hemery G, 2007, J IND MICROBIOL BIOT, V34, P49, DOI 10.1007/s10295-006-0160-x; ISAACSON LC, 1969, INVEST UROL, V6, P356; Kateete DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045741; Krake PR, 2004, SOUTH MED J, V97, P1022, DOI 10.1097/01.SMJ.0000141308.19657.BA; Lahlaoui H, 2011, EUR J CLIN MICROBIOL, V30, P1267, DOI 10.1007/s10096-011-1222-1; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Manageiro V., 2015, GENOME ANNOUNC, V3; Manos J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P245, DOI 10.1007/0-387-30746-x_12; Mc Gann P, 2012, ANTIMICROB AGENTS CH, V56, P1673, DOI 10.1128/AAC.05604-11; McHale P J, 1981, J Hosp Infect, V2, P155, DOI 10.1016/0195-6701(81)90024-4; Mishra B., 2015, ACS MED CHEM LETT; MOBLEY HLT, 1986, J GEN MICROBIOL, V132, P2863; Ostrowska K, 2014, POL J MICROBIOL, V63, P423; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Phillips NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038303; RAMAN A, 1972, British Journal of Urology, V44, P537, DOI 10.1111/j.1464-410X.1972.tb10120.x; Simon C, 2010, CIRCULATION, V122, pE401, DOI 10.1161/CIRCULATIONAHA.110.943118; Sipahi OR, 2010, J CLIN MICROBIOL, V48, P4667, DOI 10.1128/JCM.01349-10; Song WL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004255; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stickler DJ, 2014, J INTERN MED, V276, P120, DOI 10.1111/joim.12220; Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231; Sturgill G, 2004, J BACTERIOL, V186, P7610, DOI 10.1128/JB.186.22.7610-7617.2004; Tran QT, 2010, J BIOL CHEM, V285, P32273, DOI 10.1074/jbc.M110.143305; Tumbarello M, 2004, J ANTIMICROB CHEMOTH, V53, P277, DOI 10.1093/jac/dkh047; Unverdi S, 2011, PERITON DIALYSIS INT, V31, P216, DOI 10.3747/pdi.2010.00172; WARREN JW, 1986, REV INFECT DIS, V8, P61; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wie SH, 2015, KOREAN J INTERN MED, V30, P167, DOI 10.3904/kjim.2015.30.2.167; Zalewska-Piatek BM, 2009, POL J MICROBIOL, V58, P223; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371	49	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174213	10.1371/journal.pone.0174213	http://dx.doi.org/10.1371/journal.pone.0174213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334028	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200064
J	Gravningen, K; Mitchell, KR; Wellings, K; Johnson, AM; Geary, R; Jones, KG; Clifton, S; Erens, B; Lu, M; Chayachinda, C; Field, N; Sonnenberg, P; Mercer, CH				Gravningen, Kirsten; Mitchell, Kirstin R.; Wellings, Kaye; Johnson, Anne M.; Geary, Rebecca; Jones, Kyle G.; Clifton, Soazig; Erens, Bob; Lu, Michelle; Chayachinda, Chenchit; Field, Nigel; Sonnenberg, Pam; Mercer, Catherine H.			Reported reasons for breakdown of marriage and cohabitation in Britain: Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	PLOS ONE			English	Article							DIVORCE; DISTRESS; MOTIVES	Objectives Breakdown of marriage and cohabitation is common in Western countries and is costly for individuals and society. Most research on reasons for breakdown has focused on marriages ending in divorce and/or have used data unrepresentative of the population. We present prevalence estimates of, and differences in, reported reasons for recent breakdown of marriages and cohabitations in Britain. Methods Descriptive analyses of data from Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), a probability sample survey (15,162 people aged 16-74 years) undertaken 2010-2012, using computer-assisted personal interviewing. We examined participants' reported reasons for live-in partnership breakdown in the past 5 years and how these varied by gender and partnership type (married vs. cohabitation). Results Overall, 10.9% (95% CI: 9.9-11.9%) of men and 14.1% (13.2-15.0%) of women reported live-in partnership breakdown in the past 5 years. Mean duration of men's marriages was 14.2 years (95% CI: 12.8-15.7) vs. cohabitations; 3.5 years (3.0-4.0), and for women: 14.6 years (13.5-15.8) vs. 4.2 years (3.7-4.8). Among 706 men and 1254 women reporting experience of recent breakdown, the reasons 'grew apart' (men 39%, women 36%), 'arguments' (27%, 30%), 'unfaithfulness/adultery' (18%, 24%, p<0.05), and 'lack of respect/appreciation' (17%, 25%, p<0.05) were the most common, irrespective of partnership type. A total of 16% of women vs. 4% of men cited domestic violence. After adjusting for age at interview and duration of partnership, there were no significant differences in reasons given for breakup by partnership type, except that men more commonly cited 'moving due to changing circumstances' as a reason for a cohabitation ending than for a marriage (AOR = 3.78, 95% CI: 1.08-13.21); and among women, 'not sharing housework' (0.54, 0.35-0.83) and 'sexual difficulties' (0.45, 0.25-0.84) were less commonly cited as reasons for cohabitation ending than marriage. Conclusion These representative data on recently ended marriages and cohabitations among men and women in Britain show that there were more similarities than differences in the reasons reported for breakdown across partnership type. For both marriages and cohabitations, cited reasons relating to communication and relationship quality issues were most common, followed by unfaithfulness/adultery. Our findings support a focus on relationship quality, including communication and conflict resolution, in preventive and therapeutic interventions addressing breakdown of live-in partnerships.	[Gravningen, Kirsten] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Gravningen, Kirsten; Johnson, Anne M.; Geary, Rebecca; Jones, Kyle G.; Clifton, Soazig; Lu, Michelle; Chayachinda, Chenchit; Field, Nigel; Sonnenberg, Pam; Mercer, Catherine H.] UCL, Res Dept Infect & Populat Hlth, London, England; [Mitchell, Kirstin R.] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Mitchell, Kirstin R.; Wellings, Kaye] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Erens, Bob] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Chayachinda, Chenchit] Mahidol Univ, Dept Obstet & Gynaecol, Fac Med, Siriraj Hosp, Bangkok, Thailand	UiT The Arctic University of Tromso; University Hospital of North Norway; University of London; University College London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Mahidol University	Gravningen, K (corresponding author), Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway.; Gravningen, K (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	kirsten.gravningen@unn.no	Field, Nigel/ABG-3948-2020	Johnson, Anne/0000-0003-1330-7100; Gravningen, Kirsten/0000-0002-8194-3208; Mercer, Catherine/0000-0002-4220-5034; Field, Nigel/0000-0002-2825-6652	UK Medical Research Council [G0701757]; Wellcome Trust [084840]; UK Medical Research Council through the MRC/CSO Social & Public Health Sciences Unit, University of Glasgow [MC_UU_12017-11, SPHSU11]; National Institute for Health Research (NIHR Research Methods Programme) [NIHR-RMFI-2014-05-28]; MRC [MC_UU_12017/11, G0701757] Funding Source: UKRI; Medical Research Council [MC_UU_12017/11, G0701757] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10078, NIHR-RMFI-2014-05-28-101, NF-SI-0508-10244] Funding Source: researchfish; Chief Scientist Office [SPHSU11] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council through the MRC/CSO Social & Public Health Sciences Unit, University of Glasgow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR Research Methods Programme); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	Natsal-3 was supported by grants from: UK Medical Research Council (www.mrc.ac.uk; grant number G0701757; funding source for Natsal-3) and the Wellcome Trust (www.wellcome.ac.uk; 084840; funding source for Natsal-3), with contributions from the Economic and Social Research Council and Department of Health. AMJ has been a Governor of the Wellcome Trust since 2011. Since September 2015, KRM has been core funded by the UK Medical Research Council through the MRC/CSO Social & Public Health Sciences Unit, University of Glasgow [MC_UU_12017-11, SPHSU11]; SC was funded to undertake independent research supported by the National Institute for Health Research (NIHR Research Methods Programme, Fellowships and Internships, NIHR-RMFI-2014-05-28). The funders had no role in study design, data collection an analysis, decision to publish, or preparation of the manuscript.	Amato P. R., 2010, FAMILY SCI, V1, P2, DOI DOI 10.1080/19424620903381583; Amato PR, 2003, J FAM ISSUES, V24, P602, DOI 10.1177/0192513X03254507; Amato PR, 2000, J MARRIAGE FAM, V62, P1269, DOI 10.1111/j.1741-3737.2000.01269.x; Andersson G., 2002, DEMOGR RES, V7, P67, DOI [DOI 10.4054/DEMRES.2002.7.4, 10.4054/DemRes.2002.7.4]; [Anonymous], 2014, DOM VIOL AB HLTH SER; Beaujouan Eva, 2011, Popul Trends, P31, DOI 10.1057/pt.2011.16; Bradbury TN, 2000, J MARRIAGE FAM, V62, P964, DOI 10.1111/j.1741-3737.2000.00964.x; CLEEK MG, 1985, J MARRIAGE FAM, V47, P179, DOI 10.2307/352080; de Graaf PM, 2006, J FAM ISSUES, V27, P483, DOI 10.1177/0192513X05283982; Erens B, 2013, NATL SURVEY SEXUAL A; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Eurostat Statistics Explained, 2011, MARR DIV STAT; GIGY L, 1992, J DIVORCE REMARRIAGE, V18, P169; Hawkins A.J., 2012, J DIVORCE REMARRIAGE, V53, P453, DOI [10.1080/10502556.2012.682898, DOI 10.1080/10502556.2012.682898]; Heuveline P, 2004, J MARRIAGE FAM, V66, P1214, DOI 10.1111/j.0022-2445.2004.00088.x; HOPPER J, 1993, J MARRIAGE FAM, V55, P801, DOI 10.2307/352763; KITSON GC, 1985, J FAM ISSUES, V6, P255, DOI 10.1177/019251385006003002; KITSON GC, 1982, J MARRIAGE FAM, V44, P87, DOI 10.2307/351265; Lampard R, 2014, EUR SOCIOL REV, V30, P315, DOI 10.1093/esr/jct034; Lyngstad TH, 2010, DEMOGR RES, V23, P257, DOI 10.4054/DemRes.2010.23.10; Macdowall W, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007837; Mitchell KR, 2013, LANCET, V382, P1817, DOI 10.1016/S0140-6736(13)62366-1; Office for National Statistics (ONS), 2013, DIV ENGL WAL; ONS (Office of National Statistics), 2012, SHORT REP COH UK; Relationships Foundation, 2015, COST FAM FAIL IND; Scott SB, 2013, COUPLE FAM PSYCHOL, V2, P131, DOI 10.1037/a0032025; Slater & Gordon Lawyers, 2015, SOC MED NEW MARR MIN; Tavares LP, 2013, SOC SCI RES, V42, P1599, DOI 10.1016/j.ssresearch.2013.07.008; VANPOPPEL F, 1993, DEMOGRAPHY, V30, P425, DOI 10.2307/2061649; Wilson Ben, 2010, Popul Trends, P37, DOI 10.1057/pt.2010.4; Wolcott I, 201999 AUSTR I FAM S	31	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174129	10.1371/journal.pone.0174129	http://dx.doi.org/10.1371/journal.pone.0174129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333973	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000399102200051
J	Helms, L; Clune, J				Helms, Lucas; Clune, Jeff			Improving HybrID: How to best combine indirect and direct encoding in evolutionary algorithms	PLOS ONE			English	Article							NETWORKS; REPRESENTATIONS	Many challenging engineering problems are regular, meaning solutions to one part of a problem can be reused to solve other parts. Evolutionary algorithms with indirect encoding perform better on regular problems because they reuse genomic information to create regular phenotypes. However, on problems that are mostly regular, but contain some irregularities, which describes most real-world problems, indirect encodings struggle to handle the irregularities, hurting performance. Direct encodings are better at producing irregular phenotypes, but cannot exploit regularity. An algorithm called HybrID combines the best of both: it first evolves with indirect encoding to exploit problem regularity, then switches to direct encoding to handle problem irregularity. While HybrID has been shown to outperform both indirect and direct encoding, its initial implementation required the manual specification of when to switch from indirect to direct encoding. In this paper, we test two new methods to improve HybrID by eliminating the need to manually specify this parameter. Auto-SwitchHybrID automatically switches from indirect to direct encoding when fitness stagnates. Offset-HybrID simultaneously evolves an indirect encoding with directly encoded offsets, eliminating the need to switch. We compare the original HybrID to these alternatives on three different problems with adjustable regularity. The results show that both Auto-Switch-HybrID and Offset-HybrID outperform the original HybrID on different types of problems, and thus offer more tools for researchers to solve challenging problems. The Offset-HybrID algorithm is particularly interesting because it suggests a path forward for automatically and simultaneously combining the best traits of indirect and direct encoding.	[Helms, Lucas; Clune, Jeff] Univ Wyoming, Evolving Artificial Intelligence Lab, Laramie, WY 82071 USA	University of Wyoming	Clune, J (corresponding author), Univ Wyoming, Evolving Artificial Intelligence Lab, Laramie, WY 82071 USA.	jeffclune@uwyo.edu			NSF CAREER award [CAREER: 1453549]; National Science Foundation CAREER award [CAREER: 1453549]	NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation CAREER award(National Science Foundation (NSF))	Jeff Clune was supported by an NSF CAREER award (CAREER: 1453549). All experiments were conducted on the Mount Moran IBM System X cluster computer at the University of Wyoming Advanced Research Computing Center (ARCC). The authors thank the ARCC staff for their support, and the members of the Evolving AI Lab at the University of Wyoming for valuable feedback on this draft, especially Joost Huizinga, Mohammad Norouzzadeh, Roby Velez, and Kai Olav Ellefsen.; JC was supported by a National Science Foundation CAREER award (CAREER: 1453549) (http://www.nsf.gov/funding/pgm_summ.jsp? pims _id=503214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheney N, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P222, DOI 10.7551/978-0-262-32621-6-ch037; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Clune J, 2011, ADV ARTIFICIAL LIFE, P134; Clune J, 2009, P GEN EV COMP C, P675; Clune J, 2008, LECT NOTES COMPUT SC, V5199, P358, DOI 10.1007/978-3-540-87700-4_36; Clune J, 2011, IEEE T EVOLUT COMPUT, V15, P346, DOI 10.1109/TEVC.2010.2104157; Clune J, 2009, IEEE C EVOL COMPUTAT, P2764, DOI 10.1109/CEC.2009.4983289; Cully A., 2014, ARXIV14073501; D'Ambrosio DB, 2011, IEEE INT C INT ROBOT, P2802, DOI 10.1109/IROS.2011.6048150; DAmbrosio D. B., 2010, P 9 INT C AUT AG MUL, V1; Drchal J, 2009, IEEE C EVOL COMPUTAT, P1087, DOI 10.1109/CEC.2009.4983067; Ellefsen KO, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004128; Floreano D., 2008, BIOINSPIRED ARTIFICI; Fontana A, 2008, P EPIROB; Fontana A, 2014, POET EVODEVO METHOD; Gauci J, 2008, AAAI, P628; Gauci J, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P997; Gauci J, 2010, LECT NOTES COMPUT SC, V6238, P354, DOI 10.1007/978-3-642-15844-5_36; Gauci J, 2010, NEURAL COMPUT, V22, P1860, DOI 10.1162/neco.2010.06-09-1042; Ghazzai H, 2014, IEEE T VEH TECHNOL, V63, P4508, DOI 10.1109/TVT.2014.2312380; Haasdijk E, 2010, LECT NOTES COMPUT SC, V6274, P169, DOI 10.1007/978-3-642-15323-5_15; Hornby GS, 2011, EVOL COMPUT, V19, P1, DOI 10.1162/EVCO_a_00005; Hornby GS, 2003, IEEE T ROBOTIC AUTOM, V19, P703, DOI 10.1109/TRA.2003.814502; Hornby GS, 2002, ARTIF LIFE, V8, P223, DOI 10.1162/106454602320991837; Huizinga J, 2014, P GECCO, P1; Koza JR, 1992, GENETIC PROGRAMMING; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lee S., 2013, LNCS, V7835, P540, DOI DOI 10.1007/978-3-642-37192-954; Lipson H, 2004, GECCO WORKSH MOD REG; Secretan J, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1759; Silva F, 2015, TOPOLOGY, V34, P37; Spiliopoulou M, 2010, P 12 C GEN EV COMP, V27, P547, DOI [DOI 10.1145/1830483.1830587, 10.1145/1830483.1830587]; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Stanley KO, 2009, ARTIF LIFE, V15, P185, DOI 10.1162/artl.2009.15.2.15202; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Tonelli P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079138; van den Berg T, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P759; Verbancsics P, 2010, J MACH LEARN RES, V11, P1737; WELCH TA, 1984, COMPUTER, V17, P8, DOI 10.1109/MC.1984.1659158; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519	42	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174635	10.1371/journal.pone.0174635	http://dx.doi.org/10.1371/journal.pone.0174635			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334002	gold, Green Published			2022-12-27	WOS:000399102200113
J	Xie, ZC; Wang, JQ; Liu, M; Chen, DS; Qiu, C; Sun, KY				Xie, Zichen; Wang, Jiqin; Liu, Mei; Chen, Deshan; Qiu, Chao; Sun, Keyu			CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo	PLOS ONE			English	Article							MTOR INHIBITORS; PRECLINICAL EVALUATION; CANCER STATISTICS; RAPAMYCIN; GROWTH; POTENT; TARGET	Hepatocellular carcinoma (HCC) is a leading cause of cancer-related human mortalities. Over-activation of mammalian target of rapamycin (mTOR) is important for HCC tumorigenesis and progression. The current study assessed the potential anti-HCC activity by a novel mTOR kinase inhibitor, CC-223. We demonstrate that CC-223, at nM concentrations, induced profound cytotoxic and anti-proliferative activities against established HCC cell lines (HepG2, KYN-2 and Huh-7) and primary human HCC cells. Meanwhile, CC-223 activated caspase-3/-9 and apoptosis in the above HCC cells. CC-223 concurrently blocked mTORC1 and mTORC2 activation, and its cytotoxicity against HCC cells was much more potent than the traditional mTORC1 inhibitors (RAD001 and rapamycin). Further studies demonstrated that CC-223 disrupted mitochondrial function, and induced mitochondrial permeability transition pore (mPTP) opening and reactive oxygen species (ROS) production. On the other hand, ROS scavengers and mPTP blockers (cyclosporin A or sanglifehrin A) largely attenuated CC-223-induced HepG2 cell apoptosis. In vivo studies showed that oral administration of CC-223 dramatically inhibited growth of HepG2 xenografts in severe combined immuno-deficient (SCID) mice. mTORC1/2 activation was also blocked in xenografts with CC-223 administration. Together, CC-223 simultaneously blocks mTORC1/2 and efficiently inhibits human HCC cells.	[Xie, Zichen; Wang, Jiqin; Liu, Mei; Chen, Deshan; Sun, Keyu] Fudan Univ, Minhang Hosp, Emergency Dept, Shanghai, Peoples R China; [Qiu, Chao] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China	Fudan University; Fudan University	Sun, KY (corresponding author), Fudan Univ, Minhang Hosp, Emergency Dept, Shanghai, Peoples R China.; Qiu, C (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.	zzspjcsk11@163.com; sunkeyulunwen@163.com			Shanghai medical key subject construction project [ZK2015615]; Shanghai Minhang District science and technology research plan [2015MHZ039]	Shanghai medical key subject construction project; Shanghai Minhang District science and technology research plan	This study is supported by Shanghai medical key subject construction project (ZK2015615 to KS), and Shanghai Minhang District science and technology research plan (2015MHZ039 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth RE, 2014, WORLD J HEPATOL, V6, P776, DOI 10.4254/wjh.v6.i11.776; Chen MC, 2016, ONCOTARGET, V7, P51608, DOI 10.18632/oncotarget.9958; Chen MB, 2016, ONCOTARGET, V7, P17047, DOI 10.18632/oncotarget.7742; Chen MB, 2015, BIOCHEM BIOPH RES CO, V463, P954, DOI 10.1016/j.bbrc.2015.06.041; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Copur MS, 2008, NEW ENGL J MED, V359, P2498; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dong YY, 2016, TUMOUR BIOL; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; Hasskarl J, 2014, RECENT RESULTS CANC, V201, P373, DOI 10.1007/978-3-642-54490-3_23; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Husseinzadeh HD, 2011, CURR CLIN PHARMACOL, V6, P214, DOI 10.2174/157488411797189433; Ji DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085116; Kai S, 2014, BIOCHEM BIOPH RES CO, V452, P768, DOI 10.1016/j.bbrc.2014.08.147; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Lamming DW, 2013, J CLIN INVEST, V123, P980, DOI 10.1172/JCI64099; Li JP, 2016, ONCOTARGET, V7, P77815, DOI 10.18632/oncotarget.12802; Li Z, 2016, ONCOTARGET, V7, P61366, DOI 10.18632/oncotarget.11351; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Lu PH, 2016, ONCOTARGET, V7, P45889, DOI 10.18632/oncotarget.9969; Lu PH, 2016, ONCOTARGET; Lu XS, 2016, ONCOTARGET; Mortensen DS, 2015, MOL CANCER THER, V14, P1295, DOI 10.1158/1535-7163.MCT-14-1052; Pal SK, 2013, CANCER TREAT REV, V39, P709, DOI 10.1016/j.ctrv.2012.12.015; Palmer DH, 2008, NEW ENGL J MED, V359, P2498; Qiu Y, 2014, BIOCH BIOPHYS RES CO; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schenone S, 2011, CURR MED CHEM, V18, P2995, DOI 10.2174/092986711796391651; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh S, 2014, NAT REV GASTRO HEPAT, V11, P45, DOI 10.1038/nrgastro.2013.143; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Tanaka S, 2012, SEMIN ONCOL, V39, P486, DOI 10.1053/j.seminoncol.2012.05.005; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang L, 2015, EXP CELL RES, V332, P47, DOI 10.1016/j.yexcr.2014.12.017; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhao H, 2015, ONCOTARGET, V6, P31927, DOI 10.18632/oncotarget.5578; Zheng B, 2015, CANCER LETT, V357, P468, DOI 10.1016/j.canlet.2014.11.012; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281	44	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173252	10.1371/journal.pone.0173252	http://dx.doi.org/10.1371/journal.pone.0173252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334043	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200011
J	Di Bartolomeo, A; Chauleur, C; Gris, JC; Chapelle, C; Noblot, E; Laporte, S; Raia-Barjat, T				Di Bartolomeo, Aurelie; Chauleur, Celine; Gris, Jean-Christophe; Chapelle, Celine; Noblot, Edouard; Laporte, Silvy; Raia-Barjat, Tiphaine			Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study	PLOS ONE			English	Article							GESTATIONAL VASCULAR COMPLICATIONS; VENOUS THROMBOSIS; PREECLAMPSIA; PLASMA; RESISTANCE	Objective The study aimed to evaluate if the rate of tissue factor pathway inhibitor during pregnancy and following delivery could be a predictive factor for placenta-mediated adverse pregnancy outcomes in high-risk women. Methods This was a prospective multicentre cohort study of 200 patients at a high risk of occurrence or recurrence of placenta-mediated adverse pregnancy outcomes conducted between June 2008 and October 2010. Measurements of tissue factor pathway inhibitor resistance (normalized ratio) and tissue factor pathway inhibitor activity were performed for the last 72 patients at 20, 24, 28, 32, and 36 weeks of gestation and during the postpartum period. Results Overall, 15 patients presented a placenta-mediated adverse pregnancy outcome. There was no difference in normalized tissue factor pathway inhibitor ratios between patients with and without placenta-mediated adverse pregnancy outcomes during pregnancy and in the post-partum period. Patients with placenta-mediated adverse pregnancy outcomes had tissue factor pathway inhibitor activity rates that were significantly higher than those in patients without at as early as 24 weeks of gestation. The same results were observed following delivery. Conclusion Among high-risk women, the tissue factor pathway inhibitor activity of patients with gestational vascular complications is higher than that in other patients. Hence, these markers could augment a screening strategy that includes an analysis of angiogenic factors as well as clinical and ultrasound imaging with Doppler measurement of the uterine arteries.	[Di Bartolomeo, Aurelie; Chauleur, Celine; Noblot, Edouard; Raia-Barjat, Tiphaine] Univ Hosp, Dept Obstet & Gynaecol, St Etienne, France; [Chauleur, Celine; Chapelle, Celine; Laporte, Silvy; Raia-Barjat, Tiphaine] St Etienne Univ Jean Monnet, INSERM UMR 1059, St Etienne, France; [Gris, Jean-Christophe] Univ Hosp, Lab Haematol, Nimes, France; [Gris, Jean-Christophe] Montpellier Univ, Res Unit EA2992, Montpellier, France; [Chapelle, Celine; Laporte, Silvy] Univ Hosp, Clin Pharmacol Unit, St Etienne, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de St Etienne	Raia-Barjat, T (corresponding author), Univ Hosp, Dept Obstet & Gynaecol, St Etienne, France.; Raia-Barjat, T (corresponding author), St Etienne Univ Jean Monnet, INSERM UMR 1059, St Etienne, France.	tiphaine.barjat@chu-st-etienne.fr	GRIS, Jean-Christophe/AAA-2923-2019; BARJAT, Tiphaine/AAJ-7310-2021	GRIS, Jean-Christophe/0000-0002-9899-9910; Raia-Barjat, Tiphaine/0000-0002-4408-6075; Chapelle, Celine/0000-0003-3281-3666				Aharon A, 2009, J THROMB HAEMOST, V7, P1047, DOI 10.1111/j.1538-7836.2009.03342.x; Bergrem A, 2011, BRIT J HAEMATOL, V154, P241, DOI 10.1111/j.1365-2141.2011.08712.x; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Castoldi E, 2010, J THROMB HAEMOST, V8, P294, DOI 10.1111/j.1538-7836.2009.03712.x; Chang J., 2003, MMWR SURVEILL SUMM, V52, P1; Chauhan SP, 2006, J MATERN-FETAL NEO M, V19, P557, DOI 10.1080/14767050600798267; Dahm A, 2006, BRIT J HAEMATOL, V132, P333, DOI 10.1111/j.1365-2141.2005.05876.x; Dahm A, 2003, BLOOD, V101, P4387, DOI 10.1182/blood-2002-10-3188; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Erez O, 2010, J MATERN-FETAL NEO M, V23, P23, DOI 10.3109/14767050902994770; Erez O, 2008, J MATERN-FETAL NEO M, V21, P855, DOI 10.1080/14767050802361872; ESKENAZI B, 1991, JAMA-J AM MED ASSOC, V266, P237; Gader AMA, 2006, INT J GYNECOL OBSTET, V95, P248, DOI 10.1016/j.ijgo.2006.07.014; Godoi LC, 2012, J THROMB THROMBOLYS, V34, P1, DOI 10.1007/s11239-012-0708-8; Hackeng TM, 2009, ARTERIOSCL THROM VAS, V29, P2015, DOI 10.1161/ATVBAHA.108.177436; Harris GM, 1999, AM J HEMATOL, V60, P175, DOI 10.1002/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.3.CO;2-O; Ittel A, 2011, THROMB HAEMOSTASIS, V105, P66, DOI 10.1160/TH10-06-0399; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Sandset PR, 2000, HAEMOSTASIS, V30, P48; Tardy-Poncet B, 2003, J THROMB HAEMOST, V1, P507, DOI 10.1046/j.1538-7836.2003.00086.x; Tardy-Poncet B, 2012, THROMB RES, V130, P925, DOI 10.1016/j.thromres.2012.07.025; Teng YC, 2010, THROMB RES, V126, pE41, DOI 10.1016/j.thromres.2010.02.012	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173596	10.1371/journal.pone.0173596	http://dx.doi.org/10.1371/journal.pone.0173596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328938	Green Published, gold			2022-12-27	WOS:000399094700026
J	Garcia, FH; Fischer, G; Liu, C; Audisio, TL; Alpert, GD; Fisher, BL; Economo, EP				Garcia, Francisco Hita; Fischer, Georg; Liu, Cong; Audisio, Tracy L.; Alpert, Gary D.; Fisher, Brian L.; Economo, Evan P.			X-Ray microtomography for ant taxonomy: An exploration and case study with two new Terataner (Hymenoptera, Formicidae, Myrmicinae) species from Madagascar	PLOS ONE			English	Article							IMAGING TECHNIQUES; STING APPARATUS; MICRO-CT; MORPHOLOGY; CHARACTERS; EVOLUTION; DIAGNOSIS; DIPLOPODA; ACULEATA; REVISION	We explore the potential of x-ray micro computed tomography (mu CT) for the field of ant taxonomy by using it to enhance the descriptions of two remarkable new species of the ant genus Terataner: T. balrog sp. n. and T. nymeria sp. n.. We provide an illustrated worker-based species identification key for all species found on Madagascar, as well as detailed taxonomic descriptions, which include diagnoses, discussions, measurements, natural history data, high-quality montage images and distribution maps for both new species. In addition to conventional morphological examination, we have used virtual reconstructions based on volumetric mu CT scanning data for the species descriptions. We also include 3D PDFs, still images of virtual reconstructions, and 3D rotation videos for both holotype workers and one paratype queen. The complete mu CT datasets have been made available online (Dryad, https://datadryad.org) and represent the first cybertypes in ants (and insects). We discuss the potential of mu CT scanning and critically assess the usefulness of cybertypes for ant taxonomy.	[Garcia, Francisco Hita; Fischer, Georg; Liu, Cong; Audisio, Tracy L.; Economo, Evan P.] Okinawa Inst Sci & Technol Grad Univ, Biodivers & Biocomplex Unit, Onna Son, Okinawa, Japan; [Alpert, Gary D.] Harvard Univ, Museum Comparat Zool, Dept Entomol, Cambridge, MA 02138 USA; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	Okinawa Institute of Science & Technology Graduate University; Harvard University; California Academy of Sciences	Garcia, FH (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Biodivers & Biocomplex Unit, Onna Son, Okinawa, Japan.	fhitagarcia@gmail.com	Fischer, Georg/Y-3059-2019; Liu, Cong/B-9927-2015; Garcia, Francisco Hita/C-9636-2015	Fischer, Georg/0000-0002-4033-2005; Liu, Cong/0000-0002-8664-6931; Garcia, Francisco Hita/0000-0003-4709-3083; Audisio, Tracy/0000-0002-4663-8101; Fisher, Brian/0000-0002-4653-3270	Okinawa Institute of Science and Technology; National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395]; Museum of Comparative Zoology, Harvard University	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University); National Science Foundation(National Science Foundation (NSF)); Museum of Comparative Zoology, Harvard University	Subsidy funding to EPE by Okinawa Institute of Science and Technology (http://www.oist.jp); DEB-0072713, DEB-0344731, DEB-0842395 to BLF by National Science Foundation (http://www.nsf.gov); Ernst Mayr Travel Grant & research travel grant to FHG by Museum of Comparative Zoology, Harvard University (http://www.mcz.harvard.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135243; Akkari N, 2013, ZOOKEYS, P5, DOI 10.3897/zookeys.328.5763; Alpert Gary D., 1992, Psyche (Cambridge), V99, P117, DOI 10.1155/1992/27380; Baroni Urbani Cesare, 2003, Museo Regionale di Scienze Naturali Monografie (Turin), V36, P1; Belshaw Robert, 1994, Journal of Hymenoptera Research, V3, P5; Blanke A, 2014, ARTHROPOD STRUCT DEV, V43, P63, DOI 10.1016/j.asd.2013.10.003; Bolton B., 1981, Bulletin of the British Museum (Natural History) Entomology, V43, P245; Bolton B., 1980, Bulletin of the British Museum (Natural History) Entomology, V40, P193; Bolton B., 2020, ONLINE CATALOG ANTS; Bolton Barry, 2000, Memoirs of the American Entomological Institute (Gainesville), V65, P1; Bolton Barry, 1994, P1; Boudinot BE, 2015, EUR J TAXON, V120, P1, DOI 10.5852/ejt.2015.120; Boudinot BE, 2013, J HYMENOPT RES, V30, P29, DOI 10.3897/JHR.30.3535; Boudinot BE, 2013, ZOOTAXA, V3635, P301, DOI 10.11646/zootaxa.3635.4.1; Carbayo F, 2016, ZOOL SCR, V45, P566, DOI 10.1111/zsc.12175; Carbayo F, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0119-4; Csosz S, 2012, MYRMECOL NEWS, V17, P27; Eguchi K, 2005, SOCIOBIOLOGY, V45, P721; Evenhuis NL, 2020, INSECT SPIDER COLLEC; Faulwetter Sarah, 2014, Microscopy and Analysis, V11, pS9; Faulwetter Sarah, 2013, Microscopy and Analysis, V4, pS4; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fernandes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087436; Fischer G, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0158544, 10.1371/journal.pone.0161520]; Fischer G, 2015, ZOOKEYS, P77, DOI 10.3897/zookeys.525.6057; Fischer G, 2012, ZOOTAXA, P1; Fisher BL, 1999, FIELD ZOOL, P129; Fisher BL, 1997, J NAT HIST, V31, P269, DOI 10.1080/00222939700770141; Fisher BL, 2004, CALIFORNIA ACAD SCI, V28, P269; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P86; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P657; Garcia FH, 2015, ZOOKEYS, P97, DOI 10.3897/zookeys.475.8761; Garcia FH, 2014, ZOOKEYS, P47, DOI 10.3897/zookeys.447.7766; Garcia Francisco Hita, 2013, Journal of East African Natural History, V101, P127; Garwood RJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0125; Garwood RJ, 2014, PEERJ, V2, DOI 10.7717/peerj.641; Garwood RJ, 2014, CURR BIOL, V24, P1017, DOI 10.1016/j.cub.2014.03.039; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Godfray HCJ, 2007, NATURE, V446, P259, DOI 10.1038/446259a; Greco M, 2008, J APICULT RES, V47, P286, DOI 10.1080/00218839.2008.11101476; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Harris RA, 1979, OCC PAP ENT, V28, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henderickx H., 2013, PALAEONTOL ELECTRON, V16, P16; Hita Garcia F, 2014, EUR J TAXON, V90, P1, DOI 10.5852/ejt.2014.90; Jochum A, 2014, ZOOKEYS, P23, DOI 10.3897/zookeys.410.7488; Keller RA, 2014, ELIFE, V3, DOI 10.7554/eLife.01539; KUGLER C, 1980, J AUST ENTOMOL SOC, V19, P263; KUGLER C, 1978, Studia Entomologica, V20, P413; KUGLER C, 1979, EVOLUTION, V33, P117, DOI 10.1111/j.1558-5646.1979.tb04668.x; KUGLER C, 1986, Insecta Mundi, V1, P221; LaPolla John S., 2005, Proceedings of the California Academy of Sciences, V56, P601; LaPolla John S., 2004, Contributions of the American Entomological Institute, V33, P1; LaPolla JS, 2005, T AM ENTOMOL SOC, V131, P365; Liew TS, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.393.6717; Lipke E, 2014, J MORPHOL, V275, P1238, DOI 10.1002/jmor.20298; Michalik P, 2013, ZOOKEYS, P117, DOI 10.3897/zookeys.352.6021; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Qing X, 2015, NEMATOLOGY, P1; Rowe T, 2011, SCIENCE, V331, P712, DOI 10.1126/science.1202828; Sarnat EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156709; Schmelzle S, 2015, ZOOL ANZ, V254, P27, DOI 10.1016/j.jcz.2014.09.002; Schmelzle Sebastian, 2012, Soil Organisms, V84, P431; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Shattuck SO, 2008, ZOOTAXA, P1; Sidlauskas BL, 2011, ZOOL J LINN SOC-LOND, V162, P103, DOI 10.1111/j.1096-3642.2010.00677.x; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Steiner FM, 2010, ZOOL ANZ, V249, P223, DOI 10.1016/j.jcz.2010.09.003; Stoev Pavel, 2013, Biodivers Data J, pe1013, DOI 10.3897/BDJ.1.e1013; Ward PS, 2011, MYRMECOL NEWS, V15, P21; Ward PS, 2001, INVERTEBR TAXON, V15, P589, DOI 10.1071/IT01001; Wheeler QD, 2010, NATURE ED KNOWLEDGE, V3, P6; Wheeler Q, 2012, ZOOKEYS, P193, DOI 10.3897/zookeys.209.3486; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1; Xu Q, 2012, IEEE T BIO-MED ENG, V59, P1711, DOI 10.1109/TBME.2012.2192119; Yoshimura M, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.394.6446; Ziegler A, 2012, ZOOSYMPOSIA, V7, P53, DOI 10.11646/zoosymposia.7.1.6; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Zimmermann D, 2011, ARTHROPOD STRUCT DEV, V40, P571, DOI 10.1016/j.asd.2011.06.003	79	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172641	10.1371/journal.pone.0172641	http://dx.doi.org/10.1371/journal.pone.0172641			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328931	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700005
J	Kopperstad, O; Skogen, JC; Sivertsen, B; Tell, GS; Saether, SMM				Kopperstad, Oyvind; Skogen, Jens Christoffer; Sivertsen, Borge; Tell, Grethe S.; Saether, Solbjorg Makalani Myrtveit			Physical activity is independently associated with reduced mortality: 15-years follow-up of the Hordaland Health Study (HUSK)	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; SEDENTARY BEHAVIOR; LEISURE-TIME; POPULATION; SMOKING; LEVEL; RISK; SYMPTOMS	Background Physical activity (PA) is associated with lower risk for non-communicable diseases and mortality. We aimed to investigate the prospective association between PA and all-cause and cause-specific mortality, and the impact of other potentially contributing factors. Method Data from the community-based Hordaland Health Study (HUSK, 1997-99) were linked to the Norwegian Cause of Death Registry. The study included 20,506 individuals born 1950-1957 and 2,225 born in 1925-1927 (baseline age 40-49 and 70-74). Based on self-report, individuals were grouped as habitually performing low intensity, short duration, low intensity, longer duration or high intensity PA. The hazard ratios (HR) for all-cause and cause-specific mortality during follow-up were calculated. Measures of socioeconomic status, physical health, mental health, smoking and alcohol consumption were added separately and cumulatively to the model. Results PA was associated with lower all-cause mortality in both older (HR 0.75 (95% Cl 0.67-0.84)) and younger individuals (HR 0.82 (95% Cl 0.72-0.92)) (crude models, HR: risk associated with moving from low intensity, short duration to low intensity, longer duration PA, and from low intensity, longer duration to high intensity). Smoking, education, somatic diagnoses and mental health accounted for some of the association between physical activity and mortality, but a separate protective effect of PA remained in fully adjusted models for cardiovascular (HR 0.78 (95% Cl 0.66-0.92)) and respiratory (HR 0.45 (95% Cl 0.32-0.63) mortality (both age-groups together), as well as all-cause mortality in the older age group (HR 0.74, 95% Cl 0.66-0.83). Conclusion Low intensity, longer duration and high intensity physical activity was associated with reduced all-cause, respiratory and cardiovascular mortality, indicating that physical activity is beneficial also among older individuals, and that a moderate increase in PA can be beneficial.	[Kopperstad, Oyvind; Tell, Grethe S.; Saether, Solbjorg Makalani Myrtveit] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Kopperstad, Oyvind; Skogen, Jens Christoffer; Sivertsen, Borge; Saether, Solbjorg Makalani Myrtveit] Norwegian Inst Publ Hlth, Dept Hlth Promot, Bergen, Norway; [Skogen, Jens Christoffer] Stavanger Univ Hosp, Ctr Alcohol & Drug Res, Stavanger, Norway; [Sivertsen, Borge] Uni Res Hlth, Reg Ctr Child & Youth Mental Hlth & Child Welf, Bergen, Norway; [Sivertsen, Borge] Helse Fonna, Dept Res & Innovat, Haugesund, Norway; [Saether, Solbjorg Makalani Myrtveit] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Norwegian Institute of Public Health (NIPH); Stavanger University Hospital; University of Bergen	Saether, SMM (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.; Saether, SMM (corresponding author), Norwegian Inst Publ Hlth, Dept Hlth Promot, Bergen, Norway.; Saether, SMM (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	makalani@myrtveit.com	Sæther, Solbjørg Makalani Myrtveit/O-3633-2014; Tell, Grethe/G-5639-2015	Sæther, Solbjørg Makalani Myrtveit/0000-0002-5948-3794; Tell, Grethe/0000-0003-1386-1638; Skogen, Jens Christoffer/0000-0003-0722-5440; Sivertsen, Borge/0000-0003-4654-9296				Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Arem H, 2014, INT J CANCER, V135, P423, DOI 10.1002/ijc.28659; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Butler EN, 2014, TOP STROKE REHABIL; Da Silva MA, 2012, EUR J EPIDEMIOL, V27, P537, DOI 10.1007/s10654-012-9692-8; Engeland A, 2003, NORSK EPIDEMIOLOGI, V13; Evenson KR, 2014, J CARDIOPULM REHABIL, V34, P406, DOI 10.1097/HCR.0000000000000064; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FORD ES, 1991, AM J EPIDEMIOL, V133, P1246, DOI 10.1093/oxfordjournals.aje.a115836; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Gjertsen Finn, 2002, Tidsskr Nor Laegeforen, V122, P2551; Graff-Iversen S, 2008, EUR J EPIDEMIOL, V23, P167, DOI 10.1007/s10654-007-9214-2; Gulsvik AK, 2012, INT J EPIDEMIOL, V41, P521, DOI 10.1093/ije/dyr205; Hamer M, 2013, BRIT J SPORT MED; Helsedirektoratet, RAD FYS AKT; Holme I, 2000, TIDSSKR NOR LAEGEFOR, V134, P1743; HUSK, 2016, HELS HORD 2016; ICD-10, 2016, ICD 10; Janney CA, 2014, J AFFECT DISORDERS, V152, P498, DOI 10.1016/j.jad.2013.09.009; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Kull M, 2002, SCAND J MED SCI SPOR, V12, P241, DOI 10.1034/j.1600-0838.2002.00341.x; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; LAPIDUS L, 1986, BRIT HEART J, V55, P295, DOI 10.1136/hrt.55.3.295; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Myrtveit SM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-129; Nandi A, 2014, EPIDEMIOLOGY, V25, P170, DOI 10.1097/EDE.0000000000000038; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Noble N, 2015, PREV MED, V81, P16, DOI 10.1016/j.ypmed.2015.07.003; Organization WH, 2009, GLOB HLTH RISKS MORT; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519; Portegijs E, 2007, SCAND J MED SCI SPOR, V17, P473, DOI 10.1111/j.1600-0838.2006.00606.x; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Pratt M, 2014, BRIT J SPORT MED, V48, P171, DOI 10.1136/bjsports-2012-091810; Rimmer J. H., 2007, Morbidity and Mortality Weekly Report, V56, P1021; Rosengren A, 1997, ANN EPIDEMIOL, V7, P69, DOI 10.1016/S1047-2797(96)00106-8; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Sogaard AJ, 2003, NOR EPIDEMIOL, V13, P279, DOI DOI 10.5324/NJE.V13I2.296; SSB, DODS 2012; StataCorp, 2015, STAT STAT SOFTW REL; Stensvold D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-109; Stessman J, 2000, J AM GERIATR SOC, V48, P499, DOI 10.1111/j.1532-5415.2000.tb04995.x; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172932	10.1371/journal.pone.0172932	http://dx.doi.org/10.1371/journal.pone.0172932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328994	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000399094700013
J	Rice, WS; Turan, B; Stringer, KL; Helova, A; White, K; Cockrill, K; Turan, JM				Rice, Whitney S.; Turan, Bulent; Stringer, Kristi L.; Helova, Anna; White, Kari; Cockrill, Kate; Turan, Janet M.			Norms and stigma regarding pregnancy decisions during an unintended pregnancy: Development and predictors of scales among young women in the US South	PLOS ONE			English	Article							ABORTION; HEALTH; TERM	Background Norms and stigma regarding pregnancy decisions (parenting, adoption, and abortion) are salient to maternal well-being, particularly for groups disproportionately affected by unintended pregnancy. However, there are few validated measures of individual-level perceptions of norms and stigma around pregnancy decisions. Additionally, little is known about variation in the content of norms regarding pregnancy decisions, and in stigma related to violations of these norms, across socio-demographic groups. Methods To create measures of perceived norms and stigma around pregnancy decisions, we developed and pre-tested 97 survey items using a mixed methods approach. The resulting survey was administered to 642 young adult women recruited from health department clinics and a public university campus in Birmingham, Alabama. Principal components factor analyses, reliability analyses, independent t-tests, and correlation analyses were conducted to establish the reliability and validity of scales. Additionally, multiple linear regression was used to identify demographic predictors of higher scale scores. Results Factor analyses revealed four subscales for each pregnancy decision: conditional acceptability, anticipated reactions, stereotypes/misperceptions, and attitudes. The total scales and their subscales demonstrated good internal reliability (alpha coefficients 0.72-0.94). The mean scores for each scale were significantly associated with each other, with related measures, and differed by sociodemographic characteristics. Specifically, in adjusted analyses, women in the university setting and White women expressed more negative attitudes and stigma around parenting. Minority women endorsed more negative norms and stigma around adoption. Finally, women from the health department, White women, and religious women expressed more negative norms and stigma around abortion. Conclusion Findings suggest that our multidimensional measures have good psychometric properties in our sample of young women in the U.S. South, and highlight the importance of conceptualizing and measuring norms and stigmas around all pregnancy decisions. These scales may be of use in research on pregnancy decision-making and evaluation of stigma-reduction interventions.	[Rice, Whitney S.; Turan, Bulent] Univ Alabama Birmingham, Dept Psychol, Coll Arts & Sci, Birmingham, AL 35294 USA; [Stringer, Kristi L.] Univ Alabama Birmingham, Dept Med Sociol, Coll Arts & Sci, Birmingham, AL USA; [Helova, Anna; White, Kari; Turan, Janet M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [Cockrill, Kate] Tides Fdn, Sea Change Program, Oakland, CA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Turan, JM (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA.	jmturan@uab.edu		Rice, Whitney/0000-0003-1749-023X; Turan, Janet/0000-0002-7802-6206; Turan, Bulent/0000-0003-2008-227X; Stringer, Kristi/0000-0001-6181-5789	Society of Family Planning Research Fund [SFPPRF7-10, SFPRF9-T5]; Human Resources and Services Administration as a predoctoral trainee under an institutional training grant [T76MC00008]; Agency for Healthcare Research and Quality as a postdoctoral fellow under an institutional training grant [T32HS013852]; National Institute of Drug Abuse as a predoctoral fellow under a fellowship grant [F31 DA037106-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS013852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA037106] Funding Source: NIH RePORTER	Society of Family Planning Research Fund; Human Resources and Services Administration as a predoctoral trainee under an institutional training grant; Agency for Healthcare Research and Quality as a postdoctoral fellow under an institutional training grant; National Institute of Drug Abuse as a predoctoral fellow under a fellowship grant; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was conducted with grant support from the Society of Family Planning Research Fund (www.http://societyfp.org/; SFPPRF7-10 and SFPRF9-T5). W.S.R. was supported by the Human Resources and Services Administration (www.hrsa.gov/) as a predoctoral trainee under an institutional training grant (T76MC00008), and is currently supported by the Agency for Healthcare Research and Quality (www.ahrq.gov/) as a postdoctoral fellow under an institutional training grant (T32HS013852). K.S. is currently supported by the National Institute of Drug Abuse (www.drugabuse.gov/) as a predoctoral fellow under a fellowship grant (F31 DA037106-01). The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken ARA, 2016, PERSPECT SEX REPRO H, V48, P147, DOI 10.1363/48e10316; Argys L, 2013, DEMOGRAPHY, V50, P933, DOI 10.1007/s13524-012-0166-0; Biggs M, 2016, JAMA PSYCHIAT; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; Cockrill K, 2013, DEVIANT BEHAV, V34, P973, DOI 10.1080/01639625.2013.800423; Cockrill K, 2013, PERSPECT SEX REPRO H, V45, P79, DOI 10.1363/4507913; Contract Software Ltd, 2010, SURVEY; Cook RJ, 2014, INT J GYNECOL OBSTET, V125, P89, DOI 10.1016/j.ijgo.2014.01.002; Creswell JW, 2011, DESIGNING AND CONDUC; Dinno A, 2009, MULTIVAR BEHAV RES, V44, P362, DOI 10.1080/00273170902938969; Dott M, 2010, MATERN CHILD HLTH J, V14, P373, DOI 10.1007/s10995-009-0458-1; Edin K, 2011, PROMISES I CAN KEEP: WHY POOR WOMEN PUT MOTHERHOOD BEFORE MARRIAGE, P1; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Finer LB, 2011, PERSPECT SEX REPRO H, V43, P78, DOI 10.1363/4307811; Foster DG, 2015, PSYCHOL MED, V45, P2073, DOI 10.1017/S0033291714003213; Foster DG, 2008, CONTRACEPTION, V77, P289, DOI 10.1016/j.contraception.2007.10.010; Gomez-Scott J, 2014, CULT HEALTH SEX, V16, P648, DOI 10.1080/13691058.2014.898794; Hanschmidt F, 2016, ABORTION STIGMA A SY; Hayford SR, 2016, PERSPECT SEX REPRO H, V48, P83, DOI 10.1363/48e9116; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hess C, 2015, THE STATUS OF WOMEN, pR400; Jones Jo, 2008, Vital Health Stat 23, P1; Kendall C, 2005, SOC SCI MED, V60, P297, DOI 10.1016/j.socscimed.2004.05.007; Khanna N, 2015, SOCIOL PERSPECT, V58, P570, DOI 10.1177/0731121415572688; Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9; Kumar A, 2009, CULT HEALTH SEX, V11, P625, DOI 10.1080/13691050902842741; Mauldon J, 2015, PERSPECT SEX REPRO H, V47, P11, DOI 10.1363/47e2315; Mollborn S, 2015, QUAL HEALTH RES, V25, P1283, DOI 10.1177/1049732314557086; Monaghan M, 2014, TRANSL BEHAV MED, V4, P170, DOI 10.1007/s13142-013-0245-9; Park J, 2016, AM J OBSTET GYNECOL, V214, P74, DOI 10.1016/j.ajog.2015.08.045; Pew Research Center, 2013, WIDENING REGIONAL DI; Shellenberg KM, 2014, WOMEN HEALTH, V54, P599, DOI 10.1080/03630242.2014.919982; Sisson G, 2015, WOMEN HEALTH ISS, V25, P349, DOI 10.1016/j.whi.2015.05.007; Smith W, 2016, PERSPECT SEX REPRO H, V48, P73, DOI 10.1363/48e9016; Sorhaindo AM, 2016, CONTRACEPTION, V93, P421, DOI 10.1016/j.contraception.2016.01.013; Steinberg JR, 2016, SOC SCI MED, V150, P67, DOI 10.1016/j.socscimed.2015.12.007	36	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174210	10.1371/journal.pone.0174210	http://dx.doi.org/10.1371/journal.pone.0174210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328960	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700070
J	Gelderblom, H; Wustenberg, T; McLean, T; Mutze, L; Fischer, W; Saft, C; Hoffmann, R; Sussmuth, S; Schlattmann, P; van Duijn, E; Landwehrmeyer, B; Priller, J				Gelderblom, Harald; Wuestenberg, Torsten; McLean, Tim; Muetze, Lisanne; Fischer, Wilhelm; Saft, Carsten; Hoffmann, Rainer; Suessmuth, Sigurd; Schlattmann, Peter; van Duijn, Erik; Landwehrmeyer, Bernhard; Priller, Josef			Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PSYCHOMETRIC PROPERTIES; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; REWARD ANTICIPATION; EVALUATION SCALE; PROGRESSION; DEPRESSION; ATROPHY; PREMANIFEST	Objective To evaluae the efficacy and safety of bupropion in the treatment of apathy in Huntington's disease (HD). Methods In this phase 2b multicentre, double-blind, placebo-controlled crossover trial, individuals with HD and clinical signs of apathy according to the Structured Clinical Interview for Apathy D Dementia (SCIA-D), but not depression (n = 40) were randomized to receive either bupropion 150/300mg or placebo daily for 10 weeks. The primary outcome parameter was a significant change of the Apathy Evaluation Scale (AES) score after ten weeks of treatment as judged by an informant (AES-I) living in close proximity with the study participant. The secondary outcome parameters included changes of 1. AES scores determined by the patient (AES-S) or the clinical investigator (AES-C), 2. psychiatric symptoms (NPI, HADS-SIS, UHDRS-Behavior), 3. cognitive performance (SDMT, Stroop, VFT, MMSE), 4. motor symptoms (UHDRS-Motor), 5. activities of daily function (TFC, UHDRS-Function), and 6. caregiver distress (NPI-D). In addition, we investigated the effect of bupropion on brain structure as well as brain responses and functional connectivity during reward processing in a gambling task using magnetic resonance imaging (MRI). Results At baseline, there were no significant treatment group differences in the clinical primary and secondary outcome parameters. At endpoint, there was no statistically significant difference between treatment groups for all clinical primary and secondary outcome variables. Study participation, irrespective of the intervention, lessened symptoms of apathy according to the informant and the clinical investigator. Conclusion Bupropion does not alleviate apathy in HD. However, study participation/placebo effects were observed, which document the need for carefully controlled trials when investigating therapeutic interventions for the neuropsychiatric symptoms of HD.	[Gelderblom, Harald; Priller, Josef] Charite, Dept Neuropsychiat, Berlin, Germany; [Wuestenberg, Torsten] Charite, Dept Psychiat, Berlin, Germany; [McLean, Tim; Muetze, Lisanne; Suessmuth, Sigurd; Landwehrmeyer, Bernhard] European Huntingtons Dis Network, Ulm, Germany; [Fischer, Wilhelm; Landwehrmeyer, Bernhard] Univ Ulm, Dept Neurol, Ulm, Germany; [Saft, Carsten; Hoffmann, Rainer] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Huntington Ctr NRW, Bochum, Germany; [Schlattmann, Peter] Jena Universityhosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany; [van Duijn, Erik] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [Priller, Josef] DZNE, Cluster Excellence, Berlin, Germany; [Priller, Josef] BIH, Berlin, Germany; [Gelderblom, Harald] Natl Assoc Statutory Hlth Insurance Funds, Dept Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University; Ruhr University Bochum; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health	Priller, J (corresponding author), Charite, Dept Neuropsychiat, Berlin, Germany.; Priller, J (corresponding author), DZNE, Cluster Excellence, Berlin, Germany.; Priller, J (corresponding author), BIH, Berlin, Germany.	Josef.priller@charite.de	Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Priller, Josef/ABW-3835-2022	Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Wustenberg, Torsten/0000-0001-8408-2864; Saft, Carsten/0000-0002-3983-7292; Priller, Josef/0000-0001-7596-0979	Huntington Study Group (HSG), Rochester, New York, USA; Huntington Society of Canada (HSC), Ontario, Canada; European Huntington's Disease Network (EHDN), Ulm, Germany; Cluster of Excellence NeuroCure, Charite - Universitatsmedizin Berlin; EHDN; MRC [MC_PC_16031] Funding Source: UKRI	Huntington Study Group (HSG), Rochester, New York, USA; Huntington Society of Canada (HSC), Ontario, Canada; European Huntington's Disease Network (EHDN), Ulm, Germany; Cluster of Excellence NeuroCure, Charite - Universitatsmedizin Berlin; EHDN; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Huntington Study Group (HSG), Rochester, New York, USA (www.huntingtonstudygroup.org); Huntington Society of Canada (HSC), Ontario, Canada (www.huntingtonsociety.ca); European Huntington's Disease Network (EHDN), Ulm, Germany (www.euro-hd.net); Cluster of Excellence NeuroCure, Charite - Universitatsmedizin Berlin (www.neurocure.de). EHDN funded data collection but had no role in study design, data analysis, decision to publish, or preparation of the manuscript. HSG, HSC and NeuroCure had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre VM, 2010, CNS NEUROSCI THER, V16, P163, DOI 10.1111/j.1755-5949.2010.00134.x; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Bonnelle V, 2014, J PHYSL PARIS; Chatterjee A, 2005, J NEUROPSYCH CLIN N, V17, P378, DOI 10.1176/appi.neuropsych.17.3.378; Clarke DE, 2011, J PSYCHOSOM RES, V70, P73, DOI 10.1016/j.jpsychores.2010.01.012; Corcoran C, 2004, J PSYCHOPHARMACOL, V18, P133, DOI 10.1177/0269881104043284; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Cubo E, 2012, MOVEMENT DISORD, V27, P439, DOI 10.1002/mds.24062; Cummings J, 2015, J GERIATR PSYCH NEUR, V28, P159, DOI 10.1177/0891988715573534; Dogan I, 2013, NEURODEGENER DIS, V12, P23, DOI 10.1159/000339528; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Duff K, 2010, J NEUROPSYCH CLIN N, V22, P196, DOI 10.1176/appi.neuropsych.22.2.196; Enzi B, 2012, EXP NEUROL, V235, P256, DOI 10.1016/j.expneurol.2012.02.003; Fennema-Notestine C, 2004, NEUROLOGY, V63, P989, DOI 10.1212/01.WNL.0000138434.68093.67; Frank S, 2016, JAMA-J AM MED ASSOC, V316, P40, DOI 10.1001/jama.2016.8655; de Yebenes JG, 2011, LANCET NEUROL, V10, P1049, DOI 10.1016/S1474-4422(11)70233-2; Ho AK, 2006, MOVEMENT DISORD, V21, P385, DOI 10.1002/mds.20739; Hoth KF, 2007, J CLIN EXP NEUROPSYC, V29, P365, DOI 10.1080/13803390600718958; Hsieh CJ, 2012, PSYCHIAT CLIN NEUROS, V66, P227, DOI 10.1111/j.1440-1819.2011.02315.x; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Krishnamoorthy A, 2011, CURR TREAT OPTION NE, V13, P508, DOI 10.1007/s11940-011-0140-y; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lorenz RC, 2014, HUM BRAIN MAPP, V35, P5153, DOI 10.1002/hbm.22540; Lueken U, 2006, FORTSCHR NEUROL PSYC, V74, P714, DOI 10.1055/s-2006-932164; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mason S, 2015, J HUNTINGTONS DIS, V4, P49, DOI 10.3233/JHD-140133; Mason SL, 2015, EXPERT OPIN PHARMACO, P1; McCarrey AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049787; Mestre TA, 2016, MOVEMENT DISORD, V31, P1466, DOI 10.1002/mds.26675; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Ninphius D, 2008, J NEUROL NEUROSUR PS, V79, pA21; Paul RH, 2005, J NEUROPSYCH CLIN N, V17, P167, DOI 10.1176/appi.neuropsych.17.2.167; Pfeifer L, 2013, INT PSYCHOGERIATR, V25, P1345, DOI 10.1017/S1041610213000562; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Roze E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00055; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schwab LC, 2015, EXPERT REV NEUROTHER, P1; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Starkstein SE, 2014, CORTEX, V61, P64, DOI 10.1016/j.cortex.2014.07.019; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Thompson JC, 2012, J NEUROPSYCH CLIN N, V24, P53, DOI 10.1176/appi.neuropsych.11030057; van Duijn E, 2014, J NEUROL NEUROSUR PS, V85, P1411, DOI 10.1136/jnnp-2013-307343; Weiser M, 2015, EUR NEUROPSYCHOPHARM, V25, P1060, DOI 10.1016/j.euroneuro.2014.08.018	49	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173872	10.1371/journal.pone.0173872	http://dx.doi.org/10.1371/journal.pone.0173872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323838	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000035
J	Pisarska, M; Malczak, P; Major, P; Wysocki, M; Budzynski, A; Pedziwiatr, M				Pisarska, Magdalena; Malczak, Piotr; Major, Piotr; Wysocki, Michal; Budzynski, Andrzej; Pedziwiatr, Michal			Enhanced recovery after surgery protocol in oesophageal cancer surgery: Systematic review and meta-analysis	PLOS ONE			English	Article							CLINICAL PATHWAY; COLONIC SURGERY; PROGRAM; STAY; IMPLEMENTATION; REHABILITATION; OUTCOMES; COHORT; IMPACT; CARE	Background Enhanced Recovery After Surgery (ERAS) protocol are well established in many surgical disciplines, leading to decrease in morbidity and length of hospital stay. These multi-modal protocols have been also introduced to oesophageal cancer surgery. This review aimed to evaluate current literature on ERAS in oesophageal cancer surgery and conduct a meta analysis on primary and secondary outcomes. Methods MEDLINE, Embase, Scopus and Cochrane Library were searched for eligible studies. We analyzed data up to May 2016. Eligible studies had to contain four described ERAS protocol elements. The primary outcome was overall morbidity. Secondary outcomes included length of hospital stay, specific complications, mortality and readmissions. Random effect meta analyses were undertaken. Results Initial search yielded 1,064 articles. Thorough evaluation resulted in 13 eligible articles which were analyzed. A total of 2,042 patients were included in the analysis (1,058 ERAS group and 984 treated with traditional protocols). Analysis of overall morbidity as well as complication rate did not show any significant reduction. Non-surgical complications and pulmonary complications were significantly lower in the ERAS group, RR = 0.71 95% CI 0.62-0.80, p < 0.00001 and RR = 0.75, 95% CI 0.60-0.94, p = 0.01, respectively. Meta-analysis on length of stay presented significant reduction Mean difference = -3.55, 95% CI -4.41 to -2.69, p for effect<0.00001. Conclusions This systematic review with a meta-analysis on ERAS in oesophageal surgery indicates a reduction of non-surgical complications and no negative influence on overall morbidity. Moreover, a reduction in the length of hospital stay was presented.	[Pisarska, Magdalena; Malczak, Piotr; Major, Piotr; Wysocki, Michal; Budzynski, Andrzej; Pedziwiatr, Michal] Jagiellonian Univ, Coll Med, Dept Gen Surg 2, Krakow, Poland; [Pisarska, Magdalena; Malczak, Piotr; Major, Piotr; Wysocki, Michal; Budzynski, Andrzej; Pedziwiatr, Michal] Dept Endoscop Metab & Soft Tissue Tumors Surg, Krakow, Poland; [Pisarska, Magdalena; Malczak, Piotr; Major, Piotr; Wysocki, Michal; Budzynski, Andrzej; Pedziwiatr, Michal] Ctr Res Training & Innovat Surg CERTAIN Surg, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Pedziwiatr, M (corresponding author), Jagiellonian Univ, Coll Med, Dept Gen Surg 2, Krakow, Poland.; Pedziwiatr, M (corresponding author), Dept Endoscop Metab & Soft Tissue Tumors Surg, Krakow, Poland.; Pedziwiatr, M (corresponding author), Ctr Res Training & Innovat Surg CERTAIN Surg, Krakow, Poland.	michal.pedziwiatr@uj.edu.pl	Pedziwiatr, Michal/B-1594-2016; Pisarska-Adamczyk, Magdalena/ABD-7785-2020	Pedziwiatr, Michal/0000-0001-9073-2667; Pisarska-Adamczyk, Magdalena/0000-0001-8936-1977				Aahlin EK, 2014, PERIOPER MED-LONDON, V3, DOI 10.1186/2047-0525-3-5; Al-Herz F, 2015, J Perioper Pract, V25, P111; [Anonymous], WORLD J SURG; BARDRAM L, 1995, LANCET, V345, P763, DOI 10.1016/S0140-6736(95)90643-6; Beamish AJ, 2015, INT J SURG, V19, P46, DOI 10.1016/j.ijsu.2015.05.021; Blom RLGM, 2013, WORLD J SURG, V37, P2372, DOI 10.1007/s00268-013-2135-1; Cao SQ, 2013, SUPPORT CARE CANCER, V21, P707, DOI 10.1007/s00520-012-1570-0; Coolsen M, 2013, WORLD J SURG, V37, P1909, DOI 10.1007/s00268-013-2044-3; Findlay JM, 2015, DIS ESOPHAGUS, V28, P567, DOI 10.1111/dote.12234; Ford SJ, 2014, INT J SURG, V12, P320, DOI 10.1016/j.ijsu.2014.01.015; Gatenby PAC, 2015, ANN ROY COLL SURG, V97, P502, DOI 10.1308/003588415X14181254789880; Gemmill EH, 2015, ANN ROY COLL SURG, V97, P173, DOI 10.1308/003588414X14055925061630; Greco M, 2014, WORLD J SURG, V38, P1531, DOI 10.1007/s00268-013-2416-8; Gustafsson UO, 2013, WORLD J SURG, V37, P259, DOI 10.1007/s00268-012-1772-0; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kehlet H, 1999, BRIT J SURG, V86, P227, DOI 10.1046/j.1365-2168.1999.01023.x; Kehlet H, 1997, BRIT J ANAESTH, V78, P606, DOI 10.1093/bja/78.5.606; Li C, 2012, SURGERY, V152, P606, DOI 10.1016/j.surg.2012.07.021; Munitiz V, 2010, BRIT J SURG, V97, P714, DOI 10.1002/bjs.6942; Ni TG, 2015, WORLD J GASTROENTERO, V21, P9209, DOI 10.3748/wjg.v21.i30.9209; Pan HG, 2014, INTERACT CARDIOV TH, V19, P441, DOI 10.1093/icvts/ivu172; Pedziwiatr M, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0738-8; Pedziwiatr M, 2015, INT J SURG, V21, P75, DOI 10.1016/j.ijsu.2015.06.087; Preston SR, 2013, BRIT J SURG, V100, P105, DOI 10.1002/bjs.8974; Scott MJ, 2015, ACTA ANAESTH SCAND, V59, P1212, DOI 10.1111/aas.12601; Shewale JB, 2015, ANN SURG, V261, P1114, DOI 10.1097/SLA.0000000000000971; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang J, 2013, ANN ROY COLL SURG, V95, P323, DOI 10.1308/003588413X13629960046039; Urbach DR, 2005, BMJ-BRIT MED J, V330, P1401, DOI 10.1136/bmj.330.7505.1401; Wang JY, 2015, ASIA PAC J CLIN NUTR, V24, P206, DOI 10.6133/apjcn.2015.24.2.18; Zhao GB, 2014, SUPPORT CARE CANCER, V22, P351, DOI 10.1007/s00520-013-1979-0	31	59	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174382	10.1371/journal.pone.0174382	http://dx.doi.org/10.1371/journal.pone.0174382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350805	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174400031
J	Sun, LX; Ren, J; He, WJ				Sun, Luxi; Ren, Jie; He, Weijie			Neural correlates of facial expression processing during a detection task: An ERP study	PLOS ONE			English	Article							BRAIN POTENTIALS; EMOTIONAL EXPRESSION; SPATIAL ATTENTION; FACE PERCEPTION; TIME-COURSE; RESPONSES; WORD; FEAR; ACTIVATION; PICTURES	Given finite attentional resources, how emotional aspects of stimuli are processed automatically is controversial. Present study examined the time-course for automatic processing of facial expression by assessing N170, and late positive potentials (LPPs) of event-related potentials (ERPs) using a modified rapid serial visual presentation (RSVP) paradigm. Observers were required to confirm a certain house image and to detect whether a face image was presented at the end of a series of pictures. There were no significant main effects on emotional type for P1 amplitudes, whereas happy and fearful expressions elicited larger N170 amplitudes than neutral expressions. Significantly different LPP amplitudes were elicited depending on the type of emotional facial expressions (fear > happy > neutral). These results indicated that threatening priority was absent but discrimination of expressive vs. neutral faces occurred in implicit emotional tasks, at approximately 250 ms post-stimulus. Moreover, the three types of expressions were discriminated during the later stages of processing. Encoding emotional information of faces can be automated to a relatively higher degree, when attentional resources are mostly allocated to superficial analyzing.	[Sun, Luxi] Chongqing Univ, Sch Econ & Business Adm, Chongqing, Peoples R China; [Ren, Jie; He, Weijie] Chongqing Univ Arts & Sci, Lab Emot & Mental Hlth, Chongqing, Peoples R China	Chongqing University; Chongqing University of Arts & Sciences	He, WJ (corresponding author), Chongqing Univ Arts & Sci, Lab Emot & Mental Hlth, Chongqing, Peoples R China.	hweijie@foxmail.com		Ren, Jie/0000-0002-8000-302X	National Natural Science Foundation of China [31600917]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WH received the funding of National Natural Science Foundation of China (31600917) for this work, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the National Natural Science Foundation of China (31600917)	Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Donchin E., 1986, PSYCHOPHYSIOLOGY SYS; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Ekman P., 2003, EMOTIONS REVEALED, V2; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Luck S. J., 2000, NEW COGNITIVE NEUROS; LUCK Steven J., INTRO EVENT RELATED; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Miltner WHR, 2005, INT J PSYCHOPHYSIOL, V57, P43, DOI 10.1016/j.ijpsycho.2005.01.012; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2006, PROG BRAIN RES, V156, P67, DOI 10.1016/S0079-6123(06)56004-2; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Van Strien JW, 2010, NEUROREPORT, V21, P656, DOI 10.1097/WNR.0b013e32833ab89e; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wild-Wall N, 2008, BIOL PSYCHOL, V77, P138, DOI 10.1016/j.biopsycho.2007.10.001; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188	54	13	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174016	10.1371/journal.pone.0174016	http://dx.doi.org/10.1371/journal.pone.0174016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350800	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174400011
J	Jegede, FE; Oyeyi, TI; Abdulrahman, SA; Mbah, HA; Badru, T; Agbakwuru, C; Adedokun, O				Jegede, Feyisayo Ebenezer; Oyeyi, Tinuade Ibijoke; Abdulrahman, Surajudeen Abiola; Mbah, Henry Akwen.; Badru, Titilope; Agbakwuru, Chinedu; Adedokun, Oluwasanmi			Effect of HIV and malaria parasites coinfection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano,Nigeria	PLOS ONE			English	Article							HEMOGLOBIN LEVELS; NIGERIA; PREVALENCE; ADULTS; IMPACT; THERAPY; AFRICA; COUNT	Background Human immunodeficiency virus (HIV) and malaria co-infection may present worse health outcomes in the tropics. Information on HIV/malaria co-infection effect on immune-hemato-logical profiles is critical for patient care and there is a paucity of such data in Nigeria. Objective To evaluate immune-hematological profiles among HIV infected patients compared to HIV/malaria co-infected for ART management improvement. Methods This was a cross sectional study conducted at Infectious Disease Hospital, Kano. A total of 761 consenting adults attending ART clinic were randomly selected and recruited between June and December 2015. Participants' characteristics and clinical details including two previous CD4 counts were collected. Venous blood sample (4ml) was collected in EDTA tube for malaria parasite diagnosis by rapid test and confirmed with microscopy. Hematological profiles were analyzed by Sysmex XP-300 and CD4 count by Cyflow cytometry. Data was analyzed with SPSS 22.0 using Chi-Square test for association between HIV/malaria parasites co-infection with age groups, gender, ART, cotrimoxazole and usage of treated bed nets. Mean hematological profiles by HIV/malaria co-infection and HIV only were compared using independent t-test and mean CD4 count tested by mixed design repeated measures ANOVA. Statistical significant difference at probability of <0.05 was considered for all variables. Results Of the 761 HIV infected, 64% were females, with a mean age of +/-(SD) 37.30 (10.4) years. Prevalence of HIV/malaria co-infection was 27.7% with Plasmodium falciparum specie accounting for 99.1%. No statistical significant difference was observed between HIV/malaria co-infection in association to age (p = 0.498) and gender (p = 0.789). A significantly (p = 0.026) higher prevalence (35.2%) of co-infection was observed among non-ART patients compared to (26%) ART patients. Prevalence of co-infection was significantly lower (20.0%) among cotrimoxazole users compared to those not on cotrimoxazole (37%). The same significantly lower co-infection prevalence (22.5%) was observed among treated bed net users compared to those not using treated bed nets (42.9%) (p = 0.001). Out of 16 hematology profiles evaluated, six showed significant difference between the two groups (i) packed cell volume (p = < 0.001), (ii) mean cell volume (p = 0.005), (iii) mean cell hemoglobin concentration (p = 0.011), (iv) absolute lymphocyte count (p = 0.022), (v) neutrophil percentage count (p = 0.020) and (vi) platelets distribution width (p = < 0.001). Current mean CD4 count cell/mu l (349 +/- 12) was significantly higher in HIV infected only compared to co-infected (306 +/- 17), (p = 0.035). A significantly lower mean CD4 count (234.6 +/- 6.9) was observed among respondents on ART compared to non-ART (372.5 +/- 13.2), p< 0.001, mean difference = -137.9). Conclusion The study revealed a high burden of HIV and malaria co-infection among the studied population. Co-infection was significantly lower among patients who use treated bed nets as well as cotrimoxazole chemotherapy and ART. Six hematological indices differed significantly between the two groups. Malaria and HIV co-infection significantly reduces CD4 count. In general, to achieve better management of all HIV patients in this setting, diagnosing malaria, prompt anti-retroviral therapy, monitoring CD4 and some hematology indices on regular basis is critical.	[Jegede, Feyisayo Ebenezer; Badru, Titilope; Agbakwuru, Chinedu; Adedokun, Oluwasanmi] Family Hlth Int, 360 Plot 1073-A1 GODAB Plaza,Area 3 Garki Abuja, Abuja, Nigeria; [Jegede, Feyisayo Ebenezer; Oyeyi, Tinuade Ibijoke] Bayero Univ, Dept Biol Sci, Kano, Nigeria; [Abdulrahman, Surajudeen Abiola] Penang Med Coll, Dept Publ Hlth, George Town, Penang, Malaysia; [Mbah, Henry Akwen.] LabTrail Global LLC, Smyrna, DE USA	Bayero University	Jegede, FE (corresponding author), Family Hlth Int, 360 Plot 1073-A1 GODAB Plaza,Area 3 Garki Abuja, Abuja, Nigeria.; Jegede, FE (corresponding author), Bayero Univ, Dept Biol Sci, Kano, Nigeria.	feyitab@yahoo.com		Adedokun, Oluwasanmi/0000-0002-4678-9735	LabTrail, Global LLC	LabTrail, Global LLC	There was no specific funding received for this research work. LabTrail, Global LLC provided support in the form of salaries for author HAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Afolabi JK, 2014, J INT ASS PROVID AID; Akinbo Frederick O., 2009, New Zealand Journal of Medical Laboratory Science, V63, P78; Akinbo FO, 2012, J RES HEALTH SCI, V12, P15; Alemu A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-18; Amuta E. U., 2012, Asian Pacific Journal of Tropical Disease, pS378; Analyzer AH, 2012, SYSMEX STAND OPER PR; Audu RA, 2005, ANN AFRICAN MED, P10; Bergen A., 2014, P 3 INT WORKSH GREEN, P9; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Chavale H, 2012, MEM I OSWALDO CRUZ, V107, P985, DOI 10.1590/S0074-02762012000800004; Chirenda J, 2003, Cent Afr J Med, V49, P66; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Cunnington A, 2012, HIV MALARIA COINTECT, P335; Cyflow Partec, 2010, MAN UISOP CYFLOW SPA; Dikshit Byomakesh, 2009, BMC Blood Disord, V9, P5, DOI 10.1186/1471-2326-9-5; Erhabor O, 2006, Niger J Med, V15, P52; Etusim P., 2013, J SCI MULTIDISCIP RE, V5, P100; Ezeugwunne I. P., 2012, International Journal of Biological and Chemical Sciences, V6, P1409; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Goselle ON, 2009, J VECTOR DIS, V46, P205; Hochman Sarah, 2009, Interdiscip Perspect Infect Dis, V2009, P617954, DOI 10.1155/2009/617954; Iliyasu Z, 2013, ACTA TROP, V128, P630, DOI 10.1016/j.actatropica.2013.09.011; Iroezindu Michael O, 2012, Niger J Med, V21, P209; Kasirye RP, 2016, AIDS, V30, P635, DOI 10.1097/QAD.0000000000000956; Laufer MK, 2006, J INFECT DIS, V193, P872, DOI 10.1086/500245; Manyando C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056916; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Nkuo-Akenji T, 2008, AJAR-AFR J AIDS RES, V7, P229, DOI 10.2989/AJAR.2008.7.2.8.525; Ojurongbe O, 2014, J TROP MED, V2014, P8; Omoti CE, 2013, PREVALENCE PARASITEM, P126; Onyenekwe C. C., 2008, Journal of Vector Borne Diseases, V45, P151; Onyenekwe C. C., 2007, Journal of Vector Borne Diseases, V44, P250; Orish VN, 2013, INT J GYNECOL OBSTET, V120, P236, DOI 10.1016/j.ijgo.2012.09.021; Renia L, 2006, PARASITE IMMUNOL, V28, P589, DOI 10.1111/j.1365-3024.2006.00903.x; Sahle Tsion, 2017, BMC Hematol, V17, P2, DOI 10.1186/s12878-017-0072-1; Sanyaolu AO, 2013, AFR HEALTH SCI, V13, P295, DOI 10.4314/ahs.v13i2.14; Saracino A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-241; Skinner-Adams TS, 2008, TRENDS PARASITOL, V24, P264, DOI 10.1016/j.pt.2008.03.008; Tagoe DNA, 2012, J INFECT DEV COUNTR, V6, P660, DOI 10.3855/jidc.2124; Tay SCK, 2015, ANN CLIN MICROB ANTI, P14; Tchinda GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040553; Uneke C. J., 2005, Journal of Vector Borne Diseases, V42, P151; Van geertruyden JP, 2014, CLIN MICROBIOL INFEC, V20, P278, DOI 10.1111/1469-0691.12597; Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363; World Health Organisation, 2013, WHO GUID, P272; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2015, METH MAN MAL MICR ME	50	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174233	10.1371/journal.pone.0174233	http://dx.doi.org/10.1371/journal.pone.0174233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346490	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174300033
J	Ulrich, D; Bjelic-Radisic, V; Hollein, A; Trutnovsky, G; Tamussino, K; Aigmuller, T				Ulrich, Daniela; Bjelic-Radisic, Vesna; Hoellein, Anna; Trutnovsky, Gerda; Tamussino, Karl; Aigmueller, Thomas			Quality of life and objective outcome assessment in women with tape division after surgery for stress urinary incontinence	PLOS ONE			English	Article							FREE VAGINAL TAPE; POSTOPERATIVE VOIDING DYSFUNCTION; SLING REVISION; MOBILIZATION; QUESTIONNAIRE; VALIDATION; RETENTION; PROLAPSE; IMPACT	Background Midurethral tapes may cause long-term complications such as voiding dysfunction, groin pain, de novo urgency or mesh erosion, which necessitate a reoperation. There is a paucity of data regarding health related quality of life in patients undergoing tape removal. The aim of the study was to evaluate quality of life (QoL) and objective outcome after midurethral tape division or excision. Methods All patients who underwent a midurethral tape division for voiding difficulties, pain or therapy resistant de novo overactive bladder between 1999 and 2014 were invited for follow-up. A control group with a suburethral tape without division was established in a 1:2 ratio and matched for age, tape used and year of tape insertion. Patients completed the Kings A Health Questionnaire (KHQ), Incontinence Outcome Questionnaire, Female Sexual Function Index Questionnaire and the Patient Global Impression of Improvement score. Results Tape division or excision was performed in 32 women. Overall, 15 (60%) of 25 women who were alive were available for clinical examination and completed the questionnaires. Tape division was performed for voiding dysfunction (n = 7), overactive bladder (n = 2), mesh extrusion (n = 3) and ongoing pain (n = 3). Median time to tape division/excision was 10 months. Three women in the tape division group had undergone reoperation for stress urinary incontinence (SUI). At a median follow-up of 11 years (IQR 9-13) subjective SUI rate was 53% (8/15 women) in the tape division group and 17% (5/30) in the control group (p = 0.016), with no significant differences in objective SUI rates between groups. With regard to quality of life, the study group had significantly worse scores in the SUI related domains role limitation, physical limitation, severity measures and social limitations (KHQ) compared to the control group. Conclusions Women needing tape division or excision have lower SUI related QoL scores compared to controls mostly because of higher subjective SUI rates.	[Ulrich, Daniela; Bjelic-Radisic, Vesna; Hoellein, Anna; Trutnovsky, Gerda; Tamussino, Karl; Aigmueller, Thomas] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria	Medical University of Graz	Trutnovsky, G (corresponding author), Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria.	gerda.trutnovsky@medunigraz.at	Gold, Daniela/ABE-4818-2020	Gold, Daniela/0000-0002-7196-454X; Trutnovsky, Gerda/0000-0001-6445-2418				Aigmueller T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.010; Berner MM, 2004, GEBURTSH FRAUENHEILK, V64, P293; Bjelic-Radisic V, 2005, NEUROUROL URODYNAM, V24, P63, DOI 10.1002/nau.20092; Bjelic-Radisic V, 2007, INT UROGYNECOL J, V18, P1139, DOI 10.1007/s00192-007-0302-3; Chang WC, 2010, INT UROGYNECOL J, V21, P229, DOI 10.1007/s00192-009-1016-5; de Leval J, 2003, EUR UROL, V44, P724, DOI 10.1016/j.eururo.2003.09.003; Fong EDM, 2010, BJU INT, V106, P596, DOI 10.1111/j.1464-410X.2010.09544.x; George A, 2012, FEMALE PELVIC MED RE, V18, P332, DOI 10.1097/SPV.0b013e318270adfe; Glazener CM, 2015, COCHRANE DB SYST REV, V7; Leng WW, 2004, J UROLOGY, V172, P1379, DOI 10.1097/01.ju.0000138555.70421.ca; Nguyen JN, 2005, UROLOGY, V66, P523, DOI 10.1016/j.urology.2005.03.055; Nilsson CG, 2013, INT UROGYNECOL J, V24, P1265, DOI 10.1007/s00192-013-2090-2; Ogah J, 2011, NEUROUROL URODYNAM, V30, P284, DOI 10.1002/nau.20980; Ogah J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub2; Price N, 2009, INT UROGYNECOL J, V20, P855, DOI 10.1007/s00192-009-0858-1; Rautenberg O, 2014, NEUROUROL URODYNAM, V33, P1147, DOI 10.1002/nau.22459; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Sokol AI, 2005, AM J OBSTET GYNECOL, V192, P1537, DOI 10.1016/j.ajog.2004.10.623; Srikrishna S, 2010, INT UROGYNECOL J, V21, P523, DOI 10.1007/s00192-009-1069-5; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; Ulrich D, 2016, J UROLOGY IN PRESS; Unger CA, 2016, INT UROGYNECOL J, V27, P117, DOI 10.1007/s00192-015-2769-7	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174628	10.1371/journal.pone.0174628	http://dx.doi.org/10.1371/journal.pone.0174628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346541	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300064
J	Ashfaq, M; Akhtar, S; Rafi, MA; Mansoor, S; Hebert, PDN				Ashfaq, Muhammad; Akhtar, Saleem; Rafi, Muhammad Athar; Mansoor, Shahid; Hebert, Paul D. N.			Mapping global biodiversity connections with DNA barcodes: Lepidoptera of Pakistan	PLOS ONE			English	Article							INVENTORY; FAUNA; DIVERSITY; RATES	Sequences from the DNA barcode region of the mitochondrial COI gene are an effective tool for specimen identification and for the discovery of new species. The Barcode of Life Data Systems (BOLD) (www.boldsystems.org) currently hosts 4.5 million records from animals which have been assigned to more than 490,000 different Barcode Index Numbers (BINs), which serve as a proxy for species. Because a fourth of these BINs derive from Lepidoptera, BOLD has a strong capability to both identify specimens in this order and to support studies of faunal overlap. DNA barcode sequences were obtained from 4503 moths from 329 sites across Pakistan, specimens that represented 981 BINs from 52 families. Among 379 species with a Linnaean name assignment, all were represented by a single BIN excepting five species that showed a BIN split. Less than half (44%) of the 981 BINs had counterparts in other countries; the remaining BINs were unique to Pakistan. Another 218 BINs of Lepidoptera from Pakistan were coupled with the 981 from this study before being compared with all 116,768 BINs for this order. As expected, faunal overlap was highest with India (21%), Sri Lanka (21%), United Arab Emirates (20%) and with other Asian nations (2.1%), but it was very low with other continents including Africa (0.6%), Europe (1.3%), Australia (0.6%), Oceania (1.0%), North America (0.1%), and South America (0.1%). This study indicates the way in which DNA barcoding facilitates measures of faunal overlap even when taxa have not been assigned to a Linnean species.	[Ashfaq, Muhammad; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada; [Akhtar, Saleem; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Rafi, Muhammad Athar] Natl Agr Res Ctr, Insect Museum, Islamabad, Pakistan	University of Guelph; Pakistan Institute of Engineering & Applied Science; National Agricultural Research Council - Pakistan	Ashfaq, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada.	mashfaq@uoguelph.ca	Ashfaq, Muhammad/J-4723-2019	Ashfaq, Muhammad/0000-0003-1351-4126; Mansoor, Shahid/0000-0001-7418-1826	grant HEC "Sequencing DNA Barcodes of Economically Important Insect Species from Pakistan" from the Higher Education Commission of Pakistan [20-1403/RD/09]; "Engaging Developing Nations in iBOL" from the International Development Research Centre in Canada [106106-001]; Government of Canada through Genome Canada; Ontario Genomics Institute; Canada First Research Excellence Fund	grant HEC "Sequencing DNA Barcodes of Economically Important Insect Species from Pakistan" from the Higher Education Commission of Pakistan; "Engaging Developing Nations in iBOL" from the International Development Research Centre in Canada; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Canada First Research Excellence Fund	This research was enabled by grant HEC No. 20-1403/R&D/09 "Sequencing DNA Barcodes of Economically Important Insect Species from Pakistan" from the Higher Education Commission of Pakistan and by grant 106106-001 "Engaging Developing Nations in iBOL" from the International Development Research Centre in Canada.r Sequence analysis was made possible by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project. This is a contribution to the Food From Thought project supported by the Canada First Research Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashfaq M, 2016, GENOME, V59, P933, DOI 10.1139/gen-2016-0024; Ashfaq M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14188; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blagoev GA, 2016, MOL ECOL RESOUR, V16, P325, DOI 10.1111/1755-0998.12444; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brehm G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150327; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Capinera JL, 2008, ENCY ENTOMOLOGY, V4, P626, DOI DOI 10.1007/978-1-4020-6359-6_498; Chambers EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154363; De Broyer C, 2011, DEEP-SEA RES PT II, V58, P5, DOI 10.1016/j.dsr2.2010.10.007; Deharveng L, 2015, ZOOSYSTEMA, V37, P9, DOI 10.5252/z2015n1a1; Drummond AJ, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0086-1; Finn DS, 2016, FRESHW SCI, V33, P207; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Gwiazdowski RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125635; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0333; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Janzen DH, 2016, GENOME, V59, P641, DOI 10.1139/gen-2016-0005; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019874; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Joschko M, 2006, AGR ECOSYST ENVIRON, V112, P367, DOI 10.1016/j.agee.2005.08.026; Kamaluddin S, 2014, FUUAST J BIOL, V4, P157; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Landry JF, 2013, ZOOTAXA, V3749, P4, DOI 10.11646/zootaxa.3749.1.1; Meza-Joya FL, 2016, ECOL EVOL, V6, P1901, DOI 10.1002/ece3.1968; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; MANTEL N, 1967, CANCER RES, V27, P209; McKinney LA, 2009, HUM ECOL REV, V16, P103; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niu YQ, 2014, J APPL ENTOMOL, V138, P692, DOI 10.1111/jen.12130; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Perveen F, 2013, J ADV BIOL, V2, P115; Rafi MA, 2014, ZOOTAXA, V3794, P393, DOI 10.11646/zootaxa.3794.3.4; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Roberts TJ, 2001, BUTTERFLIES PAKISTAN; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rosetti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040807; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telfer AC, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6313; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Wilson JJ, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e7159; Wirta H, 2016, MOL ECOL RESOUR, V16, P809, DOI 10.1111/1755-0998.12489; Yakovlev RV, 2016, BIOL B BOGDAN CHMELN, V6, P67, DOI 10.15421/201636; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zenker MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148423; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1	65	17	20	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174749	10.1371/journal.pone.0174749	http://dx.doi.org/10.1371/journal.pone.0174749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339501	gold, Green Published			2022-12-27	WOS:000399116700039
J	Avens, L; Goshe, LR; Coggins, L; Shaver, DJ; Higgins, B; Landry, AM; Bailey, R				Avens, Larisa; Goshe, Lisa R.; Coggins, Lewis; Shaver, Donna J.; Higgins, Ben; Landry, Andre M., Jr.; Bailey, Rhonda			Variability in age and size at maturation, reproductive longevity, and long-term growth dynamics for Kemp's ridley sea turtles in the Gulf of Mexico	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; LEPIDOCHELYS-KEMPII; CARETTA-CARETTA; CENTRAL FLORIDA; MATURITY; POPULATION; ECOLOGY; DIET; VALIDATION; IMMATURE	Effective management of protected sea turtle populations requires knowledge not only of mean values for demographic and life-history parameters, but also temporal and spatial trends, variability, and underlying causes. For endangered Kemp's ridley sea turtles (Lepidochelys kempii), the need for baseline information of this type has been emphasized during attempts to understand causes underlying the recent truncation in the recovery trajectory for nesting females. To provide insight into variability in age and size at sexual maturation (ASM and SSM) and long-term growth patterns likely to influence population trends, we conducted skeletochronological analysis of humerus bones from 333 Kemp's ridleys stranded throughout the Gulf of Mexico (GOM) from 1993 to 2010. Ranges of possible ASMs (6.8 to 21.8 yr) and SSMs (53.3 to 68.3 cm straightline carapace length (SCL)) estimated using the "rapprochement" skeletal growth mark associated with maturation were broad, supporting incorporation of a maturation schedule in Kemp's ridley population models. Mean ASMs estimated from rapprochement and by fitting logistic, generalized additive mixed, and von Bertalanffy growth models to age and growth data ranged from 11 to 13 yr; confidence intervals for the logistic model predicted maturation of 95% of the population between 11.9 and 14.8 yr. Early juvenile somatic growth rates in the GOM were greater than those previously reported for the Atlantic, indicating potential for differences in maturation trajectories between regions. Finally, long-term, significant decreases in somatic growth response were found for both juveniles and adults, which could influence recruitment to the reproductive population and observed nesting population trends.	[Avens, Larisa; Goshe, Lisa R.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA; [Coggins, Lewis] US Fish & Wildlife Serv, Yukon Delta Natl Wildlife Refuge, Bethel, AK USA; [Shaver, Donna J.] Natl Pk Serv, Padre Isl Natl Seashore, Corpus Christi, TX USA; [Higgins, Ben] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Galveston Lab, Galveston, TX USA; [Landry, Andre M., Jr.] Texas A&M Univ, Galveston, TX USA; [Bailey, Rhonda] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System; Florida Fish & Wildlife Conservation Commission	Avens, L (corresponding author), NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA.	Larisa.Avens@noaa.gov	Shaver, Donna J/D-6227-2013	Shaver, Donna J/0000-0003-1379-8974; Avens, Larisa/0000-0001-6297-065X				Arendt MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081097; Avens L, 2015, MAR BIOL, V162, P1749, DOI 10.1007/s00227-015-2705-x; Avens L, 2013, CRC MAR BIOL SER, P97; Avens L, 2013, MAR ECOL PROG SER, V491, P235, DOI 10.3354/meps10454; Avens L, 2012, MAR ECOL PROG SER, V458, P213, DOI 10.3354/meps09720; Barichivich WJ, 2006, THESIS; BERNARDO J, 1993, TRENDS ECOL EVOL, V8, P166, DOI 10.1016/0169-5347(93)90142-C; Bevan E, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1244; Bjorndal KA, 2014, ENDANGER SPECIES RES, V25, P57, DOI 10.3354/esr00608; Bjorndal KA, 2013, MAR BIOL, V160, P607, DOI 10.1007/s00227-012-2116-1; Braun-McNeill J, 2008, HERPETOL CONSERV BIO, V3, P273; Caillouet Charles W. Jr., 1995, Chelonian Conservation and Biology, V1, P231; Caillouet CW, 2016, CHELONIAN CONSERV BI, V15, P115, DOI 10.2744/CCB-1189.1; Caillouet Charles W. Jr., 2014, Marine Turtle Newsletter, P1; Caillouet CW, 2011, CHELONIAN CONSERV BI, V10, P288, DOI 10.2744/CCB-0836.1; Carr AF, 1956, THE WINDWARD ROAD; CARR ARCHIE, 1963, ERGEBNISSE BIOL, V26, P298; Chaloupka M, 1997, FISH B-NOAA, V95, P849; Chaloupka M, BIOL SEA TURTLES, V1, P233; CHEN Y, 1994, AQUAT SCI, V56, P206, DOI 10.1007/BF00879965; Coleman AT, 2016, HERPETOL CONSERV BIO, V11, P253; Coleman AT, 2016, AQUATIC CONSERV MAR; Craig JK, 2013, ESTUAR COAST, V36, P268, DOI 10.1007/s12237-012-9577-9; Craig JK, 2001, COAST EST S, V58, P269; Crowder L, 2011, SOLUTIONS, V2, P67; Deepwater Horizon Natural Resource Damage Assessment Trustees (DWH NRDA), 2016, DEEPWATER HORIZON OI; ElMouden E, 1997, ANN SCI NAT ZOOL, V18, P63; Engle VD, 2009, ENVIRON MONIT ASSESS, V150, P193, DOI 10.1007/s10661-008-0677-8; FABENS AJ, 1965, GROWTH, V29, P265; Fracillon-Viellot H, 1990, J HERPETOL, V24, P13; Goshe LR, 2016, ECOL EVOL, V6, P3208, DOI 10.1002/ece3.2108; Goshe LR, 2010, MAR BIOL, V157, P1725, DOI 10.1007/s00227-010-1446-0; Guarino FM, 2008, ACTA ZOOL ACAD SCI H, V54, P99; Heppell S.S., 2007, BIOL CONSERVATION RI, P325; HILDEBRAND HENRY H., 1963, CIENCIA [MEXICO], V22, P105; Karnauskas M, 2013, NOAA TECHNICAL MEMOR, P52; KAWECKI TJ, 1993, EVOL ECOL, V7, P155, DOI 10.1007/BF01239386; Lyn Heidi, 2012, Marine Turtle Newsletter, P10; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Marquez R, 1994, NMFSSEFSC343 NOAA; Metz TL, 2004, THESIS; Morreale SJ, 2005, CHELONIAN CONSERV BI, V4, P872; NMFS (National Marine Fisheries Service) U. S. Fish and Wildlife Service and SEMARNAT, 2011, BIN REC PLAN KEMPS R; NMFS & USFWS (National Marine Fisheries Service and U.S. Fish and Wildlife Service), 2015, KEMPS RIDL SEA TURTL; NOAA (National Oceanic and Atmospheric Administration), 2014, 2010 GULF MEX OIL SP; Putman NF, 2015, CURR BIOL, V25, P1221, DOI 10.1016/j.cub.2015.03.014; Putman NF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0345; R Core Team, R LANG ENV STAT COMP; Ramirez MD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00255.1; Renaud ML, 2005, CHELONIAN CONSERV BI, V4, P808; Rudloe A, 2005, GULF MEXICO SCI, V2005, P185; Sanchez-Rubio G, 2011, FISH B-NOAA, V109, P139; Schmid Jeffrey R., 1997, Chelonian Conservation and Biology, V2, P532; Schmid Jeffrey R., 2006, Gulf of Mexico Science, V24, P28; Schmid JR, 2005, CHELONIAN CONSERV BI, V4, P828; Schmid JR, 2003, J WILDLIFE MANAGE, V67, P196, DOI 10.2307/3803075; Schmid JR, 1998, FISH B-NOAA, V96, P589; Schroeder BA, LOGGERHEAD SEA TURTL, P114; Seney EE, 2008, THESIS; Seney EE, 2016, CHELONIAN CONSERV BI, V15, P132, DOI 10.2744/CCB-1191.1; Seney EE, 2011, MAR ECOL PROG SER, V440, P241, DOI 10.3354/meps09380; Servis JA, 2015, CHELONIAN CONSERV BI, V14, P173; Shaver D. J., GULF MEXICO IN PRESS; SHAVER DJ, 1991, J HERPETOL, V25, P327, DOI 10.2307/1564592; Shaver DJ, 2016, BIOL CONSERV, V194, P158, DOI 10.1016/j.biocon.2015.12.014; Shaver DJ, 2015, HERPETOL CONSERV BIO, V10, P378; Shaver DJ, 2013, ECOL EVOL, V3, P2002, DOI 10.1002/ece3.594; Snover Melissa L., 2007, Endangered Species Research, V3, P95, DOI 10.3354/esr003095; Snover ML, 2004, FISH B-NOAA, V102, P682; Snover ML, 2007, BIOL CONSERVATION RI, P89; Sutton G, 2007, TEXAS PARKS WILDLIFE, P249; TEWG (Turtle Expert Working Group), 2000, NMFSSEFSC444 TEWG NO; VANBUSKIRK J, 1994, COPEIA, P66; VanderKooy S, 2013, 215 GULF STAT MAR FI; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970; Witzell WN, 2005, B MAR SCI, V77, P191; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zug G.R., 1986, SMITHSONIAN CONTRIBU, V427, P1, DOI 10.5479/si.00810282.427; Zug GR, 1997, BIOL CONSERV, V80, P261, DOI 10.1016/S0006-3207(96)00143-7	80	33	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173999	10.1371/journal.pone.0173999	http://dx.doi.org/10.1371/journal.pone.0173999			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333937	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200036
J	Caku, A; Seidah, NG; Lortie, A; Gagne, N; Perron, P; Dube, J; Corbin, F				Caku, Artuela; Seidah, Nabil G.; Lortie, Audrey; Gagne, Nancy; Perron, Patrice; Dube, Jean; Corbin, Francois			New insights of altered lipid profile in Fragile X Syndrome	PLOS ONE			English	Article							CHOLESTEROL LEVELS; CGG REPEAT; DYSLIPIDEMIA; LOVASTATIN; BEHAVIOR; ADULTS; HEALTH; PCSK9	Background Fragile X Syndrome (FXS) is the main genetic cause of autism and intellectual deficiency resulting the absence of the Fragile X Mental Retardation Protein (FMRP). Clinical picture is characterized by cognitive impairment associated with a broad spectrum of psychiatric comorbidities including autism spectrum disorders and attention-deficit/hyperactivity disorders. Some of these disorders have been associated with lipid abnormalities and lower cholesterol levels. Since lipids are important for neuronal development, we aim to investigate the lipid profile of French Canadian-FXS individuals and to identify the altered components of cholesterol metabolism as well as their association with clinical profile. Methods Anthropometric data were collected from 25 FXS individuals and 26 controls. Lipid assessment included: total cholesterol (TC), triglycerides, LDL, HDL, ApoB, ApoA1, PCSK9, Lp(a) and lipoprotein electrophoresis. Aberrant and adaptive behaviour of affected individuals was respectively assessed by the ABC-C and ABAS questionnaires. Results FXS participants had a higher body mass index as compared to controls while 38% of them had TC< 10th percentile. Lower levels of LDL, HDL and apoA1 were observed in FXS group as compared to controls. However, PCSK9 levels did not differ between the two groups. As expected, PCSK9 levels correlated with total cholesterol (r(s) = 0.61, p = 0.001) and LDL (r(s) = 0.46, p = 0.014) in the control group, while no association was present in the FXS group. An inverse relationship was observed between total cholesterol and aberrant behaviour as determined by ABC-C total score. Conclusion Our results showed the presence of hypocholesterolemia in French Canadian-FXS population, a condition that seems to influence their clinical phenotype. We identified for the first time a potential underlying alteration of PCSK9 function in FXS that could result from the absence of FMRP. Further investigations are warranted to better understand the association between cholesterol metabolism, PCSK9, FMRP and clinical profile.	[Caku, Artuela; Lortie, Audrey; Dube, Jean; Corbin, Francois] Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst, Nabil G Seidah Lab Biochem Neuroendocrinol, Montreal, PQ, Canada; [Gagne, Nancy] Univ Sherbrooke, Dept Paediat, Sherbrooke, PQ, Canada; [Perron, Patrice] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada	University of Sherbrooke; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Sherbrooke; University of Sherbrooke	Caku, A (corresponding author), Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada.	artuela.s.caku@usherbrooke.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Corbin, Francois/0000-0001-7712-5897; Caku, Artuela/0000-0002-9485-7245	Foundation of Stars; "Diabetes, Obesity, and Cardiovascular Complications" axis of Research Center of Centre Hospitalier de l'Universite de Sherbrooke	Foundation of Stars; "Diabetes, Obesity, and Cardiovascular Complications" axis of Research Center of Centre Hospitalier de l'Universite de Sherbrooke	FC received funding from Foundation of Stars. JD received funding from "Diabetes, Obesity, and Cardiovascular Complications" axis of Research Center of Centre Hospitalier de l'Universite de Sherbrooke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry-Kravis E, 2015, AM J MED GENET A, V167, P379, DOI 10.1002/ajmg.a.36850; Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20; Caku A, 2014, AM J MED GENET A, V164, P2834, DOI 10.1002/ajmg.a.36750; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gagne CaG, 2007, DANIEL DYSLIPOPROTEI; Gallagher A, 2012, J NEUROL, V259, P401, DOI 10.1007/s00415-011-6161-3; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; Lisik MZ, 2016, LIPIDS, V51, P189, DOI 10.1007/s11745-015-4109-6; MacLean DR, 1999, CAN J CARDIOL, V15, P434; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P211, DOI 10.1161/01.ATV.9.2.211; Raeder MB, 2006, J CLIN PSYCHIAT, V67, P1974, DOI 10.4088/JCP.v67n1219; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Sansone SM, 2012, J AUTISM DEV DISORD, V42, P1377, DOI 10.1007/s10803-011-1370-2; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Tulenko TN, 2002, J NUCL CARDIOL, V9, P638, DOI 10.1067/mnc.2002.128959; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144	21	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174301	10.1371/journal.pone.0174301	http://dx.doi.org/10.1371/journal.pone.0174301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334053	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200076
J	Lam, WK; Ryue, J; Lee, KK; Park, SK; Cheung, JTM; Ryu, J				Lam, Wing-Kai; Ryue, Jaejin; Lee, Ki-Kwang; Park, Sang-Kyoon; Cheung, Jason Tak-Man; Ryu, Jiseon			Does shoe heel design influence ground reaction forces and knee moments during maximum lunges in elite and intermediate badminton players?	PLOS ONE			English	Article							MIDSOLE HARDNESS; IMPACT; STRESS; PERFORMANCE; TASKS; STEP	Background Lunge is one frequently executed movement in badminton and involves a unique sagittal footstrike angle of more than 40 degrees at initial ground contact compared with other manoeuvres. This study examined if the shoe heel curvature design of a badminton shoe would influence shoe-ground kinematics, ground reaction forces, and knee moments during lunge. Methods Eleven elite and fifteen intermediate players performed five left-forward maximum lunge trials with Rounded Heel Shoe (RHS), Flattened Heel Shoe (FHS), and Standard Heel Shoes (SHS). Shoe-ground kinematics, ground reaction forces, and knee moments were measured by using synchronized force platform and motion analysis system. A 2 (Group) x 3 (Shoe) ANOVA with repeated measures was performed to determine the effects of different shoes and different playing levels, as well as the interaction of two factors on all variables. Results Shoe effect indicated that players demonstrated lower maximum vertical loading rate in RHS than the other two shoes (P < 0.05). Group effect revealed that elite players exhibited larger footstrike angle, faster approaching speed, lower peak horizontal force and horizontal loading rates but higher vertical loading rates and larger peak knee flexion and extension moments (P < 0.05). Analysis of Interactions of Group x Shoe for maximum and mean vertical loading rates (P < 0.05) indicated that elite players exhibited lower left maximum and mean vertical loading rates in RHS compared to FHS (P < 0.01), while the intermediate group did not show any Shoe effect on vertical loading rates. Conclusions These findings indicate that shoe heel curvature would play some role in altering ground reaction force impact during badminton lunge. The differences in impact loads and knee moments between elite and intermediate players may be useful in optimizing footwear design and training strategy to minimize the potential risks for impact related injuries in badminton.	[Lam, Wing-Kai; Cheung, Jason Tak-Man] Li Ning Sports Sci Res Ctr, Beijing, Peoples R China; [Lam, Wing-Kai] Shenyang Sports Inst, Dept Kinesiol, Shenyang, Peoples R China; [Ryue, Jaejin; Lee, Ki-Kwang] Kookmin Univ, Biomech & Sport Engn Lab, Seoul, South Korea; [Park, Sang-Kyoon; Ryu, Jiseon] Korea Natl Sport Univ, Mot Innovat Ctr, Seoul, South Korea	Kookmin University; Korea National Sport University	Lam, WK (corresponding author), Li Ning Sports Sci Res Ctr, Beijing, Peoples R China.; Lam, WK (corresponding author), Shenyang Sports Inst, Dept Kinesiol, Shenyang, Peoples R China.	gilbertlam@li-ning.com.cn	Lam, Gilbert Wing-Kai/AAG-8490-2020	Lam, Gilbert Wing-Kai/0000-0001-8692-2206; Cheung, Jason Tak-Man/0000-0001-8502-5431				Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; Boesen AP, 2011, KNEE SURG SPORT TR A, V19, P30, DOI 10.1007/s00167-010-1208-z; Cabello Manrique D, 2003, BRIT J SPORT MED, V37, P62; Clansey AC, 2014, MED SCI SPORT EXER, V46, P973, DOI 10.1249/MSS.0000000000000182; Cohen J., 1998, STAT POWER ANAL BEHA; COLE GK, 1995, J APPL BIOMECH, V11, P25, DOI 10.1123/jab.11.1.25; Cong Y, 2014, J BIOMECH, V47, P3799, DOI 10.1016/j.jbiomech.2014.10.028; Cronin J, 2003, J SPORT SCI, V21, P49, DOI 10.1080/0264041031000070958; Grice T., 2008, BADMINTON STEP SUCCE; Hong YL, 2014, J APPL BIOMECH, V30, P113, DOI 10.1123/jab.2012-0151; Hu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137558; Huang MT, 2014, J SPORT SCI, V32, P690, DOI 10.1080/02640414.2013.848998; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kersting UG, 2005, ERGONOMICS, V48, P380, DOI 10.1080/00140130512331332882; Kersting Uwe G, 2006, Res Sports Med, V14, P1, DOI 10.1080/15438620500528158; Kong PW, 2009, BRIT J SPORT MED, V43, P745, DOI 10.1136/bjsm.2008.047761; Kroner K, 1990, Br J Sports Med, V24, P169; Kuntze G, 2010, J SPORT SCI, V28, P183, DOI 10.1080/02640410903428533; Lake MJ, 2000, ERGONOMICS, V43, P1610, DOI 10.1080/001401300750004032; Lam GWK, 2015, J SPORT SCI, V33, P1738, DOI 10.1080/02640414.2015.1011206; Lam WK, 2010, J SPORT SCI, V28, P1543, DOI 10.1080/02640414.2010.517543; Lam WK, 2009, J SPORT SCI, V27, P179, DOI 10.1080/02640410802448764; Lam WK, 2017, J SPORT SCI, V35, P587, DOI 10.1080/02640414.2016.1180420; Markovic G, 2007, MED SCI SPORT EXER, V39, P1757, DOI 10.1249/mss.0b013e31811ece35; Mei QC, 2017, J SPORT SCI, V35, P457, DOI 10.1080/02640414.2016.1172723; Nigg B, 2013, FOOTWEAR SCI, V5, P1, DOI 10.1080/19424280.2013.766649; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; Nigg BM, 2009, J SPORT SCI, V27, P427, DOI 10.1080/02640410802669161; NIGG BM, 1995, J APPL BIOMECH, V11, P407, DOI 10.1123/jab.11.4.407; Nin DZ, 2016, J SPORT SCI, V34, P756, DOI 10.1080/02640414.2015.1069381; Phomsoupha M, 2014, COMPUT METHOD BIOMEC, V17, P140, DOI 10.1080/10255842.2014.931550; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Robinson G., 2008, INT J PERF ANAL SPOR, V8, P127, DOI [DOI 10.1080/24748668.2008.11868428, 10.1080/24748668.2008.11868428]; Shariff AH, 2009, SINGAP MED J, V50, P1095; Sigward S, 2006, CLIN BIOMECH, V21, P740, DOI 10.1016/j.clinbiomech.2006.03.003; Sinclair J, 2010, SPORT BIOMECH, V9, P65, DOI 10.1080/14763141.2010.491161; Sterzing T., 2012, SCI FOOTWEAR, P605; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005; Zhang SN, 2005, J APPL BIOMECH, V21, P3, DOI 10.1123/jab.21.1.3; Zhu FF, 2010, BIOL PSYCHOL, V84, P221, DOI 10.1016/j.biopsycho.2010.01.015	40	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174604	10.1371/journal.pone.0174604	http://dx.doi.org/10.1371/journal.pone.0174604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334016	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200112
J	Melillo, P; Orrico, A; Chirico, F; Pecchia, L; Rossi, S; Testa, F; Simonelli, F				Melillo, Paolo; Orrico, Ada; Chirico, Franco; Pecchia, Leandro; Rossi, Settimio; Testa, Francesco; Simonelli, Francesca			Identifying fallers among ophthalmic patients using classification tree methodology	PLOS ONE			English	Article							VISUAL IMPAIRMENT; OLDER-PEOPLE; RISK PROFILE; VISION; PREDICTORS; FRACTURES; OUTCOMES; TOOL	Purpose To develop and validate a tool aiming to support ophthalmologists in identifying, during routine ophthalmologic visits, patients at higher risk of falling in the following year. Methods A group of 141 subjects (age: 73.2 +/- 11.4 years), recruited at our Eye Clinic, underwent a baseline ophthalmic examination and a standardized questionnaire, including lifestyles, general health, social engagement and eyesight problems. Moreover, visual disability was assessed by the Activity of Daily Vision Scale (ADVS). The subjects were followed up for 12 months in order to record prospective falls. A subject who reported at least one fall within one year from the baseline assessment was considered as faller, otherwise as non-faller. Different tree-based algorithms (i.e., C4.5, AdaBoost and Random Forests) were used to develop automatic classifiers and their performances were evaluated by the cross-validation approach. Results Over the follow-up, 25 falls were referred by 13 patients. The logistic regression analysis showed the following variables as significant predictors of prospective falls: pseudophakia and use of prescribed eyeglasses as protective factors, recent worsening of visual acuity as risk factor. Random Forest ranked best corrected visual acuity, number of sleeping hours and job type as the most important features. Finally, AdaBoost enabled the identification of subjects at higher risk of falling in the following 12 months with a sensitivity rate of 69.2% and a specificity rate of 76.6%. Conclusions The current study proposes a novel method, based on classification trees applied to self-reported factors and health information assessed by a standardized questionnaire during ophthalmological visits, to identify ophthalmic patients at higher risk of falling in the following	[Melillo, Paolo; Orrico, Ada; Chirico, Franco; Rossi, Settimio; Testa, Francesco; Simonelli, Francesca] Univ Campania Luigi Vanvitelli, Eye Clin, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy; [Pecchia, Leandro] Univ Warwick, Sch Engn, Coventry, W Midlands, England	Universita della Campania Vanvitelli; University of Warwick	Melillo, P (corresponding author), Univ Campania Luigi Vanvitelli, Eye Clin, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy.	paolo.melillo@unina2.it	Simonelli, Francesca/AHE-7571-2022; Rossi, Settimio/AHI-1119-2022; Pecchia, Leandro/P-6344-2015; Pecchia, Leandro/AAF-7325-2019	Simonelli, Francesca/0000-0001-8520-6769; Pecchia, Leandro/0000-0002-7900-5415; Pecchia, Leandro/0000-0002-7900-5415	Project Smart Health and Artificial intelligence for Risk Estimation - National Operational Programme for Research and Competitiveness [PON04a3_00139]	Project Smart Health and Artificial intelligence for Risk Estimation - National Operational Programme for Research and Competitiveness	The work was supported by the Project Smart Health and Artificial intelligence for Risk Estimation under Grant PON04a3_00139, funded in the framework of 2007-2013 National Operational Programme for Research and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2004, HLTH INFORM J, V10, P221; Bath PA, 2000, J GERONTOL A-BIOL, V55, pM17; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bongue B, 2011, J CLIN EPIDEMIOL, V64, P1152, DOI 10.1016/j.jclinepi.2010.12.014; Boon MY, 2015, OPTOMETRY VISION SCI, V92, P995, DOI 10.1097/OPX.0000000000000695; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1993, CLASSIFICATION REGRE, Vx; Casilari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140929; Castaldo R, 2016, J BIOMEDICAL HLTH IN; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Coleman AL, 2004, OPHTHALMOLOGY, V111, P857, DOI 10.1016/j.ophtha.2003.09.033; de Boer MR, 2004, J BONE MINER RES, V19, P1539, DOI 10.1359/JBMR.040504; Dhital A, 2010, EYE, V24, P1437, DOI 10.1038/eye.2010.60; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Gadkaree SK, 2015, GERONTOLOGY GERIATRI, P1, DOI DOI 10.1177/2333721415584850; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Glas AS, J CLIN EPIDEMIOLOGY, V56, P1129; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Ivers Rebecca, 2002, N S W Public Health Bull, V13, P8, DOI 10.1071/NB02005; Jeter PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129646; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Klein BEK, 1998, OPHTHALMOLOGY, V105, P160, DOI 10.1016/S0161-6420(98)91911-X; Knudtson MD, 2009, ARCH GERONTOL GERIAT, V49, P22, DOI 10.1016/j.archger.2008.04.006; Kulmala J, 2008, AGING CLIN EXP RES, V20, P25; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord SR, 2002, J AM GERIATR SOC, V50, P1760, DOI 10.1046/j.1532-5415.2002.50502.x; Marks R, 2014, OPEN MED J, V1; McCarty CA, 2002, AUST NZ J PUBL HEAL, V26, P116, DOI 10.1111/j.1467-842X.2002.tb00902.x; Melillo P, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S3-S6; Melillo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118504; Palumbo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146247; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Reed-Jones RJ, 2013, MATURITAS, V75, P22, DOI 10.1016/j.maturitas.2013.01.019; Russell MA, 2009, AGE AGEING, V38, P40, DOI 10.1093/ageing/afn196; Sannino G, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0292-5; Siracuse JJ, 2012, AM J SURG, V203, P335, DOI 10.1016/j.amjsurg.2011.09.018; Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644; Yuki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129316	48	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174083	10.1371/journal.pone.0174083	http://dx.doi.org/10.1371/journal.pone.0174083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334052	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200044
J	Severson, JP; Hagen, CA; Tack, JD; Maestas, JD; Naugle, DE; Forbes, JT; Reese, KP				Severson, John P.; Hagen, Christian A.; Tack, Jason D.; Maestas, Jeremy D.; Naugle, David E.; Forbes, James T.; Reese, Kerry P.			Better living through conifer removal: A demographic analysis of sage-grouse vital rates	PLOS ONE			English	Article							WESTERN JUNIPER; SAGEBRUSH ECOSYSTEM; WATER AVAILABILITY; NEST SURVIVAL; CONSERVATION; RESTORATION; POPULATIONS; SELECTION; HABITATS; SUCCESS	Sagebrush (Artemisia spp.) obligate wildlife species such as the imperiled greater sagegrouse (Centrocercus urophasianus) face numerous threats including altered ecosystem processes that have led to conifer expansion into shrub-steppe. Conifer removal is accelerating despite a lack of empirical evidence on grouse population response. Using a beforeafter-control-impact design at the landscape scale, we evaluated effects of conifer removal on two important demographic parameters, annual survival of females and nest survival, by monitoring 219 female sage-grouse and 225 nests in the northern Great Basin from 2010 to 2014. Estimates from the best treatment models showed positive trends in the treatment area relative to the control area resulting in an increase of 6.6% annual female survival and 18.8% nest survival relative to the control area by 2014. Using stochastic simulations of our estimates and published demographics, we estimated a 25% increase in the population growth rate in the treatment area relative to the control area. This is the first study to link sage-grouse demographics with conifer removal and supports recommendations to actively manage conifer expansion for sage-grouse conservation. Sage-grouse have become a primary catalyst for conservation funding to address conifer expansion in the West, and these findings have important implications for other ecosystem services being generated on the wings of species conservation.	[Severson, John P.; Reese, Kerry P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Hagen, Christian A.] Oregon State Univ, Dept Fisheries & Wildlife, Bend, OR USA; [Tack, Jason D.; Naugle, David E.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Maestas, Jeremy D.] Nat Resources Conservat Serv, USDA, Redmond, OR USA; [Forbes, James T.] Bur Land Management, Lakeview, OR USA	Idaho; University of Idaho; Oregon State University; Oregon State University Cascades; University of Montana System; University of Montana; United States Department of Agriculture (USDA)	Severson, JP (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	seve0951@vandals.uidaho.edu		Severson, John/0000-0002-1754-6689; Maestas, Jeremy/0000-0002-9171-9576	US Bureau of Land Management; US Natural Resources Conservation Service through the Conservation Effects Assessment Project; Sage Grouse Initiative	US Bureau of Land Management; US Natural Resources Conservation Service through the Conservation Effects Assessment Project; Sage Grouse Initiative	This study was funded by the US Bureau of Land Management and the US Natural Resources Conservation Service through the Conservation Effects Assessment Project and the Sage Grouse Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.R, 2007, MODEL BASED INFERENC, DOI [10.2307/23014412, DOI 10.2307/23014412]; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baruch-Mordo S, 2013, BIOL CONSERV, V167, P233, DOI 10.1016/j.biocon.2013.08.017; Bates JD, 2000, J RANGE MANAGE, V53, P119, DOI 10.2307/4003402; Bates JD, 1998, GREAT BASIN NAT, V58, P363; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; Blomberg EJ, 2015, CONDOR, V117, P577, DOI 10.1650/CONDOR-15-39.1; Blomberg EJ, 2013, WILDLIFE BIOL, V19, P347, DOI 10.2981/13-001; Bureau of Land Management [BLM], 2011, DOIBLML05020090037EA; Casazza ML, 2011, STUD AVIAN BIOL, P151; Chambers JC, 2014, RANGELAND ECOL MANAG, V67, P440, DOI 10.2111/REM-D-13-00074.1; Coates PS, 2017, RANGELAND ECOL MANAG, V70, P25, DOI 10.1016/j.rama.2016.09.001; Coates PS, 2014, CONDOR, V116, P341, DOI 10.1650/CONDOR-13-126.1; Coates PS, 2010, J WILDLIFE MANAGE, V74, P240, DOI 10.2193/2009-047; Connelly JW, 2011, STUD AVIAN BIOL, P549; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Dahlgren DK, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1249; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Donnelly JP, 2017, RANGELAND ECOL MANAG, V70, P95, DOI 10.1016/j.rama.2016.10.009; Freese M. T, 2009, THESIS; Garton EO, 2011, STUD AVIAN BIOL, P293; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hagen CA, 2011, STUD AVIAN BIOL, P95; Hamerstrom F, 1952, SHARPTAILS SHADOWS; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Holmes AL, 2017, RANGELAND ECOL MANAG, V70, P87, DOI 10.1016/j.rama.2016.10.006; Howe KB, 2014, CONDOR, V116, P35, DOI 10.1650/CONDOR-13-115-R2.1; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knick ST, 2011, STUD AVIAN BIOL, P1; Kormos PR, 2017, RANGELAND ECOL MANAG, V70, P116, DOI 10.1016/j.rama.2016.05.003; Laake J.L, 2013, RMARK R INTERFACE AN; Lautenbach J., 2015, THESIS; Manzer DL, 2005, J WILDLIFE MANAGE, V69, P110, DOI 10.2193/0022-541X(2005)069&lt;0110:RGNSAC&gt;2.0.CO;2; McClain A, 2012, THESIS; Mcnew LB, 2012, J WILDLIFE MANAGE, V76, P38, DOI 10.1002/jwmg.237; Michener WK, 1997, RESTOR ECOL, V5, P324, DOI 10.1046/j.1526-100X.1997.00546.x; Miller R.F, 2008, RMRSRP69; Miller R. F., 2001, P INV SPEC WORKSH RO, V11, P15; MILLER RE, 1995, GREAT BASIN NAT, V55, P37; Miller RF, 1999, J RANGE MANAGE, V52, P550, DOI 10.2307/4003623; Miller RF, 2001, USDA TECHNICAL B; Miller RF, 2005, USDA TECHNICAL B; Miller RF, 2014, RANGELAND ECOL MANAG, V67, P468, DOI 10.2111/REM-D-13-00003.1; Miller RF, 2011, STUD AVIAN BIOL, P145; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Roundy BA, 2014, RANGELAND ECOL MANAG, V67, P495, DOI 10.2111/REM-D-13-00022.1; Sandford CP, 2017, RANGELAND ECOL MANAG, V70, P59, DOI 10.1016/j.rama.2016.09.002; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Severson J. P., 2016, THESIS; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Taylor RL, 2012, J WILDLIFE MANAGE, V76, P336, DOI 10.1002/jwmg.267; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WELCH B, 2005, BIG SAGEBRUSH SEA FR; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WIENS JA, 1995, ECOL APPL, V5, P1069, DOI 10.2307/2269355; Wisconsin, 1948, WISCONSIN; Wolff JO, 1999, CAN J ZOOL, V77, P535, DOI 10.1139/cjz-77-4-535; YOUNG JA, 1985, WEED SCI, V33, P513, DOI 10.1017/S0043174500082758; [No title captured]	63	16	16	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174347	10.1371/journal.pone.0174347	http://dx.doi.org/10.1371/journal.pone.0174347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333995	Green Submitted, gold, Green Published			2022-12-27	WOS:000399102200082
J	Wu, CM; Evans, CE; Dai, ZY; Huang, XJ; Zhang, XM; Jin, H; Hu, GC; Song, YL; Zhao, YY				Wu, Chaomin; Evans, Colin E.; Dai, Zhiyu; Huang, Xiaojia; Zhang, Xianming; Jin, Hua; Hu, Guochang; Song, Yuanlin; Zhao, You-Yang			Lipopolysaccharide-induced endotoxemia in corn oil-preloaded mice causes an extended course of lung injury and repair and pulmonary fibrosis: A translational mouse model of acute respiratory distress syndrome	PLOS ONE			English	Article							INFLAMMATION; MECHANISMS; RESOLUTION; FEATURES; OUTCOMES; ANIMALS; CELLS	Acute respiratory distress syndrome (ARDS) is characterized by acute hypoxemia respiratory failure, bilateral pulmonary infiltrates, and pulmonary edema of non-cardiac origin. Effective treatments for ARDS patients may arise from experimental studies with translational mouse models of this disease that aim to delineate the mechanisms underlying the disease pathogenesis. Mouse models of ARDS, however, can be limited by their rapid progression from injured to recovery state, which is in contrast to the course of ARDS in humans. Furthermore, current mouse models of ARDS do not recapitulate certain prominent aspects of the pathogenesis of ARDS in humans. In this study, we developed an improved endotoxemic mouse model of ARDS resembling many features of clinical ARDS including extended courses of injury and recovery as well as development of fibrosis following i.p. injection of lipopolysaccharide (LPS) to corn oil-preloaded mice. Compared with mice receiving LPS alone, those receiving corn oil and LPS exhibited extended course of lung injury and repair that occurred over a period of > 2 weeks instead of 3-5days. Importantly, LPS challenge of corn oil-preloaded mice resulted in pulmonary fibrosis during the repair phase as often seen in ARDS patients. In summary, this simple novel mouse model of ARDS could represent a valuable experimental tool to elucidate mechanisms that regulate lung injury and repair in ARDS patients.	[Wu, Chaomin; Evans, Colin E.; Dai, Zhiyu; Huang, Xiaojia; Zhang, Xianming; Jin, Hua; Hu, Guochang; Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA; [Wu, Chaomin; Evans, Colin E.; Dai, Zhiyu; Huang, Xiaojia; Zhang, Xianming; Jin, Hua; Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA; [Wu, Chaomin] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Pulm Dis, Shanghai, Peoples R China; [Evans, Colin E.] Univ Cambridge, Sch Biol Sci, Dept Physiol Dev & Neurosci, Cambridge, England; [Hu, Guochang] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA; [Song, Yuanlin] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Fudan University; University of Cambridge; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Fudan University	Zhao, YY (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.; Zhao, YY (corresponding author), Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA.	yyzhao@uic.edu	zhang, xian/GYA-0290-2022; Dai, Zhiyu/H-3453-2019	Dai, Zhiyu/0000-0002-2945-7923; Evans, Colin/0000-0002-9251-357X; ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health [R01HL123957, R01HL125350, R01HL133951, P01HL077806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, R01HL125350, R01HL133951, R01HL104092, R01HL123957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health grants, R01HL123957, R01HL125350, R01HL133951, and P01HL077806 to YYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2015, TOXICOL PATHOL, V43, P1074, DOI 10.1177/0192623315598399; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Cabrera-Benitez NE, 2014, ANESTHESIOLOGY, V121, P189, DOI 10.1097/ALN.0000000000000264; Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Huang X, 2016, CIRCULATION; Huang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088814; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; Liebler JM, 1998, THORAX, V53, P823, DOI 10.1136/thx.53.10.823; Liu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05543; Maca J, 2017, RESP CARE, V62, P113, DOI 10.4187/respcare.04716; Mao SZ, 2015, ARTERIOSCL THROM VAS, V35, P1635, DOI 10.1161/ATVBAHA.115.305519; Marshall R, 1998, THORAX, V53, P815, DOI 10.1136/thx.53.10.815; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; Mirza MK, 2010, J EXP MED, V207, P1675, DOI 10.1084/jem.20091857; Papazian L, 2007, CRIT CARE MED, V35, P755, DOI 10.1097/01.CCM.0000257325.88144.30; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; RAGHU G, 1985, AM REV RESPIR DIS, V131, P281, DOI 10.1164/ajrccm/138.3.703; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rizzo AN, 2015, AM J PHYSIOL-LUNG C, V309, pL1294, DOI 10.1152/ajplung.00031.2015; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Santos FB, 2006, J APPL PHYSIOL, V100, P98, DOI 10.1152/japplphysiol.00395.2005; Volman TJH, 2005, SHOCK, V23, P291, DOI 10.1097/01.shk.0000155350.95435.28; Williamson JD, 2015, EXP LUNG RES, V41, P57, DOI 10.3109/01902148.2014.979516; ZAPOL WM, 1979, AM REV RESPIR DIS, V119, P547; Zhao YDD, 2014, STEM CELLS, V32, P1855, DOI 10.1002/stem.1690; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	33	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174327	10.1371/journal.pone.0174327	http://dx.doi.org/10.1371/journal.pone.0174327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333981	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200079
J	Bear, A; Prudic, KL; Monteiro, A				Bear, Ashley; Prudic, Kathleen L.; Monteiro, Antonia			Steroid hormone signaling during development has a latent effect on adult male sexual behavior in the butterfly Bicyclus anynana	PLOS ONE			English	Article							ECDYSONE RECEPTOR ISOFORMS; ORGANIZATIONAL-ACTIVATIONAL HYPOTHESIS; JUVENILE-HORMONE; MANDUCA-SEXTA; PHENOTYPIC PLASTICITY; AGROTIS-IPSILON; GENE-EXPRESSION; MALE MOTH; UPLC-MS; DROSOPHILA	It is well established that steroid hormones regulate sexual behavior in vertebrates via organizational and activational effects. However, whether the organizational/activational paradigm applies more broadly to the sexual behavior of other animals such as insects is not well established. Here we describe the hormonal regulation of a sexual behavior in the seasonally polyphenic butterfly Bicyclus anynana is consistent with the characteristics of an organizational effect. By measuring hormone titer levels, quantifying hormone receptor gene expression in the brain, and performing hormone manipulations, we demonstrate steroid hormone signaling early in pupal development has a latent effect on adult male sexual behavior in B. anynana. These findings suggest the organizational/activational paradigm may be more highly conserved across animal taxa than previously thought.	[Bear, Ashley; Prudic, Kathleen L.; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Prudic, Kathleen L.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Monteiro, Antonia] Natl Univ Singapore, Biol Sci, Singapore, Singapore; [Monteiro, Antonia] Yale NUS Coll, Singapore, Singapore; [Bear, Ashley] Natl Sci Fdn, Arlington, VA 22230 USA	Yale University; University of Arizona; National University of Singapore; Yale NUS College; National Science Foundation (NSF)	Monteiro, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	abear@nsf.gov; antonia.monteiro@nus.edu.sg	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Prudic, Kathleen/0000-0001-8242-7769	NSF [IOS 1146933]; Ministry of Education of Singapore [M0E2014-T2-1-146]	NSF(National Science Foundation (NSF)); Ministry of Education of Singapore(Ministry of Education, Singapore)	This work wad funded by NSF IOS 1146933 award to AM and KLP, and Ministry of Education of Singapore, M0E2014-T2-1-146 award to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argue KJ, 2013, HORM BEHAV, V64, P589, DOI 10.1016/j.yhbeh.2013.08.018; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Arun A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120401; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000794; Bear A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064061; Boulanger A, 2015, BBA-GENE REGUL MECH, V1849, P187, DOI 10.1016/j.bbagrm.2014.05.024; Brakefield P, 2009, POLYPHENISMS IN LEPI; Brakefield Paul M., 1997, V83, P65; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brown MR, 2009, ANNU REV ENTOMOL, V54, P105, DOI 10.1146/annurev.ento.53.103106.093334; Champlin DT, 1998, DEVELOPMENT, V125, P269; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Crockford DJ, 2006, ANAL CHEM, V78, P363, DOI 10.1021/ac051444m; Dalton JE, 2009, CURR BIOL, V19, P1447, DOI 10.1016/j.cub.2009.06.063; De Loof A, 2010, J INSECT PHYSIOL, V56, P919, DOI 10.1016/j.jinsphys.2010.02.021; Dion E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39002; Duportets L, 2013, GEN COMP ENDOCR, V186, P58, DOI 10.1016/j.ygcen.2013.02.024; Duportets L, 2012, GEN COMP ENDOCR, V176, P158, DOI 10.1016/j.ygcen.2012.01.005; Elekonich MM, 2000, J INSECT PHYSIOL, V46, P1509, DOI 10.1016/S0022-1910(00)00101-3; Everett A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-232; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Jindra M, 1996, DEV BIOL, V180, P258, DOI 10.1006/dbio.1996.0299; Kamimura M, 1997, EUR J BIOCHEM, V248, P786, DOI 10.1111/j.1432-1033.1997.t01-1-00786.x; Koch PB, 1996, J INSECT PHYSIOL, V42, P223, DOI 10.1016/0022-1910(95)00103-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Macias-Munoz A, 2016, MOL BIOL EVOL, V33, P79, DOI 10.1093/molbev/msv197; Mateus ARA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0097-x; McCarthy MM, 2009, HORM BEHAV, V55, P655, DOI 10.1016/j.yhbeh.2009.02.012; Mensch J, 2007, J CHROMATOGR B, V847, P182, DOI 10.1016/j.jchromb.2006.10.031; Monteiro A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005529; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Olofsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010798; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Pedraglio S, 2007, J PHARMACEUT BIOMED, V44, P665, DOI 10.1016/j.jpba.2006.12.012; Pereira R, 2010, J INSECT PHYSIOL, V56, P1552, DOI 10.1016/j.jinsphys.2010.05.008; Pijpe J, 2011, EXP GERONTOL, V46, P426, DOI 10.1016/j.exger.2010.11.033; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; Prudic KL, 2015, P R SOC LOND, V282; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Tibbetts EA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1123, DOI 10.1007/s00265-010-1126-6; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; Vitecek S, 2013, HORM BEHAV; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Zera AJ, 2009, J INSECT PHYSIOL, V55, P450, DOI 10.1016/j.jinsphys.2008.11.012	53	6	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174403	10.1371/journal.pone.0174403	http://dx.doi.org/10.1371/journal.pone.0174403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328961	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700088
J	Wiegering, A; Riegel, J; Wagner, J; Kunzmann, V; Baur, J; Walles, T; Dietz, U; Loeb, S; Germer, CT; Steger, U; Klein, I				Wiegering, Armin; Riegel, Johannes; Wagner, Johanna; Kunzmann, Volker; Baur, Johannes; Walles, Thorsten; Dietz, Ulrich; Loeb, Stefan; Germer, Christoph-Thomas; Steger, Ulrich; Klein, Ingo			The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases	PLOS ONE			English	Article							HEPATIC RESECTION; PROGNOSTIC-FACTORS; IMPROVED SURVIVAL; SURGICAL RESECTION; HEPATECTOMY; RECURRENCE; MODEL	Background 40-50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) during the course of the disease. One third of these patients will additionally develop pulmonary metastases. Methods 137 consecutive patients with CRLM, were analyzed regarding survival data, clinical, histological data and treatment. Results were stratified according to the occurrence of pulmonary metastases and metastases resection. Results 39% of all patients with liver resection due to CRLM developed additional lung metastases. 44% of these patients underwent subsequent pulmonary resection. Patients undergoing pulmonary metastasectomy showed a significantly better five-year survival compared to patients not qualified for curative resection (5-year survival 71.2% vs. 28.0%; p = 0.001). Interestingly, the 5-year survival of these patients was even superior to all patients with CRLM, who did not develop pulmonary metastases (77.5% vs. 63.5%; p = 0.015). Patients, whose pulmonary metastases were not resected, were more likely to redevelop liver metastases (50.0% vs 78.6%; p = 0.034). However, the rate of distant metastases did not differ between both groups (54.5 vs. 53.6; p = 0.945). Conclusion The occurrence of colorectal lung metastases after curative liver resection does not impact patient survival if pulmonary metastasectomy is feasible. Those patients clearly benefit from repeated resections of the liver and the lung metastases.	[Wiegering, Armin; Riegel, Johannes; Wagner, Johanna; Baur, Johannes; Dietz, Ulrich; Loeb, Stefan; Germer, Christoph-Thomas; Steger, Ulrich; Klein, Ingo] Univ Wurzburg, Univ Hosp, Dept Gen Visceral Vasc & Pediat Surg, Oberduerrbacherstr, Wurzburg, Germany; [Wiegering, Armin] Univ Wurzburg, Dept Biochem & Mol Biol, Oberduerrbacherstr, Wurzburg, Germany; [Kunzmann, Volker] Univ Wurzburg, Med Ctr, Dept Internal Med 2, Oberduerrbacherstr, Wurzburg, Germany; [Kunzmann, Volker; Walles, Thorsten; Germer, Christoph-Thomas; Klein, Ingo] Univ Wurzburg, Med Ctr, Comprehens Canc Ctr Mainfranken, Josef Schneiderstr, Wurzburg, Germany; [Walles, Thorsten] Univ Wurzburg, Med Ctr, Dept Cardiothorac Surg, Oberduerrbacherstr, Wurzburg, Germany; [Steger, Ulrich] Mathias Spital Rheine, Frankenburgerstr, Rheine, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Wiegering, A; Klein, I (corresponding author), Univ Wurzburg, Univ Hosp, Dept Gen Visceral Vasc & Pediat Surg, Oberduerrbacherstr, Wurzburg, Germany.; Wiegering, A (corresponding author), Univ Wurzburg, Dept Biochem & Mol Biol, Oberduerrbacherstr, Wurzburg, Germany.; Klein, I (corresponding author), Univ Wurzburg, Med Ctr, Comprehens Canc Ctr Mainfranken, Josef Schneiderstr, Wurzburg, Germany.	wiegering_a@ukw.de; klein_i@ukw.de	Wagner, Johanna/AAN-2289-2020; Klein, Ingo/AAY-3371-2020; Wiegering, Armin/X-7541-2018	Wagner, Johanna/0000-0002-2999-6900; Klein, Ingo/0000-0003-1097-0986; Wiegering, Armin/0000-0001-7777-0909	Open Access Publication Fund of the University of Wuerzburg	Open Access Publication Fund of the University of Wuerzburg	This publication was supported by the Open Access Publication Fund of the University of Wuerzburg given to Dr. Armin Wiegering.	Brouquet A, 2011, J AM COLL SURGEONS, V213, P62, DOI 10.1016/j.jamcollsurg.2011.05.001; Castaing D, 2009, ANN SURG, V250, P849, DOI 10.1097/SLA.0b013e3181bcaf63; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Fong YM, 1997, J CLIN ONCOL, V15, P938, DOI 10.1200/JCO.1997.15.3.938; Gonzalez M, 2012, WORLD J SURG, V36, P386, DOI 10.1007/s00268-011-1381-3; Kanemitsu Y, 2004, BRIT J SURG, V91, P112, DOI 10.1002/bjs.4370; Kanemitsu Y, 2010, WORLD J SURG, V34, P2973, DOI 10.1007/s00268-010-0745-4; Kato T, 2003, DIS COLON RECTUM, V46, pS22, DOI 10.1097/01.DCR.0000089106.71914.00; Kim HK, 2014, WORLD J GASTROENTERO, V20, P6133, DOI 10.3748/wjg.v20.i20.6133; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Labianca R, 2010, CRIT REV ONCOL HEMAT, V74, P106, DOI 10.1016/j.critrevonc.2010.01.010; Landes U, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-17; Lee WS, 2007, INT J COLORECTAL DIS, V22, P699, DOI 10.1007/s00384-006-0218-2; Lumachi F, 2016, ANTICANCER RES, V36, P13; MCCORMACK PM, 1992, ARCH SURG-CHICAGO, V127, P1403; Miller G, 2007, OUTCOMES AFTER RESEC; Neeff H, 2009, J GASTROINTEST SURG, V13, P1813, DOI 10.1007/s11605-009-0960-1; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Pfannschmidt J, 2007, ANN THORAC SURG, V84, P324, DOI 10.1016/j.athoracsur.2007.02.093; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Riquet M, 2010, ANN THORAC SURG, V89, P375, DOI 10.1016/j.athoracsur.2009.10.005; Scheele J, 2001, CHIRURG, V72, P547, DOI 10.1007/s001040051345; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Watanabe K, 2009, BRIT J SURG, V96, P1058, DOI 10.1002/bjs.6682; Wiegering A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-816	27	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173933	10.1371/journal.pone.0173933	http://dx.doi.org/10.1371/journal.pone.0173933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328956	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700038
J	Huan, YW; Bengtsson, RJ; MacIntyre, N; Guthrie, J; Finlayson, H; Smith, SH; Archibald, AL; Ait-Ali, T				Huan, Yang W.; Bengtsson, Rebecca J.; MacIntyre, Neil; Guthrie, Jack; Finlayson, Heather; Smith, Sionagh H.; Archibald, Alan L.; Ait-Ali, Tahar			Lawsonia intracellularis exploits beta-catenin/Wnt and Notch signalling pathways during infection of intestinal crypt to alter cell homeostasis and promote cell proliferation	PLOS ONE			English	Article							STEM-CELLS; WNT/BETA-CATENIN; GOBLET CELLS; BACTERIAL-INFECTION; COLORECTAL-CANCER; PROGENITOR CELLS; MOUSE INTESTINE; SOX9; EPITHELIUM; EXPRESSION	Lawsonia intracellularis is an obligate intracellular bacterial pathogen that causes proliferative enteropathy (PE) in pigs. L. intracellularis infection causes extensive intestinal crypt cell proliferation and inhibits secretory and absorptive cell differentiation. However, the affected host upstream cellular pathways leading to PE are still unknown. beta-catenin/Wnt signalling is essential in maintaining intestinal stem cell (ISC) proliferation and self-renewal capacity, while Notch signalling governs differentiation of secretory and absorptive lineage specification. Therefore, in this report we used immunofluorescence (IF) and quantitative reverse transcriptase PCR (RTqPCR) to examine beta-catenin/Wnt and Notch-1 signalling levels in uninfected and L. intracellularis infected pig ileums at 3, 7, 14, 21 and 28 days post challenge (dpc). We found that while the significant increase in Ki67(+) nuclei in crypts at the peak of L. intracellularis infection suggested enhanced cell proliferation, the expression of c-MYC and ASCL2, promoters of cell growth and ISC proliferation respectively, was down-regulated. Peak infection also coincided with enhanced cytosolic and membrane-associated beta-catenin staining and induction of AXIN2 and SOX9 transcripts, both encoding negative regulators of beta-catenin/Wnt signalling and suggesting a potential alteration to beta-catenin/Wnt signalling levels, with differential regulation of the expression of its target genes. We found that induction of HES1 and OLFM4 and the down-regulation of ATOH1 transcript levels was consistent with the increased Notch-1 signalling in crypts at the peak of infection. Interestingly, the significant down-regulation of ATOH1 transcript levels coincided with the depletion of MUC2 expression at 14 dpc, consistent with the role of ATOH1 in promoting goblet cell maturation. The lack of significant change to LGR5 transcript levels at the peak of infection suggested that the crypt hyperplasia was not due to the expansion of ISC population. Overall, simultaneous induction of Notch-1 signalling and the attenuation of beta-catenin/Wnt pathway appear to be associated with the inhibition of goblet cell maturation and enhanced crypt cell proliferation at the peak of L. intracellularis infection. Moreover, the apparent differential regulation of apoptosis between crypt and lumen cells together with the strong induction of Notch-1 signalling and the enhanced SOX9 expression along crypts 14 dpc suggest an expansion of actively dividing transit amplifying and/or absorptive progenitor cells and provide a potential basis for understanding the development and maintenance of PE.	[Huan, Yang W.; Bengtsson, Rebecca J.; Guthrie, Jack; Finlayson, Heather; Smith, Sionagh H.; Archibald, Alan L.; Ait-Ali, Tahar] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Roslin, Midlothian, Scotland; [Bengtsson, Rebecca J.; MacIntyre, Neil; Finlayson, Heather; Smith, Sionagh H.; Archibald, Alan L.; Ait-Ali, Tahar] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Ait-Ali, T (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Roslin, Midlothian, Scotland.; Ait-Ali, T (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Roslin, Midlothian, Scotland.	tahar.aitali@roslin.ed.ac.uk		Archibald, Alan/0000-0001-9213-1830	UK Biotechnology and Biological Sciences Research Council (BBRSC) Institute Strategic Programme Grants [BB/J004235/1, BB/J004227/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20002173, BBS/E/D/20002174, BBS/E/D/20231761] Funding Source: researchfish; BBSRC [BBS/E/D/20002173, BBS/E/D/20231761, BBS/E/D/20002174] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBRSC) Institute Strategic Programme Grants; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	UK Biotechnology and Biological Sciences Research Council (BBRSC) Institute Strategic Programme Grants (BB/J004235/1, BB/J004227/1), http://www.bbsrc.ac.uk/.	Ahmed I, 2012, INFECT IMMUN, V80, P3107, DOI 10.1128/IAI.00236-12; Ait-Ali T, 2007, VIRAL IMMUNOL, V20, P105, DOI 10.1089/vim.2006.0078; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bengtsson RJ, 2015, VET IMMUNOL IMMUNOP, V168, P61, DOI 10.1016/j.vetimm.2015.08.005; Benhaj K., 2006, ONCOLOGY REPORTS; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Borewicz KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139106; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Dunn SJ, 2016, MOL BIOL CELL, V27, P1863, DOI 10.1091/mbc.E15-12-0854; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Golan L, 2009, J INFECT DIS, V199, P350, DOI 10.1086/596033; Gregorieff A, 2015, NATURE, V526, P715, DOI 10.1038/nature15382; Hirata A., 2013, J CELL SCI, V126, pe1, DOI DOI 10.1242/jcs.130047; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kim TH, 2011, J BIOL CHEM, V286, P11427, DOI 10.1074/jbc.M110.188797; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Krausova M, 2012, NEOPLASMA, V59, P708, DOI 10.4149/neo_2012_090; Kroll Jeremy J., 2005, Animal Health Research Reviews, V6, P173, DOI 10.1079/AHR2005109; LAWSON GHK, 1979, RES VET SCI, V27, P46, DOI 10.1016/S0034-5288(18)32858-3; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; MacIntyre N, 2003, VET PATHOL, V40, P421, DOI 10.1354/vp.40-4-421; Marchelletta RR, 2013, GASTROENTEROLOGY, V145, P1358, DOI 10.1053/j.gastro.2013.08.054; McCole DF, 2000, INFECT IMMUN, V68, P1710, DOI 10.1128/IAI.68.3.1710-1713.2000; McOrist S., 1994, VET MICROBIOL, V41, P1; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Oliveira L. G., 2015, J VET ADV, V5, P952; Pannequin J, 2009, CANCER RES, V69, P6065, DOI 10.1158/0008-5472.CAN-08-2409; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Qi LS, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0107-4; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rodney Withers H., 1974, CANCER, V34, P39; Rodriguez NRM, 2012, INFECT IMMUN, V80, P266, DOI 10.1128/IAI.05638-11; Roy BC, 2015, ONCOGENE, V34, P4519, DOI 10.1038/onc.2014.386; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Serizawa T, 2016, INFECT IMMUN, V84, P562, DOI 10.1128/IAI.01437-15; Shi ZC, 2013, AM J PHYSIOL-GASTR L, V305, pG74, DOI 10.1152/ajpgi.00086.2013; Smith DGE, 2001, VET MICROBIOL, V82, P331, DOI 10.1016/S0378-1135(01)00397-2; Smith DGE, 2000, INFECT IMMUN, V68, P6737, DOI 10.1128/IAI.68.12.6737-6743.2000; Smith SH, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-55; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Tian H, 2015, CELL REP, V11, P33, DOI 10.1016/j.celrep.2015.03.007; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vannucci FA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-421; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang ZY, 2009, J MOL CELL CARDIOL, V46, P370, DOI 10.1016/j.yjmcc.2008.11.016	66	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173782	10.1371/journal.pone.0173782	http://dx.doi.org/10.1371/journal.pone.0173782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323899	Green Submitted, gold, Green Published			2022-12-27	WOS:000399089000031
J	Luo, L; Orlow, I; Kanetsky, PA; Thomas, NE; Fang, SY; Lee, JE; Berwick, M; Lee, JH				Luo, Li; Orlow, Irene; Kanetsky, Peter A.; Thomas, Nancy E.; Fang, Shenying; Lee, Jeffrey E.; Berwick, Marianne; Lee, Ji-Hyun		GEM Study Grp	No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival	PLOS ONE			English	Article							CUTANEOUS MELANOMA; CANCER; RISK; EXPRESSION; GENOTYPE; LOCI	The prognostic improvement attributed to genetic markers over current prognostic system has not been well studied for melanoma. The goal of this study is to evaluate the added prognostic value of Vitamin D Pathway (VitD) SNPs to currently known clinical and demographic factors such as age, sex, Breslow thickness, mitosis and ulceration (CDF). We utilized two large independent well-characterized melanoma studies: the Genes, Environment, and Melanoma (GEM) and MD Anderson studies, and performed variable selection of VitD pathway SNPs and CDF using Random Survival Forest (RSF) method in addition to Cox proportional hazards models. The Harrell's C-index was used to compare the performance of model predictability. The population-based GEM study enrolled 3,578 incident cases of cutaneous melanoma (CM), and the hospital-based MD Anderson study consisted of 1,804 CM patients. Including both VitD SNPs and CDF yielded C-index of 0.85, which provided slight but not significant improvement by CDF alone (C-index = 0.83) in the GEM study. Similar results were observed in the independent MD Anderson study (C-index = 0.84 and 0.83, respectively). The Cox model identified no significant associations after adjusting for multiplicity. Our results do not support clinically significant prognostic improvements attributable to VitD pathway SNPs over current prognostic system for melanoma survival.	[Luo, Li; Berwick, Marianne; Lee, Ji-Hyun] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Luo, Li; Berwick, Marianne; Lee, Ji-Hyun] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA; [Orlow, Irene] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Epidemiol Serv, New York, NY 10021 USA; [Kanetsky, Peter A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Thomas, Nancy E.] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27514 USA; [Fang, Shenying; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of New Mexico; University of New Mexico; Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center	Luo, L (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.; Luo, L (corresponding author), Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	LLuo@salud.unm.edu; mberwick@salud.unm.edu		Fang, Shenying/0000-0002-0604-793X	National Cancer Institute (NCI) [R01CA112243, R01CA112524, R01CA112243-05S1, R0 1CM 12524-05S2, R01CA098438, U01CA83180, R33CA10704339, P30CA016086, P30CA008748, P30CA014089, P30CA118100]; National Institutes of Health/National Cancer Institute Specialized Program of Research Excellence [P50 CA093459]; University of Texas MD Anderson Cancer Center Various Donors Melanoma and Skin Cancers Priority Program Fund; Miriam and Jim Mulva Research Fund; McCarthy Skin Cancer Research Fund; Marit Peterson Fund for Melanoma Research; National Institute of Environmental Health Sciences [P30ES010126]; University of Sydney Medical Foundation Program grant; Michael Smith Foundation for Health Research Infrastructure Award; NATIONAL CANCER INSTITUTE [R01CA112243, P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Cancer Institute Specialized Program of Research Excellence; University of Texas MD Anderson Cancer Center Various Donors Melanoma and Skin Cancers Priority Program Fund; Miriam and Jim Mulva Research Fund; McCarthy Skin Cancer Research Fund; Marit Peterson Fund for Melanoma Research; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Sydney Medical Foundation Program grant(University of Sydney); Michael Smith Foundation for Health Research Infrastructure Award(Michael Smith Foundation for Health Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Cancer Institute (NCI) grants R01CA112243, R01CA112524, R01CA112243-05S1, R0 1CM 12524-05S2, R01CA098438, U01CA83180, R33CA10704339, P30CA016086, P30CA008748, P30CA014089, and P30CA118100; the National Institutes of Health/National Cancer Institute Specialized Program of Research Excellence grant P50 CA093459; The University of Texas MD Anderson Cancer Center Various Donors Melanoma and Skin Cancers Priority Program Fund; the Miriam and Jim Mulva Research Fund; the McCarthy Skin Cancer Research Fund and the Marit Peterson Fund for Melanoma Research; the National Institute of Environmental Health Sciences (P30ES010126); a University of Sydney Medical Foundation Program grant (Bruce Armstrong); and a Michael Smith Foundation for Health Research Infrastructure Award (Richard Gallagher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Begg CB, 2006, INT J EPIDEMIOL, V35, P756, DOI 10.1093/ije/dyl044; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berwick M, 2014, CANCER EPIDEM BIOMAR, V23, P2145, DOI 10.1158/1055-9965.EPI-14-0431; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brozyna AA, 2016, ONCOTARGET, V7, P63261, DOI 10.18632/oncotarget.11211; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; Cust AE, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-406; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dwyer T, 2004, AM J EPIDEMIOL, V159, P826, DOI 10.1093/aje/kwh120; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Jolliffe DA, 2016, J STEROID BIOCHEM, V164, P18, DOI 10.1016/j.jsbmb.2015.12.007; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Miao F, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/303250; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Orlow I, 2016, CARCINOGENESIS, V37, P30, DOI 10.1093/carcin/bgv157; Orlow I, 2012, INT J CANCER, V130, P405, DOI 10.1002/ijc.26023; Penn LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101507; Rendleman J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-279; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slominski A.T., 2016, J STEROID BIOCH MOL; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Vogelsang M, 2016, CLIN CANCER RES, V22, P3268, DOI 10.1158/1078-0432.CCR-15-2066; Wyatt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126394; Yin JY, 2016, PIGM CELL MELANOMA R, V29, P176, DOI 10.1111/pcmr.12437	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174234	10.1371/journal.pone.0174234	http://dx.doi.org/10.1371/journal.pone.0174234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323902	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000078
J	Masika, WG; O'Meara, WP; Holland, TL; Armstrong, J				Masika, Wechuli Geoffrey; O'Meara, Wendy Prudhomme; Holland, Thomas L.; Armstrong, Janice			Contribution of urinary tract infection to the burden of febrile illnesses in young children in rural Kenya	PLOS ONE			English	Article							MALARIA; PREVALENCE; TRANSMISSION; SENSITIVITY; CHILDHOOD; CITY; UTI	Introduction The clinical features of UTI in young children may not localize to the urinary tract and closely resemble other febrile illnesses. In malaria endemic areas, a child presenting with fever is often treated presumptively for malaria without investigation for UTI. Delayed or inadequate treatment of UTI increases the risk of bacteremia and renal scarring in young children and subsequently complications as hypertension and end stage renal disease in adulthood. Methods A cross-sectional study was carried out in a hospital in western Kenya. Inpatients and outpatients 2 months to five years with axillary temperature >= 37.5 degrees C and no antibiotic use in the previous week were enrolled between September 2012 and April 2013. Urine dipstick tests, microscopy, and cultures were done and susceptibility patterns to commonly prescribed antibiotics established. UTI was defined as presence of pyuria (a positive urine dipstick or microscopy test) plus a positive urine culture. Results A total of 260 subjects were recruited; 45.8% were female and the median age was 25months (IQR: 13, 43.5). The overall prevalence of UTI was 11.9%. Inpatients had a higher prevalence compared to outpatients (17.9% v 7.8%, p = 0.027). UTI co-existed with malaria but the association was not significant (OR 0.80, p = 0.570). The most common organisms isolated were Escherichia coli (64.5%) and Staphylococcus aureus (12.9%) and were sensitive to cipro-flaxin, cefuroxime, ceftriaxone, gentamycin and nitrofurantoin but largely resistant to more commonly used antibiotics such as ampicillin (0%), amoxicillin (16.7%), cotrimoxazole (16.7%) and amoxicillin-clavulinate (25%). Conclusion Our study demonstrates UTI contributes significantly to the burden of febrile illness in young children and often co-exists with other infections. Multi-drug resistant organisms are common therefore choice of antimicrobial therapy should be based on local sensitivity pattern.	[Masika, Wechuli Geoffrey; Armstrong, Janice] Webuye Sub Cty Hosp, Dept Family Med, Webuye, Kenya; [Masika, Wechuli Geoffrey] Kabarak Univ, Dept Family Med, Kabarak, Kenya; [O'Meara, Wendy Prudhomme; Holland, Thomas L.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [O'Meara, Wendy Prudhomme] Duke Global Hlth Inst, Durham, NC USA; [O'Meara, Wendy Prudhomme] Moi Univ, Coll Hlth Sci, Sch Publ Hlth, Eldoret, Kenya	Duke University; Duke University; Moi University	Masika, WG (corresponding author), Webuye Sub Cty Hosp, Dept Family Med, Webuye, Kenya.; Masika, WG (corresponding author), Kabarak Univ, Dept Family Med, Kabarak, Kenya.	wechuligeoffrey@gmail.com	Holland, Thomas/AAA-6096-2022	Wechuli, Geoffrey/0000-0002-2883-1821; Holland, Thomas/0000-0001-7745-9010				Ali Eltigani MA, 2009, ARAB J NEPHROLOGY TR, V2, P11; Anis-ur-Rehman, 2008, J Ayub Med Coll Abbottabad, V20, P63; [Anonymous], 2013, BAS PAED PROT AG 5 Y; [Anonymous], ARCH CLIN MICROBIOL; Bano K, 2012, AFR J MICROBIOL RES, V6, P414, DOI 10.5897/AJMR11.1171; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Bauer AW, 1996, AM J CLIN PATHOL, V451, P493; Baumer JH, 2005, ARCH DIS CHILDHOOD-E, V90, pep78; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; CLSI, 2008, PERF STAND ANT DISK, V28, P1; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Friedman S, 2006, ARCH DIS CHILD, V91, P845, DOI 10.1136/adc.2005.080721; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Hiraoka M, 2002, PEDIATR INT, V44, P658, DOI 10.1046/j.1442-200X.2002.01633.x; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Jeena PM, 1996, J TROP PEDIATRICS, V42, P112, DOI 10.1093/tropej/42.2.112; Jonathan B, 1999, PEDIATR CLIN N AM, V46, P1125; KALA UK, 1992, ANN TROP PAEDIATR, V12, P75, DOI 10.1080/02724936.1992.11747549; Kebira A. N., 2009, Journal of Applied Biosciences, V22, P1320; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Marild S, 1998, ACTA PAEDIATR, V87, P549, DOI 10.1080/08035259850158272; Msaki BP, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-4; Musa-Aisien AS, 2003, ANN TROP PAEDIATR, V23, P39, DOI 10.1179/000349803125002850; Muvunyi CM, 2011, AM J TROP MED HYG, V84, P923, DOI 10.4269/ajtmh.2011.11-0057; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; O'meara WP, 2015, AM J TROP MED HYG, P14; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Okunola PO, 2012, SAUDI J KIDNEY DIS T, V23, P629; Okwara FN, 2004, E AFR MED J, V81; Patel HD, 2005, J CLIN PATHOL, V58, P951, DOI 10.1136/jcp.2004.025429; Rabasa AI, 2009, NIGER J CLIN PRACT, V12, P124; Ravichandran D, 1995, J R Soc Med, V88, P303; Raymond J., 1998, Archives de Pediatrie, V5, p260S, DOI 10.1016/S0929-693X(98)80145-0; Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122; Sibal A, 1996, J TROP PEDIATRICS, V42, P64, DOI 10.1093/tropej/42.2.64; SMELLIE JM, 1994, BRIT MED J, V308, P1193, DOI 10.1136/bmj.308.6938.1193; SORENSEN K, 1988, EUR J PEDIATR, V148, P146, DOI 10.1007/BF00445924; TAYLOR CM, 1983, INT J PED NEPHROL, V4, P113; Waitumbi JN, 2010, AM J TROP MED HYG, V83, P1010, DOI 10.4269/ajtmh.2010.10-0174; Whiting Penny, 2005, BMC Pediatr, V5, P4; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organisation (WHO), 2005, WHO HDB IMCI INT MAN; 2011, PAEDIATRICS, V128, P595, DOI DOI 10.1542/PEDS.2011-1330	46	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174199	10.1371/journal.pone.0174199	http://dx.doi.org/10.1371/journal.pone.0174199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323886	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000074
J	Yu, EJ; Hooker, E; Johnson, DT; Kwak, MK; Zou, K; Luong, R; He, YF; Sun, ZJ				Yu, Eun-Jeong; Hooker, Erika; Johnson, Daniel T.; Kwak, Mi Kyung; Zou, Kang; Luong, Richard; He, Yongfeng; Sun, Zijie			LZTS2 and PTEN collaboratively regulate ss-catenin in prostatic tumorigenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BETA-CATENIN; PROTEIN; PTEN/MMAC1; CANCER; IDENTIFICATION; INHIBITION; DELETION; PATHWAY; INSULIN	The leucine zipper tumor suppressor 2 (LZTS2) was identified as a tumor susceptibility gene within the 10q24.3 chromosomal region, and is approximately 15Mb from the PTEN locus. This region containing the both loci is frequently deleted in a variety of human malignancies, including prostate cancer. LZTS2 is a ss-catenin-binding protein and a negative regulator of Wnt signaling. Overexpression of PTEN in prostate cancer cell lines reduces ss-catenin-mediated transcriptional activity. In this study, we examined the collaborative effect of PTEN and LZTS2 using multiple in vitro and in vivo approaches. Co-expression of PTEN and LZTS2 in prostate cancer cells shows stronger repressive effect on ss-catenin mediated transcription. Using a newly generated mouse model, we further assessed the effect of simultaneous deletion of Pten and Lzts2 in the murine prostate. We observed that mice with both Lzts2 and Pten deletion have an earlier onset of prostate carcinomas as well as an accelerated tumor progression compared to mice with Pten or Lzts2 deletion alone. Immunohistochemical analyses show that atypical and tumor cells from compound mice with both Pten and Lzts2 deletion are mainly composed of prostate luminal epithelial cells and possess higher levels of cytoplasmic and nuclear beta-catenin. These cells also exhibit a higher proliferative capacity than cells isolated from single deletion mice. These data demonstrate the significance of simultaneous Pten and Lzts2 deletion in oncogenic transformation in prostate cells and implicates a new mechanism for the dysregulation of Wnt/beta-catenin signaling in prostate tumorigenesis.	[Yu, Eun-Jeong; Hooker, Erika; He, Yongfeng; Sun, Zijie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Yu, Eun-Jeong; Hooker, Erika; Johnson, Daniel T.; Kwak, Mi Kyung; Zou, Kang; He, Yongfeng; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	City of Hope; Beckman Research Institute of City of Hope; Stanford University; Stanford University	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.; Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zjsun@coh.org	He, Yongfeng/AAR-8257-2020; Zou, Kang/R-6626-2019; Zou, Kang/ABB-2412-2020	Zou, Kang/0000-0002-1253-1816; Johnson, Daniel/0000-0003-4669-037X; Hooker, Erika/0000-0002-4515-4041	Public Health Service grants; National Cancer Institute [R21CA190021, R01DK104941, R01CA070297, R01CA151623, R01CA166894]; National Institute of Diabetes and Digestive and Kidney Diseases; Ruth L. Kirschstein Nation Research Service Award [NIH/NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [R01CA070297, R01CA151623, T32CA009523, R01CA166894, R21CA190021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941, R01DK061002] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein Nation Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grants, R01CA070297, R01CA151623, R01CA166894, R21CA190021, and R01DK104941 from the National Cancer Institute and the National Institute of Diabetes and Digestive and Kidney Diseases, as well as a Ruth L. Kirschstein Nation Research Service Award NIH/NCI T32 CA009523 (for Daniel Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P4169, DOI 10.1038/sj.onc.1204539; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hansen GM, 1998, MAMM GENOME, V9, P88, DOI 10.1007/s003359900690; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Johnson DT, 2013, J BIOL CHEM, V288, P3727, DOI 10.1074/jbc.M112.417568; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Povelones M, 2002, NAT CELL BIOL, V4, pE249, DOI 10.1038/ncb1102-e249; Rasheed BK, 1995, ONCOGENE, V10; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki H, 1998, CANCER RES, V58, P204; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Verras M, 2005, MOL ENDOCRINOL, V19, P391, DOI 10.1210/me.2004-0208; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	35	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174357	10.1371/journal.pone.0174357	http://dx.doi.org/10.1371/journal.pone.0174357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323888	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000089
J	Armstrong, MJ; Mullins, CD; Gronseth, GS; Gagliardi, AR				Armstrong, Melissa J.; Mullins, C. Daniel; Gronseth, Gary S.; Gagliardi, Anna R.			Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naive patients	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE; INVOLVEMENT; POLICY	Background Patient and consumer engagement in clinical practice guideline development is internationally advocated, but limited research explores mechanisms for successful engagement. Objective To investigate the perspectives of potential patient/consumer guideline representatives on topics pertaining to engagement including guideline development group composition and barriers to and facilitators of engagement. Setting and participants Participants were guideline-naive volunteers for programs designed to link community members to academic research with diverse ages, gender, race, and degrees of experience interacting with health care professionals. Methods Three focus groups and one key informant interview were conducted and analyzed using a qualitative descriptive approach. Results Participants recommended small, diverse guideline development groups engaging multiple patient/consumer stakeholders with no prior relationships with each other or professional panel members. No consensus was achieved on the ideal balance of patient/consumer and professional stakeholders. Pre-meeting reading/training and an identified contact person were described as keys to successful early engagement; skilled facilitators, understandable speech and language, and established mechanisms for soliciting patient opinions were suggested to enhance engagement at meetings. Conclusions Most suggestions for effective patient/consumer engagement in guidelines require forethought and planning but little additional expense, making these strategies easily accessible to guideline developers desiring to achieve more meaningful patient and consumer engagement.	[Armstrong, Melissa J.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Pharmaceut Hlth Res Dept, Baltimore, MD 21201 USA; [Gronseth, Gary S.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Gagliardi, Anna R.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada	State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; University of Kansas; University of Kansas Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Armstrong, MJ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	Melissa.Armstrong@neurology.ufl.edu		Mullins, C. Daniel/0000-0003-4322-2490; Armstrong, Melissa/0000-0002-2163-1907	Agency for Healthcare Research and Quality (AHRQ) [K08HS24159]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024159] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	MJA is supported by an Agency for Healthcare Research and Quality (AHRQ) K08 career development award (K08HS24159) for research on patient engagement in clinical practice guidelines, through which this work was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; [Anonymous], PATIENT INVOLVEMENT; Boivin A, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.034835; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cluzeau Francoise, 2012, Proc Am Thorac Soc, V9, P269, DOI 10.1513/pats.201208-062ST; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Fearns N, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1319-4; Forsythe LP, 2014, J GEN INTERN MED, V29, pS788, DOI 10.1007/s11606-014-2895-9; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guidelines International Network, 2015, G I N PUBL TOOLK PAT; Lavis JN, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-54; Legare F, 2011, MED DECIS MAKING, V31, pE45, DOI 10.1177/0272989X11424401; Loudon K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-321; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Shippee ND, 2015, HEALTH EXPECT, V18, P1151, DOI 10.1111/hex.12090; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van de Bovenkamp HM, 2009, HEALTH CARE ANAL, V17, P198, DOI 10.1007/s10728-008-0099-3; van der Ham AJ, 2016, HEALTH EXPECT, V19, P471, DOI 10.1111/hex.12370; van Wersch A, INVOLVEMENT CONSUMER	21	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174329	10.1371/journal.pone.0174329	http://dx.doi.org/10.1371/journal.pone.0174329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319201	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800068
J	Kong, FYS; Rupasinghe, TW; Simpson, JA; Vodstrcil, LA; Fairley, CK; McConville, MJ; Hocking, JS				Kong, Fabian Y. S.; Rupasinghe, Thusitha W.; Simpson, Julie A.; Vodstrcil, Lenka A.; Fairley, Christopher K.; McConville, Malcolm J.; Hocking, Jane S.			Pharmacokinetics of a single 1 g dose of azithromycin in rectal tissue in men	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; INFECTION; PLASMA; SUSCEPTIBILITY; DISPOSITION; HEALTHY; SERUM; MODEL; PH	Chlamydia is the most common bacterial sexually transmitted infection among men who have sex with men. Repeat infection following treatment with 1 g azithromycin is common and treatment failure of up to 22% has been reported. This study measured the pharmacokinetics of azithromycin in rectal tissue in men following a single 1g dose to assess whether azithromycin reaches the rectal site in adequate concentrations to kill chlamydia. Ten healthy men took a single oral dose of 1 g azithromycin and provided nine self-collected swabs and one blood sample over 14 days. Participant demographics, medications, sexual behaviour, treatment side effects, lubricant use and douching practices were recorded with each swab. Drug concentration over time was determined using liquid chromatography mass spectrometry and total exposure (AUC(0-infinity)) was estimated from the concentration time profiles. Following 1 g of azithromycin, rectal concentrations peaked after a median of 24 hours (median 133mcg/g) and remained above the minimum inhibitory concentration for chlamydia (0.125mcg/mL) for at least 14 days in all men. AUC(0-infinity) was the highest ever reported in human tissue (13103((mcg/g).hr)). Tissue concentrations were not associated with weight (mg/kg), but data suggest that increased gastric pH could increase azithromycin levels and diarrhoea or use of water-based lubricants could decrease concentrations. High and sustained concentrations of azithromycin were found in rectal tissue following a single 1 g dose suggesting that inadequate concentrations are unlikely to cause treatment failure. Factors effecting absorption (pH and diarrhoea) or drug depletion (douching and water based lubricants) may be more important determinants of concentrations in situ.	[Kong, Fabian Y. S.; Simpson, Julie A.; Vodstrcil, Lenka A.; Hocking, Jane S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Rupasinghe, Thusitha W.] Univ Melbourne, Sch BioSci, Metab Australia, Melbourne, Vic, Australia; [Vodstrcil, Lenka A.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Vodstrcil, Lenka A.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Metab Australia, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; University of Melbourne	Kong, FYS (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.	kongf@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019	Hocking, Jane/0000-0001-9329-8501; Vodstrcil, Lenka/0000-0003-3679-9195; Christopher, Fairley/0000-0001-9081-1664; Kong, Fabian/0000-0002-9349-3080	University of Melbourne; FYSK; Australian Postgraduate Award; National Health and Medical Research Council (NHMRC) Senior Research Fellowship	University of Melbourne(University of Melbourne); FYSK; Australian Postgraduate Award(Australian Government); National Health and Medical Research Council (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The funding for this specific project was provided internally by the University of Melbourne through Professor Jane Hocking. Professor Jane Hocking led the project with FYSK (PhD student) and was involved in study design. FYSK is supported by an Australian Postgraduate Award, JSH and JAS are supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship. The funders of the Australian Postgraduate Award and the NHMRC Senior research Fellowship had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB INC PREV SEL CU; Australasian Sexual Health Alliance, 2014, AUSTR STI MAN GUID U; Babic S, 2007, TRAC-TREND ANAL CHEM, V26, P1043, DOI 10.1016/j.trac.2007.09.004; Barcia-Macay M, 2006, ANTIMICROB AGENTS CH, V50, P841, DOI 10.1128/AAC.50.3.841-851.2006; BITTERMAN W, 1969, DIS COLON RECTUM, V12, P96, DOI 10.1007/BF02629003; Blandizzi C, 1999, J PERIODONTOL, V70, P960, DOI 10.1902/jop.1999.70.9.960; Carbon C, 1998, CLIN INFECT DIS, V27, P28, DOI 10.1086/514619; Craig WA, 2001, CLIN INFECT DIS, V33, pS233, DOI 10.1086/321854; Crokaert F, 1998, CLIN DRUG INVEST, V16, P161, DOI 10.2165/00044011-199816020-00009; Danesi R, 2003, J ANTIMICROB CHEMOTH, V51, P939, DOI 10.1093/jac/dkg138; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Drummond F, 2011, INT J STD AIDS, V22, P478, DOI 10.1258/ijsa.2011.010490; Ernst EJ, 2000, PHARMACOTHERAPY, V20, P657, DOI 10.1592/phco.20.7.657.35176; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; FOULDS G, 1991, EUR J CLIN MICROBIOL, V10, P868, DOI 10.1007/BF01975845; FOULDS G, 1993, J ANTIMICROB CHEMOTH, V31, P39, DOI 10.1093/jac/31.suppl_E.39; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; GLADUE RP, 1989, ANTIMICROB AGENTS CH, V33, P277, DOI 10.1128/AAC.33.3.277; HARRISON JD, 1991, EUR J CLIN MICROBIOL, V10, P862, DOI 10.1007/BF01975843; Hocking JS, 2015, J ANTIMICROB CHEMOTH, V70, P961, DOI 10.1093/jac/dku493; Islam M., 2012, DHAKA U J PHARM SCI, V11, P55, DOI 10.3329/dujps.v1111.12488; Jordan SJ, 2014, SEX TRANSM DIS, V41, P86, DOI 10.1097/OLQ.0000000000000092; Kanji S, 2015, CLIN PHARMACOKINET, V54, P783, DOI 10.1007/s40262-015-0236-8; Kirchheiner J, 2009, EUR J CLIN PHARMACOL, V65, P19, DOI 10.1007/s00228-008-0576-5; Kirchhoff RM, 1999, INT J CLIN PHARM TH, V37, P361; Kong FYS, 2015, J ANTIMICROB CHEMOTH, V70, P1290, DOI 10.1093/jac/dku574; KROHN K, 1991, EUR J CLIN MICROBIOL, V10, P864, DOI 10.1007/BF01975844; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Lewis D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-113; Luke DR, 1997, CLIN PHARMACOL THER, V61, P641, DOI 10.1016/S0009-9236(97)90098-9; MALANOSKI GJ, 1993, EUR J CLIN MICROBIOL, V12, P131, DOI 10.1007/BF01967591; Matzneller P, 2013, ANTIMICROB AGENTS CH, V57, P1736, DOI 10.1128/AAC.02011-12; Meanwell NA, 2015, TACTICS CONT DRUG DE; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; National Notifiable Diseases Surveillance System, 2015, NUMB NOT CHLAM INF A; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Pfizer Australia, 2008, ZITHR PROD INF; Pfizer Canada, 2013, ZITHR PROD INF; Schmelzer M, 2004, APPL NURS RES, V17, P265, DOI 10.1016/S0897-1897(04)00080-1; Shen Y, 2010, J PHARMACEUT BIOMED, V52, P99, DOI 10.1016/j.jpba.2009.12.001; Steedman NM, 2009, INT J STD AIDS, V20, P16, DOI 10.1258/ijsa.2008.008211; Suchland RJ, 2003, ANTIMICROB AGENTS CH, V47, P636, DOI 10.1128/AAC.47.2.636-642.2003; Vodstrcil L, 2017, POSTTREATME IN PRESS; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; WORM AM, 1995, GENITOURIN MED, V71, P244; Yuzuak N, 2007, CHROMATOGRAPHIA, V66, pS115, DOI 10.1365/s10337-007-0294-7; Zheng SM, 2014, ANTIMICROB AGENTS CH, V58, P6675, DOI 10.1128/AAC.02904-14	47	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174372	10.1371/journal.pone.0174372	http://dx.doi.org/10.1371/journal.pone.0174372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350806	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174400029
J	Jaworska, N; Cox, SM; Casey, KF; Boileau, I; Cherkasova, M; Larcher, K; Dagher, A; Benkelfat, C; Leyton, M				Jaworska, Natalia; Cox, Sylvia M.; Casey, Kevin F.; Boileau, Isabelle; Cherkasova, Mariya; Larcher, Kevin; Dagher, Alain; Benkelfat, Chawki; Leyton, Marco			Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness?	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR AVAILABILITY; HEALTHY-ADULTS; SURFACE-AREA; INDIVIDUAL-DIFFERENCES; PARKINSONS-DISEASE; SENSATION SEEKING; DECISION-MAKING; AMPHETAMINE; IMPULSIVITY	Background Novelty-seeking (NS) and impulsive personality traits have been proposed to reflect an interplay between fronto-cortical and limbic systems, including the limbic striatum (LS). Although neuroimaging studies have provided some evidence for this, most are comprised of small samples and many report surprisingly large effects given the challenges of trying to relate a snapshot of brain function or structure to an entity as complex as personality. The current work tested a priori hypotheses about associations between striatal dopamine (DA) release, cortical thickness (CT), and NS in a large sample of healthy adults. Methods Fifty-two healthy adults (45M/7F; age: 23.8 +/- 4.93) underwent two positron emission tomography scans with [C-11] raclopride (specific for striatal DA D2/3 receptors) with or without amphetamine (0.3 mg/kg, p.o.). Structural magnetic resonance image scans were acquired, as were Tridimensional Personality Questionnaire data. Amphetamine-induced changes in [C-11] raclopride binding potential values (Delta BPND) were examined in the limbic, sensorimotor (SMS) and associative (AST) striatum. CT measures, adjusted for whole brain volume, were extracted from the dorsolateral sensorimotor and ventromedial/limbic cortices. Results BPND values were lower in the amphetamine vs. no-drug sessions, with the largest effect in the LS. When comparing low vs. high LS Delta BPND groups (median split), higher NS2 (impulsiveness) scores were found in the high Delta BPND group. Partial correlations (age and gender as covariates) yielded a negative relation between ASTS Delta BPND and sensorimotor CT; trends for inverse associations existed between Delta BPND values in other striatal regions and frontal CT. In other words, the greater the amphetamine-induced striatal DA response, the thinner the frontal cortex. Conclusions These data expand upon previously reported associations between striatal DA release in the LS and both NS related impulsiveness and CT in the largest sample reported to date. The findings add to the plausibility of these associations while suggesting that the effects are likely weaker than has been previously proposed.	[Jaworska, Natalia; Cox, Sylvia M.; Benkelfat, Chawki; Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Jaworska, Natalia] Mental Hlth Res Inst, Ottawa, ON, Canada; [Casey, Kevin F.] Le Ctr Hosp Univ CHU St Justine, Montreal, PQ, Canada; [Boileau, Isabelle] CAMH, Toronto, ON, Canada; [Cherkasova, Mariya] Univ British Columbia, Div Neurol, Vancouver, BC, Canada; [Larcher, Kevin; Dagher, Alain] McGill Univ, MNI, Montreal, PQ, Canada	McGill University; University of Ottawa; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of British Columbia; McGill University	Leyton, M (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	marco.leyton@mcgill.ca	Leyton, Marco/AAY-7557-2020; Cherkasova, Mariya/Q-2437-2018	Leyton, Marco/0000-0002-1243-2252; Cherkasova, Mariya/0000-0002-4750-8093				Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; Aupperle RL, 2015, HUM BRAIN MAPP, V36, P449, DOI 10.1002/hbm.22639; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boileau I, 2007, J NEUROSCI, V27, P3998, DOI 10.1523/JNEUROSCI.4370-06.2007; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Boileau I, 2013, ADDICTION, V108, P953, DOI 10.1111/add.12066; Boulos PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152983; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Casey KF, 2013, J NEUROSCI, V33, P15285, DOI 10.1523/JNEUROSCI.5029-12.2013; Cherkasova MV, 2014, NEUROPSYCHOPHARMACOL, V39, P1498, DOI 10.1038/npp.2013.349; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cox SML, 2009, BIOL PSYCHIAT, V65, P846, DOI 10.1016/j.biopsych.2009.01.021; D'Amour-Horvat V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00432; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; First MB, 1995, AXIS 1 DISORDERS; Fortier CB, 2011, ALCOHOL CLIN EXP RES, V35, P2193, DOI 10.1111/j.1530-0277.2011.01576.x; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Haber SN., 2011, NEUROBIOLOGY SENSATI, P49; Holmes AJ, 2016, J NEUROSCI, V36, P4038, DOI 10.1523/JNEUROSCI.3206-15.2016; HURD YL, 1994, NEUROSCIENCE, V63, P357, DOI 10.1016/0306-4522(94)90535-5; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ishii T, 2016, J NEUROL, V263, P1828, DOI 10.1007/s00415-016-8206-0; Jacobus J, 2015, DEV COGN NEUROS-NETH, V16, P101, DOI 10.1016/j.dcn.2015.04.006; Jiang Y, 2015, PSYCHOL MED, V45, P3467, DOI 10.1017/S0033291715001361; Josefsson K, 2013, DEV PSYCHOPATHOL, V25, P713, DOI 10.1017/S0954579413000126; Kim JH, 2014, ACTA NEUROPSYCHIATR, V26, P35, DOI 10.1017/neu.2013.29; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Ko JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023298; Lange E., 2016, PSYCHOL MED, V47, P1; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Lawrence AD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00086; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Leyton M, 2010, PLEASURES BRAIN, P222; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Milella MS, 2016, J PSYCHIATR NEUROSCI, V41, P322, DOI 10.1503/jpn.150207; Morris LS, 2016, CORTEX, V74, P118, DOI 10.1016/j.cortex.2015.11.004; Nordstrom AL, 1998, PSYCHIAT RES-NEUROIM, V83, P1, DOI 10.1016/S0925-4927(98)00021-3; Oberlin BG, 2015, PSYCHOPHARMACOLOGY, V232, P2207, DOI 10.1007/s00213-014-3850-5; Oswald LM, 2007, NEUROIMAGE, V36, P153, DOI 10.1016/j.neuroimage.2007.01.055; Oswald LM, 2015, NEUROIMAGE, V113, P26, DOI 10.1016/j.neuroimage.2015.03.022; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Reeves SJ, 2012, PSYCHIAT RES-NEUROIM, V202, P60, DOI 10.1016/j.pscychresns.2011.09.011; Riccardi P, 2006, AM J PSYCHIAT, V163, P1639, DOI 10.1176/appi.ajp.163.9.1639; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Robertson CL, 2015, J NEUROSCI, V35, P5990, DOI 10.1523/JNEUROSCI.4850-14.2015; Savage SW, 2014, OBESITY, V22, P1452, DOI 10.1002/oby.20690; Schilling C, 2013, MOL PSYCHIATR, V18, P624, DOI 10.1038/mp.2012.56; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Schultz W, 2016, DIALOGUES CLIN NEURO, V18, P23; Shao N, 2015, NEUROSCI LETT, V587, P79, DOI 10.1016/j.neulet.2014.12.007; Smith CT, 2016, J NEUROPHYSIOL, V115, P1146, DOI 10.1152/jn.00261.2015; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayakumar N, 2016, HUM BRAIN MAPP, V37, P2027, DOI 10.1002/hbm.23154; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zald DH, 2008, J NEUROSCI, V28, P14372, DOI 10.1523/JNEUROSCI.2423-08.2008; Zhou Q., 2014, THESCIENTIFICWORLDJO, V2014	68	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174219	10.1371/journal.pone.0174219	http://dx.doi.org/10.1371/journal.pone.0174219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346539	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300031
J	Lynch, SM; Mitra, N; Ross, M; Newcomb, C; Dailey, K; Jackson, T; Zeigler-Johnson, CM; Riethman, H; Branas, CC; Rebbeck, TR				Lynch, Shannon M.; Mitra, Nandita; Ross, Michelle; Newcomb, Craig; Dailey, Karl; Jackson, Tara; Zeigler-Johnson, Charnita M.; Riethman, Harold; Branas, Charles C.; Rebbeck, Timothy R.			A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness	PLOS ONE			English	Article							LOCI; POPULATION; PATTERNS; SURVIVAL; HEALTH; LEVEL	Purpose Cancer results from complex interactions of multiple variables at the biologic, individual, and social levels. Compared to other levels, social effects that occur geospatially in neighborhoods are not as well-studied, and empiric methods to assess these effects are limited. We propose a novel Neighborhood-Wide Association Study(NWAS), analogous to genomewide association studies(GWAS), that utilizes high-dimensional computing approaches from biology to comprehensively and empirically identify neighborhood factors associated with disease. Methods Pennsylvania Cancer Registry data were linked to U.S. Census data. In a successively more stringent multiphase approach, we evaluated the association between neighborhood (n = 14,663 census variables) and prostate cancer aggressiveness(PCA) with n = 6,416 aggressive (Stage <= 3/Gleason grade >= 7 cases) vs. n = 70,670 non-aggressive (Stage< 3/Gleason grade< 7) cases in White men. Analyses accounted for age, year of diagnosis, spatial correlation, and multiple-testing. We used generalized estimating equations in Phase 1 and Bayesian mixed effects models in Phase 2 to calculate odds ratios(OR) and confidence/credible intervals(CI). In Phase 3, principal components analysis grouped correlated variables. Results We identified 17 new neighborhood variables associated with PCA. These variables represented income, housing, employment, immigration, access to care, and social support. The top hits or most significant variables related to transportation (OR = 1.05; CI = 1.001-1.09) and poverty (OR = 1.07; CI = 1.01-1.12). Conclusions This study introduces the application of high-dimensional, computational methods to largescale, publically-available geospatial data. Although NWAS requires further testing, it is hypothesis-generating and addresses gaps in geospatial analysis related to empiric assessment. Further, NWAS could have broad implications for many diseases and future precision medicine studies focused on multilevel risk factors of disease.	[Lynch, Shannon M.] Fox Chase Canc Ctr, Canc Prevent & Control, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Mitra, Nandita; Ross, Michelle; Newcomb, Craig; Dailey, Karl; Jackson, Tara; Branas, Charles C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zeigler-Johnson, Charnita M.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Riethman, Harold] Old Dominion Univ, Norfolk, VA USA; [Branas, Charles C.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Rebbeck, Timothy R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Rebbeck, Timothy R.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Old Dominion University; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Lynch, SM (corresponding author), Fox Chase Canc Ctr, Canc Prevent & Control, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	shannon.lynch@fccc.edu	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900	Public Health Service [P50-CA105641, P60-NM006900, R01-CA85074, F31-AG039986]; NATIONAL CANCER INSTITUTE [P30CA006927, P30CA010815] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Public Health Service (P50-CA105641, P60-NM006900 and R01-CA85074 to TRR and F31-AG039986 to SML). The authors have no competing financial interests to report.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], 2000, SEER PROGR COD STAG; Aslibekyan S, 2013, CIRC-CARDIOVASC GENE, V6, P409, DOI 10.1161/CIRCGENETICS.112.000010; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Carpenter WR, 2010, CANCER CAUSE CONTROL, V21, P1071, DOI 10.1007/s10552-010-9535-4; Carriere GM, 2013, CAN J PUBLIC HEALTH, V104, pE443, DOI 10.17269/cjph.104.3884; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Department of Health and Human Services. National Institutes of Health, 2017, HELP ME UND GEN PREC; Dietz RD, 2002, SOC SCI RES, V31, P539, DOI 10.1016/S0049-089X(02)00005-4; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Geronimus AT, 2006, AM J EPIDEMIOL, V164, P835, DOI 10.1093/aje/kwj314; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Guidry JJ, 1997, CANCER PRACT, V5, P361; Hill TD, 2005, SOC SCI MED, V61, P965, DOI 10.1016/j.socscimed.2004.12.027; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Kondo MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129582; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Li HQ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.6; Lynch SM, 2013, CANCER EPIDEM BIOMAR, V22, P485, DOI 10.1158/1055-9965.EPI-13-0010; Lyratzopoulos G, 2010, BMJ, V340; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Meuwissen THE, 2000, GENETICS, V155, P421; Monroe A C, 1992, J Rural Health, V8, P212, DOI 10.1111/j.1748-0361.1992.tb00354.x; Moore JH, 2004, JAMA-J AM MED ASSOC, P291; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Patel K, 2010, J HEALTH CARE POOR U, V21, P114, DOI 10.1353/hpu.0.0235; Paternoster L, AM J HUMAN GENETICS, V90, P478; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Schupp CW, 2014, CANCER-AM CANCER SOC, V120, P1401, DOI 10.1002/cncr.28587; Thomas DC, 2009, STAT SCI, V24, P414, DOI 10.1214/09-STS288; Thompson EE, 1998, J GERONTOL B-PSYCHOL, V53, pS354, DOI 10.1093/geronb/53B.6.S354; Thomson H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008657.pub2; United States Census Bureau, 2007, 2000 CENS TECHN DOC; Varghese JS, 2010, CURR OPIN GENET DEV, V20, P201, DOI 10.1016/j.gde.2010.03.012; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zeigler-Johnson C, 2013, J NATL MED ASSOC, V105, P173, DOI 10.1016/S0027-9684(15)30107-3; Zeigler-Johnson CM, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/846263	46	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174548	10.1371/journal.pone.0174548	http://dx.doi.org/10.1371/journal.pone.0174548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346484	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300054
J	van Deudekom, FJ; Postmus, I; van der Ham, DJ; Pothof, AB; Broekhuizen, K; Blauw, GJ; Mooijaart, SP				van Deudekom, Floor J.; Postmus, Iris; van der Ham, Danielle J.; Pothof, Alexander B.; Broekhuizen, Karen; Blauw, Gerard J.; Mooijaart, Simon P.			External validity of randomized controlled trials in older adults, a systematic review	PLOS ONE			English	Review							CLINICAL-TRIALS; CRITERIA; WOMEN	Background To critically assess the external validity of randomized controlled trials (RCTs) it is important to know what older adults have been enrolled in the trials. The aim of this systematic review is to study what proportion of trials specifically designed for older patients report on somatic status, physical and mental functioning, social environment and frailty in the patient characteristics. Methods PubMed was searched for articles published in 2012 and only RCTs were included. Articles were further excluded if not conducted with humans or only secondary analyses were reported. A random sample of 10% was drawn. The current review analyzed this random sample and further selected trials when the reported mean age was > 60 years. We extracted geriatric assessments from the population descriptives or the in- and exclusion criteria. Results In total 1396 trials were analyzed and 300 trials included. The median of the reported mean age was 66 (IQR 63-70) and the median percentage of men in the trials was 60 (IQR 4572). In 34% of the RCTs specifically designed for older patients somatic status, physical and mental functioning, social environment or frailty were reported in the population descriptives or the in- and exclusion criteria. Physical and mental functioning was reported most frequently (22% and 14%). When selecting RCTs on a mean age of 70 or 80 years the report of geriatric assessments in the patient characteristics was 46% and 85% respectively but represent only 5% and 1% of the trials. Conclusion Somatic status, physical and mental functioning, social environment and frailty are underreported even in RCTs specifically designed for older patients published in 2012. Therefore, it is unclear for clinicians to which older patients the results can be applied. We recommend systematic to transparently report these relevant characteristics of older participants included in RCTs.	[van Deudekom, Floor J.; Postmus, Iris; van der Ham, Danielle J.; Broekhuizen, Karen; Blauw, Gerard J.; Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Postmus, Iris; Pothof, Alexander B.; Mooijaart, Simon P.] Inst Evidence Based Med Old Age IEMO, Leiden, Netherlands; [Pothof, Alexander B.] Beth Israel Deaconess Med Ctr, Dept Surg, Div Vasc & Endovasc Surg, 330 Brookline Ave, Boston, MA 02215 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Beth Israel Deaconess Medical Center	van Deudekom, FJ (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	F.J.A.van_Deudekom@lumc.nl	Blauw, Gerard/AAW-7904-2021; Blauw, Gerard/GWD-1079-2022; Mooijaart, Simon P./A-5306-2008	Mooijaart, Simon P./0000-0003-3106-3568	Dutch Ministry of Health and Welfare; ZonMw [62700.3002]	Dutch Ministry of Health and Welfare; ZonMw(Netherlands Organization for Health Research and Development)	The Institute for Evidence-Based Medicine in Old Age (IEMO) is funded by the Dutch Ministry of Health and Welfare and supported by ZonMw (project number 62700.3002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benraad CEM, 2016, INT J GERIATR PSYCH, V31, P990, DOI 10.1002/gps.4443; Benraad CE, 2016, INT J GERIATRIC PSYC; Broekhuizen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126709; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Kemeny MM, 2003, J CLIN ONCOL, V21, P2268, DOI 10.1200/JCO.2003.09.124; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Rosen SL, 2011, MT SINAI J MED, V78, P489, DOI 10.1002/msj.20277; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; van de Water W, 2011, J GEN INTERN MED, V26, P831, DOI 10.1007/s11606-011-1705-x; Van de Water W, 2011, J GEN INTERNAL MED, V26, P2; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	15	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174053	10.1371/.journal.pone.0174053	http://dx.doi.org/10.1371/.journal.pone.0174053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346503				2022-12-27	WOS:000399174300019
J	Abo-Haded, HM; Elkablawy, MA; Al-Johani, Z; Al-ahmadi, O; El-Agamy, DS				Abo-Haded, Hany M.; Elkablawy, Mohamed A.; Al-Johani, Zeyad; Al-ahmadi, Osama; El-Agamy, Dina S.			Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity	PLOS ONE			English	Article							PEPTIDASE-4 INHIBITOR-SITAGLIPTIN; INDUCED OXIDATIVE STRESS; NF-KAPPA-B; INDUCED CARDIOTOXICITY; INJURY; DYSREGULATION; ENZYMES; TARGET; IV	Sitagliptin is selective dipeptidyl peptidase-4 inhibitor (DPP4-I), used clinically as a new oral anti-diabetic agent. This study explored the underlying mechanisms of the hepatoprotective role of sitagliptin pretreatment against methotrexate (MTX) induced hepatotoxicity in mice. Forty mice were divided into four groups (10 mice each); control, MTX, and two sitagliptin groups (pretreated with sitagliptin 10 and 20 mg/kg/day, respectively) for five consecutive days prior to MTX injection. Results showed that MTX induced marked hepatic injury in the form of cloudy swelling, hydropic degeneration, apoptosis and focal necrosis in all hepatic zones. Biochemical analysis revealed significant increase in the serum transaminases, alkaline phosphatase and lactate dehydrogenase in MTX group. Oxidative stress and depressed antioxidant system of the hepatic tissues were evident in MTX group. MTX down-regulated nuclear factor erythroid 2-related factor 2 (Nrf2) expression and reduced its binding capacity. Additionally, MTX increased the activation and the expression of nuclear factor kappa-B (NF-kappa B) and downstream inflammatory mediators. MTX induced the activation of inducible nitric oxide synthase (iNOS) and increased nitrite/nitrate level. Finally, hepatic cellular apoptosis was clearly obvious in MTX-intoxicated animals using TUNEL staining. Also, there was increase in the immunoexpression of pro-apoptotic protein Bax, increase in Bax and caspase-3 levels and decrease in the level of anti-apoptotic Bcl2 in liver. On the other hand, sitagliptin pretreatment significantly ameliorated all of the above mentioned biochemical, histopathological, immunohistochemical changes induced by MTX. These results provide new evidences that the hepatoprotective effect of sitagliptin is possibly mediated through modulation of Nrf2 and NF-kappa B signaling pathways with subsequent suppression of inflammatory and apoptotic processes.	[Abo-Haded, Hany M.; Al-Johani, Zeyad; Al-ahmadi, Osama] Taibah Univ, Coll Med, Cardiogenet Team, Almadinah Almonawarah, Saudi Arabia; [Elkablawy, Mohamed A.] Taibah Univ, Dept Pathol, Coll Med, Almadinah Almonawarah, Saudi Arabia; [Elkablawy, Mohamed A.] Menoufia Univ, Dept Pathol, Fac Med, Menoufia, Egypt; [El-Agamy, Dina S.] Taibah Univ, Dept Pharmacol & Toxicol, Coll Pharm, Almadinah Almonawarah, Saudi Arabia; [El-Agamy, Dina S.] Mansoura Univ, Dept Pharmacol & Toxicol, Fac Pharm, Mansoura, Egypt	Taibah University; Taibah University; Egyptian Knowledge Bank (EKB); Menofia University; Taibah University; Egyptian Knowledge Bank (EKB); Mansoura University	Abo-Haded, HM (corresponding author), Taibah Univ, Coll Med, Cardiogenet Team, Almadinah Almonawarah, Saudi Arabia.	hany_haded@yahoo.com	Abo-Haded, Hany/M-7749-2014; El-Agamy, Dina S/N-3617-2018	Abo-Haded, Hany/0000-0003-1343-9031; El-Agamy, Dina S/0000-0002-7545-6235; ELKABLAWY, MOHAMED/0000-0002-6483-0017	Deanship of Scientific Research, Taibah University, Saudi Arabia	Deanship of Scientific Research, Taibah University, Saudi Arabia	The Authors acknowledge the Deanship of Scientific Research, Taibah University, Saudi Arabia, for help and support. The authors thank Dr. Irfan Ansari for reviewing the language and grammar of the manuscript. Also, authors thank Mr. Mohamed Abdelsammad, Faculty of Medicine, Taibah University, for technical help.	Cetin A, 2008, AM J CHINESE MED, V36, P861, DOI 10.1142/S0192415X08006302; Cetinkaya A, 2006, MED SCI MONITOR, V12, pBR274; Chang GL, 2013, EUR J PHARMACOL, V718, P105, DOI 10.1016/j.ejphar.2013.09.007; Chinda K, 2013, INT J CARDIOL, V167, P451, DOI 10.1016/j.ijcard.2012.01.011; Choi SH, 2015, VASC PHARMACOL, V73, P11, DOI 10.1016/j.vph.2015.07.005; Dalaklioglu S, 2013, HUM EXP TOXICOL, V32, P662, DOI 10.1177/0960327112468178; El-Agamy DS, 2017, CANCER CHEMOTH PHARM, V79, P399, DOI 10.1007/s00280-016-3233-1; El-Agamy DS, 2016, EXP BIOL MED, V241, P1577, DOI 10.1177/1535370216643418; El-Sheikh AAK, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/859383; Elkablawy Mohamed A, 2015, Asian Pac J Cancer Prev, V16, P1129; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Hafez HM, 2015, EUR J PHARM; Hytiroglou P, 2004, AM J CLIN PATHOL, V121, P324, DOI 10.1309/5HR90TNC4Q4JRXWX; Jahovic N, 2003, J PINEAL RES, V34, P282, DOI 10.1034/j.1600-079X.2003.00043.x; Jung YA, 2014, DIABETES RES CLIN PR, V105, P47, DOI 10.1016/j.diabres.2014.04.028; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Lee TI, 2013, INT J CARDIOL, V168, P5390, DOI 10.1016/j.ijcard.2013.08.051; Lin CH, 2016, EXP THER MED, V11, P2609, DOI 10.3892/etm.2016.3255; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Marques C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/538737; Mega C, 2011, EXP DIABETES RES, DOI 10.1155/2011/162092; Mukherjee S, 2013, J NUTR BIOCHEM, V24, P2040, DOI 10.1016/j.jnutbio.2013.07.005; Muriel P, 2009, J APPL TOXICOL, V29, P91, DOI 10.1002/jat.1393; Onoyama T, 2015, MOL MED REP, V12, P6895, DOI 10.3892/mmr.2015.4329; Ragab A. R., 2013, J ENV ANAL TOXICOL, V3, P163, DOI [DOI 10.4172/2161-0525.1000163, 10.4172/2161-0525.1000163]; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Sener G, 2006, EUR J PHARMACOL, V542, P170, DOI 10.1016/j.ejphar.2006.02.056; Uraz S, 2008, DIGEST DIS SCI, V53, P1071, DOI 10.1007/s10620-007-9949-3; Vaghasiya J, 2011, REGUL PEPTIDES, V166, P48, DOI 10.1016/j.regpep.2010.08.007; Vardi N, 2009, FERTIL STERIL, V92, P2028, DOI 10.1016/j.fertnstert.2008.09.015; Zhu W, 2000, FREE RADICAL BIO MED, V29, P870, DOI 10.1016/S0891-5849(00)00396-8	33	80	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174295	10.1371/journal.pone.0174295	http://dx.doi.org/10.1371/journal.pone.0174295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334048	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200074
J	Bodemer, C; Guillet, G; Cambazard, F; Boralevi, F; Ballarini, S; Milliet, C; Bertuccio, P; La Vecchia, C; Bach, JF; de Prost, Y				Bodemer, Christine; Guillet, Gerard; Cambazard, Frederic; Boralevi, Franck; Ballarini, Stefania; Milliet, Christian; Bertuccio, Paola; La Vecchia, Carlo; Bach, Jean-Francois; de Prost, Yves			Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study	PLOS ONE			English	Article							MYCOBACTERIUM-VACCAE SUSPENSION; REMITTING MULTIPLE-SCLEROSIS; DOUBLE-BLIND; HYGIENE HYPOTHESIS; RESPIRATORY-TRACT; T-CELLS; CHILDREN; PROBIOTICS; DISEASE; ASTHMA	Background Environmental factors play a major role on atopic dermatitis (AD) which shows a constant rise in prevalence in western countries over the last decades. The Hygiene Hypothesis suggesting an inverse relationship between incidence of infections and the increase in atopic diseases in these countries, is one of the working hypothesis proposed to explain this trend. Objective This study tested the efficacy and safety of oral administration of the bacterial lysate OM-85 (Broncho-Vaxom (R), Broncho-Munal (R), Ommunal (R), Paxoral (R), Vaxoral (R)), in the treatment of established AD in children. Methods Children aged 6 months to 7 years, with confirmed AD diagnosis, were randomized in a double-blind, placebo-controlled trial to receive, in addition to conventional treatment with emollients and topical corticosteroids, 3.5mg of the bacterial extract OM-85 or placebo daily for 9 months. The primary end-point was the difference between groups in the occurrence of new flares (NF) during the study period, evaluated by Hazard Ratio (HR) derived from conditional Cox proportional hazard regression models accounting for repeated events. Results Among the 179 randomized children, 170 were analysed, 88 in the OM-85 and 82 in the placebo group. As expected most children in both treatment groups experienced at least 1 NF during the study period (75 (85%) patients in the OM-85 group and 72 (88%) in the placebo group). Patients treated with OM-85 as adjuvant therapy had significantly fewer and delayed NFs (HR of repeated flares = 0.80; 95% confidence interval (CI): 0.67-0.96), also when potential confounding factors, as family history of atopy and corticosteroids use, were taken into account (HR = 0.82; 95% CI: 0.69-0.98). No major side effect was reported, with comparable and good tolerability for OM-85 and placebo. Conclusions Results show an adjuvant therapeutic effect of a well standardized bacterial lysate OM-85 on established AD.	[Bodemer, Christine; de Prost, Yves] Hop Necker Enfants Malad, AP HP, Dept Dermatol, Paris, France; [Guillet, Gerard] Univ Poitiers, Dept Dermatol, Poitiers, France; [Cambazard, Frederic] Univ St Etienne, Hop St Etienne, Dept Dermatol, St Etienne, France; [Boralevi, Franck] Univ Bordeaux, Hop Pellegrin Enfants, Pediat Dermatol Unit, Bordeaux, France; [Ballarini, Stefania; Milliet, Christian] Vifor Pharma OM Pharma, Meyrin, Switzerland; [Bertuccio, Paola; La Vecchia, Carlo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Bach, Jean-Francois] Univ Paris 05, Sorbone Paris Cite, Paris, France; [Bach, Jean-Francois] INEM, CNRS, INSERM, U1151,UMR 8253, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Poitiers; CHU de St Etienne; Universite Jean Monnet; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Milan; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bach, JF (corresponding author), Univ Paris 05, Sorbone Paris Cite, Paris, France.; Bach, JF (corresponding author), INEM, CNRS, INSERM, U1151,UMR 8253, Paris, France.	jean-francois.bach@academie-sciences.fr	La Vecchia, Carlo/Z-1710-2019	La Vecchia, Carlo/0000-0003-1441-897X; boralevi, franck/0000-0002-0477-5909	European Research Council [250290]; ViforPharma/OM Pharma [BV-2002/1]	European Research Council(European Research Council (ERC)European Commission); ViforPharma/OM Pharma(Dexcel Pharma)	This work was supported by the European Research Council, grant agreement number 250290. The funder (ViforPharma/OM Pharma), inquality of official sponsor of the clinical study (Sponsor's Protocol Code Number BV-2002/1),had a relevant role in the study design, data collection and analysis and decision to publish; the funders' employees since 2011 (StefaniaBallarini and ChristianMilliet) had a role in the preparation and review of the manuscript.	Ahrens B, 2011, INT ARCH ALLERGY IMM, V156, P196, DOI 10.1159/000322352; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arkwright PD, 2003, BRIT J DERMATOL, V149, P1029, DOI 10.1111/j.1365-2133.2003.05557.x; Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V107, P531, DOI 10.1067/mai.2001.113081; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Berth-Jones J, 2006, CLIN EXP ALLERGY, V36, P1115, DOI 10.1111/j.1365-2222.2006.02558.x; Boyle RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006135.pub2; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Brothers S, 2009, CLIN EXP DERMATOL, V34, P770, DOI 10.1111/j.1365-2230.2008.03153.x; Davies MG, 2006, J DERMATOL TREAT, V17, P74, DOI 10.1080/09546630500515321; Donaldson DS, 2013, MUCOSAL IMMUNOL, V6, P535, DOI 10.1038/mi.2012.93; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Figueiredo CA, 2013, J ALLERGY CLIN IMMUN, V131, P1064, DOI 10.1016/j.jaci.2013.01.016; Fiocchi A, 2012, WORLD ALLERGY ORGAN, V5, P148, DOI 10.1097/WOX.0b013e3182784ee0; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Gerasimov SV, 2010, AM J CLIN DERMATOL, V11, P351, DOI 10.2165/11531420-000000000-00000; Gueniche A, 2006, EUR J DERMATOL, V16, P380; Han L, 2014, AM J RHINOL ALLERGY, V28, P110, DOI 10.2500/ajra.2013.27.4021; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Isolauri E, 2012, GASTROENTEROL CLIN N, V41, P747, DOI 10.1016/j.gtc.2012.08.007; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5; Lau S, 2012, J ALLERGY CLIN IMMUN, V129, P1040, DOI 10.1016/j.jaci.2012.02.005; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Rosche B, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-112; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Sayers I, 2004, J ALLERGY CLIN IMMUN, V114, P302, DOI 10.1016/j.jaci.2004.03.057; Schaad UB, 2002, CHEST, V122, P2042, DOI 10.1378/chest.122.6.2042; Schaad UB, 2010, WORLD J PEDIATR, V6, P5, DOI 10.1007/s12519-010-0001-x; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Smit JJ, 2003, CLIN EXP ALLERGY, V33, P1083, DOI 10.1046/j.1365-2222.2003.01727.x; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43; Sutton A.J., 2000, METHODS METAANALYSIS; Therneau T.M., 2000, MODELING SURVIVAL DA; Thorburn AN, 2012, J IMMUNOL, V188, P4611, DOI 10.4049/jimmunol.1101299; Versalovic J, 2013, ANN NUTR METAB, V63, P42, DOI 10.1159/000354899; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Wolkerstorfer A, 1999, ACTA DERM-VENEREOL, V79, P356; Yang HJ, 2014, ALLERGY ASTHMA IMMUN, V6, P208, DOI 10.4168/aair.2014.6.3.208; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	50	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0161555	10.1371/journal.pone.0161555	http://dx.doi.org/10.1371/journal.pone.0161555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333952	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200001
J	Bonney, E; Jelsma, LD; Ferguson, GD; Smits-Engelsman, BCM				Bonney, Emmanuel; Jelsma, Lemke Dorothee; Ferguson, Gillian D.; Smits-Engelsman, Bouwien C. M.			Learning better by repetition or variation? Is transfer at odds with task specific training?	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; NINTENDO WII FIT; CONTEXTUAL INTERFERENCE; MOTOR-PERFORMANCE; VARIABLE PRACTICE; BALANCE CONTROL; CEREBRAL-PALSY; IMPROVE MOTOR; CHILDREN; ACQUISITION	Objective Transfer of motor skills is the ultimate goal of motor training in rehabilitation practice. In children with Developmental Coordination Disorder (DCD), very little is known about how skills are transferred from training situations to real life contexts. In this study we examined the influence of two types of practice on transfer of motor skills acquired in a virtual reality (VR) environment. Method One hundred and eleven children with DCD and their typically developing (TD) peers, aged 6-10 years (M = 8.0 SD = 1.0) were randomly assigned to either variable (n = 56) or repetitive practice (n = 55). Participants in the repetitive practice played the same exergame (ski slalom) twice weekly for 20 minutes, over a period of 5 weeks, while those in the variable group played 10 different games. Motor skills such as balance tasks (hopping), running and agility tasks, ball skills and functional activities were evaluated before and after 5 weeks of training. Results ANOVA repeated measures indicated that both DCD and TD children demonstrated transfer effects to real life skills with identical and non-identical elements at exactly the same rate, irrespective of the type of practice they were assigned to. Conclusion Based on these findings, we conclude that motor skills acquired in the VR environment, transfers to real world contexts in similar proportions for both TD and DCD children. The type of practice adopted does not seem to influence children's ability to transfer skills acquired in an exergame to life situations but the number of identical elements does.	[Bonney, Emmanuel; Ferguson, Gillian D.; Smits-Engelsman, Bouwien C. M.] Univ Cape Town, Dept Hlth & Rehabil Sci, Cape Town, South Africa; [Bonney, Emmanuel] Univ Ghana, Dept Phys Therapy, Accra, Ghana; [Jelsma, Lemke Dorothee] Univ Groningen, Dev & Clin Neuropsychol, Groningen, Netherlands	University of Cape Town; University of Ghana; University of Groningen	Jelsma, LD (corresponding author), Univ Groningen, Dev & Clin Neuropsychol, Groningen, Netherlands.	djelsma@live.nl	Jelsma, Dorothee/AAE-5876-2020; Bonney, Emmanuel/AAW-5906-2021; Ferguson, Gillian/AAS-7117-2020	Bonney, Emmanuel/0000-0001-7179-2816; Ferguson, Gillian/0000-0002-2698-965X; Jelsma, Lemke Dorothee/0000-0002-3311-435X				Aertssen WFM, 2016, PHYS THER, V96, P888, DOI 10.2522/ptj.20140018; Al-Mustafa AA, 1989, ANN M N AM SOC PSYCH; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bar-Haim S, 2010, CLIN REHABIL, V24, P1009, DOI 10.1177/0269215510371428; Blank R, 2012, DEV MED CHILD NEUROL, V54, P54, DOI 10.1111/j.1469-8749.2011.04171.x; Boutin A, 2012, PSYCHOL RES-PSYCH FO, V76, P611, DOI 10.1007/s00426-011-0355-2; Bovend'eerdt J, 1980, MOPER FITNESSTEST HA; Breslin G, 2012, ACTA PSYCHOL, V140, P154, DOI 10.1016/j.actpsy.2012.04.002; Bruininks R. H, 2005, BRUININKS OSERETSKY; BYRD R, 1986, PERCEPT MOTOR SKILL, V62, P87, DOI 10.2466/pms.1986.62.1.87; Cairney J, 2005, INT J OBESITY, V29, P369, DOI 10.1038/sj.ijo.0802893; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deutsch JE, 2008, PHYS THER, V88, P1196, DOI 10.2522/ptj.20080062; Di Tore P.A., 2012, J PHYS ED SPORT, V12, P4; Douvis SJ, 2005, PERCEPT MOTOR SKILL, V101, P531; Farhat F, 2015, APPL PHYSIOL NUTR ME, V40, P1269, DOI 10.1139/apnm-2015-0154; Farrow D, 1997, J HUM MOVEMENT STUD, V33, P47; Ferguson GD, 2013, RES DEV DISABIL, V34, P2449, DOI 10.1016/j.ridd.2013.05.007; Ferguson GD, 2015, PHYS OCCUP THER PEDI, V35, P147, DOI 10.3109/01942638.2015.1009230; Ferguson GD, 2014, RES DEV DISABIL, V35, P1087, DOI 10.1016/j.ridd.2014.01.031; Field A, 2013, DISCOVERING STAT USI; Hammond J, 2014, CHILD CARE HLTH DEV, V40, P165, DOI 10.1111/cch.12029; Henderson S., 2007, MOVEMENT ASSESSMENT, DOI 10.1037/t55281-000; Jarus T, 1999, PERCEPT MOTOR SKILL, V88, P437, DOI 10.2466/PMS.88.2.437-447; Jelsma D, 2014, HUM MOVEMENT SCI, V33, P404, DOI 10.1016/j.humov.2013.12.007; Jelsma J, 2013, DEV NEUROREHABIL, V16, P27, DOI 10.3109/17518423.2012.711781; Jokic CS, 2013, ADAPT PHYS ACT Q, V30, P103, DOI 10.1123/apaq.30.2.103; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Lee T.D., 1988, COMPLEX MOVEMENT BEH, V50, P201, DOI DOI 10.1016/S0166-4115(08)62557-1; Levac DE, 2013, ARCH PHYS MED REHAB, V94, P795, DOI 10.1016/j.apmr.2012.10.021; Lewthwaite R, 2015, PSYCHON B REV, V22, P1383, DOI 10.3758/s13423-015-0814-7; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; Mechelen WV, 1991, EUROFIT HANDLEIDING, P243; Miller LT, 2001, HUM MOVEMENT SCI, V20, P183, DOI 10.1016/S0167-9457(01)00034-3; Mombarg R, 2013, RES DEV DISABIL, V34, P2996, DOI 10.1016/j.ridd.2013.06.008; Niemeijer AS, 2007, DEV MED CHILD NEUROL, V49, P406, DOI 10.1111/j.1469-8749.2007.00406.x; Pinto-Zipp G, 1995, SOC NEUR ABSTR, V21, P1620; Polatajko H. J., 2004, ENABLING OCCUPATION; Robert MT, 2013, DEV MED CHILD NEUROL, V55, P1121, DOI 10.1111/dmcn.12219; Sandlund M, 2011, DEV NEUROREHABIL, V14, P15, DOI 10.3109/17518423.2010.533329; Sanli Elizabeth A, 2012, Front Psychol, V3, P611, DOI 10.3389/fpsyg.2012.00611; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Schmidt RA, 1987, TRANSFER LEARNING IS, P47, DOI DOI 10.1016/B978-0-12-188950-0.50009-6; Schoemaker Marina M, 2015, Curr Dev Disord Rep, V2, P150; Schoemaker MM, 2003, NEURAL PLAST, V10, P157; Schoemaker MM, 2005, CHILDREN DEV COORDIN, P212; Seidler RD, 2008, J NEUROPHYSIOL, V99, P1836, DOI 10.1152/jn.01187.2007; Smethurst CJ, 2001, HUM MOVEMENT SCI, V20, P499, DOI 10.1016/S0167-9457(01)00065-3; Smits-Engelsman B. C. M., 2010, MOVEMENT ABC 2 NL DU; Smits-Engelsman BC, 2016, HUM MOV SCI; Smits-Engelsman BCM, 2012, FUNCTIONAL STRENGTH; Smits-Engelsman BCM, 1998, JB FYSIOTHERAPIELKNI, P202; Smits-Engelsman B, 2015, HUM MOVEMENT SCI, V42, P293, DOI 10.1016/j.humov.2015.03.010; Smits-Engelsman BCM, 2013, DEV MED CHILD NEUROL, V55, P229, DOI 10.1111/dmcn.12008; Swinnen SP, 1997, HUM MOVEMENT SCI, V16, P749, DOI 10.1016/S0167-9457(97)00020-1; Vera JG, 2003, PERCEPT MOTOR SKILL, V96, P1015, DOI 10.2466/PMS.96.3.1015-1024; William HE, 2011, MOTOR LEARNING CONTR, P193; Wilson PH, 2013, DEV MED CHILD NEUROL, V55, P217, DOI 10.1111/j.1469-8749.2012.04436.x; Wuang YP, 2012, DEV MED CHILD NEUROL, V54, P160, DOI 10.1111/j.1469-8749.2011.04177.x; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276	60	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174214	10.1371/journal.pone.0174214	http://dx.doi.org/10.1371/journal.pone.0174214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333997	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200065
J	Huttermann, S; Noel, B; Memmert, D				Huettermann, Stefanie; Noeel, Benjamin; Memmert, Daniel			Evaluating erroneous offside calls in soccer	PLOS ONE			English	Article							ASSISTANT REFEREES; FOOTBALL; POSITION; ERRORS	The ability to simultaneously attend to multiple objects declines with increases in the visual angle separating distant objects. We explored whether these laboratory-measured limits on visual attentional spread generalize to a real life context: offside calls by soccer assistant referees. We coded all offside calls from a full year of first division German soccer matches. By determining the x-y coordinates of the relevant players and assistant referee on the soccer field we were able to calculate how far assistant referees had to spread their visual attention to perform well. Counterintuitively, assistant referees made fewer errors when they were farther away from the action due to an advantageous (smaller) visual angle on the game action. The pattern held even when we accounted for individual differences in a laboratory-based attentional spread measure of ten of the assistant referees. Our finding that errors are linked to smaller visual angles may explain the complaints of fans in some situations: Those seated directly behind the assistant referee, further from the players, might actually have it easier to make the right call because the relevant players would form a smaller visual angle.	[Huettermann, Stefanie; Noeel, Benjamin; Memmert, Daniel] German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany	German Sport University Cologne	Huttermann, S (corresponding author), German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany.	s.huettermann@dshs-koeln.de	Klatt, Stefanie/AAP-8354-2020	Klatt, Stefanie/0000-0002-2477-8699; Noel, Benjamin/0000-0002-0074-4697				Baldo MVC, 2002, PERCEPTION, V31, P1205, DOI 10.1068/p3422; Barte JCM, 2012, INT J SPORTS SCI COA, V7, P481, DOI 10.1260/1747-9541.7.3.481; Catteeuw P, 2010, J SPORT EXERCISE PSY, V32, P845, DOI 10.1123/jsep.32.6.845; Catteeuw P, 2010, J SPORT SCI, V28, P471, DOI 10.1080/02640410903518184; Helsen W, 2006, J SPORT SCI, V24, P521, DOI 10.1080/02640410500298065; Helsen W, 2004, J SPORTS SCI, V22, P97; Huttermann S, 2014, J EXP PSYCHOL-APPL, V20, P147, DOI 10.1037/xap0000012; Huttermann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065673; Huttermann S, RES Q EXERC IN PRESS; Larkin P, 2016, INT J SPORT EXERC PS; Maruenda FB, 2004, BMJ-BRIT MED J, V329, P1470, DOI 10.1136/bmj.329.7480.1470; Mascarenhas D, 2006, INT J SPORT PSYCHOL, V37, P99; Oudejans RRD, 2005, INT J SPORT PSYCHOL, V36, P3; Oudejans RRD, 2000, NATURE, V404, P33, DOI 10.1038/35003639; Oudejans RRD, 2005, SCI FOOTBALL, P604; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5	16	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174358	10.1371/journal.pone.0174358	http://dx.doi.org/10.1371/journal.pone.0174358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333996	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200085
J	Kauzlaric, A; Ecco, G; Cassano, M; Duc, J; Imbeault, M; Trono, D				Kauzlaric, Annamaria; Ecco, Gabriela; Cassano, Marco; Duc, Julien; Imbeault, Michael; Trono, Didier			The mouse genome displays highly dynamic populations of KRAB-zinc finger protein genes and related genetic units	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOGENOUS RETROVIRUSES; TRANSCRIPTIONAL REPRESSION; TRANSPOSABLE ELEMENTS; REGULATORY NETWORKS; EVOLUTION; DNA; FAMILY; EXPRESSION; DOMAINS	KRAB-containing poly-zinc finger proteins (KZFPs) constitute the largest family of transcription factors encoded by mammalian genomes, and growing evidence indicates that they fulfill functions critical to both embryonic development and maintenance of adult homeostasis. KZFP genes underwent broad and independent waves of expansion in many higher vertebrates lineages, yet comprehensive studies of members harbored by a given species are scarce. Here we present a thorough analysis of KZFP genes and related units in the murine genome. We first identified about twice as many elements than previously annotated as either KZFP genes or pseudogenes, notably by assigning to this family an entity formerly considered as a large group of Satellite repeats. We then could delineate an organization in clusters distributed throughout the genome, with signs of recombination, translocation, duplication and seeding of new sites by retrotransposition of KZFP genes and related genetic units (KZFP/rGUs). Moreover, we harvested evidence indicating that closely related para-logs had evolved through both drifting and shifting of sequences encoding for zinc finger arrays. Finally, we could demonstrate that the KAP1-SETDB1 repressor complex tames the expression of KZFP/rGUs within clusters, yet that the primary targets of this regulation are not the KZFP/rGUs themselves but enhancers contained in neighboring endogenous retroelements and that, underneath, KZFPs conserve highly individualized patterns of expression.	[Kauzlaric, Annamaria; Ecco, Gabriela; Cassano, Marco; Duc, Julien; Imbeault, Michael; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.	didier.trono@epfl.ch	Cassano, Marco/T-3473-2019	Cassano, Marco/0000-0002-8526-1319; Imbeault, Michael/0000-0002-0073-0922	Swiss National Foundation; European Union (FP7/REA) [290123]; European Research Council (ERC) [268721, 694658]; CARIGEST SA Student Fellowship Program in Stem Cells Research	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union (FP7/REA); European Research Council (ERC)(European Research Council (ERC)); CARIGEST SA Student Fellowship Program in Stem Cells Research	This work was financed through grants from the Swiss National Foundation, the European Union (FP7/2007-2013/REA no. 290123) and the European Research Council (ERC 268721 and ERC 694658) to D.T and the CARIGEST SA Student Fellowship Program in Stem Cells Research to A.K.	Balasubramanian R, 2004, BIOINFORMATICS, V20, P3353, DOI 10.1093/bioinformatics/bth405; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Bojkowska K, 2012, HEPATOLOGY, V56, P1279, DOI 10.1002/hep.25767; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Carey VJ, 2005, BIOINFORMATICS, V21, P135, DOI 10.1093/bioinformatics/bth458; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Fasching L, 2015, CELL REP, V10, P20, DOI 10.1016/j.celrep.2014.12.004; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Hamilton AT, 2003, COLD SPRING HARB SYM, V68, P131, DOI 10.1101/sqb.2003.68.131; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Imbeault M, 2017, NATURE; Iuchi S, 2005, MOL B INT U, P151; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Nowick K, 2010, BRIEF FUNCT GENOMICS, V9, P65, DOI 10.1093/bfgp/elp056; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; Rao SS, 2014, CELL, P159; Ravasi T, 2003, GENOME RES, V13, P1430, DOI 10.1101/gr.949803; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2013, DEVELOPMENT, V140, P519, DOI 10.1242/dev.087585; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Shannon M, 1998, DNA SEQUENCE, V8, P303, DOI 10.3109/10425179809034075; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Tengs T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh120; THIESEN H-J, 1990, New Biologist, V2, P363; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolf G, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0050-8; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	59	27	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173746	10.1371/journal.pone.0173746	http://dx.doi.org/10.1371/journal.pone.0173746			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334004	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200024
J	Kim, M; Kim, M; Yoo, HJ; Jang, HY; Lee, SH; Lee, JH				Kim, Minjoo; Kim, Minkyung; Yoo, Hye Jin; Jang, Hye Young; Lee, Sang-Hyun; Lee, Jong Ho			Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); CARDIOVASCULAR-DISEASE; LP-PLA(2) ACTIVITY; METABOLIC SYNDROME; GENE; LEVEL; RISK	This prospective study aimed to determine the effects of the persistence of overweight for three years and the PLA2G7 V279F polymorphism, as well as the interaction between these factors, on the association of age with blood pressure (BP). Healthy middle-aged subjects with normotensive BP were divided into the normal-weight and overweight groups. The PLA2G7 V279F genotype, BP, lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity, and oxidized low-density lipoprotein (ox-LDL) were determined. Lp-PLA(2) activity was lower in the F allele subjects (n = 111) than in those with the VV genotype (n = 389). The overweight individuals with the F allele had lower Lp-PLA(2) activity and ox-LDL at both baseline and after three years and lower systolic and diastolic BP and LDL cholesterol after three years compared with those with the VV phenotype. After three years, the overweight subjects with the VV phenotype exhibited greater increases in Lp-PLA(2) activity, systolic BP, and ox-LDL than those with the F allele and normal-weight subjects with the VV phenotype. A multivariate analysis revealed that the PLA2G7 V279F genotype, baseline BMI, changes in Lp-PLA(2) activity and ox-LDL remained independently and positively associated with changes in systolic BP. The simultaneous presence of the PLA2G7 279VV genotype and persistence of overweight synergistically increases the risk for hypertension, whereas lower Lp-PLA(2) activity in PLA2G7 279F allele carriers might offer certain protection against hypertension, even in individuals who have been overweight for over three years.	[Kim, Minjoo; Kim, Minkyung; Lee, Jong Ho] Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea; [Yoo, Hye Jin; Jang, Hye Young; Lee, Jong Ho] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul, South Korea; [Yoo, Hye Jin; Jang, Hye Young; Lee, Jong Ho] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Brain Korea PLUS Project 21, Seoul, South Korea; [Lee, Sang-Hyun] Natl Hlth Insurance Corp, Ilsan Hosp, Dept Family Practice, Goyang, South Korea	Yonsei University; Yonsei University; Yonsei University; NHIS Ilsan Hospital	Lee, JH (corresponding author), Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Brain Korea PLUS Project 21, Seoul, South Korea.	jhleeb@yonsei.ac.kr			Ministry of Science, ICT and Future Planning through the National Research Foundation, Republic of Korea [NRF-2016R1A2B4011662, NRF-2012M3A9C4048762]	Ministry of Science, ICT and Future Planning through the National Research Foundation, Republic of Korea	This study was funded by the Bio-Synergy Research Project (NRF-2012M3A9C4048762) and the Mid-career Researcher Program (NRF-2016R1A2B4011662) of the Ministry of Science, ICT and Future Planning through the National Research Foundation, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, J FUNCT FOODS, V23, P95; Cha TW, 2016, HYPERTENS RES, V39, P449, DOI 10.1038/hr.2016.7; da Silva IT, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-19; Fleming I, 2005, CARDIOVASC RES, V65, P897, DOI 10.1016/j.cardiores.2004.11.003; Garg S, 2016, DIABETES METAB SYND, V10, pS21, DOI 10.1016/j.dsx.2015.09.003; Jang Y, 2006, J CLIN ENDOCR METAB, V91, P3521, DOI 10.1210/jc.2006-0116; Jang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018208; Jung S, 2014, J ATHEROSCLER THROMB, V21, P1243; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119519; Kugiyama K, 1999, ATHEROSCLEROSIS, V143, P201, DOI 10.1016/S0021-9150(98)00288-3; Li JH, 2016, BIOMED ENVIRON SCI, V29, P205, DOI 10.3967/bes2016.025; Macphee CH, 2005, CURR OPIN LIPIDOL, V16, P442, DOI 10.1097/01.mol.0000174155.61307.5f; Maiolino G, 2015, WORLD J CARDIOL, V7, P609, DOI 10.4330/wjc.v7.i10.609; Paik JK, 2010, CLIN CHIM ACTA, V411, P486, DOI 10.1016/j.cca.2009.12.021; Sakka S, 2015, CLIN CHEM LAB MED, V53, P1119, DOI 10.1515/cclm-2014-1081; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Tuan NT, 2008, J NUTR, V138, P1377, DOI 10.1093/jn/138.7.1377; Wang T, 2009, AM J HYPERTENS, V22, P742, DOI 10.1038/ajh.2009.70; Yeo HY, 2011, METABOLISM, V60, P537, DOI 10.1016/j.metabol.2010.05.003	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173611	10.1371/journal.pone.0173611	http://dx.doi.org/10.1371/journal.pone.0173611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334001	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200020
J	Lee, J; Hong, BS; Ryu, HS; Lee, HB; Lee, M; Park, IA; Kim, J; Han, W; Noh, DY; Moon, HG				Lee, Jiwoo; Hong, Bok Sil; Ryu, Han Suk; Lee, Han-Byoel; Lee, Minju; Park, In Ae; Kim, Jisun; Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon			Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism	PLOS ONE			English	Article							EPITHELIAL-CELLS; ADIPOSE-TISSUE; PROMOTE; CARCINOMA; IL-6; METALLOPROTEINASE-1; TUMORIGENESIS; EXPRESSION; CONTRIBUTE; INHIBITOR	The role of adipocytes in cancer microenvironment has gained focus during the recent years. However, the characteristics of the cancer-associated adipocytes (CAA) in human breast cancer tissues and the underlying regulatory mechanism are not clearly understood. We reviewed pathology specimens of breast cancer patients to understand the morphologic characteristics of CAA, and profiled the mRNA and miRNA expression of CAA by using indirect co-culture system in vitro. The CAAs in human breast cancers showed heterogeneous topographic relationship with breast cancer cells within the breast microenvironment. The CAAs exhibited the characteristics of de-differentiation determined by their microscopic appearance and the expression levels of adipogenic markers. Additionally, the 3T3-L1 adipocytes indirectly co-cultured with breast cancer cells showed up-regulation of inflammation-related genes including Il6 and Ptx3. The up-regulation of IL6 in CAA was further observed in human breast cancer tissues. miRNA array of indirectly co-cultured 3T3-L1 cells showed increased expression of mmu-miR-5112 which may target Cpeb1. Cpeb1 is a negative regulator of Il6. The suppressive role of mmu-miR-5112 was confirmed by dual luciferase reporter assay, and mmu-miR-5112-treated adipocytes showed up-regulation of Il6. The transition of adipocytes into more inflammatory CAA resulted in proliferation-promoting effect in ER positive breast cancer cells such as MCF7 and ZR-75-1 but not in ER negative cells. In this study, we have determined the de-differentiated and inflammatory natures of CAA in breast cancer microenvironment. Additionally, we propose a miRNA-based regulatory mechanism underlying the process of acquiring inflammatory phenotypes in CAA.	[Lee, Jiwoo; Hong, Bok Sil; Lee, Han-Byoel; Lee, Minju; Kim, Jisun; Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon] Seoul Natl Univ Hosp, Ctr Med Innovat, Seoul, South Korea; [Ryu, Han Suk; Park, In Ae] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Lee, Han-Byoel; Kim, Jisun; Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Moon, HG (corresponding author), Seoul Natl Univ Hosp, Ctr Med Innovat, Seoul, South Korea.; Moon, HG (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.; Moon, HG (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	moonhg74@snu.ac.kr	Han, Wonshik/B-3699-2008; Hong, Bok Sil/GYQ-5150-2022	Han, Wonshik/0000-0001-7310-0764; KIM, JISUN/0000-0002-4884-6107; Moon, Hyeong-Gon/0000-0002-9981-0286; Hong, Bok Sil/0000-0002-2710-7727	Research Resettlement Fund for the New Faculty of Seoul National University; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2005929, 2015R1C1A1A02036629, 2015R1D1A1A02061904]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [A1520250]; grant of the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C2148]	Research Resettlement Fund for the New Faculty of Seoul National University; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; grant of the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by the Research Resettlement Fund for the New Faculty of Seoul National University, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2005929, 2015R1C1A1A02036629, and 2015R1D1A1A02061904), by the grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (A1520250), and by the grant of the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI13C2148).	Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Arner P, 2015, NAT REV ENDOCRINOL, V11, P276, DOI 10.1038/nrendo.2015.25; Arrigoni C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-238; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Bochet L, 2013, CANCER RES, V73, P5657, DOI 10.1158/0008-5472.CAN-13-0530; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carter JC, 2012, EXP MOL PATHOL, V92, P312, DOI 10.1016/j.yexmp.2012.03.005; Che Q, 2014, INT J CANCER, V135, P282, DOI 10.1002/ijc.28679; Clarke MR, 2015, MOL CARCINOGEN, V54, P1214, DOI 10.1002/mc.22178; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Fisher DT, 2014, SEMIN IMMUNOL, V26, P38, DOI 10.1016/j.smim.2014.01.008; Groppo R, 2011, MOL CELL BIOL, V31, P2707, DOI 10.1128/MCB.05133-11; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Ivshina M, 2015, MOL CELL BIOL, V35, P610, DOI 10.1128/MCB.00800-14; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kuninty PR, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00003; Li P, 2015, CELL RES, V25, P588, DOI 10.1038/cr.2015.51; Liu XW, 2005, CANCER RES, V65, P898; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Marret H, 2001, BREAST CANCER RES TR, V66, P17, DOI 10.1023/A:1010699912768; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Meng L, 2001, CANCER RES, V61, P2250; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Rupaimoole R, 2016, CANCER DISCOV, V6, P235, DOI 10.1158/2159-8290.CD-15-0893; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sung SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071637; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119348; Wang YY, 2012, CANCER LETT, V324, P142, DOI 10.1016/j.canlet.2012.05.019; Yang L, 2014, BIOCHEM BIOPH RES CO, V453, P582, DOI 10.1016/j.bbrc.2014.09.129	36	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174126	10.1371/journal.pone.0174126	http://dx.doi.org/10.1371/journal.pone.0174126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333977	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200050
J	Prahm, KP; Hogdall, C; Karlsen, MA; Christensen, J; Novotny, GW; Knudsen, S; Hansen, A; Jensen, PB; Jensen, T; Mirza, MR; Ekmann-Gade, AW; Nedergaard, L; Hogdall, E				Prahm, Kira Philipsen; Hogdall, Claus; Karlsen, Mona Aarenstrup; Christensen, Jarle; Novotny, Guy Wayne; Knudsen, Steen; Hansen, Anker; Jensen, Peter Buhl; Jensen, Thomas; Mirza, Mansoor Raza; Ekmann-Gade, Anne Weng; Nedergaard, Lotte; Hogdall, Estrid			Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; UP-REGULATION; SENSITIVITY; MIR-200; LET-7; CHEMOSENSITIVITY; PROLIFERATION; TUMORIGENESIS; PACLITAXEL; PHENOTYPE	Objective Ovarian cancer is the leading cause of death among gynecologic malignancies. This is partly due to a non-durable response to chemotherapy. Prediction of resistance to chemotherapy could be a key role in more personalized treatment. In the current study we aimed to examine if microRNA based predictors could predict resistance to chemotherapy in ovarian cancer, and to investigate if the predictors could be prognostic factors for progression free and overall survival. Methods Predictors of chemotherapy-resistance were developed based on correlation between miRNA expression and differences in measured growth inhibition in a variety of human cancer cell lines in the presence of Carboplatin, Paclitaxel and Docetaxel. These predictors were then, retrospectively, blindly validated in a cohort of 170 epithelial ovarian cancer patients treated with Carboplatin and Paclitaxel or Docetaxel as first line treatment. Results In a multivariate cox proportional analysis the predictors of chemotherapy-resistance were not able to predict time to progression after end of chemotherapy (hazard ratio: 0.64, 95% CI: 0.36-1.12, P = 0.117). However, in a multivariate logistic analysis, where time to progression was considered as either more or less than 6 months, the predictors match clinical observed chemotherapy-resistance (odds ratio: 0.19, 95% CI: 0.05-0.73, P = 0.015). Neither univariate nor multivariate, time-dependent, cox analysis for progression free survival (PFS) or overall survival (OS) in all 170 patients showed to match predicted resistance to chemotherapy (PFS: hazard ratio: 0.69, 95% CI: 0.40-1.19, P = 0.183, OS: hazard ratio: 0.76, 95% CI: 0.42-1.40, P = 0.386). Conclusion In the current study, microRNA based predictors of chemotherapy-resistance did not demonstrate any convincing correlation to clinical observed chemotherapy-resistance, progression free survival, or overall survival, in patients with epithelial ovarian cancer. However the predictors did reflect relapse more or less than 6 months.	[Prahm, Kira Philipsen; Karlsen, Mona Aarenstrup; Christensen, Jarle; Novotny, Guy Wayne; Hogdall, Estrid] Herlev Univ Hosp, Dept Pathol, Mol Unit, Danish Canc Biobank, Herlev, Denmark; [Prahm, Kira Philipsen; Hogdall, Claus; Karlsen, Mona Aarenstrup; Ekmann-Gade, Anne Weng] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark; [Knudsen, Steen; Hansen, Anker; Jensen, Peter Buhl; Jensen, Thomas] Med Prognosis Inst, Horsholm, Denmark; [Mirza, Mansoor Raza] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark; [Nedergaard, Lotte] Copenhagen Univ Hosp, Dept Pathol, Rigshosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Prahm, KP (corresponding author), Herlev Univ Hosp, Dept Pathol, Mol Unit, Danish Canc Biobank, Herlev, Denmark.; Prahm, KP (corresponding author), Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark.	kira.philipsen.prahm@regionh.dk	Karlsen, Mona/AAT-6331-2021	Karlsen, Mona/0000-0002-2631-5516; Hogdall, Claus/0000-0002-5959-8874; Ekmann-Gade, Anne Weng/0000-0001-8136-3951; Hogdall, Estrid/0000-0003-4689-5658	Herlev Hospital Research Council; Dansk Kraeftforsknings Fond [106/1]	Herlev Hospital Research Council; Dansk Kraeftforsknings Fond	This work was supported by: Herlev Hospital Research Council, URL: https://www. herlevhospital.dk/forskning/kontakt/Sider/ Forskningsr%C3%A5d.aspx (KPP and EH received the funding), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The Mermaid Foundation, URL:http://www. mermaidprojektet.dk/ (KPP, CH and EH received the funding), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Dansk Kraeftforsknings Fond: Grant number: 106/1, URL: http://www.dansk-kraeftforsknings-fond.dk/ (KPP received the funding), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Medical Prognosis Institute (MPI): URL:http:// www.medical-prognosis.com/, MPI has performed the micro array analyses, been part of the statistical analyses and writing and editing of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; [Anonymous], DEV THER PROGR; Association of the Nordic Cancer Registries, 2015, MORT PREV SURV NORD; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Brozovic A, 2015, MOL ONCOL, V9, P1678, DOI 10.1016/j.molonc.2015.04.015; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chen XP, 2014, CANCER LETT, V353, P201, DOI 10.1016/j.canlet.2014.07.026; Chien JR, 2007, J CELL BIOCHEM, V102, P1117, DOI 10.1002/jcb.21552; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Covens A, 2002, GYNECOL ONCOL, V85, P71, DOI 10.1006/gyno.2001.6552; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Danish Gynecological Cancer Database, 2015, ANB DANSK I, P1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garcia A, 2013, THER ADV MED ONCOL, V5, P133, DOI 10.1177/1758834012467661; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Knudsen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115538; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Langhe R, 2015, ADV EXP MED BIOL, V889, P119, DOI 10.1007/978-3-319-23730-5_8; Ledermann JA, 2015, BRIT J CANCER, V113, pS10, DOI 10.1038/bjc.2015.395; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Li ZM, 2010, GYNECOL ONCOL, V119, P125, DOI 10.1016/j.ygyno.2010.06.004; Liu N, 2015, NEOPLASMA, V62, P550, DOI 10.4149/neo_2015_066; Martin LP, 2009, SEMIN ONCOL, V36, P112, DOI 10.1053/j.seminoncol.2008.12.003; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mirza MR, 2016, NEW ENGLAND J MED, DOI 10.1056/NEJMoa1611310; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Pedersen CB, 2006, DAN MED BULL, V53, P441; Prahm KP, 2016, APMIS, V124, P337, DOI 10.1111/apm.12514; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Sant M, 2015, EUROPEAN J CANC; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Sugio A, 2014, GYNECOL ONCOL, V134, P615, DOI 10.1016/j.ygyno.2014.06.024; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vecchione A, 2013, P NATL ACAD SCI USA, V110, P9845, DOI 10.1073/pnas.1305472110; Wang LJ, 2014, GYNECOL ONCOL, V134, P96, DOI 10.1016/j.ygyno.2014.04.055; Weinberg LE, 2010, J SURG ONCOL, V101, P334, DOI 10.1002/jso.21482; Winther M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148070; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yu PN, 2014, INT J CANCER, V134, P542, DOI 10.1002/ijc.28399; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao HM, 2015, TUMOR BIOL, V36, P6867, DOI 10.1007/s13277-015-3399-x	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174300	10.1371/journal.pone.0174300	http://dx.doi.org/10.1371/journal.pone.0174300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334047	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200075
J	Zhang, CJ; Wei, B; Li, P; Yang, K; Wang, ZZ; Ma, J; Guo, YJ				Zhang, Chengjuan; Wei, Bing; Li, Peng; Yang, Ke; Wang, Zhizhong; Ma, Jie; Guo, Yongjun			Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE-KINASE INHIBITORS; POLYMERASE-CHAIN-REACTION; ACQUIRED-RESISTANCE; NEXT-GENERATION; DIGITAL PCR; MUTATION; DNA; T790M; ERLOTINIB	Objective Epidermal growth factor receptor (EGFR) specific mutations have been known to improve survival of patients with non-small-cell lung carcinoma (NSCLC). However, whether there are any changes of EGFR mutations after targeted therapy and its clinical significance is unclear. This study was to identify the status of EGFR mutations after targeted therapy and predict the prognostic significance for NSCLC patients. Methods A total of forty-five (45) NSCLC patients who received EGFR-TKI therapy were enrolled. We identified the changes of EGFR mutations in plasma ctDNA by Amplification Refractory Mutation System (ARMS) PCR technology. Results In the 45 cases of NSCLC with EGFR mutations, the EGFR mutation status changed in 26 cases, in which, 12 cases (26.7%) from positive to negative, and 14 cases (31.1%) from T790M mutation negative to positive after TKI targeted therapy. The T790M occurance group had a shorter Progression - Free-Survival (PFS) than the groups of EGFR mutation undetected and EGFR mutation turned out to have no change after EGFR-TKI therapy (p < 0.05). Conclusions According to this study, it's necessary to closely monitor EGFR mutations during follow-up to predict the prognosis of NSCLC patients who are to receive the TKI targeted therapy.	[Zhang, Chengjuan; Wei, Bing; Yang, Ke; Wang, Zhizhong; Ma, Jie; Guo, Yongjun] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Mol Pathol, Zhengzhou, Peoples R China; [Li, Peng] Henan Prov Peoples Hosp, Dept Infect Dis, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Ma, J; Guo, YJ (corresponding author), Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Mol Pathol, Zhengzhou, Peoples R China.	majie@medmail.com.cn; yongjunguo@hotmail.com		Guo, Yongjun/0000-0003-1641-2969	Funding Program for National Natural Science Foundation [81602637]; Medical Sciences and Technologies of Henan Province [201501001]	Funding Program for National Natural Science Foundation; Medical Sciences and Technologies of Henan Province	This work was supported by the Funding Program for National Natural Science Foundation (Project #81602637) and Medical Sciences and Technologies of Henan Province (Project #201501001)	Bolton L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115672; Borsu L, 2016, J MOL DIAGN, V18, P903, DOI 10.1016/j.jmoldx.2016.07.004; Chiu CH, 2014, J THORAC ONCOL, V9, P91, DOI 10.1097/JTO.0000000000000041; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Denis JA, 2016, MOL ONCOL, V10, P1221, DOI 10.1016/j.molonc.2016.05.009; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Hrustanovic G, 2013, CANCER BIOL THER, V14, P304, DOI 10.4161/cbt.23627; Ko R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2902-0; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lee JY, 2016, ONCOTARGET, V7, P6984, DOI 10.18632/oncotarget.6874; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Seki Y, 2016, ONCOLOGIST, V21, P156, DOI 10.1634/theoncologist.2015-0288; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Skoulidis F, 2017, CLIN CANCER RES, V23, P618, DOI 10.1158/1078-0432.CCR-15-2815; Soria JC, 2015, LANCET ONCOL, V16, P990, DOI 10.1016/S1470-2045(15)00121-7; Soria JC, 2015, LANCET ONCOL, V16, P897, DOI 10.1016/S1470-2045(15)00006-6; Steuer CE, 2015, CANCER-AM CANCER SOC, V121, pE1, DOI 10.1002/cncr.29139; Suda K, 2014, PROG TUMOR RES, V41, P62, DOI 10.1159/000355902; Tannock IF, 2015, NATURE, V517, P152, DOI 10.1038/nature14075; Thress KS, 2015, LUNG CANCER, V90, P509, DOI 10.1016/j.lungcan.2015.10.004; Wu YL, 2015, ANN ONCOL, V26, P1883, DOI 10.1093/annonc/mdv270; Xu Q, 2015, ONCOTARGETS THER, V8, P1533, DOI 10.2147/OTT.S84938; Yu HA, 2017, J THORAC ONCOL, V12, P102, DOI 10.1016/j.jtho.2016.08.140; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07; Zhang B, 2015, EXP THER MED, V9, P1383, DOI 10.3892/etm.2015.2221; Zhang WS, 2014, DRUG DES DEV THER, V8, P735, DOI 10.2147/DDDT.S60672; Zheng D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20913; Zhou Q, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0316-8; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622; Zwitter M, 2016, CANCER BIOL THER, V17, P833, DOI 10.1080/15384047.2016.1195049	32	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173524	10.1371/journal.pone.0173524	http://dx.doi.org/10.1371/journal.pone.0173524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333951	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200016
J	De Jong, A; Carreira, S; Na, N; Carillion, A; Jiang, C; Beuvin, M; Lacorte, JM; Bonnefont-Rousselot, D; Riou, B; Coirault, C				De Jong, Audrey; Carreira, Serge; Na, Na; Carillion, Aude; Jiang, Cheng; Beuvin, Maud; Lacorte, Jean-Marc; Bonnefont-Rousselot, Dominique; Riou, Bruno; Coirault, Catherine			Diaphragmatic function is enhanced in fatty and diabetic fatty rats	PLOS ONE			English	Article							BODY-MASS INDEX; MECHANICAL VENTILATION; INTENSIVE-CARE; OBESE-PATIENTS; MUSCLE DYSFUNCTION; MORBID-OBESITY; MORTALITY; METAANALYSIS; OUTCOMES; IMPACT	Background Obesity is associated with a decrease in mortality in the intensive care unit (ICU) (the "obesity paradox"). We hypothesized that obesity may paradoxically improve diaphragmatic function. Methods Diaphragm contractility was prospectively recorded in vitro in adult male Zucker lean (control), fatty, and diabetic fatty rats, at rest, after 12h mechanical ventilation and after fatigue. We analyzed diaphragm morphology, cytokines, and protein expression of the protein kinase signaling pathways. Results Diaphragm active-force (AF) was higher in fatty (96 +/- 7mN.mm(-2),P = 0.02) but not in diabetic fatty rats (90 +/- 17mN.mm(-2)) when compared with controls (84 +/- 8mN.mm(-2)). Recovery from fatigue was improved in fatty and diabetic fatty groups compared with controls. Ventilator-induced diaphragmatic dysfunction was observed in each group, but AF remained higher in fatty (82 +/- 8mN.mm(-2), P = 0.03) compared with controls (70 +/- 8mN.mm(-2)). There was neutral lipid droplet accumulation in fatty and diabetic fatty. There were shifts towards a higher cross-sectional-area (CSA) of myosin heavy chain isoforms (MyHC)-2A fibers in fatty and diabetic fatty compared with control rats (P = 0.002 and P < 0.001, respectively) and a smaller CSA of MyHC-2X in fatty compared with diabetic fatty and control rats (P < 0.001 and P < 0.001, respectively). The phosphorylated total-protein-kinase-B (pAKT)/AKT ratio was higher in fatty (182 +/- 58%, P = 0.03), but not in diabetic fatty when compared with controls and monocarboxylate-transporter-1 was higher in diabetic fatty (147 +/- 36%, P = 0.04), but not in fatty. Conclusions Diaphragmatic force is increased in Zucker obese rats before and after mechanical ventilation, and is associated with activation of AKT pathway signaling and complex changes in morphology.	[De Jong, Audrey; Carreira, Serge; Na, Na; Carillion, Aude; Jiang, Cheng; Bonnefont-Rousselot, Dominique; Riou, Bruno] UPMC Univ Paris 06, Sorbonne Univ, UMR INSERM UPMC 1166, IHU ICAN, Paris, France; [De Jong, Audrey; Carreira, Serge; Carillion, Aude] Hop La Pitie Salpetriere, APHP, Dept Anesthesiol & Crit Care Med, Paris, France; [De Jong, Audrey] CHU Montpellier, Dept Anesthesia & Crit Care B, Hop St Eloi, Montpellier, France; [Na, Na; Riou, Bruno] Hop La Pitie Salpetriere, APHP, Dept Emergency Med & Surg, Paris, France; [Jiang, Cheng] Wuhan Univ, Zonghnan Univ Hosp, Emergency Dept, Wuhan, Peoples R China; [Beuvin, Maud; Coirault, Catherine] UPMC Univ Paris 06, Sorbonne Univ, INSERM, CNRS,CRM,GH Pitie Salpetriere, Paris, France; [Lacorte, Jean-Marc] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol & Oncol Biochem, Paris, France; [Bonnefont-Rousselot, Dominique] Hop La Pitie Salpetriere, APHP, Dept Metab Biochem, Paris, France; [Bonnefont-Rousselot, Dominique] Univ Paris 05, Fac Pharm, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Wuhan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	De Jong, A (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMR INSERM UPMC 1166, IHU ICAN, Paris, France.; De Jong, A (corresponding author), Hop La Pitie Salpetriere, APHP, Dept Anesthesiol & Crit Care Med, Paris, France.; De Jong, A (corresponding author), CHU Montpellier, Dept Anesthesia & Crit Care B, Hop St Eloi, Montpellier, France.	audreydejong@hotmail.fr	Coirault, Catherine/S-2454-2019; Coirault, Catherine/I-2979-2016; Rousselot, Bonnefont/U-7434-2019; De Jong, Audrey/AAA-8553-2020; De Jong, Audrey/N-6406-2018	Coirault, Catherine/0000-0002-5594-1057; De Jong, Audrey/0000-0002-3413-2752; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202	People's Republic of China (the State Scholarship Fund by China Scholarship Council) [201206270014]	People's Republic of China (the State Scholarship Fund by China Scholarship Council)	Support was provided solely from institutional and/or departmental sources. Dr. Cheng Jiang was the recipient of a doctoral grant from the People's Republic of China (the State Scholarship Fund by China Scholarship Council, file no 201206270014). The sponsor had no role in the analysis or reporting of the data.	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Anzueto A, 2011, THORAX, V66, P66, DOI 10.1136/thx.2010.145086; Arabi YM, 2013, CRIT CARE, V17, DOI 10.1186/cc12680; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKI NK, 1984, AM REV RESPIR DIS, V129, P538; Cairns SP, 2006, SPORTS MED, V36, P279, DOI 10.2165/00007256-200636040-00001; Carreira S, 2014, ANESTHESIOLOGY, V120, P425, DOI 10.1097/ALN.0000000000000011; Chlif M, 2009, RESP PHYSIOL NEUROBI, V168, P198, DOI 10.1016/j.resp.2009.06.012; Coirault C, 2007, AM J PHYSIOL-HEART C, V292, pH1009, DOI 10.1152/ajpheart.00438.2006; Criswell DS, 2003, CHEST, V124, P2302, DOI 10.1378/chest.124.6.2302; De Jong A, 2013, CHEST, V143, P1554, DOI 10.1378/chest.12-2115; De Jong A, 2012, CHEST, V141, P1637, DOI 10.1378/chest.11-3302; De Stefano F, 2015, J NUTR HEALTH AGING, V19, P785, DOI 10.1007/s12603-015-0482-3; Demoule A, 2013, AM J RESP CRIT CARE, V188, P213, DOI 10.1164/rccm.201209-1668OC; FARKAS GA, 1994, J APPL PHYSIOL, V77, P2250, DOI 10.1152/jappl.1994.77.5.2250; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Guellich Aziz, 2013, Methods Mol Biol, V952, P207, DOI 10.1007/978-1-62703-155-4_15; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Indrakusuma I, 2015, CURR OBES REP, V4, P411, DOI 10.1007/s13679-015-0174-7; Jaber S, 2011, CRIT CARE, V15, DOI 10.1186/cc10023; Jiang C, 2015, CRIT CARE MED, V43, pE241, DOI 10.1097/CCM.0000000000000999; Kress JP, 1999, AM J RESP CRIT CARE, V160, P883, DOI 10.1164/ajrccm.160.3.9902058; LECARPENTIER YC, 1979, AM J PHYSIOL, V237, pH455, DOI 10.1152/ajpheart.1979.237.4.H455; Lin CK, 2012, RESPIROLOGY, V17, P402, DOI 10.1111/j.1440-1843.2011.02124.x; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahul M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1457-4; Michelet P, 2015, ANESTHESIOLOGY, V122, P876, DOI 10.1097/ALN.0000000000000574; O'Brien JM, 2012, CRIT CARE MED, V40, P1456, DOI 10.1097/CCM.0b013e31823e9a80; Oliveros H, 2008, OBESITY, V16, P515, DOI 10.1038/oby.2007.102; Orliaguet G, 2001, ANESTHESIOLOGY, V94, P468, DOI 10.1097/00000542-200103000-00018; Pepin JL, 2016, LANCET RESP MED, V4, P407, DOI 10.1016/S2213-2600(16)00054-0; Pickkers P, 2013, CRIT CARE MED, V41, P1878, DOI 10.1097/CCM.0b013e31828a2aa1; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Sakr Y, 2015, CRIT CARE MED, V43, P2623, DOI 10.1097/CCM.0000000000001310; Salvi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011494; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; Sasaki N, 2013, ANESTHESIOLOGY, V118, P961, DOI 10.1097/ALN.0b013e318288834f; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; Tumova J, 2016, PHYSIOL RES, V65, P193, DOI 10.33549/physiolres.932993; van Lunteren E, 2006, RESP PHYSIOL NEUROBI, V153, P157, DOI 10.1016/j.resp.2005.09.015; vanderHeijden HFM, 1997, AM J RESP CRIT CARE, V155, P1072, DOI 10.1164/ajrccm.155.3.9116989; vanLunteren E, 1996, EUR RESPIR J, V9, P2139; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; YEE HY, 1972, CLIN CHEM, V18, P1416; Yu S, 2013, CRIT CARE MED, V41, P2720, DOI 10.1097/CCM.0b013e318298a2eb	51	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174043	10.1371/journal.pone.0174043	http://dx.doi.org/10.1371/journal.pone.0174043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328996	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700045
J	Deliberato, RO; Rocha, LL; Lima, AH; Santiago, CRM; Terra, JCC; Dagan, A; Celi, LA				Deliberato, Rodrigo Octavio; Rocha, Leonardo Lima; Lima, Alex Heitor; Maia Santiago, Caroline Reis; Cyrineu Terra, Jose Claudio; Dagan, Alon; Celi, Leo Anthony			Physician satisfaction with a multi-platform digital scheduling system	PLOS ONE			English	Article							SHIFT SYSTEMS; HEALTH	Objective Physician shift schedules are regularly created manually, using paper or a shared online spreadsheet. Mistakes are not unusual, leading to last minute scrambles to cover a shift. We developed a web-based shift scheduling system and a mobile application tool to facilitate both the monthly scheduling and shift exchanges between physicians. The primary objective was to compare physician satisfaction before and after the mobile application implementation. Methods Over a 9-month period, three surveys, using the 4-point Likert type scale were performed to assess the physician satisfaction. The first survey was conducted three months prior mobile application release, a second survey three months after implementation and the last survey six months after. Results 51 (77%) of the physicians answered the baseline survey. Of those, 32 (63%) were males with a mean age of 37.8 +/- 5.5 years. Prior to the mobile application implementation, 36 (70%) of the responders were using more than one method to carry out shift exchanges and only 20 (40%) were using the official department report sheet to document shift exchanges. The second and third survey were answered by 48 (73%) physicians. Forty-eight (98%) of them found the mobile application easy or very easy to install and 47 (96%) did not want to go back to the previous method. Regarding physician satisfaction, at baseline 37% of the physicians were unsatisfied or very unsatisfied with shift scheduling. After the mobile application was implementation, only 4% reported being unsatisfied (OR = 0.11, p < 0.001). The satisfaction level improved from 63% to 96% between the first and the last survey. Satisfaction levels significantly increased between the three time points (OR = 13.33, p < 0.001). Conclusion Our web and mobile phone-based scheduling system resulted in better physician satisfaction.	[Deliberato, Rodrigo Octavio; Rocha, Leonardo Lima; Maia Santiago, Caroline Reis] Hosp Israelita Albert Einstein, Crit Care Dept, Sao Paulo, Brazil; [Deliberato, Rodrigo Octavio; Lima, Alex Heitor; Cyrineu Terra, Jose Claudio] Hosp Israelita Albert Einstein, Innovat Dept, Sao Paulo, Brazil; [Deliberato, Rodrigo Octavio; Dagan, Alon; Celi, Leo Anthony] MIT, Harvard MIT Hlth Sci & Technol, Lab Computat Physiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dagan, Alon] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Celi, Leo Anthony] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Deliberato, RO (corresponding author), Hosp Israelita Albert Einstein, Crit Care Dept, Sao Paulo, Brazil.; Deliberato, RO (corresponding author), Hosp Israelita Albert Einstein, Innovat Dept, Sao Paulo, Brazil.; Deliberato, RO (corresponding author), MIT, Harvard MIT Hlth Sci & Technol, Lab Computat Physiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rodrigo2@mit.edu		Dagan, Alon/0000-0002-3404-9983				Angeli P, 2016, J MED ENG TECHNOL, Vxx, P1; Aykin T, 2000, EUR J OPER RES, V125, P381, DOI 10.1016/S0377-2217(99)00413-0; Badri M. A., 1993, International Journal of Operations & Production Management, V13, P13, DOI 10.1108/01443579310025989; Bard JF, 2014, OPER RES HEALTH CARE, V3, P200, DOI 10.1016/j.orhc.2014.08.002; Carter M W, 2001, Health Care Manag Sci, V4, P347; dos Santos MAFRN, 2014, INT J HEALTH CARE Q, V27, P76, DOI 10.1108/IJHCQA-02-2012-0018; Eric R., 2011, LEAN STARTUP TODAYS; Franko OI, 2012, J MED SYST, V36, P3135, DOI 10.1007/s10916-011-9798-7; KNAUTH P, 1993, ERGONOMICS, V36, P15, DOI 10.1080/00140139308967850; Knauth P, 1996, APPL ERGON, V27, P39, DOI 10.1016/0003-6870(95)00044-5; Mosa AM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-67; Patel RK, 2015, ANN MED SURG, V4, P107, DOI 10.1016/j.amsu.2015.03.004; Payne KFB, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-121; Research2guidance, 6 GLOB MHEALTH APP D; Rudin RS, 2016, NEW ENGL J MED, V375, P815, DOI 10.1056/NEJMp1606884; Silva BMC, 2015, J BIOMED INFORM, V56, P265, DOI 10.1016/j.jbi.2015.06.003; Union IT, 2016, ICT FACTS FIG	17	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174127	10.1371/journal.pone.0174127	http://dx.doi.org/10.1371/journal.pone.0174127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328958	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700056
J	Pomati, F; Jokela, J; Castiglioni, S; Thomas, MK; Nizzetto, L				Pomati, Francesco; Jokela, Jukka; Castiglioni, Sara; Thomas, Mridul K.; Nizzetto, Luca			Water-borne pharmaceuticals reduce phenotypic diversity and response capacity of natural phytoplankton communities	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; WIDELY USED BIOCIDE; LIQUID-CHROMATOGRAPHY; MULTICLASS DETERMINATION; ORGANIC CONTAMINANTS; FUNCTIONAL DIVERSITY; FIELD-MEASUREMENTS; THERAPEUTIC DRUGS; MASS-SPECTROMETRY; TREATMENT PLANTS	Chemical micropollutants occur worldwide in the environment at low concentrations and in complex mixtures, and how they affect the ecology of natural systems is still uncertain. Dynamics of natural communities are driven by the interaction between individual organisms and their growth environment, which is mediated by the organisms' expressed phenotypic traits. We tested whether exposure to a mixture of 12 pharmaceuticals and personal care products (PPCP) influences phenotypic trait diversity in lake phytoplankton communities and their ability to regulate biomass production to fit environmental changes (response capacity). We exposed natural phytoplankton assemblages to three mixture levels in permeable microcosms maintained at three depths in a eutrophic lake for one week, during which the environmental conditions were fluctuating. We studied individual-level traits, phenotypic diversity and community biomass. PPCP reduced individual-level trait variance and overall community phenotypic diversity, but maintained higher standing phytoplankton biomass compared to untreated controls. Estimated effect sizes of PPCP on traits and community properties were very large (partial Eta-squared > 0.15). The PPCP mixture antagonistically interacted with the natural environmental gradient in habitats offered by different depths and, at concentrations comparable to those in waste-water effluents, prevented communities from converging to the same phenotypic structure and total biomass of unexposed controls. We show that micropollutants can alter individual-level trait diversity of lake phytoplankton communities and therefore their capacity to respond to natural environmental gradients, potentially affecting aquatic ecosystem processes.	[Pomati, Francesco; Thomas, Mridul K.] Eawag Swiss Fed Inst Water Sci & Technol, Dubendorf, Switzerland; [Pomati, Francesco; Jokela, Jukka] Swiss Fed Inst Technol, Inst Integrat Biol, Dubendorf, Switzerland; [Castiglioni, Sara] IRCCS, Ist Ric Farmacol Mario Negri, Milan, Italy; [Nizzetto, Luca] NIVA Norwegian Inst Water Res, Oslo, Norway; [Nizzetto, Luca] Masaryk Univ, RECETOX, Brno, Czech Republic	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Norwegian Institute for Water Research (NIVA); Masaryk University Brno	Pomati, F (corresponding author), Eawag Swiss Fed Inst Water Sci & Technol, Dubendorf, Switzerland.; Pomati, F (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Dubendorf, Switzerland.	francesco.pomati@eawag.ch	Nizzetto, Luca/AAC-4461-2021; Castiglioni, Sara/AAA-9189-2020; Nizzetto, Luca/B-6059-2019	Nizzetto, Luca/0000-0003-1400-657X; Castiglioni, Sara/0000-0002-7313-8495; Nizzetto, Luca/0000-0003-1400-657X; Thomas, Mridul/0000-0002-5089-5610; pomati, francesco/0000-0002-9746-3735	NIVA; Eawag through internal funds	NIVA; Eawag through internal funds	This study was supported by NIVA and Eawag through internal funds.; This study was supported by NIVA and Eawag through internal funds. The authors thank: D. Steiner for assistance in fieldwork; F. Hammes for support with bacterial flow- cytometry; O. Petchey for advice; B. Matthews, K. Fenner and J. Hering for commenting on the manuscript. FP, SC and LN dedicate this work to the memory of D. Calamari.	Arnold KE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0492; Backhaus T, 2004, ENVIRON SCI TECHNOL, V38, P6363, DOI 10.1021/es0497678; Backhaus T, 2011, ENVIRON TOXICOL CHEM, V30, P2030, DOI 10.1002/etc.586; Baert JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12486; Becks L, 2012, ECOL LETT, V15, P492, DOI 10.1111/j.1461-0248.2012.01763.x; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castiglioni S, 2006, ENVIRON SCI TECHNOL, V40, P357, DOI 10.1021/es050991m; Castiglioni S, 2005, J CHROMATOGR A, V1092, P206, DOI 10.1016/j.chroma.2005.07.012; Collins S, 2009, ECOL LETT, V12, P744, DOI 10.1111/j.1461-0248.2009.01340.x; De Laender F, 2014, ECOL LETT, V17, P72, DOI 10.1111/ele.12210; Dubelaar GBJ, 2004, J ENVIRON MONITOR, V6, P946, DOI 10.1039/b409350j; Fischer BB, 2013, SCI TOTAL ENVIRON, V449, P253, DOI 10.1016/j.scitotenv.2013.01.066; Foladori P, 2008, WATER RES, V42, P3757, DOI 10.1016/j.watres.2008.06.026; Gonzalez-Marino I, 2009, RAPID COMMUN MASS SP, V23, P1756, DOI 10.1002/rcm.4069; Gonzalez-Pleiter M, 2013, WATER RES, V47, P2050, DOI 10.1016/j.watres.2013.01.020; Gracia-Lor E, 2012, TALANTA, V99, P1011, DOI 10.1016/j.talanta.2012.07.091; Gracia-Lor E, 2011, J CHROMATOGR A, V1218, P2264, DOI 10.1016/j.chroma.2011.02.026; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Harris TD, 2016, INLAND WATERS, V6, P124, DOI 10.5268/IW-6.2.887; Kasprzyk-Hordern B, 2008, WATER RES, V42, P3498, DOI 10.1016/j.watres.2008.04.026; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lawrence JR, 2012, ENVIRON TOXICOL CHEM, V31, P508, DOI 10.1002/etc.1723; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Lopez-Serna R, 2011, CHEMOSPHERE, V85, P1390, DOI 10.1016/j.chemosphere.2011.07.071; Malaj E, 2014, P NATL ACAD SCI USA, V111, P9549, DOI 10.1073/pnas.1321082111; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; Moe SJ, 2013, ENVIRON TOXICOL CHEM, V32, P49, DOI 10.1002/etc.2045; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Negreira N, 2009, ANAL CHIM ACTA, V654, P162, DOI 10.1016/j.aca.2009.09.033; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Peters K, 2013, ENVIRON POLLUT, V180, P324, DOI 10.1016/j.envpol.2013.05.025; Pomati F, 2006, ENVIRON SCI TECHNOL, V40, P2442, DOI 10.1021/es051715a; Pomati F, 2008, TOXICOL SCI, V102, P129, DOI 10.1093/toxsci/kfm291; Pomati F, 2007, CHEMOSPHERE, V70, P65, DOI 10.1016/j.chemosphere.2007.07.048; Pomati F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071677; Pomati F, 2013, ECOTOXICOLOGY, V22, P779, DOI 10.1007/s10646-013-1068-7; R Development Core Team, 2014, R LANG ENV STAT COMP; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Richardson SD, 2014, ANAL CHEM, V86, P2813, DOI 10.1021/ac500508t; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodil R, 2008, ANAL CHEM, V80, P1307, DOI 10.1021/ac702240u; Rodil R, 2012, CHEMOSPHERE, V86, P1040, DOI 10.1016/j.chemosphere.2011.11.053; Rosi-Marshall EJ, 2013, ECOL APPL, V23, P583, DOI 10.1890/12-0491.1; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Savage VM, 2007, J THEOR BIOL, V247, P213, DOI 10.1016/j.jtbi.2007.03.007; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Tixier C, 2002, ENVIRON SCI TECHNOL, V36, P3482, DOI 10.1021/es025647t; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Violle C, 2012, TRENDS ECOLOGY EVOLU, V27; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wilson BA, 2003, ENVIRON SCI TECHNOL, V37, P1713, DOI 10.1021/es0259741; Wilson CJ, 2004, ENVIRON SCI TECHNOL, V38, P6430, DOI 10.1021/es049766f; Yang LH, 2008, ENVIRON TOXICOL CHEM, V27, P1201, DOI 10.1897/07-471.1; Zuccato E, 2000, LANCET, V355, P1789, DOI 10.1016/S0140-6736(00)02270-4; Zuccato E, 2005, J HAZARD MATER, V122, P205, DOI 10.1016/j.jhazmat.2005.03.001	63	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174207	10.1371/journal.pone.0174207	http://dx.doi.org/10.1371/journal.pone.0174207			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328933	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700069
J	de Guzman-Barrera, JR; Martinez, CS; Boronat-Catala, M; Montiel-Company, JM; Paredes-Gallardo, V; Gandia-Franco, JL; Almerich-Silla, JM; Bellot-Arcis, C				Rodriguez de Guzman-Barrera, Jorge; Saez Martinez, Carla; Boronat-Catala, Montserrat; Maria Montiel-Company, Jose; Paredes-Gallardo, Vanessa; Luis Gandia-Franco, Jose; Manuel Almerich-Silla, Jose; Bellot-Arcis, Carlos			Effectiveness of interceptive treatment of class III malocclusions with skeletal anchorage: A systematic review and meta-analysis	PLOS ONE			English	Review							MAXILLARY PROTRACTION; ORTHOPEDIC TREATMENT; FACE MASK	Recently, new strategies for treating class III malocclusions have appeared. Skeletal anchorage appears to reduce the dentoalveolar effects while maximising the orthopaedic effect in growing patients. The purpose of this systematic review and meta-analysis is to examine the effectiveness of bone anchorage devices for interceptive treatment of skeletal class III malocclusions. Searches were made in the Pubmed, Embase, Scopus and Cochrane databases, as well as in a grey literature database, and were complemented by hand-searching. The criteria for eligibility were: patients who had undergone orthodontic treatment with skeletal anchorage (miniplates and miniscrews). Patients with syndromes or craniofacial deformities or who had undergone maxillofacial surgery were excluded. The following variables were recorded for each article: author, year of publication, type of study, sample size, dropouts, demographic variables, treatment carried out, radiographic study (2D or 3D), follow-up time, and quality of the articles on the Newcastle-Ottawa Scale. The means and confidence intervals of the following variables were employed: Wits, overjet, ANB, SNA and SNB. Initially, 239 articles were identified. After removing the duplicates and applying the selection criteria, 9 were included in the qualitative synthesis and 7 in the quantitative synthesis (meta-analysis). It may be concluded that skeletal anchorage is an effective treatment for improving skeletal Class III malocclusion, but when compared with other traditional treatments such as disjunction and face mask, there is no clear evidence that skeletal anchorage improves the results.	[Rodriguez de Guzman-Barrera, Jorge; Saez Martinez, Carla; Boronat-Catala, Montserrat] Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia, Spain; [Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Fac Med & Dent, Dept Stomatol, Prevent Dent Teaching Unit, Valencia, Spain; [Paredes-Gallardo, Vanessa; Luis Gandia-Franco, Jose; Bellot-Arcis, Carlos] Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia	Bellot-Arcis, C (corresponding author), Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain.	bellot.arcis@gmail.com	Montiel-Company, José María/S-1836-2018; Paredes, Vanessa/AAA-4540-2019; BELLOT-ARCIS, CARLOS/AGP-0731-2022	Montiel-Company, José María/0000-0002-3952-7681; Paredes, Vanessa/0000-0002-4137-5808; BELLOT-ARCIS, CARLOS/0000-0003-4363-2713				Baccetti T, 2011, EUR J ORTHODONT, V33, P121, DOI 10.1093/ejo/cjq170; Barrett AAF, 2010, AM J ORTHOD DENTOFAC, V138, P468, DOI 10.1016/j.ajodo.2008.12.024; Cevidanes L, 2010, ANGLE ORTHOD, V80, P799, DOI 10.2319/111709-651.1; Cha BK., 2011, SEMIN ORTHOD, V17, P124, DOI [10.1053/j.sodo.2010.12.005, DOI 10.1053/J.S0D0.2010.12.005]; Cornelis MA, 2008, AM J ORTHOD DENTOFAC, V133, DOI 10.1016/j.ajodo.2006.09.049; Coscia G, 2012, J CRANIO MAXILL SURG, V40, pE350, DOI 10.1016/j.jcms.2012.01.019; De Clerck EEB, 2011, ANGLE ORTHOD, V81, P1010, DOI 10.2319/012311-47.1; De Toffol L, 2008, ANGLE ORTHOD, V78, P561, DOI 10.2319/030207-108.1; Delaire J, 1971, Trans Eur Orthod Soc, P81; ELLIS E, 1984, AM J ORTHOD DENTOFAC, V86, P277, DOI 10.1016/0002-9416(84)90138-6; Feng XX, 2012, ANGLE ORTHOD, V82, P1107, DOI 10.2319/111411-705.1; Ge YS, 2012, ANGLE ORTHOD, V82, P1083, DOI 10.2319/012912-76.1; Hardy DK., 2012, OPEN J EPIDEMIOL, V2, P75, DOI [10.4236/ojepi.2012.24012, DOI 10.4236/OJEPI.2012.24012]; Hino CT, 2013, AM J ORTHOD DENTOFAC, V144, P705, DOI 10.1016/j.ajodo.2013.07.011; Jamilian A, 2016, J ORTHOD, V43, P102, DOI 10.1080/14653125.2016.1155334; Kaya D, 2011, ANGLE ORTHOD, V81, P639, DOI 10.2319/081010-473.1; Koh SD, 2014, ANGLE ORTHOD, V84, P628, DOI 10.2319/060313-421.1; KOKICH VG, 1985, AM J ORTHOD DENTOFAC, V88, P303, DOI 10.1016/0002-9416(85)90129-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee NK, 2012, ANGLE ORTHOD, V82, P846, DOI 10.2319/090811-584.1; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ludwig Bjorn, 2010, J Clin Orthod, V44, P533; Nguyen T, 2011, AM J ORTHOD DENTOFAC, V140, P790, DOI 10.1016/j.ajodo.2011.04.025; Nienkemper M, 2015, ANGLE ORTHOD, V85, P764, DOI 10.2319/071614-497.1; Proffit WR., 2007, CONT ORTHODONTICS, P689; Sahin T, 2016, INT ORTHOD, V14, P263, DOI 10.1016/j.ortho.2016.07.004; Sar C, 2014, AM J ORTHOD DENTOFAC, V145, P41, DOI 10.1016/j.ajodo.2013.09.009; Wells G., 2014, S SYST REV BAS; Wilmes B, 2014, J ORTHOD, V41, pS47, DOI 10.1179/1465313314Y.0000000107; Yang XR, 2014, AM J ORTHOD DENTOFAC, V146, P143, DOI 10.1016/j.ajodo.2014.04.017	30	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173875	10.1371/journal.pone.0173875	http://dx.doi.org/10.1371/journal.pone.0173875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328995	Green Published, gold			2022-12-27	WOS:000399094700035
J	Ying, JZ; Zhao, J; Hou, YX; Wang, YF; Qiu, JH; Li, ZY; Tong, XH; Shi, ZM; Zhu, J; Zhang, J				Ying, Jiezheng; Zhao, Juan; Hou, Yuxuan; Wang, Yifeng; Qiu, Jiehua; Li, Zhiyong; Tong, Xiaohong; Shi, Zhaomei; Zhu, Jun; Zhang, Jian			Mapping the N-linked glycosites of rice (Oryza sativa L.) germinating embryos	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SEED-GERMINATION; ARABIDOPSIS-THALIANA; PROTEIN-PHOSPHORYLATION; INTERACTION NETWORKS; GLUCOSIDASE-I; GLYCOSYLATION; GLYCOPROTEOME; GENE; EXPRESSION	Germination is a key event in the angiosperm life cycle. N-glycosylation of proteins is one of the most common post-translational modifications, and has been recognized to be an important regulator of the proteome of the germinating embryo. Here, we report the first N-linked glycosites mapping of rice embryos during germination by using a hydrophilic interaction chromatography (HILIC) glycopeptides enrichment strategy associated with high accuracy mass spectrometry identification. A total of 242 glycosites from 191 unique proteins was discovered. Inspection of the motifs and sequence structures involved suggested that all the glycosites were concentrated within [NxS/T] motif, while 82.3% of them were in a coil structure. N-glycosylation preferentially occurred on proteins with glycoside hydrolase activities, which were significantly enriched in the starch and sucrose metabolism pathway, suggesting that N-glycosylation is involved in embryo germination by regulating carbohydrate metabolism. Notably, protein-protein interaction analysis revealed a network with several Brassinosteroids signaling proteins, including XIAO and other BR-responsive proteins, implying that glycosylation-mediated Brassinosteroids signaling may be a key mechanism regulating rice embryo germination. In summary, this study expanded our knowledge of protein glycosylation in rice, and provided novel insight into the PTM regulation in rice seed germination.	[Ying, Jiezheng; Zhao, Juan; Hou, Yuxuan; Wang, Yifeng; Qiu, Jiehua; Li, Zhiyong; Tong, Xiaohong; Zhang, Jian] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Shi, Zhaomei; Zhu, Jun] Jingjie PTM Biolabs, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Zhang, J (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	zhangjian@caas.cn	Wang, Yifeng/J-6999-2019	Wang, Yifeng/0000-0002-5187-3755; Zhang, Jian/0000-0003-2804-0162; Zhiyong, Li/0000-0002-1309-7732; Qiu, Jiehua/0000-0002-6990-7247	Agricultural Sciences and Technologies Innovation Program of Chinese Academy of Agricultural Sciences (CAAS) [2016ZX08001-004]; National Natural Science Foundation of China [31401366, 31371605]; Jingjie PTM-Biolabs	Agricultural Sciences and Technologies Innovation Program of Chinese Academy of Agricultural Sciences (CAAS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jingjie PTM-Biolabs	This work was supported by Agricultural Sciences and Technologies Innovation Program of Chinese Academy of Agricultural Sciences (CAAS) to Rice Reproductive Developmental Biology Group, Chinese High-yielding Transgenic Program (No. 2016ZX08001-004) and National Natural Science Foundation of China (grant number: 31401366 and 31371605). Jingjie PTM-Biolabs provided support in the form of salaries for authors [SZ and JZhu], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. We thank Dr. Qin Liu for assistance in bioinformatics analysis.r This work was supported by Agricultural Sciences and Technologies Innovation Program of Chinese Academy of Agricultural Sciences (CAAS) to Rice Reproductive Developmental Biology Group, Chinese High-yielding Transgenic Program (No. 2016ZX08001-004) and National Natural Science Foundation of China (grant number: 31401366 and 31371605). Jingjie PTM-Biolabs provided support in the form of salaries for authors [ZS and JZhu], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn YH, 2015, MASS SPECTROM REV, V34, P148, DOI 10.1002/mas.21428; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Baker MR, 2016, J PROTEOME RES; Barba-Espin G, 2014, PLANT PHYSIOL, V164, P951, DOI 10.1104/pp.113.233163; Berger S, 1996, PLANT PHYSIOL, V112, P259, DOI 10.1104/pp.112.1.259; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Dam S, 2013, J PROTEOME RES, V12, P3383, DOI 10.1021/pr400224s; Dedvisitsakul P, 2014, J PROTEOME RES, V13, P2696, DOI 10.1021/pr401282r; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Furumizu C, 2008, FEBS LETT, V582, P2237, DOI 10.1016/j.febslet.2008.05.019; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; Han C, 2014, PLANT CELL PHYSIOL, V55, P1376, DOI 10.1093/pcp/pcu060; Han C, 2014, J PROTEOME RES, V13, P1766, DOI 10.1021/pr401295c; He DL, 2016, J PROTEOME RES, V15, P879, DOI 10.1021/acs.jproteome.5b00805; He DL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00246; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Hu YR, 2014, PLANT CELL, V26, P4394, DOI 10.1105/tpc.114.130849; Jiang YH, 2012, PLANT J, V70, P398, DOI 10.1111/j.1365-313X.2011.04877.x; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kumar S, 2013, MOL CELL PROTEOMICS, V12, P3677, DOI 10.1074/mcp.M113.030726; Lannoo N, 2015, PLANT SCI, V239, P67, DOI 10.1016/j.plantsci.2015.06.023; Le Roy K, 2007, NEW PHYTOL, V176, P317, DOI 10.1111/j.1469-8137.2007.02174.x; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Li D, 2009, PLANT BIOTECHNOL J, V7, P791, DOI 10.1111/j.1467-7652.2009.00444.x; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075826; Liu SJ, 2016, J PLANT PHYSIOL, V196-197, P79, DOI 10.1016/j.jplph.2016.02.021; Matsukura C, 2000, PLANT PHYSIOL, V124, P85, DOI 10.1104/pp.124.1.85; Melo-Braga MN, 2012, MOL CELL PROTEOMICS, V11, P945, DOI 10.1074/mcp.M112.020214; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Ruiz-May E, 2014, MOL CELL PROTEOMICS, V13, P566, DOI 10.1074/mcp.M113.028969; Shandala T, 2011, ELS; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Silva-Sanchez C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00063; Song DH, 2008, MOL BIOL REP, V35, P275, DOI 10.1007/s11033-007-9080-8; Song W, 2013, J PROTEOMICS, V93, P343, DOI 10.1016/j.jprot.2013.07.032; Strasser R., 2016, GLYCOBIOLOGY; Strasser R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00363; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takano S, 2015, PLANT SCI, V236, P75, DOI 10.1016/j.plantsci.2015.03.022; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; von Numers N, 2010, MOL PLANT, V3, P740, DOI 10.1093/mp/ssq017; Vuylsteker C, 2000, J EXP BOT, V51, P839, DOI 10.1093/jexbot/51.346.839; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang Q, 2015, MOLECULES, V20, P13689, DOI 10.3390/molecules200813689; Wiederschain GY, 2013, BIOCHEMISTRY-MOSCOW+, V78, P679, DOI 10.1134/S0006297913070018; Xiao C, 2014, PLANT CELL, V26, P1018, DOI 10.1105/tpc.114.123968; Xu SL, 2016, MOL CELL PROTEOMICS; Zhang J, 2007, PLANT J, V49, P947, DOI 10.1111/j.1365-313X.2006.03001.x; Zhang M, 2015, J PROTEOME RES, V14, P1727, DOI 10.1021/pr501080r; Zhu J, 2014, J PROTEOME RES, V13, P1713, DOI 10.1021/pr401200h; Zhu J, 2012, ANAL CHEM, V84, P5146, DOI 10.1021/ac3000732; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	62	12	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173853	10.1371/journal.pone.0173853	http://dx.doi.org/10.1371/journal.pone.0173853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328971	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700032
J	Francioli, C; Wang, XY; Parapanov, R; Abdelnour, E; Lugrin, J; Gronchi, F; Perentes, J; Eckert, P; Ris, HB; Piquilloud, L; Krueger, T; Liaudet, L				Francioli, Cyril; Wang, Xingyu; Parapanov, Roumen; Abdelnour, Etienne; Lugrin, Jerome; Gronchi, Fabrizio; Perentes, Jean; Eckert, Philippe; Ris, Hans-Beat; Piquilloud, Lise; Krueger, Thorsten; Liaudet, Lucas			Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia	PLOS ONE			English	Article							FACTOR-KAPPA-B; PRIMARY GRAFT DYSFUNCTION; ALVEOLAR EPITHELIAL-CELLS; REPERFUSION INJURY; CIRCULATORY DEATH; OXIDATIVE STRESS; IN-VIVO; TRANSPLANTATION; INTERLEUKIN-6; ACTIVATION	Damaged lung grafts obtained after circulatory death (DCD lungs) and warm ischemia may be at high risk of reperfusion injury after transplantation. Such lungs could be pharmacologically reconditioned using ex-vivo lung perfusion (EVLP). Since acute inflammation related to the activation of nuclear factor kappaB (NF-kappa B) is instrumental in lung reperfusion injury, we hypothesized that DCD lungs might be treated during EVLP by pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-kappa B. Rat lungs exposed to 1h warm ischemia and 2 h cold ischemia were subjected to EVLP during 4h, in absence (CTRL group, N = 6) or in presence of PDTC (2.5g/L, PDTC group, N = 6). Static pulmonary compliance (SPC), peak airway pressure (PAWP), pulmonary vascular resistance (PVR), and oxygenation capacity were determined during EVLP. After EVLP, we measured the weight gain of the heart-lung block (edema), and the concentration of LDH (cell damage), proteins (permeability edema) and of the cytokines IL-6, TNF-alpha and CINC-1 in bronchoalveolar lavage (BAL), and we evaluated NF-kappa B activation by the degree of phosphorylation and degradation of its inhibitor I.Ba in lung tissue. In CTRL, we found significant NF-kappa B activation, lung edema, and a massive release of LDH, proteins and cytokines. SPC significantly decreased, PAWP and PVR increased, while oxygenation tended to decrease. Treatment with PDTC during EVLP inhibited NF-kappa B activation, did not influence LDH release, but markedly reduced lung edema and protein concentration in BAL, suppressed TNF alpha and IL-6 release, and abrogated the changes in SPC, PAWP and PVR, with unchanged oxygenation. In conclusion, suppression of innate immune activation during EVLP using the NF-kappa B inhibitor PDTC promotes significant improvement of damaged rat DCD lungs. Future studies will determine if such rehabilitated lungs are suitable for in vivo transplantation.	[Francioli, Cyril; Wang, Xingyu; Parapanov, Roumen; Abdelnour, Etienne; Perentes, Jean; Ris, Hans-Beat; Krueger, Thorsten] Univ Hosp Med Ctr, Serv Thorac Surg, Lausanne, Switzerland; [Francioli, Cyril; Wang, Xingyu; Parapanov, Roumen; Abdelnour, Etienne; Lugrin, Jerome; Gronchi, Fabrizio; Perentes, Jean; Eckert, Philippe; Ris, Hans-Beat; Piquilloud, Lise; Krueger, Thorsten; Liaudet, Lucas] Fac Biol & Med, Lausanne, Switzerland; [Parapanov, Roumen; Lugrin, Jerome; Eckert, Philippe; Piquilloud, Lise; Liaudet, Lucas] Univ Hosp Med Ctr, Serv Adult Intens Care Med, Lausanne, Switzerland; [Gronchi, Fabrizio] Univ Lausanne Hosp, Med Ctr, Anesthesiol Serv, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Liaudet, L (corresponding author), Fac Biol & Med, Lausanne, Switzerland.; Liaudet, L (corresponding author), Univ Hosp Med Ctr, Serv Adult Intens Care Med, Lausanne, Switzerland.	lucas.liaudet@chuv.ch	Lugrin, Jérôme/N-8772-2019; Piquilloud, Lise/ABC-4402-2021; Krueger, Thorsten/AAK-1780-2021	Lugrin, Jérôme/0000-0002-1178-2752; Parapanov, Roumen/0000-0001-8101-7813; Perentes, Jean/0000-0001-7918-0793	Swiss National Foundation for Scientific Research [310030_162629/1]; Service of Thoracic Surgery and Service of Intensive Care Medicine at Lausanne University Hospital Medical Center	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Service of Thoracic Surgery and Service of Intensive Care Medicine at Lausanne University Hospital Medical Center	This work was supported by: 1) A grant from the Swiss National Foundation for Scientific Research (Nr 310030_162629/1 to L.L.) (URL: www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2) A grant from the Loterie Romande (to HBR and TK) (URL: https://www.loro.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3) Departmental funds from the Service of Thoracic Surgery and Service of Intensive Care Medicine at Lausanne University Hospital Medical Center.	Altemeier WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077123; Andreasson AS, 2017, EUR J CARDIOTHORAC S; Chaney J, 2014, J THORAC DIS, V6, P1032, DOI 10.3978/j.issn.2072-1439.2014.03.24; Cypel M, 2016, CURR OPIN ORGAN TRAN, V21, P329, DOI 10.1097/MOT.0000000000000320; Cypel M, 2015, J HEART LUNG TRANSPL, V34, P1278, DOI 10.1016/j.healun.2015.08.015; Cypel M, 2015, THORAC SURG CLIN, V25, P27, DOI 10.1016/j.thorsurg.2014.09.002; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; den Hengst WA, 2010, AM J PHYSIOL-HEART C, V299, pH1283, DOI 10.1152/ajpheart.00251.2010; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; Diamond JM, 2013, CURR OPIN ORGAN TRAN, V18, P518, DOI 10.1097/MOT.0b013e3283651994; Erasmus ME, 2016, TRANSPL INT, V29, P790, DOI 10.1111/tri.12738; Farkas D, 2014, AM J RESP CELL MOL, V51, P413, DOI 10.1165/rcmb.2013-0355OC; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Gurkan OU, 2011, EXP LUNG RES, V37, P575, DOI 10.3109/01902148.2011.620680; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Latanich CA, 2009, J INVEST SURG, V22, P301, DOI 10.1080/08941930903040155; Liaudet L, 2002, ANN SURG, V235, P568, DOI 10.1097/00000658-200204000-00016; Liaudet Lucas, 2013, Front Biosci (Schol Ed), V5, P86; Liu SF, 1997, J IMMUNOL, V159, P3976; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Lugrin J, 2014, BIOL CHEM, V395, P203, DOI 10.1515/hsz-2013-0241; Machuca TN, 2015, AM J TRANSPLANT, V15, P993, DOI 10.1111/ajt.13124; Moreno I, 2007, TRANSPL P, V39, P2425, DOI 10.1016/j.transproceed.2007.07.056; Moreno I, 2008, TRANSPL P, V40, P3082, DOI 10.1016/j.transproceed.2008.08.124; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Perlman CE, 2011, AM J RESP CELL MOL, V44, P34, DOI 10.1165/rcmb.2009-0005OC; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232; Punch JD, 2007, AM J TRANSPLANT, V7, P1327, DOI 10.1111/j.1600-6143.2007.01779.x; Reeb J, 2015, CURR OPIN ORGAN TRAN, V20, P498, DOI 10.1097/MOT.0000000000000233; Ross SD, 2000, AM J PHYSIOL-LUNG C, V279, pL528, DOI 10.1152/ajplung.2000.279.3.L528; Sadaria MR, 2011, ANN THORAC SURG, V92, P478, DOI 10.1016/j.athoracsur.2011.04.027; Sawant DA, 2014, J PHYSIOL BIOCHEM, V70, P971, DOI 10.1007/s13105-014-0366-8; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shen H, 2013, J IMMUNOL, V191, P2857, DOI 10.4049/jimmunol.1301539; Steen S, 2003, ANN THORAC SURG, V76, P244, DOI 10.1016/S0003-4975(03)00191-7; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Stone ML, 2015, TRANSPLANTATION, V99, P2494, DOI 10.1097/TP.0000000000000830; Suter D, 2007, ANESTH ANALG, V104, P638, DOI 10.1213/01.ane.0000255046.06058.58; Teixeira RHOB, 2010, TRANSPL P, V42, P531, DOI 10.1016/j.transproceed.2010.01.033; Wang XY, 2016, TRANSPLANTATION, V100, P1465, DOI 10.1097/TP.0000000000001183; Yeung JC, 2012, J HEART LUNG TRANSPL, V31, P1120, DOI 10.1016/j.healun.2012.08.016	48	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e017391	10.1371/journal.pone.0173916	http://dx.doi.org/10.1371/journal.pone.0173916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323904	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000043
J	Hong, R; Ahn, PY; Wieringa, F; Rathavy, T; Gauthier, L; Hong, R; Laillou, A; Van Geystelen, J; Berger, J; Poirot, E				Hong, Rathmony; Ahn, Pauline Yongeun; Wieringa, Frank; Rathavy, Tung; Gauthier, Ludovic; Hong, Rathavuth; Laillou, Arnaud; Van Geystelen, Judit; Berger, Jacques; Poirot, Etienne			The unfinished health agenda: Neonatal mortality in Cambodia	PLOS ONE			English	Article								Background Reduction of neonatal and under-five mortality rates remains a primary target in the achievement of universal health goals, as evident in renewed investments of Sustainable Development Goals. Various studies attribute declines in mortality to the combined effects of improvements in health care practices and changes in socio-economic factors. Since the early nineties, Cambodia has managed to evolve from a country devastated by war to a nation soon to enter the group of middle income countries. Cambodia's development efforts are reflected in some remarkable health outcomes such as a significant decline in child mortality rates and the early achievement of related Millennium Development Goals. An achievement acknowledged through the inclusion of Cambodia as one of the ten fast-track countries in the Partnership for Maternal, Newborn and Child Health. This study aims to highlight findings from the field so to provide evidence for future programming and policy efforts. It will be argued that to foster further advances in health, Cambodia will need to keep neonatal survival and health high on the agenda and tackle exacerbating inequities that arise from a pluralistic health system with considerable regional differences and socio-economic disparities. Methods/Findings Data was drawn from Demographic Health Surveys (2000, 2005, 2010, 2014). Information on a series of demographic and socio-economic household characteristics and on child anthropometry, feeding practices and child health were collected from nationally representative samples. To reach the required sample size, live-births that occurred over the past 10 years before the date of the interview were included. Demographic variables included: gender of the child, living area (urban or rural; four ecological regions (constructed by merging provinces and the capital), mother's age at birth (<20, 20-35, 35+), birth interval (long, short) and birth order (1st, 2-3, 4-6, 7+). Socio-economic variables included: mother education level (none, primary, secondary+) and household wealth (asset-based index). Data on antenatal care, tetanus injection and skilled assistance at birth were used for the mother's last child. Between 2000 and 2014, Cambodia achieved a considerable reduction in neonatal mortality (46% reduction rate). By 2014, gender inequities became almost non-existent (for all measures of equality); inequity related to mother's education decreased for all time periods; improvements were observed for differences in neonatal mortality by preceding birth interval; and a reduction in neonatal mortality rates could be noted among all the regional subgroups. Inequities increased between mothers who had limited antenatal care and those who received more than four antenatal care visits. In most scale indicators, the Slope Index of Inequality and Relative Index of Inequality estimates for all four rounds of the survey suggest inequity exacerbated in deprived communities. Also, wealth and residence (urban/rural divide) continued to be major determinants in neonatal mortality rates and related inequity trends. Conclusion Analysis highlighted some of the complex patterns and determinants of neonatal mortality, in Cambodia. There has been a considerable decline in neonatal mortality which echoes global trends. Our analysis reveals that despite these advances, additional socio-economic and demographic characteristics considerably affected neonatal mortality rates and its inequities. There continue to be pockets of vulnerable groups that are lagging behind. This analysis highlights the determinants along the urban-rural and rich-poor divides in neonatal mortality inequities and how these affect access to and utilization of quality basic health services. This calls for future policy and programming efforts to be deliberate in their equity approach. Quality improvements in health services and targeted interventions for specific socio-economic groups will be required to further accelerate progress in reducing neonatal mortality and address Cambodia's pressing unfinished agenda in health.	[Hong, Rathmony; Ahn, Pauline Yongeun; Laillou, Arnaud; Poirot, Etienne] UNICEF, Child Survival & Dev Sect, Phnom Penh, Cambodia; [Ahn, Pauline Yongeun] KOICA Cambodia, Multilateral Cooperat, Phnom Penh, Cambodia; [Wieringa, Frank; Gauthier, Ludovic; Berger, Jacques] Inst Rech Dev, JRU Nutripass IRD SupAgro UM, Montpellier, France; [Rathavy, Tung] Minist Hlth, Maternal Newborn Child Hlth Ctr, Phnom Penh, Cambodia; [Hong, Rathavuth] ICF, Int Hlth & Dev, Rockville, MD USA	Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Hong, R (corresponding author), UNICEF, Child Survival & Dev Sect, Phnom Penh, Cambodia.	rhong@unicef.org	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X; Berger, Jacques/0000-0003-4455-6847	UNICEF Cambodia; Ministry of Health of Cambodia; Korea International Cooperation Agency (KOICA); UNICEF National committee (South Korea); UNICEF National committee (Australia); UNICEF National committee (Canada); UNICEF National committee (Denmark); UNICEF National committee (Hong Kong); ICF International	UNICEF Cambodia; Ministry of Health of Cambodia; Korea International Cooperation Agency (KOICA); UNICEF National committee (South Korea); UNICEF National committee (Australia); UNICEF National committee (Canada); UNICEF National committee (Denmark); UNICEF National committee (Hong Kong); ICF International	This work was funded by UNICEF Cambodia, the Ministry of Health of Cambodia, Korea International Cooperation Agency (KOICA) and UNICEF National committees (South Korea, Australia, Canada, Denmark and Hong Kong). ICF International provided support in the form of salary for author Rathavuth Hong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Chen XK, 2007, AUST NZ J OBSTET GYN, V47, P122, DOI 10.1111/j.1479-828X.2007.00697.x; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Department of Planning and Health Information, 2016, CAMB HLTH MAN SYST L; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; National Institute of Public Health National Institute if Statistics ORC Macro Calverton, 2006, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health and ORC Macro, 2014, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health ORC Macro, 2001, CAMB DEM HLTH SURV 2; National Institute of Statistics Ministry of Planning Directory General of Health MEASURE DHS ICF Macro Calverton, 2011, CAMB DEM HLTH SURV 2; PMNCH WHO World Bank AHPSR, 2014, SUCC FACT WOM CHILDR; Royal Government of Cambodia, 2000, SUBD CIV STAT CIV RE; Sam Harper, 2010, IMPLICIT VALUE JUDGM; UN Inter-agency group for child mortality estimation, 2015, LEV TRENDS CHILD MOR; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	20	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173763	10.1371/journal.pone.0173763	http://dx.doi.org/10.1371/journal.pone.0173763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323854	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000030
J	Ren, QQ; He, M; Zeng, YH; Liu, ZY; Liu, H; Xu, JG				Ren, Qingqing; He, Min; Zeng, Yunhui; Liu, Zhiyong; Liu, Hao; Xu, Jianguo			Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients	PLOS ONE			English	Article							VASCULAR MALFORMATIONS; GRADING SYSTEM; SELECTING PATIENTS; NATURAL-HISTORY; OLMSTED COUNTY; RISK-FACTORS; BRAIN; HEMORRHAGE; MANAGEMENT; ARUBA	Background The management of intracranial arteriovenous malformations(AVMs) poses challenges to the cerebrovascular specialists. Objective To review the long-term outcomes of intracranial AVMs treated with microsurgical resections. Methods We performed a retrospective review of 445 patients with intracranial AVMs treated in our hospital from January 1 st, 2008 to December 31 st, 2014. The extracted data included demographic characteristics, clinical presentations, Spetzler-Martin (SM) grades, Supplemented Spetzler-Martin (SM-Supp) Grades, treatment modalities, long-term outcomes, and obliteration rates. Outcome was assessed with a post-operative modified Rankin Scale (mRS) score at the last follow-up visit. Results Of the 445 patients treated with microsurgery, 298 (67.0%) patients initially presented with hemorrhage. Based on the SM grading system, the patients were graded as follows: 83 (18.6%) Grade I, 156(35.1%) Grade II, 132(29.7%) Grade III, 61(13.7%) Grade IV and 13 (2.9%) Grade V. Overall, 344(77.3%) patients had a favorable outcome (mRS score of 0-2). The favorable outcome for Grade I and II were 92.8% and 85.9%, respectively, sharply reducing to 52.5% in patients with Grade IV and 15.4% in patients with Grade V AVMs. 388 (87.2%) patients achieved complete obliteration of the AVMs. 63(14.2%) patients experienced recurrent hemorrhage, and the frequency of rehemorrhage was highest in Grade V patients (77.0%), dropping to 3.6% and 3.8% in patients with Grade I and II lesions, respectively. Permanent neurological deficits occurred in 66(14.8%) patients and death in 35 7.9%) patients. There was no difference of AUROC values between SM grading system and SM-supp grading system (0.726 and 0.734, respectively, p =.715). Conclusion The Spetzler-Martin grading system is a simple and effective method to estimate the risk of surgery and to evaluate the prognosis. Microsurgical resection for AVMs depends on the SM grades, and the morbidity-mortality rate increases with an increasing SM grade.	[Ren, Qingqing; He, Min; Zeng, Yunhui; Liu, Zhiyong; Liu, Hao; Xu, Jianguo] Sichuan Univ, West China Med Sch, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China	Sichuan University	Xu, JG (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.	jgx_2015@163.com						Abecassis IJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS14250; Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9; Al-Shahi R, 2001, BRAIN, V124, P1900, DOI 10.1093/brain/124.10.1900; Bendok BR, 2014, NEUROSURGERY, V74, pS60, DOI 10.1227/NEU.0000000000000230; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; Brown RD, 1996, J NEUROSURG, V85, P29, DOI 10.3171/jns.1996.85.1.0029; Brown RD, 2000, NEUROSURGERY, V46, P1024, DOI 10.1097/00006123-200004000-00055; Brown RD, 1996, NEUROLOGY, V46, P949, DOI 10.1212/WNL.46.4.949; Castel JP, 2001, NEUROCHIRURGIE, V47, P369; da Costa L, 2009, STROKE, V40, P100, DOI 10.1161/STROKEAHA.108.524678; Darsaut TE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1019-0; Davies JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.5.FOCUS12107; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Gabriel RA, 2010, STROKE, V41, P21, DOI 10.1161/STROKEAHA.109.566018; GRAF CJ, 1983, J NEUROSURG, V58, P331, DOI 10.3171/jns.1983.58.3.0331; Grasso G, 2014, WORLD NEUROSURG, V82, pE576, DOI 10.1016/j.wneu.2014.04.057; Gross BA, 2014, LANCET, V383, P1635, DOI 10.1016/S0140-6736(14)60785-6; Gross BA, 2013, J NEUROSURG, V118, P437, DOI 10.3171/2012.10.JNS121280; HAMILTON MG, 1994, NEUROSURGERY, V34, P2; Hartmann A, 1998, STROKE, V29, P931, DOI 10.1161/01.STR.29.5.931; Hartmann A, 2005, STROKE, V36, P2431, DOI 10.1161/01.STR.0000185723.98111.75; Hartmann A, 2000, STROKE, V31, P2361, DOI 10.1161/01.STR.31.10.2361; HEROS RC, 1990, NEUROSURGERY, V26, P570, DOI 10.1227/00006123-199004000-00003; Hillman J, 2001, J NEUROSURG, V95, P633, DOI 10.3171/jns.2001.95.4.0633; HOLLERHAGE HG, 1990, NEUROCHIRURGIA, V33, P59; HOLLERHAGE HG, 1992, ACTA NEUROCHIR, V117, P129, DOI 10.1007/BF01400609; JESSURUN GAJ, 1993, CLIN NEUROL NEUROSUR, V95, P193, DOI 10.1016/0303-8467(93)90123-X; Kim H, 2007, STROKE, V38, P2430, DOI 10.1161/STROKEAHA.107.485573; Kim H, 2015, NEUROSURGERY, V76, P25, DOI 10.1227/NEU.0000000000000556; Kim H, 2012, STROKE, V43, P2497, DOI 10.1161/STROKEAHA.112.661942; Langer DJ, 1998, NEUROSURGERY, V42, P481, DOI 10.1097/00006123-199803000-00008; Lawton MT, 2014, LANCET, V383, P1634, DOI 10.1016/S0140-6736(14)60783-2; Lawton MT, 2010, NEUROSURGERY, V66, P702, DOI 10.1227/01.NEU.0000367555.16733.E1; Lawton MT, 2005, NEUROSURGERY, V56, P485, DOI 10.1227/01.NEU.0000153924.67360.EA; Luessenhop A J, 1977, Neurosurgery, V1, P30; Magro E, 2016, NEURO CHIRURG; MALIK GM, 1994, NEW TRENDS IN MANAGEMENT OF CEREBRO-VASCULAR MALFORMATIONS, P328; MAST H, 1995, STROKE, V26, P1215, DOI 10.1161/01.STR.26.7.1215; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Nerva JD, 2015, NEUROSURGERY, V76, P563, DOI 10.1227/NEU.0000000000000663; Ogilvy CS, 2001, CIRCULATION, V103, P2644; PASQUALIN A, 1991, NEUROSURGERY, V28, P370, DOI 10.1227/00006123-199103000-00006; Pellettieri L, 1979, Acta Neurochir Suppl (Wien), V29, P1; PERRET G, 1966, J NEUROSURG, V25, P467, DOI 10.3171/jns.1966.25.4.0467; PERTUISET B, 1991, ACTA NEUROCHIR, V110, P6, DOI 10.1007/BF01402041; Peschillo S, 2014, THESCIENTIFICWORLDJO, V2014; Plasencia Andres R, 2012, Surg Neurol Int, V3, pS90, DOI 10.4103/2152-7806.95420; Ross J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003436.pub3; Rubin BA, 2014, NEUROSURGERY, V74, pS50, DOI 10.1227/NEU.0000000000000219; Ruiz-Sandoval JL, 1999, STROKE, V30, P537, DOI 10.1161/01.STR.30.3.537; Russin J, 2014, NEUROSURGERY, V75, pE96, DOI 10.1227/NEU.0000000000000357; Salman RAS, 2014, LANCET, V383, P1633, DOI 10.1016/S0140-6736(14)60782-0; Serrone Joseph, 2014, Methodist Debakey Cardiovasc J, V10, P240, DOI 10.14797/mdcj-10-4-240; SHI YQ, 1986, J NEUROSURG, V65, P484, DOI 10.3171/jns.1986.65.4.0484; Speizler RF, 1986, J NEUROSURG, V108, P186, DOI [10.3171/JNS/2008/108/01/0186, DOI 10.3171/JNS/2008/108/01/0186]; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Spetzler RF, 2011, J NEUROSURG, V114, P842, DOI 10.3171/2010.8.JNS10663; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Stapf C, 2003, STROKE, V34, pE29, DOI 10.1161/01.STR.0000068784.36838.19; Starke RM, 2014, WORLD NEUROSURG, V82, pE668, DOI 10.1016/j.wneu.2014.07.001; STEINMEIER R, 1989, NEUROSURGERY, V24, P193, DOI 10.1227/00006123-198902000-00007; TAMAKI N, 1991, NEUROSURGERY, V29, P856, DOI 10.1227/00006123-199112000-00009; Theofanis T, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14160; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Virchow R., 1856, HDB SPECIELLEN PATHO; von LH, 1855, ADERGEFLECHTE MENSCH; Warlow C, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60781-9; Weisscher N, 2008, J NEUROL, V255, P867, DOI 10.1007/s00415-008-0796-8; Yamada S, 2007, J NEUROSURG, V107, P965, DOI 10.3171/JNS-07/11/0965; Yasargil MG, 1987, MICRONEUROSURGERY3A; Zhao JZ, 2005, SURG NEUROL, V63, P156, DOI 10.1016/j.surneu.2004.04.021; 1999, NEW ENGLAND J MED, V340, P1812	73	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174325	10.1371/journal.pone.0174325	http://dx.doi.org/10.1371/journal.pone.0174325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323878	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000087
J	Deddens, JC; Feyen, DA; Zwetsloot, PP; Brans, MA; Siddiqi, S; van Laake, LW; Doevendans, PA; Sluijter, JP				Deddens, Janine C.; Feyen, Dries A.; Zwetsloot, Peter-Paul; Brans, Maike A.; Siddiqi, Sailay; van Laake, Linda W.; Doevendans, Pieter A.; Sluijter, Joost P.			Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury	PLOS ONE			English	Article							SPECKLE TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; MYOCARDIAL-INFARCTION; STEM-CELLS; HEART REGENERATION; THERAPY; TRANSPLANTATION; REPAIR; GUIDELINES; DISEASE	Background Translational failure for cardiovascular disease is a substantial problem involving both high research costs and an ongoing lack of novel treatment modalities. Despite the progress already made, cell therapy for chronic heart failure in the clinical setting is still hampered by poor translation. We used a murine model of chronic ischemia/reperfusion injury to examine the effect of minimally invasive application of cardiac progenitor cells (CPC) in cardiac remodeling and to improve clinical translation. Methods 28 days after the induction of I/R injury, mice were randomized to receive either CPC (0.5 million) or vehicle by echo-guided intra-myocardial injection. To determine retention, CPC were localized in vivo by bioluminescence imaging (BLI) two days after injection. Cardiac function was assessed by 3D echocardiography and speckle tracking analysis to quantify left ventricular geometry and regional myocardial deformation. Results BLI demonstrated successful injection of CPC (18/23), which were mainly located along the needle track in the anterior/septal wall. Although CPC treatment did not result in overall restoration of cardiac function, a relative preservation of the left ventricular end-diastolic volume was observed at 4 weeks follow-up compared to vehicle control (+ 5.3 +/- 2.1 mu l vs. + 10.8 +/- 1.5 mu l). This difference was reflected in an increased strain rate (+ 16%) in CPC treated mice. Conclusions CPC transplantation can be adequately studied in chronic cardiac remodeling using this study set-up and by that provide a translatable murine model facilitating advances in research for new therapeutic approaches to ultimately improve therapy for chronic heart failure.	[Deddens, Janine C.; Feyen, Dries A.; Zwetsloot, Peter-Paul; Brans, Maike A.; Siddiqi, Sailay; van Laake, Linda W.; Doevendans, Pieter A.; Sluijter, Joost P.] Univ Med Ctr Utrecht, Dept Cardiol, Expt Cardiol Lab, Utrecht, Netherlands; [Deddens, Janine C.; Doevendans, Pieter A.; Sluijter, Joost P.] Netherlands Heart Inst ICIN, Utrecht, Netherlands; [Feyen, Dries A.; van Laake, Linda W.; Doevendans, Pieter A.; Sluijter, Joost P.] Univ Med Ctr Utrecht, Regenerat Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Sluijter, JP (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Expt Cardiol Lab, Utrecht, Netherlands.; Sluijter, JP (corresponding author), Netherlands Heart Inst ICIN, Utrecht, Netherlands.; Sluijter, JP (corresponding author), Univ Med Ctr Utrecht, Regenerat Med Ctr Utrecht, Utrecht, Netherlands.	J.Sluijter@umcutrecht.nl	Zwetsloot, Peter-Paul/N-8846-2019	Zwetsloot, Peter-Paul/0000-0002-2634-4667; Doevendans, Pieter/0000-0002-6257-7169	Innovation and the Netherlands Cardio Vascular Research Initiative (CVON): The Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Science; Alexandre Suerman program for MD/PhD students of the University Medical Center Utrecht, the Netherlands; ZonMW Translational Adult Stem Cell [1161002016]	Innovation and the Netherlands Cardio Vascular Research Initiative (CVON): The Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Science; Alexandre Suerman program for MD/PhD students of the University Medical Center Utrecht, the Netherlands; ZonMW Translational Adult Stem Cell	We acknowledge the support from Innovation and the Netherlands Cardio Vascular Research Initiative (CVON): The Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Science and the Alexandre Suerman program for MD/PhD students of the University Medical Center Utrecht, the Netherlands. Additionally, the ZonMW Translational Adult Stem Cell grant 1161002016.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Aguirre A, 2013, CELL STEM CELL, V12, P275, DOI 10.1016/j.stem.2013.02.008; Baranyai T, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0313-1; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bhan A, 2014, AM J PHYSIOL-HEART C, V306, pH1371, DOI 10.1152/ajpheart.00553.2013; Bolli R, 2015, J AM COLL CARDIOL, V66, P2000, DOI 10.1016/j.jacc.2015.09.002; Clifford DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037373; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Feyen DAM, 2016, ADV HEALTHC MAT; Feyen D, 2013, CARDIOVASC RES, V99, P83, DOI 10.1093/cvr/cvt078; Gaetani R, 2014, J CELL MOL MED, V18, P2147, DOI 10.1111/jcmm.12458; Giricz Z, 2006, J PHARMACOL EXP THER, V316, P154, DOI 10.1124/jpet.105.091140; Goumans MJ, 2014, HEART, V100, P1153, DOI 10.1136/heartjnl-2014-305646; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Lara-Pezzi E, 2015, J CARDIOVASC TRANSL, V8, P3, DOI 10.1007/s12265-015-9606-8; Latham N, 2013, CIRCULATION, V128, pS105, DOI 10.1161/CIRCULATIONAHA.112.000374; Lecour S, 2014, CARDIOVASC RES, V104, P399, DOI 10.1093/cvr/cvu225; Lorkeers S. J., 2015, PLOS ONE, V10; Madonna R, 2016, EUR HEART J; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; McCafferty K, 2014, DIS MODEL MECH, V7, P1321, DOI 10.1242/dmm.016741; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Oskouei BN, 2012, STEM CELL TRANSL MED, V1, P116, DOI 10.5966/sctm.2011-0015; Peng Y, 2009, AM J PHYSIOL-HEART C, V297, pH811, DOI 10.1152/ajpheart.00385.2009; Prendiville TW, 2014, JOVE-J VIS EXP, DOI 10.3791/51566; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tang X- L, 2016, CIRC RES; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Thibault H, 2007, AM J PHYSIOL-HEART C, V293, pH496, DOI 10.1152/ajpheart.00087.2007; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Tseliou E, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0443-8; van den Akker F, 2013, BBA-GEN SUBJECTS, V1830, P2449, DOI 10.1016/j.bbagen.2012.08.026; van den Akker F., 2016, EUR HEART J; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; van Zuylen VL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1128-y; Xu ZB, 2014, JOVE-J VIS EXP, DOI 10.3791/51329; Yamada S, 2013, J PHYSIOL-LONDON, V591, P4335, DOI 10.1113/jphysiol.2013.252288; Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805; Zwetsloot PP, 2016, CIRC RES	50	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173657	10.1371/journal.pone.0173657	http://dx.doi.org/10.1371/journal.pone.0173657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319168	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800021
J	Fehlberg, HF; Maciel, BM; Albuquerque, GR				Fehlberg, Hllytchaikra Ferraz; Maciel, Bianca Mendes; Albuquerque, George Rego			Identification and discrimination of Toxoplasma gondii, Sarcocystis spp., Neospora spp., and Cryptosporidium spp. by righ-resolution melting analysis	PLOS ONE			English	Article							ANIMALS; CANINUM; BRADYZOITES; INFECTION; EVOLUTION; HUMANS	The objective of this study was to standardize the high-resolution melting method for identification and discrimination of Toxoplasma gondii, Sarcocystis spp., Neospora spp., and Cryptosporidium spp. by amplification of 18S ribosomal DNA (rDNA) using a single primer pair. The analyses were performed on individual reactions (containing DNA from a single species of a protozoan), on duplex reactions (containing DNA from two species of protozoa in each reaction), and on a multiplex reaction (containing DNA of four parasites in a single reaction). The proposed method allowed us to identify and discriminate the four species by analyzing the derivative, normalized, and difference melting curves, with high reproducibility among and within the experiments, as demonstrated by low coefficients of variation (less than 2.2% and 2.0%, respectively). This is the first study where this method is used for discrimination of these four species of protozoa in a single reaction.	[Fehlberg, Hllytchaikra Ferraz] Univ Estadual Santa Cruz, Grad Program Anim Sci, Ilheus, BA, Brazil; [Maciel, Bianca Mendes] Univ Estadual Santa Cruz, Dept Biol Sci, Ilheus, BA, Brazil; [Albuquerque, George Rego] Univ Estadual Santa Cruz, Dept Agr & Environm Sci, Rod Ilheus Itabuna BR 415, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	Albuquerque, GR (corresponding author), Univ Estadual Santa Cruz, Dept Agr & Environm Sci, Rod Ilheus Itabuna BR 415, Ilheus, BA, Brazil.	gralbu@uesc.br	Albuquerque, George Rego/J-1568-2015	Albuquerque, George Rego/0000-0002-0556-8856; Ferraz Fehlberg, Hllytchaikra/0000-0003-0547-6182; Maciel, Bianca/0000-0001-6455-8108	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [480912/2013-0]; Coordenageo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenageo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) 480912/2013-0 Coordenageo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Aksoy U, 2014, FOOD MICROBIOL, V44, P128, DOI 10.1016/j.fm.2014.05.012; [Anonymous], 2009, TOXOPLASMOSIS ANIMAL; Arisue N, 2015, PARASITOL INT, V64, P254, DOI 10.1016/j.parint.2014.10.005; Blazejewski T, 2015, MBIO, V6, DOI 10.1128/mBio.02445-14; Bruzzone CM, 2013, GENET TEST MOL BIOMA; Costa JM, 2011, J MICROBIOL METH, V86, P357, DOI 10.1016/j.mimet.2011.06.017; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey J.P, 2011, VET PARASITOL; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dubey JP, 2015, VET PARASITOL; Dubey JP, 2007, CLIN MICROBIOL REV; Dubey JP, 2010, J PARASITOL; Dwight ZL, 2014, HUM MUTAT; Fayer R, 2000, INT J PARASITOL, V30, P1305, DOI 10.1016/S0020-7519(00)00135-1; Ghorashi SA, 2013, VET MICROBIOL, V167, P440, DOI 10.1016/j.vetmic.2013.09.032; Gondim LFP, 2001, VET PARASITOL, V101, P1, DOI 10.1016/S0304-4017(01)00493-9; Goodswen SJ, 2013, INFECT GENET EVOL, V13, P133, DOI 10.1016/j.meegid.2012.08.012; Graham R, 2005, CLIN CHEM, V51, P1295, DOI 10.1373/clinchem.2005.051516; Hamilton MS, 2002, J CLIN MICROBIOL; Lalonde LF, 2011, J PARASITOL; Monis PT, 2005, ANAL BIOCH; Nolan MJ, 2013, WATER RES, V47, P1726, DOI 10.1016/j.watres.2012.12.027; Pangasa A, 2009, MOL CELL PROBE, V23, P10, DOI 10.1016/j.mcp.2008.10.003; Piper MB, 1998, GENOME RES, V8, P1299, DOI 10.1101/gr.8.12.1299; Price EP, 2007, APPL ENV MICROBIOL; Reed GH, 2007, FUTURE MED; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Singh P, 2014, FOOD MICROBIOL, V44, P6, DOI 10.1016/j.fm.2014.04.014; Sofaly CD, 2002, J PARASITOL, V88, P1164, DOI 10.1645/0022-3395(2002)088[1164:EIOEPM]2.0.CO;2; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174168	10.1371/journal.pone.0174168	http://dx.doi.org/10.1371/journal.pone.0174168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346485	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300027
J	Kieneker, LM; Eisenga, MF; Joosten, MM; de Boer, RA; Gansevoort, RT; Kootstra-Ros, JE; Navis, G; Bakker, SJL				Kieneker, Lyanne M.; Eisenga, Michele F.; Joosten, Michel M.; de Boer, Rudolf A.; Gansevoort, Ron T.; Kootstra-Ros, Jenny E.; Navis, Gerjan; Bakker, Stephan J. L.			Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population	PLOS ONE			English	Article							END-STAGE DISEASE; SERUM POTASSIUM; RENAL-DISEASE; BLOOD-PRESSURE; SALT SENSITIVITY; DEVELOPING HYPERTENSION; GLUCOSE-INTOLERANCE; RACIAL-DIFFERENCES; BODY POTASSIUM; CYSTATIN C	Objective Both hypokalemia and hyperkalemia are associated with disease progression in patients with chronic kidney disease (CKD). It is unclear whether similar associations are present in the general population. Our aim was to examine the association of plasma potassium with risk of developing CKD and the role of diuretics in this association in a population-based cohort. Research design and methods We studied 5,130 subjects free of CKD at baseline of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study, a prospective, population-based cohort of Dutch men and women aged 28-75 years. Hypokalemia was defined as plasma potassium <3.5 mmol/L, and hyperkalemia as plasma potassium >= 5.0 mmol/L. Risk of CKD was defined as de novo development of eGFR <60 ml/min/1.73m(2) and/or albuminuria >30 mg/24h. Results Mean baseline plasma potassium was 4.4 +/- 0.3 mmol/L. The prevalences of hypokalemia and hyperkalemia were 0.5% and 3.8%, respectively; 3.0% of the subjects used diuretics. During a median follow-up of 10.3 years (interquartile range: 6.3-11.4 years), 753 subjects developed CKD. The potassium-CKD association was modified by diuretic use (P-interaction = 0.02). Both hypokalemia without (HR, 7.74, 95% CI, 3.43-17.48) or with diuretic use (HR, 4.32, 95% CI, 1.77-10.51) were associated with an increased CKD risk as compared to plasma potassium 4.0-4.4 mmol/L without diuretic use. Plasma potassium concentrations >= 3.5 mmol/L were associated with an increased CKD risk among subjects using diuretics (Ptrend = 0.01) but not among subjects not using diuretics (P-trend = 0.74). Conclusion In this population-based cohort, hypokalemia was associated with an increased CKD risk, regardless of diuretic use. In the absence of hypokalemia, plasma potassium was not associated with an increased CKD risk, except among subjects using diuretics.	[Kieneker, Lyanne M.; Eisenga, Michele F.; Joosten, Michel M.; Gansevoort, Ron T.; Navis, Gerjan; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [de Boer, Rudolf A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Kootstra-Ros, Jenny E.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Kieneker, LM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands.	lyannekieneker@gmail.com	de Boer, Rudolf/ABE-9879-2020	Joosten, Michel Marinus/0000-0002-0039-6629	Dutch Kidney Foundation	Dutch Kidney Foundation	The Prevention of Renal and Vascular End-Stage Disease (PREVEND) study has been made possible by grants from the Dutch Kidney Foundation. The funder of the work had no role in the conception, execution, or analysis of the research and had no role in drafting the manuscript.	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Ardiles L, 2013, AM J PHYSIOL-RENAL, V304, pF1399, DOI 10.1152/ajprenal.00604.2012; BARDEN AE, 1986, J HYPERTENS, V4, P339, DOI 10.1097/00004872-198606000-00013; Chatterjee R, 2011, AM J CLIN NUTR, V93, P1087, DOI 10.3945/ajcn.110.007286; Chen Y, 2016, MAYO CLIN PROC, V91, P1403, DOI 10.1016/j.mayocp.2016.05.018; EDDY AA, 1991, AM J PATHOL, V138, P1111; Erlinger TP, 2003, AM J KIDNEY DIS, V42, P256, DOI 10.1016/S0272-6386(03)00650-4; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; Foley RN, 2007, J AM SOC NEPHROL, V18, P2575, DOI 10.1681/ASN.2006121411; FOTHERBY MD, 1992, J HYPERTENS, V10, P1403, DOI 10.1097/00004872-199211000-00013; Fukui M, 2014, INT J CLIN PRACT, V68, P700, DOI 10.1111/ijcp.12367; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; GONICK HC, 1971, AM J MED SCI, V261, P281, DOI 10.1097/00000441-197105000-00007; GORDEN P, 1973, DIABETES, V22, P544, DOI 10.2337/diab.22.7.544; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; GROBBEE DE, 1987, J HYPERTENS, V5, P115, DOI 10.1097/00004872-198702000-00016; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Gumz ML, 2015, NEW ENGL J MED, V373, P60, DOI 10.1056/NEJMra1313341; Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200; Hawkins RC, 2003, CLIN CHIM ACTA, V331, P171, DOI 10.1016/S0009-8981(03)00112-8; Hayes J, 2012, NEPHRON CLIN PRACT, V120, pC8, DOI 10.1159/000329511; He FJ, 2010, HYPERTENSION, V55, P681, DOI 10.1161/HYPERTENSIONAHA.109.147488; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hollander-Rodriguez JC, 2006, AM FAM PHYSICIAN, V73, P283; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Joosten MM, 2015, KIDNEY INT, V87, P1262, DOI 10.1038/ki.2015.33; Kieneker LM, 2016, KIDNEY INT; Kieneker LM, 2014, HYPERTENSION, V64, P769, DOI 10.1161/HYPERTENSIONAHA.114.03750; KLEINFELD M, 1993, J NATL MED ASSOC, V85, P861; KNOCHEL JP, 1984, AM J MED, V77, P18, DOI 10.1016/S0002-9343(84)80004-2; Koenig W, 2003, AM J EPIDEMIOL, V158, P357, DOI 10.1093/aje/kwg135; Korgaonkar S, 2010, CLIN J AM SOC NEPHRO, V5, P762, DOI 10.2215/CJN.05850809; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; LIN HB, 1994, CIRCULATION, V89, P331, DOI 10.1161/01.CIR.89.1.331; Luo JC, 2016, CLIN J AM SOC NEPHRO, V11, P90, DOI 10.2215/CJN.01730215; MACGREGOR GA, 1982, LANCET, V2, P567; MCCABE RD, 1994, AM J HYPERTENS, V7, P346, DOI 10.1093/ajh/7.4.346; MCCABE RD, 1994, HYPERTENSION, V24, P77, DOI 10.1161/01.HYP.24.1.77; Nakhoul GN, 2015, AM J NEPHROL, V41, P456, DOI 10.1159/000437151; NATH KA, 1991, AM J KIDNEY DIS, V17, P654, DOI 10.1016/S0272-6386(12)80344-1; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; PRATT JH, 1989, NEW ENGL J MED, V321, P1152, DOI 10.1056/NEJM198910263211703; Ray PE, 2001, KIDNEY INT, V59, P1850, DOI 10.1046/j.1523-1755.2001.0590051850.x; Reungjui S, 2007, KIDNEY INT, V72, P1483, DOI 10.1038/sj.ki.5002564; Reungjui S, 2008, CURR OPIN NEPHROL HY, V17, P470, DOI 10.1097/MNH.0b013e328305b9a5; Riphagen IJ, 2016, J HYPERTENS, V34, P215, DOI 10.1097/HJH.0000000000000786; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; STANTON BA, 1989, AM J PHYSIOL, V257, pR989, DOI 10.1152/ajpregu.1989.257.5.R989; Suga S, 2002, KIDNEY INT, V61, P951, DOI 10.1046/j.1523-1755.2002.00208.x; Suga SI, 2001, AM J PHYSIOL-RENAL, V281, pF620, DOI 10.1152/ajprenal.2001.281.4.F620; TOLINS JP, 1987, J CLIN INVEST, V79, P1447, DOI 10.1172/JCI112973; Turban S, 2008, J AM SOC NEPHROL, V19, P1396, DOI 10.1681/ASN.2007101142; van Ballegooijen AJ, 2015, HYPERTENSION, V66, P563, DOI 10.1161/HYPERTENSIONAHA.115.05837; Visser ST, 2013, EXPERT REV PHARM OUT, V13, P285, DOI [10.1586/ERP.13.20, 10.1586/erp.13.20]; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067140; Wysowski DK, 2003, CLIN CHEM, V49, P190, DOI 10.1373/49.1.190; YOUNG DB, 1995, AM J PHYSIOL-REG I, V268, pR825, DOI 10.1152/ajpregu.1995.268.4.R825	61	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174686	10.1371/journal.pone.0174686	http://dx.doi.org/10.1371/journal.pone.0174686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346526	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300070
J	Okonofua, F; Randawa, A; Ogu, R; Agholor, K; Okike, O; Abdus-Salam, RA; Gana, M; Abe, E; Durodola, A; Galadanci, H				Okonofua, Friday; Randawa, Abdullahi; Ogu, Rosemary; Agholor, Kingsley; Okike, Ola; Abdus-salam, Rukayat Adeola; Gana, Mohammed; Abe, Eghe; Durodola, Adetoye; Galadanci, Hadiza		WHARC WHO FMOH MNCH Implementation	Views of senior health personnel about quality of emergency obstetric care: A qualitative study in Nigeria	PLOS ONE			English	Article								Background Late arrival in hospital by women experiencing pregnancy complications is an important background factor leading to maternal mortality in Nigeria. The use of effective and timely emergency obstetric care determines whether women survive or die, or become near-miss cases. Healthcare managers have the responsibility to deploy resources for implementing emergency obstetric care. Objectives To determine the nature of institutional policies and frameworks for managing obstetric complications and reducing maternal deaths in Nigeria. Methods Thirty-six hospital managers, heads of obstetrics department and senior midwives were interviewed about hospital infrastructure, resources, policies and processes relating to emergency obstetric care, whilst allowing informants to discuss their thoughts and feelings. The interviews were audiotaped, transcribed and analyzed using Atlas ti 6.2software. Results Hospital managers are aware of the seriousness of maternal mortality and the steps to improve maternal healthcare. Many reported the lack of policies and specific action-plans for maternal mortality prevention, and many did not purposely disburse budgets orresources to address the problem. Although some reported that maternal/perinatal audit take place in their hospitals, there was no substantive evidence and no records of maternal/perinatal audits were made available. Respondents decried the lack of appropriate data collection system in the hospitals for accurate monitoring of maternal mortality and identification of appropriate remediating actions. Conclusion Healthcare managers are handicapped to properly manage the healthcare system for maternal mortality prevention. Relevant training of healthcare managers would be crucial to enable the development of strategic implementation plans for the prevention of maternal mortality.	[Okonofua, Friday; WHARC WHO FMOH MNCH Implementation] Womens Hlth & Act Res Ctr, Benin, Edo State, Nigeria; [Okonofua, Friday] Univ Med Sci, Ondo City, Ondo State, Nigeria; [Randawa, Abdullahi] Ahmadu Bello Univ, Zaria, Kaduna State, Nigeria; [Ogu, Rosemary] Univ Port Harcourt, Port Harcourt, Rivers State, Nigeria; [Agholor, Kingsley] Cent Hosp, Warri, Delta State, Nigeria; [Okike, Ola] Karshi Gen Hosp, Abuja, Federal Capital, Nigeria; [Abdus-salam, Rukayat Adeola] Adeoyo Hosp, Ibadan, Oyo State, Nigeria; [Gana, Mohammed] Gen Hosp, Minna, Niger State, Niger; [Abe, Eghe] Cent Hosp, Benin, Edo State, Nigeria; [Durodola, Adetoye] Gen Hosp, Abeokuta, Ogun State, Nigeria; [Galadanci, Hadiza] Aminu Kano Teaching Hosp, Ungwa Uku, Kano State, Nigeria	Ahmadu Bello University; University of Port Harcourt	Okonofua, F (corresponding author), Womens Hlth & Act Res Ctr, Benin, Edo State, Nigeria.; Okonofua, F (corresponding author), Univ Med Sci, Ondo City, Ondo State, Nigeria.; Ogu, R (corresponding author), Univ Port Harcourt, Port Harcourt, Rivers State, Nigeria.	feokonofua@yahoo.co.uk; rosemary.ogu@uniport.edu.ng	Ogu, Rosemary/AAS-6474-2021; Ogu, Rosemary/GZM-7255-2022; Okonofua, Friday/AAB-9703-2021	Ogu, Rosemary/0000-0002-5467-302X; 	Alliance for Health Policy and Systems Research, World Health Organization [A65869]	Alliance for Health Policy and Systems Research, World Health Organization	The research project was funded by the Alliance for Health Policy and Systems Research, World Health Organization (Implementation Research Protocol ID A65869).	Achem FF, 2014, BJOG-INT J OBSTET GY, V121, P75, DOI 10.1111/1471-0528.12817; Aisien OA, 2010, J CLIN MED RES, V2, P55; Erim DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039555; Esan OT, 2014, AFR J REPROD HEALTH, V18, P105; Federal Ministry of Health, 2008, STAND TREATM GUID NI; Galadanci H, 2011, INT J GYNECOL OBSTET, V114; HARRISON KA, 1985, BRIT J OBSTET GYNAEC, V92, P1; Igberase GO, 2007, J OBSTET GYNAECOL, V27, P275, DOI 10.1080/01443610701213687; Kullima AA, 2009, ANN AFR MED, V8, P221, DOI 10.4103/1596-3519.59575; Mbachu I I, 2013, Niger J Med, V22, P117; Ochejele S., 2004, Tropical Journal of Obstetrics and Gynaecology, V21, P160; Okonofua FE, 2014, J OBSTET GYNAECOLOGY; Okonofua FE, 2013, ACTA OBSTET GYN SCAN, V92, P716, DOI 10.1111/aogs.12135; OLADAPO OT, 2015, BJOG, DOI [10.1111/1471-0528.13450, DOI 10.1111/1471-0528.13450]	14	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173414	10.1371/journal.pone.0173414	http://dx.doi.org/10.1371/journal.pone.0173414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346519	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300005
J	Armero, A; Baudouin, L; Bocs, S; This, D				Armero, Alix; Baudouin, Luc; Bocs, Stephanie; This, Dominique			Improving transcriptome de novo assembly by using a reference genome of a related species: Translational genomics from oil palm to coconut	PLOS ONE			English	Article							RNA-SEQ; SEQUENCE; DATABASE; FAMILY; BIOSYNTHESIS; DIVERSITY; GENES; SIZE	The palms are a family of tropical origin and one of the main constituents of the ecosystems of these regions around the world. The two main species of palm represent different challenges: coconut (Cocos nucifera L.) is a source of multiple goods and services in tropical communities, while oil palm (Elaeis guineensis Jacq) is the main protagonist of the oil market. In this study, we present a workflow that exploits the comparative genomics between a target species (coconut) and a reference species (oil palm) to improve the transcriptomic data, providing a proteome useful to answer functional or evolutionary questions. This workflow reduces redundancy and fragmentation, two inherent problems of transcriptomic data, while preserving the functional representation of the target species. Our approach was validated in Arabidopsis thaliana using Arabidopsis lyrata and Capsella rubella as references species. This analysis showed the high sensitivity and specificity of our strategy, relatively independent of the reference proteome. The workflow increased the length of proteins products in A. thaliana by 13%, allowing, often, to recover 100% of the protein sequence length. In addition redundancy was reduced by a factor greater than 3. In coconut, the approach generated 29,366 proteins, 1,246 of these proteins deriving from new contigs obtained with the BRANCH software. The coconut proteome presented a functional profile similar to that observed in rice and an important number of metabolic pathways related to secondary metabolism. The new sequences found with BRANCH software were enriched in functions related to biotic stress. Our strategy can be used as a complementary step to de novo transcriptome assembly to get a representative proteome of a target species. The results of the current analysis are available on the website PalmComparomics (http://palm-comparomics.southgreen.fr/).	[Armero, Alix; This, Dominique] Montpellier SupAgro, UMR AGAP, Montpellier, France; [Baudouin, Luc; Bocs, Stephanie] CIRAD, UMR AGAP, Montpellier, France; [Bocs, Stephanie] South Green Bioinformat Platform, Montpellier, France	Institut Agro; Montpellier SupAgro; Universite de Montpellier; CIRAD; Universite de Montpellier	Baudouin, L (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	luc.baudouin@cirad.fr		This, Dominique/0000-0003-0280-6596; Armero Villanueva, Alix Augusto/0000-0002-6930-5932; Baudouin, Luc/0000-0003-2620-7125	Montpellier SupAgro; CIRAD	Montpellier SupAgro; CIRAD	The research works were funded by Montpellier SupAgro through a graduate research allocation to Alix Armero, and by CIRAD through a specific financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], COC NUC GQUERY GLOB; [Anonymous], 2008, PARASITOLOGY RES PAR, V102, P1281; [Anonymous], 2011, PLOS ONE, V6; Arendsee ZW, 2014, TRENDS PLANT SCI, V19, P698, DOI 10.1016/j.tplants.2014.07.003; Baker WJ, 2011, ANN BOT-LONDON, V108, P1417, DOI 10.1093/aob/mcr020; Bao E, 2013, BIOINFORMATICS, V29, P1250, DOI 10.1093/bioinformatics/btt127; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Couvreur T.L.P., 2013, BIOMED CENTRAL, V11, P1; de la Torre JE, 2006, BMC EVOLUTIONARY BIO, V6, P1; *DEV COR TEAM, 2008, R LANG ENV STAT COMP; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guignon V, BANANA GENOME HUB; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; He ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145385; Honaas LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146062; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang YY, 2014, G3-GENES GENOM GENET, V4, P2147, DOI 10.1534/g3.114.013409; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iovieno P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2325-3; JAS, NEMATODES RHYNCHOPHO; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; Kang YJ, 2016, PLANT BIOTECHNOL J, V14, P1057, DOI 10.1111/pbi.12449; Karp PD, 2015, BRIEFINGS BIOINFORMA; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Morrone D, 2010, BIOCHEM J, V431, P337, DOI 10.1042/BJ20100597; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Murat F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0814-y; National Center for Biotechnology Information, US NAT LIB MED; Nejat N, 2015, MOL GENET GENOMICS, V290, P1899, DOI 10.1007/s00438-015-1046-2; Ono H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2247-0; Prabh N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1102-x; Ruttink T, 2013, PLANT BIOTECHNOL J, V11, P605, DOI 10.1111/pbi.12051; Shang Y, 2014, SCIENCE, V346, P1084, DOI 10.1126/science.1259215; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang Q, 2012, PLANT PHYSIOL, V158, P1418, DOI 10.1104/pp.111.187518; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu HP, 2016, MOL PLANT, V9, P749, DOI 10.1016/j.molp.2015.12.018	67	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173300	10.1371/journal.pone.0173300	http://dx.doi.org/10.1371/journal.pone.0173300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334050	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200012
J	Bryla, M; Dziankowska-Zaborszczyk, E; Bryla, P; Pikala, M; Maniecka-Bryla, I				Bryla, Marek; Dziankowska-Zaborszczyk, Elzbieta; Bryla, Pawel; Pikala, Malgorzata; Maniecka-Bryla, Irena			Years of life lost due to infectious diseases in Poland	PLOS ONE			English	Article							STANDARD EXPECTED YEARS; AVOIDABLE MORTALITY; PREMATURE MORTALITY; BURDEN; TUBERCULOSIS	Purpose An evaluation of mortality due to infectious diseases in Poland in 1999-2012 and an analysis of standard expected years of life lost due to the above diseases. Methods The study material included a database created on the basis of 5,219,205 death certificates of Polish inhabitants, gathered between 1999 and 2012 and provided by the Central Statistical Office. Crude Death Rates (CDR), Standardized Death Rates (SDR) and Standard Expected Years of Life Lost (SEYLL) due to infectious and parasitic diseases were also evaluated in the study period as well as Standard Expected Years of Life Lost per living person (SEYLLp) and Standard Expected Years of Life Lost per dead person (SEYLLd). Time trends were evaluated with the application of joinpoint models and an annual percentage change in their values. Results Death certificates report that 38,261 people died due to infectious diseases in Poland in the period 1999-2012, which made up 0.73% of the total number of deaths. SDR caused by these diseases decreased, particularly in the male group: Annual Percentage Change (APC = -1.05; 95% CI:-2.0 to -0.2; p<0.05). The most positive trends were observed in mortality caused by tuberculosis (A15-A19) (APC = -5.40; 95% CI:-6.3 to -4.5; p<0.05) and also meningitis, encephalitis, myelitis and encephalomyelitis (G03-G04) (APC = -3.42; 95% CI:4.7 to -2.1; p<0.05). The most negative mortality trends were observed for intestinal infectious diseases (A00-A09) Annual Average Percentage Change (AAPC = 7.3; 95% CI: 3.1 to 11.7; p<0.05). SDR substantially decreased in the first half of the study period, but then significantly increased in the second half. Infectious and parasitic diseases contributed to a loss of around 37,000 standard expected years of life in 1999 and more than 28,000 in 2012. During the study period, the SEYLLp index decreased from 9.59 to 7.39 per 10,000 population and the SEYLLd index decreased from 14.26 to 10.34 years (AAPC = 2.3; 95% CI:-2,9 to -1.7; p<0.05). Conclusions Despite smaller numbers of deaths reported from infectious causes these diseases still represent a serious problem for Poland compared to countries in Western Europe.	[Bryla, Marek] Med Univ Lodz, Dept Social Med, Chair Social & Prevent Med, Lodz, Poland; [Dziankowska-Zaborszczyk, Elzbieta; Pikala, Malgorzata; Maniecka-Bryla, Irena] Med Univ Lodz, Dept Epidemiol & Biostat, Chair Social & Prevent Med, Lodz, Poland; [Bryla, Pawel] Univ Lodz, Dept Int Mkt & Retailing, Lodz, Poland	Medical University Lodz; Medical University Lodz; University of Lodz	Maniecka-Bryla, I (corresponding author), Med Univ Lodz, Dept Epidemiol & Biostat, Chair Social & Prevent Med, Lodz, Poland.	irena.maniecka-bryla@umed.lodz.pl	Bryła, Paweł/B-8262-2013; Bryla, Marek/AAW-5787-2021; Maniecka-Bryla, Irena/AAW-5779-2021; Pikala, Malgorzata/S-9898-2016	Bryła, Paweł/0000-0003-1535-5659; Bryla, Marek/0000-0001-6757-9211; Maniecka-Bryla, Irena/0000-0002-6671-7456; Pikala, Malgorzata/0000-0003-4426-4908; Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606	National Science Centre [DEC-2013/11/B/HS4/00465]; Medical University of Lodz [503/6-029-07/503-61-001]	National Science Centre(National Science Centre, Poland); Medical University of Lodz	This study was funded by the National Science Centre no. DEC-2013/11/B/HS4/00465 and by the Medical University of Lodz (project no. 503/6-029-07/503-61-001).The funders had no role in study design, data col lection and analysis, decision to publish, or preparation of the manuscript	Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; [Anonymous], 2003, GLOWRIY INSPEKTORAT; [Anonymous], EST APC SURV RES PRO; [Anonymous], WHO MEMB STAT 2012 X; [Anonymous], 2016, DEMOGRAPHIC YB POLAN; [Anonymous], 2015, JOINT REGR PROGR VER; [Anonymous], 2015, GLOBAL BURDEN DIS ST; Bryla M, 2017, INT J TUBERC LUNG D, V21, P202, DOI 10.5588/ijtld.16.0268; Castillo-Rodriguez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125456; COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567; European Centre for Disease Prevention and Control, TUB SURV MON EUR 201; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Gawryszewski A., 2006, PAN; Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787; Gonzalez-Gonzalez C, 2015, SALUD PUBLICA MEX S1, V57, P39; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Leowski J, 2008, HLTH POLICY PUBLIC H, P44; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malta Deborah Carvalho, 2007, Ciênc. saúde coletiva, V12, P765, DOI 10.1590/S1413-81232007000300027; Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x; Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262; Marshall R., 2009, HDB DIS BURDENS QUAL, P3421; Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x; Moore P, 2006, NEW KILLER GERMS WHA; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJL, 1999, B WORLD HEALTH ORGAN, V77, P537; Murray CJL, 2000, VESALIUS, V1; Ollandezos M, 2011, HIPPOKRATIA, V15, P330; Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237; Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830; Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863; Rosinska M., 2016, PRZEGL EPIDEMIOLOG, V70; Stevens G, 2010, EUR J PUBLIC HEALTH, V20, P241, DOI 10.1093/eurpub/ckq051; Tobias M, 2009, AUST NZ J PUBL HEAL, V33, P70, DOI 10.1111/j.1753-6405.2009.00342.x; Treurniet HF, 2004, J EPIDEMIOL COMMUN H, V58, P290, DOI 10.1136/jech.2002.006452; World Health Organization, 2004, ANN C AN CAT MORT DA; Wroblewska W., 2012, STUDIA DEMOGRAFICZNE, V1, P129; Zielinski Andrzej, 2006, Przegl Epidemiol, V60, P857	39	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174391	10.1371/journal.pone.0174391	http://dx.doi.org/10.1371/journal.pone.0174391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333988	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200094
J	Koch, J; Bui, TT; Belleza, EL; Brinkmann, M; Hollert, H; Breitholtz, M				Koch, Josef; Bui, Thuy T.; Belleza, Elin Lundstrom; Brinkmann, Markus; Hollert, Henner; Breitholtz, Magnus			Temperature and food quantity effects on the harpacticoid copepod Nitocra spinipes: Combining in vivo bioassays with population modeling	PLOS ONE			English	Article							TISBE-BATTAGLIAI COPEPODA; CALANUS-HELGOLANDICUS; MARINE COPEPODS; CLIMATE-CHANGE; LIFE-CYCLE; EMBRYONIC-DEVELOPMENT; NAUPLIAR DEVELOPMENT; DEVELOPMENT RATES; GROWTH; REPRODUCTION	The harpacticoid copepod Nitocra spinipes has become a popular model species for toxicity testing over the past few decades. However, the combined influence of temperature and food shortage, two climate change-related stressors, has never been assessed in this species. Consequently, effects of three temperatures (15, 20 and 25 degrees C) and six food regimes (between 0 and 5 x 10(5) algal cells/mL) on the life cycle of N. spinipes were examined in this study. Similarly to other copepod species, development times and brood sizes decreased with rising temperatures. Mortality was lowest in the 20 degrees C temperature setup, indicating a close-by temperature optimum for this species. Decreasing food concentrations led to increased development times, higher mortality and a reduction in brood size. A sex ratio shift toward more females per male was observed for increasing temperatures, while no significant relationship with food concentration was found. Temperature and food functions for each endpoint were integrated into an existing individual-based population model for N. spinipes which in the future may serve as an extrapolation tool in environmental risk assessment. The model was able to accurately reproduce the experimental data in subsequent verification simulations. We suggest that temperature, food shortage, and potentially other climate change-related stressors should be considered in environmental risk assessment of chemicals to account for non-optimal exposure conditions that may occur in the field. Furthermore, we advocate combining in vivo bioassays with population modeling as a cost effective higher tier approach to assess such considerations.	[Koch, Josef] Univ Ghent, Environm Toxicol Unit GhEnToxLab, Lab Environm Toxicol & Aquat Ecol, Ghent, Belgium; [Bui, Thuy T.; Breitholtz, Magnus] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Belleza, Elin Lundstrom] IVL Swedish Environm Res Inst, Stockholm, Sweden; [Brinkmann, Markus] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany	Ghent University; Stockholm University; IVL Swedish Environmental Research Institute; University of Saskatchewan; RWTH Aachen University	Koch, J (corresponding author), Univ Ghent, Environm Toxicol Unit GhEnToxLab, Lab Environm Toxicol & Aquat Ecol, Ghent, Belgium.	josef.koch@ugent.be	Hollert, Henner/A-1027-2009; Brinkmann, Markus/L-3879-2013	Hollert, Henner/0000-0001-5776-5619; Brinkmann, Markus/0000-0002-4985-263X; Bui, Thuy/0000-0001-6782-8310; Koch, Josef/0000-0003-4811-865X	Swedish Foundation for Strategic Environmental Research (MISTRA) through the MistraPharma program; German Academic Exchange Service; German National Academic Foundation	Swedish Foundation for Strategic Environmental Research (MISTRA) through the MistraPharma program; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German National Academic Foundation	This research was supported by the Swedish Foundation for Strategic Environmental Research (MISTRA) through the MistraPharma program (http://www.mistrapharma.se/). M. Brinkmann was supported by the German National Academic Foundation (http s://www.studienstiftung.de/) and is currently a Banting Fellow of the Natural Science s and Engineering Research Council of Canada (NSERC). T. T. Bui and J. Koch were supported by the German Academic Exchange Service (https://eu.daad.de/de/) with in the frame work of the LLP/ERASMUS student exchange program. J. Koch is currently a SB PhD Fellow at the Research Foundation - Flanders (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe PB, 1997, HYDROBIOLOGIA, V350, P131, DOI 10.1023/A:1003087815861; [Anonymous], 1934, INT REV GES HYDROBIO, V31, P421; [Anonymous], 2009, EMB DELPH 2009; BENGTSSON BE, 1987, ECOTOX ENVIRON SAFE, V14, P260, DOI 10.1016/0147-6513(87)90069-8; BENGTSSON BE, 1978, MAR POLLUT BULL, V9, P238, DOI 10.1016/0025-326X(78)90378-8; Bliss CI, 1926, J GEN PHYSIOL, V9, P467, DOI 10.1085/jgp.9.4.467; BOTTRELL HH, 1975, OECOLOGIA, V18, P63, DOI 10.1007/BF00350636; Breitholtz M, 2003, AQUAT TOXICOL, V64, P85, DOI 10.1016/S0166-445X(03)00025-0; Breitholtz M, 2003, AQUAT TOXICOL, V63, P103, DOI 10.1016/S0166-445X(02)00159-5; Breitholtz M, 2001, MAR POLLUT BULL, V42, P879, DOI 10.1016/S0025-326X(01)00046-7; Breitholtz M, 2008, CHEMOSPHERE, V72, P1242, DOI 10.1016/j.chemosphere.2008.05.004; BRETELER WCM, 1994, J PLANKTON RES, V16, P1039, DOI 10.1093/plankt/16.8.1039; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Campbell RG, 2001, MAR ECOL PROG SER, V221, P161, DOI 10.3354/meps221161; Carlotti F, 1997, MAR ECOL PROG SER, V149, P91, DOI 10.3354/meps149091; Chandler GT, 2004, ENVIRON TOXICOL CHEM, V23, P117, DOI 10.1897/03-124; Chang W, 2015, SHINY WEB APPL FRAME; Cnudde C, 2013, THESIS; Cook KB, 2007, J PLANKTON RES, V29, P757, DOI 10.1093/plankt/fbm056; CORKETT CJ, 1970, J MAR BIOL ASSOC UK, V50, P161, DOI 10.1017/S0025315400000680; CORKETT CJ, 1984, CRUSTACEANA S, V0007, P00150; Dahl U, 2009, ECOTOX ENVIRON SAFE, V72, P351, DOI 10.1016/j.ecoenv.2008.04.008; Dahl U, 2008, AQUAT TOXICOL, V88, P191, DOI 10.1016/j.aquatox.2008.04.006; Ebert D, 2011, SCIENCE, V331, P539, DOI 10.1126/science.1202092; EDGAR AJ, 1990, HYDROBIOLOGIA, V194, P177, DOI 10.1007/BF00007117; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Escribano R, 1997, MAR BIOL, V128, P281, DOI 10.1007/s002270050093; GAUDY R, 1982, J EXP MAR BIOL ECOL, V57, P257, DOI 10.1016/0022-0981(82)90196-4; Gusmao LFM, 2009, J PLANKTON RES, V31, P1101, DOI 10.1093/plankt/fbp059; HART RC, 1990, HYDROBIOLOGIA, V206, P175, DOI 10.1007/BF00014085; HERZIG A, 1983, HYDROBIOLOGIA, V100, P65, DOI 10.1007/BF00027423; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hooper MJ, 2013, ENVIRON TOXICOL CHEM, V32, P32, DOI 10.1002/etc.2043; HUNTLEY ME, 1992, AM NAT, V140, P201, DOI 10.1086/285410; Hutchinson TH, 1999, SCI TOTAL ENVIRON, V233, P167, DOI 10.1016/S0048-9697(99)00223-5; Hygum BH, 2000, MAR BIOL, V136, P1057, DOI 10.1007/s002270000292; Jimenez-Melero R, 2005, J PLANKTON RES, V27, P1175, DOI 10.1093/plankt/fbi083; Jimenez-Melero R, 2012, HYDROBIOLOGIA, V686, P241, DOI 10.1007/s10750-012-1014-3; KAMPS DM, 1978, HYDROBIOLOGIA, V61, P75, DOI 10.1007/BF00019026; KINNE OTTO, 1964, HELGOLANDER WISSENSCHAFTLICHE MEERESUNTERSUCH, V9, P433, DOI 10.1007/BF01610056; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Korsman JC, 2014, ENVIRON SCI TECHNOL, V48, P5709, DOI 10.1021/es5004439; Koski M, 2010, MAR ECOL PROG SER, V399, P141, DOI 10.3354/meps08357; Krogh A., 1914, Zeitschrift fuer Allgemeine Physiologie Jena, V16; Kulkarni D, 2014, CHEMOSPHERE, V112, P340, DOI 10.1016/j.chemosphere.2014.04.062; Kusk KO, 1999, ENVIRON TOXICOL CHEM, V18, P1564, DOI 10.1002/etc.5620180731; Landis WG, 2013, ENVIRON TOXICOL CHEM, V32, P79, DOI 10.1002/etc.2047; Larrain A, 1998, B ENVIRON CONTAM TOX, V61, P391, DOI 10.1007/s001289900775; Lundstrom Belleza E, 2014, THESIS; Lundstrom E, 2010, AQUAT TOXICOL, V96, P298, DOI 10.1016/j.aquatox.2009.11.011; Martinez-Jeronimo Fernando, 1994, Journal of Aquatic Ecosystem Health, V3, P247, DOI 10.1007/BF00115283; Mayor DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13690; McKinnon AD, 1996, LIMNOL OCEANOGR, V41, P1438, DOI 10.4319/lo.1996.41.7.1438; MCLAREN IA, 1978, J FISH RES BOARD CAN, V35, P1330, DOI 10.1139/f78-208; Moe SJ, 2013, ENVIRON TOXICOL CHEM, V32, P49, DOI 10.1002/etc.2045; MOORE CG, 1991, MAR POLLUT BULL, V22, P72, DOI 10.1016/0025-326X(91)90139-J; OECD, 2014, ENV HLTH SAF PUBL SE, V201; OECD, 2007, ENV HLTH SAF PUBL SE, V79; OECD, 2011, ENV HLTH SAF PUBL SE, V158; PAFFENHOFER GA, 1970, HELGOLAND WISS MEER, V20, P346, DOI 10.1007/BF01609912; Preuss TG, 2011, ENVIRON TOXICOL CHEM, V30, P2353, DOI 10.1002/etc.614; R Core Team, 2013, R LANG ENV STAT COMP; Raisuddin S, 2007, AQUAT TOXICOL, V83, P161, DOI 10.1016/j.aquatox.2007.04.005; Rey-Rassat C, 2002, MAR ECOL PROG SER, V238, P125, DOI 10.3354/meps238125; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Rigler FH, 1984, MANUAL METHODS ASSES, V17, ppp19; SARVALA J, 1979, FRESHWATER BIOL, V9, P515, DOI 10.1111/j.1365-2427.1979.tb01536.x; Souissi S, 2001, J PLANKTON RES, V23, P1279, DOI 10.1093/plankt/23.11.1279; THISTLE D, 1990, MAR BIOL, V107, P443, DOI 10.1007/BF01313427; Ward DJ, 2013, ENVIRON TOXICOL CHEM, V32, P644, DOI 10.1002/etc.2086; Weiss GM, 1996, MAR ECOL PROG SER, V132, P57, DOI 10.3354/meps132057; Wernersson AS, 2015, ENVIRON SCI EUR, V27, P1, DOI 10.1186/s12302-015-0039-4; Williams TD, 1999, J EXP MAR BIOL ECOL, V236, P273, DOI 10.1016/S0022-0981(98)00209-3; WILLIAMS TD, 1994, J EXP MAR BIOL ECOL, V183, P283, DOI 10.1016/0022-0981(94)90093-0; Wyckmans M, 2007, J EXP MAR BIOL ECOL, V345, P119, DOI 10.1016/j.jembe.2007.02.002	77	7	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174384	10.1371/journal.pone.0174384	http://dx.doi.org/10.1371/journal.pone.0174384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334000	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200092
J	Goldin, AP; Pedroncini, O; Sigman, M				Paula Goldin, Andrea; Pedroncini, Olivia; Sigman, Mariano			Producing or reproducing reasoning? Socratic dialog is very effective, but only for a few	PLOS ONE			English	Article							KNOWLEDGE; BRAIN	Successful communication between a teacher and a student is at the core of pedagogy. A well known example of a pedagogical dialog is 'Meno', a socratic lesson of geometry in which a student learns (or 'discovers') how to double the area of a given square 'in essence, a demonstration of Pythagoras' theorem. In previous studies we found that after engaging in the dialog participants can be divided in two kinds: those who can only apply a rule to solve the problem presented in the dialog and those who can go beyond and generalize that knowledge to solve any square problems. Here we study the effectiveness of this socratic dialog in an experimental and a control high-school classrooms, and we explore the boundaries of what is learnt by testing subjects with a set of 9 problems of varying degrees of difficulty. We found that half of the adolescents did not learn anything from the dialog. The other half not only learned to solve the problem, but could abstract something more: the geometric notion that the diagonal can be used to solve diverse area problems. Conceptual knowledge is critical for achievement in geometry, and it is not clear whether geometric concepts emerge spontaneously on the basis of universal experience with space, or reflect intrinsic properties of the human mind. We show that, for half of the learners, an exampled-based Socratic dialog in lecture form can give rise to formal geometric knowledge that can be applied to new, different problems.	[Paula Goldin, Andrea; Pedroncini, Olivia; Sigman, Mariano] Univ Torcuato Tella, Lab Neurociencia, Buenos Aires, DF, Argentina; [Paula Goldin, Andrea; Sigman, Mariano] Minist Sci, CONICET, Buenos Aires, DF, Argentina	Universidad Torcuato Di Tella; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Goldin, AP (corresponding author), Univ Torcuato Tella, Lab Neurociencia, Buenos Aires, DF, Argentina.; Goldin, AP (corresponding author), Minist Sci, CONICET, Buenos Aires, DF, Argentina.	apgoldin@gmail.com		Goldin, Andrea/0000-0002-6402-0890	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) through the Fondo para la Investigacion Cientifica y Tecnologica (FonCyT) [PICT-2013-1653]; James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) through the Fondo para la Investigacion Cientifica y Tecnologica (FonCyT); James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) through the Fondo para la Investigacion Cientifica y Tecnologica (FonCyT), grant number: PICT-2013-1653, URL: http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt, funded: MS. MS is sponsored by the James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition-Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar Tikva J, 2010, TEACH TEACH EDUC, V26, P656, DOI 10.1016/j.tate.2009.10.001; Chazan D., 1993, EDUC STUD MATH, V24, P359, DOI [https://doi.org/10.1007/BF01273371, DOI 10.1007/BF01273371]; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Goldin AP, 2011, MIND BRAIN EDUC, V5, P180, DOI 10.1111/j.1751-228X.2011.01126.x; Goldin AP, 2016, MIND BRAIN ED ERICE, P180; Holper L, 2013, INT J EDUC RES, V59, P1, DOI 10.1016/j.ijer.2013.02.002; Newcombe NS, 2006, TRENDS COGN SCI, V10, P394, DOI 10.1016/j.tics.2006.07.008; Papert S, 1971, ARTIF INTELL, V249, P26; Paul R, 2007, J DEV ED, V31, P36, DOI DOI 10.1007/S10804-014-9190-1; Plato, 2008, APOLOGIA SOCRATES; Rittle-Johnson B, 1999, J EDUC PSYCHOL, V91, P175, DOI 10.1037/0022-0663.91.1.175; Satlow E, 1998, COGNITIVE DEV, V13, P547, DOI 10.1016/S0885-2014(98)90006-5; Spelke E, 2010, COGNITIVE SCI, V34, P863, DOI 10.1111/j.1551-6709.2010.01110.x; Star JR, 2005, J RES MATH EDUC, V36, P404, DOI 10.2307/30034943; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Vallortigara G, 2009, CURR OPIN NEUROBIOL, V19, P20, DOI 10.1016/j.conb.2009.02.002; Van Hiele P.M., 1959, ENGLISH TRANSLATION, P243; Wearne D, 1984, CHILDHOOD ED, V60, P239; Zare P, 2015, LANGUAGE INDIA, V15, P256; Zodik I, 2007, PME CONFERENCE PROCE, P265	20	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173584	10.1371/journal.pone.0173584	http://dx.doi.org/10.1371/journal.pone.0173584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333955	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200018
J	Berger, AW; Schwerdel, D; Welz, H; Marienfeld, R; Schmidt, SA; Kleger, A; Ettrich, TJ; Seufferlein, T				Berger, Andreas W.; Schwerdel, Daniel; Welz, Hanna; Marienfeld, Ralf; Schmidt, Stefan A.; Kleger, Alexander; Ettrich, Thomas J.; Seufferlein, Thomas			Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; CARCINOEMBRYONIC ANTIGEN; BRAF MUTATIONS; EGFR BLOCKADE; LUNG-CANCER; PLASMA; EVOLUTION; THERAPY; HETEROGENEITY; COMBINATION	Treatment of metastatic colorectal cancer (CRC) has continuously improved over the last decade. However, disease monitoring remains underdeveloped and mostly dependent on imaging e.g. RECIST 1.1 criteria. The genetic landscape of individual cancers and subsequently occurring treatment-induced evolution remain neglected in current surveillance strategies. Novel biomarkers demand minimally invasive and repetitive tracking of the cancer mutagenome for therapy stratification and to make prognostic predictions. Carcinoembryonic antigen (CEA), a routinely used tumor marker for CRC, does not meet these goals and thus prevents its use as a reliable monitoring tool. A tumor-derived fraction of circulating cell-free DNA (cfDNA), isolated from blood samples, may bypass the limitations of currently available biomarkers and could be a tool for noninvasive disease monitoring. Here, total cfDNA levels differentiated a cohort of metastatic CRC patients from healthy controls. Furthermore, we correlated cfDNA during chemotherapy of 27 stage IV patients with clinical parameters to establish its prognostic and predictive value. Indeed, cfDNA levels in chemotherapy naive patients correlate with the tumor burden and CEA values at diagnosis and increase upon disease progression during 1st and 2nd line treatment. Moreover, we confirm the possibility of cfDNA-based genotyping of KRAS to early detect the emergence of resistance during chemotherapy. These data indicate that repetitive quantitative and mutational analysis of cfDNA might complement current treatment standards but may have also limited value in some patients.	[Berger, Andreas W.; Schwerdel, Daniel; Welz, Hanna; Kleger, Alexander; Ettrich, Thomas J.; Seufferlein, Thomas] Univ Ulm, Dept Internal Med 1, Ulm, Germany; [Marienfeld, Ralf] Univ Ulm, Inst Pathol, Ulm, Germany; [Schmidt, Stefan A.] Univ Ulm, Dept Diagnost & Intervent Radiol, Ulm, Germany	Ulm University; Ulm University; Ulm University	Seufferlein, T (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, Ulm, Germany.	Thomas.seufferlein@uniklinik-ulm.de	Seufferlein, Thomas TW/P-7147-2018; Schmidt, Stefan Andreas/AAZ-3047-2020	Kleger, Alexander/0000-0003-0592-5232; Ettrich, Thomas J./0000-0002-7654-2442; Schmidt, Stefan/0000-0001-7954-4542				Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Arena S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5640; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Berger AW, 2016, GASTROENTEROLOGY, V151, P267, DOI 10.1053/j.gastro.2016.04.034; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frattini M, 2008, CANCER LETT, V263, P170, DOI 10.1016/j.canlet.2008.03.021; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Gonzalez D, 2013, BRIT J DERMATOL, V168, P700, DOI 10.1111/bjd.12248; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; KOFFLER D, 1973, J CLIN INVEST, V52, P198, DOI 10.1172/JCI107165; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rhim AD, 2014, GASTROENTEROLOGY, V146, P647, DOI 10.1053/j.gastro.2013.12.007; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Sharma MR, 2012, CANCER RES, V72, P5145, DOI 10.1158/0008-5472.CAN-12-0058; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Sorbye H, 2003, J CLIN ONCOL, V21, P4466, DOI 10.1200/JCO.2003.99.200; Spindler KLG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0108247; Spindler KLG, 2013, ACTA ONCOL, V52, P963, DOI 10.3109/0284186X.2013.776175; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; Szpechcinski A, 2015, BRIT J CANCER, V113, P476, DOI 10.1038/bjc.2015.225; Szpechcinski A, 2016, CANCER LETT, V374, P202, DOI 10.1016/j.canlet.2016.02.002; Tabernero J, 2015, LANCET ONCOL, V16, P937, DOI 10.1016/S1470-2045(15)00138-2; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Tie J, 2015, ANN ONCOL, V26, P1715, DOI 10.1093/annonc/mdv177; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Toth K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115415	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174308	10.1371/journal.pone.0174308	http://dx.doi.org/10.1371/journal.pone.0174308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328955	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700081
J	Li, L; Wojtowicz, JL; Malin, JH; Huang, T; Lee, EB; Chen, ZJ				Li, Lei; Wojtowicz, Jennifer L.; Malin, John H.; Huang, Tao; Lee, Eric B.; Chen, Zijiang			GnRH-mediated olfactory and visual inputs promote mating-like behaviors in male zebrafish	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; COURTSHIP BEHAVIOR; DANIO-RERIO; TERMINALIS; NEURONS; GENES; SENSITIVITY; EXPRESSION; PREFERENCE; DROSOPHILA	The engagement of sexual behaviors is regulated by a number of factors which include gene expression, hormone circulation, and multi-sensory information integration. In zebrafish, when a male and a female are placed in the same container, they show mating-like behaviors regardless of whether they are kept together or separated by a net. No mating-like behaviors are observed when same-sex animals are put together. Through the olfacto-visual centrifugal pathway, activation of the terminalis nerve in the olfactory bulb increases GnRH signaling in the brain and triggers mating-like behaviors between males. In zebrafish mutants or wild-type fish in which the olfacto-visual centrifugal pathway is impaired or chemically ablated, in response to odor stimulation the mating-like behaviors between males are no longer evident. Together, the data suggest that the combination of olfactory and visual signals alter male zebrafish's mating-like behaviors via GnRH signaling.	[Li, Lei; Wojtowicz, Jennifer L.; Malin, John H.; Lee, Eric B.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Huang, Tao; Chen, Zijiang] Shandong Univ, Ctr Reprod Med, Jinan, Peoples R China	University of Notre Dame; Shandong University	Li, L (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Chen, Zi-Jiang/GOE-6119-2022; Li, Lei/F-5722-2015; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022	Li, Lei/0000-0001-9703-2102; Chen, Zi-Jiang/0000-0001-6637-6631; Lee, Eric/0000-0002-3659-1020	Department of Defense [65632 LS-II, 68008-LS-II]; National Natural Science Foundation of China [81671242]; National Basic Research Program of China [9732012CB944700]	Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by grants from the Department of Defense (65632 LS-II; 68008-LS-II), the National Natural Science Foundation of China (81671242), and the National Basic Research Program of China (9732012CB944700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2009, GEN COMP ENDOCR, V164, P151, DOI 10.1016/j.ygcen.2009.01.012; Argiolas A, 2013, PROG NEUROBIOL, V108, P80, DOI 10.1016/j.pneurobio.2013.06.006; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020313; Clowney EJ, 2015, NEURON, V87, P1036, DOI 10.1016/j.neuron.2015.07.025; Cortes-Campos C, 2015, BIOL OPEN, V4, P1077, DOI 10.1242/bio.010447; Cox KH, 2014, FRONT NEUROENDOCRIN, V35, P405, DOI 10.1016/j.yfrne.2013.12.004; DOWLING JE, 1991, VISUAL NEUROSCI, V7, P87, DOI 10.1017/S0952523800010968; Dubois EA, 2002, BRAIN RES BULL, V57, P413, DOI 10.1016/S0361-9230(01)00676-1; Esposti F, 2013, NEURON, V79, P97, DOI 10.1016/j.neuron.2013.05.001; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Foster DL, 2006, MOL CELL ENDOCRINOL, V254, P109, DOI 10.1016/j.mce.2006.04.004; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gomez-Diaz C, 2013, EMBO REP, V14, P874, DOI 10.1038/embor.2013.140; Gopinath A, 2004, GENE EXPR PATTERNS, V4, P65, DOI 10.1016/S1567-133X(03)00149-2; Grens KE, 2005, BRAIN BEHAV EVOLUT, V66, P1, DOI 10.1159/000085043; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Howard RD, 2015, EVOLUTION, V69, P1143, DOI 10.1111/evo.12662; Huang LX, 2011, BRAIN RES, V1367, P43, DOI 10.1016/j.brainres.2010.10.024; Huang LX, 2005, J PHYSIOL-LONDON, V569, P939, DOI 10.1113/jphysiol.2005.099531; Iqbal T, 2010, CHEM SENSES, V35, P351, DOI 10.1093/chemse/bjq019; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Keverne EB, 2002, CELL, V108, P735, DOI 10.1016/S0092-8674(02)00687-6; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2000, J NEUROSCI, V20, P1893; Maaswinkel H, 2003, J EXP BIOL, V206, P2201, DOI 10.1242/jeb.00397; MacColl G, 2002, TRENDS ENDOCRIN MET, V13, P112, DOI 10.1016/S1043-2760(01)00545-8; Moore HA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086176, 10.1371/journal.pone.0114565]; Navarro VM, 2012, NAT REV ENDOCRINOL, V8, P40, DOI 10.1038/nrendo.2011.147; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Paredes Raul G., 1997, V8, P68; Pradhan A, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0068-6; Roselli CE, 2004, PHYSIOL BEHAV, V83, P233, DOI 10.1016/j.physbeh.2004.08.017; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sessa AK, 2008, ZEBRAFISH, V5, P335, DOI 10.1089/zeb.2008.0535; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; Somoza GM, 2002, CELL MOL NEUROBIOL, V22, P589, DOI 10.1023/A:1021888420271; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; TILBROOK AJ, 1993, HORM BEHAV, V27, P5, DOI 10.1006/hbeh.1993.1002; Torgersen J, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-25; UMINO O, 1991, J NEUROSCI, V11, P3034; Wang XK, 2011, J CELL PHYSIOL, V226, P608, DOI 10.1002/jcp.22369; Whitlock KE, 2004, MICROSC RES TECHNIQ, V65, P2, DOI 10.1002/jemt.20094; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Xia W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03676; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104330; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	52	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174143	10.1371/journal.pone.0174143	http://dx.doi.org/10.1371/journal.pone.0174143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329004	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700060
J	Bauer, H; Henschel, P; Packer, C; Sillero-Zubiri, C; Chardonnet, B; Sogbohossou, EA; De Iongh, HH; Macdonald, DW				Bauer, H.; Henschel, P.; Packer, C.; Sillero-Zubiri, C.; Chardonnet, B.; Sogbohossou, E. A.; De Iongh, H. H.; Macdonald, D. W.			Lion trophy hunting in West Africa: A response to Bouche et al.	PLOS ONE			English	Editorial Material							POPULATION-DYNAMICS; RESERVE		[Bauer, H.; Packer, C.; Sillero-Zubiri, C.; Macdonald, D. W.] Univ Oxford, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Zool, Tubney, England; [Henschel, P.] Panthera, New York, NY USA; [Packer, C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Chardonnet, B.] African Protected Areas & Wildlife, St Cloud, France; [Sogbohossou, E. A.] Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin; [De Iongh, H. H.] Leiden Univ, Inst Environm Sci, Leiden, Netherlands	University of Oxford; University of Minnesota System; University of Minnesota Twin Cities; University of Abomey Calavi; Leiden University; Leiden University - Excl LUMC	Bauer, H (corresponding author), Univ Oxford, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Zool, Tubney, England.	hans.bauer@zoo.ox.ac.uk	SOGBOHOSSOU, Etotepe A/HDL-8938-2022	Bauer, Hans/0000-0001-5031-5842				Bertola LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30807; Bouche P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155763; Bouche P, 2012, ENVIRON MONIT ASSESS, V184, P7001, DOI 10.1007/s10661-011-2475-y; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; Creel S, 2016, ECOLOGICAL APPL; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; Henschel P., 2015, IUCN RED LIST THREAT; Henschel P, 2016, FRONTIERS ECOLOGY EV, V4; IUCN/PACO, 2009, BIG GAM HUNT W AFR W; Lescuyer G, 2016, INT FORESTRY REV, V18; Lindsey PA, 2016, CONSERVATION LETT; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Ogutu JO, 2002, AFR J ECOL, V40, P120, DOI 10.1046/j.1365-2028.2002.00343.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Sogbohossou EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084674; STANDER P E, 1991, Madoqua, V18, P1; Watson FGR, 2015, REG ENVIRON CHANGE, V15, P415, DOI 10.1007/s10113-014-0629-5; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395	22	10	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173691	10.1371/journal.pone.0173691	http://dx.doi.org/10.1371/journal.pone.0173691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323837	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000024
J	Ma, JN; Meng, XL; Guo, XH; Lan, YR; Zhang, SS				Ma, Junnan; Meng, Xianglong; Guo, Xiaohui; Lan, Yaru; Zhang, Shuosheng			Thermal analysis during partial carbonizing process of rhubarb, moutan and burnet	PLOS ONE			English	Article							ISOCONVERSION METHODS; CELLULOSE PYROLYSIS; ACTIVATION-ENERGY; KINETIC-ANALYSIS; THERMOGRAVIMETRY; DECOMPOSITION; MODEL	Control of temperature and duration of partial carbonization for Chinese medicines have been mainly based on experience of the processors. No quantitative methods and parameters are available that can be used to precisely control the temperature and determine the energy changes during the process. In our research, with a simulated atmosphere air condition, the partial carbonization processes of three Chinese herb medicines rhubarb, moutan and burnet were simulated at different heating rates (5, 10 and 20 degrees C . min(-1)) and analyzed by thermal gravimetric analysis (TGA) to quantify the upper limits of the temperature. The activation energy was calculated with Friedman, Kissinger-Akahira-Sunose (KAS) method and Ozawa-Flynn- Wall (OFW) methods in iso-conversional models and independent parallel reaction model (IPR). The upper temperatures were calculated to be 280, 184 and 246 degrees C for rhubarb, moutan and burnet, respectively, at corresponding conversion rates of 0.4, 0.2 and 0.1. Calculation of the activation energy has been found impossible with the IPR model. Results obtained from the three iso-conversional methods were different. For rhubarb and burnet, the conversion rates at the upper temperature limits were at the highest or second highest activation energy, while for moutan, it was at the lowest value of activation energy. These results confirmed scientific rationales of traditional Chinese medicine theory that rhubarb and burnet be prepared at high temperature and moutan be prepared at medium temperature. Application of thermal analysis techniques would broaden and deepen traditional Chinese medicine research, and are applicable to the processing of medicinal materials including traditional Chinese medicines. Results obtained from the study could provide new ideas and methods for research to modernize the preparation of traditional Chinese medicines.	[Ma, Junnan; Meng, Xianglong] Dongguk Univ, Coll Oriental Med, Dept Herbol, Gyeongju, South Korea; [Ma, Junnan; Meng, Xianglong; Lan, Yaru; Zhang, Shuosheng] Shanxi Univ Tradit Chinese Med, Inst Pharmaceut & Food Engn, Jinzhong, Shanxi, Peoples R China; [Guo, Xiaohui] Chinese Acad Sci, Key Lab Carbon Mat, Inst Coal Chem, Taiyuan, Shanxi, Peoples R China	Dongguk University; Chinese Academy of Sciences; Institute of Coal Chemistry, CAS	Zhang, SS (corresponding author), Shanxi Univ Tradit Chinese Med, Inst Pharmaceut & Food Engn, Jinzhong, Shanxi, Peoples R China.	zhangshuosheng@aliyun.com	Meng, Xiang-Long/GXV-5867-2022		National Natural Science Foundation of China [81173555]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (81173555)	Bian J, 2013, THESIS; Brown ME, 2000, THERMOCHIM ACTA, V355, P125, DOI 10.1016/S0040-6031(00)00443-3; Brown ME, 1997, J THERM ANAL, V49, P17, DOI 10.1007/BF01987418; Cai BC, 2009, PREPARATION TRADITIO, P1; Cai JM, 2008, ENERG FUEL, V22, P867, DOI 10.1021/ef7006672; Chen JY, 2010, MODERNIZATION TRADIT, V04, P511; [陈佩东 CHEN Peidong], 2006, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V22, P302; Chen XJ, 2013, CHINESE ARCH TRADITI, V07, P1671; China Pharmacopoeia Committee, 2010, CHINESE PHARMACOPOEI, P62; Chunxiu G, 2004, J THERM ANAL CALORIM, V76, P203, DOI 10.1023/B:JTAN.0000027819.43154.52; Damartzis T, 2011, BIORESOURCE TECHNOL, V102, P6230, DOI 10.1016/j.biortech.2011.02.060; Deng GH, 2013, CHINESE J EXPT TRADI, V7, P35; Fan XF, 2012, CHINESE J GRASSLAND, V1, P48; FLYNN JH, 1990, J THERM ANAL, V36, P1579, DOI 10.1007/BF01914077; Flynn JH, 1997, THERMOCHIM ACTA, V300, P83, DOI 10.1016/S0040-6031(97)00046-4; FRIEDMAN HL, 1964, J POLYM SCI POL SYM, P183; Hill J.O, 1991, INT CONFEDERATION TH, Vthird; Hu FL, 2009, THESIS; Jiang T, 2013, CHINA J CHINESE MAT, V7, P1000; Ke J, 2013, FUEL, V104, P781, DOI 10.1016/j.fuel.2012.06.066; KEATTCH CJ, 1991, J THERM ANAL, V37, P2089, DOI 10.1007/BF01905580; Kim S, 2006, KOREAN J CHEM ENG, V23, P409, DOI 10.1007/BF02706742; Li X, 2012, PLANT DIS PEST, V3, P34; Li ZQ, 2008, BIORESOURCE TECHNOL, V99, P7616, DOI 10.1016/j.biortech.2008.02.003; Liao Q, 2013, PHARM CLINICS CHINES, V2, P21; Lin T.C., 2010, THESIS; Lopez R. J., 2001, ADV ENG MATH; Lu LM, 2012, THERM ANAL, P112; Ma JN, 2013, WORLD J INTEGRATED T, V8, P468; Meng X.J., 2013, THESIS; Meng XL, 2014, CHIN J NAT MEDICINES, V12, P55, DOI [10.3724/SP.J.1009.2014.00055, 10.1016/S1875-5364(14)60010-8]; Meng XL, 2012, CHINA J CHINESE MAT, V23, P3558; Orfao JJM, 1999, FUEL, V78, P349, DOI 10.1016/S0016-2361(98)00156-2; OZAWA T, 1992, THERMOCHIM ACTA, V203, P159, DOI 10.1016/0040-6031(92)85192-X; [彭凯 Peng Kai], 2013, [中成药, Chinese Traditional Patent Medicine], V35, P140; [宋爱新 Song Aixin], 2003, [中草药, Chinese Traditional and Herbal Drugs], V34, P169; Starink MJ, 2003, THERMOCHIM ACTA, V404, P163, DOI 10.1016/S0040-6031(03)00144-8; Su M., 2013, CHINESE J EXPT TRADI, V19, P190, DOI [10.11653/syfj2013090190, DOI 10.11653/SYFJ2013090190]; Sun FJ, 2011, LIAONING J TRADITION, V1, P177; Tang S, 2013, CHINESE J EXPT TRADI, V8, P10, DOI DOI 10.1371/J0URNAL.P0NE; Tu YS, 2013, CHINESE J EXPT TRADI, V5, P13; Varhegyi G, 1997, J ANAL APPL PYROL, V42, P73, DOI 10.1016/S0165-2370(96)00971-0; Vyazovkin S, 1997, J PHYS CHEM A, V101, P8279, DOI 10.1021/jp971889h; Wang DZ, 2013, J CHINESE MED MAT, V1, P35; Wang Shu-Jun, 2007, Zhongguo Zhong Yao Za Zhi, V32, P296; Ye F, 2013, CHINESE J EXPT TRADI, V12, P83; Yu FR, 2012, THESIS; Yu LiPing, 2011, Acta Scientiarum Naturalium Universitatis Sunyatseni, V50, P94; Zeng JJ, 2011, INT BIODETER BIODEGR, V65, P410, DOI 10.1016/j.ibiod.2011.01.004; Zeng LY, 2013, CHINESE TRADITIONAL, V12, P1584; Zhou YF, 2012, CHINESE J EXPT TRADI, V16, P16; Zhuang G, 2013, CHINA J CHINESE MAT, V10, P1526	52	15	18	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173946	10.1371/journal.pone.0173946	http://dx.doi.org/10.1371/journal.pone.0173946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323877	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000047
J	Philippon, H; Souvane, A; Brochier-Armanet, C; Perriere, G				Philippon, Heloise; Souvane, Alexia; Brochier-Armanet, Celine; Perriere, Guy			IsoSel: Protein Isoform Selector for phylogenetic reconstructions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; POSITIVE SELECTION; EVOLUTION; VERSION; TREE; GENERATION; ALGORITHM; SOFTWARE	The reliability of molecular phylogenies is strongly dependent on the quality of the assembled datasets. In the case of eukaryotes, the selection of only one protein isoform per genomic locus is mandatory to avoid biases linked to redundancy. Here, we present IsoSel, a tool devoted to the selection of alternative isoforms in the context of phylogenetic reconstruction. It provides a better alternative to the widely used approach consisting in the selection of the longest isoforms and it performs better than Guidance, its only available counterpart. IsoSel is publicly available at http://doua.prabl.fr/softvvare/isosel.	[Philippon, Heloise; Souvane, Alexia; Brochier-Armanet, Celine; Perriere, Guy] Univ Claude Bernard Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Perriere, G (corresponding author), Univ Claude Bernard Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France.	guy.perriere@univ-lyon1.fr	Brochier-Armanet, Celine/B-7898-2011	Brochier-Armanet, Celine/0000-0003-4669-3589	CNRS; Institut Francais de Bioinformatique; France Genomique consortium; Region Rhone-Alpes PhD [13012735-01]; "Ancestrome" project through the Agence Nationale de la Recherche [ANR-10-BINF-01-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Francais de Bioinformatique; France Genomique consortium; Region Rhone-Alpes PhD; "Ancestrome" project through the Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the Institut Francais de Bioinformatique to GP, the France Genomique consortium for GP, and the Region Rhone-Alpes PhD thesis grant 13012735-01, which was funding the Ph.D of HP. CBA is a member of the Institut Universitaire de France and is funded by the "Ancestrome" project through the Agence Nationale de la Recherche grant ANR-10-BINF-01-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Carneiro M, 2012, MOL BIOL EVOL, V29, P1837, DOI 10.1093/molbev/mss025; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hughes AL, 2007, MOL PHYLOGENET EVOL, V45, P81, DOI 10.1016/j.ympev.2007.04.022; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lecointre G., 2006, TREE LIFE PHYLOGENET; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Villanueva-Canas JL, 2013, GENOME BIOL EVOL, V5, P457, DOI 10.1093/gbe/evt017; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stolzer M, 2012, BIOINFORMATICS, V28, pI409, DOI 10.1093/bioinformatics/bts386; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zou ZT, 2015, MOL BIOL EVOL, V32, P2085, DOI 10.1093/molbev/msv091	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174250	10.1371/journal.pone.0174250	http://dx.doi.org/10.1371/journal.pone.0174250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323858	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000080
J	Roets-Merken, L; Zuidema, S; Vernooij-Dassen, M; Dees, M; Hermsen, P; Kempen, G; Graff, M				Roets-Merken, Lieve; Zuidema, Sytse; Vernooij-Dassen, Myrra; Dees, Marianne; Hermsen, Pieter; Kempen, Gertrudis; Graff, Maud			Problems identified by dual sensory impaired older adults in long-term care when using a self-management program: A qualitative study	PLOS ONE			English	Article							NURSING-HOME; DEAFBLINDNESS; COMMUNICATION; RESIDENTS; HEARING; RECORDS; PEOPLE	Objective To gain insights into the problems of dual sensory impaired older adults in long-term care. Insights into these problems are essential for developing adequate policies which address the needs of the increasing population of dual sensory impaired older adults in long-term care. Methods A qualitative study was conducted in parallel with a cluster randomized controlled trial. Dual sensory impaired older adults in the intervention group (n = 47, age range 82-98) were invited by a familiar nurse to identify the problems they wanted to address. Data were taken from the semi-structured intervention diaries in which nurses noted the older adults' verbal responses during a five-month intervention period in 17 long-term care homes across the Netherlands. The data were analyzed using descriptive statistics and qualitative content analysis based on the Grounded Theory. Findings The 47 dual sensory impaired older adults identified a total of 122 problems. Qualitative content analysis showed that the older adults encountered participation problems and problems controlling what happens in their personal environment. Three categories of participation problems emerged: (1) existential concerns of not belonging or not being able to connect with other people, (2) lack of access to communication, information and mobility, and (3) the desire to be actively involved in care delivery. Two categories of control-in-personal-space problems emerged: (1) lack of control of their own physical belongings, and (2) lack of control regarding the behavior of nurses providing daily care in their personal environment. Conclusions The invasive problems identified indicate that dual sensory impaired older adults experience great existential pressures on their lives. Long-term care providers need to develop and implement policies that identify and address these problems, and be aware of adverse consequences of usual care, in order to improve dual sensory impaired residents' autonomy and quality of life.	[Roets-Merken, Lieve; Vernooij-Dassen, Myrra; Graff, Maud] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Donders Inst Cognit Brain & Behav, Nijmegen, Netherlands; [Roets-Merken, Lieve] Kalorama Fdn, Beek Ubbergen, Netherlands; [Zuidema, Sytse] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands; [Dees, Marianne; Graff, Maud] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands; [Hermsen, Pieter] Severinus Fdn, Veldhoven, Netherlands; [Kempen, Gertrudis] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Maastricht, Netherlands	Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen; Maastricht University	Roets-Merken, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Donders Inst Cognit Brain & Behav, Nijmegen, Netherlands.; Roets-Merken, L (corresponding author), Kalorama Fdn, Beek Ubbergen, Netherlands.	lieve.roets-merken@radboudumc.nl	Dees, marianne/E-5608-2016; Kempen, Gertrudis/Y-8796-2019; Graff, M.J.L./L-4333-2015; Dees, Marianne/AAL-2814-2021; Kempen, Gertrudis I/H-5978-2016	Dees, marianne/0000-0001-9749-880X; Kempen, Gertrudis/0000-0002-7053-2198; Kempen, Gertrudis I/0000-0002-7053-2198; Roets-Merken, Lieve/0000-0002-7248-7968	Joannes de Deo Foundation; Mother Catharina Fund in the Netherlands	Joannes de Deo Foundation; Mother Catharina Fund in the Netherlands	This study is made possible by the financial support from the Joannes de Deo Foundation and the Mother Catharina Fund in the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bakker-de Pree B, 1983, CONSTRUCTIONELE GEDR; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Centraal Indicatieorgaan Zorg, 2014, TRENDR 2013; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Dammeyer J, 2014, SCAND J PUBLIC HEALT, V42, P554, DOI 10.1177/1403494814544399; Danermark B, 2008, INT J AUDIOL, V47, pS119, DOI 10.1080/14992020802307388; de Boer MR, 2005, EUR J OPHTHALMOL, V15, P400, DOI 10.1177/112067210501500314; Dullard B, 2016, GERONTOLOGIST, V56, P313, DOI 10.1093/geront/gnu032; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Goll JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116664; Gopinath B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055054; Gustavsson M, 2015, SCAND J OCCUP THER, V22, P435, DOI 10.3109/11038128.2015.1044907; Guthrie DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155073; Heine C, 2004, AGEING SOC, V24, P113, DOI 10.1017/S0144686X03001491; Hersh M, 2013, J DEAF STUD DEAF EDU, V18, P446, DOI 10.1093/deafed/ent022; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Larsen FA, 2014, RES DEV DISABIL, V35, P2568, DOI 10.1016/j.ridd.2014.05.029; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lupsakko T, 2002, INT J GERIATR PSYCH, V17, P808, DOI 10.1002/gps.689; Roets-Merken LM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013122; Roets-Merken LM, 2015, CLIN REHABIL, V29, P107, DOI 10.1177/0269215514542639; Roets-Merken LM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-321; Schneider JM, 2011, J AGING HEALTH, V23, P1309, DOI 10.1177/0898264311408418; Sinoo MM, 2012, J CLIN NURS, V21, P1913, DOI 10.1111/j.1365-2702.2012.04128.x; Theurer K, 2015, J AGING STUD, V35, P201, DOI 10.1016/j.jaging.2015.08.011; Vaal J, 2007, Ned Tijdschr Geneeskd, V151, P1459; WHO, HEAR IMP GRAD 2016; Yamada Y, 2015, J GERONTOL A; Yamada Y, 2017, J OCEANOGR, V73, P11, DOI 10.1007/s10872-015-0336-y	30	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173601	10.1371/journal.pone.0173601	http://dx.doi.org/10.1371/journal.pone.0173601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323846	Green Published, gold			2022-12-27	WOS:000399089000021
J	Gallimidi, AB; Nussbaum, G; Hermano, E; Weizman, B; Meirovitz, A; Vlodavsky, I; Gotte, M; Elkin, M				Gallimidi, Adi Binder; Nussbaum, Gabriel; Hermano, Esther; Weizman, Barak; Meirovitz, Amichay; Vlodavsky, Israel; Goette, Martin; Elkin, Michael			Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; INFLAMMATORY-BOWEL-DISEASE; CELL-SURFACE PROTEOGLYCAN; EPITHELIAL SYNDECAN-1; LINKING INFLAMMATION; ULCERATIVE-COLITIS; KAPPA-B; CANCER; EXPRESSION; STAT3	Syndecan-1 (Sdc1) is an important member of the cell surface heparan sulfate proteoglycan family, highly expressed by epithelial cells in adult organisms. Sdc1 is involved in the regulation of cell migration, cell-cell and cell-matrix interactions, growth-factor, chemokine and integrin activity, and implicated in inflammatory responses and tumorigenesis. Gastrointestinal tract represents an important anatomic site where loss of Sdc1 expression was reported both in inflammation and malignancy. However, the biological significance of Sdc1 in chronic colitis-associated tumorigenesis has not been elucidated. To the best of our knowledge, this study is the first to test the effects of Sdc1 loss on colorectal tumor development in inflammation-driven colon tumorigenesis. Utilizing a mouse model of colitis-related colon carcinoma induced by the carcinogen azoxymethane (AOM), followed by the inflammatory agent dextran sodium sulfate (DSS), we found that Sdc1 deficiency results in increased susceptibility to colitis-associated tumorigenesis. Importantly, colitis-associated tumors developed in Sdc1-defficient mice were characterized by increased local production of IL-6, activation of STAT3, as well as induction of several STAT3 target genes that act as important effectors of colonic tumorigenesis. Altogether, our results highlight a previously unknown effect of Sdc1 loss in progression of inflammation-associated cancer and suggest that decreased levels of Sdc1 may serve as an indicator of colon carcinoma progression in the setting of chronic inflammation.	[Gallimidi, Adi Binder; Hermano, Esther; Weizman, Barak; Meirovitz, Amichay; Elkin, Michael] Hadassah Hebrew Univ, Med Ctr, Sharett Oncol Inst, Jerusalem, Israel; [Nussbaum, Gabriel] Hebrew Univ Jerusalem, Inst Dent Sci, Hadassah Fac Dent Med, Jerusalem, Israel; [Vlodavsky, Israel] Technion, Canc & Vasc Biol Res Ctr, Rappaport Fac Med, Haifa, Israel; [Goette, Martin] Muenster Univ, Dept Gynecol & Obstet, Med Ctr, Munster, Germany	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Munster	Elkin, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Oncol Inst, Jerusalem, Israel.	melkin@hadassah.org.il	Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496	German Israel Research Foundation (GIF) [1-1004-202.15/2008]; Israel Science Foundation [806/14]; Mizutani Foundation for Glycoscience	German Israel Research Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Mizutani Foundation for Glycoscience	This work was supported by the German Israel Research Foundation (GIF) grant No. 1-1004-202.15/2008 (to ME, MG and IV), Israel Science Foundation (grant 806/14) and the Mizutani Foundation for Glycoscience (to ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl MR, 2015, ONCOTARGET, V6, P28693, DOI 10.18632/oncotarget.4981; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; BEAULIEU JF, 1991, ANAT EMBRYOL, V183, P363; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Becker C, 2005, CELL CYCLE, V4, P217; Belmiro CLR, 2005, INT J COLORECTAL DIS, V20, P295, DOI 10.1007/s00384-004-0677-2; Bento AF, 2012, BIOCHEM PHARMACOL, V84, P1459, DOI 10.1016/j.bcp.2012.09.007; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Cekic C, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/850351; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Clevers H, 2006, NEW ENGL J MED, V354, P761, DOI 10.1056/NEJMcibr055457; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Day R, 1999, DIGEST DIS SCI, V44, P2508, DOI 10.1023/A:1026647308089; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hashimoto Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-185; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kim SY, 2015, INT J MED SCI, V12, P92, DOI 10.7150/ijms.10497; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Knelson EH, 2014, TRENDS BIOCHEM SCI, V39, P277, DOI 10.1016/j.tibs.2014.03.001; Kumar K, 2005, ROBBINS COTRANS PATH, V7, P213; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Lundin M, 2005, ONCOLOGY-BASEL, V68, P306, DOI 10.1159/000086969; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oshiro M, 2001, HISTOCHEM CELL BIOL, V115, P373; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Patterson AM, 2012, INFLAMM BOWEL DIS, V18, P1112, DOI 10.1002/ibd.21879; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; SIMONASSMANN P, 1989, J CELL BIOL, V109, P1837, DOI 10.1083/jcb.109.4.1837; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wei HT, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0383-2; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yablecovitch D, 2011, J PHARMACOL EXP THER, V337, P391, DOI 10.1124/jpet.110.174276; Yuan K, 2004, BLOOD, V104, P1025, DOI 10.1182/blood-2003-09-3334; Zhang SH, 2013, INFLAMM BOWEL DIS, V19, P1025, DOI 10.1097/MIB.0b013e318280298f; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931	70	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174343	10.1371/journal.pone.0174343	http://dx.doi.org/10.1371/journal.pone.0174343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350804	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174400026
J	Sanchez, PR; Prieto, L; De Ory, SJ; Cooke, EF; Navarro, ML; Ramos, JT; Holguin, A				Sanchez, Patricia Rojas; Prieto, Luis; De Ory, Santiago Jimenez; Cooke, Elisa Fernandez; Navarro, Maria Luisa; Ramos, Jose Tomas; Holguin, Africa		Madrid Cohort HIV-1 Infected; Spanish Natl AIDS Network CoRISPe	Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; 1ST-LINE ANTIRETROVIRAL THERAPY; PROTEASE-INHIBITOR; DRUG-RESISTANCE; PEDIATRIC POPULATION; VIROLOGICAL SUCCESS; LOPINAVIR/RITONAVIR; NEVIRAPINE; MUTATIONS; LABEL	Background The most-used protease-inhibitor in children is Lopinavir-ritonavir (LPV/r), which provides durable suppression of viral load and increases CD4+T-counts. This study describes the virological outcome of the HIV-1-infected paediatric population exposed to LPV/r during 15 years in Spain. Methodology Patients from the Madrid Cohort of HIV-1- infected-children and adolescents exposed to LPV/r as different line therapy during 2000 - 2014 were selected. The baseline epidemiological-clinical features, viral suppression, changes in CD4+T-CD8+T cell counts and drug susceptibility were recorded before and during LPV/r exposure. Drug resistance mutations (DRM) were identified in viruses from samples collected until 2011. We predicted drug susceptibility to 19 antiretrovirals among those carrying DRM using the Stanford's HIVdb Algorithm. Results A total of 199 (37.3%) of the 534 patients from the cohort were exposed to LPV/r during 2000-2014 in first (group 1), second (group 2) or more line-therapies (group 3). Patients were mainly Spaniards (81.9%), perinatally infected (96.5%) with subtype-B (65.3%) and HIV-diagnosed before year 2000 (67.8%). The mean age at first LPV/r exposure was 9.7 years. After protease-inhibitor exposure, viral suppression was higher in groups 1 and 2 than in group 3. Viral suppression occurred in 87.5%, 68.6% and 64.8% patients from groups 1, 2 and 3, respectively. Among the 64 patients with available resistance data during LPV/r treatment, 27(42.3%) carried DRM to protease-inhibitor, 28 (58.3%) to reverse-transcriptase- inhibitors and 21 (43.7%) to non-reverse-transcriptase-inhibitors. Darunavir/ritonavir, atazanavir-ritonavir and tipranavir/ritonavir presented the highest susceptibility and nelfinavir the lowest. Conclusions A better lymphocyte recovering occurred when protease-inhibitor was taken as part of a first-line regimen and a higher number of patients reached viral suppression. The least compromised antiretrovirals for rescue antiretroviral regimens, according to DRM in the LPV/rexposed- paediatric cohort, were mainly the new protease inhibitors.	[Sanchez, Patricia Rojas; Holguin, Africa] Hosp RamOn y Cajal IRYCIS, Microbiol & Parasitol Dept, HIV Mol Epidemiol Lab 1, Madrid, Spain; [Sanchez, Patricia Rojas; Holguin, Africa] CIBER ESP, Madrid, Spain; [Prieto, Luis] Hosp Univ Getafe, Dept Infect Dis, Madrid, Spain; [De Ory, Santiago Jimenez] Hosp Univ Gregorio Maranon IISGM, Mol Inmunobiol Lab, Madrid, Spain; [De Ory, Santiago Jimenez] CIBER BBN, Madrid, Spain; [Cooke, Elisa Fernandez] Hosp Univ Doce Octubre, Infect Dis Dept, Madrid, Spain; [Navarro, Maria Luisa] Hosp Univ Gregorio Maranon, Paediat Dept, Infect Dis Unit, Madrid, Spain; [Ramos, Jose Tomas] Hosp Clin Univ, Infect Dis Dept, Madrid, Spain; [Ramos, Jose Tomas] Univ Complutense, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario de Getafe; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; Complutense University of Madrid	Holguin, A (corresponding author), Hosp RamOn y Cajal IRYCIS, Microbiol & Parasitol Dept, HIV Mol Epidemiol Lab 1, Madrid, Spain.; Holguin, A (corresponding author), CIBER ESP, Madrid, Spain.	africa.holguin@salud.madrid.org	Holguín, Africa/AAF-9001-2021; Prieto, Luis Enrique/HFZ-7903-2022	Holguín, Africa/0000-0002-1330-8050; Fernandez-Cooke, Elisa/0000-0002-5921-8261; , Patricia/0000-0001-6935-0066	Plan Nacional de I+D+I, Institute de Salud Carlos III (ISCIII) [FIS PI12/00240]; European Development Regional Fund "A way to achieve Europe" (ERDF); Institute de Salud Carlos III, Spanish Health Ministry [RD06/0006/0035]; Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE); Plan Nacional de I+D+I [RD12/0017/0035, RD12/0017/0037]; ISCIII-Subdireccion General de Evaluacion	Plan Nacional de I+D+I, Institute de Salud Carlos III (ISCIII); European Development Regional Fund "A way to achieve Europe" (ERDF); Institute de Salud Carlos III, Spanish Health Ministry; Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE); Plan Nacional de I+D+I; ISCIII-Subdireccion General de Evaluacion	This study was supported by Plan Nacional de I+D+I 2008-2011, Institute de Salud Carlos III (ISCIII), FIS PI12/00240 and cofinanced by the European Development Regional Fund "A way to achieve Europe" (ERDF). This study is included in the Subprograma de Inmigracion y Salud from CIBERESP (Spain). We want to particularly acknowledge the patients in this study for their participation and the Pediatric HIV BioBank integrated in the Spanish AIDS Research Network for providing two clinical samples used in this work. The Pediatric HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by Institute de Salud Carlos III, Spanish Health Ministry (Grant no RD06/0006/0035) and Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE). CoRISPe cohort is funded by RD12/0017/0035 and RD12/0017/0037 Project, supported by Plan Nacional de I+D+I and cofinanced by the ISCIII-Subdireccion General de Evaluacion and European Development Regional Fund "A way to achieve Europe" (ERDF). We thank CoRISPE and the professionals responsible for the routine resistance testing in the participant hospitals for providing epidemiological-clinical data and pol sequences of enrolled patients when available.; We want to particularly acknowledge the patients in this study for their participation and the Paediatric HIV BioBank integrated in the Spanish AIDS Research Network for providing two clinical samples used in this work. The Paediatric HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by Instituto de Salud Carlos III, Spanish Health Ministry (Grant no RD06/0006/0035) and Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE). CoRISPe cohort is funded by RD12/0017/0035 and RD12/0017/0037 Project, supported by Plan Nacional de I+D+I and cofinanced by the ISCIII-Subdireccion General de Evaluacion and European Development Regional Fund "A way to achieve Europe" (ERDF). We thank CoRISPE and the professionals responsible for the routine resistance testing in the participant hospitals for providing epidemiological-clinical data and pol sequences of enrolled patients when available.	Abbott laboratories, 2010, KAL HIGHL PRESCR INF; Aldeguer L, 2007, ENFERM INFEC MICR CL, V25, P32, DOI 10.1157/13096750; [Anonymous], US ANT DRUGS TREAT P; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Bongiovanni M, 2003, ANTIVIR THER, V8, P209; Chadwick EG, 2011, AIDS, V25, P643, DOI 10.1097/QAD.0b013e32834403f6; Childs T, 2015, LANCET HIV, V2, pE151, DOI 10.1016/S2352-3018(15)00021-1; Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9; Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004; de Mulder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052155; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Delaugerre C, 2004, JAIDS-J ACQ IMM DEF, V37, P1269, DOI 10.1097/01.qai.0000137408.78031.37; European Medicines Agency, 2009, EMEAHC00036820090; Fernandez-Cooke E, 2016, ANTIVIR THER, V21, P65, DOI 10.3851/IMP2973; Frange P, 2011, PEDIATR INFECT DIS J, V30, P684, DOI 10.1097/INF.0b013e31821752d6; Garcia-Merino I, 2010, AIDS RES HUM RETROV, V26, P241, DOI 10.1089/aid.2009.0122; Holguin A, 2011, PEDIATR INFECT DIS J, V30, pE82, DOI 10.1097/INF.0b013e3182117289; Huang XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08528; Jenabian MA, 2015, EXPERT REV ANTI-INFE, V13, P1213, DOI 10.1586/14787210.2015.1068117; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Martinez BL, 2010, HIV AIDS-RES PALLIAT, V2, P59; Meyers T, 2015, PEDIATR INFECT DIS J, V34, P175, DOI 10.1097/INF.0000000000000544; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Penazzato M, 2014, COCHRANE DB SYST REV, V22; Penazzato M, 2015, CLIN INFECT DIS, V60, pS177, DOI 10.1093/cid/civ110; Ramos JT, 2009, HIV MED, V10, P536, DOI 10.1111/j.1468-1293.2009.00728.x; Sanchez PR, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.003; Sanchez PR, 2014, J ANTIMICROB CHEMOTH, V69, P2032, DOI 10.1093/jac/dku104; Saez-Llorens X, 2003, PEDIATR INFECT DIS J, V22, P216, DOI 10.1097/00006454-200303000-00003; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Yin DE, 2014, PEDIATRICS, V134, pE1104, DOI 10.1542/peds.2014-0527	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173168	10.1371/journal.pone.0173168	http://dx.doi.org/10.1371/journal.pone.0173168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350802	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174400005
J	Griva, K; Stygall, J; Wilson, MH; Martin, D; Levett, D; Mitchell, K; Mythen, M; Montgomery, HE; Grocott, MP; Aref-Adib, G; Edsell, M; Plant, T; Imray, C; Cooke, D; Harrington, J; Khosravi, M; Newman, SP				Griva, Konstadina; Stygall, Jan; Wilson, Mark H.; Martin, Daniel; Levett, Denny; Mitchell, Kay; Mythen, Monty; Montgomery, Hugh E.; Grocott, Mike P.; Aref-Adib, Golnar; Edsell, Mark; Plant, Tracie; Imray, Chris; Cooke, Debbie; Harrington, Jane; Khosravi, Maryam; Newman, Stanton P.		Caudwell Xtreme Everest Res Grp	Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning	PLOS ONE			English	Article							ALTITUDE; PERFORMANCE; DYSFUNCTION; SURGERY	Background The neuropsychological consequences of exposure to environmental hypobaric hypoxia (EHH) remain unclear. We thus investigated them in a large group of healthy volunteers who trekked to Mount Everest base camp (5,300 m). Methods A neuropsychological (NP) test battery assessing memory, language, attention, and executive function was administered to 198 participants (age 44.5 +/- 13.7 years; 60% male). These were studied at baseline (sea level), 3,500 m (Namche Bazaar), 5,300 m (Everest Base Camp) and on return to 1,300 m (Kathmandu) (attrition rate 23.7%). A comparable control group (n = 25; age 44.5 +/- 14.1 years; 60% male) for comparison with trekkers was tested at/or near sea level over an equivalent timeframe so as to account for learning effects associated with repeat testing. The Reliable Change Index (RCI) was used to calculate changes in cognition and neuropsychological function during and after exposure to EHH relative to controls. Results Overall, attention, verbal ability and executive function declined in those exposed to EHH when the performance of the control group was taken into account (RCI.05 to -. 95) with decline persisting at descent. Memory and psychomotor function showed decline at highest ascent only (RCI -. 08 to -. 56). However, there was inter-individual variability in response: whilst NP performance declined in most, this improved in some trekkers. Cognitive decline was greater amongst older people (r =.42; p <.0001), but was otherwise not consistently associated with socio-demographic, mood, or physiological variables. Conclusions After correcting for learning effects, attention, verbal abilities and executive functioning declined with exposure to EHH. There was considerable individual variability in the response of brain function to sustained hypoxia with some participants not showing any effects of hypoxia. This might have implications for those facing sustained hypoxia as a result of any disease.	[Griva, Konstadina; Stygall, Jan; Newman, Stanton P.] City Univ London, Hlth Serv Res Grp, Coll Bldg Room A224, London, England; [Griva, Konstadina] Natl Univ Singapore, Dept Psychol, 9 Arts Link AS4-02-28, Singapore, Singapore; [Wilson, Mark H.] Imperial Coll, Traumat Brain Injury Ctr, London, England; [Wilson, Mark H.] Queen Mary Univ, Londons Air Ambulance, London, England; [Martin, Daniel; Mitchell, Kay; Mythen, Monty; Montgomery, Hugh E.; Grocott, Mike P.; Khosravi, Maryam] UCL, Inst Human Hlth & Performance, London, England; [Levett, Denny; Grocott, Mike P.] Univ Hosp Southampton, Anaesthesia & Crit Care Res Unit, Southampton, Hants, England; [Grocott, Mike P.] Univ Southampton, Fac Med, Div Clin & Expt Sci, Integrat Physiol & Crit Illness Grp, Southampton, Hants, England; [Grocott, Mike P.] Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England; [Aref-Adib, Golnar; Harrington, Jane] UCL, Div Psychiat, London, England; [Edsell, Mark] St George Hosp, London, England; [Plant, Tracie] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Imray, Chris] Warwick Med Sch, Div Translat & Syst Med, Warwick, England; [Cooke, Debbie] Univ Surrey, Fac Hlth & Med Sci, Sch Hlth Sci, Surrey, England	City University London; National University of Singapore; Imperial College London; University of London; Queen Mary University London; University of London; University College London; University of Southampton; University of Southampton; University of London; University College London; St Georges University London; University of Edinburgh; University of Warwick; University of Surrey	Newman, SP (corresponding author), City Univ London, Hlth Serv Res Grp, Coll Bldg Room A224, London, England.	Stanton.Newman.1@city.ac.uk	Grocott, Michael/C-4394-2008; Griva, Konstadina/A-6549-2018; Levett, Denny Zelda Hope/AAY-4627-2021; Levett, Denny/F-4474-2011; Levett, Denny/D-2239-2017; Mitchell, Kay/ABC-2981-2020; Mitchell, Kay/F-8974-2012; Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	Grocott, Michael/0000-0002-9484-7581; Levett, Denny Zelda Hope/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Mitchell, Kay/0000-0001-6393-8475; Newman, Stanton/0000-0001-6712-6079; Montgomery, Hugh/0000-0001-8797-5019; GRIVA, KONSTADINA/0000-0001-8173-5663; Cooke, Debbie/0000-0003-1944-7905; Wilson, Mark/0000-0002-2346-4911; Richardson, Alan/0000-0001-8931-2518; imray, chris/0000-0001-8451-4102; Martin, Daniel/0000-0001-6220-8235; Aref-Adib, Golnar/0000-0003-2220-5317; Murray, Andrew/0000-0002-0929-9315	United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Eli Lilly; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; National Institute for Health Research [ACF-2013-18-011] Funding Source: researchfish	United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Eli Lilly(Eli Lilly); London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded from a variety of sources, none of which are public: Mr John Caudwell, BOC Medical (now part of Linde Gas therapeutics), Eli Lilly Critical Care, the London Clinic, Smiths Medical, Deltex Medical and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation and the Sir Halley Stewart Trust. The Caudwell Xtreme Everest volunteers who trekked to Everest base camp also kindly donated to support the research. Some of this work was undertaken at University College London Hospital University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of, Mr. John Caudwell, BOC Medical (now part of Linde Gas Therapeutics), Eli Lilly, the London Clinic, Smiths Medical, Deltex Medical, and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation, the Sir Halley Stewart Trust, Tonia Griva, Kevin FY Lam and all members of the Caudwell Xtreme Everest Research Group as follows: Investigators V. Ahuja, G. Aref-Adib, R. Burnham, A. Chisholm, K. Clarke, D. Coates, M. Coates, D. Cook, M. Cox, S. Dhillon, C. Dougall, P. Doyle, P. Duncan, M. Edsell, L. Edwards, L. Evans, P. Gardiner, M. P. Grocott, P. Gunning, N. Hart, J. Harrington, J. Harvey, C. Holloway, D. Howard, D. Hurlbut, C. Imray, C. Ince, M. Jonas, J. van der Kaaij, M. Khosravi, N. Kolfschoten, D. Levett, H. Luery, A. Luks, D. Martin, R. McMorrow, P. Meale, K. Mitchell, H. E. Montgomery, G. Morgan, J. Morgan, A. Murray, M. Mythen, S. P. Newman, M. O'Dwyer, J. Pate, T. Plant, M. Pun, P. Richards, A. Richardson, G. Rodway, J. Simpson, C. Stroud, M. Stroud, J. Stygal, B. Symons, P. Szawarski, A. Van Tulleken, C. Van Tulleken, A. Vercueil, L. Wandrag, M. Wilson, J. Windsor; Scientific Advisory Group B. Basnyat, C. Clarke, T. Hornbein, J. Milledge, J. West.	Abraini JH, 1998, PFLUG ARCH EUR J PHY, V436, P553, DOI 10.1007/s004240050671; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Basnyat B, 2004, HIGH ALT MED BIOL, V5, P171, DOI 10.1089/1527029041352126; Benton AL, 1994, MULTILINGUAL APHASIA; Bjursten H, 2010, HIGH ALT MED BIOL, V11, P31, DOI 10.1089/ham.2009.1041; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Grocott MPW, 2010, HIGH ALT MED BIOL, V11, P133, DOI 10.1089/ham.2009.1093; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Harris GA, 2009, WILD ENVIRON MED, V20, P261, DOI 10.1580/08-WEME-OR-261R.1; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hopkins RO, 2001, PULMONARY DISORDERS; Jansen GFA, 2007, J APPL PHYSIOL, V103, P518, DOI 10.1152/japplphysiol.01429.2006; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; Lewis MS, 2006, ARCH CLIN NEUROPSYCH, V21, P421, DOI 10.1016/j.acn.2006.05.004; Lezak DH, 2004, NEUROPSYCHOLOGICAL A, V4; Lieberman P, 2005, AVIAT SPACE ENVIR MD, V76, pB198; Masyn K. E., 2013, OXFORD HDB QUANTITAT, V2, P551, DOI DOI 10.1093/OXFORDHB/9780199934898.013.0025; Matthews C, 1964, INSTRUCTION MANUAL A; McLachlan G., 2000, WILEY SER PROB STAT; MCLACHLAN GJ, 1987, J R STAT SOC C-APPL, V36, P318; Mitrushina MN, 1999, HDB NORMATIVE DATA N, DOI DOI 10.1016/S1474-4422(06)70630-5; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Newman S, 1993, CARDIAC SURG BRAIN, P34; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; NOBLE J, 1993, ANAESTH INTENS CARE, V21, P180, DOI 10.1177/0310057X9302100208; Pavlicek V, 2005, AVIAT SPACE ENVIR MD, V76, P28; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAMASWAMY V, 1993, MARKET SCI, V12, P103, DOI 10.1287/mksc.12.1.103; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; ROACH RC, 1993, LAKE LOUISE ACUTE MO, P272; Schou L, 2012, RESP MED, V106, P1071, DOI 10.1016/j.rmed.2012.03.013; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith A., 1973, SYMBOL DIGIT MODALIT, DOI 10.1037/t27513-000; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Trenerry MR., 1989, STROOP NEUROPSYCHOLO; Turner CE, 2015, PHYSIOL BEHAV, V142, P104, DOI 10.1016/j.physbeh.2015.02.006; van der Post J, 2002, J PSYCHOPHARMACOL, V16, P337, DOI 10.1177/026988110201600408; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; Wechsler D., 1939, MEASUREMENT ADULT IN; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x	53	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174277	10.1371/journal.pone.0174277	http://dx.doi.org/10.1371/journal.pone.0174277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346535	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300036
J	Levast, B; Barblu, L; Coutu, M; Prevost, J; Brassard, N; Peres, A; Stegen, C; Madrenas, J; Kaufmann, DE; Finzi, A				Levast, Benoit; Barblu, Lucie; Coutu, Mathieu; Prevost, Jeremie; Brassard, Nathalie; Peres, Adam; Stegen, Camille; Madrenas, Joaquin; Kaufmann, Daniel E.; Finzi, Andres			HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes	PLOS ONE			English	Article							PROTEIN GP120; CD4-BOUND CONFORMATION; NEURONAL DEGENERATION; BLOOD MONOCYTES; CELL CHEMOTAXIS; DENDRITIC CELLS; INFECTION; CYTOTOXICITY; ACTIVATION; EXPRESSION	The first step of HIV infection involves the interaction of the gp120 envelope glycoprotein to its receptor CD4, mainly expressed on CD4(+) T cells. Besides its role on HIV-1 entry, the gp120 has been shown to be involved in the production of IL-1, IL-6, CCL20 and other innate response cytokines by bystander, uninfected CD4(+) T cells and monocytes. However, the gp120 determinants involved in these functions are not completely understood. Whether signalling leading to cytokine production is due to CD4 or other receptors is still unclear. Enhanced chemokine receptor binding and subsequent clustering receptors may lead to cytokine production. By using a comprehensive panel of gp120 mutants, here we show that CD4 binding is mandatory for cytokine outburst in monocytes. Our data suggest that targeting monocytes in HIV-infected patients might decrease systemic inflammation and the potential tissue injury associated with the production of inflammatory cytokines. Understanding how gp120 mediates a cytokine burst in monocytes might help develop new approaches to improve the chronic inflammation that persists in these patients despite effective suppression of viremia by antiretroviral therapy.	[Levast, Benoit; Peres, Adam; Stegen, Camille; Madrenas, Joaquin; Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Levast, Benoit; Peres, Adam; Stegen, Camille; Madrenas, Joaquin; Finzi, Andres] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Barblu, Lucie; Coutu, Mathieu; Prevost, Jeremie; Brassard, Nathalie; Kaufmann, Daniel E.; Finzi, Andres] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Prevost, Jeremie; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Madrenas, Joaquin] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Kaufmann, Daniel E.] Univ Montreal, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Universite de Montreal	Madrenas, J; Finzi, A (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Madrenas, J; Finzi, A (corresponding author), McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada.; Kaufmann, DE; Finzi, A (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada.; Finzi, A (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.; Madrenas, J (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.; Kaufmann, DE (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	andres.finzi@umontreal.ca; daniel.kaufmann@umontreal.ca; joaquin.madrenas@labiomed.org	Peres, Adam G/R-5245-2017	Peres, Adam G/0000-0002-7331-1112; Prevost, Jeremie/0000-0002-5260-5154; Finzi, Andres/0000-0002-4992-5288	Canadian Institutes for Health Research [13442, 137694, 352417]; NIH [R01 HL092565]; Canada Research Chairs [950-229930, 228107]; Research Scholar Career Award of the Quebec Health Research Fund (FRQ-S) [31035]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs(Canada Research ChairsCGIAR); Research Scholar Career Award of the Quebec Health Research Fund (FRQ-S)	This work was supported by grants from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) held by Drs. JM (#13442), DEK (#137694) and AF (#352417); and NIH R01 HL092565 (https://www.nih.gov) to DEK. AF (#950-229930) and JM (#228107) are the recipients of Canada Research Chairs (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). DEK is supported by a Research Scholar Career Award of the Quebec Health Research Fund (FRQ-S, #31035) (http://www.frqs.gouv.qc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Bahraoui E, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0214-z; Baran J, 2001, CLIN DIAGN LAB IMMUN, V8, P303, DOI 10.1128/CDLI.8.2.303-313.2001; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Coutu M, 2015, J VIROL METHODS, V215, P37, DOI 10.1016/j.jviromet.2015.02.017; Del Corno M, 2014, J VIROL, V88, P11045, DOI 10.1128/JVI.00307-14; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Ellegard R, 2015, J IMMUNOL, V195, P1698, DOI 10.4049/jimmunol.1500618; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Florio C, 2000, AIDS, V14, P931, DOI 10.1097/00002030-200005260-00004; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; Garg A, 2014, J INFECT DIS, V209, P441, DOI 10.1093/infdis/jit469; George MD, 2014, CURR OPIN INFECT DIS, V27, P275, DOI [10.1097/QCO.0000000000000059, 10.1097/QCO.0000000000000056]; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Jones G, 2005, VIROLOGY, V334, P178, DOI 10.1016/j.virol.2005.01.027; Kong LY, 1996, CELL IMMUNOL, V172, P77, DOI 10.1006/cimm.1996.0217; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Melendez RI, 2015, J NEUROVIROLOGY; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nosheny RL, 2005, NEUROTOX RES, V8, P187, DOI 10.1007/BF03033829; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Patella V, 2000, J IMMUNOLOGY, V164; Richard J, 2016, EBIOMEDICINE, V3, P122, DOI 10.1016/j.ebiom.2015.12.004; Richard J, 2014, J VIROL METHODS, V208, P107, DOI 10.1016/j.jviromet.2014.08.003; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shutt DC, 1998, J CELL SCI, V111, P99; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Zhen A, 2014, J VIROL, V88, P9934, DOI 10.1128/JVI.00616-14	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174550	10.1371/journal.pone.0174550	http://dx.doi.org/10.1371/journal.pone.0174550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346521	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300055
J	Rim, TH; Kang, MJ; Choi, M; Seo, KY; Kim, SS				Rim, Tyler Hyungtaek; Kang, Min Jae; Choi, Moonjung; Seo, Kyoung Yul; Kim, Sung Soo			The incidence and prevalence of pterygium in South Korea: A 10-year population-based Korean cohort study	PLOS ONE			English	Article							RISK-FACTORS; ADULT CHINESE; BARBADOS EYE; BEIJING EYE; SINGAPORE; SEVERITY	Although numerous population-based studies have reported the prevalences and risk factors for pterygium, information regarding the incidence of pterygium is scarce. This population-based cohort study aimed to evaluate the South Korean incidence and prevalence of pterygium. We retrospectively obtained data from a nationally representative sample of 1,116,364 South Koreans in the Korea National Health Insurance Service National Sample Cohort (NHIS-NSC). The associated sociodemographic factors were evaluated using multivariable Cox regression analysis, and the hazard ratios and confidence intervals were calculated. Pterygium was defined based on the Korean Classification of Diseases code, and surgically removed pterygium was defined as cases that required surgical removal. We identified 21,465 pterygium cases and 8,338 surgically removed pterygium cases during the study period. The overall incidences were 2.1 per 1,000 person-years for pterygium and 0.8 per 1,000 person-years for surgically removed pterygium. Among subjects who were >= 40 years old, the incidences were 4.3 per 1,000 person-years for pterygium and 1.7 per 1,000 person-years for surgically removed pterygium. The overall prevalences were 1.9% for pterygium and 0.6% for surgically removed pterygium, and the prevalences increased to 3.8% for pterygium and 1.4% for surgically removed pterygium among subjects who were >= 40 years old. The incidences of pterygium decreased according to year. The incidence and prevalence of pterygium were highest among 60-79-year-old individuals. Increasing age, female sex, and living in a relatively rural area were associated with increased risks of pterygium and surgically removed pterygium in the multivariable Cox regression analysis. Our analyses of South Korean national insurance claims data revealed a decreasing trend in the incidence of pterygium during the study period.	[Rim, Tyler Hyungtaek; Kang, Min Jae; Choi, Moonjung; Seo, Kyoung Yul; Kim, Sung Soo] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol,Severance Hosp, Seoul, South Korea; [Rim, Tyler Hyungtaek] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Ophthalmol, Gyeonggi Do, South Korea; [Kim, Sung Soo] Yonsei Univ, Coll Med, Yonsei Healthcare Big Data Based Knowledge Integr, Seoul, South Korea; [Kim, Sung Soo] Yonsei Univ, Coll Med, Inst Convergence Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; National Health Insurance Service; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Seo, KY; Kim, SS (corresponding author), Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol,Severance Hosp, Seoul, South Korea.; Kim, SS (corresponding author), Yonsei Univ, Coll Med, Yonsei Healthcare Big Data Based Knowledge Integr, Seoul, South Korea.; Kim, SS (corresponding author), Yonsei Univ, Coll Med, Inst Convergence Sci, Seoul, South Korea.	seoky@yuhs.ac; semekim@yuhs.ac	Seo, Kyoung Yul/I-5484-2019	Rim, Tyler Hyungtaek/0000-0001-6465-2620; Seo, Kyoung Yul/0000-0002-9855-1980; Kim, Sung Soo/0000-0003-3049-9554; Kim, Sung Soo/0000-0002-0574-7993				Ang M, 2012, OPHTHALMOLOGY, V119, P1509, DOI 10.1016/j.ophtha.2012.02.009; Cajucom-Uy H, 2010, BRIT J OPHTHALMOL, V94, P977, DOI 10.1136/bjo.2008.150847; Chun CB, 2009, HEALTH, V11; Durkin SR, 2008, BRIT J OPHTHALMOL, V92, P25, DOI 10.1136/bjo.2007.119842; Gazzard G, 2002, BRIT J OPHTHALMOL, V86, P1341, DOI 10.1136/bjo.86.12.1341; Jeong H, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/s40557-014-0028-x; Lee Juneyoung, 2016, INT J EPIDEMIOLOGY; Luthra R, 2001, ARCH OPHTHALMOL-CHIC, V119, P1827, DOI 10.1001/archopht.119.12.1827; Ma K, 2007, CORNEA, V26, P1184, DOI 10.1097/ICO.0b013e318151f9c6; McCarty CA, 2000, BRIT J OPHTHALMOL, V84, P289, DOI 10.1136/bjo.84.3.289; Nemesure B, 2008, OPHTHALMOLOGY, V115, P2153, DOI 10.1016/j.ophtha.2008.08.003; Nolan TM, 2003, AM J PATHOL, V162, P567, DOI 10.1016/S0002-9440(10)63850-3; Panchapakesan J, 1998, AUST NZ J OPHTHALMOL, V26, pS2, DOI 10.1111/j.1442-9071.1998.tb01362.x; Park SM, 2010, J BIOSOC SCI, V42, P99, DOI 10.1017/S0021932009990204; Rim THT, 2013, CORNEA, V32, P962, DOI 10.1097/ICO.0b013e3182801668; Tang YT, 2015, OPHTHALMOLOGY, V122, P1480, DOI 10.1016/j.ophtha.2015.03.022; Tomidokoro A, 2000, OPHTHALMOLOGY, V107, P1568, DOI 10.1016/S0161-6420(00)00219-0; Wong TY, 2001, AM J OPHTHALMOL, V131, P176, DOI 10.1016/S0002-9394(00)00703-0; Zhao L, 2013, INVEST OPHTH VIS SCI, V54, P1509, DOI 10.1167/iovs.12-11183	19	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0171954	10.1371/journal.pone.0171954	http://dx.doi.org/10.1371/journal.pone.0171954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346495	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300002
J	Gupta, S; Rodier, JT; Sharma, A; Giuliano, EA; Sinha, PR; Hesemann, NP; Ghosh, A; Mohan, RR				Gupta, Suneel; Rodier, Jason T.; Sharma, Ajay; Giuliano, Elizabeth A.; Sinha, Prashant R.; Hesemann, Nathan P.; Ghosh, Arkasubhra; Mohan, Rajiv R.			Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; SMAD7; FIBROSIS; AAV; EXPRESSION; VECTORS; CELLS; TRANSDUCTION; ANTAGONIST	Corneal scarring is due to aberrant activity of the transforming growth factor beta (TGF beta) signaling pathway following traumatic, mechanical, infectious, or surgical injury. Altered TGF beta signaling cascade leads to downstream Smad (Suppressor of mothers against decapentaplegic) protein-mediated signaling events that regulate expression of extracellular matrix and myogenic proteins. These events lead to transdifferentiation of keratocytes into myofibroblasts through fibroblasts and often results in permanent corneal scarring. Hence, therapeutic targets that reduce transdifferentiation of fibroblasts into myofibroblasts may provide a clinically relevant approach to treat corneal fibrosis and improve long-term visual outcomes. Smad7 protein regulates the functional effects of TGFI3 signaling during corneal wound healing. We tested that targeted delivery of Smad7 using recombinant adeno-associated virus serotype 5 (AAV5-Smad7) delivered to the corneal stroma can inhibit corneal haze post photorefractive keratectomy (PRK) in vivo in a rabbit corneal injury model. We demonstrate that a single topical application of AAV5-Smad7 in rabbit cornea post-PRK led to a significant decrease in corneal haze and corneal fibrosis. Further, histopathology revealed lack of immune cell infiltration following AAV5-Smad7 gene transfer into the corneal stroma. Our data demonstrates that AAV5-Smad7 gene therapy is relatively safe with significant potential for the treatment of corneal disease currently resulting in fibrosis and impaired vision.	[Gupta, Suneel; Rodier, Jason T.; Sharma, Ajay; Giuliano, Elizabeth A.; Sinha, Prashant R.; Hesemann, Nathan P.; Mohan, Rajiv R.] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Gupta, Suneel; Sharma, Ajay; Giuliano, Elizabeth A.; Sinha, Prashant R.; Mohan, Rajiv R.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Rodier, Jason T.; Hesemann, Nathan P.; Mohan, Rajiv R.] Univ Missouri, Sch Med, Mason Eye Inst, Columbia, MO 65211 USA; [Sharma, Ajay] Chapman Univ, Sch Pharm, Irvine, CA USA; [Ghosh, Arkasubhra] Narayana Nethralaya Fdn, GROW Res Lab, Bangalore, Karnataka, India	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Chapman University System; Chapman University	Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.; Mohan, RR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.; Mohan, RR (corresponding author), Univ Missouri, Sch Med, Mason Eye Inst, Columbia, MO 65211 USA.	MohanR@health.missouri.edu	Gupta, Suneel/AAC-3946-2022	Gupta, Suneel/0000-0002-6141-3728; Ghosh, Arkasubhra/0000-0002-6570-5891	Veteran Health Affairs, Washington, DC [11016X00035701]; National Eye Institute, NIH, Bethesda, MD [R01EY17294]; University of Missouri	Veteran Health Affairs, Washington, DC; National Eye Institute, NIH, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Missouri	This work was funded by Biomedical Laboratory Research and Development Merit 11016X00035701 Award (RRM) from the Veteran Health Affairs, Washington, DC; R01EY17294 Award (RRM) from the National Eye Institute, NIH, Bethesda, MD; and Ruth M. Kraeuchi Missouri Endowed Chair Ophthalmology Fund (RRM) from the University of Missouri.	Akanda ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119934; Bosiack AP, 2012, VET OPHTHALMOL, V15, P291, DOI 10.1111/j.1463-5224.2011.00980.x; Chaikuad A., 2016, COLD SPRING HARB PER, V8; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Funaki T, 2003, CORNEA, V22, P153, DOI 10.1097/00003226-200303000-00015; Guo Hui, 2007, ELECT PACKAGING, V7, P18, DOI DOI 10.1681/ASN2007010121; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He J, 2009, BBA-MOL BASIS DIS, V1792, P56, DOI 10.1016/j.bbadis.2008.10.010; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Klausner EA, 2010, BIOMATERIALS, V31, P1814, DOI 10.1016/j.biomaterials.2009.10.031; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Lim RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20841; Liu J, 2008, MOL VIS, V14, P2087; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Margo Jordan A, 2016, Int Ophthalmol Clin, V56, P111, DOI 10.1097/IIO.0000000000000112; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Mohan RR, 2016, EXP EYE RES, V146, P145, DOI 10.1016/j.exer.2015.12.003; Mohan RR, 2012, PROG RETIN EYE RES, V31, P43, DOI 10.1016/j.preteyeres.2011.09.001; Mohan RR, 2011, INVEST OPHTH VIS SCI, V52, P4833, DOI 10.1167/iovs.11-7357; Mohan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018771; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Saika S, 2010, EYE CONTACT LENS, V30, pc80; Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Sharma A, 2015, MOL VIS, V21, P974; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Sharma A, 2010, BRAIN RES BULL, V81, P273, DOI 10.1016/j.brainresbull.2009.07.005; Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919; Stechschulte SU, 2001, INVEST OPHTH VIS SCI, V42, P1975; Sumioka T, 2008, MOL VIS, V14, P2272; Surace EM, 2008, VISION RES, V48, P353, DOI 10.1016/j.visres.2007.07.027; Tandon A, 2010, CURR MOL MED, V10, P565; Tandon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066434; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang BQ, 2002, AM J PHYSIOL-HEART C, V282, pH1685, DOI 10.1152/ajpheart.00266.2001; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Yan XH, 2016, J BIOL CHEM, V291, P382, DOI 10.1074/jbc.M115.694281; [张树林 ZHANG Shulin], 2007, [天然气工业, Natural Gas Industry], V27, P7; Zhou QJ, 2010, J CELL PHYSIOL, V224, P135, DOI 10.1002/jcp.22110; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	51	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0172928	10.1371/journal.pone.0172928	http://dx.doi.org/10.1371/journal.pone.0172928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339457	Green Submitted, gold, Green Published			2022-12-27	WOS:000399116700004
J	Havumaki, J; Hillemann, D; Ismail, N; Omar, SV; Georghiou, SB; Schumacher, SG; Boehme, C; Denkinger, CM				Havumaki, Joshua; Hillemann, Doris; Ismail, Nazir; Omar, Shaheed Vally; Georghiou, Sophia B.; Schumacher, Samuel G.; Boehme, Catharina; Denkinger, Claudia M.			Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; MUTATIONS; CONFIDENCE; DIAGNOSIS; KATG	Introduction Despite recent diagnostic advances, the majority of multidrug-resistant tuberculosis (MDR-TB) cases remain undiagnosed. Line probes assays (LiPAs) hold great promise to curb the spread of MDR-TB as they can rapidly detect MDR-TB even when laboratory infrastructure is limited, yet few of these assays are currently widely available or supported by World Health Organization (WHO) policy. Methods The aim of this prospective, blinded, non-inferiority study was to compare the performance of YD Diagnostics REBA MTB MDR LiPA (YD) to the WHO-endorsed Hain MTBDRplus V1 LiPA (Hain V1) for the detection of rifampicin and isoniazid resistance. In phase 1, YD and Hain V1 diagnostic performance was assessed with selected culture isolates and results were compared to phenotypic drug susceptibility testing (DST) results and targeted sequencing data. In phase 2, both assays were tested on processed sputum samples and results were compared to phenotypic DST results. Results In phase 1, YD did not achieve non-inferiority to Hain V1. For isoniazid resistance detection, Hain V1 had a sensitivity of 89% (95% CI 83.8-93%) and specificity of 99.4% (95% CI 96.9-100%). While YD had a similar sensitivity of 92% (95% CI 87.3-95.4%), the specificity was inferior at 92.6% (95% CI 87.6-96%). For rifampicin resistance detection, Hain V1 had a sensitivity of 90.2% (95% CI 84.8-94.2%) and specificity of 98.5% (95% CI 95.7-99.7%) while YD had an inferior sensitivity of 72.4% (95% CI 65.1-78.9%) and a comparable specificity of 98% (95% CI 95-99.5%). Similar results were observed in phase 2. For MDR-TBdetection, the sensitivity and specificity of Hain V1 was 93.4% (95% CI 88.2-96.2%) and 96.2% (95% CI 88.2-96.8%), respectively, compared to 75.7% (95% CI 68-82.2%) and 92% (95% CI 88.2-94.9%) for YD. Conclusions YD did not achieve non-inferiority with Hain V1. Further improvements and repeat evaluation of YD is necessary prior to recommending its use for clinical settings.	[Havumaki, Joshua; Georghiou, Sophia B.; Schumacher, Samuel G.; Boehme, Catharina; Denkinger, Claudia M.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Hillemann, Doris] Forschungszentrum Borstel, Natl Reference Lab Mycobacteria, Borstel, Germany; [Ismail, Nazir; Omar, Shaheed Vally] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa	Foundation For Innovative New Diagnostics; Forschungszentrum Borstel; National Institute for Communicable Diseases (NICD)	Schumacher, SG (corresponding author), Fdn Innovat New Diagnost, Geneva, Switzerland.	samuel.schumacher@finddx.org	Omar, Shaheed Vally/AAB-5071-2020	Omar, Shaheed Vally/0000-0001-6983-1636; Georghiou, Sophia/0000-0003-0099-903X; Schumacher, Samuel G/0000-0002-6136-206X	Department for International Development; Bill and Melinda Gates Foundation	Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this study came from Department for International Development and the Bill and Melinda Gates Foundation.	Bang H, 2011, J MED MICROBIOL, V60, P1447, DOI 10.1099/jmm.0.032292-0; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Georghiou SB, 2016, ANTIMICROB AGENTS CH, V60, P3994, DOI 10.1128/AAC.00222-16; Hain Lifescience, 2015, MOL GEN ASS ID M TUB; Jaber M, 1996, J CLIN PATHOL, V49, P945, DOI 10.1136/jcp.49.11.945; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Ling Daphne I, 2008, Expert Rev Respir Med, V2, P583, DOI 10.1586/17476348.2.5.583; Nathavitharana RR, 2016, J CLIN MICROBIOL, V54, P1624, DOI 10.1128/JCM.00251-16; Rothmann MD, 2017, DESIGN ANAL NONINFER; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P600, DOI 10.1128/AAC.41.3.600; Tango T, 1998, STAT MED, V17, P891, DOI 10.1002/(SICI)1097-0258(19980430)17:8<891::AID-SIM780>3.0.CO;2-B; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), 2010, GUID IND NON CLIN TR; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; World Health Organisation, 2012, UPD INT CRIT CONC 1; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2015, GLOB TUB REP 2015; YD Diagnostics, 2011, REV BLOT HYBR ASS SY; Zhang M, 2005, J CLIN MICROBIOL, V43, P5477, DOI 10.1128/JCM.43.11.5477-5482.2005	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173804	10.1371/journal.pone.0173804	http://dx.doi.org/10.1371/journal.pone.0173804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339465	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700011
J	Ceulemans, T; Hulsmans, E; Berwaers, S; Van Acker, K; Honnay, O				Ceulemans, Tobias; Hulsmans, Eva; Berwaers, Sigi; Van Acker, Kasper; Honnay, Olivier			The role of above-ground competition and nitrogen vs. phosphorus enrichment in seedling survival of common European plant species of semi-natural grasslands	PLOS ONE			English	Article							DIVERSITY; LIMITATION; DEPOSITION; FERTILIZATION; LIGHT; EUTROPHICATION; ABUNDANCE	Anthropogenic activities have severely altered fluxes of nitrogen and phosphorus in ecosystems worldwide. In grasslands, subsequent negative effects are commonly attributed to competitive exclusion of plant species following increased above-ground biomass production. However, some studies have shown that this does not fully account for nutrient enrichment effects, questioning whether lowering competition by reducing grassland productivity through mowing or herbivory can mitigate the environmental impact of nutrient pollution. Furthermore, few studies so far discriminate between nitrogen and phosphorus pollution. We performed a full factorial experiment in greenhouse mesocosms combining nitrogen and phosphorus addition with two clipping regimes designed to relax above-ground competition. Next, we studied the survival and growth of seedlings of eight common European grassland species and found that five out of eight species showed higher survival under the clipping regime with the lowest above-ground competition. Phosphorus addition negatively affected seven plant species and nitrogen addition negatively affected four plant species. Importantly, the negative effects of nutrient addition and higher above-ground competition were independent of each other for all but one species. Our results suggest that at any given level of soil nutrients, relaxation of above-ground competition allows for higher seedling survival in grasslands. At the same time, even at low levels of above-ground competition, nutrient enrichment negatively affects survival as compared to nutrient-poor conditions. Therefore, although maintaining low above-ground competition appears essential for species' recruitment, for instance through mowing or herbivory, these management efforts are likely to be insufficient and we conclude that environmental policies aimed to reduce both excess nitrogen and particularly phosphorus inputs are also necessary.	[Ceulemans, Tobias; Hulsmans, Eva; Van Acker, Kasper; Honnay, Olivier] Univ Leuven, Plant Conservat & Populat Biol, Leuven, Belgium; [Berwaers, Sigi] Univ Antwerp, Plant & Vegetat Ecol, Antwerp, Belgium	KU Leuven; University of Antwerp	Ceulemans, T (corresponding author), Univ Leuven, Plant Conservat & Populat Biol, Leuven, Belgium.	tobias.ceulemans@kuleuven.be	Honnay, Olivier/AAH-8625-2019	Honnay, Olivier/0000-0002-4287-8511; Hulsmans, Eva/0000-0001-6942-7342; Ceulemans, Tobias/0000-0001-6861-4613	Research Foundation Flanders (FWO); FWO	Research Foundation Flanders (FWO)(FWO); FWO(FWO)	Tobias Ceulemans holds a postdoctoral fellowship of the Research Foundation Flanders (FWO). This work was funded by FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Tobias Ceulemans holds a postdoctoral fellowship of the Research Foundation Flanders (FWO). This work was funded by FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Gerrit Peeters for his practical assistance and Pablo Deschepper for his assistance with developing the figures.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Caswell, 2000, MATRIX POPULATION MO; Ceulemans T, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.224; Ceulemans T, 2013, GLOBAL ECOL BIOGEOGR, V22, P73, DOI 10.1111/j.1466-8238.2012.00771.x; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; De Beenhouwer M, 2015, SOIL BIOL BIOCHEM, V91, P133, DOI 10.1016/j.soilbio.2015.08.037; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fay PA, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.80, 10.1038/nplants.2015.80]; Fujita Y, 2014, NATURE, V505, P82, DOI 10.1038/nature12733; Grime J.P., 2002, PLANT STRATEGIES VEG; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Harpole WS, 2016, NATURE, V537, P93, DOI 10.1038/nature19324; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Horswill P, 2008, ENVIRON POLLUT, V155, P336, DOI 10.1016/j.envpol.2007.11.006; NEWMAN EI, 1995, J ECOL, V83, P713, DOI 10.2307/2261638; Payne RJ, 2013, P NATL ACAD SCI USA, V110, P984, DOI 10.1073/pnas.1214299109; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Stevens CJ, 2015, ECOLOGY, V96, P1459, DOI 10.1890/14-1902.1; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Turner BL, 2001, NATURE, V411, P258, DOI 10.1038/35077146; van den Berg LJL, 2005, NEW PHYTOL, V166, P551, DOI 10.1111/j.1469-8137.2005.01338.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950	31	6	6	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174380	10.1371/journal.pone.0174380	http://dx.doi.org/10.1371/journal.pone.0174380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333985	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200091
J	Chen, J; Clark, LH; Kong, WM; Yan, Z; Han, C; Zhao, H; Liu, TT; Zhang, TQ; Song, D; Jiao, SM; Zhou, CX				Chen, Jiao; Clark, Leslie H.; Kong, Wei-Min; Yan, Zhen; Han, Chao; Zhao, Hui; Liu, Ting-Ting; Zhang, Tong-Qing; Song, Dan; Jiao, Si-Meng; Zhou, Chunxiao			Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma?	PLOS ONE			English	Article							POSITIVE PERITONEAL CYTOLOGY; UTERINE CARCINOSARCOMAS; CANCER-CELLS; STAGE; DISSEMINATION; RISK; SURVIVAL; METASTASIS; SURGERY; SPREAD	Background Prior studies evaluating the impact of hysteroscopy on outcomes in endometrial cancer have predominantly evaluated type I tumors. We sought to evaluate whether hysteroscopy worsens prognosis in type II endometrial cancer. Methods A retrospective cohort analysis of 140 patients from two institutions with type II endometrial cancer was performed. Women who underwent either diagnostic hysteroscopy (HSC) or dilation and curettage (D&C) for cancer diagnosis from June 2001 until June 2010 were included. The clinical and pathologic characteristics, including peritoneal cytology results were reviewed. The primary endpoint was disease-specific survival (DSS). The exposure of interest was hysteroscopy. Survival curves were projected using the Kaplan-Meier method and compared using the log-rank test. Results There was no difference in age, histology, stage, depth of myometrial invasion, adnexal involvement, or nodal metastasis between HSC and D& C patients. Positive cytology was found in 16/54 (30%) patients following HSC and in 10/86 (12%) following D&C (p = 0.008). Fourteen patients with stage I and II disease had positive peritoneal cytology, with 11/40 (27.5%) patients in the HSC group and 3/59 (5%) patients in the D& C group(p = 0.002). Median DSS was clinically different for the HSC and D& C groups, but statistical significance was not reached (53 versus 63.5 months, p = 0.34). For stage I and II patients, 18/99 (18%) were dead of EC, with a median DSS of 60 months for HSC and 71 months for D& C (p = 0.82). Overall 46 (33%) patients developed a recurrence, with 18/54 (33%) in the HSC group compared to 28/86 (32%) in the D& C group (p = 0.92). There was no difference in recurrence location between groups. Conclusions Diagnostic hysteroscopy significantly increased the rate of positive peritoneal cytology at the time of surgical staging in this cohort of patients with type II EC. However, we were unable to detect a difference in prognosis as measured by DSS.	[Chen, Jiao; Kong, Wei-Min; Yan, Zhen; Han, Chao; Zhao, Hui; Liu, Ting-Ting; Zhang, Tong-Qing; Song, Dan; Jiao, Si-Meng] Capital Med Univ, Dept Gynecol Oncol, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China; [Clark, Leslie H.; Zhou, Chunxiao] Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC 27599 USA; [Clark, Leslie H.; Zhou, Chunxiao] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Capital Medical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kong, WM (corresponding author), Capital Med Univ, Dept Gynecol Oncol, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China.; Zhou, CX (corresponding author), Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC 27599 USA.; Zhou, CX (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	kwm1967@163.com; czhou@med.unc.edu						Arikan G, 2001, GYNECOL ONCOL, V83, P221, DOI 10.1006/gyno.2001.6380; Ayeni TA, 2013, GYNECOL ONCOL, V128, P71, DOI 10.1016/j.ygyno.2012.10.025; Bansal N, 2008, OBSTET GYNECOL, V112, P64, DOI 10.1097/AOG.0b013e318176157c; Ben-Arie A, 2008, INT J GYNECOL CANCER, V18, P813, DOI 10.1111/j.1525-1438.2007.01076.x; Biewenga P, 2004, GYNECOL ONCOL, V93, P194, DOI 10.1016/j.ygyno.2004.01.005; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bradley WH, 2004, OBSTET GYNECOL, V104, P1030, DOI 10.1097/01.AOG.0000143263.19732.18; Chang YN, 2011, FERTIL STERIL, V96, P957, DOI 10.1016/j.fertnstert.2011.07.1146; Cicinelli E, 2010, MENOPAUSE, V17, P511, DOI 10.1097/gme.0b013e3181c8534d; Cirisano FD, 2000, GYNECOL ONCOL, V77, P55, DOI 10.1006/gyno.2000.5737; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; de Jong RA, 2011, MODERN PATHOL, V24, P1368, DOI 10.1038/modpathol.2011.88; de la Cuesta RS, 2004, EUR J OBSTET GYN R B, V115, P211, DOI 10.1016/j.ejogrb.2004.01.029; Dinkelspiel HE, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/583891; Felix AS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv158; Garg G, 2013, INT J GYNECOL CANCER, V23, P90, DOI 10.1097/IGC.0b013e318275afd2; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gkrozou F, 2015, ARCH GYNECOL OBSTET, V291, P1347, DOI 10.1007/s00404-014-3585-x; Gottwald L, 2010, ARCH MED SCI, V6, P937, DOI 10.5114/aoms.2010.19305; Haltia UM, 2014, J GYNECOL ONCOL, V25, P30, DOI 10.3802/jgo.2014.25.1.30; Han KH, 2014, GYNECOL ONCOL, V134, P293, DOI 10.1016/j.ygyno.2014.05.010; Hirai Y, 2001, OBSTET GYNECOL, V97, P725, DOI 10.1016/S0029-7844(01)01325-4; Juhasz-Boss I, 2010, ANTICANCER RES, V30, P2425; Koh WJ, 2014, J NATL COMPR CANC NE, V12, P248, DOI 10.6004/jnccn.2014.0025; Kyrgiou M, 2013, J OBSTET GYNAECOL, V33, P729, DOI 10.3109/01443615.2013.813916; Llaurado M, 2012, MOL CELL ENDOCRINOL, V358, P244, DOI 10.1016/j.mce.2011.10.003; Lo KWK, 2004, INT J GYNECOL CANCER, V14, P921, DOI 10.1111/j.1048-891X.2004.014530.x; Mendivil A, 2009, CANCER CONTROL, V16, P46, DOI 10.1177/107327480901600107; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Obermair A, 2000, CANCER, V88, P139, DOI 10.1002/(SICI)1097-0142(20000101)88:1<139::AID-CNCR19>3.3.CO;2-L; Polyzos NP, 2010, INT J GYNECOL CANCER, V20, P261, DOI 10.1111/IGC.0b013e3181ca2290; Revel A, 2004, OBSTET GYNECOL SURV, V59, P280, DOI 10.1097/01.OGX.0000120173.09136.4A; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Skirnisdottir I, 2015, INT J GYNECOL CANCER, V25, P1239, DOI 10.1097/IGC.0000000000000484; Soucie JE, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.026; Takac I, 2007, GYNECOL ONCOL, V107, P94, DOI 10.1016/j.ygyno.2007.05.031; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vilos GA, 2007, J MINIM INVAS GYN, V14, P205, DOI 10.1016/j.jmig.2006.10.010; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Zerbe MJ, 2000, GYNECOL ONCOL, V79, P55, DOI 10.1006/gyno.2000.5892	40	20	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174226	10.1371/journal.pone.0174226	http://dx.doi.org/10.1371/journal.pone.0174226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334032	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200067
J	King, HC; Khera-Butler, T; James, P; Oakley, BB; Erenso, G; Aseffa, A; Knight, R; Wellington, EM; Courtenay, O				King, Hayley C.; Khera-Butler, Tanya; James, Phillip; Oakley, Brian B.; Erenso, Girume; Aseffa, Abraham; Knight, Rob; Wellington, Elizabeth M.; Courtenay, Orin			Environmental reservoirs of pathogenic mycobacteria across the Ethiopian biogeographical landscape	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; GROWING MYCOBACTERIA; UNITED-STATES; WATER; INFECTION; AVIUM; EPIDEMIOLOGY; SOIL; BCG; ASSOCIATION	The Mycobacterium genus comprises over one-hundred-and-fifty recognised species, the majority of which reside in the environment and many of which can be pathogenic to mammals. Some species of environmental mycobacteria may interfere with BCG vaccination efficacy and in tuberculin test interpretation. Examining biogeographic trends in the distribution of members of the mycobacteria across a number of physicochemical and spatial gradients in soil and water environments across Ethiopia using oligotyping identified differential distributions of pathogenic and significant species. The tuberculosis complex was identified in more than 90% of water samples and taxonomic groups implicated in lower BCG vaccine efficiency were core in both soil and water Mycobacterium communities. A reservoir of Mycobacterium bovis was identified in water, with up to 7.3x10(2) genome equivalents per ml. Elevation, temperature, habitat and vegetation type were important predictors of both soil and water Mycobacterium communities. These results represent the first step in understanding the potential risk of exposure to environmental mycobacteria that may undermine efforts to reduce disease incidence.	[King, Hayley C.; Khera-Butler, Tanya; James, Phillip; Wellington, Elizabeth M.; Courtenay, Orin] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Oakley, Brian B.] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA; [Erenso, Girume] St Pauls Hosp Millennium Med Coll, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Erenso, Girume; Aseffa, Abraham] AHRI, ALERT Campus, Addis Ababa, Ethiopia; [Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci, San Diego, CA 92103 USA	University of Warwick; Western University of Health Sciences; University of California System; University of California San Diego; University of California System; University of California San Diego	King, HC (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	H.king@warwick.ac.uk	Oakley, Brian Oakley B/AAG-4015-2019; Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Wellington, ELizabeth/0000-0002-4329-0699; Knight, Rob/0000-0002-0975-9019; Oakley, Brian/0000-0003-2098-6439	Natural Environment research Council studentship; Biotechnology and Biological Sciences Research Council studentship; BBSRC [BB/L027801/1, BB/N004655/1] Funding Source: UKRI; NERC [NBAF010001] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L027801/1, BB/N004655/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Natural Environment research Council studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	TKB was in receipt of a Natural Environment research Council studentship. Hayley King was in receipt of a Biotechnology and Biological Sciences Research Council studentship.	Barasona JA, 2016, TRANSBOUND EMERG DIS; Berg S, 2009, PLOS ONE, V4, P1; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; BROOKS RW, 1984, AM REV RESPIR DIS, V130, P630; Chilima BZ, 2006, APPL ENVIRON MICROB, V72, P2343, DOI 10.1128/AEM.72.4.2343-2350.2006; Cook JL, 2010, BRIT MED BULL, V96, P45, DOI 10.1093/bmb/ldq035; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Dailloux M, 1999, WATER RES, V33, P2219, DOI 10.1016/S0043-1354(98)00466-7; Donoghue HD, 1997, J APPL MICROBIOL, V82, P57, DOI 10.1111/j.1365-2672.1997.tb03297.x; Eren AM, 2013, METH ECOL EVO; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Falkinham JO, 2009, ENV MICROBIOL REP, V1, P477, DOI 10.1111/j.1758-2229.2009.00054.x; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flaherty DK, 2006, J LEUKOCYTE BIOL, V80, P1262, DOI 10.1189/jlb.0606407; Ghodbane R, 2014, MICROBIOL-SGM, V160, P496, DOI 10.1099/mic.0.073379-0; Horsburg CR, MYCOBACTERIUM AVIUM, P1; Howard ST, 2000, MICROBES INFECT, V2, P1845, DOI 10.1016/S1286-4579(00)01338-1; Jacobs J, 2009, APPL ENVIRON MICROB, V75, P7378, DOI 10.1128/AEM.01900-09; KAMALA T, 1994, APPL ENVIRON MICROB, V60, P2180, DOI 10.1128/AEM.60.6.2180-2183.1994; KIRSCHNER RA, 1992, AM REV RESPIR DIS, V145, P271, DOI 10.1164/ajrccm/145.2_Pt_1.271; Kopecky J, 2011, SOIL BIOL BIOCHEM, V43, P697, DOI 10.1016/j.soilbio.2010.11.033; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002; Leclerc MC, 2003, ANTON LEEUW INT J G, V83, P265, DOI 10.1023/A:1023327929535; Leys NM, 2005, FEMS MICROBIOL ECOL, V51, P375, DOI 10.1016/j.femsec.2004.09.015; Niva M, 2006, BOREAL ENVIRON RES, V11, P45; Norby B, 2007, VET MICROBIOL, V124, P153, DOI 10.1016/j.vetmic.2007.04.015; Pickup RW, 2005, APPL ENVIRON MICROB, V71, P2130, DOI 10.1128/AEM.71.4.2130-2139.2005; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Rastogi N, 2001, REV SCI TECH OIE, V20, P21, DOI 10.20506/rst.20.1.1265; Reed C, 2006, AM J EPIDEMIOL, V164, P32, DOI 10.1093/aje/kwj159; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Shitaye JE, 2009, VET MED, V8, P317; Thorel MF, 2004, FEMS MICROBIOL ECOL, V49, P343, DOI 10.1016/j.femsec.2004.04.016; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; Torvinen E, 2006, APPL ENVIRON MICROB, V72, P6822, DOI 10.1128/AEM.00588-06; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Weir RE, 2006, CLIN EXP IMMUNOL, V146, P390, DOI 10.1111/j.1365-2249.2006.03222.x; World Health Organization, GLOB TUB REP 2013	42	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173811	10.1371/journal.pone.0173811	http://dx.doi.org/10.1371/journal.pone.0173811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333945	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200025
J	Weiss, A; Sommer, G; Kuonen, R; Scheinemann, K; Grotzer, M; Kompis, M; Kuehni, CE				Weiss, Annette; Sommer, Grit; Kuonen, Rahel; Scheinemann, Katrin; Grotzer, Michael; Kompis, Martin; Kuehni, Claudia E.		Swiss Paediat Oncology Grp SPOG	Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study	PLOS ONE			English	Article							PLATINUM-INDUCED OTOTOXICITY; STEM-CELL TRANSPLANTATION; QUALITY-OF-LIFE; HANDICAP INVENTORY; CHILDREN; COMPLICATIONS; ACCURACY; TOXICITY; COHORT	Background Hearing loss is a potential late effect after childhood cancer. Questionnaires are often used to assess hearing in large cohorts of childhood cancer survivors and it is important to know if they can provide valid measures of hearing loss. We therefore assessed agreement and validity of questionnaire-reported hearing in childhood cancer survivors using medical records as reference. Procedure In this validation study, we studied 361 survivors of childhood cancer from the Swiss Childhood Cancer Survivor Study (SCCSS) who had been diagnosed after 1989 and had been exposed to ototoxic cancer treatment. Questionnaire-reported hearing was compared to the information in medical records. Hearing loss was defined as >= grade 1 according to the SIOP Boston Ototoxicity Scale. We assessed agreement and validity of questionnaire-reported hearing overall and stratified by questionnaire respondents (survivor or parent), sociodemographic characteristics, time between follow-up and questionnaire and severity of hearing loss. Results Questionnaire reports agreed with medical records in 85% of respondents (kappa 0.62), normal hearing was correctly assessed in 92% of those with normal hearing (n = 249), and hearing loss was correctly assessed in 69% of those with hearing loss (n = 112). Sensitivity of the questionnaires was 92%, 74%, and 39% for assessment of severe, moderate and mild bilateral hearing loss; and 50%, 33% and 10% for severe, moderate and mild unilateral hearing loss, respectively. Results did not differ by sociodemographic characteristics of the respondents, and survivor- and parent-reports were equally valid. Conclusions Questionnaires are a useful tool to assess hearing in large cohorts of childhood cancer survivors, but underestimate mild and unilateral hearing loss. Further research should investigate whether the addition of questions with higher sensitivity for mild degrees of hearing loss could improve the results.	[Weiss, Annette; Sommer, Grit; Kuonen, Rahel; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [Scheinemann, Katrin] Univ Childrens Hosp Basel, Div Pediat Hematol Oncol, Basel, Switzerland; [Grotzer, Michael] Univ Zurich, Dept Pediat Oncol, Univ Childrens Hosp Zurich, Zurich, Switzerland; [Kompis, Martin] Univ Bern, Univ Hosp Bern, Dept ENT Head & Neck Surg, Bern, Switzerland; [Kuehni, Claudia E.] Univ Bern, Childrens Univ Hosp Bern, Bern, Switzerland	University of Bern; University of Basel; University Children's Hospital Zurich; University of Zurich; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.; Kuehni, CE (corresponding author), Univ Bern, Childrens Univ Hosp Bern, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	ANSARI, Marc/V-3334-2017	ansari, marc/0000-0002-9649-6498; Grotzer, Michael/0000-0002-1154-2732; Weiss, Annette/0000-0001-8295-3574	Swiss Cancer Research [02783-02-2011]; Swiss Cancer League [3412-02-2014]; European Union's Seventh Framework Programme for research, technological development and demonstration [602030]; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); Institute of Cancer Epidemiology and Registration	Swiss Cancer Research; Swiss Cancer League; European Union's Seventh Framework Programme for research, technological development and demonstration; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); Institute of Cancer Epidemiology and Registration	This study was supported by the Swiss Cancer Research (grant no: 02783-02-2011), Swiss Cancer League (grant no: 3412-02-2014), and received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602030. The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www gdk.cds.ch), Swiss Cancer Research (www. krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), the Federal Office of Health (FOH) and the Institute of Cancer Epidemiology and Registration (www.nicer.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolini P, 2004, J PEDIAT HEMATOL ONC, V26, P649, DOI 10.1097/01.mph.0000141348.62532.73; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Castelan-Martinez OD, 2014, INT J PEDIATR OTORHI, V78, P1456, DOI 10.1016/j.ijporl.2014.06.007; Children's Oncology Group, 2013, LONG TERM FOLL UP GU; Christopherson KM, 2014, ACTA ONCOL, V53, P471, DOI 10.3109/0284186X.2013.862596; Deepthi R, 2012, ARCH GERONTOL GERIAT, V55, P762, DOI 10.1016/j.archger.2012.07.006; Fleiss JL, 2003, STAT METHODS RATES P, Vxxvii; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; Gates GA, 2003, J FAM PRACTICE, V52, P56; Gurney JG, 2007, PEDIATRICS, V120, pE1229, DOI 10.1542/peds.2007-0178; Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752; Kamil RJ, 2015, EAR HEARING, V36, P164, DOI 10.1097/AUD.0000000000000075; Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088; Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142; Landier W, 2016, CANCER-AM CANCER SOC, V122, P1647, DOI 10.1002/cncr.29779; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Louie AD, 2000, BONE MARROW TRANSPL, V25, P1191, DOI 10.1038/sj.bmt.1702419; Michel G, 2007, SWISS MED WKLY, V137, P502; NOBLE WG, 1979, J AM AUDITORY SOC, V5, P95; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Overbeek A, 2013, HUM REPROD, V28, P819, DOI 10.1093/humrep/des405; Peleva E, 2014, PEDIATR BLOOD CANCER, V61, P2012, DOI 10.1002/pbc.25123; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Salonen J, 2011, INT J AUDIOL, V50, P297, DOI 10.3109/14992027.2010.549517; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Stark D, 2016, J SPEECH LANG HEAR R, V59, P1247, DOI 10.1044/2016_JSLHR-H-15-0363; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Valete-Rosalino Cláudia Maria, 2005, Rev. Bras. Otorrinolaringol., V71, P193, DOI 10.1590/S0034-72992005000200013; VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006; Weiss A, 2017, PEDIATR BLOOD CANCER, V64, P364, DOI 10.1002/pbc.26212; Whelan K, 2011, PEDIATR BLOOD CANCER, V57, P126, DOI 10.1002/pbc.23025	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174479	10.1371/journal.pone.0174479	http://dx.doi.org/10.1371/journal.pone.0174479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333999	Green Published, gold, Green Accepted			2022-12-27	WOS:000399102200103
J	Mottet, D; van Dokkum, LEH; Froger, J; Gouaich, A; Laffont, I				Mottet, Denis; van Dokkum, Liesjet Elisabeth Henriette; Froger, Jerome; Gouaich, Abdelkader; Laffont, Isabelle			Trajectory formation principles are the same after mild or moderate stroke	PLOS ONE			English	Article							PLANAR REACHING MOVEMENTS; SIGNAL-DEPENDENT NOISE; FITTS TASK; HEMIPARETIC STROKE; ACCURACY; INFORMATION; PERFORMANCE; IMPAIRMENT; AMPLITUDE; ADULTS	When we make rapid reaching movements, we have to trade speed for accuracy. To do so, the trajectory of our hand is the result of an optimal balance between feed-forward and feedback control in the face of signal-dependant noise in the sensorimotor system. How far do these principles of trajectory formation still apply after a stroke, for persons with mild to moderate sensorimotor deficits who recovered some reaching ability? Here, we examine the accuracy of fast hand reaching movements with a focus on the information capacity of the sensorimotor system and its relation to trajectory formation in young adults, in persons who had a stroke and in age-matched control participants. We find that persons with stroke follow the same trajectory formation principles, albeit parameterized differently in the face of higher sensorimotor uncertainty. Higher directional errors after a stroke result in less feed-forward control, hence more feed-back loops responsible for segmented movements. As a consequence, movements are globally slower to reach the imposed accuracy, and the information throughput of the sensorimotor system is lower after a stroke. The fact that the most abstract principles of motor control remain after a stroke suggests that clinicians can capitalize on existing theories of motor control and learning to derive principled rehabilitation strategies.	[Mottet, Denis; Froger, Jerome; Laffont, Isabelle] Univ Montpellier, EuroMov, Montpellier, France; [van Dokkum, Liesjet Elisabeth Henriette] Univ Montpellier, Lab Charles Coulomb, Montpellier, France; [Froger, Jerome] Univ Hosp Nimes, Phys & Rehabil Med, Nimes, France; [Gouaich, Abdelkader] Univ Montpellier, Lab Informat Robot & Microelect Montpellier, Montpellier, France; [Laffont, Isabelle] Univ Hosp Montpellier, Phys & Rehabil Med, Montpellier, France	Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Mottet, D (corresponding author), Univ Montpellier, EuroMov, Montpellier, France.	denis.mottet@umontpellier.fr	Mottet, Denis/J-3098-2012; LAFFONT, Isabelle/X-4186-2019; van Dokkum, Liesjet/AAC-8026-2019	Mottet, Denis/0000-0002-7564-5394; van Dokkum, Liesjet/0000-0002-3278-7456	Ministere de l'economie, de l'industrie et de l'emploi [MoJOS: 092930679]; Ministere des Affaires sociales et de la Sante [MARGAUT: PHRC 2010-A00596-33]; Agence Nationale de la Recherche [NUMEV: ANR-10-LABX-20]	Ministere de l'economie, de l'industrie et de l'emploi; Ministere des Affaires sociales et de la Sante; Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was funded by the French institutions: Ministere de l'economie, de l'industrie et de l'emploi (MoJOS: 092930679), Ministere des Affaires sociales et de la Sante (MARGAUT: PHRC 2010-A00596-33) and by the Agence Nationale de la Recherche (NUMEV: ANR-10-LABX-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Ministere de l'economie, de l'industrie et de l'emploi (MoJOS: 092930679), by the Ministere des Affaires sociales et de la Sante (MARGAUT: PHRC 2010-A00596-33) and by the Agence Nationale de la Recherche (NUMEV: ANR-10-LABX-20).	Ao D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128328; Azouvi P, 2003, ARCH PHYS MED REHAB, V84, P51, DOI 10.1053/apmr.2003.50062; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Beer RF, 2007, MUSCLE NERVE, V36, P242, DOI 10.1002/mus.20817; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 1999, HUM MOVEMENT SCI, V18, P121, DOI 10.1016/S0167-9457(99)00004-4; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Enjalbert M, 1988, ANN READAPTATION MED, P31; Fernandez L, 2004, EXP BRAIN RES, V159, P458, DOI 10.1007/s00221-004-1964-4; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flash T, 2009, ENCY NEUROSCIENCE, P168; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141996; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Guiard Y, 2015, BRITISH HCI 2015, P91, DOI 10.1145/2783446.2783574; Han CE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000133; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; JAGACINSKI RJ, 1980, J EXP PSYCHOL HUMAN, V6, P309, DOI 10.1037/0096-1523.6.2.309; Kamper DG, 2002, ARCH PHYS MED REHAB, V83, P702, DOI 10.1053/apmr.2002.32446; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Knorr S, 2011, Exp Brain Res, V214, P303, DOI 10.1007/s00221-011-2826-5; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Levin MF, 2015, NEUROREHABIL NEURAL; MACKENZIE IS, 1989, J MOTOR BEHAV, V21, P323; McCrea P, 2005, EXP BRAIN RES, V162, P70, DOI 10.1007/s00221-004-2106-8; Metrot J, 2013, J NEUROL SCI, V333, pe230; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Nelsen WF, AGE, V38, P45; Nowak DA, 2008, NEUROSCI BIOBEHAV R, V32, P1439, DOI 10.1016/j.neubiorev.2008.05.021; Poletti C, 2016, ACTA PSYCHOL, V163, P1, DOI 10.1016/j.actpsy.2015.10.003; Poletti C, 2015, J EXP PSYCHOL HUMAN, V41, P542, DOI 10.1037/xhp0000033; Poston B, 2009, BRAIN COGNITION, V69, P30, DOI 10.1016/j.bandc.2008.05.002; Reinkensmeyer DJ, 2003, NEURAL COMPUT, V15, P2619, DOI 10.1162/089976603322385090; Reinkensmeyer DJ, 2002, EXP BRAIN RES, V143, P525, DOI 10.1007/s00221-002-1055-3; Rigoux L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002716; Rohrer B, 2002, J NEUROSCI, V22, P8297; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; SCHMIDT RA, 1985, RES Q EXERCISE SPORT, V56, P188, DOI 10.1080/02701367.1985.10608457; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Shannon CE, 1949, THE MATHEMATICAL THE; Silva PL, HUM MOV SCI, V48, P161; Stewart JC, 2014, EXP BRAIN RES, V232, P3431, DOI 10.1007/s00221-014-4025-7; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; Takahashi CD, 2003, EXP BRAIN RES, V149, P131, DOI 10.1007/s00221-002-1340-1; Temprado JJ, 2013, EXP BRAIN RES, V228, P105, DOI 10.1007/s00221-013-3542-0; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; van Dokkum L, 2014, NEUROREHAB NEURAL RE, V28, P4, DOI 10.1177/1545968313498514; Van Halewyck F, 2015, EXP BRAIN RES, V233, P1733, DOI 10.1007/s00221-015-4247-3; WELFORD AT, 1969, ACTA PSYCHOL, V30, P3, DOI 10.1016/0001-6918(69)90034-1; WINSTEIN CJ, 1995, EXP BRAIN RES, V105, P163; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Zhai SM, 2004, INT J HUM-COMPUT ST, V61, P791, DOI 10.1016/j.ijhcs.2004.09.006	61	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173674	10.1371/journal.pone.0173674	http://dx.doi.org/10.1371/journal.pone.0173674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28329000	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700028
J	Baker, SL; Hogg, JR				Baker, Stacey L.; Hogg, J. Robert			A system for coordinated analysis of translational readthrough and nonsense-mediated mRNA decay	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; MURINE LEUKEMIA-VIRUS; STOP CODON; READ-THROUGH; 3' UTRS; SACCHAROMYCES-CEREVISIAE; TERMINATION EFFICIENCY; SMG5-SMG7 HETERODIMER; LUCIFERASE REPORTER; MAMMALIAN-CELLS	The nonsense-mediated mRNA decay (NMD) pathway degrades mRNAs containing premature termination codons, limiting the expression of potentially deleterious truncated proteins. This activity positions the pathway as a regulator of the severity of genetic diseases caused by nonsense mutations. Because many genetic diseases result from nonsense alleles, therapeutics inducing readthrough of premature termination codons and/or inhibition of NMD have been of great interest. Several means of enhancing translational readthrough have been reported to concomitantly inhibit NMD efficiency, but tools for systematic analysis of mammalian NMD inhibition by translational readthrough are lacking. Here, we introduce a system that allows concurrent analysis of translational readthrough and mRNA decay. We use this system to show that diverse readthrough-promoting RNA elements have similar capacities to inhibit NMD. Further, we provide evidence that the level of translational readthrough required for protection from NMD depends on the distance of the suppressed termination codon from the end of the mRNA.	[Baker, Stacey L.; Hogg, J. Robert] NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hogg, JR (corresponding author), NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	j.hogg@nih.gov	Hogg, J. Robert/O-2327-2018; Hogg, J. Robert/AAE-6539-2021	Hogg, J. Robert/0000-0001-5729-5135; 	Intramural Research Program; National Institutes of Health, National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006158] Funding Source: NIH RePORTER	Intramural Research Program; National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute. The funder had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.; We thank Thomas Baird, Nazmul Haque, Aparna Kishor, Soumya Ranganathan, and Lisa Postow for critical reading of the manuscript, Stephen P. Goff and Haiwei Song for helpful discussions, and Brian Houck Loomis for providing MLVPK sequences. This work was supported by the Intramural Research Program, National Heart, Lung, and Blood Institute, National Institutes of Health.	Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bidou L, 2017, RNA BIOL; Boehm V, 2014, CELL REP, V9, P555, DOI 10.1016/j.celrep.2014.09.012; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Cardno TS, 2009, RNA, V15, P1614, DOI 10.1261/rna.1586709; Cassan M, 2001, BMC Mol Biol, V2, P3, DOI 10.1186/1471-2199-2-3; Chakrabarti S, 2014, NUCLEIC ACIDS RES, V42, P9447, DOI 10.1093/nar/gku578; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chao AT, 2003, GENETICS, V165, P601; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Ge Z, 2016, ELIFE, V5; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Grentzmann G, 1998, RNA, V4, P479; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Hogg JR, 2016, J VIROL; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Hurt JA, 2013, GENOME RES, V23, P1636, DOI 10.1101/gr.157354.113; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jonas S, 2013, GENE DEV, V27, P211, DOI 10.1101/gad.206672.112; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Keeling KM, 2014, ANN REV GENOMICS HUM; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kurosaki T, 2013, P NATL ACAD SCI USA, V110, P3357, DOI 10.1073/pnas.1219908110; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Loh B, 2013, GENE DEV, V27, P2125, DOI 10.1101/gad.226951.113; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen S, 2014, GENE DEV, V28, P2498, DOI 10.1101/gad.246538.114; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mascarenhas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074791; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Myerowitz R, 1997, HUM MUTAT, V9, P195, DOI 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Napthine S, 2012, RNA, V18, P241, DOI 10.1261/rna.030338.111; Nicholson P, 2014, NUCLEIC ACIDS RES, V42, P9217, DOI 10.1093/nar/gku645; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Pacho F, 2011, J MED GENET, P1; Pinotti M, 2012, HUM MUTAT, V33, P1373, DOI 10.1002/humu.22120; Sako Yusuke, 2006, Nucleic Acids Symp Ser (Oxf), P239, DOI 10.1093/nass/nrl119; Schmidt SA, 2015, NUCLEIC ACIDS RES, V43, P309, DOI 10.1093/nar/gku1258; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Smith JE, 2015, BIOESSAYS, V37, P612, DOI 10.1002/bies.201500007; Stenson Peter D, 2009, Hum Genomics, V4, P69; Tang XH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12070; Tate WP, 1995, BIOCHEM CELL BIOL, V73, P1095, DOI 10.1139/o95-118; Tork S, 2004, NUCLEIC ACIDS RES, V32, P415, DOI 10.1093/nar/gkh201; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635	70	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173980	10.1371/journal.pone.0173980	http://dx.doi.org/10.1371/journal.pone.0173980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323884	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000052
J	Zhang, DL; Chen, X; Wang, Q; Wu, SH; Zheng, Y; Liu, X				Zhang, Daoliang; Chen, Xiaoqing; Wang, Qian; Wu, Shaohui; Zheng, Yue; Liu, Xu			Role of the MAPKs/TGF-beta 1/TRAF6 signaling pathway in postoperative atrial fibrillation	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; EXPRESSION; FIBROSIS; JNK; ACTIVATION; RECEPTORS; MORTALITY; MICE; P38	Objectives To explore the relationship between the MAPKs/TGF-beta 1/TRAF6 signaling pathway and atrial fibrosis in patients with rheumatic heart disease (RHD) and its role in atrial fibrillation (AF) after cardiac surgery on the basis of our previous animal study of the MAPKs/TGF-beta 1/TRAF6 signaling pathway in atrial fibrosis. Methods A total of 57 patients with RHD without a history of AF consented to left atrial biopsy. Histopathology quantified the percentage of fibrosis, and real-time PCR and western blot assessed the mRNA and protein expression of TGF-beta 1, TRAF6, and connective tissue growth factor (CTGF), respectively. Western blot was also used to measure the protein expression of phosphorylated MAPKs and TGF-beta-activated kinase 1 (TAK1). Serum angiotensin II (Ang II) levels were assayed using enzyme-linked immunosorbent assay (ELISA). Results Eighteen patients developed AF, whereas 39 remained in sinus rhythm (SR). The severity of atrial fibrosis was significantly higher in patients who developed AF versus those who remained in SR; the mRNA and protein expression of TGF-beta 1, TRAF6 and CTGF were significantly higher in patients with AF. The protein expression of phosphorylated MAPKs and TAK1 was significantly increased in patients who developed AF compared with the patients who remained in SR. Serum Ang II levels were significantly higher in patients who developed AF versus those who remained in SR. Conclusion The MAPKs/TGF-beta 1/TRAF6 signaling pathway is involved in atrial fibrosis in patients with RHD, which results in the occurrence of AF after cardiac surgery.	[Zhang, Daoliang; Wu, Shaohui; Liu, Xu] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China; [Chen, Xiaoqing] Shanghai First Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China; [Wang, Qian] Shanghai Xinhua Hosp, Dept Cardiol, Shanghai, Peoples R China; [Zheng, Yue] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiac Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, X (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China.	xkzhangdaoliang@126.com						Beyerbach DM, 2004, HEART RHYTHM, V1, pB8, DOI 10.1016/j.hrthm.2004.04.018; Boldt A, 2003, J AM COLL CARDIOL, V42, P1785, DOI 10.1016/j.jacc.2003.07.014; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369; Huang G, 2011, EUR J CLIN INVEST, V41, P719, DOI 10.1111/j.1365-2362.2010.02460.x; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Ko WC, 2011, CIRC J, V75, P1592, DOI 10.1253/circj.CJ-10-0892; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lapar DJ, 2014, ANN THORAC SURG, V98, P527, DOI 10.1016/j.athoracsur.2014.03.039; Liu B, 2006, J CELL BIOCHEM, V97, P1104, DOI 10.1002/jcb.20709; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Nakashima H, 2007, CIRC J, V71, P1977, DOI 10.1253/circj.71.1977; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Swartz MF, 2012, J AM COLL CARDIOL, V60, P1799, DOI 10.1016/j.jacc.2012.06.048; Tan AY, 2011, J CARDIOVASC PHARM, V57, P625, DOI 10.1097/FJC.0b013e3182073c78; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; YAFEI N, 1990, BIOCHEM SOC T, V18, P884, DOI 10.1042/bst0180884; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002	22	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173759	10.1371/journal.pone.0173759	http://dx.doi.org/10.1371/journal.pone.0173759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323847	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000029
J	Campobello, D; Lindstrom, J; Di Maggio, R; Sara, M				Campobello, D.; Lindstrom, J.; Di Maggio, R.; Sara, M.			An integrated analysis of micro- and macro-habitat features as a tool to detect weather-driven constraints: A case study with cavity nesters	PLOS ONE			English	Article							KESTREL FALCO-NAUMANNI; CLIMATE-CHANGE; PARUS-MAJOR; MICROCLIMATE; TEMPERATURE; RESPONSES; SELECTION; EVOLUTIONARY; DYNAMICS; SURVIVAL	The effects of climate change on animal populations may be shaped by habitat characteristics at both micro- and macro-habitat level, however, empirical studies integrating these two scales of observation are lacking. As analyses of the effects of climate change commonly rely on data from a much larger scale than the microhabitat level organisms are affected at, this mismatch risks hampering progress in developing understanding of the details of the ecological and evolutionary responses of organisms and, ultimately, effective actions to preserve their populations. Cavity nesters, often with a conservation status of concern, are an ideal model because the cavity is a microenvironment potentially different from the macroenvironment but nonetheless inevitably interacting with it. The lesser kestrel (Falco naumanni) is a cavity nester which was until recently classified by as Vulnerable species. Since 2004, for nine years, we collected detailed biotic and abiotic data at both micro- and macro-scales of observation in a kestrel population breeding in the Gela Plain (Italy), a Mediterranean area where high temperatures may reach lethal values for the nest content. We show that macro-climatic features needed to be integrated with both abiotic and biotic factors recorded at a microscale before reliably predicting nest temperatures. Among the nest types used by lesser kestrels, we detected a preferential occupation of the cooler nest types, roof tiles, by early breeders whereas, paradoxically, late breeders nesting with hotter temperatures occupied the overheated nest holes. Not consistent with such a suggested nest selection, the coolest nest type did not host a higher reproductive success than the overheated nests. We discussed our findings in the light of cavity temperatures and nest types deployed within conservation actions assessed by integrating selected factors at different observation scales.	[Campobello, D.; Di Maggio, R.; Sara, M.] Univ Palermo, Sect Anim Biol, Dept STEBICEF, Palermo, Italy; [Lindstrom, J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Palermo; University of Glasgow	Campobello, D (corresponding author), Univ Palermo, Sect Anim Biol, Dept STEBICEF, Palermo, Italy.	daniela.campobello@unipa.it	Sarà, Maurizio/H-2662-2012; Lindstrom, Jan/A-8890-2008	Sarà, Maurizio/0000-0003-4274-422X; Lindstrom, Jan/0000-0001-5630-6680; Campobello, Daniela/0000-0003-4094-9395	University of Palermo, Scientific Research Grants [FFR 2012-ATE-0441]; Italian Ministry of Education,University and Research [20108 TZKHC]	University of Palermo, Scientific Research Grants; Italian Ministry of Education,University and Research(Ministry of Education, Universities and Research (MIUR))	Funding was provided by University of Palermo, Scientific Research Grants (FFR 2012-ATE-0441 ) and by the Italian Ministry of Education,University and Research (PRIN 2010-2011, 20108 TZKHC)to MS. The fundershad norole in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alcaide M, 2005, IBIS, V147, P608, DOI 10.1111/j.1474-919x.2005.00429.x; Amat-Valero M, 2014, INT J BIOMETEOROL, V58, P1983, DOI 10.1007/s00484-014-0801-0; Angilletta MJ, 2006, AM NAT, V168, pE123, DOI 10.1086/507880; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Bellia E, 2011, INT J WILDLAND FIRE, V20, P605, DOI 10.1071/WF09129; Berntsen HH, 2016, J AVIAN BIOL, V47, P141, DOI 10.1111/jav.00688; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Campobello D, 2007, ETHOL ECOL EVOL, V19, P237; Campobello D, 2015, EVOLUTION, V69, P916, DOI 10.1111/evo.12629; Campobello D, 2012, BEHAV ECOL, V23, P425, DOI 10.1093/beheco/arr207; Catry I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058320; Catry I, 2011, BIOL CONSERV, V144, P1111, DOI 10.1016/j.biocon.2010.12.030; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cooper CB, 2005, ECOLOGY, V86, P2018, DOI 10.1890/03-8028; De Frenne P, 2013, P NATL ACAD SCI USA, V110, P18561, DOI 10.1073/pnas.1311190110; De Marchi G, 2015, IBIS, V157, P31, DOI 10.1111/ibi.12208; Di Maggio R, 2015, J ZOOL, V295, P108, DOI 10.1111/jzo.12191; Di Maggio R, 2016, BIOL CONSERV, V193, P116, DOI 10.1016/j.biocon.2015.11.016; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gienapp P, 2006, EVOLUTION, V60, P2381; Inigo A, 2011, BEHAV ECOL; IPCC, 2014, CLIMATE CHANGE 2014, P1132; Isaac JL, 2008, WILDLIFE RES, V35, P441, DOI 10.1071/WR08016; Lambrechts M, 2012, J ORNITHOL, V153, P23, DOI 10.1007/s10336-011-0720-3; Lei BR, 2014, BIRD CONSERV INT, V24, P201, DOI 10.1017/S0959270913000671; Lima FP, 2009, LIMNOL OCEANOGR-METH, V7, P347, DOI 10.4319/lom.2009.7.347; Maziarz M, 2013, AVIAN BIOL RES, V6, P47, DOI 10.3184/175815513X13611994806259; Molenaar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059637; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Ortego J, 2007, ANIM CONSERV, V10, P312, DOI 10.1111/j.1469-1795.2007.00114.x; Oswald SA, 2012, INTEGR ZOOL, V7, P121, DOI 10.1111/j.1749-4877.2012.00287.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; Pigliucci M., 2001, SYNTHESIS ECOLOGY EV; Pike DA, 2013, ANIM CONSERV, V16, P694, DOI 10.1111/acv.12049; Pliscoff P, 2014, ECOL MODEL, V288, P166, DOI 10.1016/j.ecolmodel.2014.06.003; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; R Core Team, 2021, R LANGUAGE ENV STAT; Salaberria C, 2014, IBIS, V156, P265, DOI 10.1111/ibi.12121; Sara M, 2014, BIRD STUDY, V61, P29, DOI 10.1080/00063657.2013.867476; Sara M, 2012, AVIAN BIOL RES, V5, P209, DOI 10.3184/175815512X13535044854571; Sara M, 2010, ARDEOLA, V57, P3; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Serrano D, 2007, AM NAT, V169, pE53, DOI 10.1086/510598; Skagen SK, 2012, ECOL APPL, V22, P1131, DOI 10.1890/11-0291.1; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Triolo S, 2011, WILDLIFE RES, V38, P152, DOI 10.1071/WR10185; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiebe KL, 2001, AUK, V118, P412, DOI 10.1642/0004-8038(2001)118[0412:MOTCNI]2.0.CO;2; Zuur Alain F., 2009, P1	55	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174090	10.1371/journal.pone.0174090	http://dx.doi.org/10.1371/journal.pone.0174090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319183	gold, Green Published, Green Accepted			2022-12-27	WOS:000398945800048
J	Kumar, R; Mota, LC; Litoff, EJ; Rooney, JP; Boswell, WT; Courter, E; Henderson, CM; Hernandez, JP; Corton, JC; Moore, DD; Baldwin, WS				Kumar, Ramiya; Mota, Linda C.; Litoff, Elizabeth J.; Rooney, John P.; Boswell, W. Tyler; Courter, Elliott; Henderson, Charles M.; Hernandez, Juan P.; Corton, J. Christopher; Moore, David D.; Baldwin, William S.			Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice	PLOS ONE			English	Article							PREGNANE-X RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; HEPATOCYTE NUCLEAR FACTORS; P450 GENE-EXPRESSION; CYTOCHROMES P450; DRUG-METABOLISM; XENOBIOTIC METABOLISM; LIVER-MICROSOMES; GROWTH-HORMONE; TESTOSTERONE BIOTRANSFORMATION	Targeted mutant models are common in mechanistic toxicology experiments investigating the absorption, metabolism, distribution, or elimination (ADME) of chemicals from individuals. Key models include those for xenosensing transcription factors and cytochrome P450s (CYP). Here we investigated changes in transcript levels, protein expression, and steroid hydroxylation of several xenobiotic detoxifying CYPs in constitutive androstane receptor (CAR)-null and two CYP-null mouse models that have subfamily members regulated by CAR; the Cyp3a-null and a newly described Cyp2b9/10/13-null mouse model. Compensatory changes in CYP expression that occur in these models may also occur in polymorphic humans, or may complicate interpretation of ADME studies performed using these models. The loss of CAR causes significant changes in several CYPs probably due to loss of CAR mediated constitutive regulation of these CYPs. Expression and activity changes include significant repression of Cyp2a and Cyp2b members with corresponding drops in 6 alpha- and 16 beta-testosterone hydroxylase activity. Further, the ratio of 6 alpha-/15 alpha-hydroxylase activity, a biomarker of sexual dimorphism in the liver, indicates masculinization of female CAR-null mice, suggesting a role for CAR in the regulation of sexually dimorphic liver CYP profiles. The loss of Cyp3a causes fewer changes than CAR. Nevertheless, there are compensatory changes including gender-specific increases in Cyp2a and Cyp2b. Cyp2a and Cyp2b were down-regulated in CAR-null mice, suggesting activation of CAR and potentially PXR following loss of the Cyp3a members. However, the loss of Cyp2b causes few changes in hepatic CYP transcript levels and almost no significant compensatory changes in protein expression or activity with the possible exception of 6a-hydroxylase activity. This lack of a compensatory response in the Cyp2b9/10/13-null mice is probably due to low CYP2B hepatic expression, especially in male mice. Overall, compensatory and regulatory CYP changes followed the order CAR-null > Cyp3a-null > Cyp2b-null mice.	[Kumar, Ramiya; Litoff, Elizabeth J.; Boswell, W. Tyler; Courter, Elliott; Henderson, Charles M.; Baldwin, William S.] Clemson Univ, Biol Sci, Clemson, SC 29634 USA; [Mota, Linda C.; Baldwin, William S.] Clemson Univ, Environm Toxicol, Pendleton, SC 29670 USA; [Rooney, John P.; Corton, J. Christopher] US EPA, NHEERL, Res Triangle Pk, NC 27711 USA; [Hernandez, Juan P.; Moore, David D.] Baylor Coll Med, Mol & Cellular Biol, Houston, TX 77030 USA	Clemson University; Clemson University; United States Environmental Protection Agency; Baylor College of Medicine	Baldwin, WS (corresponding author), Clemson Univ, Biol Sci, Clemson, SC 29634 USA.; Baldwin, WS (corresponding author), Clemson Univ, Environm Toxicol, Pendleton, SC 29670 USA.	Baldwin@clemson.edu		Mota, Linda/0000-0002-1261-5403	National Institutes of Health [R15ES017321, ES017321-S1, ES017321-S2, R01DK46546]; U.S. Environmental Protection Agency; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES017321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Primary research support for this study was provided by National Institutes of Health (www.nih.gov) grants R15ES017321 (WSB), ES017321-S1 and S2 (WSB, EC, CMH), and R01DK46546 (DDM). Some of the information in this document has been funded by the U.S. Environmental Protection Agency (www.epa.gov).	Acevedo R, 2005, J APPL TOXICOL, V25, P339, DOI 10.1002/jat.1078; Anakk S, 2003, FASEB J, V17, P1736, DOI 10.1096/fj.02-1004fje; Baldwin WS, 2009, TOXICOL SCI, V107, P93, DOI 10.1093/toxsci/kfn206; BALDWIN WS, 1992, CHEM-BIOL INTERACT, V83, P155, DOI 10.1016/0009-2797(92)90043-K; BURKHART BA, 1985, J BIOL CHEM, V260, P5357; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865; Choi HK, 2000, GROWTH HORM IGF RES, pS1; Cui JY, 2012, DRUG METAB DISPOS, V40, P1226, DOI 10.1124/dmd.111.042697; Damiri B, 2012, TOXICOL SCI, V125, P368, DOI 10.1093/toxsci/kfr309; Dong BN, 2009, HEPATOLOGY, V50, P622, DOI 10.1002/hep.23025; Dostalek M, 2011, BRIT J PHARMACOL, V163, P937, DOI 10.1111/j.1476-5381.2011.01270.x; Du LP, 2005, ARCH BIOCHEM BIOPHYS, V435, P125, DOI 10.1016/j.abb.2004.11.023; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Foxenberg RJ, 2007, DRUG METAB DISPOS, V35, P189, DOI 10.1124/dmd.106.012427; Gaytan BD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00110; Gelboin HV, 1995, BIOCHEM PHARMACOL, V50, P1841, DOI 10.1016/0006-2952(95)02077-2; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Hasegawa M, 2011, MOL PHARMACOL, V80, P518, DOI 10.1124/mol.111.071845; Hashimoto M, 2013, J LIPID RES, V54, P2060, DOI 10.1194/jlr.M033464; Hashita T, 2008, DRUG METAB DISPOS, V36, P1080, DOI 10.1124/dmd.107.019729; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Hernandez J. P., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P81; Hernandez JP, 2009, TOXICOLOGY, V256, P53, DOI 10.1016/j.tox.2008.11.002; Hernandez JP, 2007, TOXICOL SCI, V98, P416, DOI 10.1093/toxsci/kfm107; Hernandez JP, 2006, TOXICOL APPL PHARM, V216, P186, DOI 10.1016/j.taap.2006.05.014; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; IMAOKA S, 1989, J BIOCHEM-TOKYO, V105, P939, DOI 10.1093/oxfordjournals.jbchem.a122783; Jarukamjorn K, 2002, BIOCHEM PHARMACOL, V63, P2037, DOI 10.1016/S0006-2952(02)00989-9; Jarukamjorn K, 2001, BIOCHEM PHARMACOL, V62, P161, DOI 10.1016/S0006-2952(01)00656-6; Je YT, 2015, ARCH TOXICOL, V89, P579, DOI 10.1007/s00204-014-1268-9; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Keeney DS, 1998, J BIOL CHEM, V273, P32071, DOI 10.1074/jbc.273.48.32071; Kodama S, 2011, NUCLEIC ACIDS RES, V39, P8392, DOI 10.1093/nar/gkr458; Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003; Ledda-Columbano GM, 2003, CARCINOGENESIS, V24, P1059, DOI 10.1093/carcin/bgg063; Lee C, 2006, DRUG METAB DISPOS, V34, P1530, DOI 10.1124/dmd.106.009936; Lee PC, 1998, TOXICOL LETT, V99, P117, DOI 10.1016/S0378-4274(98)00153-2; Luisier R, 2014, TOXICOL SCI, V139, P501, DOI 10.1093/toxsci/kfu038; MAUREL P, 1996, CYTOCHROMES P450 MET, P241; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Mo SL, 2009, CURR DRUG METAB, V10, P730, DOI 10.2174/138920009789895534; Mota LC, 2011, TOXICOL APPL PHARM, V252, P259, DOI 10.1016/j.taap.2011.02.017; Mota LC, 2010, DRUG METAB DISPOS, V38, P1582, DOI 10.1124/dmd.110.032961; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; NOSHIRO M, 1986, J BIOL CHEM, V261, P5923; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150284; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; Patoine D, 2013, DRUG METAB DISPOS, V41, P952, DOI 10.1124/dmd.112.050641; Peng L, 2012, DRUG METAB DISPOS, V40, P1198, DOI 10.1124/dmd.112.045088; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Petrick JS, 2007, DRUG METAB DISPOS, V35, P1806, DOI 10.1124/dmd.107.015974; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Scheer N, 2014, DRUG METAB DISPOS, V42, P1022, DOI 10.1124/dmd.114.057885; Scheer N, 2010, DRUG METAB DISPOS, V38, P1046, DOI 10.1124/dmd.109.031872; Shou MG, 2000, EUR J PHARMACOL, V394, P199, DOI 10.1016/S0014-2999(00)00079-0; Smith G, 1998, BIOCHEM J, V331, P783, DOI 10.1042/bj3310783; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Sueyoshi T, 2008, MOL PHARMACOL, V73, P1113, DOI 10.1124/mol.107.042960; Tien ES, 2006, XENOBIOTICA, V36, P1152, DOI 10.1080/00498250600861827; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; van Herwaarden AE, 2007, J CLIN INVEST, V117, P3583, DOI 10.1172/JCI33435; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; VANDERHO.TA, 1974, J BIOL CHEM, V249, P6302; Vrzal R, 2010, TOXICOL LETT, V193, P183, DOI 10.1016/j.toxlet.2010.01.004; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang J, 2014, EXCLI J, V13, P728; Warner NA, 2009, ENVIRON SCI TECHNOL, V43, P114, DOI 10.1021/es802237u; WAXMAN DJ, 1983, J BIOL CHEM, V258, P1937; WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3; Wei Y, 2013, DRUG METAB DISPOS, V41, P132, DOI 10.1124/dmd.112.048736; Wilson VS, 1998, TOXICOL APPL PHARM, V148, P158, DOI 10.1006/taap.1997.8319; Wilson VS, 1999, ENVIRON HEALTH PERSP, V107, P377, DOI 10.2307/3434541; Wiwi CA, 2005, J BIOL CHEM, V280, P3259, DOI 10.1074/jbc.M409294200; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamada H, 2002, TOXICOL APPL PHARM, V180, P1, DOI 10.1006/taap.2002.9366	86	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174355	10.1371/journal.pone.0174355	http://dx.doi.org/10.1371/journal.pone.0174355			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350814	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174400027
J	Frederiksen, P; Indahl, A; Andersen, LL; Burton, K; Hertzum-Larsen, R; Bendix, T				Frederiksen, Pernille; Indahl, Aage; Andersen, Lars L.; Burton, Kim; Hertzum-Larsen, Rasmus; Bendix, Tom			Can group-based reassuring information alter low back pain behavior? A cluster-randomized controlled trial	PLOS ONE			English	Article							WORK ABILITY INDEX; OCCUPATIONAL-HEALTH GUIDELINES; PSYCHOSOCIAL RISK-FACTORS; TERM SICK LEAVE; LIGHT MOBILIZATION; FOLLOW-UP; EDUCATIONAL BOOKLET; EARLY INTERVENTION; OUTCOME MEASURES; MEDIA CAMPAIGN	Background Low back pain (LBP) is common in the population and multifactorial in nature, often involving negative consequences. Reassuring information to improve coping is recommended for reducing the negative consequences of LBP. Adding a simple non-threatening explanation for the pain (temporary muscular dysfunction) has been successful at altering beliefs and behavior when delivered with other intervention elements. This study investigates the isolated effect of this specific information on future occupational behavior outcomes when delivered to the workforce. Design A cluster-randomized controlled trial. Methods Publically employed workers (n = 505) from 11 Danish municipality centers were randomized at center-level (cluster) to either intervention (two 1-hour group-based talks at the workplace) or control. The talks provided reassuring information together with a simple non-threatening explanation for LBP-the 'functional-disturbance'-model. Data collections took place monthly over a 1-year period using text message tracking (SMS). Primary outcomes were self-reported days of cutting down usual activities and work participation. Secondary outcomes were self-reported back beliefs, work ability, number of healthcare visits, bothersomeness, restricted activity, use of pain medication, and sadness/depression. Results There was no between-group difference in the development of LBP during follow-up. Cumulative logistic regression analyses showed no between-group difference on days of cutting down activities, but increased odds for more days of work participation in the intervention group (OR = 1.83 95% CI: 1.08-3.12). Furthermore, the intervention group was more likely to report: higher work ability, reduced visits to healthcare professionals, lower bothersomeness, lower levels of sadness/depression, and positive back beliefs. Conclusion Reassuring information involving a simple non-threatening explanation for LBP significantly increased the odds for days of work participation and higher work ability among workers who went on to experience LBP during the 12-month follow-up. Our results confirm the potential for public-health education for LBP, and add to the discussion of simple versus multidisciplinary interventions.	[Frederiksen, Pernille; Bendix, Tom] Ctr Rheumatol & Spine Dis, Copenhagen Ctr Back Res COPE BACK, Glostrup, Denmark; [Frederiksen, Pernille] Metropolitan Univ Coll, Copenhagen, Denmark; [Frederiksen, Pernille; Bendix, Tom] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Indahl, Aage] Univ Bergen, Uni Hlth, Bergen, Norway; [Indahl, Aage] Vestfold Hosp Trust, Dept Res & Dev, Clin Phys Med & Rehabil, Stavern, Norway; [Andersen, Lars L.] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Lars L.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Phys Act & Human Performance Grp, Aalborg, Denmark; [Burton, Kim] Univ Huddersfield, Ctr Appl Psychol & Hlth Res, Huddersfield, W Yorkshire, England; [Hertzum-Larsen, Rasmus] Danish Canc Soc Res & Data, Copenhagen, Denmark	University of Copenhagen; University of Bergen; National Research Centre for the Working Environment; Aalborg University; University of Huddersfield; Danish Cancer Society	Frederiksen, P (corresponding author), Ctr Rheumatol & Spine Dis, Copenhagen Ctr Back Res COPE BACK, Glostrup, Denmark.; Frederiksen, P (corresponding author), Metropolitan Univ Coll, Copenhagen, Denmark.; Frederiksen, P (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.	frederiksarbejde@outlook.dk	Andersen, Lars Louis/AAQ-4802-2020	Frederiksen, Pernille/0000-0001-9528-0735	Danish Working Environment Research Fund [20130069209]; Danish Rheumatism Association [R102-Rp3794]; Danish Working Environment Research Fund (Arbejdsmiljoforskningsfonden); Danish Rheumatism Association (Gigtforeningen)	Danish Working Environment Research Fund; Danish Rheumatism Association; Danish Working Environment Research Fund (Arbejdsmiljoforskningsfonden); Danish Rheumatism Association (Gigtforeningen)	This work was supported by The Danish Working Environment Research Fund, URL: https://arbejdstilsynet.dk/da/om%20arbejdstilsynet/arbejdsmiljoforskningsfonden/opslag-og-ansogninger/opslag-marts-2016, Grant number: 20130069209. The funder provided the study with money to pay the salary of the first author (PF) for one year. The funder took no part in the study at any time nor did they have any say on how the study was performed, analyzed, and they did not interfere in the writing process of the paper. This work was also supported by The Danish Rheumatism Association, URL: https://www.gigtforeningen.dk/, Grant number: R102-Rp3794. The funder granted a smaller amount of money to pay for equipment used for the study. The funder took no part in the study at any time nor did they have any say on how the study was performed, analyzed, and they did not interfere in the writing process of the paper.; We owe great thanks to the participating municipalities and employees for their engagement and great contribution to the study. Thanks to Nina Beier for typing data and to Anne Keller, who contributed in the planning of the study. Thanks also to Sebastian Werngreen Nielsen for reviewing the manuscript. Funding was provided by The Danish Working Environment Research Fund (Arbejdsmiljoforskningsfonden) and The Danish Rheumatism Association (Gigtforeningen).	Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917; Andersen LL, 2011, OCCUP ENVIRON MED, V68, P590, DOI 10.1136/oem.2010.056259; Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; Bethge M, 2013, ARCH PHYS MED REHAB, V94, P2262, DOI 10.1016/j.apmr.2013.05.003; Bethge M, 2012, J REHABIL MED, V44, P980, DOI 10.2340/16501977-1063; Bostick GP, 2013, EUR J PAIN, V17, P1074, DOI 10.1002/j.1532-2149.2012.00275.x; Brage Soren, 2010, Tidsskr Nor Laegeforen, V130, P2369, DOI 10.4045/tidsskr.10.0236; Buchbinder R, 2005, SPINE, V30, P1323, DOI 10.1097/01.brs.0000164121.77862.4b; Buchbinder R, 2007, SPINE, V32, pE156, DOI 10.1097/01.brs.0000256885.00681.00; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Coudeyre E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000706; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Dunn KM, 2011, EUR J PAIN, V15, P313, DOI 10.1016/j.ejpain.2010.07.008; Emch TM, 2011, SKELETAL RADIOL, V40, P1175, DOI 10.1007/s00256-011-1163-x; Eriksen HR, 1999, SCAND J PUBLIC HEALT, V27, P63, DOI 10.1177/14034948990270010401; Ersek M, 2008, PAIN, V138, P29, DOI 10.1016/j.pain.2007.11.003; Fisher EB, 1997, INT J BEHAV MED, V4, P131, DOI 10.1207/s15327558ijbm0402_3; Frederiksen P, 2015, J OCCUP REHABIL, V25, P707, DOI 10.1007/s10926-015-9578-1; Frost P, 2007, SPINE, V32, P1949, DOI 10.1097/BRS.0b013e3181342659; Hagen EM, 2005, SPINE, V30, P2717, DOI 10.1097/01.brs.0000190394.05359.c7; Hagen EM, 2003, SPINE, V28, P2309, DOI 10.1097/01.BRS.0000085817.33211.3F; Hagen EM, 2000, SPINE, V25, P1973, DOI 10.1097/00007632-200008010-00017; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Hodges PW, 2013, EUR J PAIN, V17, P1138, DOI 10.1002/j.1532-2149.2013.00286.x; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Indahl A, 1998, SPINE, V23, P2625, DOI 10.1097/00007632-199812010-00018; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; Indahl A., 1999, THESIS; Jensen C, 2013, SPINE, V38, P1059, DOI 10.1097/BRS.0b013e31828ca0af; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Karayannis NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067779; Kendall NAS, 2009, TACKLING MUSCULOSKEL; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Koch M, 2011, SAMFUNDSMAESSIGE OMK; Kovacs F, 2007, SPINE, V32, P1053, DOI 10.1097/01.brs.0000261556.84266.0f; Krause N, 2005, AM J IND MED, V48, P326, DOI 10.1002/ajim.20221; Lund Thomas, 2007, Work, V28, P225; MacDonald D, 2009, PAIN, V142, P183, DOI 10.1016/j.pain.2008.12.002; Macedo LG, 2012, SPINE, V37, P1151, DOI 10.1097/BRS.0b013e3182422df0; Main CJ, 2012, ACUTE CHRONIC PAIN R, P433; Mehlsen M, 2015, PATIENT EDUC COUNS, V98, P677, DOI 10.1016/j.pec.2015.01.008; Moseley GL, 2004, BRAIN, V127, P2339, DOI 10.1093/brain/awh248; O'Keeffe M, 2016, J PAIN, P1526; Odeen M, 2013, J OCCUP REHABIL, V23, P209, DOI 10.1007/s10926-013-9451-z; Palmer KT, 2012, RHEUMATOLOGY, V51, P230, DOI 10.1093/rheumatology/ker086; Pengel LHM, 2007, ANN INTERN MED, V146, P787, DOI 10.7326/0003-4819-146-11-200706050-00007; Petit A, 2015, INT J OCCUP SAF ERGO, V21, P15, DOI 10.1080/10803548.2015.1017940; Ramond-Roquin A, 2014, FAM PRACT, V31, P379, DOI 10.1093/fampra/cmu008; Ree E, 2016, SCAND J PUBLIC HEALT, V44, P571, DOI 10.1177/1403494816653854; Ree E, 2014, SCAND J PUBLIC HEALT, V42, P821, DOI 10.1177/1403494814554029; Reme SE, 2014, SPINE, V39, pE455, DOI 10.1097/BRS.0000000000000214; Shaw WS., 2012, ACUTE CHRONIC BACK P, P377; Sorensen PH, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-212; Staal JB, 2003, OCCUP ENVIRON MED, V60, P618, DOI 10.1136/oem.60.9.618; Storheim K, 2012, EUR SPINE J, V21, P2539, DOI 10.1007/s00586-012-2393-x; Symonds TL, 1995, SPINE, V20, P2738, DOI 10.1097/00007632-199512150-00016; Thiese MS, 2014, HUM FACTORS, V56, P86, DOI 10.1177/0018720813493641; Tveito TH, 2010, DISABIL REHABIL, V32, P2035, DOI 10.3109/09638281003797398; URSIN H, 1988, EUR J APPL PHYSIOL O, V57, P282, DOI 10.1007/BF00635986; Videman T, 2003, SPINE, V28, P582, DOI 10.1097/00007632-200303150-00013; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Waddell G., 1998, BACK PAIN REVOLUTION; Waddell G, 2007, SPINE, V32, P2139, DOI 10.1097/BRS.0b013e31814541bc; Werner EL, 2008, PATIENT EDUC COUNS, V71, P198, DOI 10.1016/j.pec.2007.12.009; World Medical Association, WMA DECL HELS ETH PR	69	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0172003	10.1371/journal.pone.0172003	http://dx.doi.org/10.1371/journal.pone.0172003			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346472	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000399174300003
J	Amado, D; Sanchez-Miguel, PA; Molero, P				Amado, Diana; Antonio Sanchez-Miguel, Pedro; Molero, Pablo			Creativity associated with the application of a motivational intervention programme for the teaching of dance at school and its effect on the both genders	PLOS ONE			English	Article							PHYSICAL-EDUCATION; INTRINSIC MOTIVATION; SELF-DETERMINATION; STUDENTS; AUTONOMY; COMPETENCE; TEACHERS; EXERCISE; SPORT; SEX	The current study reviews processes of teaching-learning based on creativity, with the application by teachers of several strategies to support the need for autonomy, competence, and relatedness. The aim is to learn the effect of pupil's gender on their motivational level and the psychological consequences that might arise in the cognitive, affective, and behavioural domains. A quasi-experimental study was carried out at four schools in Mexico, with 12 physical education teachers and 40 natural groups of pupils aged between 11 and 17 (M = 13.17). The groups were randomly assigned to either an experimental group (24 groups, 447 pupils) or a control group (16 groups, 474 pupils). A prior training programme was carried out with the teachers in the experimental group to enable them to support the psychological need for autonomy, competence, and relatedness. Initial and final measurements were taken in both groups, and the results revealed that independently of the programme used, girls showed higher motivation and positive psychological consequences in the teaching of dance compared to the male participants. In conclusion, it is important to continue with research and set a methodology that addresses those differences, dedicating the necessary time and treatment to resolve their questions and necessities.	[Amado, Diana] Univ Extremadura, Dept Didact Mus Plast & Corporal Express, Fac Sport Sci, Caceres, Spain; [Antonio Sanchez-Miguel, Pedro; Molero, Pablo] Univ Extremadura, Dept Didact Mus Plast & Corporal Express, Fac Teacher Training, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura	Amado, D (corresponding author), Univ Extremadura, Dept Didact Mus Plast & Corporal Express, Fac Sport Sci, Caceres, Spain.	diamal@unex.es	Amado, Diana/M-1888-2017; NAVAJAS, PABLO MOLERO/AAI-2250-2021					Allen J, 1981, DRAMA SCH ITS THEORY; Amado D, 2013, DANZA ENTENDIDA PERS; Amado D, 2014, J CREATIVE BEHAV, P1; Amado D, 2012, 2 NAT C DANC RES BAR; Amado D., 2012, ELECT J RES ED PSYCH, V10, P867, DOI DOI 10.25115/EJREP.V10I27.1512; Amado D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085275; Auger P, 2016, J APPL BEHAV SCI, V52, P342, DOI 10.1177/0021886316656973; Baer J., 2014, CREATIVITY DIVERGENT; Beghetto RA, 2016, NURTURING CREATIVITY; Cairney J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-26; Cano G, 2012, GENERO PODER POLITIC; Chalabaev A, 2013, PSYCHOL SPORT EXERC, V14, P136, DOI 10.1016/j.psychsport.2012.10.005; Cheon SH, 2012, J SPORT EXERCISE PSY, V34, P365, DOI 10.1123/jsep.34.3.365; Cox AE, 2010, PSYCHOL SPORT EXERC, V11, P337, DOI 10.1016/j.psychsport.2010.04.001; Csikszentmihalyi M, 2014, FLOW FDN POSITIVE PS, P155; Davenport D., 2006, J DANCE ED, V6, P25, DOI [10.1080/15290824.2006.10387309, DOI 10.1080/15290824.2006.10387309]; Davies D, 2013, THINK SKILLS CREAT, V8, P80, DOI 10.1016/j.tsc.2012.07.004; De Meyer J, 2016, PSYCHOL SPORT EXERC, V22, P72, DOI 10.1016/j.psychsport.2015.06.001; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Escarti A., 2006, REV PSICOL DEPORTE, V15, P23; Fisette JL, 2011, PHYS EDUC SPORT PEDA, V16, P179, DOI 10.1080/17408989.2010.535199; Fredricks JA, 2002, DEV PSYCHOL, V38, P519, DOI 10.1037/0012-1649.38.4.519; Gard M, 2000, SPORT EDUC SOC, V5, P19, DOI 10.1080/135733200114415; Gard M, 2011, SPORT EDUC SOC, V16, P399, DOI 10.1080/13573322.2011.565970; Goodyear VA, 2012, SPORT ED SOC, P1; Granero-Gallegos A, 2012, J SPORT SCI MED, V11, P614; Grieser M, 2006, HEALTH EDUC BEHAV, V33, P40, DOI 10.1177/1090198105282416; Haerens L, 2015, PSYCHOL SPORT EXERC, V16, P26, DOI 10.1016/j.psychsport.2014.08.013; Haerens L, 2011, QUEST, V63, P321, DOI 10.1080/00336297.2011.10483684; Hastie PA, 2013, SPORT EDUC SOC, V18, P38, DOI 10.1080/13573322.2012.701203; Hickey C, 1999, SPORT EDUC SOC, V4, P51, DOI 10.1080/1357332990040104; Hong E, 2009, J CREATIVE BEHAV, V43, P192, DOI 10.1002/j.2162-6057.2009.tb01314.x; Kousoulas F, 2009, J CREATIVE BEHAV, V43, P209, DOI 10.1002/j.2162-6057.2009.tb01315.x; Learreta B, 2009, EXPRESION CORPORAL E; Lee AM, 1999, SPORT EDUC SOC, V4, P161, DOI 10.1080/1357332990040204; Lykesas G., 2009, Studies in Physical Culture and Tourism, V16, P207; Lyu M, 2011, EDUC PSYCHOL-UK, V31, P247, DOI 10.1080/01443410.2010.545105; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Murcia JAM, 2008, REV MEX PSICOL, V25, P295; Mouratidis A, 2013, LEARN INDIVID DIFFER, V23, P179, DOI 10.1016/j.lindif.2012.09.001; Mouratidis AA, 2011, J EDUC PSYCHOL, V103, P353, DOI 10.1037/a0022773; O'Neill JR, 2011, RES Q EXERCISE SPORT, V82, P373, DOI 10.1080/02701367.2011.10599769; Reeve J, 2006, ELEM SCHOOL J, V106, P225, DOI 10.1086/501484; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sanchez-Oliva D, 2014, J TEACH PHYS EDUC, V33, P232, DOI 10.1123/jtpe.2013-0043; Sanchez-Oliva D, 2013, CULT EDUC, V25, P495, DOI 10.1174/113564013808906843; Skinner E., 2002, HDB SELF DETERMINATI, P297; SKINNER EA, 1993, J EDUC PSYCHOL, V85, P571, DOI 10.1037/0022-0663.85.4.571; Taylor IM, 2010, J SPORT EXERCISE PSY, V32, P99, DOI 10.1123/jsep.32.1.99; Tessier D, 2010, CONTEMP EDUC PSYCHOL, V35, P242, DOI 10.1016/j.cedpsych.2010.05.005; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; Watson DE, 2012, RES DANC EDUC, V13, P153, DOI 10.1080/14647893.2012.694415; With-Nielsen N, 2011, SPORT EDUC SOC, V16, P645, DOI 10.1080/13573322.2011.601145; Zander L, 2014, PSYCHOL SPORT EXERC, V15, P418, DOI 10.1016/j.psychsport.2014.04.004	54	9	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174393	10.1371/journal.pone.0174393	http://dx.doi.org/10.1371/journal.pone.0174393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333990	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200095
J	Rodriguez-Losada, N; Romero, P; Estivill-Torrus, G; de Villoria, RG; Aguirre, JA				Rodriguez-Losada, Noela; Romero, Pablo; Estivill-Torrus, Guillermo; Guzman de Villoria, Roberto; Aguirre, Jose A.			Cell survival and differentiation with nanocrystalline glass-like carbon using substantia nigra dopaminergic cells derived from transgenic mouse embryos	PLOS ONE			English	Article							HISTONE H3; GRAPHENE; COATINGS; ADHESION; GROWTH	Regenerative medicine requires, in many cases, physical supports to facilitate appropriate cellular architecture, cell polarization and the improvement of the correct differentiation processes of embryonic stem cells, induced pluripotent cells or adult cells. Because the interest in carbon nanomaterials has grown within the last decade in light of a wide variety of applications, the aim of this study was to test and evaluate the suitability and cytocompatibility of a particular nanometer-thin nanocrystalline glass-like carbon film (NGLC) composed of curved graphene flakes joined by an amorphous carbon matrix. This material is a disordered structure with high transparency and electrical conductivity. For this purpose, we used a cell line (SN4741) from substantia nigra dopaminergic cells derived from transgenic mouse embryos. Cells were cultured either in a powder of increasing concentrations of NGLC microflakes (82 +/- 37 mu m) in the medium or on top of nanometer-thin films bathed in the same culture medium. The metabolism activity of SN4741 cells in presence of NGLC was assessed using methylthiazolyldiphenyl-tetrazolium (MTT) and apoptosis/necrosis flow cytometry assay respectively. Growth and proliferation as well as senescence were demonstrated by western blot (WB) of proliferating cell nuclear antigen (PCNA), monoclonal phosphorylate Histone 3 (serine 10) (PH3) and SMP30 marker. Specific dopaminergic differentiation was confirmed by the WB analysis of tyrosine hydroxylase (TH). Cell maturation and neural capability were characterized using specific markers (SYP: synaptophysin and GIRK2: G-protein-regulated inward-rectifier potassium channel 2 protein) via immunofluorescence and coexistence measurements. The results demonstrated cell positive biocompatibility with different concentrations of NGLC. The cells underwent a process of adaptation of SN4741 cells to NGLC where their metabolism decreases. This process is related to a decrease of PH3 expression and significant increase SMP30 related to senescence processes. After 7 days, the cells increased the expression of TH and PCNA that is related to processes of DNA replication. On the other hand, cells cultured on top of the film showed axonal-like alignment, edge orientation, and network-like images after 7 days. Neuronal capability was demonstrated to a certain extent through the analysis of significant coexistence between SYP and GIRK2. Furthermore, we found a direct relationship between the thickness of the films and cell maturation. Although these findings share certain similarities to our previous findings with graphene oxide and its derivatives, this particular nanomaterial possesses the advantages of high conductivity and transparency. In conclusion, NGLC could represent a new platform for biomedical applications, such as for use in neural tissue engineering and biocompatible devices.	[Rodriguez-Losada, Noela; Aguirre, Jose A.] Univ Malaga, Fac Med, Dept Human Physiol, Malaga, Spain; [Rodriguez-Losada, Noela; Aguirre, Jose A.] Biomed Biomed Res Inst Malaga IBIMA, Campus Teatinos,Blvd Louis Pasteur, Malaga, Spain; [Romero, Pablo; Guzman de Villoria, Roberto] IMDEA Mat Inst, C Eric Kandel 2, Madrid, Spain; [Estivill-Torrus, Guillermo] Reg Univ Hosp Malaga, Biomed Res Inst Malaga IBIMA, Unidad Clin Neurociencia, Av Carlos Haya S-N, Malaga, Spain; [Guzman de Villoria, Roberto] FIDAMC Fdn Res Dev & Applicat Composite Mat, Avda Rita Levi Montalcini 29, Madrid, Spain	Universidad de Malaga; IMDEA Materials Institute; Universidad de Malaga	Rodriguez-Losada, N; Aguirre, JA (corresponding author), Univ Malaga, Fac Med, Dept Human Physiol, Malaga, Spain.; Rodriguez-Losada, N; Aguirre, JA (corresponding author), Biomed Biomed Res Inst Malaga IBIMA, Campus Teatinos,Blvd Louis Pasteur, Malaga, Spain.	noela@uma.es; Jose.Aguirre@uma.es	Torrús, Guillermo Estivill/L-5157-2015; de Villoria, Roberto Guzman/AAH-4787-2019; Rodriguez-Losada, Noela/O-4739-2015	Torrús, Guillermo Estivill/0000-0002-7124-2678; de Villoria, Roberto Guzman/0000-0001-6369-5266; Rodriguez-Losada, Noela/0000-0003-3629-4883	University of Malaga and Campus de Exceiencia Internacional Andalucia Tech (UMA); Junta de Andalucia Government, Spain [PAIDI-CTS156]; Spanish Ministry of Science and Innovation through the Ramon y Cajal Fellowship	University of Malaga and Campus de Exceiencia Internacional Andalucia Tech (UMA); Junta de Andalucia Government, Spain(Junta de Andalucia); Spanish Ministry of Science and Innovation through the Ramon y Cajal Fellowship	This work was supported by 1) Funds from the University of Malaga and Campus de Excelencia Internacional Andalucia Tech (UMA); 2) Junta de Andalucia Government, Spain (PAIDI-CTS156); 3) Spanish Ministry of Science and Innovation through the Ramon y Cajal Fellowship (RG).; This work was supported by funds from the University of Malaga, Campus de Excelencia Internacional Andalucia Tech, and Andalucia Government PAIDI-CTS156, Spain. We thank Prof. E. Arenas from Karolinska Institutet, Stockholm, Sweden, for providing us with the SN4741 cell line. R. Guzman de Villoria gratefully acknowledges the Spanish Ministry of Science and Innovation for funding through the Ramon y Cajal Fellowship.	Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Ariga K, 2016, ANALYST, V141, P2629, DOI 10.1039/c6an00057f; Aronov D, 2006, PROCESS BIOCHEM, V41, P2367, DOI 10.1016/j.procbio.2006.06.006; Assanga S. B. I., 2013, International Journal for Biotechnology and Molecular Biology Research, V4, P60; Biazar E, 2011, INT J NANOMED, V6, P631, DOI 10.2147/IJN.S17218; Chen EYT, 2012, J BIOMED MATER RES A, V100A, P2006, DOI 10.1002/jbm.a.34201; Cowlard FC, 1967, J MATER SCI, V2, P507, DOI 10.1007/BF00752216; Cragg SJ, 2000, EXP NEUROL, V164, P145, DOI 10.1006/exnr.2000.7420; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; De S, 2010, ACS NANO, V4, P2713, DOI 10.1021/nn100343f; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Edgington RJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056022; Eqtesadi S, 2017, J EUR CERAM SOC, V3846; Fabbro A, 2015, GRAPHENE BASED INTER; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Garci D., 2014, EFFECTS COMPOSITE FI, P2731; Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71; Heo C, 2011, BIOMATERIALS, V32, P19, DOI 10.1016/j.biomaterials.2010.08.095; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.0.CO;2-M; Jahani H, 2014, CONTROLLED SURFACE M, P1875; Jalvo B, 2016, RSC ADV, V6, P50278, DOI 10.1039/c6ra04960e; Kabiri M, 2015, EXCLI J, V14, P851, DOI 10.17179/excli2015-282; Li DW, 2005, CELL RES, V15, P120, DOI 10.1038/sj.cr.7290276; Lines C., 2015, ANAL CYTOTOXICITY CA, P1; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nayak AA, 2015, INT J COMPUT APPL, V116, P975; Odawara A, 2013, RSC ADV, V3, P23620, DOI 10.1039/c3ra44757j; Oprych KM, 2016, REPAIRING PERIPHERAL, P1253; Regan EM, 2010, BIOMATERIALS, V31, P207, DOI 10.1016/j.biomaterials.2009.09.042; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodriguez-Lozano FJ, 2014, J MATER SCI-MATER M, V25, P2731, DOI 10.1007/s10856-014-5293-2; Romero P, 2016, CHEM ENG J, V299, P8, DOI 10.1016/j.cej.2016.04.005; Sahni D, 2013, J NEUROSURG-PEDIATR, V11, P575, DOI 10.3171/2013.1.PEDS12374; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIEUWERTS AM, 1995, EUR J CLIN CHEM CLIN, V33, P813; Sliwka L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155772; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Sweet JA, 2014, J NEUROSURG, V120, P988, DOI 10.3171/2013.12.JNS131537; Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109; van Pelt J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00160; VanDersarl JJ, 2015, ADV FUNCT MATER, V25, P78, DOI 10.1002/adfm.201402934; VISTICA DT, 1991, CANCER RES, V51, P2515; Wang Q, 2002, COMPUT VIS IMAGE UND, V85, P100, DOI 10.1006/cviu.2001.0955; Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151	46	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173978	10.1371/journal.pone.0173978	http://dx.doi.org/10.1371/journal.pone.0173978			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334019	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200032
J	Yin, QQ; Li, J; Zheng, QS; Yang, XL; Lv, R; Ma, LX; Liu, J; Zhu, T; Zhang, WS				Yin, Qinqin; Li, Jun; Zheng, Qingshan; Yang, Xiaolin; Lv, Rong; Ma, Longxiang; Liu, Jin; Zhu, Tao; Zhang, Wensheng			The quaternary lidocaine derivative QX-314 in combination with bupivacaine for long-lasting nerve block: Efficacy, toxicity, and the optimal formulation in rats	PLOS ONE			English	Article							BRACHIAL-PLEXUS BLOCK; LIPOSOMAL BUPIVACAINE; DEXMEDETOMIDINE; ROPIVACAINE; PROLONGS; DURATION; RELEASE; FUTURE; ENTRY	Objective The quaternary lidocaine derivative (QX-314) in combination with bupivacaine can produce long-lasting nerve blocks in vivo, indicating potential clinical application. The aim of the study was to investigate the efficacy, safety, and the optimal formulation of this combination. Methods QX-314 and bupivacaine at different concentration ratios were injected in the vicinity of the sciatic nerve in rats; bupivacaine and saline served as controls (n= 6 similar to 10). Rats were inspected for durations of effective sensory and motor nerve blocks, systemic adverse effects, and histological changes of local tissues. Mathematical models were established to reveal drug-interaction, concentration-effect relationships, and the optimal ratio of QX-314 to bupivacaine. Results 0.2 similar to 1.5% QX-314 with .03 similar to 0.5% bupivacaine produced 5.8 similar to 23.8 h of effective nerve block; while 0.5% bupivacaine alone was effective for 4 h. No systemic side effects were observed; local tissue reactions were similar to those caused by 0.5% bupivacaine if QX-314 were used < 1.2%. The weighted modification model was successfully established, which revealed that QX-314 was the main active ingredient while bupivacaine was the synergist. The formulation, 0.9% QX-314 plus 0.5% bupivacaine, resulted in 10.1 +/- 0.8 h of effective sensory and motor nerve blocks. Conclusion The combination of QX-314 and bupivacaine facilitated prolonged sciatic nerve block in rats with a satisfactory safety profile, maximizing the duration of nerve block without clinically important systemic and local tissue toxicity. It may emerge as an alternative approach to post-operative pain treatment.	[Yin, Qinqin; Lv, Rong; Liu, Jin; Zhu, Tao; Zhang, Wensheng] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu, Sichuan, Peoples R China; [Li, Jun; Yang, Xiaolin] North Sichuan Med Coll, Nanchong, Sichuan, Peoples R China; [Zheng, Qingshan] Shanghai Univ Chinese Med, Ctr Drug Clin Res, Shanghai, Peoples R China; [Ma, Longxiang] Kunming Med Univ, Kunming, Yunnan, Peoples R China; [Liu, Jin; Zhu, Tao; Zhang, Wensheng] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China	Sichuan University; North Sichuan Medical University; Shanghai University of Traditional Chinese Medicine; Kunming Medical University; Sichuan University	Zhang, WS (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu, Sichuan, Peoples R China.; Zhang, WS (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China.	zhang_ws@scu.edu.cn		Liu, Jin/0000-0002-2026-2513	National Science and Technology Major Project from the Ministry of Science and Technology of China [2014ZX09101-003]	National Science and Technology Major Project from the Ministry of Science and Technology of China	This study was supported by National Science and Technology Major Project (grants No.2014ZX09101-003) from the Ministry of Science and Technology of the People's Republic of China (website:http://most.gov.cn/). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.; This study was supported by National Science and Technology Major Project (grants No. 2014ZX09101-003) from the Ministry of Science and Technology of the Peoples Republic of China (website:http://most.gov.cn/).	BENOIT PW, 1970, J ANAT, V107, P547; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; Biswas S, 2014, ETHIOP J HEALTH SCI, V24, P203, DOI 10.4314/ejhs.v24i3.3; Brenneis C, 2014, BRIT J PHARMACOL, V171, P438, DOI 10.1111/bph.12466; Brummett CM, 2008, ANESTHESIOLOGY, V109, P502, DOI 10.1097/ALN.0b013e318182c26b; Brummett CM, 2011, ANESTHESIOLOGY, V115, P836, DOI 10.1097/ALN.0b013e318221fcc9; Candido KD, 2002, REGION ANESTH PAIN M, V27, P162, DOI 10.1053/rapm.2002.30671; Cheung HMC, 2011, CAN J ANESTH, V58, P443, DOI 10.1007/s12630-011-9479-5; Dalkilic N, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0009-9; Huang JY, 2011, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2011-16; [黄晓晖 Huang Xiaohui], 2012, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V17, P521; Ilfeld BM, 2013, ANESTH ANALG, V117, P1248, DOI 10.1213/ANE.0b013e31829cc6ae; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; Kimko H, 2015, BRIT J CLIN PHARMACO, V79, P108, DOI 10.1111/bcp.12341; Kirksey MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137312; Kohane DS, 2002, J BIOMED MATER RES, V59, P450, DOI 10.1002/jbm.1261; Kuusniemi K, 2016, J PAIN RES, V9, P25, DOI 10.2147/JPR.S92502; Lambrechts M, 2013, PATIENT PREFER ADHER, V7, P885, DOI 10.2147/PPA.S32175; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Leone Stefania, 2008, Acta Biomed, V79, P92; McAlvin JB, 2014, BIOMATERIALS, V35, P4557, DOI 10.1016/j.biomaterials.2014.02.015; McCartney CIL, 2007, REGION ANESTH PAIN M, V32, P330, DOI 10.1016/j.rapm.2007.02.010; Movafegh A, 2006, ANESTH ANALG, V102, P263, DOI 10.1213/01.ane.0000189055.06729.0a; Padera R, 2008, ANESTHESIOLOGY, V108, P921, DOI 10.1097/ALN.0b013e31816c8a48; Sagie I, 2010, P NATL ACAD SCI USA, V107, P3740, DOI 10.1073/pnas.0911542107; Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761; Shankarappa SA, 2012, REGION ANESTH PAIN M, V37, P483, DOI 10.1097/AAP.0b013e31826125b3; Templin JS, 2015, ANESTHESIOLOGY, V123, P886, DOI 10.1097/ALN.0000000000000832; Verlinde M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030339; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Zheng QS, 1999, ACTA PHARMACOL SIN, V20, P1043; Zink W, 2005, ANESTH ANALG, V101, P548, DOI 10.1213/01.ANE.0000155956.59842.0A; Zink W, 2003, ANESTH ANALG, V97, P1173, DOI 10.1213/01.ANE.0000080610.14265.C8	34	10	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174421	10.1371/journal.pone.017442	http://dx.doi.org/10.1371/journal.pone.017442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334014				2022-12-27	WOS:000399102200097
J	Azumah, BK; Addo, PG; Dodoo, A; Awandare, G; Mosi, L; Boakye, DA; Wilson, MD				Azumah, Bright K.; Addo, Phyllis G.; Dodoo, Alfred; Awandare, Gordon; Mosi, Lydia; Boakye, Daniel A.; Wilson, Michael D.			Experimental demonstration of the possible role of Acanthamoeba polyphaga in the infection and disease progression in Buruli Ulcer (BU) using ICR mice	PLOS ONE			English	Article							FREE-LIVING AMEBAS; MYCOBACTERIUM-ULCERANS; AQUATIC INSECTS; TRANSMISSION; AVIUM; EPIDEMIOLOGY; PATHOGENESIS; MACROPHAGE; VIRULENCE; PROTOZOA	The transmission of Buruli ulcer (BU), caused by Mycobacterium ulcerans (MU), remains puzzling although a number of hypothesis including through bites of infected aquatic insects have been proposed. We report the results of experiments using ICR mice that give credence to our hypothesis that Acanthamoeba species may play a role in BU transmission. We cocultured MU N2 and MU 1615 which expresses red fluorescent protein (RFP) and Acanthamoeba polyphaga (AP), and confirmed infected AP by Ziehl-Neelsen (ZN) staining. We tested for viability of MU inside AP and observed strong RFP signals inside both tropho-zoites and cysts after 3 and 42 days of coculturing respectively. ICR mice were topically treated, either on shaved intact or shaved pinpricked rumps, with one of the following; MU N2 only (2.25 x 10(6) colony forming units [CFU] / ml), MUN2: AP coculture (2.96 x 10(4) CFU: 1.6 x 10(6) cells/ml), AP only (1.6 x 10(6) cells/ml), PYG medium and sterile distilled water. Both MUN2 only and MU N2: AP elicited reddening on day (D) 31; edema on D 45 and D 44 respectively, and ulcers on D 49 at pinpricked sites only. To ascertain infectivity and pathogenicity of MU N2 only and MU N2: AP, and compare their virulence, the standard mouse footpad inoculation method was used. MU N2: AP elicited reddening in footpads by D 3 compared to D 14 with MU N2 only of the same dose of MU N2 (2.96 x 10(4) CFU). ZN-stained MU were observed in both thin sectioned and homogenized lesions, and aspirates from infected sites. Viable MU N2 were recovered from cultures of the homogenates and aspirates. This study demonstrates in ICR mice MU transmission via passive infection, and shows that punctures in the skin are prerequisite for infection, and that coculturing of MU with AP enhances pathogenesis.	[Azumah, Bright K.; Addo, Phyllis G.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Anim Experimentat, Legon, Accra, Ghana; [Azumah, Bright K.] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana; [Dodoo, Alfred] Univ Ghana, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana; [Awandare, Gordon; Mosi, Lydia] Univ Ghana, Dept Biochem Cell & Mol Biol, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana; [Boakye, Daniel A.; Wilson, Michael D.] Univ Ghana, Dept Parasitol, Noguchi Mem Inst Med Res, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana; University of Ghana; University of Ghana	Addo, PG (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Anim Experimentat, Legon, Accra, Ghana.; Wilson, MD (corresponding author), Univ Ghana, Dept Parasitol, Noguchi Mem Inst Med Res, Legon, Accra, Ghana.	PAddo@noguchi.ug.edu.gh; MWilson@noguchi.ug.edu.gh	Mosi, Lydia/AAA-5255-2021; Awandare, Gordon/J-1392-2019	Awandare, Gordon/0000-0002-8793-3641; Wilson, Michael/0000-0002-6048-8509	Office of Research Innovation and Development (ORID); University of Ghana [URF/7/ILG-021/2013-2014]	Office of Research Innovation and Development (ORID); University of Ghana	The study was funded with a grant award by the Office of Research Innovation and Development (ORID), University of Ghana (www.orid.ug.edu.gh) to Phyllis Gertrude Addo (grant award #: URF/7/ILG-021/2013-2014). ORID had no role in the study design, data collection and analysis, and the decision to publish, or in the preparation of the manuscript.	Addo P, 2005, Ghana Med J, V39, P86; Addo P, 2006, INTERNET J TROPICAL, V3, P1; Amissah NA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003148; Boleira M, 2010, AN BRAS DERMATOL, V85, P281, DOI 10.1590/S0365-05962010000300002; Bratschi MW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002252; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Gryseels S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001764; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hospers IC, 2005, T ROY SOC TROP MED H, V99, P196, DOI 10.1016/j.trstmh.2004.05.004; Huang GKL, 2014, EXPERT REV ANTI-INFE, V12, P855, DOI 10.1586/14787210.2014.910113; Jacobsen KH, 2010, INT J INFECT DIS, V14, pE677, DOI 10.1016/j.ijid.2009.11.013; Jordan HR, 2015, DECTECTION MYCOBACTE, P23; Lahiri R, 2008, LEPROSY REV, V79, P401; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Marsollier L, 2007, M S-MED SCI, V23, P572, DOI 10.1051/medsci/20072367572; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Quek TYJ, 2007, EMERG INFECT DIS, V13, P1661, DOI 10.3201/eid1311.061206; Salah IB, 2009, CLIN MICROBIOL INFEC, V15, P894, DOI 10.1111/j.1469-0691.2009.03011.x; Silva MT, 2009, LANCET INFECT DIS, V9, P699, DOI 10.1016/S1473-3099(09)70234-8; Snelling WJ, 2006, MICROBES INFECT, V8, P578, DOI 10.1016/j.micinf.2005.09.001; Stinear PT, 2015, MECH TRANSMISSION MY, P25; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Wallace JR, 2010, APPL ENVIRON MICROB, V76, P6215, DOI 10.1128/AEM.00340-10; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; White CI, 2010, VET REC, V166, P401, DOI 10.1136/vr.b4797; Williamson HR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002770; Wilson M D, 2011, Ghana Med J, V45, P31	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172843	10.1371/journal.pone.0172843	http://dx.doi.org/10.1371/journal.pone.0172843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329001	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700011
J	Ishemgulova, A; Butenko, A; Kortisova, L; Boucinha, C; Grybchuk-Ieremenko, A; Morelli, KA; Tesarova, M; Kraeva, N; Grybchuk, D; Panek, T; Flegontov, P; Lukes, J; Votypka, J; Pavan, MG; Opperdoes, FR; Spodareva, V; d'Avila-Levy, CM; Kostygov, AY; Yurchenko, V				Ishemgulova, Aygul; Butenko, Anzhelika; Kortisova, Lucie; Boucinha, Carolina; Grybchuk-Ieremenko, Anastasiia; Morelli, Karina A.; Tesarova, Martina; Kraeva, Natalya; Grybchuk, Danyil; Panek, Tomas; Flegontov, Pavel; Lukes, Julius; Votypka, Jan; Pavan, Marcio Galvao; Opperdoes, Fred R.; Spodareva, Viktoria; d'Avila-Levy, Claudia M.; Kostygov, Alexei Yu.; Yurchenko, Vyacheslav			Molecular mechanisms of thermal resistance of the insect trypanosomatid Crithidia thermophilal	PLOS ONE			English	Article							MONOXENOUS TRYPANOSOMATIDS; MITOCHONDRIAL HSP70; COSTA-RICA; DIVERSITY; PHYLOGENY; PARASITES; GENUS; TRYPANOTHIONE; LEPTOMONAS; PROTOZOA	In the present work, we investigated molecular mechanisms governing thermal resistance of a monoxenous trypanosomatid Crithidia luciliae thermophila, which we reclassified as a separate species C. thermophila. We analyzed morphology, growth kinetics, and transcriptomic profiles of flagellates cultivated at low (23 degrees C) and elevated (34 degrees C) temperature. When maintained at high temperature, they grew significantly faster, became shorter, with genes involved in sugar metabolism and mitochondrial stress protection significantly upregulated. Comparison with another thermoresistant monoxenous trypanosomatid, Leptomonas seymouri, revealed dramatic differences in transcription profiles of the two species with only few genes showing the same expression pattern. This disparity illustrates differences in the biology of these two parasites and distinct mechanisms of their thermotolerance, a prerequisite for living in warm-blooded vertebrates.	[Ishemgulova, Aygul; Butenko, Anzhelika; Kortisova, Lucie; Grybchuk-Ieremenko, Anastasiia; Kraeva, Natalya; Grybchuk, Danyil; Panek, Tomas; Flegontov, Pavel; Spodareva, Viktoria; Kostygov, Alexei Yu.; Yurchenko, Vyacheslav] Univ Ostrava, Life Sci Res Ctr, Fac Sci, Ostrava, Czech Republic; [Ishemgulova, Aygul; Butenko, Anzhelika; Tesarova, Martina; Grybchuk, Danyil; Flegontov, Pavel; Lukes, Julius; Votypka, Jan; Yurchenko, Vyacheslav] Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Budweis, Czech Republic; [Boucinha, Carolina; Morelli, Karina A.; d'Avila-Levy, Claudia M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Colecao Protozoarios, Rio De Janeiro, Brazil; [Morelli, Karina A.] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Ecol, Rio De Janeiro, Brazil; [Flegontov, Pavel] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON, Canada; [Votypka, Jan] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Pavan, Marcio Galvao] Fundacao Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Opperdoes, Fred R.] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium; [Spodareva, Viktoria; Kostygov, Alexei Yu.] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Yurchenko, Vyacheslav] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Yurchenko, Vyacheslav] Univ Ostrava, Inst Environm Technol, Fac Sci, Ostrava, Czech Republic	University of Ostrava; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; University of South Bohemia Ceske Budejovice; Canadian Institute for Advanced Research (CIFAR); Charles University Prague; Fundacao Oswaldo Cruz; Universite Catholique Louvain; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Yeshiva University; Albert Einstein College of Medicine; University of Ostrava	Kostygov, AY; Yurchenko, V (corresponding author), Univ Ostrava, Life Sci Res Ctr, Fac Sci, Ostrava, Czech Republic.; Yurchenko, V (corresponding author), Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Budweis, Czech Republic.; Kostygov, AY (corresponding author), Russian Acad Sci, Zool Inst, St Petersburg, Russia.; Yurchenko, V (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.; Yurchenko, V (corresponding author), Univ Ostrava, Inst Environm Technol, Fac Sci, Ostrava, Czech Republic.	aleksei.kostygov@osu.cz; vyacheslav.yurchenko@osu.cz	Yurchenko, Vyacheslav/E-4532-2013; Flegontov, Pavel/G-9748-2014; Votypka, Jan/C-5313-2012; Opperdoes, Fred/N-9922-2019; Pánek, Tomáš/S-8539-2017; Butenko, Anzhelika/AAC-5009-2019; Cepicka, Ivan/M-6993-2017; Lukes, Julius/H-6760-2012; Kostygov, Alexei Y/D-3931-2015; Opperdoes, Frederik R/C-8897-2018; Pánek, Tomáš/AAS-4567-2021; Flegontov, Pavel/U-6664-2017; Pavan, Marcio G/F-3270-2015; Spodareva, Viktoria/S-7287-2017; Kraeva, Natalya/AAY-2807-2020; Ieremenko, Anastasiia/GNP-1324-2022; d'Avila-Levy, Claudia M/O-7192-2014	Yurchenko, Vyacheslav/0000-0003-4765-3263; Votypka, Jan/0000-0002-0552-9363; Opperdoes, Fred/0000-0003-1984-3764; Butenko, Anzhelika/0000-0001-8685-2404; Cepicka, Ivan/0000-0002-4322-0754; Lukes, Julius/0000-0002-0578-6618; Kostygov, Alexei Y/0000-0002-1516-437X; Opperdoes, Frederik R/0000-0003-1984-3764; Pánek, Tomáš/0000-0002-1738-8430; Pavan, Marcio G/0000-0002-5699-242X; Spodareva, Viktoria/0000-0001-7713-1824; Kraeva, Natalya/0000-0001-9111-5265; Flegontov, Pavel/0000-0001-9759-4981; d'Avila-Levy, Claudia M/0000-0001-8042-4695	Grant Agency of Czech Republic [17-10656S, 15-16406S, 14-23986S, 16-18699S, DT01-021358]; Statutory City of Ostrava [0924/2016/SaS]; Russian Foundation for Basic Research [15-29-02734]; COST action [CM1307, LD14076]; Ministry of Education, Youth and Sports of the Czech Republic in the "National Feasibility Program I" [L01208 "TEWEP"]; EU Operational programme on Research and Development for Innovation (ec.europa.eu) [CZ.1.05/2.1.00/19.0388]; University of Ostrava [SGS16/PRF/2017]; Institutional Development Program of the University of Ostrava	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Statutory City of Ostrava; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); COST action(European Cooperation in Science and Technology (COST)); Ministry of Education, Youth and Sports of the Czech Republic in the "National Feasibility Program I"; EU Operational programme on Research and Development for Innovation (ec.europa.eu); University of Ostrava; Institutional Development Program of the University of Ostrava	Support from the Grant Agency of Czech Republic (www.gacr.cz) awards 17-10656S to V.Y. and A.B., 15-16406S to A.B. and T.P., 14-23986S to J.L., 16-18699S to J.L. and V.Y., Moravskosiezsky kraj research initiative (www.msk.cz) DT01-021358 to V.Y. and A.K., Statutory City of Ostrava (www.ostrava.cz) award 0924/2016/SaS to A.K. who was also supported by the grant 15-29-02734 from the Russian Foundation for Basic Research (wavy.rfbr..ru), and the COST action (www.cost.eu) CM1307 and LD14076 to J.L. and J.V., respectively is kindly acknowledged. This work was also financially supported by the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) in the "National Feasibility Program I", project L01208 "TEWEP" and the EU Operational programme on Research and Development for Innovation (ec.europa.eu), project CZ.1.05/2.1.00/19.0388. A.B., Al., A.G.-I., V.S., N.K., and D.G. were funded by grant from the University of Ostrava (www.osu.cz) SGS16/PRF/2017. P.F. was supported by the Institutional Development Program of the University of Ostrava (www.osu.cz). The access to computing and storage facilities owned by parties and projects of the National Grid Infrastructure MetaCentrum in the Czech Republic (www.metacentrum.cz) was provided under the program LM2010005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Balogh G, 2013, FEBS LETT, V587, P1970, DOI 10.1016/j.febslet.2013.05.016; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chicharro C, 2003, ANN TROP MED PARASIT, V97, P75, DOI 10.1179/000349803225002552; Clark CG, 1997, J EUKARYOT MICROBIOL, V44, P277, DOI 10.1111/j.1550-7408.1997.tb05667.x; d'Avila-Levy CM, 2016, TRENDS PARASITOL, V32, P840, DOI 10.1016/j.pt.2016.08.001; d'Avila-Levy CM, 2015, MEM I OSWALDO CRUZ, V110, P956, DOI 10.1590/0074-02760150253; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; DESA MFG, 1980, J PROTOZOOL, V27, P253; Docampo R, 2014, EUR J PHARMACOL, V739, P4, DOI 10.1016/j.ejphar.2013.11.015; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; FREYMULLER E, 1981, J PROTOZOOL, V28, P175, DOI 10.1111/j.1550-7408.1981.tb02829.x; Frolov AO, 2016, EUR J PROTISTOL, V52, P1, DOI 10.1016/j.ejop.2015.08.002; Gerasimov ES, 2012, EUR J PROTISTOL, V48, P185, DOI 10.1016/j.ejop.2011.09.002; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton PB, 2004, INT J PARASITOL, V34, P1393, DOI 10.1016/j.ijpara.2004.08.011; Hamilton PT, 2015, MBIO, V6, DOI 10.1128/mBio.01356-15; Hollar L, 1998, J EUKARYOT MICROBIOL, V45, P293, DOI 10.1111/j.1550-7408.1998.tb04539.x; Hughes LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025700; Jirku M, 2012, J EUKARYOT MICROBIOL, V59, P537, DOI 10.1111/j.1550-7408.2012.00636.x; Jobb G, 2011, TREEFINDER; Kostygov AY, 2014, PROTIST, V165, P594, DOI 10.1016/j.protis.2014.07.001; Kozminsky E, 2015, PROTIST, V166, P551, DOI 10.1016/j.protis.2015.08.004; Kraeva N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005127; Kraeva N, 2017, INFECT GENET EVOL, V50, P121, DOI 10.1016/j.meegid.2016.06.054; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lacomble S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007685; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; LAIRD MARSHALL, 1959, CANADIAN JOUR ZOOL, V37, P749, DOI 10.1139/z59-075; Leger L, 1902, CR SOC BIOL, V54, P354; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; MCGHEE RB, 1959, J INFECT DIS, V105, P18, DOI 10.1093/infdis/105.1.18; Merzlyak E, 2001, J EUKARYOT MICROBIOL, V48, P161, DOI 10.1111/j.1550-7408.2001.tb00298.x; Opperdoes FR, 2016, J EUKARYOT MICROBIOL, V63, P657, DOI 10.1111/jeu.12315; Pacheco RS, 1998, MEM I OSWALDO CRUZ, V93, P531, DOI 10.1590/S0074-02761998000400021; Podlipaev S, 2001, INT J PARASITOL, V31, P648, DOI 10.1016/S0020-7519(01)00139-4; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Ready PD, 2014, CLIN EPIDEMIOL, V6, P147, DOI 10.2147/CLEP.S44267; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Rodrigues Juliany Cola Fernandes, 2014, Subcell Biochem, V74, P1, DOI 10.1007/978-94-007-7305-9_1; ROITMAN C, 1972, J PROTOZOOL, V19, P346, DOI 10.1111/j.1550-7408.1972.tb03473.x; ROITMAN I, 1977, J PROTOZOOL, V24, P553, DOI 10.1111/j.1550-7408.1977.tb01013.x; Skodova-Sverakova I, 2015, MOL MICROBIOL, V96, P55, DOI 10.1111/mmi.12920; Strickland C., 1911, Parasitology Cambridge, V4; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; Tomas AM, 2013, ANTIOXID REDOX SIGN, V19, P696, DOI 10.1089/ars.2012.4948; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; Tyc J, 2015, MBIO, V6, DOI 10.1128/mBio.02425-14; Verner Z, 2014, MOL BIOCHEM PARASIT, V193, P55, DOI 10.1016/j.molbiopara.2014.02.003; Vickerman K., 1976, P35; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Vickers TJ, 2004, J BIOL CHEM, V279, P27246, DOI 10.1074/jbc.M311039200; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Votypka J, 2015, TRENDS PARASITOL, V31, P460, DOI 10.1016/j.pt.2015.06.015; Votypka J, 2014, PROTIST, V165, P825, DOI 10.1016/j.protis.2014.09.002; Votypka J, 2012, PROTIST, V163, P616, DOI 10.1016/j.protis.2011.12.004; WALLACE FG, 1983, J PROTOZOOL, V30, P308, DOI 10.1111/j.1550-7408.1983.tb02921.x; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; WALLACE FG, 1959, J PROTOZOOL, V6, P58, DOI 10.1111/j.1550-7408.1959.tb03927.x; Westenberger SJ, 2004, PARASITOLOGY, V129, P537, DOI 10.1017/S003118200400592X; Yurchenko V, 2006, J EUKARYOT MICROBIOL, V53, P103, DOI 10.1111/j.1550-7408.2005.00078.x; Yurchenko VY, 2001, MOL BIOL+, V35, P1, DOI 10.1023/A:1004813414607; Yurchenko V, 2016, J EUKARYOT MICROBIOL, V63, P198, DOI 10.1111/jeu.12268; Yurchenko V, 2014, FOLIA PARASIT, V61, P97, DOI 10.14411/fp.2014.023; Yurchenko VY, 2008, PROTIST, V159, P99, DOI 10.1016/j.protis.2007.07.003; Yurchenko VY, 2009, INT J SYST EVOL MICR, V59, P893, DOI 10.1099/ijs.0.001149-0	75	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174165	10.1371/journal.pone.0174165	http://dx.doi.org/10.1371/journal.pone.0174165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328988	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700063
J	Lipert, B; Wilamowski, M; Gorecki, A; Jura, J				Lipert, Barbara; Wilamowski, Mateusz; Gorecki, Andrzej; Jura, Jolanta			MCPIP1, alias Regnase-1 binds and cleaves mRNA of C/EBP beta	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-BETA; GENE; EXPRESSION; CELLS; TRANSCRIPTION; ACTIVATION; REVEALS; NF-IL6; SITE	CCAAT/enhancer-binding protein beta (C/EBP beta) is a transcription factor controlling a broad range of genes essential for homeostasis, including genes related to immune functions, inflammation, metabolism and growth. Monocyte chemoattractant protein-1-induced protein 1 (MCPIP1) also called as Regnase-1 is an RNase and has been shown to decrease the stability of short-lived transcripts coding for inflammation-related proteins, including IL-1 beta, IL-6, IL-2, IL-8, IL-12b, IER-3, c-Rel. We found previously that the half-life of the C/EBP beta transcript is regulated by MCPIP. To understand the mechanism driving down-regulation of C/EBP beta by MCPIP1, we applied an in vitro cleavage assay, followed by a luciferase-reporter assay and RNA immunoprecipitation (RIP). We demonstrated that MCPIP1 recognizes regions of the 3'UTR of C/EBP beta mRNA and promotes its decay by introducing direct endo-nucleolytic cleavage.	[Lipert, Barbara; Wilamowski, Mateusz; Jura, Jolanta] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Gen Biochem, Krakow, Poland; [Gorecki, Andrzej] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland	Jagiellonian University; Jagiellonian University	Jura, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Gen Biochem, Krakow, Poland.	jolanta.jura@uj.edu.pl	Jura, Jolanta/F-8889-2015	Jura, Jolanta/0000-0002-0816-3475; Wilamowski, Mateusz/0000-0001-8760-0700; Gorecki, Andrzej/0000-0002-4159-447X	National Science Centre [2013/11/B/NZZ/00125, 2015/17/B/NZ3/01051]; Ministry of Science and Higher Education	National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by the research grants from the National Science Centre 2013/11/B/NZZ/00125 and 2015/17/B/NZ3/01051. The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Cheadle C, 2005, ANN NY ACAD SCI, V1058, P196, DOI 10.1196/annals.1359.026; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dobosz E, 2016, J INNATE IMMUN, V8, P564, DOI 10.1159/000448038; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Herrero J, 2016, DATABASE; Jones H, 2007, BIOCHEM BIOPH RES CO, V355, P217, DOI 10.1016/j.bbrc.2007.01.136; Kochan J, 2016, BIOL OPEN, V5, P889, DOI 10.1242/bio.018010; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lipert B, 2014, BBA-MOL CELL RES, V1843, P780, DOI 10.1016/j.bbamcr.2014.01.001; Lu WB, 2016, CANCER RES, V76, P1429, DOI 10.1158/0008-5472.CAN-15-1115; Makki MS, 2016, CONNECT TISSUE RES; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Niu JL, 2011, J MOL CELL CARDIOL, V51, P177, DOI 10.1016/j.yjmcc.2011.04.018; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SHIRAKAWA F, 1993, MOL CELL BIOL, V13, P1332, DOI 10.1128/MCB.13.3.1332; Skalniak L, 2009, FEBS J, V276, P5892, DOI 10.1111/j.1742-4658.2009.07273.x; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wedel A, 1996, CYTOKINE, V8, P335, DOI 10.1006/cyto.1996.0046; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Yang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.486; Yokogawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22324; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174381	10.1371/journal.pone.0174381	http://dx.doi.org/10.1371/journal.pone.0174381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328949	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700086
J	Schmitz, S; Tacke, S; Guth, B; Henke, J				Schmitz, Sabrina; Tacke, Sabine; Guth, Brian; Henke, Julia			Repeated anaesthesia with isoflurane and medetomidine-midazolam-fentanyl in guinea pigs and its influence on physiological parameters	PLOS ONE			English	Article								Repeated anaesthesia may be required in experimental protocols and in daily veterinary practice, but anaesthesia is known to alter physiological parameters in GPs (Cavia porcellus, GPs). This study investigated the effects of repeated anaesthesia with either medetomidine-midazolam-fentanyl (MMF) or isoflurane (Iso) on physiological parameters in the GP. Twelve GPs were repeatedly administered with MMF or Iso in two anaesthesia sets. One set consisted of six 40-min anaesthesias, performed over 3 weeks (2 per week); the anaesthetic used first was randomized. Prior to Iso anaesthesia, atropine was injected. MMF anaesthesia was antagonized with AFN (atipamezole-flumazenil-naloxone). Abdominally implanted radio-telemetry devices recorded the mean arterial blood pressure (MAP), heart rate (HR) and core body temperature continuously. Additionally, respiratory rate, blood glucose and body weight were assessed. An operable state could be achieved and maintained for 40 min in all GPs. During the surgical tolerance with MMF, the GPs showed a large MAP range between the individuals. In the MMF wake-up phase, the time was shortened until the righting reflex (RR) returned and that occurred at lower MAP and HR values. Repeated Iso anaesthesia led to an increasing HR during induction (anaesthesias 2-6), non-surgical tolerance (anaesthesias 3-6) and surgical tolerance (anaesthesias 4, 6). Both anaesthetics may be used repeatedly, as repeating the anaesthesias resulted in only slightly different physiological parameters, compared to those seen with single anaesthesias. The regular atropine premedication induced HR increases and repeated MMF anaesthesia resulted in a metabolism increase which led to the faster return of RR. Nevertheless, Iso's anaesthesia effects of strong respiratory depression and severe hypotension remained. Based on this increased anaesthesia risk with Iso, MMF anaesthesia is preferable for repeated use in GPs.	[Schmitz, Sabrina; Henke, Julia] Boehringer Ingelheim Pharma GmbH & Co KG, Biol Lab Serv, Dept Nonclin Drug Safety, Biberach, Germany; [Tacke, Sabine] Justus Liebig Univ, Clin Small Anim Surg, Dept Vet Clin Sci, Giessen, Germany; [Guth, Brian] Boehringer Ingelheim Pharma GmbH & Co KG, Gen Pharmacol, Dept Drug Discovery Support, Biberach, Germany; [Guth, Brian] North West Univ, Fac Hlth Sci, DST NWU Preclin Drug Dev Platform, Potchefstroom, South Africa	Boehringer Ingelheim; Justus Liebig University Giessen; Boehringer Ingelheim; North West University - South Africa	Schmitz, S (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Biol Lab Serv, Dept Nonclin Drug Safety, Biberach, Germany.	Sabrina.schmitz@boehringer-ingelheim.com	Tacke, Sabine/A-3213-2019		Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	Boehringer Ingelheim Pharma GmbH & Co. KG provided support in the form of salaries for authors SS, BG and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albrecht M., 2014, BMC VET RES, V10, P963; Birck MM, 2014, JOVE-J VIS EXP, DOI 10.3791/51982; Braga V.A., 2011, MODERN TELEMETRY; Csiernik R., 2016, SUBSTANCE USE ABUSE; Erhardt W, 2004, CAN VET J; Fleischmann T, 2016, LAB ANIM-UK, V50, P264, DOI 10.1177/0023677216631458; Hein J., 2001, LABORDIAGNOSTISCHE R; Henke J., 1998, KLEINT KONKR, V1, P36; Henke J, 2010, PRAKT TIERARZT, V91, P294; Popesko P., 1992, COLOUR ATLAS ANATOMY; SALONEN S, 1995, J VET PHARMACOL THER, V18, P328, DOI 10.1111/j.1365-2885.1995.tb00599.x; Schmitz S, 2016, PLOS ONE IN PRESS; Schmitz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161258; Schmitz S, 2016, J PHARMACOL TOX MET, V80, P9, DOI 10.1016/j.vascn.2016.03.003; Tremoleda JL, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-44	15	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174423	10.1371/journal.pone.0174423	http://dx.doi.org/10.1371/journal.pone.0174423			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328950	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700090
J	Yang, CX; Zhang, M; Dong, WP; Cui, GW; Ren, ZM; Wang, WL				Yang, Chuanxi; Zhang, Ming; Dong, Wenping; Cui, Guanwei; Ren, Zongming; Wang, Weiliang			Highly efficient photocatalytic degradation of methylene blue by PoPD/TiO2 nanocomposite	PLOS ONE			English	Article							ORGANIC POLLUTANTS; TIO2; NANOPARTICLES; PHOTOACTIVITY; PERFORMANCE; COMPOSITE; ELECTRODE; PANI	The poly-o-phenylenediamine (PoPD)/TiO2 nanocomposite was successfully synthesized via 'in situ' oxidative polymerization method. The modified photocatalysts were characterized by BET, scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier-transform infrarad spectra (FT-IR), thermogravimrtic analysis (TGA), X-ray photoelectron spectroscopy (XPS), Ultraviolet-visible diffuse reflectance spectrum (UV-Vis DRS) and Photocurrent Test. The results showed that the PoPD exists on the surface of TiO2, the presence of PoPD does not impact on the lattice structure and grain size of TiO2, and the presence of PoPD enhances the visible response and photoelectric property. The photocatalytic degradation of methylene blue (MB) was chosen as a model reaction to evaluate the photocatalytic activities of TiO2 and PoPD/TiO2. The optimal preparation condition was the molar ratio of oPD to TiO2 = 3:1, HCl concentration = 1.2 mol/L, the molar ratio of APS to oPD = 1:1. The apparent first-order rate constant k(app) of PoPD/TiO2 nanocomposite was 0.0098 min(-1), which is 6 times higher than TiO2 (0.0016 min(-1)). Meanwhile, the PoPD/TiO2 nanocomposites showed excellent photocatalytic stability, and the photocatalytic stability was depended on the stability of structure. At last, the photocatalytic mechanism of POPD/TiO2 nanocomposites was also proposed based on the synergetic effect between TiO2 and PoPD.	[Yang, Chuanxi; Ren, Zongming; Wang, Weiliang] Shandong Normal Univ, Coll Geog & Environm, Jinan, Peoples R China; [Yang, Chuanxi] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China; [Zhang, Ming] NJTECH Environm Technol Co Ltd, Nanjing, Jiangsu, Peoples R China; [Dong, Wenping] Shandong Acad Environm Sci, Jinan, Peoples R China; [Dong, Wenping] Environm Engn Co Ltd, Jinan, Peoples R China; [Cui, Guanwei] Shandong Normal Univ, Minist Educ, Coll Chem Chem Engn & Mat Sci, Key Lab Mol & Nano Probes, Jinan, Peoples R China; [Ren, Zongming; Wang, Weiliang] Shandong Normal Univ, Inst Environm & Ecol, Jinan, Peoples R China	Shandong Normal University; China Agricultural University; Shandong Normal University; Shandong Normal University	Ren, ZM; Wang, WL (corresponding author), Shandong Normal Univ, Coll Geog & Environm, Jinan, Peoples R China.; Ren, ZM; Wang, WL (corresponding author), Shandong Normal Univ, Inst Environm & Ecol, Jinan, Peoples R China.	zmren@sdnu.edu.cn; sdqcsdnu@163.com			National Natural Science Foundation of China [41672340]; NJTECH Environment Technology Co., Ltd.; Shandong Academy of Environmental Science and Environmental Engineering Co, Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NJTECH Environment Technology Co., Ltd.; Shandong Academy of Environmental Science and Environmental Engineering Co, Ltd.	This work was financially supported by the National Natural Science Foundation of China (41672340). Authors [Zhang Ming] are supported in the form of salary by NJTECH Environment Technology Co., Ltd. Authors [Dong Wenping] are supported in the form of salary by Shandong Academy of Environmental Science and Environmental Engineering Co, Ltd. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen S, 2009, J ALLOY COMPD, V487, P382, DOI 10.1016/j.jallcom.2009.07.126; Chen Q, 2014, APPL SURF SCI, V311, P230, DOI 10.1016/j.apsusc.2014.05.046; Chen XB, 2008, J AM CHEM SOC, V130, P5018, DOI 10.1021/ja711023z; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Zhang H, 2008, ENVIRON SCI TECHNOL, V42, P3803, DOI 10.1021/es703037x; Janaky C, 2014, ELECTROCHIM ACTA, V122, P303, DOI 10.1016/j.electacta.2013.12.008; Jeong WH, 2014, CHEM ENG J, V246, P204, DOI 10.1016/j.cej.2014.02.054; Jo WK, 2013, MATER CHEM PHYS, V143, P247, DOI 10.1016/j.matchemphys.2013.08.060; Li JP, 2003, ANAL CHIM ACTA, V478, P337, DOI 10.1016/S0003-2670(02)01513-1; Li XC, 2014, CHEM ENG J, V236, P480, DOI 10.1016/j.cej.2013.10.057; Li XY, 2008, APPL CATAL B-ENVIRON, V81, P267, DOI 10.1016/j.apcatb.2007.12.022; Liang HC, 2009, APPL CATAL B-ENVIRON, V86, P8, DOI 10.1016/j.apcatb.2008.07.015; Liao GZ, 2011, APPL CATAL B-ENVIRON, V102, P126, DOI 10.1016/j.apcatb.2010.11.033; Liao GZ, 2010, ENVIRON SCI TECHNOL, V44, P3481, DOI 10.1021/es903833f; Lin YM, 2012, J PHYS CHEM C, V116, P5764, DOI 10.1021/jp211222w; MALITESTA C, 1990, ANAL CHEM, V62, P2735, DOI 10.1021/ac00223a016; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Park H, 2013, J PHOTOCH PHOTOBIO C, V15, P1, DOI 10.1016/j.jphotochemrev.2012.10.001; Pawar RC, 2015, APPL CATAL B-ENVIRON, V176, P654, DOI 10.1016/j.apcatb.2015.04.045; Pawar RC, 2014, DALTON T, V43, P12514, DOI 10.1039/c4dt01278j; Pawar RC, 2014, APPL CATAL B-ENVIRON, V144, P57, DOI 10.1016/j.apcatb.2013.06.022; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Rufford TE, 2008, ELECTROCHEM COMMUN, V10, P1594, DOI 10.1016/j.elecom.2008.08.022; Salem MA, 2009, APPL CATAL B-ENVIRON, V91, P59, DOI 10.1016/j.apcatb.2009.05.027; Seoudi R, 2010, SYNTHETIC MET, V160, P479, DOI 10.1016/j.synthmet.2009.11.035; Shadpour M, 2015, HIGH PERFORM POLYM, V27, P458; Singh S, 2013, APPL CATAL A-GEN, V462, P178, DOI 10.1016/j.apcata.2013.04.039; Tan F, 2013, J HAZARD MATER, V244, P750, DOI 10.1016/j.jhazmat.2012.11.003; Wang DS, 2008, CATAL COMMUN, V9, P1162, DOI 10.1016/j.catcom.2007.10.027; Wang HL, 2013, DESALIN WATER TREAT, V51, P2826, DOI 10.1080/19443994.2012.750789; Wang HL, 2012, SYNTHETIC MET, V162, P296, DOI 10.1016/j.synthmet.2011.12.009; Wang YJ, 2011, J SOLID STATE CHEM, V184, P1433, DOI 10.1016/j.jssc.2011.04.001; Yang JH, 2013, ACCOUNTS CHEM RES, V46, P1900, DOI 10.1021/ar300227e; Zhang R, 2014, APPL SURF SCI, V289, P237, DOI 10.1016/j.apsusc.2013.10.143; Zhang S, 2012, INT J HYDROGEN ENERG, V37, P791, DOI 10.1016/j.ijhydene.2011.04.060	36	23	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174104	10.1371/journal.pone.0174104	http://dx.doi.org/10.1371/journal.pone.0174104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329007	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700053
J	Yumura, M; Yamamoto, N; Yokoyama, K; Mori, H; Yomo, T; Ichihashi, N				Yumura, Mio; Yamamoto, Natsuko; Yokoyama, Katsushi; Mori, Hirotada; Yomo, Tetsuya; Ichihashi, Norikazu			Combinatorial selection for replicable RNA by Q beta replicase while maintaining encoded gene function	PLOS ONE			English	Article							IN-VITRO; SYNTHETIC BIOLOGY; PROTEIN; SYSTEM; LIPOSOMES; EVOLUTION; ENZYME	Construction of a complex artificial self-replication system is challenging in the field of in vitro synthetic biology. Recently, we developed a translation-coupled RNA replication system, wherein an artificial genomic RNA replicates with the Q beta RNA replicase gene encoded on itself. The challenge is to introduce additional genes into the RNA to develop a complex system that mimics natural living systems. However, most RNA sequence encoding genes are not replicable by the Q beta replicase owing to its requirement for strong secondary structures throughout the RNA sequence that are absent in most genes. In this study, we establish a new combinatorial selection method to find an RNA sequence with secondary structures and functional amino acid sequences of the encoded gene. We selected RNA sequences based on their in vitro replication and in vivo gene functions. First, we used the alpha-domain gene of beta-galactosidase as a model-encoding gene, with functional selection based on blue-white screening. Through the combinatorial selection, we developed more replicable RNAs while maintaining the function of the encoded alpha-domain. The selected sequence improved the affinity between the minus strand RNA and Q beta replicase. Second, we established an in vivo selection method applicable to a broader range of genes by using an Escherichia coli strain with one of the essential genes complemented with a plasmid. We performed the combinatorial selection using an RNA encoding serS and obtained more replicable RNA encoding functional serS gene. These results suggest that combinatorial selection methods are useful for the development of RNA sequences replicable by Q beta replicase while maintaining the encoded gene function.	[Yumura, Mio; Ichihashi, Norikazu] Osaka Univ, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka, Japan; [Yamamoto, Natsuko; Yokoyama, Katsushi; Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Biol Sci, Takayama, Ikoma, Japan; [Yamamoto, Natsuko] Osaka Univ, Grad Sch Med, Dept Biomed Eth & Publ Policy, 2-2 Yamadaoka, Suita, Osaka, Japan; [Yomo, Tetsuya] East China Normal Univ, Shanghai, Peoples R China; [Ichihashi, Norikazu] Osaka Univ, Grad Sch Frontier Biosci, 1-5 Yamadaoka, Suita, Osaka, Japan	Osaka University; Nara Institute of Science & Technology; Osaka University; East China Normal University; Osaka University	Ichihashi, N (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka, Japan.; Ichihashi, N (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-5 Yamadaoka, Suita, Osaka, Japan.	ichihashi@ist.osaka-u.ac.jp	Ichihashi, Norikazu/AAY-6897-2020		JSPS KAKENHI [JP15H04407, JP15KT0080]; Grants-in-Aid for Scientific Research [15H04407, 15KT0080] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the JSPS KAKENHI Grants, JP15H04407 and JP15KT0080 (NI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Attwater J, 2014, NAT METHODS, V11, P495, DOI 10.1038/nmeth.2893; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Forlin M, 2012, CURR OPIN CHEM BIOL, V16, P586, DOI 10.1016/j.cbpa.2012.10.020; Forster AC, 2007, GENOME RES, V17, P1, DOI 10.1101/gr.5776007; Garamella J, 2016, ACS SYNTH BIOL, V5, P344, DOI 10.1021/acssynbio.5b00296; GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; Ichihashi N, 2010, J BIOL CHEM, V285, P37210, DOI 10.1074/jbc.M110.117846; Ichihashi N, 2008, CHEMBIOCHEM, V9, P3023, DOI 10.1002/cbic.200800518; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Kobori S, 2013, MOL BIOSYST, V9, P1282, DOI 10.1039/c3mb70032a; LANGLEY KE, 1975, P NATL ACAD SCI USA, V72, P1254, DOI 10.1073/pnas.72.4.1254; Lewis Daniel D, 2014, Front Bioeng Biotechnol, V2, P66, DOI 10.3389/fbioe.2014.00066; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Nishiyama K, 2015, PROTEIN SCI; Sambrook J, 2001, MOLECULAR CLONING A, V1; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; Simpson ML, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100104; Stano P, 2013, CURR OPIN BIOTECH, V24, P633, DOI 10.1016/j.copbio.2013.01.002; Swartz JR, 2009, NAT BIOTECHNOL, V27, P731, DOI 10.1038/nbt0809-731; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tomita K, 2015, BIOCHEM BIOPH RES CO, V467, P293, DOI 10.1016/j.bbrc.2015.09.169; Usui K, 2015, NUCLEIC ACIDS RES, V43, P8033, DOI 10.1093/nar/gkv742; Usui K, 2013, FEBS LETT, V587, P2565, DOI 10.1016/j.febslet.2013.06.033; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; WALKER GT, 1992, P NATL ACAD SCI USA, V89, P392, DOI 10.1073/pnas.89.1.392; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174130	10.1371/journal.pone.0174130	http://dx.doi.org/10.1371/journal.pone.0174130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328998	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700057
J	Fedurek, P; Lehmann, J				Fedurek, Piotr; Lehmann, Julia			The effect of excluding juveniles on apparent adult olive baboons (Papio anubis) social networks	PLOS ONE			English	Article							FEMALE BABOONS; SAVANNA BABOONS; AGONISTIC INTERACTIONS; SEX-DIFFERENCES; RANK; BEHAVIOR; BONDS; TRANSMISSION; ACQUISITION; DOMINANCE	In recent years there has been much interest in investigating the social structure of group living animals using social network analysis. Many studies so far have focused on the social networks of adults, often excluding younger, immature group members. This potentially may lead to a biased view of group social structure as multiple recent studies have shown that younger group members can significantly contribute to group structure. As proof of the concept, we address this issue by investigating social network structure with and without juveniles in wild olive baboons (Papio anubis) at Gashaka Gumti National Park, Nigeria. Two social networks including all independently moving individuals (i.e., excluding dependent juveniles) were created based on aggressive and grooming behaviour. We used knockout simulations based on the random removal of individuals from the network in order to investigate to what extent the exclusion of juveniles affects the resulting network structure and our interpretation of age-sex specific social roles. We found that juvenile social patterns differed from those of adults and that the exclusion of juveniles from the network significantly altered the resulting overall network structure. Moreover, the removal of juveniles from the network affected individuals in specific age-sex classes differently: for example, including juveniles in the grooming network increased network centrality of adult females while decreasing centrality of adult males. These results suggest that excluding juveniles from the analysis may not only result in a distorted picture of the overall social structure but also may mask some of the social roles of individuals belonging to different age-sex classes.	[Fedurek, Piotr; Lehmann, Julia] Univ Roehampton, Dept Life Sci, London, England	Roehampton University	Fedurek, P (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	fedurekpiotr@yahoo.co.uk		Lehmann, Julia/0000-0001-7278-1705				Abell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082541; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold ME, 2004, PREV VET MED, V66, P35, DOI 10.1016/j.prevetmed.2004.07.007; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2012, PHILOS T R SOC B, V367, P2108, DOI 10.1098/rstb.2012.0113; BERNSTEIN IS, 1993, AM J PRIMATOL, V31, P197, DOI 10.1002/ajp.1350310305; Blumstein D.T, 2009, BIOL SCI; Brent LJN, 2015, CURR BIOL, V25, P746, DOI 10.1016/j.cub.2015.01.037; Brent LJN, 2013, BEHAV ECOL SOCIOBIOL, V67, P349, DOI 10.1007/s00265-012-1455-8; Brent LJN, 2011, AM J PRIMATOL, V73, P720, DOI 10.1002/ajp.20949; Bret C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083015; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Carne C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095039; Chasalow S, 2012, COMBINAT COMBINATORI; CHENEY DL, 1977, BEHAV ECOL SOCIOBIOL, V2, P303, DOI 10.1007/BF00299742; CHENEY DL, 1978, ANIM BEHAV, V26, P389, DOI 10.1016/0003-3472(78)90057-X; CHENEY DL, 1978, ANIM BEHAV, V26, P1038, DOI 10.1016/0003-3472(78)90093-3; CHISM JB, 1986, ETHOLOGY, V72, P31; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dormann C.F., 2008, INTRO BIPARTITE PACK, V1; Duboscq J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22095; Dunbar R.I.M., 2013, PRIMATE SOCIAL SYSTE; Dytham C., 2011, CHOOSING USING STAT; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Franz M, 2015, CURR ZOOL, V61, P107, DOI 10.1093/czoolo/61.1.107; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gonzalez-Hernandez M, 2014, INT J PRIMATOL, V35, P445, DOI 10.1007/s10764-014-9751-y; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; HARRIS S, 1992, ANIM BEHAV, V44, P1085, DOI 10.1016/S0003-3472(05)80320-3; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Higham JP, 2009, AM J PRIMATOL, V71, P293, DOI 10.1002/ajp.20651; HILL DA, 1986, PRIMATES, V27, P425, DOI 10.1007/BF02381888; Hirsch BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037301; Horrocks Julia A., 1993, P228; Johnson J. T., 1984, THESIS; JOHNSON JA, 1987, ANIM BEHAV, V35, P1694, DOI 10.1016/S0003-3472(87)80062-3; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kawai, 1958, PRIMATES, V1, P111, DOI DOI 10.1007/BF01813699; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; LEE PC, 1979, ANIM BEHAV, V27, P576, DOI 10.1016/0003-3472(79)90193-3; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lehmann J, 2016, BEHAV ECOL, V27, P20, DOI 10.1093/beheco/arv169; Lehmann J, 2011, AM J PRIMATOL, V73, P775, DOI 10.1002/ajp.20967; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; MacIntosh AJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051144; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; McComb K, 2011, P ROY SOC LOND B BIO; McFarland R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0428; Naug D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1023, DOI 10.1007/s00265-009-0721-x; Nunez CMV, 2015, BEHAV ECOL, V26, P138, DOI 10.1093/beheco/aru163; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Opsahl Tore, 2009, THESIS; Parr NA, 2013, INT J PRIMATOL, V34, P1137, DOI 10.1007/s10764-013-9728-2; PEREIRA ME, 1989, ETHOLOGY, V80, P152; PEREIRA ME, 1988, ETHOLOGY, V79, P195, DOI 10.1111/j.1439-0310.1988.tb00711.x; Pereira Michael E., 1993, P3; Ramos-Fernandez G, 2009, BEHAV ECOL SOCIOBIOL, V63, P999, DOI 10.1007/s00265-009-0719-4; Rimbach R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0110; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Rubenstein Daniel I., 2007, Erforschung Biologischer Ressourcen der Mongolei, V10, P159; Schaffner CM, 2012, PRIMATES, V53, P49, DOI 10.1007/s10329-011-0271-5; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schultz A. H., 1956, P887; SEYFARTH RM, 1976, ANIM BEHAV, V24, P917, DOI 10.1016/S0003-3472(76)80022-X; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Silk MJ, 2015, ANIM BEHAV, V104, P1, DOI 10.1016/j.anbehav.2015.03.005; SIMONDS PE, 1974, ARCH SEX BEHAV, V3, P151, DOI 10.1007/BF01540999; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; Sommer V, 2011, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-7403-7; Stanton MA, 2011, ANIM BEHAV, V82, P405, DOI 10.1016/j.anbehav.2011.05.026; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Suomi SJ, 2005, HUM DEV, V48, P67, DOI 10.1159/000083216; Templeton CN, BEHAV ECOL, V201; Tiddi B, 2011, AM J PRIMATOL, V73, P812, DOI 10.1002/ajp.20939; Warren Y, THESIS; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	99	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173146	10.1371/journal.pone.0173146	http://dx.doi.org/10.1371/journal.pone.0173146			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323851	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000015
J	Hamilton, MJ; Robb, Y; Cumming, S; Gregory, H; Duncan, A; Rahman, M; McKeown, A; McWilliam, C; Dean, J; Wilcox, A; Farrugia, ME; Cooper, A; McGhie, J; Adam, B; Petty, R; Longman, C; Findlay, I; Japp, A; Monckton, DG; Denvir, MA				Hamilton, Mark J.; Robb, Yvonne; Cumming, Sarah; Gregory, Helen; Duncan, Alexis; Rahman, Monika; McKeown, Anne; McWilliam, Catherine; Dean, John; Wilcox, Alison; Farrugia, Maria E.; Cooper, Anneli; McGhie, Josephine; Adam, Berit; Petty, Richard; Longman, Cheryl; Findlay, Iain; Japp, Alan; Monckton, Darren G.; Denvir, Martin A.		Scottish Myotonic Dystrophy Consor	Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HIGHLY SENSITIVE ASSAY; HEART-FAILURE; MAGNETIC-RESONANCE; GENERAL-POPULATION; SKELETAL-MUSCLE; SUDDEN-DEATH; MORTALITY; RISK; DISEASE	Objective High sensitivity plasma cardiac troponin-I (cTnI) is emerging as a strong predictor of cardiac events in a variety of settings. We have explored its utility in patients with myotonic dystrophy type 1 (DM1). Methods 117 patients with DM1 were recruited from routine outpatient clinics across three health boards. A single measurement of cTnI was made using the ARCHITECT STAT Troponin I assay. Demographic, ECG, echocardiographic and other clinical data were obtained from electronic medical records. Follow up was for a mean of 23 months. Results Fifty five females and 62 males (mean age 47.7 years) were included. Complete data were available for ECG in 107, echocardiography in 53. Muscle Impairment Rating Scale score was recorded for all patients. A highly significant excess (p = 0.0007) of DM1 patients presented with cTnI levels greater than the 99(th) centile of the range usually observed in the general population (9 patients; 7.6%). Three patients with elevated troponin were found to have left ventricular systolic dysfunction (LVSD), compared with four of those with normal range cTnI (33.3% versus 3.7%; p = 0.001). Sixty two patients had a cTnI level < 5ng/L, of whom only one had documented evidence of LVSD. Elevated cTnI was not predictive of severe conduction abnormalities on ECG, or presence of a cardiac device, nor did cTnI level correlate with muscle strength expressed by Muscle Impairment Rating Scale score. Conclusions Plasma cTnI is highly elevated in some ambulatory patients with DM1 and shows promise as a tool to aid cardiac risk stratification, possibly by detecting myocardial involvement. Further studies with larger patient numbers are warranted to assess its utility in this setting.	[Hamilton, Mark J.; Duncan, Alexis; Rahman, Monika; McKeown, Anne; Wilcox, Alison; Longman, Cheryl] Queen Elizabeth Univ Hosp, West Scotland Clin Genet Serv, Glasgow, Lanark, Scotland; [Hamilton, Mark J.; Cumming, Sarah; Cooper, Anneli; McGhie, Josephine; Adam, Berit; Monckton, Darren G.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Robb, Yvonne] Western Gen Hosp, Clin Genet Serv, Edinburgh, Midlothian, Scotland; [Gregory, Helen; Dean, John] North Scotland Clin Genet Serv, Ashgrove House,Foresterhill Hlth Campus, Aberdeen, Scotland; [McWilliam, Catherine] Ninewells Hosp, Human Genet Unit, Dundee, Scotland; [Farrugia, Maria E.; Petty, Richard] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Neurol, Glasgow, Lanark, Scotland; [Findlay, Iain] Queen Elizabeth Univ Hosp, Inherited Cardiac Condit Serv, Glasgow, Lanark, Scotland; [Japp, Alan; Denvir, Martin A.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	Queen Elizabeth University Hospital (QEUH); University of Glasgow; University of Edinburgh; University of Dundee; Queen Elizabeth University Hospital (QEUH); University of Glasgow; Queen Elizabeth University Hospital (QEUH); University of Edinburgh	Hamilton, MJ (corresponding author), Queen Elizabeth Univ Hosp, West Scotland Clin Genet Serv, Glasgow, Lanark, Scotland.; Hamilton, MJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	markhamilton1@nhs.net	Denvir, Martin A/ABA-3141-2021; Monckton, Darren/B-4943-2013	Hamilton, Mark James/0000-0001-9719-243X; Dean, John/0000-0003-3841-0841; Monckton, Darren/0000-0002-8298-8264	Chest, Heart and Stroke Scotland; British Heart Foundation; Chief Scientist Office; Muscular Dystrophy UK; Muscular Dystrophy Association; Myotonic Dystrophy Support Group (UK); Muscular Dystrophy UK [MC3/1073] Funding Source: researchfish; Chief Scientist Office [CAF/MD/15/01] Funding Source: researchfish	Chest, Heart and Stroke Scotland; British Heart Foundation(British Heart Foundation); Chief Scientist Office; Muscular Dystrophy UK; Muscular Dystrophy Association(Muscular Dystrophy Association); Myotonic Dystrophy Support Group (UK); Muscular Dystrophy UK; Chief Scientist Office	This work was supported by research grants from Chest, Heart and Stroke Scotland, the British Heart Foundation, Chief Scientist Office, Muscular Dystrophy UK and Muscular Dystrophy Association, as well as awards from the Myotonic Dystrophy Support Group (UK).	Aggarwal R, 2009, J RHEUMATOL, V36, P2711, DOI 10.3899/jrheum.090562; Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Aw TC, 2013, CLIN CHIM ACTA, V422, P26, DOI 10.1016/j.cca.2013.03.034; Baum H, 1997, CLIN CHEM, V43, P1877; Bhakta D, 2011, J CARDIOVASC ELECTR, V22, P1369, DOI 10.1111/j.1540-8167.2011.02200.x; Bhakta D, 2010, AM HEART J, V160, P1137, DOI 10.1016/j.ahj.2010.07.032; Biener M, 2015, EUR HEART J ACUTE CA; BODOR GS, 1995, CLIN CHEM, V41, P1710; British Society of Echocardiography, TRANSTH ECH MIN DAT; Carda R, 2015, CARDIOLOGY, V132, P1, DOI 10.1159/000381259; Choudhary P, 2016, HEART; Cox FM, 2010, J NEUROL, V257, P447, DOI 10.1007/s00415-009-5350-9; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; De Pooter J, 2012, ACTA CARDIOL, V67, P253, DOI 10.1080/AC.67.2.2154220; DEAMBROGGI L, 1995, EUR HEART J, V16, P1007, DOI 10.1093/oxfordjournals.eurheartj.a061011; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; Gagnon C, 2013, CAN J NEUROL SCI, V40, P42, DOI 10.1017/S0317167100012932; Groh WJ, 2008, NEW ENGL J MED, V358, P2688, DOI 10.1056/NEJMoa062800; Groh WJ, 2011, MUSCLE NERVE, V43, P648, DOI 10.1002/mus.21934; Hammerer-Lercher A, 2001, CLIN CHEM, V47, P451; Hermans MCE, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-48; Hoff J, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0566-5; Hoogerwaard EM, 2001, CLIN CHEM, V47, P962; Jackson C. E., 2016, EUR J HEART FAIL; Jaffe AS, 2011, J AM COLL CARDIOL, V58, P1819, DOI 10.1016/j.jacc.2011.08.026; Kaminsky P, 2011, MEDICINE, V90, P262, DOI 10.1097/MD.0b013e318226046b; Lau JK, 2015, INT J CARDIOL, V184, P600, DOI 10.1016/j.ijcard.2015.03.069; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Matsumura T, 2007, BRAIN DEV-JPN, V29, P496, DOI 10.1016/j.braindev.2007.01.009; Matsumura T, 2009, J NEUROL SCI, V276, P60, DOI 10.1016/j.jns.2008.08.037; Mladenovic J, 2006, EUR J NEUROL, V13, P451, DOI 10.1111/j.1468-1331.2006.01261.x; Morales F, 2015, EUR J HUM GENET, V23, P646, DOI 10.1038/ejhg.2014.138; Morales F, 2012, HUM MOL GENET, V21, P3558, DOI 10.1093/hmg/dds185; Morner S, 2010, J INTERN MED, V268, P59, DOI 10.1111/j.1365-2796.2010.02213.x; Omland T, 2015, CLIN CHEM, V61, P646, DOI 10.1373/clinchem.2014.234369; Petri H, 2012, INT J CARDIOL, V160, P82, DOI 10.1016/j.ijcard.2011.08.037; REARDON W, 1993, ARCH DIS CHILD, V68, P177, DOI 10.1136/adc.68.2.177; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shah ASV, 2015, LANCET, V386, P2481, DOI 10.1016/S0140-6736(15)00391-8; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]; Shah ASV, 2014, CIRCULATION, V130, P1607, DOI 10.1161/CIRCULATIONAHA.114.011085; Sorensen NA, 2015, EUR HEART J ACUTE CA; Stojanovic VR, 2013, J CLIN NEUROSCI, V20, P1002, DOI 10.1016/j.jocn.2012.09.014; Thorsteinsdottir I, 2016, CLIN CHEM, V62, P623, DOI 10.1373/clinchem.2015.250811; Turner C, 2014, CURR OPIN NEUROL, V27, P599, DOI 10.1097/WCO.0000000000000128; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Valaperta R, 2016, CLIN CHIM ACTA, V463, P122, DOI 10.1016/j.cca.2016.10.026; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Zeller T, 2014, EUR HEART J, V35, P271, DOI 10.1093/eurheartj/eht406	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174166	10.1371/journal.pone.0174166	http://dx.doi.org/10.1371/journal.pone.0174166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323905	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000399089000071
J	Hatthakaroon, C; Pharkjaksu, S; Chongtrakool, P; Suwannakarn, K; Kiratisin, P; Ngamskulrungroj, P				Hatthakaroon, Chanin; Pharkjaksu, Sujiraphong; Chongtrakool, Piriyaporn; Suwannakarn, Kamol; Kiratisin, Pattarachai; Ngamskulrungroj, Popchai			Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand	PLOS ONE			English	Article							HIV-ASSOCIATED CRYPTOCOCCOSIS; MYCOBACTERIUM-TUBERCULOSIS; NEOFORMANS; GATTII; CHINA; COINFECTION; INFECTION; STRAINS; KOREA	Despite the strong association between Cryptococcus neoformans infection and the Human immunodeficiency virus (HIV) status of patients globally, most cryptococcosis cases in Far East Asia occur in non-HIV individuals. Molecular epidemiological studies, using multilocus sequence typing (MLST), have shown that more than 95% of cryptococcal strains belong to a specific subtype of VNI. However, this association has never been specifically examined in other parts of Asia. Therefore, in this study, we investigated the VNIc/ST5 genotype distribution among cryptococcosis patients in Thailand. Fifty-one C. neoformans isolates were collected from clinical samples in Siriraj Hospital, Bangkok, Thailand. The strains were predominantly isolated from HIV-positive patients (88.57%) and all were molecular type VNI MAT alpha. An MLST analysis identified five sequence types (ST) in Siriraj Hospital, of which ST4 (45.10%) and ST6 (35.29%) were most common, and ST5 (15.69%), ST32 (1.96%), and ST93 (1.96) were less common. Contrary to reports from Far East Asia, ST5 was predominantly (83.33%) found in HIV patients (P = 0.657), and there was no significant change in the prevalence of ST5 over the past 10 years (P = 0.548). A further analysis of comorbidities showed higher morbidity and delays in the cryptococcal diagnosis in patients with tuberculosis coinfection or without HIV. Our study suggests that although the Thai population is genetically closely related to the Far East Asian population, ST5 is not associated with non-HIV status in Thailand. Therefore, this association may not be related to the host's genetic background. However, its mechanism remains unclear.	[Hatthakaroon, Chanin; Pharkjaksu, Sujiraphong; Chongtrakool, Piriyaporn; Suwannakarn, Kamol; Kiratisin, Pattarachai; Ngamskulrungroj, Popchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand	Mahidol University	Ngamskulrungroj, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.	popchai.nga@mahidol.ac.th	Ngamskulrungroj, Popchai/ABE-7699-2021; Ngamskulrungroj, Popchai/N-8545-2019	Ngamskulrungroj, Popchai/0000-0001-5162-5498; Pharkjaksu, Sujiraphong/0000-0002-6831-5303	Thailand Research Fund Grant for New Researchers [TRG5780088]	Thailand Research Fund Grant for New Researchers	This work was supported by a Thailand Research Fund Grant for New Researchers to PN (TRG5780088). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; COGLIATI M, 2013, SCIENTIFICA, DOI DOI 10.1155/2013/675213; Danesi P, 2014, FEMS YEAST RES, V14, P897, DOI 10.1111/1567-1364.12178; Dou HT, 2015, EUR J CLIN MICROBIOL, V34, P753, DOI 10.1007/s10096-014-2289-2; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Huang CT, 2010, INFECTION, V38, P373, DOI 10.1007/s15010-010-0045-9; Kaocharoen S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002297; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Khongphatthanayothin M, 2006, HIV MED, V7, P281, DOI 10.1111/j.1468-1293.2006.00377.x; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Manfredi R, 2008, INT J INFECT DIS, V12, P438, DOI 10.1016/j.ijid.2007.09.009; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Mihara T, 2013, MED MYCOL, V51, P252, DOI 10.3109/13693786.2012.708883; Ngamskulrungroj P., 2015, NON HIV SPECIFIC ST5, V67; Ormerod KL, 2013, G3-GENES GENOM GENET, V3, P675, DOI 10.1534/g3.113.005660; Park SH, 2015, MYCOBIOLOGY, V43, P360, DOI 10.5941/MYCO.2015.43.3.360; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Van Tongeren L, 2011, CAN RESPIR J, V18, pE62, DOI 10.1155/2011/812345; Yan Z, 2002, J CLIN MICROBIOL, V40, P965, DOI 10.1128/JCM.40.3.965-972.2002; ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234	25	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173744	10.1371/journal.pone.0173744	http://dx.doi.org/10.1371/journal.pone.0173744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323835	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000026
J	Kang, KM; Sohn, CH; Choi, SH; Jung, KH; Yoo, RE; Yun, TJ; Kim, JH; Park, SW				Kang, Koung Mi; Sohn, Chul-Ho; Choi, Seung Hong; Jung, Keun-Hwa; Yoo, Roh-Eul; Yun, Tae Jin; Kim, Ji-Hoon; Park, Sun-Won			Detection of crossed cerebellar diaschisis in hyperacute ischemic stroke using arterial spin-labeled MR imaging	PLOS ONE			English	Article							SPECT; CT; ACCURACY; INDEXES; FLOW	Background and purpose Arterial spin-labeling (ASL) was recently introduced as a noninvasive method to evaluate cerebral hemodynamics. The purposes of this study were to assess the ability of ASL imaging to detect crossed cerebellar diaschisis (CCD) in patients with their first unilateral supratentorial hyperacute stroke and to identify imaging or clinical factors significantly associated with CCD. Materials and methods We reviewed 204 consecutive patients who underwent MRI less than 8 hours after the onset of stroke symptoms. The inclusion criteria were supratentorial abnormality in diffusion-weighted images in the absence of a cerebellar or brain stem lesion, bilateral supratentorial infarction, subacute or chronic infarction, and MR angiography showing vertebrobasilar system disease. For qualitative analysis, asymmetric cerebellar hypoperfusion in ASL images was categorized into 3 grades. Quantitative analysis was performed to calculate the asymmetric index (AI). The patients' demographic and clinical features and outcomes were recorded. Univariate and multivariate analyses were also performed. Results A total of 32 patients met the inclusion criteria, and 24 (75%) presented CCD. Univariate analyses revealed more frequent arterial occlusions, higher diffusion-weighted imaging (DWI) lesion volumes and higher initial NIHSS and mRS scores in the CCD-positive group compared with the CCD-negative group (all p < .05). The presence of arterial occlusion and the initial mRS scores were related with the AI (all p < .05). Multivariate analyses revealed that arterial occlusion and the initial mRS scores were significantly associated with CCD and AI. Conclusion ASL imaging could detect CCD in 75% of patients with hyperacute infarction. We found that CCD was more prevalent in patients with arterial occlusion, larger ischemic brain volumes, and higher initial NIHSS and mRS scores. In particular, vessel occlusion and initial mRS score appeared to be significantly related with CCD pathophysiology in the hyperacute stage.	[Kang, Koung Mi; Sohn, Chul-Ho; Choi, Seung Hong; Yoo, Roh-Eul; Yun, Tae Jin; Kim, Ji-Hoon] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Kang, Koung Mi; Sohn, Chul-Ho; Choi, Seung Hong; Yoo, Roh-Eul; Yun, Tae Jin; Kim, Ji-Hoon] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Jung, Keun-Hwa] Seoul Natl Univ Hosp, Dept Neurol, Clin Res Inst, Seoul, South Korea; [Park, Sun-Won] Seoul Natl Univ, Dept Radiol, Boramae Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Sohn, CH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Sohn, CH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	neurorad63@gmail.com	Sohn, ChulHo/AAV-4565-2021	Jung, Keun-Hwa/0000-0003-1433-8005				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Baron J C, 1981, Trans Am Neurol Assoc, V105, P459; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen S, 2014, J STROKE CEREBROVASC, V23, P2378, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.009; DeReuck J, 1997, CLIN NEUROL NEUROSUR, V99, P11, DOI 10.1016/S0303-8467(96)00561-6; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Jeon YW, 2012, KOREAN J RADIOL, V13, P12, DOI 10.3348/kjr.2012.13.1.12; Kajimoto K, 2007, ANN NUCL MED, V21, P109, DOI 10.1007/BF03033988; Kamouchi M, 2004, J NEUROL SCI, V225, P65, DOI 10.1016/j.jns.2004.07.004; Kang KM, 2015, AM J NEURORADIOL, V36, P1662, DOI 10.3174/ajnr.A4366; Kang KM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-11; Kim SE, 1997, J NUCL MED, V38, P14; LALOUX P, 1995, STROKE, V26, P816, DOI 10.1161/01.STR.26.5.816; Lin DDM, 2009, AM J NEURORADIOL, V30, P710, DOI 10.3174/ajnr.A1435; Liu Y, 2007, J CEREBR BLOOD F MET, V27, P1724, DOI 10.1038/sj.jcbfm.9600467; Madai VI, 2011, J CEREBR BLOOD F MET, V31, P1493, DOI 10.1038/jcbfm.2011.15; Mani S, 1997, MAGN RESON MED, V37, P898, DOI 10.1002/mrm.1910370615; MEYER JS, 1993, NEUROL RES, V15, P362; Olivot JM, 2009, STROKE, V40, P469, DOI 10.1161/STROKEAHA.108.526954; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; SERRATI C, 1994, J NEUROL NEUROSUR PS, V57, P174, DOI 10.1136/jnnp.57.2.174; Sobesky J, 2005, J CEREBR BLOOD F MET, V25, P1685, DOI 10.1038/sj.jcbfm.9600162; Takasawa M, 2002, AM J NEURORADIOL, V23, P189; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; von Monakow C, 1914, J AM MED ASS, VLXIII, P797; Wang DJJ, 2012, STROKE, V43, P1018, DOI 10.1161/STROKEAHA.111.631929; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Yamada H, 1999, RADIOLOGY, V210, P558, DOI 10.1148/radiology.210.2.r99fe02558	32	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173971	10.1371/journal.pone.0173971	http://dx.doi.org/10.1371/journal.pone.0173971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323841	Green Submitted, gold, Green Published			2022-12-27	WOS:000399089000050
J	Schetinin, V; Jakaite, L				Schetinin, Vitaly; Jakaite, Livija			Extraction of features from sleep EEG for Bayesian assessment of brain development	PLOS ONE			English	Article							AUTOMATIC DETECTION; MODEL	Brain development can be evaluated by experts analysing age-related patterns in sleep electroencephalograms (EEG). Natural variations in the patterns, noise, and artefacts affect the evaluation accuracy as well as experts' agreement. The knowledge of predictive posterior distribution allows experts to estimate confidence intervals within which decisions are distributed. Bayesian approach to probabilistic inference has provided accurate estimates of intervals of interest. In this paper we propose a new feature extraction technique for Bayesian assessment and estimation of predictive distribution in a case of newborn brain development assessment. The new EEG features are verified within the Bayesian framework on a large EEG data set including 1,100 recordings made from newborns in 10 age groups. The proposed features are highly correlated with brain maturation and their use increases the assessment accuracy.	[Schetinin, Vitaly; Jakaite, Livija] Univ Bedfordshire, Sch Comp Sci, Pk Sq, Luton LU1 3JU, Beds, England	University of Bedfordshire	Schetinin, V (corresponding author), Univ Bedfordshire, Sch Comp Sci, Pk Sq, Luton LU1 3JU, Beds, England.	vitaly.schetinin@beds.ac.uk			UK Leverhulme Trust [F/00 811/A]; UK Leverhulme Trust	UK Leverhulme Trust(Leverhulme Trust); UK Leverhulme Trust(Leverhulme Trust)	This work was supported by the UK Leverhulme Trust, Grant F/00 811/A (https://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the reviewers for constructive and useful comments. The research has been largely supported by the UK Leverhulme Trust.	Agarwal R, 1998, ELECTROEN CLIN NEURO, V107, P44, DOI 10.1016/S0013-4694(98)00009-1; [Anonymous], [No title captured]; AUFRICHTIG R, 1991, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 13, PTS 1-5, P453, DOI 10.1109/IEMBS.1991.684023; BODENSTEIN G, 1977, P IEEE, V65, P642, DOI 10.1109/PROC.1977.10543; Boylan GB, 2008, IFMBE P, V23, P83; Buntine W., 1992, Statistics and Computing, V2, P63, DOI 10.1007/BF01889584; Chipman HA, 1998, J AM STAT ASSOC, V93, P935, DOI 10.2307/2669832; Costa F, 2015, IEEE T BIO-MED ENG, V62, P2888, DOI 10.1109/TBME.2015.2450015; Denison D.G., 2002, BAYESIAN METHODS NON; Holthausen K, 1999, NEUROSCI LETT, V268, P123, DOI 10.1016/S0304-3940(99)00397-3; Jakaite L, 2011, P 24 IEEE INT S COMP; James G., 2014, INTRO STAT LEARNING, DOI DOI 10.1016/J.PEVA.2007.06.006; Krajca V, 2005, P ANN INT IEEE EMBS, P6014, DOI 10.1109/IEMBS.2005.1615862; Kuncheva L I, 2004, COMBINING PATTERN CL; Low E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100973; MCEWEN JA, 1975, IEEE T BIO-MED ENG, V22, P361, DOI 10.1109/TBME.1975.324504; Neve M, 2008, IEEE T BIO-MED ENG, V55, P41, DOI 10.1109/TBME.2007.902240; Olischar M, 2004, PEDIATRICS, V113, pE61, DOI 10.1542/peds.113.1.e61; PARMELEE AH, 1967, DEV MED CHILD NEUROL, V9, P70; Paul K, 2003, SLEEP MED, V4, P543, DOI 10.1016/j.sleep.2003.08.008; Pressler R, 2003, CLINICAL NEUROPHYSIOLOGY, VOL 2, P450; Rankine L, 2007, IEEE T BIO-MED ENG, V54, P19, DOI 10.1109/TBME.2006.886667; Santos VJ, 2009, IEEE T BIO-MED ENG, V56, P552, DOI 10.1109/TBME.2008.2006033; Schetinin V, 2004, IEEE T INF TECHNOL B, V8, P28, DOI 10.1109/TITB.2004.824735; Schetinin V, 2007, IEEE T INF TECHNOL B, V11, P312, DOI 10.1109/TITB.2006.880553; West CR, 2011, ARCH DIS CHILD-FETAL, V96, pF108, DOI 10.1136/adc.2009.180539; Wong L, 2008, INT CONF ACOUST SPEE, P421, DOI 10.1109/ICASSP.2008.4517636	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174027	10.1371/journal.pone.0174027	http://dx.doi.org/10.1371/journal.pone.0174027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323852	Green Published, gold			2022-12-27	WOS:000399089000055
J	Simon, UK; Enzinger, SM; Fink, A				Simon, Uwe K.; Enzinger, Sonja M.; Fink, Andreas			"The evil virus cell": Students' knowledge and beliefs about viruses	PLOS ONE			English	Article							HIV; RISK; PERCEPTIONS; ADOLESCENTS; HIV/AIDS; IMPACT	Education about virus biology at school is of pivotal interest to raise public awareness concerning means of disease transmission and, thus, methods to prevent infection, and to reduce unnecessary antibiotic treatment due to patient pressure on physicians in case of viral diseases such as influenza. This study aimed at making visible the knowledge of Austrian high school and university students with respect to virus biology, virus structure and health-education issues. The data presented here stem from comprehensive questionnaire analyses, including the task to draw a virus, from a cross-sectional study with 133 grade 7 and 199 grade 10 high school students, and 133 first-year biology and 181 first-year nonbiology university students. Analyses were performed both quantitatively and qualitatively. ANOVA revealed a highly significant group effect for total knowledge relating to virus biology and health issues (F(3, 642) = 44.17, p < 0.01, eta(2)p = 0.17). Specific post-hoc tests by means of the Tukey test showed significant differences between all groups (p < .01) with the exception of 1 st year non-biology students and grade 10 high school students. Students enrolled in university-level biology outperformed all other groups, even though they had not yet encountered this topic at their courses; part of this phenomenon might be due to their affinity for learning about biological topics. However, even many first-year biology students had a high number of severe misconceptions, e.g., defining a virus as a pro-or eukaryotic cell, or falsely naming malaria as a viral disease. Since there was no significant difference in virus-related knowledge between high schools, virus biology seems to have been taught similarly among the tested schools. However, the majority of participants stated that the virus-related knowledge they had acquired at school was not sufficient. Based on the results presented here we urgently suggest improving and intensifying teaching this topic at school, since virus-related knowledge was by far too fragmentary among many participants. Such lack of health-relevant knowledge may contribute to pressure on physicians by patients to unnecessarily prescribe antibiotics, and possibly lead to potentially dangerous neglect concerning vaccination. The effectiveness of newly developed virus-related teaching units and material could be tested with the instrument used here.	[Simon, Uwe K.; Enzinger, Sonja M.] Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr, Graz, Austria; [Simon, Uwe K.] Univ Teacher Educ Weingarten, Dept Biol, Kirchpl, Weingarten, Germany; [Fink, Andreas] Karl Franzens Univ Graz, Inst Psychol, Univ Pl 2-DG, Graz, Austria	University of Graz; University of Graz	Simon, UK (corresponding author), Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr, Graz, Austria.; Simon, UK (corresponding author), Univ Teacher Educ Weingarten, Dept Biol, Kirchpl, Weingarten, Germany.	uwe.simon@uni-graz.at	Simon, Uwe K./D-4555-2015	Simon, Uwe K./0000-0003-4164-8287; Fink, Andreas/0000-0001-7316-3140				ADEJUYIGBE FF, 2015, AFR J REPROD HEALTH, V19, P140; Aylikci Bahadir Ugur, 2013, J Nat Sci Biol Med, V4, P81, DOI 10.4103/0976-9668.107265; BIRENBAUM M, 1987, APPL PSYCH MEAS, V11, P385, DOI 10.1177/014662168701100404; Dumais N, 2009, CBE-LIFE SCI EDUC, V8, P62, DOI 10.1187/cbe.08-08-0048; European Union, 2016, SPEC EUR 445; Hartig, 2010, PSYCHOL TEST ASSESSM, V52, P354; Keselman A, 2004, SCI EDUC, V88, P548, DOI 10.1002/sce.10135; Keselman A, 2007, J RES SCI TEACH, V44, P844, DOI 10.1002/tea.20173; Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Lohrmann C, 2000, J ADV NURS, V31, P696, DOI 10.1046/j.1365-2648.2000.01326.x; McCusker SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-264; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mwamwenda TS, 2013, J AIDS HIV RES, V5, P472; Patel VL, 1999, ADV INSTRUCTIONAL PS, P329; Peate I, 2002, NURS EDUC TODAY, V22, P492, DOI 10.1054/nedt.2002.0747; Romine WL, 2013, INT J SCI EDUC, V35, P1874, DOI 10.1080/09500693.2013.778439; Simon UK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150014; Simonneaux L, 2000, INT J SCI EDUC, V22, P619, DOI 10.1080/095006900289705; Sisay Solomon, 2014, BMC Res Notes, V7, P518, DOI 10.1186/1756-0500-7-518; Sunil B, 2014, INT J RES HLTH SCI, V2, P182; Suominen T, 2015, BMC NURS, V14, DOI 10.1186/s12912-014-0053-7; Sutton MY, 2011, PUBLIC HEALTH REP, V126, P653, DOI 10.1177/003335491112600507; Sychareun V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1126; Tahir S.S., 2009, J FM BAGHDAD, V51, P174; Tobin E. A., 2010, Benin Journal of Postgraduate Medicine, V12, P43; Tonkin-Crine S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3413; Zeyer A, 2015, PRAVENT GESUNDHEIT, V10, P153, DOI 10.1007/s11553-014-0479-5	28	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174402	10.1371/journal.pone.0174402	http://dx.doi.org/10.1371/journal.pone.0174402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350815	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174400037
J	Ding, Y; Wang, EC; Zou, YC; Song, Y; Xiao, X; Huang, WY; Li, YF				Ding, Ying; Wang, Encong; Zou, Yuchen; Song, Yan; Xiao, Xue; Huang, Wanyi; Li, Yanfang			Gender differences in reward and punishment for monetary and social feedback in children: An ERP study	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; SEX-DIFFERENCES; INDIVIDUAL-DIFFERENCES; PREDICTION-ERROR; NEGATIVITY FRN; SENSITIVITY; AGE; REINFORCEMENT; ANTICIPATION; QUESTIONNAIRE	Gender differences in feedback processing have been observed among adolescents and adults through event-related potentials. However, information on whether and how this feedback processing is affected by feedback valence, feedback type, and individual sensitivity in reward/punishment among children remains minimal. In this study, we used a guessing game task coupled with electroencephalography to investigate gender differences in feedback processing, in which feedback to reward and punishment was presented in the context of monetary and social conditions. Results showed that boys were less likely to switch their response after punishment, had generally less feedback-related negativity (FRN) amplitude, and longer FRN latency in monetary and punishment conditions than girls. Moreover, FRN for monetary punishment, which is related to individual difference in reward sensitivity, was observed only in girls. The study provides gender-specific evidence for the neural processing of feedback, which may offer educational guidance for appropriate feedback for girls and boys.	[Ding, Ying; Wang, Encong; Zou, Yuchen; Song, Yan; Xiao, Xue] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Ding, Ying; Li, Yanfang] Beijing Normal Univ, Collaborat Innovat Ctr Assessment Basic Educ Qual, Beijing, Peoples R China; [Huang, Wanyi] Sun Yat Sen Univ, Brain & Cognit Lab, Dept Psychol, Guangzhou, Guangdong, Peoples R China	Beijing Normal University; Beijing Normal University; Sun Yat Sen University	Li, YF (corresponding author), Beijing Normal Univ, Collaborat Innovat Ctr Assessment Basic Educ Qual, Beijing, Peoples R China.	liyanfang@bnu.edu.cn	Xiao, Xue/AAA-2231-2021	Li, Yanfang/0000-0003-0197-9962; Song, Yan/0000-0002-5923-7673; Huang, Wanyi/0000-0002-3221-4439	National Natural Science Foundation of China [31271203]; Humanity and Social Science Foundation of Ministry of Education, PR China [14YJA190006]; National Social Science Foundation of China [15BPRK011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanity and Social Science Foundation of Ministry of Education, PR China; National Social Science Foundation of China	This study was supported by grants from National Natural Science Foundation of China (31271203), the Humanity and Social Science Foundation of Ministry of Education, PR China (Grant No.14YJA190006), and the National Social Science Foundation of China (Grant No.15BPRK011).	Achtziger A, 2015, SOC COGN AFFECT NEUR, V10, P1477, DOI 10.1093/scan/nsv036; Alarcon G, 2015, NEUROIMAGE, V115, P235, DOI 10.1016/j.neuroimage.2015.04.013; Banis S, 2012, BIOL PSYCHOL, V91, P163, DOI 10.1016/j.biopsycho.2012.06.009; Becker MPI, 2014, J NEUROSCI, V34, P3005, DOI 10.1523/JNEUROSCI.3684-13.2014; BERTI AE, 1981, CHILD DEV, V52, P1179, DOI 10.2307/1129504; Bress JN, 2012, BIOL PSYCHOL, V89, P156, DOI 10.1016/j.biopsycho.2011.10.004; Carlson JM, 2015, BRAIN STRUCT FUNCT, V220, P1861, DOI 10.1007/s00429-014-0725-9; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Chase HW, 2011, J COGNITIVE NEUROSCI, V23, P936, DOI 10.1162/jocn.2010.21456; Coch D, 2012, OXFORD HDB EVENT REL; Colder CR, 2004, J ABNORM CHILD PSYCH, V32, P435, DOI 10.1023/B:JACP.0000030296.54122.b6; Connellan J, 2000, INFANT BEHAV DEV, V23, P113, DOI 10.1016/S0163-6383(00)00032-1; Corpus JH, 2007, EDUC PSYCHOL-UK, V27, P487, DOI 10.1080/01443410601159852; Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P1; Corr PJ, 2001, PERS INDIV DIFFER, V30, P333, DOI 10.1016/S0191-8869(00)00028-3; Crowley MJ, 2013, DEV NEUROPSYCHOL, V38, P595, DOI 10.1080/87565641.2012.694512; De Pascalis V, 2010, CLIN NEUROPHYSIOL, V121, P60, DOI 10.1016/j.clinph.2009.10.004; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ferdinand NK, 2014, BEHAV BRAIN RES, V263, P122, DOI 10.1016/j.bbr.2014.01.029; Flores A, 2015, BIOL PSYCHOL, V109, P10, DOI 10.1016/j.biopsycho.2015.04.005; Foti D, 2011, HUM BRAIN MAPP, V32, P2207, DOI 10.1002/hbm.21182; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Grammer JK, 2014, DEV COGN NEUROS-NETH, V9, P93, DOI 10.1016/j.dcn.2014.02.001; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Grunberg NE, 1980, BASIC APPL SOC PSYCH, V1, P343, DOI 10.1207/s15324834basp0104_5; Guyer AE, 2012, SOC COGN AFFECT NEUR, V7, P81, DOI 10.1093/scan/nsr043; Hauser TU, 2014, NEUROIMAGE, V84, P159, DOI 10.1016/j.neuroimage.2013.08.028; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2011, NEUROREPORT, V22, P249, DOI 10.1097/WNR.0b013e328345441d; Jansen BRJ, 2014, DEV PSYCHOL, V50, P237, DOI 10.1037/a0032493; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kohls G, 2009, DEVELOPMENTAL SCI, V12, P614, DOI 10.1111/j.1467-7687.2009.00816.x; Kujawa A, 2013, PSYCHOPHYSIOLOGY, V50, P134, DOI 10.1111/psyp.12002; Lange S, 2012, BIOL PSYCHOL, V89, P416, DOI 10.1016/j.biopsycho.2011.12.004; Li P, 2015, BRAIN COGNITION, V100, P15, DOI 10.1016/j.bandc.2015.08.004; Luman M, 2012, J ABNORM CHILD PSYCH, V40, P145, DOI 10.1007/s10802-011-9547-x; McPartland JC, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-16; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Muller SV, 2005, CLIN NEUROPHYSIOL, V116, P63, DOI 10.1016/j.clinph.2004.07.009; Mushtaq F, 2016, NEUROIMAGE, V125, P868, DOI 10.1016/j.neuroimage.2015.10.046; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Raven JC, 1996, MANUAL RAVENS STANDA; Santesso DL, 2011, PSYCHOPHYSIOLOGY, V48, P1481, DOI 10.1111/j.1469-8986.2011.01229.x; Smillie LD, 2011, SOC COGN AFFECT NEUR, V6, P646, DOI 10.1093/scan/nsq078; Spreckelmeyer KN, 2013, NEUROIMAGE, V66, P223, DOI 10.1016/j.neuroimage.2012.10.068; Spreckelmeyer KN, 2009, SOC COGN AFFECT NEUR, V4, P158, DOI 10.1093/scan/nsn051; Stavropoulos KKM, 2014, J CHILD PSYCHOL PSYC, V55, P1398, DOI 10.1111/jcpp.12270; Sturmer B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00335; Sumich A, 2008, CORTEX, V44, P1342, DOI 10.1016/j.cortex.2007.10.012; Sumich AL, 2012, DEV NEUROPSYCHOL, V37, P415, DOI 10.1080/87565641.2011.653461; Turetsky BI, 1998, BIOL PSYCHIAT, V43, P84, DOI 10.1016/S0006-3223(97)00258-8; Van de Weijer-Bergsma E, 2016, BEHAV RES METHODS, V48, P756, DOI 10.3758/s13428-015-0607-y; Vrticka P, 2014, BRAIN BEHAV, V4, P703, DOI 10.1002/brb3.251; Walsh MM, 2012, NEUROSCI BIOBEHAV R, V36, P1870, DOI 10.1016/j.neubiorev.2012.05.008; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Wood JL, 2008, SOC COGN AFFECT NEUR, V3, P168, DOI 10.1093/scan/nsn010; Zottoli TM, 2012, PSYCHOPHYSIOLOGY, V49, P413, DOI 10.1111/j.1469-8986.2011.01312.x	61	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174100	10.1371/journal.pone.0174100	http://dx.doi.org/10.1371/journal.pone.0174100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346515	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300023
J	Gandica, Y; Carvalho, J; dos Aidos, FS; Lambiotte, R; Carletti, T				Gandica, Yerali; Carvalho, Joao; dos Aidos, Fernando Sampaio; Lambiotte, Renaud; Carletti, Timoteo			Stationarity of the inter-event power-law distributions	PLOS ONE			English	Article							HEAVY TAILS; BURSTS	A number of human activities exhibit a bursty pattern, namely periods of very high activity that are followed by rest periods. Records of these processes generate time series of events whose inter-event times follow a probability distribution that displays a fat tail. The grounds for such phenomenon are not yet clearly understood. In the present work we use the freely available Wikipedia's editing records to unravel some features of this phenomenon. We show that even though the probability to start editing is conditioned by the circadian 24 hour cycle, the conditional probability for the time interval between successive edits at a given time of the day is independent from the latter. We confirm our findings with the activity of posting on the social network Twitter. Our results suggest that there is an intrinsic humankind scheduling pattern: after overcoming the encumbrance of starting an activity, there is a robust distribution of new related actions, which does not depend on the time of day at which the activity started.	[Gandica, Yerali; Lambiotte, Renaud; Carletti, Timoteo] Univ Namur, Dept Math, Namur, Belgium; [Gandica, Yerali; Lambiotte, Renaud; Carletti, Timoteo] Univ Namur, Namur Ctr Complex Syst NaXys, Namur, Belgium; [Carvalho, Joao; dos Aidos, Fernando Sampaio] Univ Coimbra CFisUC, Dept Phys, Ctr Phys, Coimbra, Portugal	University of Namur; University of Namur; Universidade de Coimbra	Gandica, Y (corresponding author), Univ Namur, Dept Math, Namur, Belgium.; Gandica, Y (corresponding author), Univ Namur, Namur Ctr Complex Syst NaXys, Namur, Belgium.	ygandica@gmail.com	Carletti, Timoteo/M-4373-2019; Carvalho, Joao/M-4060-2013; Lambiotte, Renaud/HDO-4530-2022; GANDICA, YERALI/M-6261-2013	Carvalho, Joao/0000-0002-3015-7821; Lambiotte, Renaud/0000-0002-0583-4595; GANDICA, YERALI/0000-0002-6262-1801	Interuniversity Attraction Poles Programme; Belgian State, Science Policy Office; FCT Portugal [UID/FIS/04564/2016]	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State, Science Policy Office(Belgian Federal Science Policy Office); FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	The work of Y.G., T.C. and R. L. presents research results of the Belgian Network DYSCO (Dynamical Systems, Control, and Optimisation), funded by the Interuniversity Attraction Poles Programme, initiated by the Belgian State, Science Policy Office. The work of J.C and F.S was financially supported by FCT Portugal with reference UID/FIS/04564/2016.	Anteneodo C, 2010, EUR PHYS J B, V75, P389, DOI 10.1140/epjb/e2010-00139-9; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Brun R, 1997, NUCL INSTRUM METH A, V389, P81, DOI 10.1016/S0168-9002(97)00048-X; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Gandica Y, 2016, CIRCADIAN PATTERNS W; Gandica Y, 2016, P 10 INT AAAI C WEB; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Hang-Hyun J, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Harada J, 2012, 2589568 RHS SMITH SC; Hidalgo CA, 2006, PHYSICA A, V369, P877, DOI 10.1016/j.physa.2005.12.035; Kobayashi R, 2016, P 10 INT AAAI C WEB, P91; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Yasseri T, 2013, J STAT PHYS, V151, P414, DOI 10.1007/s10955-013-0728-6; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]	19	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174509	10.1371/journal.pone.0174509	http://dx.doi.org/10.1371/journal.pone.0174509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346480	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300052
J	Jin, X; Liu, J; Chen, YP; Xiang, Z; Ding, JX; Li, YM				Jin, Xi; Liu, Jiang; Chen, Yi-peng; Xiang, Zun; Ding, Jie-xia; Li, You-ming			Effect of miR-146 targeted HDMCP up regulation in the pathogenesis of nonalcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; UNCOUPLING PROTEIN-2; MICRORNA EXPRESSION; NATURAL-HISTORY; PROTON LEAK; MITOCHONDRIAL; CELLS; NASH; CANCER; MICE	Backgrounds/Aims Mitochondrial dysfunction plays an important role inthe pathogenesis of nonalcoholic steatohepatitis (NASH), where uncoupling protein (UCP) is actively involved. We previously reported the uncoupling activity of HDMCP and its role in liver steatosis. We now aim to investigate the degree and therapeutic effect of HDMCP in NASH and the regulatory role of miR-146 on HDMCP. Methods NASH animal model was established by feeding BALB/c mice with MCD diet while L02 cell was cultured with high concentration of fatty acid (HFFA) for 72h to mimic the steatosis and inflammation of NASH in -vitro appearance. The steatosis level was assessed by H-E/oil-red staining and serum/supernatant marker detection. The inflammation activity was evaluated by levels of Hepatic activity index, transwell, apoptosis degree (TUNEL/flow cytometry) and serum/supernatant marker. HDMCP level was detected by western blot and miRNA expression was tested by qRT-PCR. NASH severity change was recorded after RNA interference while the regulatory role of miR-146 on HDMCP was confirmed by dual luciferase report system. The H202 and ATP levels were measured for mechanism exploration. Results Increased HDMCP expression was identified in NASH animal model and HFFA-72h cultured L02 cell. Moreover, under regulation of miR-146, NASH alleviation was achieved after HDMCP downregulation in both in vivo and in vitro, according to the declination of steatosis and inflammation related markers. Though H202 and ATP levels were increased and decreased in NASH models, HDMCP down regulation both increased their levels. Conclusions The miR-146-HDMCP-ATP/H202 pathway may provide novel mechanism and treatment option for NASH.	[Jin, Xi; Chen, Yi-peng; Xiang, Zun; Li, You-ming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Liu, Jiang] Huzhou Cent Hosp, Dept Gastroenterol, Huzhou, Peoples R China; [Ding, Jie-xia] Hangzhou First Peoples Hosp, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Huzhou University	Jin, X (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	jxfl007@zju.edu.cn		Ma, Han/0000-0001-9985-3035	National Natural Science Foundation of China [81370008, 81000169]; Natural Science Foundation of Zhejiang province [R2110159, LY15H030006, LY16H030003]; Zhejiang Traditional Chinese Medicine Administration Bureau [2010ZA065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Zhejiang Traditional Chinese Medicine Administration Bureau	There is no conflict of interest of this manuscript and commercial financial support. This study is sponsored by the National Natural Science Foundation of China (81370008, 81000169), The Natural Science Foundation of Zhejiang province (R2110159, LY15H030006 and LY16H030003) and Project 2010ZA065 of The Zhejiang Traditional Chinese Medicine Administration Bureau. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baffy G, 2002, HEPATOLOGY, V35, P753, DOI 10.1053/jhep.2002.32028; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Blesson CS, 2012, MOL CELL ENDOCRINOL, V361, P179, DOI 10.1016/j.mce.2012.04.006; BRADY LJ, 1985, BIOCHEM J, V231, P439, DOI 10.1042/bj2310439; BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Hui JM, 2003, HEPATOLOGY, V38, P420, DOI 10.1053/jhep.2003.50320; Hur W, 2015, INT J BIOCHEM CELL B, V64, P265, DOI 10.1016/j.biocel.2015.04.016; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Jin X, 2009, DIGEST LIVER DIS, V41, P289, DOI 10.1016/j.dld.2008.08.008; Jin X, 2013, CHINESE MED J-PEKING, V126, P3151, DOI 10.3760/cma.j.issn.0366-6999.20130940; Jin X, 2009, J HEPATOL, V50, P1019, DOI 10.1016/j.jhep.2008.10.034; Kang Min, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1062; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Le TH, 2004, HEPATOLOGY, V39, P1423, DOI 10.1002/hep.20202; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Liu RH, 2015, CANCER RES, V75, P1703, DOI 10.1158/0008-5472.CAN-14-2108; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Negri M, 2010, BRIT J BIOMED SCI, V67, P120, DOI 10.1080/09674845.2010.11730308; Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198; Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan MGK, 2004, J BIOL CHEM, V279, P45235, DOI 10.1074/jbc.M403683200; Tanaka N, 2014, BBA-MOL CELL BIOL L, V1841, P1596, DOI 10.1016/j.bbalip.2014.08.015; Vincent Robert, 2014, Curr Pathobiol Rep, V2, P109; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Zhang BG, 2014, MOL MED REP, V10, P3080, DOI 10.3892/mmr.2014.2592; Zhang YF, 2014, BIOCHEM BIOPH RES CO, V446, P940, DOI 10.1016/j.bbrc.2014.03.037	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174218	10.1371/journal.pone.0174218	http://dx.doi.org/10.1371/journal.pone.0174218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346483	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300030
J	Kim, SK; Bae, JC; Baek, JH; Jee, JH; Hur, KY; Lee, MK; Kim, JH				Kim, Soo Kyoung; Bae, Ji Cheol; Baek, Jong-Ha; Jee, Jae Hwan; Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon			Decline in lung function rather than baseline lung function is associated with the development of metabolic syndrome: A six-year longitudinal study	PLOS ONE			English	Article							INSULIN-RESISTANCE; PULMONARY-FUNCTION; CARDIOVASCULAR RISK; OBESITY; INFLAMMATION; HEALTH; HEART; DISEASE; COHORT; ADULTS	This study was conducted to investigate whether baseline lung function or change in lung function is associated with the development of metabolic syndrome (MS) in Koreans. We analyzed clinical and laboratory data from 3,768 Koreans aged 40-60 years who underwent medical check-ups over a six-year period between 2006 and 2012. We calculated the percent change in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) over the study period. We tested for an association between baseline lung function or lung function change during the follow-up period and the development of MS. The 533 subjects (14.1%) developed MS after the six-year follow-up. The baseline FVC and FEV1 were not different between the subjects who developed MS after six years and the subject without MS after six years. The percent change in FVC over six years in subjects who developed MS after six years was higher than that in subjects who did not develop MS (-5.75 [-10.19 -1.17],-3.29 [-7.69-1.09], respectively, P = 0.001). The percent change in FVC over six years was associated with MS development after adjusting for age, sex, body mass index (BMI), glucose, HDL, triglyceride, waist circumferences (WC), and systolic blood pressure. However, these association was not significant after adjusting for change of BMI and change of WC over six years (P = 0.306). The greater change in vital capacity over six years of follow-up was associated with MS development, predominantly due to obesity and abdominal obesity. The prospective study is needed to determine the relationship between lung function decline and MS.	[Kim, Soo Kyoung; Baek, Jong-Ha] Gyeongsang Natl Univ, Sch Med, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea; [Kim, Soo Kyoung] Gyeongsang Natl Univ, Sch Med, Gyeongsang Natl Univ Hosp, Inst Hlth Sci, Jinju, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Chang Won, South Korea; [Jee, Jae Hwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth Promot Ctr, Seoul, South Korea; [Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.	jaehyeon@skku.edu						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bolton C E, 2007, COPD, V4, P121, DOI 10.1080/15412550701341053; Cuttica MJ, 2015, AM J RESP CRIT CARE, V192, P76, DOI 10.1164/rccm.201501-0116OC; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Engstrom G, 2001, J HYPERTENS, V19, P1203, DOI 10.1097/00004872-200107000-00004; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kim Soo Kyoung, 2010, Korean Diabetes J, V34, P253, DOI 10.4093/kdj.2010.34.4.253; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Koo HK, 2013, INT J TUBERC LUNG D, V17, P1507, DOI 10.5588/ijtld.12.0906; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lim SY, 2010, J KOREAN MED SCI, V25, P1480, DOI 10.3346/jkms.2010.25.10.1480; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Shore SA, 1985, J APPL PHYSIOL, V2010, P108; Yeh F, 2011, DIABETES CARE, V34, P2306, DOI 10.2337/dc11-0682; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174228	10.1371/journal.pone.0174228	http://dx.doi.org/10.1371/journal.pone.0174228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346522	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300032
J	Hyrina, A; Meng, FR; McArthur, SJ; Eivemark, S; Nabi, IR; Jean, F				Hyrina, Anastasia; Meng, Fanrui; McArthur, Steven J.; Eivemark, Sharlene; Nabi, Ivan R.; Jean, Francois			Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents	PLOS ONE			English	Article							SITE-1 PROTEASE; CHOLESTEROL; ACID; BINDING; CELLS; INHIBITION; EXPRESSION; PATHWAY; REPLICATION; INFECTION	Viral hijacking and manipulation of host-cell biosynthetic pathways by human enveloped viruses are shared molecular events essential for the viral lifecycle. For Flaviviridae members such as hepatitis C virus and dengue virus (DENV), one of the key subsets of cellular pathways that undergo manipulation is the lipid metabolic pathways, underlining the importance of cellular lipids and, in particular, lipid droplets (LDs) in viral infection. Here, we hypothesize that targeting cellular enzymes that act as key regulators of lipid homeostasis and LD formation could represent a powerful approach to developing a novel class of broadspectrum antivirals against infection associated with all DENV serotypes (1-4) circulating around the world. Using PF-429242, an active-site-directed inhibitor of SKI-1/S1P, we demonstrate that inhibition of SKI-1/S1P enzymatic activity in human hepatoma Huh-7.5.1 cells results in a robust reduction of the LD numbers and LD-positive areas and provides a means of effectively inhibiting infection by DENV (1-4). Pre-treatment of Huh-7.5.1 cells with PF-429242 results in a dose-dependent inhibition of DENV infection [median inhibitory dose (EC50) = 1.2 microM; median cytotoxic dose (CC50) = 81 microM; selectivity index (SI) = 68)] and a similar to 3-log decrease in DENV-2 titer with 20 microM of PF-429242. Post-treatment of DENV-2 infected Huh-7.5.1 cells with PF-429242 does not affect viral RNA abundance, but it does compromise the assembly and/or release of infectious virus particles. PF-429242 antiviral activity is reversed by exogenous oleic acid, which acts as an inducer of LD formation in PF-429242-treated and non-treated control cells. Collectively, our results demonstrate that human SKI-1/S1P is a potential target for indirect-acting pan-serotypic anti-DENV agents and reveal new therapeutic opportunities associated with the use of lipid-modulating drugs for controlling DENV infection.	[Hyrina, Anastasia; McArthur, Steven J.; Eivemark, Sharlene; Jean, Francois] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Meng, Fanrui; Nabi, Ivan R.] Univ British Columbia, Inst Life Sci, Dept Cell & Physiol Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Jean, F (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC, Canada.	fjean@mail.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513; Hyrina, Anastasia/0000-0003-0412-6404; Holloway, Courtney Jean/0000-0003-3661-1957	Canadian Institutes of Health Research (CHIR) grant [MOP-84462]; British Columbia Proteomics Network - Michael Smith Foundation for Health Research (MSFHR)/small Projects Health Research Grant [22R18661]; Canadian Network on Hepatitis C (CanHepC) scholarship	Canadian Institutes of Health Research (CHIR) grant; British Columbia Proteomics Network - Michael Smith Foundation for Health Research (MSFHR)/small Projects Health Research Grant; Canadian Network on Hepatitis C (CanHepC) scholarship	This work was supported by a Canadian Institutes of Health Research (CHIR) grant (MOP-84462) and a British Columbia Proteomics Network - Michael Smith Foundation for Health Research (MSFHR)/small Projects Health Research Grant (22R18661) (to F.Jean). A. Hyrina acknowledge generous support from a Canadian Network on Hepatitis C (CanHepC) scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanchet M, 2012, ANTIVIR RES, V95, P159, DOI 10.1016/j.antiviral.2012.05.006; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005; Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1974, AM J TROP MED HYG, V23, P974, DOI 10.4269/ajtmh.1974.23.974; Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hay BA, 2007, BIOORG MED CHEM LETT, V17, P4411, DOI 10.1016/j.bmcl.2007.06.031; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Klunder S, 2015, J LIPID RES, V56, P1625, DOI 10.1194/jlr.M060756; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Loveday EK, 2015, J GEN VIROL, V96, P30, DOI 10.1099/vir.0.068585-0; Mangold KA, 2013, PEDIATR EMERG CARE, V29, P665, DOI 10.1097/PEC.0b013e31828ed30e; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; Medina F, 2012, CURR PROTOC MICROBIO; Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rohwedder A, 2014, J CELL SCI, V127, P3104, DOI 10.1242/jcs.145854; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002; Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Uchida L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020046; Urata S, 2011, J VIROL, V85, P795, DOI 10.1128/JVI.02019-10; WHO, 2015, FACT SHEET N 117; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	62	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174483	10.1371/journal.pone.0174483	http://dx.doi.org/10.1371/journal.pone.0174483			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339489	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700032
J	Koppensteiner, M; Primes, G; Stephan, P				Koppensteiner, Markus; Primes, Georg; Stephan, Pia			Create your own stimulus: Manipulating movements according to social categories	PLOS ONE			English	Article							BIOLOGICAL MOTION; POINT-LIGHT; PERCEPTION; EMOTION; JUDGMENTS; DOMINANCE; CUES; COMMUNICATION; COMPETENCE; PREDICTORS	People ascribe purposeful behaviour to the movements of artificial objects and social qualities to human body motion. We investigated how people associate simple motion cues with social categories. For a first rating-experiment we converted the body movements of speakers into stick-figure animations; for a second rating-experiment we used animations of one single dot. Rating-experiments were "reversed" because we asked participants to alter the movements (i.e., vertical amplitude, horizontal amplitude, and velocity) of the stimuli according to different instructions (e.g., create a stimulus of high dominance). Participants equipped stick figures and dot animations with expansive movements to represent high dominance. Expansive and fast movements (i.e., high velocity) were mainly associated with high aggressiveness. Fast movements were also associated with low friendliness, low trustworthiness, and low competence. Overall, patterns found for stick figure and dot animations were similar indicating that certain motion cues convey social information even when only a dot and no body form is visible. The "reverse approach" we propose here makes the impact of different components directly observable. The data generated by this method offers better insights into the interplay of these components and the ways in which they form meaningful patterns. The proposed method can be extended to other types of nonverbal cues and a variety of social categories.	[Koppensteiner, Markus; Primes, Georg; Stephan, Pia] Univ Vienna, Dept Anthropol, Vienna, Austria; [Koppensteiner, Markus] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Adv Study NIAS, Amsterdam, Netherlands	University of Vienna	Koppensteiner, M (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.; Koppensteiner, M (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Adv Study NIAS, Amsterdam, Netherlands.	markus-koppensteiner@gmx.net		Koppensteiner, Markus/0000-0003-4653-908X	Austrian Science Fund (FWF) [P 25262-G16]; EURIAS Fellowship programme; European Commission (Marie-Sklodowska-Curie Actions - COFUND Programme - FP7)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EURIAS Fellowship programme; European Commission (Marie-Sklodowska-Curie Actions - COFUND Programme - FP7)	The work was funded by the Austrian Science Fund (FWF; grant number P 25262-G16), www.fwf.ac.at. Large parts of manuscript preparation, manuscript revision, and data analyses were done during a research stay at the Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS/KNAW), www.nias.knaw.nl. This research stay was funded by the EURIAS Fellowship programme and by the European Commission (Marie-Sklodowska-Curie Actions - COFUND Programme - FP7).	Ambady N, 2010, NONVERBAL BEHAV; ANDERSSON M, 1980, J THEOR BIOL, V86, P773, DOI 10.1016/0022-5193(80)90310-0; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Barrett HC, 2005, EVOL HUM BEHAV, V26, P313, DOI 10.1016/j.evolhumbehav.2004.08.015; Batrinca L, 2013, CICERO MULTIMODAL VI, P116; Bechinie M, 2003, LECT NOTES ARTIF INT, V2792, P212; Bernhardt PC, 1997, CURR DIR PSYCHOL SCI, V6, P44, DOI 10.1111/1467-8721.ep11512620; Buss DM, 1999, J PERS, V67, P209, DOI 10.1111/1467-6494.00053; Carney DR, 2005, J NONVERBAL BEHAV, V29, P105, DOI 10.1007/s10919-005-2743-z; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Dael N, 2012, EMOTION, V12, P1085, DOI 10.1037/a0025737; Dahl S, 2003, LECT NOTES ARTIF INT, V2915, P479; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Waal F., 2007, CHIMPANZEE POLITICS; Eisenberg P, 1939, J SOC PSYCHOL, V10, P345, DOI 10.1080/00224545.1939.9713373; Fink B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00220; Fiske ST, 1999, J SOC ISSUES, V55, P473, DOI 10.1111/0022-4537.00128; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hicheur H., 2013, MODELING SIMULATION, P71, DOI [DOI 10.1007/978-3-642-36368-9_, 10.1007/978-3-642-36368-9_6, DOI 10.1007/978-3-642-36368-9_6]; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kiiski H, 2015, ACM T APPL PERCEPT, V13, DOI 10.1145/2791293; Koppensteiner M, 2016, PERS INDIV DIFFER, V94, P101, DOI 10.1016/j.paid.2016.01.013; Koppensteiner M, 2015, J RES PERS, V58, P21, DOI 10.1016/j.jrp.2015.05.006; Koppensteiner M, 2015, PERS INDIV DIFFER, V74, P182, DOI 10.1016/j.paid.2014.10.019; Koppensteiner M, 2013, J EXP SOC PSYCHOL, V49, P1137, DOI 10.1016/j.jesp.2013.08.002; Koppensteiner M, 2011, J RES PERS, V45, P358, DOI 10.1016/j.jrp.2011.04.003; Koppensteiner M, 2010, J RES PERS, V44, P374, DOI 10.1016/j.jrp.2010.04.002; KOZLOWSKI LT, 1978, PERCEPT PSYCHOPHYS, V23, P459, DOI 10.3758/BF03204150; Kraha A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00044; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P625, DOI 10.1080/17470210903490977; Luck G, 2010, J RES PERS, V44, P714, DOI 10.1016/j.jrp.2010.10.001; Mehrabian A., 1972, NONVERBAL COMMUNICAT; Mehu M, 2014, J NONVERBAL BEHAV, V38, P569, DOI 10.1007/s10919-014-0192-2; MONTEPARE JM, 1993, J NONVERBAL BEHAV, V17, P55, DOI 10.1007/BF00987008; Oberzaucher Elizabeth, 2008, EMBODIED COMMUNICATI, P151; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; R Core Team, 2012, R LANG ENV STAT COMP; Roether CL, 2009, J VISION, V9, DOI 10.1167/9.6.15; Safonova A, 2005, P 2005 ACM SIGGRAPH, P171; Svare B. B., 1983, HORMONES AGGRESSIVE, P563; Tagiuri R., 1958, PERSON PERCEPTION IN; Thoresen JC, 2012, COGNITION, V124, P261, DOI 10.1016/j.cognition.2012.05.018; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Tonidandel S, 2010, ORGAN RES METHODS, V13, P767, DOI 10.1177/1094428109341993; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; Van Dyck E, 2013, J NONVERBAL BEHAV, V37, P175, DOI 10.1007/s10919-013-0153-1; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174422	10.1371/journal.pone.0174422	http://dx.doi.org/10.1371/journal.pone.0174422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9AZ	28339490	Green Published, gold			2022-12-27	WOS:000399116700030
J	Mo, HY; Liao, YY; You, XM; Cucchetti, A; Yuan, BH; Li, RH; Zhong, JH; Li, LQ				Mo, Han-Yue; Liao, Ying-Yang; You, Xue-Mei; Cucchetti, Alessandro; Yuan, Bao-Hong; Li, Ru-Hong; Zhong, Jian-Hong; Li, Le-Qun			Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy	PLOS ONE			English	Article							INDUCED KILLER-CELLS; ADJUVANT THERAPY; ANTIVIRAL THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC RESECTION; RECURRENCE RATES; LIVER RESECTION; SURVIVAL; CHEMOIMMUNOTHERAPY; IMMUNOSUPPRESSION	Aims The role of adoptive immunotherapy (AIT) for patients with hepatocellular carcinoma (HCC) who have received curative therapy is still not well illustrated. This timely meta-analysis aims to update the current evidence on efficacy and safety of AIT for patients with HCC who have received curative therapy. Methods We searched PubMed, EMBASE, Scopus and the Cochrane Library Through January 2017 for relevant studies. Mortality and tumor recurrence were compared between patients with or without adjuvant AIT. The meta-analysis was performed using Review Manager 5.3. Results Eight studies involving 1861 patients met the eligibility criteria and were meta-analyzed. Adjuvant AIT was associated with significantly lower mortality at 1 year (RR 0.64, 95% CI 0.52 +/- 0.79), 3 years (RR 0.73, 95% CI 0.65 +/- 0.81) and 5 years (RR 0.86, 95% CI 0.79 +/- 0.94). Similarly, adjuvant AIT was associated with significantly lower recurrence rate than curative therapies alone at 1 year (RR 0.64, 95% CI 0.49 +/- 0.82), 3 years (RR 0.85, 95% CI 0.79 +/- 0.91) and 5 years (RR 0.90, 95% CI 0.85 +/- 0.95). Short-term outcomes were confirmed in sensitivity analyses based on randomized trials or choice of random-or fixed-effect meta-analysis model. None of the included patients experienced grade 4 adverse events. Conclusions This timely meta-analysis confirms the evidence that adjuvant AIT for patients with HCC after curative treatment lowers risk of mortality and tumor recurrence.	[Mo, Han-Yue] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Chemotherapy, Nanning, Peoples R China; [Liao, Ying-Yang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Nutr, Nanning, Peoples R China; [You, Xue-Mei; Zhong, Jian-Hong; Li, Le-Qun] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China; [You, Xue-Mei; Zhong, Jian-Hong; Li, Le-Qun] Guangxi Liver Canc Diag & Treatment Engn & Techno, Nanning, Peoples R China; [Cucchetti, Alessandro] Univ Bologna, Alma Mater Studiorum, S Orsola Malpighi Hosp, Dept Med & Surg Sci, Bologna, Italy; [Yuan, Bao-Hong; Li, Ru-Hong] Kunming Med Univ, YanAn Hosp, Dept Gen Surg, Kunming, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Kunming Medical University	You, XM; Zhong, JH (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China.; You, XM; Zhong, JH (corresponding author), Guangxi Liver Canc Diag & Treatment Engn & Techno, Nanning, Peoples R China.	youxuemei1@126.com; zhongjianhong66@163.com	Li, Li/AEM-3636-2022; Yuan, Baohong/HGE-1166-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022; Zhong, Jian-Hong/D-6641-2018	Zhong, Jian-Hong/0000-0002-1494-6396	Guangxi University of Science and Technology Research Projects [KY2015LX056]; Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province [Z2016512, Z2015621, GZZC15-34, Z2014241]; Innovation Project of Guangxi Graduate Education [YCBZ2015030]; Guangxi Science and Technology Development Projects [14124003-4]; National Science and Technology Major Special Project [2012ZX10002010001009]; Traditional Chinese Medicine Science and Technology projects of the Ministry of Health of Guangxi Province [GZLC16-36]; Guangxi Medical Care Appropriate Technology Research and Development [S201417-03]	Guangxi University of Science and Technology Research Projects; Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province; Innovation Project of Guangxi Graduate Education; Guangxi Science and Technology Development Projects; National Science and Technology Major Special Project; Traditional Chinese Medicine Science and Technology projects of the Ministry of Health of Guangxi Province; Guangxi Medical Care Appropriate Technology Research and Development	This study was supported in part by the Guangxi University of Science and Technology Research Projects (KY2015LX056), the Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province (Z2016512, Z2015621, GZZC15-34, Z2014241), the Innovation Project of Guangxi Graduate Education (YCBZ2015030), Guangxi Science and Technology Development Projects (14124003-4), the National Science and Technology Major Special Project (2012ZX10002010001009), the Traditional Chinese Medicine Science and Technology projects of the Ministry of Health of Guangxi Province (GZLC16-36), and the Guangxi Medical Care Appropriate Technology Research and Development (S201417-03).	Chen CL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1176653; Chen JL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002665; Cheng JW, 2011, J CANCER RES CLIN, V137, P1445, DOI 10.1007/s00432-011-1014-0; Ding M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168798; Dong H, 2009, DIGEST LIVER DIS, V41, P36, DOI 10.1016/j.dld.2008.04.007; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Guo Weiwei, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P674; Guo Z, 2014, ANN SURG ONCOL, V21, P3069, DOI 10.1245/s10434-014-3704-8; Hao Ming-Zhi, 2010, Chin J Cancer, V29, P172; Harding JJ, 2016, CANCER-AM CANCER SOC, V122, P367, DOI 10.1002/cncr.29769; He XL, 2016, ONCOTARGET, V7, P22834, DOI 10.18632/oncotarget.8071; Huang G, 2015, ANN SURG, V261, P56, DOI 10.1097/SLA.0000000000000858; Huang ZM, 2013, J IMMUNOTHER, V36, P287, DOI 10.1097/CJI.0b013e3182948452; KAWATA A, 1995, AM J CLIN ONCOL-CANC, V18, P257, DOI 10.1097/00000421-199506000-00014; Ke Yang, 2013, Cancer Biology Medicine, V10, P158, DOI 10.7497/j.issn.2095-3941.2013.03.006; Lee DH, 2017, CANCER BIOL THER, V18, P67, DOI 10.1080/15384047.2016.1276132; Lee JH, 2015, GASTROENTEROLOGY, V148, P1383, DOI 10.1053/j.gastro.2015.02.055; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim KC, 2012, BRIT J SURG, V99, P1622, DOI 10.1002/bjs.8915; Mathurin P, 2003, ALIMENT PHARM THER, V17, P1247, DOI 10.1046/j.1365-2036.2003.01580.x; Miao RY, 2010, WORLD J GASTROENTERO, V16, P2931, DOI 10.3748/wjg.v16.i23.2931; Morse MA, 2002, EXPERT OPIN BIOL TH, V2, P237, DOI 10.1517/14712598.2.3.237; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pan Chang-Chuan, 2010, Chin J Cancer, V29, P596; Pan K, 2013, ANN SURG ONCOL, V20, P4305, DOI 10.1245/s10434-013-3144-x; Pan QZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09202; Peng BG, 2006, HEPATO-GASTROENTEROL, V53, P409; Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173; Samuel M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001199.pub2; Sasaki K, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2016.5059; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tagliamonte M, 2016, CURR OPIN IMMUNOL, V39, P103, DOI 10.1016/j.coi.2016.01.005; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Takayama T, 2002, HEPATO-GASTROENTEROL, V49, P87; UCHINO J, 1993, SEMIN SURG ONCOL, V9, P332, DOI 10.1002/ssu.2980090410; Wells G, NEWCASTLEE OTTAWA SC; Weng DS, 2008, J IMMUNOTHER, V31, P63, DOI 10.1097/CJI.0b013e31815a121b; Xie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042879; Xie L, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P142; Xie ZB, 2015, J SURG ONCOL, V112, P634, DOI 10.1002/jso.24044; Xu L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1083671; Yu XZ, 2014, J CLIN IMMUNOL, V34, P194, DOI 10.1007/s10875-013-9976-0; Yuan BH, 2017, HARMS BENEFITS ADOPT; Zhong JH, 2012, EJSO-EUR J SURG ONC, V38, P286, DOI 10.1016/j.ejso.2012.01.006; Zhong JH, 2012, INT J CLIN PRACT, V66, P21, DOI 10.1111/j.1742-1241.2011.02814.x; Zhong JH, 2017, TUMOR STAGE PRIMARY; Zhong JH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000396; Zhong JH, 2014, SCAND J GASTROENTERO, V49, P649, DOI 10.3109/00365521.2014.905626; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058082; Zhong JH, 2010, HEPATOL RES, V40, P943, DOI 10.1111/j.1872-034X.2010.00710.x; Zhou Qi-Ming, 2006, Ai Zheng, V25, P1414; Zhou W, 1995, Zhonghua Wai Ke Za Zhi, V33, P35; Zhu GQ, 2015, ONCOTARGET, V6, P18151, DOI 10.18632/oncotarget.4098	55	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174222	10.1371/journal.pone.0174222	http://dx.doi.org/10.1371/journal.pone.0174222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339493	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700023
J	Trouve, P; Genin, E; Ferec, C				Trouve, Pascal; Genin, Emmanuelle; Ferec, Claude			In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN GENOME EPIDEMIOLOGY; OBSTRUCTIVE PULMONARY-DISEASE; UBIQUITIN-PROTEASOME PATHWAY; AIRWAY EPITHELIAL-CELLS; NCBI GEO ARCHIVE; NONALCOHOLIC STEATOHEPATITIS; NEUTROPHIL ELASTASE; DELTA-F508 MUTATION; NASAL EPITHELIUM	Cystic Fibrosis is the most common lethal autosomal recessive disorder in the white population, affecting among other organs, the lung, the pancreas and the liver. Whereas Cystic Fibrosis is a monogenic disease, many studies reveal a very complex relationship between genotype and clinical phenotype. Indeed, the broad phenotypic spectrum observed in Cystic Fibrosis is far from being explained by obvious genotype-phenotype correlations and it is admitted that Cystic Fibrosis disease is the result of multiple factors, including effects of the environment as well as modifier genes. Our objective was to highlight new modifier genes with potential implications in the lung, pancreatic and liver outcomes of the disease. For this purpose we performed a system biology approach which combined, database mining, literature mining, gene expression study and network analysis as well as pathway enrichment analysis and protein-protein interactions. We found that IFI16, CCNE2 and IGFBP2 are potential modifiers in the altered lung function in Cystic Fibrosis. We also found that EPHX1, HLA-DQA1, HLA-DQB1, DSP and SLC33A1, GPNMB, NCF2, RASGRP1, LGALS3 and PTPN13, are potential modifiers in pancreas and liver, respectively. Associated pathways indicate that immune system is likely involved and that Ubiquitin C is probably a central node, linking Cystic Fibrosis to liver and pancreatic disease. We highlight here new modifier genes with potential implications in Cystic Fibrosis. Nevertheless, our in silico analysis requires functional analysis to give our results a physiological relevance.	[Trouve, Pascal; Genin, Emmanuelle; Ferec, Claude] INSERM, UMR1078, Brest, France; [Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Ferec, Claude] CHU Brest, Hop Morvan, Lab Genet Mol, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale	Trouve, P (corresponding author), INSERM, UMR1078, Brest, France.	pascal.trouve@univ-brest.fr	Ferec, Claude/ABG-9699-2020; Genin, Emmanuelle/C-4974-2013	Ferec, Claude/0000-0002-2325-0710; Genin, Emmanuelle/0000-0003-4117-2813	Inserm and Universite de Bretagne Occidentale; Inserm; Universite de Bretagne Occidentale (UBO)	Inserm and Universite de Bretagne Occidentale; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Bretagne Occidentale (UBO)	The study was funded by internal funds from our organizations: Inserm and Universite de Bretagne Occidentale. PT and EG received a salary from Inserm and CF received a salary from Universite de Bretagne Occidentale (UBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Akata D, 2007, EUR J RADIOL, V61, P11, DOI 10.1016/j.ejrad.2006.11.008; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Aron Y, 1999, AM J RESP CRIT CARE, V159, P1464, DOI 10.1164/ajrccm.159.5.9807046; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Ben-Farhat K, 2016, J CLIN IMMUNOL; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Bombieri C, 2015, SEMIN RESP CRIT CARE, V36, P180, DOI 10.1055/s-0035-1547318; Bradbury NA, 1999, PHYSL REV S, V79, P175, DOI DOI 10.1152/physrev.1999.79.1.S175; BREZILLON S, 1995, LAB INVEST, V72, P191; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Croft David, 2013, Methods Mol Biol, V1021, P273, DOI 10.1007/978-1-62703-450-0_14; Cui J, 2014, HUM VACC IMMUNOTHER, V10, P3270, DOI 10.4161/21645515.2014.979640; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Edelman A, 2014, INT J BIOCHEM CELL B, V52, P68, DOI 10.1016/j.biocel.2014.03.018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Ferrari M, 1996, ANN BIOL CLIN-PARIS, V54, P235; Fischer BM, 2007, AM J PHYSIOL-LUNG C, V293, pL762, DOI 10.1152/ajplung.00067.2007; Flass T, 2013, J CYST FIBROS, V12, P116, DOI 10.1016/j.jcf.2012.11.010; Fluge G, 2009, J CYST FIBROS, V8, P198, DOI 10.1016/j.jcf.2009.02.002; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hampton TH, 2010, AM J PHYSIOL-LUNG C, V298, pL473, DOI 10.1152/ajplung.00379.2009; Haws CM, 1996, AM J PHYSL, V270; Henderson MJ, 2010, J BIOL CHEM, V285, P11314, DOI 10.1074/jbc.M109.044057; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; Hubert D, 1996, EUR RESPIR J, V9, P2207, DOI 10.1183/09031936.96.09112207; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karlas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042139; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kelly T, 2015, DIGEST DIS SCI, V60, P1903, DOI 10.1007/s10620-015-3546-7; Kerbirou M, 2007, BBA MOL BASIS DISEAS, V1772; Kerem B, 1996, EUR J HUM GENET, V4, P65; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kobelska-Dubiel N, 2014, PRZ GASTROENTEROL, V9, P136, DOI 10.5114/pg.2014.43574; Korytina G. F., 2003, Molekulyarnaya Biologiya (Moscow), V37, P784; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Laguna TA, 2010, DIABETES OBES METAB, V12, P858, DOI 10.1111/j.1463-1326.2010.01250.x; Lake AD, 2011, DRUG METAB DISPOS, V39, P1954, DOI 10.1124/dmd.111.040592; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lee SH, 2009, J IMMUNOL, V183, P7931, DOI 10.4049/jimmunol.0902012; Li H, 2013, ONCOL LETT, V5, P1022, DOI 10.3892/ol.2012.1099; Lipner EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146585; Loffek S, 2012, EXP DERMATOL, V21, P791, DOI 10.1111/j.1600-0625.2012.01564.x; Losa D, 2015, CELL MOL LIFE SCI, V72, P2793, DOI 10.1007/s00018-015-1960-9; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mekus F, 2003, HUM GENET, V112, P1, DOI 10.1007/s00439-002-0839-7; Mekus F, 2000, Twin Res, V3, P277, DOI 10.1375/twin.3.4.277; Michael RK, 2012, COLD SPRING HARB PER, V2; Mondini M, 2010, AUTOIMMUNITY, V43, P226, DOI 10.3109/08916930903510922; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Nakata S, 2013, IMMUNOL LETT, V156, P149, DOI 10.1016/j.imlet.2013.10.004; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Norez C, 2014, BRIT J PHARMACOL, V171, P4831, DOI 10.1111/bph.12859; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V174, P997, DOI 10.1164/rccm.200605-721OC; Payton M, 2002, INT J BIOCHEM CELL B, V34, P315, DOI 10.1016/S1357-2725(01)00137-6; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Peluso MEM, 2013, ENVIRON MOL MUTAGEN, V54, P375, DOI 10.1002/em.21788; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Slavotinek A, 2003, HUM MOL GENET, V12, pR45, DOI 10.1093/hmg/ddg099; Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290; Street ME, 2006, EUR J ENDOCRINOL, V154, P47, DOI 10.1530/eje.1.02064; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Trzcinska-Daneluti AM, 2009, MOL CELL PROTEOMICS, V8, P780, DOI 10.1074/mcp.M800268-MCP200; Tsui KH, 2012, PROSTATE, V72, P1431, DOI 10.1002/pros.22494; Tsui LC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009472; Vaclavikova R, 2015, GENE, V571, P1, DOI 10.1016/j.gene.2015.07.071; Valentine CD, 2012, J BIOL CHEM, V287, P43630, DOI 10.1074/jbc.M112.421172; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vibhuti A, 2007, BIOCHEM BIOPH RES CO, V359, P136, DOI 10.1016/j.bbrc.2007.05.076; Virella-Lowell I, 2004, MOL THER, V10, P562, DOI 10.1016/j.ymthe.2004.06.215; Walkowiak J, 2010, ACTA BIOCHIM POL, V57, P115; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC; Yesupriya A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-31; Younossi ZM, 2005, HEPATOLOGY, V42, P665, DOI 10.1002/hep.20838; Younossi ZM, 2005, LIVER INT, V25, P760, DOI 10.1111/j.1478-3231.2005.01117.x; Yu W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-436; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005; Zubillaga P, 2002, J PEDIATR GASTR NUTR, V34, P548, DOI 10.1097/00005176-200205000-00014	106	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173822	10.1371/journal.pone.0173822	http://dx.doi.org/10.1371/journal.pone.0173822			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339466	Green Submitted, Green Published, gold			2022-12-27	WOS:000399116700013
J	Bayer, CR; Smith, LL; Darko, RV; McKool, M; Yan, FX; Heiman, H				Bayer, Carey Roth; Smith, L. Lerissa; Darko, Renee Volny; McKool, Marissa; Yan, Fengxia; Heiman, Harry			Understanding health policy leaders' training needs	PLOS ONE			English	Article							EDUCATION	Purpose We assessed the training needs of health policy leaders and practitioners across career stages; identified areas of core content for health policy training programs; and, identified training modalities for health policy leaders. Methods We convened a focus group of health policy leaders at varying career stages to inform the development of the Health Policy Leaders' Training Needs Assessment tool. We piloted and distributed the tool electronically. We used descriptive statistics and thematic coding for analysis. Results Seventy participants varying in age and stage of career completed the tool. "Cost implications of health policies" ranked highest for personal knowledge development and "intersection of policy and politics" ranked highest for health policy leaders in general. "Effective communication skills" ranked as the highest skill element and "integrity" as the highest attribute element. Format for training varied based on age and career stage. Conclusions This study highlighted the training needs of health policy leaders personally as well as their perceptions of the needs for training health policy leaders in general. The findings are applicable for current health policy leadership training programs as well as those in development.	[Bayer, Carey Roth; Smith, L. Lerissa; Darko, Renee Volny; McKool, Marissa; Heiman, Harry] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Bayer, Carey Roth; Yan, Fengxia] Morehouse Sch Med, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA; [Bayer, Carey Roth] Morehouse Sch Med, Dept Med Educ, Atlanta, GA 30310 USA; [Heiman, Harry] Morehouse Sch Med, Dept Family Med, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine	Bayer, CR (corresponding author), Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA.; Bayer, CR (corresponding author), Morehouse Sch Med, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA.; Bayer, CR (corresponding author), Morehouse Sch Med, Dept Med Educ, Atlanta, GA 30310 USA.	cbayer@msm.edu		Bayer, Carey/0000-0002-1691-2712	National Institute on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH) [U54MD008173]; National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project described is supported by the National Institute on Minority Health and Health Disparities (NIMHD) Grant Number U54MD008173, a component of the National Institutes of Health (NIH) and its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMHD or NIH.	Allan J, 2004, AM J PREV MED, V27, P471, DOI 10.1016/j.amepre.2004.08.010; American Association of Colleges of Nursing, ESS SER; Clancy T E, 1995, JAMA, V274, P1084, DOI 10.1001/jama.274.13.1084; Cohen SS, 2001, ADV NURS SCI, V23, P28, DOI 10.1097/00012272-200103000-00004; Diers D, 1985, Nurs Health Care, V6, P421; Diers D., 1985, HLTH POLICY NURSING, V6, p[421, 433]; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Heiman HJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010020; McFarlane D R, 1992, J Public Health Policy, V13, P428, DOI 10.2307/3342532; Mou D, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1101603; Patel MS, 2011, NEW ENGL J MED, V364, P695, DOI 10.1056/NEJMp1009202; Who Will Keep the Public Healthy, ED PUB HLTH PROF 21	12	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174054	10.1371/journal.pone.0174054	http://dx.doi.org/10.1371/journal.pone.0174054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333982	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200041
J	Jin, X; Mi, WD				Jin, Xin; Mi, Weidong			Adenosine for postoperative analgesia: A systematic review and meta-analysis	PLOS ONE			English	Review							INTRATHECAL ADENOSINE; INTRAVENOUS ADENOSINE; MEDIATED CARDIOPROTECTION; FLOW RESERVE; DOUBLE-BLIND; INFUSION; PAIN; ANTINOCICEPTION; REMIFENTANIL; TOLERANCE	Purpose Perioperative infusion of adenosine has been suggested to reduce the requirement for inhalation anesthetics, without causing serious adverse effects in humans. We conducted a meta-analysis of randomized controlled trials evaluating the effect of adenosine on postoperative analgesia. Methods We retrieved articles in computerized searches of Scopus, Web of Science, PubMed, EMBASE, and Cochrane Library databases, up to July 2016. We used adenosine, postoperative analgesia, and postoperative pain(s) as key words, with humans, RCT, and CCT as filters. Data of eligible studies were extracted, which included pain scores, cumulative opioid consumption, adverse reactions, and vital signs. Overall incidence rates, relative risk (RR), and 95% confidence intervals (CI) were calculated employing fixed-effects or random-effects models, depending on the heterogeneity of the included trials. Results In total, 757 patients from 9 studies were included. The overall effect of adenosine on postoperative VAS/VRS scores and postoperative opioid consumption was not significantly different from that of controls (P >0.1). The occurrence of PONV and pruritus was not statistically significantly different between an adenosine and nonremifentanil subgroup (P >0.1), but the rate of PONV occurrence was greater in the remifentanil subgroup (P <0.01). Time to first postoperative analgesic requirement in the adenosine group was not significantly difference from that of the saline group (SMD = 0.07, 95%CI: -0.28 to 0.41, P = 0.71); but this occurred significantly later than with remifentanil (SMD = 1.10, 95%CI: 2.48 to 4.06, P <0.01). Time to hospital discharge was not significantly different between the control and adenosine groups (P = 0.78). The perioperative systolic blood pressure was significantly lower in the adenosine than in the control group in the mannitol subgroup (P < 0.01). The incidence of bradycardia, transient first-degree atrioventricular block, and tachycardia was not significantly different between the adenosine and control groups (P > 0.1). Conclusion Adenosine has no analgesic effect or prophylactic effect against PONV, but reduce systolic blood pressure and heart rates. Adenosine may benefit patients with hypertension, ischemic heart disease, and tachyarrhythmia, thereby improving cardiac function.	[Jin, Xin; Mi, Weidong] Chinese Peoples Liberat Army Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Jin, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China.	why08317@163.com						Abo-Salem OM, 2004, J PHARMACOL EXP THER, V308, P358, DOI 10.1124/jpet.103.056036; Ahmed N, 2016, INT J CARDIOL, V202, P305, DOI 10.1016/j.ijcard.2015.09.014; Apan A, 2003, ANAESTH INTENS CARE, V31, P648, DOI 10.1177/0310057X0303100606; Apan A, 2003, EUR J ANAESTH, V20, P916, DOI 10.1097/00003643-200311000-00010; Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Baraldi PG, 2004, EUR J MED CHEM, V39, P855, DOI 10.1016/j.ejmech.2004.06.009; Bercovitch M, 1999, CANCER-AM CANCER SOC, V86, P871, DOI 10.1002/(SICI)1097-0142(19990901)86:5<871::AID-CNCR25>3.0.CO;2-L; Chiari A, 1999, ANESTHESIOLOGY, V91, P824, DOI 10.1097/00000542-199909000-00035; Dahl V, 2000, ACTA ANAESTH SCAND, V44, P1191, DOI 10.1034/j.1399-6576.2000.441003.x; DELANDER GE, 1992, J PHARMACOL EXP THER, V263, P1097; Dhalla AK, 2006, J PHARMACOL EXP THER, V316, P695, DOI 10.1124/jpet.105.095323; Ernens I, 2015, J LEUKOCYTE BIOL, V97, P9, DOI 10.1189/jlb.3HI0514-249RR; Fukunaga AF, 2003, PAIN, V101, P129, DOI 10.1016/S0304-3959(02)00321-4; Gan TJ, 2007, ANESTH ANALG, V105, P487, DOI 10.1213/01.ane.0000267260.00384.d9; Gao QY, 2015, INT J OPHTHALMOL-CHI, V8, P437, DOI 10.3980/j.issn.2222-3959.2015.03.01; Ghai A, 2011, SOUTH AFR J ANAESTH, V17, P288, DOI 10.1080/22201173.2011.10872793; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Habib AS, 2008, ANESTHESIOLOGY, V109, P1085, DOI 10.1097/ALN.0b013e31818db88c; Headrick JP, 2003, J PHYSIOL-LONDON, V549, P823, DOI 10.1113/jphysiol.2003.041541; Ihara M, 2015, AM J PHYSIOL-HEART C, V308, pH1287, DOI 10.1152/ajpheart.00835.2014; Katz NK, 2015, NEUROSCIENCE, V285, P312, DOI 10.1016/j.neuroscience.2014.10.065; Lee C, 2011, KOREAN J PAIN, V24, P7, DOI 10.3344/kjp.2011.24.1.7; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Martins DF, 2015, J NEUROSCI RES, V93, P157, DOI 10.1002/jnr.23461; McIntosh VJ, 2012, J CARDIOVASC PHARM T, V17, P21, DOI 10.1177/1074248410396877; Mishriky BM, 2014, ANESTH ANALG, V119, P268, DOI 10.1213/ANE.0b013e3182a8fa7b; Murata Tomoaki, 2006, Archives of Gynecology and Obstetrics, V273, P331, DOI 10.1007/s00404-005-0091-1; Omoigui S, 2007, MED HYPOTHESES, V69, P70, DOI 10.1016/j.mehy.2006.11.028; Peart J, 2002, J CARDIOVASC PHARM, V39, P117, DOI 10.1097/00005344-200201000-00013; Rane K, 2003, ACTA ANAESTH SCAND, V47, P601, DOI 10.1034/j.1399-6576.2003.00110.x; Rane K, 2000, ACTA ANAESTH SCAND, V44, P868, DOI 10.1034/j.1399-6576.2000.440714.x; Rawlinson Alex, 2012, Evid Based Med, V17, P75, DOI 10.1136/ebmed-2011-100265; Segerdahl M, 1996, ACTA ANAESTH SCAND, V40, P792, DOI 10.1111/j.1399-6576.1996.tb04534.x; Segerdahl M, 1997, ACTA ANAESTH SCAND, V41, P473, DOI 10.1111/j.1399-6576.1997.tb04726.x; SEGERDAHL M, 1995, ANESTH ANALG, V80, P1145, DOI 10.1097/00000539-199506000-00013; Serdiuk S E, 2012, Ross Fiziol Zh Im I M Sechenova, V98, P325; Sharma M, 2006, EUR J ANAESTH, V23, P449, DOI 10.1017/S0265021506000342; Singh Mukesh, 2012, Ther Adv Cardiovasc Dis, V6, P101, DOI 10.1177/1753944712446670; Sjolund KF, 1997, ANESTH ANALG, V85, P627, DOI 10.1097/00000539-199709000-00025; Tomiyama T, 2015, INT J CARDIOVAS IMAG, V31, P1089, DOI 10.1007/s10554-015-0654-6	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173518	10.1371/journal.pone.0173518	http://dx.doi.org/10.1371/journal.pone.0173518			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333936	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200015
J	Lin, CH; Wu, JB; Jian, JY; Shih, CC				Lin, Cheng-Hsiu; Wu, Jin-Bin; Jian, Jia-Ying; Shih, Chun-Ching			(-)-Epicatechin-3-O-beta-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; GLUCOSE; INSULIN; ACID; GLUCOSE-TRANSPORTER-4; HYPERLIPIDEMIA; TRANSLOCATION; ANTIOXIDANT; EXPRESSION	The objective of this study was to evaluate the effects and molecular mechanism of (-)-epicatechin- 3-O-beta-D-allopyranoside from Davallia formosana (BB) (also known as Gu-Sui-Bu) on type 1 diabetes mellitus and dyslipidemia in streptozotocin (STZ)-induced diabetic mice. This plant was demonstrated to display antioxidant activities and possess polyphenol contents. Diabetic mice were randomly divided into six groups and were given daily oral gavage doses of either BB (at three dosage levels), metformin (Metf) (at 0.3 g/kg body weight), feno-fibrate (Feno) (at 0.25 g/kg body weight) or vehicle (distilled water) and a group of control (CON) mice were gavaged with vehicle over a period of 4 weeks. Treatment with BB led to reduced levels of blood glucose, HbA(1C), triglycerides and leptin and to increased levels of insulin and adiponectin compared with the vehicle-treated STZ group. The diabetic islets showed retraction from their classic round-shaped as compared with the control islets. The BB-treated groups (at middle and high dosages) showed improvement in islets size and number of Langerhans islet cells. The membrane levels of skeletal muscular glucose transporter 4 (GLUT4) were significantly higher in BB-treated mice. This resulted in a net glucose lowering effect among BB-treated mice. Moreover, BB enhanced the expression of skeletal muscle phospho-AMPK in treated mice. BB-treated mice increased expression of fatty acid oxidation enzymes, including peroxisome proliferator-activated receptor a (PPAR alpha) and mRNA levels of carnitine palmitoyl transferase Ia (CPT1a). These mice also expressed lower levels of lipogenic genes such as fatty acid synthase (FAS), as well as lower mRNA levels of sterol regulatory element binding protein 1c (SREBP1c) and liver adipocyte fatty acid binding protein 2 (aP2). This resulted in a reduction in plasma triglyceride levels. BB-treated mice also expressed lower levels of PPAR. and FAS protein. This led to reduced adipogenesis, fatty acid synthesis and lipid accumulation within adipose tissue, and consequently, to lower triglyceride levels in liver, blood, and adipose tissue. Moreover, BB treatment not only displayed the activation Akt in liver tissue and skeletal muscle, but also in C2C12 myotube to cause an increase in phosphorylation of Akt in the absence of insulin. These results demonstrated that BB act as an activator of AMPK and/or regulation of insulin pathway (Akt), and the antioxidant activity within the pancreas. Therefore, BB treatment ameliorated the diabetic and dyslipidemic state in STZ-induced diabetic mice.	[Lin, Cheng-Hsiu] Fengyuan Hosp, Minist Hlth & Welf, Dept Internal Med, Taichung, Taiwan; [Wu, Jin-Bin] China Med Univ, Grad Inst Pharmaceut Chem, Taichung, Taiwan; [Jian, Jia-Ying; Shih, Chun-Ching] Cent Taiwan Univ Sci & Technol, Grad Inst Biotechnol & Biomed Engn, Coll Hlth Sci, Taichung, Taiwan	China Medical University Taiwan; Central Taiwan University Science & Technology	Shih, CC (corresponding author), Cent Taiwan Univ Sci & Technol, Grad Inst Biotechnol & Biomed Engn, Coll Hlth Sci, Taichung, Taiwan.	ccshih@ctust.edu.tw			Central Taiwan University of Science and Technology [CTUP-104-P-1]	Central Taiwan University of Science and Technology	This study was supported by a grant CTUP-104-P-1 from the Central Taiwan University of Science and Technology (internal for machines). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. The authors thank Director of Pathology of Show Chwan Memorial Hospital Pei-Yi Chu for pathological examination.	ALSHAMAONY L, 1994, J ETHNOPHARMACOL, V43, P167, DOI 10.1016/0378-8741(94)90038-8; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bastard JP, 1999, DIABETES-METAB RES, V15, P92, DOI 10.1002/(SICI)1520-7560(199903/04)15:2<92::AID-DMRR21>3.3.CO;2-W; Chang HC, 2007, BOT STUD, V48, P397; Cherrington AD, 2009, US ENDOCRINOL, V5, P34; CHOI JS, 1991, PLANTA MED, V57, P208, DOI 10.1055/s-2006-960075; Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Deshmukh AS, 2005, INT J OBESITY S4, V32, pS18; Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564; Fukudome D, 2008, EUR J PHARMACOL, V583, P164, DOI 10.1016/j.ejphar.2008.01.033; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; GUMA A, 1995, AM J PHYSIOL-ENDOC M, V268, pE613, DOI 10.1152/ajpendo.1995.268.4.E613; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Hsu SC, 2006, J NUTR, V136, P1779, DOI 10.1093/jn/136.7.1779; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huebschmann AG, 2006, DIABETES CARE, V29, P1420, DOI 10.2337/dc05-2096; HWANG TH, 1989, PHYTOCHEMISTRY, V28, P891, DOI 10.1016/0031-9422(89)80138-4; Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kersten S, 2002, EUR J PHARMACOL, V440, P223, DOI 10.1016/S0014-2999(02)01431-0; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; Kuo YH, 2015, J AGR FOOD CHEM, V63, P10140, DOI 10.1021/acs.jafc.5b04400; Kuo YH, 2015, J AGR FOOD CHEM, V63, P2479, DOI 10.1021/acs.jafc.5b00073; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; LIN YY, 1965, CHEM PHARM BULL, V13, P986; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Maritim AC, 2003, J NUTR BIOCHEM, V14, P288, DOI 10.1016/S0955-2863(03)00036-6; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Namkoong C, 2005, DIABETES, V54, P63, DOI 10.2337/diabetes.54.1.63; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Scott DK, 1998, J BIOL CHEM, V273, P24145, DOI 10.1074/jbc.273.37.24145; Shih CC, 2015, INT J MOL SCI, V16, P24983, DOI 10.3390/ijms161024983; Shih CC, 2009, J ETHNOPHARMACOL, V123, P82, DOI 10.1016/j.jep.2009.02.039; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Syversen U, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-10; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu Z. X., 2010, GLOBAL J PHARM, V4, P111; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504; ZIERATH JR, 1995, ACTA PHYSIOL SCAND, V155, P11	55	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173984	10.1371/journal.pone.0173984	http://dx.doi.org/10.1371/journal.pone.0173984			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333970	Green Submitted, gold, Green Published			2022-12-27	WOS:000399102200033
J	Miles, JC; Hua, J; Sepulveda, MS; Krupke, CH; Hoverman, JT				Miles, Jesse C.; Hua, Jessica; Sepulveda, Maria S.; Krupke, Christian H.; Hoverman, Jason T.			Effects of clothianidin on aquatic communities: Evaluating the impacts of lethal and sublethal exposure to neonicotinoids	PLOS ONE			English	Article							PESTICIDE TOLERANCE; IMIDACLOPRID PULSES; SURFACE WATERS; ACUTE TOXICITY; INSECTICIDE; ECOTOXICOLOGY; BIODIVERSITY; AMPHIBIANS; ORGANISMS; FIPRONIL	The widespread usage of neonicotinoid insecticides has sparked concern over their effects on non-target organisms. While research has largely focused on terrestrial systems, the low soil binding and high water solubility of neonicotinoids, paired with their extensive use on the landscape, puts aquatic environments at high risk for contamination via runoff events. We assessed the potential threat of these compounds to wetland communities using a combination of field surveys and experimental exposures including concentrations that are representative of what invertebrates experience in the field. In laboratory toxicity experiments, LC50 values ranged from 0.002 ppm to 1.2 ppm for aquatic invertebrates exposed to clothianidin. However, freshwater snails and amphibian larvae showed high tolerance to the chemical with no mortality observed at the highest dissolvable concentration of the insecticide. We also observed behavioral effects of clothianidin. Water bugs, Belostoma flumineum, displayed a dose-dependent reduction in feeding rate following exposure to clothianidin. Similarly, crayfish, Orconectes propinquus, exhibited reduced responsiveness to stimulus with increasing clothianidin concentration. Using a semi-natural mesocosm experiment, we manipulated clothianidin concentration (0.6, 5, and 352 ppb) and the presence of predatory invertebrates to explore community-level effects. We observed high invertebrate predator mortality with increases in clothianidin concentration. With increased predator mortality, prey survival increased by 50% at the highest clothianidin concentration. Thus, clothianidin contamination can result in a top-down trophic cascade in a community dominated by invertebrate predators. In our Indiana field study, we detected clothianidin (max = 176 ppb), imidacloprid (max = 141 ppb), and acetamiprid (max = 7 ppb) in soil samples. In water samples, we detected clothianidin (max = 0.67 ppb), imidacloprid (max = 0.18 ppb), and thiamethoxam (max = 2,568 ppb). Neonicotinoids were detected in > 56% of soil samples and > 90% of the water samples, which reflects a growing understanding that neonicotinoids are ubiquitous environmental contaminants. Collectively, our results underscore the need for additional research into the effects of neonicotinoids on aquatic communities and ecosystems.	[Miles, Jesse C.; Sepulveda, Maria S.; Hoverman, Jason T.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Hua, Jessica] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA; [Krupke, Christian H.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hoverman, JT (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	jhoverm@purdue.edu	Hoverman, Jason/AGR-0056-2022; Hoverman, Jason T/D-1756-2013	Hoverman, Jason/0000-0002-4002-2728; Hoverman, Jason T/0000-0002-4002-2728	Purdue University College of Agriculture AgSEED program	Purdue University College of Agriculture AgSEED program	We thank the Purdue University College of Agriculture AgSEED program for funding this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank V. Wuerthner, K. Pochini, S. Guffey, M. Hiatt, K. DeRolf, and N. Buss for their assistance with the research and several anonymous reviewers for helpful comments on the manuscript. We thank A. Jannasch for conducting the insecticide testing. We thank the Purdue University College of Agriculture AgSEED program for funding this study. The Purdue Institutional Animal Care and Use Committee (IACUC) approved all animal husbandry and euthanasia procedures (protocol # 1304000846). Field permits were provided by the Indiana Department of Natural Resources, Division of Fish and Wildlife.	Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson JC, 2015, SCI TOTAL ENVIRON, V505, P409, DOI 10.1016/j.scitotenv.2014.09.090; [Anonymous], 2003, PEST FACT SHEET CLOT; [Anonymous], 2008, E47 ASTM INT; Baxter LR, 2011, ENVIRON TOXICOL CHEM, V30, P1689, DOI 10.1002/etc.552; Beketov MA, 2008, SCI TOTAL ENVIRON, V405, P96, DOI 10.1016/j.scitotenv.2008.07.001; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Beketov MA, 2008, ENVIRON POLLUT, V156, P1364, DOI 10.1016/j.envpol.2008.08.014; Berghahn R, 2012, AQUAT TOXICOL, V122, P56, DOI 10.1016/j.aquatox.2012.05.012; Bottger R, 2013, ECOTOX ENVIRON SAFE, V93, P93, DOI 10.1016/j.ecoenv.2013.04.006; Bridges CM, 2000, CONSERV BIOL, V14, P1490, DOI 10.1046/j.1523-1739.2000.99343.x; Burgess EPJ, 2014, INSECT SCI, P1; Carew ME, 2011, ECOTOXICOLOGY, V20, P595, DOI 10.1007/s10646-011-0615-3; Chen XD, 2010, ECOTOX ENVIRON SAFE, V73, P132, DOI 10.1016/j.ecoenv.2009.09.016; Colombo V, 2013, ARCH ENVIRON CON TOX, V65, P683, DOI 10.1007/s00244-013-9940-2; Cothran RD, 2013, EVOL APPL, V6, P832, DOI 10.1111/eva.12069; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Daam MA, 2013, ECOTOX ENVIRON SAFE, V97, P78, DOI 10.1016/j.ecoenv.2013.07.011; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; FAO, 2014, FAO SPEC EV AGR PEST; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Hammond JI, 2012, EVOL APPL, V5, P593, DOI 10.1111/j.1752-4571.2011.00237.x; Hayasaka D, 2013, J PESTIC SCI, V38, P44, DOI 10.1584/jpestics.D12-061; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P421, DOI 10.1007/s10646-011-0802-2; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P191, DOI 10.1007/s10646-011-0778-y; Hladik ML, 2016, ENVIRON CHEM, V13, P12, DOI 10.1071/EN15061; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Hoverman JT, 2011, ECOGRAPHY, V34, P1049, DOI 10.1111/j.1600-0587.2011.06856.x; Hua J, 2015, ENVIRON POLLUT, V206, P56, DOI 10.1016/j.envpol.2015.06.030; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kattwinkel M, 2016, ENVIRON SCI TECHNOL, V50, P3165, DOI 10.1021/acs.est.5b04068; Kreutzweiser D, 2007, ECOTOX ENVIRON SAFE, V68, P315, DOI 10.1016/j.ecoenv.2007.04.011; Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Mills NE, 2004, ECOL APPL, V14, P1041, DOI 10.1890/02-5134; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Morin PJ, 2011, COMMUNITY ECOLOGY, 2ND EDITION, P1, DOI 10.1002/9781444341966; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Motobayashi T, 2012, JPN J APPL ENTOMOL Z, V56, P169, DOI 10.1303/jjaez.2012.169; Nyman AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062472; Pestana JLT, 2010, CHEMOSPHERE, V78, P241, DOI 10.1016/j.chemosphere.2009.10.066; Pestana JLT, 2009, AQUAT TOXICOL, V93, P138, DOI 10.1016/j.aquatox.2009.04.008; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; PRESING M, 1993, ARCH ENVIRON CON TOX, V25, P387, DOI 10.1007/BF00210731; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea RA, 2005, ECOL APPL, V15, P1125, DOI 10.1890/04-0559; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Relyea RA, 2008, OIKOS, V117, P1647, DOI 10.1111/j.1600-0706.2008.16933.x; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353; Rosenberg David M., 1993, P1; Sanchez-Bayo F, 2006, ENVIRON TOXICOL CHEM, V25, P1677, DOI 10.1897/05-404R.1; Sanchez-Bayo F, 2006, AQUAT TOXICOL, V78, P262, DOI 10.1016/j.aquatox.2006.03.009; Sanchez-Bayo F, 2014, CHEMOSPHERE, V99, P143, DOI 10.1016/j.chemosphere.2013.10.051; Schaafsma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118139; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Smit CE, 2015, HUM ECOL RISK ASSESS, V21, P1608, DOI 10.1080/10807039.2014.964071; Song MY, 1997, ENVIRON TOXICOL CHEM, V16, P2494, DOI [10.1002/etc.5620161209, 10.1897/1551-5028(1997)016&lt;2494:CTOFII&gt;2.3.CO;2]; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P8, DOI 10.1016/j.pestbp.2013.05.012; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Tuttle G., 2008, SURFACE WATER MONITO; US Environmental Protection Agency Office of Pesticide Programs, 2003, FACTSH CLOTH, P13; Usgs, 2016, PEST NAT SYNTH PROJ; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Yamamoto A, 2012, J ENVIRON MONITOR, V14, P2189, DOI 10.1039/c2em30296a	71	55	55	8	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174171	10.1371/journal.pone.0174171	http://dx.doi.org/10.1371/journal.pone.0174171			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334022	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200056
J	Zhang, Y; Zhang, R; Ding, XX; Peng, BG; Wang, N; Ma, F; Peng, YM; Wang, QD; Chang, JB				Zhang, Yan; Zhang, Rong; Ding, Xixi; Peng, Bangan; Wang, Ning; Ma, Fang; Peng, Youmei; Wang, Qingduan; Chang, Junbiao			FNC efficiently inhibits mantle cell lymphoma growth	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; NUCLEOSIDE ANALOG; VORINOSTAT; RITUXIMAB	FNC, 2'-deoxy-2'-beta-fluoro-4'-azidocytidine, is a novel cytidine analogue, that has shown strong antiproliferative activity in human lymphoma, lung adenocarcinoma and acute myeloid leukemia. In this study, we investigated the effects of FNC on mantle cell lymphoma (MCL) and the underlying mechanisms. In in vitro experiments, cell viability was detected by the CCK8 assay, and cell cycle progression and apoptosis were assessed by flow cytometry, and the expression of relative apoptosis proteins were detected by Western Blot. The in vivo antitumor effect of FNC was investigated in a SCID xenograft model. Finally, the mechanisms of action of FNC were assessed using a whole human genome expression profile chip. The data showed that FNC inhibited cell growth in a dose-and time-dependent manner, and FNC could induce apoptosis by the death recepter pathways in JeKo-1 cells and arrest the cell cycle in the G1/S or G2/M phase. Notably, FNC showed in vivo efficacy in mice bearing JeKo-1 xenograft tumors. Gene expression profile analysis revealed that the differentially expressed genes were mainly focused on the immune system process, cellular process and death. These findings implied that FNC may be a valuable therapeutic in mantle cell lymphoma and provided an experimental basis for the early clinical application of FNC.	[Zhang, Yan; Wang, Ning; Ma, Fang; Peng, Youmei; Wang, Qingduan] Zhengzhou Univ, Inst Med & Pharmaceut Sci, Zhengzhou, Henan, Peoples R China; [Zhang, Rong] Sun Yat Sen Univ, Canc Ctr, Dept Endoscopy, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Guangdong, Peoples R China; [Ding, Xixi; Peng, Bangan] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou, Peoples R China; [Chang, Junbiao] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou, Peoples R China	Zhengzhou University; State Key Lab Oncology South China; Sun Yat Sen University; Zhengzhou University; Zhengzhou University	Wang, QD (corresponding author), Zhengzhou Univ, Inst Med & Pharmaceut Sci, Zhengzhou, Henan, Peoples R China.; Chang, JB (corresponding author), Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou, Peoples R China.	wangqd@zzu.edu.cn; changjunbiao@zzu.edu.cn			National Natural Science Foundation of China [21172202]; Science and technology research Key project of Henan Province [142102310085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology research Key project of Henan Province	This work was supported by the National Natural Science Foundation of China (NO. 21172202 for Junbiao Chang), the Science and technology research Key project of Henan Province (NO. 142102310085 for Yan Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai J, 2011, PHYTOMEDICINE, V18, P366, DOI 10.1016/j.phymed.2010.08.006; Campo E, 1999, SEMIN HEMATOL, V36, P115; Christopherson RI, 2014, NUCLEOS NUCLEOT NUCL, V33, P375, DOI 10.1080/15257770.2013.863334; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; Delarue R, 2013, BLOOD, V121, P48, DOI 10.1182/blood-2011-09-370320; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Fordham SE, 2015, LEUKEMIA, V29, P491, DOI 10.1038/leu.2014.284; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; HARPER JW, 1993, CELL, V75, P805; Hodge LS, 2011, BIOCHEM PHARMACOL, V81, P950, DOI 10.1016/j.bcp.2011.01.016; Hong Jin-Quan, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1460, DOI 10.7534/j.issn.1009-2137.2013.06.017; Karube K, 2013, CANCER LETT, V333, P47, DOI 10.1016/j.canlet.2012.12.022; Kumar A, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0460-2; Liu W, 2013, NUCLEOS NUCLEOT NUCL, V32, P161, DOI 10.1080/15257770.2013.770523; Maddocks Kami, 2015, Cancer Treat Res, V165, P251, DOI 10.1007/978-3-319-13150-4_10; Mulherin BP, 2015, AM J CLIN ONCOL-CANC, V38, P373, DOI 10.1097/COC.0b013e31829e19e0; Ogura M, 2014, BRIT J HAEMATOL, V165, P768, DOI 10.1111/bjh.12819; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Sabattini E, 2010, PATHOLOGICA, V102, P83; Sun J, 2013, ONCOL REP, V30, P2785, DOI 10.3892/or.2013.2786; Vose JM, 2015, AM J HEMATOL, V90, P739, DOI 10.1002/ajh.24094; Wang QA, 2011, BIOCHEM PHARMACOL, V81, P848, DOI 10.1016/j.bcp.2011.01.001; Witzig TE, 2015, ANN ONCOL, V26, P1667, DOI 10.1093/annonc/mdv102; Xu JY, 2013, CHINESE J CANCER RES, V25, P183, DOI 10.3978/j.issn.1000-9604.2013.02.06; Zhang Y, 2014, ASIAN PAC J CANCER P, V15, P6829, DOI 10.7314/APJCP.2014.15.16.6829	26	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174112	10.1371/journal.pone.0174112	http://dx.doi.org/10.1371/journal.pone.0174112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333959	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200047
J	Lopez, M; Mayer, C; Fernandez-Garcia, L; Blasco, L; Muras, A; Ruiz, FM; Bou, G; Otero, A; Tomas, M				Lopez, Maria; Mayer, Celia; Fernandez-Garcia, Laura; Blasco, Lucia; Muras, Andrea; Martin Ruiz, Federico; Bou, German; Otero, Ana; Tomas, Maria		GEIH-GEMARA SEIMC	Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme	PLOS ONE			English	Article							ACYL-HOMOSERINE LACTONE; PSEUDOMONAS-AERUGINOSA PAO1; N-ACYLHOMOSERINE LACTONASE; ACINETOBACTER-BAUMANNII; OXIDATIVE STRESS; BIOFILM FORMATION; AGROBACTERIUM-TUMEFACIENS; EFFLUX PUMPS; SIGNAL; AUTOINDUCER-2	Acinetobacter baumannii is an important pathogen that causes nosocomial infections generally associated with high mortality and morbidity in Intensive Care Units (ICUs). Currently, little is known about the Quorum Sensing (QS)/Quorum Quenching (QQ) systems of this pathogen. We analyzed these mechanisms in seven clinical isolates of A. baumannii. Micro array analysis of one of these clinical isolates, Ab1 (A. baumanniiST-2_clon_2010), previously cultured in the presence of 3-oxo-C12-HSL (a QS signalling molecule) revealed a putative QQ enzyme (a/beta hydrolase gene, AidA). This QQ enzyme was present in all non motile clinical isolates (67% of which were isolated from the respiratory tract) cultured in nutrient depleted LB medium. Interestingly, this gene was not located in the genome of the only motile clinical strain growing in this medium (A. baumannii strain Ab421_GEIH-2010 [Ab7], isolated from a blood sample). The AidA protein expressed in E. coli showed QQ activity. Finally, we observed downregulation of the AidA protein (QQ system attenuation) in the presence of H2O2 (ROS stress). In conclusion, most of the A. baumanni clinical strains were not surface motile (84%) and were of respiratory origin (67%). Only the pilT gene was involved in surface motility and related to the QS system. Finally, a new QQ enzyme (a/beta hydrolase gene, AidA protein) was detected in these strains.	[Lopez, Maria; Fernandez-Garcia, Laura; Blasco, Lucia; Bou, German; Tomas, Maria] Complejo Hosp Univ A Coruna, INIBIC, Dept Microbiol, La Coruna, Spain; [Lopez, Maria; Bou, German; Tomas, Maria] Spanish Network Res Infect Dis REIPI, Seville, Spain; [Mayer, Celia; Muras, Andrea; Otero, Ana] Univ Santiago de Compostela, Fac Biol CIBUS, Dept Microbiol, Santiago De Compostela, Spain; [Martin Ruiz, Federico] CSIC, CIB, Biol Res Ctr, Madrid, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Tomas, M (corresponding author), Complejo Hosp Univ A Coruna, INIBIC, Dept Microbiol, La Coruna, Spain.	MA.del.Mar.Tomas.Carmona@sergas.es	Blasco, Lucía/T-8156-2019; Iftimie, Simona/GLU-5446-2022; LOPEZ, MARIA/AAE-3502-2022; De La Luz Cádiz Gurrea, María/K-9398-2014; Anibarro, Luis/A-3959-2009; Tomas, Maria/AAQ-5899-2020; Otero, Ana/AAH-1623-2020; Otero, Ana/S-1882-2018; Cisneros, José Miguel/ABI-6103-2020; Rodríguez-Baño, Jesús/F-2453-2011; Rodriguez, Azucena/AAT-9404-2021; Ruiz, Federico M./AAO-9600-2021; Bou, German/H-6683-2015; Vila, Jordi/P-3613-2016; Pascual Hernandez, Alvaro/Y-5854-2018; Fernandez-Garcia, Laura/E-3256-2017	Blasco, Lucía/0000-0002-4039-4142; Iftimie, Simona/0000-0003-0714-8414; LOPEZ, MARIA/0000-0003-4217-3295; De La Luz Cádiz Gurrea, María/0000-0002-2613-4889; Anibarro, Luis/0000-0001-8790-6320; Tomas, Maria/0000-0003-4501-0387; Otero, Ana/0000-0002-3315-5709; Otero, Ana/0000-0002-3315-5709; Cisneros, José Miguel/0000-0001-5001-672X; Rodríguez-Baño, Jesús/0000-0001-6732-9001; Rodriguez, Azucena/0000-0002-4279-2179; Ruiz, Federico M./0000-0002-0385-7777; Alonso Garcia, Maria Pilar/0000-0002-6094-3903; Casas-Ciria, Francisco Javier/0000-0001-9820-261X; Mayer, Celia/0000-0002-6981-6601; Pallares Gonzalez, Maria de los Angeles/0000-0003-2237-9501; Tormo, Nuria/0000-0002-4514-7730; Bou, German/0000-0001-8837-0062; Vila, Jordi/0000-0002-8025-3926; Pascual Hernandez, Alvaro/0000-0002-8672-5891; Horcajada, Juan Pablo/0000-0001-9873-5459; Fernandez-Garcia, Laura/0000-0002-8531-6105; Muras, Andrea/0000-0003-1603-9762; Pachon, Jeronimo/0000-0002-8166-5308	National Plan for Scientific Research, Technological Development and Innovation [PI13/02390]; ISCIII-Deputy General Directorate of evaluation and Promotion of Research - European Regional Development Fund; Institute de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015]; Miguel Servet Research Programme; Xunta de Galicia (Plan 12C)	National Plan for Scientific Research, Technological Development and Innovation; ISCIII-Deputy General Directorate of evaluation and Promotion of Research - European Regional Development Fund; Institute de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases; Miguel Servet Research Programme; Xunta de Galicia (Plan 12C)	This study was funded by grant PI13/02390 awarded to MT within the State Plan for R+D+I 2013-2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011) and co-financed by the ISCIII-Deputy General Directorate of evaluation and Promotion of Research - European Regional Development Fund "A way of Making Europe" and Institute de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015). M. Tomas was financially supported by the Miguel Servet Research Programme (C.H.U.A Coruna and ISCIII). A. Muras was financially supported by a predoctoral fellowship from the Xunta de Galicia (Plan 12C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fraga L, 2016, VIRULENCE, V7, P443, DOI 10.1080/21505594.2016.1145335; Bhargava N, 2014, INFECT IMMUN, V82, P3417, DOI 10.1128/IAI.01600-14; Bhargava N, 2010, CRIT REV MICROBIOL, V36, P349, DOI 10.3109/1040841X.2010.512269; Bzdrenga J, 2016, CHEM BIOL INTERACT; Carlier A, 2004, MOL PLANT MICROBE IN, V17, P951, DOI 10.1094/MPMI.2004.17.9.951; Castillo-Juarez I, 2015, WORLD J CLIN CASES, V3, P575, DOI 10.12998/wjcc.v3.i7.575; Chai YR, 2007, J BACTERIOL, V189, P3674, DOI 10.1128/JB.01274-06; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Gao MS, 2007, MOL PLANT MICROBE IN, V20, P843, DOI 10.1094/MPMI-20-7-0843; Gonzalez RH, 2001, MICROBIOL RES, V155, P271, DOI 10.1016/S0944-5013(01)80004-5; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; He XL, 2015, ANTIMICROB AGENTS CH, V59, P4817, DOI 10.1128/AAC.00877-15; Heindorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101033; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Irie Y, 2008, CURR TOP MICROBIOL, V322, P67; Kang YS, 2011, J MICROBIOL, V49, P29, DOI 10.1007/s12275-011-0315-y; Kendall MM, 2007, CURR OPIN GASTROEN, V23, P10, DOI 10.1097/MOG.0b013e3280118289; Kim Hye Joo, 2012, Evid Based Complement Alternat Med, V2012, P639469, DOI 10.1155/2012/639469; Krysciak D, 2011, APPL ENVIRON MICROB, V77, P5089, DOI 10.1128/AEM.00112-11; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lin L, 2016, MOL MICROBIOL, V100, P527, DOI 10.1111/mmi.13331; Lopez M., 2016, GENOME ANNOUNC, V4; Mayer C, 2015, APPL MICROBIOL BIOT, V99, P9523, DOI 10.1007/s00253-015-6741-8; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moreira CG, 2010, INFECT IMMUN, V78, P914, DOI 10.1128/IAI.01038-09; Ochiai S, 2014, APPL ENVIRON MICROB, V80, P6919, DOI 10.1128/AEM.02190-14; RICHMOND GE, 2016, MBIO, V7; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rumbo C, 2013, ANTIMICROB AGENTS CH, V57, P5247, DOI 10.1128/AAC.00730-13; Schipper C, 2009, APPL ENVIRON MICROB, V75, P224, DOI 10.1128/AEM.01389-08; Semmelhack MF, 2005, ORG LETT, V7, P569, DOI 10.1021/ol047695j; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Soares JA, 2011, CURR OPIN MICROBIOL, V14, P188, DOI 10.1016/j.mib.2011.01.006; Stacy DM, 2012, ACS CHEM BIOL, V7, P1719, DOI 10.1021/cb300351x; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Tang KH, 2014, MAR DRUGS, V12, P3245, DOI 10.3390/md12063245; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; Vijayakumar S, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00105; Weiland-Brauer N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01098; Weiland-Brauer N, 2015, APPL ENVIRON MICROB, V81, P1477, DOI 10.1128/AEM.03290-14; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x	48	43	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174454	10.1371/journal.pone.0174454	http://dx.doi.org/10.1371/journal.pone.0174454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328989	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700095
J	Niang, MN; Diop, NS; Fall, A; Kiori, DE; Sarr, FD; Sy, S; Goudiaby, D; Barry, MA; Fall, M; Dia, N				Niang, Mbayame Ndiaye; Diop, Ndeye Sokhna; Fall, Amary; Kiori, Davy E.; Sarr, Fatoumata Diene; Sy, Sara; Goudiaby, Deborah; Barry, Mamadou Aliou; Fall, Malick; Dia, Ndongo			Respiratory viruses in patients with influenza like illness in Senegal: Focus on human respiratory adenoviruses	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MOLECULAR CHARACTERIZATION; VIRAL-INFECTIONS; CLINICAL CHARACTERISTICS; TRACT INFECTIONS; KOREAN CHILDREN; EPIDEMIOLOGY; OUTBREAK; IDENTIFICATION; SEROTYPES	Background Human adenoviruses (HAdVs) are highly contagious pathogens that are associated with a wide spectrum of human illnesses involving the respiratory tract. In the present study, we investigate the epidemiologic and viral molecular features of HAdVs circulating in Senegal after 4 consecutive years of sentinel surveillance of influenza-like Illness cases. Methodology and results From January 2012 to December 2015 swabs were collected from consenting ILI outpatients. Adenoviral detection is performed by rRT-PCR with the Anyplex TM I I RV16 Detection kit (Seegene) and molecular characterization was performed using a partial hexon gene sequence. 6381 samples were collected. More than half of patients (51.7%; 3297/6381) were children of < 5 years. 1967 (30.8%) were positive for HAdV with 1561 (79.4%) found in co-infection with at least one another respiratory virus. The most common co-detections were with influenza viruses (53.1%; 1045/1967), rhinoviruses (30%; 591/1967), enteroviruses (18.5%; 364/1967) and RSV (13.5%; 266/1967). Children under 5 were the most infected group (62.2%; 1224/1967; p <0.05). We noted that HAdV was detected throughout the year at a high level with detection peaks of different amplitudes without any clear seasonality. Phylogenetic analysis revealed species HAdV-C in majority, species HAdV-B and one HAdV- 4 genome type. The 9 HAdV-B species like strains from Senegal grouped with genome types HAdV-7, HAdV-55 and HAdV-11 as shown by a phylogenetic branch with a high bootstrap value of (88%). Conclusion In conclusion, the results of the present study suggest strong year-round HAdV activity in Senegal, especially in children up to 5 years of age. Molecular studies revealed that the dominant species in circulation in patients with ILI appears to be HAdV-C and HAdV-B species. The circulation of though HAdV-7 and HAdV-55 genome types is of note as these serotypes are recognized causes of more severe and even fatal acute respiratory infections.	[Niang, Mbayame Ndiaye; Diop, Ndeye Sokhna; Fall, Amary; Kiori, Davy E.; Sy, Sara; Goudiaby, Deborah; Dia, Ndongo] Inst Pasteur, Unite Virol Med, Dakar, Senegal; [Sarr, Fatoumata Diene; Barry, Mamadou Aliou] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal; [Fall, Malick] Univ Cheikh Anta DIOP Dakar, Dept Biol Anim, Fac Sci & Tech, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Dia, N (corresponding author), Inst Pasteur, Unite Virol Med, Dakar, Senegal.	ndia@pasteur.sn	Fall, Amary/AAR-8776-2021	Fall, Amary/0000-0002-6890-7915	DHSS; Institut Pasteur de Dakar	DHSS; Institut Pasteur de Dakar	This work was supported by DHSS and Institut Pasteur de Dakar.	Abbas KZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-15; Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Ahmed JA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-7; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Ampuero JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046898; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Calder JAM, 2004, EMERG INFECT DIS, V10, P149, DOI 10.3201/eid1001.020605; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155412; Cheng CC, 2008, EUR J PEDIATR, V167, P633, DOI 10.1007/s00431-007-0562-4; CHERRY JD, 1998, TXB PEDIAT INFECT DI, P1666; Comach G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044511; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; Demian PN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-50; Dia N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093227; DUDDING BA, 1972, NEW ENGL J MED, V286, P1289, DOI 10.1056/NEJM197206152862403; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Erdman DD, 2002, EMERG INFECT DIS, V8, P269, DOI 10.3201/eid0803.010190; Esposito S, 2016, PLOS ONE, V11; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Fu YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119513; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P327, DOI 10.1111/j.1750-2659.2009.00107.x; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; Ison MG, 2006, CLIN INFECT DIS, V43, P331, DOI 10.1086/505498; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Kandel R, 2010, INFECT CONT HOSP EP, V31, P755, DOI 10.1086/653612; Kenmoe S, 2016, INFLUENZA OTHER RESP, V10, P386, DOI 10.1111/irv.12391; Kidd AH, 1996, J CLIN MICROBIOL, V34, P622, DOI 10.1128/JCM.34.3.622-627.1996; Kim JK, 2013, J MICROBIOL BIOTECHN, V23, P267, DOI 10.4014/jmb.1212.12050; Koren MA, 2016, INFLUENZA OTHER RESP, V10, P414, DOI 10.1111/irv.12392; Lafolie J, 2016, EMERG INFECT DIS, V22, P2012, DOI 10.3201/eid2211.160728; Lebeck MG, 2009, J CLIN VIROL, V46, P331, DOI 10.1016/j.jcv.2009.09.023; Lee J, 2010, J CLIN VIROL, V49, P115, DOI 10.1016/j.jcv.2010.07.007; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; Li HX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-143; Li QG, 1996, J MED VIROL, V49, P170, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;170::AID-JMV3&gt;3.0.CO;2-1; Li Y, 2015, PLOS ONE, V10; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Liu CY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1126-2; Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232; Lu Y, 2013, CLIN DEV IMMUNOL; Luiz LN, 2010, MEM I OSWALDO CRUZ, V105, P712, DOI 10.1590/S0074-02762010000500019; Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923; Madeley CRPM, 1996, VIRAL OTHER INFECT R, P169; Moe N, 2016, PLOS ONE, V11; Moura PO, 2007, J MED VIROL, V79, P174, DOI 10.1002/jmv.20778; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; Noh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064295; Otomaru H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123755; Palomino MA, 2004, PEDIATR INFECT DIS J, V23, P337, DOI 10.1097/00006454-200404000-00012; Pavia Andrew T, 2011, Clin Infect Dis, V52 Suppl 4, pS284, DOI 10.1093/cid/cir043; Rosete DP, 2008, MEM I OSWALDO CRUZ, V103, P195, DOI 10.1590/S0074-02762008000200012; San Martin C, 2003, CURR TOP MICROBIOL, V272, P57; SCHEPETIUK SK, 1993, J MED VIROL, V41, P316, DOI 10.1002/jmv.1890410411; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Seto D, 2013, J CLIN VIROL, V58, P741, DOI 10.1016/j.jcv.2013.09.025; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Thavagnanam S, 2010, ACTA PAEDIATR, V99, P394, DOI 10.1111/j.1651-2227.2009.01627.x; Wansaula Z, 2016, INFLUENZA OTHER RESP, V10, P161, DOI 10.1111/irv.12360; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Yu ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37216; Zhang SY, 2016, INFECT DIS-NOR, V48, P40, DOI 10.3109/23744235.2015.1055585; Zhao SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07365	69	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174287	10.1371/journal.pone.0174287	http://dx.doi.org/10.1371/journal.pone.0174287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328944	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700079
J	Chang, YW; Singh, KP				Chang, Yu-Wei; Singh, Kamaleshwar P.			Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; DNA MISMATCH REPAIR; CYCLE ARREST; RESISTANCE; DOXORUBICIN; DAMAGE; GROWTH; COMBINATION; EXPRESSION; INHIBITOR	Chemotherapy is the most common clinical option for treatment of breast cancer. However, the efficacy of chemotherapy depends on the age of breast cancer patients. Breast tissues are estrogen responsive and the levels of ovarian estrogen vary among the breast cancer patients primarily between pre- and post-menopausal age. Whether this age-dependent variation in estrogen levels influences the chemotherapeutic efficacy in breast cancer patients is not known. Therefore, the objective of this study was to evaluate the effects of natural estrogen 17 beta-estradiol (E2) on the efficacy of chemotherapeutic drugs in breast cancer cells. Estrogen responsive MCF-7 and T47D breast cancer cells were long-term exposed to 100 pg/ml estrogen, and using these cells the efficacy of chemotherapeutic drugs doxorubicin and cisplatin were determined. The result of cell viability and cell cycle analysis revealed increased sensitivities of doxorubicin and cisplatin in estrogen-exposed MCF-7 and T47D cells as compared to their respective control cells. Gene expression analysis of cell cycle, anti-apoptosis, DNA repair, and drug transporter genes further confirmed the increased efficacy of chemotherapeutic drugs in estrogen-exposed cells at molecular level. To further understand the role of epigenetic mechanism in enhanced chemotherapeutic efficacy by estrogen, cells were pre-treated with epigenetic drugs, 5-aza-2-deoxycytidine and Trichostatin A prior to doxorubicin and cisplatin treatments. The 5-aza-2 deoxycytidine pre-treatment significantly decreased the estrogen-induced efficacy of doxorubicin and cisplatin, suggesting the role of estrogen-induced hypermethylation in enhanced sensitivity of these drugs in estrogen-exposed cells. In summary, the results of this study revealed that sensitivity to chemotherapy depends on the levels of estrogen in breast cancer cells. Findings of this study will have clinical implications in selecting the chemotherapy strategies for treatment of breast cancer patients depending on the serum estrogen levels that varies among pre- and post-menopausal age of the patients.	[Chang, Yu-Wei; Singh, Kamaleshwar P.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth TIEHH, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Singh, KP (corresponding author), Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth TIEHH, Lubbock, TX 79409 USA.	Kamaleshwar.singh@ttu.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Abe O, 1998, LANCET, V352, P930; Aebi S, 1996, CANCER RES, V56, P3087; Alami N, 2007, BRIT J CANCER, V97, P58, DOI 10.1038/sj.bjc.6603829; [Anonymous], 1983, Lancet, V1, P257; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1992, Lancet, V339, P1; Aquilina G, 1999, CARCINOGENESIS, V20, P2317, DOI 10.1093/carcin/20.12.2317; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Barrios CH, 2009, ANN ONCOL, V20, P1157, DOI 10.1093/annonc/mdn756; BAUM M, 1983, LANCET, V2, P450; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Caldoe CE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00106; CHALBOS D, 1982, J CLIN ENDOCR METAB, V55, P276, DOI 10.1210/jcem-55-2-276; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332; Cole BF, 2001, LANCET, V358, P277, DOI 10.1016/S0140-6736(01)05483-6; Cummings SR, 1998, NEW ENGL J MED, V339, P733, DOI 10.1056/NEJM199809103391104; Dai XF, 2015, AM J CANCER RES, V5, P2929; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Elmlinger MW, 2002, CLIN CHEM LAB MED, V40, P1151, DOI 10.1515/CCLM.2002.202; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Goswami PC, 1996, MOL CELL BIOL, V16, P1500; Hsu MS, 2010, ANN SURG ONCOL, V17, P760, DOI 10.1245/s10434-009-0802-0; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Jarvinen TAH, 2000, AM J PATHOL, V156, P839, DOI 10.1016/S0002-9440(10)64952-8; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kim H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0589-7; Kim WJ, 2007, J BIOL CHEM, V282, P32021, DOI 10.1074/jbc.M701451200; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller WR, 2007, BREAST CANCER RES TR, V103, P149, DOI 10.1007/s10549-006-9369-7; Mjelle R, 2015, DNA REPAIR, V30, P53, DOI 10.1016/j.dnarep.2015.03.007; Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175; Muss HB, 2011, ONCOLOGIST, V16, P79, DOI 10.1634/theoncologist.2011-S1-79; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Pabla N, 2011, J BIOL CHEM, V286, P10411, DOI 10.1074/jbc.M110.210989; Papouli E, 2004, CANCER RES, V64, P3391, DOI 10.1158/0008-5472.CAN-04-0513; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Prouillac C, 2009, TOXICOLOGY, V263, P100, DOI 10.1016/j.tox.2009.06.023; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Rossi A, 2005, CURR MED CHEM, V12, P297, DOI 10.2174/0929867053363261; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; SCHOBER C, 1994, BIOCHEM PHARMACOL, V48, P997, DOI 10.1016/0006-2952(94)90370-0; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; Singh KP, 2012, CANCER LETT, V316, P62, DOI 10.1016/j.canlet.2011.10.022; Slot AJ, 2008, DRUG METAB DISPOS, V36, P552, DOI 10.1124/dmd.107.019661; Srikantan S, 2011, MOL CELL BIOL, V31, P3790, DOI 10.1128/MCB.05639-11; Sugiyama D, 2003, PHARM RES-DORDR, V20, P1394, DOI 10.1023/A:1025749925541; Taheri M, 2013, DIS MARKERS, V34, P387, DOI 10.1155/2013/728410; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Travis RC, 2003, BREAST CANCER RES, V5, P239, DOI 10.1186/bcr628; Treas JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043880; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; WATT PM, 1994, BIOCHEM J, V303, P681, DOI 10.1042/bj3030681; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Zhang FX, 2013, J BIOL CHEM, V288, P11348, DOI 10.1074/jbc.M112.429134	66	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174227	10.1371/journal.pone.0174227	http://dx.doi.org/10.1371/journal.pone.0174227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323900	gold, Green Submitted, Green Published			2022-12-27	WOS:000399089000076
J	Dai, TM; Lu, ZC; Liu, WX; Wan, FH				Dai, Tian-Mei; Lu, Zhi-Chuang; Liu, Wan-Xue; Wan, Fang-Hao			Selection and validation of reference genes for qRT-PCR analysis during biological invasions: The thermal adaptability of Bemisia tabaci MED	PLOS ONE			English	Article							ENDOGENOUS REFERENCE GENES; SUITABLE REFERENCE GENES; QUANTITATIVE RT-PCR; SHOCK-PROTEIN GENES; CLIMATE-CHANGE; EXPRESSION ANALYSIS; HOST-PLANT; HEMIPTERA; TEMPERATURE; ALEYRODIDAE	The Bemisia tabaci Mediterranean (MED) cryptic species has been rapidly invading to most parts of the world owing to its strong ecological adaptability, which is considered as a model insect for stress tolerance studies under rapidly changing environments. Selection of a suitable reference gene for quantitative stress-responsive gene expression analysis based on qRT-PCR is critical for elaborating the molecular mechanisms of thermotolerance. To obtain accurate and reliable normalization data in MED, eight candidate reference genes (beta-act, GAPDH, beta-tub, EF1-alpha, GST, 18S, RPL13A and alpha-tub) were examined under various thermal stresses for varied time periods by using geNorm, NormFinder and BestKeeper algorithms, respectively. Our results revealed that beta-tub and EF1-alpha were the best reference genes across all sample sets. On the other hand, 18S and GADPH showed the least stability for all the samples studied. beta-act was proved to be highly stable only in case of short-term thermal stresses. To our knowledge this was the first comprehensive report on validation of reference genes under varying temperature stresses in MED. The study could expedite particular discovery of thermotolerance genes in MED. Further, the present results can form the basis of further research on suitable reference genes in this invasive insect and will facilitate transcript profiling in other invasive insects.	[Dai, Tian-Mei; Lu, Zhi-Chuang; Liu, Wan-Xue; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Wan, Fang-Hao] Chinese Acad Agr Sci, Agr Genome Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.; Wan, FH (corresponding author), Chinese Acad Agr Sci, Agr Genome Inst Shenzhen, Shenzhen, Peoples R China.	wanfanghao@caas.cn			National Key Research and Development Program [2016YFC1200600]; Ministry of Science and Technology, China; National Natural Science Foundation of China [31672088]; Special Fund for Scientific Research in Environmental Protection Public Interest [201409061]; Common Wealth Special Fund for the Agricultural Industry [201303019]; International Science & Technology Cooperation Program of China [2015DFG32300]	National Key Research and Development Program; Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Scientific Research in Environmental Protection Public Interest; Common Wealth Special Fund for the Agricultural Industry; International Science & Technology Cooperation Program of China	This work was funded by the National Key Research and Development Program (2016YFC1200600), the Ministry of Science and Technology, China, and the National Natural Science Foundation of China (31672088), and the Special Fund for Scientific Research in Environmental Protection Public Interest (201409061), and the Common Wealth Special Fund for the Agricultural Industry (No. 201303019), and the International Science & Technology Cooperation Program of China (2015DFG32300).; This research project was supported by the National Key Research and Development Program (2016YFC1200600), the Ministry of Science and Technology, China, and the National Natural Science Foundation of China (31672088), and the Special Fund for Scientific Research in Environmental Protection Public Interest (201409061), and the Common Wealth Special Fund for the Agricultural Industry (No. 201303019), and the International Science & Technology Cooperation Program of China (2015DFG32300).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bonato O, 2007, PHYSIOL ENTOMOL, V32, P50, DOI 10.1111/j.1365-3032.2006.00540.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; Collins C, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.63; de Boer ME, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-11; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Drost YC, 1998, B ENTOMOL RES, V88, P219, DOI 10.1017/S0007485300025840; Dukes JS, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P345; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Fu Xue, 2011, Chinese Journal of Applied Entomology, V48, P32; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Guirao P, 1997, B ENTOMOL RES, V87, P587, DOI 10.1017/S0007485300038682; Guo R, 2013, J APPL PHYCOL, V25, P1101, DOI 10.1007/s10811-012-9908-z; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lancaster LT, 2016, NAT CLIM CHANGE, V6, P618, DOI 10.1038/NCLIMATE2945; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Li J., 2009, RES OCCURRENCE POPUL; Li RH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/743716; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Liu G, 2016, PLOS ONE, V11; Liu Y Q, 2012, J BIOSAFETY, V21, P247; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu J, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.37; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Lu ZC, 2008, COMP BIOCHEM PHYS D, V3, P257, DOI 10.1016/j.cbd.2008.06.003; Ma FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103279; Ma HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103792; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Muniz M, 2001, ENVIRON ENTOMOL, V30, P720, DOI 10.1603/0046-225X-30.4.720; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Nava-Camberos U, 2001, ENVIRON ENTOMOL, V30, P55, DOI 10.1603/0046-225X-30.1.55; Niu JZ, 2012, MOL BIOL REP, V39, P5841, DOI 10.1007/s11033-011-1394-x; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard DJ, 2004, COMP BIOCHEM PHYS A, V137, P205, DOI 10.1016/S1095-6433(03)00292-7; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Purohit GK, 2015, FISH PHYSIOL BIOCHEM, V42, P1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Shang F, 2015, J ECON ENTOMOL, V108, P2040, DOI 10.1093/jee/tov184; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Su YL, 2013, J ECON ENTOMOL, V106, P1446, DOI 10.1603/EC12459; Tang XT, 2015, J ASIA-PAC ENTOMOL, V18, P529, DOI 10.1016/j.aspen.2015.07.005; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan FH, 2008, J INSECT SCI, V8, P49; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wang Jia, 2014, Acta Entomologica Sinica, V57, P1375; Wang KH, 1996, ANN ENTOMOL SOC AM, V89, P375, DOI 10.1093/aesa/89.3.375; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Xiao L, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00388, 10.3389/fpls.2014.00788]; Xie W, 2012, PLOS ONE, V7; Yu H, 2012, BIOL INVASIONS, V14, P1587, DOI 10.1007/s10530-012-0171-7; Yu SH, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2548-z; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93; Zhao W., 2014, POPULATION DYNAMICS	76	30	34	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173821	10.1371/journal.pone.0173821	http://dx.doi.org/10.1371/journal.pone.0173821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323834	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000033
J	Diao, F; Chen, KY; Wang, Y; Li, YD; Xu, WD; Lu, J; Chen, YX				Diao, Fei; Chen, Kangyao; Wang, Yan; Li, Yidong; Xu, Weidong; Lu, Jian; Chen, Yu-Xia			Involvement of small G protein RhoB in the regulation of proliferation, adhesion and migration by dexamethasone in osteoblastic cells	PLOS ONE			English	Article							HUMAN OSTEOSARCOMA CELLS; NF-KAPPA-B; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVATION; MESSENGER-RNA; UP-REGULATION; TGF-BETA; IN-VITRO	Long-term exposure to therapeutic doses of glucocorticoids (GCs) results in bone remodeling, which frequently causes osteoporosis and fracture healing retardation because of the abnormality of osteoblastic proliferation and differentiation. The mechanisms of GCs' effect on osteoblasts are largely unknown. In this present study, we found that dexamethasone (Dex) could induce the expression of the small G protein, RhoB, in mRNA and protein levels in the osteoblast-derived osteosarcoma cell lines MG-63. The up-regulation of RhoB mRNA by Dex mainly occurs at posttranscriptional level by increasing its mRNA stability through PI-3K/Akt and p38 mitogen-activated protein kinase signaling pathways. Over-expression of RhoB in MG-63 cells magnified while down-regulation of RhoB level by RNA interference impaired Dex-induced growth inhibition but not differentiation. What's more, over-expression of RhoB mimicked the effect of Dex on cell adhesion and migration. And interfering RhoB expression partially suppressed Dex-induced pro-adhesion and anti-migration in MG-63 cells. In conclusion, these results indicate that RhoB plays an important role in the pathological effect of Dex on osteoblastic growth and migration, which is a part of the mechanisms of GCs' adverse effect on bone remodeling.	[Diao, Fei; Wang, Yan; Li, Yidong; Lu, Jian; Chen, Yu-Xia] Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China; [Chen, Kangyao; Xu, Weidong] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Chen, Kangyao] Xiamen Univ, Fuzhou Hosp 2, Dept Orthoped, Fuzhou, Fujian, Peoples R China	Naval Medical University; Naval Medical University; Xiamen University	Lu, J; Chen, YX (corresponding author), Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China.	lujian326@163.com; yxchen_2013@163.com			National Natural Science Foundation of China [81172471, 81172100, 81472690]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the fundings from National Natural Science Foundation of China to YX Chen (81172471), YD Li (81172100) and J Lu (81472690). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEM BIOPH RES CO, V409, P211, DOI 10.1016/j.bbrc.2011.04.121; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Bladh LG, 2009, BBA-MOL CELL RES, V1793, P439, DOI 10.1016/j.bbamcr.2008.11.013; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7; Chen L, 2003, RECENT PROG HORM RES, V58, P155, DOI 10.1210/rp.58.1.155; Chen TL, 2004, BONE, V35, P83, DOI 10.1016/j.bone.2004.03.019; Chen YX, 2006, J STEROID BIOCHEM, V101, P179, DOI 10.1016/j.jsbmb.2006.06.030; Cortet B, 2011, OSTEOPOROSIS INT, V22, P2007, DOI 10.1007/s00198-011-1612-3; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Femandes D, 1999, AM J RESP CELL MOL B, V21, P77; Fritz G, 2001, NUCLEIC ACIDS RES, V29, P792, DOI 10.1093/nar/29.3.792; Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12; Gille J, 2001, J INVEST DERMATOL, V117, P1581, DOI 10.1046/j.0022-202x.2001.01573.x; Gilley RS, 2009, CLIN ORTHOP RELAT R, V467, P3104, DOI 10.1007/s11999-009-0782-1; Heidari N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.89; Hulley PA, 1998, ENDOCRINOLOGY, V139, P2423, DOI 10.1210/en.139.5.2423; Igarashi M, 2004, J MOL HISTOL, V35, P3, DOI 10.1023/B:HIJO.0000020883.33256.fe; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Larange A, 2012, J LEUKOCYTE BIOL, V91, P105, DOI 10.1189/jlb.1110615; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Li J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.348; Li YD, 2011, J CELL PHYSIOL, V226, P729, DOI 10.1002/jcp.22394; Manolagas SC, 2000, J BONE MINER RES, V15, P1001, DOI 10.1359/jbmr.2000.15.6.1001; Mikami Y, 2007, BIOCHEM BIOPH RES CO, V362, P368, DOI 10.1016/j.bbrc.2007.07.192; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Olkku A, 2004, BONE, V34, P320, DOI 10.1016/j.bone.2003.09.010; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Ridley AJ, 2013, J MICROSC-OXFORD, V251, P242, DOI 10.1111/jmi.12025; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Siggelkow H, 2002, J CELL BIOCHEM, V85, P279, DOI 10.1002/jcb.10122; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; SONG LN, 1994, ONCOL RES, V6, P111; Stellato Cristiana, 2004, Proc Am Thorac Soc, V1, P255, DOI 10.1513/pats.200402-015MS; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Van Staa TP, 2000, J BONE MINER RES, V20, P1487, DOI [10.1359/jbmr.2000.15.6.993, DOI 10.1002/ART.22117]; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Wang XH, 2013, J PHYSIOL BIOCHEM, V69, P189, DOI 10.1007/s13105-012-0201-z; Waters RV, 2000, ACTA ORTHOP SCAND, V71, P316, DOI 10.1080/000164700317411951; Yamamoto T, 2002, ANTICANCER RES, V22, P4151; Zhang TY, 2007, J IMMUNOL, V178, P2517, DOI 10.4049/jimmunol.178.4.2517	45	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174273	10.1371/journal.pone.0174273	http://dx.doi.org/10.1371/journal.pone.0174273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323887	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000081
J	Mendizabal-Ruiz, G; Roman-Godinez, I; Torres-Ramos, S; Salido-Ruiz, RA; Morales, JA				Mendizabal-Ruiz, Gerardo; Roman-Godinez, Israel; Torres-Ramos, Sulema; Salido-Ruiz, Ricardo A.; Alejandro Morales, J.			On DNA numerical representations for genomic similarity computation	PLOS ONE			English	Article							SEQUENCES; GENES	Genomic signal processing (GSP) refers to the use of signal processing for the analysis of genomic data. GSP methods require the transformation or mapping of the genomic data to a numeric representation. To date, several DNA numeric representations (DNR) have been proposed; however, it is not clear what the properties of each DNR are and how the selection of one will affect the results when using a signal processing technique to analyze them. In this paper, we present an experimental study of the characteristics of nine of the most frequently-used DNR. The objective of this paper is to evaluate the behavior of each representation when used to measure the similarity of a given pair of DNA sequences.	[Mendizabal-Ruiz, Gerardo; Roman-Godinez, Israel; Torres-Ramos, Sulema; Salido-Ruiz, Ricardo A.; Alejandro Morales, J.] Univ Guadalajara, Dept Ciencias Computac, Div Elect & Computac, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara	Morales, JA (corresponding author), Univ Guadalajara, Dept Ciencias Computac, Div Elect & Computac, Guadalajara, Jalisco, Mexico.	alejandro.morales@cucei.udg.mx	Morales, J. Alejandro/G-1938-2018; Salido-Ruiz, Ricardo Antonio/B-3957-2018	Morales, J. Alejandro/0000-0001-8088-9724; Salido-Ruiz, Ricardo Antonio/0000-0001-6135-9306; Roman-Godinez, Israel/0000-0002-7404-8096	Consejo Nacional de Ciencia y Tecnologia; Programa para el Desarrollo Profesional Docente	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa para el Desarrollo Profesional Docente	The authors thank the support received by Consejo Nacional de Ciencia y Tecnologia and Programa para el Desarrollo Profesional Docente. Any opinions, findings, conclusions or recommendations expressed in this material are the authors' and may not reflect the views of the sponsors.	Akhtar M, 2007, IEEE INT WORK GENOM, P54; Akhtar M, 2008, IEEE J-STSP, V2, P310, DOI 10.1109/JSTSP.2008.923854; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; Bansal M, 2003, CURR SCI INDIA, V85, P1556; Berger JA, 2004, J FRANKLIN I, V341, P37, DOI 10.1016/j.jfranklin.2003.12.002; Borrayo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110954; Chakravarthy N, 2004, EURASIP J APPL SIG P, V2004, P13, DOI 10.1155/S111086570430925X; CHASSIN D, 1993, NUCLEIC ACIDS RES, V21, P745, DOI 10.1093/nar/21.3.745; Cheever E. A., 1989, Proceedings of the Fifteenth Annual Northeast Bioengineering Conference (Cat. No.89-CH2689-8), P173, DOI 10.1109/NEBC.1989.36756; Cristea PD, 2002, J CELL MOL MED, V6, P279, DOI 10.1111/j.1582-4934.2002.tb00196.x; Das B, 2015, SIG PROCESS COMMUN, P2529, DOI 10.1109/SIU.2015.7130399; Deza MM, 2009, ENCY DISTANCES, P1, DOI DOI 10.1007/978-3-642-00234-2; Gabrielian A, 1996, FEBS LETT, V393, P65, DOI 10.1016/0014-5793(96)00855-1; Hamburg M, 1974, BASIC STATISTICS A M; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holden T, 2007, OPT ENG; Hon Keung Kwan, 2009, 2009 IEEE International Conference on Electro/Information Technology (EIT '09), P307, DOI 10.1109/EIT.2009.5189632; Inbamalar TM, 2012, INT P COMP SCI INF T, V28, P1; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; Marhon SA, 2011, J COMPUT BIOL, V18, P639, DOI 10.1089/cmb.2010.0184; Nair AS, 2006, BIOINFORMATION, V1, P197; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palmer J. D., 1992, MOL SYSTEMATICS PLAN, P36, DOI DOI 10.1007/978-1-4615-3276-7; Patwardhan A, 2014, JOURNAL OF PHYLOGENE; Rao KR, 2010, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4020-6629-0; Ravichandran L, 2010, INT CONF ACOUST SPEE, P4174, DOI 10.1109/ICASSP.2010.5495708; Rioul O, 1991, IEEE SIGNAL PROC MAG, V8, P14, DOI 10.1109/79.91217; Rushdi A, 2006, 2006 IEEE INT C AC S, V2, P1024; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; SILVERMAN BD, 1986, J THEOR BIOL, V118, P295, DOI 10.1016/S0022-5193(86)80060-1; Skutkova H, 2015, J THEOR BIOL, V385, P20, DOI 10.1016/j.jtbi.2015.08.007; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wolfram Research I, 2010, NORMALIZED SQUARED E; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2014, J COMPUT BIOL, V21, P867, DOI 10.1089/cmb.2014.0120; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661; ZHANG R, 1994, J BIOMOL STRUCT DYN, V11, P767, DOI 10.1080/07391102.1994.10508031; Zhao J, 2001, P WAV AN ITS APPL 2, P424, DOI DOI 10.1007/3-540-45333-4_53	41	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173288	10.1371/journal.pone.0173288	http://dx.doi.org/10.1371/journal.pone.0173288			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323839	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000017
J	Milfont, TL; Wilson, MS; Sibley, CG				Milfont, Taciano L.; Wilson, Marc S.; Sibley, Chris G.			The public's belief in climate change and its human cause are increasing over time	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES; EFFICACY	Polls examining public opinion on the subject of climate change are now commonplace, and one-off public opinion polls provide a snapshot of citizen's opinions that can inform policy and communication strategies. However, cross-sectional polls do not track opinions over time, thus making it impossible to ascertain whether key climate change beliefs held by the same group of individuals are changing or not. Here we examine the extent to which individual's level of agreement with two key beliefs ("climate change is real" and "climate change is caused by humans") remain stable or increase/decrease over a six-year period in New Zealand using latent growth curve modelling (n = 10,436). Data were drawn from the New Zealand Attitudes and Values Study, a probabilistic national panel study, and indicated that levels of agreement to both beliefs have steadily increased over the 2009-2015 period. Given that climate change beliefs and concerns are key predictors of climate change action, our findings suggest that a combination of targeted endeavors, as well as serendipitous events, may successfully convey the emergency of the issue.	[Milfont, Taciano L.; Wilson, Marc S.] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Sibley, Chris G.] Univ Auckland, Sch Psychol, Auckland, New Zealand	Victoria University Wellington; University of Auckland	Milfont, TL (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	taciano.milfont@vuw.ac.nz	Milfont, Taciano L/GCA-0840-2022; Sibley, Chris/D-2974-2009	Milfont, Taciano L/0000-0001-6838-6307; Wilson, Marc/0000-0002-3009-5229; Sibley, Chris/0000-0002-4064-8800	Templeton World Charity Foundation [0077]; Royal Society of New Zealand [E1908]	Templeton World Charity Foundation(Templeton World Charity Foundation); Royal Society of New Zealand(Royal Society of New Zealand)	This research was supported by a Templeton World Charity Foundation grant (http://www.templetonworldcharity.org/; ID: 0077) to CGS and a Marsden Fast-Start grant (E1908) from The Royal Society of New Zealand (http://www.royalsociety.org.nz/programmes/funds/marsden/) to TLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capstick S, 2015, WIRES CLIM CHANGE, V6, P35, DOI 10.1002/wcc.321; Carlton JS, 2016, CLIMATE CHANGE; Connor LH, 2013, GLOBAL ENVIRON CHANG, V23, P1852, DOI 10.1016/j.gloenvcha.2013.07.002; Grimm KJ, 2010, STRUCT EQU MODELING, V17, P424, DOI 10.1080/10705511.2010.489006; Guy S, 2014, EUR J SOC PSYCHOL, V44, P421, DOI 10.1002/ejsp.2039; Hancock GR, 2006, QUANT METH EDUC BEHA, P171; Hart PS, 2015, NAT CLIM CHANGE, V5, P541, DOI 10.1038/nclimate2577; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Howell RA, 2011, GLOBAL ENVIRON CHANG, V21, P177, DOI 10.1016/j.gloenvcha.2010.09.004; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Leviston Z., 2014, 4 ANN SURVEY AUSTR A; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; Milfont TL, 2015, NEW ZEAL J PSYCHOL, V44, P17; Milfont TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103180; Milfont TL, 2013, PERS SOC PSYCHOL B, V39, P1127, DOI 10.1177/0146167213490805; Milfont TL, 2012, RISK ANAL, V32, P1003, DOI 10.1111/j.1539-6924.2012.01800.x; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Pugliese A, 2009, AWARENESS CLIMATE CH; Satherley N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121950; Schmidt A, 2013, GLOBAL ENVIRON CHANG, V23, P1233, DOI 10.1016/j.gloenvcha.2013.07.020; Scruggs L, 2012, GLOBAL ENVIRON CHANG, V22, P505, DOI 10.1016/j.gloenvcha.2012.01.002; Sibley CG, NZAVS TECHNICAL DO E; Sibley CG, 2013, ANAL SOC ISS PUB POL, V13, P245, DOI 10.1111/asap.12008; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Wike Richard, 2016, WHAT WORLD THINKS CL; Zhao XQ, 2014, B AM METEOROL SOC, V95, P117, DOI 10.1175/BAMS-D-12-00144.1	27	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174246	10.1371/journal.pone.0174246	http://dx.doi.org/10.1371/journal.pone.0174246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319190	Green Submitted, gold, Green Published			2022-12-27	WOS:000398945800059
J	La Fountaine, MF; Cirnigliaro, CM; Kirshblum, SC; McKenna, C; Bauman, WA				La Fountaine, Michael F.; Cirnigliaro, Christopher M.; Kirshblum, Steven C.; McKenna, Cristin; Bauman, William A.			Effect of functional sympathetic nervous system impairment of the liver and abdominal visceral adipose tissue on circulating triglyceride-rich lipoproteins	PLOS ONE			English	Article							SPINAL-CORD-INJURY; HOMEOSTASIS MODEL ASSESSMENT; ISOLATED RAT HEPATOCYTES; BODY-FAT DISTRIBUTION; INSULIN-RESISTANCE; LIPID-METABOLISM; TRIACYLGLYCEROL SECRETION; INTERNATIONAL STANDARDS; MOLECULAR-MECHANISMS; DIABETES-MELLITUS	Background Interruption of sympathetic innervation to the liver and visceral adipose tissue (VAT) in animal models has been reported to reduce VAT lipolysis and hepatic secretion of very low density lipoprotein (VLDL) and concentrations of triglyceride-rich lipoprotein particles. Whether functional impairment of sympathetic nervous system (SNS) innervation to tissues of the abdominal cavity reduce circulating concentrations of triglyceride (TG) and VLDL particles (VLDL-P) was tested in men with spinal cord injury (SCI). Methods One hundred-three non-ambulatory men with SCI [55 subjects with neurologic injury at or proximal to the 4th thoracic vertebrae (T up arrow 4); 48 subjects with SCI at or distal to the 5th thoracic vertebrae (down arrow T5)] and 53 able-bodied (AB) subjects were studied. Fasting blood samples were obtained for determination of TG, VLDL-P concentration by NMR spectroscopy, serum glucose by autoanalyzer, and plasma insulin by radioimmunoassay. VAT volume was determined by dual energy x-ray absorptiometry imaging with calculation by a validated proprietary software package. Results Significant group main effects for TG and VLDL-P were present; post-hoc tests revealed that serum TG concentrations were significantly higher in down arrow T5 group compared to AB and up arrow T4 groups [150 +/- 9 vs. 101 +/- 8 (p<0.01) and 112 +/- 8 mg/dl (p<0.05), respectively]. VLDL-P concentration was significantly elevated in down arrow T5 group compared to AB and up arrow T4 groups [74 +/- 4 vs. 58 4 (p<0.05) and 55 +/- 4 mu mol/l(p<0.05)]. VAT volume was significantly higher in both SCI groups than in the AB group, and HOMA-IR was higher and approached significance in the SCI groups compared to the AB group. A linear relationship between triglyceride rich lipoproteins (i.e., TG or Large VLDL-P) and VAT volume or HOMA-IR was significant only in the down arrow T5 group. Conclusions Despite a similar VAT volume and insulin resistance in both SCI groups, the down arrow T5 group had significantly higher serum TG and VLDL-P values than that observed in the up arrow T4 and the AB control groups. Thus, level of injury is an important determinate of the concentration of circulating triglyceride rich lipoproteins, which may play a role in the genesis of cardiometabolic dysfunction.	[La Fountaine, Michael F.; Cirnigliaro, Christopher M.; Bauman, William A.] James J Peters Vet Affairs Med Ctr, Dept Vet Affairs, Rehabil Res & Dev Serv, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA; [La Fountaine, Michael F.; Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [La Fountaine, Michael F.] Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA; [La Fountaine, Michael F.] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, Sch Hlth & Med Sci, S Orange, NJ 07079 USA; [Kirshblum, Steven C.; McKenna, Cristin] Kessler Inst Rehabil, W Orange, NJ USA; [Kirshblum, Steven C.; McKenna, Cristin] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Seton Hall University; Seton Hall University; Kessler Institute for Rehabilitation; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai	La Fountaine, MF (corresponding author), James J Peters Vet Affairs Med Ctr, Dept Vet Affairs, Rehabil Res & Dev Serv, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA.; La Fountaine, MF (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, Sch Hlth & Med Sci, S Orange, NJ 07079 USA.	michael.lafountaine@va.gov	La Fountaine, Michael/Q-6769-2019		Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service National Center of Excellence for the Medical Consequences of Spinal Cord Injury [139212-C, B2020-C]	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service National Center of Excellence for the Medical Consequences of Spinal Cord Injury	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service National Center of Excellence for the Medical Consequences of Spinal Cord Injury (#139212-C and #B2020-C). The funders had no role in study design, data collection and analysis,	ABBOTT WGH, 1987, DIABETES, V36, P897, DOI 10.2337/diabetes.36.8.897; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Apostolopoulos V, 2016, MOL NUTR FOOD RES, V60, P43, DOI 10.1002/mnfr.201500272; Arner P, 1998, LANCET, V351, P1301, DOI 10.1016/S0140-6736(05)79052-8; Bauman W A, 2001, J Spinal Cord Med, V24, P266; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bauman WA, 1999, SPINAL CORD, V37, P765, DOI 10.1038/sj.sc.3100893; BERSON SA, 1966, AM J MED, V40, P676, DOI 10.1016/0002-9343(66)90148-3; Bonora M, 2012, PURINERG SIGNAL, V8, P343, DOI 10.1007/s11302-012-9305-8; BRINDLE NPJ, 1988, BIOCHEM J, V250, P363, DOI 10.1042/bj2500363; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carreno FR, 2004, CELL BIOCHEM FUNCT, V22, P9, DOI 10.1002/cbf.1047; Chen YK, 2013, INT J CARDIOL, V168, P1681, DOI 10.1016/j.ijcard.2013.03.077; Cirnigliaro CM, 2015, OBESITY, V23, P1811, DOI 10.1002/oby.21194; Cragg JJ, 2013, NEUROLOGY, V81, P1864, DOI 10.1212/01.wnl.0000436074.98534.6e; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Edwards LA, 2008, AM J CLIN NUTR, V87, P600, DOI 10.1093/ajcn/87.3.600; Engfeldt P, 1988, Horm Metab Res Suppl, V19, P26; Frenais R, 2001, J CLIN ENDOCR METAB, V86, P1962, DOI 10.1210/jc.86.5.1962; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Gilbert O, 2014, ATHEROSCLEROSIS, V232, P305, DOI 10.1016/j.atherosclerosis.2013.11.028; GINSBERG HN, 1991, DIABETES CARE, V14, P839, DOI 10.2337/diacare.14.9.839; GOLAY A, 1987, J CLIN ENDOCR METAB, V65, P512, DOI 10.1210/jcem-65-3-512; Gorgey AS, 2011, METABOLISM, V60, P843, DOI 10.1016/j.metabol.2010.08.002; Gorgey AS, 2011, J SPINAL CORD MED, V34, P99, DOI 10.1179/107902610X12911165975106; Grassi G, 2004, J HYPERTENS, V22, P2363, DOI 10.1097/00004872-200412000-00019; GUTTMANN L, 1963, Paraplegia, V1, P4; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Ikeda Y, 2001, ENDOCR J, V48, P81, DOI 10.1507/endocrj.48.81; Jungermann K, 1999, HEPATO-GASTROENTEROL, V46, P1414; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krassioukov A, 2012, J SPINAL CORD MED, V35, P201, DOI 10.1179/1079026812Z.00000000053; Krebs M, 2005, DIABETES OBES METAB, V7, P621, DOI 10.1111/j.1463-1326.2004.00439.x; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LEHTONEN A, 1985, AM HEART J, V109, P1192, DOI 10.1016/0002-8703(85)90707-0; Lessard SJ, 2009, ENDOCRINOLOGY, V150, P4883, DOI 10.1210/en.2009-0158; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Lima MMO, 2013, OBESITY, V21, pE182, DOI 10.1002/oby.20030; MATHIAS CJ, 1975, CLIN SCI MOL MED, V49, P291, DOI 10.1042/cs0490291; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MUNRO AF, 1960, J PHYSIOL-LONDON, V154, P244, DOI 10.1113/jphysiol.1960.sp006576; Nishida C, 2010, EUR J CLIN NUTR, V64, P2, DOI 10.1038/ejcn.2009.139; Otvos James D, 2002, Clin Lab, V48, P171; Poynten AM, 2005, J CLIN ENDOCR METAB, V90, P1035, DOI 10.1210/jc.2004-0943; Rasouli M, 2006, EUR J PHARMACOL, V545, P109, DOI 10.1016/j.ejphar.2006.06.066; ROSELL S, 1966, ACTA PHYSIOL SCAND, V67, P343, DOI 10.1111/j.1748-1716.1966.tb03320.x; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; ROSENTHAL J, 1993, J CLIN PHARMACOL, V33, P883; SEDLOCK DA, 1990, PARAPLEGIA, V28, P448, DOI 10.1038/sc.1990.60; Shimazu T, 1996, NUTRITION, V12, P65; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; Spungen AM, 2000, J APPL PHYSIOL, V88, P1310, DOI 10.1152/jappl.2000.88.4.1310; TASKINEN M-R, 1987, Diabetes Metabolism Reviews, V3, P551; Tavares FL, 2008, CELL BIOCHEM FUNCT, V26, P557, DOI 10.1002/cbf.1476; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; VOLLENWEIDER P, 1994, J CLIN INVEST, V93, P2365, DOI 10.1172/JCI117242; Wahman K, 2010, J REHABIL MED, V42, P489, DOI 10.2340/16501977-0541; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 1998, PFLUG ARCH EUR J PHY, V435, P368, DOI 10.1007/s004240050525	65	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173934	10.1371/journal.pone.0173934	http://dx.doi.org/10.1371/journal.pone.0173934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346471	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300015
J	Milekhina, ON; Nechaev, DI; Klishin, VO; Supin, AY				Milekhina, Olga N.; Nechaev, Dmitry I.; Klishin, Vladimir O.; Supin, Alexander Ya.			Discrimination of rippled-spectrum patterns in noise: A manifestation of compressive nonlinearity	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; AUDITORY FILTER SHAPES; FREQUENCY DISCRIMINATION; RESOLUTION DEPENDENCE; DENSITY RESOLUTION; NOTCHED-NOISE; MASKING; LEVEL; SELECTIVITY; MODULATION	In normal-hearing listeners, rippled-spectrum discrimination was psychophysically investigated in both silence and with a simultaneous masker background using the following two paradigms: measuring the ripple density resolution with the phase-reversal test and measuring the ripple-shift threshold with the ripple-shift test. The 0.5-oct wide signal was centered on 2 kHz, the signal levels were 50 and 80 dB SPL, and the masker levels varied from 30 to 100 dB SPL. The baseline ripple density resolutions were 8.7 oct(-1) and 8.6 oct(-1) for the 50-dB and 80-dB signals, respectively. The baseline ripple shift thresholds were 0.015 oct and 0.018 oct for the 50-dB and 80-dB signals, respectively. The maskers were 0.5-oct noises centered on 2 kHz (on-frequency) or 0.75 to 1.25 oct below the signal (off-frequency maskers). The effects of the maskers were as follows: (i) both on-and low-frequency maskers reduced the ripple density resolution and increased the ripple shift thresholds, (ii) the masker levels at threshold (the ripple density resolution decrease down to 3 oct(-1) or ripple shift threshold increased up to 0.1 oct) increased with increasing frequency spacing between the signal and masker, (iii) the masker levels at threshold were higher for the 80-dB signal than for the 50-dB signal, and (iv) the difference between the masker levels at threshold for the 50-dB and 80-dB signals decreased with increasing frequency spacing between the masker and signal. Within the 30-dB (from 50 to 80 dB SPL) signal level, the growth of the masker level at threshold was 27.8 dB for the on-frequency masker and 9 dB for the low-frequency masker. It is assumed that the difference between the on-and low-frequency masking of the rippled-spectrum discrimination reflects the cochlear compressive non-linearity. With this assumption, the compression was 0.3 dB/dB.	[Milekhina, Olga N.; Nechaev, Dmitry I.; Klishin, Vladimir O.; Supin, Alexander Ya.] Russian Acad Sci, Inst Ecol & Evolut, 33 Leninsky Prospect, Moscow, Russia	Russian Academy of Sciences	Supin, AY (corresponding author), Russian Acad Sci, Inst Ecol & Evolut, 33 Leninsky Prospect, Moscow, Russia.	alex_supin@mail.ru			Russian Foundation for basic research [14-04-00237]; Russian Science Foundation [16-15-10046]	Russian Foundation for basic research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The Russian Foundation for basic research (Grant 14-04-00237 to AYS) and the Russian Science Foundation (Grant 16-15-10046 to AYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EMMERICH DS, 1983, J ACOUST SOC AM, V74, P1702, DOI 10.1121/1.390278; EMMERICH DS, 1986, J ACOUST SOC AM, V80, P1668, DOI 10.1121/1.394278; FANTINI DA, 1989, J ACOUST SOC AM, V85, P1691, DOI 10.1121/1.397958; Glasberg BR, 2000, J ACOUST SOC AM, V108, P2318, DOI 10.1121/1.1315291; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; GLASBERG BR, 1984, J ACOUST SOC AM, V75, P536, DOI 10.1121/1.390487; Goldstein J. L., 1977, PSYCHOPHYSICS PHYSL, P337; Green D., 1986, AUDITORY FREQUENCY S, P351; Green DM, 1987, PROFILE ANAL AUDITOR; HENNING GB, 1967, J ACOUST SOC AM, V41, P774, DOI 10.1121/1.1910405; HOUTGAST T, 1977, J ACOUST SOC AM, V62, P409, DOI 10.1121/1.381541; Houtgast T, 1974, FACTS MODELS HEARING, P258; JESTEADT W, 1975, J ACOUST SOC AM, V57, P1161, DOI 10.1121/1.380574; Lopez-Poveda EA, 2003, J ACOUST SOC AM, V113, P951, DOI 10.1121/1.1534838; Masking Zwicker E., 1970, FREQUENCY ANAL PERIO, P376; MOORE BCJ, 1992, J ACOUST SOC AM, V92, P3119, DOI 10.1121/1.404208; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Nechaev DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140313; Nechaev DI, 2013, J ACOUST SOC AM, V134, P2913, DOI 10.1121/1.4820789; Nelson DA, 2001, J ACOUST SOC AM, V110, P2045, DOI 10.1121/1.1404439; OLOUGHLIN BJ, 1981, J ACOUST SOC AM, V69, P1119, DOI 10.1121/1.385691; Oxenham AJ, 1997, J ACOUST SOC AM, V101, P3666, DOI 10.1121/1.418327; PATTERSON RD, 1977, J ACOUST SOC AM, V62, P649, DOI 10.1121/1.381578; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Pick G., 1977, PSYCHOPHYSICS PHYSL, P273; PICK GF, 1980, J ACOUST SOC AM, V68, P1085, DOI 10.1121/1.384979; SEK A, 1995, J ACOUST SOC AM, V97, P2479, DOI 10.1121/1.411968; Shower EG, 1931, J ACOUST SOC AM, V3, P275, DOI 10.1121/1.1915561; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; STELMACHOWICZ PG, 1987, J ACOUST SOC AM, V81, P1881, DOI 10.1121/1.394752; SUMMERS V, 1994, J ACOUST SOC AM, V95, P3518, DOI 10.1121/1.409969; Supin AY, 2005, HEARING RES, V204, P191, DOI 10.1016/j.heares.2005.01.010; Supin AY, 2003, HEARING RES, V185, P1, DOI 10.1016/S0378-5955(03)00215-6; Supin AY, 1999, J ACOUST SOC AM, V106, P2800, DOI 10.1121/1.428105; SUPIN AY, 1994, HEARING RES, V78, P31, DOI 10.1016/0378-5955(94)90041-8; Supin AY, 1997, HEARING RES, V108, P17, DOI 10.1016/S0378-5955(97)00035-X; Supin AY, 1998, J ACOUST SOC AM, V103, P2042, DOI 10.1121/1.421351; Supin AY, 2001, HEARING RES, V151, P157, DOI 10.1016/S0378-5955(00)00223-9; Tyler R. S, 1986, AUDITORY FREQUENCY S, P323; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; YOST WA, 1978, J ACOUST SOC AM, V63, P1166, DOI 10.1121/1.381824; ZWICKER E, 1982, PSYCHOACUSTIC; ZWICKER E, 1974, FACTS MODELS HEARING, P132	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174685	10.1371/journal.pone.0174685	http://dx.doi.org/10.1371/journal.pone.0174685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346538	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300069
J	Palmer, R; Hughes, H; Chater, T				Palmer, Rebecca; Hughes, Helen; Chater, Tim			What do people with aphasia want to be able to say? A content analysis of words identified as personally relevant by people with aphasia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NAMING DISORDERS; COMPUTER THERAPY; STROKE; PROTOCOL; ANOMIA	Background Word finding is a common difficulty for people with aphasia. Targeting words that are relevant to the individual could maximise the usefulness and impact of word finding therapy. Aims To provide insights into words that people with aphasia perceive to be personally relevant. Methods and procedures 100 people with aphasia were each asked to identify 100 words that would be particularly important for them to be able to say. Two speech and language therapist researchers conducted a quantitative content analysis of the words selected. The words were coded into a framework of topics and subtopics. The frequency with which different words and topics were selected was then calculated. Outcomes and results 100 participants representing 20 areas of the United Kingdom ranged in age from 23 to 85 years. Word finding difficulties ranged from mild to severe. The sample of 9999 words selected for practice included 3095 different words in 27 topics. The majority of words selected (79.4%) were from the topics 'food and drink' (30.6%), 'nature and gardening' (10.3%), 'entertainment' (9.4%), 'places' (7.3%), 'people' (6.7%), 'house' (6.5%), 'clothes' (5.2%) and 'travel' (3.5%). The 100 words types chosen with the greatest frequency were identified. These account for 27 percent of the 9999 words chosen by the participants. Discussion Personally relevant vocabulary is unique to each individual and is likely to contain specific or specialist words for which material needs to be individually prepared. However there is some commonality in the words chosen by people with aphasia. This could inform pre-prepared materials for use in word finding therapy from which personally relevant words could be selected for practice.	[Palmer, Rebecca; Chater, Tim] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Palmer, Rebecca; Hughes, Helen] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Palmer, R (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.; Palmer, R (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England.	r.l.palmer@sheffield.ac.uk	; Chater, Tim/Q-4355-2016	Palmer, Rebecca/0000-0002-2335-7104; Chater, Tim/0000-0002-1138-0147	National Institute for Health Research [12/21/01AB]; NIHR/HEFCE; Tavistock Trust	National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR/HEFCE; Tavistock Trust	This report is independent research funded by the National Institute for Health Research (Health Technology Assessment - 12/21/01AB Clinical and cost effectiveness of aphasia computer therapy compared with usual stimulation or attention control long term post stroke (CACTUS)). RP is partially funded by an NIHR/HEFCE senior academic clinical lectureship. The Tavistock Trust for Aphasia also provides additional funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR or the Department of Health.	Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Best W, 2008, INT J LANG COMM DIS, V43, P390, DOI 10.1080/13682820701608001; Best W, 2013, CORTEX, V49, P2345, DOI 10.1016/j.cortex.2013.01.005; Cherney LR, 2008, J SPEECH LANG HEAR R, V51, P1282, DOI 10.1044/1092-4388(2008/07-0206); Fink RB, 2002, APHASIOLOGY, V16, P1061, DOI 10.1080/02687030244000400; Jayes M, 2014, INT J SPEECH-LANG PA, V16, P159, DOI 10.3109/17549507.2013.795999; List D, 2007, KNOW YOUR AUDIENCE P; Mortley J, 2004, APHASIOLOGY, V18, P193, DOI 10.1080/02687030344000553; Nickels L, 2002, APHASIOLOGY, V16, P935, DOI 10.1080/02687030244000563; Palmer R, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0527-7; Palmer R, 2013, INT J LANG COMM DIS, V48, P508, DOI 10.1111/1460-6984.12024; Palmer R, 2012, STROKE, V43, P1904, DOI 10.1161/STROKEAHA.112.650671; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Raymer AM, 2008, J SPEECH LANG HEAR R, V51, pS259, DOI 10.1044/1092-4388(2008/020); Swinburn K., 2004, COMPREHENSIVE APHASI; Swinburn K, 2010, CONNECT COMMUNICATIO; Worrall L, 2011, APHASIOLOGY, V25, P309, DOI 10.1080/02687038.2010.508530	17	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174065	10.1371/journal.pone.0174065	http://dx.doi.org/10.1371/journal.pone.0174065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346518	Green Published, Green Accepted, gold			2022-12-27	WOS:000399174300021
J	Chen, C; Twycross, J; Garibaldi, JM				Chen, Chao; Twycross, Jamie; Garibaldi, Jonathan M.			A new accuracy measure based on bounded relative error for time series forecasting	PLOS ONE			English	Article							FUZZY INFERENCE SYSTEM; NETWORK; ANFIS	Many accuracy measures have been proposed in the past for time series forecasting comparisons. However, many of these measures suffer from one or more issues such as poor resistance to outliers and scale dependence. In this paper, while summarising commonly used accuracy measures, a special review is made on the symmetric mean absolute percentage error. Moreover, a new accuracy measure called the Unscaled Mean Bounded Relative Absolute Error (UMBRAE), which combines the best features of various alternative measures, is proposed to address the common issues of existing measures. A comparative evaluation on the proposed and related measures has been made with both synthetic and real-world data. The results indicate that the proposed measure, with user selectable benchmark, performs as well as or better than other measures on selected criteria. Though it has been commonly accepted that there is no single best accuracy measure, we suggest that UMBRAE could be a good choice to evaluate forecasting methods, especially for cases where measures based on geometric mean of relative errors, such as the geometric mean relative absolute error, are preferred.	[Chen, Chao; Twycross, Jamie; Garibaldi, Jonathan M.] Univ Nottingham, Sch Comp Sci, Nottingham, England	University of Nottingham	Chen, C (corresponding author), Univ Nottingham, Sch Comp Sci, Nottingham, England.	chao.chen@nottingham.ac.uk	; Twycross, Jamie/N-9010-2016	Chen, Chao/0000-0001-9719-7361; Twycross, Jamie/0000-0002-1684-0886	School of Computer Science, University of Nottingham	School of Computer Science, University of Nottingham	Chao Chen was part funded by the School of Computer Science, University of Nottingham.	Armstrong J., 1985, LONG RANGE FORECASTI, P346; Armstrong JS, 2001, INT SER OPER RES MAN, V30, P443; ARMSTRONG JS, 1992, INT J FORECASTING, V8, P69, DOI 10.1016/0169-2070(92)90008-W; ARMSTRONG JS, 1995, J FORECASTING, V14, P67, DOI 10.1002/for.3980140106; Boyacioglu MA, 2010, EXPERT SYST APPL, V37, P7908, DOI 10.1016/j.eswa.2010.04.045; CHATFIELD C, 1988, INT J FORECASTING, V4, P515, DOI 10.1016/0169-2070(88)90127-6; Chen Z., 2004, FANGSHANXIANG CHRONI; CLEMENTS MP, 1993, J FORECASTING, V12, P617, DOI 10.1002/for.3980120802; Davydenko A, 2013, INT J FORECASTING, V29, P510, DOI 10.1016/j.ijforecast.2012.09.002; De Gooijer JG, 2006, INT J FORECASTING, V22, P443, DOI 10.1016/j.ijforecast.2006.01.001; Esfahanipour A, 2010, EXPERT SYST APPL, V37, P4742, DOI 10.1016/j.eswa.2009.11.020; FILDES R, 1992, INT J FORECASTING, V8, P81, DOI 10.1016/0169-2070(92)90009-X; FLEMING PJ, 1986, COMMUN ACM, V29, P218, DOI 10.1145/5666.5673; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Goodwin P, 1999, INT J FORECASTING, V15, P405, DOI 10.1016/S0169-2070(99)00007-2; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; MAKRIDAKIS S, 1993, INT J FORECASTING, V9, P527, DOI 10.1016/0169-2070(93)90079-3; MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202; Makridakis S., 1998, FORECASTING METHODS; Olaofe ZO, 2014, SUSTAIN ENERGY TECHN, V6, P1, DOI 10.1016/j.seta.2013.12.001; Ord K, 2001, INT J FORECASTING, V17, P537; Svalina I, 2013, EXPERT SYST APPL, V40, P6055, DOI 10.1016/j.eswa.2013.05.029; Wei LY, 2011, EXPERT SYST APPL, V38, P13625, DOI 10.1016/j.eswa.2011.04.127; WRIGHT DJ, 1986, INT J FORECASTING, V2, P139, DOI 10.1016/0169-2070(86)99002-3	28	92	93	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174202	10.1371/journal.pone.0174202	http://dx.doi.org/10.1371/journal.pone.0174202			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9AZ	28339480	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700022
J	Hosokawa, Y; Nomura, K; Tsushima, E; Kudo, K; Noto, Y; Nishizawa, Y				Hosokawa, Yoichiro; Nomura, Kazuki; Tsushima, Eiki; Kudo, Kohsei; Noto, Yuka; Nishizawa, Yoshiko			Whole-Body Counter(WBC) and food radiocesium contamination surveys in Namie, Fukushima Prefecture	PLOS ONE			English	Article							CHERNOBYL ACCIDENT; NUCLEAR ACCIDENT; SMOKING-CESSATION; INTERNAL EXPOSURE; INHABITANTS; EVACUEES; RUSSIA; GENDER	Purpose This study examined the internal Cs exposure of residents and the Cs present in food products produced in Namie. Whole-body counter (WBC) was used for the measurement of internal exposure per each whole body of examinees. Methods The food products which appeared to be used for consumption, were brought by residents and commercially available food items were excluded. Most of them were wild plants or food items produced by residents. Four years of data from April 2012 to March 2013 (fiscal 2012) and April 2015 to March 2016 (Fiscal 2015) were analyzed and studied. Results The average radioactivity measured by WBC was approximately 5 Bq for Cs-134, and 20 Bq for Cs-137 and the average committed effective dose was approximately 1 mu Sv. The average for the residents with detectable radioactivity was 25 mu Sv, and the human health effects are considered to be extremely low risk. However, the radioactivity of the affected individuals showed a higher value than the theoretical attenuation rate. The majority (83.2%) of individuals exhibiting radioactivity were over 50 years old. The number of food products brought in for detection decreased as the study period progressed, but the number of food products with radioactivity had increased. While the items with a higher detection rate of radioactivity included fruits such as citron and persimmon, shiitake mushrooms exhibited the highest radioactivity. Moreover, the radioactivity of seven items in these 10 items decreased from fiscal 2012 to fiscal 2015. Mushrooms had high radioactivity and were produced over a wide area. Conclusion We suggest that the elderly try to enjoy life and eat wild plants in moderation while inspecting food products. Therefore, we will continue to work in raising awareness of radiation and its potential presence in food products and thus the continuing necessity of monitoring radioactivity in food in the future.	[Hosokawa, Yoichiro; Nomura, Kazuki; Kudo, Kohsei] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiat Sci, Hirosaki, Aomori, Japan; [Tsushima, Eiki] Hirosaki Univ, Grad Sch Hlth Sci, Dept Comprehens Rehabil Sci, Hirosaki, Aomori, Japan; [Noto, Yuka; Nishizawa, Yoshiko] Hirosaki Univ, Grad Sch Hlth Sci, Dept Nursing Sci, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University; Hirosaki University	Hosokawa, Y (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiat Sci, Hirosaki, Aomori, Japan.	hosokawa@hirosaki-u.ac.jp			Research on the Health Effects of Radiation	Research on the Health Effects of Radiation	This work was supported by Research on the Health Effects of Radiation organized by Ministry of the Environment, Japan.; This work was supported by Research on the Health Effects of Radiation organized by Ministry of the Environment, Japan.(httpliwww. env.go.jp/chenmi/rhm/reports/h2803d_1.pdf). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardsson C, 2011, SCI TOTAL ENVIRON, V409, P4811, DOI 10.1016/j.scitotenv.2011.07.066; Consumer Affairs Agency Government of Japan Food and radiation Q& A, 2013, FUK REV STAT WEB SIT; Hayashida N, 2011, J RADIAT RES, V52, P629, DOI 10.1269/jrr.11017; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; Hosoda M, 2016, J RADIAT RES, V57, P422, DOI 10.1093/jrr/rrv102; Hosoda M, 2013, ENVIRON INT, V61, P73, DOI 10.1016/j.envint.2013.09.013; Hosokawa Y., 2013, RAD EMERG MED, V2, P82; Kurihara, 2012, P 1 NIRS S REC EARL, P67; McKee SA, 2005, ADDICT BEHAV, V30, P423, DOI 10.1016/j.addbeh.2004.05.027; Merz S, 2015, ENVIRON SCI TECHNOL, V49, P2875, DOI 10.1021/es5057648; Nakashima K, 2015, PEERJ, V3, DOI 10.7717/peerj.1427; Orita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114407; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Toll BA, 2008, NICOTINE TOB RES, V10, P195, DOI 10.1080/14622200701767803; Travnikova IG, 2001, RADIAT PROT DOSIM, V93, P331, DOI 10.1093/oxfordjournals.rpd.a006445; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsuda T, 2016, EPIDEMIOLOGY, V27, P316, DOI 10.1097/EDE.0000000000000385; Watanobe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113804	18	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174549	10.1371/journal.pone.0174549	http://dx.doi.org/10.1371/journal.pone.0174549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334042	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200110
J	Smith, HE; Yun, SJ				Smith, Harold E.; Yun, Sijung			Evaluating alignment and variant-calling software for mutation identification in C. elegans by whole-genome sequencing	PLOS ONE			English	Article							DISCOVERY; FRAMEWORK; FORMAT; GALAXY	Whole-genome sequencing is a powerful tool for analyzing genetic variation on a global scale. One particularly useful application is the identification of mutations obtained by classical phenotypic screens in model species. Sequence data from the mutant strain is aligned to the reference genome, and then variants are called to generate a list of candidate alleles. A number of software pipelines for mutation identification have been targeted to C. elegans, with particular emphasis on ease of use, incorporation of mapping strain data, subtraction of background variants, and similar criteria. Although success is predicated upon the sensitive and accurate detection of candidate alleles, relatively little effort has been invested in evaluating the underlying software components that are required for mutation identification. Therefore, we have benchmarked a number of commonly used tools for sequence alignment and variant calling, in all pair-wise combinations, against both simulated and actual datasets. We compared the accuracy of those pipelines for mutation identification in C. elegans, and found that the combination of BBMap for alignment plus FreeBayes for variant calling offers the most robust performance.	[Smith, Harold E.; Yun, Sijung] NIDDK, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Smith, HE (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	smithhe2@niddk.nih.gov			Intramural Research Program, NIDDK, NIH; Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071001] Funding Source: NIH RePORTER	Intramural Research Program, NIDDK, NIH; Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program, NIDDK, NIH. The funder had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Tetsu Fukushige, Mike Krause, and members of the Baltimore Worm Club for fruitful discussions. This study was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, and is subject to the NIH Public Access Policy.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Broad Institute, 2016, PIC; Broad Institute, 2016, GATK BEST PRACT; Bushnell B., 2016, BBMAP SHORT READ ALI; Connolly AA, 2014, MOL BIOL CELL, V25, P1298, DOI 10.1091/mbc.E13-11-0687; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doitsidou M, 2016, GENETICS, V204, P451, DOI 10.1534/genetics.115.186197; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Flibotte S, 2010, GENETICS, V185, P431, DOI 10.1534/genetics.110.116616; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Garrison E., 2016, VCFLIB SIMPLE C LIB; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hodgkin J, 1997, GENETICS, V146, P149; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jaramillo-Lambert A, 2016, GENETICS, V204, P1407, DOI 10.1534/genetics.116.195099; Jaramillo-Lambert A, 2015, G3-GENES GENOM GENET, V5, P1007, DOI 10.1534/g3.115.017038; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Labed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033887; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liau WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057266; Maier W, MUTATION IDENTIFICAT; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Novocraft Technologies, 2016, NOV; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; SAM/BAM Format Specification Working Group, 2016, VAR FORM VCF VERS 4; SAM/BAM Format Specification Working Group, 2016, SEQ AL MAP FORM SPEC; Shen YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004012; Smith HE, 2016, G3-GENES GENOM GENET, V6, P1297, DOI 10.1534/g3.116.028316; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Thompson OA, 2015, GENETICS, V200, P975, DOI 10.1534/genetics.115.175950; Wang YM, 2014, G3-GENES GENOM GENET, V4, P231, DOI 10.1534/g3.113.009126; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	42	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174446	10.1371/journal.pone.0174446	http://dx.doi.org/10.1371/journal.pone.0174446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333980	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200100
J	Yang, CQ; Hu, GQ; Li, ZZ; Wang, QZ; Wang, XM; Yuan, CM; Wang, ZW; Hong, W; Lu, WH; Cao, L; Chen, J; Wang, Y; Yu, SY; Zhou, YM; Yi, ZH; Fang, YR				Yang, Chengqing; Hu, Guoqin; Li, Zezhi; Wang, Qingzhong; Wang, Xuemei; Yuan, Chengmei; Wang, Zuowei; Hong, Wu; Lu, Weihong; Cao, Lan; Chen, Jun; Wang, Yong; Yu, Shunying; Zhou, Yimin; Yi, Zhenghui; Fang, Yiru			Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder	PLOS ONE			English	Article							METABOLIC-DISORDER; YOUNG-CHILDREN; DEFICITS; CYSTINOSIS; VARIANTS; BLOOD	Background Subsyndromal symptomatic depression (SSD) is a subtype of subthreshold depressive and can lead to significant psychosocial functional impairment. Although the pathogenesis of major depressive disorder (MDD) and SSD still remains poorly understood, a set of studies have found that many same genetic factors play important roles in the etiology of these two disorders. Nowadays, the differential gene expression between MDD and SSD is still unknown. In our previous study, we compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD and matched healthy controls (8 subjects in each group), and finally determined 48 gene expression signatures. Based on these findings, we further clarify whether these genes mRNA was different expressed in peripheral blood in patients with SSD, MDD and healthy controls (60 subjects respectively) Method With the help of the quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR), we gained gene relative expression levels among the three groups. Results We found that there are three of the forty eight co-regulated genes had differential expression in peripheral blood among the three groups, which are CD84, STRN, CTNS gene (F = 3.528, p = 0.034; F = 3.382, p = 0.039; F = 3.801, p = 0.026, respectively) while there were no significant differences for other genes. Conclusion CD84, STRN, CTNS gene may have significant value for performing diagnostic functions and classifying SSD, MDD and healthy controls.	[Yang, Chengqing; Hu, Guoqin; Wang, Xuemei; Yuan, Chengmei; Hong, Wu; Lu, Weihong; Cao, Lan; Chen, Jun; Wang, Yong; Yi, Zhenghui; Fang, Yiru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai, Peoples R China; [Li, Zezhi] Shanghai Jiao Tong Univ, Sch Med, Dept Neurol, Shanghai Renji Hosp, Shanghai, Peoples R China; [Wang, Qingzhong; Yu, Shunying] Shanghai Jiao Tong Univ, Sch Med, Dept Genet, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Wang, Zuowei] Hongkou Dist Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China; [Zhou, Yimin] Univ Calif San Diego, Neurobiol Sect, San Diego, CA 92103 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California San Diego	Yi, ZH; Fang, YR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai, Peoples R China.	yizhenghui1971@gmail.com; yirufang@aliyun.com	Wang, Xuemei/GXF-3702-2022; Chen, Jun/AAJ-1972-2020; Li, Zezhi/K-3125-2019; Li, Zezhi/I-5524-2018		National Natural Science Foundation of China [91232719, 81171272, 81301159]; National High-tech R&D Program (863 Program) [2006AA02Z430]; "12th Five-year Plan" of National Key Technologies RD Program [2012BA101604]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH) [2011-873]; Shanghai Public Health Training Scheme outstanding academic leaders [GWDTR201227]; Training Plan for Excellent Academic Leaders of Shanghai Health System [XBR2013087]; Shanghai Key Medicine Specialties Program [ZK2012A12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); "12th Five-year Plan" of National Key Technologies RD Program; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH); Shanghai Public Health Training Scheme outstanding academic leaders; Training Plan for Excellent Academic Leaders of Shanghai Health System; Shanghai Key Medicine Specialties Program	This work was supported by the National Natural Science Foundation of China (91232719, 81171272), the National High-tech R&D Program (863 Program, 2006AA02Z430); partially supported by The "12th Five-year Plan" of National Key Technologies R&D Program (2012BA101604), the National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH, 2011-873), Shanghai Public Health Training Scheme outstanding academic leaders (GWDTR201227); The National Natural Science Foundation of China (Grant# 81301159), Training Plan for Excellent Academic Leaders of Shanghai Health System (Grant# XBR2013087) and Shanghai Key Medicine Specialties Program (Grant# ZK2012A12). The funder had no role in the design, collection, management, analysis, and approval of manuscript or decision to submit the manuscript for publication.	Ballantyne AO, 2000, NEUROPSY NEUROPSY BE, V13, P254; Ballantyne AO, 1997, AM J MED GENET, V74, P157, DOI 10.1002/(SICI)1096-8628(19970418)74:2<157::AID-AJMG8>3.0.CO;2-R; Forestier L, 1999, AM J HUM GENET, V65, P353, DOI 10.1086/302509; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Judd LL, 1994, J CLIN PSYCHIAT, V55, P518; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Maier W, 1997, J AFFECT DISORDERS, V45, P41, DOI 10.1016/S0165-0327(97)00058-X; Meurs KM, 2010, HUM GENET, V128, P315, DOI 10.1007/s00439-010-0855-y; Rivas M, 2011, REV PSIQUIATR SALUD, V4, P144, DOI 10.1016/j.rpsm.2011.05.005; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Spijker S, 2006, BIOL PSYCHIAT, P179; Spilkin AM, 2007, AM J MED GENET B, V144B, P444, DOI 10.1002/ajmg.b.30448; Trauner DA, 1998, J PEDIAT, V112, P912; Trauner DA, 2007, J PEDIATR-US, V151, P192, DOI 10.1016/j.jpeds.2007.02.062; Turck Christoph W., 2008, P57, DOI 10.1007/978-0-387-79251-4_3; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; WILLIAMS BLH, 1994, AM J MED GENET, V49, P83, DOI 10.1002/ajmg.1320490115; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Yi Z, 2006, PLOS ONE, V7; Zieker J, 2007, MOL PSYCHIATR, V12, P116, DOI 10.1038/sj.mp.4001905	22	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0172692	10.1371/journal.pone.0172692	http://dx.doi.org/10.1371/journal.pone.0172692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333931	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200008
J	Bergstrom, I; Lundberg, AK; Jonsson, S; Sarndahl, E; Ernerudh, J; Jonasson, L				Bergstrom, Ida; Lundberg, Anna K.; Jonsson, Simon; Sarndahl, Eva; Ernerudh, Jan; Jonasson, Lena			Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity	PLOS ONE			English	Article							HUMAN-LEUKOCYTE SUBSETS; LIPOCORTIN-1 ANNEXIN-1; EXPRESSION; ATHEROSCLEROSIS; DEXAMETHASONE; MONOCYTES; CORTISOL; RECEPTOR; SYSTEM	Annexin A1 (AnxA1) is a key player in resolution of inflammation and a mediator of glucocorticoid actions. In atherosclerotic tissue, increased expression of AnxA1 has been associated with protective plaque-stabilizing effects. Here, we investigated the expression of AnxA1 in peripheral blood mononuclear cells (PBMCs) from patients with coronary artery disease (CAD). Blood was collected from 57 patients with stable CAD (SCAD) and 41 healthy controls. We also included a minor group (n = 10) with acute coronary syndrome (ACS). AnxA1 mRNA was measured in PBMCs. Expression of AnxA1 protein (total and surface-bound) and glucocorticoid receptors (GR) were detected in PBMC subsets by flow cytometry. Also, salivary cortisol, interleukin(IL)-6 and IL-10 in plasma, and LPS-induced cytokine secretion from PBMCs, with or without dexamethasone, were assessed. AnxA1 mRNA was found to be slightly increased in PBMCs from SCAD patients compared with controls. However, protein expression of AnxA1 or GRs in PBMC subsets did not differ between SCAD patients and controls, despite SCAD patients showing a more proinflammatory cytokine profile ex vivo. Only surface expression of AnxA1 on monocytes correlated with dexamethasone-mediated suppression of cytokines. In ACS patients, a marked activation of AnxA1 was seen involving both gene expression and translocation of protein to cell surface probably reflecting a rapid glucocorticoid action modulating the acute inflammatory response in ACS. To conclude, surface expression of AnxA1 on monocytes may reflect the degree of glucocorticoid sensitivity. Speculatively, "normal" surface expression of AnxA1 indicates that anti-inflammatory capacity is impaired in SCAD patients.	[Bergstrom, Ida; Lundberg, Anna K.; Jonsson, Simon; Jonasson, Lena] Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci, Fac Hlth Sci, Linkoping, Sweden; [Bergstrom, Ida; Ernerudh, Jan] Linkoping Univ, Dept Clin Immunol & Transfus Med, Dept Clin & Expt Med, Linkoping, Sweden; [Sarndahl, Eva] Orebro Univ, Fac Med & Hlth, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden; [Sarndahl, Eva] Orebro Univ, Fac Med & Hlth, IRiSC Inflammatory Response & Infect Susceptibil, Orebro, Sweden	Linkoping University; Linkoping University; Orebro University; Orebro University	Jonasson, L (corresponding author), Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci, Fac Hlth Sci, Linkoping, Sweden.	lena.jonasson@liu.se		Jonasson, Lena/0000-0002-0586-6618	Swedish Research Council [K2015-65x-14599-13-3]; Heart-Lung Foundation [20150648]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by the Swedish Research Council, www.vr.se, K2015-65x-14599-13-3, to LJ; and the Heart-Lung Foundation, www.hjart-lungfonden.se, 20150648, to LJ.	Backteman K, 2007, J IMMUNOL METHODS, V322, P20, DOI 10.1016/j.jim.2007.01.021; Bagnato C, 2007, MOL CELL PROTEOMICS, V6, P1088, DOI 10.1074/mcp.M600259-MCP200; Calvert PA, 2011, ARTERIOSCL THROM VAS, V31, P2157, DOI 10.1161/ATVBAHA.111.229237; Cheuk BLY, 2011, EUR J VASC ENDOVASC, V41, P364, DOI 10.1016/j.ejvs.2010.11.021; COMERA C, 1995, BRIT J PHARMACOL, V115, P1043, DOI 10.1111/j.1476-5381.1995.tb15916.x; Eisenberg EH, 2013, ATHEROSCLEROSIS, V231, P346, DOI DOI 10.1016/J.ATHER0SCLER0SIS.2013.09.036; Fantidis P, 2002, EUR J CLIN INVEST, V32, P304, DOI 10.1046/j.1365-2362.2002.00988.x; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Ghattas A, 2013, J AM COLL CARDIOL, V62, P1541, DOI 10.1016/j.jacc.2013.07.043; GOULDING NJ, 1990, LANCET, V335, P1416, DOI 10.1016/0140-6736(90)91445-G; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Lange C, 2007, J LEUKOCYTE BIOL, V82, P1592, DOI 10.1189/jlb.0307158; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; MCLEOD JD, 1995, CELL MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02073328; MCLEOD JD, 1995, BIOCHEM PHARMACOL, V50, P1103, DOI 10.1016/0006-2952(95)00234-Q; MORAND EF, 1994, ARTHRITIS RHEUM, V37, P207, DOI 10.1002/art.1780370209; MORAND EF, 1995, CLIN IMMUNOL IMMUNOP, V76, P195, DOI 10.1006/clin.1995.1115; Mulla A, 2005, J CLIN ENDOCR METAB, V90, P557, DOI 10.1210/jc.2004-1230; Nijm J, 2007, J INTERN MED, V262, P375, DOI 10.1111/j.1365-2796.2007.01817.x; Perretti M., 2009, NAT REV IMMUNOL, V9, P62; Quax RA, 2013, NAT REV ENDOCRINOL, V9, P670, DOI 10.1038/nrendo.2013.183; Sarndahl E, 2010, METABOLISM, V59, P433, DOI 10.1016/j.metabol.2009.07.044; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Spurr L, 2011, INT IMMUNOPHARMACOL, V11, P55, DOI 10.1016/j.intimp.2010.10.006; Strausbaugh HJ, 2001, J IMMUNOL, V166, P6294, DOI 10.4049/jimmunol.166.10.6294; van Erk MJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-5; Viiri LE, 2013, J MOL CELL CARDIOL, V54, P65, DOI 10.1016/j.yjmcc.2012.11.002; Yazid S, 2012, PROSTAG OTH LIPID M, V98, P94, DOI 10.1016/j.prostaglandins.2011.11.005	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174177	10.1371/journal.pone.0174177	http://dx.doi.org/10.1371/journal.pone.0174177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329022	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700065
J	Chen, WH; Xu, JL; Zhou, JJ; Gu, ZQ; Huang, SH; Li, HM; Qin, ZE; Yu, XP				Chen, Wuhe; Xu, Jinling; Zhou, Jinjing; Gu, Zhouqun; Huang, Shenghai; Li, Heming; Qin, Zhuoer; Yu, Xinping			Thickness of retinal layers in the foveas of children with anisometropic amblyopia	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; MACULAR THICKNESS; STRABISMIC AMBLYOPIA; UNILATERAL AMBLYOPIA; DOMAIN; EYES; HISTOLOGY; FEATURES; FUNDUS	Purpose To use highly precise spectral-domain optical coherence tomography (SD-OCT) to determine whether there were structural abnormalities in the layers of different regions of the fovea in children with anisometropic amblyopia. Methods Eighteen children (mean age 7.8 years old; range 5-11 years) with unilateral anisometropic amblyopia and 18 age-matched control subjects participated. Foveal thickness was measured with an enhanced depth imaging system, SD-OCT and segmented into layers using custom developed software. The thickness of each layer of the fovea was compared among amblyopic eyes, fellow eyes and control eyes with optical magnification correction for axial length and statistical correction for age and sex. Results The total thickness and each intra-ocular layer of the central fovea were the same for each group. However, the amblyopic eyes were significantly thicker than the normal control eyes in 2 of 4 quadrants of the peripheral retina. Exploring intra-retinal layers in these two quadrants, the nasal nerve fiber layer (NFL) and inferior inner nuclear layer (INL)were significantly thicker in amblyopic eyes than in control eyes (p = 0.01 and 0.012, respectively, by ANCOVA). Conclusion The SD-OCT data revealed marginal differences in some foveal layers at peripheral locations and indicated that structural differences might exist between individuals with amblyopia and visually normal control subjects. However, the differences were scattered and represented no identifiable pattern. More studies with large samples and precise locations of the retinal layers must be performed to extend the present results.	[Yu, Xinping] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; Wenzhou Med Univ, Eye Hosp, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Yu, XP (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	yu-xinping@163.com			Chinese Ministry of Health [201302015]; National Key Research and Development Program [201611E130401203]	Chinese Ministry of Health; National Key Research and Development Program	This study was funded by Chinese Ministry of Health (Health research projects 201302015) and the National Key Research and Development Program (201611E130401203). The fee of the open access was paid by the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad CE, 2011, BRIT J OPHTHALMOL, V95, P1696, DOI 10.1136/bjo.2010.195081; Al-Haddad CE, 2013, BRIT J OPHTHALMOL, V97, P318, DOI 10.1136/bjophthalmol-2012-302434; Altintas O, 2005, J PEDIAT OPHTH STRAB, V42, P216; American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus Panel, 2012, PREF PRACT PATT GUID; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bruce A, 2013, OPHTHALMOLOGY, V120, P395, DOI 10.1016/j.ophtha.2012.07.088; Chen WH, 2013, CURR EYE RES, V38, P1248, DOI 10.3109/02713683.2013.805233; Delint PJ, 1998, VISION RES, V38, P613, DOI 10.1016/S0042-6989(97)00191-0; Dickmann A, 2011, J AAPOS, V15, P338, DOI 10.1016/j.jaapos.2011.03.019; Grover S, 2010, INVEST OPHTH VIS SCI, V51, P2644, DOI 10.1167/iovs.09-4774; HELVESTON EM, 1967, AM J OPHTHALMOL, V64, P687, DOI 10.1016/0002-9394(67)92849-8; HENDRICKSON AE, 1987, J NEUROSCI, V7, P1327; Hendrickson A, 2012, AM J OPHTHALMOL, V154, P767, DOI 10.1016/j.ajo.2012.05.007; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; Kee Se-Young, 2006, Korean J Ophthalmol, V20, P177; LEVI DM, 1982, NATURE, V298, P268, DOI 10.1038/298268a0; LEVI DM, 1982, INVEST OPHTH VIS SCI, V23, P398; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Liu XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087996; Nishi T, 2015, BRIT J OPHTHALMOL, V99, P1060, DOI 10.1136/bjophthalmol-2014-305685; Pang Y, 2011, INVEST OPHTH VIS SCI, V52, P2444, DOI 10.1167/iovs.10-5550; Park KA, 2011, BRIT J OPHTHALMOL, V95, P1700, DOI 10.1136/bjo.2010.192765; ROMANO PE, 1980, J PEDIAT OPHTH STRAB, V17, P318; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Simons K, 2005, SURV OPHTHALMOL, V50, P123, DOI 10.1016/j.survophthal.2004.12.005; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Stewart CE, 2005, INVEST OPHTH VIS SCI, V46, P3152, DOI 10.1167/iovs.05-0357; Turk A, 2012, AM J OPHTHALMOL, V153, P552, DOI 10.1016/j.ajo.2011.08.026; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; VONNOORDEN GK, 1975, INVEST OPHTH VISUAL, V14, P674; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Xu JL, 2013, CLIN EXP OPTOM, V96, P267, DOI 10.1111/cxo.12001; Yanni SE, 2013, AM J OPHTHALMOL, V155, P354, DOI 10.1016/j.ajo.2012.08.010; Yoon Sang Won, 2005, Korean J Ophthalmol, V19, P62	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174537	10.1371/journal.pone.0174537	http://dx.doi.org/10.1371/journal.pone.0174537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328978	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700096
J	Kashiwagi, K; Inoue, N; Yoshida, T; Bessyo, R; Yoneno, K; Imaeda, H; Ogata, H; Kanai, T; Sugino, Y; Iwao, Y				Kashiwagi, Kazuhiro; Inoue, Nagamu; Yoshida, Toshifumi; Bessyo, Rieko; Yoneno, Kazuaki; Imaeda, Hiroyuki; Ogata, Haruhiko; Kanai, Takanori; Sugino, Yoshinori; Iwao, Yasushi			Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy	PLOS ONE			English	Article							ADENOMA DETECTION RATES; QUALITY INDICATORS; COLORECTAL-CANCER; INTERVAL CANCER; DISTAL COLON; IMPACT; CLASSIFICATION; ENDOSCOPIST; PERFORMANCE; VALIDATION	Background The guidelines for colonoscopy present withdrawal time (WT) and adenoma detection rate (ADR) as the quality indicator. The purpose of this retrospective study is to analyze the predicting factors with polyp detection rate (PDR) as a surrogate for ADR by using comprehensive health checkup data, and assess the correlation between PDR per each colonic segment and WT, and factors influencing WT. Methods One thousand and thirty six consecutive health checkup cases from April 2015 to March 2016 were enrolled in this study, and 880 subjects who undertook colonoscopy without polyp removal or biopsy were divided into the two groups (polyp not detected group vs polyp detected group). The two groups were compared by subjects and clinical characteristics with univariate analysis followed by multivariate analysis. Colonoscopies with longer WT (>= 6 min) and those with shorter WT (< 6 min) were compared by PDR per each colonic segment, and also by subjects and clinical characteristics. Results A total of 1009 subjects included two incomplete colonoscopies (CIR, 99.9%) and overall PDR was 35.8%. A multiple logistic regression model demonstrated that age, gender, and WT were significantly related factors for polyp detection (odds ratio, 1.036; 1.771; 1.217). PDR showed a linear increase as WT increased from 3 min to 9 min (r = 0.989, p = 0.000) and PDR with long WT group was higher than that with short WT group per each colonic segment, significantly in transverse (2.3 times, p = 0.004) and sigmoid colon (2.1 times, p = 0.001). Not only bowel preparation quality but also insertion difficulty evaluated by endoscopist were significant factors relating with WT (odds ratio, 3.811; 1.679). Conclusion This study suggests that endoscopists should be recommended to take more time up to 9 min of WT to observe transverse and sigmoid colon, especially when they feel no difficulty during scope insertion.	[Kashiwagi, Kazuhiro; Inoue, Nagamu; Yoshida, Toshifumi; Bessyo, Rieko; Sugino, Yoshinori; Iwao, Yasushi] Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan; [Yoneno, Kazuaki; Kanai, Takanori] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan; [Imaeda, Hiroyuki] Saitama Med Univ, Sch Med, Dept Gen Med, Saitama, Japan; [Ogata, Haruhiko] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan	Keio University; Keio University; Saitama Medical University; Keio University	Kashiwagi, K (corresponding author), Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan.	kazuuk075@aol.com		Kanai, Takanori/0000-0002-1466-4532				Adler A, 2013, GUT, V62, P236, DOI 10.1136/gutjnl-2011-300167; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Boroff ES, 2013, AM J GASTROENTEROL, V108, P993, DOI 10.1038/ajg.2013.68; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Corporaal S, 2010, SCAND J GASTROENTERO, V45, P1380, DOI 10.3109/00365521003734158; Francis DL, 2011, GASTROINTEST ENDOSC, V73, P493, DOI 10.1016/j.gie.2011.01.005; Gupta S, 2012, CLIN GASTROENTEROL H, V10, P1395, DOI 10.1016/j.cgh.2012.07.004; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Hayashi N, 2013, GASTROINTEST ENDOSC, V78, P625, DOI 10.1016/j.gie.2013.04.185; Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Laiyemo AO, 2011, GASTROINTEST ENDOSC, V74, P253, DOI 10.1016/j.gie.2011.02.023; Lee RH, 2011, GASTROINTEST ENDOSC, V74, P128, DOI 10.1016/j.gie.2011.03.003; Lee TJW, 2013, ENDOSCOPY, V45, P20, DOI 10.1055/s-0032-1325803; Lee TJW, 2012, GUT, V61, P1050, DOI 10.1136/gutjnl-2011-300651; Patel SG, 2016, GASTROENTEROLOGY, V150, P406, DOI 10.1053/j.gastro.2015.10.042; Pohl H, 2016, ENDOSCOPY, V48, P817, DOI 10.1055/s-0042-108432; Rembacken B, 2012, ENDOSCOPY, V44, P957, DOI 10.1055/s-0032-1325686; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2015, GASTROINTEST ENDOSC, V81, P31, DOI 10.1016/j.gie.2014.07.058; Rex DK, 2010, AM J GASTROENTEROL, V105, P2312, DOI 10.1038/ajg.2010.245; Rondagh EJA, 2012, GASTROINTEST ENDOSC, V75, P1218, DOI 10.1016/j.gie.2012.02.010; Sawhney MS, 2008, GASTROENTEROLOGY, V135, P1892, DOI 10.1053/j.gastro.2008.08.024; Shaukat A, 2015, GASTROENTEROLOGY, V149, P952, DOI 10.1053/j.gastro.2015.06.044; Simmons DT, 2006, ALIMENT PHARM THERAP, V24, P965, DOI 10.1111/j.1365-2036.2006.03080.x; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Tanaka S, 2015, J GASTROENTEROL, V50, P252, DOI 10.1007/s00535-014-1021-4; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174155	10.1371/journal.pone.0174155	http://dx.doi.org/10.1371/journal.pone.0174155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328936	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700061
J	Oprisan, SA; Austin, DI				Oprisan, Sorinel A.; Austin, Dave I.			A generalized phase resetting method for phase-locked modes prediction	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; SYNCHRONIZATION; NETWORKS; PRECESSION; MECHANISMS; RESPONSES; DYNAMICS; PATTERNS; SPEECH; 2-CELL	We derived analytically and checked numerically a set of novel conditions for the existence and the stability of phase-locked modes in a biologically relevant master-slave neural network with a dynamic feedback loop. Since neural oscillators even in the three-neuron network investigated here receive multiple inputs per cycle, we generalized the concept of phase resetting to accommodate multiple inputs per cycle. We proved that the phase resetting produced by two or more stimuli per cycle can be recursively computed from the traditional, single stimulus, phase resetting. We applied the newly derived generalized phase resetting definition to predicting the relative phase and the stability of a phase-locked mode that was experimentally observed in this type of master-slave network with a dynamic loop network.	[Oprisan, Sorinel A.; Austin, Dave I.] Coll Charleston, Dept Phys & Astron, Charleston, SC 29401 USA	College of Charleston	Oprisan, SA (corresponding author), Coll Charleston, Dept Phys & Astron, Charleston, SC 29401 USA.	oprisans@cofc.edu			US National Science Foundation [10S-1054914]; Division Of Integrative Organismal Systems [1054914] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Career award 10S-1054914 from US National Science Foundation to SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Buhusi CV, 2013, BEHAV PROCESS, V95, P60, DOI 10.1016/j.beproc.2013.02.015; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Buzsaki G., 2011, NEURON; Calvo O, 2004, CHAOS, V14, P7, DOI 10.1063/1.1620991; Ciszak M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046203; Colgin LL, 2015, CURR OPIN NEUROBIOL, V31, P45, DOI 10.1016/j.conb.2014.08.001; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dilgen JE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00213; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout GB, 2012, NEURAL COMPUT, V24, P3111, DOI 10.1162/NECO_a_00370; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Malerba P, 2013, J MATH BIOL, V66, P1361, DOI 10.1007/s00285-012-0534-9; Matias FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140504; Matias FS, 2014, NEUROIMAGE, V99, P411, DOI 10.1016/j.neuroimage.2014.05.063; Matias FS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021922; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nadim F, 2012, SPR SER COMPUT NEURO, V6, P399, DOI 10.1007/978-1-4614-0739-3_16; Netoff TI, 2005, J COMPUT NEUROSCI, V18, P287, DOI 10.1007/s10827-005-0336-9; Oprisan S., 2013, ISRN COMPUT BIOL, V2013, P1, DOI [DOI 10.1155/2013/230571, 10.1155/2013/230571]; Oprisan SA, 2005, NEUROCOMPUTING, V65, P733, DOI 10.1016/j.neucom.2004.10.069; Oprisan SA, 2004, BIOPHYS J, V87, P2283, DOI 10.1529/biophysj.104.046193; Oprisan SA, 2003, BIOPHYS J, V84, P2919, DOI 10.1016/S0006-3495(03)70019-8; Oprisan SA, 2002, J DIFFER EQUATIONS, P243; Oprisan SA, 2014, ENCY COMPUTATIONAL N, P1; Oprisan SA, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00125; Oprisan SA, 2014, BEHAV PROCESS, V101, P146, DOI 10.1016/j.beproc.2013.09.005; Oprisan SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0459; Oprisan SA, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-84; Oprisan SA, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052717; Oprisan SA, 2008, INT J NEUROSCI, V118, P867, DOI 10.1080/00207450701750471; Oprisan SA, 2012, SPR SER COMPUT NEURO, V6, P131, DOI 10.1007/978-1-4614-0739-3_6; Oprisan SA, 2010, J THEOR BIOL, V262, P232, DOI 10.1016/j.jtbi.2009.09.036; Oprisan SA, 2009, INT J NEUROSCI, V119, P482, DOI 10.1080/00207450802336766; PERKEL DH, 1964, SCIENCE, V145, P61, DOI 10.1126/science.145.3627.61; Pervouchine DD, 2006, NEURAL COMPUT, V18, P2617, DOI 10.1162/neco.2006.18.11.2617; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Sausedo-Solorio JM, 2014, PHYS LETT A, V378, P2108, DOI 10.1016/j.physleta.2014.05.003; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Simonov AY, 2014, JETP LETT+, V98, P632, DOI 10.1134/S0021364013230136; Skinner FK, 2005, J COMPUT NEUROSCI, V18, P343, DOI 10.1007/s10827-005-0331-1; Stephan KE, 2000, PHILOS T R SOC B, V355, P37, DOI 10.1098/rstb.2000.0548; Stepp N, 2010, COGN SYST RES, V11, P148, DOI 10.1016/j.cogsys.2009.03.003; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Vollmer MK, 2015, J S CAROLINA ACAD SC, V13, P5; Voss HU, 2000, PHYS REV E, V61, P5115, DOI 10.1103/PhysRevE.61.5115; Wilson CJ, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00050; WINFREE AT, 1989, J THEOR BIOL, V138, P353, DOI 10.1016/S0022-5193(89)80200-0; Winfree AT., 1980, GEOMETRY BIOL TIME	70	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174304	10.1371/journal.pone.0174304	http://dx.doi.org/10.1371/journal.pone.0174304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323894	Green Submitted, gold, Green Published			2022-12-27	WOS:000399089000084
J	Shi, JM; Pei, J; Liu, EQ; Zhang, L				Shi, Jing-Ming; Pei, Jie; Liu, En-Qi; Zhang, Lin			Bis(sulfosuccinimidyl) suberate (BS3) crosslinking analysis of the behavior of amyloid-beta peptide in solution and in phospholipid membranes	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ION CHANNELS; PROTEIN; OLIGOMERS; FIBRILLOGENESIS; DIMERIZATION; AGGREGATION; A-BETA-42; FORMS	The structure and state of amyloid-beta peptide (A beta) oligomers often need to be checked by reliable experimental methods. Electrophoresis is a commonly applied measurement method. However, due to the presence of detergents, oligomers are easily broken during electrophoresis, which makes it very hard to accurately assess A beta aggregate states. In the current study, bis(sulfosuccinimidyl) suberate (BS3) was used to cross-link A beta 1-42 oligomers prior to electrophoresis. When compared to a previously reported A beta cross-linking agent, glutaraldehyde, it was quite apparent that BS3 is more suitable for detecting intra-membrane A beta oligomers and extra-membrane A beta oligomers states. As such, our findings provide an efficient method for analyzing A beta proteins or other proteins that are easily aggregated in solution and in phospholipid membranes.	[Shi, Jing-Ming; Liu, En-Qi; Zhang, Lin] Xi An Jiao Tong Univ, Res Inst Atherosclerot Dis, Cardiovasc Res Ctr, Xian, Peoples R China; [Shi, Jing-Ming] Xizang Minzu Univ, Sch Med, Xian Yang, Peoples R China; [Pei, Jie] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China	Xi'an Jiaotong University; Xizang Minzu University; Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Liu, EQ (corresponding author), Xi An Jiao Tong Univ, Res Inst Atherosclerot Dis, Cardiovasc Res Ctr, Xian, Peoples R China.	liuenqi@mail.xjtu.edu.cn	liu, enqi/S-7771-2019; Shi, Jing-Ming/ACS-3321-2022	Shi, Jing-Ming/0000-0002-8185-3130; Liu, Enqi/0000-0002-2092-3158	National Nature Science Foundation of China [31660243]; Public Service Platform Grant of Shaanxi province [2012FWPT-03, 2014FWPT-07]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Platform Grant of Shaanxi province	This work was supported by the National Nature Science Foundation of China (Grant 31660243) and a Public Service Platform Grant of Shaanxi province (2012FWPT-03; 2014FWPT-07). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan Gal, 2004, V299, P3; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419; Fortea J, 2014, ANN NEUROL, V76, P223, DOI 10.1002/ana.24186; Ivanov KI, 2014, JOVE-J VIS EXP, DOI 10.3791/51536; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Melah KE, 2016, J ALZHEIMERS DIS, V50, P873, DOI 10.3233/JAD-150897; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Ochiishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22712; PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Schmidt C, 2014, NAT PROTOC, V9, P2224, DOI 10.1038/nprot.2014.144; SORKIN A, 1991, J BIOL CHEM, V266, P23453; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Turk HF, 2015, METHODS MOL BIOL, V1233, P25, DOI 10.1007/978-1-4939-1789-1_3; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang XT, 2015, BIO-MED MATER ENG, V26, P19, DOI 10.3233/BME-151548; Zhang YJ, 2012, J BIOL CHEM, V287, P748, DOI 10.1074/jbc.M111.281295	33	8	10	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173871	10.1371/journal.pone.0173871	http://dx.doi.org/10.1371/journal.pone.0173871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323849	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000034
J	Iwamoto, A; Taira, R; Yokomaku, Y; Koibuchi, T; Rahman, M; Izumi, Y; Tadokoro, K				Iwamoto, Aikichi; Taira, Rikizo; Yokomaku, Yoshiyuki; Koibuchi, Tomohiko; Rahman, Mahbubur; Izumi, Yoko; Tadokoro, Kenji			The HIV care cascade: Japanese perspectives	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; PREVENTION; INDINAVIR; MORTALITY	Japan has been known as a low HIV-prevalence country with a concentrated epidemic among high-risk groups. However, it has not been determined whether Japan meets the 90-90-90 goals set by the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO). Moreover, to date, the HIV care cascade has not been examined. We estimated the total number of diagnosed people living with HIV/AIDS (PLWHA) (n = 22,840) based on legal reports to the Ministry of Health, Labour and Welfare by subtracting the number of foreigners who left Japan (n = 2,273) and deaths (n = 2,321) from the cumulative diagnosis report (n = 27,434). The number of total undiagnosed PLWHA was estimated by age and sex specific HIV-positive rates observed among first-time blood donors between 2011-2015 in Japan. Our estimates show that 14.4% (n = 3,830) of all PLWHA (n = 26,670) were undiagnosed in Japan at the end of 2015. The number of patients retained in care (n = 20,615: 77.3% of PLWHA), the percentage of those on antiretroviral therapy (n = 18,921: 70.9% of PLWHA) and those with suppressed viral loads (<200 copies/mL; n = 18,756: 70.3% of PLWHA) were obtained through a questionnaire survey conducted in the AIDS Core Hospitals throughout the country. According to these estimates, Japan failed to achieve the first two of the three UNAIDS/WHO targets (22,840/26,670 = 85.6% of HIV-positive cases were diagnosed; 18,921/22,840 = 82.8% of those diagnosed were treated; 18,756/18,921 = 99.1% of those treated experienced viral suppression). Although the antiretroviral treatment uptake and success after retention in medical care appears to be excellent in Japan, there are unmet needs, mainly at the surveillance level before patients are retained in care. The promotion of HIV testing and treatment programs among the key affected populations (especially men who have sex with men) may contribute to further decreasing the HIV epidemic and achieving the UNAIDS/WHO targets in Japan.	[Iwamoto, Aikichi; Izumi, Yoko] Japan Agcy Med Res & Dev, Tokyo, Japan; [Taira, Rikizo; Tadokoro, Kenji] Japanese Red Cross Soc, Blood Serv Headquarters, Tokyo, Japan; [Yokomaku, Yoshiyuki] Natl Hosp Organ, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Koibuchi, Tomohiko] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Rahman, Mahbubur] St Lukes Int Univ, Tokyo, Japan	Nagoya Medical Center; University of Tokyo; St. Luke's International Hospital	Iwamoto, A (corresponding author), Japan Agcy Med Res & Dev, Tokyo, Japan.	aikichi@zj9.so-net.ne.jp			Ministry of Health, Labour, and Welfare of Japan [H27-AIDS-SHITEI-005, H27-AIDS-SHITEI-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Health and Labour Sciences Research Grants (H27-AIDS-SHITEI-005) (YY) and (H27-AIDS-SHITEI-004) (TK) from the Ministry of Health, Labour, and Welfare of Japan (http://www.mhlw.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Surveillance Committee Ministry of Health Labour and Welfare Japan, 2015, ANN AIDS OCC REP; AIDS Surveillance Committee Ministry of Health Labour and Welfare Japan, 2016, HIV POS SAMPL DON BL; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gisslen M, 2016, SWEDEN 1 COUNTRY ACH; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084318; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hashimoto S, 2004, J EPIDEMIOL, V14, P182, DOI 10.2188/jea.14.182; Hashimoto S, 2009, J AIDS RES, V11, P152; Law MG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-10; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; MacCarthy Sarah, 2015, J Int AIDS Soc, V18, P19395, DOI 10.7448/IAS.18.1.19395; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; Ministry of Health Labour and Welfare Japan, 1993, IMPL AIDS COR HOSP; Ministry of Health Labour and Welfare Japan, STAND REP HIV INF AI; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakao T., 2016, RES INCREASE EFFECTI, P3; Okano JT, 2016, LANCET INFECT DIS, V16, P789, DOI 10.1016/S1473-3099(16)30022-6; Raymond A, 2014, J INT AIDS SOC, V17, P13, DOI 10.7448/IAS.17.4.19507; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Sabin CA, 2009, CURR OPIN INFECT DIS, V22, P191, DOI 10.1097/QCO.0b013e328326cd34; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Tanaka K, 2009, J HEALTHCARE ASS INF, V2, P1; UNAIDS, 2016, REP UNAIDS HIV AIDS; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231; Yokomaku Y, 2016, RES STATUS MED CARE	33	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174360	10.1371/journal.pone.0174360	http://dx.doi.org/10.1371/journal.pone.0174360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319197	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800070
J	Lell, MM; Fleischmann, U; Pietsch, H; Korporaal, JG; Haberland, U; Mahnken, AH; Flohr, TG; Uder, M; Jost, G				Lell, Michael M.; Fleischmann, Ulrike; Pietsch, Hubertus; Korporaal, Johannes G.; Haberland, Ulrike; Mahnken, Andreas H.; Flohr, Thomas G.; Uder, Michael; Jost, Gregor			Relationship between low tube voltage (70 kV) and the iodine delivery rate (IDR) in CT angiography: An experimental in-vivo study	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DUAL-SOURCE CT; PULMONARY ANGIOGRAPHY; TEST BOLUS; CONTRAST MATERIAL; INJECTION PROTOCOLS; IMAGE-QUALITY; ENHANCEMENT; FEASIBILITY; PERFORMANCE	Objective Very short acquisition times and the use of low- kV protocols in CTA demand modifications in the contrast media (CM) injection regimen. The aim of this study was to optimize the use of CM delivery parameters in thoraco- abdominal CTA in a porcine model. Materials and methods Six pigs (55-68 kg) were examined with a dynamic CTA protocol (454 mm scan length, 2.5 s temporal resolution, 70 s total acquisition time). Four CM injection protocols were applied in a randomized order. 120 kV CTA protocol: (A) 300 mg iodine/kg bodyweight (bw), IDR = 1.5 g/s (flow = 5 mL/s), injection time (t1) 12 s (60 kg bw). 70 kV CTA protocols: 150 mg iodine/kg bw: (B) IDR = 0.75 g/s (flow = 2.5 mL/s), t1 = 12 s (60 kg bw); (C) IDR = 1.5 g/s (flow = 5 mL/s), t1 = 12 s (60 kg bw); (D) IDR = 3.0 g/s (flow = 10 mL/s), t1 = 3 s (60 kg bw). The complete CM bolus shape was monitored by creating time attenuation curves (TAC) in different vascular territories. Based on the TAC, the time to peak (TTP) and the peak enhancement were determined. The diagnostic window (relative enhancement >300 HU), was calculated and compared to visual inspection of the corresponding CTA data sets. Results The average relative arterial peak enhancements after baseline correction were 358.6 HU (A), 356.6 HU (B), 464.0 HU (C), and 477.6 HU (D). The TTP decreased with increasing IDR and decreasing ti, protocols A and B did not differ significantly (systemic arteries, p = 0.843; pulmonary arteries, p = 0.183). The delay time for bolus tracking (trigger level 100 HU; target enhancement 300 HU) for single- phase CTA was comparable for protocol A and B (3.9, 4.3 s) and C and D (2.4, 2.0 s). The scan window time frame was comparable for the different protocols by visual inspection of the different CTA data sets and by analyzing the TAC. Conclusions All protocols provided sufficient arterial enhancement. The use of a 70 kV CTA protocol isrecommended because of a 50% reduction of total CM volume and a 50% reduced flow ratewhile maintaining the bolus profile. In contrast to pulmonary arterial enhancement, the systemicarterial enhancement improved only slightly increasing the IDR from 1.5 g/s to 3 g/sbecause of bolus dispersion of the very short bolus (3s) in the lungs.	[Lell, Michael M.; Uder, Michael] Paracelsus Med Univ, Dept Radiol & Nucl Med, Nurnberg, Germany; [Fleischmann, Ulrike] Friedrich Alexander Univ Erlangen, Dept Radiol, Erlangen, Germany; [Pietsch, Hubertus; Jost, Gregor] Bayer Healthcare, MR&CT Contrast Media Res, Berlin, Germany; [Korporaal, Johannes G.; Haberland, Ulrike; Flohr, Thomas G.] Siemens Healthcare, Forchheim, Germany; [Mahnken, Andreas H.] Univ Marburg, Dept Radiol, Marburg, Germany; [Uder, Michael] Imaging Sci Inst ISI Erlangen, Erlangen, Germany	University of Erlangen Nuremberg; Bayer AG; Bayer Healthcare Pharmaceuticals; Siemens AG; Siemens Germany; Philipps University Marburg	Lell, MM (corresponding author), Paracelsus Med Univ, Dept Radiol & Nucl Med, Nurnberg, Germany.	michael.lell@klinikum-nuernberg.de		Lell, Michael/0000-0002-4800-4428; Mahnken, Andreas H./0000-0001-8077-9306				Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; Bach AG, 2015, EUR J RADIOL, V84, P332, DOI 10.1016/j.ejrad.2014.11.023; Bae KT, 2000, RADIOLOGY, V216, P872, DOI 10.1148/radiology.216.3.r00au43872; Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Baxa J, 2014, EUR J RADIOL, V83, pE147, DOI 10.1016/j.ejrad.2013.12.004; Benner T, 1997, MAGN RESON IMAGING, V15, P307, DOI 10.1016/S0730-725X(96)00392-X; Bulla S, 2012, ACTA RADIOL, V53, P69, DOI 10.1258/ar.2011.110244; Dawson P, 2006, EUR J RADIOL, V60, P331, DOI 10.1016/j.ejrad.2006.06.023; Eller A, 2012, INVEST RADIOL, V47, P559, DOI 10.1097/RLI.0b013e318260c5d6; Fleischmann D, 2000, RADIOLOGY, V214, P363, DOI 10.1148/radiology.214.2.r00fe18363; Henzler T, 2012, EUR J RADIOL, V81, P132, DOI 10.1016/j.ejrad.2010.06.023; Higashigaito K, 2016, INVEST RADIOL, V51, P241, DOI 10.1097/RLI.0000000000000233; Kandel SM, 2014, RADIOLOGY, V270, P125, DOI 10.1148/radiol.13130024; Kanematsu M, 2014, AM J ROENTGENOL, V202, pW106, DOI 10.2214/AJR.13.10720; Kerl JM, 2012, EUR J RADIOL, V81, P2887, DOI 10.1016/j.ejrad.2011.09.018; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Klotz E, 2015, EUR J RADIOL, V84, P2359, DOI 10.1016/j.ejrad.2015.06.010; Kok M, 2014, INVEST RADIOL, V49, P217, DOI 10.1097/RLI.0000000000000019; Korporaal JG, 2015, INVEST RADIOL, V50, P1, DOI 10.1097/RLI.0000000000000088; Lell MM, 2006, RADIOGRAPHICS, V26, pS45, DOI 10.1148/rg.26si065508; Lell MM, 2015, INVEST RADIOL, V50, P629, DOI 10.1097/RLI.0000000000000172; Lell MM, 2015, INVEST RADIOL, V50, P161, DOI 10.1097/RLI.0000000000000119; Meinel FG, 2014, EUR RADIOL, V24, P1643, DOI 10.1007/s00330-014-3194-x; Meyer M, 2014, RADIOLOGY, V273, P373, DOI 10.1148/radiol.14140244; Mihl C, 2015, INVEST RADIOL, V50, P464, DOI 10.1097/RLI.0000000000000153; Miles KA, 2012, EUR RADIOL, V22, P1430, DOI 10.1007/s00330-012-2379-4; Rossi A, 2014, RADIOLOGY, V270, P24, DOI 10.1148/radiol.13112739; Runge VM, 2015, INVEST RADIOL, V50, P119, DOI 10.1097/RLI.0000000000000125; Wichmann JL, 2015, J THORAC IMAG, V30, P69, DOI 10.1097/RTI.0000000000000124; Winklehner A, 2015, EUR RADIOL, V25, P2346, DOI 10.1007/s00330-015-3632-4; Wintersperger BJ, 2015, INVEST RADIOL, V50, P557, DOI 10.1097/RLI.0000000000000164	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173592	10.1371/journal.pone.0173592	http://dx.doi.org/10.1371/journal.pone.0173592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319203	Green Published, gold			2022-12-27	WOS:000398945800020
J	Fortin, Y; Crispo, JAG; Cohen, D; McNair, DS; Mattison, DR; Krewski, D				Fortin, Yannick; Crispo, James A. G.; Cohen, Deborah; McNair, Douglas S.; Mattison, Donald R.; Krewski, Daniel			External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality	PLOS ONE			English	Article							ADMINISTRATIVE DATA; PERFORMANCE; SCORES; INFORMATION; ADJUSTMENT; CHARLSON; INDEXES; MODEL	Assessing prevalent comorbidities is a common approach in health research for identifying clinical differences between individuals. The objective of this study was to validate and compare the predictive performance of two variants of the Elixhauser comorbidity measures (ECM) for inhospital mortality at index and at 1-year in the Cerner Health Facts (R) (HF) U.S. database. We estimated the prevalence of select comorbidities for individuals 18 to 89 years of age who received care at Cerner contributing health facilities between 2002 and 2011 using the AHRQ (version 3.7) and the Quan Enhanced ICD-9-CM ECMs. External validation of the ECMs was assessed with measures of discrimination [c-statistics], calibration [Hosmer Lemeshow goodness-of-fit test, Brier Score, calibration curves], added predictive ability [Net Reclassification Improvement], and overall model performance [R-2]. Of 3,273,298 patients with a mean age of 43.9 years and a female composition of 53.8%, 1.0% died during their index encounter and 1.5% were deceased at 1-year. Calibration measures were equivalent between the two ECMs. Calibration performance was acceptable when predicting inhospital mortality at index, although recalibration is recommended for predicting inhospital mortality at 1 year. Discrimination was marginally better with the Quan ECM compared the AHRQ ECM when predicting inhospital mortality at index (C-Quan =0.887, 95% CI: 0.885-0.889 vs. cAHRQ = 0.880, 95% CI: 0.878-0.882; p <.0001) and at 1-year (c(Quan) 0.884, 95% CI: 0.883-0.886 vs. c(AHRQ) = 0.880, 95% CI: 0.878-0.881, p < .0001). Both the Quan and the AHRQ ECMs demonstrated excellent discrimination for inhospital mortality of all-causes in Cerner Health Facts (R), a HIPAA compliant observational research and privacy protected data warehouse. While differences in discrimination performance between the ECMs were statistically significant, they are not likely clinically meaningful.	[Fortin, Yannick; Crispo, James A. G.; Mattison, Donald R.; Krewski, Daniel] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada; [Fortin, Yannick; Crispo, James A. G.; Cohen, Deborah; Krewski, Daniel] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Crispo, James A. G.] Univ Penn, Philadelphia, PA 19104 USA; [Cohen, Deborah] CIHI, CPHI, Ottawa, ON, Canada; [Cohen, Deborah] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [McNair, Douglas S.] Cerner Corp, Kansas City, MO USA; [Mattison, Donald R.; Krewski, Daniel] Risk Sci Int, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Pennsylvania; Canadian Institute Health Information; University of Toronto	Fortin, Y (corresponding author), Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada.; Fortin, Y (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	yfort006@uottawa.ca	McNair, Douglas/GSJ-0611-2022	Crispo, James/0000-0001-9065-1170	Fonds de recherche du Quebec en sante [FF11 23D]; University of Ottawa; Ontario Ministry of Advanced Education and Skills Development	Fonds de recherche du Quebec en sante(Fonds de la Recherche en Sante du Quebec); University of Ottawa; Ontario Ministry of Advanced Education and Skills Development	This study was supported by doctoral training awards from the Fonds de recherche du Quebec en sante (FF11 23D, http://www.frgs.gouv.qc.ca), the University of Ottawa (www.uottawa.ca), and the Ontario Ministry of Advanced Education and Skills Development (https://osap.gov.on.ca).	AHRQ, 2014, COM SOFTW VERS 3 7; [Anonymous], 2014, BRIDGE DATA CERNER H; Barrett M, 2014, EXAMINATION EXPECTED; Bosetti C, 2015, PHARMACOEPIDEMIOL DR; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; CDC, 2009, CLASS DIS FUNCT DIS; Chu YT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-140; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Cook NR, 2010, CURR CARDIOVASC RISK, V4, P112, DOI 10.1007/s12170-010-0084-x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Esposito D, 2013, RELIABILITY AND VALI, P2013; Fischer C, 2015, EUROPEAN J SURGICAL; French DD, 2005, PHARMACOEPIDEM DR S, V14, P17, DOI 10.1002/pds.967; Glynn RJ, 2012, PHARMACOEPIDEM DR S, V21, P138, DOI 10.1002/pds.3231; Gonen M., 2006, SAS USERS GROUP INT, V31, P210; Hall SF, 2006, J CLIN EPIDEMIOL, V59, P849, DOI 10.1016/j.jclinepi.2005.11.013; Holmes HM, 2013, PHARMACOEPIDEM DR S, V22, P728, DOI 10.1002/pds.3431; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Hughes JS, 1996, J GEN INTERN MED, V11, P303, DOI 10.1007/BF02598273; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; Kennedy KF, 2010, SOUTHEEAST SAS US GR; Keyes GR, 2008, PLAST RECONSTR SURG, V122, P245, DOI 10.1097/PRS.0b013e31817747fd; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Laniece I, 2008, AGE AGEING, V37, P416, DOI 10.1093/ageing/afn093; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lix LM, 2011, OSTEOPOROSIS INT, V22, P2633, DOI 10.1007/s00198-010-1516-7; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raymond EG, 2014, CONTRACEPTION, V90, P476, DOI 10.1016/j.contraception.2014.07.012; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Stukenborg GJ, 2001, MED CARE, V39, P727, DOI 10.1097/00005650-200107000-00009; Suh HS, 2012, PHARMACOEPIDEM DR S, V21, P470, DOI 10.1002/pds.3261; Taylor R., 2014, RISK SCI INT PHARMAC, P48; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010; Zhang JX, 1999, MED CARE, V37, P1128, DOI 10.1097/00005650-199911000-00005; Zhu HF, 2008, NEUROLOGY, V71, P283, DOI 10.1212/01.wnl.0000318278.41347.94	49	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174379	10.1371/journal.pone.0174379	http://dx.doi.org/10.1371/journal.pone.0174379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350807	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174400030
J	Denny, MC; Vahidy, F; Vu, KYT; Sharrief, AZ; Savitz, SI				Denny, Mary Carter; Vahidy, Farhaan; Vu, Kim Y. T.; Sharrief, Anjail Z.; Savitz, Sean I.			Video-based educational intervention associated with improved stroke literacy, self-efficacy, and patient satisfaction	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRANSIENT ISCHEMIC ATTACK; HEALTH-EDUCATION; RISK-FACTORS; INFORMATION; CAREGIVERS; AWARENESS; SYMPTOMS; PROGRAM	Background and purpose Interventions are needed to improve stroke literacy among recent stroke survivors. We developed an educational video for patients hospitalized with acute ischemic stroke (AIS) and intracerebral hemorrhage (ICH). Methods A 5-minute stroke education video was shown to our AIS and ICH patients admitted from March to June 2015. Demographics and a 5-minute protocol Montreal Cognitive Assessment were also collected. Questions related to stroke knowledge, self-efficacy, and patient satisfaction were answered before, immediately after, and 30 days after the video. Results Among 250 screened, 102 patients consented, and 93 completed the video intervention. There was a significant difference between pre-video median knowledge score of 6 (IQR 4-7) and the post-video score of 7 (IQR 6-8; p<0.001) and between pre-video and the 30 day score of 7 (IQR 5-8; p = 0.04). There was a significant difference between the proportion of patients who were very certain in recognizing symptoms of a stroke pre- and post-video, which was maintained at 30-days (35.5% vs. 53.5%, p = 0.01; 35.5% vs. 54.4%, p = 0.02). The proportion who were "very satisfied" with their education post-video (74.2%) was significantly higher than pre-video (49.5%, p<0.01), and this was maintained at 30 days (75.4%, p<0.01). There was no association between MoCA scores and stroke knowledge acquisition or retention. There was no association between stroke knowledge acquisition and rates of home blood pressure monitoring or primary care provider follow-up. Conclusions An educational video was associated with improved stroke knowledge, self-efficacy in recognizing stroke symptoms, and satisfaction with education in hospitalized stroke patients, which was maintained at 30 days after discharge.	[Denny, Mary Carter; Vahidy, Farhaan; Sharrief, Anjail Z.; Savitz, Sean I.] UTHealth, Stroke Program, Dept Neurol, Houston, TX 77030 USA; [Denny, Mary Carter] MedStar Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA; [Vu, Kim Y. T.] Mem Hermann Hosp, Texas Med Ctr, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Georgetown University; Baylor College of Medicine	Denny, MC (corresponding author), UTHealth, Stroke Program, Dept Neurol, Houston, TX 77030 USA.; Denny, MC (corresponding author), MedStar Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA.	carterdenny@gmail.com	Vahidy, Farhaan/AAC-1049-2019	Vahidy, Farhaan/0000-0002-3464-2111	National Institutes of Health [T32NS007412]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following grant from the National Institutes of Health: T32NS007412. Dr. Savitz(PI) and Dr. Denny (Fellow).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartholomew LK, 2011, PLANNING HLTH PROMOT; Brenner DA, 2010, J STROKE CEREBROVASC, V19, P311, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.001; Centers for Disease Control and Prevention (CDC), 2005, BEH RISK FACT SURV S; Chan YF, 2008, J EMERG MED, V34, P215, DOI 10.1016/j.jemermed.2007.04.003; Das K, 2007, J CLIN NEUROSCI, V14, P12, DOI 10.1016/j.jocn.2005.12.049; Eames Sally, 2003, Top Stroke Rehabil, V10, P70; Eames S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002538; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Hafsteinsdottir TB, 2011, PATIENT EDUC COUNS, V85, P14, DOI 10.1016/j.pec.2010.07.046; Hoffmann T, 2007, AGE AGEING, V36, P280, DOI 10.1093/ageing/afm003; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; Lowe DB, 2007, AGE AGEING, V36, P83, DOI 10.1093/ageing/afl145; Lowenstein AJ, 2009, TEACHING STRATEGIES, P158; Maasland E, 2007, ACTA NEUROL SCAND, V115, P41, DOI 10.1111/j.1600-0404.2006.00722.x; Maasland L, 2011, INT J STROKE, V6, P67, DOI 10.1111/j.1747-4949.2010.00541.x; Mant J, 1998, CLIN REHABIL, V12, P465, DOI 10.1191/026921598668972226; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Park JH, 2016, EUR J NEUROL, V23, P361, DOI 10.1111/ene.12837; Rodgers H, 1999, STROKE, V30, P2585, DOI 10.1161/01.STR.30.12.2585; Rodgers H, 2001, AGE AGEING, V30, P129, DOI 10.1093/ageing/30.2.129; Sharrief AZ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00133; Stata Corp, 2015, STAT STAT SOFTW REL; The Joint Commission, 2016, STROK STK MEAS INT; Tuong W, 2014, J BEHAV MED, V37, P218, DOI 10.1007/s10865-012-9480-7; Willey JZ, 2009, NEUROLOGY, V73, P1950, DOI 10.1212/WNL.0b013e3181c51a7d; Wong A, 2015, STROKE, V46, P1059, DOI 10.1161/STROKEAHA.114.007253	26	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0171952	10.1371/journal.pone.0171952	http://dx.doi.org/10.1371/journal.pone.0171952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333925	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200004
J	Petalas, DP; van Schie, H; Vettehen, PH				Petalas, Diamantis Petropoulos; van Schie, Hein; Vettehen, Paul Hendriks			Forecasted economic change and the self-fulfilling prophecy in economic decision-making	PLOS ONE			English	Article							RISK-TAKING; BAD-NEWS; MEDIA COVERAGE; OLDER-ADULTS; SENTIMENT; EXPECTATIONS; PERCEPTION; BEHAVIOR; IMPACT; EMOTIONS	This study addresses the self-fulfilling prophecy effect, in the domain of economic decision-making. We present experimental data in support of the hypothesis that speculative forecasts of economic change can impact individuals' economic decision behavior, prior to any realized changes. In a within-subjects experiment, participants (N = 40) played 180 trials in a Balloon Analogue Risk Talk (BART) in which they could make actual profit. Simple messages about possible (positive and negative) changes in outcome probabilities of future trials had significant effects on measures of risk taking (number of inflations) and actual profits in the game. These effects were enduring, even though no systematic changes in actual outcome probabilities took place following any of the messages. Risk taking also found to be reflected in reaction times revealing increasing reaction times with riskier decisions. Positive and negative economic forecasts affected reaction times slopes differently, with negative forecasts resulting in increased reaction time slopes as a function of risk. These findings suggest that forecasted positive or negative economic change can bias people's mental model of the economy and reduce or stimulate risk taking. Possible implications for media-fulfilling prophecies in the domain of the economy are considered.	[Petalas, Diamantis Petropoulos; van Schie, Hein; Vettehen, Paul Hendriks] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands	Radboud University Nijmegen	Petalas, DP (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.	d.petropoulos@bsi.ru.nl		Petropoulos Petalas, Diamantis/0000-0002-4273-8172	Radboud University; Behavioural Science Institute	Radboud University; Behavioural Science Institute	This research is sponsored by Radboud University, and the Behavioural Science Institute, http://www.ru.nl/bsi/, http://www.ru.nl/bsi/research/research-programmes/communication-media/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2012, J BANK FINANC, V36, P3289, DOI 10.1016/j.jbankfin.2012.07.019; An SK, 2009, PUBLIC RELAT REV, V35, P107, DOI 10.1016/j.pubrev.2009.01.010; ANSOLABEHERE S, 1994, AM POLIT SCI REV, V88, P829, DOI 10.2307/2082710; Bagneux V, 2012, COGNITION EMOTION, V26, P568, DOI 10.1080/02699931.2011.602237; Beber A, 2010, REV FINANC, V14, P119, DOI 10.1093/rof/rfp006; Benjamin AM, 2007, PERS INDIV DIFFER, V43, P221, DOI 10.1016/j.paid.2006.11.026; Blais A. R., 2006, JUDGM DECIS MAK, V1; Bomfim AN, 2003, J BANK FINANC, V27, P133, DOI 10.1016/S0378-4266(01)00211-4; Boomgaarden HG, 2011, ACTA POLIT, V46, P353, DOI 10.1057/ap.2011.18; Casarin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067721; Chanel O, 2009, J RISK UNCERTAINTY, V39, P271, DOI 10.1007/s11166-009-9079-8; Chen C.-W., 2013, J FINANC RES, V36, P175, DOI [10.1111/j.1475-6803.2013.12007.x, DOI 10.1111/J.1475-6803.2013.12007.X]; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; den Ouden HEM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00548; Elster J, 1998, J ECON LIT, V36, P47; Engelberg JE, 2011, J FINANC, V66, P67, DOI 10.1111/j.1540-6261.2010.01626.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Friston KJ, 2014, LANCET PSYCHIAT, V1, P148, DOI 10.1016/S2215-0366(14)70275-5; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gabriel KI, 2010, PSYCHOL REP, V107, P699, DOI 10.2466/02.09.20.PR0.107.6.699-712; Garcia D, 2013, J FINANC, V68, P1267, DOI 10.1111/jofi.12027; Goidel K, 2010, AM POLIT RES, V38, P759, DOI 10.1177/1532673X09355671; Griffin JM, 2011, REV FINANC STUD, V24, P3941, DOI 10.1093/rfs/hhr099; Griskevicius V, 2013, PSYCHOL SCI; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Hetherington MJ, 1996, AM J POLIT SCI, V40, P372, DOI 10.2307/2111629; Hetsroni A, 2014, COMMUN RES, V41, P180, DOI 10.1177/0093650212442373; Hollanders D, 2011, J ECON PSYCHOL, V32, P367, DOI 10.1016/j.joep.2011.01.003; Jensen A. R., 2006, CLOCKING MIND MENTAL; Joris W, 2014, EUR J COMMUN, V29, P608, DOI 10.1177/0267323114538852; Kalogeropoulos A, 2016, INT J PUBLIC OPINION, V8; Kleinnijenhuis J, 2013, JOURNALISM, V14, P271, DOI 10.1177/1464884912468375; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Kuhnen CM, 2011, J FINANC QUANT ANAL, V46, P605, DOI 10.1017/S0022109011000123; Laakkonen H, 2009, STUDIES NONLINEAR DY, V4; Lee CJ, 2011, J MARKETING RES, V48, pS121, DOI 10.1509/jmkr.48.SPL.S121; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; LEVIN IP, 1987, J ECON PSYCHOL, V8, P43, DOI 10.1016/0167-4870(87)90005-5; Lighthall NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006002; Lischka JA, 2015, J MASS COMMUN Q, V92, P374, DOI 10.1177/1077699015574098; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Manning P, 2013, JOURNALISM, V14, P173, DOI 10.1177/1464884912448915; Mather M, 2012, PSYCHOL AGING, V27, P801, DOI 10.1037/a0030174; Merton RK, 1948, ANTIOCH REV, V8, P193, DOI DOI 10.2307/4609267; Mishra S, 2012, BRIT J PSYCHOL, V103, P83, DOI 10.1111/j.2044-8295.2011.02047.x; Mitchell SH, 2008, PSYCHON B REV, V15, P272, DOI 10.3758/PBR.15.2.272; Mushtaq F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00249; Mussel P, 2015, SOC NEUROSCI-UK, V10, P126, DOI 10.1080/17470919.2014.965340; Nofsinger J, 2005, J BEHAV FINANC, V6, P144, DOI 10.1207/s15427579jpfm0603_4; Papadimas L, 2015, REUTERS, P1; Parkinson B, 2012, EMOTION, V12, P817, DOI 10.1037/a0026434; Pleskac TJ, 2014, J EXP PSYCHOL GEN, V143, P142, DOI 10.1037/a0031106; Radu L., 2012, ROM J COMMUN PUB REL, V14, P29; Rolison JJ, 2012, PSYCHOL AGING, V27, P129, DOI 10.1037/a0024689; Rosenthal R., 1968, URBAN REV, P16, DOI [10.1007/BF02322211, DOI 10.1007/BF02322211]; Rubaltelli E, 2016, J BEHAV DECIS MAKING, V29, P295, DOI 10.1002/bdm.1885; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; Scheufele B, 2011, J COMMUN, V61, P48, DOI 10.1111/j.1460-2466.2010.01526.x; Schjoedt U, 2013, RELIG BRAIN BEHAV, V3, P39, DOI 10.1080/2153599X.2012.736714; Schoen JW, HERES ONE MORE SIGN, P1; Sheafer T, 2008, INT J PUBLIC OPIN R, V20, P33, DOI 10.1093/ijpor/edn004; Smales LA, 2014, FINANC RES LETT, V11, P122, DOI 10.1016/j.frl.2013.07.003; SNYDER M, 1977, J PERS SOC PSYCHOL, V35, P656, DOI 10.1037/0022-3514.35.9.656; Soroka SN, 2006, J POLIT, V68, P372, DOI 10.1111/j.1468-2508.2006.00413.x; Soroka S, 2015, POLIT COMMUN, V32, P1, DOI 10.1080/10584609.2014.881942; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Summerfield C, 2014, NAT REV NEUROSCI, V15, P745, DOI 10.1038/nrn3838; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; Veronesi P, 1999, REV FINANC STUD, V12, P975, DOI 10.1093/rfs/12.5.975; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Weaver J, 2016, J SOC PSYCHOL, V156, P179, DOI 10.1080/00224545.2015.1076761; Wu CC, 2012, DECISION MAKING UNCE, V6, P134	75	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174353	10.1371/journal.pone.0174353	http://dx.doi.org/10.1371/journal.pone.0174353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334031	Green Published, gold			2022-12-27	WOS:000399102200084
J	Zhao, JG; Wang, J; Meng, XH; Zeng, XT; Kan, SL				Zhao, Jia-Guo; Wang, Jia; Meng, Xiao-Hui; Zeng, Xian-Tie; Kan, Shi-Lian			Surgical interventions to treat humerus shaft fractures: A network meta-analysis of randomized controlled trials	PLOS ONE			English	Article							INVASIVE PLATE OSTEOSYNTHESIS; DYNAMIC COMPRESSION PLATE; INTRAMEDULLARY NAIL; FIXATION; MANAGEMENT; SHOULDER; COMPLICATIONS; REDUCTION	Background There are three main surgical techniques to treat humeral shaft fractures: open reduction and plate fixation (ORPF), intramedullary nail (IMN) fixation, and minimally invasive percutaneous osteosynthesis (MIPO). We performed a network meta-analysis to compare three surgical procedures, including ORPF, IMN fixation, and MIPO, to provide the optimum treatment for humerus shaft fractures. Methods MEDLINE, EMBASE, Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, and Cochrane library were researched for reports published up to May 2016. We only included randomized controlled trials (RCTs) comparing two or more of the three surgical procedures, including the ORPF, IMN, and MIPO techniques, for humeral shaft fractures in adults. The methodological quality was evaluated based on the Cochrane risk of bias tool. We used WinBUGS1.4 to conduct this Bayesian network meta-analysis. We used the odd ratios (ORs) with 95% confidence intervals (CIs) to calculate the dichotomous outcomes and analyzed the percentages of the surface under the cumulative ranking curve. Results Seventeen eligible publications reporting 16 RCTs were included in this study. Eight hundred and thirty-two participants were randomized to receive one of three surgical procedures. The results showed that shoulder impingement occurred more commonly in the IMN group than with either ORPF (OR, 0.13; 95% CI, 0.03 - 0.37) or MIPO fixation (OR, 0.08; 95% CI, 0.00 - 0.69). Iatrogenic radial nerve injury occurred more commonly in the ORPF group than in the MIPO group (OR, 11.09; 95% CI, 1.80 - 124.20). There were no significant differences among the three procedures in nonunion, delayed union, and infection. Conclusion Compared with IMN and ORPF, MIPO technique is the preferred treatment method for humeral shaft fractures.	[Zhao, Jia-Guo] Tianjin Med Univ, Dept Orthopaed Surg, Clin Coll Orthopaed Surg, Tianjin, Peoples R China; [Zhao, Jia-Guo; Wang, Jia; Zeng, Xian-Tie; Kan, Shi-Lian] Tianjin Hosp, Dept Orthopaed Surg, Tianjin, Peoples R China; [Meng, Xiao-Hui] Yixing Tradit Chinese Med Hosp, Dept Orthopaed Surg, Yixing, Jiangsu, Peoples R China	Tianjin Medical University	Zhao, JG (corresponding author), Tianjin Med Univ, Dept Orthopaed Surg, Clin Coll Orthopaed Surg, Tianjin, Peoples R China.; Zhao, JG; Kan, SL (corresponding author), Tianjin Hosp, Dept Orthopaed Surg, Tianjin, Peoples R China.	orthopaedic@163.com; kanshilian@126.com		Zhao, Jia Guo/0000-0001-5799-3988	Tianjin Science and Technology Plan Project [16ZLZXZF00220]	Tianjin Science and Technology Plan Project	This work was supported by the Tianjin Science and Technology Plan Project (No. 16ZLZXZF00220). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baltov A, 2014, INJURY, V45, pS9, DOI 10.1016/j.injury.2013.10.044; Benegas E, 2014, J SHOULDER ELB SURG, V23, P767, DOI 10.1016/j.jse.2014.02.010; Bolano LE., 1995, ORTHOPAEDIC T, V19, P33; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Carroll EA, 2012, J AM ACAD ORTHOP SUR, V20, P423, DOI 10.5435/JAAOS-20-07-423; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Changulani M, 2007, INT ORTHOP, V31, P391, DOI 10.1007/s00264-006-0200-1; Chapman JR, 2000, J ORTHOP TRAUMA, V14, P162, DOI 10.1097/00005131-200003000-00002; Chen F, 2013, J ORTHOP TRAUMA, V27, P68, DOI 10.1097/BOT.0b013e31824a3e66; Clement ND, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.28013v2; Dai JZ, 2014, J ORTHOP SCI, V19, P282, DOI 10.1007/s00776-013-0497-8; Esmailiejah AA, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.26271v2; Fan Y, 2015, ORTHOPEDICS, V38, pE825, DOI 10.3928/01477447-20150902-62; Farragos AF, 1999, J ORTHOP TRAUMA, V13, P258, DOI 10.1097/00005131-199905000-00006; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hu XQ, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0394-x; Kesemenli Cumhur Cevdet, 2003, Acta Orthop Traumatol Turc, V37, P120; Kim JW, 2015, J ORTHOP TRAUMA, V29, P189, DOI 10.1097/BOT.0000000000000232; Kobayashi M, 2010, J ORTHOP TRAUMA, V24, P212, DOI 10.1097/BOT.0b013e3181c2fe49; Kurup H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005959.pub2; Li Y, 2011, J SHOULDER ELB SURG, V20, P947, DOI 10.1016/j.jse.2010.12.016; Lian KJ, 2013, ORTHOPEDICS, V36, pE1025, DOI 10.3928/01477447-20130724-18; Liu YW, 2016, MINIM INVASIV THER, V25, P215, DOI 10.3109/13645706.2016.1151891; Malhan S, 2012, J ORTHOP SURG-HONG K, V20, P292, DOI 10.1177/230949901202000305; McCormack RG, 2000, J BONE JOINT SURG BR, V82B, P336, DOI 10.1302/0301-620X.82B3.9675; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Ouyang HB, 2013, J SHOULDER ELB SURG, V22, P387, DOI 10.1016/j.jse.2012.06.007; Putti Amit B, 2009, J Orthop Surg (Hong Kong), V17, P139; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Shah SHU, 2015, MED FORUM MONTHLY, V26, P51; Shin SJ, 2012, J ORTHOP TRAUMA, V26, P585, DOI 10.1097/BOT.0b013e318254895f; Singisetti K, 2010, INT ORTHOP, V34, P571, DOI 10.1007/s00264-009-0813-2; Smejkal K, 2014, ACTA CHIR ORTHOP TR, V81, P129; Wali MGR, 2014, STRATEG TRAUMA LIMB, V9, P133, DOI 10.1007/s11751-014-0204-0; Walker M, 2011, J SHOULDER ELB SURG, V20, P833, DOI 10.1016/j.jse.2010.11.030; Wang C, 2013, ARCH ORTHOP TRAUM SU, V133, P1089, DOI 10.1007/s00402-013-1768-8; Wang J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000595; Zhao J-G, 2016, COCHRANE DATABASE SY; Zhao JG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000599; Zhiquan A, 2007, J ORTHOP TRAUMA, V21, P628, DOI 10.1097/BOT.0b013e31815928c2	40	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173634	10.1371/journal.pone.0173634	http://dx.doi.org/10.1371/journal.pone.0173634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333947	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200021
J	Ghaffar, S; Stevenson, RJ; Khan, Z				Ghaffar, Sajeela; Stevenson, R. Jan; Khan, Zahiruddin			Effect of phosphorus stress on Microcystis aeruginosa growth and phosphorus uptake	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS; ENVIRONMENTAL-FACTORS; PHOSPHATE-UPTAKE; POLYPHOSPHATE; KINETICS; EUTROPHICATION; CYANOPHYCEAE; QUOTAS; GREEN; MODEL	This study was designed to advance understanding of phosphorus regulation of Microcystis aeruginosa growth, phosphorus uptake and storage in changing phosphorus (P) conditions as would occur in lakes. We hypothesized that Microcystis growth and nutrient uptake would fit classic models by Monod, Droop, and Michaelis-Menten in these changing conditions. Microcystis grown in luxury nutrient concentrations was transferred to treatments with phosphorus concentrations ranging from 0-256 mu g P.L-1 and luxury nitrogen. Dissolved phosphorus concentration, cell phosphorus quota, P uptake rate and cell densities were measured at day 3 and 6. Results showed little relationship to predicted models. Microcystis growth was asymptotically related to P treatment from day 0-3, fitting Monod model well, but negatively related to P treatment and cell quota from day 3-6. From day 0-3, cell quota was negatively related to P treatments at <2 mu g.L-1, but increased slightly at higher P. Cell quota decreased greatly in low P treatments from day 3-6, which may have enabled high growths in low P treatments. P uptake was positively and linearly related to P treatment during both periods. Negative uptake rates and increases in measured culture phosphorus concentrations to 5 mu g.L-1 in the lowest P treatments indicated P leaked from cells into culture medium. This leakage during early stages of the experiment may have been sufficient to stimulate metabolism and use of intracellular P stores in low P treatments for rapid growth. Our study shows P regulation of Microcystis growth can be complex as a result of changing P concentrations, and this complexity may be important for modeling Microcystis for nutrient and ecosystem management.	[Ghaffar, Sajeela; Khan, Zahiruddin] NUST, IESE SCEE, Sect H-12 Campus, Islamabad, Pakistan; [Stevenson, R. Jan] Michigan State Univ, Ctr Water Sci, E Lansing, MI 48824 USA; [Stevenson, R. Jan] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA	National University of Sciences & Technology - Pakistan; Michigan State University; Michigan State University	Ghaffar, S (corresponding author), NUST, IESE SCEE, Sect H-12 Campus, Islamabad, Pakistan.	sajeela_g@yahoo.com			Higher Education Commission (HEC) under "International Research Support Initiative Program (IRSIP)"	Higher Education Commission (HEC) under "International Research Support Initiative Program (IRSIP)"	The airfare and living costs at Michigan State University were funded by Higher Education Commission (HEC) under "International Research Support Initiative Program (IRSIP)". The funding was received by Sajeela Ghaffar. HEC's URL is: http://www.hec.gov.pk/english/Pages/Horneaspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 2005, STAND METH EX WAT WA, V20th; Bjorkman KM, 2014, P NATL ACAD SCI USA, V111, P7890, DOI 10.1073/pnas.1407195111; Boulinguiez B, 2009, ENERG FUEL, V23, P912, DOI 10.1021/ef800757u; BROWN EJ, 1978, LIMNOL OCEANOGR, V23, P35, DOI 10.4319/lo.1978.23.1.0035; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Chen DH, 2000, ACTA SCI CIRCUMSTANT, V20, P349; Chu ZS, 2007, J PLANKTON RES, V29, P739, DOI 10.1093/plankt/fbm054; Cormier SM, 2008, ENVIRON MANAGE, V42, P543, DOI 10.1007/s00267-008-9138-y; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Falconer IR, 2005, ACTA HYDROCH HYDROB, V33, P64, DOI 10.1002/aheh.200300551; Flynn KJ, 2008, OCEANOGR MAR BIOL, V46, P1, DOI 10.1201/9781420065756.ch1; GOTHAM IJ, 1981, J PHYCOL, V17, P257, DOI 10.1111/j.1529-8817.1981.tb00848.x; JACOBSON L, 1982, J PLANKTON RES, V4, P481, DOI 10.1093/plankt/4.3.481; Jacoby JM, 2000, CAN J FISH AQUAT SCI, V57, P231, DOI 10.1139/cjfas-57-1-231; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Leadbeater BSC, 2006, PROTIST, V157, P345, DOI 10.1016/j.protis.2006.05.009; LEAN DRS, 1976, J FISH RES BOARD CAN, V33, P1312, DOI 10.1139/f76-169; Lemesle V, 2008, ACTA BIOTHEOR, V56, P87, DOI 10.1007/s10441-008-9031-3; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Lyck S, 2004, J PLANKTON RES, V26, P727, DOI 10.1093/plankt/fbh071; Martin P, 2014, P NATL ACAD SCI USA, V111, P8089, DOI 10.1073/pnas.1321719111; Michaelis L, 1913, BIOCHEM Z, V49, P333; Monod J., 1942, RECHERCHES CROISSANC, P1; Norris RH, 2012, FRESHW SCI, V31, P5, DOI 10.1899/11-027.1; OLSEN Y, 1989, J PHYCOL, V25, P499, DOI 10.1111/j.1529-8817.1989.tb00255.x; Ou MM, 2006, BIOMED ENVIRON SCI, V19, P399; Ozawa K, 2005, ENVIRON TOXICOL, V20, P270, DOI 10.1002/tox.20117; Pahlow M, 2013, MAR ECOL PROG SER, V473, P1, DOI 10.3354/meps10181; Penfold WJ, 1912, J HYG-CAMBRIDGE, V12, P527, DOI 10.1017/S0022172400005180; Qu J., 2001, J ZHANJIANG OCEAN U, V22, P13; R Core Team, 2021, R LANGUAGE ENV STAT; Rabouille S, 2005, AQUAT MICROB ECOL, V39, P281, DOI 10.3354/ame039281; Saxton MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00003; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; SOMMER U, 1991, FUNCT ECOL, V5, P535, DOI 10.2307/2389636; Tsukada H, 2006, LIMNOLOGY, V7, P185, DOI 10.1007/s10201-006-0188-7; Kumar KV, 2006, J HAZARD MATER, V136, P197, DOI 10.1016/j.jhazmat.2005.09.018; Verspagen JMH, 2004, J PHYCOL, V40, P260, DOI 10.1111/j.1529-8817.2004.03174.x; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; Watson SB, 2008, CAN J FISH AQUAT SCI, V65, P1779, DOI 10.1139/F08-084; Wisniak J, 1999, FLUID PHASE EQUILIBR, V164, P61, DOI 10.1016/S0378-3812(99)00246-0; Yang Z, 2008, J PHYCOL, V44, P716, DOI 10.1111/j.1529-8817.2008.00502.x; Yue T, 2014, J APPL PHYCOL, V26, P333, DOI 10.1007/s10811-013-0067-7	47	21	22	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174349	10.1371/journal.pone.0174349	http://dx.doi.org/10.1371/journal.pone.0174349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328927	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700084
J	Han, J; Yue, J; Zhang, Y; Bai, LF				Han, Jing; Yue, Jiang; Zhang, Yi; Bai, Lianfa			Local structure preserving sparse coding for infrared target recognition	PLOS ONE			English	Article							UNSUPERVISED FEATURE-SELECTION; FACE RECOGNITION; SINGLE IMAGE; REPRESENTATION; CLASSIFICATION; REGRESSION; REDUCTION; FRAMEWORK; TRACKING; KERNELS	Sparse coding performs well in image classification. However, robust target recognition requires a lot of comprehensive template images and the sparse learning process is complex. We incorporate sparsity into a template matching concept to construct a local sparse structure matching (LSSM) model for general infrared target recognition. A local structure preserving sparse coding (LSPSc) formulation is proposed to simultaneously preserve the local sparse and structural information of objects. By adding a spatial local structure constraint into the classical sparse coding algorithm, LSPSc can improve the stability of sparse representation for targets and inhibit background interference in infrared images. Furthermore, a kernel LSPSc (K-LSPSc) formulation is proposed, which extends LSPSc to the kernel space to weaken the influence of the linear structure constraint in nonlinear natural data. Because of the anti-interference and fault-tolerant capabilities, both LSPSc- and K-LSPSc-based LSSM can implement target identification based on a simple template set, which just needs several images containing enough local sparse structures to learn a sufficient sparse structure dictionary of a target class. Specifically, this LSSM approach has stable performance in the target detection with scene, shape and occlusions variations. High performance is demonstrated on several datasets, indicating robust infrared target recognition in diverse environments and imaging conditions.	[Han, Jing; Yue, Jiang; Zhang, Yi; Bai, Lianfa] Nanjing Univ Sci & Technol, Jiangsu Key Lab Spectral Imaging & Intelligent Se, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Bai, LF (corresponding author), Nanjing Univ Sci & Technol, Jiangsu Key Lab Spectral Imaging & Intelligent Se, Nanjing, Jiangsu, Peoples R China.	blf@njust.edu.cn	Yue, Jiang/S-6750-2019; Yue, Jiang/AAB-6980-2020	Yue, Jiang/0000-0002-7097-755X; 	Natural Science Foundation of China [61231014, 61501235]; Fundamental Research Funds for the Central Universities [30915011335, 30916011320]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (61231014 L.B., 61501235 J.H.) and the Fundamental Research Funds for the Central Universities (30915011335 J.Y., 30916011320 J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, IEEE T PATTERN ANAL, V26, P1475, DOI 10.1109/TPAMI.2004.108; Bai TX, 2012, PATTERN RECOGN, V45, P2390, DOI 10.1016/j.patcog.2011.12.004; Chang H, 2006, PATTERN RECOGN, V39, P1053, DOI 10.1016/j.patcog.2005.07.011; Chen CLP, 2014, IEEE T GEOSCI REMOTE, V52, P574, DOI 10.1109/TGRS.2013.2242477; Chen Y, 2013, IEEE T GEOSCI REMOTE, V51, P217, DOI 10.1109/TGRS.2012.2201730; Cheng Q, 2014, IEEE T PATTERN ANAL, V36, P2117, DOI 10.1109/TPAMI.2014.2327978; Cuicui Kang, 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P3009, DOI 10.1109/ICIP.2011.6116296; Devernay F, 1995, RR2724 I NAT RECH IN; Donoho D., 2004, TECHNICAL REPORT; Duan CH, 2013, IEEE SIGNAL PROC LET, V20, P177, DOI 10.1109/LSP.2012.2237550; Gao CQ, 2013, IEEE T IMAGE PROCESS, V22, P4996, DOI 10.1109/TIP.2013.2281420; Gao SH, 2014, IEEE T IMAGE PROCESS, V23, P623, DOI 10.1109/TIP.2013.2290593; Gao SH, 2013, IEEE T IMAGE PROCESS, V22, P423, DOI 10.1109/TIP.2012.2215620; Gao SH, 2013, IEEE T PATTERN ANAL, V35, P92, DOI 10.1109/TPAMI.2012.63; Gao SH, 2010, LECT NOTES COMPUT SC, V6314, P1; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Lee H, 2007, P C NEUR INF PROC SY, P19; Li XX, 2013, IEEE T IMAGE PROCESS, V22, P1889, DOI 10.1109/TIP.2013.2237920; Li ZC, 2015, IEEE T IMAGE PROCESS, V24, P5343, DOI 10.1109/TIP.2015.2479560; Li ZC, 2015, IEEE T PATTERN ANAL, V37, P2085, DOI 10.1109/TPAMI.2015.2400461; Li ZC, 2014, IEEE T KNOWL DATA EN, V26, P2138, DOI 10.1109/TKDE.2013.65; Liu HC, 2013, OPT COMMUN, V289, P45, DOI 10.1016/j.optcom.2012.10.014; Lu ZW, 2013, PATTERN RECOGN, V46, P1799, DOI 10.1016/j.patcog.2012.09.027; Mairal J., 2008, P IEEE C COMP VIS PA; Ng A.Y, 2007, SELF TAUGHT LEARNING, DOI [10.1145/1273496.1273592, DOI 10.1145/1273496.1273592]; Pan YZ, 2009, PATTERN RECOGN, V42, P798, DOI 10.1016/j.patcog.2008.08.024; Peng C., 2016, ACM T INTEL SYST TEC, V8; Qiao LS, 2010, PATTERN RECOGN, V43, P331, DOI 10.1016/j.patcog.2009.05.005; Rigamonti R, 2011, PROC CVPR IEEE, P1545, DOI 10.1109/CVPR.2011.5995313; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Saul LK, 2004, J MACH LEARN RES, V4, P119, DOI 10.1162/153244304322972667; Seo HJ, 2011, IEEE T PATTERN ANAL, V33, P867, DOI 10.1109/TPAMI.2010.156; Seo HJ, 2010, IEEE T PATTERN ANAL, V32, P1688, DOI 10.1109/TPAMI.2009.153; Seo HJ, 2009, J VISION, V9, DOI 10.1167/9.12.15; Seo HJ, 2008, IEEE IMAGE PROC, P2380, DOI 10.1109/ICIP.2008.4712271; Seo HJ, 2009, P IEEE INT C COMP VI; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Wang ZL, 2012, APPL OPTICS, V51, P5051, DOI 10.1364/AO.51.005051; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xu ZB, 2010, IEEE T IMAGE PROCESS, V19, P1153, DOI 10.1109/TIP.2010.2042098; Yang J., 2009, P IEEE C COMP VIS PA; Yang SY, 2012, PATTERN RECOGN LETT, V33, P1951, DOI 10.1016/j.patrec.2012.07.004; Yin J, 2012, NEUROCOMPUTING, V77, P120, DOI 10.1016/j.neucom.2011.08.018; Yu K, 2009, P C NEUR INF PROC SY, P22; Zhang KB, 2012, IEEE T IMAGE PROCESS, V21, P4544, DOI 10.1109/TIP.2012.2208977; Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277; Zhang L, 2012, IEEE T SIGNAL PROCES, V60, P1684, DOI 10.1109/TSP.2011.2179539; Zhang SQ, 2009, PATTERN RECOGN LETT, V30, P1208, DOI 10.1016/j.patrec.2009.05.011; Zhang Z, 2016, IEEE T SIGNAL PROCES, V64, P3790, DOI 10.1109/TSP.2016.2550016; Zhang Z, 2013, IEEE T IMAGE PROCESS, V22, P4640, DOI 10.1109/TIP.2013.2277780; Zhao JF, 2013, INFRARED PHYS TECHN, V56, P85, DOI 10.1016/j.infrared.2012.11.001; Zoidi O, 2013, IEEE T CIRC SYST VID, V23, P870, DOI 10.1109/TCSVT.2012.2226527	52	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173613	10.1371/journal.pone.0173613	http://dx.doi.org/10.1371/journal.pone.0173613			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323824	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000022
J	Marti, N; Bouchoucha, N; Sauter, KS; Fluck, CE				Marti, Nesa; Bouchoucha, Nadia; Sauter, Kay-Sara; Fluck, Christa E.			Resveratrol inhibits androgen production of human adrenocortical H295R cells by lowering CYP17 and CYP21 expression and activities	PLOS ONE			English	Article							CALORIC RESTRICTION; LIFE-SPAN; GRANULOSA-CELLS; RHESUS-MONKEYS; STEROIDOGENESIS; METFORMIN; BIOSYNTHESIS; COMPLEX; IMPACT; OVARY	Resveratrol, a natural compound found in grapes, became very popular for its suggested protective effects against aging. It was reported to have similar positive effects on the human metabolism as caloric restriction. Recently, positive effects of resveratrol on steroid biosynthesis in cell systems and in humans suffering from polycystic ovary syndrome have also been reported, but the exact mechanism of this action remains unknown. Sirtuins seem targeted by resveratrol to mediate its action on energy homeostasis. In this study, we investigated the mechanisms of action of resveratrol on steroidogenesis in human adrenal H295R cells. Resveratrol was found to inhibit protein expression and enzyme activities of CYP17 and CYP21. It did not alter CYP17 and CYP21 mRNA expression, nor protein degradation. Only SIRT3 mRNA expression was found to be altered by resveratrol, but SIRT1, 3 and 5 overexpression did not result in a change in the steroid profile of H295R cells, indicating that resveratrol may not engage sirtuins to modulate steroid production. Previous studies showed that starvation leads to a hyperandrogenic steroid profile in H295R cells through inhibition of PKB/Akt signaling, and that resveratrol inhibits steroidogenesis of rat ovarian theca cells via the PKB/Akt pathway. Therefore, the effect of resveratrol on PKB/Akt signaling was tested in H295R cells and was found to be decreased under starvation growth conditions, but not under normal growth conditions. Overall, these properties of action together with recent clinical findings make resveratrol a candidate for the treatment of hyperandrogenic disorders such as PCOS.	[Marti, Nesa; Bouchoucha, Nadia; Sauter, Kay-Sara; Fluck, Christa E.] Univ Bern, Dept Pediat, Div Pediat Endocrinol, Bern, Switzerland; [Marti, Nesa; Bouchoucha, Nadia; Sauter, Kay-Sara; Fluck, Christa E.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Marti, Nesa] Univ Bern, Grad Sch Bern, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Fluck, CE (corresponding author), Univ Bern, Dept Pediat, Div Pediat Endocrinol, Bern, Switzerland.; Fluck, CE (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	christa.flueck@dkf.unibe.ch		Flueck, Christa/0000-0002-4568-5504; Marti, Nesa/0000-0002-0482-4280	Swiss National Science Foundation [320030-146127]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, Grant 320030-146127 (to CEF).	Anisimov VN, 2010, AGING-US, V2, P760, DOI 10.18632/aging.100230; Banaszewska B, 2016, J CLIN ENDOCR METAB, V101, P4322, DOI 10.1210/jc.2016-1858; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fukao H, 2004, BLOOD COAGUL FIBRIN, V15, P441, DOI 10.1097/00001721-200408000-00001; Hirsch A, 2012, ENDOCRINOLOGY, V153, P4354, DOI 10.1210/en.2012-1145; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kempna P, 2015, MOL CELL ENDOCRINOL, V408, P124, DOI 10.1016/j.mce.2014.12.015; Kempna P, 2010, ENDOCRINOLOGY, V151, P3686, DOI 10.1210/en.2010-0093; Li DH, 2012, ENDOCRINOLOGY, V153, P3258, DOI 10.1210/en.2011-2088; Lin CJ, 2014, BIOCHEM PHARMACOL, V90, P288, DOI 10.1016/j.bcp.2014.05.013; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; Morita Y, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-14; Ortega I, 2012, ENDOCRINOLOGY, V153, P4019, DOI 10.1210/en.2012-1385; Oskarsson A, 2014, PROSTATE, V74, P839, DOI 10.1002/pros.22801; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Reverchon M, 2013, MOL HUM REPROD, V19, P313, DOI 10.1093/molehr/gat002; Supornsilchai V, 2005, HORM RES, V64, P280, DOI 10.1159/000089487; Svechnikov K, 2009, J APPL TOXICOL, V29, P673, DOI 10.1002/jat.1456; Udhane S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068691; Udhane SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10132; Wang ZR, 2005, INT J MOL MED, V16, P533; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	29	30	31	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174224	10.1371/journal.pone.0174224	http://dx.doi.org/10.1371/journal.pone.0174224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323907	Green Submitted, gold, Green Published			2022-12-27	WOS:000399089000075
J	Xu, MH; Ma, L; Jia, YY; Liu, M				Xu, Manhou; Ma, Li; Jia, Yanyan; Liu, Min			Integrating the effects of latitude and altitude on the spatial differentiation of plant community diversity in a mountainous ecosystem in China	PLOS ONE			English	Article							SPECIES-DIVERSITY; ELEVATIONAL GRADIENT; WULU MOUNTAIN; RICHNESS; PATTERNS; BIOGEOGRAPHY; SHANXI; AREA	Varying patterns of plant community diversity along geographical gradients are a significant topic in biodiversity research. Here, to explore the integrated effects of latitude and altitude on the plant community diversity in a mountainous ecosystem, we set Guancen Mountain in the northern section, Guandi Mountain in the middle section, and Wulu Mountain in the southern section of the Lvliang Mountains as study areas, and the plant community diversity (basal diameter and height of tree and species diversity indices of shrub and herb) was measured horizontally at different latitude gradients and vertically at different altitude gradients in late July 2015. The results showed that (1) the trees were taller and wider at the middle latitude and higher altitude with a stronger spatial heterogeneity in the structures along the latitudinal and altitudinal gradients. The evergreen tree growth preceded that of the deciduous trees in the higher latitude and lower altitude regions, whereas the deciduous tree growth preceded that of the evergreen trees in the middle latitude and higher altitude regions. (2) Shrubs and herbs tended to grow well in the lower latitude and middle-lower altitude regions. The shrubs had a larger species diversity at lower latitude and lower altitude, but the species diversity of the herbs was not sensitive to the influences of the latitudinal and altitudinal gradients. With the latitude and altitude increasing, perennial herbs tended to grow well at higher latitude and higher altitude, while annual herbs tended to thrive at the middle latitude and lower altitude. In conclusion, environmental deviations caused by latitudinal and altitudinal gradients had great influences on the spatial distributions of the plant community diversity in the Lvliang Mountains.	[Xu, Manhou; Ma, Li; Jia, Yanyan; Liu, Min] Taiyuan Normal Univ, Inst Geog Sci, Jinzhong, Peoples R China	Taiyuan Normal University	Xu, MH (corresponding author), Taiyuan Normal Univ, Inst Geog Sci, Jinzhong, Peoples R China.	xumanhou@163.com	manhou, xu/AAA-3630-2019	manhou, xu/0000-0001-7558-6227	National Natural Science Fund [41501219]	National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Fund (41501219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batunacun Hu YF, 2015, J NAT RESOUR, V30, P24; Bolger T, 2000, BIODIVERS CONSERV, V9, P1323; Cardillo M, 2002, GLOBAL ECOL BIOGEOGR, V11, P59, DOI 10.1046/j.1466-822X.2001.00265.x; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Deng HongBing, 2001, Journal of Forestry Research, V12, P89, DOI 10.1007/BF02867202; Fang J-Y, 2004, BIODIVERSITY SCI, V12, P1; Fidan EC, 2016, EKOLOJI, V25, P17, DOI 10.5053/ekoloji.2015.24; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; GREEN J, 1994, HYDROBIOLOGIA, V272, P13, DOI 10.1007/BF00006509; HAMILTON AC, 1981, VEGETATIO, V45, P107, DOI 10.1007/BF00119220; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; He J, 1997, ACTA ECOLOGICA SINIC, V17, P91; [何明珠 HE Ming-zhu], 2010, [中国沙漠, Journal of Desert Research], V30, P528; [何艳华 He Yanhua], 2013, [生态学报, Acta Ecologica Sinica], V33, P2452; Horuz A, 2014, EKOLOJI, V23, P1, DOI 10.5053/ekoloji.2014.911; Johst K, 2005, DIVERS DISTRIB, V11, P111, DOI 10.1111/j.1366-9516.2005.00133.x; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; [李景欣 LI Jingxin], 2008, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V26, P619; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P47; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; PIANKA ER, 1989, TRENDS ECOL EVOL, V4, P223, DOI 10.1016/0169-5347(89)90163-8; Qian H, 1999, ANN BOT-LONDON, V83, P271, DOI 10.1006/anbo.1998.0816; Qu Bo, 2012, Plant Diversity and Resources, V34, P376, DOI 10.3724/SP.J.1143.2012.12022; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rey Benayas Jose M., 1995, Journal of Vegetation Science, V6, P95; Schwilk DW, 2005, ECOL LETT, V8, P272, DOI 10.1111/j.1461-0248.2004.00720.x; Sevindik TO, 2015, EKOLOJI, V24, P14, DOI 10.5053/ekoloji.2015.09; Sun Ju, 2009, Yingyong Shengtai Xuebao, V20, P2049; Tang ZY, 2004, BIODIVERSITY SCI, V12, P20, DOI DOI 10.1111/J.1600-0587.2011.07338.X; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tsewang N, 2011, J PLANT RES, V125, P93; Uysal H, 2015, EKOLOJI, V24, P57, DOI 10.5053/ekoloji.2015.04; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; [王丽丽 Wang Lili], 2012, [生态学报, Acta Ecologica Sinica], V32, P5494; Webb GE, 1997, J PALEONTOL, V71, P780, DOI 10.1017/S0022336000035733; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Xie JY., 1994, ACTA ECOLOGICA SINIC, V14, P337; Yildiz S, 2015, EKOLOJI, V24, P1, DOI 10.5053/ekoloji.2015.34; Zhang XP, 2006, SHENG TAI XUE BAO, V26, P754; 郝占庆, 2001, 生态学报, V21, P1421	42	31	40	11	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174231	10.1371/journal.pone.0174231	http://dx.doi.org/10.1371/journal.pone.0174231			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323909	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000077
J	McNamee, LM; Ledley, FD				McNamee, Laura M.; Ledley, Fred D.			Modeling timelines for translational science in cancer; the impact of technological maturation	PLOS ONE			English	Article							DRUG DISCOVERY; GROWTH-CURVES; INNOVATION; TRENDS; PATTERNS; WAR	This work examines translational science in cancer based on theories of innovation that posit a relationship between the maturation of technologies and their capacity to generate successful products. We examined the growth of technologies associated with 138 anticancer drugs using an analytical model that identifies the point of initiation of exponential growth and the point at which growth slows as the technology becomes established. Approval of targeted and biological products corresponded with technological maturation, with first approval averaging 14 years after the established point and 44 years after initiation of associated technologies. The lag in cancer drug approvals after the increases in cancer funding and dramatic scientific advances of the 1970s thus reflects predictable timelines of technology maturation. Analytical models of technological maturation may be used for technological forecasting to guide more efficient translation of scientific discoveries into cures.	[McNamee, Laura M.; Ledley, Fred D.] Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA; [Ledley, Fred D.] Bentley Univ, Dept Nat & Appl Sci, Waltham, MA 02452 USA; [Ledley, Fred D.] Bentley Univ, Dept Management, Waltham, MA 02452 USA	Bentley University; Bentley University; Bentley University	Ledley, FD (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA.; Ledley, FD (corresponding author), Bentley Univ, Dept Nat & Appl Sci, Waltham, MA 02452 USA.; Ledley, FD (corresponding author), Bentley Univ, Dept Management, Waltham, MA 02452 USA.	fledley@bentley.edu			National Biomedical Research Foundation	National Biomedical Research Foundation	This work was supported by a grant from the National Biomedical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Biomedical Research Foundation. The authors thank Dr. Kenneth Kaitin for providing data on drug approvals from the Tufts Center for Study of Drug Development as well as Aaron Perlman and Drs. Andrea Ballabeni, Michael Boss, Nancy Hsiung, David Nathan, and anonymous reviewers for their constructive contributions to this research. Portions of this work were described in testimony to the House Energy and Commerce Committee "Roundtable on 21st Century Cures" and at hearings on the "21st Century Cures" (May 6, 2014). An expanded transcript of this testimony was published in the Federal Register.	Agarwal P, 2009, NAT REV DRUG DISCOV, V8, P865, DOI 10.1038/nrd2973; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Austin DH, RES DEV PHARM IND 20; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Balconi M, 2010, RES POLICY, V39, P1, DOI 10.1016/j.respol.2009.09.013; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Beierlein JM, 2015, CLIN THER, V37, P1643, DOI 10.1016/j.clinthera.2015.07.003; Brown D, 2007, DRUG DISCOV TODAY, V12, P1007, DOI 10.1016/j.drudis.2007.10.017; Bush V, 1945, DTIC DOCUMENT; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Christensen C., 2013, INNOVATORS DILEMMA N; Christensen C.M., 1992, PROD OPER MANAG, V1, P334; Christensen C.M., 1992, PROD OPER MANAG, V1, P358, DOI 10.1111/j.1937-5956.1992.tb00002.x; Christensen Clayton M., 2003, INNOVATORS DILEMMA R; CHRISTENSEN CM, 1995, RES POLICY, V24, P233, DOI 10.1016/0048-7333(93)00764-K; Cockburn IM, 1998, J IND ECON, V46, P157; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Edgerton D, THE LINEAR MODEL; Faguet G. B., 2005, THE WAR ON CANC; Firat A.K., 2008, 200815 CISL; FISHER JC, 1971, TECHNOL FORECAST SOC, V3, P75, DOI 10.1016/S0040-1625(71)80005-7; Foster R. N., 1988, INNOVATION ATTACKERS; Foster R. N., 1986, INNOVATION ATTACKERS; Gannon F, 2014, EMBO REP, V15, P1107, DOI 10.15252/embr.201439587; Garfield E, 1997, CELL DEATH DIFFER, V4, P352, DOI 10.1038/sj.cdd.4400261; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Godin B, 2006, SCI TECHNOL HUM VAL, V31, P639, DOI 10.1177/0162243906291865; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hutton J, 2007, TRANSFORMING TRANSLA; Jantsch Erich., 1967, TECHNOLOGICAL FORECA; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kim W, 2001, P AMIA S 2001 AM MED; Ledley F, 2013, GENE THERAPY; Lichtenberg FR, 2013, IMPACT BIOMEDICAL KN; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Louie G, 2009, PERSISTENT FORECASTI; Mankins J. C., 1995, CISC VIS NETW IND GL; Mankins JC, 2009, ACTA ASTRONAUT, V65, P1216, DOI 10.1016/j.actaastro.2009.03.058; Marshall A, 2009, NAT BIOTECHNOL, V27, P789, DOI 10.1038/nbt0909-789; Martell RE, 2013, ONCOLOGIST, V18, P104, DOI 10.1634/theoncologist.2012-0235; Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X; McGeary M, 1999, SOURCES CANC RES FUN; McNamee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082195; McNamee LM, 2012, NAT BIOTECHNOL, V30, P937, DOI 10.1038/nbt.2389; Meade N, 1998, MANAGE SCI, V44, P1115, DOI 10.1287/mnsc.44.8.1115; MEADE N, 1995, INT J FORECASTING, V11, P199, DOI 10.1016/0169-2070(94)00556-R; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nagy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052669; Narayanamurti V., 2016, CYCLES INVENTION DIS; Nathan David G, 2007, Trans Am Clin Climatol Assoc, V118, P317; Nelson RR, 2011, RES POLICY, V40, P1339, DOI 10.1016/j.respol.2011.06.014; Office USGA, 2016, TECHN READ ASS GUID; Petrick IJ, 2004, TECHNOL FORECAST SOC, V71, P81, DOI 10.1016/S0040-1625(03)00064-7; Phaal R., 2001, TECHNOLOGY ROADMAPPI, P1; Pisano G., 2006, SCI BUSINESS PROMISE; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Sampat BN, U NATL INNOVATION SY; Sansone SA, 2012, NAT GENET, V44, P121, DOI 10.1038/ng.1054; Schully S, 2009, PUBLIC HEALTH GENOM, V14, P1; Sorger P. K., 2011, QUANTITATIVE SYSTEMS; Stokes D. E, 2011, PASTEURS QUADRANT BA; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taroncher-Oldenburg G, 2008, NAT BIOTECHNOL, V26, P1062, DOI 10.1038/nbt1008-1062; Taroncher-Oldenburg G, 2007, NAT BIOTECHNOL, V25, P961, DOI 10.1038/nbt0907-961; Toole AA, 2012, RES POLICY, V41, P1, DOI 10.1016/j.respol.2011.06.004; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Varmus H, 2012, NATURE, V481, P436, DOI 10.1038/481436a; Vogelstein B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004246; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; YOUNG P, 1993, TECHNOL FORECAST SOC, V44, P375, DOI 10.1016/0040-1625(93)90042-6	78	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174538	10.1371/journal.pone.0174538	http://dx.doi.org/10.1371/journal.pone.0174538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346525	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300053
J	Muhammed, MK; Krych, L; Nielsen, DS; Vogensen, FK				Muhammed, Musemma K.; Krych, Lukasz; Nielsen, Dennis S.; Vogensen, Finn K.			A high-throughput qPCR system for simultaneous quantitative detection of dairy Lactococcus lactis and Leuconostoc bacteriophages	PLOS ONE			English	Article							STREPTOCOCCUS-THERMOPHILUS BACTERIOPHAGES; STARTER CULTURES; CHEDDAR CHEESE; MULTIPLEX PCR; ACID BACTERIA; PHAGES; CLASSIFICATION; IDENTIFICATION; MILK; FERMENTATION	Simultaneous quantitative detection of Lactococcus (Lc.) lactis and Leuconostoc species bacteriophages (phages) has not been reported in dairies using undefined mixed-strain DL-starters, probably due to the lack of applicable methods. We optimized a high-throughput qPCR system that allows simultaneous quantitative detection of Lc. lactis 936 (now SK1virus), P335, c2 (now C2virus) and Leuconostoc phage groups. Component assays are designed to have high efficiencies and nearly the same dynamic detection ranges, i.e., from similar to 1.1 x 10(5) to similar to 1.1 x 10(1) phage genomes per reaction, which corresponds to similar to 9 x 10(7) to similar to 9 x 10(3) phage particles mL(-1) without any additional up-concentrating steps. The amplification efficiencies of the corresponding assays were 100.1 +/- 2.6, 98.7 +/- 2.3, 101.0 +/- 2.3 and 96.2 +/- 6.2. The qPCR system was tested on samples obtained from a dairy plant that employed traditional mother-bulk-cheese vat system. High levels of 936 and P335 phages were detected in the mother culture and the bulk starter, but also in the whey samples. Low levels of phages were detected in the cheese milk samples.	[Muhammed, Musemma K.; Krych, Lukasz; Nielsen, Dennis S.; Vogensen, Finn K.] Univ Copenhagen, Dept Food Sci, Frederiksberg C, Denmark	University of Copenhagen	Vogensen, FK (corresponding author), Univ Copenhagen, Dept Food Sci, Frederiksberg C, Denmark.	fkv@food.ku.dk	Nielsen, Dennis/A-9769-2015; Krych, Lukasz/F-4446-2015; Vogensen, Finn/E-1245-2015	Nielsen, Dennis/0000-0001-8121-1114; Krych, Lukasz/0000-0003-3224-1346; Muhammed, Musemma Kedir/0000-0003-4806-7020; Vogensen, Finn/0000-0003-2151-7802	MetaPhageLAB project; Danish Council for Independent Research | Technology and Production Sciences [0602-022170B]	MetaPhageLAB project; Danish Council for Independent Research | Technology and Production Sciences(Det Frie Forskningsrad (DFF))	This work was funded by the Danish Council for Independent Research | Technology and Production Sciences grant 0602-022170B, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council/the-danish-council-for-independent-research-technology-and-production-sciences?set_language=en&cl=en. This work was carried out as part of the MetaPhageLAB project. Musemma K. Muhammed had been the recipient of a PhD stipend from the MetaPhageLAB project. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Y, 2013, APPL ENVIRON MICROB, V79, P3628, DOI 10.1128/AEM.00076-13; Atamer Z, 2011, INT DAIRY J, V21, P327, DOI 10.1016/j.idairyj.2010.11.005; Bellengier P, 1997, J DAIRY SCI, V80, P1520, DOI 10.3168/jds.S0022-0302(97)76081-8; Binetti AG, 2005, APPL ENVIRON MICROB, V71, P6096, DOI 10.1128/AEM.71.10.6096-6103.2005; Bissonnette F, 2000, J DAIRY SCI, V83, P620, DOI 10.3168/jds.S0022-0302(00)74921-6; BRAUN V, 1989, J GEN MICROBIOL, V135, P2551; BRUSSOW H, 1994, APPL ENVIRON MICROB, V60, P4537, DOI 10.1128/AEM.60.12.4537-4543.1994; CASEY CN, 1993, J APPL BACTERIOL, V74, P268, DOI 10.1111/j.1365-2672.1993.tb03025.x; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; COGAN TM, 1994, J DAIRY SCI, V77, P2704, DOI 10.3168/jds.S0022-0302(94)77213-1; del Rio B, 2007, FOOD MICROBIOL, V24, P75, DOI 10.1016/j.fm.2006.03.001; del Rio B., 2012, BACTERIOPHAGES, P81; del Rio B, 2008, APPL ENVIRON MICROB, V74, P4779, DOI 10.1128/AEM.00295-08; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Dupont K, 2005, J APPL MICROBIOL, V98, P1001, DOI 10.1111/j.1365-2672.2005.02548.x; Gabs S, 2003, LETT APPL MICROBIOL, V36, P332, DOI 10.1046/j.1472-765X.2003.01320.x; Jang SH, 2010, ARCH VIROL, V155, P1883, DOI 10.1007/s00705-010-0799-5; JARVIS AW, 1991, INTERVIROLOGY, V32, P2, DOI 10.1159/000150179; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kelleher P, 2015, DAIRY SCI TECHNOL, V95, P545, DOI 10.1007/s13594-015-0227-4; Kelly WJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00257; Kleppen HP, 2011, INT DAIRY J, V21, P592, DOI 10.1016/j.idairyj.2011.02.010; Labrie S, 2000, APPL ENVIRON MICROB, V66, P987, DOI 10.1128/AEM.66.3.987-994.2000; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Ly-Chatain MH, 2011, INT J MICROBIOL, V2011, P1; Mackay John, 2007, Methods Mol Biol, V353, P167; Madera C, 2004, APPL ENVIRON MICROB, V70, P7365, DOI 10.1128/AEM.70.12.7365-7371.2004; Mahony J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00335; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Marco Mariangeles Briggiler, 2012, Bacteriophage, V2, P149; Marvig CL, 2011, INT DAIRY J, V21, P556, DOI 10.1016/j.idairyj.2011.03.004; McSweeney PLH, 2000, LAIT, V80, P293, DOI 10.1051/lait:2000127; Merrall A, 2008, AUSTR SOC MICR ANN S; Miklic A, 2003, INT J FOOD SCI TECH, V38, P305, DOI 10.1046/j.1365-2621.2003.00676.x; MOINEAU S, 1992, CAN J MICROBIOL, V38, P875, DOI 10.1139/m92-143; Moineau S, 1996, J DAIRY SCI, V79, P2104, DOI 10.3168/jds.S0022-0302(96)76584-0; Moineau S, 1999, ANTON LEEUW INT J G, V76, P377, DOI 10.1023/A:1002045701064; Murphy J, 2016, COMP GENOMICS FUNCTI, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Ponchel F., 2006, REAL TIME PCR RED, P139; Quiberoni A, 2006, J DAIRY SCI, V89, P3791, DOI 10.3168/jds.S0022-0302(06)72420-1; Raiski A, 2009, INT J FOOD MICROBIOL, V130, P1, DOI 10.1016/j.ijfoodmicro.2008.12.024; Samson JE, 2010, APPL ENVIRON MICROB, V76, P6843, DOI 10.1128/AEM.00796-10; Server-Busson C, 1999, J DAIRY RES, V66, P245, DOI 10.1017/S0022029999003374; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Szczepanska AK, 2007, ACTA BIOCHIM POL, V54, P151; VEDAMUTHU ER, 1994, J DAIRY SCI, V77, P2725, DOI 10.3168/jds.S0022-0302(94)77215-5; Verreault D, 2011, APPL ENVIRON MICROB, V77, P491, DOI 10.1128/AEM.01391-10; Zago M, 2008, J DAIRY RES, V75, P196, DOI 10.1017/S0022029908003208	48	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174223	10.1371/journal.pone.0174223	http://dx.doi.org/10.1371/journal.pone.0174223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339484	Green Submitted, Green Published, gold			2022-12-27	WOS:000399116700024
J	Gutpell, KM; Tasevski, N; Wong, B; Hrinivich, WT; Su, F; Hadway, J; Desjardins, L; Lee, TY; Hoffman, LM				Gutpell, Kelly M.; Tasevski, Nikola; Wong, Boaz; Hrinivich, William Thomas; Su, Feng; Hadway, Jennifer; Desjardins, Lise; Lee, Ting-Yim; Hoffman, Lisa Marie			ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SKELETAL-MUSCLE; VEGF OVEREXPRESSION; STEM-CELLS; ANGIOPOIETIN-1; PHOSPHORYLATION; ANGIOGENESIS; REGENERATION; EXPRESSION; DYSTROPHIN	Vascular endothelial growth factor (VEGF) and other pro-angiogenic growth factors have been investigated to enhance muscle tissue perfusion and repair in Duchenne muscular dystrophy (DMD). Current understanding is limited by a lack of functional data following in vivo delivery of these growth factors. We previously used dynamic contrast-enhanced computed tomography to monitor disease progression in murine models of DMD, but no study to date has utilized this imaging technique to assess vascular therapy in a preclinical model of DMD. In the current study, we locally delivered VEGF and ANG1 alone or in combination to dystrophic hind limb skeletal muscle. Using functional imaging, we found the combination treatment as well as ANG1 alone prevented decline in muscle perfusion whereas VEGF alone had no effect compared to controls. These findings were validated histologically as demonstrated by increased alpha-smooth muscle actin-positive vessels in muscles that received either VEGF+ANG1 or ANG1 alone compared to the sham group. We further show that ANG1 alone slows progression of fibrosis compared to either sham or VEGF treatment. The findings from this study shed new light on the functional effects of vascular therapy and suggest that ANG1 alone may be a candidate therapy in the treatment of DMD.	[Gutpell, Kelly M.; Tasevski, Nikola; Wong, Boaz; Hadway, Jennifer; Desjardins, Lise; Lee, Ting-Yim; Hoffman, Lisa Marie] Lawson Hlth Res Inst, London, ON, Canada; [Gutpell, Kelly M.; Hoffman, Lisa Marie] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Hrinivich, William Thomas; Lee, Ting-Yim; Hoffman, Lisa Marie] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Hrinivich, William Thomas; Su, Feng; Lee, Ting-Yim] Robarts Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gutpell, KM (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Gutpell, KM (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	kelly_gutpell@hotmail.com	Lee, Ting-Yim/M-1721-2013; Hoffman, Lisa/B-5324-2015	Hrinivich, William/0000-0002-0048-9411	Canadian Institutes of Health Research [LRI7765289]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research (LRI7765289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam E, 2009, Acta Myol, V28, P94; Abdel-Salam E, 2010, Acta Myol, V29, P398; Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Ahmad N, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-127; Beckman SA, 2013, ARTERIOSCL THROM VAS, V33, P2004, DOI 10.1161/ATVBAHA.112.301166; Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007; Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573; Chen F, 2007, ACTA PHARMACOL SIN, V28, P493, DOI 10.1111/j.1745-7254.2007.00527.x; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gutpell KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117306; Hostettler KE, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0157-3; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Karvinen H, 2011, GENE THER, V18, P1166, DOI 10.1038/gt.2011.66; Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807; Lee RJ, 2000, CIRCULATION, V102, P898; Lee SW, 2011, MOL MED, V17, P1095, DOI 10.2119/molmed.2011.00106; Loufrani L, 2004, ARTERIOSCL THROM VAS, V24, P671, DOI 10.1161/01.ATV.0000118683.99628.42; Maurer B, 2014, ANN RHEUM DIS, V73, P1880, DOI 10.1136/annrheumdis-2013-203535; McClung JM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00161; Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com; Mofarrahi M, 2015, AM J PHYSIOL-REG I, V308, pR576, DOI 10.1152/ajpregu.00267.2014; Nguyen F, 2005, NEUROMUSCULAR DISORD, V15, P154, DOI 10.1016/j.nmd.2004.11.002; Nico B, 2007, BRAIN PATHOL, V17, P399, DOI 10.1111/j.1750-3639.2007.00090.x; Novotny NM, 2009, SHOCK, V31, P335, DOI 10.1097/SHK.0b013e3181862c63; Palladino M, 2013, ARTERIOSCL THROM VAS, V33, P2867, DOI 10.1161/ATVBAHA.112.301172; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Sahani DV, 2007, RADIOLOGY, V243, P736, DOI 10.1148/radiol.2433052020; Shimizu-Motohashi Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00050; Shyu KG, 2003, LIFE SCI, V73, P563, DOI 10.1016/S0024-3205(03)00318-7; Stewart EE, 2006, RADIOLOGY, V239, P740, DOI 10.1148/radiol.2393041382; Yamauchi A, 2003, J GENE MED, V5, P994, DOI 10.1002/jgm.439; Zacchigna S, 2007, HUM GENE THER, V18, P515, DOI 10.1089/hum.2006.162; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	40	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174315	10.1371/journal.pone.0174315	http://dx.doi.org/10.1371/journal.pone.0174315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334037	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200078
J	Lowdon, RF; Wang, T				Lowdon, Rebecca F.; Wang, Ting			Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; SPLICING REGULATORY PROTEIN-1; SOMATIC MUTATIONS; HEPATOCELLULAR-CARCINOMA; RECURRENT MUTATIONS; LANDSCAPE; GENOME; GENES; EXPRESSION; PATTERNS	Evidence that noncoding mutation can result in cancer driver events is mounting. However, it is more difficult to assign molecular biological consequences to noncoding mutations than to coding mutations, and a typical cancer genome contains many more noncoding mutations than protein-coding mutations. Accordingly, parsing functional noncoding mutation signal from noise remains an important challenge. Here we use an empirical approach to identify putatively functional noncoding somatic single nucleotide variants (SNVs) from liver cancer genomes. Annotation of candidate variants by publicly available epigenome datasets finds that 40.5% of SNVs fall in regulatory elements. When assigned to specific regulatory elements, we find that the distribution of regulatory element mutation mirrors that of nonsynonymous coding mutation, where few regulatory elements are recurrently mutated in a patient population but many are singly mutated. We find potential gain-of-binding site events among candidate SNVs, suggesting a mechanism of action for these variants. When aggregating noncoding somatic mutation in promoters, we find that genes in the ERBB signaling and MAPK signaling pathways are significantly enriched for promoter mutations. Altogether, our results suggest that functional somatic SNVs in cancer are sporadic, but occasionally occur in regulatory elements and may affect phenotype by creating binding sites for transcriptional regulators. Accordingly, we propose that noncoding mutation should be formally accounted for when determining gene-and pathway-mutation burden in cancer.	[Lowdon, Rebecca F.; Wang, Ting] Washington Univ, Dept Genet, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Wang, T (corresponding author), Washington Univ, Dept Genet, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.	twang@genetics.wustl.edu	Gallinger, Steven/E-4575-2013	Wang, Ting/0000-0002-6800-242X	National Science Foundation, Graduate Research Fellowship Program [DGE-1143954]; National Human Genome Research Institute [R01HG007354, R01HG007175]; National Institute for Environmental Health Sciences [R01ES024992]; National Cancer Institute [U01CA200060]; American Cancer Society [RSG-14-049-01-DMC]; NATIONAL CANCER INSTITUTE [U01CA200060] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007354, U01HG009391, R01HG007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024992, U24ES026699] Funding Source: NIH RePORTER	National Science Foundation, Graduate Research Fellowship Program(National Science Foundation (NSF)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by the National Science Foundation, Graduate Research Fellowship Program [https://www.nsfgrfp.org] DGE-1143954 (RL); National Human Genome Research Institute [https://www.genome.gov] R01HG007354, R01HG007175 (TW); National Institute for Environmental Health Sciences [http://www.niehs.nih.gov] R01ES024992, U24ES026699 (TW); National Cancer Institute [http://www.cancer.gov] U01CA200060 (TW); American Cancer Society [http://cancer.org] Research Scholar grant RSG-14-049-01-DMC (TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allerstorfer S, 2008, ONCOGENE, V27, P4180, DOI 10.1038/onc.2008.61; Araya C. L., 2015, NAT PUBL GR, V48, P117, DOI DOI 10.1038/NG; Bailey SD, 2016, NAT GENET, V48, P1260, DOI 10.1038/ng.3650; Bapat SA, 2010, EPIGENETICS-US, V5, P716, DOI 10.4161/epi.5.8.13014; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Drier Y, 2016, NAT GENET, V48, P265, DOI 10.1038/ng.3502; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guda K, 2015, P NATL ACAD SCI USA, V112, P1149, DOI 10.1073/pnas.1417064112; Guturu H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004711; Hahn MA, 2014, CANCER RES, V74, P3617, DOI 10.1158/0008-5472.CAN-13-3147; HASSE A, 1994, J BIOL CHEM, V269, P1821; Heidenreich B, 2014, CURR OPIN GENET DEV, V24, P30, DOI 10.1016/j.gde.2013.11.005; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Hnisz D, 2016, SCIENCE, V64; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu HM, 2013, FASEB J, V27, P163, DOI 10.1096/fj.12-216622; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kuwahara Y, 2004, GENE CHROMOSOME CANC, V41, P125, DOI 10.1002/gcc.20075; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Lekva T, 2012, J CLIN ENDOCR METAB, V97, pE1506, DOI 10.1210/jc.2012-1760; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Li J, 2015, CANCER LETT, V369, P307, DOI 10.1016/j.canlet.2015.09.015; Li T, 2015, CANCER RES, V75, P3181, DOI 10.1158/0008-5472.CAN-14-3721; Liu JQ, 2015, BIOCHEM BIOPH RES CO, V465, P777, DOI 10.1016/j.bbrc.2015.08.086; Manyam G, 2015, BMC SYSTEMS BIOL, V9, P1; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Reinke LM, 2012, J BIOL CHEM, V287, P36435, DOI 10.1074/jbc.M112.397125; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Slattery ML, 2012, CARCINOGENESIS, V33, P2398, DOI 10.1093/carcin/bgs305; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svetlichnyy D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004590; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Ueda J, 2014, ONCOGENE, V33, P4485, DOI 10.1038/onc.2013.392; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang WL, 2016, PATHOL RES PRACT, V212, P690, DOI 10.1016/j.prp.2016.05.003; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yao J, 2016, CANCER IMMUNOL RES, V4, P552, DOI 10.1158/2326-6066.CIR-15-0255; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Zhang B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-868; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhou X, 2015, NAT BIOTECHNOL, V33, P345, DOI 10.1038/nbt.3158; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	91	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174032	10.1371/journal.pone.0174032	http://dx.doi.org/10.1371/journal.pone.0174032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333948	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200038
J	Lu, WX; Wan, YM; Ma, FR; Johnson, RP; Li, QS				Lu, Wuxun; Wan, Yanmin; Ma, Fangrui; Johnson, R. Paul; Li, Qingsheng			Distinct transcriptome profiles of Gag-specific CD8+T cells temporally correlated with the protection elicited by SIV Delta nef live attenuated vaccine	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CYTOTOXIC T-LYMPHOCYTES; RHESUS MACAQUES; IMMUNE-RESPONSES; CD28 EXPRESSION; MEMORY; REPLICATION; BLOCKADE; DIFFERENTIATION; CHALLENGE	The live attenuated vaccine (LAV) SIVmac239 Delta nef (SIV Delta nef) confers the best protection among all the vaccine modalities tested in rhesus macaque model of HIV-1 infection. This vaccine has a unique feature of time-dependent protection: macaques are not protected at 3-5 weeks post vaccination (WPV), whereas immune protection emerges between 15 and 20 WPV. Although the exact mechanisms of the time-dependent protection remain incompletely understood, studies suggested that both cellular and humoral immunities contribute to this time-dependent protection. To further elucidate the mechanisms of protection induced by SIV Delta nef, we longitudinally compared the global gene expression profiles of SIV Gag-CM9+ CD8+ (Gag-specific CD8+) T cells from peripheral blood of Mamu-A*01+ rhesus macaques at 3 and 20 WPV using rhesus microarray. We found that gene expression profiles of Gag-specific CD8+ T cells at 20 WPV are qualitatively different from those at 3 WPV. At 20 WPV, the most significant transcriptional changes of Gag-specific CD8+ T cells were genes involved in TCR signaling, differentiation and maturation toward central memory cells, with increased expression of CCR7, TCR alpha, TCR beta, CD28 and decreased expression of CTLA-4, IFN-y., RANTES, granzyme A and B. Our study suggests that a higher quality of SIV-specific CD8+ T cells elicited by SIV Delta nef over time contributes to the maturation of time-dependent protection.	[Lu, Wuxun; Wan, Yanmin; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Lu, Wuxun; Wan, Yanmin; Ma, Fangrui; Li, Qingsheng] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA; [Johnson, R. Paul] Harvard Med Sch, New England Primate Res Ctr, Boston, MA USA; [Johnson, R. Paul] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Johnson, R. Paul] Emory Univ, Sch Med, Atlanta, GA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Harvard Medical School; Emory University	Li, QS (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.; Li, QS (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.	qli@unl.edu	, yanmin/GQH-2789-2022	, yanmin/0000-0001-5027-9423	NIH [DK087625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, U24OD011023] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This is work was supported by NIH grant DK087625 (to Li, Q.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 1998, J IMMUNOL, V160, P6062; Appay V, 2004, SEMIN IMMUNOL, V16, P205, DOI 10.1016/j.smim.2004.02.007; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Billingsley JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004740; CLEMENTS JE, 1995, J VIROL, V69, P2737, DOI 10.1128/JVI.69.5.2737-2744.1995; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Cromwell MA, 2000, J VIROL, V74, P8762, DOI 10.1128/JVI.74.18.8762-8766.2000; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fukada K, 2002, J IMMUNOL, V168, P2225, DOI 10.4049/jimmunol.168.5.2225; Gamberg J, 2004, IMMUNOL CELL BIOL, V82, P38, DOI 10.1111/j.1440-1711.2004.01204.x; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Jenkins MR, 2007, J IMMUNOL, V179, P64, DOI 10.4049/jimmunol.179.1.64; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1997, J VIROL, V71, P7711, DOI 10.1128/JVI.71.10.7711-7718.1997; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Knox JJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00217; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Mendoza D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003195; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Nixon DF, 2000, VIROLOGY, V266, P203, DOI 10.1006/viro.1999.0078; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sasikala-Appukuttan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081623; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shresta S, 1997, J BIOL CHEM, V272, P20236, DOI 10.1074/jbc.272.32.20236; Shrikant P, 1999, IMMUNITY, V11, P483, DOI 10.1016/S1074-7613(00)80123-5; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Smith AJ, 2014, J IMMUNOL, V193, P3126, DOI 10.4049/jimmunol.1400822; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Topp MS, 2003, J EXP MED, V198, P947, DOI 10.1084/jem.20021288; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173929	10.1371/journal.pone.0173929	http://dx.doi.org/10.1371/journal.pone.0173929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333940	Green Published, gold			2022-12-27	WOS:000399102200031
J	Ohashi, A; Murata, A; Cho, Y; Ichinose, S; Sakamaki, Y; Nishio, M; Hoshi, O; Fischer, S; Preissner, KT; Koyama, T				Ohashi, Ayaka; Murata, Aya; Cho, Yuichiro; Ichinose, Shizuko; Sakamaki, Yuriko; Nishio, Miwako; Hoshi, Osamu; Fischer, Silvia; Preissner, Klaus T.; Koyama, Takatoshi			The expression and localization of RNase and RNase inhibitor in blood cells and vascular endothelial cells in homeostasis of the vascular system	PLOS ONE			English	Article							HUMAN PANCREATIC RIBONUCLEASE; EXTRACELLULAR RNA; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; COAGULATION; PLATELETS; POLYPHOSPHATE; MECHANISM; COFACTOR; COMPLEX	RNA may be released from vascular cells including endothelial cells in the event of injury and in vascular disease. Extracellular RNAs have been recognized as novel procoagulant and permeability-increasing factors. Extracellular RNA may function as inflammatory host alarm signals that serve to amplify the defense mechanism, but it may provide important links to thrombus formation. Extracellular RNA is degraded by RNase. We propose that RNase and its inhibitor RNase inhibitor (RI) act as modulators of homeostasis in the vasculature to control the functions of extracellular RNA. We aimed to investigate the expression and localization of RNase 1 and RI in cells that contact blood, such as platelets, mononuclear cells, polymorphonuclear cells, and red blood cells. RNase 1 and RI expression and localization in blood cells were compared with those in the human umbilical vein endothelial cell line, EAhy926. Additionally, we further investigated the effect of thrombin on the expression of RNase 1 and RI in platelets. We used an RNase activity assay, reverse transcriptionpolymerase chain reaction, western blot, immunocytochemistry, transmission electron microscopy, and immunoelectron microscopy (pre- and post-embedding methods). RNase activity in the supernatant from EAhy926 cells was 50 times than in blood cells (after 60 min). RNase 1 mRNA and protein expression in EAhy926 cells was highest among the cells examined. However, RI mRNA and protein expression was similar in most cell types examined. Furthermore, we observed that RNase 1 and von Willebrand factor were partially colocalized in EAhy926 cells and platelets. In conclusion, we propose that high RNase activity is ordinarily released from endothelial cells to support anticoagulation in the vasculature. On the other hand, platelets and leukocytes within thrombi at sites of vascular injury show very low RNase activity, which may support hemostatic thrombus formation. However, activated platelets and leukocytes may accelerate pathologic thrombus formation.	[Ohashi, Ayaka; Murata, Aya; Nishio, Miwako; Koyama, Takatoshi] Tokyo Med & Dent Univ, Lab Mol Genet Hematol, Field Appl Lab Sci, Grad Sch Hlth Care Sci, Tokyo, Japan; [Cho, Yuichiro; Hoshi, Osamu] Tokyo Med & Dent Univ, Anat & Physiol Sci, Field Appl Lab Sci, Grad Sch Hlth Care Sci, Tokyo, Japan; [Ichinose, Shizuko; Sakamaki, Yuriko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo, Japan; [Fischer, Silvia; Preissner, Klaus T.] Justus Liebig Univ, Inst Biochem, Med Fac, Giessen, Germany	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Justus Liebig University Giessen	Koyama, T (corresponding author), Tokyo Med & Dent Univ, Lab Mol Genet Hematol, Field Appl Lab Sci, Grad Sch Hlth Care Sci, Tokyo, Japan.	koyama.lmg@outlook.jp	Fischer, Silvia/ABG-3104-2021		ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Von-Behring-Roentgen-Foundation (Marburg, Germany)	ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Von-Behring-Roentgen-Foundation (Marburg, Germany)	This study was supported by a research grant for TK from the ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Part of the work was supported by a grant (to KTP and SF) from the von-Behring-Roentgen-Foundation (Marburg, Germany). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; CRAMER EM, 1985, BLOOD, V66, P710; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gansler J, 2014, FASEB J, V28, P752, DOI 10.1096/fj.13-238600; Gansler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050399; Gaur D, 2001, J BIOL CHEM, V276, P24978, DOI 10.1074/jbc.M102440200; Ichinose S, 2013, MED MOL MORPHOL, V46, P24, DOI 10.1007/s00795-012-0005-9; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Landre JBP, 2002, J CELL BIOCHEM, V86, P540, DOI 10.1002/jcb.10234; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nakazawa F, 2005, BIOCHEM J, V385, P831, DOI 10.1042/BJ20041021; PODACK ER, 1982, J BIOL CHEM, V257, P5204; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Suzuki S, 2014, INT J LAB HEMATOL, V36, P676, DOI 10.1111/ijlh.12208; Valentijn KM, 2013, J THROMB HAEMOST, V11, P581, DOI 10.1111/jth.12160; WARSHAW AL, 1967, J BIOL CHEM, V242, P2094; Weyrich AS, 2009, J THROMB HAEMOST, V7, P241, DOI 10.1111/j.1538-7836.2008.03211.x; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747; ZUCKER MB, 1989, METHOD ENZYMOL, V169, P117	28	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174237	10.1371/journal.pone.0174237	http://dx.doi.org/10.1371/journal.pone.0174237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329009	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700075
J	Pereira, SR; Pereira, R; Figueiredo, I; Freitas, V; Dinis, TCP; Almeida, LM				Pereira, Sonia R.; Pereira, Rita; Figueiredo, Isabel; Freitas, Victor; Dinis, Teresa C. P.; Almeida, Leonor M.			Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ANTIOXIDANT PROPERTIES; NUCLEAR TRANSLOCATION; COLONIC INFLAMMATION; DIETARY POLYPHENOLS; ENDOTHELIAL-CELLS; CROHNS-DISEASE; EXPRESSION; EXTRACTS	Despite the actual therapeutic approaches for inflammatory bowel disease (IBD), efficient and secure alternative options remain a research focus. In this context, anthocyanins seem promising natural anti-inflammatory agents, but their action mechanisms and efficacy as compared with established drugs still require more clarification. The main aim of this study was to compare the anti-inflammatory action of a chemically characterized anthocyanin-rich fraction (ARF), obtained from Portuguese blueberries (Vaccinium corymbosum L.), with that of 5-aminosalicylic acid (5-ASA), a first-line drug in IBD, in a 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis rat model. Such fraction showed a high content and great molecular diversity of anthocyanins, with malvidin-3-galactoside and petunidin-3-arabinoside in the highest concentrations. After daily administration by intragastric infusion for 8 days, ARF, at a molar anthocyanin concentration about 30 times lower than 5-ASA, showed a higher effectiveness in counteracting the intestinal inflammation, as assessed by i) body weight variation and colon damage score, ii) reduction in leukocyte infiltration, iii) increase in antioxidant defenses and iv) by downregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in colon tissue homogenates. The strong inhibition of COX-2 expression seems to be a crucial anti-inflammatory mechanism common to both ARF and 5-ASA, but the additional higher abilities of anthocyanins to downregulate iNOS and to decrease leukocytes infiltration and to increase antioxidant defenses in colon may account for the much higher anti-inflammatory action of anthocyanins. These data may contribute to the development of a promising natural approach in IBD management.	[Pereira, Sonia R.; Pereira, Rita; Figueiredo, Isabel; Dinis, Teresa C. P.; Almeida, Leonor M.] CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Pereira, Sonia R.; Pereira, Rita; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Freitas, Victor] Univ Porto, Fac Sci, Dept Chem & Biochem, Oporto, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto	Almeida, LM (corresponding author), CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.; Almeida, LM (corresponding author), Univ Coimbra, Fac Pharm, Coimbra, Portugal.	malmeida@ci.uc.pt	Pereira, Sónia/AAD-4366-2019; Figueiredo, Isabel V/J-9181-2015	Pereira, Sónia/0000-0001-7061-3169; Figueiredo, Isabel V/0000-0003-0127-4575; Almeida, Leonor Martins/0000-0002-7769-4712; Freitas, Victor/0000-0003-0586-2278	FCT (Fundagao para a Ciencia e a Tecnologia) [PTDC/SAU-OSM/102907/2008, UID/NEU/04539/2013]; FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal, through Programa Operacional Factoresde Competitividade); FCT [SFRH/BD/89758/2012]	FCT (Fundagao para a Ciencia e a Tecnologia); FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal, through Programa Operacional Factoresde Competitividade); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the grants PTDC/SAU-OSM/102907/2008 and UID/NEU/04539/2013, funded by FCT (Fundagao para a Ciencia e a Tecnologia) and FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal, through Programa Operacional Factoresde Competitividade). Sonia Pereira is a recipient of the grant SFRH/BD/89758/2012 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algieri F, 2013, J ETHNOPHARMACOL, V146, P750, DOI 10.1016/j.jep.2013.01.041; Ancha HR, 2008, EXP BIOL MED, V233, P1301, DOI 10.3181/0805-RM-140; Rosillo MA, 2012, PHARMACOL RES, V66, P235, DOI 10.1016/j.phrs.2012.05.006; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; BELL CJ, 1995, AM J PHYSIOL-GASTR L, V268, pG622, DOI 10.1152/ajpgi.1995.268.4.G622; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Bunea A, 2013, PHYTOCHEMISTRY, V95, P436, DOI 10.1016/j.phytochem.2013.06.018; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Dahan S, 2007, IMMUNOL REV, V215, P243, DOI 10.1111/j.1600-065X.2006.00484.x; de Medina FS, 2004, BIOCHEM PHARMACOL, V68, P2317, DOI 10.1016/j.bcp.2004.07.045; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Esposito D, 2014, J AGR FOOD CHEM, V62, P7022, DOI 10.1021/jf4051599; Faria A, 2005, J AGR FOOD CHEM, V53, P6896, DOI 10.1021/jf0511300; Farzaei MH, 2015, CURR PHARM BIOTECHNO, V16, P196, DOI 10.2174/1389201016666150118131704; George S, 2005, J AGR FOOD CHEM, V53, P1370, DOI 10.1021/jf048396b; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Huang WY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1591803; Kahle K, 2006, MOL NUTR FOOD RES, V50, P418, DOI 10.1002/mnfr.200500211; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Lee SG, 2014, J NUTR BIOCHEM, V25, P404, DOI 10.1016/j.jnutbio.2013.12.001; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06234; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Liu LN, 2015, PLANTA MED, V81, P705, DOI 10.1055/s-0035-1545945; Loddo I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00551; Maor I, 2008, DIGEST DIS SCI, V53, P2208, DOI 10.1007/s10620-007-0141-6; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Miyoshi J, 2012, ANTICANCER RES, V32, P1193; Nieto N, 2000, DIGEST DIS SCI, V45, P1820, DOI 10.1023/A:1005565708038; OSZMIANSKI J, 1988, AM J ENOL VITICULT, V39, P259; Paixao J, 2012, CHEM-BIOL INTERACT, V199, P192, DOI 10.1016/j.cbi.2012.08.013; Paixao J, 2011, APOPTOSIS, V16, P976, DOI 10.1007/s10495-011-0632-y; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rodriguez-Saona L. E., 2001, CURRENT PROTOCOLS FO, DOI DOI 10.1002/0471142913.FAF0101S00; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Sanchez-Fidalgo S, 2010, EUR J PHARMACOL, V633, P78, DOI 10.1016/j.ejphar.2010.01.025; Scalzo J, 2013, FOOD CHEM, V139, P44, DOI 10.1016/j.foodchem.2013.01.091; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Serra D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109048; Serra FCO, 2013, PLOS ONE, V8, P1, DOI [10.1371/journal.pone.0063915, 10.1371/journal.pone.0073001]; Siddiqui A, 2006, DIGEST DIS SCI, V51, P698, DOI 10.1007/s10620-006-3194-z; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Sodagari HR, 2015, EXPERT REV GASTROENT, V13, P1; Stucchi AF, 2000, AM J PHYSIOL-GASTR L, V279, pG1298, DOI 10.1152/ajpgi.2000.279.6.G1298; Wu LM, 2011, ELECTRON J QUAL THEO, P1, DOI 10.1007/978-3-642-20847-8_1; Yi WG, 2006, J AGR FOOD CHEM, V54, P5651, DOI 10.1021/jf0531959; Youdim KA, 2002, J NUTR BIOCHEM, V13, P282, DOI 10.1016/S0955-2863(01)00221-2	51	46	46	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174116	10.1371/journal.pone.0174116	http://dx.doi.org/10.1371/journal.pone.0174116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329021	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700055
J	Qi, HG; Song, K; Li, CY; Wang, W; Li, BS; Li, L; Zhang, GF				Qi, Haigang; Song, Kai; Li, Chunyan; Wang, Wei; Li, Busu; Li, Li; Zhang, Guofan			Construction and evaluation of a high-density SNP array for the Pacific oyster (Crassostrea gigas)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; GENOTYPING ARRAY; GENETIC DIVERSITY; SUMMER MORTALITY; SEQUENCING DATA; CUPPED OYSTER; LINKAGE MAPS; VALIDATION; MARKERS	Single nucleotide polymorphisms (SNPs) are widely used in genetics and genomics research. The Pacific oyster (Crassostrea gigas) is an economically and ecologically important marine bivalve, and it possesses one of the highest levels of genomic DNA variation among animal species. Pacific oyster SNPs have been extensively investigated; however, the mechanisms by which these SNPs may be used in a high-throughput, transferable, and economical manner remain to be elucidated. Here, we constructed an oyster 190K SNP array using Affymetrix Axiom genotyping technology. We designed 190,420 SNPs on the chip; these SNPs were selected from 54 million SNPs identified through re-sequencing of 472 Pacific oysters collected in China, Japan, Korea, and Canada. Our genotyping results indicated that 133,984 (70.4%) SNPs were polymorphic and successfully converted on the chip. The SNPs were distributed evenly throughout the oyster genome, located in 3,595 scaffolds with a length of similar to 509.4 million; the average interval spacing was 4,210 bp. In addition, 111,158 SNPs were distributed in 21,050 coding genes, with an average of 5.3 SNPs per gene. In comparison with genotypes obtained through re-sequencing, similar to 69% of the converted SNPs had a concordance rate of > 0.971; the mean concordance rate was 0.966. Evaluation based on genotypes of full-sib family individuals revealed that the average genotyping accuracy rate was 0.975. Carrying 133 K polymorphic SNPs, our oyster 190K SNP array is the first commercially available high-density SNP chip for mollusks, with the highest throughput. It represents a valuable tool for oyster genome-wide association studies, fine linkage mapping, and population genetics.	[Qi, Haigang; Song, Kai; Li, Chunyan; Wang, Wei; Li, Busu; Li, Li; Zhang, Guofan] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Qi, Haigang; Li, Chunyan; Wang, Wei; Li, Busu; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Qi, Haigang; Song, Kai; Li, Chunyan; Wang, Wei; Li, Busu; Li, Li; Zhang, Guofan] Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Peoples R China; [Song, Kai; Li, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology	Li, L; Zhang, GF (corresponding author), Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.; Zhang, GF (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Li, L; Zhang, GF (corresponding author), Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Peoples R China.; Li, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022		National Natural Science Foundation of China [31530079, 31572620]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB06010101]; Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02-03]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholars Climbing Program of Shandong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology; Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholars Climbing Program of Shandong	This work was supported by the National Natural Science Foundation of China (31530079, 31572620), the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDB06010101), the Technological Innovation Project Financially Supported by Qingdao National Laboratory for Marine Science and Technology (2015ASKJ02-03), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), and the Taishan Scholars Climbing Program of Shandong.	Alunno-Bruscia M, 2011, J SEA RES, V66, P340, DOI 10.1016/j.seares.2011.07.008; An HS, 2013, GENES GENOM, V35, P805, DOI 10.1007/s13258-013-0140-2; Bassil NV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1310-1; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Degremont L, 2013, AQUACULTURE, V408, P51, DOI 10.1016/j.aquaculture.2013.05.025; Devos A, 2015, MAR POLLUT BULL, V95, P688, DOI 10.1016/j.marpolbul.2015.03.039; Dundon WG, 2011, AQUACULTURE, V314, P49, DOI 10.1016/j.aquaculture.2011.02.005; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; GRIZEL H, 1991, J CONSEIL, V47, P399; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Keightley J, 2015, AFR J MAR SCI, V37, P89, DOI 10.2989/1814232X.2015.1020874; Kochmann J, 2014, J EXP MAR BIOL ECOL, V451, P122, DOI 10.1016/j.jembe.2013.11.007; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lapegue S, 2014, MOL ECOL RESOUR, V14, P820, DOI 10.1111/1755-0998.12230; Lavoie RE, 2005, 1 INT OYST S P; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Liu Shikai, 2014, BMC Research Notes, V7, P135, DOI 10.1186/1756-0500-7-135; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meistertzheim AL, 2013, MAR BIOL, V160, P453, DOI 10.1007/s00227-012-2102-7; Mortensen S, 2016, DIS AQUAT ORGAN, V117, P171, DOI 10.3354/dao02944; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Olivier D, 2013, FOOD SECUR, V5, P251, DOI 10.1007/s12571-013-0244-1; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Park YJ, 2009, MOLECULES, V14, P4546, DOI 10.3390/molecules14114546; Plough LV, 2011, GENETICS, V189, P1473, DOI 10.1534/genetics.111.131854; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rohfritsch A, 2013, EVOL APPL, V6, P1064, DOI 10.1111/eva.12086; Roque A, 2012, AQUACULTURE, V324, P303, DOI 10.1016/j.aquaculture.2011.10.018; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; Sauvage C, 2010, ANIM GENET, V41, P390, DOI 10.1111/j.1365-2052.2009.02018.x; Schmidt A, 2008, HELGOLAND MAR RES, V62, P367, DOI 10.1007/s10152-008-0125-8; Schmitt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075900; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11600; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang HY, 2010, J SHELLFISH RES, V29, P857, DOI 10.2983/035.029.0420; Wang JF, 2015, MOL ECOL RESOUR, V15, P123, DOI 10.1111/1755-0998.12278; Ward RD, 2000, AQUAC RES, V31, P35, DOI 10.1046/j.1365-2109.2000.00388.x; Wrange AL, 2010, BIOL INVASIONS, V12, P1453, DOI 10.1007/s10530-009-9565-6; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhong XX, 2013, J WORLD AQUACULT SOC, V44, P455, DOI 10.1111/jwas.12044	52	36	42	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174007	10.1371/journal.pone.0174007	http://dx.doi.org/10.1371/journal.pone.0174007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328985	gold, Green Submitted, Green Published			2022-12-27	WOS:000399094700042
J	Bergemalm, D; Kruse, R; Sapnara, M; Halfvarson, J; Hornquist, EH				Bergemalm, Daniel; Kruse, Robert; Sapnara, Maria; Halfvarson, Jonas; Hornquist, Elisabeth Hultgren			Elevated fecal peptidase D at onset of colitis in Galphai2(-/-) mice, a mouse model of IBD	PLOS ONE			English	Article							ULCERATIVE-COLITIS; ACTIVATION; PROLIDASE; DISEASE; PATHOPHYSIOLOGY; INFLAMMATION; PROTEINS; CANCER; STOOL; PAR-2	Background The identification of novel fecal biomarkers in inflammatory bowel disease (IBD) is hampered by the complexity of the human fecal proteome. On the other hand, in experimental mouse models there is probably less variation. We investigated the fecal protein content in mice to identify possible biomarkers and pathogenic mechanisms. Methods Fecal samples were collected at onset of inflammation in Galphai2(-/-) mice, a well-described spontaneous model of chronic colitis, and from healthy littermates. The fecal proteome was analyzed by two-dimensional electrophoresis and quantitative mass spectrometry and results were then validated in a new cohort of mice. Results As a potential top marker of disease, peptidase D was found at a higher ratio in Galphai24mouse feces relative to controls (fold change 27; p = 0.019). Other proteins found to be enriched in Gai2(-/-) mice were mainly pancreatic proteases, and proteins from plasma and blood cells. A tendency of increased calprotectin, subunit S100-A8, was also observed (fold change 21; p = 0.058). Proteases are potential activators of inflammation in the gastrointestinal tract through their interaction with the proteinase-activated receptor 2 (PAR2). Accordingly, the level of PAR2 was found to be elevated in both the colon and the pancreas of Galphai24- mice at different stages of disease. Conclusions These findings identify peptidase D, an ubiquitously expressed intracellular peptidase, as a potential novel marker of colitis. The elevated levels of fecal proteases may be involved in the pathogenesis of colitis and contribute to the clinical phenotype, possibly by activation of intestinal PAR2.	[Bergemalm, Daniel; Halfvarson, Jonas] Univ Orebro, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden; [Kruse, Robert; Hornquist, Elisabeth Hultgren] Univ Orebro, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden; [Sapnara, Maria] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Sapnara, Maria] Univ Gothenburg, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	Orebro University; Orebro University; University of Gothenburg; University of Gothenburg	Bergemalm, D (corresponding author), Univ Orebro, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden.	daniel.bergemalm@regionorebrolan.se	Halfvarson, Jonas/AAU-4687-2020		Bengt lhre research foundation; Region Orebro county [OLL-526131]	Bengt lhre research foundation; Region Orebro county	DB reports grants from the Bengt lhre research foundation (http://ihrefellowship.se) and grants from Region Orebro county (http://www fou.nu/is/oil/forskningskomintten, OLL-526131), during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CS, 2010, J CHROMATOGR A, V1217, P3330, DOI 10.1016/j.chroma.2009.10.007; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bergemalm D, 2010, J NEUROCHEM, V114, P408, DOI 10.1111/j.1471-4159.2010.06753.x; Bjursten M, 2005, INFLAMM BOWEL DIS, V11, P997, DOI 10.1097/01.MIB.0000185401.27170.22; BOHE M, 1987, SCAND J GASTROENTERO, V22, P59, DOI 10.3109/00365528708991857; Carroll IM, 2013, WORLD J GASTROENTERO, V19, P7531, DOI 10.3748/wjg.v19.i43.7531; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Christerson U, 2009, J CROHNS COLITIS, V3, P100, DOI 10.1016/j.crohns.2008.11.003; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Gotlind YY, 2013, INT IMMUNOL, V25, P35, DOI 10.1093/intimm/dxs089; Gotlind YYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025073; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; JACKSON SH, 1975, CAN MED ASSOC J, V113, P759; Karna E, 2012, MOL CELL BIOCHEM, V361, P235, DOI 10.1007/s11010-011-1108-7; Kawabata A, 2002, LIFE SCI, V71, P2435, DOI 10.1016/S0024-3205(02)02044-1; Kim JA, 2003, INFLAMM BOWEL DIS, V9, P224, DOI 10.1097/00054725-200307000-00002; Lichtman JS, 2013, MOL CELL PROTEOMICS, V12, P3310, DOI 10.1074/mcp.M113.029967; Lohman RJ, 2012, J PHARMACOL EXP THER, V340, P256, DOI 10.1124/jpet.111.187062; Mooiweer E, 2015, J CROHNS COLITIS, V9, P50, DOI 10.1093/ecco-jcc/jju003; Ohman L, 2000, SCAND J IMMUNOL, V52, P80; Oleksiewicz MB, 2005, BIOMARKERS, V10, P29, DOI 10.1080/13547500500038775; Palka JA, 1997, J CELL BIOCHEM, V67, P166, DOI 10.1002/(SICI)1097-4644(19971101)67:2<166::AID-JCB2>3.0.CO;2-V; QIAGEN, 2015, THE FUNCTIONAL ANALY; Rangel I, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw098; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Soreide K, 2008, SCAND J GASTROENTERO, V43, P902, DOI 10.1080/00365520801942141; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlig HH, 2001, EUR J GASTROEN HEPAT, V13, P1421, DOI 10.1097/00042737-200112000-00005; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wright EK, 2015, GASTROENTEROLOGY, V148, P938, DOI 10.1053/j.gastro.2015.01.026	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174275	10.1371/journal.pone.0174275	http://dx.doi.org/10.1371/journal.pone.0174275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323866	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000082
J	Cho, HR; Son, Y; Kim, SM; Kim, BY; Eo, SK; Park, YC; Kim, K				Cho, Hyok-rae; Son, Yonghae; Kim, Sun-Mi; Kim, Bo-Young; Eo, Seong-Kug; Park, Young Chul; Kim, Koanhoi			7 alpha-Hydroxycholesterol induces monocyte/macrophage cell expression of interleukin-8 via C5a receptor	PLOS ONE			English	Article							NF-KAPPA-B; MONOCYTIC CELLS; ATHEROSCLEROTIC LESIONS; HUMAN MACROPHAGES; GENE-EXPRESSION; OXYSTEROLS; 7-KETOCHOLESTEROL; ACCUMULATION; INFLAMMATION; INHIBITION	We investigated effects of 7-oxygenated cholesterol derivatives present in atherosclerotic lesions, 7 alpha-hydroxycholesterol (7 alpha OHChol), 7 beta-hydroxycholesterol (7 beta OHChol), and 7-ketocholesterol (7K), on IL-8 expression. Transcript levels of IL-8 and secretion of its corresponding gene product by monocytes/macrophages were enhanced by treatment with 7 alpha OHChol and, to a lesser extent, 7K, but not by 7 beta OHChol. The 7-oxygenated cholesterol derivatives, however, did not change transcription of the IL-8 gene in vascular smooth muscle cells. 7 alpha OHChol-induced IL-8 gene transcription was inhibited by cycloheximide and Akt1 downregulation, but not by OxPAPC. Expression of C5a receptor was upregulated after stimulation with 7 alpha OHChol, but not with 7K and 7 beta OHChol, and a specific antagonist of C5a receptor inhibited 7 alpha OHChol-induced IL-8 gene expression in a dose dependent manner. Pharmacological inhibitors of PI3K and MEK almost completely inhibited expression of both IL-8 and cell-surface C5a receptor induced by 7 alpha OHChol. These results indicate that 7-oxygenated cholesterol derivatives have differential effects on monocyte/macrophage expression of IL-8 and C5a receptor and that C5a receptor is involved in 7 alpha OHChol-induced IL-8 expression via PI3K and MEK.	[Cho, Hyok-rae] Kosin Univ, Coll Med, Dept Neurosurg, Busan, South Korea; [Son, Yonghae; Kim, Sun-Mi; Kim, Bo-Young; Kim, Koanhoi] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea; [Eo, Seong-Kug] Chonbuk Natl Univ, Coll Vet Med, Iksan, Jeonbuk, South Korea; [Eo, Seong-Kug] Chonbuk Natl Univ, Biosafety Res Inst, Iksan, Jeonbuk, South Korea; [Park, Young Chul] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Yangsan, Gyeongnam, South Korea	Pusan National University; Pusan National University Hospital; Jeonbuk National University; Jeonbuk National University; Pusan National University; Pusan National University Hospital	Kim, K (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea.	koanhoi@pusan.ac.kr	Son, Yonghae/R-6194-2019					Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Apostolopoulos J, 1996, ARTERIOSCL THROM VAS, V16, P1007, DOI 10.1161/01.ATV.16.8.1007; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; EMBER JA, 1994, AM J PATHOL, V144, P393; Erridge C, 2007, FREE RADICAL RES, V41, P260, DOI 10.1080/10715760601070091; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; GUYTON JR, 1992, AM J PATHOL, V141, P925; Hayden JM, 2002, J LIPID RES, V43, P26; Hsu MH, 1999, BLOOD, V93, P3241, DOI 10.1182/blood.V93.10.3241.410k02_3241_3249; Hulten LM, 1996, J CLIN INVEST, V97, P461, DOI 10.1172/JCI118436; Kim SM, 2015, BIOCHEM BIOPH RES CO, V467, P879, DOI 10.1016/j.bbrc.2015.10.050; Kim SM, 2015, BIOCHEM BIOPH RES CO, V463, P1152, DOI 10.1016/j.bbrc.2015.06.075; Kim SM, 2014, TOXICOL APPL PHARM, V274, P462, DOI 10.1016/j.taap.2013.12.007; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Lim HK, 2003, LIFE SCI, V72, P1389, DOI 10.1016/S0024-3205(02)02377-9; Manthey HD, 2011, FASEB J, V25, P2447, DOI 10.1096/fj.10-174284; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Miguet-Alfonsi C, 2002, BIOCHEM PHARMACOL, V64, P527, DOI 10.1016/S0006-2952(02)01110-3; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oksjoki R, 2007, ATHEROSCLEROSIS, V195, P90, DOI 10.1016/j.atherosclerosis.2006.12.016; Palozza P, 2011, J NUTR BIOCHEM, V22, P259, DOI 10.1016/j.jnutbio.2010.02.003; Prunet C, 2006, CYTOM PART A, V69A, P359, DOI 10.1002/cyto.a.20272; Rus HG, 1996, ATHEROSCLEROSIS, V127, P263, DOI 10.1016/S0021-9150(96)05968-0; Seo HC, 2015, BIOMOL THER, V23, P84, DOI 10.4062/biomolther.2014.067; Son Y, 2013, BIOCHEM BIOPH RES CO, V438, P161, DOI 10.1016/j.bbrc.2013.07.046; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001	27	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173749	10.1371/journal.pone.0173749	http://dx.doi.org/10.1371/journal.pone.0173749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323848	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000028
J	Dohmen, W; Dorado-Garcia, A; Bonten, MJM; Wagenaar, JA; Mevius, D; Heederik, DJJ				Dohmen, Wietske; Dorado-Garcia, Alejandro; Bonten, Marc J. M.; Wagenaar, Jaap A.; Mevius, Dik; Heederik, Dick J. J.			Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; PUBLIC-HEALTH; RESISTANCE; LIVESTOCK; PERSPECTIVE; PREVALENCE; CARRIAGE; ANIMALS; FOOD	The presence of extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-E. coli) in food animals is a public health concern. This study aimed to determine prevalence of ESBL-E. coli on pig farms and to assess the effect of reducing veterinary antimicrobial use (AMU) and farm management practices on ESBL-E. coli occurrence on pig farms. During 2011-2013, 36 Dutch conventional pig farms participated in a longitudinal study (4 sampling times in 18 months). Rectal swabs were taken from 60 pigs per farm and pooled per 6 pigs within the same age category. Presence of ESBL-E. coli was determined by selective plating and ESBL genes were characterized by microarray, PCR and gene sequencing. An extensive questionnaire on farm characteristics and AMU as Defined Daily Dosages per Animal Year (DDDA/Y) was available for the 6-month periods before each sampling moment. Associations between the presence of ESBL-E. coli-positive pigs and farm management practices were modelled with logistic regression. The number of farms with ESBL-E. coli carrying pigs decreased from 16 to 10 and the prevalence of ESBL-E. coli-positive pooled pig samples halved from 27% to 13%. Overall, the most detected ESBL genes were blaCTX-M-1, blaTEM-52 and blaCTX-M-14. The presence of ESBL-E. coli carrying pigs was not related to total AMU, but it was strongly determined by the presence or absence of cephalosporin use at the farm (OR = 46.4, p = 0.006). Other farm management factors, related with improved biosecurity, were also plausibly related to lower probabilities for ESBL-E. coli-positive farms (e.g. presence of a hygiene lock, pest control delivered by a professional). In conclusion, ESBL-E. coli prevalence decreased in pigs during 2011 and 2013 in the Netherlands. On pig farms, the use of cephalosporins was associated with the presence of ESBL-E. coli carrying pigs.	[Dohmen, Wietske; Dorado-Garcia, Alejandro; Heederik, Dick J. J.] Univ Utrecht, Inst Risk Assessment Sci, Dept Environm Epidemiol, Utrecht, Netherlands; [Dorado-Garcia, Alejandro; Wagenaar, Jaap A.; Mevius, Dik] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Wagenaar, Jaap A.; Mevius, Dik] Wageningen Univ & Res Ctr, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Dohmen, W; Dorado-Garcia, A (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Dept Environm Epidemiol, Utrecht, Netherlands.; Dorado-Garcia, A (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	w.dohmen@uu.nl; a.doradogarcia@uu.nl		Dorado-Garcia, Alejandro/0000-0003-4981-6927; Heederik, Dick/0000-0002-4550-1437	Senter Novem [FND07003]; Product Boards for Livestock and Meat [13.31.001]; Netherlands Organization for Research and Development ZonMw [50-51700-98-053]; 1Health4Food (1H4F) project under the ESBLAT consortium [TKI-AF-12067]	Senter Novem; Product Boards for Livestock and Meat; Netherlands Organization for Research and Development ZonMw; 1Health4Food (1H4F) project under the ESBLAT consortium	This work was supported by Senter Novem (Contract no. FND07003); Product Boards for Livestock and Meat (Contractno. 13.31.001); Netherlands Organization for Research and Development ZonMw (Contractno. 50-51700-98-053); and by the 1Health4Food (1H4F) project under the ESBLAT consortium (TKI-AF-12067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2013, J ANTIMICROB CHEMOTH, V68, P569, DOI 10.1093/jac/dks427; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Carmo Luis P., 2014, Infection Ecology & Epidemiology, V4, P22924, DOI 10.3402/iee.v4.22924; Cavaco LM, 2008, ANTIMICROB AGENTS CH, V52, P3612, DOI 10.1128/AAC.00354-08; Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326; Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032; Dorado-Garcia A, 2016, J ANTIMICROB CHEMOTH, V71, P3607, DOI 10.1093/jac/dkw308; Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706; Dunlop RH, 1998, PREV VET MED, V34, P283, DOI 10.1016/S0167-5877(97)00095-0; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Hering J, 2014, PREV VET MED, V116, P129, DOI 10.1016/j.prevetmed.2014.06.014; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Schmithausen RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138173; SDa (The Netherlands Veterinary Medicines Authority), 2013, SDA EXP PAN REP; SDa (The Netherlands Veterinary Medicines Authority), 2014, SDA EXP PAN REP; SDa (The Netherlands Veterinary Medicines Authority), 2012, SDA EXP PAN REP; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Taylor NM, 2009, EPIDEMIOL INFECT, V137, P1121, DOI 10.1017/S0950268808001854	24	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174094	10.1371/journal.pone.0174094	http://dx.doi.org/10.1371/journal.pone.0174094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323856	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000059
J	Ishola, F; Owolabi, O; Filippi, V				Ishola, Foluso; Owolabi, Onikepe; Filippi, Veronique			Disrespect and abuse of women during childbirth in Nigeria: A systematic review	PLOS ONE			English	Review							HEALTH-CARE SERVICES; QUALITY-OF-CARE; MATERNITY SERVICES; DELIVERY; LABOR; DETERMINANTS; SATISFACTION; ACCOUNTS; DISTRICT; REASONS	Background Promoting respectful care at childbirth is important to improve quality of care and encourage women to utilize skilled delivery services. However, there has been a relative lack of public health research on this topic in Nigeria. A systematic review was conducted to synthesize current evidence on disrespect and abuse of women during childbirth in Nigeria in order to understand its nature and extent, contributing factors and consequences, and propose solutions. Methods Five electronic databases were searched for relevant published studies, and five data sources for additional grey literature. A qualitative synthesis was conducted using the Bowser and Hill landscape analytical framework on disrespect and abuse of women during childbirth. Results Fourteen studies were included in this review. Of these studies, eleven were cross sectional studies, one was a qualitative study and two used a mixed method approach. The type of abuse most frequently reported was non-dignified care in form of negative, poor and unfriendly provider attitude and the least frequent were physical abuse and detention in facilities. These behaviors were influenced by low socioeconomic status, lack of education and empowerment of women, poor provider training and supervision, weak health systems, lack of accountability and legal redress mechanisms. Overall, disrespectful and abusive behavior undermined the utilization of health facilities for delivery and created psychological distance between women and health providers. Conclusion This systematic review documented a broad range of disrespectful and abusive behavior experienced by women during childbirth in Nigeria, their contributing factors and consequences. The nature of the factors influencing disrespectful and abusive behavior suggests that educating women on their rights, strengthening health systems to respond to specific needs of women at childbirth, improving providers training to encompass interpersonal aspects of care, and implementing and enforcing policies on respectful maternity care are important. This review has also shown that more robust research is needed to explore disrespect and abuse of women during childbirth in Nigeria and propose compelling interventions.	[Ishola, Foluso] Atlas Serv Corps, Washington, DC 20001 USA; [Ishola, Foluso] Int Ctr Evaluat & Dev, Nairobi, Kenya; [Owolabi, Onikepe; Filippi, Veronique] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Owolabi, Onikepe] Guttmacher Inst, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine	Ishola, F (corresponding author), Atlas Serv Corps, Washington, DC 20001 USA.; Ishola, F (corresponding author), Int Ctr Evaluat & Dev, Nairobi, Kenya.	folusoishola@gmail.com						Abuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123606; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Ashimi AO, 2015, SEX REPROD HEALTHC, V6, P119, DOI 10.1016/j.srhc.2015.01.004; Asuquo EEJ, 2000, AFRICAN J REPROD HLT, V4, P69; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Bowser D, 2010, EXPLORING EVIDENCE D; Chigbu CO, 2011, INT J GYNECOL OBSTET, V114, P226, DOI 10.1016/j.ijgo.2011.04.006; Critical Appraisal Skills Programme, CASP CHECKL; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; d'Oliveira AFPL, 2002, LANCET, V359, P1681, DOI 10.1016/S0140-6736(02)08592-6; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Freedman LP, 2014, B WORLD HEALTH ORGAN, V92, P915, DOI 10.2471/BLT.14.137869; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Idris Suleman Hadejia, 2013, Niger Med J, V54, P27, DOI 10.4103/0300-1652.108890; Igboanugo G. M., 2011, African Journal of Reproductive Health, V15, P63; Iloh GUP, 2012, NIGER J CLIN PRACT, V15, P469, DOI 10.4103/1119-3077.104529; Iyaniwura C A, 2009, Afr J Reprod Health, V13, P111; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Kaye D, 2000, E AFR MED J, V77, P558; Kowalewski M, 2000, Afr J Reprod Health, V4, P100, DOI 10.2307/3583247; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kumbani L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-9; Kumbani LC, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-30; Lamina M A, 2004, Niger J Med, V13, P52; Moore B M, 2011, East Afr J Public Health, V8, P49; Moronkola OA, 2007, TROP DOCT, V37, P94, DOI 10.1258/004947507780609365; Moyer CA, 2014, MIDWIFERY, V30, P262, DOI 10.1016/j.midw.2013.05.006; Mselle LT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-174; Mugweni E, 2008, Curationis, V31, P5; Nnebue CC, 2014, NIGER J CLIN PRACT, V17, P594, DOI 10.4103/1119-3077.141425; Okafor II, 2015, INT J GYNECOL OBSTET, V128, P110, DOI 10.1016/j.ijgo.2014.08.015; Onah HE, 2006, SOC SCI MED, V63, P1870, DOI 10.1016/j.socscimed.2006.04.019; Onyango-Ouma W, 2001, HEALTH POLICY PLANN, V16, P24, DOI 10.1093/heapol/16.suppl_1.24; Pettersson Karen Odberg, 2006, Health Care Women Int, V27, P145, DOI 10.1080/07399330500457994; Population Council USAID TRAction Project, ADDR DISR AB KEN 201; Reis V, 2012, RESPECTFUL MATERNITY; Sule Sa'adatu Talatu, 2012, East Afr J Public Health, V9, P80; Tamara Windau-Melmer, 2013, GUIDE ADVOCATING RES; Udoma EJ, 2008, NIGER J CLIN PRACT, V11, P100; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; United Nations, 2015, SUST DEV GOALS NEW Y; Uzochukwu B S C, 2004, East Afr Med J, V81, P293; Warren CE, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-21, 10.1186/1471-2393-13-150]; White Ribbon Alliance, 2015, PREV MAT NEWB DEATHS; White Ribbon Alliance, 2015, RESP MAT CAR NIG FOC; White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; World Health Organisation. NIGERIA, 2015, MAT MORT 1990 2015 W; World Health Organization, 2013, COUNS MAT NEWB HLTH; World Health Organization, 2015, PREVENTION ELIMINATI	52	84	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174084	10.1371/journal.pone.0174084	http://dx.doi.org/10.1371/journal.pone.0174084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323860	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000399089000058
J	Unlu, I; Faraji, A; Morganti, M; Vaeth, R; Akaratovic, K; Kiser, J; Abadam, C; Kline, D				Unlu, Isik; Faraji, Ary; Morganti, Michael; Vaeth, Randy; Akaratovic, Karen; Kiser, Jay; Abadam, Charles; Kline, Dan			Reduced performance of a PVC-coated Biogents Sentinel prototype in comparison to the original Biogents Sentinel for monitoring the Asian tiger mosquito, Aedes albopictus, in temperate North America	PLOS ONE			English	Article							DIPTERA-CULICIDAE; CARBON-DIOXIDE; BG-SENTINEL; FIELD EFFICACY; TRAP; SURVEILLANCE; 1-OCTEN-3-OL; POPULATIONS; ATTRACTANTS; AEGYPTI	Aedes albopictus is a major nuisance pest and also a public health concern because of the role it plays in the transmission of arboviruses. There is a continuing demand for effective surveillance tools for this species. The first generation of Biogents Sentinel (BGS1) traps have proven to be an effective tool for surveillance of Ae. albopictus throughout its range, however, some defects in construction led to the eventual development of the next generation. We compared the performance of the new generation prototype trap (BGS2P) to the original. Studies were conducted in suburban and urban areas in Florida, Louisiana, New Jersey, and Virginia, USA in the summer of 2014 (July-October). BGS1 traps collected significantly more Ae. albopictus when compared to the BGS2P with or without CO2 in all locations (P<0.05). When a white cloth was wrapped around the BGS2P traps, efficiency did not change in Louisiana, New Jersey, and Virginia; however, numbers of adult Ae. albopictus collected from the BGS2P and the BGS1 were significantly different based on lure type (P<0.0001). Results from Florida showed that BGS1 with the BG lure and CO2 collected significantly higher adult numbers compared to BGS2P with a three component cartridge lure and CO2 (P<0.0001). Overall, our results indicate that despite improvements in construction and durability of the BGS2P, this newer trap type did not increase the capture rates of Ae. albopictus in North America. Biogents modified BGS2P based on the data collected from the current study and updated as Biogents Sentinel 2 is now commercially available and its efficacy in comparison to the original will require further study.	[Unlu, Isik; Faraji, Ary] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA; [Unlu, Isik] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA; [Morganti, Michael; Vaeth, Randy] East Baton Rouge Parish Mosquito Abatement & Rode, Baton Rouge, LA USA; [Akaratovic, Karen; Kiser, Jay; Abadam, Charles] City Suffolk Mosquito Control, Suffolk, VA USA; [Kline, Dan] USDA, ARS, CMAVE, Gainesville, FL USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Unlu, I (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.; Unlu, I (corresponding author), Mercer Cty Mosquito Control, West Trenton, NJ USA.	iunlu@mercercounty.org		Akaratovic, Karen/0000-0001-6999-9818				Arimoto H, 2015, J AM MOSQUITO CONTR, V31, P384, DOI 10.2987/moco-31-04-384-387.1; Armstrong PM, 2013, J MED ENTOMOL, V50, P1310, DOI 10.1603/ME13099; Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1; Crepeau TN, 2013, J AM MOSQUITO CONTR, V29, P177, DOI 10.2987/12-6277r.1; Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524; Faraji A, 2014, COMP HOST FEEDING PA; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; GILLIES MT, 1969, B ENTOMOL RES, V59, P441, DOI 10.1017/S0007485300003412; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; KLINE DL, 1991, J AM MOSQUITO CONTR, V7, P165; KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1; Mulhern TD, 1953, MOSQ NEWS, V13, P180; REITER P, 1983, MOSQ NEWS, V43, P496; REITER P, 1991, J AM MOSQUITO CONTR, V7, P52; ROBERTSON R. C., 1935, China Journal, V23, P299; Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184; Service MW, 1993, MOSQUITO ECOLOGY FIE, V2-6, P988; SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126; Unlu I, 2016, PEST MANAG SCI, V72, P1427, DOI 10.1002/ps.4174; Unlu I, 2014, ACTA TROP, V137, P201, DOI 10.1016/j.actatropica.2014.05.009; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2	24	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0172963	10.1371/journal.pone.0172963	http://dx.doi.org/10.1371/journal.pone.0172963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319188	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800007
J	Uno, K; Miyazaki, T; Sodeyama, K; Miyamoto, Y; Nitta, A				Uno, Kyosuke; Miyazaki, Toh; Sodeyama, Kengo; Miyamoto, Yoshiaki; Nitta, Atsumi			Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism	PLOS ONE			English	Article							N-ACETYLTRANSFERASE; PLACE PREFERENCE; MOLECULE SHATI; NEURONS; SENSITIZATION; COCAINE; MICE; ACETYLASPARTATE; HYPERLOCOMOTION; AMPHETAMINE	Shati/Nat8L significantly increased in the nucleus accumbens (NAc) of mice after repeated methamphetamine (METH) treatment. We reported that Shati/Nat8L overexpression in mouse NAc attenuated METH-induced hyperlocomotion, locomotor sensitization, and conditioned place preference. We recently found that Shati/Nat8L overexpression in NAc regulates the dopaminergic neuronal system via the activation of group II mGluRs by elevated Nacetylaspartylglutamate following N-acetylaspartate increase due to the overexpression. These findings suggest that Shati/Nat8L suppresses METH-induced responses. However, the mechanism by which METH increases the Shati/Nat8L mRNA expression in NAc is unclear. To investigate the regulatory mechanism of Shati/Nat8L mRNA expression, we performed a mouse Shati/Nat8L luciferase assay using PC12 cells. Next, we investigated the response of METH to Shati/Nat8L expression and CREB activity using mouse brain slices of NAc, METH administration to mice, and western blotting for CREB activity of specific dopamine receptor signals in vivo and ex vivo. We found that METH activates CREB binding to the Shati/Nat8L promoter to induce the Shati/Nat8L mRNA expression. Furthermore, the dopamine Di receptor antagonist SCH23390, but not the dopamine D2 receptor antagonist sulpiride, inhibited the upregulation of Shati/Nat8L and CREB activities in the mouse NAc slices. Thus, the administration of the dopamine D1 receptor agonist SKF38393 increased the Shati/Nat8L mRNA expression in mouse NAc. These results showed that the Shati/Nat8L mRNA was increased by METH-induced CREB pathway via dopamine D1 receptor signaling in mouse NAc. These findings may contribute to development of a clinical tool for METH addiction.	[Uno, Kyosuke; Miyazaki, Toh; Sodeyama, Kengo; Miyamoto, Yoshiaki; Nitta, Atsumi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Japan	University of Toyama	Nitta, A (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Japan.	nitta@pha.u-toyama.ac.jp	Nitta, Atsumi/AAF-4211-2019	Nitta, Atsumi/0000-0001-6916-9160	Japan Society for the Promotion of Science [L5047, JPI5H04622, JPI5K15050]; Kyosuke Uno [16K18933]; Smoking Research Foundation; Japan Agency for Medical Research and Development [16mk0101076h0001]; Kobayashi International Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyosuke Uno; Smoking Research Foundation; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Kobayashi International Foundation	This work was supported by the Japan Society for the Promotion of Science, (https://www.jsps.go.jp/english/index.html) to Atsumi Nitta (L5047, JPI5H04622, JPI5K15050), to Kyosuke Uno (16K18933), the Smoking Research Foundation Grant for Biomedical Research and Foundation, (http://www.srf.or.jp/). Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/) (16mk0101076h0001) to Atsumi Nitta, Kobayashi International Foundation, (http://www.kisf.or.jp/english/index.html) to Atsumi Nitta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi E, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-24; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Beauvais G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028946; Becker I, 2010, J BIOL CHEM, V285, P29156, DOI 10.1074/jbc.M110.111765; Bilbao A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00212; Bocklisch C, 2013, SCIENCE, V341, P1521, DOI 10.1126/science.1237059; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kirchheim F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00248; Kuribara H, 1996, J PHARM PHARMACOL, V48, P292, DOI 10.1111/j.2042-7158.1996.tb05919.x; Kurokawa K, 2012, NEUROSCIENCE, V227, P22, DOI 10.1016/j.neuroscience.2012.09.029; Kurokawa K, 2010, J NEUROCHEM, V115, P1206, DOI 10.1111/j.1471-4159.2010.07010.x; Maier H, 2015, J NEUROSCI, V35, P14501, DOI 10.1523/JNEUROSCI.1056-15.2015; Miyamoto Y, 2014, INT J NEUROPSYCHOPH, V17, P1283, DOI 10.1017/S146114571400011X; Nakajima A, 2004, J NEUROSCI, V24, P2212, DOI 10.1523/JNEUROSCI.4847-03.2004; NISHIKAWA T, 1983, EUR J PHARMACOL, V88, P195, DOI 10.1016/0014-2999(83)90006-7; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Niwa M, 2008, J NEUROCHEM, V107, P1697, DOI 10.1111/j.1471-4159.2008.05738.x; Paxions G, 2008, MOUSE BRAIN STEREOTA; Pessentheiner AR, 2013, J BIOL CHEM, V288, P36040, DOI 10.1074/jbc.M113.491324; Sulzer D, 2015, PROG NEUROBIOLB, V75, P406; Sumi K, 2015, NEUROREPORT, V26, P740, DOI 10.1097/WNR.0000000000000416; Takeuchi S, 1999, MOL BRAIN RES, V74, P208, DOI 10.1016/S0169-328X(99)00298-3; Toriumi K, 2015, EUR NEUROPSYCHOPHARM, V25, P2108, DOI 10.1016/j.euroneuro.2015.08.003; Toriumi K, 2014, INT J NEUROPSYCHOPH, V17, P443, DOI 10.1017/S1461145713001302; Uno K, 2011, J CELL PHYSIOL, V226, P2953, DOI 10.1002/jcp.22642	28	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174196	10.1371/journal.pone.0174196	http://dx.doi.org/10.1371/journal.pone.0174196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319198	Green Submitted, gold, Green Published			2022-12-27	WOS:000398945800057
J	Gombert, A; Barbati, ME; Storck, M; Kotelis, D; Keschenau, P; Pape, HC; Andruszkow, H; Lefering, R; Hildebrand, F; Greiner, A; Jacobs, MJ; Grommes, J				Gombert, Alexander; Barbati, Mohammad E.; Storck, Martin; Kotelis, Drosos; Keschenau, Paula; Pape, Hans-Christoph; Andruszkow, Hagen; Lefering, Rolf; Hildebrand, Frank; Greiner, Andreas; Jacobs, Michael J.; Grommes, Jochen			Treatment of blunt thoracic aortic injury in Germany-Assessment of the TraumaRegister DGU (R)	PLOS ONE			English	Article							ENDOVASCULAR REPAIR; TRAUMATIC RUPTURE; MULTICENTER; MANAGEMENT; SURGERY; SCORE; CARE	Purpose Using the data delivered by the German Trauma Register DGU (R) from 2002 till 2013, the value of different therapies of blunt thoracic aortic injury (BTAI) in Germany was analyzed. Methods Prospectively collected data of patients suffering from BTAI were retrospectively analyzed with focus on the different treatment modalities for grade I-IV injuries. Results 821 patients suffering from BTAI were identified: 51.6% (424) grade I injury, 35.4% (291) grade II or III injury and 12.9% (106) grade IV injury (77.5% men [44.94 +/- 20.6 years]). The main patterns of injury were high-speed accidents and falls (78.0% [n = 640], 21.8% [n = 171] respectively). Significant differences between grade I and grade II/ III as well as IV injuries could be assessed for the incidence of cardiopulmonary resuscitation, a Glasgow Coma Scale score below 8 and a systolic blood pressure below 90 mmHg (p-value: <0.001). In the primary admission subgroup, 44.1% (197/447) of the patients received best medical treatment, 55.9% received surgical intervention (250/447): Thereof 37.2% (93/250) received open surgery and 62.8% (147/250) had been treated by endovascular means. Significantly lower 24-h-and in-hospital-mortality rates were encountered after endovascular treatment for all gradings of BTAI (p-value: <0.001). Yet this subgroup of patients showed the lowest incidence of further severe injuries and cardiac arrest. Conclusion Endovascular therapy became the treatment of choice for BTAI in Germany. Patients who have been treated by surgical means showed the highest survival rate, especially endovascular therapy showed a favorable low mortality rate.	[Gombert, Alexander; Barbati, Mohammad E.; Kotelis, Drosos; Keschenau, Paula; Jacobs, Michael J.; Grommes, Jochen] Univ Hosp RWTH Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany; [Storck, Martin] Univ Freiburg, Acad Teaching Hosp, Klinikum Karlsruhe, Karlsruhe, Germany; [Pape, Hans-Christoph; Andruszkow, Hagen; Hildebrand, Frank] Univ Aachen, Dept Orthoped Trauma, Aachen, Germany; [Pape, Hans-Christoph; Andruszkow, Hagen; Hildebrand, Frank] Univ Hosp RWTH Aachen, Harald Tscherne Lab, Aachen, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Greiner, Andreas] Univ Hosp Charite Berlin, Dept Vasc Surg, Berlin, Germany	Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital; Municipal Hospital Karlsruhe; University of Freiburg; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Witten Herdecke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gombert, A (corresponding author), Univ Hosp RWTH Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany.	agombert@ukaachen.de	Storck, Martin/L-6893-2017; Barbati, Mohammad Esmaeil/F-5529-2016; Hildebrand, Frank/J-3176-2017; Keschenau, Paula/HCI-8033-2022	Barbati, Mohammad Esmaeil/0000-0003-0709-8533; Pape, Hans-Christoph/0000-0002-2059-4980; Grommes, Jochen/0000-0002-6419-6802				Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Asmat Atasha, 2009, Asian Cardiovasc Thorac Ann, V17, P458, DOI 10.1177/0218492309348624; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BEEL T, 1980, ANN EMERG MED, V9, P483, DOI 10.1016/S0196-0644(80)80309-X; Bone RC, 2009, CHEST, V136, pe28; DuBose JJ, 2015, J TRAUMA ACUTE CARE, V78, P360, DOI 10.1097/TA.0000000000000521; Fox N, 2015, J TRAUMA NURS, V22, P99, DOI 10.1097/JTN.0000000000000118; Garcia-Toca M, 2010, ARCH SURG-CHICAGO, V145, P679, DOI 10.1001/archsurg.2010.114; Khoynezhad A, 2013, J VASC SURG, V57, P899, DOI 10.1016/j.jvs.2012.10.099; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Lettinga-van de Poll T, 2007, BRIT J SURG, V94, P525, DOI 10.1002/bjs.5795; Lin CC, 2016, SURG TODAY, V46, P188, DOI 10.1007/s00595-015-1152-0; LUNDEVALL J, 1964, ACTA PATHOL MIC SC, V62, P34, DOI 10.1111/apm.1964.62.1.34; Osgood MJ, 2014, J VASC SURG, V59, P334, DOI 10.1016/j.jvs.2013.09.007; Pillai J, 2015, S AFR J SURG, V53, P19, DOI 10.7196/SAJS.2407; Reddy VS, 2007, J TRAUMA, V62, pS23, DOI 10.1097/TA.0b013e3180653fee; TEASDALE G, 1974, LANCET, V2, P81; Teixeira PGR, 2011, J TRAUMA, V70, P197, DOI 10.1097/TA.0b013e3181df68b3; Tong MZY, 2010, J VASC SURG, V52, P31, DOI 10.1016/j.jvs.2010.01.087; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WILLIAMS JS, 1994, ANN THORAC SURG, V57, P726, DOI 10.1016/0003-4975(94)90576-2; Xenos ES, 2008, J VASC SURG, V48, P1343, DOI 10.1016/j.jvs.2008.04.060	22	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0171837	10.1371/journal.pone.0171837	http://dx.doi.org/10.1371/journal.pone.0171837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346475	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000399174300001
J	Li, Y; Dong, YC; Huang, ZY; Kuang, QF; Wu, YM; Li, YZ; Li, ML				Li, Yan; Dong, Yongcheng; Huang, Ziyan; Kuang, Qifan; Wu, Yiming; Li, Yizhou; Li, Menglong			Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma	PLOS ONE			English	Article							HEPATITIS-B; CANCER; EXPRESSION; SEQUENCE; DISEASE; GENOME; MICRORNA-107; BIOMARKER; DATABASE; REVEALS	Hepatocellular carcinoma (HCC) is currently still a major factor leading to death, lacking of reliable biomarkers. Therefore, deep understanding the pathogenesis for HCC is of great importance. The emergence of circular RNA (circRNA) provides a new way to study the pathogenesis of human disease. Here, we employed the prediction tool to identify circRNAs based on RNA-seq data. Then, to investigate the biological function of the circRNA, the candidate circRNAs were associated with the protein-coding genes (PCGs) by GREAT. We found significant candidate circRNAs expression alterations between normal and tumor samples. Additionally, the PCGs associated with these candidate circRNAs were also found have discriminative expression patterns between normal and tumor samples. The enrichment analysis illustrated that these PCGs were predominantly enriched for liver/cardiovascular- related diseases such as atherosclerosis, myocardial ischemia and coronary heart disease, and participated in various metabolic processes. Together, a further network analysis indicated that these PCGs play important roles in the regulatory and the PPI network. Finally, we built a classification model to distinguish normal and tumor samples by using candidate circRNAs and their associated genes, respectively. Both of them obtained satisfactory results (similar to 0.99 of AUC for circRNA and PCG). Our findings suggested that the circRNA could be a critical factor in HCC, providing a useful resource to explore the pathogenesis of HCC.	[Li, Yan; Huang, Ziyan; Kuang, Qifan; Wu, Yiming; Li, Yizhou; Li, Menglong] Sichuan Univ, Coll Chem, Chengdu, Peoples R China; [Dong, Yongcheng] Sichuan Univ, Coll Life Sci, Chengdu, Peoples R China	Sichuan University; Sichuan University	Li, YZ; Li, ML (corresponding author), Sichuan Univ, Coll Chem, Chengdu, Peoples R China.	liyizhou@scu.edu.cn; liml@scu.edu.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [21375090, 21675114, 21305096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (21375090, 21675114, 21305096), to ML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (21375090, 21675114) and the National Natural Science Foundation of China (21305096).	Adinolfi LE, 2013, EXPERT REV GASTROENT, V7, P205, DOI [10.1586/EGH.13.7, 10.1586/egh.13.7]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baniasadi H, 2013, ELECTROPHORESIS, V34, P2910, DOI 10.1002/elps.201300029; BEAUDRY D, 1995, NUCLEIC ACIDS RES, V23, P3064; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chao CW, 1998, MOL MED, V4, P614, DOI 10.1007/BF03401761; Chen L, 2013, J NEURO-ONCOL, V112, P59, DOI 10.1007/s11060-012-1037-7; Ertle JM, 2013, DIGESTION, V87, P121, DOI 10.1159/000346080; Gao J, 2015, ONCOGENE, V34, P4142, DOI 10.1038/onc.2014.348; Ghosal Suman, 2013, Frontiers in Genetics, V4, P283, DOI 10.3389/fgene.2013.00283; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1458; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hyogo H, 2014, CURR PHARM DESIGN, V20, P2403, DOI 10.2174/13816128113199990476; Inoue T, 2012, ONCOL REP, V27, P1759, DOI 10.3892/or.2012.1709; Jarcuska P, 2016, WORLD J GASTROENTERO, V22, P155, DOI 10.3748/wjg.v22.i1.155; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Kelly JG, 2011, J PROTEOME RES, V10, P1437, DOI 10.1021/pr101067u; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li JQ, 2015, AM J CANCER RES, V5, P472; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liu YC, 2016, NUCLEIC ACIDS RES, V44, pD209, DOI 10.1093/nar/gkv940; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meinshausen N, 2007, COMPUT STAT DATA AN, V52, P374, DOI 10.1016/j.csda.2006.12.019; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pineau P, 2010, PATHOL BIOL, V58, P444, DOI 10.1016/j.patbio.2009.03.004; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	40	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174436	10.1371/journal.pone.0174436	http://dx.doi.org/10.1371/journal.pone.0174436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346469	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300046
J	Sans, L; Radosevic, A; Quintian, C; Montanes, R; Gracia, S; Vilaplana, C; Mojal, S; Ballarin, JA; Fernandez-Llama, P; Torra, R; Pascual, J				Sans, Laia; Radosevic, Aleksandar; Quintian, Claudia; Montanes, Rosario; Gracia, Silvia; Vilaplana, Carles; Mojal, Sergi; Ballarin, Jose A.; Fernandez-Llama, Patricia; Torra, Roser; Pascual, Julio			Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease	PLOS ONE			English	Article							PROGRESSION; CREATININE; OUTCOMES; VOLUME; BIOMARKER; EQUATIONS; ADPKD	Background/Aims Height-adjusted total kidney volume (htTKV) is the best marker of disease progression in early autosomal dominant polycystic kidney disease (ADPKD) when renal function still remains normal. The usefulness of cystatin-C as a biomarker to assess renal function according to renal volume has not been studied in ADPKD patients. Methods Observational and cross-sectional study of 62 ADPKD patients. htTKV, creatinine and cystatin-C estimated glomerular filtration rate (eGFR) were determined. Correlations between htTKV and eGFR were studied. A control group was used to determine the association between renal function differences and htTKV. Results htTKV significantly correlated with cystatin-C-eGFR (r = -0.384, p = 0.002) but not with creatinine- eGFR (r = -0.225, p = 0.078). With htTKV stratified into tertiles, a significant difference of cystatin-C-eGFR but not in creatinine-eGFR was detected in the third tertile when compared with the first tertile group (110.0 +/- 22.2 vs 121.3 +/- 7.2; p = 0.023 and 101.8 +/- 17.2 vs 106.9 +/- 15.1; p = 0.327 respectively). When cystatin-C-eGFR of the controls was used as the reference, htTKV above 605 ml/m identified with a 75% sensitivity and 84.9% specificity those patients with a significant worse kidney function. However, this cut-off value could not be identified using creatinine-eGFR. Conclusions Cystatin-C-eGFR but not creatinine-eGFR correlated with htTKV in ADPKD patients in early stages of the disease. Differences in cystatin-C-eGFR but not in creatinine-eGFR have been identified through htTKV tertiles. A htTKV above 605 ml/m is associated with a worse renal function only if cystatin-C-eGFR is used. Cystatin-C-eGFR should be studied in prospective studies of early stages of ADPKD to determine its usefulness as an early marker of disease progression.	[Sans, Laia; Pascual, Julio] Hosp del Mar, Dept Nephrol, Barcelona, Spain; [Sans, Laia; Mojal, Sergi; Pascual, Julio] Inst Mar Med Res, Barcelona, Spain; [Sans, Laia; Ballarin, Jose A.; Torra, Roser; Pascual, Julio] Inst Carlos III, Red Temat Invest Cooperat RedinRen, Madrid, Spain; [Radosevic, Aleksandar] Hosp del Mar, Dept Radiol, Barcelona, Spain; [Quintian, Claudia] Fundacio Puigvert, Dept Radiol, Barcelona, Spain; [Montanes, Rosario; Gracia, Silvia] Fundacio Puigvert, Lab Dept, Barcelona, Spain; [Vilaplana, Carles] Lab Referencia Catalunya, Lab Dept, Barcelona, Spain; [Ballarin, Jose A.; Fernandez-Llama, Patricia; Torra, Roser] Fundacio Puigvert, Dept Nephrol, Barcelona, Spain; [Ballarin, Jose A.; Fernandez-Llama, Patricia; Torra, Roser] Univ Autonoma Barcelona, Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Fundacio Puigvert; Fundacio Puigvert; Fundacio Puigvert; Autonomous University of Barcelona	Pascual, J (corresponding author), Hosp del Mar, Dept Nephrol, Barcelona, Spain.; Pascual, J (corresponding author), Inst Mar Med Res, Barcelona, Spain.; Pascual, J (corresponding author), Inst Carlos III, Red Temat Invest Cooperat RedinRen, Madrid, Spain.	julpascual@gmail.com	Fernadez-Llama, Patricia/X-9236-2019; sans, laia/AAO-6389-2021; Torra, Roser/A-9983-2008	Fernadez-Llama, Patricia/0000-0002-7472-2124; sans, laia/0000-0002-3628-9489; Radosevic, Aleksandar/0000-0001-6453-9361; Mojal, Sergi/0000-0003-0523-3869; Torra, Roser/0000-0001-8714-2332				Ars E, 2014, NEPHROL DIAL TRANSPL, V29, P95, DOI 10.1093/ndt/gfu186; Bhutani H, 2015, KIDNEY INT, V88, P146, DOI 10.1038/ki.2015.71; Casal JA, 2005, KIDNEY INT, V68, P948, DOI 10.1111/j.1523-1755.2005.00488.x; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Chapman AB, 2011, SEMIN NEPHROL, V31, P237, DOI 10.1016/j.semnephrol.2011.05.003; Ferguson TW, 2015, CURR OPIN NEPHROL HY, V24, P295, DOI 10.1097/MNH.0000000000000115; GABOW PA, 1990, KIDNEY INT, V38, P1177, DOI 10.1038/ki.1990.330; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Helal I, 2012, AM J NEPHROL, V36, P162, DOI 10.1159/000341263; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kline TL, 2016, NEPHROL DIAL TRANSPL, V31, P241, DOI 10.1093/ndt/gfv314; Madero M, 2011, CURR OPIN NEPHROL HY, V20, P622, DOI 10.1097/MNH.0b013e32834ba210; Montaries BR, 2010, NEFROLOGIA, V30, P185; O'Neill WC, 2005, AM J KIDNEY DIS, V46, P1058, DOI 10.1053/j.ajkd.2005.08.026; Orskov B, 2010, AM J NEPHROL, V31, P53, DOI 10.1159/000256657; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Salgado JV, 2013, J CARDIOL, V62, P331, DOI 10.1016/j.jjcc.2013.05.015; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Spithoven EM, 2013, AM J KIDNEY DIS, V62, P531, DOI 10.1053/j.ajkd.2013.03.030; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174583	10.1371/journal.pone.0174583	http://dx.doi.org/10.1371/journal.pone.0174583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346513	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174300058
J	Tatay-Dualde, J; Prats-van der Ham, M; de la Fe, C; Paterna, A; Sanchez, A; Corrales, JC; Contreras, A; Tola, S; Gomez-Martin, A				Tatay-Dualde, Juan; Prats-van der Ham, Miranda; de la Fe, Christian; Paterna, Ana; Sanchez, Antonio; Carlos Corrales, Juan; Contreras, Antonio; Tola, Sebastiana; Gomez-Martin, Angel			Antimicrobial susceptibility and multilocus sequence typing of Mycoplasma capricolum subsp capricolum	PLOS ONE			English	Article							IN-VITRO SUSCEPTIBILITIES; MOLECULAR CHARACTERIZATION; CONTAGIOUS AGALACTIA; MYCOIDES CLUSTER; COLONY TYPE; DIAGNOSIS; BOVIS; EPIDEMIOLOGY; PUTREFACIENS; PHYLOGENY	Mycoplasma capricolum subsp. capricolum is one of the causative agents of contagious agalactia (CA). Nevertheless, there is still a lack of information about its antimicrobial susceptibility and genetic characteristics. Therefore, the aim of this work was to study the antimicrobial and genetic variability of different Mycoplasma capricolum subsp. capricolum field isolates. For this purpose, the growth inhibition effect of 18 antimicrobials and a multilocus sequence typing (MLST) scheme based on five housekeeping genes (fusA, glpQ, gyrB, lepA and rpoB) were performed on 32 selected field isolates from Italy and Spain. The results showed a wide range of growth inhibitory effects for almost all the antimicrobials studied. Macrolides presented lower efficacy inhibiting Mcc growth than in previous works performed on other CA-causative mycoplasmas. Erythromycin was not able to inhibit the growth of any of the studied strains, contrary to doxycycline, which inhibited the growth of all of them from low concentrations. On the other hand, the study of the concatenated genes revealed a high genetic variability among the different Mcc isolates. Hence, these genetic variations were greater than the ones reported in prior works on other mycoplasma species.	[Tatay-Dualde, Juan; Prats-van der Ham, Miranda; de la Fe, Christian; Paterna, Ana; Sanchez, Antonio; Carlos Corrales, Juan; Contreras, Antonio; Gomez-Martin, Angel] Univ Murcia, Fac Vet Sci, Dept Anim Hlth, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Tola, Sebastiana] Ist Zooprofilatt Sperimentale Sardegna G Pegreffi, Sassari, Italy	University of Murcia; IZS Della Sardegna	de la Fe, C (corresponding author), Univ Murcia, Fac Vet Sci, Dept Anim Hlth, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	cdelafe@um.es	Sánchez, Antonio/HCI-2643-2022; Sánchez, Antonio/AAA-6672-2020; DE LA FE, CHRISTIAN/F-3373-2016	Sánchez, Antonio/0000-0002-1868-3829; Sánchez, Antonio/0000-0002-1868-3829; Corrales, Juan Carlos/0000-0002-0096-4913; Contreras de Vera, Antonio/0000-0002-4455-8730; DE LA FE, CHRISTIAN/0000-0002-4354-1689; tola, sebastiana/0000-0002-8488-3773	Spanish Ministry of Economy, government of Spain [AGL2013-44771-R]; FEDER funds; University of Murcia	Spanish Ministry of Economy, government of Spain; FEDER funds(European Commission); University of Murcia	This study was funded by project AGL2013-44771-R awarded by the Spanish Ministry of Economy, government of Spain, and co-financed by FEDER funds. Juan Tatay-Dualde holds a fellowship awarded by the University of Murcia (F.P.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Momani W, 2006, TROP ANIM HEALTH PRO, V38, P1, DOI 10.1007/s11250-006-4334-3; ALBERS AC, 1982, APPL ENVIRON MICROB, V43, P958, DOI 10.1128/AEM.43.4.958-960.1982; Antunes NT, 2007, ANTIMICROB AGENTS CH, V51, P3452, DOI 10.1128/AAC.00420-07; Antunes NT, 2007, VET MICROBIOL, V119, P72, DOI 10.1016/j.vetmic.2006.08.013; Ariza-Miguel J, 2013, J CLIN MICROBIOL, V51, P656, DOI 10.1128/JCM.02835-12; Ayling RD, 2014, VET REC, V175, DOI 10.1136/vr.102303; Ayling RD, 2005, ANTIMICROB AGENTS CH, V49, P5162, DOI 10.1128/AAC.49.12.5162-5165.2005; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Chazel M, 2010, BMC VET RES, P6; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; de Garnica ML, 2013, J APPL MICROBIOL, V114, P1575, DOI 10.1111/jam.12176; De la Fe C, 2007, VET J, V173, P440, DOI 10.1016/j.tvjl.2005.09.011; European Committee on Antimicrobial Susceptability Testing (EUCAST), 2016, BREAKP TABL INT MICS; Fischer A, 2012, PLOS ONE, V7, P6; Francoz D, 2005, VET MICROBIOL, V105, P57, DOI 10.1016/j.vetmic.2004.10.006; Gerchman I, 2009, VET MICROBIOL, V137, P268, DOI 10.1016/j.vetmic.2009.01.028; Gomez-Martin A, 2013, VET J, V198, P48, DOI 10.1016/j.tvjl.2013.04.015; Gomez-Martin A, 2012, VET MICROBIOL, V157, P355, DOI 10.1016/j.vetmic.2012.01.004; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; Heller M, 2015, JMM CASE REPORTS; JHA VK, 1989, INDIAN J ANIM SCI, V59, P68; Khalil D, 2017, MICROB DRUG RESIST; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; Manso-Silvan L, 2012, VET MICROBIOL, V161, P104, DOI 10.1016/j.vetmic.2012.07.015; McAuliffe L, 2011, J MED MICROBIOL, V60, P803, DOI 10.1099/jmm.0.028159-0; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Olaogun OM, 2015, VET MICROBIOL, V180, P123, DOI 10.1016/j.vetmic.2015.07.028; Paterna A, 2013, J DAIRY SCI, V96, P7073, DOI 10.3168/jds.2012-6492; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seersholm FV, 2015, GEN ANNOUN, P3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatay-Dualde J, 2016, VET MICROBIOL, V191, P60, DOI 10.1016/j.vetmic.2016.06.002; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Waites B., 2014, MOLLICUTES MOL BIOL; Woubit S, 2007, MOL CELL PROBE, V21, P391, DOI 10.1016/j.mcp.2007.05.008	36	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174700	10.1371/journal.pone.0174700	http://dx.doi.org/10.1371/journal.pone.0174700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346546	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300072
J	Chen, Y; Li, JK; Fan, KJ; Du, YC; Ren, ZJ; Xu, J; Zheng, J; Liu, YJ; Fu, JJ; Ren, DT; Wang, GY				Chen, Yan; Li, Jiankun; Fan, Kaijian; Du, Yicong; Ren, Zhenjing; Xu, Jing; Zheng, Jun; Liu, Yunjun; Fu, Junjie; Ren, Dongtao; Wang, Guoying			Mutations in the maize zeta-carotene desaturase gene lead to viviparous kernel	PLOS ONE			English	Article							BIOSYNTHETIC-PATHWAY; PHYTOENE DESATURASE; ISOPRENOID BIOSYNTHESIS; PRIMITIVE SPOROPHYTE; LOCUS ENCODES; ENDOSPERM; ACCUMULATION; PLANTS; LOCALIZATION; EXPRESSION	Preharvest sprouting reduces the maize quality and causes a significant yield loss in maize production. vp-wl2 is a Mutator (Mu)-induced viviparous mutant in maize, causing white or pale yellow kernels, dramatically reduced carotenoid and ABA content, and a high level of zeta-carotene accumulation. Here, we reported the cloning of the vp-wl2 gene using a modified digestion-ligation-amplification method (DLA). The results showed that an insertion of Mu9 in the first intron of the zeta-carotene desaturase (ZDS) gene results in the vp-wl2 mutation. Previous studies have suggested that ZDS is likely the structural gene of the viviparous9 (vp9) locus. Therefore, we performed an allelic test using vp-wl2 and three vp9 mutants. The results showed that vp-wl2 is a novel allele of the vp9 locus. In addition, the sequences of ZDS gene were identified in these three vp9 alleles. The vp-wl2 mutant gene was subsequently introgressed into four maize inbred lines, and a viviparous phenotype was observed with yield losses from 7.69% to 13.33%.	[Chen, Yan; Li, Jiankun; Fan, Kaijian; Du, Yicong; Ren, Zhenjing; Zheng, Jun; Liu, Yunjun; Fu, Junjie; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Chen, Yan; Ren, Dongtao] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China; [Xu, Jing] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Natl Maize Improvement Ctr China, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; China Agricultural University; China Agricultural University	Wang, GY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangguoying@caas.cn	Xu, Jinge/AFY-8305-2022	Xu, Jinge/0000-0002-4478-5095	National Basic Research Program of China [2014CB138200]; National Natural Science Foundation of China [31330056]; Agricultural Science and Technology Innovation Program of WS	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program of WS	This work was supported by the National Basic Research Program of China (2014CB138200), National Natural Science Foundation of China - 31330056, and the Agricultural Science and Technology Innovation Program of WS. The funders had no role in the study design, data collection and analysis, decision to publish, preparation of the manuscript.	Araujo PG, 1997, BRAZ J GENET, V20, P71, DOI 10.1590/S0100-84551997000100013; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Breitenbach J, 2005, PLANTA, V220, P785, DOI 10.1007/s00425-004-1395-2; Britton G, 1998, CAROTENOIDS BIOSYNTH, P13; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Dong HL, 2007, CELL RES, V17, P458, DOI 10.1038/cr.2007.37; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Evans MMS, 1997, PLANT J, V12, P769, DOI 10.1046/j.1365-313X.1997.12040769.x; Eyster WH, 1924, AM J BOT, V11, P7, DOI 10.2307/2446568; Eyster WH, 1924, AM NAT, V58, P436, DOI 10.1086/279994; Fraser PD, 2000, PLANT J, V24, P551, DOI 10.1111/j.1365-313X.2000.00896.x; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; Hable WE, 1998, MOL GEN GENET, V257, P167; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Kirk J., 1978, PLASTIDS, P525; La Rocca N, 2000, PHOTOSYNTH RES, V64, P119, DOI 10.1023/A:1006477215572; Lee MH, 2013, METHODS MOL BIOL, V1043, P113, DOI 10.1007/978-1-62703-532-3_12; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; Li ZH, 1996, PLANT MOL BIOL, V30, P269, DOI 10.1007/BF00020113; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lindstrom EW, 1923, J HERED, V14, P127, DOI 10.1093/oxfordjournals.jhered.a102292; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Luo RuiBai, 1999, Plant Physiology, V120, P1206; Lv HK, 2014, PLANT MOL BIOL, V84, P243, DOI 10.1007/s11103-013-0129-x; Lyznik Leszek A., 1994, P603; MANGELSDORF P. C., 1926, CONNECTICUT [ NEW HAVEN] AGRIC EXP STA BULL, V279, P513; Mangelsdorf PC, 1923, J HERED, V14, P119, DOI 10.1093/oxfordjournals.jhered.a102290; Matthews PD, 2003, J EXP BOT, V54, P2215, DOI 10.1093/jxb/erg235; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; NEILL SJ, 1986, PLANTA, V169, P87, DOI 10.1007/BF01369779; Porch TG, 2006, PLANT J, V45, P250, DOI 10.1111/j.1365-313X.2005.02621.x; ROBERTSON DS, 1955, GENETICS, V40, P744; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Singh M, 2003, PLANT CELL, V15, P874, DOI 10.1105/tpc.010249; Smith J. D., 1978, Maize Genetics Cooperation News Letter, P107; Sprague GF, 1929, SCIENCE, V69, P526, DOI 10.1126/science.69.1794.526-a; Sprague GF, 1932, GENETICS, V17, P0358; Suzuki M, 2006, PLANT J, V45, P264, DOI 10.1111/j.1365-313X.2005.02620.x; Suzuki M, 2001, PLANT J, V28, P409, DOI 10.1046/j.1365-313X.2001.01165.x; Suzuki M, 2008, PLANT PHYSIOL, V146, P1193, DOI 10.1104/pp.107.114108; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Tan BC, 2001, PLANT J, V27, P373, DOI 10.1046/j.1365-313X.2001.01102.x; Taylor M, 2005, PHYSIOL PLANTARUM, V124, P143, DOI 10.1111/j.1399-3054.2005.00509.x; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Yang WP, 2008, HEREDITAS, V145, P225, DOI 10.1111/j.1601-5223.2008.02056.x; Yi G, 2015, PLANT PHYSIOL, V167, P443, DOI 10.1104/pp.114.251413; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	49	10	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174270	10.1371/journal.pone.0174270	http://dx.doi.org/10.1371/journal.pone.0174270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339488	Green Submitted, gold, Green Published			2022-12-27	WOS:000399116700026
J	Fathi, E; Farahzadi, R				Fathi, Ezzatollah; Farahzadi, Raheleh			Enhancement of osteogenic differentiation of rat adipose tissue-derived mesenchymal stem cells by zinc sulphate under electromagnetic field via the PKA, ERK1/2 and Wnt/beta-catenin signaling pathways	PLOS ONE			English	Article							FREQUENCY MAGNETIC-FIELD; MARROW STROMAL CELLS; IN-VITRO; GENE-EXPRESSION; ACTIVATION; GROWTH; RUNX2; ION; WNT	Zinc ion as an essential trace element and electromagnetic fields (EMFs) has been reported to be involved in the regulation of bone metabolism. The aim of this study was to elucidate the effects of zinc sulphate (ZnSO4) on the osteogenic differentiation of adipose tissue-derived mesenchymal stem cells (ADSCs) in the presence of EMF as a strategy in osteoporosis therapy. Alkaline phophatase (ALP) activity measurement, calcium assay and expression of several osteoblastic marker genes were examined to assess the effect of ZnSO4 on the osteogenic differentiation of ADSCs under EMF. The expression of cAMP and PKA was evaluated by ELISA. The expression of beta-catenin, Wnt1, Wnt3a, low-density lipoprotein receptor-related protein 5 (LRP5) and reduced dickkopf1 (DKK1) genes were used to detect the Wnt/beta-catenin pathway. It was found that ZnSO4, in the presence of EMF, resulted in an increase in the expression of osteogenic genes, ALP activity and calcium levels. EMF, in the presence of ZnSO4, increased the cAMP level and protein kinase A (PKA) activity. Treatment of ADSCs with (MAPK)/ERK kinase 1/2 inhibitor, or PKA inhibitor, significantly inhibited the promotion of osteogenic markers, indicating that the induction of osteogenesis was dependent on the ERK and PKA signaling pathways. Real-time PCR analysis showed that ZnSO4, in the presence of EMF, increased the mRNA expressions of beta-catenin, Wnt1, Wnt3a, LRP5 and DKK1. In this study, it was shown that 0.432 mu g/ml ZnSO4, in the presence of 50 Hz, 20 mT EMF, induced the osteogenic differentiation of ADSCs via PKA, ERK1/2 and Wnt/beta-catenin signaling pathways.	[Fathi, Ezzatollah] Univ Tabriz, Fac Vet Med, Dept Clin Sci, Tabriz, Iran; [Farahzadi, Raheleh] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran	University of Tabriz; Tabriz University of Medical Science	Farahzadi, R (corresponding author), Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran.	r.farahzadi@iaut.ac.ir	Farahzadi, Raheleh/W-4103-2019	Farahzadi, Raheleh/0000-0003-3159-9522; Fathi, Ezzatollah/0000-0003-0806-2735	University of Tabriz [S/27/3523-2, 15/12/1395, S/146, 30/11/1394]	University of Tabriz	This research was supported by a grant (No. S/27/3523-2, 15/12/1395, No. S/146, 30/11/1394) from the University of Tabriz.	Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; BASSETT CAL, 1974, SCIENCE, V184, P575; Collard JF, 2013, PROG BIOPHYS MOL BIO, V111, P37, DOI 10.1016/j.pbiomolbio.2012.12.004; Collard JF, 2011, BIOELECTROMAGNETICS, V32, P28, DOI 10.1002/bem.20608; Farahzadi R, 2016, INT J STEM CELLS, V9, P107, DOI 10.15283/ijsc.2016.9.1.107; Fathi Ezzatollah, 2015, Romanian Journal of Biochemistry, V52, P67; Fathi E, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016150383; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghasemzadeh-Hasankolai M, 2012, BIOL TRACE ELEM RES, V150, P137, DOI 10.1007/s12011-012-9484-8; Gholizadeh-Ghalehaziz S, 2015, INT J STEM CELLS, V8, P115, DOI 10.15283/ijsc.2015.8.2.115; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Hinsenkamp M, 2011, INT ORTHOP, V35, P1577, DOI 10.1007/s00264-011-1215-9; Hogan MV, 2004, NEUROSCI LETT, V366, P43, DOI 10.1016/j.neulet.2004.05.006; Hou Xu, 2006, Zhonghua Yan Ke Za Zhi, V42, P1103; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; Ishido M, 2001, CARCINOGENESIS, V22, P1043, DOI 10.1093/carcin/22.7.1043; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jin GD, 2014, COLLOID SURFACE B, V117, P158, DOI 10.1016/j.colsurfb.2014.02.025; Kaivosoja E, 2012, J TISSUE ENG REGENER; Kaya S., 2011, Journal of Animal and Veterinary Advances, V10, P295; Ko KS, 2007, J KOREAN NEUROSURG S, V42, P118; Kocic J, 2012, BBA-MOL CELL RES, V1823, P838, DOI 10.1016/j.bbamcr.2012.01.001; Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017; Li XD, 2011, CELL PHYSIOL BIOCHEM, V28, P367, DOI 10.1159/000331753; Lim KT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/895816; Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417; Manjhi J, 2013, J REHABIL RES DEV, V50, P17, DOI 10.1682/JRRD.2011.12.0248; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; MOONGA BS, 1995, J BONE MINER RES, V10, P453; Oh SA, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/475260; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Rico H, 2000, CALCIFIED TISSUE INT, V67, P422, DOI 10.1007/s002230001138; Seyedmajidi Seyed Ali, 2014, Dent Res J (Isfahan), V11, P475; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862; Varani K, 2002, HYPERTENSION, V40, P909, DOI 10.1161/01.HYP.0000039505.79741.15; Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026; Wagner Eric R, 2011, Curr Mol Pharmacol, V4, P14; Wang Q, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-271; Wang T, 2007, J TRACE ELEM MED BIO, V21, P84, DOI 10.1016/j.jtemb.2007.01.002; Xiao CW, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015013; YAMAGUCHI M, 1986, ACTA ENDOCRINOL-COP, V111, P285, DOI 10.1530/acta.0.1110285; YAMAGUCHI M, 1994, PEPTIDES, V15, P1367, DOI 10.1016/0196-9781(94)90110-4; Yan JH, 2010, ELECTROMAGN BIOL MED, V29, P165, DOI 10.3109/01676830.2010.505490; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Yong Y, 2014, J TISSUE ENG REGENER; Yuge L, 2003, BIOCHEM BIOPH RES CO, V311, P32, DOI 10.1016/j.bbrc.2003.09.156; Yusa K, 2011, BIOCHEM BIOPH RES CO, V412, P273, DOI 10.1016/j.bbrc.2011.07.082; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693; Zhou J, 2012, ARCH MED RES, V43, P274, DOI 10.1016/j.arcmed.2012.06.002	52	33	37	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173877	10.1371/journal.pone.0173877	http://dx.doi.org/10.1371/journal.pone.0173877			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339498	Green Submitted, Green Published, gold			2022-12-27	WOS:000399116700015
J	Maina, JN; McCracken, KG; Chua, B; York, JM; Milsom, WK				Maina, John N.; McCracken, Kevin G.; Chua, Beverly; York, Julia M.; Milsom, William K.			Morphological and morphometric specializations of the lung of the Andean goose, Chloephaga melanoptera: A lifelong high-altitude resident	PLOS ONE			English	Article							BAR-HEADED GEESE; PULMONARY DIFFUSING-CAPACITY; AVIAN LUNG; DOMESTIC-FOWL; RESPIRATORY SYSTEM; FUNCTIONAL DESIGN; STRUCTURAL DESIGN; ANSER INDICUS; HEMOGLOBIN; BIRD	High altitude flight in rarefied, extremely cold and hypoxic air is a very challenging activity. Only a few species of birds can achieve it. Hitherto, the structure of the lungs of such birds has not been studied. This is because of the rarity of such species and the challenges of preparing well-fixed lung tissue. Here, it was posited that in addition to the now proven physiological adaptations, high altitude flying birds will also have acquired pulmonary structural adaptations that enable them to obtain the large amounts of oxygen (O-2) needed for flight at high elevation, an environment where O-2 levels are very low. The Andean goose (Chloephaga melanoptera) normally resides at altitudes above 3000 meters and flies to elevations as high as 6000 meters where O-2 becomes limiting. In this study, its lung was morphologically-and morphometrically investigated. It was found that structurally the lungs are exceptionally specialized for gas exchange. Atypically, the infundibulae are well-vascularized. The mass-specific volume of the lung (42.8 cm(3).kg(-1)), the massspecific respiratory surface area of the blood-gas (tissue) barrier (96.5 cm(2).g(-1)) and the mass-specific volume of the pulmonary capillary blood (7.44 cm(3).kg(-1))were some of the highest values so far reported in birds. The pulmonary structural specializations have generated a mass-specific total (overall) pulmonary morphometric diffusing capacity of the lung for oxygen (DLo(2)) of 0.119 mlO(2).sec(-1).mbar(-1).kg(-1), a value that is among some of the highest ones in birds that have been studied. The adaptations of the lung of the Andean goose possibly produce the high O-2 conductance needed to live and fly at high altitude.	[Maina, John N.] Univ Johannesburg, Dept Zool, Johannesburg, South Africa; [McCracken, Kevin G.] Univ Miami, Dept Biol & Marine Biol & Ecol, Rosenstiel Sch Marine & Atmospher Sci, Coral Gables, FL 33124 USA; [Chua, Beverly; York, Julia M.; Milsom, William K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of Johannesburg; University of Miami; University of British Columbia	Maina, JN (corresponding author), Univ Johannesburg, Dept Zool, Johannesburg, South Africa.	jmaina@uj.ac.za	York, Julia/AAJ-9145-2021	Maina, John/0000-0001-7549-2861; York, Julia/0000-0003-4947-0591				ABDALLA MA, 1981, J ANAT, V133, P677; ABDALLA MA, 1982, RESP PHYSIOL, V47, P267, DOI 10.1016/0034-5687(82)90057-3; Altshuler DL, 2006, INTEGR COMP BIOL, V46, P4; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; BLACK CP, 1980, RESP PHYSIOL, V39, P217, DOI 10.1016/0034-5687(80)90046-8; Butler PJ, 2010, COMP BIOCHEM PHYS A, V156, P325, DOI 10.1016/j.cbpa.2010.01.016; DUBACH M, 1981, RESP PHYSIOL, V46, P43, DOI 10.1016/0034-5687(81)90067-0; DUNCKER HR, 1971, ERGEBNISSE ANATOMIE, V0045, P00001; FEDDE MR, 1989, RESP PHYSIOL, V77, P239, DOI 10.1016/0034-5687(89)90010-8; FEDDE MR, 1980, POULTRY SCI, V59, P2642, DOI 10.3382/ps.0592642; Fjeldsa J, 1990, BIRDS HIGH ANDES MAN; GEHR P, 1981, RESP PHYSIOL, V44, P61, DOI 10.1016/0034-5687(81)90077-3; Gillooly JF, 2016, P NATL ACAD SCI USA, V113, P5340, DOI 10.1073/pnas.1519617113; Gou X, 2007, COMP BIOCHEM PHYS B, V147, P147, DOI 10.1016/j.cbpb.2006.11.031; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; HIEBL I, 1987, BIOL CHEM H-S, V368, P1559, DOI 10.1515/bchm3.1987.368.2.1559; Hsia CCW, 2016, COMPR PHYSIOL, V6, P827, DOI 10.1002/cphy.c150028; Irwin Darren E., 2005, P27; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; Koppen U, 2010, J ORNITHOL, V151, P703, DOI 10.1007/s10336-010-0492-1; Lague SL, 2017, J EXP BIOL; Maina J.N., 1989, P307; Maina J. N., 2011, BIOENGINEERING ASPEC; Maina J. N., 2015, VERTEBRATE BLOOD GAS, V2015, P15; MAINA JN, 1982, ACTA ANAT, V112, P264, DOI 10.1159/000145519; MAINA JN, 1989, PHILOS T R SOC B, V326, P1, DOI 10.1098/rstb.1989.0104; MAINA JN, 1989, J ANAT, V163, P67; MAINA JN, 1987, RESP PHYSIOL, V68, P99, DOI 10.1016/0034-5687(87)90080-6; Maina JN, 2000, J EXP BIOL, V203, P3045; MAINA JN, 1984, RESP PHYSIOL, V55, P291, DOI 10.1016/0034-5687(84)90052-5; Maina JN, 2005, PHYSIOL REV, V85, P811, DOI 10.1152/physrev.00022.2004; MAINA JN, 1982, J ANAT, V134, P604; Maina JN, 2002, BIOL REV, V77, P97, DOI 10.1017/S1464793101005838; Maina JN, 2001, J EXP BIOL, V204, P2313; MAINA JN, 1987, ANAT HISTOL EMBRYOL, V16, P293; Maina JN, 2013, BIOOPEN; Maina JN, 2002, FUNCTIONAL MORPHOLOG; Maina JN, 1997, DIVERSITY BIOL DESIG, P177; Maina JN, 2005, DESIGN LUNG AIR SAC; MAINA JN, 1994, ADV COMP ENV PHYSL, P111; Maina JN, 2016, BIOL REV; Maina JN, 2017, CELL TISSUE RES, V367, P747, DOI 10.1007/s00441-016-2549-9; Maina JN, 2013, BIOMED ENG COMPUT BI, V5, P77, DOI 10.4137/BECB.S12988; Maine JN, 2002, FUNDAMENTAL STRUCTUR; McCracken KG, 2010, MOL PHYLOGENET EVOL, V56, P649, DOI 10.1016/j.ympev.2010.04.034; McLelland J., 1989, P221; Nudds RL, 2000, J EXP BIOL, V203, P1561; Remmers J.E., 1990, HYPOXIA ADAPTATIONS, P4; Sapoval B, 2002, P NATL ACAD SCI USA, V99, P10411, DOI 10.1073/pnas.122352499; Scheid P, 1979, Rev Physiol Biochem Pharmacol, V86, P137, DOI 10.1007/BFb0031533; SCHERLE W, 1970, Mikroskopie, V26, P57; Scott GR, 2007, AM J PHYSIOL-REG I, V293, pR379, DOI 10.1152/ajpregu.00161.2007; Scott GR, 2015, PHYSIOLOGY, V30, P107, DOI 10.1152/physiol.00050.2014; Scott GR, 2011, J EXP BIOL, V214, P2455, DOI 10.1242/jeb.052548; STANISLAUS MARIANNE, 1937, ZEITSCHR MORPH U OKOL TIERE, V33, P261, DOI 10.1007/BF00403415; Suarez RK, 2004, COMP BIOCHEM PHYS B, V139, P531, DOI 10.1016/j.cbpc.2004.05.001; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; Tucker V.A., 1974, Publications Nuttall Orn Club, VNo. 15, P298; VIDYADARAN MK, 1987, SCHWEIZ ARCH TIERH, V129, P225; WEBER RE, 1988, BIOL CHEM H-S, V369, P233, DOI 10.1515/bchm3.1988.369.1.233; WEIBEL E R, 1970, Respiration Physiology, V11, P54; WEIBEL ER, 1993, RESP PHYSIOL, V93, P125, DOI 10.1016/0034-5687(93)90001-Q; Weibel ER., 1990, MODELS LUNG DIS MICR, P199; WELLS DJ, 1993, J EXP BIOL, V178, P39; WELSCH U, 1986, CELL TISSUE RES, V243, P137; White CR, 2014, COMPR PHYSIOL, V4, P231, DOI 10.1002/cphy.c110049; Whiteman L., 2000, THE HIGH LIFE; Zhang J, 1996, J MOL BIOL, V255, P484, DOI 10.1006/jmbi.1996.0040	69	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174395	10.1371/journal.pone.0174395	http://dx.doi.org/10.1371/journal.pone.0174395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339478	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700028
J	Bhandare, S; Goldberg, DS; Dowell, R				Bhandare, Shweta; Goldberg, Debra S.; Dowell, Robin			Discriminating between HuR and TTP binding sites using the k-spectrum kernel method	PLOS ONE			English	Article							MESSENGER-RNA; SEQUENCE MOTIFS; DNA-SEQUENCE; IDENTIFICATION; PREDICTION; DATABASE	Background The RNA binding proteins (RBPs) human antigen R (HuR) and Tristetraprolin (TTP) are known to exhibit competitive binding but have opposing effects on the bound messenger RNA (mRNA). How cells discriminate between the two proteins is an interesting problem. Machine learning approaches, such as support vector machines (SVMs), may be useful in the identification of discriminative features. However, this method has yet to be applied to studies of RNA binding protein motifs. Results Applying the k-spectrum kernel to a support vector machine (SVM), we first verified the published binding sites of both HuR and TTP. Additional feature engineering highlighted the U-rich binding preference of HuR and AU-rich binding preference for TTP. Domain adaptation along with multi-task learning was used to predict the common binding sites. Conclusion The distinction between HuR and TTP binding appears to be subtle content features. HuR prefers strongly U-rich sequences whereas TTP prefers AU-rich as with increasing A content, the sequences are more likely to be bound only by TTP. Our model is consistent with competitive binding of the two proteins, particularly at intermediate AU-balanced sequences. This suggests that fine changes in the A/U balance within a untranslated region (UTR) can alter the binding and subsequent stability of the message. Both feature engineering and domain adaptation emphasized the extent to which these proteins recognize similar general sequence features. This work suggests that the k-spectrum kernel method could be useful when studying RNA binding proteins and domain adaptation techniques such as feature augmentation could be employed particularly when examining RBPs with similar binding preferences.	[Bhandare, Shweta; Goldberg, Debra S.; Dowell, Robin] Univ Colorado, Dept Comp Sci, 1111 Engn Dr, Boulder, CO 80303 USA; [Goldberg, Debra S.; Dowell, Robin] Univ Colorado, Sch Med, Computat Biosci Program, 12801 E 17th Ave,RC1N-6129, Aurora, CO 80045 USA; [Dowell, Robin] Univ Colorado, Dept Mol Cellular & Dev Biol, 596 UCB, Boulder, CO 80309 USA; [Dowell, Robin] Univ Colorado, BioFrontiers Inst, 596 UCB, Boulder, CO 80309 USA; [Goldberg, Debra S.] Cage Free Learning, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Bhandare, S (corresponding author), Univ Colorado, Dept Comp Sci, 1111 Engn Dr, Boulder, CO 80303 USA.	bhandare@colorado.edu		DOWELL, ROBIN/0000-0001-7665-9985	National Science Foundation [CNS-0821794, DGE 0841423]; University of Colorado Boulder	National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder	DSG was supported in part by the National Science Foundation under Grant No. DGE 0841423.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Berezikov E, 2004, GENOME RES, V14, P170; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Daume H, 2009, FRUSTRATINGLY EASY D; Eliscovich C, 2013, J BIOL CHEM, V288, P20361, DOI 10.1074/jbc.R113.452094; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; Hafner M, 2010, J VISUALIZED EXPT JO; Holloway Dustin T, 2007, Syst Synth Biol, V1, P25, DOI 10.1007/s11693-006-9003-3; Lebedeva S, 2011, MOL CELL; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Leslie Christina, 2002, Pac Symp Biocomput, P564; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Lodhi H, 2002, J MACH LEARN RES, V2, P419, DOI 10.1162/153244302760200687; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Schultheiss SJ, 2009, BIOINFORMATICS, V25, P2126, DOI 10.1093/bioinformatics/btp278; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Teramoto R, 2005, FEBS LETT, V579, P2878, DOI 10.1016/j.febslet.2005.04.045; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wasserman WW, 2003, NATURWISSENSCHAFTEN, V90, P156, DOI 10.1007/s00114-003-0409-4	32	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174052	10.1371/journal.pone.0174052	http://dx.doi.org/10.1371/journal.pone.0174052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333956	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200040
J	Coldwell, DF; Evans, KL				Coldwell, Deborah F.; Evans, Karl L.			Contrasting effects of visiting urban green-space and the countryside on biodiversity knowledge and conservation support	PLOS ONE			English	Article							MANAGEMENT; QUALITY; HEALTH	Conservation policy frequently assumes that increasing people's exposure to green-space enhances their knowledge of the natural world and desire to protect it. Urban development is, however, considered to be driving declining connectedness to nature. Despite this the evidence base supporting the assumption that visiting green-spaces promotes biodiversity knowledge and conservation support, and the impacts of urbanization on these relationships, is surprisingly limited. Using data from door-to-door surveys of nearly 300 residents in three pairs of small and large urban areas in England we demonstrate that people who visit green-space more regularly have higher biodiversity knowledge and support for conservation (measured using scales of pro-environmental behavior). Crucially these relationships only arise when considering visits to the countryside and not the frequency of visits to urban green-space. These patterns are robust to a suite of confounding variables including nature orientated motivations for visiting green-space, socio-economic and demographic factors, garden-use and engagement with natural history programs. Despite this the correlations that we uncover cannot unambiguously demonstrate that visiting the countryside improves biodiversity knowledge and conservation support. We consider it likely, however, that two mechanisms operate through a positive feedback loop i.e. increased visits to green-space promote an interest in and knowledge of biodiversity and support for conservation, which in turn further increase the desire to visit green-space and experience nature. The intensity of urbanization around peoples' homes, but not city size, is negatively associated with their frequency of countryside visits and biodiversity knowledge. Designing less intensely urbanized cities with good access to the countryside, combined with conservation policies that promote access to the countryside thus seems likely to maximize urban residents' biodiversity knowledge and support for conservation.	[Coldwell, Deborah F.; Evans, Karl L.] Univ Sheffield, Western Bank, Anim & Plant Sci, Alfred Denny Bldg, Sheffield, S Yorkshire, England	University of Sheffield	Coldwell, DF (corresponding author), Univ Sheffield, Western Bank, Anim & Plant Sci, Alfred Denny Bldg, Sheffield, S Yorkshire, England.	bop12dc@sheffield.ac.uk			Biodiversity and Ecosystem Service Sustainability (BESS) [NE/K500914/1]; Natural England's Dark Peak Nature Improvement Area; Moors for the Future Partnership; UK Natural Environment Research Council; Biotechnology and Biological Sciences Research Council, UK's Living with Environmental Change program	Biodiversity and Ecosystem Service Sustainability (BESS); Natural England's Dark Peak Nature Improvement Area; Moors for the Future Partnership; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council, UK's Living with Environmental Change program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded witha studentship award [NE/K500914/1] to KLE from the Biodiversity and Ecosystem Service Sustainability (BESS, http://www.nerc-bess.net/) program with CASE partner funding from Natural England's Dark Peak Nature Improvement Area through, and with support from, Moors for the Future Partnership (http://www.moorsforthefuture.org.uk/). BESS is a six year program (2011-2017) funded by the UK Natural Environment Research Council (http://www.nerc.ac.uk/) and the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) as part of the UK's Living with Environmental Change program. The views expressed are those of the authors and not necessarily those of the BESS Directorate or NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock I, 2017, GLOBAL ENVIRON CHANG, V42, P136, DOI 10.1016/j.gloenvcha.2016.11.005; Bates D, LME4 LINEAR MIXED EF; Booth JE, 2009, BIOL CONSERV, V142, P3196, DOI 10.1016/j.biocon.2009.07.024; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Buijs AE, 2013, BIOL CONSERV, V168, P184, DOI 10.1016/j.biocon.2013.08.020; Chawla L., 2001, ENVIRON EDUC RES, V7, P451, DOI [10.1080/13504620120081313, DOI 10.1080/13504620120081313]; Church A., 2011, UK NATL ECOSYSTEM AS; Cooper C, 2015, J WILDLIFE MANAGE, V79, P446, DOI 10.1002/jwmg.855; Cotton DRE, 2013, STUD HIGH EDUC, V38, P1457, DOI 10.1080/03075079.2011.627423; Davis JL, 2011, J ENVIRON PSYCHOL, V31, P257, DOI 10.1016/j.jenvp.2011.01.004; Defra, 2010, WHAT NAT CAN DO YOU; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fischer A, 2007, BIOL CONSERV, V136, P271, DOI 10.1016/j.biocon.2006.11.024; Frederiks ER, 2015, RENEW SUST ENERG REV, V41, P1385, DOI 10.1016/j.rser.2014.09.026; Kabisch N, 2014, LANDSCAPE URBAN PLAN, V122, P129, DOI 10.1016/j.landurbplan.2013.11.016; Kareiva P, 2008, P NATL ACAD SCI USA, V105, P2757, DOI 10.1073/pnas.0800474105; Kennedy EH, 2009, RURAL SOCIOL, V74, P309, DOI 10.1526/003601109789037268; Kormos C, 2014, J ENVIRON PSYCHOL, V40, P359, DOI 10.1016/j.jenvp.2014.09.003; Leopold Aldo, 1949, S COUNTY ALMANAC; Lindemann-Matthies P, 2008, HUM ECOL, V36, P731, DOI 10.1007/s10745-008-9194-1; Louv R., 2005, LAST CHILD WOODS WHY; Luckmann K, 2014, J BIOL EDUC, V48, P80, DOI 10.1080/00219266.2013.837404; MOSES LE, 1984, NEW ENGL J MED, V311, P442, DOI 10.1056/NEJM198408163110705; Moss S, 2012, NATURAL CHILDHOOD NA; Natural England, 2010, NAT NEARB ACC NAT GR; Natural England, 2013, ANN REP 2012 13 SURV; Office for National Statistics, ENGL IND DEPR; Pasta D.J., 2009, SAS GLOBAL FORUM, V248; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pienaar EF, 2015, SOC SCI RES, V51, P338, DOI 10.1016/j.ssresearch.2014.09.005; Pilgrim S, 2007, ECOL APPL, V17, P1742, DOI 10.1890/06-1358.1; Pilgrim SE, 2008, ENVIRON SCI TECHNOL, V42, P1004, DOI 10.1021/es070837v; Pyle RM, 2003, ORYX, V37, P206, DOI 10.1017/S0030605303000383; Randler C, 2007, ANTHROZOOS, V20, P65, DOI 10.2752/089279307780216696; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Seress G, 2014, LANDSCAPE URBAN PLAN, V131, P42, DOI 10.1016/j.landurbplan.2014.07.010; Swanwick C., 2003, BUILT ENV, V29, P94, DOI [DOI 10.2148/BENV.29.2.94.54467, 10.1016/j.cities.2017.03.011, DOI 10.1016/J.CITIES.2017.03.011]; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; TREMBLAY KR, 1978, RURAL SOCIOL, V43, P474; Trzyna T, 2014, BEST PRACTICE PROTEC, V22; van Dillen SME, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2009.104695; Zaradic PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007367	43	16	17	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174376	10.1371/journal.pone.0174376	http://dx.doi.org/10.1371/journal.pone.0174376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334034	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000399102200088
J	Droznin, M; Johnson, A; Johnson, AM				Droznin, Maxwell; Johnson, Allen; Johnson, Asal Mohamadi			Multidrug resistant tuberculosis in prisons located in former Soviet countries: A systematic review	PLOS ONE			English	Review							MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; PULMONARY TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; INCREASING INCIDENCE; HIV-INFECTION; RISK-FACTOR; MDR-TB; RUSSIA; INMATES	Background A systematic literature review was performed to investigate the occurrence of multidrug-resistant tuberculosis (MDR TB) in prisons located in countries formerly part of the Soviet Union. Methods A systematic search of published studies reporting MDR TB occurrence in prisons located in former Soviet countries was conducted by probing PubMed and Cumulative Index Nursing and Allied Health Literature for articles that met predetermined inclusion criteria. Results Seventeen studies were identified for systematic review. Studies were conducted in six different countries. Overall, prevalence of MDR TB among prisoners varied greatly between studies. Our findings suggest a high prevalence of MDR TB in prisons of Post-Soviet states with percentages as high as 16 times more than the worldwide prevalence estimated by the WHO in 2014. Conclusion All studies suggested a high prevalence of MDR TB in prison populations in Post-Soviet states.	[Droznin, Maxwell; Johnson, Allen] Rollins Coll, Dept Hlth Profess, Winter Pk, FL 32789 USA; [Johnson, Asal Mohamadi] Stetson Univ, Dept Sociol Anthropol & Publ Hlth, Deland, FL 32720 USA	Rollins College; Stetson University	Johnson, A (corresponding author), Rollins Coll, Dept Hlth Profess, Winter Pk, FL 32789 USA.	jajohnson@rollins.edu		Droznin, Maxwell/0000-0003-1828-3208				Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; Angie B, 2000, TUBERCULOSIS CONTROL; [Anonymous], 1998, NEWSLETTER PENAL REF; [Anonymous], 2016, INT COMP PROGR DAT; Arbatov Alexei, 1997, MANAGING CONFLICT FO; Atun R, 2008, B WORLD HEALTH ORGAN, V86, P147, DOI 10.2471/BLT.06.034991; Balabanova Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-44; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020531; Banatvala N, 1999, LANCET, V353, P999, DOI 10.1016/S0140-6736(99)02059-0; Barrera L, 2008, WHO GUIDELINES APPRO; Blondal K, 2011, INT J TUBERC LUNG D, V15, P892, DOI 10.5588/ijtld.10.0601; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; Boltaev AA, 2013, DRUG ALCOHOL DEPEN, V132, pS41, DOI 10.1016/j.drugalcdep.2013.07.033; Bone A., 2000, TUBERCULOSIS CONTROL; Bonnet M, 2005, INT J TUBERC LUNG D, V9, P1147; BRAUN MM, 1989, JAMA-J AM MED ASSOC, V261, P393, DOI 10.1001/jama.261.3.393; Bremmer I., 2006, INDEPENDENCE MAKING, P141; Cohen T, 2014, DRUG RESIST UPDATE, V17, P105, DOI 10.1016/j.drup.2014.10.001; CONINX R, 1995, LANCET, V346, P1238, DOI 10.1016/S0140-6736(95)92952-5; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; Dara M, 2009, GUIDELINES CONTROL T; Das V, 2006, PHARM URBAN ECOLOGIE; Davitaia A, 2010, ISHR GEORGIA REPORT; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014; Fattorini L, 2016, EUR RESPIR J, V47, P1273, DOI 10.1183/13993003.01844-2015; Henostroza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067338; Ibrayeva A, 2014, INT J TUBERC LUNG D, V18, P298, DOI 10.5588/ijtld.13.0558; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; JENKINS HE, 2011, EUROSURVEILLANCE, V19, P20743; Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812; Jugheli L, 2008, INT J TUBERC LUNG D, V12, P561; Kim J., 2000, DYING FOR GROWTH; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Long R, 1999, CAN MED ASSOC J, V160, P1185; Lukoye D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1614-8; Mar'iandyshev AO, 2005, PROBL TUBERK BOLEZN, V5, P19; Mataev S. V., 2004, Voprosy Pitaniya, V73, P25; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; Ministry of the Interior/Ministry of Justice of the Russian, 1989, OFF STAT PEN SYST; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Niveau G, 2006, PUBLIC HEALTH, V120, P33, DOI 10.1016/j.puhe.2005.03.017; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; Pfyffer GE, 2001, EMERG INFECT DIS, V7, P855, DOI 10.3201/eid0705.017514; Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; Schluger NW, 2013, DRUG ALCOHOL DEPEN, V132, pS32, DOI 10.1016/j.drugalcdep.2013.07.012; Shemyakin IG, 2004, INT J TUBERC LUNG D, V8, P1194; Shkolnikov VM, 1996, RAND CONF PROC, P113; SKOLNICK AA, 1992, JAMA-J AM MED ASSOC, V268, P3175, DOI 10.1001/jama.268.22.3175; Spradling R, 2002, INT J TUBERC LUNG D, V6, P757; Stephens TT, 2003, INT J STD AIDS, V14, P514, DOI 10.1258/095646203767869101; Stern V., 1999, SENTENCED DIE PROBLE; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Victor TC, 2007, INT J TUBERC LUNG D, V11, P195; Walmsley R, 2016, WORLD PRISON BRIEF; Whyte SR, 2002, SOCIAL LIVES MED; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2000, WHO GLOB TUB CONTR; World Health Organization (WHO), 2015, MULT RES TUB MDR TB; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	67	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174373	10.1371/journal.pone.0174373	http://dx.doi.org/10.1371/journal.pone.0174373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334036	Green Submitted, gold, Green Published			2022-12-27	WOS:000399102200087
J	Holmila, R; Sklias, A; Muller, DC; Esposti, DD; Guilloreau, P; Mckay, J; Sangrajrang, S; Srivatanakul, P; Hainaut, P; Merle, P; Herceg, Z; da Costa, AN				Holmila, Reetta; Sklias, Athena; Muller, David C.; Esposti, Davide Degli; Guilloreau, Paule; Mckay, James; Sangrajrang, Suleeporn; Srivatanakul, Petcharin; Hainaut, Pierre; Merle, Philippe; Herceg, Zdenko; da Costa, Andre Nogueira			Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; COLORECTAL-CANCER; GASTRIC-CANCER; BLADDER-CANCER; GENES; HYPERMETHYLATION; SERUM; PROGRESSION; METASTASIS; EXPRESSION	Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide, but is still lacking sensitive and specific biomarkers for early diagnosis and prognosis. In this study, we applied targeted massively parallel semiconductor sequencing to assess methylation on a panel of genes (FBLN1, HINT2, LAMC1, LTBP1, LTBP2, PSMA2, PSMA7, PXDN, TGFB1, UBE2L3, VIM and YWHAZ) in plasma circulating cell-free DNA (cfDNA) and to evaluate the potential of these genes as HCC biomarkers in two different series, one from France (42 HCC cases and 42 controls) and one from Thailand (42 HCC cases, 26 chronic liver disease cases and 42 controls). We also analyzed a set of HCC and adjacent tissues and liver cell lines to further compare with 'The Cancer Genome Atlas' (TCGA) data. The methylation in cfDNA was detected for FBLN1, PSMA7, PXDN and VIM, with differences in methylation patterns between cases and controls for FBLN1 and VIM. The average methylation level across analyzed CpG-sites was associated with higher odds of HCC for VIM (1.48 [1.02, 2.16] for French cases and 2.18 [1.28, 3.72] for Thai cases), and lower odds of HCC for FBLN1 (0.89 [0.76, 1.03] for French cases and 0.75 [0.63, 0.88] for Thai cases). In conclusion, our study provides evidence that changes in VIM and FBLN1 methylation levels in cfDNA are associated with HCC and could represent useful plasma-based biomarkers. Also, the potential to investigate methylation patterns in cfDNA could bring new strategies for HCC detection and monitoring high-risk groups and response to treatment.	[Holmila, Reetta; Sklias, Athena; Esposti, Davide Degli; Herceg, Zdenko] Int Agcy Res Canc IARC, Epigenet Grp, Lyon, France; [Muller, David C.] Int Agcy Res Canc IARC, Genet Epidemiol Grp, Lyon, France; [Guilloreau, Paule; Merle, Philippe] Croix Rousse Hosp, Lyon, France; [Mckay, James] Int Agcy Res Canc IARC, Genet Canc Susceptibil Grp, Lyon, France; [Sangrajrang, Suleeporn; Srivatanakul, Petcharin] Natl Canc Inst, Mol Epidemiol Sect, Bangkok, Thailand; [Hainaut, Pierre] INSERM, Inst Albert Bonniot, Unite 823, La Tronche, France; [Merle, Philippe] INSERM, CRCL, UMR 1052, Lyon, France; [da Costa, Andre Nogueira] Int Agcy Res Canc IARC, Mol Mech & Biomarkers Grp, Lyon, France; [Holmila, Reetta] Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA; [da Costa, Andre Nogueira] UCB BioPharma SPRL, Braine Lalleud, Belgium	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon; World Health Organization; International Agency for Research on Cancer (IARC); National Cancer Institute - Thailand; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); World Health Organization; International Agency for Research on Cancer (IARC); Wake Forest University; Wake Forest Baptist Medical Center	Holmila, R; Herceg, Z (corresponding author), Int Agcy Res Canc IARC, Epigenet Grp, Lyon, France.; da Costa, AN (corresponding author), Int Agcy Res Canc IARC, Mol Mech & Biomarkers Grp, Lyon, France.; Holmila, R (corresponding author), Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA.; da Costa, AN (corresponding author), UCB BioPharma SPRL, Braine Lalleud, Belgium.	rholmila@wakehealth.edu; HercegZ@iarc.fr; andre.dacosta@ucb.com	Degli Esposti, Davide/M-1917-2015; Muller, David C/V-8207-2017; Hainaut, Pierre/B-6018-2012	Degli Esposti, Davide/0000-0003-1390-4845; Muller, David C/0000-0002-2350-0417; Hainaut, Pierre/0000-0002-1303-1610; Holmila, Reetta/0000-0002-2825-5676	IARC; EC FP7 Marie Curie Actions - People - Co-funding of regional, national and international programmes (COFUND); IARC regular budget	IARC(World Health Organization); EC FP7 Marie Curie Actions - People - Co-funding of regional, national and international programmes (COFUND); IARC regular budget	ANdC was a recipient of a Postdoctoral Fellowship from the IARC, partially supported by the EC FP7 Marie Curie Actions - People - Co-funding of regional, national and international programmes (COFUND). This work in the IARC Epigenetics Group was supported by IARC regular budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ms Daniela de Santos-Silva is thanked for her assistance in the sample collection. This work in the IARC Epigenetics Group was supported by IARC regular budget. ANdC was a recipient of a Postdoctoral Fellowship from the IARC, partially supported by the EC FP7 Marie Curie Actions-People-Co-funding of regional, national and international programmes (COFUND).	Arai E, 2009, INT J CANCER, V125, P2854, DOI 10.1002/ijc.24708; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang H, 2008, EXP MOL PATHOL, V85, P96, DOI 10.1016/j.yexmp.2008.07.001; Cheng YY, 2008, BRIT J CANCER, V99, P2083, DOI 10.1038/sj.bjc.6604760; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; da Costa AN, 2015, INT J CANCER, V136, P172, DOI 10.1002/ijc.28953; Desmond JC, 2007, LEUKEMIA, V21, P1026, DOI 10.1038/sj.leu.2404611; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gomaa AI, 2009, WORLD J GASTROENTERO, V15, P1301, DOI 10.3748/wjg.15.1301; Hernandez-Vargas H, PLOS ONE, V5, pe9749; Hu XT, 2008, ONCOL REP, V19, P441; IARC, 2014, WORLD CANC REPORT 20; Iizuka N, 2006, J CANCER RES CLIN, V132, P473, DOI 10.1007/s00432-006-0094-8; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Kitamura YH, 2009, ANTICANCER RES, V29, P2227; Kitamura Y, 2011, ANTICANCER RES, V31, P1289; Lee MK, 2014, ONCOLOGY-BASEL, V86, P359, DOI 10.1159/000362738; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li YW, 2014, TUMOR BIOL, V35, P6783, DOI 10.1007/s13277-014-1905-1; Lu HN, 2014, ONCOL LETT, V8, P1751, DOI 10.3892/ol.2014.2413; Martin J, 2006, GASTROENTEROLOGY, V130, P2179, DOI 10.1053/j.gastro.2006.03.024; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pupa SM, 2007, CANCER RES, V67, P4271, DOI 10.1158/0008-5472.CAN-06-4162; Radhakrishnan VM, 2011, GENE CHROMOSOME CANC, V50, P830, DOI 10.1002/gcc.20904; Salvi A, 2015, INT J ONCOL, V46, P1901, DOI 10.3892/ijo.2015.2923; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Shirahata A, 2014, ANTICANCER RES, V34, P4121; Shirahata A, 2012, ANTICANCER RES, V32, P791; Song BP, 2012, J MOL DIAGN, V14, P112, DOI 10.1016/j.jmoldx.2011.12.003; Team RC, 2014, LANG ENV STAT COMP; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ulirsch J, 2013, BREAST CANCER RES TR, V137, P383, DOI 10.1007/s10549-012-2353-5; Vaca-Paniagua F, 2015, EPIGENOMICS-UK, V7, P353, DOI 10.2217/epi.14.94; Wang L, 2014, TUMOR BIOL, V35, P9, DOI 10.1007/s13277-013-1141-0; Wang YQ, 2013, WORLD J GASTROENTERO, V19, P5557, DOI 10.3748/wjg.v19.i33.5557; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Xiao W, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-677; Xiao W, 2013, J UROLOGY, V190, P291, DOI 10.1016/j.juro.2013.01.098; Zhang YJ, 2007, CLIN CANCER RES, V13, P2378, DOI 10.1158/1078-0432.CCR-06-1900; Zhou YF, 2014, WORLD J GASTROENTERO, V20, P13172, DOI 10.3748/wjg.v20.i36.13172	48	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174265	10.1371/journal.pone.0174265	http://dx.doi.org/10.1371/journal.pone.0174265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333958	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200068
J	Karat, AS; Tlali, M; Fielding, KL; Charalambous, S; Chihota, VN; Churchyard, GJ; Hanifa, Y; Johnson, S; McCarthy, K; Martinson, NA; Omar, T; Kahn, K; Chandramohan, D; Grant, AD				Karat, Aaron S.; Tlali, Mpho; Fielding, Katherine L.; Charalambous, Salome; Chihota, Violet N.; Churchyard, Gavin J.; Hanifa, Yasmeen; Johnson, Suzanne; McCarthy, Kerrigan; Martinson, Neil A.; Omar, Tanvier; Kahn, Kathleen; Chandramohan, Daniel; Grant, Alison D.			Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data	PLOS ONE			English	Article							DEATH ASSIGNMENT; ANTIRETROVIRAL THERAPY; ASSIGNING CAUSES; AIDS MORTALITY; CAPE-TOWN; VALIDATION; PERFORMANCE; TB; POPULATION; INTERVA	Background The World Health Organization (WHO) aims to reduce tuberculosis (TB) deaths by 95% by 2035; tracking progress requires accurate measurement of TB mortality. International Classification of Diseases (ICD) codes do not differentiate between HIV-associated TB and HIV more generally. Verbal autopsy (VA) is used to estimate cause of death (CoD) patterns but has mostly been validated against a suboptimal gold standard for HIV and TB. This study, conducted among HIV-positive adults, aimed to estimate the accuracy of VA in ascertaining TB and HIV CoD when compared to a reference standard derived from a variety of clinical sources including, in some, minimally-invasive autopsy (MIA). Methods and findings Decedents were enrolled into a trial of empirical TB treatment or a cohort exploring diagnostic algorithms for TB in South Africa. The WHO 2012 instrument was used; VA CoD were assigned using physician-certified VA (PCVA), InterVA-4, and SmartVA-Analyze. Reference CoD were assigned using MIA, research, and health facility data, as available. 259 VAs were completed: 147 (57%) decedents were female; median age was 39 (interquartile range [IQR] 33-47) years and CD4 count 51 (IQR 22-102) cells/mu L. Compared to reference CoD that included MIA (n = 34), VA underestimated mortality due to HIV/AIDS (94% reference, 74% PCVA, 47% InterVA-4, and 41% SmartVA-Analyze; chance-corrected concordance [CCC] 0.71, 0.42, and 0.31, respectively) and HIV-associated TB (41% reference, 32% PCVA; CCC 0.23). For individual decedents, all VA methods agreed poorly with reference CoD that did not include MIA (n = 259; overall CCC 0.14, 0.06, and 0.15 for PCVA, InterVA-4, and SmartVA-Analyze); agreement was better at population level (cause-specific mortality fraction accuracy 0.78, 0.61, and 0.57, for the three methods, respectively). Conclusions Current VA methods underestimate mortality due to HIV-associated TB. ICD and VA methods need modifications that allow for more specific evaluation of HIV-related deaths and direct estimation of mortality due to HIV-associated TB.	[Karat, Aaron S.; Hanifa, Yasmeen; Grant, Alison D.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Tlali, Mpho; Charalambous, Salome; Chihota, Violet N.; Churchyard, Gavin J.; McCarthy, Kerrigan] Aurum Inst, Johannesburg, South Africa; [Fielding, Katherine L.; Churchyard, Gavin J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Fielding, Katherine L.; Charalambous, Salome; Chihota, Violet N.; Churchyard, Gavin J.; McCarthy, Kerrigan; Grant, Alison D.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Johnson, Suzanne] Fdn Profess Dev, Pretoria, South Africa; [McCarthy, Kerrigan] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Med Res Council, Soweto Matlosana Collaborating Ctr HIV AIDS & TB, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Ctr Excellence Biomed TB Res, Johannesburg, South Africa; [Omar, Tanvier] Natl Hlth Lab, Dept Anat Pathol, Johannesburg, South Africa; [Omar, Tanvier] Univ Witwatersrand, Johannesburg, South Africa; [Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Kahn, Kathleen] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden; [Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Grant, Alison D.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Africa Hlth Res Inst, Durban, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; South African Medical Research Council; University of Witwatersrand; Johns Hopkins University; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; INDEPTH Network; Umea University; University of London; London School of Hygiene & Tropical Medicine; Africa Health Research Institute; University of Kwazulu Natal	Karat, AS (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London, England.	aaron.karat@lshtm.ac.uk	Chihota, Violet/DWH-9372-2022	Churchyard, Gavin/0000-0002-4269-3699; Chihota, Violet/0000-0003-1444-9266; Tlali, Mpho/0000-0003-0283-2022; HANIFA, YASMEEN/0000-0002-1677-0697; Kahn, Kathleen/0000-0003-3339-3931; McCarthy, Kerrigan/0000-0001-8958-9795; Charalambous, Salome/0000-0001-7143-1009; Karat, Aaron/0000-0001-9643-664X	Bill & Melinda Gates Foundation [OPP1083118]; Medical Research Council [MR/K012126/1, G1100689] Funding Source: researchfish; MRC [G1100689] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a grant from the Bill & Melinda Gates Foundation (OPP1083118; http//www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld SC, 2013, INT J TUBERC LUNG D, V17, P186, DOI 10.5588/ijtld.12.0530; Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Bhattacharya M, 2008, Indian J Public Health, V52, P21; Boerma T, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25931; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Byass P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002173; Byass P, 2016, LANCET, V387, P26, DOI 10.1016/S0140-6736(15)01292-1; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Cain KP, 2015, INT J TUBERC LUNG D, V19, P1270, DOI 10.5588/ijtld.15.0782; Carel P, 2016, METHODS USED WHO EST; Castillo P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002171; Caviglia G, 2016, RAW MISSING LINK SPR; Center for Disease Control / National Center for Health Statistics, 2011, MORT MED DAT SYST; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Chandramohan D, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-22; CoDe Working Group Copenhagen HIV Programme (CHIP), 2013, PROT COD CAUS DEATH; de Savigny D, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1272882; Desai N, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-20; Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022; Doctor HV, 2003, AIDS, V17, P2509, DOI 10.1097/00002030-200311210-00014; Fielding KL, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0650-0; Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-35; Fottrell E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027200; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P164, DOI 10.2471/BLT.05.029124; Glaziou P, 2016, INT J TUBERC LUNG D, V20, P143, DOI 10.5588/ijtld.15.0985; Glynn JR, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23621; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Hussain-Alkhateeb L, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0051-1; Institute for Health Metrics and Evaluation, 2016, SMARTVA AN APPL; InterVA-4, 2012, INTERVA 4 US GUID; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kamali A, 1996, INT J EPIDEMIOL, V25, P679, DOI 10.1093/ije/25.3.679; Karat AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166158; Karat AS, 2015, 22 C RETR OPP INF; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Leitao J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-22; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; Liu TT, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/937013; Lopman B, 2010, J EPIDEMIOL COMMUN H, V64, P330, DOI 10.1136/jech.2008.081554; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50; Lulu K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-58; Maher D, 2005, INT J TUBERC LUNG D, V9, P123; Martinez MJ, 2016, DIAGN MICR INFEC DIS, V84, P80, DOI 10.1016/j.diagmicrobio.2015.10.002; McBride GB, 2005, PROPOSAL STRENGTH OF; McCormick TH, 2016, J AM STAT ASSOC, V111, P1036, DOI 10.1080/01621459.2016.1152191; Melaku YA, 2014, PLOS ONE, P9; Miasnikof P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0521-2; Misganaw A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-130; Mossong J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25496; Murithi S, 2015, 46 UN WORLD C LUNG H; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-30; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-28; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27; Nojilana B, 2009, SAMJ S AFR MED J, V99, P648; Omar T, 2015, INT J TUBERC LUNG D, V19, P1320, DOI 10.5588/ijtld.15.0222; Podewils LJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2117-3; Sankoh O, 2014, LANCET GLOB HEALTH, V2, pE693, DOI 10.1016/S2214-109X(14)70340-7; Serina P, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0105-1; Serina P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0527-9; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25370; Tadesse S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1039; Tensou B, 2010, TROP MED INT HEALTH, V15, P547, DOI 10.1111/j.1365-3156.2010.02484.x; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; Todd J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24787; WHO, 2015, END TB STRAT GLOB ST; WHO, 2016, INT STAT CLASS DIS R, V2; WHO, 2015, VERB AUT STAND 2014; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, VERB AUT STAND 2012; World Health Organization, 2016, ICD 11 JOINT LIN MOR; World Health Organization, 2016, ICD 11 BET IN PRESS	78	41	41	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174097	10.1371/journal.pone.0174097	http://dx.doi.org/10.1371/journal.pone.0174097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334030	gold, Green Accepted, Green Published			2022-12-27	WOS:000399102200046
J	Figueras-Roca, M; Molins, B; Sala-Puigdollers, A; Matas, J; Vinagre, I; Rios, J; Adan, A				Figueras-Roca, Marc; Molins, Blanca; Sala-Puigdollers, Anna; Matas, Jessica; Vinagre, Irene; Rios, Jose; Adan, Alfredo			Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema	PLOS ONE			English	Article							AQUEOUS CONCENTRATIONS; CLINICAL-RESPONSE; TNF-ALPHA; RETINOPATHY; CYTOKINES; BEVACIZUMAB; ISCHEMIA; PATTERNS; IMPACT	Aims To study the association between peripheral blood metabolic and inflammatory factors and presence of diabetic macular edema (DME) and its related anatomic features in type 2 diabetic mellitus (T2DM) patients. Material and methods Observational cross-sectional study on a proof of concept basis. Seventy-six T2DM included patients were divided based on the presence (n = 58) or absence of DME (n = 18) according to optical coherence tomography (OCT). Ultra-widefield fluorescein angiography (UWFA) was performed in DME patients. Fasting peripheral blood sample testing included glycemia, glycated hemoglobin, creatinin and lipid levels among others. Serum levels of a broad panel of cytokines and inflammatory mediators were also analysed. OCT findings included central subfoveal thickness, diffuse retinal thickness (DRT), cystoid macular edema (CME), serous retinal detachment and epirretinal membrane. UWFA items included pattern of DME, presence of peripheral retinal ischemia and enlarged foveal avascular zone (FAZ). Results Metabolic and inflammatory factors did not statistically differ between groups. However, several inflammatory mediators did associate to certain ocular items of DME cases: IL-6 was significantly higher in patients with DRT (p = 0.044), IL-10 was decreased in patients with CME (p = 0.012), and higher IL-8 (p = 0.031) and VEGF levels (p = 0.031) were observed in patients with enlarged FAZ. Conclusion Inflammatory and metabolic peripheral blood factors in T2DM may not be differentially associated to DME when compared to non-DME cases. However, some OCT and UWFA features of DME such as DRT, CME and enlarged FAZ may be associated to certain systemic inflammatory mediators.	[Figueras-Roca, Marc; Sala-Puigdollers, Anna; Matas, Jessica; Adan, Alfredo] Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain; [Figueras-Roca, Marc; Molins, Blanca; Sala-Puigdollers, Anna; Matas, Jessica; Adan, Alfredo] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Vinagre, Irene] Hosp Clin Barcelona, Dept Endocrinol, Barcelona, Spain; [Rios, Jose] IDIBAPS, Med Stat Core Facil, Barcelona, Spain; [Rios, Jose] Univ Autonoma Barcelona, Fac Med, Biostat Unit, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; University of Barcelona	Figueras-Roca, M (corresponding author), Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain.; Figueras-Roca, M (corresponding author), August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.	mafiguer@clinic.cat	Ríos, José/AAZ-2341-2020; Figueras-Roca, Marc/G-9095-2017	Ríos, José/0000-0002-0716-8784; Figueras-Roca, Marc/0000-0002-0548-0539; Sala-Puigdollers, Anna/0000-0001-5792-6937				Browning DJ, 2008, AM J OPHTHALMOL, V146, P649, DOI 10.1016/j.ajo.2008.07.013; Chen E, 2010, CURR MED RES OPIN, V26, P1587, DOI 10.1185/03007995.2010.482503; Das R, 2015, OPHTHALMOLOGY, V122, P1820, DOI 10.1016/j.ophtha.2015.05.011; Doganay S, 2002, EYE, V16, P163, DOI 10.1038/sj.eye.6700095; Dong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125329; Dong N, 2013, MOL VIS, V19, P1734; Frank RN, 2015, MIDDLE EAST AFR J OP, V22, P151, DOI 10.4103/0974-9233.154388; Greenfield JR, 2006, CURR DIABETES REV, V2, P195, DOI 10.2174/157339906776818532; Gustavsson C, 2008, J DIABETES COMPLICAT, V22, P309, DOI 10.1016/j.jdiacomp.2007.03.001; Kim JY, 2014, J CLIN EXP OPHTHALMO, V5; Kim M, 2015, INDIAN J OPHTHALMOL, V63, P312, DOI 10.4103/0301-4738.158069; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Kocabora MS, 2015, OCUL IMMUNOL INFLAMM, V23, P1; Lee JH, 2008, ANN CLIN LAB SCI, V38, P361; Mackenzie S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014811; Macky TA, 2012, EUR J OPHTHALMOL, P30; Matsuda S, 2014, J DIABETES COMPLICAT, V28, P166, DOI 10.1016/j.jdiacomp.2013.11.009; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Romero-Aroca P, 2011, WORLD J DIABETES, V2, P98, DOI 10.4239/wjd.v2.i6.98; Semeraro F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/582060; Sim DA, 2014, AM J OPHTHALMOL, V158, P144, DOI 10.1016/j.ajo.2014.03.009; Singh RP, 2016, OPHTHALMOLOGY, V123, P1581, DOI 10.1016/j.ophtha.2016.03.038; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Stitt AW, 2010, INVEST OPHTH VIS SCI, V51, P4867, DOI 10.1167/iovs.10-5881; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Vinagre I, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-34; Wessel MM, 2012, BRIT J OPHTHALMOL, V96, P694, DOI 10.1136/bjophthalmol-2011-300774; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Xu AJ, 2010, MOL CELL BIOCHEM, V344, P163, DOI 10.1007/s11010-010-0539-x; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	33	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173865	10.1371/journal.pone.0173865	http://dx.doi.org/10.1371/journal.pone.0173865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328965	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700034
J	Lutkenhoner, B				Luetkenhoener, Bernd			What the electrical impedance can tell about the intrinsic properties of an electrodynamic shaker	PLOS ONE			English	Article							EVOKED MYOGENIC POTENTIALS; EQUIVALENT-CIRCUIT; HUMAN HEAD; MODEL; FORCE	Small electrodynamic shakers are becoming increasingly popular for diagnostic investigations of the human vestibular system. More specifically, they are used as mechanical stimulators for eliciting a vestibular evoked myogenic potential (VEMP). However, it is largely unknown how shakers perform under typical measurement conditions, which considerably differ from the normal use of a shaker. Here, it is shown how the basic properties of a shaker can be determined without requiring special sensors such as accelerometers or force gauges. In essence, the mechanical parts of the shaker leave a signature in the electrical impedance, and an interpretation of this signature using a simple model allows for drawing conclusions about the properties of the shaker. The theory developed (which is quite general so that it is usable also in other contexts) is applied to experimental data obtained for the minishaker commonly used in VEMP measurements. It is shown that the experimental conditions substantially influence the properties of the shaker. Relevant factors are, in particular, the spatial orientation of the shaker (upright, horizontal or upside-down) and the static force acting on the table of the shaker (which in a real measurement corresponds to the force by which the shaker is pressed against the test person's head). These results underline the desirability of a proper standardization of VEMP measurements. Direct measurements of displacement and acceleration prove the consistency of the conclusions derived from the electrical impedance.	[Luetkenhoener, Bernd] Munster Univ Hosp, ENT Clin, Munster, Germany	University of Munster	Lutkenhoner, B (corresponding author), Munster Univ Hosp, ENT Clin, Munster, Germany.	lutkenh@uni-muenster.de			Deutsche Forschungsgemeinschaft [LU342/12-1]; Open Access Publication Fund of the University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster	This work was supported by the Deutsche Forschungsgemeinschaft (grant LU342/12-1) and Open Access Publication Fund of the University of Munster. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript; This work was supported by the Deutsche Forschungsgemeinschaft (grant LU 342/12-1) and the Open Access Publication Fund of the University of Munster. The author thanks Mr. Marc Kocian for manufacturing custom-made parts for the experimental investigations.	Bekesy G., 1960, EXPT HEARING; Colebatch JG, 2016, HAND CLINIC, V137, P133, DOI 10.1016/B978-0-444-63437-5.00010-8; de Silva CW, 2005, VIBRATION SHOCK HDB; De Silva CW, 2000, VIBRATION FUNDAMENTA; Dodd M., 2004, AUDIO ENG SOC CONVEN, V117; Doebelin EO, 1980, SYSTEM MODELING RESP; HAKANSSON B, 1986, J ACOUST SOC AM, V80, P1065, DOI 10.1121/1.393848; HAKANSSON B, 1994, J ACOUST SOC AM, V95, P1474, DOI 10.1121/1.408535; Kelly S. Graham, 2012, MECH VIBRATIONS THEO; Kim N, 2014, BIOMED RES INT, V2014; KIRIKAE I, 1959, Acta Otolaryngol Suppl, V145, P1; Kleppner D., 2013, INTRO MECH; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lang GF, 2001, SOUND VIB, V35, P24; Lang GF, 1997, SOUND VIB, V31, P14; Leach WM, 2002, J AUDIO ENG SOC, V50, P442; Marchewka A, 2004, AM J PHYS, V72, P477, DOI 10.1119/1.1624113; Rao S. S., 2011, MECH VIBRATIONS, V5th; Ripper GP, 2009, MEASUREMENT, V42, P1363, DOI 10.1016/j.measurement.2009.05.002; Rosengren SM, 2010, CLIN NEUROPHYSIOL, V121, P636, DOI 10.1016/j.clinph.2009.10.016; Rosengren SM, 2013, CURR OPIN NEUROL, V26, P74, DOI 10.1097/WCO.0b013e32835c5ef3; Rosengren SM, 2009, J APPL PHYSIOL, V107, P841, DOI 10.1152/japplphysiol.00296.2009; Schellmanns A, 2000, IEEE IND APPLIC SOC, P3105; Stenfelt S, 2005, J ACOUST SOC AM, V118, P2373, DOI 10.1121/1.2005847; Thorborg K, 2008, J AUDIO ENG SOC, V56, P696; Todd NPM, 2008, CLIN NEUROPHYSIOL, V119, P1638, DOI 10.1016/j.clinph.2008.03.009; Todd NPM, 2008, NEUROSCI LETT, V444, P36, DOI 10.1016/j.neulet.2008.08.011; v Bekesy G, 1932, ANN PHYS, V405, P111; VANDERKOOY J, 1989, J AUDIO ENG SOC, V37, P119; Varoto PS, 2002, SHOCK VIB, V9, P165, DOI 10.1155/2002/675674; Varoto PS, 2002, SOUND VIB, V36, P20; White GD, 2004, THE AUDIO DICT; WRIGHT JR, 1990, J AUDIO ENG SOC, V38, P749; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	34	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174184	10.1371/journal.pone.0174184	http://dx.doi.org/10.1371/journal.pone.0174184			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328999	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700067
J	Rocha, MM; Castro, ACMCE; Cuezzo, C; Cancello, EM				Rocha, Mauricio M.; Morales-Correa e Castro, Adriana C.; Cuezzo, Carolina; Cancello, Eliana M.			Phylogenetic reconstruction of Syntermitinae (Isoptera, Termitidae) based on morphological and molecular data	PLOS ONE			English	Article							TAXONOMIC REVISION; DIGESTIVE TUBE; MITOCHONDRIAL; GENUS; EVOLUTION; MODELS; NASUTITERMITINAE; AMPLIFICATION; PRIMERS; BIOLOGY	The subfamily Syntermitinae comprises a group of Neotropical termites with 18 genera and 101 species described. It has been considered a natural group, but relationships among the genera within the subfamily remain uncertain, and some genera appear to be non-monophyletic. Here, we provide a comprehensive phylogeny including six Neotropical species of Termitinae as outgroup, 42 Syntermitinae species as ingroup, 92 morphological characters (from external and internal anatomy of soldier and worker castes) and 117 molecular sequences (109 obtained for this study and 8 from GenBank) of 4 gene regions (41 and 22 from Cytochrome Oxidase I and II respectively, 19 from Cytochrome b, and 35 from 16S rDNA). Morphological and molecular data were analyzed in combination, with the Bayesian inference method, and the important aspects of termite biology, defense and feeding habits are discussed based on the resulting tree. Although useful for providing diagnostic characters, the morphology of the soldier caste reveals several cases of convergence; whereas the feeding habit shows indications of evolutionary significance.	[Rocha, Mauricio M.; Cuezzo, Carolina; Cancello, Eliana M.] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Morales-Correa e Castro, Adriana C.] FCAV UNESP Campus Jaboticabal, Dept Biol Aplicada Agr, Jaboticabal, SP, Brazil	Universidade de Sao Paulo	Rocha, MM (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil.	mrocha@usp.br	Cancello, Eliana M./K-3423-2012; Cancello, Eliana/AAS-5600-2020; Cuezzo, Carolina/E-1531-2012	Cancello, Eliana M./0000-0003-3125-6335; Cancello, Eliana/0000-0003-3125-6335; Cuezzo, Carolina/0000-0002-7716-6100; Coletto Morales, Adriana/0000-0002-2108-427X; Rocha, Mauricio/0000-0002-6568-068X	Sao Paulo Research Foundation, Brazil (FAPESP) [2012/00952-9, 2013/20068-9, 2013/05610-1]; National Council for Scientific and Technological Development, Brazil (CNPq) [308227/2013-0]	Sao Paulo Research Foundation, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We received support from the Sao Paulo Research Foundation, Brazil (FAPESP) [http://www.fapesp.br/], grants 2012/00952-9 to M MR, 2013/20068-9 to EMC and 2013/05610-1 to CC, and from the National Council for Scientific and Technological Development, Brazil (CNPq) [http://cnpq.br/] grant 308227/2013-0 to EMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1945, B AM MUS NAT HIST, V195095, P37; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Bown T.M., 1990, Ichnos, V1, P73; Cancello Eliana Marques, 1992, Papeis Avulsos de Zoologia (Sao Paulo), V38, P1; Cancello EM, 2000, SOCIOBIOLOGY, V36, P531; Carvalho SHC, 2011, SOCIOBIOLOGY, V57, P643; Constantini JP, 2016, ZOOTAXA, V4109, P501, DOI 10.11646/zootaxa.4109.5.1; Constantino R, 1997, SOCIOBIOLOGY, V30, P225; Constantino Reginaldo, 1995, University of Kansas Science Bulletin, V55, P455; Constantino R, 2006, ZOOTAXA, P1; Constantino Reginaldo, 2002, Zootaxa, V67, P1; Constantino R, 2012, ZOOTAXA, P25; Constantino R, 2011, SOCIOBIOLOGY, V57, P377; Constantino Reginaldo, 1999, Papeis Avulsos de Zoologia (Sao Paulo), V40, P387; Constantino Reginaldo, 1994, Sociobiology, V25, P285; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DELIGNE J, 1966, CR ACAD SCI D NAT, V263, P1323; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Donovan SE, 2000, BIOL J LINN SOC, V70, P467, DOI 10.1111/j.1095-8312.2000.tb01235.x; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Emerson AE, 1944, B AM MUS NAT HIST, V83, P429; Engel MS, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)432<0001:FNFTI>2.0.CO;2; Erra G, 2016, ACTA BIOL COLOMB, V21, P63, DOI 10.15446/abc.v21n1.44687; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Genise JF, 1997, PALAEOGEOGR PALAEOCL, V136, P139, DOI 10.1016/S0031-0182(97)00077-1; Hare L., 1937, ANN ENTOMOLOGICAL SO, V37, P459, DOI [10.1093/aesa/30.3.459, DOI 10.1093/AESA/30.3.459]; HAVERTY M I, 1977, Sociobiology, V2, P199; Holmgren N, 1912, KUNGLIGA SVENSKA VET, V48, P1; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Kambhampati S, 1995, INSECT MOL BIOL, V4, P233, DOI 10.1111/j.1365-2583.1995.tb00028.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Krishna K, 1969, BIOL TERMITES, P146; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Maddison WP., 2021, MESQUITE MODULAR SYS; Miller M.A., 2010, P GAT COMP ENV WORKS; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Noirot C, 1991, 1 EUR C SOC INS LEUV; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; Rambaut A., 2014, TRACER V1 6; REDFORD KH, 1984, BIOTROPICA, V16, P112, DOI 10.2307/2387842; Rocha MM, 2015, DEUT ENTOMOL Z, V62, P29, DOI 10.3897/dez.62.8550; Rocha MM, 2013, ZOOKEYS, P107, DOI 10.3897/zookeys.340.6131; Rocha MM, 2011, ZOOKEYS, P125, DOI 10.3897/zookeys.148.1278; Rocha MM, 2012, SYST ENTOMOL, V37, P793, DOI 10.1111/j.1365-3113.2012.00645.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANDS W. A., 1965, Bulletin of the British Museum (Natural History), B. Entomology, V34; SANDS W. A., 1957, INSECTES SOCIAUX, V4, P13, DOI 10.1007/BF02226245; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174366	10.1371/journal.pone.0174366	http://dx.doi.org/10.1371/journal.pone.0174366			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329010	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700085
J	Yi, XP; Liu, WG; Zhang, YM; Xiao, DS; Yin, HL; Long, XY; Li, L; Zai, HY; Chen, MF; Li, WZ; Sun, LQ				Yi, Xiaoping; Liu, Wenguang; Zhang, Youming; Xiao, Desheng; Yin, Hongling; Long, Xueying; Li, Li; Zai, Hongyan; Chen, Minfeng; Li, Wenzheng; Sun, Lunquan			Radiological features of primitive neuroectodermal tumors in intra-abdominal and retroperitoneal regions: A series of 18 cases	PLOS ONE			English	Article							EWINGS-SARCOMA; CHEMOTHERAPY	Objectives To characterize the imaging and clinicopathological features of primitive neuroectodermal tumors (PNETs) arising in intra-abdominal and retroperitoneal regions. Methods Eighteen patients with histopathologically proven intra-abdominal and retroperitoneal PNET were enrolled; computed tomography was performed for all cases, and magnetic resonance imaging was performed for a single case. Typical computed tomography and magnetic resonance imaging findings, including morphology, texture and enhancement features, as well as clinicopathological characteristics and prognosis data were retrospectively analyzed. Results Of eighteen PNET patients, fifteen were male and three were female, with a median age of 36 years (range, 2-65 years). The onset of symptoms was most often nonspecific and insidious. The mean tumor diameter was 7.2 cm (range, 3.0 -12.1 cm), with necrosis in fifteen cases, cystic changes in eight, partition structure in five, calcification in five, hemorrhage in two, and mural nodules in one. Contrast enhanced computed tomography showed multiple tiny feeding arteries within the masses in six cases, resulting in a crab-like appearance, and mild ring enhancement pattern in five cases. Eleven cases showed surrounding invasion and metastasis. Of the eighteen PNET cases, nine cases showed smooth, well-defined margins, and nine cases had irregular, ill-defined margins. A median survival was 10.0-1.6 months. However, chemotherapy had efficacy on patients even those with advanced disease. Conclusions Primary intra-abdominal and retroperitoneal PNETs are rare, and imaging features documented here may help the diagnosis of this severe disease. Notably, two signs present in retroperitoneal PNET tumors, including a mild ring enhancement pattern and a crab-like appearance of the tiny feeding arteries, may have the potential to help us improve the ability to make a relatively reliable diagnosis.	[Yi, Xiaoping; Liu, Wenguang; Zhang, Youming; Long, Xueying; Li, Wenzheng] Cent S Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China; [Yi, Xiaoping; Sun, Lunquan] Cent S Univ, Postdoctoral Res Workstn Pathol & Pathophysiol, Basic Med Sci, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Xiao, Desheng; Yin, Hongling] Cent S Univ, Dept Pathol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Li, Li] Sun Yat Sen Univ, Ctr Canc, Imaging Diag & Intervent Ctr, Changsha, Hunan, Peoples R China; [Zai, Hongyan] Cent S Univ, Dept Gen Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Chen, Minfeng] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Sun, Lunquan] Cent S Univ, Ctr Mol Med, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Sun Yat Sen University; Central South University; Central South University; Central South University	Yi, XP; Liu, WG (corresponding author), Cent S Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China.; Yi, XP (corresponding author), Cent S Univ, Postdoctoral Res Workstn Pathol & Pathophysiol, Basic Med Sci, Xiangya Hosp, Changsha, Hunan, Peoples R China.	doctoryixiaoping@126.com; doctorwenzhengli@126.com		yi, xiaoping/0000-0002-4220-1981	Freedom Exploration Program of Central South University [2011QNZT153]; Xiang Ya-Peking University Wei Ming Clinical and Rehabilitation Research Fund [xywm2015I35]; Natural Science Foundation of Hunan Province [14JJ6001]	Freedom Exploration Program of Central South University; Xiang Ya-Peking University Wei Ming Clinical and Rehabilitation Research Fund; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This study was supported by The Freedom Exploration Program of Central South University (No. 2011QNZT153), Xiang Ya-Peking University Wei Ming Clinical and Rehabilitation Research Fund (No. xywm2015I35) and Natural Science Foundation of Hunan Province (No. 14JJ6001). Dr.Xiaoping Yiisrightnowa Postdoctoral Fellow in Postdoctoral Research	Aminimoghaddam S, 2015, ARCH IRAN MED, V18, P260, DOI 015184/AIM.0014; Ba L, 2015, ACTA RADIOL, V56, P820, DOI 10.1177/0284185114539321; Biswas B, 2013, ANN THORAC SURG, V96, P2006, DOI 10.1016/j.athoracsur.2013.06.062; Busato WFS, 2011, CLIN GENITOURIN CANC, V9, P63, DOI 10.1016/j.clgc.2011.03.002; Carvajal R, 2005, HEMATOL ONCOL CLIN N, V19, P501, DOI 10.1016/j.hoc.2005.03.004; de Alava E, 2000, J CLIN ONCOL, V18, P204, DOI 10.1200/JCO.2000.18.1.204; Dong JQ, 2015, CELL BIOCHEM BIOPHYS, V73, P59, DOI 10.1007/s12013-015-0570-3; Dutta D, 2013, J CANCER RES THER, V9, P709, DOI 10.4103/0973-1482.126459; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; JURGENS H, 1988, CANCER, V61, P349, DOI 10.1002/1097-0142(19880115)61:2<349::AID-CNCR2820610226>3.0.CO;2-0; Kim MS, 2006, AM J ROENTGENOL, V186, P1125, DOI 10.2214/AJR.04.1688; Kuwabara K, 2006, SURG TODAY, V36, P193, DOI 10.1007/s00595-005-3104-6; Li XC, 2011, ABDOM IMAGING, V36, P590, DOI 10.1007/s00261-010-9655-z; Maccioni F, 2000, ABDOM IMAGING, V25, P103, DOI 10.1007/s002619910021; Muller K, 2013, STRAHLENTHER ONKOL, V189, P372, DOI 10.1007/s00066-013-0315-4; Tan Y, 2014, ONCOTARGET, V5, P12968, DOI 10.18632/oncotarget.2649; Teixeira U, 2015, CASE REP SURG, V2015, DOI 10.1155/2015/276869; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Xu Q, 2013, EUR J RADIOL, V82, pE888, DOI 10.1016/j.ejrad.2013.08.049; Zhang Y, 2016, CLIN TRANSL ONCOL	20	4	6	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173536	10.1371/journal.pone.0173536	http://dx.doi.org/10.1371/journal.pone.0173536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319177	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800018
J	Busby, ER; Sherwood, NM				Busby, Ellen R.; Sherwood, Nancy M.			Gonadotropin-releasing hormone receptor (Gnrhr) gene knock out: Normal growth and development of sensory, motor and spatial orientation behavior but altered metabolism in neonatal and prepubertal mice	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; SEXUAL-DIFFERENTIATION; ANDROGEN RECEPTOR; REPRODUCTIVE AXIS; HYPOGONADOTROPIC HYPOGONADISM; POSTNATAL-DEVELOPMENT; ESTROGEN-RECEPTORS; ADIPOSE-TISSUE; ER-BETA; EXPRESSION	Gonadotropin-releasing hormone (GnRH) is important in the control of reproduction, but its actions in non-reproductive processes are less well known. In this study we examined the effect of disrupting the GnRH receptor in mice to determine if growth, metabolism or behaviors that are not associated with reproduction were affected. To minimize the effects of other hormones such as FSH, LH and sex steroids, the neonatal-prepubertal period of 2 to 28 days of age was selected. The study shows that regardless of sex or phenotype in the Gnrhr gene knockout line, there was no significant difference in the daily development of motor control, sensory detection or spatial orientation among the wildtype, heterozygous or null mice. This included a series of behavioral tests for touch, vision, hearing, spatial orientation, locomotory behavior and muscle strength. Neither the daily body weight nor the final weight on day 28 of the kidney, liver and thymus relative to body weight varied significantly in any group. However by day 28, metabolic changes in the GnRH null females compared with wildtype females showed a significant reduction in inguinal fat pad weight normalized to body weight; this was accompanied by an increase in glucose compared with wildtype females shown by Student-Newman-Keuls Multiple Comparison test and Student's unpaired t tests. Our studies show that the GnRH-GnRHR system is not essential for growth or motor/sensory/orientation behavior during the first month of life prior to puberty onset. The lack of the GnRH-GnRHR axis, however, did affect females resulting in reduced subcutaneous inguinal fat pad weight and increased glucose with possible insulin resistance; the loss of the normal rise of estradiol at postnatal days 15 - 28 may account for the altered metabolism in the prepubertal female pups.	[Busby, Ellen R.; Sherwood, Nancy M.] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Busby, Ellen R.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria; University of Victoria	Sherwood, NM (corresponding author), Univ Victoria, Dept Biol, Victoria, BC, Canada.	nsherwoo@uvic.ca			NSERC (Natural Sciences and Engineering Research Council) of Canada [RGPIN 2318]; NSERC grant; NSERC	NSERC (Natural Sciences and Engineering Research Council) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Only NSERC (Natural Sciences and Engineering Research Council) of Canada funded this research (RGPIN 2318 Dr. Nancy M Sherwood). The salary of Ellen Busby was also funded from this NSERC grant. No other external or internal sources of funding were used. All individuals involved with the submitted research were funded by NSERC, which is the Canadian equivalent of NSF in the States. No individuals employed or contracted by the funder, other than the authors, played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson AJ, 2008, CEREBELLUM, V7, P379, DOI 10.1007/s12311-008-0038-8; Albertson AJ, 2008, J CHEM NEUROANAT, V35, P326, DOI 10.1016/j.jchemneu.2008.03.004; Anjum S, 2012, J EXP ZOOL PART A, V317A, P630, DOI 10.1002/jez.1765; Antal MC, 2008, P NATL ACAD SCI USA, V105, P2433, DOI 10.1073/pnas.0712029105; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; AZAD N, 1991, ENDOCRINOLOGY, V128, P1679, DOI 10.1210/endo-128-3-1679; AZAD N, 1993, ENDOCRINOLOGY, V133, P215, DOI 10.1210/en.133.1.215; AZAD N, 1993, ENDOCRINOLOGY, V133, P1252, DOI 10.1210/en.133.3.1252; BAHK JY, 1995, J UROLOGY, V154, P1958, DOI 10.1016/S0022-5347(01)66834-4; Bakker J, 2010, J NEUROENDOCRINOL, V22, P728, DOI 10.1111/j.1365-2826.2010.02016.x; Botte MC, 1998, J ENDOCRINOL, V159, P179, DOI 10.1677/joe.0.1590179; Brock O, 2011, J NEUROSCI, V31, P5574, DOI 10.1523/JNEUROSCI.0209-11.2011; Caraty A, 2008, ENDOCRINOLOGY, V149, P5227, DOI 10.1210/en.2007-1636; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chen M, 2009, MOL CELL BIOCHEM, V321, P145, DOI 10.1007/s11010-008-9928-9; Cheng XBB, 2013, AM J PHYSIOL-ENDOC M, V305, pE717, DOI 10.1152/ajpendo.00263.2013; Clarkson J, 2012, J NEUROENDOCRINOL, V24, P907, DOI 10.1111/j.1365-2826.2012.02294.x; Clarkson J, 2014, J NEUROSCI, V34, P15297, DOI 10.1523/JNEUROSCI.3061-14.2014; Clarkson J, 2009, ENDOCRINOLOGY, V150, P3214, DOI 10.1210/en.2008-1733; CORBIER P, 1992, ARCH INT PHYSIOL BIO, V100, P127, DOI 10.3109/13813459209035274; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006; Chu DT, 2014, J BIOL CHEM, V289, P18478, DOI 10.1074/jbc.M114.555821; DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898; Dolan S, 2003, NEUROSCI LETT, V346, P120, DOI 10.1016/S0304-3940(03)00594-9; Dupont S, 2000, DEVELOPMENT, V127, P4277; Evans MC, 2017, J MOL ENDOCRINOL, V58, pR107, DOI 10.1530/JME-16-0212; Finch AR, 2008, J ENDOCRINOL, V196, P353, DOI 10.1677/JOE-07-0471; Fraser HM, 1996, MOL HUM REPROD, V2, P117, DOI 10.1093/molehr/2.2.117; Ganong WF, 2005, REV MED PHYSL, P184; Granger A, 2004, ENDOCRINOLOGY, V145, P983, DOI 10.1210/en.2003-0881; Heyser CJ, 2004, CURR PROTOC NEUROSCI, V8, P1; JENNES L, 1994, FRONT NEUROENDOCRIN, V15, P51, DOI 10.1006/frne.1994.1003; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009; Louis GW, 2011, ENDOCRINOLOGY, V152, P2302, DOI 10.1210/en.2011-0096; Maniu A, 2016, J ENDOCRINOL, V230, P171, DOI 10.1530/JOE-15-0530; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Morgan K, 2004, GEN COMP ENDOCR, V139, P191, DOI 10.1016/j.ygcen.2004.09.015; Motz BA, 2005, NEUROTOXICOL TERATOL, V27, P529, DOI 10.1016/j.ntt.2005.06.005; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; OIKAWA M, 1990, ENDOCRINOLOGY, V127, P2350, DOI 10.1210/endo-127-5-2350; Pask AJ, 2005, MOL ENDOCRINOL, V19, P972, DOI 10.1210/me.2004-0192; PENG C, 1994, ENDOCRINOLOGY, V135, P1740, DOI 10.1210/en.135.5.1740; POINTIS G, 1980, J ENDOCRINOL, V86, P483, DOI 10.1677/joe.0.0860483; Poling MC, 2012, ENDOCRINOLOGY, V153, P782, DOI 10.1210/en.2011-1838; Rosner W, 2013, J CLIN ENDOCR METAB, V98, P1376, DOI 10.1210/jc.2012-3780; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Skinner DC, 2009, J NEUROENDOCRINOL, V21, P282, DOI 10.1111/j.1365-2826.2009.01842.x; Stewart AJ, 2009, NEUROENDOCRINOLOGY, V90, P416, DOI 10.1159/000233303; Stewart MD, 2012, MOL ENDOCRINOL, V26, P1847, DOI 10.1210/me.2012-1072; Taylor AE, 2015, EUR J ENDOCRINOL, V173, pD1, DOI 10.1530/EJE-15-0338; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tiong JDR, 2004, ENDOCRINOLOGY, V145, P3608, DOI 10.1210/en.2004-0387; Wang LY, 2010, CNS NEUROL DISORD-DR, V9, P651, DOI 10.2174/187152710793361559; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305; Wolfahrt S, 2001, MOL HUM REPROD, V7, P89, DOI 10.1093/molehr/7.1.89; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Wu S, 2010, ENDOCRINOLOGY, V151, P1142, DOI 10.1210/en.2009-0598; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399	64	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174452	10.1371/journal.pone.0174452	http://dx.doi.org/10.1371/journal.pone.0174452			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346489	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300049
J	Chen, QG; Li, JJ; Liu, M; Sun, HL; Bao, MT				Chen, Qingguo; Li, Jingjing; Liu, Mei; Sun, Huiling; Bao, Mutai			Study on the biodegradation of crude oil by free and immobilized bacterial consortium in marine environment	PLOS ONE			English	Article							EXIGUOBACTERIUM SP PMA; PSEUDOMONAS-AERUGINOSA; MICROBIAL CONSORTIUM; DIESEL OIL; BIOREMEDIATION; HYDROCARBONS; ADSORPTION; ALGINATE; STRAINS; BEADS	Five strains of bacteria, namely, Exiguobacterium sp. ASW-1, Pseudomonas aeruginosa strain ASW-2, Alcaligenes sp. ASW-3, Alcaligenes sp. ASS-1, and Bacillus sp. ASS-2, were isolated from the Zhejiang coast in China. The mixed flora of the five strains performed well with degrading 75.1% crude oil (1%, w/v) in 7 days. The calcium alginate - activated carbon embedding carrier was used to immobilize bacterial consortium. Immobilized cells performed better than free ones in variations of environmental factors containing incubated temperature, initial pH, salinity of the medium and crude oil concentration. The degradation process of crude oil by immobilized bacteria was accelerated compared with that of the free ones. Bacterial consortium showed better performance on biodegradation of normal alkanes than that of PAHs. Improvement of immobilization on the biodegradation efficiency of normal alkanes (31.9%) was apparently high than that of PAHs (1.9%).	[Chen, Qingguo; Li, Jingjing; Liu, Mei; Sun, Huiling] Zhejiang Ocean Univ, Coll Marine Sci & Technol, Zhoushan, Peoples R China; [Bao, Mutai] Ocean Univ China, Minist Educ, Key Lab Marine Chem Theory & Technol, Qingdao, Peoples R China	Zhejiang Ocean University; Ocean University of China	Chen, QG (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci & Technol, Zhoushan, Peoples R China.	qgchen@zjou.edu.cn			Xingzhong sinochem oil transport (Zhoushan) Co., Ltd, China	Xingzhong sinochem oil transport (Zhoushan) Co., Ltd, China	We acknowledge and thank for the crude oil sample support by Xingzhong sinochem oil transport (Zhoushan) Co., Ltd, China.	Arora PK, 2015, J HAZARD MATER, V284, P261, DOI 10.1016/j.jhazmat.2014.11.021; Arora PK, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-150; Arora PK, 2012, BIODEGRADATION, V23, P325, DOI 10.1007/s10532-011-9512-y; Bacosa HP, 2015, MAR POLLUT BULL, V95, P265, DOI 10.1016/j.marpolbul.2015.04.005; Bai X, 2010, PROCESS BIOCHEM, V45, P60, DOI 10.1016/j.procbio.2009.08.003; Bamforth SM, 2005, J CHEM TECHNOL BIOT, V80, P723, DOI 10.1002/jctb.1276; Bao MT, 2012, MAR POLLUT BULL, V64, P1177, DOI 10.1016/j.marpolbul.2012.03.020; Bao MT, 2013, CAN J CHEM ENG, V91, P1, DOI 10.1002/cjce.20688; Bayat Z, 2015, MAR POLLUT BULL, V101, P85, DOI 10.1016/j.marpolbul.2015.11.021; Cai QH, 2014, MAR POLLUT BULL, V86, P402, DOI 10.1016/j.marpolbul.2014.06.039; Carls MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134448; Cervantes FJ, 2003, WATER SCI TECHNOL, V48, P9, DOI 10.2166/wst.2003.0345; Chen QG, 2013, MAR POLLUT BULL, V71, P269, DOI 10.1016/j.marpolbul.2013.01.037; Chen Y, 2016, CHEM ENG J, V289, P463, DOI 10.1016/j.cej.2016.01.010; Dellagnezze BM, 2016, MAR POLLUT BULL, V107, P107, DOI 10.1016/j.marpolbul.2016.04.011; Feng DQ, 1986, BIOL BULL, P37; Ha J, 2009, BIORESOURCE TECHNOL, V100, P1138, DOI 10.1016/j.biortech.2008.08.022; Hassanshahian M, 2014, MAR ENVIRON RES, V95, P28, DOI 10.1016/j.marenvres.2013.12.010; Hecht H, 2016, BIOMACROMOLECULES, V17, P2160, DOI 10.1021/acs.biomac.6b00378; Jezequel K, 2008, BIORESOURCE TECHNOL, V99, P690, DOI 10.1016/j.biortech.2007.02.002; Kumar AG, 2014, BIORESOURCE TECHNOL, V170, P556, DOI 10.1016/j.biortech.2014.08.008; Kuyukina MS, 2009, INT BIODETER BIODEGR, V63, P427, DOI 10.1016/j.ibiod.2008.12.001; [李家星 Li Jiaxing], 2012, [海洋与湖沼, Oceanologia et Limnologia Sinica], V43, P624; Li XF, 2016, MAR POLLUT BULL, V105, P43, DOI 10.1016/j.marpolbul.2016.02.073; Lin M, 2014, INT BIODETER BIODEGR, V88, P8, DOI 10.1016/j.ibiod.2013.11.015; Liu YJ, 2009, BIOCHEM ENG J, V44, P187, DOI 10.1016/j.bej.2008.12.001; Maqbool F, 2012, J HAZARD MATER, V237, P262, DOI 10.1016/j.jhazmat.2012.08.038; Massalha N, 2007, IND ENG CHEM RES, V46, P6820, DOI 10.1021/ie070057v; Maulin S, 2014, BEHAV THER, V5, P266; MENZIE CA, 1992, ENVIRON SCI TECHNOL, V26, P1278, DOI 10.1021/es00031a002; Pasumarthi R, 2013, MAR POLLUT BULL, V76, P276, DOI 10.1016/j.marpolbul.2013.08.026; Ronald A, 2009, MICROB BIOTECHNOL, V2, P213; RONTANI JF, 1992, CHEMOSPHERE, V24, P1441, DOI 10.1016/0045-6535(92)90266-T; Shen P, 2013, MICROBIOLOGY EXPT; Varjani SJ, 2015, INT BIODETER BIODEGR, V103, P116, DOI 10.1016/j.ibiod.2015.03.030; Venosa AD, 2003, SPILL SCI TECHNOL B, V8, P163, DOI 10.1016/S1353-2561(03)00019-7; Wang X, 2015, MAR POLLUT BULL, V92, P195, DOI 10.1016/j.marpolbul.2014.12.033; Wu L, 2009, J ENVIRON SCI-CHINA, V21, P237, DOI 10.1016/S1001-0742(08)62257-3; Zhang K, 2008, BIOCHEM ENG J, V41, P251, DOI 10.1016/j.bej.2008.05.003; Zhang XS, 2012, CHEM ENG J, V209, P138, DOI 10.1016/j.cej.2012.07.110; [郑琰明 ZHENG Yan-Ming], 2009, [海洋与湖沼, Oceanologia et Limnologia Sinica], V40, P275	41	64	68	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174445	10.1371/journal.pone.0174445	http://dx.doi.org/10.1371/journal.pone.0174445			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346510	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300048
J	Yang, JJ; Dai, L; Yu, QH; Yang, Q				Yang, Jingjing; Dai, Lei; Yu, Qinghua; Yang, Qian			Histological and anatomical structure of the nasal cavity of Bama minipigs	PLOS ONE			English	Article							NASOPHARYNGEAL LYMPHOID-TISSUE; DENDRITIC CELLS; GOBLET CELLS; INTRANASAL; MODEL; MUCOSAL; PIG; TRIVALENT; EFFICACY; DELIVERY	Objective The nasal mucosa is equipped with abundant lymphatic tissues, serving as the first line of defense against invasion by microorganisms. In this study, we characterized the features of the nasal mucosa of Bama minipigs (Sus scrofa domestica) via histological analysis. Methods Five cross sections (I, II, III, IV, and V) were obtained from the distal end of the nasal cavity toward the pharynx (along the cavity axis) and examined. Specifically, CD3(+) T cells, immunoglobulin A (IgA)(+) cells, and M cells were detected by immunohistochemistry, while dendritic cells (DCs) were detected by immunofluorescence. The distribution of goblet cells was determined by periodic acid-Schiff (PAS) staining. Results The nasal cavity of Bama minipigs can be divided into three parts: the regio vestibularis (I, II), regio respiratoria (III, IV), and regio olfactoria (V). Lymphoid tissue was present at random locations in the nasal cavity. Abundant lymphoid tissue was located in the roof of the nasopharyngeal meatus and was continuous with the lymphoid tissue of the pharynx. The distribution of CD3(+) T cells, IgA(+) cells, M cells, and DCs increased distally in the nasal cavity. Conclusions The present work comprises a histological study of the nasal cavity of Bama minipigs, and will be beneficial for understanding the mechanisms of immunity in these animals after nasal vaccination.	[Yang, Jingjing; Dai, Lei; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Vet Coll, Weigang 1, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Vet Coll, Weigang 1, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	Yu, Qinghua/T-3261-2019; yu, qing/HGC-4611-2022		National Natural Science Foundation of China [31372465]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (31372465) httpliwww.nsfc.gov.cnipublish/portalli and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharom F, 2016, J IMMUNOL, V196, P4498, DOI 10.4049/jimmunol.1600071; Barroso SPC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128785; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Bimczok D, 2006, CELL TISSUE RES, V325, P461, DOI 10.1007/s00441-006-0195-3; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; Casteleyn C, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/472460; Couch RB, 2009, VACCINE, V27, P5344, DOI 10.1016/j.vaccine.2009.06.084; Cunningham S, 2002, J GENE MED, V4, P438, DOI 10.1002/jgm.270; Debertin AS, 2003, CLIN EXP IMMUNOL, V134, P503, DOI 10.1111/j.1365-2249.2003.02311.x; Ellis JA, 2016, VET J, V212, P71, DOI 10.1016/j.tvjl.2016.04.004; Feng GJ, 2015, J NEUROGASTROENTEROL, V21, P182, DOI 10.5056/jnm14113; Fujimura Y, 2004, VIRCHOWS ARCH, V444, P36, DOI 10.1007/s00428-003-0898-8; Fujimura Y, 2000, VIRCHOWS ARCH, V436, P560, DOI 10.1007/s004289900177; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Kang HH, 2014, ANAT REC, V297, P916, DOI 10.1002/ar.22888; Kim DY, 2011, J IMMUNOL, V186, P4253, DOI 10.4049/jimmunol.0903794; Kuper CF, 2012, TOXICOL PATHOL, V40, P656, DOI 10.1177/0192623311436175; Larsen MO, 2004, ILAR J, V45, P303, DOI 10.1093/ilar.45.3.303; Liu X, 2007, GENE THER, V14, P1543, DOI 10.1038/sj.gt.3303014; Maroof A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003875; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McKay PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148984; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Miyazawa K, 2006, CELL TISSUE RES, V323, P425, DOI 10.1007/s00441-005-0086-z; MOGENSEN C, 1977, ANAT ANZEIGER, V141, P237; Ogasawara N, 2011, ACTA OTO-LARYNGOL, V131, P116, DOI 10.3109/00016489.2010.520022; Pabst R, 2010, Pneumologie, V64, P445, DOI 10.1055/s-0030-1255509; Pracy JP, 1998, J ANAT, V192, P359, DOI 10.1046/j.1469-7580.1998.19230359.x; Qin T, 2015, CLIN VACCINE IMMUNOL, V22, P421, DOI 10.1128/CVI.00778-14; Ranklove LB, 2006, SCAND J LAB ANIM SCI, V33, P1; Renukaradhya GJ, 2015, J CONTROL RELEASE, V219, P622, DOI 10.1016/j.jconrel.2015.09.047; Singh M, 2001, J CONTROL RELEASE, V70, P267, DOI 10.1016/S0168-3659(00)00330-8; Stokes CR, 2000, J BIOTECHNOL, V83, P51, DOI 10.1016/S0168-1656(00)00299-6; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wang JCC, 2013, INT FORUM ALLERGY RH, V3, P150, DOI 10.1002/alr.21081; Yu B, 2015, XENOBIOTICA, V45, P380, DOI 10.3109/00498254.2014.985762; Zhang RG, 2014, GENET MOL RES, V13, P7113, DOI 10.4238/2014.February.21.12	43	18	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173902	10.1371/journal.pone.0173902	http://dx.doi.org/10.1371/journal.pone.0173902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339502	gold, Green Published, Green Submitted			2022-12-27	WOS:000399116700017
J	Haffner-Luntzer, M; Muller-Graf, F; Matthys, R; Hagele, Y; Fischer, V; Jonas, R; Abaei, A; Gebhard, F; Rasche, V; Ignatius, A				Haffner-Luntzer, Melanie; Mueller-Graf, Fabian; Matthys, Romano; Haegele, Yvonne; Fischer, Verena; Jonas, Rene; Abaei, Alireza; Gebhard, Florian; Rasche, Volker; Ignatius, Anita			Evaluation of high-resolution In Vivo MRI for longitudinal analysis of endochondral fracture healing in mice	PLOS ONE			English	Article							MODEL; RAT	Mice are extensively used for experimental bone-healing studies. However, there are few established nondestructive in vivo techniques for longitudinal fracture-healing analysis in mice, including in vivo micro-computed tomography (mu CT) and radiography. Importantly, none of the established methods can discriminate between non-mineralized fibrous tissue and cartilage in the soft fracture callus. Therefore, the objective was to establish high-resolution in vivo magnetic resonance imaging (MRI) for the longitudinal assessment of soft callus formation during bone healing in mice. C57BL/6J mice received a femur osteotomy stabilized using an external fixator and were randomly assigned to five groups. Group 1 mice were scanned three times longitudinally during fracture healing using an optimized MRI scanning protocol to establish an algorithm to characterize the different fracture-callus tissues. Mice of groups 2-4 were scanned once on day 10, 14 or 21, respectively, euthanized after scanning and their femurs subjected to ex vivo mu CT and histomorphometric analysis to compare the data assessed by MRI with mu CT and histology. Control group 5 mice were not scanned. After 28 days, mice of groups 1 and 5 were euthanized and the fracture-healing outcome was evaluated by bending-test, mu CT and histology to determine whether the repeated anesthesia, handling and the MRI measurements themselves influenced fracture healing. The callus- tissue values determined by MRI were mostly comparable to those obtained by mu CT and histomorphometric analysis. However, at time points characterized by small relative bone or cartilage areas, MRI measurements were weakly comparable to histomorphometric data, possibly due to the inferior spatial resolution. Importantly, at the early and intermediate phases of healing, cartilage and fibrous-tissue values obtained by MRI were highly accurate. Furthermore, repeated anesthesia, handling and MRI scans did not impact bone healing. Therefore, we demonstrated the feasibility of high-resolution in vivo MRI for longitudinal assessment of soft callus formation during murine endochondral fracture healing.	[Haffner-Luntzer, Melanie; Mueller-Graf, Fabian; Haegele, Yvonne; Fischer, Verena; Jonas, Rene; Ignatius, Anita] Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Ulm, Germany; [Mueller-Graf, Fabian; Gebhard, Florian] Univ Med Ctr Ulm, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany; [Matthys, Romano] RISystem, Davos, Switzerland; [Abaei, Alireza; Rasche, Volker] Univ Med Ctr Ulm, Core Facil Small Anim MRI, Ulm, Germany	Ulm University; Ulm University; Ulm University	Haffner-Luntzer, M (corresponding author), Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Ulm, Germany.	melanie.haffner-luntzer@uni-ulm.de	Ignatius, Anita/M-6012-2013; Haffner-Luntzer, Melanie/L-3562-2019; Fischer, Verena/GVU-3636-2022; Rasche, Volker/P-6523-2016	Ignatius, Anita/0000-0002-4782-1979; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Rasche, Volker/0000-0001-8844-3583; Fischer, Verena/0000-0001-7039-8008; Matthys, Romano/0000-0001-9600-7060	German Research Foundation (DFG) [CRC1149]; AO Trauma Foundation Germany; German Research Foundation [CRC1149]	German Research Foundation (DFG)(German Research Foundation (DFG)); AO Trauma Foundation Germany; German Research Foundation(German Research Foundation (DFG))	RISystems provided support in the form of salaries for RM, but did not have any additional role in the study design, data collection and analysis or decision to publish. The specific role of RM is articulated in the 'author contributions' section: RM designed the ceramic pins used for this study. This study was funded by the German Research Foundation (DFG,CRC1149) and the AO Trauma Foundation Germany.; We thank Marion Tomo, Sevil Essig, Stefanie Schroth, Uschi Maile and Cherise Grieser for excellent technical support. We also thank the German Research Foundation (CRC1149) and the AO Trauma Foundation Germany for funding of this study.	Al Faraj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090829; Beckmann N, 2003, MAGNET RESON MED, V49, P1047, DOI [10.1002/mrm.10480, 10.1002/mrm10480]; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Geva T, 2006, J CARDIOVASC MAGN R, V8, P573, DOI 10.1080/10976640600755302; Haffner-Luntzer M., 2016, CURRENT MOL BIOL REP, V2, P101, DOI DOI 10.1007/S40610-016-0037-3; Haffner-Luntzer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116282; Hartwig V, 2009, INT J ENV RES PUB HE, V6, P1778, DOI 10.3390/ijerph6061778; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; Mayer-Kuckuk P, 2006, BONE, V39, P965, DOI 10.1016/j.bone.2006.05.009; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Niemeyer M, 2010, EUR RADIOL, V20, P2184, DOI 10.1007/s00330-010-1773-z; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Rolle AM, 2016, P NATL ACAD SCI USA, V113, pE1026, DOI 10.1073/pnas.1518836113; Shellock FG, 2000, J MAGN RESON IMAGING, V12, P30, DOI 10.1002/1522-2586(200007)12:1<30::AID-JMRI4>3.0.CO;2-S; SHIVERS RR, 1987, NEUROSCI LETT, V76, P25, DOI 10.1016/0304-3940(87)90186-8; Simi S, 2008, MUTAT RES-FUND MOL M, V645, P39, DOI 10.1016/j.mrfmmm.2008.08.011; Taha MA, 2013, J MAGN RESON IMAGING, V38, P231, DOI 10.1002/jmri.23876; Zachos TA, 2007, J INVEST SURG, V20, P87, DOI 10.1080/08941930701234687	22	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174283	10.1371/journal.pone.0174283	http://dx.doi.org/10.1371/journal.pone.0174283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333972	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200071
J	Kelly, HA; Ngou, J; Chikandiwa, A; Sawadogo, B; Gilham, C; Omar, T; Lompo, O; Doutre, S; Meda, N; Weiss, HA; Delany-Moretlwe, S; Segondy, M; Mayaud, P				Kelly, Helen A.; Ngou, Jean; Chikandiwa, Admire; Sawadogo, Bernard; Gilham, Clare; Omar, Tanvier; Lompo, Olga; Doutre, Sylviane; Meda, Nicolas; Weiss, Helen A.; Delany-Moretlwe, Sinead; Segondy, Michel; Mayaud, Philippe		HARP Study Group	Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RISK HUMAN-PAPILLOMAVIRUS; TRICHOMONAS-VAGINALIS; CHLAMYDIA-TRACHOMATIS; SEROPOSITIVE WOMEN; POSITIVE WOMEN; INFECTION; CANCER; LESIONS; METAANALYSIS	Objective To describe associations of high-risk human papillomavirus (HR-HPV) with high-grade cervical intraepithelial neoplasia (CIN2+) in women living with HIV (WLHIV) in Burkina Faso (BF) and South Africa (SA). Methods Prospective cohort of WLHIV attending HIV outpatient clinics and treatment centres. Recruitment was stratified by ART status. Cervical HPV genotyping using INNO-LiPA and histological assessment of 4-quadrant cervical biopsies at enrolment and 16 months later. Results Among women with CIN2+ at baseline, the prevalence of any HR-HPV genotypes included in the bi/quadrivalent (HPV16/18) or nonavalent (HPV16/18/31/35/45/52/58) HPV vaccines ranged from 37% to 90%. HPV58 was most strongly associated with CIN2+ (aOR = 5.40, 95% CI: 2.77-10.53). At 16-months follow-up, persistence of any HR-HPV was strongly associated with incident CIN2+ (aOR = 7.90, 95% CI: 3.11-20.07), as was persistence of HPV16/18 (aOR = 5.25, 95% CI: 2.14-12.91) and the additional HR types in the nonavalent vaccine (aOR = 3.23, 95% CI: 1.23-8.54). Conclusion HR-HPV persistence is very common among African WLHIV and is linked to incident CIN2+. HPV vaccines could prevent between 37-90% of CIN2+ among African WLHIV.	[Kelly, Helen A.; Gilham, Clare; Mayaud, Philippe] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Ngou, Jean; Doutre, Sylviane; Segondy, Michel] INSERM, U1058, Montpellier, France; [Ngou, Jean; Doutre, Sylviane; Segondy, Michel] Univ Hosp CHRU, Montpellier, France; [Chikandiwa, Admire; Mayaud, Philippe] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Sawadogo, Bernard; Lompo, Olga; Meda, Nicolas] Univ Ouagadougou, Ctr Rech Int Sante, Ouagadougou, Burkina Faso; [Omar, Tanvier; Delany-Moretlwe, Sinead] Natl Hlth Lab Serv, Johannesburg, South Africa; [Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Weiss, Helen A.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England	University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Witwatersrand; National Health Laboratory Service; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Kelly, HA (corresponding author), London Sch Hyg & Trop Med, Clin Res Dept, London, England.	helen.kelly@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Nagot, Nicolas/0000-0002-3493-2821; MAYAUD, Philippe/0000-0001-5730-947X; DJIGMA, Florencia Wendkuuni/0000-0002-6895-6725	European Commission (EC) 7th Framework Programme [HEALTH-2010-F2-265396]; MRC [MR/M01231X/1] Funding Source: UKRI; Medical Research Council [MR/K012126/1, MR/M01231X/1] Funding Source: researchfish	European Commission (EC) 7th Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the European Commission (EC) 7th Framework Programme under grant agreement No. HEALTH-2010-F2-265396. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Castellsague X, 2003, J NATL CANC I MONOGR, V20, P8; Clement B, 2014, ATLAS GYNECOLOGIC PA, P100; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2016, JAIDS-J ACQ IMM DEF, V73, P332, DOI 10.1097/QAI.0000000000001113; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Denslow SA, 2014, INT J STD AIDS, V25, P163, DOI 10.1177/0956462413491735; Department of Health RoSA, NAT CONS GUID PREV M; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Giuliano AR, 2002, CANCER CAUSE CONTROL, V13, P839, DOI 10.1023/A:1020668232219; Houlihan CF, 2016, J ADOLESCENT HEALTH, V58, P295, DOI 10.1016/j.jadohealth.2015.10.248; Joura EA, 2014, CANCER EPIDEM BIOMAR, V23, P1997, DOI 10.1158/1055-9965.EPI-14-0410; Kelly HA, 2016, EPIDEMIOLOGY HIGH RI; Konopnicki D, 2016, AIDS, V30, P425, DOI 10.1097/QAD.0000000000000929; Lazenby GB, 2014, CLIN THER, V36, P38, DOI 10.1016/j.clinthera.2013.11.009; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; Ngou J, 2015, JAIDS-J ACQ IMM DEF, V68, P162, DOI 10.1097/QAI.0000000000000428; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Smith JS, 2002, JNCI-J NATL CANCER I, V94, P1604, DOI 10.1093/jnci/94.21.1604; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Trottier H, 2009, CANCER EPIDEM BIOMAR, V18, P854, DOI 10.1158/1055-9965.EPI-08-1012; VIH/SIDA Mdlscmdlcl, NORM PROT PRIS CHARG; ZHANG ZF, 1994, INT J EPIDEMIOL, V23, P682, DOI 10.1093/ije/23.4.682; Zhu HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003077	33	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174117	10.1371/journal.pone.0174117	http://dx.doi.org/10.1371/journal.pone.0174117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333966	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200048
J	Zhao, Y; Yu, YJ; Li, H; Chang, ZR; Li, YJ; Duan, YF; Wang, J; Jiang, S; Yang, ZY; Yin, SA				Zhao, Yao; Yu, Yingjie; Li, Hong; Chang, Zhirong; Li, Yongjin; Duan, Yifan; Wang, Jie; Jiang, Shan; Yang, Zhenyu; Yin, Shi-an			Vitamin D status and the prevalence of deficiency in lactating women from eight provinces and municipalities in China	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; RANDOMIZED CONTROLLED-TRIAL; D SUPPLEMENTATION; PREGNANCY; INFANTS; HEALTH; AGE; DETERMINANTS; METAANALYSIS; OUTCOMES	Background Vitamin D deficiency has become prevalent worldwide in recent years. However, less evidence was available for lactating women. Objective The purpose of the study was to understand vitamin D status and prevalence of deficiency in lactating women and associated risk factors for vitamin D deficiency from eight provinces and municipalities in China. Methods Lactating women within 1-10 months postpartum were recruited in 2011-2013 from eight provinces and municipalities in China. Radioimmunoassay was used to measure serum 25-hydroxyvitamin D [ 25(OH) D] concentration. Standardized questionnaire was used to collect information on season, living site, ethnicity and socio-demographic characteristics. Results Totally 2004 lactating women were recruited. The median (p25, p75) of 25(OH) D was 15.8 (10.5, 24.0) nmol/L. The prevalence of vitamin D deficiency was 85.3% as 25(OH) D <30nmol/L. Serum 25(OH) D levels of lactating women were significantly lower during October-January (14.0nmol/L) than during February-May (18.0nmol/L) (P<0.001), and were significantly higher in Dai ethnicity (22.5nmol/L) than in Hui ethnicity (Chinese Muslims) (9.0nmol/L) (P<0.001). For every 10,000 CNY annual income per capita increasing, serum 25(OH) D levels significantly increased 1.04 times (P<0.001). The odds of vitamin D deficiency in winter were 2.56 times higher than that in spring (OR 2.56, 95% CI: 1.91-3.43). Conclusions Vitamin D deficiency of lactating women was highly prevalent in the eight provinces and municipalities in China. It is urgent to study the strategy and intervention ways for improving vitamin D status of lactating women, especially for certain population groups during low sunlight exposure season.	[Zhao, Yao; Yu, Yingjie; Li, Hong] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhao, Yao; Yu, Yingjie; Li, Hong] Beijing Res Ctr Prevent Med, Beijing, Peoples R China; [Chang, Zhirong] Beijing Dongcheng Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Yongjin] Beijing Shunyi Ctr Dis Control & Prevent, Beijing, Peoples R China; [Duan, Yifan; Wang, Jie; Jiang, Shan; Yang, Zhenyu; Yin, Shi-an] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Yang, ZY; Yin, SA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China.	yang_zhenyuid@126.com; shianyin@126.com	li, yong/HDN-3885-2022		Chinese National Technique R&D Program (863 Projects) by titled the research and development of nutritional and fortified foods promoting growth and development [2010AA023004]; National Technique R & D Program (863 Projects) [2010AA023004]	Chinese National Technique R&D Program (863 Projects) by titled the research and development of nutritional and fortified foods promoting growth and development; National Technique R & D Program (863 Projects)	This study was partly supported by Chinese National Technique R&D Program (863 Projects) by titled the research and development of nutritional and fortified foods promoting growth and development (project number: 2010AA023004).; We thank the National Technique R & D Program (863 Projects) for its financial support by the project of research and development of nutritional and fortified foods promoting growth and development (project number: 2010AA023004). The authors would like to acknowledge volunteers who supplied with her venous blood samples in Beijing and Shanghai municipalities, Guangdong, Heilongjiang, Yunnan, Gansu, Zhejiang and Shandong provinces. We thank the field team from local County Center for Disease Control and Prevention, which was involved in field organization and data collection. We are indebted to the local community health doctors and nurses who assisted with our field work.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Basile LA, 2006, BREASTFEED MED, V1, P27, DOI 10.1089/bfm.2006.1.27; Bischoff-Ferrari HA, 2011, ANN NUTR METAB, V59, P17, DOI 10.1159/000332069; Botros RM, 2015, ENDOCRINOL NUTR, V62, P314, DOI 10.1016/j.endonu.2015.03.010; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Brembeck Petra, 2013, Br J Nutr, V110, P856, DOI 10.1017/S0007114512005855; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Cuhaci-Cakir B, 2014, TURKISH J PEDIATR, V56, P475; Dawodu A, 2012, ADV NUTR, V3, P353, DOI 10.3945/an.111.000950; Dong CX, 2014, ASIA PAC J CLIN NUTR, V23, P671, DOI 10.6133/apjcn.2014.23.4.22; Forsythe LK, 2012, BRIT J NUTR, V107, P126, DOI 10.1017/S0007114511002662; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Godar DE, 2011, DERM-ENDOCRINOL, V3, P243, DOI 10.4161/derm.3.4.15292; Godar DE, 2012, ENVIRON HEALTH PERSP, V120, P139, DOI 10.1289/ehp.1003195; Hedlund L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060864; Holick MF, 1995, AM J CLIN NUTR S, V61, p638S, DOI DOI 10.1093/ajcn/61.3.638S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Hossain N, 2011, INT J GYNECOL OBSTET, V112, P229, DOI 10.1016/j.ijgo.2010.09.017; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Kovacs CS, 2013, SEMIN FETAL NEONAT M; Luxwolda MF, 2013, EUR J NUTR, V52, P1115, DOI 10.1007/s00394-012-0421-6; March KM, 2015, AM J CLIN NUTR, V102, P402, DOI 10.3945/ajcn.114.106385; MATSUOKA LY, 1988, ARCH DERMATOL, V124, P1802, DOI 10.1001/archderm.124.12.1802; Medicine Io, 2011, DIETARY REFERENCE IN; Mohamed HJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100705; Morales E, 2012, PEDIATRICS, V130, pE913, DOI 10.1542/peds.2011-3289; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; Oberhelman SS, 2013, MAYO CLIN PROC, V88, P1378, DOI 10.1016/j.mayocp.2013.09.012; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pratumvinit B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131126; Prevalence CfDCa, 2012, 2 NAT REP BIOCH IND; Saadi HF, 2007, AM J CLIN NUTR, V85, P1565, DOI 10.1093/ajcn/85.6.1565; Samuel L, 2014, ANN EPIDEMIOL, V24, P781, DOI 10.1016/j.annepidem.2014.07.016; Sharif S, 2013, JCPSP-J COLL PHYSICI, V23, P862, DOI 12.2013/JCPSP.862865; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Society CN, 2013, CHIN DIET REF INT; Song SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085081; [宋淑军 Song Shujun], 2014, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V20, P900; Specker BL, 2012, P NUTR SOC, V71, P38, DOI 10.1017/S0029665111003053; Thandrayen K, 2012, RHEUM DIS CLIN N AM, V38, P61, DOI 10.1016/j.rdc.2012.03.007; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; van den Berg G, 2013, EUR J NUTR, V52, P273, DOI 10.1007/s00394-012-0327-3; Wagner CL, 2012, WOMENS HEALTH, V8, P323, DOI [10.2217/WHE.12.17, 10.2217/whe.12.17]	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174378	10.1371/journal.pone.0174378	http://dx.doi.org/10.1371/journal.pone.0174378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334009	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200090
J	Plomgaard, AM; Alderliesten, T; Austin, T; van Bel, F; Benders, M; Claris, O; Dempsey, E; Fumagalli, M; Gluud, C; Hagmann, C; Hyttel-Sorensen, S; Lemmers, P; van Oeveren, W; Pellicer, A; Petersen, TH; Pichler, G; Winkel, P; Greisen, G				Plomgaard, Anne M.; Alderliesten, Thomas; Austin, Topun; van Bel, Frank; Benders, Manon; Claris, Olivier; Dempsey, Eugene; Fumagalli, Monica; Gluud, Christian; Hagmann, Cornelia; Hyttel-Sorensen, Simon; Lemmers, Petra; van Oeveren, Wim; Pellicer, Adelina; Petersen, Tue H.; Pichler, Gerhard; Winkel, Per; Greisen, Gorm			Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; RANDOMIZED CLINICAL-TRIAL; EXTREMELY PRETERM INFANTS; ACID-BINDING PROTEINS; INTRAVENTRICULAR HEMORRHAGE; TREATMENT GUIDELINE; OXYGEN-SATURATION; EARLY INDICATOR; SERUM; PREDICTION	Background The randomized clinical trial, SafeBoosC II, examined the effect of monitoring of cerebral oxygenation by near-infrared spectroscopy combined with a guideline on treatment when cerebral oxygenation was out of the target range. Data on cerebral oxygenation was collected in both the intervention and the control group. The primary outcome was the reduction in the burden of cerebral hypo- and hyperoxia between the two groups. In this study we describe the associations between the burden of cerebral hypo- and hyperoxia, regardless of allocation to intervention or control group, and the biomarkers of brain injury from birth till term equivalent age that was collected as secondary and explorative outcomes in the SafeBoosC II trial. Methods Cerebral oxygenation was continuously monitored during the first 72h of life in 166 extremely preterm infants. Cranial ultrasound was performed at day 1,4,7,14, and 35 and at term. Electroencephalogram ( EEG) was recorded at 64h. Blood-samples taken at 6 and 64 hours were analysed for the brain injury biomarkers; S100beta, brain-fatty-acid-binding-protein, and neuroketal. All analyses were conducted post hoc. Results Significantly more infants with a cerebral burden of hypoxia within the 4(th) quartile versus infants within quartile 1-3 were diagnosed with severe intracranial haemorrhage (11/39 versus 11/117, p = 0.003), had low burst rate on EEG (12/28 versus 21/103, p = 0.015), or died (14/41 versus 18/123, p = 0.006), whereas none of these events were significantly associated with cerebral hyperoxia. The blood biomarkers were not significantly associated with the burden of cerebral hypo- or hyperoxia. Conclusions The explorative analysis showed that early burden of cerebral hypoxia, but not hyperoxia was significantly associated with low brain electrical activity and severe intracranial haemorrhage while none of the three blood biomarkers were associated with the burden of either cerebral hypo- or hyperoxia.	[Plomgaard, Anne M.; Hyttel-Sorensen, Simon; Greisen, Gorm] Copenhagen Univ Hosp, Dept Neonatol, Rigshosp, Copenhagen, Denmark; [Alderliesten, Thomas; van Bel, Frank; Benders, Manon; Lemmers, Petra] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Austin, Topun] Rosie Hosp Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Claris, Olivier] Univ Claude Bernard, Hosp Civils Lyon, Dept Neonatol, Lyon, France; [Dempsey, Eugene] Univ Coll Cork, INFANT Ctr, Cork, Ireland; [Fumagalli, Monica] Univ Milan, NICU, Fdn RCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Gluud, Christian; Winkel, Per] Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Rigshosp, Copenhagen, Denmark; [Hagmann, Cornelia] Univ Zurich, Clin Neonatol, Zurich, Switzerland; [van Oeveren, Wim] Haemoscan BV, Groningen, Netherlands; [Pellicer, Adelina] La Paz Univ Hosp, Dept Neonatol, Madrid, Spain; [Petersen, Tue H.] Copenhagen Univ Hosp, Dept Neurorehabil, Res Unit Brain Injury Neurorehabil Copenhagen, Rigshosp,TBI Unit, Hvidovre, Denmark; [Pichler, Gerhard] Med Univ Graz, Dept Pediat, Res Unit Neonatal Micro & Macrocirculat, Graz, Austria	Rigshospitalet; University of Copenhagen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University College Cork; University of Milan; Rigshospitalet; University of Copenhagen; University of Zurich; Hospital Universitario La Paz; Rigshospitalet; University of Copenhagen; Medical University of Graz	Plomgaard, AM (corresponding author), Copenhagen Univ Hosp, Dept Neonatol, Rigshosp, Copenhagen, Denmark.	amplomgaard@gmail.com	Dempsey, Eugene/AAG-3037-2021; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022; Austin, Topun/ABG-1960-2021; Greisen, Gorm/AAA-6463-2022; Fumagalli, Monica/K-6717-2016; Dempsey, Eugene Michael/H-8051-2015	Gluud, Christian/0000-0002-8861-0799; Austin, Topun/0000-0002-8428-8624; Greisen, Gorm/0000-0001-8042-3262; Fumagalli, Monica/0000-0002-0186-0710; Dempsey, Eugene Michael/0000-0002-6266-3462; Hagmann, Cornelia/0000-0003-2647-9809	Danish Council for Strategic Research [DKK 11,100,105]; HaemoScan	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); HaemoScan	This work was funded by the Danish Council for Strategic Research (DKK 11,100,105). Grant number URL:http://ufm.dk/forskning-og-innovation/tilskud-til-forskning-og-innovation/hvem-har-modtaget-tilskud/2011/bevillinger-(fradet-strategiske-forskringsrad-programkomiteen-for-individ-sygdom-og-samfund-november- 2011. HaemoScan provided support in the form of salary for author WvO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alderliesten T, 2014, J PEDIATR-US, V164, P986, DOI 10.1016/j.jpeds.2013.12.042; [Anonymous], 2004, OXIDATIVE INJURY INF, P1; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baik N, 2015, ARCH DIS CHILD FETAL; Bassan H, 2006, PEDIATRICS, V117, P2111, DOI 10.1542/peds.2005-1570; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Eskesen V., 2014, UGESKRIFT LAEGER, V176; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Greco A, 2004, CURR NEUROVASC RES, V1, P341, DOI 10.2174/1567202043362036; GREISEN G, 1989, BRAIN DEV-JPN, V11, P164, DOI 10.1016/S0387-7604(89)80091-9; GREISEN G, 1987, ACTA PAEDIATR SCAND, V76, P519, DOI 10.1111/j.1651-2227.1987.tb10509.x; Hahn GH, 2012, PEDIATR RES, V71, P253, DOI 10.1038/pr.2011.46; Hartley C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031543; Hellstrom-Westas L, 2001, NEUROPEDIATRICS, V32, P319, DOI 10.1055/s-2001-20408; Hou XL, 2007, PHYSIOL MEAS, V28, P1251, DOI 10.1088/0967-3334/28/10/010; Hyttel-Sorensen S, 2015, COCHRANE LIB, P1; Hyttel-Sorensen S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7635; Hyttel-Sorensen S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-120; Inder T, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000020088.11295.13; Kok WF, 2016, NEURONAL DAMAGE BIOM; Kurth CD, 2009, ANESTH ANALG, V108, P1268, DOI 10.1213/ane.0b013e318196ac8e; Lemmers PMA, 2013, PEDIATR RES, V74, P180, DOI 10.1038/pr.2013.84; Noori S, 2014, J PEDIATR-US, V164, P264, DOI 10.1016/j.jpeds.2013.09.045; O'Reilly D, 2012, CLIN NEUROPHYSIOL, V123, P2139, DOI 10.1016/j.clinph.2012.02.087; Pellicer A, 2013, NEONATOLOGY, V104, P171, DOI 10.1159/000351346; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Plomgaard AM, 2016, PEDIATR RES, V79, P528, DOI 10.1038/pr.2015.266; Plomgaard AM, 2016, PEDIATR RES, V79, P466, DOI 10.1038/pr.2015.239; Rogers LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082537; Sanchez-de-Toledo J, 2014, NEUROCRIT CARE, V21, P133, DOI 10.1007/s12028-013-9934-y; Sorensen LC, 2008, ACTA PAEDIATR, V97, P1529, DOI 10.1111/j.1651-2227.2008.00970.x; Soubasi V, 2012, EUR J PAEDIATR NEURO, V16, P625, DOI 10.1016/j.ejpn.2012.02.008; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Teunissen CE, 2011, EUR J NEUROL, V18, P865, DOI 10.1111/j.1468-1331.2010.03273.x; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Tina Lucia Gabriella, 2010, Front Biosci (Elite Ed), V2, P159, DOI 10.2741/e78; West CR, 2011, ARCH DIS CHILD-FETAL, V96, pF108, DOI 10.1136/adc.2009.180539; Wintermark P, 2014, NEUROIMAGE, V85, P287, DOI 10.1016/j.neuroimage.2013.04.072; Wolf M, 2009, CLIN PERINATOL, V36, P807, DOI 10.1016/j.clp.2009.07.007; Wong FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043165; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Yis U, 2008, BRAIN DEV-JPN, V30, P556, DOI 10.1016/j.braindev.2008.01.010	43	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173440	10.1371/journal.pone.0173440	http://dx.doi.org/10.1371/journal.pone.0173440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328980	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000399094700019
J	Thomas, T; Amouroux, F; Vincent, P				Thomas, Thierry; Amouroux, Francoise; Vincent, Patrice			Intra articular hyaluronic acid in the management of knee osteoarthritis: Pharmaco-economic study from the perspective of the national health insurance system	PLOS ONE			English	Article							CONTROLLED-TRIALS; METAANALYSIS; VISCOSUPPLEMENTATION; EFFICACY; PAIN; INJECTIONS; WOMAC; COST; HIP	Introduction Pharmaco-economic data on the management of knee osteoarthritis (OA) with intra articular hyaluronic acid (IA HA) viscosupplementation is limited. We contrasted IA HA with non-steroidal anti-inflammatory drugs (NSAIDs). Methods Observational, prospective and multicenter study comparing treatments of knee OA costs and efficacy with either NSAIDs alone, or hyaluronic acid (Arthrum H 2%(R)), during a 6-month follow-up period. The investigators were pharmacists who recorded data on disease, drug consumption and healthcare circuit. Retrospectively, the 6-month period preceding inclusion was also studied, to ensure the comparability of groups. Results 199 patients were analyzed in a NSAIDs group and 202 in an IA HA group. Any of the WOMAC sub-scores and the EQ-5D Quality of Life index were significantly improved in the IA HA group (p<0.0001) at 3 and 6 months. Clinical results were therefore in favor of the IA HA group. The total drug expenses per 6-month period were comparable before and after inclusion, sic96 and sic98 for NSAIDs group vs sic94 and sic101 for IA HA group, which indicates no evidence of additional cost from IA HA. For the active part of the population, the incidence of sick leave was lower in the IA HA group, indicating a better maintenance of patient activity. The overall expense on 12 months (6 months before and 6 months after inclusion) for the national health insurance system was comparable for NSAIDs and IA HA groups: sic528 and sic526, respectively. The number of patients taking NSAIDs significantly decreased in IA HA group (from 100% at inclusion to 66% at 1-3 months and 44% at 4-6 months), but remained unchanged (100%) during the follow-up period, in NSAIDs group. Conclusion Treatment with IA HA did not generate additional cost for the national health insurance and was associated with a functional improvement of knee osteoarthritis and Quality of Life. The cost- utility analysis was in favor of IA HA, with a gain of QALY equivalent to half a month, after the 6-month follow-up period comparing both treatments. The NSAIDs consumption was decreased in the IA HA group, resulting in an improved estimated benefit/risk ratio.	[Thomas, Thierry] CHU, Serv Rhumatol, St Etienne, France; [Amouroux, Francoise] UFR Sci Pharmaceut, Bordeaux, France; [Vincent, Patrice] LCA Pharmaceut, Chartres, France	CHU de St Etienne	Vincent, P (corresponding author), LCA Pharmaceut, Chartres, France.	pvincent@lca-pharma.com			LCA Pharmaceutical	LCA Pharmaceutical	This research was entirely funded by LCA Pharmaceutical. PV is employed by LCA Pharmaceutical. LCA Pharmaceutical provided support in the form of salary for PV but did not have any additional role in the study design, data collection and analysis and final report of the study. The only role was the participation to the article.	Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; [Anonymous], 2016, CLIN TRIALS REG REC; Arramon JY, 2008, MINERVA ORTOP TRAUMA, V59, P69; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bannuru RR, 2014, SEMIN ARTHRITIS RHEU, V43, P593, DOI 10.1016/j.semarthrit.2013.10.002; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Bruyere O, 2014, SEMIN ARTHRITIS RHEU, V44, P253, DOI 10.1016/j.semarthrit.2014.05.014; Campbell KA, 2015, J ARTHROSCOPIC RELAT, P1; Cheung K, 2009, EUROQOL GROUP 2009; Germonville T, 2015, MINERVA ORTOP TRAUMA, V66, P235; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Hatoum Hind T, 2014, J Med Econ, V17, P326, DOI 10.3111/13696998.2014.902843; Henrotin Y, 2015, SEMIN ARTHRITIS RHEU, V45, P140, DOI 10.1016/j.semarthrit.2015.04.011; Hilliquin P., 2016, REFLEXIONS RHUMATOLO, V181, P41; Kahan A, 2003, JOINT BONE SPINE, V70, P276, DOI 10.1016/S1297-319X(03)00043-5; Le Pen C, 2005, JOINT BONE SPINE, V72, P567, DOI 10.1016/j.jbspin.2005.01.011; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Mazieres B, 2007, JOINT BONE SPINE, V74, P453, DOI 10.1016/j.jbspin.2007.01.037; McAlindon TE, NATURE REV RHEUMATOL, V2012, P635; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; Medina JM, 2006, J FAM PRACTICE, V55, P669; Miller LE, 2013, CLIN MED INSIGHTS-AR, V6, P57, DOI 10.4137/CMAMD.S12743; Modawal A, 2005, J FAM PRACTICE, V54, P758; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Roth SH, 2011, PHYSICIAN SPORTSMED, V39, P62, DOI 10.3810/psm.2011.09.1922; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Societe Francaise de Rhumatologie, 2006, EP MAL RHUM; Waddell DD, 2007, DRUG AGING, V24, P629, DOI 10.2165/00002512-200724080-00002; Wang CT, 2004, J BONE JOINT SURG AM, V86A, P538, DOI 10.2106/00004623-200403000-00012; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	34	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173683	10.1371/journal.pone.0173683	http://dx.doi.org/10.1371/journal.pone.0173683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328935	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700029
J	Haga, Y; Kanda, T; Nakamura, M; Nakamoto, S; Sasaki, R; Takahashi, K; Wu, S; Yokosuka, O				Haga, Yuki; Kanda, Tatsuo; Nakamura, Masato; Nakamoto, Shingo; Sasaki, Reina; Takahashi, Koji; Wu, Shuang; Yokosuka, Osamu			Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ADVANCED HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; ACTIVATION; INHIBITION; JNK; EXPRESSION; THERAPY	Background Despite recent advances in treatment strategies, it is still difficult to cure patients with hepatocellular carcinoma (HCC). Sorafenib is the only approved multiple kinase inhibitor for systemic chemotherapy in patients with advanced HCC. The majority of advanced HCC patients are resistant to sorafenib. The mechanisms of sorafenib resistance are still unknown. Methods The expression of molecules involved in the mitogen-activated protein kinase (MAPK) signaling pathway in human hepatoma cell lines was examined in the presence or absence of sorafenib. Apoptosis of human hepatoma cells treated with sorafenib was investigated, and the expression of Jun proto-oncogene (c-Jun) was measured. Results The expression and phosphorylation of c-Jun were enhanced in human hepatoma cell lines after treatment with sorafenib. Inhibiting c-Jun enhanced sorafenib-induced apoptosis. The overexpression of c-Jun impaired sorafenib-induced apoptosis. The expression of osteopontin, one of the established AP-1 target genes, was enhanced after treatment with sorafenib in human hepatoma cell lines. Conclusions The protein c-Jun plays a role in sorafenib resistance in human hepatoma cell lines. The modulation and phosphorylation of c-Jun could be a new therapeutic option for enhancing responsiveness to sorafenib. Modulating c-Jun may be useful for certain HCC patients with sorafenib resistance.	[Haga, Yuki; Kanda, Tatsuo; Nakamura, Masato; Nakamoto, Shingo; Sasaki, Reina; Takahashi, Koji; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo] Chiba Univ, Dept Mol Virol, Grad Sch Med, Chiba, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat@aol.com		Kanda, Tatsuo/0000-0002-1654-5385	MSD, Chugai Pharmaceutical [AC-1-20160603004715-334801]; Abbvie [58]; Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED	MSD, Chugai Pharmaceutical; Abbvie(AbbVie); Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by research grants from MSD, Chugai Pharmaceutical (AC-1-20160603004715-334801) and Abbvie (201606_CASE No.58). This research was (partially) supported by the a Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arao T, 2013, HEPATOLOGY, V57, P1407, DOI 10.1002/hep.25956; Chen J, 2015, CANCER LETT, V367, P1, DOI 10.1016/j.canlet.2015.06.019; Chen W, 2016, SCI REP-UK, V6, DOI 10.1038/srep22976; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ding K, 2015, ONCOL REP, V34, P3297, DOI 10.3892/or.2015.4306; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Guo LL, 2005, LIFE SCI, V77, P1869, DOI 10.1016/j.lfs.2005.03.019; Hagiwara S, 2012, BRIT J CANCER, V106, P1997, DOI 10.1038/bjc.2012.145; Huang XY, 2013, HEPATOLOGY, V57, P2235, DOI 10.1002/hep.26255; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Jiang X, 2014, EXP CELL RES, V323, P326, DOI 10.1016/j.yexcr.2014.02.017; Kanda T, 2004, J VIRAL HEPATITIS, V11, P479, DOI 10.1111/j.1365-2893.2004.00531.x; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; Kuo KK, 2016, STEM CELLS; Lathia C, 2006, CANCER CHEMOTH PHARM, V57, P685, DOI 10.1007/s00280-005-0068-6; Lee S, 2016, BIOCHEM BIOPH RES CO, V473, P1247, DOI 10.1016/j.bbrc.2016.04.049; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin CL, 2015, J FORMOS MED ASSOC, V114, P901, DOI 10.1016/j.jfma.2015.06.003; Lind JSW, 2010, CLIN CANCER RES, V16, P3078, DOI 10.1158/1078-0432.CCR-09-3033; Mandal R, 2016, ONCOGENE, V35, P2547, DOI 10.1038/onc.2015.329; Mao K, 2014, CANCER LETT, V352, P245, DOI 10.1016/j.canlet.2014.07.004; Mazzanti Roberto, 2016, World J Exp Med, V6, P21, DOI 10.5493/wjem.v6.i1.21; Omata M, 2016, HEPATOL INT, V10, P702, DOI 10.1007/s12072-016-9717-6; Ou DL, 2010, CANCER RES, V70, P9309, DOI 10.1158/0008-5472.CAN-10-1033; Qiu JX, 2004, J NEUROSCI RES, V77, P108, DOI 10.1002/jnr.20156; Sasaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146314; Sasaki R, 2015, BIOCHEM BIOPH RES CO, V464, P1192, DOI 10.1016/j.bbrc.2015.07.102; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Trierweiler C, 2016, CELL DEATH DIFFER, V23, P576, DOI 10.1038/cdd.2015.121; Villaruz LC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0092-2; Vin H, 2014, MOL CANCER THER, V13, P221, DOI 10.1158/1535-7163.MCT-13-0561; Wang J, 2016, TARGET ONCOL, V11, P723, DOI 10.1007/s11523-016-0446-5; Yan D, 2016, J CELL MOL MED, V20, P2013, DOI 10.1111/jcmm.12908; Yin X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0119-3; Zurita AJ, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mdr047	38	33	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174153	10.1371/journal.pone.0174153	http://dx.doi.org/10.1371/journal.pone.0174153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323861	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000068
J	Takashima, M; Ray-Barruel, G; Ullman, A; Keogh, S; Rickard, CM				Takashima, Mari; Ray-Barruel, Gillian; Ullman, Amanda; Keogh, Samantha; Rickard, Claire M.			Randomized controlled trials in central vascular access devices: A scoping review	PLOS ONE			English	Review							CENTRAL VENOUS CATHETER; BLOOD-STREAM INFECTIONS; INSERTED CENTRAL CATHETERS; INTERNAL JUGULAR-VEIN; HOME PARENTERAL-NUTRITION; NEONATAL INTENSIVE-CARE; CRITICALLY-ILL PATIENTS; CHLORHEXIDINE-IMPREGNATED SPONGES; ULTRASOUND-GUIDED CATHETERIZATION; PATIENTS RECEIVING CHEMOTHERAPY	Background Randomized controlled trials evaluate the effectiveness of interventions for central venous access devices, however, high complication rates remain. Scoping reviews map the available evidence and demonstrate evidence deficiencies to focus ongoing research priorities. Method A scoping review (January 2006-December 2015) of randomized controlled trials evaluating the effectiveness of interventions to improve central venous access device outcomes; including peripherally inserted central catheters, non-tunneled, tunneled and totally implanted venous access catheters. MeSH terms were used to undertake a systematic search with data extracted by two independent researchers, using a standardized data extraction form. Results In total, 178 trials were included (78 non-tunneled [44%]; 40 peripherally inserted central catheters [22%]; 20 totally implanted [11%]; 12 tunneled [6%]; 6 non-specified [3%]; and 22 combined device trials [12%]). There were 119 trials (68%) involving adult participants only, with 18 (9%) pediatric and 20 (11%) neonatal trials. Insertion-related themes existed in 38% of trials (67 RCTs), 35 RCTs (20%) related to post-insertion patency, with fewer trials on infection prevention (15 RCTs, 8%), education (14RCTs, 8%), and dressing and securement (12 RCTs, 7%). There were 46 different study outcomes reported, with the most common being infection outcomes (161 outcomes; 37%), with divergent definitions used for catheter-related bloodstream and other infections. Conclusion More high quality randomized trials across central venous access device management are necessary, especially in dressing and securement and patency. These can be encouraged by having more studies with multidisciplinary team involvement and consumer engagement. Additionally, there were extensive gaps within population sub-groups, particularly in tunneled devices, and in pediatrics and neonates. Finally, outcome definitions need to be unified for results to be meaningful and comparable across studies.	[Takashima, Mari; Ray-Barruel, Gillian; Ullman, Amanda; Rickard, Claire M.] Griffith Univ, Menzies Hlth Inst Queensland, Alliance Vasc Access Teaching & Res AVATAR Grp, Nathan, Qld, Australia; [Keogh, Samantha] Queensland Univ Technol, Sch Nursing, Brisbane, Qld, Australia; [Keogh, Samantha] Queensland Univ Technol, Inst Hlth & Biomed Innovat IHBI, Brisbane, Qld, Australia	Griffith University; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Takashima, M (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Alliance Vasc Access Teaching & Res AVATAR Grp, Nathan, Qld, Australia.	m.takashima@griffith.edu.au	Ray-Barruel, Gillian/B-9305-2008; Rickard, Claire M./C-3440-2008	Ray-Barruel, Gillian/0000-0001-8875-7523; Rickard, Claire M./0000-0002-6341-7415; Takashima, Mari/0000-0002-1167-9106; Ullman, Amanda/0000-0001-8860-5319; Keogh, Samantha/0000-0002-2797-4388				Abdelkefi Abderrahman, 2007, J Support Oncol, V5, P273; Abualenain J, 2014, ANN EMERG MED S1, V64, pS113; Agarwal A, 2009, INDIAN J CRIT CARE M, V13, P213, DOI 10.4103/0972-5229.60174; Ainsworth S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004219.pub4; Akobeng AK, 2005, ARCH DIS CHILD, V90, P840, DOI 10.1136/adc.2004.058222; Alba GA, 2013, MED EDUC, V47, P1099, DOI 10.1111/medu.12259; Alexandrou E, 2014, CRIT CARE MED, V42, P536, DOI 10.1097/CCM.0b013e3182a667f0; Alic Y., 2009, CRIT CARE, V13, pP198; Alport B, 2012, CAN ASSOC RADIOL J, V63, P323, DOI 10.1016/j.carj.2011.05.002; Andreatta P, 2011, SUPPORT CARE CANCER, V19, P539, DOI 10.1007/s00520-010-0849-2; [Anonymous], 2015, VASCULAR ACCESS; [Anonymous], J ASS VASC ACCESS, DOI DOI 10.1016/J.JAVA.2013.04.002; Anton N, 2009, PEDIATRICS, V123, pe453, DOI 10.1542/peds.2008-1508; Antonelli M, 2012, J HOSP INFECT, V82, P101, DOI 10.1016/j.jhin.2012.07.010; Aouad MT, 2010, ANESTH ANALG, V111, P724, DOI 10.1213/ANE.0b013e3181e9c475; Apiliogullari B, 2012, J CARDIOTHOR VASC AN, V26, P985, DOI 10.1053/j.jvca.2012.07.005; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong R, 2011, J PUBLIC HEALTH-UK, V33, P147, DOI 10.1093/pubmed/fdr015; Arvaniti K, 2012, CRIT CARE MED, V40, P420, DOI 10.1097/CCM.0b013e31822f0d4b; Atahan K, 2012, BRATISL MED J, V113, P548, DOI 10.4149/BLL_2012_123; Aziz N, 2013, J MED SCI PESHAWAR, V21, P187; Ball RD, 2012, BRIT J ANAESTH, V108, P72, DOI 10.1093/bja/aer329; Barreras F, 2013, J VASC ACCESS, V14, P77, DOI 10.5301/jva.5000095; Biffi R, 2009, ANN ONCOL, V20, P935, DOI 10.1093/annonc/mdn701; Biffi R, 2014, ANN SURG ONCOL, V21, P3725, DOI 10.1245/s10434-014-3784-5; Biffi R, 2011, SUPPORT CARE CANCER, V19, P1573, DOI 10.1007/s00520-010-0984-9; Birch P, 2010, ARCH DIS CHILD FETAL; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Boersma RS, 2015, SUPPORT CARE CANCER, V23, P37, DOI 10.1007/s00520-014-2320-2; Bowers L, 2008, J INFUS MURS, V31, P22, DOI 10.1097/01.NAN.0000308542.90615.c2; Bowers N, 2013, J VASC SURG, V57, p59S, DOI 10.1016/j.jvs.2013.02.099; Bozzetti F, 2002, CLIN NUTR, V21, P475, DOI 10.1054/clnu.2002.0578; Bracho-Blanchet E, 2010, CIR CIR, V78, P422; Brandao LR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005982.pub2; Britt RC, 2009, AM J SURG, V197, P533, DOI 10.1016/j.amjsurg.2008.11.016; Broadhurst D, 2014, J VASC ACCESS, V15, P218; Bruzoni M, 2013, J AM COLL SURGEONS, V216, P939, DOI 10.1016/j.jamcollsurg.2013.01.054; Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4; Burlacu CL, 2011, J CLIN ANESTH, V23, P286, DOI 10.1016/j.jclinane.2010.12.007; Byon HJ, 2013, BRIT J ANAESTH, V111, P788, DOI 10.1093/bja/aet202; Camargo LFA, 2009, J HOSP INFECT, V72, P227, DOI 10.1016/j.jhin.2009.03.018; Campos F, 2009, CRIT CAR C 29 INT S, V13, pS79; Caparas Jona, 2014, Nursing, V44, P65, DOI 10.1097/01.NURSE.0000444725.83265.1d; Casey AL, 2007, J HOSP INFECT, V65, P212, DOI 10.1016/j.jhin.2006.09.029; Casey AL, 2012, J HOSP INFECT, V80, P299, DOI 10.1016/j.jhin.2012.01.005; Cesaro S, 2009, J CLIN ONCOL, V27, P2059, DOI 10.1200/JCO.2008.19.4860; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Daudt HML, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-48; Onofre PSD, 2012, PEDIATR CRIT CARE ME, V13, pE282, DOI 10.1097/PCC.0b013e318245597c; De Cicco M, 2009, ANN ONCOL, V20, P1936, DOI 10.1093/annonc/mdp235; Decembrino N, 2014, BONE MARROW TRANSPL, V49, pS467; Dettenkofer M, 2010, CLIN MICROBIOL INFEC, V16, P600, DOI 10.1111/j.1469-0691.2009.02917.x; Di Carlo I, 2011, SURG ONCOL, V20, P20, DOI 10.1016/j.suronc.2009.09.003; Douard MC, 2006, SUPPORT CARE CANCER, V14, P161, DOI 10.1007/s00520-005-0852-1; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Eisen Lewis A, 2006, J Intensive Care Med, V21, P40, DOI 10.1177/0885066605280884; Esteve F, 2007, J HOSP INFECT, V67, P30, DOI 10.1016/j.jhin.2007.05.021; Evans LV, 2010, ACAD MED, V85, P1462, DOI 10.1097/ACM.0b013e3181eac9a3; Ezaru CS, 2009, ANESTH ANALG, V109, P130, DOI 10.1213/ane.0b013e31818f87e9; Ezri T, 2007, J CARDIOTHOR VASC AN, V21, P497, DOI 10.1053/j.jvca.2006.05.011; Fallat ME, 1998, J PEDIATR SURG, V33, P1383, DOI 10.1016/S0022-3468(98)90013-6; Fan YY, 2013, CHINESE J CANC PREVE, V20, P1679; Feng BL, 2010, CHINESE J CLIN NUTR, V18, P87; Fenik Y, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-60; Chacon JMF, 2011, CHEMOTHERAPY, V57, P285, DOI 10.1159/000328976; Filippi L, 2007, PEDIATR CRIT CARE ME, V8, P556, DOI 10.1097/01.PCC.0000288711.46009.58; Fraenkel D, 2006, CRIT CARE MED, V34, P668, DOI 10.1097/01.CCM.0000201404.05523.34; Fragou M, 2011, CRIT CARE MED, V39, P1607, DOI 10.1097/CCM.0b013e318218a1ae; Pumarola CFI, 2007, ENFERM INTENSIV, V18, P25, DOI 10.1016/S1130-2399(07)74386-9; Gabrail N, 2010, J VASC INTERV RADIOL, V21, P1852, DOI 10.1016/j.jvir.2010.09.002; Galipeau J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0561-2; Garg AX, 2008, CLIN J AM SOC NEPHRO, V3, P253, DOI 10.2215/CJN.01430307; Garland JS, 2009, J PERINATOL, V29, P808, DOI 10.1038/jp.2009.161; Gebhard RE, 2007, ANESTH ANALG, V104, P65, DOI 10.1213/01.ane.0000250224.02440.fe; Glauser F, 2014, J VASC ACCESS, V15, P221; Goossens GA, 2008, SUPPORT CARE CANCER, V16, P1367, DOI 10.1007/s00520-008-0436-y; Goossens GA, 2013, ANN ONCOL, V24, P1892, DOI 10.1093/annonc/mdt114; Graf JM, 2006, JPEN-PARENTER ENTER, V30, P532, DOI 10.1177/0148607106030006532; Hagau N, 2009, EUR J ANAESTH, V26, P752, DOI 10.1097/EJA.0b013e32832a3a84; Handrup MM, 2013, PEDIATR BLOOD CANCER, V60, P1292, DOI 10.1002/pbc.24482; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Harron K, 2011, INTENS CARE MED, V37, P1641, DOI 10.1007/s00134-011-2343-9; Heden L, 2014, ACTA PAEDIATR, V103, P314, DOI 10.1111/apa.12509; Heden LE, 2011, EUR J PAIN, V15, P1056, DOI 10.1016/j.ejpain.2011.05.010; Hemels MAC, 2011, PEDIATR CRIT CARE ME, V12, P445, DOI 10.1097/PCC.0b013e3182070f5d; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hill ML, 2010, J PERINATOL, V30, P469, DOI 10.1038/jp.2009.190; Hitz F, 2012, ANN HEMATOL, V91, P613, DOI 10.1007/s00277-011-1343-8; Hockley Simon J G, 2007, Crit Care Resusc, V9, P251; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horne MK, 2006, PHARMACOTHERAPY, V26, P1262, DOI 10.1592/phco.26.9.1262; Hosseini MB, 2014, FEYZ J KASHAN U MED, V17, P561; Hu KK, 2004, CLIN INFECT DIS, V39, P1441, DOI 10.1086/425309; Ishikawa Y, 2010, ANN SURG, V251, P620, DOI 10.1097/SLA.0b013e3181d48a6a; Ishizuka M, 2011, HEPATO-GASTROENTEROL, V58, P1882, DOI 10.5754/hge09563; Islam M Tajul, 2009, Mymensingh Med J, V18, pS82; Itkin M, 2014, J VASC INTERV RADIOL, V25, P85, DOI 10.1016/j.jvir.2013.10.009; Fuentes MTI, 2008, ENFERM INTENSIV, V19, P35, DOI 10.1016/S1130-2399(08)72741-X; Jain K, 2010, ASIA PAC J CLIN ONCO, V6; Johansson E, 2009, SUPPORT CARE CANCER, V17, P137, DOI 10.1007/s00520-008-0449-6; Johnston AJ, 2012, J VASC ACCESS, V13, P421, DOI 10.5301/jva.5000071; Jun L, 2011, J NURSING SCI, V26, P7; Kalfon P, 2007, CRIT CARE MED, V35, P1032, DOI 10.1097/01.CCM.0000259378.53166.1B; Kang M, 2011, BRIT J ANAESTH, V106, P344, DOI 10.1093/bja/aeq340; Karakitsos D, 2007, ANESTHESIOLOGY, V107, P181, DOI 10.1097/01.anes.0000268280.02529.88; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Karanlik H, 2011, AM J SURG, V202, P10, DOI 10.1016/j.amjsurg.2010.05.005; Karpanen TJ, 2011, CLIN MICROBIOL INFEC, V17, pS326; Karthaus M, 2006, ANN ONCOL, V17, P289, DOI 10.1093/annonc/mdj059; Katheria AC, 2013, J PERINATOL, V33, P791, DOI 10.1038/jp.2013.58; Kaye Alan D., 2011, Middle East Journal of Anesthesiology, V21, P61; Khalidi N, 2009, JAVA, V14, P84, DOI DOI 10.2309/JAVA.14-2-6; Khouli H, 2011, CHEST, V139, P80, DOI 10.1378/chest.10-0979; Klek S, 2015, JPEN-PARENTER ENTER, V39, P331, DOI 10.1177/0148607114525804; Knebel P, 2009, BRIT J SURG, V96, P159, DOI 10.1002/bjs.6457; Knebel P, 2011, ANN SURG, V253, P1111, DOI 10.1097/SLA.0b013e318214ba21; Kocum A, 2011, J CARDIOTHOR VASC AN, V25, P1018, DOI 10.1053/j.jvca.2011.02.006; Konstantinou EA, 2013, J VASC ACCESS, V14, P373, DOI 10.5301/jva.5000160; Krikava I, 2011, CRIT CARE, V15, pS80; Kwakman PH, 2012, CRIT CARE, V16, DOI 10.1186/cc11849; Lago P, 2008, PEDIATR ANESTH, V18, P736, DOI 10.1111/j.1460-9592.2008.02636.x; Laiq N., 2015, J MED SCI, V23, P137; Lamkinsi T, 2012, ANN FR ANESTH, V31, P512, DOI 10.1016/j.annfar.2012.01.024; Latif RK, 2012, ANESTH ANALG, V114, P626, DOI 10.1213/ANE.0b013e3182405eb3; Lavau-Denes S, 2013, CANCER CHEMOTH PHARM, V72, P65, DOI 10.1007/s00280-013-2169-y; Lee JB, 2010, J INT MED RES, V38, P134, DOI 10.1177/147323001003800115; Lee J-H, 2009, BRIT J ANAESTH; Lee YH, 2015, CRIT CARE MED, V43, P2112, DOI 10.1097/CCM.0000000000001167; Lemyre B, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-11; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Li J, 2014, EUR J ONCOL NURS, V18, P94, DOI 10.1016/j.ejon.2013.08.003; Liang SY, 2011, ANN EMERG MED, V58, P447, DOI 10.1016/j.annemergmed.2011.07.035; Lim T, CRITICAL CARE MED, V20; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Lyons MG, 2014, J INFUS MURS, V37, P270, DOI 10.1097/NAN.0000000000000050; Maecken T, 2015, ANAESTHESIA, V70, P1242, DOI 10.1111/anae.13187; Marcatto JD, 2011, ARCH DIS CHILD-FETAL, V96, pF467, DOI 10.1136/adc.2011.215152; Marcy PY, 2014, J VASC ACCESS, V15, P206; Marmol MT, 2012, REV LAT-AM ENFERM, V20, P1134, DOI 10.1590/S0104-11692012000600016; Marsteller JA, 2012, CRIT CARE MED, V40, P2933, DOI 10.1097/CCM.0b013e31825fd4d8; Matzie KA, 2010, AM J RESP CRIT CARE, V181; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; McMullan C, 2013, JT COMM J QUAL PATIE, V39, P61, DOI 10.1016/S1553-7250(13)39009-6; Mer M, 2008, CLIN APPL THROMB HEM; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Merry AE, 2003, ANAESTH INTENS CARE, V31, P80, DOI 10.1177/0310057X0303100116; Miao JZ, 2014, CELL BIOCHEM BIOPHYS, V70, P559, DOI 10.1007/s12013-014-9956-x; Michel F, 2010, PEDIATR ANESTH, V20, P712, DOI 10.1111/j.1460-9592.2010.03334.x; Milling T, 2006, ACAD EMERG MED, V13, P245, DOI 10.1197/j.aem.2005.09.004; Mimoz O, 1996, CRIT CARE MED, V24, P1818, DOI 10.1097/00003246-199611000-00010; Mimoz O, 2007, ARCH INTERN MED, V167, P2066, DOI 10.1001/archinte.167.19.2066; Mimoz O, 2015, LANCET, V386, P2069, DOI 10.1016/S0140-6736(15)00244-5; Mitre CI, 2010, EUR J ANAESTH, V27, P300, DOI 10.1097/EJA.0b013e328333c2d6; Miyagaki H, 2012, CLIN NUTR, V31, P48, DOI 10.1016/j.clnu.2011.09.002; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moll S, 2006, J CLIN ONCOL, V24, P3056, DOI 10.1200/JCO.2006.05.8438; Muller MC, 2015, TRANSFUSION, V55, P26, DOI 10.1111/trf.12750; Niers TMH, 2007, J THROMB HAEMOST, V5, P1878, DOI 10.1111/j.1538-7836.2007.02660.x; Nocito A, 2009, BRIT J SURG, V96, P1129, DOI 10.1002/bjs.6730; Oh AY, 2014, BMC ANESTHESIOL, V14; Ong CK, 2010, J VASC INTERV RADIOL, V21, P1191, DOI 10.1016/j.jvir.2010.04.020; Osma S, 2006, J HOSP INFECT, V62, P156, DOI 10.1016/j.jhin.2005.06.030; Ovezov A, 2010, INTENSIVE CARE MED; Palepu Gopal B, 2009, Indian J Radiol Imaging, V19, P191, DOI 10.4103/0971-3026.54877; Panagiotounakou P, 2014, J PERINATOL, V34, P461, DOI 10.1038/jp.2014.36; Patel GS, 2014, SUPPORT CARE CANCER, V22, P121, DOI 10.1007/s00520-013-1941-1; Pawlik MT, 2006, ANASTH INTENSIV NOTF, V41, P79, DOI 10.1055/s-2005-870451; Pedrolo E, 2014, REV ENFERMAGEM UERJ, V22; Pedrolo E, 2014, REV LAT-AM ENFERM, V22, P764, DOI 10.1590/0104-1169.3443.2478; Pedrolo E, 2011, ACTA PAUL ENFERM, V24, P278, DOI 10.1590/S0103-21002011000200019; Perez-Parra A, 2011, J HOSP INFECT, V77, P309, DOI 10.1016/j.jhin.2010.11.021; Periard D, 2008, J THROMB HAEMOST, V6, P1281, DOI 10.1111/j.1538-7836.2008.03053.x; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Phipps K, 2012, J PERINATOL, V32, P498, DOI 10.1038/jp.2011.129; Pittiruti M, 2014, J VASC ACCESS, V15, P519, DOI 10.5301/jva.5000280; Poletti N, 2012, SCENARIO OFFICIAL IT, V29, P19; Pontes-Arruda A, 2012, JPEN-PARENTER ENTER, V36, P574, DOI 10.1177/0148607111427040; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rando K, 2014, HEART LUNG VESSEL, V6, P13; Rosen Jennifer, 2013, Adv Mind Body Med, V27, P12; Ruschulte H, 2009, ANN HEMATOL, V88, P267, DOI 10.1007/s00277-008-0568-7; Ruud E, 2006, ACTA PAEDIATR, V95, P1053, DOI 10.1080/08035250600729092; Samantaray A, 2014, INDIAN J CRIT CARE M, V18, P421, DOI 10.4103/0972-5229.136069; Sanders J, 2008, J ANTIMICROB CHEMOTH, V62, P809, DOI 10.1093/jac/dkn284; Schallom ME, 2012, CRIT CARE MED, V40, P1820, DOI 10.1097/CCM.0b013e31824e11b4; Schoot RA, 2015, EUR J CANCER, V51, P2031, DOI 10.1016/j.ejca.2015.06.126; Schroeder AR, 2010, PEDIATR CRIT CARE ME, V11, P489, DOI 10.1097/PCC.0b013e3181ce6e29; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schwebel C, 2012, CRIT CARE MED, V40, P11, DOI 10.1097/CCM.0b013e31822f0604; Schweickert WD, 2009, CRIT CARE MED, V37, P1217, DOI 10.1097/CCM.0b013e31819cee7f; SCOTT WL, 1988, CHEST, V94, P1221, DOI 10.1378/chest.94.6.1221; Shah PS, 2007, PEDIATRICS, V119, pE284, DOI 10.1542/peds.2006-0529; Shin SH, 2014, PEDIATR CRIT CARE ME, V15, P451, DOI 10.1097/PCC.0000000000000123; Slobbe L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010840; Smith CC, 2010, SIMUL HEALTHC, V5, P146, DOI 10.1097/SIH.0b013e3181dd9672; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Taddio A, 2006, JAMA-J AM MED ASSOC, V295, P793, DOI 10.1001/jama.295.7.793; Takashima M, 2015, VASCULAR ACCESS, V1, P10; Taylor JE, 2015, J MATERN-FETAL NEO M, V28, P1224, DOI 10.3109/14767058.2014.949663; Teichgraber Ulf Karl-Martin, 2009, Cardiovasc Intervent Radiol, V32, P975, DOI 10.1007/s00270-008-9477-3; Timsit J, 2005, ANN FR ANESTH REANIM; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Tricco AC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0465-6; Ullman AJ, 2015, PEDIATRICS, V136, pE1331, DOI 10.1542/peds.2015-1507; Uslu S, 2010, J PERINATOL, V30, P794, DOI 10.1038/jp.2010.46; Valles J, 2008, INFECT CONT HOSP EP, V29, P847, DOI 10.1086/590259; van den Hoogen A, 2006, J PERINAT MED, V34, P71, DOI 10.1515/JPM.2006.009; van Rooden CJ, 2008, J CLIN ONCOL, V26, P428, DOI 10.1200/JCO.2007.11.7754; Vandoni RE, 2009, SWISS MED WKLY, V139, P313, DOI smw-12523; Vickers Andrew J, 2006, J Soc Integr Oncol, V4, P194, DOI 10.2310/7200.2006.023; Vokurka S, 2009, MED SCI MONITOR, V15, pCR107; Walz JM, 2010, CRIT CARE MED, V38, P2095, DOI 10.1097/CCM.0b013e3181f265ba; Wang Jing, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P468, DOI 10.3760/cma.j.issn.2095-4352.2014.07.005; Wang YH, 2011, CHINESE J CLIN NUTR, V19, P124; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Worth LJ, 2014, J HOSP INFECT, V88, P48, DOI 10.1016/j.jhin.2014.06.007; [夏琛 Xia Chen], 2014, [中华临床营养杂志, Chinese Journal of Clinical Nutrition], V22, P187; Xiao Y, 2007, CRIT CARE MED, V35, P1302, DOI 10.1097/01.CCM.0000263457.81998.27; Yamamoto N, 2014, AM J INFECT CONTROL, V42, P574, DOI 10.1016/j.ajic.2013.12.023; Young AM, 2009, LANCET, V373, P567, DOI 10.1016/S0140-6736(09)60205-1	221	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174164	10.1371/journal.pone.0174164	http://dx.doi.org/10.1371/journal.pone.0174164			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323880	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000070
J	Chi, W; Gao, Y; Hu, Q; Guo, W; Li, DP				Chi, Wei; Gao, Yu; Hu, Qing; Guo, Wei; Li, Dapeng			Genome-wide analysis of brain and gonad transcripts reveals changes of key sex reversal-related genes expression and signaling pathways in three stages of Monopterus albus	PLOS ONE			English	Article							RICE FIELD EEL; DM-DOMAIN GENE; DIFFERENTIAL EXPRESSION; LUTEINIZING-HORMONE; ANGUILLA-ANGUILLA; GROWTH; CLONING; FISH; GONADOTROPIN; INSIGHTS	Background The natural sex reversal severely affects the sex ratio and thus decreases the productivity of the rice field eel (Monopterus albus). How to understand and manipulate this process is one of the major issues for the rice field eel stocking. So far the genomics and transcriptomics data available for this species are still scarce. Here we provide a comprehensive study of transcriptomes of brain and gonad tissue in three sex stages (female intersex and male) from the rice field eel to investigate changes in transcriptional level during the sex reversal process. Results Approximately 195 thousand unigenes were generated and over 44.4 thousand were functionally annotated. omparative study between stages provided multiple differentially expressed genes in brain and gonad tissue. Overall 4668 genes were found to be of unequal abundance between gonad tissues far more than that of the brain tissues (59 genes). These genes were enriched in several different signaling pathways. A number of 231 genes were found with different levels in gonad in each stage with several reproduction related genes included. A total of 19 candidate genes that could be most related to sex reversal were screened out part of these genes' expression patterns were validated by RT-qPCR. The expression of spef2,maats1,spag6 and dmc1 were abundant in testis but was barely detected in female while the 17 beta-hsd12, zpsbp3, gal3 and foxn5 were only expressed in ovary. Conclusion This study investigated the complex of brain and gonad transcriptomes in three sex stages of the rice field eel.Integrated analysis of different gene expression and changes in signalling pathways,such as PI3K-Akt pathway,provided crucial data for further study of sex transformation mechanisms.	[Chi, Wei; Gao, Yu; Hu, Qing; Guo, Wei; Li, Dapeng] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Chi, Wei; Gao, Yu; Hu, Qing; Guo, Wei; Li, Dapeng] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China	Huazhong Agricultural University	Li, DP (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China.; Li, DP (corresponding author), Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China.	ldp@mail.hzau.edu.cn		Gao, Yu/0000-0003-2887-2559	Fundamental Research Funds for the Central Universities [2014QC016]; Special Fund for Agro-scientific Research in the Public Interest [201003076]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the Fundamental Research Funds for the Central Universities (project number: 2014QC016) and Special Fund for Agro-scientific Research in the Public Interest (201003076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2016, ENDOCRINOLOGY, V157; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BULL JJ, 1979, SCIENCE, V206, P1186, DOI 10.1126/science.505003; BULL JJ, 1985, EXPERIENTIA, V41, P1285, DOI 10.1007/BF01952071; CHAN STH, 1967, J ZOOL, V152, P31; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crews D, 2009, SEMIN CELL DEV BIOL, V20, P251, DOI 10.1016/j.semcdb.2009.02.004; Das D, 2016, GEN COMP ENDOCRINOL; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FISHMAN J, 1981, J BIOL CHEM, V256, P4466; Gao Y, 2014, SEX DEV, V8, P387, DOI 10.1159/000369181; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grandi G, 2003, GEN COMP ENDOCR, V131, P66, DOI 10.1016/S0016-6480(02)00646-9; Holmgren K, 1996, J FISH BIOL, V49, P910, DOI 10.1111/j.1095-8649.1996.tb00089.x; Holmgren K, 1997, CAN J FISH AQUAT SCI, V54, P2775, DOI 10.1139/cjfas-54-12-2775; Hu Q, 2014, FISH PHYSIOL BIOCHEM, V40, P1721, DOI 10.1007/s10695-014-9962-3; Hurvitz A, 2005, GEN COMP ENDOCR, V140, P61, DOI 10.1016/j.ygcen.2004.09.019; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Kanda S, 2011, GEN COMP ENDOCR, V173, P253, DOI 10.1016/j.ygcen.2011.05.015; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kent J, 1996, DEVELOPMENT, V122, P2813; KEYES PL, 1969, SCIENCE, V164, P846, DOI 10.1126/science.164.3881.846; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Lee YH, 2001, J EXP ZOOL, V290, P715, DOI 10.1002/jez.1122; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu C. K., 1944, Sinensia, V15, P1; Liu JH, 2009, DECT2008: PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCE AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, VOL 5, P11; Liu JK, 1951, ACTA HYDROBIOL SINIC, V2, P85; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOUVET JP, 1975, ENDOCRINOLOGY, V96, P1179, DOI 10.1210/endo-96-5-1179; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Ostrer H, 2001, J APPL PHYSIOL, V91, P2384, DOI 10.1152/jappl.2001.91.5.2384; Pace MC, 2005, BIOL REPROD, V73, P988, DOI 10.1095/biolreprod.105.041400; Panda H, 2012, J CLIN ENDOCR METAB, V97, pE1316, DOI 10.1210/jc.2012-1018; Pandian TJ, 1995, AQUACULTURE, V138, P1, DOI 10.1016/0044-8486(95)01075-0; Poirier D, 2010, EXPERT OPIN THER PAT, V20, P1123, DOI 10.1517/13543776.2010.505604; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sansam CL, 2015, FEBS J, V282, P2431, DOI 10.1111/febs.13317; Senior AM, 2013, BIOL INVASIONS, V15, P1765, DOI 10.1007/s10530-013-0407-1; Shibahara Y, 2012, J PATHOL, V227, P357, DOI 10.1002/path.4019; Simoni M, 1999, ANN ENDOCRINOL-PARIS, V60, P102; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sironen A, 2011, BIOL REPROD, V85, P690, DOI 10.1095/biolreprod.111.091132; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Stelkens RB, 2010, MOL ECOL, V19, P627, DOI 10.1111/j.1365-294X.2010.04526.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teves ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107271; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Vihko P, 2004, MOL CELL ENDOCRINOL, V215, P83, DOI 10.1016/j.mce.2003.11.021; WALLACE RA, 1990, J ELECTRON MICR TECH, V16, P175, DOI 10.1002/jemt.1060160302; Wang R, 2003, BIOCHEM BIOPH RES CO, V303, P452, DOI 10.1016/S0006-291X(03)00361-9; Western PS, 1999, DEV DYNAM, V214, P171, DOI 10.1002/(SICI)1097-0177(199903)214:3<171::AID-AJA1>3.3.CO;2-J; Wu F., 2009, J HAZARD MATER, V1, P1, DOI DOI 10.1016/J.CBPA.2008.12.013; Xiao YM, 2010, J EXP ZOOL PART B, V314B, P242, DOI 10.1002/jez.b.21332; Ye JD, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201895; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Yu HS, 2003, BIOCHEM BIOPH RES CO, V307, P165, DOI 10.1016/S0006-291X(03)01137-9; Yu JH, 2008, BIOCHEM GENET, V46, P267, DOI 10.1007/s10528-008-9154-x; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Zhang SXL, 2003, FASEB J, V17, P1709, DOI 10.1096/fj.02-1111fje; Zhou F, 2010, J BIOL CHEM, V285, P37030, DOI 10.1074/jbc.M110.161968; Zhou RJ, 2002, GENET SEL EVOL, V34, P129, DOI [10.1051/gse:2001008, 10.1186/1297-9686-34-1-129]	70	30	31	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173974	10.1371/journal.pone.0173974	http://dx.doi.org/10.1371/journal.pone.0173974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319194	Green Published, gold			2022-12-27	WOS:000398945800039
J	Nguyen, HH; Varadi, M; Tompa, P; Pauwels, K				Hung Huy Nguyen; Varadi, Mihaly; Tompa, Peter; Pauwels, Kris			Affinity purification of human m-calpain through an intrinsically disordered inhibitor, calpastatin	PLOS ONE			English	Article							IMMOBILIZED PEPTIDE; ESCHERICHIA-COLI; EXPRESSION; CHROMATOGRAPHY; PREDICTION; MECHANISM	Calpains are calcium-activated proteases that have biomedical and biotechnological potential. Their activity is tightly regulated by their endogenous inhibitor, calpastatin that binds to the enzyme only in the presence of calcium. Conventional approaches to purify calpain comprise multiple chromatographic steps, and are labor-intensive, leading to low yields. Here we report a new purification procedure for the human m-calpain based on its reversible calcium-mediated interaction with the intrinsically disordered calpastatin. We exploit the specific binding properties of human calpastatin domain 1 (hCSD1) to physically capture human m-calpain from a complex biological mixture. The dissociation of the complex is mediated by chelating calcium, upon which heterodimeric calpain elutes while hCSD1 remains immobilized onto the stationary phase. This novel affinity-based purification was compared to the conventional multistep purification strategy and we find that it is robust, it yields a homogeneous preparation, it can be scaled up easily and it rests on a non-disruptive step that maintains close to physiological conditions that allow further biophysical and functional studies.	[Hung Huy Nguyen; Varadi, Mihaly; Tompa, Peter; Pauwels, Kris] VIB, Struct Biol Ctr, Brussels, Belgium; [Hung Huy Nguyen; Varadi, Mihaly; Tompa, Peter; Pauwels, Kris] Vrije Univ Brussel, SBB, Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Varadi, Mihaly] European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Cambridge, England	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; European Molecular Biology Laboratory (EMBL)	Pauwels, K (corresponding author), VIB, Struct Biol Ctr, Brussels, Belgium.; Pauwels, K (corresponding author), Vrije Univ Brussel, SBB, Brussels, Belgium.	krpauwel@vub.ac.be		Tompa, Peter/0000-0001-8042-9939; Varadi, Mihaly/0000-0002-3687-0839; Nguyen, Hung/0000-0002-1810-0144; Pauwels, Kris/0000-0002-7341-0890	Stichting Alzheimer Onderzoek [12017]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [1218713]	Stichting Alzheimer Onderzoek; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO)	This work was supported by a pilot grant of Stichting Alzheimer Onderzoek (P#12017) (http://www.alzh.org/) and Kris Pauwels received a long-term postdoctoral fellowship from Fonds voor Wetenschappelijk Onderzoek Vlaanderen (#1218713) - (http:\\www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagli J, 1996, EUR J BIOCHEM, V241, P948, DOI 10.1111/j.1432-1033.1996.00948.x; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cong JY, 2002, PROTEIN EXPRES PURIF, V25, P283, DOI 10.1016/S1046-5928(02)00010-4; Croall DE, 2000, METH MOL B, V144, P33; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; EDMUNDS T, 1991, BIOCHIM BIOPHYS ACTA, V1077, P197, DOI 10.1016/0167-4838(91)90059-9; Elce JS, 2000, METH MOL B, V144, P47; Elce JS, 1997, BIOCHEM J, V326, P31, DOI 10.1042/bj3260031; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Gautier A, 2015, SITE SPECIFIC PROTEI, DOI [DOI 10.1007/978-1-4939-2272-7, 10.1007/978-1-4939-2272-7]; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Hata S, 2012, J BIOCHEM, V151, P417, DOI 10.1093/jb/mvs002; Hitomi K, 1998, BIOCHEM BIOPH RES CO, V246, P681, DOI 10.1006/bbrc.1998.8686; KAPPRELL HP, 1989, J BIOL CHEM, V264, P17888; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Larsen AK, 2004, PROTEIN EXPRES PURIF, V33, P246, DOI 10.1016/j.pep.2003.10.005; MA H, 1994, J BIOL CHEM, V269, P24430; Masumoto H, 1998, J BIOCHEM, V124, P957, DOI 10.1093/oxfordjournals.jbchem.a022213; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Molinari M, 2000, METH MOL B, V144, P41; MOLINARI M, 1995, J BIOL CHEM, V270, P14576, DOI 10.1074/jbc.270.24.14576; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Varadi M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0592-2	31	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174125	10.1371/journal.pone.0174125	http://dx.doi.org/10.1371/journal.pone.0174125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319173	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800051
J	Li, YW; Liu, HF; Zeng, W; Wei, J				Li, Yanwei; Liu, Haifeng; Zeng, Wei; Wei, Jing			Edaravone protects against hyperosmolarity-induced oxidative stress and apoptosis in primary human corneal epithelial cells	PLOS ONE			English	Article							DRY EYE DISEASE; MITOCHONDRIA	An increase in the osmolarity of tears induced by excessive evaporation of the aqueous tear phase is a major pathological mechanism behind dry eye. Exposure of epithelial cells on the surface of the human eye to hyperosmolarity leads to oxidative stress, mitochondrial dysfunction, and apoptosis. Edaravone, a hydroxyl radical scavenging agent, is clinically used to reduce neuronal damage following ischemic stroke. In this study, we found that treatment with hyperosmotic media at 400 and 450 mOsM increased the levels of ROS and mitochondrial oxidative damage, which were ameliorated by edaravone treatment in a dose-dependent manner. We also found that edaravone could improve mitochondrial function in HCEpiCs by increasing the levels of ATP and mitochondrial membrane potential. MTT and LDH assays indicated that edaravone could attenuate hyperosmolarity-induced cell death. It was found that edaravone prevented apoptosis by decreasing the level of cleaved caspase-3, and attenuating the release of cytochrome C. Mechanistically, we found that edaravone augmented the expression of Nrf2 and its target genes, such as HO-1, GPx-1, and GCLC.	[Li, Yanwei; Wei, Jing] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Ophthalmol, Luoyang, Peoples R China; [Li, Yanwei; Zeng, Wei; Wei, Jing] Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China; [Liu, Haifeng] Xinxiang Med Univ, Affiliated Hosp 3, Dept Ophthalmol, Xinxiang, Peoples R China; [Zeng, Wei] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Luoyang, Peoples R China	Henan University of Science & Technology; Henan University of Science & Technology; Xinxiang Medical University; Henan University of Science & Technology	Li, YW (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Ophthalmol, Luoyang, Peoples R China.; Li, YW (corresponding author), Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China.	ywli539@163.com	li, yan/GTI-4638-2022		Henan University of Science and Technology [201307yk]	Henan University of Science and Technology	This project was supported by the doctoral research foundation of Henan University of Science and Technology (no. 201307yk). Dr. Y. Li acquired the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the doctoral research foundation of Henan University of Science and Technology (No. 201307yk).	Bai G, 2001, J NEUROSCI RES, V66, P981, DOI 10.1002/jnr.10056; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Bron AJ, 2009, OCUL SURF, V7, P78, DOI 10.1016/S1542-0124(12)70299-9; Choi IY, 2001, PROTECTION MANGANESE, V31, P155; Keum YS, 2000, PHARM RES, V20, P1351; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Li B, 2013, J MOL NEUROSCI, V51, P539, DOI 10.1007/s12031-013-0022-8; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li Q, 2014, ENVIRON TOXICOL, V31, P372; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; Peecoaolldo N, 2000, AGING EYE ROLE L CAM, V9, P3; Png E, 2006, J CELL PHYSL, V226, P693; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Shokrzadeh M, 2014, IRAN J PHARM RES, V13, P675; Smith JA, 2007, OCUL SURF, V5, P93; Toyoda K, 2004, J NEUROL SCI, V221, P11, DOI 10.1016/j.jns.2004.03.002; Uchino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045805; Watanabe T, 2004, J PHARMACOL EXP THER, V268, P1597; Xi H, 2007, ATHEROSCLEROSIS, V191, P281, DOI 10.1016/j.atherosclerosis.2006.05.040; Zheng Q, 2012, EXP EYE RES, V125, P1	21	31	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174437	10.1371/journal.pone.0174437	http://dx.doi.org/10.1371/journal.pone.0174437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346481	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300047
J	Peco, B; Rivera, D; Garcia-Palacios, P; Jauregui, BM				Peco, Begona; Rivera, Desiree; Garcia-Palacios, Pablo; Jauregui, Berta M.			Is manure an alternative to topsoil in road embankment restoration?	PLOS ONE			English	Article							SOIL PHYSICAL-PROPERTIES; ORGANIC-MATTER; MICROBIAL ACTIVITY; VEGETATION ESTABLISHMENT; MOTORWAY SLOPES; MINE TAILINGS; SEED SOURCE; REVEGETATION; RESPIRATION; EROSION	One of the main steps in road and railway embankment restoration is the spreading of previously removed topsoil, which provides an input of seeds, organic matter and microorganisms and encourages the establishment of a vegetation cover, essential to stabilise the embankment and blend it with the landscape. However, topsoil is a scarce resource, prompting the search for economic alternatives with similar results. The present study compares the results of spreading topsoil with an organic amendment (manure) for the soil's physico-chemical properties, erosion resistance and microbial activity, floristic richness and composition, and bare soil cover. For this purpose, experimental plots with three treatments (Control, Topsoil and Manure) were maintained on a recently built embankment in Central Spain for 20 months. Manure was found to be an effective alternative to topsoil for the improvement of soil fertility (organic matter content and total nitrogen). The two types of organic amendment produced similar reductions in bare soil cover and erosion rates. However, plots with topsoil showed greater soil respiration and species richness and a different floristic composition in comparison to those treated with manure, which was closer to control plots. These results suggest that manure can be used to replace topsoil to enhance embankment stability during the early stages of restoration. However, if the aim of the restoration process is to promote plant diversity, topsoil is recommended.	[Peco, Begona; Rivera, Desiree] Univ Autonoma Madrid, Dept Ecol, Madrid, Spain; [Garcia-Palacios, Pablo] Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Madrid, Spain; [Jauregui, Berta M.] Obrascon Huarte Lain SA OHL, Direcc Tecn, Madrid, Spain	Autonomous University of Madrid; Universidad Rey Juan Carlos	Peco, B (corresponding author), Univ Autonoma Madrid, Dept Ecol, Madrid, Spain.	begonna.peco@uam.es	Peco, Begoña/C-1197-2012; García-Palacios, Pablo/K-7567-2014	Peco, Begoña/0000-0003-2149-1438; García-Palacios, Pablo/0000-0002-6367-4761	Ministry of Science and Innovation Centre for Industrial and Technology Development (CDTI); Madrid Regional Government grants for research groups, REMEDINAL 2 from the Spanish Ministry of Science and Innovation [S-2009/AMB/783]; Madrid Regional Government grants for research groups, REMEDINAL 3 from the Spanish Ministry of Science and Innovation [P2013-MAE2719]; Ministry of Science and Innovation	Ministry of Science and Innovation Centre for Industrial and Technology Development (CDTI); Madrid Regional Government grants for research groups, REMEDINAL 2 from the Spanish Ministry of Science and Innovation; Madrid Regional Government grants for research groups, REMEDINAL 3 from the Spanish Ministry of Science and Innovation; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This paper is part of a broader industrial research project, CENIT-OASIS (Safe, Intelligent and Sustainable Highway Operation), approved under CENIT tender 2008-2011, and was a collaboration between Obrascon Huarte Lain S.A. Corporation (OHL) and the Ecology Department of the Autonoma University of Madrid. Grants were received from the Ministry of Science and Innovation Centre for Industrial and Technology Development (CDTI). The project is jointly funded by Madrid Regional Government grants for research groups, REMEDINAL 2 (S-2009/AMB/783) and REMEDINAL 3 (P2013-MAE2719) from the Spanish Ministry of Science and Innovation, and assistance from the Torres Quevedo Sub-programme for the employment of Dr. Berta Martinez Jauregui by OHL, under the auspices of the Ministry of Science and Innovation.	Andres P, 2000, RESTOR ECOL, V8, P268, DOI 10.1046/j.1526-100x.2000.80038.x; Araujo ASF, 2008, EUR J SOIL BIOL, V44, P225, DOI 10.1016/j.ejsobi.2007.06.001; Arnaez J, 1995, PHYS CHEM EARTH, V20, P395, DOI 10.1016/0079-1946(95)00053-4; Baker LR, 2011, APPL SOIL ECOL, V48, P1, DOI 10.1016/j.apsoil.2011.02.007; Balaguer L, 2002, ECOSISTEMAS, V11, P72; Barzegar AR, 2002, PLANT SOIL, V247, P295, DOI 10.1023/A:1021561628045; Benik SR, 2003, J SOIL WATER CONSERV, V58, P98; Berg B, 1986, SCAND J FOREST RES, V1, P359, DOI 10.1080/02827588609382428; Bochet E, 2004, RESTOR ECOL, V12, P166, DOI 10.1111/j.1061-2971.2004.0325.x; Bochet E, 2010, RESTOR ECOL, V18, P656, DOI 10.1111/j.1526-100X.2008.00496.x; Bote D., 2005, MONTES, V80, P19; Bowen CK, 2005, ARID LAND RES MANAG, V19, P267, DOI 10.1080/15324980590951441; Burton CH, 2003, EDITIONS QUAE; Castillo-Monroy AP, 2010, THESIS; Chiu KK, 2006, BIORESOURCE TECHNOL, V97, P158, DOI 10.1016/j.biortech.2005.01.038; Clemente R, 2006, ENVIRON POLLUT, V143, P397, DOI 10.1016/j.envpol.2005.12.011; Cottenie A., 1975, Pedologie, V25, P134; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Day P.R., 1965, METHODS SOIL ANAL 1, P545, DOI DOI 10.2134/AGRONMONOGR9.1.C43; Dellaguardia CS, 2010, MANAGEMENT USES ENV; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; EKWUE EI, 1992, SOIL TILL RES, V22, P199, DOI 10.1016/0167-1987(92)90037-C; EnrIquez A, 2004, INGENIERIA CIVIL, V134, P27; European Union (EU), 2011, EU TRANSP FIG STAT P; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Garcia-Fayos P, 2000, J VEG SCI, V11, P77, DOI 10.2307/3236778; Garcia-Palacios P, 2011, ECOL APPL, V21, P2806, DOI 10.1890/11-0204.1; Garcia-Palacios P, 2011, SOIL BIOL BIOCHEM, V43, P1245, DOI 10.1016/j.soilbio.2011.02.014; Garcia-Palacios P, 2010, ECOL ENG, V36, P1290, DOI 10.1016/j.ecoleng.2010.06.005; Gonzalez-Alday J, 2009, ECOL ENG, V35, P1062, DOI 10.1016/j.ecoleng.2009.03.007; Hall SL, 2010, RESTOR ECOL, V18, P834, DOI 10.1111/j.1526-100X.2008.00509.x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Holl KD, 2002, J APPL ECOL, V39, P960, DOI 10.1046/j.1365-2664.2002.00767.x; Holmes PM, 2001, RESTOR ECOL, V9, P71, DOI 10.1046/j.1526-100x.2001.009001071.x; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Jacinthe PA, 2002, SOIL TILL RES, V67, P147, DOI 10.1016/S0167-1987(02)00058-2; Jimenez MD, 2011, LAND DEGRAD DEV; Jochimsen ME, 2001, ECOL ENG, V17, P187, DOI 10.1016/S0925-8574(00)00158-0; King JA, 2002, COMMUN SOIL SCI PLAN, V33, P403, DOI 10.1081/CSS-120002753; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Leps J, 2003, MULTIVARIATE ANAL EC; Litton CM, 2003, GLOBAL CHANGE BIOL, V9, P680, DOI 10.1046/j.1365-2486.2003.00626.x; Martinez-Alonso C, 2002, ECOLOGIA, V16, P59; Matesanz S, 2006, RESTOR ECOL, V14, P297, DOI 10.1111/j.1526-100X.2006.00132.x; Mitchell DJ, 2003, SOIL USE MANAGE, V19, P182, DOI 10.1079/SUM2002165; Mola I, 2011, RESTOR ECOL, V19, P83, DOI 10.1111/j.1526-100X.2009.00547.x; Moral R, 2005, BIORESOURCE TECHNOL, V96, P153, DOI 10.1016/j.biortech.2004.05.003; Nicolau JM, 2002, HYDROL PROCESS, V16, P631, DOI 10.1002/hyp.308; Pascual JA, 1997, BIOL FERT SOILS, V24, P429, DOI 10.1007/s003740050268; Patzelt A, 2001, RESTOR ECOL, V9, P127, DOI 10.1046/j.1526-100x.2001.009002127.x; Petersen SL, 2004, RESTOR ECOL, V12, P248, DOI 10.1111/j.1061-2971.2004.00321.x; Prosdocimi M, 2016, CATENA, V141, P1, DOI 10.1016/j.catena.2016.02.010; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; REDENTE EF, 1984, RECLAM REVEG RES, V3, P153; Richards LA, 1954, DIAGNOSIS IMPROVEMEN, P109; Rickson RJ, 2006, EARTH SURF PROC LAND, V31, P550, DOI 10.1002/esp.1368; Rivera D, 2012, THESIS; Rokich DP, 2000, RESTOR ECOL, V8, P196, DOI 10.1046/j.1526-100x.2000.80027.x; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Ruser R, 2006, SOIL BIOL BIOCH; SCHNURER J, 1985, SOIL BIOL BIOCHEM, V17, P611, DOI 10.1016/0038-0717(85)90036-7; Scoles SJ, 2003, LAKE MEAD NATL RECRE; Smilauer P, 1993, CANODRAW 3 0; Stafford RF, 1982, TRANSPORTATION RES B, V859, P19; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tormo J, 2007, RESTOR ECOL, V15, P97, DOI 10.1111/j.1526-100X.2006.00194.x; Traba J, 2003, RESTOR ECOL, V11, P378, DOI 10.1046/j.1526-100X.2003.00227.x; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; VISSER S, 1984, PLANT SOIL, V82, P41, DOI 10.1007/BF02220768; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Ye ZH, 2000, RESTOR ECOL, V8, P289, DOI 10.1046/j.1526-100x.2000.80041.x; Zhang ZQ, 2001, RESTOR ECOL, V9, P378, DOI 10.1046/j.1526-100X.2001.94007.x; Zhen Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108555	77	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174622	10.1371/journal.pone.0174622	http://dx.doi.org/10.1371/journal.pone.0174622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346511	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300062
J	Saito, Y; Sugimoto, C; Mituyama, T; Wakao, H				Saito, Yutaka; Sugimoto, Chie; Mituyama, Toutai; Wakao, Hiroshi			Epigenetic silencing of V(D)J recombination is a major determinant for selective differentiation of mucosal-associated invariant t cells from induced pluripotent stem cells	PLOS ONE			English	Article							EXPRESSION; INDUCTION	Mucosal-associated invariant T cells (MAITs) are innate-like T cells that play a pivotal role in the host defense against infectious diseases, and are also implicated in autoimmune diseases, metabolic diseases, and cancer. Recent studies have shown that induced pluripotent stem cells (iPSCs) derived from MAITs selectively redifferentiate into MAITs without altering their antigen specificity. Such a selective differentiation is a prerequisite for the use of MAITs in cell therapy and/or regenerative medicine. However, the molecular mechanisms underlying this phenomenon remain unclear. Here, we performed methylome and transcriptome analyses of MAITs during the course of differentiation from iPSCs. Our multi-omics analyses revealed that recombination-activating genes (RAG1 and RAG2) and DNA nucleotidylexotransferase (DNTT) were highly methylated with their expression being repressed throughout differentiation. Since these genes are essential for V(D) J recombination of the T cell receptor (TCR) locus, this indicates that nascent MAITs are kept from further rearrangement that may alter their antigen specificity. Importantly, we found that the repression of RAGs was assured in two layers: one by the modulation of transcription factors for RAGs, and the other by DNA methylation at the RAG loci. Together, our study provides a possible explanation for the unaltered antigen specificity in the selective differentiation of MAITs from iPSCs.	[Saito, Yutaka; Mituyama, Toutai] Natl Inst Adv Ind Sci & Technol, Artificial Intelligence Res Ctr, Koto Ku, Tokyo, Japan; [Saito, Yutaka] Natl Inst Adv Ind Sci & Technol, Computat Bio Big Data Open Innovat Lab CBBD OIL, Shinjuku Ku, Tokyo, Japan; [Saito, Yutaka; Mituyama, Toutai] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Sugimoto, Chie; Wakao, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido, Japan; [Wakao, Hiroshi] Dokkyo Med Univ, Int Epidemiol, Mibu, Tochigi, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Hokkaido University; Dokkyo Medical University	Wakao, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido, Japan.; Wakao, H (corresponding author), Dokkyo Med Univ, Int Epidemiol, Mibu, Tochigi, Japan.	hwakao@dokkyomed.ac.jp	Saito, Yutaka/A-9895-2017; Mituyama, Toutai/A-5610-2017	Saito, Yutaka/0000-0002-4853-0153; Mituyama, Toutai/0000-0002-1110-6375	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [15K16089]; JSPS [26430084]; Asubio Pharma Co., LTD; Grants-in-Aid for Scientific Research [15K16089] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asubio Pharma Co., LTD; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST; http://www.jst.go.jp/EN/index.html) to TM and YS; a Grant-in-Aid for Young Scientists (B) (15K16089) from the Japan Society for the Promotion of Science (JSPS; http://www. jsps.go.jp/english/index.html) to YS; and a Grant-in-Aid for Scientific Research (C) (26430084) from JSPS to CS and HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HW receives are search fund from Asubio Pharma Co., LTD for the data collection of DNA methylation in reMAITs. However, the funder had no role in data analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Hauser J, 2014, J IMMUNOL, V192, P2460, DOI 10.4049/jimmunol.1302216; Hauser J, 2010, MOL IMMUNOL, V47, P1031, DOI 10.1016/j.molimm.2009.11.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson K, 2010, ESSAYS BIOCHEM, V48, P221, DOI [10.1042/BSE0480221, 10.1042/bse0480221]; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Kurioka A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.51; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sugimoto C, 2016, WORLD J STEM CELLS, V8, P158, DOI 10.4252/wjsc.v8.i4.158; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174699	10.1371/journal.pone.0174699	http://dx.doi.org/10.1371/journal.pone.0174699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346544	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300071
J	Schock, EN; Struve, JN; Chang, CF; Williams, TJ; Snedeker, J; Attia, AC; Stottmann, RW; Brugmann, SA				Schock, Elizabeth N.; Struve, Jaime N.; Chang, Ching-Fang; Williams, Trevor J.; Snedeker, John; Attia, Aria C.; Stottmann, Rolf W.; Brugmann, Samantha A.			A tissue-specific role for intraflagellar transport genes during craniofacial development	PLOS ONE			English	Article							PRIMARY CILIUM; NEURAL CREST; SONIC HEDGEHOG; KINESIN-II; REPRESSOR FUNCTIONS; SIGNALING CENTER; MOUSE; CILIARY; DISEASE; ECTODERM	Primary cilia are nearly ubiquitous, cellular projections that function to transduce molecular signals during development. Loss of functional primary cilia has a particularly profound effect on the developing craniofacial complex, causing several anomalies including craniosynostosis, micrognathia, midfacial dysplasia, cleft lip/palate and oral/dental defects. Development of the craniofacial complex is an intricate process that requires interactions between several different tissues including neural crest cells, neuroectoderm and surface ectoderm. To understand the tissue -specific requirements for primary cilia during craniofacial development we conditionally deleted three separate intraflagellar transport genes, Kif3a, 1ft88 and Ttc2lb with three distinct drivers, Wntl-Cre, Crectand AP2-Cre which drive recombination in neural crest, surface ectoderm alone, and neural crest, surface ectoderm and neuroectoderm, respectively. We found that tissue -specific conditional loss of ciliary genes with different functions produces profoundly different facial phenotypes. Furthermore, analysis of basic cellular behaviors in these mutants suggests that loss of primary cilia in a distinct tissue has unique effects on development of adjacent tissues. Together, these data suggest specific spatiotemporal roles for intraflagellar transport genes and the primary cilium during craniofacial development.	[Schock, Elizabeth N.; Struve, Jaime N.; Chang, Ching-Fang; Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Dept Surg, Div Plast Surg, Cincinnati, OH 45229 USA; [Schock, Elizabeth N.; Struve, Jaime N.; Chang, Ching-Fang; Stottmann, Rolf W.; Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Dept Pediat, Cincinnati, OH 45229 USA; [Williams, Trevor J.] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO USA; [Snedeker, John; Attia, Aria C.; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center	Brugmann, SA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Surg, Div Plast Surg, Cincinnati, OH 45229 USA.; Brugmann, SA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Dept Pediat, Cincinnati, OH 45229 USA.	samantha.brugmann@cchmc.org	Stottmann, Rolf/U-6589-2019; Stottmann, Rolf/GRO-3453-2022	Stottmann, Rolf/0000-0003-4512-6806; Schock, Elizabeth/0000-0002-3970-799X; Chang, Ching-Fang/0000-0001-6754-2769	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) [RO1DE023804, F31DE025537, 1R01 DE019843, RO1GM112744]; March of Dimes Foundation [5-FY13-194]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE025537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) grant RO1DE023804 (SAB), F31DE025537 (ENS), 1R01 DE019843 (TJW), and from RO1GM112744 and March of Dimes Foundation 5-FY13-194 (RWS).	Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Brugmann SA, 2006, CURR TOP DEV BIOL, V73, P1, DOI 10.1016/S0070-2153(05)73001-5; Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chang CF, 2016, PLOS GENETI IN PRESS; Chang CF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006351; Chang CF, 2015, CURR TOP DEV BIOL, V111, P97, DOI 10.1016/bs.ctdb.2014.11.004; Chang CF, 2014, DEVELOPMENT, V141, P3003, DOI 10.1242/dev.105924; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Falk N, 2015, CELLS-BASEL, V4, P500, DOI 10.3390/cells4030500; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hu D, 1999, DEVELOPMENT, V126, P4873; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Hu D, 2012, DEV DYNAM, V241, P732, DOI 10.1002/dvdy.23764; Hu D, 2009, DEV BIOL, V325, P200, DOI 10.1016/j.ydbio.2008.10.026; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Irigoin F, 2011, CURR GENOMICS, V12, P285, DOI 10.2174/138920211795860134; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Marcucio R., 2002, SHH DEPENDENT UNPUB; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Marszalek JR, 2000, BBA-MOL CELL RES, V1496, P142, DOI 10.1016/S0167-4889(00)00015-X; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mourao A, 2016, CURR OPIN STRUC BIOL, V41, P98, DOI 10.1016/j.sbi.2016.06.009; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Reid BS, 2011, DEV BIOL, V349, P261, DOI 10.1016/j.ydbio.2010.11.012; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sasai N, 2012, WIRES DEV BIOL, V1, P753, DOI 10.1002/wdev.43; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schock EN, 2015, DIS MODEL MECH, V8, P855, DOI 10.1242/dmm.020222; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Szabo-Rogers HL, 2009, DEVELOPMENT, V136, P219, DOI 10.1242/dev.023978; Tabler JM, 2013, DEV CELL, V25, P623, DOI 10.1016/j.devcel.2013.05.021; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tran PV, 2014, J AM SOC NEPHROL, V25, P2201, DOI 10.1681/ASN.2013070735; Vasudevan HN, 2014, DEV CELL, V31, P332, DOI 10.1016/j.devcel.2014.10.005; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Willaredt Marc August, 2012, Cilia, V1, P23, DOI 10.1186/2046-2530-1-23; Zaghloul NA, 2011, GENESIS, V49, P231, DOI 10.1002/dvg.20728; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]	62	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174206	10.1371/journal.pone.0174206	http://dx.doi.org/10.1371/journal.pone.0174206			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346501	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300029
J	Kitreerawutiwong, N; Jordan, S; Hughes, D				Kitreerawutiwong, Nithra; Jordan, Sue; Hughes, David			Facility type and primary care performance in sub-district health promotion hospitals in Northern Thailand	PLOS ONE			English	Article							SOUTH-KOREA; EXPERIENCES; QUALITY; SYSTEMS; CENTERS	Background Poor and middle-income Thai people rely heavily on primary care health services. These are staffed by a range of professionals. However, it is unknown whether the performance of primary care varies according to the staffing and organization of local service delivery units. Tambon (sub-district) health promotion hospitals (THPHs) were introduced in 2009 to upgrade the services offered by the previous health centres, but were faced with continuing shortages of doctors and nurses. The Ministry of Public Health (MoPH) designated three categories of THPH, defined according to whether they were regularly staffed by a medical practitioner, a qualified nurse or non-clinical public health officers. This study aimed to compare the performance of primary care offered by the three different types of primary care facilities in one public health region of Northern Thailand (Public Health Region 2). Methods A cross-sectional survey was undertaken in 2013. Data were collected on accessibility, continuity, comprehensiveness, co-ordination and community orientation of care from 825 patients attending 23 primary care facilities. These were selected to include the three officially-designated types of Tambon (sub-district) health promotion hospitals (THPHs) led by medical, nursing or public health personnel. Survey scores were compared in unadjusted and adjusted analyses. Results THPHs staffed only by public health officers achieved the highest performance score (Mean = 85.14, SD. = 7.30), followed by THPHs staffed by qualified nurses (Mean = 82.86, SD. = 7.06). THPHs staffed by a doctor on rotation returned the lowest scores (Mean = 81.63, SD. = 7.22). Conclusions Differences in overall scores resulted mainly from differences in reported accessibility, continuity, and comprehensiveness of care, rather than staff skill-mix per se. Policy on quality improvement should therefore focus on improving performance in these areas.	[Kitreerawutiwong, Nithra] Naresuan Univ, Fac Publ Hlth, Phitsanulok, Thailand; [Jordan, Sue; Hughes, David] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales	Naresuan University; Swansea University	Kitreerawutiwong, N (corresponding author), Naresuan Univ, Fac Publ Hlth, Phitsanulok, Thailand.	nithrakm@gmail.com	jordan, sue/O-1297-2019	jordan, sue/0000-0002-5691-2987; Hughes, David/0000-0002-7631-7763	Naresuan University	Naresuan University	This study was funded by Naresuan University.	[Anonymous], 2008, PRIM HLTH CAR NOW MO; Arah OA, 2003, INT J QUAL HEALTH C, V15, P377, DOI 10.1093/intqhc/mzg049; Bower Peter, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P551, DOI 10.1586/14737167.3.5.551; Bureau of Primary Care Development Coordination, 2009, THEM DEV TAMB HLTH P; Crampton P, 2005, INT J HEALTH SERV, V35, P465, DOI 10.2190/K6KV-K8EL-C7N9-J2AU; Damrongplasit K, 2009, HEALTH AFFAIR, V28, pW457, DOI 10.1377/hlthaff.28.3.w457; Donaldson M, 1996, PRIMARY CARE AM HLTH; Eibner C, 2009, CONTROLLING HLTH CAR; Hughes D, 2010, SOC SCI MED, V70, P447, DOI 10.1016/j.socscimed.2009.10.031; IBM Corp, IBM SPSS STAT WIND V; Institute of Medicine, 2010, ADV HLTH; Intaranongpai S, 2012, INT J HEALTH PLAN M, V27, P308, DOI 10.1002/hpm.2113; Jaturapatporn D, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-14; Kitreerawutiwong N, ASIA PACIFIC J PUBLI, V22, P289; Kravet SJ, 2008, AM J MED, V121, P142, DOI 10.1016/j.amjmed.2007.10.021; Lee JH, 2007, FAM MED, V39, P425; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Macinko J, 2009, J AMBUL CARE MANAG, V32, P150, DOI 10.1097/JAC.0b013e3181994221; [Ministry of Public Health Thailand Bureau of Primary Care Development Coordination], 2010, BUR PRIM CAR DEV COO; Nanyonjo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079943; Nitayarumphong S, 2005, ANNEX 8 ACHIEVING UN; Norman G., 2014, BIOSTATISTICS BARE E, V4; Office of Tambol Health Promotion Hospital, 2010, DAT PRIM CAR UN HLTH; Pagaiya N, 2007, RES REPORT SATISFACT; Pagaiya N, 2012, ASSESSMENT THAI UNIV; Pagaiya N., 2009, THAILANDS HLTH WORKF; Patcharanarumol P, 2011, WHY DID THAILAND ACH; Patcharanarumol W, 2014, UNIVERSAL HLTH COVER; Pongsupap Y, 2012, ASSESSMENT THAI UNIV; Rice Thomas, 2010, Mod Healthc, V40, P17; Rosenthal EG, 1996, MED CARE, V35, P58; Shi LY, 2007, J AMBUL CARE MANAG, V30, P159, DOI 10.1097/01.JAC.0000264606.50123.6d; Shi LY, 2003, SOUTH MED J, V96, P787, DOI 10.1097/01.SMJ.0000066811.53167.2E; Srithamrongsawat S, 2009, REPORT FINANCIAL SIT; Starfield B, 2002, HEALTH POLICY, V60, P201, DOI 10.1016/S0168-8510(01)00208-1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 1998, PRIMARY CARE BALANCI; Sung NJ, 2010, INT J QUAL HEALTH C, V22, P493, DOI 10.1093/intqhc/mzq053; Supawong C, 2009, MANUAL PROVIDING PRI; Thoresen SH, 2011, HEALTH POLICY, V99, P17, DOI 10.1016/j.healthpol.2010.07.010; Tollman S, 2006, PRIMARY HLTH CARE KE; Tsai J, 2010, J AM BOARD FAM MED, V23, P402, DOI 10.3122/jabfm.2010.03.090222; Wang HHX, 2013, ANN FAM MED, V11, P517, DOI 10.1370/afm.1545; Wayne WD, 2014, BIOSTATISTICS FDN AN; Wei XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121269; Wibulpolprasert, 2010, THAILAND HLTH PROFIL; Wibulpolprasert S, 2003, HUMAN RESOURCES HLTH, V1, P1; Wibulpolprasert Suwit, 2003, Hum Resour Health, V1, P12, DOI 10.1186/1478-4491-1-12; Wong SYS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-397; World Health Organization, 2007, REN PRIM HLTH CAR AM; World Health Organization (WHO), 1978, ALM AT DECL, V1	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174055	10.1371/journal.pone.0174055	http://dx.doi.org/10.1371/journal.pone.0174055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9AZ	28339494	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700020
J	Fan, L; Shen, HB; Huang, HC; Yang, R; Yao, L				Fan, Lin; Shen, Hongbo; Huang, Huichang; Yang, Rui; Yao, Lan			Impairment of Wnt/beta-catenin signaling in blood cells of patients with severe cavitary pulmonary tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; LUNG-CANCER; STEM-CELLS; WNT; PATHWAY; PROLIFERATION; EXPRESSION; RESPONSES; SURVIVAL	Tuberculosis (TB) remains as a leading infectious disease worldwide. Our previous study showed interferon (IFN)-gamma and CD3 T cell impairment in patients with severe cavitary pulmonary TB (PTB). However, the cause of the change in immune responses during the progression of TB is still poorly understood. In this study, eight newly diagnosed patients with severe cavitary and mild lesion non-cavity PTB were recruited, and three healthy volunteers were recruited as the control. RNA extracted from blood was tested by whole genome oligo microarrays. A PCR array was used to further test the same samples. Two additional groups of patients were recruited according to the same criteria with healthy control(HC) recruited as well and subjected to peripheral blood mononuclear cell isolation (PBMC) and analysis of TCF-7, alpha-catenin, cyclin D2, IFN-gamma, and tumor necrosis factor (TNF)-alpha expression in CD14-cells (lymphocytes) and CD14+ cells by quantitative PCR. The changes of expression of beta-catenin, CD69+ and IFN-gamma by CD3+, CD14- and CD14+ cells in vitro with stimulation of LiCl were tested by flow cytometry. Whole genome oligo microarrays showed a significant decrease in expression of the Wnt signaling pathway in severe PTB patients. Further analysis of the Wnt pathway by PCR array indicated that TCF-7, beta-catenin, and cyclin D2 expression was significantly reduced in severe PTB patients compared with mild PTB patients. In the additionally recruited patients, TCF-7, beta-catenin, and cyclin D2 were expressed in both CD14+ and CD14- cells, while beta-catenin was decreased significantly in CD14-cells compared with CD14+ cells in severe PTB patients, and IFN-gamma and TNF-alpha expression in CD14-cells was also reduced significantly in severe PTB patients. beta-catenin can directly trigger T cell activation and IFN-gamma secretion in PBMCs stimulated for 24 hours. These findings indicate that Wnt pathway and its key genes, such as beta-catenin, were impaired in blood cells of patients with severe PTB. Therefore, Wnt/beta-catenin pathway is closely associated with T cell proliferation and TB lesion deterioration.	[Fan, Lin; Yao, Lan] Tongji Univ, Sch Med, Clin & Res Ctr TB, Shanghai Key Lab TB,Shanghai Pulm Hosp, Shanghai, Peoples R China; [Shen, Hongbo; Huang, Huichang; Yang, Rui] Chinese Acad Sci, Unit AntiTB Immun, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Fan, L (corresponding author), Tongji Univ, Sch Med, Clin & Res Ctr TB, Shanghai Key Lab TB,Shanghai Pulm Hosp, Shanghai, Peoples R China.; Shen, HB (corresponding author), Chinese Acad Sci, Unit AntiTB Immun, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	fanlinsj@163.com; hbshen@ips.ac.cn	Yang, Rui/AAC-6246-2022	Yang, Rui/0000-0001-7679-9646; Fan, Lin/0000-0002-9411-496X	National Basic Research Program of China (973 Program) [2012CB518706]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the National Basic Research Program of China (973 Program), number: 2012CB518706.	Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui JJ, 2012, CURR PHARM DESIGN, V18, P2464, DOI 10.2174/13816128112092464; Dosen G, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-13; Fan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127087; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042716; Goodridge A, 2012, TUBERCULOSIS, V92, P243, DOI 10.1016/j.tube.2012.02.004; Hu X, 2014, PLOS ONE; Kim ES, 2013, TUBERCULOSIS, V93, P222, DOI 10.1016/j.tube.2012.10.014; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Schaale K, 2013, J IMMUNOL, V191, P5182, DOI 10.4049/jimmunol.1201819; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Song XW, 2015, ONCOTARGET, V6, P35579, DOI 10.18632/oncotarget.5758; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Suryawanshi A, 2015, J IMMUNOL, V194, P3295, DOI 10.4049/jimmunol.1402691; Swafford D, 2015, DISCOV MED, V19, P303; Novo MCT, 2015, IMMUNOBIOLOGY, V220, P60, DOI 10.1016/j.imbio.2014.09.001; Weerkamp F, 2006, P NATL ACAD SCI USA, V103, P3322, DOI 10.1073/pnas.0511299103; Wong CS, 2015, J IMMUNOL, V194, P158, DOI 10.4049/jimmunol.1401238; World Health Organization, 2015, GLOB TUB REP 2015; Wu XL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0080-5; Xi YM, 2014, CANCER LETT, V353, P8, DOI 10.1016/j.canlet.2014.07.010; Yasuhara R, 2015, EXP CELL RES, V338, P22, DOI 10.1016/j.yexcr.2015.09.003; Zhang XY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0462-1	27	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0172549	10.1371/journal.pone.0172549	http://dx.doi.org/10.1371/journal.pone.0172549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333932	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200006
J	Guan, QX; Zhang, GY; Sun, DD; Wang, Y; Liu, K; Wang, M; Sun, C; Zhang, Z; Li, BJ; Lv, JY				Guan, Qingxiang; Zhang, Guangyuan; Sun, Dandan; Wang, Yue; Liu, Kun; Wang, Miao; Sun, Cheng; Zhang, Zhuo; Li, Bingjin; Lv, Jiayin			In vitro and in vivo evaluation of docetaxel-loaded stearic acid-modified Bletilla striata polysaccharide copolymer micelles	PLOS ONE			English	Article							BLOCK-COPOLYMER; DRUG-DELIVERY; PHYSICOCHEMICAL CHARACTERIZATION; CHAIN-LENGTH; NANOPARTICLES; PROLIFERATION; GLUCOMANNAN; NANOSPHERES; CHITOSAN; GROWTH	Bletilla striata polysaccharides (BSPs) have been used in pharmaceutical and biomedical industry, the aim of the present study was to explore a BSPs amphiphilic derivative to overcome its application limit as poorly water-soluble drug carriers due to water-soluble polymers. Stearic acid (SA) was selected as a hydrophobic block to modify B. striata polysaccharides (SA-BSPs). Docetaxel (DTX)-loaded SA-BSPs (DTX-SA-BSPs) copolymer micelles were prepared and characterized. The DTX release percentage in vitro and DTX concentration in vivo was carried out by using high performance liquid chromatography. HepG2 and HeLa cells were subjected to MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazonium bromide) assay to evaluate the cell viability. In vitro evaluation of copolymer micelles showed higher drug encapsulation and loading capacity. The release percentage of DTX from DTX-SA-BSPs copolymer micelles and docetaxel injection was 66.93 +/- 1.79% and 97.06 +/- 1.56% in 2 days, respectively. The DTX-SA-BSPs copolymer micelles exhibited a sustained release of DTX. A 50% increase in growth inhibition was observed for HepG2 cells treated with DTX-SA-BSPs copolymer micelles as compared to those treated with docetaxel injection for 72 h. DTX-SA-BSPs copolymer micelles presented a similar growth inhibition effect on Hela cells. Furthermore, absolute bioavailability of DTX-SA-BSPs copolymer micelles was shown to be 1.39-fold higher than that of docetaxel injection. Therefore, SA-BSPs copolymer micelles may be used as potential biocompatible polymers for cancer chemotherapy.	[Guan, Qingxiang; Zhang, Guangyuan; Sun, Dandan; Liu, Kun; Wang, Miao; Sun, Cheng] Jilin Univ, Sch Pharm, Changchun, Peoples R China; [Wang, Yue] Northeast Normal Univ, Fac Chem, Changchun, Peoples R China; [Zhang, Zhuo; Lv, Jiayin] Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China; [Li, Bingjin] Jilin Univ, Hosp 2, Changchun, Peoples R China	Jilin University; Northeast Normal University - China; Jilin University; Jilin University	Lv, JY (corresponding author), Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China.; Li, BJ (corresponding author), Jilin Univ, Hosp 2, Changchun, Peoples R China.	libingjin@jlu.edu.cn; lvjiajinmg63@sina.com	sun, dandan/GZG-6540-2022	Liu, Kun/0000-0003-1366-4546; Sun, Dandan/0000-0002-6853-0898	Graduate Innovation Fund of Jilin University [2016225]; Jilin Science and Technology Agency [20140307018YY, 20140414040GH]	Graduate Innovation Fund of Jilin University(Jilin University); Jilin Science and Technology Agency	The research was supported by Graduate Innovation Fund of Jilin University (2016225); Jilin Science and Technology Agency funding (20140307018YY; 20140414040GH).; The authors are grateful to Lichun Zhao professor who provides us with Hela and HepG2 cells. The research was supported by Graduate Innovation Fund of Jilin University (2016225); Jilin Science and Technology Agency funding (20140307018YY; 20140414040GH,).	AKIYOSHI K, 1996, SUPRAMOL SCI, V3, P157, DOI DOI 10.1016/0968-5677(96)00031-4; [Anonymous], 1991, WAT SOL POL SYNTH SO, V3, P95; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Chae SY, 2005, J CONTROL RELEASE, V109, P330, DOI 10.1016/j.jconrel.2005.09.040; [钱骏 Qian Jun], 2005, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V25, P391; Feng JQ, 2008, HELV CHIM ACTA, V91, P520, DOI 10.1002/hlca.200890056; Fonseca C, 2002, J CONTROL RELEASE, V83, P273, DOI 10.1016/S0168-3659(02)00212-2; Gong CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215103; Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Guan QX, 2016, BIOL PHARM BULL, V39, P762, DOI 10.1248/bpb.b15-00854; Gullotti E, 2009, MOL PHARMACEUT, V6, P1041, DOI 10.1021/mp900090z; Han GX, 2002, CHINESE CHEM LETT, V13, P231; Han M, 2007, J CONTROL RELEASE, V121, P38, DOI 10.1016/j.jconrel.2007.05.012; Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65; Huang JB, 2014, BIOMATERIALS, V35, P550, DOI 10.1016/j.biomaterials.2013.09.089; Jaimuang S, 2015, POLYMER, V67, P249, DOI 10.1016/j.polymer.2015.04.077; Jeong YI, 2006, J PHARM SCI-US, V95, P2348, DOI 10.1002/jps.20586; Jeong YI, 2006, INT J PHARMACEUT, V322, P154, DOI 10.1016/j.ijpharm.2006.05.020; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kong LS, 2015, CARBOHYD POLYM, V125, P1, DOI 10.1016/j.carbpol.2015.02.042; KWON G, 1994, J CONTROL RELEASE, V29, P17, DOI 10.1016/0168-3659(94)90118-X; Lee KY, 1998, MACROMOLECULES, V31, P378, DOI 10.1021/ma9711304; Li W., 2001, ACTA U MED TANGJI, V30, P501; Liu JY, 2012, CARBOHYD POLYM, V89, P158, DOI 10.1016/j.carbpol.2012.02.065; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Morris GA, 2011, CARBOHYD POLYM, V84, P1430, DOI 10.1016/j.carbpol.2011.01.044; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagarajan R, 2001, POLYM ADVAN TECHNOL, V12, P23, DOI 10.1002/1099-1581(200101/02)12:1/2<23::AID-PAT75>3.3.CO;2-3; Cuong NV, 2012, J MATER CHEM, V22, P1006, DOI 10.1039/c1jm13588k; Sallustio S, 2004, J PHYS CHEM B, V108, P18876, DOI 10.1021/jp048068e; Savic R, 2006, J DRUG TARGET, V14, P343, DOI 10.1080/10611860600874538; Wang CM, 2006, BIOTECHNOL LETT, V28, P539, DOI 10.1007/s10529-006-0011-x; Wang Y, 2014, FITOTERAPIA, V92, P72, DOI 10.1016/j.fitote.2013.10.008; Xia J., 1994, BERLIN HEIDELBERG MA; Xiang W., 2009, WORLD CHINESE J DIGE, V17, P1832; Yanasarn N, 2009, INT J PHARMACEUT, V379, P174, DOI 10.1016/j.ijpharm.2009.06.004; YOKOYAMA M, 1990, CANCER RES, V50, P1693; Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1; Zhu XX, 2002, ACCOUNTS CHEM RES, V35, P539, DOI 10.1021/ar0101180	40	17	20	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173172	10.1371/journal.pone.0173172	http://dx.doi.org/10.1371/journal.pone.0173172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334044	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200010
J	McGorum, BC; Symonds, HW; Knottenbelt, C; Cave, TA; MacDonald, SJ; Stratton, J; Leon, I; Turner, JA; Pirie, RS				McGorum, Bruce C.; Symonds, Herb W.; Knottenbelt, Clare; Cave, Tom A.; MacDonald, Susan J.; Stratton, Joanna; Leon, Irene; Turner, Judith A.; Pirie, R. Scott			Alterations in amino acid status in cats with feline dysautonomia	PLOS ONE			English	Article							KEY-GASKELL-SYNDROME; EQUINE GRASS SICKNESS; BOTULINUM TYPE-C; CLOSTRIDIUM-BOTULINUM; RETINAL DEGENERATION; TAURINE DEFICIENCY; FUSARIUM-MYCOTOXINS; DOMESTIC-ANIMALS; CLOSED COLONY; FED CASEIN	Feline dysautonomia (FD) is a multiple system neuropathy of unknown aetiology. An apparently identical disease occurs in horses (equine grass sickness, EGS), dogs, rabbits, hares, sheep, alpacas and llamas. Horses with acute EGS have a marked reduction in plasma concentrations of the sulphur amino acids (SAA) cyst(e)ine and methionine, which may reflect exposure to a neurotoxic xenobiotic. The aim of this study was to determine whether FD cats have alterations in amino acid profiles similar to those of EGS horses. Amino acids were quantified in plasma/serum from 14 FD cats, 5 healthy in-contact cats which shared housing and diet with the FD cats, and 6 healthy control cats which were housed separately from FD cats and which received a different diet. The adequacy of amino acids in the cats' diet was assessed by determining the amino acid content of tinned and dry pelleted foods collected immediately after occurrences of FD. Compared with controls, FD cats had increased concentrations of many essential amino acids, with the exception of methionine which was significantly reduced, and reductions in most non-essential amino acids. In-contact cats also had inadequate methionine status. Artefactual loss of cysteine during analysis precluded assessment of the cyst(e)ine status. Food analysis indicated that the low methionine status was unlikely to be attributable to dietary inadequacy of methionine or cystine. Multi-mycotoxin screening identified low concentrations of several mycotoxins in dry food from all 3 premises. While this indicates fungal contamination of the food, none of these mycotoxins appears to induce the specific clinico-pathologic features which characterise FD and equivalent multiple system neuropathies in other species. Instead, we hypothesise that ingestion of another, as yet unidentified, dietary neurotoxic mycotoxin or xenobiotic, may cause both the characteristic disease pathology and the plasma SAA depletion.	[McGorum, Bruce C.; Pirie, R. Scott] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [McGorum, Bruce C.; Pirie, R. Scott] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Knottenbelt, Clare] Univ Glasgow, Sch Vet Med, Glasgow, Strathclyde, Scotland; [Cave, Tom A.] Cave Vet Specialists, Wellington, Somerset, England; [MacDonald, Susan J.; Stratton, Joanna; Leon, Irene; Turner, Judith A.] Fera Sci Ltd, York, N Yorkshire, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow; Food & Environment Research Agency	McGorum, BC (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.; McGorum, BC (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	bruce.mcgorum@ed.ac.uk	Knottenbelt, Clare/K-7101-2019		Royal Society of Edinburgh/Scottish Office of Higher Education Department; Equine Grass Sickness Fund	Royal Society of Edinburgh/Scottish Office of Higher Education Department; Equine Grass Sickness Fund	This study was funded by The Royal Society of Edinburgh/Scottish Office of Higher Education Department (BM), and The Equine Grass Sickness Fund (www.grasssicskness.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by The Royal Society of Edinburgh/Scottish Office of Higher Education Department (BM), The Equine Grass Sickness Fund (www.grasssicskness.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abysique A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133355; ANDERSON PA, 1979, J ANIM SCI, V49, P1227, DOI 10.2527/jas1979.4951227x; Anderson PJB, 2002, J NUTR, V132, P2037; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; [Anonymous], OFFICIAL J EUROPEAN; [Anonymous], 2016, OFFICIAL J EUROPEAN; BERSON EL, 1976, INVEST OPHTH VISUAL, V15, P52; Blajet-Kosicka A, 2014, FOOD ADDIT CONTAM B, V7, P302, DOI 10.1080/19393210.2014.933269; Bohm Josef, 2010, Mycotoxin Res, V26, P147, DOI 10.1007/s12550-010-0049-4; Cave TA, 2003, VET REC, V153, P387, DOI 10.1136/vr.153.13.387; DIAZ GJ, 1994, VET HUM TOXICOL, V36, P548; Edney ATB, 1987, J SMALL ANIM PRACT, V28, P333; FRIEDMAN M, 1994, J AGR FOOD CHEM, V42, P3, DOI 10.1021/jf00037a002; FRIEDMAN M, 1994, ACS SYM SER, V564, P258; GIBSON MK, 1993, B ENVIRON CONTAM TOX, V51, P6, DOI 10.1007/BF00200993; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; Hughes DM, 1999, J ANIM SCI, V77, P693; Hunter LC, 2001, EQUINE VET J, V33, P547, DOI 10.2746/042516401776563418; Hunter LC, 1999, EQUINE VET J, V31, P492, DOI 10.1111/j.2042-3306.1999.tb03857.x; ISO, 2005, 59831 ISO; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; KEY TJA, 1982, VET REC, V110, P160, DOI 10.1136/vr.110.7.160; Kidder AC, 2008, J FELINE MED SURG, V10, P130, DOI 10.1016/j.jfms.2007.08.005; Martins Maria Ligia, 2003, Revista Portuguesa de Ciencias Veterinarias, V98, P179; McCarthy HE, 2004, EQUINE VET J, V36, P123, DOI 10.2746/0425164044868611; McGorum BC, 2001, EQUINE VET J, V33, P473, DOI 10.2746/042516401776254763; Morgan MK, 1997, VET HUM TOXICOL, V39, P334; MORRIS JG, 1978, SCIENCE, V199, P431, DOI 10.1126/science.619464; MORRIS JG, 1978, J NUTR, V108, P1944, DOI 10.1093/jn/108.12.1944; Nahm KH., 1991, POULTY SCI, V70S, P501; NASH AS, 1994, VET REC, V134, P175, DOI 10.1136/vr.134.7.175; National Research Council (US) Ad Hoc Committee on Dog and Cat Nutrition, 2006, NUTR REQ DOGS CATS, P111; Nunn F, 2004, VET REC, V155, P111, DOI 10.1136/vr.155.4.111; Obremski K, 2004, POL J VET SCI, V7; PERRY TL, 1975, J NEUROCHEM, V24, P587, DOI 10.1111/j.1471-4159.1975.tb07680.x; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Pirie RS, 2014, EQUINE VET J, V46, P545, DOI 10.1111/evj.12254; Placinta CM, 1999, ANIM FEED SCI TECH, V78, P21, DOI 10.1016/S0377-8401(98)00278-8; POLLIN MM, 1992, J COMP PATHOL, V106, P99, DOI 10.1016/0021-9975(92)90041-R; RESTUM JC, 1995, ARCH ENVIRON CON TOX, V29, P545, DOI 10.1007/BF00208387; ROGERS QR, 1979, J NUTR, V109, P718, DOI 10.1093/jn/109.4.718; Ruaux CG, 2001, AM J VET RES, V62, P1852, DOI 10.2460/ajvr.2001.62.1852; SCHMIDT SY, 1976, INVEST OPHTH VISUAL, V15, P47; SHARP NJH, 1984, J SMALL ANIM PRACT, V25, P599, DOI 10.1111/j.1748-5827.1984.tb03372.x; SMALLEY KA, 1983, BRIT J NUTR, V49, P411, DOI 10.1079/BJN19830050; Smith TK, 2012, WOODHEAD PUBL FOOD S, P326; Sulyok M, 2007, ANAL BIOANAL CHEM, V389, P1505, DOI 10.1007/s00216-007-1542-2; Sunvold GD., 2021, NUTR GUIDELINES COMP; SYMONDS HW, 1995, VET REC, V136, P353, DOI 10.1136/vr.136.14.353; TEETER RG, 1978, J ANIM SCI, V46, P1287, DOI 10.2527/jas1978.4651287x; Torres CL, 2004, VET CLIN PATH, V33, P228, DOI 10.1111/j.1939-165X.2004.tb00378.x; VELTMANN JR, 1983, POULTRY SCI, V62, P1518; Yu S, 2001, J SMALL ANIM PRACT, V42, P176, DOI 10.1111/j.1748-5827.2001.tb01798.x; ZICKER SC, 1990, PROCEEDINGS OF THE IVTH CONGRESS OF THE INTERNATIONAL SOCIETY FOR ANIMAL CLINICAL BIOCHEMISTRY, P107; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	55	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174346	10.1371/journal.pone.0174346	http://dx.doi.org/10.1371/journal.pone.0174346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333983	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200081
J	Seden, K; Gibbons, S; Marzolini, C; Schapiro, JM; Burger, DM; Back, DJ; Khoo, SH				Seden, Kay; Gibbons, Sara; Marzolini, Catia; Schapiro, Jonathan M.; Burger, David M.; Back, David J.; Khoo, Saye H.			Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection	PLOS ONE			English	Review							INFECTED NIGERIAN SUBJECTS; ARTEMETHER-LUMEFANTRINE; PHARMACOKINETIC INTERACTIONS; HEALTHY-VOLUNTEERS; ANTIRETROVIRAL THERAPY; UNCOMPLICATED MALARIA; IN-VITRO; PLASMA-CONCENTRATIONS; PROTEASE INHIBITORS; ADULT PATIENTS	Background In all settings, there are challenges associated with safely treating patients with multimorbidity and polypharmacy. The need to characterise, understand and limit harms resulting from medication use is therefore increasingly important. Drug-drug interactions (DDIs) are prevalent in patients taking antiretrovirals (ARVs) and if unmanaged, may pose considerable risk to treatment outcome. One of the biggest challenges in preventing DDIs is the substantial gap between theory and clinical practice. There are no robust methods published for formally assessing quality of evidence relating to DDIs, despite the diverse sources of information. We defined a transparent, structured process for developing evidence quality summaries in order to guide therapeutic decision making. This was applied to a systematic review of DDI data with considerable public health significance: HIV and malaria. Methods and findings This was a systematic review of DDI data between antiretrovirals and drugs used in prophylaxis and treatment of malaria. The data comprised all original research in humans that evaluated pharmacokinetic data and/or related adverse events when antiretroviral agents were combined with antimalarial agents, including healthy volunteers, patients with HIV and/or malaria, observational studies, and case reports. The data synthesis included 36 articles and conference presentations published via PubMed and conference websites/abstract books between 1987-August 2016. There is significant risk of DDIs between HIV protease inhibitors, or NNRTIs and artemesinin-containing antimalarial regimens. For many antiretrovirals, DDI studies with antimalarials were lacking, and the majority were of moderate to very low quality. Quality of evidence and strength of recommendation categories were defined and developed specifically for recommendations concerning DDIs. Conclusions There is significant potential for DDIs between antiretrovirals and antimalarials. The application of quality of evidence and strength of recommendation criteria to DDI data is feasible, and allows the assessment of DDIs to be robust, consistent, transparent and evidencebased.	[Seden, Kay; Gibbons, Sara; Back, David J.; Khoo, Saye H.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Marzolini, Catia] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Med, Basel, Switzerland; [Marzolini, Catia] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland; [Schapiro, Jonathan M.] Sheba Med Ctr, Natl Hemophilia Ctr, Ramat Gan, Israel; [Burger, David M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands; [Burger, David M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands	University of Liverpool; University of Basel; University of Basel; Chaim Sheba Medical Center; Radboud University Nijmegen; Radboud University Nijmegen	Khoo, SH (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England.	Khoo@liverpool.ac.uk	Marzolini, Catia/C-8253-2019; Burger, David/C-9929-2013	Seden, Kay/0000-0001-6612-7344	Medical Research Council Population Health Science Fellowship [MR/L012413/1]; Medical Research Council [MR/L012413/1] Funding Source: researchfish; MRC [MR/L012413/1] Funding Source: UKRI	Medical Research Council Population Health Science Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Author KS is supported by a Medical Research Council Population Health Science Fellowship (MR/L012413/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhady AM, 2016, J CARDIOVASC ELECTRO; Abgrall S, 2013, HIV CLIN TRIALS, V14, P313, DOI 10.1310/hct1406-313; Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Alemu A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-18; Byakika-Kibwika P, 2011, CHEMOTHER RES PRACT, V2011; Byakika-Kibwika P, 2012, J ANTIMICROB CHEMOTH, V67, P2213, DOI 10.1093/jac/dks207; Byakika-Kibwika P, 2012, J ANTIMICROB CHEMOTH, V67, P1217, DOI 10.1093/jac/dkr596; Calderon MM, 2016, CLIN INFECT DIS, V62, P1036, DOI 10.1093/cid/ciw028; Chijioke-Nwauche I, 2013, ANTIMICROB AGENTS CH, V57, P4146, DOI 10.1128/AAC.02508-12; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Evans-Jones JG, 2010, CLIN INFECT DIS, V50, P1419, DOI 10.1086/652149; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; FDA, 2012, FDA GUID IND DRUG IN; Fehintola FA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/703604; Ganesan S, 2009, TOXICOL APPL PHARM, V241, P14, DOI 10.1016/j.taap.2009.07.012; Gasasira AF, 2008, CLIN INFECT DIS, V46, P985, DOI 10.1086/529192; German P, 2007, CLIN INFECT DIS, V44, P889, DOI 10.1086/511882; German P, 2009, JAIDS-J ACQ IMM DEF, V51, P424, DOI 10.1097/QAI.0b013e3181acb4ff; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hoglund RM, 2014, BR J CLIN PHARM; Huang L, 2015, ANN C RETR OPP INF S; Huang LS, 2012, JAIDS-J ACQ IMM DEF, V61, P310, DOI 10.1097/QAI.0b013e31826ebb5c; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Jacobson MA, 1996, J ACQ IMMUN DEF SYND, V11, P45, DOI 10.1097/00042560-199601010-00006; Kajubi R, 2016, EFV RED PK PIP MAL P; Kakuda TN, 2013, HIV MED, V14, P421, DOI 10.1111/hiv.12019; Kakuru A, 2014, CLIN INFECT DIS, V59, P446, DOI 10.1093/cid/ciu286; Kaneko A, 1999, PHARMACOGENETICS, V9, P317; Kayentao K, 2014, AM J TROP MED HYG, V90, P530, DOI 10.4269/ajtmh.13-0655; Khaliq Y, 2001, BRIT J CLIN PHARMACO, V51, P591, DOI 10.1046/j.1365-2125.2001.01393.x; Kigen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016800; Kredo T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1345-1; Kredo T, 2011, ANTIMICROB AGENTS CH, V55, P5616, DOI 10.1128/AAC.05265-11; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; Lee BL, 1996, CLIN PHARMACOL THER, V59, P14, DOI 10.1016/S0009-9236(96)90019-3; Maat MMR, 2004, J CLIN PHARM THER, V29, P121, DOI 10.1111/j.1365-2710.2003.00541.x; Maganda BA, 2016, PHARMACOGENOMICS J, V16, P88, DOI 10.1038/tpj.2015.37; Maganda BA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0695-2; Maganda BA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-205; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540; Miller CD, 2007, PHARMACOTHERAPY, V27, P1379, DOI 10.1592/phco.27.10.1379; Morris CA, 2012, AM J TROP MED HYG, V86, P489, DOI 10.4269/ajtmh.2012.11-0558; Mwebaza N, 2013, 20 C RETR OPP INF MA; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Nyunt MM, 2012, CLIN PHARMACOL THER, V91, P889, DOI 10.1038/clpt.2011.326; Omoti CE, 2013, ASIAN PAC J TROP MED, V6, P126, DOI 10.1016/S1995-7645(13)60007-3; Parikh S, 2007, CLIN PHARMACOL THER, V82, P197, DOI 10.1038/sj.clpt.6100122; Parikh S, 2015, ANTIMICROB AGENTS CH, V59, P7852, DOI 10.1128/AAC.01153-15; Pybus BS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-259; Qi J, 2002, ACTA PHARMACOL SIN, V23, P544; Rastegar DA, 2006, CLIN INFECT DIS, V43, P933, DOI 10.1086/507538; Rattanapunya S, 2015, AM J TROP MED HYG, V93, P1383, DOI 10.4269/ajtmh.15-0453; Rattanapunya S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0916-8; Rijpma SR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-359; Scarsi KK, 2014, J ANTIMICROB CHEMOTH, V69, P1370, DOI 10.1093/jac/dkt513; Schippers EF, 2000, AIDS, V14, P2794, DOI 10.1097/00002030-200012010-00023; Seden K, 2015, J ANTIMICROB CHEMOTH, V70, P3317, DOI 10.1093/jac/dkv259; Seden K, 2013, INT J STD AIDS, V24, P237, DOI 10.1177/0956462412472428; Siccardi Marco, 2013, In Silico Pharmacology, V1, P4, DOI 10.1186/2193-9616-1-4; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; Soyinka JO, 2010, BRIT J CLIN PHARMACO, V69, P262, DOI 10.1111/j.1365-2125.2009.03566.x; Soyinka JO, 2009, J PHARM PHARMACOL, V61, P439, DOI [10.1211/jpp.61.04.0004, 10.1211/jpp/61.04.0004]; Soyinka JO, 2010, EUR J PHARM SCI, V39, P213, DOI 10.1016/j.ejps.2009.11.012; Teja-Isavadharm P, 2001, AM J TROP MED HYG, V65, P717, DOI 10.4269/ajtmh.2001.65.717; Tommasi C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-141; Trapnell CB, 1998, ANTIMICROB AGENTS CH, V42, P1592, DOI 10.1128/AAC.42.7.1592; Uriel A, 2011, INT J STD AIDS, V22, P768, DOI 10.1258/ijsa.2009.009489; Van Luin M, 2010, AIDS, V24, P1223, DOI 10.1097/QAD.0b013e3283389129; Wakeham K, 2010, J ANTIMICROB CHEMOTH, V65, P316, DOI 10.1093/jac/dkp451; Wynalda MA, 2003, DRUG METAB DISPOS, V31, P878, DOI 10.1124/dmd.31.7.878; Yeh RF, 2006, JAIDS-J ACQ IMM DEF, V42, P52; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447	73	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173509	10.1371/journal.pone.0173509	http://dx.doi.org/10.1371/journal.pone.0173509			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334018	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200014
J	Tsuruta, JK; Schaub, NP; Rojas, JD; Streeter, J; Klauber-DeMore, N; Dayton, P				Tsuruta, James K.; Schaub, Nicholas P.; Rojas, Juan D.; Streeter, Jason; Klauber-DeMore, Nancy; Dayton, Paul			Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; MICROBUBBLE; THERAPY; VOLUME; PEG	Secreted frizzled related protein 2 (SFRP2) is a tumor endothelial marker expressed in angiosarcoma. Previously, we showed ultrasound molecular imaging with SFRP2-targeted contrast increased average video pixel intensity (VI) of angiosarcoma vessels by 2.2 +/- 0.6 VI versus streptavidin contrast. We hypothesized that redesigning our contrast agents would increase imaging performance. Improved molecular imaging reagents were created by combining NeutrAvidin (TM)-functionalized microbubbles with biotinylated SFRP2 or IgY control antibodies. When angiosarcoma tumors in nude mice reached 8 mm, time-intensity, antibody loading, and microbubble dose experiments optimized molecular imaging. 10 minutes after injection, the control-subtracted time-intensity curve (TIC) for SFRP2-targeted contrast reached a maximum, after subtracting the contribution of free-flowing contrast. SFRP2 antibody-targeted VI was greater when contrast was formulated with 10-fold molar excess of maleimide-activated NeutrAvidin (TM) versus 3-fold (4.5 +/- 0.18 vs. 0.32 +/- 0.15, VI +/- SEM, 5 x 10(6) dose, p < 0.001). Tumor vasculature returned greater average video pixel intensity using 5 x 10(7) versus 5 x 10(6) microbubbles (21.2 +/- 2.5 vs. 4.5 +/- 0.18, p = 0.0011). Specificity for tumor vasculature was confirmed by low VI for SFRP2-targeted, and control contrast in peri-tumoral vasculature (3.2 +/- 0.52 vs. 1.6 +/- 0.71, p = 0.92). After optimization, average video pixel intensity of tumor vasculature was 14.2 +/- 3.0 VI units higher with SFRP2-targeted contrast versus IgY-targeted control (22.1 +/- 2.5 vs. 7.9 +/- 1.6, p < 0.001). After log decompression, 14.2 Delta VI was equal to similar to 70% higher signal, in arbitray acoustic units (AU), for SFRP2 versus IgY. This provided similar to 18-fold higher acoustic signal enhancement than provided previously by 2.2.VI. Basing our targeted contrast on NeutrAvidin (TM) -functionalized microbubbles, using IgY antibodies for our control contrast, and optimizing our imaging protocol significantly increased the SFRP2-specific signal returned from angiosarcoma vasculature, and may provide new opportunities for targeted molecular imaging.	[Tsuruta, James K.; Rojas, Juan D.; Streeter, Jason; Dayton, Paul] North Carolina State Univ, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Tsuruta, James K.; Rojas, Juan D.; Streeter, Jason; Dayton, Paul] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Tsuruta, James K.] Univ North Carolina Chapel Hill, Dept Pediat, Chapel Hill, NC USA; [Schaub, Nicholas P.] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC USA; [Klauber-DeMore, Nancy] Med Coll South Carolina, Dept Surg, Charleston, SC 29425 USA; [Dayton, Paul] UNC Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA; [Streeter, Jason] Loyola Univ Chicago, Engn Sci, Chicago, IL USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Loyola University Chicago	Klauber-DeMore, N (corresponding author), Med Coll South Carolina, Dept Surg, Charleston, SC 29425 USA.	demore@musc.edu	Streeter, Jason/ABA-4809-2020	Rojas, Juan/0000-0001-9465-2939	Kristen Ann Carr Foundation; NIH [U01 CA 189281]; shared instrumentation grant [S10OD010410]	Kristen Ann Carr Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); shared instrumentation grant	Funding for this project was provided by NIH U01 CA 189281, Kristen Ann Carr Foundation, and imaging equipment was provided by shared instrumentation grant S10OD010410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by NIH U01 CA189281, Kristen Ann Carr Foundation, and imaging equipment was provided by shared instrumentation grant S10OD010410.	Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Bierig SM, 2009, J DIAGN MED SONOG, V25, P138, DOI 10.1177/8756479309336240; Celebi M, 2016, ANDROLOGIA, V48, P907, DOI 10.1111/and.12531; Chen CC, 2012, ULTRASOUND MED BIOL, V38, P492, DOI 10.1016/j.ultrasmedbio.2011.12.007; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Fontenot E, 2013, MOL CANCER THER, V12, P685, DOI 10.1158/1535-7163.MCT-12-1066; Gessner R, 2010, MOL IMAGING, V9, P117, DOI 10.2310/7290.2010.00022; Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0; LEE HB, 1985, J NUCL MED, V26, P72; Machtaler S, 2015, THERANOSTICS, V5, P1175, DOI 10.7150/thno.13048; Rubin JM, 1999, RADIOLOGY, V213, P429, DOI 10.1148/radiology.213.2.r99nv14429; Shelton SE, 2016, ULTRASOUND MED BIOL, V42, P769, DOI 10.1016/j.ultrasmedbio.2015.10.015; Sirsi SR, 2012, ULTRASOUND MED BIOL, V38, P1019, DOI 10.1016/j.ultrasmedbio.2012.01.014; Sirsi SR, 2012, J CONTROL RELEASE, V157, P224, DOI 10.1016/j.jconrel.2011.09.071; Streeter JE, 2013, TECHNOL CANCER RES T, V12, P311, DOI 10.7785/tcrt.2012.500321; Tsuruta JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086642; Xu Y, 2013, CURR PHARM BIOTECHNO, V14, P644; Yang Q, 2016, ANAL CHEM, V88, P11804, DOI 10.1021/acs.analchem.6b03437; Yang Q, 2015, WIRES NANOMED NANOBI, V7, P655, DOI 10.1002/wnan.1339; Yeh JSM, 2015, ULTRASOUND MED BIOL, V41, P2478, DOI 10.1016/j.ultrasmedbio.2015.04.011; Zhang H, 2015, BIOMATERIALS, V56, P104, DOI 10.1016/j.biomaterials.2015.03.043	21	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174281	10.1371/journal.pone.0174281	http://dx.doi.org/10.1371/journal.pone.0174281			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333964	Green Submitted, gold, Green Published			2022-12-27	WOS:000399102200070
J	Yu, MY; Yeo, JH; Park, JS; Lee, CH; Kim, GH				Yu, Mi-Yeon; Yeo, Jee Hyun; Park, Joon-Sung; Lee, Chang Hwa; Kim, Gheun-Ho			Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM POTASSIUM; INHIBITION; PATIROMER; SORBITOL; NECROSIS; LEVEL; RESIN	Background Calcium polystyrene sulfonate (CPS) has long been used to treat hyperkalemia in patients with chronic kidney disease (CKD). However, its efficacy and safety profile have not been systematically explored. We investigated the long-term efficacy of oral CPS for treating mild hyperkalemia on an outpatient basis. Methods We performed a retrospective analysis of ambulatory CKD patients who were prescribed CPS for >= 1 week because of elevated serum potassium levels >= 5.0 mmol/L. Patients were divided into four groups according to the length of time that they took a fixed dosage of CPS (Group 1, < 3 months; Group 2, 3-6 months; Group 3, 6-12 months; and Group 4, >= 1 year). Response was defined as a decrease in the serum potassium level (>= 0.3 mmol/L) after treatment with CPS. Results We enrolled a total of 247 adult patients with a basal eGFR level of 30 +/- 15 mL/min/1.73 m(2). All patients took small doses of CPS (8.0 +/- 3.6 g/d), and serum potassium decreased in a dose-dependent fashion. Serum potassium of all patients decreased significantly from 5.8 +/- 0.3 mmol/L to 4.9 +/- 0.7 mmol/L with CPS treatment (P < 0.001). The response rates were 79.9%, 71.4%, 66.7%, and 86.8% in Groups 1, 2, 3, and 4, respectively. No serious adverse effects were reported during CPS administration, though constipation was noted in 19 patients (8%). Conclusion Small doses of oral CPS are effective and safe for controlling mild hyperkalemia in CKD patients over a long period of time.	[Yu, Mi-Yeon; Yeo, Jee Hyun; Park, Joon-Sung; Lee, Chang Hwa; Kim, Gheun-Ho] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Hanyang University	Kim, GH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kimgh@hanyang.ac.kr	Yu, Mi-Yeon/ABB-7937-2021	YU, Mi-Yeon/0000-0001-5112-6955; Kim, Gheun-Ho/0000-0002-8445-9892				Ash SR, 2015, KIDNEY INT, V88, P404, DOI 10.1038/ki.2014.382; Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P151, DOI 10.1001/jama.2015.7446; Cejas MDC, 2013, REV ESP ENFERM DIG, V105, P232, DOI 10.4321/s1130-01082013000400010; Chernin G, 2012, CLIN CARDIOL, V35, P32, DOI 10.1002/clc.20987; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; EVANS BM, 1953, LANCET, V265, P791; FLINN RB, 1961, NEW ENGL J MED, V264, P111, DOI 10.1056/NEJM196101192640302; Goutorbe Philippe, 2011, Ann Pharmacother, V45, pe13, DOI 10.1345/aph.1M547; Gruy-Kapral C, 1998, J AM SOC NEPHROL, V9, P1924; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Joo M, 2009, J KOREAN MED SCI, V24, P1207, DOI 10.3346/jkms.2009.24.6.1207; Lee Sung Hoa, 2010, Korean J Gastroenterol, V55, P261; Lepage L, 2015, CLIN J AM SOC NEPHRO, V10, P2136, DOI 10.2215/CJN.03640415; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Liamis G, 2014, WORLD J CLIN CASES, V2, P488, DOI 10.12998/wjcc.v2.i10.488; MINFORD EJ, 1992, POSTGRAD MED J, V68, P302, DOI 10.1136/pgmj.68.798.302; Nakhoul GN, 2015, AM J NEPHROL, V41, P456, DOI 10.1159/000437151; Packham DK, 2015, NEW ENGL J MED, V372, P222, DOI 10.1056/NEJMoa1411487; Shioya Takeshi, 2007, Journal of Nippon Medical School, V74, P359, DOI 10.1272/jnms.74.359; Sterns RH, 2016, KIDNEY INT, V89, P546, DOI 10.1016/j.kint.2015.11.018; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Takeuchi N, 2013, CASE REP MED, V2013; Tomino Y, 2007, CLIN NEPHROL, V68, P379; Ueda Y, 2016, KIDNEY RES CLIN PRAC, V35, P78, DOI 10.1016/j.krcp.2016.02.001; Watson MA, 2012, AM J KIDNEY DIS, V60, P409, DOI 10.1053/j.ajkd.2012.04.023; Weir MR, 2015, NEW ENGL J MED, V372, P211, DOI 10.1056/NEJMoa1410853	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173542	10.1371/journal.pone.0173542	http://dx.doi.org/10.1371/journal.pone.0173542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328954	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700024
J	Dipasquale, O; Sethi, A; Lagana, MM; Baglio, F; Baselli, G; Kundu, P; Harrison, NA; Cercignani, M				Dipasquale, Ottavia; Sethi, Arjun; Lagana, Maria Marcella; Baglio, Francesca; Baselli, Giuseppe; Kundu, Prantik; Harrison, Neil A.; Cercignani, Mara			Comparing resting state fMRI de-noising approaches using multi- and single-echo acquisitions	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; INDEPENDENT COMPONENT ANALYSIS; BOLD-CONTRAST SENSITIVITY; DEFAULT MODE NETWORK; ARTIFACT REMOVAL; MOTION ARTIFACT; TIME-SERIES; HUMAN BRAIN; DIFFERENTIATING BOLD; CINGULATE CORTEX	Artifact removal in resting state fMRI (rfMRl) data remains a serious challenge, with even subtle head motion undermining reliability and reproducibility. Here we compared some of the most popular single-echo de-noising methods regression of Motion parameters, White matter and Cerebrospinal fluid signals (MWC method), FMRIB's ICA-based X-noiseifier (FIX) and ICA-based Automatic Removal Of Motion Artifacts (ICA-AROMA) with a multi echo approach (ME-ICA) that exploits the linear dependency of BOLD on the echo time. Data were acquired using a clinical scanner and included 30 young, healthy participants (minimal head motion) and 30 Attention Deficit Hyperactivity Disorder patients (greater head motion). De-noising effectiveness was assessed in terms of data quality after each cleanup procedure, ability to uncouple BOLD signal and motion and preservation of default mode network (DMN) functional connectivity. Most cleaning methods showed a positive impact on data quality. However, based on the investigated metrics, ME-ICA was the most robust. It minimized the impact of motion on FC even for high motion participants and preserved DMN functional connectivity structure. The high-quality results obtained using ME-ICA suggest that using a multi-echo EPI sequence, reliable rfMRl data can be obtained in a clinical setting.	[Dipasquale, Ottavia; Baselli, Giuseppe] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [Dipasquale, Ottavia; Lagana, Maria Marcella; Baglio, Francesca] IRCCS Santa Maria Nascente, Fdn Don Carlo Gnocchi ONLUS, Milan, Italy; [Dipasquale, Ottavia; Sethi, Arjun; Harrison, Neil A.; Cercignani, Mara] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Kundu, Prantik] Icahn Sch Med Mt Sinai, Brain Imaging Ctr, Sect Adv Funct Neuroimaging, New York, NY 10029 USA; [Harrison, Neil A.] Sussex Partnership NHS Fdn Trust, Brighton, E Sussex, England; [Harrison, Neil A.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England	Polytechnic University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Brighton; University of Sussex; Icahn School of Medicine at Mount Sinai; University of Sussex	Dipasquale, O (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy.; Dipasquale, O (corresponding author), IRCCS Santa Maria Nascente, Fdn Don Carlo Gnocchi ONLUS, Milan, Italy.; Dipasquale, O (corresponding author), Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England.	ottavia.dipasquale@kcl.ac.uk	baglio, francesca/AAX-6298-2020; Lagana, Maria Marcella/L-8050-2016; Baglio, Francesca/K-2808-2016	baglio, francesca/0000-0002-6145-5274; Lagana, Maria Marcella/0000-0001-7848-1711; Baglio, Francesca/0000-0002-6145-5274; Sethi, Arjun/0000-0001-5352-4164; Harrison, Neil/0000-0002-9584-3769; Dipasquale, Ottavia/0000-0002-2867-8222; Cercignani, Mara/0000-0002-4550-2456				Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Birn RM, 2014, BRAIN CONNECT, V4, P511, DOI 10.1089/brain.2014.0284; Brooks JCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00623; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Deen Ben, 2012, Nature, V491, pS20; Dipasquale O, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00043; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Griffanti L, 2016, NEUROIMAGE, V124, P704, DOI 10.1016/j.neuroimage.2015.09.021; Griffanti L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00449; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hoekzema E, 2014, HUM BRAIN MAPP, V35, P1261, DOI 10.1002/hbm.22250; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Khalili-Mahani N, 2013, NEUROIMAGE, V65, P499, DOI 10.1016/j.neuroimage.2012.09.044; Kundu P, 2015, BRAIN IMAGING BEHAV, V9, P56, DOI 10.1007/s11682-014-9346-4; Kundu P, 2014, NEUROIMAGE, V102, P861, DOI 10.1016/j.neuroimage.2014.07.025; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lombardo M. V., 2016, NEUROIMAGE; Marchitelli R, 2016, HUM BRAIN MAPP, V37, P2114, DOI 10.1002/hbm.23157; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Storti SF, 2013, FRONTIERS NEUROSCIEN, P7; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004	62	47	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173289	10.1371/journal.pone.0173289	http://dx.doi.org/10.1371/journal.pone.0173289			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323821	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000399089000018
J	Meng, J; Li, ZS; Shen, L				Meng, Jing; Li, Zuoshan; Shen, Lin			Responses to others' pain in adults with autistic traits: The influence of gender and stimuli modality	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; EMOTION RECOGNITION; SPECTRUM DISORDERS; ASPERGER-SYNDROME; EMPATHY; QUOTIENT; PERCEPTION	Individuals with autism-spectrum disorder (ASD) exhibit impairments in response to others' pain. Evidence suggests that features of autism are not restricted to individuals with ASD, and that autistic traits vary throughout the general population. To investigate the association between autistic traits and the responses to others' pain in typically developing adults, we employed the Autism-Spectrum Quotient (AQ) to quantify autistic traits in a group of 1670 healthy adults and explored whether 60 participants (30 males and 30 females) with 10% highest AQ scores (High-AQ) would exhibit difficulties in the responses to others' pain relative to 60 participants (30 males and 30 females) with 10% lowest AQ scores (Low-AQ). This study included a Visual Task and an Auditory Task to test behavioral differences between High-AQ and Low-AQ groups' responses to others' pain in both modalities. For the Visual Task, participants were instructed to respond to pictures depicting others' pain. They were instructed to judge the stimuli type (painful or not), judge others' pain intensity, and indicate the unpleasantness they personally felt. For the Auditory Task, experimental procedures were identical to the Visual Task except that painful voices were added. Results showed the High-AQ group was less accurate than the Low-AQ group in judging others' pain. Moreover, relative to Low-AQ males, High-AQ males had significantly longer reaction times in judging others' pain in the Auditory Task. However, High-AQ and Low-AQ females showed similar reaction times in both tasks. These findings demonstrated identification of others' pain by healthy adults is related to the extent of autistic traits, gender, and modality.	[Meng, Jing; Li, Zuoshan] Chongqing Normal Univ, Sch Educ, Chongqing, Peoples R China; [Shen, Lin] Chongqing Normal Univ, Sch Math Sci, Chongqing, Peoples R China	Chongqing Normal University; Chongqing Normal University	Shen, L (corresponding author), Chongqing Normal Univ, Sch Math Sci, Chongqing, Peoples R China.	qufumj@sina.com		Meng, Jing/0000-0002-7083-5551; Shen, Lin/0000-0002-5281-2217	Fundamental Research Funds for the National Natural Science Foundation of China [31400882]	Fundamental Research Funds for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the National Natural Science Foundation of China (31400882).	Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Borod JC, 2000, COGNITION EMOTION, V14, P193, DOI 10.1080/026999300378932; Brunye TT, 2012, PERS INDIV DIFFER, V52, P84, DOI 10.1016/j.paid.2011.09.004; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, PROG NEUROBIOL, V98, P38, DOI 10.1016/j.pneurobio.2012.05.001; Fan YT, 2014, SOC COGN AFFECT NEUR, V9, P1203, DOI 10.1093/scan/nst101; Farook JM, 2010, PSYCHOL MED, V40, P1919; Fitzgibbon BM, 2010, NEUROSCI BIOBEHAV R, V34, P500, DOI 10.1016/j.neubiorev.2009.10.007; Gokcen E, 2014, BRIT J PSYCHOL, V105, P187, DOI 10.1111/bjop.12033; Hadjikhani N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.113; Ibanez A, 2011, BRAIN RES, V1398, P72, DOI 10.1016/j.brainres.2011.05.014; Jones CRG, 2011, J CHILD PSYCHOL PSYC, V52, P275, DOI 10.1111/j.1469-7610.2010.02328.x; Kothari R, 2013, J AM ACAD CHILD PSY, V52, P1148, DOI 10.1016/j.jaac.2013.08.006; Liu M.-J., 2008, B SPECIAL ED, V33, P73; Meng J, 2013, NEUROIMAGE, V72, P164, DOI 10.1016/j.neuroimage.2013.01.024; Meng J, 2012, EXP BRAIN RES, V220, P277, DOI 10.1007/s00221-012-3136-2; Minio-Paluello I, 2006, SOC NEUROSCI, V1, P320, DOI 10.1080/17470910601035954; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Poljac E, 2013, AUTISM, V17, P668, DOI 10.1177/1362361312455703; Reed P, 2011, PERS INDIV DIFFER, V51, P732, DOI 10.1016/j.paid.2011.06.016; Scambler DJ, 2007, J AUTISM DEV DISORD, V37, P553, DOI 10.1007/s10803-006-0186-y; Schneider K, 2013, AUTISM RES, V6, P506, DOI 10.1002/aur.1310; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Vachon-Presseau E, 2012, NEUROIMAGE, V63, P54, DOI 10.1016/j.neuroimage.2012.06.030; Wallace GL, 2011, J AUTISM DEV DISORD, V41, P1475, DOI 10.1007/s10803-010-1170-0; Yang Z, 2012, PAIN, V153, P1742, DOI 10.1016/j.pain.2012.05.011	28	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174109	10.1371/journal.pone.0174109	http://dx.doi.org/10.1371/journal.pone.0174109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319204	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800050
J	Khumalo, J; Nicol, M; Hardie, D; Muloiwa, R; Mteshana, P; Bamford, C				Khumalo, Jermaine; Nicol, Mark; Hardie, Diana; Muloiwa, Rudzani; Mteshana, Phindile; Bamford, Colleen			Diagnostic accuracy of two multiplex real-time polymerase chain reaction assays for the diagnosis of meningitis in children in a resource-limited setting	PLOS ONE			English	Article							INFLUENZAE TYPE-B; BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID; HAEMOPHILUS-INFLUENZAE; SOUTH-AFRICA; GRAM STAIN; PCR ASSAY; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-MENINGITIDIS; ANTIBIOTIC PRETREATMENT	Introduction Accurate etiological diagnosis of meningitis is important, but difficult in resource-limited settings due to prior administration of antibiotics and lack of viral diagnostics. We aimed to develop and validate 2 real-time multiplex PCR (RT-PCR) assays for the detection of common causes of community-acquired bacterial and viral meningitis in South African children. Methods We developed 2 multiplex RT-PCRs for detection of S. pneumoniae, N. meningitidis, H. influenzae, enteroviruses, mumps virus and herpes simplex virus. We tested residual CSF samples from children presenting to a local paediatric hospital over a one-year period, whose CSF showed an abnormal cell count. Results were compared with routine diagnostic tests and the final discharge diagnosis. We calculated accuracy of the bacterial RT-PCR assay compared to CSF culture and using World Health Organisation definitions of laboratory -confirmed bacterial meningitis. Results From 292 samples, bacterial DNA was detected in 12 (4.1%) and viral nucleic acids in 94 (32%). Compared to CSF culture, the sensitivity and specificity of the bacterial RT-PCR was 100% and 97.2% with complete agreement in organism identification. None of the cases positive by viral RT-PCR had a bacterial cause confirmed on CSF culture. Only 9/90 (10%) of patients diagnosed clinically as bacterial meningitis or partially treated bacterial meningitis tested positive with the bacterial RT-PCR. Discussion In this population the use of 2 multiplex RT-PCRs targeting 6 common pathogens gave promising results. If introduced into routine diagnostic testing, these multiplex RT-PCR assays would supplement other diagnostic tests, and have the potential to limit unnecessary antibiotic therapy and hospitalisation.	[Khumalo, Jermaine; Nicol, Mark; Bamford, Colleen] Univ Cape Town, Div Med Microbiol, Dept Pathol, Cape Town, South Africa; [Hardie, Diana; Bamford, Colleen] Natl Hlth Lab Serv, Johannesburg, South Africa; [Hardie, Diana] Univ Cape Town, Div Virol, Dept Pathol, Cape Town, South Africa; [Muloiwa, Rudzani; Mteshana, Phindile] Univ Cape Town, Dept Paediat, Cape Town, South Africa	University of Cape Town; National Health Laboratory Service; University of Cape Town; University of Cape Town	Bamford, C (corresponding author), Univ Cape Town, Div Med Microbiol, Dept Pathol, Cape Town, South Africa.; Bamford, C (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	colleen.bamford@uct.ac.za	Muloiwa, Rudzani/AAG-8139-2021; Muloiwa, Rudzani/AAY-7338-2020; hardie, diana/R-6870-2019; Nicol, Mark/W-4149-2019	Muloiwa, Rudzani/0000-0002-4527-0827; Nicol, Mark/0000-0002-1366-4805	National Health Laboratory Service Research Trust [004_94336]	National Health Laboratory Service Research Trust	This work was supported by National Health Laboratory Service Research Trust, http://www.nhls.ac. za/?page=nhls_research trust&id=32, Grant 004_94336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcali A, 2009, ARCH VIROL, V154, P1807, DOI 10.1007/s00705-009-0519-1; [Anonymous], 2012, GERMS SA SURV REP S; Archimbaud C, 2009, J MED VIROL, V81, P42, DOI 10.1002/jmv.21330; Archimbaud C, 2004, J MED VIROL, V74, P604, DOI 10.1002/jmv.20217; BLAZER S, 1983, AM J CLIN PATHOL, V80, P386, DOI 10.1093/ajcp/80.3.386; Bossuyt PM, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2016.02.06; Boving MK, 2009, J CLIN MICROBIOL, V47, P908, DOI 10.1128/JCM.01966-08; Brizzi K, 2012, PEDIATR INFECT DIS J, V31, P195, DOI 10.1097/INF.0b013e31823d7b6f; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Coulson GB, 2007, EMERG INFECT DIS, V13, P273, DOI 10.3201/eid1302.051553; Deer DM, 2010, LETT APPL MICROBIOL, V50, P366, DOI 10.1111/j.1472-765X.2010.02804.x; DONALD PR, 1986, S AFR MED J, V70, P391; DONALD PR, 1987, S AFR MED J, V71, P283; Favaro M, 2013, MOL BIOTECHNOL, V53, P74, DOI 10.1007/s12033-012-9534-7; Giulieri SG, 2015, J CLIN VIROL, V62, P58, DOI 10.1016/j.jcv.2014.11.001; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Gunson RN, 2008, J CLIN VIROL, V43, P372, DOI 10.1016/j.jcv.2008.08.020; Kanegaye JT, 2001, PEDIATRICS, V108, P1169; Kessler HH, 2000, J CLIN MICROBIOL, V38, P2638, DOI 10.1128/JCM.38.7.2638-2642.2000; LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857; McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007; MCINTYRE JP, 1993, EPIDEMIOL INFECT, V111, P357, DOI 10.1017/S095026880005706X; Negrini B, 2000, PEDIATRICS, V105, P316, DOI 10.1542/peds.105.2.316; Nesher L, 2016, EPIDEMIOL INFECT, V144, P189, DOI 10.1017/S0950268815000850; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nhantumbo AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138249; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Polage CR, 2016, J CLIN MICROBIOL, V54, P1197, DOI 10.1128/JCM.00289-16; Ratnamohan VM, 1998, J VIROL METHODS, V72, P59, DOI 10.1016/S0166-0934(98)00020-2; Rhein J, 2016, DIAGN MICR INFEC DIS, V84, P268, DOI 10.1016/j.diagmicrobio.2015.11.017; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Salgado MM, 2013, ARQ NEURO-PSIQUIAT, V71, P672, DOI 10.1590/0004-282X20130148; Shin SY, 2012, ANN LAB MED, V32, P44, DOI 10.3343/alm.2012.32.1.44; Tzanakaki G, 2005, CLIN MICROBIOL INFEC, V11, P386, DOI 10.1111/j.1469-0691.2005.01109.x; Uchida K, 2005, J MED VIROL, V75, P470, DOI 10.1002/jmv.20291; von Gottberg A, 2006, B WORLD HEALTH ORGAN, V84, P811, DOI 10.2471/BLT.06.030361; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Wolzak NK, 2012, J TROP PEDIATRICS, V58, P491, DOI 10.1093/tropej/fms031; Wootton SH, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0137-1; World Health Organization, COORD INV BACT VACC; Wu HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-26; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Zimba TF, 2009, J INFECT DEV COUNTR, V3, P723; ZOLL GJ, 1992, J CLIN MICROBIOL, V30, P160, DOI 10.1128/JCM.30.1.160-165.1992	49	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173948	10.1371/journal.pone.0173948	http://dx.doi.org/10.1371/journal.pone.0173948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346504	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300016
J	Li, J; Su, L; Gong, YY; Ding, ML; Hong, SB; Yu, S; Xiao, HP				Li, Jin; Su, Lei; Gong, Ying-ying; Ding, Mei-lin; Hong, Shu-bin; Yu, Shuang; Xiao, Hai-peng			Downregulation of miR-139-5p contributes to the antiapoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; COLORECTAL-CANCER; RECEPTOR; INSULIN; APOPTOSIS; EXPRESSION; MICRORNAS; PROLIFERATION; PATHWAYS	Liraglutide is administered as glucagon-like peptide-1 (GLP-1) receptor agonist for diabetic patients and can protect pancreatic beta-cells by inhibiting their apoptosis. MicroRNA-139-5p (miRNA-139-5p) participates in the regulation of cancer cell apoptosis. However, it is not clear whether miR-139-5p contributes to the anti-apoptotic effect of liraglutide in beta-cells. The objective of the present study was to investigate the role of miR-139-5p on apoptosis of pancreatic beta-cells. MicroRNA levels in pancreatic tissue from diabetic rats and INS-1 cells treated with liraglutide were measured by real-time quantitative RT-PCR. The role of miR139-5p on apoptosis was studied by transfecting INS-1 cells with miR-139-5p mimics. The mRNA and protein expression of the target gene, insulin receptor substrate-1 (IRS1), were measured by qRT-PCR and Western blot, respectively. Apoptosis in rat pancreatic tissue and INS-1 cells was detected by TUNEL and annexin V/propidium iodide costaining. Apoptosis of pancreatic tissue from diabetic rats and INS-1 cells was decreased by administration of liraglutide. The expression of miR-139-5p increased in the pancreas of diabetic rats and decreased with liraglutide treatment. Incubation with liraglutide (100 nM) for 48 h attenuated the expression of miR-139-5p and increased the mRNA and protein levels of IRS1. Direct regulatory effects of miR-139-5p on IRS1 were found by a dual-luciferase reporter assay. Transfection of INS-1 cells with miR-139-5p mimics led to decreases in the mRNA and protein expression of IRS1. In conclusion, our observations suggest that decreased miR-139-5p expression contributes to the anti-apoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1.	[Li, Jin; Su, Lei; Gong, Ying-ying; Ding, Mei-lin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Geriatr, Guangzhou, Guangdong, Peoples R China; [Hong, Shu-bin; Yu, Shuang; Xiao, Hai-peng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xiao, HP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	xiaohp@mail.sysu.edu.cn	Su, Lei/U-6875-2019		Natural Science Foundation of Guangdong Province [S2012010009346]; Chinese International Medical Foundation [201203]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Chinese International Medical Foundation	This study was supported by the Natural Science Foundation of Guangdong Province (S2012010009346); Chinese International Medical Foundation (201203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; Burnol AF, 2013, ANN ENDOCRINOL-PARIS, V74, P74, DOI 10.1016/j.ando.2013.02.003; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Han YB, 2012, CHINESE MED J-PEKING, V125, P4202, DOI 10.3760/cma.j.issn.0366-6999.2012.23.008; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; He TT, 2011, CHINESE MED J-PEKING, V124, P3657, DOI 10.3760/cma.j.issn.0366-6999.2011.22.011; Lee YS, 2014, METABOLISM, V63, P9, DOI 10.1016/j.metabol.2013.09.010; Li QG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27157; Lin XJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/258695; Lu HM, 2016, 2016 INTERNATIONAL SYMPOSIUM ON COMPUTER, CONSUMER AND CONTROL (IS3C), P34, DOI 10.1109/IS3C.2016.19; Mi L, 2015, J CELL BIOCHEM, V116, P1195, DOI 10.1002/jcb.25065; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Osmai M, 2016, DIABETES-METAB RES, V32, P334, DOI 10.1002/dmrr.2719; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Shang JG, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/397298; Shao SY, 2014, J CELL BIOCHEM, V115, P1166, DOI 10.1002/jcb.24763; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Shirakawa J, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0138-4; Sun CC, 2015, ONCOTARGET, V6, P39756, DOI 10.18632/oncotarget.5476; Tuduri E, 2016, TRENDS ENDOCRIN MET, V27, P304, DOI 10.1016/j.tem.2016.03.004; Vienberg S., 2016, ACTA PHYSL; Wang Z, 2016, TUMOUR BIOL; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Zhao HL, 2010, PANCREAS, V39, P843, DOI 10.1097/MPA.0b013e3181d12613	29	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173576	10.1371/journal.pone.0173576	http://dx.doi.org/10.1371/journal.pone.0173576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346520	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300009
J	Ramirez-Lopez, MT; Vazquez, M; Lomazzo, E; Hofmann, C; Blanco, RN; Alen, F; Anton, M; Decara, J; Arco, R; Orio, L; Suarez, J; Lutz, B; de Heras, RG; Bindila, L; de Fonseca, FR				Teresa Ramirez-Lopez, Maria; Vazquez, Mariam; Lomazzo, Ermelinda; Hofmann, Clementine; Noemi Blanco, Rosario; Alen, Francisco; Anton, Maria; Decara, Juan; Arco, Rocio; Orio, Laura; Suarez, Juan; Lutz, Beat; Gomez de Heras, Raquel; Bindila, Laura; Rodriguez de Fonseca, Fernando			A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIORS; LOW-BIRTH-WEIGHT; FATTY-ACIDS; PRENATAL EXPOSURE; CALORIC RESTRICTION; PROTEIN RESTRICTION; ENERGY HOMEOSTASIS; EATING-DISORDERS; DUTCH FAMINE; BODY-WEIGHT	Undernutrition during pregnancy has been associated to increased vulnerability to develop metabolic and behavior alterations later in life. The endocannabinoid system might play an important role in these processes. Therefore, we investigated the effects of a moderate maternal calorie-restricted diet on the levels of the endocannabinoid 2-arachidonoyl glycerol (2-AG), arachidonic acid (AA) and the N-acylethanolamines (NAEs) anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) in the brain of newborn rat offspring. We focused on brain structures involved in metabolism, feeding behavior, as well as emotional and cognitive responses. Female Wistar rats were assigned during the entire pregnancy to either control diet (C) or restriction diet (R), consisting of a 20% calorierestricted diet. Weight gain and caloric intake of rat dams were monitored and birth outcomes were assessed. 2-AG, AA and NAE levels were measured in hypothalamus, hippocampus and olfactory bulb of the offspring. R dams displayed lower gain weight from the middle pregnancy and consumed less calories during the entire pregnancy. Offspring from R dams were underweight at birth, but litter size was unaffected. In hypothalamus, R male offspring displayed decreased levels of AA and OEA, with no change in the levels of the endocannabinoids 2-AG and AEA. R female exhibited decreased 2-AG and PEA levels. The opposite was found in the hippocampus, where R male displayed increased 2-AG and AA levels, and R female exhibited elevated levels of AEA, AA and PEA. In the olfactory bulb, only R female presented decreased levels of AEA, AA and PEA. Therefore, a moderate diet restriction during the entire pregnancy alters differentially the endocannabinoids and/or endocannabinoid-related lipids in hypothalamus and hippocampus of the underweight offspring, similarly in both sexes, whereas sex-specific alterations occur in the olfactory bulb. Consequently, endocannabinoid and endocannabinoid-related lipid signaling alterations might be involved in the long-term and sexual dimorphism effects commonly observed after undernutrition and low birth weight.	[Teresa Ramirez-Lopez, Maria; Vazquez, Mariam; Noemi Blanco, Rosario; Alen, Francisco; Anton, Maria; Orio, Laura; Gomez de Heras, Raquel; Rodriguez de Fonseca, Fernando] Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Campus Somosaguas S-N, Madrid, Spain; [Vazquez, Mariam; Decara, Juan; Arco, Rocio; Suarez, Juan; Rodriguez de Fonseca, Fernando] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, IBIMA, Malaga, Spain; [Lomazzo, Ermelinda; Hofmann, Clementine; Lutz, Beat; Bindila, Laura] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany; [Suarez, Juan] Univ Malaga, Fac Ciencias, IBIMA, Dept Biol Celular Genet & Fisiol, Campus Teatinos S-N, Malaga, Spain	Complutense University of Madrid; Universidad de Malaga; Johannes Gutenberg University of Mainz; Universidad de Malaga	de Heras, RG; de Fonseca, FR (corresponding author), Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Campus Somosaguas S-N, Madrid, Spain.; de Fonseca, FR (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, IBIMA, Malaga, Spain.	rgomezhe@psi.ucm.es; fernando.rodriguez@ibima.eu	Alen, Francisco/I-3890-2017; de Heras, Raquel Gomez/F-3484-2016; Ramírez-López, María Teresa/AAB-5705-2021; Lutz, Beat/AAG-4538-2022; Suarez, Juan/I-5188-2015; Orio, Laura/F-4827-2016; Lutz, Beat/AFK-6229-2022; Anton, Maria/A-9767-2016; Decara Del Olmo, Juan Manuel/I-1931-2015	Alen, Francisco/0000-0002-3847-3503; de Heras, Raquel Gomez/0000-0002-5846-1059; Ramírez-López, María Teresa/0000-0002-3944-5264; Suarez, Juan/0000-0001-5254-9802; Orio, Laura/0000-0002-9614-4062; Anton, Maria/0000-0002-7232-6291; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Blanco Velilla, Rosario Noemi/0000-0003-0265-6655; Arco Gonzalez, Rocio/0000-0002-5618-5687	Institute de Salud Carlos III, Ministerio de Economia y Competitividad [PI12/02261, PI16/11698, PI16/01374, CP12/03109, PSI 2012-35388]; Red de Trastornos Adictivos UE/ERDF [RD12/0028/0001]; CIBERobn; Consejeria de Economia, Innovacion y Ciencia; Junta de Andalucia; UE/ERDF [PI45403, CTS-8221, CTS-433]; Consejeria de Salud, Junta de Andalucia [SAS111224]; German Research Foundation DFG [FOR926, CRC1080]; FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte [AP-2009-0225]; National System of Health, ISCIII [CP12/03109]	Institute de Salud Carlos III, Ministerio de Economia y Competitividad; Red de Trastornos Adictivos UE/ERDF; CIBERobn; Consejeria de Economia, Innovacion y Ciencia; Junta de Andalucia(Junta de Andalucia); UE/ERDF; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); German Research Foundation DFG(German Research Foundation (DFG)); FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte; National System of Health, ISCIII	This work was supported by the Institute de Salud Carlos III, Ministerio de Economia y Competitividad (PI12/02261 and PI16/11698 to FRF, PI16/01374 and CP12/03109 to JS, and PSI 2012-35388 to RGH), Red de Trastornos Adictivos UE/ERDF (RD12/0028/0001 to FRF), CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF (PI45403, CTS-8221, CTS-433 to FRF), Consejeria de Salud, Junta de Andalucia (SAS111224 to FRF), and the German Research Foundation DFG (FOR926, project CP1 to BL; CRC1080, subproject B08 to BL). MTRL has been funded by a FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte (AP-2009-0225); JS holds "Miguel Servet" research contract from the National System of Health, ISCIII (grant numbers CP12/03109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Akitake Y, 2015, NUTR RES, V35, P76, DOI 10.1016/j.nutres.2014.10.014; Almeida SS, 1996, PHYSIOL BEHAV, V60, P675, DOI 10.1016/S0031-9384(96)80047-3; Amusquivar E, 2003, BIOL NEONATE, V83, P136, DOI 10.1159/000067963; Antonelli T, 2005, CEREB CORTEX, V15, P2013, DOI 10.1093/cercor/bhi076; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Avraham Y, 2011, J NUTR BIOCHEM, V22, P766, DOI 10.1016/j.jnutbio.2010.07.001; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bindila L, 2016, METHODS MOL BIOL, V1412, P9, DOI 10.1007/978-1-4939-3539-0_2; Bolton JL, 2014, DIALOGUES CLIN NEURO, V16, P307; Campos AC, 2010, NEUROSCIENCE, V167, P238, DOI 10.1016/j.neuroscience.2010.01.062; Cetin I, 2009, J PHYSIOL-LONDON, V587, P3441, DOI 10.1113/jphysiol.2009.173062; Clarke DJ, 2017, PROG NEURO-PSYCHOPH, V72, P9, DOI 10.1016/j.pnpbp.2016.08.006; CoupE B, 2009, J NEUROENDOCRINOL, V21, P40, DOI 10.1111/j.1365-2826.2008.01806.x; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; de Salas-Quiroga A, 2015, P NATL ACAD SCI USA, V112, P13693, DOI 10.1073/pnas.1514962112; de Souza MA, 2012, PHYSIOL BEHAV, V105, P850, DOI 10.1016/j.physbeh.2011.10.012; DEFONSECA FR, 1991, NEUROSCIENCE, V43, P713, DOI 10.1016/0306-4522(91)90329-M; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Dyall SC, 2016, NEUROPHARMACOLOGY, V107, P387, DOI 10.1016/j.neuropharm.2016.03.055; Easter A, 2013, EUR EAT DISORD REV, V21, P340, DOI 10.1002/erv.2229; Fezza F, 2014, MOLECULES, V19, P17078, DOI 10.3390/molecules191117078; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Guggenhuber S, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv091; Hadley KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040216; Hansen HS, 2008, J NEUROENDOCRINOL, V20, P94, DOI 10.1111/j.1365-2826.2008.01687.x; Hansen HS, 2013, CNS NEUROL DISORD-DR, V12, P17; Herrera E, 2002, PLACENTA, V23, pS9, DOI 10.1053/plac.2002.0771; Hoareau L, 2010, DRUG DISCOVERY TODAY, V7, pe205, DOI [10.1016/j.ddmec.2011.01.002, DOI 10.1016/J.DDMEC.2011.01.002]; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Keimpema E, 2014, EUR J NEUROSCI, V39, P334, DOI 10.1111/ejn.12431; Keimpema E, 2013, BIOCHEM SOC T, V41, P1569, DOI 10.1042/BST20130117; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Levay EA, 2008, BEHAV BRAIN RES, V191, P164, DOI 10.1016/j.bbr.2008.03.021; LUCAS A, 1991, CIBA F SYMP, V156, P38; Lukaszewski MA, 2011, AM J PHYSIOL-ENDOC M, V301, pE548, DOI 10.1152/ajpendo.00011.2011; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Lutz B, 2015, NAT REV NEUROSCI, V16, P705, DOI 10.1038/nrn4036; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Maccarrone M, 2014, NAT REV NEUROSCI, V15, P786, DOI 10.1038/nrn3846; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Marques AH, 2015, BRAIN RES, V1617, P28, DOI 10.1016/j.brainres.2014.10.051; Matias I, 2003, CELL MOL LIFE SCI, V60, P382, DOI 10.1007/s000180300031; McMillen IC, 2004, ENDOCR RES, V30, P845, DOI 10.1081/ERC-200044106; Micali N, 2007, J PSYCHOSOM RES, V63, P297, DOI 10.1016/j.jpsychores.2007.05.003; Micali N, 2007, BRIT J PSYCHIAT, V190, P255, DOI 10.1192/bjp.bp.106.020768; Moreno M, 2005, BEHAV PHARMACOL, V16, P423, DOI 10.1097/00008877-200509000-00015; Morgese MG, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030024; Morgese MG, 2016, MOL NEUROBIOL; Nomura Y, 2007, COMPR PSYCHIAT, V48, P470, DOI 10.1016/j.comppsych.2007.04.005; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Pu SH, 2016, BRIT J NUTR, V115, P1012, DOI 10.1017/S0007114515005425; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00241; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00208; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Raso GM, 2014, ENDOCRINOLOGY, V155, P1291, DOI 10.1210/en.2013-1823; Reyes-Castro LA, 2012, BEHAV BRAIN RES, V227, P324, DOI 10.1016/j.bbr.2011.06.008; Reyes-Castro LA, 2012, INT J DEV NEUROSCI, V30, P39, DOI 10.1016/j.ijdevneu.2011.10.002; Rickards AL, 2001, J DEV BEHAV PEDIATR, V22, P11, DOI 10.1097/00004703-200102000-00002; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Suzuki M, 2010, J NUTR SCI VITAMINOL, V56, P293, DOI 10.3177/jnsv.56.293; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00339; Tibirica E, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-5; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Wenzel D, 2013, P NATL ACAD SCI USA, V110, P18710, DOI 10.1073/pnas.1308130110; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953; Zhang S, 2013, REPRODUCTION, V146, P443, DOI 10.1530/REP-13-0219	85	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174307	10.1371/journal.pone.0174307	http://dx.doi.org/10.1371/journal.pone.0174307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346523	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174300037
J	Gorbach, PM; Javanbakht, M; Bornfleth, L; Bolan, RK; Blum, ML				Gorbach, Pamina M.; Javanbakht, Marjan; Bornfleth, Lorelei; Bolan, Robert K.; Blum, Martha Lewis			Drug resistant HIV: Behaviors and characteristics among Los Angeles men who have sex with men with new HIV diagnosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDRUG-RESISTANT; ENZYME-IMMUNOASSAY; UNITED-STATES; INFECTED MEN; TRANSMISSION; RISK; PERSISTENCE; PREVALENCE	Epidemiology of drug resistant HIV has focused on trends and less attention has been given to identification of factors, especially behaviors including substance use, in acquisition of drug-resistant HIV. From 2009 to 2012 The Metromates Study enrolled and followed for one year men who have sex with men (MSM) seeking testing for HIV in a community clinic in Los Angeles assessing those testing positive for acute and recent HIV infection. Behavioral data were collected via Computer-Assisted Self-Interview from 125 classified as newly HIV infected and 91 as chronically infected (newly HIV-diagnosed); specimens were available and viable for resistance testing for 154 of the 216 HIV positives with new diagnoses. In this community clinic we found prevalence of resistance among MSM with new HIV-diagnosis was 19.5% (n = 30/154) with no difference by recency of HIV infection. Sexual partnership characteristics were associated with resistance; those who reported transgendered sex partners had a higher prevalence of resistance as compared to those who did not report transgendered sex partners (40% vs. 17%; p value = 0.04), while those who reported having a main partner had a lower prevalence of drug resistance (12% vs. 24%; p value = 0.07). In multivariable analyses adjusting for HIV recency and antiviral use, reporting a main partner decreased odds [adjusted odds ratio (AOR) 0.34; 95% confidence interval (CI) 0.13-0.87], reporting a transgendered partnered increased odds (AOR = 3.37; 95% CI 0.95-12.43); and being African American increased odds of drug resistance (AOR = 5.63, 95% CI 1.41-22.38). This suggests African American MSM and TG individuals in Los Angeles represent pockets of exceptional risk that will require special approaches to prevention and care to enhance their own health and reduce their likelihood to support transmission of drug resistance in the US.	[Gorbach, Pamina M.; Javanbakht, Marjan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Gorbach, Pamina M.; Bornfleth, Lorelei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Bolan, Robert K.] Los Angeles Gay Lesbian & Transgender Hlth Ctr, Los Angeles, CA USA; [Blum, Martha Lewis] Community Hosp Monterey Peninsula, Dept Med, Dept Publ Hlth, Monterey, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gorbach, PM (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.; Gorbach, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	pgorbach@ucla.edu	Javanbakht, Marjan/Q-2183-2019; Bolan, Robert/AAD-4716-2020	Javanbakht, Marjan/0000-0003-0088-3803; 	National Institute of Drug Abuse (PIPMG) [1R01-DA022116-01A1]; National Institute of Drug Abuse NIDA (PIs PMG) [U01DA036267]; National Institute of Allergy and Infectious Diseases [5P30AI028697]; National Institute of Mental Health (NIMH); National Institute of Drug Abuse (NIDA); Office of AIDS Research, of the National Institutes of Health [UM1-AI068613]; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036267, R01DA022116] Funding Source: NIH RePORTER	National Institute of Drug Abuse (PIPMG); National Institute of Drug Abuse NIDA (PIs PMG); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of AIDS Research, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse, 1R01-DA022116-01A1 (PIPMG); National Institute of Drug Abuse, U01DA036267 NIDA (PIs PMG); National Institute of Allergy and Infectious Diseases, 5P30AI028697; and National Institute of Allergy and Infectious Diseases and the National Institute of Mental Health (NIMH), and the National Institute of Drug Abuse (NIDA), Office of AIDS Research, of the National Institutes of Health (UM1-AI068613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manu script.	Ambrosioni J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125837; Barbour JD, 2004, AIDS, V18, P1683, DOI 10.1097/01.aids.0000131391.91468.ff; Booth C, 2006, ANTIRETROVIRAL RESIS; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; Centers for Disease Control, 2012, EST HIV INC AD AD US; Chen I, 2015, J ACQUIR IMMUNE DEFI; Delaugerre C, 2004, ANTIVIR THER, V9, P415; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Gorbach PM, 2008, JAIDS-J ACQ IMM DEF, V47, P639, DOI 10.1097/QAI.0b013e3181684c3d; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Huaman MA, 2011, INT J INFECT DIS, V15, pE764, DOI 10.1016/j.ijid.2011.06.007; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Johnson AS, 2013, MMWR-MORBID MORTAL W, V62, P112; Knox DC, 2017, NEW ENGL J MED, V376, P501, DOI 10.1056/NEJMc1611639; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Mbisa JL, 2015, CLIN INFECT DIS; Mensch BS, 2015, AIDS BEHAV; Morris M, 2008, SEXUALLY TRANSMITTED, P127; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Reback CJ, 2014, AIDS BEHAV, V18, P1359, DOI 10.1007/s10461-013-0657-z; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Sanchez TH, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu084; Sevelius JM, 2010, J ASSOC NURSE AIDS C, V21, P256, DOI 10.1016/j.jana.2010.01.005; Snoeck J, 2005, J VIROL METHODS, V128, P47, DOI 10.1016/j.jviromet.2005.04.001; Werb D, 2010, LANCET INFECT DIS, V10, P464, DOI 10.1016/S1473-3099(10)70097-9	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173892	10.1371/journal.pone.0173892	http://dx.doi.org/10.1371/journal.pone.0173892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333950	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200027
J	Solari, P; Rivelli, N; De Rose, F; Picciau, L; Murru, L; Stoffolano, JG; Liscia, A				Solari, Paolo; Rivelli, Nicholas; De Rose, Francescaelena; Picciau, Lorenzo; Murru, Ludovico; Stoffolano, John G., Jr.; Liscia, Anna			Opposite effects of 5-HT/AKH and octopamine on the crop contractions in adult Drosophila melanogaster: Evidence of a double brain-gut serotonergic circuitry	PLOS ONE			English	Article							PHORMIA-REGINA MEIGEN; STOMATOGASTRIC NERVOUS-SYSTEM; INSULIN-LIKE PEPTIDE; FEEDING-BEHAVIOR; SUPERCONTRACTILE MUSCLES; DIPTERA-CALLIPHORIDAE; FOREGUT CONTRACTIONS; PARKINSONS-DISEASE; SIGNALING PATHWAYS; LOCUSTA-MIGRATORIA	This study showed that in adult Drosophila melanogaster, the type of sugar - either present within the crop lumen or in the bathing solution of the crop - had no effect on crop muscle contraction. What is important, however, is the volume within the crop lumen. Electrophysiological recordings demonstrated that exogenous applications of serotonin on crop muscles increases both the amplitude and the frequency of crop contraction rate, while adipokinetic hormone mainly enhances the crop contraction frequency. Conversely, octopamine virtually silenced the overall crop activity. The present study reports for the first time an analysis of serotonin effects along the gut-brain axis in adult D. melanogaster. Injection of serotonin into the brain between the interocellar area shows that brain applications of serotonin decrease the frequency of crop activity. Based on our results, we propose that there are two different, opposite pathways for crop motility control governed by serotonin: excitatory when added in the abdomen (i.e., directly bathing the crop) and inhibitory when supplied within the brain (i.e., by injection). Finally, our results point to a double brain-gut serotonergic circuitry suggesting that not only the brain can affect gut functions, but the gut can also affect the central nervous system. On the basis of our results, and data in the literature, a possible mechanism for these two discrete serotonergic functions is suggested.	[Solari, Paolo; De Rose, Francescaelena; Picciau, Lorenzo; Murru, Ludovico; Liscia, Anna] Univ Cagliari, Dept Biomed Sci, Univ Campus,SP 8, Monserrato, CA, Italy; [Rivelli, Nicholas; Stoffolano, John G., Jr.] Univ Massachusetts, Coll Nat Sci, Stockbridge Sch Agr, Amherst, MA 01003 USA	University of Cagliari; University of Massachusetts System; University of Massachusetts Amherst	Liscia, A (corresponding author), Univ Cagliari, Dept Biomed Sci, Univ Campus,SP 8, Monserrato, CA, Italy.	liscia@unica.it		/0000-0001-8785-1438; Liscia, Anna/0000-0002-1629-2090	National Institute of Food and Agriculture; U.S. Department of Agriculture; Massachusetts Agricultural Experiment Stationand the Stock bridge School of Agriculture at the University of Massachusetts; Amherst [MAS00448]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Massachusetts Agricultural Experiment Stationand the Stock bridge School of Agriculture at the University of Massachusetts; Amherst	This study is based up on research supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, the Massachusetts Agricultural Experiment Stationand the Stock bridge School of Agriculture at the University of Massachusetts, Amherst, under project number MAS00448 to JGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Audsley N, 2015, PEPTIDES, V68, P33, DOI 10.1016/j.peptides.2014.08.006; Bednarova A, 2013, COMP BIOCHEM PHYS A, P91; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Borrelli L, 2016, SCI REP-UK, V6, DOI 10.1038/srep30046; BOWDAN E, 1986, J COMP PHYSIOL A, V158, P713, DOI 10.1007/BF00603829; BROOKHART GL, 1987, J NEUROCHEM, V48, P1307, DOI 10.1111/j.1471-4159.1987.tb05662.x; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Cegla J, 2010, CURR OPIN CLIN NUTR, V13, P588, DOI 10.1097/MCO.0b013e32833b64a3; Clegg JS, 1961, SCIENCE, P134; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; DAY MF, 1954, AUST J BIOL SCI, V7, P515, DOI 10.1071/BI9540515; de Castro JM, 2010, PHYSIOL BEHAV, V100, P446, DOI 10.1016/j.physbeh.2010.04.028; De Rose F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146140; Douglas SJ, 2005, TRENDS NEUROSCI, V28, P644, DOI 10.1016/j.tins.2005.09.006; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Duttlinger A, 2002, PEPTIDES, V23, P1953, DOI 10.1016/S0196-9781(02)00179-1; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; ELKINS T, 1988, J NEUROSCI, V8, P428; GELPERIN A, 1972, AM ZOOL, V12, P489; GELPERIN A, 1966, J INSECT PHYSIOL, V12, P829, DOI 10.1016/0022-1910(66)90034-5; GELPERIN A, 1971, Z VERGL PHYSIOL, V72, P17, DOI 10.1007/BF00299201; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gorissen MHAG, 2006, ANIM BIOL, V56, P447, DOI 10.1163/157075606778967829; Goy MF, 1984, J NEUROSCIENCE OFFIC, P611; Graham-Smith G. S., 1934, Parasitology Cambridge, V26, P176, DOI 10.1017/S0031182000023520; Haselton AT, 2009, J INSECT BEHAV, V22, P452, DOI 10.1007/s10905-009-9184-1; Haselton AT, 2006, J INSECT PHYSIOL, V52, P436, DOI 10.1016/j.jinsphys.2005.12.003; Haselton AT, 2004, J MED ENTOMOL, V41, P684, DOI 10.1603/0022-2585-41.4.684; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Howarth CJ, 2002, J INSECT PHYSIOL, V48, P43, DOI 10.1016/S0022-1910(01)00142-1; Hsu CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20259; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kaminski S, 2002, J NEUROGENET, V16, P125, DOI 10.1080/01677060213156; KATZ AJ, 1975, GENETICS, V81, P163; Kuebler D, 2002, BRAIN RES, V958, P36, DOI 10.1016/S0006-8993(02)03431-5; Lange AB, 2008, J INSECT PHYSIOL, V54, P222, DOI 10.1016/j.jinsphys.2007.09.005; LANGLEY P. A., 1965, PROC ZOOL SOC LONDON, V144, P415; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Liscia A, 2012, J INSECT PHYSIOL, V58, P356, DOI 10.1016/j.jinsphys.2011.12.010; Liu SS, 2011, ARCH INSECT BIOCHEM, V77, P199, DOI 10.1002/arch.20434; LONG TF, 1983, P NATL ACAD SCI-BIOL, V80, P4159, DOI 10.1073/pnas.80.13.4159; LUFFY D, 1992, J INSECT PHYSIOL, V38, P287, DOI 10.1016/0022-1910(92)90129-2; Luo JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099732; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Magalhaes CP, 2010, NUTR NEUROSCI, V13, P246, DOI 10.1179/147683010X12611460764723; Majeed ZR, 2014, J COMP PHYSIOL B, V184, P205, DOI 10.1007/s00360-013-0795-7; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Merte J, 2002, PEPTIDES, V23, P209, DOI 10.1016/S0196-9781(01)00598-8; Merte J, 2002, PEPTIDES, V23, P757, DOI 10.1016/S0196-9781(01)00670-2; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Miguel-Aliaga I, 2012, SEMIN CELL DEV BIOL, V23, P614, DOI 10.1016/j.semcdb.2012.01.002; Miyamoto T, 2013, CURRENT BIOL; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Moffett SB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.20; Moloo S. K, 1970, Acta Tropica, V27, P356; Mukherjee A, 2016, WORLD J GASTROENTERO, V22, P5742, DOI 10.3748/wjg.v22.i25.5742; Nassel D. R., 2013, FRONT PHYSIOL, P4; Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nichols R, 2003, ANNU REV ENTOMOL, V48, P485, DOI 10.1146/annurev.ento.48.091801.112525; Palmer GC, 2007, J INSECT PHYSIOL, V53, P1125, DOI 10.1016/j.jinsphys.2007.06.001; Pellegrini C, 2015, PARKINSONISM RELAT D, V21, P1407, DOI 10.1016/j.parkreldis.2015.10.011; Poddighe S, 2013, PLOS ONE, P8; Price MD, 2002, PEPTIDES, V23, P787, DOI 10.1016/S0196-9781(01)00649-0; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Richer S, 2000, J COMP NEUROL, V421, P136; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Siddiqi O, 1980, Basic Life Sci, V16, P347; SIMPSON SJ, 1983, APPETITE, V4, P313, DOI 10.1016/S0195-6663(83)80024-5; Solari P, 2013, J INSECT PHYSIOL, V59, P942, DOI 10.1016/j.jinsphys.2013.06.010; Stoffolano JG, 2007, J INSECT PHYSIOL, V53, P1293, DOI 10.1016/j.jinsphys.2007.07.002; Stoffolano J.G. Jr, 1995, P210; Stoffolano JG, 2014, J INSECT PHYSIOL, V71, P147, DOI 10.1016/j.jinsphys.2014.10.014; Stoffolano JG, 2014, ANN ENTOMOL SOC AM, V107, P848, DOI 10.1603/AN13127; Stoffolano JG, 2013, ANNU REV ENTOMOL, V58, P205, DOI 10.1146/annurev-ento-120811-153653; Stoffolano JG, 2010, ARTHROPOD STRUCT DEV, V39, P251, DOI 10.1016/j.asd.2010.01.004; THOMSON AJ, 1975, CAN ENTOMOL, V107, P1193, DOI 10.4039/Ent1071193-11; THOMSON AJ, 1975, CAN J ZOOL, V53, P451, DOI 10.1139/z75-058; THOMSON AJ, 1975, CAN ENTOMOL, V107, P167, DOI 10.4039/Ent107167-2; Trumm P, 2000, PHYTOPARASITICA, V28, P7, DOI 10.1007/BF02994020; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; YANO T, 1986, EXP BIOL, V46, P37	92	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174172	10.1371/journal.pone.0174172	http://dx.doi.org/10.1371/journal.pone.0174172			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334024	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200057
J	Voskarides, K; Stefanou, C; Pieri, M; Demosthenous, P; Felekkis, K; Arsali, M; Athanasiou, Y; Xydakis, D; Stylianou, K; Daphnis, E; Goulielmos, G; Loizou, P; Savige, J; Hohne, M; Volker, LA; Benzing, T; Maxwell, PH; Gale, DP; Gorski, M; Boger, C; Kollerits, B; Kronenberg, F; Paulweber, B; Zavros, M; Pierides, A; Deltas, C				Voskarides, Konstantinos; Stefanou, Charalambos; Pieri, Myrtani; Demosthenous, Panayiota; Felekkis, Kyriakos; Arsali, Maria; Athanasiou, Yiannis; Xydakis, Dimitris; Stylianou, Kostas; Daphnis, Eugenios; Goulielmos, Giorgos; Loizou, Petros; Savige, Judith; Hoehne, Martin; Voelker, Linus A.; Benzing, Thomas; Maxwell, Patrick H.; Gale, Daniel P.; Gorski, Mathias; Boeger, Carsten; Kollerits, Barbara; Kronenberg, Florian; Paulweber, Bernhard; Zavros, Michalis; Pierides, Alkis; Deltas, Constantinos			A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; CHRONIC KIDNEY-DISEASE; FAMILIAL HEMATURIA; SLIT DIAPHRAGM; MUTATIONS; PROTEINURIA; PROGRESSION; COL4A4; MODEL	Background Recent data emphasize that thin basement membrane nephropathy (TBMN) should not be viewed as a form of benign familial hematuria since chronic renal failure (CRF) and even end-stage renal disease (ESRD), is a possible development for a subset of patients on longterm follow-up, through the onset of focal and segmental glomerulosclerosis (FSGS). We hypothesize that genetic modifiers may explain this variability of symptoms. Methods We looked in silico for potentially deleterious functional SNPs, using very strict criteria, in all the genes significantly expressed in the slit diaphragm (SD). Two variants were genotyped in a cohort of well-studied adult TBMN patients from 19 Greek-Cypriot families, with a homogeneous genetic background. Patients were categorized as "Severe" or "Mild", based on the presence or not of proteinuria, CRF and ESRD. A larger pooled cohort (HEMATURIA) of 524 patients, including IgA nephropathy patients, was used for verification. Additionally, three large general population cohorts [Framingham Heart Study (FHS), KORAF4 and SAPHIR] were used to investigate if the NEPH3-V353M variant has any renal effect in the general population. Results and conclusions Genotyping for two high-scored variants in 103 TBMN adult patients with founder mutations who were classified as mildly or severely affected, pointed to an association with variant NEPH3-V353M (filtrin). This promising result prompted testing in the larger pooled cohort (HEMATURIA), indicating an association of the 353M variant with disease severity under the dominant model (p = 3.0x10(-3), OR = 6.64 adjusting for gender/age; allelic association: p = 4.2x10(-3) adjusting for patients' kinships). Subsequently, genotyping 6,531 subjects of the Framingham Heart Study (FHS) revealed an association of the homozygous 353M/M genotype with microalbuminuria (p = 1.0x10(-3)). Two further general population cohorts, KORAF4 and SAPHIR confirmed the association, and a meta-analysis of all three cohorts (11,258 individuals) was highly significant (p = 1.3x10(-5), OR = 7.46). Functional studies showed that Neph3 homodimerization and Neph3-Nephrin heterodimerization are disturbed by variant 353M. Additionally, 353M was associated with differential activation of the unfolded protein response pathway, when overexpressed in stressed cultured undifferentiated podocyte cells, thus attesting to its functional significance. Genetics and functional studies support a "rare variant-strong effect" role for NEPH3-V353M, by exerting a negative modifier effect on primary glomerular hematuria. Additionally, genetics studies provide evidence for a role in predisposing homozygous subjects of the general population to microalbuminuria.	[Voskarides, Konstantinos; Stefanou, Charalambos; Pieri, Myrtani; Demosthenous, Panayiota; Felekkis, Kyriakos; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Voskarides, Konstantinos; Stefanou, Charalambos; Pieri, Myrtani; Demosthenous, Panayiota; Felekkis, Kyriakos; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus; [Arsali, Maria] Limassol Gen Hosp, Dept Nephrol, Limassol, Cyprus; [Athanasiou, Yiannis; Zavros, Michalis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Xydakis, Dimitris; Stylianou, Kostas; Daphnis, Eugenios] Univ Crete, Dept Nephrol, Iraklion, Crete, Greece; [Goulielmos, Giorgos] Univ Crete, Sect Mol Med & Human Genet, Sch Med, Dept Internal Med, Iraklion, Greece; [Loizou, Petros] Private Clin Lab, Paralimni, Cyprus; [Savige, Judith] Univ Melbourne, Dept Med, Northern Hlth, Epping, NSW, Australia; [Hoehne, Martin; Voelker, Linus A.; Benzing, Thomas] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Hoehne, Martin; Voelker, Linus A.; Benzing, Thomas] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Hoehne, Martin; Benzing, Thomas] Univ Cologne, Syst Biol Ageing Cologne Sybacol, Cologne, Germany; [Benzing, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Maxwell, Patrick H.] UCL, Div Med, London, England; [Gale, Daniel P.] UCL, UCL Ctr Nephrol, London, England; [Gorski, Mathias; Boeger, Carsten] Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Gorski, Mathias] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Kollerits, Barbara; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; [Paulweber, Bernhard] Paracelsus Private Med Univ Salzburg, Dept Internal Med 1, Salzburg, Austria; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus; [Voskarides, Konstantinos] Univ Cyprus, Sch Med, Nicosia, Cyprus; [Felekkis, Kyriakos] Univ Nicosia, Sch Sci & Engn, Nicosia, Cyprus	University of Cyprus; University of Cyprus; University of Crete; University of Crete; University of Melbourne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of London; University College London; University of London; University College London; University of Regensburg; University of Regensburg; Medical University of Innsbruck; Paracelsus Private Medical University; Hippocrateon Private Hospital; University of Cyprus; University of Nicosia	Deltas, C (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.; Deltas, C (corresponding author), Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus.	deltas@ucy.ac.cy	Völker, Linus Alexander/GLV-0326-2022; Stylianou, Konstantinos/C-5868-2009; Stylianou, Konstantinos/H-2806-2019; Maxwell, Patrick H/C-5557-2008; Kronenberg, Florian/B-1736-2008; Benzing, Thomas/X-5476-2019; Deltas, Constantinos/A-4936-2013; Gale, Daniel/D-5594-2013; Voskarides, Konstantinos/A-4669-2013	Völker, Linus Alexander/0000-0002-4461-6128; Stylianou, Konstantinos/0000-0003-3678-9421; Stylianou, Konstantinos/0000-0003-3678-9421; Maxwell, Patrick H/0000-0002-0338-2679; Kronenberg, Florian/0000-0003-2229-1120; Deltas, Constantinos/0000-0001-5549-9169; Gale, Daniel/0000-0002-9170-1579; Voskarides, Konstantinos/0000-0002-3705-3451; Stefanou, Harris/0000-0002-0615-986X; Pieri, Myrtani/0000-0002-8883-4434; Hohne, Martin/0000-0001-8698-5389; Felekkis, Kyriacos/0000-0002-0919-0037	Cyprus Research Promotion Foundation [PiENEK/ENISigmaX/0505/02, PiENEK/ENISigmaX/0308/08]; European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation [NEW INFRASTRUCTURE/STRATEGIC/0308/24]; University of Cyprus [3/311, 3/346]; Else Kroner-Fresenius-Stiftung [2012_A147, P48/08//A11/08]; Kamillo Eisner Stiftung from the Medizinische Forschungsgesellschaft Salzburg; Paracelsus Medical University Salzburg [08/07/039]; "Genomics of Lipid associated Disorders GOLD" of the "Austrian Genome Research Programme GEN-AU"; Austrian Heart Fund; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC25195]; Private Clinical Laboratory, Paralimni, Cyprus; National Institute for Health Research [NF-SI-0514-10122] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	Cyprus Research Promotion Foundation; European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation; University of Cyprus; Else Kroner-Fresenius-Stiftung; Kamillo Eisner Stiftung from the Medizinische Forschungsgesellschaft Salzburg; Paracelsus Medical University Salzburg; "Genomics of Lipid associated Disorders GOLD" of the "Austrian Genome Research Programme GEN-AU"; Austrian Heart Fund; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; Private Clinical Laboratory, Paralimni, Cyprus; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was partly supported from the Cyprus Research Promotion Foundation, through the grants Pi ENEK/ENI Sigma X/0505/02, Pi ENEK/ENI Sigma X/0308/08 and a grant co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project NEW INFRASTRUCTURE/STRATEGIC/0308/24 to CD), and through the University of Cyprus Articles 3/311 and 3/346 (CD). Parts of this work were funded by the Else Kroner-Fresenius-Stiftung (grant 2012_A147 to CAB. The SAPHIR study was partially supported by a grant from the Kamillo Eisner Stiftung from the Medizinische Forschungsgesellschaft Salzburg, from the Paracelsus Medical University Salzburg (08/07/039) to BP and by grants from the "Genomics of Lipid associated Disorders GOLD" of the "Austrian Genome Research Programme GEN-AU" and the Austrian Heart Fund to FK. Replication genotyping was funded by the Else Kroner-Fresenius-Stiftung (P48/08//A11/08; to CAB, BKK). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or conclusions of the Framingham Heart Study or the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Private Clinical Laboratory, Paralimni, Cyprus provided support in the form of salaries for authors (PL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Parts of this work were funded by the Else Kroner-Fresenius-Stiftung (grant 2012_A147 to CAB)".	Andrews KL, 2002, AM J PATHOL, V160, P721, DOI 10.1016/S0002-9440(10)64892-4; Athanasiou Y, 2011, CLIN J AM SOC NEPHRO, V6, P1436, DOI 10.2215/CJN.09541010; Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248; Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Baumeister SE, 2010, AM J NEPHROL, V31, P222, DOI 10.1159/000272937; Beirowski B, 2006, J AM SOC NEPHROL, V17, P1986, DOI 10.1681/ASN.2005101044; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Buzza M, 2001, KIDNEY INT, V60, P480, DOI 10.1046/j.1523-1755.2001.060002480.x; Cheng WR, 2011, NEPHROL DIAL TRANSPL, V26, P2544, DOI 10.1093/ndt/gfq768; Deltas C, 2011, PEDIAT NEPHROL; Deltas C, 2015, NEPHRON, V130, P271, DOI 10.1159/000435789; Deltas C, 2013, NEPHROL DIAL TRANSPL, V28, P2946, DOI 10.1093/ndt/gft253; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fogazzi GB, 2008, PEDIATR NEPHROL, V23, P1093, DOI 10.1007/s00467-008-0777-2; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Gast C, 2016, NEPHROL DIAL TRANSPL, V31, P961, DOI 10.1093/ndt/gfv325; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hoefele J, 2010, PEDIATR NEPHROL, V25, P1539, DOI 10.1007/s00467-010-1467-4; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hsu SIH, 2000, KIDNEY INT, V57, P1818, DOI 10.1046/j.1523-1755.2000.00032.x; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Ihalmo P, 2003, BIOCHEM BIOPH RES CO, V300, P364, DOI 10.1016/S0006-291X(02)02854-1; Ihalmo P, 2007, NEPHROL DIAL TRANSPL, V22, P1903, DOI 10.1093/ndt/gfm135; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Kamiyoshi N, 2016, CLIN J AM SOC NEPHRO; Kashtan CE, 2005, PEDIATR NEPHROL, V20, P1027, DOI 10.1007/s00467-005-1859-z; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kitamura M, 2008, CLIN EXP NEPHROL, V12, P317, DOI 10.1007/s10157-008-0060-7; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Littman MP, 2013, MAMM GENOME, V24, P119, DOI 10.1007/s00335-012-9445-8; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu M, 2010, J AM SOC NEPHROL, V21, P1510, DOI 10.1681/ASN.2010030237; Malone AF, 2014, KIDNEY INT, V86, P1253, DOI 10.1038/ki.2014.305; NATHAN DM, 1987, DIABETES CARE, V10, P414, DOI 10.2337/diacare.10.4.414; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; Papazachariou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115015; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Seri M, 2000, NAT GENET, V26, P103; Singh A, 2011, PEDIATR NEPHROL, V26, P1957, DOI 10.1007/s00467-011-1777-1; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Temme J, 2012, KIDNEY INT, V81, P779, DOI 10.1038/ki.2011.452; Tonna S, 2008, PEDIATR NEPHROL, V23, P2201, DOI 10.1007/s00467-008-0934-7; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Voskarides K, 2008, CONNECT TISSUE RES, V49, P283, DOI 10.1080/03008200802148280; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Voskarides K, 2012, PEDIATR NEPHROL, V27, P675, DOI 10.1007/s00467-011-2084-6; Vujic M, 2010, J AM SOC NEPHROL, V21, P1097, DOI 10.1681/ASN.2009101070; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Xie JY, 2015, J MOL CELL BIOL, V7, P184, DOI 10.1093/jmcb/mjv023; YOSHIDA H, 1995, J CLIN INVEST, V96, P2162, DOI 10.1172/JCI118270	65	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174274	10.1371/journal.pone.0174274	http://dx.doi.org/10.1371/journal.pone.0174274			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334007	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200069
J	Werley, CA; Chien, MP; Gaublomme, J; Shekhar, K; Butty, V; Yi, BA; Kralj, JM; Bloxham, W; Boyer, LA; Regev, A; Cohen, AE				Werley, Christopher A.; Chien, Miao-Ping; Gaublomme, Jellert; Shekhar, Karthik; Butty, Vincent; Yi, B. Alexander; Kralj, Joel M.; Bloxham, William; Boyer, Laurie A.; Regev, Aviv; Cohen, Adam E.			Geometry-dependent functional changes in iPSC-derived cardiomyocytes probed by functional imaging and RNA sequencing	PLOS ONE			English	Article							PLURIPOTENT STEM-CELL; ACTION-POTENTIALS; CARDIAC-CELLS; MATURATION; CULTURE; CALCIUM; DIFFERENTIATION; VOLTAGE; STIMULATION; MYOCARDIUM	Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are a promising platform for cardiac studies in vitro, and possibly for tissue repair in humans. However, hiPSC-CM cells tend to retain morphology, metabolism, patterns of gene expression, and electrophysiology similar to that of embryonic cardiomyocytes. We grew hiPSC-CM in patterned islands of different sizes and shapes, and measured the effect of island geometry on action potential waveform and calcium dynamics using optical recordings of voltage and calcium from 970 islands of different sizes. hiPSC-CM in larger islands showed electrical and calcium dynamics indicative of greater functional maturity. We then compared transcriptional signatures of the small and large islands against a developmental time course of cardiac differentiation. Although island size had little effect on expression of most genes whose levels differed between hiPSC-CM and adult primary CM, we identified a subset of genes for which island size drove the majority (58%) of the changes associated with functional maturation. Finally, we patterned hiPSC-CM on islands with a variety of shapes to probe the relative contributions of soluble factors, electrical coupling, and direct cell-cell contacts to the functional maturation. Collectively, our data show that optical electrophysiology is a powerful tool for assaying hiPSC-CM maturation, and that island size powerfully drives activation of a subset of genes involved in cardiac maturation.	[Werley, Christopher A.; Chien, Miao-Ping; Yi, B. Alexander; Kralj, Joel M.; Bloxham, William; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gaublomme, Jellert; Shekhar, Karthik; Regev, Aviv] Broad Inst, Cambridge, MA USA; [Butty, Vincent; Boyer, Laurie A.; Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Butty, Vincent; Boyer, Laurie A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Butty, Vincent] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Regev, Aviv; Cohen, Adam E.] Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Yi, B. Alexander] Novartis Inst BioMed Res, Cambridge, MA USA; [Kralj, Joel M.] CU Boulder, BioFrontiers Inst, Boulder, CO USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Harvard University; Novartis; University of Colorado System; University of Colorado Boulder	Cohen, AE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Cohen, AE (corresponding author), Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Cohen, AE (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	cohen@chemistry.harvard.edu		Butty, Vincent/0000-0003-1173-2429; Chien, Miao-Ping/0000-0002-6087-4688; Bloxham, Blox/0000-0002-6133-8414	Office of Naval Research grant [N000141110-549]; National Institute of Health grant [R01-EB012498, DP2-0D007428]; Gordon and Betty Moore Foundation Life Science Research Foundation Postdoctoral Fellowship [GBMF2550.05]; National Science Foundation Science and Technology Center for Emergent Behaviors of Integrated Cellular Systems [CBET-0939511]; National Cancer Institute of the National Institutes of Health [P30-CA14051]; Howard Hughes Medical Institute	Office of Naval Research grant(Office of Naval Research); National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation Life Science Research Foundation Postdoctoral Fellowship; National Science Foundation Science and Technology Center for Emergent Behaviors of Integrated Cellular Systems; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Office of Naval Research grant N000141110-549 (AEC), National Institute of Health grants R01-EB012498 (AEC) and New Innovator grant DP2-0D007428 (AEC), Gordon and Betty Moore Foundation Life Science Research Foundation Postdoctoral Fellowship GBMF2550.05 (MPG), National Science Foundation Science and Technology Center for Emergent Behaviors of Integrated Cellular Systems (CBET-0939511) (LAB), National Cancer Institute of the National Institutes of Health under award P30-CA14051 to the BioMicro Center (LAB), and the Howard Hughes Medical Institute (AEC and AR). We thank Emil Hansson for helpful discussions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Emil Hansson for helpful discussions. This work was supported by Office of Naval Research grant N000141110-549 (AEC), National Institute of Health grants 1-R01-EB012498-01 (AEC) and New Innovator grant 1-DP2-0D007428 (AEC), Gordon and Betty Moore Foundation Life Science Research Foundation Postdoctoral Fellowship GBMF2550.05 (MPC), National Science Foundation Science and Technology Center for Emergent Behaviors of Integrated Cellular Systems (CBET-0939511) (LAB), National Cancer Institute of the National Institutes of Health under award P30-CA14051 to the BioMicro Center (LAB), and the Howard Hughes Medical Institute (AEC and AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev RR, 1996, CHAOS SOLITON FRACT, V7, P293, DOI 10.1016/0960-0779(95)00089-5; Babiarz JE, 2012, STEM CELLS DEV, V21, P1956, DOI 10.1089/scd.2011.0357; Berg, 2018, RANDOM WALKS BIOL; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Chan YC, 2013, J CARDIOVASC TRANSL, V6, P989, DOI 10.1007/s12265-013-9510-z; Chang CW, 2016, PROTEOM CLIN APPL, V10, P39, DOI 10.1002/prca.201500030; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cretu Alexandra, 2010, J Vis Exp, DOI 10.3791/2089; Dempsey GT, 2016, J PHARMACOL TOX MET, V81, P240, DOI 10.1016/j.vascn.2016.05.003; Du DTM, 2015, BIOPHYS J, V108, P1, DOI 10.1016/j.bpj.2014.11.008; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Entcheva E, 2016, J PHYSIOL-LONDON, V594, P2503, DOI 10.1113/JP271559; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gumbel EJ, 2012, STAT EXTREMES COURIE; Hansen DK, 2016, STEM CELLS TOXICOLOG, P71; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Higuchi S, 2013, J BIOSCI BIOENG, V115, P320, DOI 10.1016/j.jbiosc.2012.10.004; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hou JH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00344; Jackman CP, 2016, BIOMATERIALS, V111, P66, DOI 10.1016/j.biomaterials.2016.09.024; Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li RK, 1996, CARDIOVASC RES, V32, P362, DOI 10.1016/0008-6363(96)00079-X; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Myers FB, 2013, INTEGR BIOL-UK, V5, P1495, DOI 10.1039/c2ib20191g; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; Paci M, 2013, ANN BIOMED ENG, V41, P2334, DOI 10.1007/s10439-013-0833-3; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38; Rao C, 2013, BIOMATERIALS, V34, P2399, DOI 10.1016/j.biomaterials.2012.11.055; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Ribeiro MC, 2015, BIOMATERIALS, V51, P138, DOI 10.1016/j.biomaterials.2015.01.067; Salick MR, 2014, BIOMATERIALS, V35, P4454, DOI 10.1016/j.biomaterials.2014.02.001; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Stoppel WL, 2016, ADV DRUG DELIVER REV, V96, P135, DOI 10.1016/j.addr.2015.07.009; Totaro A, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/2/025014; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Veerman CC, 2015, STEM CELLS DEV, V24, P1035, DOI 10.1089/scd.2014.0533; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang X., 2016, ELIFE, V5; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; Yang XL, 2014, J MOL CELL CARDIOL, V72, P296, DOI 10.1016/j.yjmcc.2014.04.005; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558; Yu T, 2013, CIRC J, V77, P1297, DOI 10.1253/circj.CJ-12-0977; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026; Zuppinger C, 2016, BBA-MOL CELL RES, V1863, P1873, DOI 10.1016/j.bbamcr.2015.11.036	56	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0172671	10.1371/journal.pone.0172671	http://dx.doi.org/10.1371/journal.pone.0172671			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333933	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200007
J	Winkler, MKH; Boets, P; Hahne, B; Goethals, P; Volcke, EIP				Winkler, Mari. -K. H.; Boets, Pieter; Hahne, Birk; Goethals, Peter; Volcke, Eveline I. P.			Effect of the dilution rate on microbial competition: r-strategist can win over k-strategist at low substrate concentration	PLOS ONE			English	Article							NITRITE-OXIDIZING BACTERIA; KINETIC CHARACTERIZATION; POPULATION-DYNAMICS; NITRIFYING BACTERIA; GRANULAR SLUDGE; NITROSPIRA SPP.; NITROBACTER; GROWTH; WATER; ENRICHMENT	The conditions present in both in vitro and in vivo ecosystems determine the microbial population harbouring it. One commonly accepted theory is that a species with a high substrate affinity and low growth rate (k-strategist) will win the competition against a second species with a lower substrate affinity and higher growth rate (r-strategist) if both species are subjected to low substrate concentrations. In this study two nitrite oxidizing bacteria (NOB), Nitrospira defluvii (k-strategist) and Nitrobacter vulgaris (r-strategist), were cultivated in a continuous reactor systems. The minimal hydraulic retention time (HRT) required for maintaining the slower growing Nitrospira was first determined. A reactor containing Nitrobacter was set to the same HRT and Nitrospira was injected to evaluate the effect of the dilution rate on the competition between both species. By following the microbial population dynamics with qPCR analysis, it was shown that not only the substrate affinity drives the competition between k- and r-strategists but also the dilution rate. Experimental data and numerical simulations both revealed that the washout of Nitrobacter was significantly delayed at dilution rates close to the mu max of Nitrospira. The competition could be even reverted towards Nitrobacter (r-strategist) despite of low nitrite concentrations and dilution rates lower than the ae max of Nitrospira.	[Winkler, Mari. -K. H.; Hahne, Birk; Volcke, Eveline I. P.] Univ Ghent, Dept Biosyst Engn, Ghent, Belgium; [Winkler, Mari. -K. H.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Boets, Pieter; Hahne, Birk; Goethals, Peter] Univ Ghent, Dept Appl Ecol & Biotechnol, Ghent, Belgium	Ghent University; University of Washington; University of Washington Seattle; Ghent University	Winkler, MKH (corresponding author), Univ Ghent, Dept Biosyst Engn, Ghent, Belgium.; Winkler, MKH (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	mwinkler@uw.edu	Volcke, Eveline I. P./N-1669-2015; Goethals, Peter LM/A-1116-2008	Volcke, Eveline I. P./0000-0002-7664-7033; 	Marie Curie Intra-European fellowship [PIEF-GA-2012-329328]; Research Foundation - Flanders (FWO-Vlaanderen, Belgium)	Marie Curie Intra-European fellowship(European Commission); Research Foundation - Flanders (FWO-Vlaanderen, Belgium)(FWO)	Mari Winkler was funded by a Marie Curie Intra-European fellowship (PIEF-GA-2012-329328). Pieter Boets was supported by a post-doctoral fellowship from the Research Foundation - Flanders (FWO-Vlaanderen, Belgium).	ANDREWS JH, 1986, ADV MICROB ECOL, V9, P99; Arrojo B, 2006, J BIOTECHNOL, V123, P453, DOI 10.1016/j.jbiotec.2005.12.023; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BAASBECKING LGM, 1934, GEOLOGIE INLEIDING T; Beijerinck M.W, 1913, INFUSIES ONTDEKKING; Blackburne R, 2007, WATER ENVIRON RES, V79, P2437, DOI 10.2175/106143007X212139; Blackburne R, 2007, WATER RES, V41, P3033, DOI 10.1016/j.watres.2007.01.043; Bock E., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. III., P2302; BOON B, 1962, BIOCHEM J, V85, P440, DOI 10.1042/bj0850440; Burrell P, 1999, WATER SCI TECHNOL, V39, P45, DOI 10.2166/wst.1999.0257; Burrell PC, 1998, APPL ENVIRON MICROB, V64, P1878; Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001; Dorodnikov M, 2009, FEMS MICROBIOL ECOL, V69, P43, DOI 10.1111/j.1574-6941.2009.00697.x; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Halling-Sorensen B., 1993, STUD ENV SCI; HANSEN SR, 1980, SCIENCE, V207, P1491; Hilton ABC, 1998, J WATERW PORT C-ASCE, V124, P82, DOI 10.1061/(ASCE)0733-950X(1998)124:2(82); HSU SB, 1977, SIAM J APPL MATH, V32, P366, DOI 10.1137/0132030; Innerebner G, 2007, SYST APPL MICROBIOL, V30, P408, DOI 10.1016/j.syapm.2007.02.001; Kavetski D., 2003, CALIBRATION WATERSHE, P49, DOI DOI 10.1029/WS006P0049; Kim DJ, 2006, WATER RES, V40, P887, DOI 10.1016/j.watres.2005.12.023; Kindaichi T, 2006, BIOTECHNOL BIOENG, V94, P1111, DOI 10.1002/bit.20926; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Niemann S, 1997, J APPL MICROBIOLOGY, V82; Nogueira R, 2006, BIOTECHNOL BIOENG, V95, P169, DOI 10.1002/bit.21004; O'Kelly JO, 1997, BIOCHIM BIOPHYS ACTA, V409, P951; Poly F, 2008, FEMS MICROBIOL ECOL, V63, P132, DOI 10.1111/j.1574-6941.2007.00404.x; REICHERT P, 1994, WATER SCI TECHNOL, V30, P21, DOI 10.2166/wst.1994.0025; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Scientific TF, 2009, NANODROP 2000 2000C; Spieck E, 2006, ENVIRON MICROBIOL, V8, P405, DOI 10.1111/j.1462-2920.2005.00905.x; Spieck E, 2011, METHOD ENZYMOL, P486; STEINMULLER W, 1976, ARCH MICROBIOL, V108, P299, DOI 10.1007/BF00454856; STUIVER M, 1983, SCIENCE, V219, P849, DOI 10.1126/science.219.4586.849; TRAMPER J, 1986, ENZYME MICROB TECH, V8, P477, DOI 10.1016/0141-0229(86)90051-7; Vadivelu VM, 2006, BIOTECHNOL BIOENG, V94, P1176, DOI 10.1002/bit.20956; Vannecke TPW, 2014, WATER SCI TECHNOL, V69, P208, DOI 10.2166/wst.2013.701; Vlaeminck SE, WATER SCI TECHNOLOGY, V58, P1113; Vlaeminck SE, 2010, APPL ENVIRON MICROB, V76, P900, DOI 10.1128/AEM.02337-09; Volcke EIP, 2008, PROCESS BIOCHEM, V43, P1398, DOI 10.1016/j.procbio.2008.08.013; Winkler MKH, 2011, WATER RES, V45, P3291, DOI 10.1016/j.watres.2011.03.024; Winkler MKH, 2013, APPL MICROBIOL BIOT, V97, P7459, DOI 10.1007/s00253-012-4459-4; Winkler MKH, 2012, APPL MICROBIOL BIOT, V94, P1657, DOI 10.1007/s00253-012-4126-9; Winkler MKH, 2011, ENVIRON SCI TECHNOL, V45, P7330, DOI 10.1021/es201388t; YOON H, 1977, BIOTECHNOL BIOENG, V19, P1193, DOI 10.1002/bit.260190809; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Zhang HY, 2009, CHINESE MED J-PEKING, V122, P2593, DOI 10.3760/cma.j.issn.0366-6999.2009.21.012	47	22	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0172785	10.1371/journal.pone.0172785	http://dx.doi.org/10.1371/journal.pone.0172785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333960	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200009
J	Alhasson, F; Das, S; Seth, R; Dattaroy, D; Chandrashekaran, V; Ryan, CN; Chan, LS; Testerman, T; Burch, J; Hofseth, LJ; Horner, R; Nagarkatti, M; Nagarkatti, P; Lasley, SM; Chatterjee, S				Alhasson, Firas; Das, Suvarthi; Seth, Ratanesh; Dattaroy, Diptadip; Chandrashekaran, Varun; Ryan, Caitlin N.; Chan, Luisa S.; Testerman, Traci; Burch, James; Hofseth, Lorne J.; Horner, Ronnie; Nagarkatti, Mitzi; Nagarkatti, Prakash; Lasley, Stephen M.; Chatterjee, Saurabh			Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; PYRIDOSTIGMINE BROMIDE; OXIDATIVE STRESS; GENE-EXPRESSION; COGNITIVE IMPAIRMENT; INFLAMMATION; MICE; AXIS; MECHANISMS; DISEASE	Many of the symptoms of Gulf War Illness (GWI) that include neurological abnormalities, neuroinflammation, chronic fatigue and gastrointestinal disturbances have been traced to Gulf War chemical exposure. Though the association and subsequent evidences are strong, the mechanisms that connect exposure to intestinal and neurological abnormalities remain unclear. Using an established rodent model of Gulf War Illness, we show that chemical exposure caused significant dysbiosis in the gut that included increased abundance of phylum Firmicutes and Tenericutes, and decreased abundance of Bacteroidetes. Several gram negative bacterial genera were enriched in the GWI-model that included Allobaculum sp. Altered microbiome caused significant decrease in tight junction protein Occludin with a concomitant increase in Claudin-2, a signature of a leaky gut. Resultant leaching of gut caused portal endotoxemia that led to upregulation of toll like receptor 4 (TLR4) activation in the small intestine and the brain. TLR4 knock out mice and mice that had gut decontamination showed significant decrease in tyrosine nitration and inflammatory mediators IL1 beta and MCP-1 in both the small intestine and frontal cortex. These events signified that gut dysbiosis with simultaneous leaky gut and systemic endotoxemia-induced TLR4 activation contributes to GW chemical-induced neuroinflammation and gastrointestinal disturbances.	[Alhasson, Firas; Das, Suvarthi; Seth, Ratanesh; Dattaroy, Diptadip; Chandrashekaran, Varun; Chatterjee, Saurabh] Univ South Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA; [Ryan, Caitlin N.; Chan, Luisa S.] Second Genome Inc, San Francisco, CA USA; [Testerman, Traci; Nagarkatti, Mitzi; Nagarkatti, Prakash] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Burch, James] Univ South Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC USA; [Hofseth, Lorne J.] Univ South Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC USA; [Horner, Ronnie] Univ South Carolina, Dept Hlth Serv Policy & Management, Arnold Sch Publ Hlth, Columbia, SC USA; [Lasley, Stephen M.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Das, Suvarthi] Univ Massachusetts, Sch Med, Dept Med Gastroenterol, Worcester, MA USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of Illinois System; University of Illinois Peoria; University of Massachusetts System; University of Massachusetts Worcester	Chatterjee, S (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA.	schatt@mailbox.sc.edu	Testerman, Traci L/AAI-1506-2020; Seth, Ratanesh/M-3700-2016; Das, Suvarthi/AAK-2589-2020; Das, Suvarthi/AAA-4364-2020	Testerman, Traci L/0000-0002-3883-6407; Seth, Ratanesh/0000-0002-7078-0052; , firas/0000-0002-4836-516X; Nagarkatti, Prakash/0000-0003-2663-0759	NIH [R00ES019875]; Second Genome Inc; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Second Genome Inc; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported by NIH Pathway to Independence Award, R00ES019875 to Saurabh Chatterjee. Second Genome Inc provided support in the form of salaries for authors [CNR and LSC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Abu-Qare AW, 2008, XENOBIOTICA, V38, P294, DOI [10.1080/00498250701813230, 10.1080/00498250701813230 ]; Alhasson F, 2016, AM J PHYSIOL-RENAL, V310, pF85, DOI 10.1152/ajprenal.00243.2015; [Anonymous], 2014, CHRON MULT ILLN GULF; [Anonymous], 2010, GULF WAR HLTH, V8; Aqel B, 2015, NUTR CLIN PRACTICE O; Arvonen M, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0104-6; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Barlow GM, 2015, NUTR CLIN PRACTICE O; Beilharz JE, 2016, BRAIN BEHAV IMMUN; Bennet SMP, 2015, GUT LIVER, V9, P318, DOI 10.5009/gnl14344; Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Betrapally NS, 2016, TRANSLATIONAL RES J; Boelsterli UA, 2013, TOXICOL SCI, V131, P654, DOI 10.1093/toxsci/kfs310; Boussios S, 2012, ANN GASTROENTEROL, V25, P106; Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Camilleri M, 2015, AM J PHYSIOL-GASTR L, V309, pG10, DOI 10.1152/ajpgi.00080.2015; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Cenit MC, 2014, BBA-MOL BASIS DIS, V1842, P1981, DOI 10.1016/j.bbadis.2014.05.023; Chatterjee S, 2012, J HEPATOL; Chatterjee S, 2011, FREE RADICAL BIO MED, V50, P988, DOI 10.1016/j.freeradbiomed.2010.12.037; Chatterjee S, 2009, FREE RADICAL BIO MED, V46, P454, DOI 10.1016/j.freeradbiomed.2008.10.046; Silva MCC, 2016, PROG NEURO-PSYCHOPH, V64, P142, DOI 10.1016/j.pnpbp.2015.08.002; Daulatzai MA, 2014, NEUROCHEM RES, V39, P624, DOI 10.1007/s11064-014-1266-6; El-Salhy M, 2015, WORLD J GASTROENTERO, V21, P7621, DOI 10.3748/wjg.v21.i25.7621; Escobedo G, 2014, REV INVEST CLIN, V66, P450; Everard A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033858; Giaroni C, 2003, EUR J PHARMACOL, V476, P63, DOI 10.1016/S0014-2999(03)02147-2; Guner YS, 2009, BIOCHEM BIOPH RES CO, V384, P221, DOI 10.1016/j.bbrc.2009.04.091; Hartmann P, 2015, ALCOHOL CLIN EXP RES, V39, P763, DOI 10.1111/acer.12704; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hu F, 2010, ENVIRON TOXICOL CHEM, V29, P683, DOI 10.1002/etc.73; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Kang DJ, 2016, HEPATOLOGY; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Kennedy PJ, 2014, WORLD J GASTROENTERO, V20, P14105, DOI 10.3748/wjg.v20.i39.14105; Khaiboullina SF, 2015, CYTOKINE, V72, P1, DOI 10.1016/j.cyto.2014.11.019; Kruidenier L, 2003, FREE RADICAL BIO MED, V34, P753, DOI 10.1016/S0891-5849(02)01426-0; Lau WL, 2015, NEPHRON, V130, P92, DOI 10.1159/000381990; Lee SM, 2015, FOOD FUNCT, V6, P492, DOI 10.1039/c4fo00731j; Li L, 2001, TOXICOL APPL PHARM, V177, P17, DOI 10.1006/taap.2001.9283; Llorente C, 2015, CELL MOL GASTROENTER, V1, P275, DOI 10.1016/j.jcmgh.2015.04.003; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Lush CW, 2003, GASTROENTEROLOGY, V124, P118, DOI 10.1053/gast.2003.50001; Madrigal JLM, 2014, ADV EXP MED BIOL, V824, P209, DOI 10.1007/978-3-319-07320-0_15; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Miyoshi J, 2016, TRANSLATIONAL RES J; Nagpal R, 2016, BENEF MICROBES, V7, P181, DOI [10.3920/bm2015.0062, 10.3920/BM2015.0062]; Nallu A, 2016, TRANSLATIONAL RES J; O'Callaghan JP, 2015, J NEUROCHEM, V133, P708, DOI 10.1111/jnc.13088; O'Donovan A, 2015, PSYCHONEUROENDOCRINO, V51, P557, DOI 10.1016/j.psyneuen.2014.11.010; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Ojo JO, 2014, NEUROPATHOLOGY, V34, P109, DOI 10.1111/neup.12061; Parihar VK, 2013, NEUROPSYCHOPHARMACOL, V38, P2348, DOI 10.1038/npp.2013.158; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pozuelo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12693; Rajilic-Stojanovic M, 2015, AM J GASTROENTEROL, V110, P278, DOI 10.1038/ajg.2014.427; Ray D, 2016, J CANCER, V7, P1421, DOI 10.7150/jca.15480; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rosenbaum M, 2015, TRENDS ENDOCRIN MET, V26, P493, DOI 10.1016/j.tem.2015.07.002; Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015; Schnabl B, 2013, CURR OPIN GASTROEN, V29, P264, DOI 10.1097/MOG.0b013e32835ff948; Schumm WR, 2002, PSYCHOL REP, V90, P707, DOI 10.2466/PR0.90.3.707-721; Seth RK, 2013, TOXICOLOGICAL SCI OF; Shaw KA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0331-y; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Umekawa T, 2015, GLIA, V63, P2220, DOI 10.1002/glia.22887; Vasilache AM, 2015, BRAIN BEHAV IMMUN, V48, P31, DOI 10.1016/j.bbi.2015.02.003; Wahlang B, 2013, TOXICOL PATHOL, V41, P343, DOI 10.1177/0192623312468517; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; Zakirova Z, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00071; Zakirova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119579; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999	83	87	89	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172914	10.1371/journal.pone.0172914	http://dx.doi.org/10.1371/journal.pone.0172914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328972	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700012
J	Darko, E; Gierczik, K; Hudak, O; Forgo, P; Pal, M; Turkosi, E; Kovacs, V; Dulai, S; Majlath, I; Molnar, I; Janda, T; Molnar-Lang, M				Darko, Eva; Gierczik, Krisztian; Hudak, Orsolya; Forgo, Peter; Pal, Magda; Turkosi, Edina; Kovacs, Viktoria; Dulai, Sandor; Majlath, Imre; Molnar, Istvan; Janda, Tibor; Molnar-Lang, Marta			Differing metabolic responses to salt stress in wheat-barley addition lines containing different 7H chromosomal fragments	PLOS ONE			English	Article							POLYAMINE METABOLISM; SALINITY TOLERANCE; OXIDATIVE STRESS; RICE CULTIVARS; WATER-STRESS; GENES; ACCUMULATION; HOMEOSTASIS; MECHANISMS; SEEDLINGS	Salinity-induced osmotic, ionic and oxidative stress responses were investigated on Asakaze/Manaswheat/barley addition lines 7H, 7HL and 7HS, together with their barley (salt-tolerant) and wheat (relatively salt-sensitive) parents. Growth, photosynthetic activity, chlorophyll degradation, proline, glycine betaine accumulation, sugar metabolism, Na+ and K+ uptake and transport processes and the role of polyamines and antioxidants were studied in young plants grown in hydroponic culture with or without salt treatment. Changes in plant growth and photosynthetic activity of plants demonstrated that the salt tolerance of the addition lines 7H and 7HL was similar to that of barley parent cv. Manas, while the sensitivity of the addition line 7HS was similar to that of the wheat parent cv. Asakaze. The Na accumulation in the roots and shoots did not differ between the addition lines and wheat parent. The activation of various genes related to Na uptake and transport was not correlated with the salt tolerance of the genotypes. These results indicated that the direct regulation of Na transport processes is not the main reason for the salt tolerance of these genotypes. Salt treatment induced a complex metabolic rearrangement in both the roots and shoots of all the genotypes. Elevated proline accumulation in the roots and enhanced sugar metabolism in the shoots were found to be important for salt tolerance in the 7H and 7HL addition lines and in barley cv. Manas. In wheat cv. Asakaze and the 7HS addition line the polyamine metabolism was activated. It seems that osmotic adjustment is a more important process in the improvement of salt tolerance in 7H addition lines than the direct regulation of Na transport processes or antioxidant defence.	[Darko, Eva; Pal, Magda; Kovacs, Viktoria; Majlath, Imre; Janda, Tibor] Hungarian Acad Sci, Agr Inst, Dept Plant Physiol, Ctr Agr Res, Martonvasar, Hungary; [Gierczik, Krisztian] Hungarian Acad Sci, Agr Inst, Dept Plant Mol Biol, Ctr Agr Res, Martonvasar, Hungary; [Hudak, Orsolya; Forgo, Peter] Eszterhazy Univ, Food & Wine Knowledge Ctr, Fac Sci, Eger, Hungary; [Turkosi, Edina; Molnar, Istvan; Molnar-Lang, Marta] Hungarian Acad Sci, Agr Inst, Dept Genet Resources, Ctr Agr Res, Martonvasar, Hungary; [Dulai, Sandor] Eszterhazy Univ, Dept Bot & Plant Physiol, Fac Sci, Eger, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Darko, E (corresponding author), Hungarian Acad Sci, Agr Inst, Dept Plant Physiol, Ctr Agr Res, Martonvasar, Hungary.	darko.eva@agrar.mta.hu	Darkó, Éva/AAR-8167-2021; Molnar, istvan/L-9779-2019; Türkösi, Edina/AAD-2512-2022; Kovács, Viktória Dr/AAP-1022-2021; Pál, Magda/I-5039-2019; Kovács, Viktória/D-5002-2016	Kovács, Viktória Dr/0000-0002-0029-3662; Pál, Magda/0000-0003-3468-962X; Majlath, Imre/0000-0003-3887-008X; Molnar, Istvan/0000-0002-7167-9319	OTKA [K112226]; Janos Bolyai Scholarship from the Hungarian Academy of Sciences	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Scholarship from the Hungarian Academy of Sciences	This work was funded by OTKA grant No. K112226 and by a Janos Bolyai Scholarship from the Hungarian Academy of Sciences (to Istvan Molnar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by OTKA grant No. K112226 and by a Janos Bolyai Scholarship from the Hungarian Academy of Sciences (to Istvan Molnar). The authors are grateful to Attila Vecsy for the photos and also to Barbara Hooper for revising the manuscript linguistically.	Adem GD, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-113; Alcazar R, 2006, PHYSIOL PLANTARUM, V128, P448, DOI 10.1111/j.1399-3054.2006.00780.x; Anton A, 2012, WATER AIR SOIL POLL, V223, P5175, DOI 10.1007/s11270-012-1269-3; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Do PT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00182; Dulai S., 2010, Acta Agronomica Hungarica, V58, P367, DOI 10.1556/AAgr.58.2010.4.5; El-Yazal MAS, 2014, PLANT GROWTH REGUL, V72, P211, DOI 10.1007/s10725-013-9852-1; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Gondor OK, 2016, J AGRON CROP SCI, V202, P217, DOI 10.1111/jac.12144; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Grzesiak M, 2013, PLANT GROWTH REGUL, V69, P177, DOI 10.1007/s10725-012-9760-9; Guo R, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0546-x; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Janda T, 2008, CEREAL RES COMMUN, V36, P53, DOI 10.1556/CRC.36.2008.1.6; Janda T, 2016, PLANT PHYSIOL BIOCH, V101, P68, DOI 10.1016/j.plaphy.2016.01.025; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiale S, 2004, J PLANT PHYSIOL, V161, P35, DOI 10.1078/0176-1617-01167; Majlath I, 2016, J PLANT PHYSIOL, V191, P149, DOI 10.1016/j.jplph.2015.12.004; Velarde-Buendia AM, 2012, PLANT PHYSIOL BIOCH, V61, P18, DOI 10.1016/j.plaphy.2012.09.002; Mittova V, 2004, J EXP BOT, V55, P1105, DOI 10.1093/jxb/erh113; Molnar-Lang M, 2012, GENOME, V55, P302, DOI [10.1139/G2012-013, 10.1139/g2012-013]; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Pal M, 2005, PHYSIOL PLANTARUM, V125, P356, DOI 10.1111/j.1399-3054.2005.00545.x; Pal M, 2015, PLANT SCI, V237, P16, DOI 10.1016/j.plantsci.2015.05.003; Pandolfi C, 2010, PLANT CELL PHYSIOL, V51, P422, DOI 10.1093/pcp/pcq007; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pottosin I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00154; Quinet M, 2010, J EXP BOT, V61, P2719, DOI 10.1093/jxb/erq118; Roy P, 2005, PLANT SCI, V168, P583, DOI 10.1016/j.plantsci.2004.08.014; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Saha J, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00021; Shalata A, 2001, PHYSIOL PLANTARUM, V112, P487, DOI 10.1034/j.1399-3054.2001.1120405.x; Shavrukov Y., 2014, BARLEY PHYS PROPERTI, P125; Sinay H, 2014, INT J ADV AGR RES, V2, P77, DOI DOI 10.33500/IJAAR.2014.02.008; Siringam K, 2011, AFR J BIOTECHNOL, V10, P1340; Smethurst CF, 2008, FUNCT PLANT BIOL, V35, P640, DOI 10.1071/FP08030; SMITH MA, 1985, PLANT PHYSIOL, V78, P89, DOI 10.1104/pp.78.1.89; Szopko D, 2016, PHOTOSYNTHETICA, V54; Turkosi E, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0393-2; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Zepeda-Jazo I, 2008, PLANT SIGNAL BEHAV, V3, P401, DOI 10.4161/psb.3.6.5429; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao FG, 2007, PLANT PHYSIOL, V145, P1061, DOI 10.1104/pp.107.105882	52	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174170	10.1371/journal.pone.0174170	http://dx.doi.org/10.1371/journal.pone.0174170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328973	Green Accepted, Green Published, gold			2022-12-27	WOS:000399094700064
J	Nagarajan, SR; Brandon, AE; McKenna, JA; Shtein, HC; Nguyen, TQ; Suryana, E; Poronnik, P; Cooney, GJ; Saunders, DN; Hoy, AJ				Nagarajan, Shilpa R.; Brandon, Amanda E.; McKenna, Jessie A.; Shtein, Harrison C.; Nguyen, Thinh Q.; Suryana, Eurwin; Poronnik, Philip; Cooney, Gregory J.; Saunders, Darren N.; Hoy, Andrew J.			Insulin and diet-induced changes in the ubiquitin-modified proteome of rat liver	PLOS ONE			English	Article							FATTY LIVER; PROTEASOME DEGRADATION; RECEPTOR SUBSTRATE-1; RESISTANCE; MUSCLE; PHOSPHORYLATION; PHOSPHOPROTEOME; DISEASE; GLUCONEOGENESIS; PURIFICATION	Ubiquitin is a crucial post-translational modification regulating numerous cellular processes, but its role in metabolic disease is not well characterized. In this study, we identified the in vivo ubiquitin-modified proteome in rat liver and determined changes in this ubiquitome under acute insulin stimulation and high-fat and sucrose diet-induced insulin resistance. We identified 1267 ubiquitinated proteins in rat liver across diet and insulin-stimulated conditions, with 882 proteins common to all conditions. KEGG pathway analysis of these proteins identified enrichment of metabolic pathways, TCA cycle, glycolysis/gluconeogenesis, fatty acid metabolism, and carbon metabolism, with similar pathways altered by diet and insulin resistance. Thus, the rat liver ubiquitome is sensitive to diet and insulin stimulation and this is perturbed in insulin resistance.	[Nagarajan, Shilpa R.; Brandon, Amanda E.; Shtein, Harrison C.; Nguyen, Thinh Q.; Poronnik, Philip; Hoy, Andrew J.] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW, Australia; [Nagarajan, Shilpa R.; Brandon, Amanda E.; Shtein, Harrison C.; Nguyen, Thinh Q.; Suryana, Eurwin; Poronnik, Philip; Cooney, Gregory J.; Hoy, Andrew J.] Univ Sydney, Bosch Inst, Charles Perkins Ctr, Sydney, NSW, Australia; [Brandon, Amanda E.; Suryana, Eurwin; Cooney, Gregory J.] Garvan Inst Med Res, Diabet & Metab Div, Darlinghurst, NSW, Australia; [Brandon, Amanda E.; Cooney, Gregory J.] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [McKenna, Jessie A.; Saunders, Darren N.] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [McKenna, Jessie A.; Saunders, Darren N.] Univ New South Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia	University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney	Hoy, AJ (corresponding author), Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW, Australia.; Hoy, AJ (corresponding author), Univ Sydney, Bosch Inst, Charles Perkins Ctr, Sydney, NSW, Australia.; Saunders, DN (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia.; Saunders, DN (corresponding author), Univ New South Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia.	d.saunders@unsw.edu.au; andrew.hoy@sydney.edu.au	Hoy, Andrew/J-2289-2017	Hoy, Andrew/0000-0003-3922-1137; Saunders, Darren/0000-0003-0924-0513; Poronnik, Philip/0000-0002-6246-528X	Sydney Medical School Foundation; University of Sydney; National Health and Medical Research Council [GNT1052963]; Motor Neurone Disease Research Institute of Australia; Guest Family Fellowship; Mostyn Family Foundation	Sydney Medical School Foundation; University of Sydney(University of Sydney); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Research Institute of Australia; Guest Family Fellowship; Mostyn Family Foundation	AJH is supported by a Helen and Robert Ellis Postdoctoral Research Fellowship from the Sydney Medical School Foundation and funding from the University of Sydney. DNS is supported by the National Health and Medical Research Council (project grant GNT1052963), a Neale Daniher MND Research Grant from the Motor Neurone Disease Research Institute of Australia, Guest Family Fellowship, and Mostyn Family Foundation.	Bosquet A, 2016, ATHEROSCLEROSIS, V249, P191, DOI 10.1016/j.atherosclerosis.2016.04.012; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cabre A, 2007, Atherosclerosis, V195, pe150; Charrez B, 2016, WORLD J GASTROENTERO, V22, P2494, DOI 10.3748/wjg.v22.i8.2494; Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085744; Cheng KKY, 2013, BIOCHEM J, V455, P207, DOI 10.1042/BJ20130760; Chotechuang N, 2011, AMINO ACIDS, V41, P457, DOI 10.1007/s00726-010-0765-2; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croucher DR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0793; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frangioudakis G, 2005, ENDOCRINOLOGY, V146, P5596, DOI 10.1210/en.2005-0481; Holper S, 2015, MOL BIOSYST, V11, P908, DOI 10.1039/c4mb00490f; Hoy AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1358, DOI 10.1152/ajpendo.00133.2007; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Ishii M, 2015, ARCH BIOCHEM BIOPHYS, V566, P26, DOI 10.1016/j.abb.2014.12.009; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140619; Koliaki C, 2016, ANNU REV NUTR, V36, P337, DOI 10.1146/annurev-nutr-071715-050656; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Leamy AK, 2016, BBA-MOL CELL BIOL L, V1861, P1005, DOI 10.1016/j.bbalip.2016.05.013; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tashiro H, 2014, SURG TODAY, V44, P1611, DOI 10.1007/s00595-013-0736-9; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Watt MJ, 2012, AM J PHYSL ENDOCRINO, V302; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Williams KJ, 2016, ATHEROSCLEROSIS, V247, P225, DOI 10.1016/j.atherosclerosis.2016.02.004; Wright LE, 2011, DIABETOLOGIA, V54, P1417, DOI 10.1007/s00125-011-2068-x; Yang XD, 2016, DIABETES OBES METAB, V18, P747, DOI 10.1111/dom.12677; Yugi K, 2014, CELL REP, V8, P1171, DOI 10.1016/j.celrep.2014.07.021; Zappacosta F, 2015, J PROTEOME RES, V14, P997, DOI 10.1021/pr501025e	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174431	10.1371/journal.pone.0174431	http://dx.doi.org/10.1371/journal.pone.0174431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329008	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700092
J	Russo, A; Ragusa, M; Barbagallo, C; Longo, A; Avitabile, T; Uva, MG; Bonfiglio, V; Toro, MD; Caltabiano, R; Mariotti, C; Boscia, F; Romano, M; Di Pietro, C; Barbagallo, D; Purrello, M; Reibaldi, M				Russo, Andrea; Ragusa, Marco; Barbagallo, Cristina; Longo, Antonio; Avitabile, Teresio; Uva, Maurizio G.; Bonfiglio, Vincenza; Toro, Mario D.; Caltabiano, Rosario; Mariotti, Cesare; Boscia, Francesco; Romano, Mario; Di Pietro, Cinzia; Barbagallo, Davide; Purrello, Michele; Reibaldi, Michele			miRNAs in the vitreous humor of patients affected by idiopathic epiretinal membrane and macular hole	PLOS ONE			English	Article							CARDIAC FIBROSIS; INTERSTITIAL FIBROSIS; MYOCARDIAL-INFARCTION; CIRCULATING MICRORNA; PULMONARY-FIBROSIS; CANCER; SERUM; MECHANISMS; EXPRESSION; BIOMARKERS	Purpose The aim of the present study was to assess the expression of miRNAs in the Vitreous Humor (VH) of patients with Macular Hole (MH) and Epiretinal Membrane (ERM) compared to a control group. Methods In this prospective, comparative study, 2-ml of VH was extracted from the core of the vitreous chamber in consecutive patients who underwent standard vitrectomy for ERM and MH. RNA was extracted and TaqMan Low Density Arrays (TLDAs) were used to profile the transcriptome of 754 miRNAs. Results were validated by single TaqMan assays. Finally, we created a biological network of differentially expressed miRNA targets and their nearest neighbors. Results Overall 10 eyes with MH, 16 eyes with idiopathic ERM and 6 controls were enrolled in the study. Profiling data identified 5 miRNAs differentially expressed in patients affected by MH and ERM with respect to controls. Four were downregulated (miR-19b, miR-24, miR-155, miR-451) and 1 was downregulated (miR-29a); TaqMan assays of the VH of patients affected by MH and ERM, with respect to controls, showed that the most differentially expressed were miR-19b (FC-9.13, p:<0.00004), mir-24 (FC-7.52, p:<0.004) and miR-1423p (FC-5.32, p:<0.011). Our network data showed that deregulation of differentially expressed miRNAs induces an alteration of several pathways associated with genes involved in both MH and ERM. Conclusion The present study suggests that disregulation of miR-19b, miR-24 and miR-142-3p, might be related to the alterations that characterize patients affected by MH and ERM.	[Russo, Andrea; Longo, Antonio; Avitabile, Teresio; Uva, Maurizio G.; Bonfiglio, Vincenza; Toro, Mario D.; Reibaldi, Michele] Univ Catania, Dept Ophthalmol, Catania, Italy; [Ragusa, Marco; Barbagallo, Cristina; Di Pietro, Cinzia; Barbagallo, Davide; Purrello, Michele] Univ Catania, Dept Biomed Sci & Biotechnol, Mol Genome & Complex Syst BioMed Unit, Catania, Italy; [Caltabiano, Rosario] Univ Catania, Dept Gian Filippo Ingrassia, Unita Anat Patol, Catania, Italy; [Mariotti, Cesare] Univ Ancona, Dept Ophthalmol, Ancona, Italy; [Boscia, Francesco] Univ Sassari, Dept Ophthalmol, Sassari, Italy; [Romano, Mario] Univ Naples 2, Naples, Italy	University of Catania; University of Catania; University of Catania; Marche Polytechnic University; University of Sassari; Universita della Campania Vanvitelli	Russo, A (corresponding author), Univ Catania, Dept Ophthalmol, Catania, Italy.	andrearusso2000@hotmail.com	Boscia, Francesco/AAC-7729-2022; Toro, Mario D/N-8051-2018; Ragusa, Marco/D-7691-2010; Barbagallo, Cristina/AAA-8871-2022; Caltabiano, Rosario/I-7583-2019; Russo, Andrea/AAC-5349-2022; Avitabile, Teresio/AAC-6076-2022; Toro, Mario/AAA-1371-2021; Longo, Antonio/AAC-6092-2022; TORO, Mario Damiano/R-9042-2019; Reibaldi, Michele/AAL-1113-2021	Ragusa, Marco/0000-0002-4282-920X; Barbagallo, Cristina/0000-0002-6769-4516; Caltabiano, Rosario/0000-0001-8591-8010; Russo, Andrea/0000-0002-7725-5971; TORO, Mario Damiano/0000-0001-7152-2613; LONGO, Antonio/0000-0002-9525-1800				AABERG TM, 1970, AM J OPHTHALMOL, V69, P555, DOI 10.1016/0002-9394(70)91620-X; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Charles S, 2003, GRAEF ARCH CLIN EXP, V241, P347, DOI 10.1007/s00417-003-0624-X; Chau BN, 2011, HEPATOLOGY, V53, P4, DOI 10.1002/hep.24071; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng LY, 2000, OPHTHALMOLOGY, V107, P853, DOI 10.1016/S0161-6420(00)00032-4; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Duker JS, 2013, OPHTHALMOLOGY, V120, P2611, DOI 10.1016/j.ophtha.2013.07.042; Dussaule JC, 2011, INT J EXP PATHOL, V92, P151, DOI 10.1111/j.1365-2613.2011.00760.x; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Girach A, 2013, DIS VITREO MACULAR I, P51; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Hwang JU, 2012, INVEST OPHTH VIS SCI, V53, P3562, DOI 10.1167/iovs.12-9762; Ivanova T, 2016, EYE, V30, P645, DOI 10.1038/eye.2016.30; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Klein R, 1994, Trans Am Ophthalmol Soc, V92, P403; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; lannetti L, 2011, INVEST OPHTH VIS SCI, V52, P5786; Lewis A, 2015, INFLAMM BOWEL DIS, V21, P1926, DOI 10.1097/MIB.0000000000000443; Li P, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000458; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; MARTINEZ J, 1994, AM J OPHTHALMOL, V117, P762, DOI 10.1016/S0002-9394(14)70319-8; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009; Ragusa M, 2015, CANCER BIOL THER, V16, P1387, DOI 10.1080/15384047.2015.1046021; Ragusa M, 2013, MOL VIS, V19, P430; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Sebag J, 2014, VITREOUS HLTH DIS, P266; Shah MY, 2013, NUCLEIC ACID THER, V23, P2, DOI 10.1089/nat.2012.0375; Soltaninejad E, 2015, IRAN J ALLERGY ASTHM, V14, P615; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Wang J, 2012, J CELL MOL MED, V16, P2150, DOI 10.1111/j.1582-4934.2012.01523.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wei J, 2011, AUTOIMMUN REV, V10, P267, DOI 10.1016/j.autrev.2010.09.015; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	47	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174297	10.1371/journal.pone.0174297	http://dx.doi.org/10.1371/journal.pone.0174297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328945	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700080
J	Sheringham, J; Solmi, F; Ariti, C; Baim-Lance, A; Morris, S; Fulop, NJ				Sheringham, Jessica; Solmi, Francesca; Ariti, Cono; Baim-Lance, Abigail; Morris, Steve; Fulop, Naomi J.			The value of theory in programmes to implement clinical guidelines: Insights from a retrospective mixed-methods evaluation of a programme to increase adherence to national guidelines for chronic disease in primary care	PLOS ONE			English	Article							QUALITY IMPROVEMENT; STRATEGIES; AUDIT	Background Programmes have had limited success in improving guideline adherence for chronic disease. Use of theory is recommended but is often absent in programmes conducted in 'realworld' rather than research settings. Materials and methods This mixed-methods study tested a retrospective theory-based approach to evaluate a `realworld' programme in primary care to improve adherence to national guidelines for chronic obstructive pulmonary disease (COPD). Qualitative data, comprising analysis of documents generated throughout the programme (n>300), in-depth interviews with planners (clinicians, managers and improvement experts involved in devising, planning, and implementing the programme, n = 14) and providers (practice clinicians, n = 14) were used to construct programme theories, experiences of implementation and contextual factors influencing care. Quantitative analyses comprised controlled before-and-after analyses to test 'early' and evolved' programme theories with comparators grounded in each theory.'Early' theory predicted the programme would reduce emergency hospital admissions (EHA). It was tested using national analysis of standardized borough-level EHA rates between programme and comparator boroughs. 'Evolved' theory predicted practices with higher programme participation would increase guideline adherence and reduce EHA and costs. It was tested using a difference-in-differences analysis with linked primary and secondary care data to compare changes in diagnosis, management, EHA and costs, over time and by programme participation. Results Contrary to programme planners' predictions in `early' and 'evolved' programme theories, admissions did not change following the programme. However, consistent with 'evolved' theory, higher guideline adoption occurred in practices with greater programme participation. Conclusions Retrospectively constructing theories based on the ideas of programme planners can enable evaluators to address some limitations encountered when evaluating programmes without a theoretical base. Prospectively articulating theory aided by existing models and mid-range implementation theories may strengthen guideline adoption efforts by prompting planners to scrutinise implementation methods. Benefits of deriving programme theory, with or without the aid of mid-range implementation theories, however, may be limited when the evidence underpinning guidelines is flawed.	[Sheringham, Jessica; Solmi, Francesca; Baim-Lance, Abigail; Morris, Steve; Fulop, Naomi J.] UCL, Dept Appl Hlth Res, 1-19 Torrington Pl, London, England; [Ariti, Cono] Nuffield Trust, London, England; [Solmi, Francesca] UCL, Dept Psychiat, 1-19 Torrington Pl, London, England; [Ariti, Cono] London Sch Hyg & Trop Med, London, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Sheringham, J (corresponding author), UCL, Dept Appl Hlth Res, 1-19 Torrington Pl, London, England.	j.sheringham@ucl.ac.uk	Solmi, Francesca/V-2084-2019	Solmi, Francesca/0000-0003-0219-9503; Sheringham, Jessica/0000-0003-3468-129X; Fulop, Naomi/0000-0001-5306-6140; Morris, Stephen/0000-0002-5828-3563	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research; Care North Thames at Barts Health NHS Trust	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research; Care North Thames at Barts Health NHS Trust	The research was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Barts Health NHS Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NI HR or the Department of Health. Cono Ariti was employed by the Nuffield Trust.	Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brusamento S, 2012, HEALTH POLICY, V107, P168, DOI 10.1016/j.healthpol.2012.08.005; Colquhoun HL, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-66; Coryn CLS, 2011, AM J EVAL, V32, P199, DOI 10.1177/1098214010389321; Curtis L, 2015, UNIT COSTS HLTH SOCI; Davidoff F, 2015, BMJ QUAL SAF, V24, P228, DOI 10.1136/bmjqs-2014-003627; Department of Health, 2011, OUTC STRAT COPD ASTH; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Huntley A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004746; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Langer S, 2013, HEALTH SOC CARE COMM, V21, P339, DOI 10.1111/j.1365-2524.2012.01093.x; Langley A, 1999, ACAD MANAGE REV, V24, P691, DOI 10.2307/259349; Marshall M, 2014, BRIT J GEN PRACT, V64, pE745, DOI 10.3399/bjgp14X682801; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Institute for Health and Care Excellence, 2011, CHRON OBSTR PULM DIS; National Institute of Health and Care Excellence, 2010, CG101 CHRON OBSTR PU; NHS England, 2015, NHS OUTC FRAM DOM 2; NHS England, 2014, WHAT ACT COULD TAK R; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; O'Cathain A, 2014, BMJ QUAL SAF, V23, P47, DOI 10.1136/bmjqs-2013-002003; Office for National Statistics, 2013, SMALL AR POP EST; Ogrinc Greg, 2016, BMJ Qual Saf, V25, P986, DOI 10.1136/bmjqs-2015-004411; Pinnock H, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0361-0; Portela MC, 2015, BMJ QUAL SAF, V24, P325, DOI 10.1136/bmjqs-2014-003620; Purdy S, 2012, INTERVENTIONS REDUCE; Reed JE, 2014, BMJ QUAL SAF, V23, P1040, DOI 10.1136/bmjqs-2014-003103; Renger R, 2013, CAN J PROG EVAL, V28; Roland M, 2012, BMJ, V345; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Sheringham J., 2014, MIXED METHODS EVALUA; Vale L, 2007, EUR J HEALTH ECON, V8, P111, DOI 10.1007/s10198-007-0043-8; Weiner BJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-67	36	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174086	10.1371/journal.pone.0174086	http://dx.doi.org/10.1371/journal.pone.0174086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328942	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700048
J	Gupta, N; Kabahizi, J; Mukabatsinda, C; Walker, TD; Musabeyezu, E; Kiromera, A; Van Nuil, JI; Steiner, K; Mukherjee, J; Nsanzimana, S; Mbituyumuremyi, A				Gupta, Neil; Kabahizi, Jules; Mukabatsinda, Constance; Walker, Timothy David; Musabeyezu, Emmanuel; Kiromera, Athanase; Van Nuil, Jennifer Ilo; Steiner, Kevin; Mukherjee, Joia; Nsanzimana, Sabin; Mbituyumuremyi, Aimable			"Waiting for DAAs" : A retrospective chart review of patients with untreated hepatitis C in Rwanda	PLOS ONE			English	Review							SEROPREVALENCE; AFRICA	Background Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. With the advent of direct acting antivirals (DAAs), highly effective and easy-to-deliver oral regimens are now available on the global market. This study was conducted to understand the background and characteristics of a national cohort of patients with HCV infection enrolled in care and awaiting therapy with DAAs. Methods and findings We conducted a retrospective chart review of all adult patients with confirmed HCV infection who were currently enrolled in care and treatment at the four existing hepatitis referral centers in Rwanda. Patient charts at these centers were reviewed, and routinely collected data were recorded and analyzed. Overall, 253 patients were identified; median age was 56 years (IQR: 43, 65), and 149 (58.9%) were female. Median viral load was 688,736 IU/ml and 96.7% were HCV genotype 4. As classified by FIB-4 score, 64.8% of the patients had moderate to severe fibrosis. Fibrosis stage was associated with age (OR 1.12, CI 1.09-1.17), but not with time since diagnosis, gender, treatment center, or type of insurance. There was a low frequency of documented co-morbid conditions, including hypertension, diabetes, HIV, and hepatitis B virus. Conclusions Compared to an estimated 55,000 patients eligible for HCV treatment in Rwanda, this study identified only 253 patients currently diagnosed and engaged in care, highlighting an immense treatment gap in HCV, likely due to the lack of accessible and affordable screening, diagnostic, and treatment modalities. The patients that were enrolled in care had a disproportionately advanced fibrosis stage, possibly indicating late presentation to care or lack of treatment options. In the context of newly available and effective treatment options, this study supports the overall need to accelerate access to HCV screening, diagnostics, and care and treatment services in resource-limited settings in sub-Saharan Africa.	[Gupta, Neil; Steiner, Kevin; Mukherjee, Joia] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Gupta, Neil; Van Nuil, Jennifer Ilo; Mukherjee, Joia] Partners Hlth, Inshuti Mu Buzima, Rwinkwavu, Rwanda; [Kabahizi, Jules] Rwanda Mil Hosp, Kanombe, Rwanda; [Mukabatsinda, Constance] Univ Teaching Hosp Kigali, Kigali, Rwanda; [Walker, Timothy David] Univ Teaching Hosp Butare, Butare, Rwanda; [Musabeyezu, Emmanuel] King Faisal Hosp, Kigali, Rwanda; [Kiromera, Athanase] Maryland Global Initiat Corp, Kigali, Rwanda; [Nsanzimana, Sabin; Mbituyumuremyi, Aimable] Rwanda Biomed Ctr, Kigali, Rwanda	Harvard University; Brigham & Women's Hospital; Rwanda Biomedical Center	Gupta, N (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Gupta, N (corresponding author), Partners Hlth, Inshuti Mu Buzima, Rwinkwavu, Rwanda.	ngupta@pih.org		Gupta, Neil/0000-0003-3470-5351	Rwanda Ministry of Health; Rwanda Biomedical Center; University Teaching Hospital of Kigali; University Teaching Hospital of Butare; Rwanda Military Hospital; King Faisal Hospital	Rwanda Ministry of Health; Rwanda Biomedical Center; University Teaching Hospital of Kigali; University Teaching Hospital of Butare; Rwanda Military Hospital; King Faisal Hospital	The authors acknowledge the support and contributions of the Rwanda Ministry of Health, Rwanda Biomedical Center, University Teaching Hospital of Kigali, University Teaching Hospital of Butare, Rwanda Military Hospital, and King Faisal Hospital in the establishment of HCV treatment centers and access to registry data. Finally, we are grateful to Partners In Health and Brigham & Women's Hospital for in-kind support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Binagwaho A, 2014, LANCET, V383, P3, DOI 10.1016/S0140-6736(13)62423-X; Bolton P, 2002, J NERV MENT DIS, V190, P631, DOI 10.1097/00005053-200209000-00009; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Graham CS, 2015, ANTIVIRAL RES; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heim L, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-37; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; Kateera F, 2015, T ROY SOC TROP MED H, V109, P203, DOI 10.1093/trstmh/trv004; Layden JE, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu065; Liu Zhihua, 2006, Int J Med Sci, V3, P57; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Institute of Statistics of Rwanda (NISR) [Rwanda] Ministry of Health (MOH) [ Rwanda] and ICF International, 2010, RWAND DEM HLTH SURV; NSIR, 2016, RWAND DEM HLTH SURV; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Pirillo MF, 2007, J MED VIROL, V79, P1797, DOI 10.1002/jmv.21007; Platt L, 2016, LANCET INFECT DIS; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Riou J, 2015, J VIRAL HEPATITIS; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Rwanda Biomedical Center, 2016, RWAND VIR HEP NAT OP; Rwanda Biomedical Center, 2015, RWAND NONC DIS RISK; Rwanda Military Hospital. Laboratory Costs for Viral Tests, 2012, LAB COSTS VIR TESTS; Rwanda Ministry of Health, 2013, NAT GUID PREV MAN HI; Rwanda Ministry of Health, 2013, MIN HLTH ANN REP JUL; Rwanda Ministry of Health, 2015, NAT HIV ANN REP 2014; WHO, 2014, GUID SCREEN CAR TREA	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174148	10.1371/journal.pone.0174148	http://dx.doi.org/10.1371/journal.pone.0174148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323868	gold, Green Submitted, Green Published			2022-12-27	WOS:000399089000067
J	Moores, A; Riesco, AB; Schwenk, S; Arnvig, KB				Moores, Alexandra; Riesco, Ana B.; Schwenk, Stefan; Arnvig, Kristine B.			Expression, maturation and turnover of DrrS, an unusually stable, DosR regulated small RNA in Mycobacterium tuberculosis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; BACILLUS-SUBTILIS; NONCODING RNA; TRANSCRIPTION ACTIVATION; BINDING-SITES; RIBOSOMAL-RNA; SOLUBLE-RNA; DNA-DAMAGE; SEQ DATA	Mycobacterium tuberculosis depends on the ability to adjust to stresses encountered in a range of host environments, adjustments that require significant changes in gene expression. Small RNAs (sRNAs) play an important role as post-transcriptional regulators of prokaryotic gene expression, where they are associated with stress responses and, in the case of pathogens, adaptation to the host environment. In spite of this, the understanding of M. tuberculosis RNA biology remains limited. Here we have used a DosR-associated sRNA as an example to investigate multiple aspects of mycobacterial RNA biology that are likely to apply to other M. tuberculosis sRNAs and mRNAs. We have found that accumulation of this particular sRNA is slow but robust as cells enter stationary phase. Using reporter gene assays, we find that the sRNA core promoter is activated by DosR, and we have renamed the sRNA DrrS for DosR Regulated sRNA. Moreover, we show that DrrS is transcribed as a longer precursor, DrrS(+), which is rapidly processed to the mature and highly stable DrrS. We characterise, for the first time in mycobacteria, an RNA structural determinant involved in this extraordinary stability and we show how the addition of a few nucleotides can lead to acute destabilisation. Finally, we show how this RNA element can enhance expression of a heterologous gene. Thus, the element, as well as its destabilising derivatives may be employed to post-transcriptionally regulate gene expression in mycobacteria in combination with different promoter variants. Moreover, our findings will facilitate further investigations into the severely understudied topic of mycobacterial RNA biology and into the role that regulatory RNA plays in M. tuberculosis pathogenesis.	[Moores, Alexandra; Riesco, Ana B.; Schwenk, Stefan; Arnvig, Kristine B.] UCL, Inst Struct & Mol Biol, London, England	University of London; Birkbeck University London; University College London	Arnvig, KB (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	k.arnvig@ucl.ac.uk		Arnvig, Kristine/0000-0002-6850-2547	Medical Reserach Council [MR/L018519/1]; Medical Research Council [MR/L018519/1] Funding Source: researchfish; MRC [MR/L018519/1] Funding Source: UKRI	Medical Reserach Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant to KBA from The Medical Reserach Council [MR/L018519/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2005, MICROBIOL-SGM, V151, P467, DOI 10.1099/mic.0.27597-0; Arnvig KB, 2012, RNA BIOL; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czyz A, 2014, MBIO, V5, DOI 10.1128/mBio.00931-14; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deikus G, 2009, J BIOL CHEM, V284, P26394, DOI 10.1074/jbc.M109.015875; DICHIARA JM, 2010, NUCL ACIDS RES; Durand S, 2015, FEMS MICROBIOL REV, V39, P316, DOI 10.1093/femsre/fuv007; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Feng Y, 2016, SCIENCE, V352, P1330, DOI 10.1126/science.aaf4417; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Gautam US, 2014, J BACTERIOL, V196, P790, DOI 10.1128/JB.01270-13; GonzalezyMerchand JA, 1997, J BACTERIOL, V179, P6949, DOI 10.1128/jb.179.22.6949-6958.1997; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Houghton J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080047; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Koslover DJ, 2008, STRUCTURE, V16, P1238, DOI 10.1016/j.str.2008.04.017; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lamichhane G, 2013, TUBERCULOSIS, V93, P26, DOI 10.1016/j.tube.2012.11.010; Lun DS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r142; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; Moliva JI, 2015, VACCINE, V33, P5035, DOI 10.1016/j.vaccine.2015.08.033; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Pelly S, 2012, GENE, V500, P85, DOI 10.1016/j.gene.2012.03.044; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Salina EG, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140106; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shell SS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005641; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Solans L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004183; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Taverniti V, 2011, MOL MICROBIOL, V82, P1260, DOI 10.1111/j.1365-2958.2011.07888.x; Trauner A, 2012, J BIOL CHEM, V287, P24053, DOI 10.1074/jbc.M112.364851; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001; Wang M, 2016, ACTA BIOCH BIOPH SIN, V48, P544, DOI 10.1093/abbs/gmw037; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; World Health Organization, 2016, GLOB TUB REP; Zeller ME, 2007, BIOCHEM J, V403, P207, DOI 10.1042/BJ20061530; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	75	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174079	10.1371/journal.pone.0174079	http://dx.doi.org/10.1371/journal.pone.0174079			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323872	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000399089000057
J	Silva, KR; Cortes, I; Liechocki, S; Carneiro, JRI; Souza, AAP; Borojevic, R; Maya-Monteiro, CM; Baptista, LS				Silva, Karina Ribeiro; Cortes, Isis; Liechocki, Sally; Ivar Carneiro, Joao Regis; Peixoto Souza, Antonio Augusto; Borojevic, Radovan; Maya-Monteiro, Clarissa Menezes; Baptista, Leandra Santos			Characterization of stromal vascular fraction and adipose stem cells from subcutaneous, preperitoneal and visceral morbidly obese human adipose tissue depots	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; ADIPOCYTE PRECURSOR CELLS; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; METABOLIC SYNDROME; FAT; ADIPONECTIN; MACROPHAGES; DIFFERENTIATION; ACCUMULATION	Background/Objectives The pathological condition of obesity is accompanied by a dysfunctional adipose tissue. We postulate that subcutaneous, preperitoneal and visceral obese abdominal white adipose tissue depots could have stromal vascular fractions (SVF) with distinct composition and adipose stem cells (ASC) that would differentially account for the pathogenesis of obesity. Methods In order to evaluate the distribution of SVF subpopulations, samples of subcutaneous, preperitoneal and visceral adipose tissues from morbidly obese women (n = 12, BMI: 46.2 +/- 5.1 kg/m(2)) were collected during bariatric surgery, enzymatically digested and analyzed by flow cytometry (n = 12). ASC from all depots were evaluated for morphology, surface expression, ability to accumulate lipid after induction and cytokine secretion (n = 3). Results A high content of preadipocytes was found in the SVF of subcutaneous depot (p = 0.0178). ASC from the three depots had similar fibroblastoid morphology with a homogeneous expression of CD34, CD146, CD105, CD73 and CD90. ASC from the visceral depot secreted the highest levels of IL-6, MCP-1 and G-CSF (p = 0.0278). Interestingly, preperitoneal ASC under lipid accumulation stimulus showed the lowest levels of all the secreted cytokines, except for adiponectin that was enhanced (p = 0.0278). Conclusions ASC from preperitoneal adipose tissue revealed the less pro-inflammatory properties, although it is an internal adipose depot. Conversely, ASC from visceral adipose tissue are the most pro-inflammatory. Therefore, ASC from subcutaneous, visceral and preperitoneal adipose depots could differentially contribute to the chronic inflammatory scenario of obesity.	[Silva, Karina Ribeiro; Borojevic, Radovan] Fed Univ Rio de Janeiro UFRJ, Postgraduat Program Med Clin, Rio De Janeiro, Brazil; [Silva, Karina Ribeiro; Cortes, Isis; Baptista, Leandra Santos] Natl Inst Metrol Qual & Technol INMETRO, Lab Tissue Bioengn, Duque De Caxias, RJ, Brazil; [Liechocki, Sally; Maya-Monteiro, Clarissa Menezes] Oswaldo Cruz Fdn FIOCRUZ, Oswaldo Cruz Inst, Lab Immunopharmacol, Rio De Janeiro, Brazil; [Ivar Carneiro, Joao Regis] Fed Univ Rio de Janeiro UFRJ, Clementino Fraga Filho Univ Hosp, Nutrol Dept, Rio De Janeiro, Brazil; [Peixoto Souza, Antonio Augusto] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Surg Dept, Rio De Janeiro, Brazil; [Borojevic, Radovan] Petropolis Fac Med FASE, Ctr Regenerat Med, Petropolis, RJ, Brazil; [Baptista, Leandra Santos] Fed Univ Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Xerem Biol Numpex B, Duque De Caxias, RJ, Brazil	Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, KR (corresponding author), Fed Univ Rio de Janeiro UFRJ, Postgraduat Program Med Clin, Rio De Janeiro, Brazil.; Silva, KR; Baptista, LS (corresponding author), Natl Inst Metrol Qual & Technol INMETRO, Lab Tissue Bioengn, Duque De Caxias, RJ, Brazil.; Baptista, LS (corresponding author), Fed Univ Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Xerem Biol Numpex B, Duque De Caxias, RJ, Brazil.	ribeiro.ks@gmail.com; leandrabaptista@xerem.ufrj.br	Borojevic, Radovan/V-8500-2019; Baptista, Leandra/D-4259-2013	Borojevic, Radovan/0000-0002-2393-7280; Baptista, Leandra/0000-0001-9998-8044; Ribeiro Silva, Karina/0000-0001-7394-2494	FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) [APQ1 2013/02 - 139585]; CAPES (Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior) [054/2010]	FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) - APQ1 2013/02 - 139585; CAPES (Coordenagao de Aperfeicoamento de Pessoal de Nivel Superior) - 054/2010 (Convenio Capes-SUS).	Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Azuma K, 2007, AM J PHYSIOL-ENDOC M, V293, pE435, DOI 10.1152/ajpendo.00394.2006; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Baglioni S, 2009, FASEB J, V23, P3494, DOI 10.1096/fj.08-126946; Baptista LS, 2015, WORLD J STEM CELLS, V7, P165, DOI 10.4252/wjsc.v7.i1.165; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Birgel M, 2000, ARTERIOSCL THROM VAS, V20, P1682, DOI 10.1161/01.ATV.20.6.1682; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Fernandez M, 2010, J CELL BIOCHEM, V111, P659, DOI 10.1002/jcb.22753; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hong KM, 2005, FASEB J, V19, P2029, DOI 10.1096/fj.05-4295fje; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; Lebovitz HE, 2003, INT J CLIN PRACT, P18; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Moore KL, 2014, CLIN ORIENTED ANATOM, P2355; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Peinado JR, 2010, PROTEOMICS, V10, P3356, DOI 10.1002/pmic.201000350; Perrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057892; San Martin N, 2011, ARCH PHYSIOL BIOCHEM, V117, P188; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shahparaki A, 2002, METABOLISM, V51, P1211, DOI 10.1053/meta.2002.34037; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Tchoukalova YD, 2010, OBESITY, V18, P1875, DOI 10.1038/oby.2010.56; Terkeltaub R, 1998, CURR OPIN LIPIDOL, V9, P397, DOI 10.1097/00041433-199810000-00003; Tordjman J, 2012, J HEPATOL, V56, P1152, DOI 10.1016/j.jhep.2011.12.015; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu Y, 2015, OBESITY, V23, P989, DOI 10.1002/oby.21053; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	49	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174115	10.1371/journal.pone.0174115	http://dx.doi.org/10.1371/journal.pone.0174115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323901	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000063
J	Xia, N; Ye, XZ; Hu, XH; Song, SY; Xu, H; Niu, MY; Wang, HW; Wang, J				Xia, Nan; Ye, Xiaozhen; Hu, Xiaohao; Song, Shiyu; Xu, Hui; Niu, Mengyuan; Wang, Hongwei; Wang, Jian			Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; THYROTROPIN RECEPTOR; ORBITAL FIBROBLASTS; HYALURONAN SYNTHESIS; MOUSE MODEL; DISEASE; ORBITOPATHY; EXPRESSION; MECHANISMS; SUBUNIT	Background Graves' disease is the most common form of autoimmune thyroid disorder, characterized by hyperthyroidism due to circulating autoantibodies. To address the pathological features and establish a therapeutic approach of this disease, an animal model carrying the phenotype of Graves' disease (GD) in concert with Graves' Ophthalmopathy (GO) will be very important. However, there are no ideal animal models that are currently available. The aim of the present study is to establish an animal model of GD and GO disease, and its pathological features were further characterized. Methods A recombinant plasmid pcDNA3.1-T289 was constructed by inserting the TSHR A-subunit gene into the expression vector pcDNA3.1, and genetic immunization was successfully performed by intramuscular injection of the plasmid pcDNA3.1-T289 on female 8-week-old BALB/c mice. Each injection was immediately followed by in vivo electroporation using ECM830 square wave electroporator. Morphological changes of the eyes were examined using 7.0T MRI scanner. Levels of serum T4 and TSHR antibodies (TRAb) were assessed by ELISA. The pathological changes of the thyroid and orbital tissues were examined by histological staining such as H&E staining and Alcian blue staining. Results More than 90% of the immunized mice spontaneously developed goiter, and about 80% of the immunized mice manifested increased serum T4 and TRAb levels, combined with hypertrophy and hyperplasia of thyroid follicles. A significantly increased synthesis of hyaluronic acid was detected in in the immunized mice compared with the control groups. Conclusion We have successfully established an animal model manifesting Graves' hyperthyroidism and ophthalmopathy, which provides a useful tool for future study of the pathological features and the development of novel therapies of the diseases.	[Xia, Nan; Ye, Xiaozhen; Hu, Xiaohao; Wang, Jian] Nanjing Univ, Sch Med, Jingling Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Xia, Nan; Song, Shiyu; Xu, Hui; Niu, Mengyuan; Wang, Hongwei] Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing, Jiangsu, Peoples R China; [Xia, Nan; Song, Shiyu; Xu, Hui; Niu, Mengyuan; Wang, Hongwei] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Xia, Nan] Mingci Cardiovasc Hosp, Dept Endocrinol, Wuxi, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Wang, J (corresponding author), Nanjing Univ, Sch Med, Jingling Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.; Wang, HW (corresponding author), Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing, Jiangsu, Peoples R China.; Wang, HW (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	wangjndcrn@aliyun.com; hwang@nju.edu.cn	Song, Shiyu/AAO-5023-2021; Xia, Nan/ABG-4600-2021	Song, Shiyu/0000-0001-8438-2277; 	National Natural Scientific Foundations of the People's Republic of China [81370922, 81471095, 91543131]	National Natural Scientific Foundations of the People's Republic of China	The present study was supported by the National Natural Scientific Foundations of the People's Republic of China (No. 81370922. 81471095 and 91543131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn RS, 2013, ENDOCRINOLOGY, V154, P2989, DOI 10.1210/en.2013-1705; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bahn RS, 2003, J CLIN ENDOCR METAB, V88, P1939, DOI 10.1210/jc.2002-030010; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bell A, 2000, AM J PHYSIOL-CELL PH, V279, pC335, DOI 10.1152/ajpcell.2000.279.2.C335; Chen CR, 2004, ENDOCRINOLOGY, V145, P228, DOI 10.1210/en.2003-1134; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Ciullo I, 2003, ENDOCRINOLOGY, V144, P3176, DOI 10.1210/en.2002-220884; Dagdelen S., 2009, ENDOCRINOL METAB CLI; Epstein FH, 1997, NEW ENGL J MED, V337, P1675; Guo NX, 2010, J BIOL CHEM, V285, P15794, DOI 10.1074/jbc.M109.074534; Johnson KTM, 2013, HORM METAB RES, V45, P401, DOI 10.1055/s-0032-1333224; Kaithamana S, 1999, J IMMUNOL, V163, P5157; Kaneda T, 2007, ENDOCRINOLOGY, V148, P2335, DOI 10.1210/en.2006-1077; Kohn LD, 1994, VITAM HORM, V50, P287; Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; Ludgate M, 2004, J ENDOCRINOL INVEST, V27, P211, DOI 10.1007/BF03345268; Misrahi M, 1997, EUR J ENDOCRINOL, V137, P599, DOI 10.1530/eje.0.1370599; Moshkelgosha S, 2013, ENDOCRINOLOGY, V154, P3008, DOI 10.1210/en.2013-1576; Nagayama Y, 2002, J IMMUNOL, V168, P2789, DOI 10.4049/jimmunol.168.6.2789; Saitoh O, 2006, ENDOCRINOLOGY, V147, P2417, DOI 10.1210/en.2005-1024; SCHUMACHER U, 1994, BIOTECH HISTOCHEM, V69, P18, DOI 10.3109/10520299409106256; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Smith TJ, 2002, J CLIN ENDOCR METAB, V87, P385, DOI 10.1210/jc.87.1.385; Tsui S, 2011, J BIOL CHEM, V286, P24487, DOI 10.1074/jbc.M111.241166; Ungerer M, 2016, CLIN REV ALLERG IMMU, P1; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; van Steensel L, 2010, ORBIT, V29, P202, DOI 10.3109/01676831003668443; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; Wiesweg B, 2013, HORM METAB RES, V45, P549, DOI 10.1055/s-0033-1343451	32	10	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174260	10.1371/journal.pone.0174260	http://dx.doi.org/10.1371/journal.pone.0174260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319174	gold, Green Submitted, Green Published			2022-12-27	WOS:000398945800062
J	Yu, ZG; Guo, FX; Guo, YY; Zhang, ZR; Wu, F; Luo, XQ				Yu, Zugong; Guo, Fanxi; Guo, Yangyang; Zhang, Zhenrui; Wu, Feng; Luo, Xiaoqing			Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels	PLOS ONE			English	Article							IMMUNE-ENHANCING ACTIVITY; IMMUNOSUPPRESSION; MEMBRANACEUS; CYCLOPHOSPHAMIDE; DELIVERY; SYSTEM; GAMMA; MICE	The objective of this study was to develop an injectable in situ forming gel system based on Poloxamer for sustained release of Astragalus polysaccharide (APS), thus achieved once or twice administration instead of frequent dosing during long-term treatment. The optimal formulation is 10 g APS, 18 g poloxamer 407, 2 g poloxamer 188, 0.15 g CMC-Na, 0.85 g sodium chloride in 100 ml gel in situ which had a preferable sol-gel transition temperature(T sol-gel) (34.1 +/- 0.4 degrees C), and good stability. In vitro release studies, all formulations containing polymer additives had prolonged release time and decreased initial burst to some extent. The optimal formulation containing 0.15% CMC-Na showed a best sustained release profile for about 132 h with the lowest initial burst in vitro about 16.30% in 12 h). In vivo, Male BALB/c mice (18 - 20 g) were administrated with APS in-situ gel just once, the values of immune organ indices, spleen lymphocyte proliferation, and serum IgM, IgG, IL-2 and IL-6 had significant increase, which was consistent with the mice given daily APS injections (7 times), while the above indices were increased more significantly in which administrated with APS in-situ gel twice. Based on these results, it can be concluded that the Poloxamer depot is a promising carrier for the sustained release of APS with an ideal release behavior.	[Yu, Zugong; Guo, Fanxi; Guo, Yangyang; Zhang, Zhenrui; Wu, Feng; Luo, Xiaoqing] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yu, ZG (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	yuzugong@njau.edu.cn						Asasutjarit R, 2011, INT J PHARMACEUT, V411, P128, DOI 10.1016/j.ijpharm.2011.03.054; CAO Y, 2014, OXID MED CELL LONGEV, V2014, DOI DOI 10.1155/2014/674219; Chang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122374; Chen XM, 2012, CARBOHYD POLYM, V90, P1114, DOI 10.1016/j.carbpol.2012.06.052; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Fan YP, 2012, INT J BIOL MACROMOL, V50, P125, DOI 10.1016/j.ijbiomac.2011.10.008; Fu J, 2014, PHYTOTHER RES, V28, P1275, DOI 10.1002/ptr.5188; Garala K, 2013, INT J PHARM INVESTIG, V3, P29, DOI 10.4103/2230-973X.108961; Guo LW, 2012, CARBOHYD POLYM, V90, P1055, DOI 10.1016/j.carbpol.2012.06.042; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Li MX, 2011, J ETHNOPHARMACOL, V133, P412, DOI 10.1016/j.jep.2010.10.012; Li XT, 2012, INT J MOL SCI, V13, P1747, DOI 10.3390/ijms13021747; Nguyen XN, 2010, BIOORG MED CHEM LETT, V20, P4927, DOI 10.1016/j.bmcl.2010.06.044; Qi HY, 2007, INT J PHARM, V337, P178, DOI 10.1016/j.ijpharm.2006.12.038; Ren Z, 2014, INT J BIOL MACROMOL, V70, P590, DOI 10.1016/j.ijbiomac.2014.07.044; Wei G, 2002, J CONTROL RELEASE, V83, P65, DOI 10.1016/S0168-3659(02)00175-X; Wojcikowski K, 2010, PHYTOTHER RES, V24, P875, DOI 10.1002/ptr.3038; Yu ZG, 2015, J VET PHARMACOL THER, V38, P271, DOI 10.1111/jvp.12171; Yuan HM, 2006, CANCER LETT, V243, P228, DOI 10.1016/j.canlet.2005.11.032; Yuan Y, 2009, WORLD J GASTROENTERO, V15, P3676, DOI 10.3748/wjg.15.3676; Zhang J, 2013, INT J BIOL MACROMOL, V52, P212, DOI 10.1016/j.ijbiomac.2012.09.025; Zhao XH, 2015, INT J CLIN EXP MED, V8, P558	24	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173949	10.1371/journal.pone.0173949	http://dx.doi.org/10.1371/journal.pone.0173949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350799	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174400010
J	Bhuyan, GS; Hossain, MA; Sarker, SK; Rahat, A; Islam, MT; Haque, TN; Begum, N; Qadri, SK; Muraduzzaman, AKM; Islam, NN; Islam, MS; Sultana, N; Jony, MHK; Khanam, F; Mowla, G; Matin, A; Begum, F; Shirin, T; Ahmed, D; Saha, N; Qadri, F; Mannoor, K				Bhuyan, Golam Sarower; Hossain, Mohammad Amir; Sarker, Suprovath Kumar; Rahat, Asifuzzaman; Islam, Md Tarikul; Haque, Tanjina Noor; Begum, Noorjahan; Qadri, Syeda Kashfi; Muraduzzaman, A. K. M.; Islam, Nafisa Nawal; Islam, Mohammad Sazzadul; Sultana, Nusrat; Jony, Manjur Hossain Khan; Khanam, Farhana; Mowla, Golam; Matin, Abdul; Begum, Firoza; Shirin, Tahmina; Ahmed, Dilruba; Saha, Narayan; Qadri, Firdausi; Mannoor, Kaiissar			Bacterial and viral pathogen spectra of acute respiratory infections in under-5 children in hospital settings in Dhaka city	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN METAPNEUMOVIRUS INFECTION; SYNCYTIAL VIRUS-INFECTION; CLINICAL CHARACTERISTICS; TRACT INFECTIONS; HUMAN BOCAVIRUS; INFANTS; EPIDEMIOLOGY; ETIOLOGY; IMPACT	The study aimed to examine for the first time the spectra of viral and bacterial pathogens along with the antibiotic susceptibility of the isolated bacteria in under-5 children with acute respiratory infections (ARIs) in hospital settings of Dhaka, Bangladesh. Nasal swabs were collected from 200 under-five children hospitalized with clinical signs of ARIs. Nasal swabs from 30 asymptomatic children were also collected. Screening of viral pathogens targeted ten respiratory viruses using RT-qPCR. Bacterial pathogens were identified by bacteriological culture methods and antimicrobial susceptibility of the isolates was determined following CLSI guidelines. About 82.5% (n = 165) of specimens were positive for pathogens. Of 165 infected cases, 3% (n = 6) had only single bacterial pathogens, whereas 43.5% (n = 87) cases had only single viral pathogens. The remaining 36% (n = 72) cases had coinfections. In symptomatic cases, human rhinovirus was detected as the predominant virus (31.5%), followed by RSV (31%), HMPV (13%), HBoV (11%), HPIV-3 (10.5%), and adenovirus (7%). Streptococcus pneumoniae was the most frequently isolated bacterial pathogen (9%), whereas Klebsiella pneumaniae, Streptococcus spp., Enterobacter agglomerans, and Haemophilus influenzae were 5.5%, 5%, 2%, and 1.5%, respectively. Of 15 multidrug-resistant bacteria, a Klebsiella pneumoniae isolate and an Enterobacter agglomerans isolate exhibited resistance against more than 10 different antibiotics. Both ARI incidence and predominant pathogen detection rates were higher during post-monsoon and winter, peaking in September. Pathogen detection rates and coinfection incidence in less than 1-year group were significantly higher (P = 0.0034 and 0.049, respectively) than in 1-5 years age group. Pathogen detection rate (43%) in asymptomatic cases was significantly lower compared to symptomatic group (P< 0.0001). Human rhinovirus, HPIV-3, adenovirus, Streptococcus pneumonia, and Klebsiella pneumaniae had significant involvement in coinfections with P values of 0.0001, 0.009 and 0.0001, 0.0001 and 0.001 respectively. Further investigations are required to better understand the clinical roles of the isolated pathogens and their seasonality.	[Bhuyan, Golam Sarower; Hossain, Mohammad Amir; Rahat, Asifuzzaman; Haque, Tanjina Noor; Islam, Mohammad Sazzadul; Sultana, Nusrat; Qadri, Firdausi; Mannoor, Kaiissar] Inst Dev Sci & Hlth Initiat, Infect Dis Lab, Dhaka, Bangladesh; [Sarker, Suprovath Kumar; Islam, Md Tarikul; Begum, Noorjahan; Islam, Nafisa Nawal; Mannoor, Kaiissar] Inst Dev Sci & Hlth Initiat, Genet & Genom Lab, Dhaka, Bangladesh; [Qadri, Syeda Kashfi] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore, Singapore; [Muraduzzaman, A. K. M.; Jony, Manjur Hossain Khan; Shirin, Tahmina] Inst Epidemiol Dis Control & Res, Dept Virol, Dhaka, Bangladesh; [Jony, Manjur Hossain Khan] Mymensingh Med Coll, Dept Virol, Dhaka, Bangladesh; [Khanam, Farhana; Ahmed, Dilruba; Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Dept Enter & Resp Infect Dis, Dhaka, Bangladesh; [Mowla, Golam] Suhrawardy Med Coll Hosp, Dept Pediat, Dhaka, Bangladesh; [Matin, Abdul] Dhaka Med Coll Hosp, Dept Child Hlth, Dhaka, Bangladesh; [Begum, Firoza] Bangabandhu Sheikh Mujib Med Univ, Dept Obstet & Gynecol, Dhaka, Bangladesh; [Saha, Narayan] Natl Inst Neurosci & Hosp, Pediat Neurol, Dhaka, Bangladesh	KK Women's & Children's Hospital; Mymensingh Medical College; International Centre for Diarrhoeal Disease Research (ICDDR); Dhaka Medical College; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Mannoor, K (corresponding author), Inst Dev Sci & Hlth Initiat, Infect Dis Lab, Dhaka, Bangladesh.; Mannoor, K (corresponding author), Inst Dev Sci & Hlth Initiat, Genet & Genom Lab, Dhaka, Bangladesh.	kaiissar@ideshi.org	Al, Mamun M./AAF-5850-2019; Matin, Abdul/GQH-8528-2022; Qadri, Firdausi/AAF-4583-2019	Matin, Abdul/0000-0002-2260-7888; Ahmed, Dilruba/0000-0001-8961-2406; Bhuyan, Golam Sarower/0000-0003-0472-0040; Shirin, Tahmina/0000-0002-5061-3783; Islam, Md Tarikul/0000-0003-2822-245X; Islam, Nafisa Nawal/0000-0001-6136-4025				[Anonymous], 2010, WORLD HLTH STAT 2010; Banstola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071311; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Cabello C, 2006, MEM I OSWALDO CRUZ, V101, P21, DOI 10.1590/S0074-02762006000100005; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Calvo C, 2016, J MED VIROL, V88, P2052, DOI 10.1002/jmv.24562; Collier L, 2000, HUMAN VIROLOGY, VSecond; Tran DN, 2014, J MED VIROL, V86, P988, DOI 10.1002/jmv.23789; Ditt V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016314; Domachowske JB, 1999, CLIN MICROBIOL REV, V12, P298, DOI 10.1128/CMR.12.2.298; Faris NS, 2014, ESJ, V10; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Foulongne V, 2006, PEDIATR INFECT DIS J, V25, P354, DOI 10.1097/01.inf.0000207480.55201.f6; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; Haynes LM, 2013, J INFECT DIS, V208, pS177, DOI 10.1093/infdis/jit512; Hoffmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043666; Homaira N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147982; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; HUQ F, 1990, REV INFECT DIS, V12, pS982; Konig B, 2004, J CLIN MICROBIOL, V42, P4632, DOI 10.1128/JCM.42.10.4632-4635.2004; Lagare A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1251-y; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lieberman D, 1999, J INFECTION, V39, P134, DOI 10.1016/S0163-4453(99)90005-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Martins RB, 2014, MEM I OSWALDO CRUZ, V109, P716, DOI 10.1590/0074-0276140046; McLeish NJ, 2012, J CLIN MICROBIOL, V50, P2910, DOI 10.1128/JCM.01172-12; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Murata Y, 2008, CURR OPIN PULM MED, V14, P235, DOI 10.1097/MCP.0b013e3282f79651; Panda S, 2012, INT J CURR REV, V4, P149; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Sentilhes AC, 2013, INFLUENZA OTHER RESP, V7, P1070, DOI 10.1111/irv.12135; Serin DC, 2014, J INFECT DEV COUNTR, V8, P510, DOI 10.3855/jidc.3560; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Simusika P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0779-1; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Skevaki CL, 2015, PEDIATR INFECT DIS J, V34, P1296, DOI 10.1097/INF.0000000000000872; Socan M, 1999, EUR J CLIN MICROBIOL, V18, P777, DOI 10.1007/s100960050400; Sung RYT, 2008, J CLIN MICROBIOL, V46, P3073, DOI 10.1128/JCM.01209-08; van Gageldonk-Lafeber AB, 2005, CLIN INFECT DIS, V41, P490, DOI 10.1086/431982; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WALKER TA, 1994, PEDIATR CLIN N AM, V41, P1365; Weinberg GA, 2013, J CLIN VIROL, V57, P254, DOI 10.1016/j.jcv.2013.03.016; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Wolter N, 2014, J INFECT DIS; Wu ZG, 2014, RESPIROLOGY, V19, P218, DOI 10.1111/resp.12205; Yu D, 2010, CLIN MICROBIOL INFEC, V16, P1399, DOI [10.1111/j.1469-0691.2010.03147.x, 10.1111/j.1469-0691.2009.03147.x]	59	27	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174488	10.1371/journal.pone.0174488	http://dx.doi.org/10.1371/journal.pone.0174488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346512	gold, Green Published			2022-12-27	WOS:000399174300051
J	Le, MH; Devaki, P; Ha, NB; Jun, DW; Te, HS; Cheung, RC; Nguyen, MH				Le, Michael H.; Devaki, Pardha; Ha, Nghiem B.; Jun, Dae Won; Te, Helen S.; Cheung, Ramsey C.; Nguyen, Mindie H.			Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States	PLOS ONE			English	Article							EXTERNAL VALIDATION; HEPATIC STEATOSIS; INDEX; DIAGNOSIS; ASSOCIATION; POPULATION; MARKERS; SCORE	In the United States, non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and associated with higher mortality according to data from earlier National Health and Nutrition Examination Survey (NHANES) 1988-1994. Our goal was to determine the NAFLD prevalence in the recent 1999-2012 NHANES, risk factors for advanced fibrosis (stage 3-4) and mortality. NAFLD was defined as having a United States Fatty Liver Index (USFLI) > 30 in the absence of heavy alcohol use and other known liver diseases. The probability of low/high risk of having advanced fibrosis was determined by the NAFLD Fibrosis Score (NFS). In total, 6000 persons were included; of which, 30.0% had NAFLD and 10.3% of these had advanced fibrosis. Five and eight-year overall mortality in NAFLD subjects with advanced fibrosis was significantly higher than subjects without NAFLD ((18% and 35% vs. 2.6% and 5.5%, respectively) but not NAFLD subjects without advanced fibrosis (1.1% and 2.8%, respectively). NAFLD with advanced fibrosis (but not those without) is an independent predictor for mortality on multivariate analysis (HR = 3.13, 95% CI 1.93-5.08, p<0.001). In conclusion, in this most recent NHANES, NAFLD prevalence remains at 30% with 10.3% of these having advanced fibrosis. NAFLD per se was not a risk factor for increased mortality, but NAFLD with advanced fibrosis was. Mexican American ethnicity was a significant risk factor for NAFLD but not for advanced fibrosis or increased mortality.	[Le, Michael H.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Devaki, Pardha] Cleveland Clin, Digest Dis Inst, Cleveland, OH 44106 USA; [Ha, Nghiem B.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Ha, Nghiem B.; Cheung, Ramsey C.; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Jun, Dae Won] Hanyang Univ, Dept Gastroenterol, Med Ctr, Seoul, South Korea; [Te, Helen S.] Univ Chicago Med, Dept Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL USA; [Cheung, Ramsey C.] Vet Affairs Palo Alto Hlth Care Syst, Div Gastroenterol & Hepatol, Palo Alto, CA USA	Stanford University; Cleveland Clinic Foundation; University of California System; University of California Davis; Stanford University; Hanyang University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Nguyen, MH (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA.	mindiehn@stanford.edu	Devaki, Pardha/ABC-1593-2020	Le, Michael/0000-0001-5051-3160				Abd El-Kader SM, 2015, WORLD J HEPATOL, V7, P846, DOI 10.4254/wjh.v7.i6.846; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Cuthbertson DJ, 2014, EUR J ENDOCRINOL, V171, P561, DOI 10.1530/EJE-14-0112; Data Linkage Team, 2015, COMP AN NHIS PUBL US; Ditah IC, 2016, GASTROENTEROLOGY S1, V150; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huang XL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001682; Johnson CL., 2013, ANAL GUIDELINES 1999; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0098961, 10.1371/journal.pone.0108317]; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; National Center for Health Statistics, 2010, VITAL HLTH STAT, V1, P1; National Center for Health Statistics, 2013, NCHS 2011 LINK MORT; National Center for Health Statistics [NCHS],, NAT HLTH NUTR EX SUR; NCHS, KEY CONC WEIGHT NHAN; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Paschos P, 2009, HIPPOKRATIA, V13, P9; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; StataCorp LP, 1985, STAT SURV AN EP TABL; Unalp-Arida A, 2016, HEPATOLOGY, V63, P1170, DOI 10.1002/hep.28390; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wiley TE, 2002, AM J GASTROENTEROL, V97, P700, DOI 10.1111/j.1572-0241.2002.05555.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443; Zein CO, 2011, J HEPATOL, V54, P753, DOI 10.1016/j.jhep.2010.07.040	40	147	150	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173499	10.1371/journal.pone.0173499	http://dx.doi.org/10.1371/journal.pone.0173499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346543	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300007
J	Melville, JM; McDonald, CA; Bischof, RJ; Polglase, GR; Lim, R; Wallace, EM; Jenkin, G; Moss, TJ				Melville, Jacqueline M.; McDonald, Courtney A.; Bischof, Robert J.; Polglase, Graeme R.; Lim, Rebecca; Wallace, Euan M.; Jenkin, Graham; Moss, Timothy J.			Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs	PLOS ONE			English	Article							LUNG INFLAMMATION; IMMUNE-RESPONSE; INJURY; FETAL; MACROPHAGES; MEMBRANE; TRANSPLANTATION; INTERLEUKIN-8; ACTIVATION; EXPRESSION	Ventilation of preterm neonates causes pulmonary inflammation that can contribute to lung injury, propagate systemically and result in long-term disease. Modulation of this initial response may reduce lung injury and its sequelae. We aimed to determine the effect of human amnion epithelial cells (hAECs) on immune activation and lung injury in preterm neonatal lambs. Preterm lambs received intratracheal hAECs (90x10(6)) or vehicle, prior to 2 h of mechanical ventilation. Within 5 min of ventilation onset, lambs also received intravenous hAECs (90x10(6)) or vehicle. Lung histology, bronchoalveolar lavage (BAL) cell phenotypes, and cytokine profiles were examined after 2 h of ventilation, and in unventilated controls. Histological indices of lung injury were higher than control, in vehicle-treated ventilated lambs but not in hAEC-treated ventilated lambs. Ventilation-induced pulmonary leukocyte recruitment was greater in hAEC-treated lambs than in vehicle-treated lambs. Lung IL-1 beta and IL-6 mRNA expression was higher in vehicle-and hAEC-treated ventilated lambs than in controls but IL-8 mRNA levels were greater than control only in vehicle-treated ventilated lambs. Numbers of CD44(+) and CD21(+) lymphocytes and macrophages from the lungs were altered in vehicle-and hAEC-treated ventilated lambs. Numbers of CD8(+) macrophages were lower in hAEC-treated ventilated lambs than in vehicle-treated ventilated lambs. Indices of systemic inflammation were not different between vehicle-and hAEC-treated lambs. Human amnion epithelial cells modulate the pulmonary inflammatory response to ventilation in preterm lambs, and reduce acute lung injury. Immunomodulatory effects of hAECs reduce lung injury in preterm neonates and may protect against longer-term respiratory disease.	[Melville, Jacqueline M.; McDonald, Courtney A.; Bischof, Robert J.; Polglase, Graeme R.; Lim, Rebecca; Wallace, Euan M.; Jenkin, Graham; Moss, Timothy J.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Polglase, Graeme R.; Lim, Rebecca; Wallace, Euan M.; Jenkin, Graham; Moss, Timothy J.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University	Bischof, RJ (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	robert.bischof@hudson.org.au	Lim, Rebecca/K-5175-2019; Moss, Timothy/A-6633-2008; Wallace, Euan M/K-6774-2015	Lim, Rebecca/0000-0002-0410-497X; Moss, Timothy/0000-0002-9408-4027; Wallace, Euan M/0000-0002-4506-5233; Polglase, Graeme/0000-0002-8906-614X; McDonald, Courtney/0000-0001-8421-461X; Bischof, Robert/0000-0002-6649-9612	National Health and Medical Research Council; State Government of Victoria	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria	This work was supported by the National Health and Medical Research Council (https://www.nhmrc.gov.au/), and the State Government of Victoria (http://www.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeynaike L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-46; Attar Mohammad Ali, 2002, Semin Neonatol, V7, P353, DOI 10.1053/siny.2002.0129; Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399; Ballabh P, 2003, AM J PERINAT, V20, P465; Barton SK, 2015, DEV NEUROSCI; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Bischof RJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-16; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Gahler A, 2000, PEDIATR RES, V48, P299; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; Gulbahar MY, 2009, VET PARASITOL, V160, P272, DOI 10.1016/j.vetpar.2008.11.012; Herrmann LM, 2003, AM J PATHOL, V162, P1075, DOI 10.1016/S0002-9440(10)63904-1; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Hiraki K, 2009, J NEUROSCI RES, V87, P1175, DOI 10.1002/jnr.21924; Hirji N, 1997, J IMMUNOL, V158, P1833; Hodges RJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.038; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Ko JH, 2016, P NATL ACAD SCI USA, V113, P158, DOI 10.1073/pnas.1522905113; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Li Z, 2013, AUSTR MOTHERS BABIES, V28; Lin TJ, 2000, J IMMUNOL, V164, P1783, DOI 10.4049/jimmunol.164.4.1783; Liravi B, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0097-9; Makita N, 2014, INT IMMUNOL; McDonald CA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt495; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Moss TJM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.044; Murphy Sean, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e06s13; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Murphy SV, 2012, CELL TRANSPLANT, V21, P1477, DOI 10.3727/096368911X601028; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Naik AS, 2001, AM J RESP CRIT CARE, V164, P494, DOI 10.1164/ajrccm.164.3.2010127; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Perlman JM, 2006, PEDIATRICS, V117, pE978, DOI 10.1542/ped.2006-0350; Polglase GR, 2014, J PHYSIOL-LONDON, V592, P1993, DOI 10.1113/jphysiol.2013.270348; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Stern M, 1913, J AMER MED ASSOC, V60, P973, DOI 10.1001/jama.1913.04340130021008; Tan JL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt542; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Turunen R, 2009, NEONATOLOGY, V96, P248, DOI 10.1159/000220764; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; Vosdoganes P, 2013, CYTOTHERAPY; Vosdoganes P, 2012, CELL TRANSPLANT; Vosdoganes P, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.054; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Westover AJ, 2012, AM J PHYSIOL-LUNG C, V302, P1664, DOI 10.1152/ajplung.00297.2011; Yawno T, 2013, DEV NEUROSCI-BASEL, V35, P272, DOI 10.1159/000346683	49	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173572	10.1371/journal.pone.0173572	http://dx.doi.org/10.1371/journal.pone.0173572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346529	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300008
J	Ros, M; Raut, I; Santisima-Trinidad, AB; Pascual, JA				Ros, Margarita; Raut, Iulia; Belen Santisima-Trinidad, Ana; Antonio Pascual, Jose			Relationship of microbial communities and suppressiveness of Trichoderma fortified composts for pepper seedlings infected by Phytophthora nicotianae	PLOS ONE			English	Article							FUSARIUM-WILT; BIOCONTROL AGENT; PLANT-GROWTH; RHIZOSPHERE; DIVERSITY; MICROORGANISMS; SUCCESSION; OXYSPORUM; PATHOGEN; BACTERIA	The understanding of the dynamic of soil-borne diseases is related to the microbial composition of the rhizosphere which is the key to progress in the field of biological control. Trichoderma spp. is commonly used as a biological control agent. The use of next generation sequencing approaches and quantitative PCR are two successful approaches to assess the effect of using compost as substrate fortified with two Trichoderma strains (Trichoderma harzianum or Trichoderma asperellum) on bacterial and fungal communities in pepper rhizosphere infected with Phytophthora nicotianae. The results showed changes in the bacterial rhizosphere community not attributed to the Trichoderma strain, but to the pathogen infection, while, fungi were not affected by pathogen infection and depended on the type of substrate. The Trichoderma asperellum fortified compost was the most effective combination against the pathogen. This could indicate that the effect of fortified composts is greater than compost itself and the biocontrol effect should be attributed to the Trichoderma strains rather than the compost microbiota, although some microorganisms could help with the biocontrol effect.	[Ros, Margarita; Belen Santisima-Trinidad, Ana; Antonio Pascual, Jose] CSIC, Dept Soil & Water Conservat & Organ Waste Managem, Ctr Edafol & Biol Aplicada Segura, Murcia, Spain; [Raut, Iulia] Natl Inst Res & Dev Chem & Petrochem ICECHIM, Biotechnol & Bioanal Grp, Bucharest, Romania	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); National Institute Research & Development in Chemistry & Petrochemistry	Ros, M (corresponding author), CSIC, Dept Soil & Water Conservat & Organ Waste Managem, Ctr Edafol & Biol Aplicada Segura, Murcia, Spain.	margaros@cebas.csic.es	Ros, Margarita M/L-7081-2014; pascual, Jose/I-9021-2012	Ros, Margarita M/0000-0002-0375-7004; pascual, Jose/0000-0001-7485-1092; Raut, Iuliana/0000-0002-6178-1651	Spanish National Project [AGL2014-52732-C2-1-R]; Fundacion Seneca of the Region of Murcia within the Research Groups of Excellence programme of the Region of Murcia [19896/GERM/15]	Spanish National Project(Spanish Government); Fundacion Seneca of the Region of Murcia within the Research Groups of Excellence programme of the Region of Murcia	This research has been supported by the Spanish National Project AGL2014-52732-C2-1-R. Also, the authors would like to thank the Fundacion Seneca of the Region of Murcia for its financial support within the Research Groups of Excellence programme of the Region of Murcia(19896/GERM/15).	Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Blaya J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158048; Blaya J, 2015, J SCI FOOD AGR, V95, P1482, DOI 10.1002/jsfa.6847; Blaya J, 2015, J SCI FOOD AGR, V95, P1243, DOI 10.1002/jsfa.6813; Blaya J, 2013, PESTIC BIOCHEM PHYS, V107, P112, DOI 10.1016/j.pestbp.2013.06.001; Bonanomi G, 2006, AGR ECOSYST ENVIRON, V115, P194, DOI 10.1016/j.agee.2006.01.002; Bonanomi G, 2010, SOIL BIOL BIOCHEM, V42, P136, DOI 10.1016/j.soilbio.2009.10.012; Borrero C, 2004, PHYTOPATHOLOGY, V94, P1094, DOI 10.1094/PHYTO.2004.94.10.1094; Bustamante MA, 2008, RESOUR CONSERV RECY, V52, P792, DOI 10.1016/j.resconrec.2007.11.005; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cook J, 1996, BIOL CONTROL, V7, P333, DOI 10.1006/bcon.1996.0102; Cordier C, 2009, EUR J SOIL BIOL, V45, P267, DOI 10.1016/j.ejsobi.2008.12.004; Cuesta G, 2012, J ENVIRON MANAGE, V95, pS280, DOI 10.1016/j.jenvman.2010.11.023; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; de Gannes V, 2013, BIORESOURCE TECHNOL, V133, P573, DOI 10.1016/j.biortech.2013.01.138; Dinis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021280; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Hoitink HAJ, 2006, PHYTOPATHOLOGY, V96, P186, DOI 10.1094/PHYTO-96-0186; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Kaur S, PLANT DIS RES, V25, P79; KLUEPFEL D, 1972, J ANTIBIOT, V25, P109, DOI 10.7164/antibiotics.25.109; Kyselkova M, 2009, ISME J, V3, P1127, DOI 10.1038/ismej.2009.61; Langarica-Fuentes A, 2014, FEMS MICROBIOL ECOL, V88, P296, DOI 10.1111/1574-6941.12293; Loliam B, 2013, SCIENCEASIA, V39, P584, DOI 10.2306/scienceasia1513-1874.2013.39.584; Lopez-Mondejar R, 2010, BIORESOURCE TECHNOL, V101, P3718, DOI 10.1016/j.biortech.2009.12.102; Lopez-Mondejar R, 2010, BIORESOURCE TECHNOL, V101, P2888, DOI 10.1016/j.biortech.2009.10.019; McKellar ME, 2003, APPL ENVIRON MICROB, V69, P452, DOI 10.1128/AEM.69.1.452-460.2003; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Partanen P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-94; Pascual JA, 2000, BIOL FERT SOILS, V30, P478, DOI 10.1007/s003740050026; Paulitz TC, 2000, EUR J PLANT PATHOL, V106, P401, DOI 10.1023/A:1008733927515; Pugliese M, 2011, J PLANT DIS PROTECT, V118, P45, DOI 10.1007/BF03356380; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Rheims H, 1996, J IND MICROBIOL, V17, P159, DOI 10.1007/BF01574689; Ros M, 2005, J APPL MICROBIOL, V98, P845, DOI 10.1111/j.1365-2672.2004.02508.x; Savazzini F, 2009, SOIL BIOL BIOCHEM, V41, P1457, DOI 10.1016/j.soilbio.2009.03.027; Serkebaeva YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063994; Steger K, 2003, J MICROBIOL METH, V55, P371, DOI 10.1016/S0167-7012(03)00187-8; Sugiyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100709; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Sylla J, 2013, PHYTOPATHOLOGY, V103, P1001, DOI 10.1094/PHYTO-01-13-0014-R; Veloso J, 2012, PLANT PATHOL, V61, P281, DOI 10.1111/j.1365-3059.2011.02516.x; Viebahn M, 2005, FEMS MICROBIOL ECOL, V53, P245, DOI 10.1016/j.femsec.2004.12.014; Viterbo A, 2010, MYCOPARASITISM, P676; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Woo SL, 2006, PHYTOPATHOLOGY, V96, P181, DOI 10.1094/PHYTO-96-0181; Yuan J, 2012, APPL ENVIRON MICROB, V78, P5942, DOI 10.1128/AEM.01357-12; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010	56	23	25	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174069	10.1371/journal.pone.0174069	http://dx.doi.org/10.1371/journal.pone.0174069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346470	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300022
J	Yee, LTS				Yee, Lydia T. S.			Valence, arousal, familiarity, concreteness, and imageability ratings for 292 two-character Chinese nouns in Cantonese speakers in Hong Kong	PLOS ONE			English	Article							ENGLISH WORDS ANEW; AGE-OF-ACQUISITION; AFFECTIVE NORMS; RECOGNITION MEMORY; PSYCHOLINGUISTIC NORMS; SUBJECTIVE FREQUENCY; SPANISH NORMS; FRENCH WORDS; RECOLLECTION; ADAPTATION	Words are frequently used as stimuli in cognitive psychology experiments, for example, in recognition memory studies. In these experiments, it is often desirable to control for the words' psycholinguistic properties because differences in such properties across experimental conditions might introduce undesirable confounds. In order to avoid confounds, studies typically check to see if various affective and lexico-semantic properties are matched across experimental conditions, and so databases that contain values for these properties are needed. While word ratings for these variables exist in English and other European languages, ratings for Chinese words are not comprehensive. In particular, while ratings for single characters exist, ratings for two-character words D which often have different meanings than their constituent characters, are scarce. In this study, ratings for 292 two-character Chinese nouns were obtained from Cantonese speakers in Hong Kong. Affective variables, including valence and arousal, and lexico-semantic variables, including familiarity, concreteness, and imageability, were rated in the study. The words were selected from a film subtitle database containing word frequency information that could be extracted and listed alongside the resulting ratings. Overall, the subjective ratings showed good reliability across all rated dimensions, as well as good reliability within and between the different groups of participants who each rated a subset of the words. Moreover, several well-established relationships between the variables found consistently in other languages were also observed in this study, demonstrating that the ratings are valid. The resulting word database can be used in studies where control for the above psycholinguistic variables is critical to the research design.	[Yee, Lydia T. S.] Educ Univ Hong Kong, Dept Psychol, Tai Po, Hong Kong, Peoples R China; [Yee, Lydia T. S.] Educ Univ Hong Kong, Ctr Psychosocial Hlth, Tai Po, Hong Kong, Peoples R China; [Yee, Lydia T. S.] Educ Univ Hong Kong, Ctr Brain & Educ, Tai Po, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK)	Yee, LTS (corresponding author), Educ Univ Hong Kong, Dept Psychol, Tai Po, Hong Kong, Peoples R China.; Yee, LTS (corresponding author), Educ Univ Hong Kong, Ctr Psychosocial Hlth, Tai Po, Hong Kong, Peoples R China.; Yee, LTS (corresponding author), Educ Univ Hong Kong, Ctr Brain & Educ, Tai Po, Hong Kong, Peoples R China.	ltsyee@eduhk.hk		YEE, Ting Sum Lydia/0000-0002-0464-6058	Education University of Hong Kong [RG64/2014-2015R, DRG/2014-15, DRG/2015-16]	Education University of Hong Kong	This work was supported by grants awarded to L.T.S.Y. by the Education University of Hong Kong. The grants were: RG64/2014-2015R, DRG/2014-15, and DRG/2015-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants awarded to L.T.S.Y. by the Education University of Hong Kong. The grants were: RG64/2014-2015R, DRG/2014-15, and DRG/2015-16.	Aly M, 2011, BEHAV BRAIN RES, V225, P297, DOI 10.1016/j.bbr.2011.07.043; [Anonymous], 1967, PSYCHON SCI, DOI DOI 10.3758/BF03330834; [Anonymous], 2016, PROTECTION CONTROL M; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Bonin P, 2003, ANN PSYCHOL, V103, P655; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brysbaert M, 2016, J EXP PSYCHOL HUMAN, V42, P441, DOI 10.1037/xhp0000159; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Citron FMM, 2014, APPL PSYCHOLINGUIST, V35, P313, DOI 10.1017/S0142716412000409; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Connell L, 2012, COGNITION, V125, P452, DOI 10.1016/j.cognition.2012.07.010; Cortese MJ, 2004, BEHAV RES METH INS C, V36, P384, DOI 10.3758/BF03195585; Cuetos F, 2011, PSICOLOGICA, V32, P133; Dellantonio S, 2014, FRONT PSYCHOL, P5; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; Ferrand L, 2008, BEHAV RES METHODS, V40, P1049, DOI 10.3758/BRM.40.4.1049; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; FRIENDLY M, 1982, BEHAV RES METH INSTR, V14, P375, DOI 10.3758/BF03203275; GARDINER JM, 1988, MEM COGNITION, V16, P309, DOI 10.3758/BF03197041; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; GLANZER M, 1976, J EXP PSYCHOL-HUM L, V2, P21, DOI 10.1037/0278-7393.2.1.21; GORMAN AM, 1961, J EXP PSYCHOL, V61, P23, DOI 10.1037/h0040561; Guasch M, 2016, BEHAV RES METHODS, V48, P1358, DOI 10.3758/s13428-015-0684-y; HALL JF, 1954, AM J PSYCHOL, V67, P138, DOI 10.2307/1418080; Hennessee JP, 2017, J MEM LANG, V94, P195, DOI 10.1016/j.jml.2016.12.004; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hinojosa JA, 2016, BEHAV RES METHODS, V48, P272, DOI 10.3758/s13428-015-0572-5; Ho SMY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132294; Hoppstadter M, 2015, NEUROIMAGE, V116, P112, DOI 10.1016/j.neuroimage.2015.05.026; Hoppstadter M, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00051; Moreno-Martinez FJ, 2014, BEHAV RES METHODS, V46, P1088, DOI 10.3758/s13428-013-0435-x; Kanske P, 2010, BEHAV RES METHODS, V42, P987, DOI 10.3758/BRM.42.4.987; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Klaver P, 2005, HIPPOCAMPUS, V15, P704, DOI 10.1002/hipo.20081; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kucera H., 1967, COMPUTATIONAL ANAL P; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Mandera P, 2015, BEHAV RES METHODS, V47, P471, DOI 10.3758/s13428-014-0489-4; Monnier C, 2014, BEHAV RES METHODS, V46, P1128, DOI 10.3758/s13428-013-0431-1; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; New B, 2007, APPL PSYCHOLINGUIST, V28, P661, DOI 10.1017/S014271640707035X; NOBLE CE, 1953, PSYCHOL REV, V60, P89, DOI 10.1037/h0054823; Ozubko JD, 2012, MEM COGNITION, V40, P326, DOI 10.3758/s13421-011-0165-1; Paivio, 1986, MENTAL REPRESENTATIO; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Redondo J, 2005, PSICOLOGICA, V26, P317; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Soares AP, 2016, BEHAV RES METHODS, V7, P1; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; Thorndike E.L., 1944, TEACHERS WORD BOOK 3; Tillotson SM, 2008, BEHAV RES METHODS, V40, P1075, DOI 10.3758/BRM.40.4.1075; Tse CS, 2009, BRIT J PSYCHOL, V100, P91, DOI 10.1348/000712608X318617; Turriziani P, 2008, HIPPOCAMPUS, V18, P469, DOI 10.1002/hipo.20412; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Wang Y., 2008, CHIN MENT HLTH J, V22, P39, DOI [10.3321/j.issn:1000-6729.2008.08.014, DOI 10.3321/J.ISSN:1000-6729.2008.08.014]; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Yao Z, 2014, INT J PSYCHOPHYSIOL, V93, P275, DOI 10.1016/j.ijpsycho.2014.06.005; Yonelinas AP, 1996, CONSCIOUS COGN, V5, P131, DOI 10.1006/ccog.1996.0008	70	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174569	10.1371/journal.pone.0174569	http://dx.doi.org/10.1371/journal.pone.0174569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346514	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300057
J	Woess, C; Unterberger, SH; Roider, C; Ritsch-Marte, M; Pemberger, N; Cemper-Kiesslich, J; Hatzer-Grubwieser, P; Parson, W; Pallua, JD				Woess, Claudia; Unterberger, Seraphin Hubert; Roider, Clemens; Ritsch-Marte, Monika; Pemberger, Nadin; Cemper-Kiesslich, Jan; Hatzer-Grubwieser, Petra; Parson, Walther; Pallua, Johannes Dominikus			Assessing various Infrared (IR) microscopic imaging techniques for post-mortem interval evaluation of human skeletal remains	PLOS ONE			English	Article							HERICIUM-CORALLOIDES; BRUISE DETECTION; TISSUE-TYPES; MICROSPECTROSCOPY; SPECTROSCOPY; BONE; DISCRIMINATION; CANCER; FTIR; CLASSIFICATION	Due to the influence of many environmental processes, a precise determination of the postmortem interval (PMI) of skeletal remains is known to be very complicated. Although methods for the investigation of the PMI exist, there still remains much room for improvement. In this study the applicability of infrared (IR) microscopic imaging techniques such as reflection-, ATR-and Raman-microscopic imaging for the estimation of the PMI of human skeletal remains was tested. PMI specific features were identified and visualized by overlaying IR imaging data with morphological tissue structures obtained using light microscopy to differentiate between forensic and archaeological bone samples. ATR and reflection spectra revealed that a more prominent peak at 1042 cm(-1) (an indicator for bone mineralization) was observable in archeological bone material when compared with forensic samples. Moreover, in the case of the archaeological bone material, a reduction in the levels of phospholipids, proteins, nucleic acid sugars, complex carbohydrates as well as amorphous or fully hydrated sugars was detectable at (reciprocal wavelengths/energies) between 3000 cm(-1) to 2800 cm(-1). Raman spectra illustrated a similar picture with less. V2PO43- at 450 cm(-1) and. V4PO43- from 590 cm(-1) to 584 cm(-1), amide III at 1272 cm(-1) and protein CH2 deformation at 1446 cm(-1) in archeological bone material/samples/sources. A semi-quantitative determination of various distributions of biomolecules by chemi-maps of reflection-and ATR-methods revealed that there were less carbohydrates and complex carbohydrates as well as amorphous or fully hydrated sugars in archaeological samples compared with forensic bone samples. Raman-microscopic imaging data showed a reduction in B-type carbonate and protein a-helices after a PMI of 3 years. The calculated mineral content ratio and the organic to mineral ratio displayed that the mineral content ratio increases, while the organic to mineral ratio decreases with time. Cluster-analyses of data from Raman microscopic imaging reconstructed histo-anatomical features in comparison to the light microscopic image and finally,by application of principal component analyses (PCA), it was possible to see a clear distinction between forensic and archaeological bone samples. Hence, the spectral characterization of inorganic and organic compounds by the afore mentioned techniques, followed by analyses such as multivariate imaging analysis (MIAs) and principal component analyses (PCA), appear to be suitable for the post mortem interval (PMI) estimation of human skeletal remains.	[Woess, Claudia; Hatzer-Grubwieser, Petra; Parson, Walther; Pallua, Johannes Dominikus] Med Univ Innsbruck, Inst Legal Med, Innsbruck, Austria; [Unterberger, Seraphin Hubert] Leopold Franzens Univ Innsbruck, Mat Technol, Innsbruck, Austria; [Roider, Clemens; Ritsch-Marte, Monika] Med Univ Innsbruck, Div Biomed Phys, Innsbruck, Austria; [Pemberger, Nadin] Leopold Franzens Univ Innsbruck, Dept Pharmaceut Technol, Inst Pharm, Innsbruck, Austria; [Cemper-Kiesslich, Jan] Univ Salzburg, Interfac Dept Legal Med, Salzburg, Austria; [Pallua, Johannes Dominikus] Med Univ Innsbruck, Dept Pathol, Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; University of Innsbruck; Salzburg University; Medical University of Innsbruck	Pallua, JD (corresponding author), Med Univ Innsbruck, Inst Legal Med, Innsbruck, Austria.; Pallua, JD (corresponding author), Med Univ Innsbruck, Dept Pathol, Innsbruck, Austria.	Johannes.Pallua@i-med.ac.at	Pallua, Johannes Dominikus/AGG-4994-2022; Pallua, J.D./AGU-4426-2022; Parson, Walther/AAD-6845-2020; Pallua, J.D./GRX-6505-2022	Pallua, J.D./0000-0003-0203-213X; Parson, Walther/0000-0002-5692-2392; Ritsch-Marte, Monika/0000-0002-5945-546X; Roider, Clemens/0000-0001-9967-1645	Austrian Science Fund (FWF) [P22880-B12]; Christian Doppler Laboratory CDL-MS-MACH (Federal Ministry of Economy, Family and Youth); Christian Doppler Laboratory CDL-MS-MACH (National Foundation for Research, Technology and Development)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Christian Doppler Laboratory CDL-MS-MACH (Federal Ministry of Economy, Family and Youth); Christian Doppler Laboratory CDL-MS-MACH (National Foundation for Research, Technology and Development)	The authors would like to thank Prof. Richard Scheithauer from the Institute of Legal Medicine (Medical University of Innsbruck) and Stefano Longato for their support. A Part of this research was funded by the Austrian Science Fund (FWF) [P22880-B12]. CR was supported by the Christian Doppler Laboratory CDL-MS-MACH (funded by the Federal Ministry of Economy, Family and Youth, and the National Foundation for Research, Technology and Development).; A Part of this research was funded by the Austrian Science Fund (FWF) [P22880-B12]. CR was supported by the Christian Doppler Laboratory CDL-MS-MACH (funded by the Federal Ministry of Economy, Family and Youth, and the National Foundation for Research, Technology and Development).	Argov S, 2004, BIOPOLYMERS, V75, P384, DOI 10.1002/bip.20154; Bauer CM, 2013, FORENSIC SCI INT-GEN, V7, P581, DOI 10.1016/j.fsigen.2013.05.005; Bell LS, 1996, FORENSIC SCI INT, V82, P129, DOI 10.1016/0379-0738(96)01984-6; Berg S., 1963, METHODS FORENSIC SCI, VVolume 2, P231; Bhargava R, 2005, SHEFF ANALY CHEM, P1, DOI 10.1002/9780470988541; Bhargava R, 2006, BBA-BIOMEMBRANES, V1758, P830, DOI 10.1016/j.bbamem.2006.05.007; Bird B, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-8; Blau S., 2009, HDB FORENSIC ARCHAEO; Buckley K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.111602; Cheng X, HYPERSPECTRAL IMAGIN; Chew SF, 2007, TISSUE ANTIGENS, V69, P252, DOI 10.1111/j.1399-0039.2006.00775.x; Colonese AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093854; Creagh D, 2016, RAD PHYS CHEM; Creamer JI, 2009, LUMINESCENCE, V24, P311, DOI 10.1002/bio.1110; Edwards HGM, 2007, ANAL BIOANAL CHEM, V387, P821, DOI 10.1007/s00216-006-0791-9; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Gazi E, 2003, J PATHOL, V201, P99, DOI 10.1002/path.1421; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Halcrow SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098462; Heraud P, 2007, NEW PHYTOL, V173, P216, DOI 10.1111/j.1469-8137.2006.01881.x; Hirschmugl CJ, 2006, INFRARED PHYS TECHN, V49, P57, DOI 10.1016/j.infrared.2006.01.032; Hoke N, 2013, FORENSIC SCI INT, V228, DOI 10.1016/j.forsciint.2013.03.013; Howes JM, 2012, J FORENSIC SCI, V57, P1161, DOI 10.1111/j.1556-4029.2012.02236.x; Huck-Pezzei VA, 2012, ANAL BIOANAL CHEM, V404, P1771, DOI 10.1007/s00216-012-6296-9; Introna F, 1999, J FORENSIC SCI, V44, P535; Kavdir I, 2007, POSTHARVEST BIOL TEC, V44, P165, DOI 10.1016/j.postharvbio.2006.09.002; Kavdir I, APPLE SORTING USING; Kawamura S, 2003, COMPUT ELECTRON AGR, V40, P115, DOI 10.1016/S0168-1699(03)00015-2; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; King CL, 2011, J ARCHAEOL SCI, V38, P2222, DOI 10.1016/j.jas.2011.03.023; Klarica J, 2011, J CHEM ECOL, V37, P549, DOI 10.1007/s10886-011-9956-x; KNIGHT B, 1969, HUM BIOL, V41, P322; Koc H, 2008, SPECTROSCOPY, V22; Kohler M, 2009, ANAL BIOANAL CHEM, V393, P1513, DOI 10.1007/s00216-008-2592-9; Krafft C, NEUROONCOLOGICAL APP; Krafft C, 2006, BIOPOLYMERS, V82, P301, DOI 10.1002/bip.20492; Krishna CM, 2007, ANAL BIOANAL CHEM, V387, P1649, DOI 10.1007/s00216-006-0827-1; Labbe N, 2005, WOOD SCI TECHNOL, V39, P61, DOI 10.1007/s00226-004-0274-0; Lasch P., 2008, BIOMEDICAL VIBRATION; Li QB, 2005, CLIN CHEM, V51, P346, DOI 10.1373/clinchem.2004.037986; Longato S, 2015, ANAL METHODS-UK, V7, P2917, DOI 10.1039/c4ay02943g; McCann MC, 2001, PHYTOCHEMISTRY, V57, P811, DOI 10.1016/S0031-9422(01)00144-3; McLaughlin G, 2011, ANAL BIOANAL CHEM, V401, P2511, DOI 10.1007/s00216-011-5338-z; Mills ENC, 2005, J CEREAL SCI, V41, P193, DOI 10.1016/j.jcs.2004.09.003; Muhammed HH, 2003, BIOSYST ENG, V86, P125, DOI 10.1016/S1537-5110(03)00090-4; Nagy G, 2008, FORENSIC SCI INT, V175, P55, DOI 10.1016/j.forsciint.2007.05.008; Naumann A, 2005, FUNGAL GENET BIOL, V42, P829, DOI 10.1016/j.fgb.2005.06.003; Neis P, 1999, FORENSIC SCI INT, V99, P47, DOI 10.1016/S0379-0738(98)00175-3; Pallua JD, 2014, ANAL METHODS-UK, V6, P1149, DOI 10.1039/c3ay42082e; Pallua JD, 2012, ANALYST, V137, P3965, DOI 10.1039/c2an35483g; Pallua JD, 2012, ANALYST, V137, P1584, DOI 10.1039/c1an15615b; Pezzei C, 2010, MOL BIOSYST, V6, P2287, DOI 10.1039/c0mb00041h; Podshyvalov A, 2005, APPL OPTICS, V44, P3725, DOI 10.1364/AO.44.003725; Ramsthaler F, 2009, FORENSIC SCI INT, V187, P47, DOI 10.1016/j.forsciint.2009.02.015; Ridgway C, 2002, BIOSYST ENG, V83, P21, DOI 10.1006/bioe.2002.0096; Ridgway C, 1998, JOURNAL OF NEAR INFRARED SPECTROSCOPY, VOL 6 1998, P115, DOI 10.1255/jnirs.128; Riggway C, 2001, 2001 ASAE ANN INT M; Romeo M, 1998, CELL MOL BIOL, V44, P179; Salzer R., 2014, INFRARED RAMAN SPECT; Schrag B, 2012, FORENSIC SCI INT, V220, P271, DOI 10.1016/j.forsciint.2012.03.014; Schultz M., 1997, FORENSIC TAPHONOMY P, P201; Schut AGT, NOVEL IMAGING SPECTR, V9; Steiner G, 2009, ANAL BIOANAL CHEM, V394, P671, DOI 10.1007/s00216-009-2737-5; Surovell TA, 2001, J ARCHAEOL SCI, V28, P633, DOI 10.1006/jasc.2000.0633; Swift B, 1998, FORENSIC SCI INT, V98, P119, DOI 10.1016/S0379-0738(98)00141-8; Swift B, 2001, FORENSIC SCI INT, V117, P73, DOI 10.1016/S0379-0738(00)00451-5; TAYLOR RE, 1989, J FORENSIC SCI, V34, P1196; Thomas DB, 2007, J RAMAN SPECTROSC, V38, P1533, DOI 10.1002/jrs.1851; Ubelaker DH, 2006, J FORENSIC SCI, V51, P484, DOI 10.1111/j.1556-4029.2006.00125.x; Wang TD, 2007, P NATL ACAD SCI USA, V104, P15864, DOI 10.1073/pnas.0707567104; Wetzel D, 1995, DEV FOOD SCI, V37, P2039; Wetzel DL, 1998, CELL MOL BIOL, V44, P145; Woess C, 2015, ANALYST, V140, P6363, DOI 10.1039/c5an01072a; Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R; Xing J, 2007, COMPUT ELECTRON AGR, V56, P1, DOI 10.1016/j.compag.2006.12.002; Xing J, 2006, COMPUT ELECTRON AGR, V52, P11, DOI 10.1016/j.compag.2006.01.006; Yang C, 2001, HYPERSPECTRAL IMAGIN; Yano K, 2000, ANAL BIOCHEM, V287, P218, DOI 10.1006/abio.2000.4872; YOSHINO M, 1991, FORENSIC SCI INT, V49, P143, DOI 10.1016/0379-0738(91)90074-S; Yu PQ, 2004, J AGR FOOD CHEM, V52, P7345, DOI 10.1021/jf049291b	80	37	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174552	10.1371/journal.pone.0174552	http://dx.doi.org/10.1371/journal.pone.0174552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334006	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200111
J	Brunson, JC; Wang, XY; Laubenbacher, RC				Brunson, Jason Cory; Wang, Xiaoyan; Laubenbacher, Reinhard C.			Effects of research complexity and competition on the incidence and growth of coauthorship in biomedicine	PLOS ONE			English	Article							AUTHORSHIP PATTERNS; MULTIPLE AUTHORSHIP; CO-AUTHORSHIP; SCIENTIFIC COLLABORATION; NIH BUDGET; TRENDS; JOURNALS; RADIOLOGY; CITATION; MODEL	Background Investigations into the factors behind coauthorship growth in biomedical research have mostly focused on specific disciplines or journals, and have rarely controlled for factors in combination or considered changes in their effects over time. Observers often attribute the growth to the increasing complexity or competition (or both) of research practices, but few attempts have been made to parse the contributions of these two likely causes. Objectives We aimed to assess the effects of complexity and competition on the incidence and growth of coauthorship, using a sample of the biomedical literature spanning multiple journals and disciplines. Methods Article-level bibliographic data from PubMed were combined with publicly available bibliometric data from Web of Science and SCImago over the years 1999-2007. We selected four predictors of coauthorship were selected, two (study type, topical scope of the study) associated with complexity and two (financial support for the project, popularity of the publishing journal) associated with competition. A negative binomial regression model was used to estimate the effects of each predictor on coauthorship incidence and growth. A second, mixed-effect model included the journal as a random effect. Results Coauthorship increased at about one author per article per decade. Clinical trials, supported research, and research of broader scope produced articles with more authors, while review articles credited fewer; and more popular journals published higher-authorship articles. Incidence and growth rates varied widely across journals and were themselves uncorrelated. Most effects remained statistically discernible after controlling for the publishing journal. The effects of complexity-associated factors held constant or diminished over time, while competition-related effects strengthened. These trends were similar in size but not discernible from subject-specific subdata. Conclusions Coauthorship incidence rates are multifactorial and vary with factors associated with both complexity and competition. Coauthorship growth is likewise multifactorial and increasingly associated with research competition.	[Brunson, Jason Cory; Wang, Xiaoyan; Laubenbacher, Reinhard C.] UConn Hlth, Ctr Quantitat Med, Farmington, CT 06030 USA; [Wang, Xiaoyan] UConn Hlth, Dept Family Med, Farmington, CT USA; [Laubenbacher, Reinhard C.] Jackson Lab Genom Med, Farmington, CT 06032 USA	Jackson Laboratory	Laubenbacher, RC (corresponding author), UConn Hlth, Ctr Quantitat Med, Farmington, CT 06030 USA.	laubenbacher@uchc.edu	Brunson, Jason Cory/K-8396-2019	Brunson, Jason Cory/0000-0003-3126-9494	NIDCR NIH HHS [T90 DE021989] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021989] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aboukhalil R, 2014, WINNOWER, V2; Baerlocher MO, 2009, J CLIN EPIDEMIOL, V62, P875, DOI 10.1016/j.jclinepi.2009.03.010; Bales ME, 2014, J BIOMED INFORM, V52, P311, DOI 10.1016/j.jbi.2014.07.015; BARNETT AH, 1988, REV ECON STAT, V70, P539, DOI 10.2307/1926798; Bates D, 2015, JOURNAL OF STATISTIC; Beaver DB, 1984, G SARTON CENTENNIAL, P449; Beaver DD, 2001, SCIENTOMETRICS, V52, P365, DOI 10.1023/A:1014254214337; Biagioli M, 1998, FASEB J, V12, P3, DOI 10.1096/fasebj.12.1.3; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Borry P, 2006, BIOETHICS, V20, P213, DOI 10.1111/j.1467-8519.2006.00496.x; Brunson JC, 2014, SCIENTOMETRICS, V99, P973, DOI 10.1007/s11192-013-1209-z; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Camp Mark, 2013, J Bone Joint Surg Am, V95, pe44, DOI 10.2106/JBJS.L.00519; CHEW FS, 1988, AM J ROENTGENOL, V150, P23, DOI 10.2214/ajr.150.1.23; CHEW FS, 1986, AM J ROENTGENOL, V147, P1055, DOI 10.2214/ajr.147.5.1055; Chow DS, 2015, AM J ROENTGENOL, V204, pW52, DOI 10.2214/AJR.14.12852; CLARKE BL, 1964, SCIENCE, V143, P822, DOI 10.1126/science.143.3608.822; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Couzin J, 2007, SCIENCE, V316, P356, DOI 10.1126/science.316.5823.356; Dang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139005; Dowle M, 2015, R PACKAGE VERSION 1; Druss BG, 2005, J MED LIBR ASSOC, V93, P499; EPSTEIN RJ, 1993, BRIT MED J, V306, P765, DOI 10.1136/bmj.306.6880.765; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Glanzel W, 2002, LIB TRENDS, V50; Glynn RW, 2010, BRIT J SURG, V97, P1304, DOI 10.1002/bjs.7109; Hammad FT, 2012, MED PRIN PRACT, V21, P435, DOI 10.1159/000339884; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; HOAGLIN DC, 1980, AM STAT, V34, P146, DOI 10.2307/2683871; Hsu JW, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.057101; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Khan KS, 1999, AM J OBSTET GYNECOL, V181, P503, DOI 10.1016/S0002-9378(99)70585-5; Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; Leahey E, 2008, SOC STUD SCI, V38, P425, DOI 10.1177/0306312707086190; Levsky ME, 2007, SOUTH MED J, V100, P371, DOI 10.1097/01.smj.0000257537.51929.4b; Lozano GA, 2012, J AM SOC INF SCI TEC, V63, P2140, DOI 10.1002/asi.22731; McDonald RJ, 2010, MAYO CLIN PROC, V85, P920, DOI 10.4065/mcp.2010.0291; Morillo F, 2003, J AM SOC INF SCI TEC, V54, P1237, DOI 10.1002/asi.10326; MUSSURAKIS S, 1993, ACTA RADIOL, V34, P316, DOI 10.1080/02841859309173250; MUSSURAKIS S, 1993, AM J ROENTGENOL, V161, P1317, DOI 10.2214/ajr.161.6.8249751; Nabout JC, 2015, SCIENTOMETRICS, V102, P357, DOI 10.1007/s11192-014-1385-5; Nowell C, 2011, APPL ECON, V43, P4369, DOI 10.1080/00036846.2010.491458; ORD JK, 1967, J R STAT SOC SER A-G, V130, P232, DOI 10.2307/2343403; PAO ML, 1992, INFORM PROCESS MANAG, V28, P99, DOI 10.1016/0306-4573(92)90096-I; Papatheodorou SI, 2008, J CLIN EPIDEMIOL, V61, P546, DOI 10.1016/j.jclinepi.2007.07.017; Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d; PIETTE MJ, 1992, J ECON EDUC, V23, P277, DOI 10.2307/1183230; Pinter A, 2015, EUR J PEDIATR SURG, V25, P353, DOI 10.1055/s-0034-1376395; Pinter A, 2013, J PEDIATR SURG, V48, P412, DOI 10.1016/j.jpedsurg.2012.10.069; Plan EL, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.27; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; POWERS RD, 1988, AM J EMERG MED, V6, P647, DOI 10.1016/0735-6757(88)90111-8; R Core Team, 2016, R A LANGUAGE AND ENV; Reuters T, 2015, JOURNAL CITATION REP; Barao VAR, 2011, IMPLANT DENT, V20, P68, DOI 10.1097/ID.0b013e3181fce302; Rutledge R, 2009, J EDUC BUS, V84, P130, DOI 10.3200/JOEB.84.3.130-134; SCImago, 2015, SJR SCIMAGO JOURNAL; Shaban Sami, 2009, J Occup Med Toxicol, V4, P3, DOI 10.1186/1745-6673-4-3; Sugrue CM, 2015, J HAND MICROSURGERY, P1; Thelwall M, 2014, J INFORMETR, V8, P963, DOI 10.1016/j.joi.2014.09.011; Tilak G, 2015, INQUIRY-J HEALTH CAR, V52, DOI 10.1177/0046958015598311; Weeks WB, 2004, SOC SCI MED, V59, P1949, DOI 10.1016/j.socscimed.2004.02.029	62	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173444	10.1371/journal.pone.0173444	http://dx.doi.org/10.1371/journal.pone.0173444			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28329003	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700021
J	Fu, L; Maes, JHR; Kessels, RPC; Daselaar, SM				Fu, Li; Maes, Joseph H. R.; Kessels, Roy P. C.; Daselaar, Sander M.			To boost or to CRUNCH? Effect of effortful encoding on episodic memory in older adults is dependent on executive functioning	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COGNITIVE RESERVE; WORKING-MEMORY; AGE; RETRIEVAL; BRAIN; PERFORMANCE; CAPACITY; PROGRAM	It is essential to develop effective interventions aimed at ameliorating age-related cognitive decline. Previous studies found that effortful encoding benefits episodic memory in older adults. However, to date it is unclear whether this benefit is different for individuals with strong versus weak executive functioning (EF). Fifty-one older adults were recruited and divided into low (N = 26) and high (N = 25) functioning groups, based on their EF capacity. All participants performed a semantic and a perceptual incidental encoding task. Each encoding task was performed under four difficulty levels to establish different effort levels. Encoding was followed by a recognition task. Results showed that the high EF group benefitted from increased effort in both tasks. However, the low EF group only showed a beneficial effect under low levels of effort. Results are consistent with the Compensation Related Utilization of Neural Circuits Hypothesis (CRUNCH) and suggest that future research directed at developing efficient memory strategies to reduce negative cognitive aging effects should take individual cognitive differences among older adults into account, such as differences in EF.	[Fu, Li; Maes, Joseph H. R.; Kessels, Roy P. C.; Daselaar, Sander M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Physiol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Fu, L (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	l.fu@donders.ru.nl	Maes, J.H.R./D-2009-2010; Kessels, Roy P.C./D-1902-2010	Maes, J.H.R./0000-0002-4536-695X; Kessels, Roy P.C./0000-0001-9500-9793	CSC [201306040149]	CSC	This work was supported by grant number CSC#201306040149,	Albert M. S., 1980, NEW DIRECTIONS MEMOR, P403; Angel L, 2010, NEUROPSYCHOLOGIA, V48, P3540, DOI 10.1016/j.neuropsychologia.2010.08.003; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; Bugaiska A, 2007, CONSCIOUS COGN, V16, P797, DOI 10.1016/j.concog.2006.11.007; BURKE DM, 1981, PSYCHOL BULL, V90, P513, DOI 10.1037/0033-2909.90.3.513; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Christensen H, 1999, PSYCHOL AGING, V14, P365, DOI 10.1037/0882-7974.14.3.365; Christensen H., 2008, HDB AGING COGNITION, V3, P133; Clark DO, 2016, INT J GERIATR PSYCH, V31, P809, DOI 10.1002/gps.4395; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; DAIGNEAULT S, 1992, BRAIN COGNITION, V19, P48, DOI 10.1016/0278-2626(92)90037-M; Daselaar SM, 2015, CEREB CORTEX, V25, P983, DOI 10.1093/cercor/bht289; ELLIS HC, 1984, J EXP PSYCHOL LEARN, V10, P470, DOI 10.1037/0278-7393.10.3.470; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu L, 2016, EFFORTFUL SEMANTIC D; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; Hedden T, 2006, NEUROPSYCHOLOGY, V20, P511, DOI 10.1037/0894-4105.20.5.511; Kessels RPC, 2003, AGE AGEING, V32, P529, DOI 10.1093/ageing/afg068; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Luo L, 2007, PSYCHOL AGING, V22, P269, DOI 10.1037/0882-7974.22.2.269; Macmillan N. A., 2004, DETECTION THEORY USE; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Morrow DG, 2008, HUM FACTORS, V50, P589, DOI 10.1518/001872008X312251; Moscovitch M., 1992, HDB AGING COGNITION, P315; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Sauzeon H, 2000, EXP AGING RES, V26, P57, DOI 10.1080/036107300243687; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Taconnat L, 2007, BRAIN COGNITION, V64, P1, DOI 10.1016/j.bandc.2006.09.011; Troyer AK, 2006, J GERONTOL B-PSYCHOL, V61, pP67, DOI 10.1093/geronb/61.2.P67; Tucker-Drob EM, 2011, WILEY BLACKWELL HDB, P242, DOI DOI 10.5860/CHOICE.49-2374; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; VERHAGE F, 1964, Ned Tijdschr Psychol, V19, P247; Vermeij A, 2016, BRAIN IMAGING BEHAV; Wechsler D, 2008, ADULT INTELLIGENCE S; Wechsler DW, 2009, ADULT INTELLIGENCE S; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; Zhao X, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12511	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174217	10.1371/journal.pone.0174217	http://dx.doi.org/10.1371/journal.pone.0174217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328979	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700072
J	Gantuz, M; Lorenzetti, MA; Chabay, PA; Preciado, MV				Gantuz, Magdalena; Alejandro Lorenzetti, Mario; Andrea Chabay, Paola; Victoria Preciado, Maia			A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association	PLOS ONE			English	Article							INFECTIOUS-MONONUCLEOSIS; LMP1; EVOLUTION; STRAINS; DISEASE; MEMBRANE-PROTEIN-1; CYTOSKELETON; DIVERSITY; SELECTION; PROMOTER	Epstein Barr virus (EBV) infection in Argentina occurs at an early age and occasionally develops infectious mononucleosis (IM). EBV is also related with lymphomas. LMP1, the viral oncoprotein is polymorphic and is used to define viral variants. Aim To study LMP1 variants distribution among children with EBV+ malignant and benign conditions as well as in healthy carriers. Methods Oral secretions and blood cells from 31 children with IM, and biopsies from 14 EBV+ reactive lymphoid hyperplasia and 33 EBV+ lymphomas were included. LMP1 was amplified by nested PCR and sequenced. Phylogenetic reconstructions were made under Maximun Likelihood, Bayesian and coalescent algorithms. Results Six clades were defined (China1, China2, Med-, Alaskan, B95.8 and Argentine). Argentine variants, the most prevalent (46%), harbored 3 distinctive mutations and were a recombination between Raji and China1. Despite no pathology or compartment associations were observed for LMP1, the Argentine Glade showed a phylogeographic association with our region. LMP1 estimated evolution rate was 8.591x10-5s/s/y and the estimated tMRCA for Raji and Argentine was 136ybp. Conclusions An LMP1 Argentine Glade was defined. LMP1 evolutionary rate was higher than expected for herpesviruses. The tMRCA for Raji and the Argentine agrees with African immigration and could explain the recombinant nature of the Argentine variant.	[Gantuz, Magdalena; Alejandro Lorenzetti, Mario; Andrea Chabay, Paola; Victoria Preciado, Maia] Hosp Ninos Dr Ricardo Gutierrez, IMIPP, CONICET GCBA, Lab Biol Mol,Div Patol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Preciado, MV (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, IMIPP, CONICET GCBA, Lab Biol Mol,Div Patol, Buenos Aires, DF, Argentina.	preciado@conicet.gov.ar	Lorenzetti, Mario Alejandro/O-8976-2019	Lorenzetti, Mario Alejandro/0000-0002-9434-399X; Preciado, Maria Victoria/0000-0003-4082-0698	National Agency for Science and Technology Promotion (PICT) [0291, 0052]	National Agency for Science and Technology Promotion (PICT)(ANPCyT)	This study was supported in part by grants from National Agency for Science and Technology Promotion (PICT 2012 No 0291, PICT 2008 No 0052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ai Junhong, 2012, Virol J, V9, P13, DOI 10.1186/1743-422X-9-13; Lorenzetti MA, 2012, J CLIN MICROBIOL, V50, P609, DOI 10.1128/JCM.05778-11; Avena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034695; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Burrows JM, 2004, J VIROL, V78, P7131, DOI 10.1128/JVI.78.13.7131-7137.2004; Chabay PA, 2013, INT J CANC; Chan KH, 2001, J CLIN VIROL, V21, P57, DOI 10.1016/S1386-6532(01)00149-4; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chiara M, 2016, GENOME BIOL EVOL, V8, P3284, DOI 10.1093/gbe/evw226; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Everly DN, 2004, J VIROL, V78, P13470, DOI 10.1128/JVI.78.24.13470-13478.2004; Feederle R, 2015, CURR TOP MICROBIOL, V390, P119, DOI 10.1007/978-3-319-22822-8_7; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Gantuz M, 2013, INFECT GENET EVOL, V14, P275, DOI 10.1016/j.meegid.2012.12.025; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guiretti DM, 2007, J MED VIROL, V79, P1722, DOI 10.1002/jmv.21020; GULLEY ML, 1994, BLOOD, V83, P1595; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Higuchi M, 2001, P NATL ACAD SCI USA, V98, P4675, DOI 10.1073/pnas.081075298; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; IARC, 1997, IARC MON EV CARC RIS; Ikeda T, 2014, J MED VIROL; IZUMI KM, 1994, J VIROL, V68, P4369, DOI 10.1128/JVI.68.7.4369-4376.1994; Jin YK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-92; Knecht H, 2001, ONCOLOGY-BASEL, V60, P289, DOI 10.1159/000058523; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lin Su-Xia, 2003, Ai Zheng, V22, P1147; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lorenzetti MA, 2014, CLIN MICROBIOL INFEC, V20, pO861, DOI 10.1111/1469-0691.12631; MCGEOCH DJ, 1994, J MOL BIOL, V238, P9, DOI 10.1006/jmbi.1994.1264; McGeoch DJ, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P447, DOI 10.1016/B978-0-12-374153-0.00020-5; Meckes DG, 2013, J VIROL, V87, P1301, DOI 10.1128/JVI.02519-12; Neves M, 2017, J MED VIROL, V89, P373, DOI 10.1002/jmv.24633; Nguyen-Van D, 2008, VIRUS GENES, V37, P273, DOI 10.1007/s11262-008-0262-9; Palser AL, 2015, J VIROL, V89, P5222, DOI 10.1128/JVI.03614-14; Patricio AR, 2012, J GEN VIROL, V93, P1035, DOI 10.1099/vir.0.038950-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Renzette N, 2014, J VIROL, V88, P3744, DOI 10.1128/JVI.03378-13; Rickinson AB, 2007, FIELDS VIROLOGY, V5, P2655; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Santpere G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/gbe/evu054; Shackelton LA, 2006, J VIROL, V80, P9928, DOI 10.1128/JVI.00441-06; Sitki-Green D, 2003, J VIROL, V77, P1840, DOI 10.1128/JVI.77.3.1840-1847.2003; Sitki-Green DL, 2004, J INFECT DIS, V189, P483, DOI 10.1086/380800; Soni V, 2006, J VIROL, V80, P10787, DOI 10.1128/JVI.01214-06; Stevenson D, 2005, CANCER RES, V65, P8826, DOI 10.1158/0008-5472.CAN-05-0591; Tierney RJ, 2006, J INFECT DIS, V193, P287, DOI 10.1086/498913; Tzellos S, 2012, PATHOGENS, V1, P156, DOI 10.3390/pathogens1020156; Vetsika Eleni-Kyriaki, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008440; Walling DM, 1999, J INFECT DIS, V179, P763, DOI 10.1086/314672; Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x; Yasui T, 2004, P NATL ACAD SCI USA, V101, P278, DOI 10.1073/pnas.2237224100; Zuercher E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032168	61	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174221	10.1371/journal.pone.0174221	http://dx.doi.org/10.1371/journal.pone.0174221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328987	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700074
J	Naghiloo, S; Classen-Bockhoff, R				Naghiloo, Somayeh; Classen-Bockhoff, Regine			Understanding the unique flowering sequence in Dipsacus fullonum: Evidence from geometrical changes during head development	PLOS ONE			English	Article							PHYLLOTAXIS; INFLORESCENCE; DIVERSITY; MERISTEM	The genus Dipsacus is characterized by a remarkable bidirectional flowering sequence and a rare phyllotactic pattern. Considering that flower initiation and flowering sequence may be interconnected, we document the development of the head meristem in Dipsacus fullonum. Our results indicate a gradual change in the geometry of the head meristem beginning with a dome shaped stage, continuing with a remarkable widening in the middle part of the head meristem and ending in a spindle-like form. Quantitative data confirm that meristem expansion is higher in the middle part than at the base of the meristem. Likewise, the size of the flower primordia in the middle part of the young head is significantly larger than at the base soon after initiation. We conclude that the change in the geometry of the meristem and the availability of newly generated space result in the promotion of the middle flowers and the bidirectional flowering sequence at anthesis.Our investigation on phyllotactic patterns reveals a high tendency (30%) of the head meristem to insert or lose parastichies. This finding can also be attributed to changes in the expansion rate of the meristem. Dependent on the spatio-temporal relation between meristem expansion and primordia initiation, either flower primordia are promoted or additional parastichies appear. Our results emphasize the important role of geometry in flower development and phyllotactic pattern formation.	[Naghiloo, Somayeh; Classen-Bockhoff, Regine] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut Biol, Mainz, Germany	Johannes Gutenberg University of Mainz	Naghiloo, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut Biol, Mainz, Germany.	snaghilo@uni-mainz.de			Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The work was financially supported by a fellowship given by the Alexander von Humboldt Foundation to S. Naghiloo.	Bello MA, 2013, ANN BOT-LONDON, V112, P1597, DOI 10.1093/aob/mcs301; Barabe D, 2000, CAN J BOT, V78, P557, DOI 10.1139/cjb-78-5-557; Bull-Herenu Kester, 2010, Plant Diversity and Evolution, V128, P221, DOI 10.1127/1869-6155/2010/0128-0010; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Church andA.H., 1904, RELATION PHYLLOTAXIS; Classen-Bockhoff R, 2013, ANN BOT-LONDON, V112, P1523, DOI 10.1093/aob/mct009; DOUADY S, 1992, PHYS REV LETT, V68, P2098, DOI 10.1103/PhysRevLett.68.2098; Douady S, 1996, J THEOR BIOL, V139, P178; Eichler A.W., 1875, BLUTHENDIAGRAMME, V1; FOWLER DR, 1992, COMP GRAPH, V26, P361, DOI 10.1145/142920.134093; Gola E, 1996, ACTA SOC BOT POL, V65, P235, DOI 10.5586/asbp.1996.036; HARRIS EM, 1991, AM J BOT, V78, P108, DOI 10.2307/2445234; Hofmeister W., 1868, ALLGEMEINE MORPHOLOG; Jerominek M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00613; Jeune B, 2004, ANN BOT-LONDON, V94, P913, DOI 10.1093/aob/mch213; Kwiatkowska D, 1999, ACTA SOC BOT POL, V68, P85; Landrein B, 2015, J EXP BOT, V66, P1317, DOI 10.1093/jxb/eru482; Mirabet V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002389; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Prusinkiewicz P, 2010, J EXP BOT, V61, P2117, DOI 10.1093/jxb/erq081; Szpak M, 2011, ACTA SOC BOT POL, V80, P279, DOI 10.5586/asbp.2011.043; TOMLINSON PB, 1979, BOT J LINN SOC, V78, P317, DOI 10.1111/j.1095-8339.1979.tb02574.x; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; ZAGORSKAMAREK B, 1994, ACTA SOC BOT POL, V63, P117, DOI 10.5586/asbp.1994.017	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174091	10.1371/journal.pone.0174091	http://dx.doi.org/10.1371/journal.pone.0174091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328952	gold, Green Published			2022-12-27	WOS:000399094700049
J	Yu, Y; Liang, MG; Wang, Z				Yu, Yang; Liang, Mangui; Wang, Zhe			A source-controlled data center network model	PLOS ONE			English	Article								The construction of data center network by applying SDN technology has become a hot research topic. The SDN architecture has innovatively separated the control plane from the data plane which makes the network more software-oriented and agile. Moreover, it provides virtual multi-tenancy, effective scheduling resources and centralized control strategies to meet the demand for cloud computing data center. However, the explosion of network information is facing severe challenges for SDN controller. The flow storage and lookup mechanisms based on TCAM device have led to the restriction of scalability, high cost and energy consumption. In view of this, a source-controlled data center network (SCDCN) model is proposed herein. The SCDCN model applies a new type of source routing address named the vector address (VA) as the packet-switching label. The VA completely defines the communication path and the data forwarding process can be finished solely relying on VA. There are four advantages in the SCDCN architecture. 1) The model adopts hierarchical multi-controllers and abstracts large-scale data center network into some small network domains that has solved the restriction for the processing ability of single controller and reduced the computational complexity. 2) Vector switches (VS) developed in the core network no longer apply TCAM for table storage and lookup that has significantly cut down the cost and complexity for switches. Meanwhile, the problem of scalability can be solved effectively. 3) The SCDCN model simplifies the establishment process for new flows and there is no need to download flow tables to VS. The amount of control signaling consumed when establishing new flows can be significantly decreased. 4) We design the VS on the NetFPGA platform. The statistical results show that the hardware resource consumption in a VS is about 27% of that in an OFS.	[Yu, Yang; Liang, Mangui; Wang, Zhe] Beijing Jiaotong Univ, Inst Informat Sci, Beijing, Peoples R China; [Yu, Yang; Liang, Mangui; Wang, Zhe] Beijing Key Lab Adv Informat Sci & Network Techno, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University	Liang, MG (corresponding author), Beijing Jiaotong Univ, Inst Informat Sci, Beijing, Peoples R China.; Liang, MG (corresponding author), Beijing Key Lab Adv Informat Sci & Network Techno, Beijing, Peoples R China.	mgliang58@gmail.com			National Grand Fundamental Research 973 Program of China [2011CB302203]; National High-Tech Research and Development Plan of China [863-317-01-04-99, 2007AA01Z203]; Joint Project of the National Nature Science Foundation [U1636109]; research base for the ministry of national folk literature and art development center [136023522]	National Grand Fundamental Research 973 Program of China(National Basic Research Program of China); National High-Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Joint Project of the National Nature Science Foundation; research base for the ministry of national folk literature and art development center	Supported by the National Grand Fundamental Research 973 Program of China under Grant No. 2011CB302203; the National High-Tech Research and Development Plan of China under Grant Nos. 863-317-01-04-99, 2007AA01Z203; the Joint Project of the National Nature Science Foundation under Grant No. U1636109; and the research base for the ministry of national folk literature and art development center No. 136023522.	Chaudhry MT, 2015, J ZHEJIANG U SCI C; Curtis AR, 2011, ACM SIGCOMM COMP COM, V41, P254, DOI 10.1145/2043164.2018466; Ding Ze-liu, 2011, Journal of National University of Defense Technology, V33, P1; Guo CX, 2008, ACM SIGCOMM COMP COM, V38, P75, DOI 10.1145/1402946.1402968; Koponen Teemu, 2010, P 9 USENIX C OP SYST, P351; Lai YK, 2014, MICROPROCESS MICROSY, V38, P431, DOI 10.1016/j.micpro.2014.04.005; Lakshminarayanan K, 2005, ACM SIGCOMM COMP COM, V35, P193, DOI 10.1145/1090191.1080115; Li X., 2014, J NANOMATER, V2014, P8, DOI DOI 10.1016/J.JP0WS0UR.2014.08.129; Liang MG, 2008, VECTOR ADDRESS DATA; Liu JZ, 2014, J TSINGHUA U NATURAL, V54, P437; Liu Z, 2014, J TSINGHUA U; Lockwood JW, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MICROELECTRONIC SYSTEMS EDUCATION, PROCEEDINGS, P160, DOI 10.1109/MSE.2007.69; Luo X, 2013, CHINA ED NETWORK, P24; Naous J, 2008, PRESTO 08, P1, DOI DOI 10.1145/1477942.1477944; OPEN NETWORKING FOUNDATION, 2013, OPENFLOW SPEC V1 4 0; Open Networking Foundation, 2011, OPENFLOW SWITCH SPEC; RowshanradS NamvaraslS, 2014, J ADV COMPUT SCI TEC, V3, P232, DOI 10.14419/jacst.v3i2.3754; Veeramani S., 2013, 2013 IEEE INT C ADV, P1, DOI DOI 10.1109/ANTS.2013.6802865; Wei XL, 2013, J SOFTWARE, P295; Wu Qiang, 2013, Telecommunications Science, V29, P130, DOI 10.3969/j.issn.1000-0801.2013.01.021; Wu SJ, 2013, MICROCOMPUTER APPL, V29, P27; Yu M., 2011, COMPUT COMMUN REV, V41, P351, DOI DOI 10.1145/1851182.1851224; Zhang C, 2014, TELECOMMUNICATIONS T; Zhao AQ, 2012, J ZHEJIANG U SCI C; Zhao AQ, 2011, HIGH TECHNOLOGY COMM, V21, P1246	25	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173442	10.1371/journal.pone.0173442	http://dx.doi.org/10.1371/journal.pone.0173442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328925	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700020
J	Balasubramanya, S; Evans, B; Hardy, R; Ahmed, R; Habib, A; Asad, NSM; Rahman, M; Hasan, M; Dey, D; Fletcher, L; Camargo-Valero, MA; Rao, KC; Fernando, S				Balasubramanya, Soumya; Evans, Barbara; Hardy, Richard; Ahmed, Rizwan; Habib, Ahasan; Asad, N. S. M.; Rahman, Mominur; Hasan, M.; Dey, Digbijoy; Fletcher, Louise; Camargo-Valero, Miller Alonso; Rao, Krishna Chaitanya; Fernando, Sudarshana			Towards sustainable sanitation management: Establishing the costs and willingness to pay for emptying and transporting sludge in rural districts with high rates of access to latrines	PLOS ONE			English	Article							CONTINGENT VALUATION SURVEYS; DEVELOPING-COUNTRIES; WATER; WASTE; AREAS; CITY; GROUNDWATER; BANGLADESH; QUESTIONS; SETTINGS	Motivation Proper management of fecal sludge has significant positive health and environmental externalities. Most research on managing onsite sanitation so far either simulates the costs of, or the welfare effects from, managing sludge in situ in pit latrines. Thus, designing management strategies for onsite rural sanitation is challenging, because the actual costs of transporting sludge for treatment, and sources for financing these transport costs, are not well understood. Methods In this paper we calculate the actual cost of sludge management from onsite latrines, and identify the contributions that latrine owners are willing to make to finance the costs. A spreadsheet-based model is used to identify a cost-effective transport option, and to calculate the cost per household. Then a double-bound contingent valuation method is used to elicit from pit-latrine owners their willingness-to-pay to have sludge transported away. This methodology is employed for the case of a rural subdistrict in Bangladesh called Bhaluka, a unit of administration at which sludge management services are being piloted by the Government of Bangladesh. Results The typical sludge accumulation rate in Bhaluka is calculated at 0.11 liters/person/day and a typical latrine will need to be emptied approximately once every 3 to 4 years. The costs of emptying and transport are high; approximately USD 13 per emptying event (circa 14% of average monthly income); household contributions could cover around 47% of this cost. However, if costs were spread over time, the service would cost USD 4 per year per household, or USD 0.31 per month per household-comparable to current expenditures of rural households on telecommunications. Conclusion This is one of few research papers that brings the costs of waste management together with financing of that cost, to provide evidence for an implementable solution. This framework can be used to identify cost effective sludge management options and private contributions towards that cost in other (context-specific) administrative areas where onsite sanitation is widespread.	[Balasubramanya, Soumya; Hardy, Richard; Rao, Krishna Chaitanya; Fernando, Sudarshana] Int Water Management Inst, Pelawatte, Sri Lanka; [Evans, Barbara; Fletcher, Louise; Camargo-Valero, Miller Alonso] Univ Leeds, Inst Publ Hlth & Environm Engn, Leeds, W Yorkshire, England; [Ahmed, Rizwan; Habib, Ahasan; Asad, N. S. M.] NGO Forum Publ Hlth, Dhaka, Bangladesh; [Rahman, Mominur; Hasan, M.] Bangladesh Univ Engn & Technol, Dept Chem Engn, Dhaka, Bangladesh; [Dey, Digbijoy] BRAC, Dhaka, Bangladesh; [Camargo-Valero, Miller Alonso] Univ Nacl Colombia, Dept Ingn Quim, Campus La Nubia, Manizales, Colombia	CGIAR; International Water Management Institute (IWMI); University of Leeds; Bangladesh University of Engineering & Technology (BUET); Bangladesh Rural Advancement Committee BRAC; Universidad Nacional de Colombia	Evans, B (corresponding author), Univ Leeds, Inst Publ Hlth & Environm Engn, Leeds, W Yorkshire, England.	b.e.evans@leeds.ac.uk	Camargo-Valero, Miller Alonso/AAZ-3647-2020	Camargo-Valero, Miller Alonso/0000-0003-2962-1698; Evans, Barbara/0000-0001-9815-3141	Embassy of the Kingdom of the Netherlands (Bangladesh) through the International Reference Centre (IRC) Netherlands Transnational Call on BRAC WASH Programme II [L13.0080/E11.34-WP5/479/mg]; CGIAR Research Program on Water, Land and Ecosystems	Embassy of the Kingdom of the Netherlands (Bangladesh) through the International Reference Centre (IRC) Netherlands Transnational Call on BRAC WASH Programme II; CGIAR Research Program on Water, Land and Ecosystems	This research is a result of a study, entitled Value at the end of the Sanitation Value Chain (VeSV) which was funded by the Embassy of the Kingdom of the Netherlands (Bangladesh) through the International Reference Centre (IRC) Netherlands Transnational Call on BRAC WASH Programme II, under contract number L13.0080/E11.34-WP5/479/mg. Additional funding was provided by the CGIAR Research Program on Water, Land and Ecosystems. lngeborg Krukkert of IRC and Elizabeth Kvarnstrom, who was employed by IRC as a consultant associated with the transnational call, provided detailed comments on the inception report and final report of the VeSV study. The results of the VeSv study are being used as input to design a policy framework for fecal sludge management in Bangladesh by the Ministry of Local Government, Government of Bangladesh. Some of the authors are members of the Bangladesh National Committee for Fecal Sludge Management. We would like to thank participants at the Centre for research on the Economics of Climate, Food, Energy and Environment (CECFEE) Workshop 2015, Indian Statistical Institute Delhi, and participants at the South Asia Network for Development and Environment Economics (SANDEE)- IPS Summer School in Environment and Resource Economics 2015 for questions and comments. We would also like to thank Ted Horbulyk for comments on an earlier draft of the paper.	Afroz R, 2009, J ENVIRON MANAGE, V90, P492, DOI 10.1016/j.jenvman.2007.12.012; ALBERINI A, 1995, J ENVIRON ECON MANAG, V28, P287, DOI 10.1006/jeem.1995.1019; ALBERINI A, 1995, LAND ECON, V71, P83, DOI 10.2307/3146760; Arimah BC, 1996, J ENVIRON MANAGE, V48, P127, DOI 10.1006/jema.1996.0068; Balasubramanya S, 2017, J WATER SAN IN PRESS; Balasubramanya S, 2016, J WATER SANIT HYG DE, V6, P456, DOI 10.2166/washdev.2016.049; Blaine TW, 2005, J ENVIRON MANAGE, V76, P15, DOI 10.1016/j.jenvman.2005.01.004; Bouabid A, 2015, J ENVIRON MANAGE, V161, P335, DOI 10.1016/j.jenvman.2015.07.012; Boyle K J, 2003, CONTINGENT VALUATION; Boyle KJ, 1998, LAND ECON, V74, P49, DOI 10.2307/3147212; BRISCOE J, 1993, WORLD BANK RES OBSER, V8, P47, DOI 10.1093/wbro/8.1.47; Carson RT, 2007, ENVIRON RESOUR ECON, V37, P181, DOI 10.1007/s10640-007-9124-5; COOPER JC, 1993, J ENVIRON ECON MANAG, V24, P25, DOI 10.1006/jeem.1993.1002; Delavande A, 2011, J DEV ECON, V94, P151, DOI 10.1016/j.jdeveco.2010.01.008; Dzwairo B, 2006, PHYS CHEM EARTH, V31, P779, DOI 10.1016/j.pce.2006.08.031; Engin GO, 2006, J ENVIRON MANAGE, V79, P357, DOI 10.1016/j.jenvman.2005.07.011; Evans B E, 2016, FECAL SLUDGE EMPTYIN; Evans B E, 2009, J PUBLIC FUNDING SAN; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fine P, 2006, J ENVIRON MANAGE, V78, P163, DOI 10.1016/j.jenvman.2005.04.014; Green D, 1998, RESOUR ENERGY ECON, V20, P85, DOI 10.1016/S0928-7655(97)00031-6; GRIFFIN CC, 1995, WORLD BANK ECON REV, V9, P373, DOI 10.1093/wber/9.3.373; HANEMANN M, 1991, AM J AGR ECON, V73, P1255, DOI 10.2307/1242453; Heal G M, 2003, J EUROPEAN EC ASS, V1; Herriges JA, 1996, J ENVIRON ECON MANAG, V30, P112, DOI 10.1006/jeem.1996.0008; Huang DB, 2007, J ENVIRON MANAGE, V84, P49, DOI 10.1016/j.jenvman.2006.05.004; Kennedy-Walker R, 2014, P I CIVIL ENG-MUNIC, V167, P157, DOI 10.1680/muen.13.00021; Khan I, 2015, INT J BUSINESS QUANT, V2, P110; Ministry of Planning Government of Bangladesh Community Report: Mymensingh Zila-, 2012, GOV BANGL COMM REP M; Morgan P., 2007, TOILETS MAKE COMPOST; Nixon H, 2007, J ENVIRON MANAGE, V84, P547, DOI 10.1016/j.jenvman.2006.07.003; Pattanayak SK, 2009, ANNU REV RESOUR ECON, V1, P183, DOI 10.1146/annurev.resource.050708.144053; Pek CK, 2011, J ENVIRON MANAGE, V92, P2993, DOI 10.1016/j.jenvman.2011.07.013; pez-Feldman Lo A, 2013, 41018 MPRA; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Salimonu KK., 2007, RES J APPL SCI, V2, P233; Schaub-Jones D, 2008, BUILDING PARTNERSHIP, p302 4; Schmidt WP, 2014, TROP MED INT HEALTH, V19, P522, DOI 10.1111/tmi.12286; Shivendra BT, 2015, AQUAT PR, V4, P1162, DOI 10.1016/j.aqpro.2015.02.148; Song QB, 2012, J ENVIRON MANAGE, V106, P8, DOI 10.1016/j.jenvman.2012.03.036; WHITTINGTON D, 1990, ECON DEV CULT CHANGE, V38, P293, DOI 10.1086/451794; WHITTINGTON D, 1993, WATER RESOUR RES, V29, P1539, DOI 10.1029/93WR00184; WHO, 2012, GLOB COSTS BEN DRINK; World Health Organization (WHO)/UNICEF (Joint Monitoring Programme for Water and Sanitation), 2015, METH NOT PROP IND FR	44	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0171735	10.1371/journal.pone.0171735	http://dx.doi.org/10.1371/journal.pone.0171735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323885	Green Published, gold			2022-12-27	WOS:000399089000012
J	Huang, ZR; Hu, ZZ; Xie, P; Liu, QH				Huang, ZhengRu; Hu, ZiZhong; Xie, Ping; Liu, QingHuai			Tyrosine-mutated AAV2-mediated shRNA silencing of PTEN promotes axon regeneration of adult optic nerve	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSDUCTION; RETINAL GANGLION-CELLS; GENE-THERAPY; MOUSE RETINA; TRANSGENE EXPRESSION; VISUAL-SYSTEM; MULLER CELLS; AAV2 VECTORS; CNS; GROWTH	Activating PI3K/AKT/mTOR signaling pathway via deleting phosphatase and tensin homolog (PTEN) has been confirmed to enhance intrinsic growth capacity of neurons to facilitate the axons regeneration of central nervous system after injury. Considering conditional gene deletion is currently not available in clinical practice, we exploited capsid residue tyrosine 444 to phenylalanine mutated single-stranded adeno-associated virus serotype 2 (AAV2) as a vector delivering short hairpin RNA to silence PTEN to promote retinal ganglion cells (RGCs) survival and axons regeneration in adult rat optic nerve axotomy paradigm. We found that mutant AAV2 displayed higher infection efficiency to RGCs and Muller cells by intravitreal injection, mediated PTEN suppression, resulted in much more RGCs survival and more robust axons regeneration compared with wild type AAV2, due to the different extent of the mTOR complex-1 activation and glutamate aspartate transporter (GLAST) regulation. These results suggest that high efficiency AAV2-mediated PTEN knockdown represents a practicable therapeutic strategy for optic neuropathy.	[Huang, ZhengRu; Hu, ZiZhong; Xie, Ping; Liu, QingHuai] Nanjing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Huang, ZhengRu] Second Peoples Hosp Changshu, Dept Ophthalmol, Changshu, Jiangsu, Peoples R China	Nanjing Medical University	Liu, QH (corresponding author), Nanjing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn		hu, zizhong/0000-0001-6289-1804; Xie, Ping/0000-0003-4257-8970	Research Foundation of Jiangsu Provincial Commission of Health and Family Planning [H201653]	Research Foundation of Jiangsu Provincial Commission of Health and Family Planning	This work was supported by the Research Foundation of Jiangsu Provincial Commission of Health and Family Planning (NO. H201653, http://www.jswst.gov.cn/jsswshjhsywyh/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 1998, HUM GENE THER, V9, P81, DOI 10.1089/hum.1998.9.1-81; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Day TP, 2014, ADV EXP MED BIOL, V801, P687, DOI 10.1007/978-1-4614-3209-8_86; Ding W, 2006, MOL THER, V13, P671, DOI 10.1016/j.ymthe.2005.12.002; Fischer D, 2012, PROG RETIN EYE RES, V31, P688, DOI 10.1016/j.preteyeres.2012.06.005; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; Greenberg KP, 2007, INVEST OPHTH VIS SCI, V48, P1844, DOI 10.1167/iovs.05-1570; Guzman-Aranguez A, 2013, BRIT J PHARMACOL, V170, P730, DOI 10.1111/bph.12330; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Hellstrom M, 2011, CURR GENE THER, V11, P116, DOI 10.2174/156652311794940746; Izumi Y, 2002, GLIA, V39, P58, DOI 10.1002/glia.10082; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Koch JC, 2011, NAT PROTOC, V6, P1887, DOI 10.1038/nprot.2011.403; Koch JC, 2011, FEBS J, V278, P3472, DOI 10.1111/j.1742-4658.2011.08269.x; Koeberle PD, 2008, CELL DEATH DIFFER, V15, P471, DOI 10.1038/sj.cdd.4402281; Kubowicz P, 2013, CURR MED CHEM, V20, P1801; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Lewandowski G, 2014, J NEUROSCI, V34, P9951, DOI 10.1523/JNEUROSCI.1996-14.2014; Lipinski DM, 2013, PROG RETIN EYE RES, V32, P22, DOI 10.1016/j.preteyeres.2012.09.001; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Lopez-Colome AM, 2012, ASN NEURO, V4, P331, DOI 10.1042/AN20120022; Miao L, 2016, MTORC1 IS NECESSARY, V5; Moore DL, 2010, J NEURO-OPHTHALMOL, V30, P347, DOI 10.1097/WNO.0b013e3181e755af; Morgan-Warren PJ, 2013, INVEST OPHTH VIS SCI, V54, P6903, DOI 10.1167/iovs.13-12803; Vicentini FTMD, 2013, PHARM RES-DORDR, V30, P915, DOI 10.1007/s11095-013-0971-1; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Nishikawa Y, 2016, EXP EYE RES, V146, P118, DOI 10.1016/j.exer.2015.12.012; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Sarthy VP, 2005, GLIA, V49, P184, DOI 10.1002/glia.20097; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yang P, 2012, J NEUROL SCI, V312, P1, DOI 10.1016/j.jns.2011.08.037; Yungher BJ, 2015, GENE THER, V22, P811, DOI 10.1038/gt.2015.51; Zhong L, 2008, VIROLOGY, V381, P194, DOI 10.1016/j.virol.2008.08.027; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	45	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174096	10.1371/journal.pone.0174096	http://dx.doi.org/10.1371/journal.pone.0174096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323869	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000060
J	Muniz, HS; Nascimento, AS				Muniz, Heloisa S.; Nascimento, Alessandro S.			Towards a critical evaluation of an empirical and volume-based solvation function for ligand docking	PLOS ONE			English	Article							AUGMENTED LAGRANGIAN-METHODS; MOLECULAR DOCKING; AUTOMATED DOCKING; PROTEIN SIMULATIONS; FORCE-FIELDS; MECHANICS; DATABASE; BENCHMARKING; ENRICHMENT; CONSTANT	Molecular docking is an important tool for the discovery of new biologically active molecules given that the receptor structure is known. An excellent environment for the development of new methods and improvement of the current methods is being provided by the rapid growth in the number of proteins with known structure. The evaluation of the solvation energies outstands among the challenges for the modeling of the receptor-ligand interactions, especially in the context of molecular docking where a fast, though accurate, evaluation is ought to be achieved. Here we evaluated a variation of the desolvation energy model proposed by Stouten (Stouten P. F. W. et al, Molecular Simulation, 1993, 10: 97-120), or SV model. The SV model showed a linear correlation with experimentally determined solvation energies, as available in the database FreeSolv. However, when used in retrospective docking simulations using the benchmarks DUD, charged-matched DUD and DUD-Enhanced, the SV model resulted in poorer enrichments when compared to a pure force field model with no correction for solvation effects. The data provided here is consistent with other empirical solvation models employed in the context of molecular docking and indicates that a good model to account for solvent effects is still a goal to achieve. On the other hand, despite the inability to improve the enrichment of retrospective simulations, the SV solvation model showed an interesting ability to reduce the number of molecules with net charge -2 and -3 e among the top-scored molecules in a prospective test.	[Muniz, Heloisa S.; Nascimento, Alessandro S.] Inst Fis Sao Carlos, Ave Trabalhador Sao Carlense,400 Ctr, Sao Carlos, SP, Brazil		Nascimento, AS (corresponding author), Inst Fis Sao Carlos, Ave Trabalhador Sao Carlense,400 Ctr, Sao Carlos, SP, Brazil.	asnascimento@ifsc.usp.br	Nascimento, Alessandro/Y-3394-2019; Nascimento, Alessandro S/G-9547-2012	Nascimento, Alessandro/0000-0001-6656-5379; Nascimento, Alessandro S/0000-0001-6656-5379	FAPESP [2010/15376-8, 2014/06565-2]; CNPq [485950/2013-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (2010/15376-8 and 2014/06565-2) and CNPq (485950/2013-8). HSM thanks CNPq for her PhD stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank to FAPESP and CNPq for financial support through grants 2010/15376-8 and 2014/06565-2(FAPESP) and 485950/2013-8 (CNPq). HSM thanks CNPq for her PhD stipend.	Anand P, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau029; Andreani R, 2008, SIAM J OPTIMIZ, V18, P1286, DOI 10.1137/060654797; Andreani R, 2008, MATH PROGRAM, V111, P5, DOI 10.1007/s10107-006-0077-1; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Birgin EG, 2008, OPTIM METHOD SOFTW, V23, P177, DOI 10.1080/10556780701577730; Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Coleman RG, 2014, J COMPUT AID MOL DES, V28, P201, DOI 10.1007/s10822-014-9722-6; Gao M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003302; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GILSON MK, 1988, PROTEINS, V3, P32, DOI 10.1002/prot.340030104; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jhonson SG, THE NLOPT NONLINEAR; JONES DR, 1993, J OPTIMIZ THEORY APP, V79, P157, DOI 10.1007/BF00941892; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; LUTY BA, 1995, J COMPUT CHEM, V16, P454, DOI 10.1002/jcc.540160409; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mobley DL, 2014, J COMPUT AID MOL DES, V28, P711, DOI 10.1007/s10822-014-9747-x; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muniz HD, 2015, J COMPUT AID MOL DES, V29, P713, DOI 10.1007/s10822-015-9856-1; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nascimento AS, 2010, BIOCHIMIE, V92, P499, DOI 10.1016/j.biochi.2010.01.018; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; SCHUMANN M, 2013, PLOS ONE, V8; Shoichet BK, 1999, PROTEINS, V34, P4, DOI 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; STOUTEN PFW, 1993, MOL SIMULAT, V10, P97, DOI 10.1080/08927029308022161; de Lima LACV, 2013, EUR J MED CHEM, V59, P296, DOI 10.1016/j.ejmech.2012.11.013; Verkhivker GM, 1999, J MOL RECOGNIT, V12, P371, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<371::AID-JMR479>3.0.CO;2-O; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wereszczynski J, 2012, Q REV BIOPHYS, V45, P1, DOI 10.1017/S0033583511000096; Zhang XH, 2014, J CHEM INF MODEL, V54, P324, DOI 10.1021/ci4005145	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174336	10.1371/journal.pone.0174336	http://dx.doi.org/10.1371/journal.pone.0174336			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323889	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000088
J	Paradowska-Gorycka, A; Sowinska, A; Pawlik, A; Malinowski, D; Stypinska, B; Haladyj, E; Romanowska-Prochnicka, K; Olesinska, M				Paradowska-Gorycka, Agnieszka; Sowinska, Anna; Pawlik, Andrzej; Malinowski, Damian; Stypinska, Barbara; Haladyj, Ewa; Romanowska-Prochnicka, Katarzyna; Olesinska, Marzena			FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; ANGIOGENESIS; INHIBITION; REVASCULARIZATION; INFLAMMATION; DISEASE; TISSUES; SHESIS; KDR	Objectives Inflammation and angiogenesis are a significant element of pathogenesis in rheumatoid arthritis (RA). The FLT-1-triggering factor for production of proinflammatory cytokinesmight contributes to inflammation in patients with RA. Association of the FLT-1 polymorphisms with different "angiogenic diseases" suggests that it may be a novel genetic risk factor also for RA. The aim of the study was to identify FLT-1 genetic variants and their possible association with sFLT-1 levels, susceptibility to and severity of RA. Methods The FLT-1 gene polymorphisms were genotyped for 471 RA patients and 684 healthy individuals. Correlation analysis was performed with clinical parameters, cardiovascular disease (CVD) and anti-citrullinated peptide/protein antibody (ACPA) presence. The sFLT-1 serum levels were evaluated. Results The FLT-1 gene polymorphisms showed no significant differences in the proportion of cases and controls. Furthermore, the FLT-1 rs2296188 T/C polymorphism was associated with ACPA-positive RA. Overall, rs9943922 T/C and rs2296283 G/A are in almost completed linkage disequilibrium (LD) with D' = 0.97 and r2 = 0.83. The FLT-1 rs7324510 A allele has shown association with VAS score (p = 0.035), DAS-28 score (p = 0.013) and ExRA presence (p = 0.027). Moreover, other clinical parameters were also higher in RA patients with this allele. In addition, FLT-1 genetic variants conferred higher sFLT-1 levels in RA patients compared to controls. Conclusion FLT-1 rs7324510 C/A variant may be a new genetic risk factor for severity of RA. Examined factor highly predispose to more severe disease activity as well as higher sFLT-1 levels in RA.	[Paradowska-Gorycka, Agnieszka; Stypinska, Barbara] Natl Inst Geriatr Rheumatol & Rehabil, Dept Biochem & Mol Biol, Warsaw, Poland; [Sowinska, Anna] Poznan Univ Med Sci, Dept Comp Sci & Stat, Poznan, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Physiol, Szczecin, Poland; [Malinowski, Damian] Pomeranian Med Univ, Dept Pharmacol, Szczecin, Poland; [Haladyj, Ewa; Romanowska-Prochnicka, Katarzyna; Olesinska, Marzena] Natl Inst Geriatr Rheumatol & Rehabil, Dept Connect Tissue Dis, Warsaw, Poland; [Romanowska-Prochnicka, Katarzyna] Med Univ Warsaw, Dept Pathophysiol, Warsaw, Poland	National Institute of Geriatrics, Rheumatology & Rehabilitation; Poznan University of Medical Sciences; Pomeranian Medical University; Pomeranian Medical University; National Institute of Geriatrics, Rheumatology & Rehabilitation; Medical University of Warsaw	Paradowska-Gorycka, A (corresponding author), Natl Inst Geriatr Rheumatol & Rehabil, Dept Biochem & Mol Biol, Warsaw, Poland.	paradowska_aga@interia.pl	Romanowska-Próchnicka, Katarzyna/AAJ-8318-2021; Paradowska-Gorycka, Agnieszka/C-3964-2019; Olesinska, Marzena/P-6759-2019; Malinowski, Damian/M-1455-2014	Paradowska-Gorycka, Agnieszka/0000-0002-4249-3136; Olesinska, Marzena/0000-0003-3028-1061; Malinowski, Damian/0000-0001-8393-9627; Sowinska, Anna/0000-0001-5319-5057; Stypinska, Barbara/0000-0001-8179-8066; Pawlik, Andrzej/0000-0001-6557-1208	National Institute of Geriatrics, Rheumatology and Rehabilitation [S/13]	National Institute of Geriatrics, Rheumatology and Rehabilitation	The work was supported by grant S/13, National Institute of Geriatrics, Rheumatology and Rehabilitation to APG.	Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Azizi G, 2014, INT J RHEUM DIS, V17, P369, DOI 10.1111/1756-185X.12280; Beuselinck B, 2016, BJU INT; Giatromanolaki A, 2000, J PATHOL, V192, P140, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH693>3.0.CO;2-R; Ikeda M, 2000, J PATHOL, V191, P426; Kim HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124909; Kobayashi K, J EXP MED, V91, P275; Koide M, 1999, BIOCHEM BIOPH RES CO, V259, P97, DOI 10.1006/bbrc.1999.0715; Kotulska Anna, 2011, Reumatologia (Warsaw), V49, P1; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557, DOI 10.14670/HH-21.557; Matsumoto Y, 2002, J IMMUNOL, V168, P5824, DOI 10.4049/jimmunol.168.11.5824; Owen LA, 2014, INVEST OPHTH VIS SCI, V55, P3543, DOI 10.1167/iovs.14-14047; Pabst S, 2010, CHEST, V137, P156, DOI 10.1378/chest.09-1003; Sekimoto T, 2002, J RHEUMATOL, V29, P240; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shibuya M, 2015, ENDOCR METAB IMMUNE, V15, P135, DOI 10.2174/1871530315666150316121956; Slattery ML, 2014, MOL CARCINOGEN, V53, pE140, DOI 10.1002/mc.22058; Szekanecz Z, 2009, AUTOIMMUNITY, V42, P563, DOI 10.1080/08916930903143083; Wang H, 2014, MUTAGENESIS, V29, P311, DOI 10.1093/mutage/geu020; Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289; Zhang Y, 2013, SCAND J RHEUMATOL, V42, P344, DOI 10.3109/03009742.2013.787454	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0172018	10.1371/journal.pone.0172018	http://dx.doi.org/10.1371/journal.pone.0172018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323906	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000013
J	Torres-Costoso, A; Pozuelo-Carrascosa, DP; Alvarez-Bueno, C; Ferri-Morales, A; Ibarra, JM; Notario-Pacheco, B; Martinez-Vizcaino, V				Torres-Costoso, Ana; Pozuelo-Carrascosa, Diana P.; Alvarez-Bueno, Celia; Ferri-Morales, Asuncion; Miota Ibarra, Jose; Notario-Pacheco, Blanca; Martinez-Vizcaino, Vicente			Insulin and bone health in young adults: The mediator role of lean mass	PLOS ONE			English	Article							GROWTH-FACTOR-I; MINERAL DENSITY; FAT MASS; RELATIVE CONTRIBUTIONS; PHYSICAL-ACTIVITY; PROTEIN-SYNTHESIS; MUSCLE; ASSOCIATION; OSTEOBLASTS; ADOLESCENTS	Background The positive relationship between lean mass (LM) and bone health is well known, but a positive association between insulin and LM has also been described. Insulin has some anabolic properties on bone through the stimulation of osteoblast differentiation, yet the role of LM as a confounder or mediator in this relationship remains uncertain. Objective To examine whether the association between insulin levels and bone health is mediated by LM. Methods A cross-sectional study was conducted at the Castilla La Mancha University (Spain) involving 466 young adults (113 young men; 19.5 +/- 2.3 years). LM and total-body bone mineral content (BMC) were measured by dual energy x-ray absorptiometry, and insulin was measured in fasting serum samples. Results Young adults with high total LM had higher values of total-body BMC than their peers after controlling for age and sex, this relationship persisted after adjusting for insulin levels (p< 0.001). In mediation analyses, insulin levels were positively associated with total-body BMC (b = 0.05; p< 0.001) and total LM acted as an intermediate variable, attenuating the association between insulin levels and total-body BMC (b = -31.98; p> 0.05) as indicated by Sobel test values for indirect effect (z = 4.43; p< 0.001). Conclusions LM plays an important role in the relationship between insulin levels and bone health, in such a way that while increases in LM have a positive influence on bone health, they are also negatively associated with insulin levels.	[Torres-Costoso, Ana; Ferri-Morales, Asuncion] Univ Castilla La Mancha, Sch Nursing & Physiotherapy, Toledo, Spain; [Pozuelo-Carrascosa, Diana P.; Alvarez-Bueno, Celia; Miota Ibarra, Jose; Notario-Pacheco, Blanca; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.; Martinez-Vizcaino, V (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	Vicente.Martinez@uclm.es	Alvarez-Bueno, Celia/R-4075-2019; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Carrascosa, Diana P. Pozuelo/R-4379-2017; Morales, Asuncion Ferri/I-1959-2015; Torres-Costoso, Ana/R-4847-2019; Morales, Asunción Ferri/AAC-1337-2019; Notario Pacheco, Blanca/G-2583-2016	Alvarez-Bueno, Celia/0000-0002-6176-1618; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Carrascosa, Diana P. Pozuelo/0000-0002-0527-5498; Morales, Asuncion Ferri/0000-0001-5638-4718; Morales, Asunción Ferri/0000-0001-5638-4718; Torres-Costoso, Ana/0000-0001-8961-3169; Notario Pacheco, Blanca/0000-0001-8406-6952	Foundation for Health Research of Castilla-La Mancha (FISCAM) [AN/2008/31]; Research Network in Preventive and Health Promotion Activities (Red de Investigacion en Actividades Preventivas y de Promocion de Salud) [RD06/0018/0038]; Ministry of Science and Technology [RYC-2010-05957]; Spanish Ministry of Education, Culture and Sport [FPU13/03137]	Foundation for Health Research of Castilla-La Mancha (FISCAM); Research Network in Preventive and Health Promotion Activities (Red de Investigacion en Actividades Preventivas y de Promocion de Salud); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This study was funded mainly by Foundation for Health Research of Castilla-La Mancha (FISCAM) (AN/2008/31). Additional funding was obtained from Research Network in Preventive and Health Promotion Activities (Red de Investigacion en Actividades Preventivas y de Promocion de Salud) (RD06/0018/0038) and from Ministry of Science and Technology (RYC-2010-05957). CAB is supported by a grant from the Spanish Ministry of Education, Culture and Sport (FPU13/03137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participants of the study. This study was funded mainly by the Foundation for Health Research of Castilla-La Mancha (FISCAM) (AN/2008/31). Additional funding was obtained from the Research Network in Preventive and Health Promotion Activities (Red de Investigacion en Actividades Preventivas y de Promocion de Salud) (RD06/0018/0038) and from the Ministry of Science and Technology (RYC-2010-05957)	Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; Avnet S, 2012, DIFFERENTIATION, V83, P242, DOI 10.1016/j.diff.2012.02.002; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baxter-Jones ADG, 2011, J BONE MINER RES, V26, P1729, DOI 10.1002/jbmr.412; BIOLO G, 1995, J CLIN INVEST, V95, P811, DOI 10.1172/JCI117731; Bolster DR, 2004, P NUTR SOC, V63, P351, DOI 10.1079/PNS2004355; BONADONNA RC, 1993, J CLIN INVEST, V91, P514, DOI 10.1172/JCI116230; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Breen ME, 2011, J CLIN ENDOCR METAB, V96, pE89, DOI 10.1210/jc.2010-0595; Diez-Fernandez A, 2017, HYPERTENS RES; Diez-Fernandez A, 2014, DIABETES CARE, V37, P855, DOI 10.2337/dc13-0416; El Hage RP, 2009, EUR J APPL PHYSIOL, V105, P759, DOI 10.1007/s00421-008-0959-4; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Frost HM, 2000, MED SCI SPORT EXER, V32, P911; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; FRYBURG DA, 1995, J CLIN INVEST, V96, P1722, DOI 10.1172/JCI118217; Fulzele K, 2012, BONE, V50, P452, DOI 10.1016/j.bone.2011.06.018; Garcia-Hermoso A, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0244-y; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Graham Michael R, 2008, Ther Clin Risk Manag, V4, P587; Henry YM, 2004, OSTEOPOROSIS INT, V15, P263, DOI 10.1007/s00198-003-1542-9; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Kindler JM, 2016, J CLIN ENDOCR METAB, V101, P198, DOI 10.1210/jc.2015-3451; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Lawlor DA, 2012, J CLIN ENDOCR METAB, V97, P2068, DOI 10.1210/jc.2011-2721; Lofgren B, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-25; Arias-Palencia NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141977; Pluralizam P. K., 1989, FOKUS           0330, V8, P8; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Riddle RC, 2014, J CLIN INVEST, V124, P1465, DOI 10.1172/JCI75554; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Schoenau E, 2004, HORM RES, V61, P257, DOI 10.1159/000076635; Seeman E, 1996, AM J PHYSIOL-ENDOC M, V270, pE320, DOI 10.1152/ajpendo.1996.270.2.E320; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Soot T, 2006, J SPORT MED PHYS FIT, V46, P293; Sonksen PH, 2001, J ENDOCRINOL, V170, P13, DOI 10.1677/joe.0.1700013; Tobias JH, 2007, J BONE MINER RES, V22, P101, DOI 10.1359/JBMR.060913; Torres-Costoso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123797; Torres-Costoso A, 2015, J SPORT SCI, V33, P817, DOI 10.1080/02640414.2014.964750; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; Wang MC, 2005, BONE, V37, P474, DOI 10.1016/j.bone.2005.04.038; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wetzsteon RJ, 2011, BONE, V48, P1103, DOI 10.1016/j.bone.2011.01.005; Zemel B, 2013, WORLD REV NUTR DIET, V106, P39, DOI 10.1159/000342601; Zhu K, 2014, OSTEOPOROSIS INT, V25, P1563, DOI 10.1007/s00198-014-2665-x	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173874	10.1371/journal.pone.0173874	http://dx.doi.org/10.1371/journal.pone.0173874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323845	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000036
J	Bandt, SK; Roland, JL; Pahwa, M; Hacker, CD; Bundy, DT; Breshears, JD; Sharma, M; Shimony, JS; Leuthardt, EC				Bandt, S. Kathleen; Roland, Jarod L.; Pahwa, Mrinal; Hacker, Carl D.; Bundy, David T.; Breshears, Jonathan D.; Sharma, Mohit; Shimony, Joshua S.; Leuthardt, Eric C.			The impact of high grade glial neoplasms on human cortical electrophysiology	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BRAIN; CORTEX; ACTIVATION; NETWORK; MOTOR; HEMODYNAMICS; METABOLISM; LANGUAGE	The brain's functional architecture of interconnected network- related oscillatory patterns in discrete cortical regions has been well established with functional magnetic resonance imaging (fMRI) studies or direct cortical electrophysiology from electrodes placed on the surface of the brain, or electrocorticography (ECoG). These resting state networks exhibit a robust functional architecture that persists through all stages of sleep and under anesthesia. While the stability of these networks provides a fundamental understanding of the organization of the brain, understanding how these regions can be perturbed is also critical in defining the brain's ability to adapt while learning and recovering from injury.	[Bandt, S. Kathleen] Yale Univ, Sch Med, Dept Neurol Surg, New Haven, CT 06520 USA; [Roland, Jarod L.] Washington Univ, Dept Neurol Surg, St Louis, MO USA; [Pahwa, Mrinal; Hacker, Carl D.; Sharma, Mohit; Leuthardt, Eric C.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Hacker, Carl D.; Shimony, Joshua S.; Leuthardt, Eric C.] Washington Univ, Sch Med, St Louis, MO USA; [Bundy, David T.] Univ Kansas, Dept Rehabil Med, Kansas City, KS USA; [Breshears, Jonathan D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Shimony, Joshua S.] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Ctr Innovat Neurosci & Technol, St Louis, MO USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Brain Laser Ctr, St Louis, MO USA	Yale University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Kansas; University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bandt, SK (corresponding author), Yale Univ, Sch Med, Dept Neurol Surg, New Haven, CT 06520 USA.	skbandt@gmail.com	Roland, Jarod L/J-1433-2019	Roland, Jarod L/0000-0002-1312-8826; Bundy, David/0000-0001-6491-044X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS090978] Funding Source: NIH RePORTER; NINDS NIH HHS [R25 NS090978] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Aubert A, 2002, NEUROIMAGE, V17, P1162, DOI 10.1006/nimg.2002.1224; Aubert A, 2002, ACTA BIOTHEOR, V50, P281, DOI 10.1023/A:1022620818701; Bello L, 2006, NEUROSURGERY, V59, P115, DOI 10.1227/01.NEU.0000219241.92246.FB; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borstad AL, 2013, J NEUROL PHYS THER, V37, P27, DOI 10.1097/NPT.0b013e318283de0d; Bosma I, 2008, J NEURO-ONCOL, V88, P77, DOI 10.1007/s11060-008-9535-3; Breshears JD, 2012, NEUROSURGERY, V71, P305, DOI 10.1227/NEU.0b013e318258e5d1; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Brunner P, 2009, EPILEPSY BEHAV, V15, P278, DOI 10.1016/j.yebeh.2009.04.001; Chow DS, 2016, AM J ROENTGENOL, P1; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Davis F G, 1999, Neuro Oncol, V1, P205, DOI 10.1093/neuonc/1.3.205; Di X., 2013, BRAIN STRUCT FUNCT; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Greenlee JDW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060783; Grefkes C., 2013, NEUROSCIENTIST; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunduz A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00089; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Holodny AI, 1999, AM J NEURORADIOL, V20, P609; Jiang L, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/924192; Jiang Z, 2010, NEUROIMAGE, V52, P538, DOI 10.1016/j.neuroimage.2010.04.194; Ko AL, 2013, BRAIN CONNECT, V3, P491, DOI 10.1089/brain.2013.0157; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Leuthardt EC, 2007, NEUROSURGERY, V60, P260, DOI 10.1227/01.NEU.0000255413.70807.6E; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liu X, 2015, CEREB CORTEX, V25, P2929, DOI 10.1093/cercor/bhu089; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Niedermeyer E, 1982, ELECTROENCEPHALOGRAP, Vx; Pfurtscheller G, 1999, HDB ELECTROENCEPHALO; Roland JL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00431; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Sakatani K, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823036; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Tertel K, 2011, COMPUT BIOL MED, V41, P1092, DOI 10.1016/j.compbiomed.2010.11.004; van Dellen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050122; Vannini E, 2016, NEUROONCOL; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang YJ, 2016, NEUROLOGY, V86, P1181, DOI 10.1212/WNL.0000000000002525; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Wu Melinda, 2010, Neurosurgery, V66, pE407, DOI 10.1227/01.NEU.0000345352.13696.6F	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173448	10.1371/journal.pone.0173448	http://dx.doi.org/10.1371/journal.pone.0173448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319187	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800016
J	Vidyarthi, A; Khan, N; Agnihotri, T; Siddiqui, KF; Nair, GR; Arora, A; Janmeja, AK; Agrewala, JN				Vidyarthi, Aurobind; Khan, Nargis; Agnihotri, Tapan; Siddiqui, Kaneez F.; Nair, Girish R.; Arora, Ashish; Janmeja, Ashok K.; Agrewala, Javed N.			Antibody response against PhoP efficiently discriminates among healthy individuals, tuberculosis patients and their contacts	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEDIATED IMMUNITY; PROTEIN; TESTS; BCG; PROTECTION; ANTIGENS; OPERON; STRAIN; ESAT-6	Tuberculosis continues to be one of the most devastating global health problem. Its diagnosis will benefit in timely initiation of the treatment, cure and therefore reduction in the transmission of the disease. Tests are available, but none can be comprehensively relied on for its diagnosis; especially in TB-endemic zones. PhoP is a key player in Mycobacterium tuberculosis virulence but nothing has been known about its role in the diagnosis of TB. We monitored the presence of anti-PhoP antibodies in the healthy, patients and their contacts. In addition, we also measured antibodies against early secretory antigens ESAT-6 and CFP10, and latency associated antigen Acr-1 to include proteins that are associated with the different stages of disease progression. Healthy subjects showed high antibody titer against PhoP than patients and their contacts. In addition, a distinct pattern in the ratio of Acr-1/PhoP was observed among all cohorts. This study for the first time demonstrates a novel role of anti-PhoP antibodies, as a possible marker for the diagnosis of TB and therefore will contribute in the appropriate action and management of the disease.	[Vidyarthi, Aurobind; Khan, Nargis; Agnihotri, Tapan; Siddiqui, Kaneez F.; Nair, Girish R.; Agrewala, Javed N.] CSIR, Inst Microbial Technol, Chandigarh, India; [Arora, Ashish] CSIR, Cent Drug Res Inst, Lucknow, Uttar Pradesh, India; [Janmeja, Ashok K.] Govt Med Coll & Hosp, Chandigarh, India; [Vidyarthi, Aurobind] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Khan, Nargis] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Agnihotri, Tapan] Mahatma Gandhi Cent Univ, Dept Biotech, Motihari, Bihar, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Yale University; McGill University	Agrewala, JN (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	javed@imtech.res.in	Agrewala, Javed Naim/AAS-8449-2021; Vidyarthi, Aurobind/AAR-4133-2020	Vidyarthi, Aurobind/0000-0002-3688-7657	Council of Scientific and Industrial Research, India [OLP-088]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research, India (to AV, NK, TA, GRN), Grant number OLP-088. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x; Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Das AK, 2013, J BIOL CHEM, V288, P29182, DOI 10.1074/jbc.M113.499905; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Esparza-Gonzalez SC, 2012, SCAND J IMMUNOL, V75, P259, DOI 10.1111/j.1365-3083.2011.02655.x; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Glatman-Freedman A, 2006, TUBERCULOSIS, V86, P191, DOI 10.1016/j.tube.2006.01.008; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Mattos AMM, 2016, TUBERCULOSIS, V96, P65, DOI 10.1016/j.tube.2015.11.001; Okuda Y, 2004, J CLIN MICROBIOL, V42, P1136, DOI 10.1128/JCM.42.3.1136-1141.2004; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Siddiqui KF, 2014, J INFECT DIS, V209, P1436, DOI 10.1093/infdis/jit595; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Zhang XF, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-107; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	31	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173769	10.1371/journal.pone.0173769	http://dx.doi.org/10.1371/journal.pone.0173769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319170	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800030
J	Gatti, FAD; Ceolan, E; Greco, FSR; Santos, PC; Klafke, GB; de Oliveira, GR; Von Groll, A; de Martinez, AMB; Goncalves, CV; Scaini, CJ				dos Anjos Gatti, Fabiane Aguiar; Ceolan, Etienne; Rodrigues Greco, Fernando Salles; Santos, Paula Costa; Klafke, Gabriel Baracy; de Oliveira, Gisele Rodrigues; Von Groll, Andrea; Barral de Martinez, Ana Maria; Goncalves, Carla Vitola; Scaini, Carlos James			The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; REPRODUCTIVE-AGE; PREGNANT-WOMEN; VAGINALIS; INFECTIONS; HIV	Background Trichomoniasis is the most prevalent non-viral sexually transmitted disease (STD) in the world; however, it remains a neglected parasitic disease. This study aimed to determine the prevalence of trichomoniasis and its associated epidemiological factors among women treated at a hospital in southern Brazil. Methodology/Principal findings A cross-sectional study was performed to determine the prevalence of this infection in women treated at Hospital Universitario (HU) in Rio Grande, Rio Grande do Sul, Brazil, between January 2012 and January 2015. This study consisted a self-administered questionnaire regarding demographic, clinical, and behavioural data and a molecular diagnosis with polymerase chain reaction (PCR) using the TVK3/7 primer set, which was confirmed with sequence analysis. Of the 345 women surveyed, the overall prevalence of Trichomonas vaginalis (T. vaginalis) was 4.1% (14/345). The prevalence rates were 5.9% among pregnant women, 8.5% among HIV-positive women, and 10.1% among HIV-positive pregnant women. The rates for groups with other significant demographic and clinical features were as follows: 6.6% among women with white skin, 12.3% among women with an income below the minimum monthly wage, 7.4% among women with a vaginal pH greater than or equal to 4.6, and 7.9% among women with a comorbid STD. The multivariate analysis confirmed that pregnant women who were HIV-positive (p = 0.001) and had low incomes (p = 0.026) were the most likely to have this infection. Conclusions A multivariate analysis confirmed that HIV-positive pregnant women with low incomes were the participants most likely to have trichomoniasis. These results are important because this Brazilian region presents a high prevalence of HIV-1 subtype C, which is associated with greater transmissibility. Additionally, low family income reveals a socioeconomic fragility that might favour the transmission of this STD.	[dos Anjos Gatti, Fabiane Aguiar; Ceolan, Etienne; Rodrigues Greco, Fernando Salles; Santos, Paula Costa; Klafke, Gabriel Baracy; Scaini, Carlos James] Fed Univ Rio Grande, Sch Med, Parasitol Lab, Porto Alegre, RS, Brazil; [de Oliveira, Gisele Rodrigues; Von Groll, Andrea; Barral de Martinez, Ana Maria] Fed Univ Rio Grande, Sch Med, Mol Biol Lab, Porto Alegre, RS, Brazil; [Goncalves, Carla Vitola] Fed Univ Rio Grande, Obstet & Gynaecol Ctr, Univ Hosp, Porto Alegre, RS, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul	Gatti, FAD (corresponding author), Fed Univ Rio Grande, Sch Med, Parasitol Lab, Porto Alegre, RS, Brazil.	fafagatti@gmail.com	Santos, Paula/P-2969-2017	Santos, Paula/0000-0002-8599-4176; Baracy Klafke, Gabriel/0000-0002-1397-4926				[Anonymous], 2011, PREVALENCE INCIDENCE; Benzaken AS, 2004, DST J BRAS DOENCAS S, V16, P15; Benzaken AS, 2002, J BRAS DOENCAS SEX T, V14, P9; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; CDC, 2010, SEX TRANSM DIS TREAT; Chesson HW, 2004, SEX TRANSM DIS, V31, P547, DOI 10.1097/01.olq.0000137900.63660.98; Crucitti T, 2003, SEX TRANSM INFECT, V79, P393, DOI 10.1136/sti.79.5.393; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; Martínez Ana Maria Barral de, 2002, Rev. Soc. Bras. Med. Trop., V35, P471, DOI 10.1590/S0037-86822002000500008; Silva LCF, 2013, BRAZ J INFECT DIS, V17, P701, DOI 10.1016/j.bjid.2013.03.006; Grama DF, 2013, T ROY SOC TROP MED H, V107, P584, DOI 10.1093/trstmh/trt063; Harrington KF, 2001, SEX TRANSM DIS, V28, P468, DOI 10.1097/00007435-200108000-00009; Helms DJ, SEX, P484; Hogniberg BM, 1994, PARASITIC PROTOZOA, V9, P1; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; KENGNE P, 1994, CELL MOL BIOL, V40, P819; Kissinger P, 2013, SEX TRANSM INFECT, V89, P426, DOI 10.1136/sextrans-2012-051005; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; Lobo TT, 2003, SEX TRANSM DIS, V30, P694, DOI 10.1097/01.OLQ.0000079525.04451.05; Luppi Carla Gianna, 2011, Rev. bras. epidemiol., V14, P467, DOI 10.1590/S1415-790X2011000300011; Lusk MJ, 2010, SEX TRANSM INFECT, V86, P227, DOI 10.1136/sti.2009.039362; Maciel GP, 2004, J BRAS PATOL MED LAB, V40, P153; Martins TA, 2004, J BRAS DOENCA SEX TR, V16, P50; Mascarenhas Rita Elizabeth Moreira, 2012, Infect Dis Obstet Gynecol, V2012, P378640, DOI 10.1155/2012/378640; Michel RV, 2006, REV BRAS ANAL CLIN, V38, P127; Miller WC, 2005, SEX TRANSM DIS, V32, P593, DOI 10.1097/01.olq.0000179874.76360.ad; Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001; Miranda AE, 2014, BRAZ J INFECT DIS, V18, P669, DOI 10.1016/j.bjid.2014.07.002; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Oliveira FA, 2007, MEM I OSWALDO CRUZ, V102, P751, DOI 10.1590/S0074-02762007000600015; Pastorek JG, 1996, CLIN INFECT DIS, V23, P1075, DOI 10.1093/clinids/23.5.1075; Pavletic Adriana J, 2004, Infect Dis Obstet Gynecol, V12, P63, DOI 10.1080/10647440400009839; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Rogers SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090548; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Salawu Oyetunde Timothy, 2016, J Reprod Infertil, V17, P61; Silva Filho Amadeu Ramos da, 2004, Rev. Bras. Ginecol. Obstet., V26, P509, DOI 10.1590/S0100-72032004000700002; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares VD, 2003, TROP MED INT HEALTH, V8, P595, DOI 10.1046/j.1365-3156.2003.01078.x; SOBEL JD, 1990, BRIT J CLIN PRACT, V44, P65; Sorvillo F, 1998, AM J TROP MED HYG, V58, P495, DOI 10.4269/ajtmh.1998.58.495	43	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173604	10.1371/journal.pone.0173604	http://dx.doi.org/10.1371/journal.pone.0173604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346531	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300010
J	Ma, SJ; Yang, JS; Song, C; Ge, ZJ; Zhou, J; Zhang, GX; Hu, ZB				Ma, Shijie; Yang, Jianshui; Song, Ci; Ge, Zijun; Zhou, Jing; Zhang, Guoxin; Hu, Zhibin			Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma	PLOS ONE			English	Article							CURRENT MANAGEMENT; SURVIVAL; DISEASE; TISSUES; SYSTEM; FUTURE; CANCER; CELLS	Paired-box family member PAX8 encodes a transcription factor that has a role in cell differentiation and cell growth and may participate in the prognosis of hepatocellular carcinoma (HCC). By bioinformatics analysis, we identified several single nucleotide polymorphisms (SNPs) within a newly identified long non-coding RNA (IncRNA) AC016683.6 as expression quantitative trait loci (eQTLs) for PAX8. Hence, we hypothesized that PAX8eQTLs in IncRNA AC016683.6 may influence the HCC prognosis. We then performed a case-only study to assess the association between the two SNPs as well as the prognosis of HCC in 331 HBV-positive HCC patients without surgical treatment. Cox proportional hazard models were used for survival analysis with adjustments for the age, gender, smoking status, drinking status, Barcelona-Clinic Liver Cancer (BCLC) stage, and chemotherapy or TACE (transcatheter hepatic arterial chemoembolization) status. We found that the G allele of rs1110839 and the T allele of rs4848320 in PAX8Was significantly associated with a better prognosis compared with the T allele of rs1110839 and the C allele of rs4848320 (adjusted HR = 0.74, 95% CI = 0.61-0.91, P= 0.004 for rs1110839 and adjusted HR = 0.71, 95% CI = 0.54-0.94, P= 0.015 for rs4848320 in the additive model). Furthermore, the combined effect of the variant genotypes for these two SNPs was more prominent in patients with the BCLC-C stage orpatients with chemotherapy or TACE. Although the exact biological function remains to be explored, our findings suggest a possible association of PAX8eQTLs in IncRNA AC016683.6 with the HCC prognosis inthe Chinese population. Further large and functional studies are needed to confirm our findings.	[Ma, Shijie] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Ma, Shijie; Yang, Jianshui; Song, Ci; Ge, Zijun; Zhou, Jing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Ma, Shijie; Yang, Jianshui; Song, Ci; Ge, Zijun; Zhou, Jing; Hu, Zhibin] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Hu, ZB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.; Hu, ZB (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China.; Zhang, GX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	guoxinz@njmu.edu.cn; zhibin_hu@njmu.edu.cn						Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Becker N, 2014, THYROID, V24, P319, DOI 10.1089/thy.2013.0117; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Cheung TT, 2010, WORLD J GASTROENTERO, V16, P3056, DOI 10.3748/wjg.v16.i24.3056; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Filippone MG, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-21; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Rodriguez RG, 2012, REV ESP ENFERM DIG, V104, P298, DOI 10.4321/s1130-01082012000600003; Hoist BD, 1994, J BIOL CHEM, V269, P22245; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Kos FJ, 2002, IMMUNOL CELL BIOL, V80, P364, DOI 10.1046/j.1440-1711.2002.01098.x; KOWITZ A, 1992, EUR J IMMUNOL, V22, P1199, DOI 10.1002/eji.1830220514; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Merion RM, 2010, SEMIN LIVER DIS, V30, P411, DOI 10.1055/s-0030-1267541; Mhawech-Fauceglia P, 2012, BRIT J CANCER, V107, P370, DOI 10.1038/bjc.2012.241; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nonaka D, 2008, AM J SURG PATHOL, V32, P1566, DOI 10.1097/PAS.0b013e31816d71ad; Ozcan A, 2011, MODERN PATHOL, V24, P751, DOI 10.1038/modpathol.2011.3; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Tong GX, 2008, AM J SURG PATHOL, V32, P1380, DOI 10.1097/PAS.0b013e31816b1020; Tong GX, 2009, MODERN PATHOL, V22, P1218, DOI 10.1038/modpathol.2009.88; Wen J, 2015, MOL CARCINOGEN, V54, P1275, DOI 10.1002/mc.22200; Xie KP, 2013, CANCER EPIDEMIOL, V37, P998, DOI 10.1016/j.canep.2013.09.005; Yin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132352	26	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173700	10.1371/journal.pone.0173700	http://dx.doi.org/10.1371/journal.pone.0173700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339471	Green Submitted, gold, Green Published			2022-12-27	WOS:000399116700008
J	Tsai, HT; Hsieh, MJ; Lin, CW; Su, SC; Miao, NF; Yang, SF; Huang, HC; Lai, FC; Liu, YF				Tsai, Hsiu-Ting; Hsieh, Ming-Ju; Lin, Chiao-Wen; Su, Shih-Chi; Miao, Nae-Fang; Yang, Shun-Fa; Huang, Hui-Chuan; Lai, Fu-Chih; Liu, Yu-Fan			Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks	PLOS ONE			English	Article							MASPIN EXPRESSION; SUSCEPTIBILITY; METASTASIS; SENESCENCE; SUPPRESSOR	Background We identified rs17071138 T/C, rs3744941 C/T, and rs8089104 T/C gene polymorphisms of SERPINB5 (mammary serine protease inhibitor) that are specific to patients with oral cancer susceptibility and their clinicopathological status. Methodology/Principal findings In total, 1342 participants, including 601 healthy controls and 741 patients with oral cancer, were recruited for this study. Allelic discrimination of rs17071138 T/C, rs3744941 C/T, and rs8089104 T/C of the SERPINB5 gene was assessed by a real-time PCR with a TaqMan assay. We found that individuals carrying the polymorphic rs17071138 and rs8089104 are more susceptible to oral cancer (OR, 1.57; 95% CI, 1.07-2.31 and OR, 1.58; 95% CI, 1.04-2.39, respectively). Among oral cancer-related risk factor exposures, the individuals carrying the polymorphic rs17071138 had 4.26-(95% CI: 1.65-11.01; p=0.002), 2.34(95% CI: 1.19-4.61; p = 0.01), and 2.34-fold (95% CI: 1.38-3.96; p = 0.001) higher risks of developing oral cancer. Conclusions Heterozygous TC of the SERPINB5 rs17071138 polymorphism may be a factor that increases susceptibility to oral cancer. Interactions of gene-to-gene and gene-to-oral cancer -related environmental risk factors have a synergetic effect that can further enhance oral cancer development.	[Tsai, Hsiu-Ting; Miao, Nae-Fang; Huang, Hui-Chuan; Lai, Fu-Chih] Taipei Med Univ, Coll Nursing, Accelerated Bachelor Sci Nursing, Taipei, Taiwan; [Tsai, Hsiu-Ting] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Hsieh, Ming-Ju; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Su, Shih-Chi] Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Keelung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ, Coll Med Sci & Technol, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ Hosp, Dept Pediat, Div Allergy, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Chung Shan Medical University; Changhua Christian Hospital; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, YF (corresponding author), Chung Shan Med Univ, Coll Med Sci & Technol, Dept Biomed Sci, Taichung, Taiwan.; Liu, YF (corresponding author), Chung Shan Med Univ Hosp, Dept Pediat, Div Allergy, Taichung, Taiwan.	yfliu@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234; Tsai, Hsiu Ting/0000-0003-1137-9274	Ministry of Science and Technology, Taiwan (MOST) [102-2314-B-040-002, 103-2314-6-040-005-MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from Ministry of Science and Technology, Taiwan (MOST 102-2314-B-040-002) & (MOST 103-2314-6-040-005-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Al-Mamun MA, 2016, J THEOR BIOL, V388, P37, DOI 10.1016/j.jtbi.2015.10.007; Lopes CFB, 2012, ARCH ORAL BIOL, V57, P1026, DOI 10.1016/j.archoralbio.2012.05.006; Bascones-Martinez A, 2012, ONCOL LETT, V3, P1319, DOI 10.3892/ol.2012.649; Campo-Trapero J, 2008, ACTA ONCOL, V47, P1464, DOI 10.1080/02841860802183612; Chen MK, 2009, ORAL ONCOL, V45, pE222, DOI 10.1016/j.oraloncology.2009.07.015; Department of Health, 2012, HEALTH STATISTICS II; Gupta B, 2013, INT DENT J, V63, P12, DOI 10.1111/j.1875-595x.2012.00131.x; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; Jang HL, 2008, INT J MOL MED, V22, P333, DOI 10.3892/ijmm_00000027; Kim M, 2012, CARCINOGENESIS, V33, P2344, DOI 10.1093/carcin/bgs280; Loyha K, 2012, ASIAN PAC J CANCER P, V13, P5087, DOI 10.7314/APJCP.2012.13.10.5087; Meng H, 2015, TUMOR BIOL, V36, P6231, DOI 10.1007/s13277-015-3308-3; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Murakami J, 2004, ORAL ONCOL, V40, P597, DOI 10.1016/j.oraloncology.2003.12.008; Ramot Y, 2012, TOXICOL PATHOL, V40, P40, DOI 10.1177/0192623311424169; Ray Jay Gopal, 2013, J Oral Maxillofac Pathol, V17, P45, DOI 10.4103/0973-029X.110720; Schwartz J, 2012, J ORAL MAXIL SURG, V70, P1867, DOI 10.1016/j.joms.2011.08.005; Semenzati GD, 2012, INHAL TOXICOL, V24, P723, DOI 10.3109/08958378.2012.715317; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Teng YH, 2009, HEAD NECK-J SCI SPEC, V31, P1282, DOI 10.1002/hed.21094; Tsai HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083572; Wang CC, 2011, J ORAL PATHOL MED, V40, P769, DOI 10.1111/j.1600-0714.2011.01043.x; Xia WY, 2000, ONCOGENE, V19, P2398, DOI 10.1038/sj.onc.1203535; Yang SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26605; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yasumatsu R, 2001, HEAD NECK-J SCI SPEC, V23, P962, DOI 10.1002/hed.1139; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x	30	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0163369	10.1371/journal.pone.0163369	http://dx.doi.org/10.1371/journal.pone.0163369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339463	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700001
J	Heil, A; Gonzalez, EL; Hilgenfeld, T; Kickingereder, P; Bendszus, M; Heiland, S; Ozga, AK; Sommer, A; Lux, CJ; Zingler, S				Heil, Alexander; Gonzalez, Eduardo Lazo; Hilgenfeld, Tim; Kickingereder, Philipp; Bendszus, Martin; Heiland, Sabine; Ozga, Ann-Kathrin; Sommer, Andreas; Lux, Christopher J.; Zingler, Sebastian			Lateral cephalometric analysis for treatment planning in orthodontics based on MRI compared with radiographs: A feasibility study in children and adolescents	PLOS ONE			English	Article							HEAD FILM MEASUREMENTS; COMPUTED-TOMOGRAPHY; RELIABILITY; ACCURACY; CT; CEPHALOGRAMS; EQUIVALENCE; IMAGES; LENGTH; COIL	Objective The objective of this prospective study was to evaluate whether magnetic resonance imaging (MRI) is equivalent to lateral cephalometric radiographs (LCR, "gold standard") in cephalometric analysis. Methods The applied MRI technique was optimized for short scanning time, high resolution, high contrast and geometric accuracy. Prior to orthodontic treatment, 20 patients (mean age +/- SD, 13.95 years +/- 5.34) received MRI and LCR. MRI datasets were postprocessed into lateral cephalograms. Cephalometric analysis was performed twice by two independent observers for both modalities with an interval of 4 weeks. Eight bilateral and 10 midsagittal landmarks were identified, and 24 widely used measurements (14 angles, 10 distances) were calculated. Statistical analysis was performed by using intraclass correlation coefficient (ICC), Bland-Altman analysis and two one-sided tests (TOST) within the predefined equivalence margin of +/- 2 degrees/mm. Results Geometric accuracy of the MRI technique was confirmed by phantom measurements. Mean intraobserver ICC were 0.977/0.975 for MRI and 0.975/0.961 for LCR. Average interobserver ICC were 0.980 for MRI and 0.929 for LCR. Bland-Altman analysis showed high levels of agreement between the two modalities, bias range (mean +/- SD) was -0.66 to 0.61 mm (0.06 +/- 0.44) for distances and -1.33 to 1.14 degrees (0.06 +/- 0.71) for angles. Except for the interincisal angle (p = 0.17) all measurements were statistically equivalent (p < 0.05). Conclusions This study demonstrates feasibility of orthodontic treatment planning without radiation exposure based on MRI. High-resolution isotropic MRI datasets can be transformed into lateral cephalograms allowing reliable measurements as applied in orthodontic routine with high concordance to the corresponding measurements on LCR.	[Heil, Alexander; Gonzalez, Eduardo Lazo; Hilgenfeld, Tim; Kickingereder, Philipp; Bendszus, Martin] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Heiland, Sabine] Univ Heidelberg Hosp, Div Expt Radiol, Dept Neuroradiol, Heidelberg, Germany; [Ozga, Ann-Kathrin] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Sommer, Andreas; Lux, Christopher J.; Zingler, Sebastian] Univ Heidelberg Hosp, Dept Orthodont & Dentofacial Orthopaed, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Heil, A (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	alexander.heil@med.uni-heidelberg.de	Vollmuth, Philipp/AAK-3267-2021	Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Hilgenfeld, Tim/0000-0002-3458-8899; Ozga, Ann-Kathrin/0000-0002-9501-7301; Juerchott, Alexander/0000-0003-0556-908X	Dietmar Hopp Foundation; Dietmar Hopp foundation [23011228]; postdoctoral fellowship of the University of Heidelberg	Dietmar Hopp Foundation; Dietmar Hopp foundation; postdoctoral fellowship of the University of Heidelberg	AH, SH, CJL and SZ receive a research grant from the Dietmar Hopp foundation (grant number: 23011228; littplidetmar-hopp-stiftung.de/). PK is supported by a postdoctoral fellowship of the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AH, SZ, SH and CJL wish to acknowledge the support by the Dietmar Hopp Foundation. Furthermore, the authors kindly thank NORAS MRI products GmbH (Hochberg, Germany) for providing the 16-channel multipurpose coil.	AHLQVIST J, 1986, EUR J ORTHODONT, V8, P141, DOI 10.1093/ejo/8.3.141; Ahn S, 2013, RADIOLOGY, V267, P328, DOI 10.1148/radiol.12120725; American Academy of Pediatric Dentistry, 2012, PEDIAT DENT, V34, P189; American Association of Orthodontist, 2014, CLIN PRACT GUID ORTH; American Dental Association Council on Scientific Affairs, 2012, DENT RADIOGRAPHIC EX; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P111, DOI 10.1016/0002-9416(71)90028-5; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P505, DOI 10.1016/0002-9416(71)90116-3; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; British Orthodontic Society, 2015, GUID US RAD CLIN ORT; Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI [10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2]; Cattaneo PM, 2008, AM J ORTHOD DENTOFAC, V134, P798, DOI 10.1016/j.ajodo.2008.07.008; Claus EB, 2012, CANCER-AM CANCER SOC, V118, P4530, DOI 10.1002/cncr.26625; Eggers G, 2008, BRIT J ORAL MAX SURG, V46, P639, DOI 10.1016/j.bjoms.2008.03.019; Flugge T, 2016, EUR RADIOL, V26, P4616, DOI 10.1007/s00330-016-4254-1; Gaudino C, 2011, EUR RADIOL, V21, P2575, DOI 10.1007/s00330-011-2209-0; Goto TK, 2007, ORAL SURG ORAL MED O, V103, P550, DOI 10.1016/j.tripleo.2006.03.011; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hovener JB, 2012, J MAGN RESON IMAGING, V36, P841, DOI 10.1002/jmri.23712; JACOBSON A, 1975, AM J ORTHOD DENTOFAC, V67, P125, DOI 10.1016/0002-9416(75)90065-2; Kumar V, 2008, ANGLE ORTHOD, V78, P873, DOI 10.2319/082907-399.1; Ludwig U, 2016, SCI REP-UK, V6, DOI 10.1038/srep23301; Markic G, 2015, EUR J ORTHODONT, V37, P13, DOI 10.1093/ejo/cju008; MOYERS RE, 1979, AM J ORTHOD DENTOFAC, V75, P599, DOI 10.1016/0002-9416(79)90093-9; Nalcaci R, 2010, DENTOMAXILLOFAC RAD, V39, P100, DOI 10.1259/dmfr/82724776; Periago DR, 2008, ANGLE ORTHOD, V78, P387, DOI 10.2319/122106-52.1; Pittayapat P, 2014, ORTHOD CRANIOFAC RES, V17, P69, DOI 10.1111/ocr.12034; Plooij JM, 2011, INT J ORAL MAX SURG, V40, P341, DOI 10.1016/j.ijom.2010.10.013; Prager M, 2015, J CRANIO MAXILL SURG, V43, P2175, DOI 10.1016/j.jcms.2015.10.011; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Sedlacik J, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20150177; STABRUN AE, 1982, EUR J ORTHODONT, V4, P185, DOI 10.1093/ejo/4.3.185; Steiner CC, 1959, ANGLE ORTHOD, V29, P8; The American College of Radiology, 2005, PHANT TEST GUID ACR; The European Board of Orthodontists, 2005, ILL GUID PREP EX	35	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174524	10.1371/journal.pone.0174524	http://dx.doi.org/10.1371/journal.pone.0174524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334054	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200108
J	Mieremet, A; Rietveld, M; Absalah, S; van Smeden, J; Bouwstra, JA; El Ghalbzouri, A				Mieremet, Arnout; Rietveld, Marion; Absalah, Samira; van Smeden, Jeroen; Bouwstra, Joke A.; El Ghalbzouri, Abdoelwaheb			Improved epidermal barrier formation in human skin models by chitosan modulated dermal matrices	PLOS ONE			English	Article							HUMAN STRATUM-CORNEUM; TRANSEPIDERMAL WATER-LOSS; ATOPIC ECZEMA PATIENTS; PROPERTIES IN-VITRO; LIPID-COMPOSITION; EPIDERMOLYSIS-BULLOSA; GENE LAMC2; FIBROBLASTS; DERMATITIS; DIFFERENTIATION	Full thickness human skin models (FTMs) contain an epidermal and a dermal equivalent. The latter is composed of a collagen dermal matrix which harbours fibroblasts. Current epidermal barrier properties of FTMs do not fully resemble that of native human skin (NHS), which makes these human skin models less suitable for barrier related studies. To further enhance the resemblance of NHS for epidermal morphogenesis and barrier formation, we modulated the collagen dermal matrix with the biocompatible polymer chitosan. Herein, we report that these collagen-chitosan FTMs (CC-FTMs) possess a well-organized epidermis and maintain both the early and late differentiation programs as in FTMs. Distinctively, the epidermal cell activation is reduced in CC-FTMs to levels observed in NHS. Dermal-epidermal interactions are functional in both FTM types, based on the formation of the basement membrane. Evaluation of the barrier structure by the organization of the extracellular lipid matrix of the stratum corneum revealed an elongated repeat distance of the long periodicity phase. The ceramide composition exhibited a higher resemblance of the NHS, based on the carbon chain-length distribution and subclass profile. The inside-out barrier functionality indicated by the transepidermal water loss is significantly improved in the CC-FTMs. The expression of epidermal barrier lipid processing enzymes is marginally affected, although more restricted to a single granular layer. The novel CC-FTM resembles the NHS more closely, which makes them a promising tool for epidermal barrier related studies.	[Mieremet, Arnout; Rietveld, Marion; El Ghalbzouri, Abdoelwaheb] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Absalah, Samira; van Smeden, Jeroen; Bouwstra, Joke A.] Leiden Univ, Div Drug Delivery Technol, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Mieremet, A (corresponding author), Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands.	a.mieremet@lumc.nl		van Smeden, Jeroen/0000-0002-2728-2832; Mieremet, Arnout/0000-0002-8330-7491; Absalah, Samira/0000-0002-8726-2542	Dutch Technology Foundation STW [13151]; Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs	This research was financially supported by Dutch Technology Foundation STW (grant no. 13151), which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5; BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8; Boehnke K, 2007, EUR J CELL BIOL, V86, P731, DOI 10.1016/j.ejcb.2006.12.005; Boelsma E, 2000, ACTA DERM-VENEREOL, V80, P82; Boiten W, 2016, BIOCH BIOPHYSICA ACT; Bouwstra JA, 2003, J INVEST DERMATOL, V120, P750, DOI 10.1046/j.1523-1747.2003.12128.x; BOUWSTRA JA, 1991, J INVEST DERMATOL, V97, P1005, DOI 10.1111/1523-1747.ep12492217; Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6; Damien F, 2010, J INVEST DERMATOL, V130, P611, DOI 10.1038/jid.2009.272; Dos Santos M, 2015, MATRIX BIOL, V47, P85, DOI 10.1016/j.matbio.2015.03.009; El Ghalbzouri A, 2008, TOXICOL IN VITRO, V22, P1311, DOI 10.1016/j.tiv.2008.03.012; El Ghalbzouri A, 2005, J INVEST DERMATOL, V124, P79, DOI 10.1111/j.0022-202X.2004.23549.x; El Ghalbzouri A, 2009, BIOMATERIALS, V30, P71, DOI 10.1016/j.biomaterials.2008.09.002; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Elkeeb R, 2010, SKIN RES TECHNOL, V16, P9, DOI 10.1111/j.1600-0846.2009.00406.x; Fluhr JW, 2006, EXP DERMATOL, V15, P483, DOI 10.1111/j.1600-0625.2006.00437.x; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Groen D, 2011, BBA-BIOMEMBRANES, V1808, P1529, DOI 10.1016/j.bbamem.2010.10.015; Haisma EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082800; Ishikawa J, 2010, J INVEST DERMATOL, V130, P2511, DOI 10.1038/jid.2010.161; Janssens M, 2012, J LIPID RES, V53, P2755, DOI 10.1194/jlr.P030338; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080; Masukawa Y, 2009, J LIPID RES, V50, P1708, DOI 10.1194/jlr.D800055-JLR200; MOTTA S, 1993, BIOCHIM BIOPHYS ACTA, V1182, P147, DOI 10.1016/0925-4439(93)90135-N; Netzlaff F, 2007, EUR J PHARM BIOPHARM, V66, P127, DOI 10.1016/j.ejpb.2006.08.012; Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0; Pappinen S, 2008, BBA-BIOMEMBRANES, V1778, P824, DOI 10.1016/j.bbamem.2007.12.019; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Ponec M, 2002, SKIN PHARMACOL APPL, V15, P4, DOI 10.1159/000066682; Ponec M, 2003, J INVEST DERMATOL, V120, P581, DOI 10.1046/j.1523-1747.2003.12103.x; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; PONEC M, 1988, J LIPID RES, V29, P949; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; Rabionet M, 2014, BBA-MOL CELL BIOL L, V1841, P422, DOI 10.1016/j.bbalip.2013.08.011; Rabionet M, 2013, J LIPID RES, V54, P3312, DOI 10.1194/jlr.M040097; Regnier MP, 1981, FRONT MATRIX BIOL, V9, P4; Rodriguez-Vazquez M, BIOMED; SHAHABEDDIN L, 1990, Skin Pharmacology, V3, P107; Sorrell JM, 2004, J CELL PHYSIOL, V200, P134, DOI 10.1002/jcp.10474; Stark JJ, 2006, J INVEST DERM SYMP P, V11, P93, DOI 10.1038/sj.jidsymp.5650015; Thakoersing VS, 2013, J INVEST DERMATOL, V133, P59, DOI 10.1038/jid.2012.262; Thakoersing VS, 2012, EXP DERMATOL, V21, P865, DOI 10.1111/exd.12031; Thakoersing VS, 2012, TISSUE ENG PART C-ME, V18, P1, DOI [10.1089/ten.tec.2011.0175, 10.1089/ten.TEC.2011.0175]; Uchida Y, 2000, J LIPID RES, V41, P2071; van Drongelen V, 2015, CELL TISSUE RES, V361, P789, DOI 10.1007/s00441-015-2162-3; van Drongelen V, 2014, TISSUE ENG PT A, V20, P3041, DOI [10.1089/ten.tea.2014.0011, 10.1089/ten.TEA.2014.0011]; van Smeden J, 2014, J INVEST DERMATOL, V134, P1238, DOI 10.1038/jid.2013.517; van Smeden J, 2014, EXP DERMATOL, V23, P45, DOI 10.1111/exd.12293; van Smeden J, 2014, BBA-MOL CELL BIOL L, V1841, P70, DOI 10.1016/j.bbalip.2013.10.002; van Smeden J, 2011, J LIPID RES, V52, P1211, DOI 10.1194/jlr.M014456; Yuki T, 2013, J DERMATOL SCI, V69, P148, DOI 10.1016/j.jdermsci.2012.11.595	54	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174478	10.1371/journal.pone.0174478	http://dx.doi.org/10.1371/journal.pone.0174478			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333992	Green Published, gold			2022-12-27	WOS:000399102200102
J	Neoh, KB; Bong, LJ; Muhammad, A; Itoh, M; Kozan, O; Takematsu, Y; Yoshimura, T				Neoh, Kok-Boon; Bong, Lee-Jin; Muhammad, Ahmad; Itoh, Masayuki; Kozan, Osamu; Takematsu, Yoko; Yoshimura, Tsuyoshi			The effect of remnant forest on insect successional response in tropical fire-impacted peatland: A bi-taxa comparison	PLOS ONE			English	Article							OIL PALM PLANTATIONS; RAIN-FOREST; HABITAT FRAGMENTATION; TERMITE ASSEMBLAGES; CONSERVATION VALUE; FUNCTIONAL-GROUPS; SPECIES RICHNESS; AFRICAN SAVANNA; ANT COMMUNITIES; SWAMP FORESTS	Fire has become a common feature in tropical drained peatlands, and it may have detrimental impacts on the overall biodiversity of the forest ecosystem. We investigated the effect of fire on termite and ant assemblages and the importance of remnant forest in restoring species diversity in fire-impacted tropical peat swamp forests. The species loss of both termites and ants was as high as 50% in some fire-impacted peats compared to remnant forests, but in most cases the species richness for termites and ants was statistically equal along the land uses surveyed. However, a pronounced difference in functional group composition of termites was detected. In particular, sites close to remnant forests contained two additional termite feeding groups so that they shared a similar composition structure with remnant forests but were significantly different from sites distant from remnant forests. In general, ants were resilient to fire, and the similarity index showed a high degree of similarity among ant communities in all land uses surveyed. The Shannon diversity index for termites and ants decreased with increasing distance from the remnant forests and level of ecological degradation. Peat vegetation variables and ecological degradation were important in shaping termite and ant communities in the tropical peatlands, but their relative importance was not significant in fire-impacted peats regardless of distance from the remnant forests. This study highlights the importance of remnant forests as a biodiversity repository and natural buffer that can enhance species diversity and recolonization of forest-adapted species.	[Neoh, Kok-Boon] Natl Chung Hsing Univ, Dept Entomol, Taichung, Taiwan; [Bong, Lee-Jin; Yoshimura, Tsuyoshi] Kyoto Univ, Lab Innovat Humanohabitabil, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Muhammad, Ahmad] Riau Univ, Fac Math & Nat Sci, Dept Biol, Pekanbaru, Indonesia; [Itoh, Masayuki; Kozan, Osamu] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan; [Takematsu, Yoko] Yamaguchi Univ, Fac Agr, Yamaguchi, Japan; [Bong, Lee-Jin] Natl Hlth Res Inst, Zhunan, Miaoli County, Taiwan	National Chung Hsing University; Kyoto University; Universitas Riau; Kyoto University; Yamaguchi University; National Health Research Institutes - Taiwan	Neoh, KB (corresponding author), Natl Chung Hsing Univ, Dept Entomol, Taichung, Taiwan.	neohkokboon@nchu.edu.tw	Neoh, Kok-Boon/A-4070-2011; Itoh, Masayuki/V-9221-2019	Neoh, Kok-Boon/0000-0002-8462-6662; Itoh, Masayuki/0000-0002-7070-616X	Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' - Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Institutional Collaboration Feasibility Studies 'Toward the Regeneration of Tropical Peat Land Societies : Establishment of an International Research Network and Proposal of its Future' - Research Institute for Humanity and Nature (RIHN)	Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' - Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Institutional Collaboration Feasibility Studies 'Toward the Regeneration of Tropical Peat Land Societies : Establishment of an International Research Network and Proposal of its Future' - Research Institute for Humanity and Nature (RIHN)	This study was supported by the Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' funded by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), 2011-2016 and Institutional Collaboration Feasibility Studies 'Toward the Regeneration of Tropical Peat Land Societies : Establishment of an International Research Network and Proposal of its Future' funded by Research Institute for Humanity and Nature (RIHN). K-BN was an international research fellow of the Japan Society for the Promotion of Science and L-JB was amission researcher of the Research Institute for Sustainable Humanosphere,Kyoto University.	Anand MO, 2010, BIOL CONSERV, V143, P2363, DOI 10.1016/j.biocon.2010.01.013; Andersen Alan N., 2000, P25; Arnan X, 2006, J BIOGEOGR, V33, P1246, DOI 10.1111/j.1365-2699.2006.01506.x; Avitabile SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140114; Beaudrot L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019777; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Bickel TO, 2006, BIODIVERS CONSERV, V15, P157, DOI 10.1007/s10531-004-4248-1; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bolton B., 1994, IDENTIFICATION GUIDE; Bos MM, 2008, BIOL INVASIONS, V10, P1399, DOI 10.1007/s10530-008-9215-4; Brown William L. Jr, 2000, P45; Bruhl CA, 2010, BIODIVERS CONSERV, V19, P519, DOI 10.1007/s10531-009-9596-4; Bruhl CA, 2003, BIODIVERS CONSERV, V12, P1371, DOI 10.1023/A:1023621609102; Carrera N, 2009, FUNCT ECOL, V23, P637, DOI 10.1111/j.1365-2435.2009.01560.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Costa-Milanez CB, 2015, SOCIOBIOLOGY, V62, P494; COULSON JC, 1985, BIOL CONSERV, V34, P197, DOI 10.1016/0006-3207(85)90093-X; Davies AB, 2012, J APPL ECOL, V49, P422, DOI 10.1111/j.1365-2664.2012.02107.x; Davies RG, 1999, J APPL ECOL, V36, P946, DOI 10.1046/j.1365-2664.1999.00450.x; Del Toro I, 2012, MYRMECOL NEWS, V17, P133; DESOUZA OFF, 1994, J TROP ECOL, V10, P197, DOI 10.1017/S0266467400007847; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Donovan SE, 2001, PEDOBIOLOGIA, V45, P1, DOI 10.1078/0031-4056-00063; Drinan TJ, 2013, BIOL CONSERV, V158, P175, DOI 10.1016/j.biocon.2012.10.001; Floren A, 2005, ECOSYSTEMS, V8, P559, DOI 10.1007/s10021-002-0272-8; Fox-Dobbs K, 2010, ECOLOGY, V91, P1296, DOI 10.1890/09-0653.1; Gathorne-Hardy FJ, 2004, SARAWAK MUS J, P88; Gibb H, 2003, OIKOS, V103, P469, DOI 10.1034/j.1600-0706.2003.12652.x; Gray CL, 2016, BIOL CONSERV, V194, P176, DOI 10.1016/j.biocon.2015.12.017; Hashimoto Y, 2003, INVENTORY COLLECTION, P95; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hoffmann BD, 2003, AUSTRAL ECOL, V28, P444, DOI 10.1046/j.1442-9993.2003.01301.x; Hoffmann BD, 1999, OECOLOGIA, V120, P595, DOI 10.1007/PL00008824; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Hooper ER, 2004, ECOLOGY, V85, P3313, DOI 10.1890/03-0655; Hyodo F, 2011, INSECT SOC, V58, P417, DOI 10.1007/s00040-011-0159-9; Hyodo F, 2015, FUNCT ECOL, V29, P423, DOI 10.1111/1365-2435.12357; Jones DT, 1998, RAFFLES B ZOOL, V46, P79; Jones DT, 2000, J APPL ECOL, V37, P191, DOI 10.1046/j.1365-2664.2000.00464.x; Jones DT, 2002, RAFFLES B ZOOL, V50, P117; Jones DT, 2003, J APPL ECOL, V40, P380, DOI 10.1046/j.1365-2664.2003.00794.x; Joseph GS, 2014, ECOSYSTEMS, V17, P808, DOI 10.1007/s10021-014-9761-9; Joseph GS, 2013, LANDSCAPE ECOL, V28, P1505, DOI 10.1007/s10980-013-9897-6; Joseph GS, 2011, LANDSCAPE ECOL, V26, P439, DOI 10.1007/s10980-011-9572-8; Leal IR, 2012, BIODIVERS CONSERV, V21, P1687, DOI 10.1007/s10531-012-0271-9; Livingston G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078523; Lucey JM, 2014, BIOL CONSERV, V169, P268, DOI 10.1016/j.biocon.2013.11.014; Lucey JM, 2012, BIOTROPICA, V44, P368, DOI 10.1111/j.1744-7429.2011.00824.x; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; MAJER JD, 1984, J APPL ECOL, V21, P355, DOI 10.2307/2403059; Messenger MT, 2005, FLA ENTOMOL, V88, P99, DOI 10.1653/0015-4040(2005)088[0099:NFDRFC]2.0.CO;2; Miettinen J, 2012, FRONT ECOL ENVIRON, V10, P124, DOI 10.1890/100236; Moe SR, 2009, PLANT ECOL, V202, P31, DOI 10.1007/s11258-009-9575-6; Morandin LA, 2007, BASIC APPL ECOL, V8, P117, DOI 10.1016/j.baae.2006.06.003; Moranz RA, 2013, J INSECT CONSERV, V17, P699, DOI 10.1007/s10841-013-9554-z; Neoh KB, 2016, ENVIRON ENTOMOL, V45, P1170, DOI 10.1093/ee/nvw116; Neoh KB, 2015, J INSECT CONSERV, V19, P1129, DOI 10.1007/s10841-015-9828-8; Neoh KB, 2015, ECOL RES, V30, P759, DOI 10.1007/s11284-015-1289-8; Page Susan, 2009, P263, DOI 10.1007/978-3-540-77381-8_9; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; Posa MRC, 2011, BIOSCIENCE, V61, P49, DOI 10.1525/bio.2011.61.1.10; Rein G, 2008, CATENA, V74, P304, DOI 10.1016/j.catena.2008.05.008; Relys V, 2002, J ARACHNOL, V30, P416, DOI 10.1636/0161-8202(2002)030[0416:ADASTI]2.0.CO;2; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Scott AG, 2006, BIOL CONSERV, V127, P420, DOI 10.1016/j.biocon.2005.09.001; Scriven SA, 2016, BIOTROPICA; Sherwood JH, 2013, HYDROL PROCESS, V27, P1866, DOI 10.1002/hyp.9820; Silveira JM, 2013, BIODIVERS CONSERV, V22, P513, DOI 10.1007/s10531-012-0426-8; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Tawatao N, 2014, BIODIVERS CONSERV, V23, P3113, DOI 10.1007/s10531-014-0768-5; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thapa RS, 1997, TERMITES OF SABAH; Tho YP, 1992, TERMITES PENINSULAR, V36; Thompson DK, 2013, WATER RESOUR RES, V49, P3651, DOI 10.1002/wrcr.20278; Vasconcelos HL, 2008, AUSTRAL ECOL, V33, P221, DOI 10.1111/j.1442-9993.2007.01811.x; Vasconcelos HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007762; Watts CH, 2006, RESTOR ECOL, V14, P412, DOI 10.1111/j.1526-100X.2006.00149.x; Wetterer JK, 1999, FLA ENTOMOL, V82, P381, DOI 10.2307/3496865; Wiecek M, 2013, ECOL INDIC, V34, P332, DOI 10.1016/j.ecolind.2013.05.019; Yule CM, 2010, BIODIVERS CONSERV, V19, P393, DOI 10.1007/s10531-008-9510-5; Yulianti N., 2012, GLOBAL ENV RES, V16, P105	81	6	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174388	10.1371/journal.pone.0174388	http://dx.doi.org/10.1371/journal.pone.0174388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334021	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200093
J	Pinchoff, J; Boyer, CB; Mutombo, N; Chowdhuri, RN; Ngo, TD				Pinchoff, Jessie; Boyer, Christopher B.; Mutombo, Namuunda; Chowdhuri, Rachna Nag; Ngo, Thoai D.			Why don't urban youth in Zambia use condoms? The influence of gender and marriage on non-use of male condoms among young adults	PLOS ONE			English	Article							SEXUALITY; ACCESS; RISK	Background Zambia experiences high unmet need for family planning and high rates of HIV, particularly among youth. While male condoms are widely available and 95% of adults have heard of them, self-reported use in the past 12 months is low among young adults (45%). This study describes factors associated with non-use of male condoms among urban young adults in Zambia. Methods A household cross-sectional survey in four urban districts was conducted from November 2015 to January 2016 among sexually active young adults ages 18-24 years. A random walk strategy was implemented in urban areas; eligible, enrolled participants were administered a survey on household characteristics, health access, and knowledge, attitudes and practices related to contraception. Relative risk regression models were built to determine factors associated with the decision to not use a male condom (non-use) at most recent sexual intercourse. Results A total of 2,388 individuals were interviewed; 69% were female, 35% were married, and average lifetime sex partners was 3.45 (SD +/- 6.15). Non-use of male condoms was 59% at most recent sexual intercourse. In a multivariate model, women were more likely to report non-use of a male condom compared with men (aRR = 1.24 [95% CI: 1.11, 1.38]), married individuals were more likely to report non-use compared with unmarried individuals (aRR = 1.59 [1.46, 1.73]), and those residing in the highest poverty wards were more likely to report non-use compared with those in the lowest poverty wards (aRR = 1.31 [1.16, 1.48]). Those with more negative perceptions of male condom use were 6% more likely to report non-use (aRR = 1.06 [1.03, 1.09]). Discussion regarding contraception with a partner decreased non-use 13% (aRR = 0.87 [0.80, 0.95]) and agreement regarding male condom use with a partner decreased non-use 16% (aRR = 0.84 [0.77, 0.91)]). Discussion Non-use of male condoms is high among young, married adults, particularly women, who may be interested in contraception for family planning but remain at risk of STI infection. Effective marketing strategy of dual protection methods to this population is critical.	[Pinchoff, Jessie; Boyer, Christopher B.] Innovat Poverty Act, Res Dept, New Haven, CT 06510 USA; [Mutombo, Namuunda] Soc Family Hlth, Lusaka, Zambia; [Chowdhuri, Rachna Nag] Innovat Poverty Act Zambia, Lusaka, Zambia; [Ngo, Thoai D.] Populat Council, Poverty Gender & Youth Program, One Dag Hammarskjold Plaza, New York, NY USA	Innovations for Poverty Action (IPA); Innovations for Poverty Action (IPA); Population Council	Pinchoff, J (corresponding author), Innovat Poverty Act, Res Dept, New Haven, CT 06510 USA.	jpinchoff@poverty-action.org		Ngo, Thoai/0000-0001-6683-2297	United States Agency for International Development [AIDO AA-A-13-00088]; Society for Family Health in Zambia	United States Agency for International Development(United States Agency for International Development (USAID)); Society for Family Health in Zambia	The This work was supported by United States Agency for International Development (AIDO AA-A-13-00088).; The authors would like to acknowledge Population Services International, specifically Kim Longfield, Noah Taruberekera, and Temple Cooley, and from WomanCare Global, specifically Nora Miller, for their support on this project and critical review of this manuscript. The authors would also like to acknowledge the support from Society for Family Health in Zambia and Innovations for Poverty Action Zambia including Sarah Tembo and Rachel Levenson.	Agha S, 2003, HEALTH POLICY PLANN, V18, P299, DOI 10.1093/heapol/czg036; Agha S, 2001, AM J PUBLIC HEALTH, V91, P307, DOI 10.2105/AJPH.91.2.307; Ali M, 2008, B WHO, V82; [Anonymous], 2009, AIDS EPIDEMIC UPDATE; Bayer AM, 2010, CULT HEALTH SEX, V12, P771, DOI [10.1080/13691058.2010.488299, 10.1080/13691051003728599]; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Benefo KD, 2010, STUD FAMILY PLANN, V41, P19, DOI 10.1111/j.1728-4465.2010.00221.x; Chibwesha C, 2011, INFECT DIS OBSTET GY; Cleland J, ILLUSTRATIVE QUESTIO; CSO, 2010, ZAMB SEX BEH SURV; DIXONMUELLER R, 1993, STUD FAMILY PLANN, V24, P269, DOI 10.2307/2939221; Fuente ADL, 2015, MAPPING SUBNATIONAL; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Institute G, 2010, FACTS INV FAM PLANN; Jones DL, 2009, SAHARA J-J SOC ASP H, V6, P69; Kalolo A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0097-5; Kayeyi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064881; Kilembe W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124548; Lanham M, 2014, J INT AIDS SOC, V17; Magaret AS, 2016, CLIN INFECT DIS, V62, P456, DOI 10.1093/cid/civ908; Ministry of Health aII, 2014, ZAMB DEM HLTH SURV 2; Mtenga SM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32326; Organization UaWH, 2008, 2008 GLOB REP AIDS E; Plummer ML, 2006, STUD FAMILY PLANN, V37, P29, DOI 10.1111/j.1728-4465.2006.00081.x; Rubin D. B., 2004, MULTIPLE IMPUTATION; Sahin-Hodoglugil NN, 2009, SOC SCI MED, V69, P1547, DOI 10.1016/j.socscimed.2009.08.014; Singh S, 2012, ADDING IT COSTS BENE; StataCorp, 2015, STAT STAT SOFTW REL; UNAIDS, 2014, THE GAP REP; UNPF, 2005, PROM EQ GEND EQ REPR; Vijayakumar G, 2006, INT J STD AIDS, V17, P652, DOI 10.1258/095646206780071036; White I. R., 2010, STAT MED; [Zambia] MoHM, 2010, NAT HLTH STRAT PLAN; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2	34	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0172062	10.1371/journal.pone.0172062	http://dx.doi.org/10.1371/journal.pone.0172062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333963	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200005
J	Ceccarelli, F; Sciandrone, M; Perricone, C; Galvan, G; Morelli, F; Vicente, LN; Leccese, I; Massaro, L; Cipriano, E; Spinelli, FR; Alessandri, C; Valesini, G; Conti, F				Ceccarelli, Fulvia; Sciandrone, Marco; Perricone, Carlo; Galvan, Giulio; Morelli, Francesco; Vicente, Luis Nunes; Leccese, Ilaria; Massaro, Laura; Cipriano, Enrica; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido; Conti, Fabrizio			Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; ORGAN DAMAGE; NEPHRITIS; INDEX; CLASSIFICATION; MORTALITY; MEDICINE; OUTCOMES	Objective The increased survival in Systemic Lupus Erythematosus (SLE) patients implies the development of chronic damage, occurring in up to 50% of cases. Its prevention is a major goal in the SLE management. We aimed at predicting chronic damage in a large monocentric SLE cohort by using neural networks. Methods We enrolled 413 SLE patients (M/F 30/383; mean age +/- SD 46.3 +/- 11.9 years; mean disease duration +/- SD 174.6 +/- 112.1 months). Chronic damage was assessed by the SLICC/ACR Damage Index (SDI). We applied Recurrent Neural Networks (RNNs) as a machine-learning model to predict the risk of chronic damage. The clinical data sequences registered for each patient during the follow-up were used for building and testing the RNNs. Results At the first visit in the Lupus Clinic, 35.8% of patients had an SDI >= 1. For the RNN model, two groups of patients were analyzed: patients with SDI = 0 at the baseline, developing damage during the follow-up (N = 38), and patients without damage (SDI = 0). We created a mathematical model with an AUC value of 0.77, able to predict damage development. A threshold value of 0.35 (sensitivity 0.74, specificity 0.76) seemed able to identify patients at risk to develop damage. Conclusion We applied RNNs to identify a prediction model for SLE chronic damage. The use of the longitudinal data from the Sapienza Lupus Cohort, including laboratory and clinical items, resulted able to construct a mathematical model, potentially identifying patients at risk to develop damage.	[Ceccarelli, Fulvia; Perricone, Carlo; Leccese, Ilaria; Massaro, Laura; Cipriano, Enrica; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido; Conti, Fabrizio] Sapienza Univ Roma, Lupus Clin, Rheumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy; [Sciandrone, Marco; Galvan, Giulio; Morelli, Francesco] Univ Florence, Dipartimento Ingn Informaz, Florence, Italy; [Vicente, Luis Nunes] Univ Coimbra, Dept Matemat, Coimbra, Portugal	Sapienza University Rome; University of Florence; Universidade de Coimbra	Alessandri, C (corresponding author), Sapienza Univ Roma, Lupus Clin, Rheumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy.	cristiano.alessandri@uniroma1.it	VICENTE, LIERN/B-6112-2008; Spinelli, Francesca Romana/AAM-7061-2020	VICENTE, LIERN/0000-0001-5883-9640; Spinelli, Francesca Romana/0000-0003-1969-2097; Alessandri, Cristiano/0000-0003-4149-5321; Perricone, Carlo/0000-0003-4771-6981; Vicente, Luis Nunes/0000-0003-1097-6384; Valesini, Guido/0000-0002-7757-8092; Galvan, Giulio/0000-0002-0384-0334				BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Conti F, 2016, LUPUS, V25, P719, DOI 10.1177/0961203315627199; Doria A, 2006, AM J MED, V119, P700, DOI 10.1016/j.amjmed.2005.11.034; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; Gomathi S, 2015, ADVANCED COMPUTING A; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Legge A, 2016, J RHEUMATOL, V43, P1050, DOI 10.3899/jrheum.150985; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P325, DOI 10.1002/gepi.20307; Oates JC, 2005, KIDNEY INT, V68, P2588, DOI 10.1111/j.1523-1755.2005.00730.x; Patel JL, 2007, CURR CLIN PHARMACOL, V2, P217, DOI 10.2174/157488407781668811; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P4021, DOI 10.1002/art.34672; Rahman P, 2001, LUPUS, V10, P93, DOI 10.1191/096120301670679959; Rajimehr R, 2002, LUPUS, V11, P485, DOI 10.1191/0961203302lu226oa; Rivest C, 2000, J RHEUMATOL, V27, P680; Ruiz-Irastorza G, 2004, LUPUS, V13, P900, DOI 10.1191/0961203304lu2030oa; Sheikhtaheri A, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0110-5; Sutton EJ, 2013, SEMIN ARTHRITIS RHEU, V43, P352, DOI 10.1016/j.semarthrit.2013.05.003; Tang HY, 2011, ASAIO J, V57, P300, DOI 10.1097/MAT.0b013e318222db30; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Ward MM, 2006, ARTHRIT RHEUM-ARTHR, V55, P74, DOI 10.1002/art.21695; Wolf BJ, 2016, ARTHRITIS RHEUMATOL, V68, P1955, DOI 10.1002/art.39623; Yaniv G, 2015, AUTOIMMUN REV, V14, P75, DOI 10.1016/j.autrev.2014.10.003; Zou Jinming, 2008, V458, P15	24	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174200	10.1371/journal.pone.0174200	http://dx.doi.org/10.1371/journal.pone.0174200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329014	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700068
J	Cohen, CR; Grossman, D; Onono, M; Blat, C; Newmann, SJ; Burger, RL; Shade, SB; Bett, N; Bukusi, EA				Cohen, Craig R.; Grossman, Daniel; Onono, Maricianah; Blat, Cinthia; Newmann, Sara J.; Burger, Rachel L.; Shade, Starley B.; Bett, Norah; Bukusi, Elizabeth A.			Integration of family planning services into HIV care clinics: Results one year after a cluster randomized controlled trial in Kenya	PLOS ONE			English	Article							TRANSMISSION; WOMEN	Objectives To determine if integration of family planning (FP) and HIV services led to increased use of more effective contraception (i.e. hormonal and permanent methods, and intrauterine devices) and decreased pregnancy rates. Design Cohort analysis following cluster randomized trial, when the Kenya Ministry of Health led integration of the remaining control (delayed integration) sites and oversaw integrated services at the original intervention (early integration) sites. Setting Eighteen health facilities in Kenya. Subjects Women aged 18-45 receiving care: 5682 encounters at baseline, and 11628 encounters during the fourth quarter of year 2. Intervention "One- stop shop" approach to integrating FP and HIV services. Main outcome measures Use of more effective contraceptive methods and incident pregnancy across two years of follow-up. Results Following integration of FP and HIV services at the six delayed integration clinics, use of more effective contraception increased from 31.7% to 44.2% of encounters (+12.5%; Prevalence ratio (PR) = 1.39 (1.19-1.63). Among the twelve early integration sites, the proportion of encounters at which women used more effective contraceptive methods was sustained from the end of the first to the second year of follow-up (37.5% vs. 37.0%). Pregnancy incidence including all 18 integrated sites in year two declined in comparison to the control arm in year one (rate ratio: 0.72; 95% Cl 0.60-0.87). Conclusions Integration of FP services into HIV clinics led to a sustained increase in the use of more effective contraceptives and decrease in pregnancy incidence 24 months following implementation of the integrated service model.	[Cohen, Craig R.; Grossman, Daniel; Blat, Cinthia; Newmann, Sara J.; Burger, Rachel L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Grossman, Daniel] Ibis Reprod Hlth, Oakland, CA USA; [Onono, Maricianah; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Shade, Starley B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bett, Norah] Minist Hlth, Dept Reprod Hlth, Kisumu, Kenya	University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco	Cohen, CR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	craig.cohen@ucsf.edu			Bill & Melinda Gates Foundation [OPPGH5361]; National Center for Advancing Translational Sciences; National Institutes of Health, through UCSF-Clinical Translational Science Institute [KL2TR000143]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health, through UCSF-Clinical Translational Science Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Bill & Melinda Gates Foundation, the study sponsor (Grant ID number: OPPGH5361), had no role in the study design, in the collection, analysis, and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication. Dr. Newmann was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-Clinical Translational Science Institute Grant Number KL2TR000143. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Antelman G, 2015, J FAM PLAN REPROD H, V41, DOI 10.1136/jfprhc-2013-100784; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Duerr A, 2005, LANCET, V366, P261, DOI 10.1016/S0140-6736(05)66917-6; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP; Mak J, 2013, AIDS, V27, pS55, DOI 10.1097/QAD.0000000000000046; Mutiso S M, 2008, East Afr Med J, V85, P171; Newmann Sara J, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe16, DOI 10.1016/j.ijgo.2013.08.001; Newmann SJ, AIDS CARE IN PRESS; Newmann SJ, 2013, AIDS RES TREATMENT, V2013; Patel R, 2014, AIDS PATIENT CARE ST, V28, P418, DOI 10.1089/apc.2014.0046; Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Shade SB, 2013, AIDS, V27, pS87, DOI 10.1097/QAD.0000000000000038; Steinfeld RL, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/861983; Tao AR, 2015, AIDS CARE, V27, P31, DOI 10.1080/09540121.2014.954982; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; UNAIDS, 2014, THE GAP REP, P127; United Nations Population Fund, 2004, GLION CALL ACT FAM P; WHO, 2006, SEX REPR HLTH WOM LI; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098	24	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172992	10.1371/journal.pone.0172992	http://dx.doi.org/10.1371/journal.pone.0172992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328966	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700014
J	Kamo, T; Akazawa, H; Suda, W; Saga-Kamo, A; Shimizu, Y; Yagi, H; Liu, Q; Nomura, S; Naito, AT; Takeda, N; Harada, M; Toko, H; Kumagai, H; Ikeda, Y; Takimoto, E; Suzuki, J; Honda, K; Morita, H; Hattori, M; Komuro, I				Kamo, Takehiro; Akazawa, Hiroshi; Suda, Wataru; Saga-Kamo, Akiko; Shimizu, Yu; Yagi, Hiroki; Liu, Qing; Nomura, Seitaro; Naito, Atsuhiko T.; Takeda, Norifumi; Harada, Mutsuo; Toko, Haruhiro; Kumagai, Hidetoshi; Ikeda, Yuichi; Takimoto, Eiki; Suzuki, Jun-ichi; Honda, Kenya; Morita, Hidetoshi; Hattori, Masahira; Komuro, Issei			Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; MYOCARDIAL-INFARCTION; HEALTH; DIVERSITY; DISEASE; HYPERTENSION; COMMUNITIES; HYPOTHESIS; BACTERIA; ACETATE	Emerging evidence has suggested a potential impact of gut microbiota on the pathophysiology of heart failure (HF). However, it is still unknown whether HF is associated with dysbiosis in gut microbiota. We investigated the composition of gut microbiota in patients with HF to elucidate whether gut microbial dysbiosis is associated with HF. We performed 16S ribosomal RNA gene sequencing of fecal samples obtained from 12 HF patients and 12 age-matched healthy control (HC) subjects, and analyzed the differences in gut microbiota. We further compared the composition of gut microbiota of 12 HF patients younger than 60 years of age with that of 10 HF patients 60 years of age or older. The composition of gut microbial communities of HF patients was distinct from that of HC subjects in both unweighted and weighted UniFrac analyses. Eubacterium rectale and Dorea longicatena were less abundant in the gut microbiota of HF patients than in that of HC subjects. Compared to younger HF patients, older HF patients had diminished proportions of Bacteroidetes and larger quantities of Proteobacteria. The genus Faecalibacterium was depleted, while Lactobacillus was enriched in the gut microbiota of older HF patients. These results suggest that patients with HF harbor significantly altered gut microbiota, which varies further according to age. New concept of heart-gut axis has a great potential for breakthroughs in the development of novel diagnostic and therapeutic approach for HF.	[Kamo, Takehiro; Akazawa, Hiroshi; Saga-Kamo, Akiko; Shimizu, Yu; Yagi, Hiroki; Liu, Qing; Nomura, Seitaro; Naito, Atsuhiko T.; Takeda, Norifumi; Harada, Mutsuo; Toko, Haruhiro; Kumagai, Hidetoshi; Ikeda, Yuichi; Takimoto, Eiki; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Suda, Wataru; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Suda, Wataru; Honda, Kenya] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo, Japan; [Kumagai, Hidetoshi; Suzuki, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Honda, Kenya] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Morita, Hidetoshi] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan	University of Tokyo; University of Tokyo; Keio University; University of Tokyo; RIKEN; Okayama University; Waseda University	Akazawa, H; Komuro, I (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	akazawah-tky@umin.ac.jp; komuro-tky@umin.ac.jp	Takimoto, Eiki/AAC-5100-2021; Hattori, Masahira/AAD-3785-2019; Suda, Wataru/AAF-4469-2019; Yagi, Hiroki/GMX-4161-2022	Yagi, Hiroki/0000-0001-6615-6196; Akazawa, Hiroshi/0000-0002-3574-9607; TAKEDA, NORIFUMI/0000-0003-4818-3347	Japan Society for the Promotion of Science (KAKENHI) [26670395]; Core Research for Evolutionary Medical Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED) [M1501]; Takeda Pharmaceutical Co., Ltd.; Daiichi Sankyo Co., Ltd.; Shionogi Co., Ltd.; Nippon Boehringer Ingelheim Co., Ltd.; Bristol-Myers Squibb K.K.; MSD K.K.; Sanofi K.K.; Sumitomo Dainippon Pharma Co., Ltd.; Grants-in-Aid for Scientific Research [17K08585, 16K15199] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutionary Medical Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd); Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited); Shionogi Co., Ltd.; Nippon Boehringer Ingelheim Co., Ltd.(Boehringer Ingelheim); Bristol-Myers Squibb K.K.(Bristol-Myers Squibb); MSD K.K.(Merck & Company); Sanofi K.K.; Sumitomo Dainippon Pharma Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from Japan Society for the Promotion of Science (KAKENHI 26670395, https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26670395/) to H.A., and Core Research for Evolutionary Medical Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED) (M1501,http://www.amed.go.jp/program/list/01/07/023_02.html) to K.H., H.M. H.A. has received research funding from Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Shionogi & Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Bristol-Myers Squibb K.K., MSD K.K., Sanofi K.K., and Sumitomo Dainippon Pharma Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arora T, 2016, J INTERN MED, V280, P339, DOI 10.1111/joim.12508; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Fischbach MA, 2016, CELL, V164, P1288, DOI 10.1016/j.cell.2016.02.037; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gan XT, 2014, CIRC-HEART FAIL, V7, P491, DOI 10.1161/CIRCHEARTFAILURE.113.000978; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Joice R, 2014, CELL METAB, V20, P731, DOI 10.1016/j.cmet.2014.10.003; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Lazzarini V, 2013, EUR J HEART FAIL, V15, P717, DOI 10.1093/eurjhf/hft028; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Loffredo FS, 2014, CIRC RES, V115, P97, DOI 10.1161/CIRCRESAHA.115.302929; Lopez CA, 2014, CELL HOST MICROBE, V16, P156, DOI 10.1016/j.chom.2014.07.009; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nagatomo Y, 2015, J CARD FAIL, V21, P973, DOI 10.1016/j.cardfail.2015.09.017; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Organ CL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002314; Pasini E, 2016, JACC-HEART FAIL, V4, P220, DOI 10.1016/j.jchf.2015.10.009; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Rogler G, 2014, EUR HEART J, V35, P426, DOI 10.1093/eurheartj/eht271; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Sandek A, 2014, J AM COLL CARDIOL, V64, P1092, DOI 10.1016/j.jacc.2014.06.1179; Santisteban MM, 2016, CIRC RES, V118, P1327, DOI 10.1161/CIRCRESAHA.116.307709; Sundaram V, 2016, CIRCULATION, V133, P1696, DOI 10.1161/CIRCULATIONAHA.115.020894; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Taras D, 2002, INT J SYST EVOL MICR, V52, P423, DOI 10.1099/00207713-52-2-423; Verbrugge FH, 2013, J AM COLL CARDIOL, V62, P485, DOI 10.1016/j.jacc.2013.04.070; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wright EK, 2015, INFLAMM BOWEL DIS, V21, P1219, DOI 10.1097/MIB.0000000000000382; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016	47	114	119	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174099	10.1371/journal.pone.0174099	http://dx.doi.org/10.1371/journal.pone.0174099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328981	Green Submitted, gold, Green Published			2022-12-27	WOS:000399094700051
J	McDougall, CA; Welsh, AB; Gosselin, T; Anderson, WG; Nelson, PA				McDougall, Craig A.; Welsh, Amy B.; Gosselin, Thierry; Anderson, W. Gary; Nelson, Patrick A.			Rethinking the influence of hydroelectric development on gene flow in a long-lived fish, the Lake Sturgeon Acipenser fulvescens	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; HABITAT FRAGMENTATION; PAIRWISE RELATEDNESS; WHITE STURGEON; STOCK IDENTIFICATION; ALLELIC FREQUENCIES; ASSIGNMENT METHODS; RE-IMPLEMENTATION; EFFECTIVE NUMBER; LARGE RIVER	Many hydroelectric dams have been in place for 50 - >100 years, which for most fish species means that enough generations have passed for fragmentation induced divergence to have accumulated. However, for long-lived species such as Lake Sturgeon, Acipenser fulvescens, it should be possible to discriminate between historical population structuring and contemporary gene flow and improve the broader understanding of anthropogenic influence. On the Winnipeg River, Manitoba, two hypotheses were tested: 1) Measureable quantities of former reservoir dwelling Lake Sturgeon now reside downstream of the Slave Falls Generating Station, and 2) genetically differentiated populations of Lake Sturgeon occur upstream and downstream, a result of historical structuring. Genetic methods based on ten microsatellite markers were employed, and simulations were conducted to provide context. With regards to contemporary upstream to downstream contributions, the inclusion of length -at -age data proved informative. Both pairwise relatedness and Bayesian clustering analysis substantiated that fast-growing outliers, apparently entrained after residing in the upstream reservoir for several years, accounted for -15% of the Lake Sturgeon 525-750 mm fork length captured downstream. With regards to historical structuring, upstream and downstream populations were found to be differentiated (FST = 0.011, and 0.013-0.014 when fast-growing outliers were excluded), and heterozygosity metrics were higher for downstream versus upstream juveniles. Historical asymmetric (downstream) gene flow in the vicinity of the generating station was the most logical explanation for the observed genetic structuring. In this section of the Winnipeg River, construction of a major dam does not appear to have fragmented a previously panmictic Lake Sturgeon population, but alterations to habitat may be influencing upstream to downstream contributions in unexpected ways.	[McDougall, Craig A.; Nelson, Patrick A.] North South Consultants Inc, Winnipeg, MB, Canada; [McDougall, Craig A.; Anderson, W. Gary] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Welsh, Amy B.] West Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV USA	University of Manitoba; West Virginia University	McDougall, CA (corresponding author), North South Consultants Inc, Winnipeg, MB, Canada.; McDougall, CA (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	cmcdougall@nscons.ca	Welsh, Amy/CAG-2274-2022	McDougall, Craig/0000-0002-3766-1617; Nelson, Patrick A./0000-0002-7144-5539	Manitoba Hydro; Natural Sciences and Engineering Research Council of Canada [CRDPJ 321520-0]	Manitoba Hydro; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding in support of this research was provided WGA by Manitoba Hydro (http://www.hydro.mb.ca/) and the Natural Sciences and Engineering Research Council of Canada (http//www.nserc-crsng.gc.ca/professors-professeurs/grantssubs/dgigp-psigp_engasp) (grant number CRDPJ 321520-0). The funders had no role in study design, data collection and analysis, decision	Adams WE, 2006, J APPL ICHTHYOL, V22, P97, DOI 10.1111/j.1439-0426.2006.00725.x; ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; Auer NA, 1996, CAN J FISH AQUAT SCI, V53, P152, DOI 10.1139/f95-276; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Barth CC, 2009, J APPL ICHTHYOL, V25, P18, DOI 10.1111/j.1439-0426.2009.01335.x; Barth CC, 2015, CAN J ZOOL, V93, P823, DOI 10.1139/cjz-2015-0058; Barth CC, 2011, T AM FISH SOC, V140, P1629, DOI 10.1080/00028487.2011.641881; Bateman Leonard, 2005, IEEE CANADA REV  WIN, P22; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg Gavin A., 2005, P119, DOI 10.1016/B978-012154351-8/50007-1; Benestan L, 2015, MOL ECOL, V24, P3299, DOI 10.1111/mec.13245; Bergek S, 2010, J FISH BIOL, V76, P1159, DOI 10.1111/j.1095-8649.2010.02565.x; Bruch R. M., 2008, THESIS; Bruch R.M., 2001, FIELD GUIDE IDENTIFI; Bruch RM, 1999, J APPL ICHTHYOL, V15, P142, DOI 10.1111/j.1439-0426.1999.tb00224.x; Bruch RM, 2006, J APPL ICHTHYOL, V22, P116, DOI 10.1111/j.1439-0426.2007.00938.x; Burbrink FT, 2010, MOL ECOL, V19, P5321, DOI 10.1111/j.1365-294X.2010.04861.x; Cadrin S. X., 2014, STOCK IDENTIFICATION; Caroffino DC, 2010, N AM J FISH MANAGE, V30, P295, DOI 10.1577/M09-082.1; CARVALHO GR, 1993, J FISH BIOL, V43, P53, DOI 10.1111/j.1095-8649.1993.tb01179.x; Charlier J, 2011, J FISH BIOL, V79, P2074, DOI 10.1111/j.1095-8649.2011.03124.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Cunningham M, 1998, BIOL CONSERV, V83, P19, DOI 10.1016/S0006-3207(97)00046-3; DeHaan PW, 2006, T AM FISH SOC, V135, P1478, DOI 10.1577/T05-213.1; Denis LG, 1916, WATER POWERS MANITOB; Department of Fisheries and Oceans Canada, 2010, P CENTR ARCT REG SCI; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dumont P, 2011, J APPL ICHTHYOL, V27, P394, DOI 10.1111/j.1439-0426.2011.01718.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eigenbrod F, 2008, LANDSCAPE ECOL, V23, P159, DOI 10.1007/s10980-007-9174-7; EnvironmentCanada, 2015, ONL HYDR ARCH PIN FA; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferguson MM, 1997, ENVIRON BIOL FISH, V48, P299, DOI 10.1023/A:1007367818353; Forsythe PS, 2012, CAN J FISH AQUAT SCI, V69, P60, DOI 10.1139/F2011-132; Fortin R, 1996, CAN J FISH AQUAT SCI, V53, P1150, DOI 10.1139/cjfas-53-5-1150; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; George SS, 2007, J HYDROL, V332, P396, DOI 10.1016/j.jhydrol.2006.07.014; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Hansen BD, 2009, MOL ECOL, V18, P3346, DOI 10.1111/j.1365-294X.2009.04269.x; Hardy L., 1977, GEOG PHYS QUATERN, V31, P261; Harkness W.J.K., 1961, LAKE STURGEON HIST I; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauser L, 2011, MOL ECOL RESOUR, V11, P150, DOI 10.1111/j.1755-0998.2010.02961.x; Haxton TJ, 2008, CAN J FISH AQUAT SCI, V65, P645, DOI 10.1139/F08-005; Haxton TJ, 2016, ENDANGER SPECIES RES, V31, P203, DOI 10.3354/esr00767; Hedgecock D, 2007, MAR BIOL, V150, P1173, DOI 10.1007/s00227-006-0441-y; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Heincke FR, 1898, LOKALFORMEN DIEWANDE, V2; HILBORN R, 1992; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hrenchuk CL, 2011, THESIS; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IHSSEN PE, 1981, CAN J FISH AQUAT SCI, V38, P1838, DOI 10.1139/f81-230; Jager HI, 2001, ENVIRON BIOL FISH, V60, P347, DOI 10.1023/A:1011036127663; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Johnston JT, 1915, WATER RESOURCES; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones OR, 2012, ECOL EVOL, V2, P1048, DOI 10.1002/ece3.237; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Kekkonen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043482; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Leonardi S, 2012, J HERED, V103, P408, DOI 10.1093/jhered/ess004; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Leverington DW, 2002, QUATERNARY RES, V57, P244, DOI 10.1006/qres.2001.2311; Lloyd MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063981; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Lynch M, 1999, GENETICS, V152, P1753; Macdonald, 2010, INFORM RELEVANT RECO; MacKay H. H., 1963, FISHES OF ONTARIO; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Markert JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-149; McBride RS, 2014, STOCK IDENTIFICATION, P77, DOI 10.1016/B978-0-12-397003-9.00005-9; McDermid JL, 2011, J APPL ICHTHYOL, V27, P12, DOI 10.1111/j.1439-0426.2011.01825.x; McDougall CA, 2014, J APPL ICHTHYOL, V30, P1402, DOI 10.1111/jai.12581; McDougall CA, 2014, J APPL ICHTHYOL, V30, P1149, DOI 10.1111/jai.12546; McDougall CA, 2014, N AM J FISH MANAGE, V34, P546, DOI 10.1080/02755947.2014.892547; McDougall CA, 2013, N AM J FISH MANAGE, V33, P1236, DOI 10.1080/02755947.2013.831001; McDougall CA, 2013, T AM FISH SOC, V142, P1508, DOI 10.1080/00028487.2013.815659; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McQuown E, 2003, J GREAT LAKES RES, V29, P3, DOI 10.1016/S0380-1330(03)70411-0; Milligan BG, 2003, GENETICS, V163, P1153; Mona S, 2014, HEREDITY, V112, P291, DOI 10.1038/hdy.2013.105; NEI M, 1978, GENETICS, V89, P583; Nelson RJ, 2012, J APPL ICHTHYOL, V28, P161, DOI 10.1111/j.1439-0426.2011.01930.x; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; O'Grady JJ, 2008, ANIM CONSERV, V11, P442, DOI 10.1111/j.1469-1795.2008.00201.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Peterson DL, 2007, REV FISH BIOL FISHER, V17, P59, DOI 10.1007/s11160-006-9018-6; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piyapong C, 2011, HEREDITY, V106, P749, DOI 10.1038/hdy.2010.115; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reid SM, 2008, CONSERV GENET, V9, P531, DOI 10.1007/s10592-007-9367-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Ritland K, 2000, MOL ECOL, V9, P1195, DOI 10.1046/j.1365-294x.2000.00971.x; Ritland K, 1996, GENET RES; Rosenberg DM, 2000, BIOSCIENCE, V50, P746, DOI 10.1641/0006-3568(2000)050[0746:GSEEOH]2.0.CO;2; Rosenberg DM, 2005, RIVERS N AM, P853; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Roy M, 2011, QUATERNARY SCI REV, V30, P682, DOI 10.1016/j.quascirev.2010.12.008; Schreier AD, 2013, T AM FISH SOC, V142, P1273, DOI 10.1080/00028487.2013.788554; Schueller AM, 2011, CAN J FISH AQUAT SCI, V68, P62, DOI 10.1139/F10-129; Schueller AM, 2010, T AM FISH SOC, V139, P521, DOI 10.1577/T09-035.1; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Secor DH, 2002, AM FISHERIES SOC S, V28, P183; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Smith CT, 2002, J APPL ICHTHYOL, V18, P307, DOI 10.1046/j.1439-0426.2002.00418.x; Smith KM, 2005, N AM J FISH MANAGE, V25, P301, DOI 10.1577/M03-229.1; Song S, 2006, EVOLUTION, V60, P1, DOI 10.1111/j.0014-3820.2006.tb01076.x; Stewart, 2009, HIST HARVESTS LAKE S; Strand AE, 2002, MOL ECOL NOTES, V2, P373, DOI 10.1046/j.1471-8286.2002.00208.x; Sweigart A, 1999, HEREDITY, V83, P625, DOI 10.1038/sj.hdy.6886020; Duong TY, 2013, MOL ECOL, V22, P1282, DOI 10.1111/mec.12167; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Velez-Espino LA, 2009, N AM J FISH MANAGE, V29, P1065, DOI 10.1577/M08-034.1; Verity R, 2016, GENETICS, V203, P1827, DOI 10.1534/genetics.115.180992; Vincent J.S., 1977, GEROGR PHYS QUATERN, V31, P357; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2002, GENETICS, V160, P1203; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEBB PW, 1986, CAN J ZOOL, V64, P2137, DOI 10.1139/z86-328; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WELCOMME RL, 1995, REGUL RIVER, V11, P121, DOI 10.1002/rrr.3450110110; Welsh A, 2006, J APPL ICHTHYOL, V22, P337, DOI 10.1111/j.1439-0426.2006.00814.x; Welsh AB, 2010, CAN J ZOOL, V88, P390, DOI 10.1139/Z10-009; Welsh A, 2008, N AM J FISH MANAGE, V28, P572, DOI 10.1577/M06-184.1; Welsh AB, 2015, ENVIRON BIOL FISH, V98, P755, DOI 10.1007/s10641-014-0309-9; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson CC, 2014, J APPL ICHTHYOL, V30, P1290, DOI 10.1111/jai.12615; Wozney KM, 2011, ENVIRON BIOL FISH, V90, P183, DOI 10.1007/s10641-010-9730-x; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yamamoto S, 2004, CONSERV GENET, V5, P529, DOI 10.1023/B:COGE.0000041029.38961.a0	151	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174269	10.1371/journal.pone.0174269	http://dx.doi.org/10.1371/journal.pone.0174269			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329005	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700077
J	Barbosa, LDNS; Bogdanov, D; Vainikka, P; Breyer, C				Noel Simas Barbosa, Larissa de Souza; Bogdanov, Dmitrii; Vainikka, Pasi; Breyer, Christian			Hydro, wind and solar power as a base for a 100% renewable energy supply for South and Central America	PLOS ONE			English	Article							ELECTRICITY; GENERATION; DESALINATION; PATHWAYS; BIOFUELS; BRAZIL; COST	Power systems for South and Central America based on 100% renewable energy (RE) in the year 2030 were calculated for the first time using an hourly resolved energy model. The region was subdivided into 15 sub-regions. Four different scenarios were considered: three according to different high voltage direct current (HVDC) transmission grid development levels (region, country, area-wide) and one integrated scenario that considers water desalination and industrial gas demand supplied by synthetic natural gas via power-to-gas (PtG). RE is not only able to cover 1813 TWh of estimated electricity demand of the area in 2030 but also able to generate the electricity needed to fulfil 3.9 billion m(3) of water desalination and 640 TWhLHV of synthetic natural gas demand. Existing hydro dams can be used as virtual batteries for solar and wind electricity storage, diminishing the role of storage technologies. The results for total levelized cost of electricity (LCOE) are decreased from 62 sic/MWh for a highly decentralized to 56 sic/MWh for a highly centralized grid scenario (currency value of the year 2015). For the integrated scenario, the levelized cost of gas (LCOG) and the levelized cost of water (LCOW) are 95 sic/MWhLHV and 0.91 sic/m(3), respectively. A reduction of 8% in total cost and 5% in electricity generation was achieved when integrating desalination and power-to-gas into the system.	[Noel Simas Barbosa, Larissa de Souza] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil; [Noel Simas Barbosa, Larissa de Souza; Vainikka, Pasi] VTT Tech Res Ctr Finland Ltd, Lappeenranta, Finland; [Bogdanov, Dmitrii; Breyer, Christian] Lappeenranta Univ Technol, Lappeenranta, Finland	Universidade de Sao Paulo; VTT Technical Research Center Finland; Lappeenranta University of Technology	Breyer, C (corresponding author), Lappeenranta Univ Technol, Lappeenranta, Finland.	Christian.Breyer@lut.fi	Breyer, Christian/W-2106-2018; de Souza Noel Simas Barbosa, Larissa/R-7485-2018	Breyer, Christian/0000-0002-7380-1816; de Souza Noel Simas Barbosa, Larissa/0000-0003-2619-7684; Bogdanov, Dmitrii/0000-0001-7136-4803	Public financing of Tekes (Finnish Funding Agency for Innovation) for the 'NeoCarbon Energy' project [40101/14]; CNPq (Brazil Council for Scientific and Technological Development); VTT Technical Research Centre of Finland Ltd	Public financing of Tekes (Finnish Funding Agency for Innovation) for the 'NeoCarbon Energy' project; CNPq (Brazil Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); VTT Technical Research Centre of Finland Ltd	Public financing of Tekes (Finnish Funding Agency for Innovation) for the 'NeoCarbon Energy' project under the number 40101/14; PhD scoolarship from CNPq (Brazil Council for Scientific and Technological Development). The study was funded by VTT Technical Research Centre of Finland Ltd. The funder provided support in the form of salaries for authors (LSNSB, DB, PV, CB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AAPG, 2015, GLOB HEAT FLOW DAT; Agora Energiewende, 2014, COMP COST LOW CARB T, P10; Agora Energiewende, 2015, CURR FUT COST PHOT L; Al-Nory M, 2014, RENEW ENERG, V72, P377, DOI 10.1016/j.renene.2014.07.032; [Anonymous], 2015, GUARDIAN; Becker S, 2015, ENERGY, V81, P437, DOI 10.1016/j.energy.2014.12.056; BEN, 2014, BARAZ EN BAL; Bertheau P., 2012, 5 INT C INT REN EN D; Bloomberg New Energy Finance, 2015, SUST EN AM 2015 FACT, V144; Bogdanov D, 2016, ENERG CONVERS MANAGE, V112, P176, DOI 10.1016/j.enconman.2016.01.019; Breyer Ch., 2010, 25 EU PVSEC; Breyer Ch., 2016, 22 SOLARPACES; Breyer Ch, 2011, 26 EUR PVSEC; Breyer Ch., 2012, PV BASED MINI GRIDS; Breyer C, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.08KJ01; Breyer C, 2013, PROG PHOTOVOLTAICS, V21, P121, DOI 10.1002/pip.1254; Buonocore JJ, 2016, NAT CLIM CHANGE, V6, P100, DOI [10.1038/NCLIMATE2771, 10.1038/nclimate2771]; Caldera U, 2016, DESALINATION, V385, P207, DOI 10.1016/j.desal.2016.02.004; Carvalho J.F., 2009, ENERG POLICY, V37, P1580, DOI DOI 10.1016/J.ENP0L.2008.12.020; Chamorro CR, 2014, RENEW ENERG, V66, P1, DOI 10.1016/j.renene.2013.11.065; Chamorro CR, 2014, ENERGY, V65, P250, DOI 10.1016/j.energy.2013.11.078; Comite Consultivo de Energia 2050, 2015, HOJ RUT 2050 HAC EN; Connolly D., 2014, INT J SUSTAIN ENERGY, V1, P7, DOI [DOI 10.5278/IJSEPM.2014.1.2, 10.5278/ijsepm.2014.1.2]; Cremonez PA, 2015, RENEW SUST ENERG REV, V43, P352, DOI 10.1016/j.rser.2014.11.064; Soito JLD, 2011, RENEW SUST ENERG REV, V15, P3165, DOI 10.1016/j.rser.2011.04.006; DBFZ, 2009, REG GLOB RAUML VERT; Dii, 2012, DES POW PERSP SUST P; Elliston B, 2014, RENEW ENERG, V66, P196, DOI 10.1016/j.renene.2013.12.010; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; European Commission, 2014, INT REN EN EUR STUD, p[7, 54]; European Commission, 2014, ETRI 2014 EN TECHN R; Faigon M, 2013, INT DES ASS WORLD C; Faiman D., 2009, ENERGY DESERT VERY L; Farfan J, 2017, J CLEAN PROD, V141, P370, DOI 10.1016/j.jclepro.2016.09.068; Fraunhofer ISE, 2022, REN SHAR EN CHARTS; GENI, 2009, REN EN POT LAT AM; Gerlach A., 2014, 29 EU PVSEC; Hart EK, 2011, RENEW ENERG, V36, P2278, DOI 10.1016/j.renene.2011.01.015; Hoffmann W., 2014, EU PVSEC; Huenges E, 2012, GEOTHERMAL ENERGY SY; IASPEI, 2015, IHFC DAT; IEA, 2012, TECHN ROADM BIOEN HE; IEA, 2014, WORLD EN OUTL 2014; IEA, 2015, IEA STAT; IMF, 2015, LARG AR GLOB SUBS; IPCC, 2011, SPEC REP REN EN SOUR; Kissel JM, 2009, ENERG POLICY, V37, P3621, DOI 10.1016/j.enpol.2009.04.018; Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106; Luck M., 2015, AQUEDUCT WATER STRES; MAPS, 2015, COLL DEV COUNTR EST; Martinez SH, 2015, TECHNOL FORECAST SOC, V98, P186, DOI 10.1016/j.techfore.2015.05.006; Mastropietro P, 2014, RENEW SUST ENERG REV, V40, P375, DOI 10.1016/j.rser.2014.07.074; ONS, 2011, EN ARM; Plessmann G, 2014, ENRGY PROCED, V46, P22, DOI 10.1016/j.egypro.2014.01.154; Renewables, 2015, GLOBAL STATUS REPORT; Solomon BD, 2015, ENVIRON MANAGE, V56, P1276, DOI 10.1007/s00267-014-0424-6; Teske Sven, 2015, ENERGY REVOLUTION SU; Toktarova A., 2017, THESIS; Urban W., 2009, ABSCHLUSSBERICHT BMB; Vartiainen E., 2015, 31 EU PVSEC; Water Technology, 2017, AL KHAFJ SOL SAL WAT; World Bank, 2010, M EL SUPPL DEM BAL L	62	86	87	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173820	10.1371/journal.pone.0173820	http://dx.doi.org/10.1371/journal.pone.0173820			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329023	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700030
J	Robertson, DJ; Kramer, RSS; Burton, AM				Robertson, David J.; Kramer, Robin S. S.; Burton, A. Mike			Fraudulent ID using face morphs: Experiments on human and automatic recognition	PLOS ONE			English	Article							CATEGORICAL PERCEPTION; UNFAMILIAR FACES; IMAGES; PHOTOGRAPHS; VIDEO	Matching unfamiliar faces is known to be difficult, and this can give an opportunity to those engaged in identity fraud. Here we examine a relatively new form of fraud, the use of photo-ID containing a graphical morph between two faces. Such a document may look sufficiently like two people to serve as ID for both. We present two experiments with human viewers, and a third with a smartphone face recognition system. In Experiment 1, viewers were asked to match pairs of faces, without being warned that one of the pair could be a morph. They very commonly accepted a morphed face as a match. However, in Experiment 2, following very short training on morph detection, their acceptance rate fell considerably. Nevertheless, there remained large individual differences in people's ability to detect a morph. In Experiment 3 we show that a smartphone makes errors at a similar rate to 'trained' human viewers-i.e. accepting a small number of morphs as genuine ID. We discuss these results in reference to the use of face photos for security.	[Robertson, David J.; Kramer, Robin S. S.; Burton, A. Mike] Univ York, Dept Psychol, York, N Yorkshire, England	University of York - UK	Burton, AM (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	mike.burton@york.ac.uk	Burton, Mike/A-9491-2008; Robertson, David/H-6515-2017	Burton, Mike/0000-0002-2035-2084; Robertson, David/0000-0002-8393-951X; Kramer, Robin/0000-0001-8339-8832	European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant [323262]; Economic and Social Research Council, UK [ES/J022950/1]; ESRC [ES/J022950/2, ES/J022950/1] Funding Source: UKRI; Economic and Social Research Council [ES/J022950/1, ES/J022950/2] Funding Source: researchfish	European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant; Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n.323262, and from the Economic and Social Research Council, UK (ES/J022950/1). http://erc.europa.eu/;http://www.esrc.ac.uk/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, UK NATL FRAUD AUTHOR; [Anonymous], 2015, UK HM PASSPORT OFFIC; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Campanella S, 2001, VIS COGN, V8, P237, DOI 10.1080/13506280042000072; Davis JP, 2009, APPL COGNITIVE PSYCH, V23, P482, DOI 10.1002/acp.1490; Ferrara Matteo, 2016, FACE RECOGNITION IMA, P2, DOI DOI 10.1007/978-3-319-28501-6_9; Ghatol NP, 2013, INT J COMPUT APPL, V66, P23; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Kikutani M, 2008, PSYCHON B REV, V15, P787, DOI 10.3758/PBR.15.4.787; Kikutani M, 2010, PSYCHOL SCI, V21, P865, DOI 10.1177/0956797610371964; McKone E, 2001, J EXP PSYCHOL HUMAN, V27, P573, DOI 10.1037/0096-1523.27.3.573; Megreya AM, 2007, PERCEPT PSYCHOPHYS, V69, P1175, DOI 10.3758/BF03193954; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2013, APPL COGNITIVE PSYCH, V27, P700, DOI 10.1002/acp.2965; Megreya AM, 2008, J EXP PSYCHOL-APPL, V14, P364, DOI 10.1037/a0013464; Robertson DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150036; Robertson DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119460; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510	21	49	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173319	10.1371/journal.pone.0173319	http://dx.doi.org/10.1371/journal.pone.0173319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328928	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700018
J	Hori, D; Dunkerly-Eyring, B; Nomura, Y; Biswas, D; Steppan, J; Henao-Mejia, J; Adachi, H; Santhanam, L; Berkowitz, DE; Steenbergen, C; Flavell, RA; Das, S				Hori, Daijiro; Dunkerly-Eyring, Brittany; Nomura, Yohei; Biswas, Debjit; Steppan, Jochen; Henao-Mejia, Jorge; Adachi, Hideo; Santhanam, Lakshmi; Berkowitz, Dan E.; Steenbergen, Charles; Flavell, Richard A.; Das, Samarjit			miR-181b regulates vascular stiffness age dependently in part by regulating TGF-beta signaling	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; NF-KAPPA-B; AORTIC STIFFNESS; TISSUE TRANSGLUTAMINASE; ENDOTHELIAL FUNCTION; TRABECULAR MESHWORK; MARFAN-SYNDROME; ANGIOTENSIN-II	Background Endothelial dysfunction and arterial stiffening play major roles in cardiovascular diseases. The critical role for the miR-181 family in vascular inflammation has been documented. Here we tested whether the miR-181 family can influence the pathogenesis of hypertension and vascular stiffening. Methods and results qPCR data showed a significant decrease in miR-181b expression in the aorta of the older mice. Eight miR-181a1/b1(-/-) mice and wild types (C57BL6J: WT) were followed weekly for pulse wave velocity (PWV) and blood pressure measurements. After 20 weeks, the mice were tested for endothelial function and aortic modulus. There was a progressive increase in PWV and higher systolic blood pressure in miR-181a1/b1(-/-) mice compared with WTs. At 21 weeks, aortic modulus was significantly greater in the miR-181a1/b1(-/-) group, and serum TGF-beta was found to be elevated at this time. A luciferase reporter assay confirmed miR181b targets TGF-beta i (TGF-beta induced) in the aortic VSMCs. In contrast, wire myography revealed unaltered endothelial function along with higher nitric oxide production in the miR181a1/ b1(-/-) group. Cultured VECs and VSMCs from the mouse aorta showed more secreted TGF-beta in VSMCs of the miR-181a1/b1(-/-) group; whereas, no change was observed from VECs. Circulating levels of angiotensin II were similar in both groups. Treatment with losartan (0.6 g/L) prevented the increase in PWV, blood pressure, and vascular stiffness in miR181a1/ b1(-/-) mice. Immunohistochemistry and western blot for p-SMAD2/3 validated the inhibitory effect of losartan on TGF-beta signaling in miR-181a1/b1(-/-) mice. Conclusions Decreased miR-181b with aging plays a critical role in ECM remodeling by removing the brake on the TGF-beta, pSMAD2/3 pathway.	[Hori, Daijiro; Nomura, Yohei] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Hori, Daijiro; Nomura, Yohei; Steppan, Jochen; Santhanam, Lakshmi; Berkowitz, Dan E.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Hori, Daijiro; Adachi, Hideo] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan; [Dunkerly-Eyring, Brittany; Biswas, Debjit; Steenbergen, Charles; Das, Samarjit] Johns Hopkins Univ, Dept Cardiovasc Pathol, Ross Res Bldg, Baltimore, MD 21218 USA; [Henao-Mejia, Jorge; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Jichi Medical University; Johns Hopkins University; Yale University	Das, S (corresponding author), Johns Hopkins Univ, Dept Cardiovasc Pathol, Ross Res Bldg, Baltimore, MD 21218 USA.	sdas11@jhmi.edu	Hori, Daijiro/ABC-6562-2020	Dunkerly-Eyring, Brittany/0000-0003-4684-5861	NIH [HL39752, HL124213, 14SDG18890049]; Japan Heart Foundation / Bayer Yakuhin Research Grant Abroad	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Heart Foundation / Bayer Yakuhin Research Grant Abroad	This work was supported by grants from the NIH, HL39752 (CS) and NIH, HL124213 (DEB); AHA, 14SDG18890049 (SD); Japan Heart Foundation / Bayer Yakuhin Research Grant Abroad (DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrotis A, 1996, CLIN EXP PHARMACOL P, V23, P363, DOI 10.1111/j.1440-1681.1996.tb02742.x; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13; Carrella S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144129; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Crosas-Molist E, 2015, ARTERIOSCL THROM VAS, V35, P960, DOI 10.1161/ATVBAHA.114.304412; das Neves VJ, 2014, WORLD J CARDIOL, V6, P713, DOI 10.4330/wjc.v6.i8.713; Das S, 2017, J AM HEART IN PRESS; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Fleenor BS, 2010, J PHYSIOL-LONDON, V588, P3971, DOI 10.1113/jphysiol.2010.194753; Fok H, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0569-6; Franklin SS, 1997, CIRCULATION, V96, P308; Gao YZ, 2014, AM J PHYSIOL-HEART C, V307, pH1252, DOI 10.1152/ajpheart.00392.2014; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Guo XM, 2014, AM J PHYSIOL-HEART C, V307, pH880, DOI 10.1152/ajpheart.00265.2014; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Heger J, 2011, J CELL PHYSIOL, V226, P2683, DOI 10.1002/jcp.22619; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jung SM, 2013, AM J PHYSIOL-HEART C, V305, pH803, DOI 10.1152/ajpheart.00103.2013; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Lacolley P, 2009, AM J PHYSIOL-HEART C, V297, pH1567, DOI 10.1152/ajpheart.00622.2009; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lee KS, 2014, BIOCHEM BIOPH RES CO, V448, P101, DOI 10.1016/j.bbrc.2014.04.079; Lin CH, 2014, EXP GERONTOL, V58, P174, DOI 10.1016/j.exger.2014.07.017; Lin JB, 2016, FASEB J, V30, P3216, DOI 10.1096/fj.201500163R; Ling SK, 2013, J MOL CELL CARDIOL, V65, P127, DOI 10.1016/j.yjmcc.2013.10.003; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Neel JC, 2013, CELL SIGNAL, V25, P1556, DOI 10.1016/j.cellsig.2013.03.013; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Pandey D, 2015, J MOL CELLULAR CARDI; Peiro C, 1997, BRIT J PHARMACOL, V121, P1438, DOI 10.1038/sj.bjp.0701261; Rahimi K, 2015, CIRC RES, V116, P925, DOI 10.1161/CIRCRESAHA.116.304723; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddy AK, 2003, AM J PHYSIOL-HEART C, V285, pH1464, DOI 10.1152/ajpheart.00004.2003; Remus EW, 2013, ATHEROSCLEROSIS, V228, P168, DOI 10.1016/j.atherosclerosis.2013.01.037; Saura M, 2002, CIRC RES, V91, P806, DOI 10.1161/01.RES.0000040397.23817.E5; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Sikka G, 2013, ATHEROSCLEROSIS, V231, P91, DOI 10.1016/j.atherosclerosis.2013.08.026; Spinale FG, 2013, CIRC RES, V113, P725, DOI 10.1161/CIRCRESAHA.113.300309; Srinivasan H, 2015, CANADIAN J PHYSL PHA, P1; Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599; Sullivan JC, 2006, CIRC RES, V98, P717, DOI 10.1161/01.RES.0000217594.97174.c2; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wang YX, 2000, AM J PHYSIOL-HEART C, V278, pH428, DOI 10.1152/ajpheart.2000.278.2.H428; Welge-Lussen U, 2000, INVEST OPHTH VIS SCI, V41, P2229; Wilkinson IB, 2001, HYPERTENSION, V38, P1461, DOI 10.1161/hy1201.097723; Williams A, 2013, COLD SH Q B, V78, P223, DOI 10.1101/sqb.2013.78.020024; Wu J, 2014, CIRC RES, V114, P616, DOI 10.1161/CIRCRESAHA.114.302157; Yang RH, 2011, AM J PHYSIOL-HEART C, V300, pH1467, DOI 10.1152/ajpheart.00604.2009; Zhu GS, 2015, HYPERTENSION, V65, P385, DOI 10.1161/HYPERTENSIONAHA.114.04285	61	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174108	10.1371/journal.pone.0174108	http://dx.doi.org/10.1371/journal.pone.0174108			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323879	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000062
J	Majak, GB; Reisaeter, AV; Zucknick, M; Lorentzen, B; Vangen, S; Henriksen, T; Michelsen, TM				Majak, Guri Baardstu; Reisaeter, Anna Varberg; Zucknick, Manuela; Lorentzen, Bjorg; Vangen, Siri; Henriksen, Tore; Michelsen, Trond Melbye			Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; PREGNANCY OUTCOMES; RECIPIENTS; HYPERTENSION; PREVENTION; MANAGEMENT	Women pregnant following kidney transplantation are at high risk of preeclampsia. Identifying the effects of preeclampsia on pregnancy outcome and allograft function in kidney transplanted women, and predicting which women will require more targeted follow-up and possible therapeutic intervention, could improve both maternal and neonatal outcome. In this retrospective cohort study of all pregnancies following kidney transplantation in Norway between 1969 and 2013, we used medical records to identify clinical characteristics predictive of preeclampsia. 175 pregnancies were included, in which preeclampsia was diagnosed in 65. Pregnancies with preeclampsia had significantly higher postpartum serum creatinine levels, higher risks of preterm delivery, caesarean delivery, and small for gestational age infants. In the final multivariate model chronic hypertension (aOR = 5.02 [95% CI, 2.47-10.18]), previous preeclampsia (aOR = 3.26 [95% CI, 1.43-7.43]), and elevated serum creatinine (>= 125 mu mol/ L) at the start of pregnancy (aOR = 5.79 [95% CI, 1.91 -17.59]) were prognostic factors for preeclampsia. Based on this model the risk was 19% when none of these factors were present, 45 -59% risk when one was present, 80 -87% risk when two were present, and 96% risk when all three were present. We suggest that the risk of preeclampsia in pregnancies in kidney transplanted women can be predicted with these variables, which are easily available at the start of pregnancy.	[Majak, Guri Baardstu; Lorentzen, Bjorg; Henriksen, Tore; Michelsen, Trond Melbye] Oslo Univ Hosp Rikshosp, Div Obstet & Gynecol, Dept Obstet, Oslo, Norway; [Majak, Guri Baardstu; Vangen, Siri; Michelsen, Trond Melbye] Oslo Univ Hosp, Rikshosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway; [Reisaeter, Anna Varberg] Oslo Univ Hosp, Rikshosp, Norwegian Renal Registry, Dept Transplantat Med, Oslo, Norway; [Zucknick, Manuela] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Inst Basic Med Sci, Oslo, Norway; [Vangen, Siri; Henriksen, Tore] Univ Oslo, Oslo, Norway; [Michelsen, Trond Melbye] Sorlandet Hosp, Res Unit, Arendal, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Majak, GB (corresponding author), Oslo Univ Hosp Rikshosp, Div Obstet & Gynecol, Dept Obstet, Oslo, Norway.; Majak, GB (corresponding author), Oslo Univ Hosp, Rikshosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway.	gurifb@hotmail.com		Zucknick, Manuela/0000-0003-1317-7422				American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; Bank TW, 2016, MORTALITY RATE INFAN; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; BEROYZ G, 1994, LANCET, V343, P619; Bramham K, 2016, KIDNEY INT, V89, P874, DOI 10.1016/j.kint.2015.10.012; Bramham K, 2013, CLIN J AM SOC NEPHRO, V8, P290, DOI 10.2215/CJN.06170612; Deshpande NA, 2011, AM J TRANSPLANT, V11, P2388, DOI 10.1111/j.1600-6143.2011.03656.x; Jungers P, 1997, KIDNEY INT, V52, P871, DOI 10.1038/ki.1997.408; Kasiske BL, 2004, AM J KIDNEY DIS, V43, P1071, DOI 10.1053/j.ajkd.2004.03.013; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; LeFevre ML, 2014, ANN INTERN MED, V161, P819, DOI 10.7326/M14-1884; Majak GB, 2016, ACTA OBSTET GYN SCAN, V95, P1153, DOI 10.1111/aogs.12937; Mckay DB, 2008, CLIN J AM SOC NEPHRO, V3, pS117, DOI 10.2215/CJN.02980707; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; MURRAY JE, 1963, NEW ENGL J MED, V269, P341, DOI 10.1056/NEJM196308152690704; Rahamimov R, 2006, TRANSPLANTATION, V81, P660, DOI 10.1097/01.tp.0000166912.60006.3d; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; VISINTIN C, 2010, BMJ-BRIT MED J, V341, pc2207, DOI DOI 10.1136/BMJ.C2207; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	22	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173420	10.1371/journal.pone.0173420	http://dx.doi.org/10.1371/journal.pone.0173420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319175	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800015
J	Orellano, P; Quaranta, N; Reynoso, J; Balbi, B; Vasquez, J				Orellano, Pablo; Quaranta, Nancy; Reynoso, Julieta; Balbi, Brenda; Vasquez, Julia			Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis	PLOS ONE			English	Review							EMERGENCY-DEPARTMENT VISITS; CASE-CROSSOVER ANALYSIS; SHORT-TERM EXPOSURE; HOSPITAL ADMISSIONS; TIME-SERIES; OZONE; ASSOCIATION; PM2.5; POLLUTANTS; MANAGEMENT	Background Several observational studies have suggested that outdoor air pollution may induce or aggravate asthma. However, epidemiological results are inconclusive due to the presence of numerous moderators which influence this association. The goal of this study was to assess the relationship between outdoor air pollutants and moderate or severe asthma exacerbations in children and adults through a systematic review and multilevel meta-analysis. Material and methods We searched studies published in English on PubMed, Scopus, and Google Scholar between January 2000 and October 2016. Studies following a case-crossover design with records of emergency departments and/or hospital admissions as a surrogate of moderate or severe asthma exacerbations were selected. A multilevel meta-analysis was employed, taking into account the potential clustering effects within studies examining more than one lag. Odds ratios (ORs) and 95% confidence intervals were estimated. A subgroup analysis in children aged 0 to 18 years and a sensitivity analysis based on the quality of the included studies as defined in the Newcastle-Ottawa Scale were performed. Publication bias was evaluated through visual inspection of funnel plots and by a complementary search of grey literature. (Prospero Registration number CRD42015032323). Results Database searches retrieved 208 records, and finally 22 studies were selected for quantitative analysis. All pollutants except SO2 and PM10 showed a significant association with asthma exacerbations (NO2: 1.024; 95% CI: 1.005,1.043, SO2: 1.039; 95% CI: 0.988,1.094), PM10: 1.024; 95% CI: 0.995,1.053, PM2.5: 1.028; 95% CI: 1.009,1.047, CO: 1.045; 95% CI: 1.005,1.086, O-3: 1.032; 95% CI: 1.005,1.060. In children, the association was significant for NO2, SO2 and PM2.5. Conclusion This meta-analysis provides evidence of the association between selected air pollutants and asthma exacerbations for different lags.	[Orellano, Pablo] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Orellano, Pablo; Quaranta, Nancy] Univ Tecnol Nacl, Fac Reg San Nicolas, San Nicolas, Argentina; [Quaranta, Nancy] CIC, La Plata, Buenos Aires, Argentina; [Reynoso, Julieta; Balbi, Brenda; Vasquez, Julia] Hosp Interzonal Gen Agudos San Felipe, San Nicolas, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Orellano, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Orellano, P (corresponding author), Univ Tecnol Nacl, Fac Reg San Nicolas, San Nicolas, Argentina.	porellano@frsn.utn.edu.ar	Orellano, Pablo/H-2733-2015	Orellano, Pablo/0000-0001-8911-663X	Universidad Tecnologica Nacional; Facultad Regional San Nicolas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision de Investigaciones Cientificas (CIC)	Universidad Tecnologica Nacional; Facultad Regional San Nicolas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Comision de Investigaciones Cientificas (CIC)	This study did not receive any specific funding, but was supported by there search budget of the Universidad Tecnologica Nacional, Facultad Regional San Nicolas. PO is supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and NQ by the Comision de Investigaciones Cientificas (CIC).	Alman BL, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0146-8; Arbex MA, 2012, J BRAS PNEUMOL, V38, P643, DOI 10.1590/S1806-37132012000500015; Auerbach A, 2012, CURR OPIN ALLERGY CL, V12, P133, DOI 10.1097/ACI.0b013e32835113d6; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Barone-Adesi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142565; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bostantzoglou C, 2015, BREATHE, V11, P187, DOI 10.1183/20734735.008115; Botturi K, 2011, PHARMACOL THERAPEUT, V131, P114, DOI 10.1016/j.pharmthera.2011.03.010; Bowatte G, 2015, ALLERGY, V70, P245, DOI 10.1111/all.12561; Brugha R, 2014, PAEDIATR RESPIR REV, V15, P194, DOI 10.1016/j.prrv.2014.03.001; Canova C, 2012, EPIDEMIOLOGY, V23, P607, DOI 10.1097/EDE.0b013e3182572563; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; Chen BY, 2013, AEROSOL AIR QUAL RES, V13, P1847, DOI 10.4209/aaqr.2012.11.0299; Colais P, 2008, EPIDEMIOLOGIA PRE S1, V33, P77; Crawley MJ, 2013, R BOOK, P557; Ding L, 2016, ENV POLLUT; Egger M, 2003, Health Technol Assess, V7, P1; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-31; Falcon-Rodriguez CI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00003; Figueiras A, 2005, EPIDEMIOLOGY, V16, P239, DOI 10.1097/01.ede.0000152915.58564.d3; Forno E, 2012, CURR OPIN PULM MED, V18, P63, DOI 10.1097/MCP.0b013e32834db288; Fung KY, 2003, INT J EPIDEMIOL, V32, P1064, DOI 10.1093/ije/dyg246; Gasana J, 2012, ENVIRON RES, V117, P36, DOI 10.1016/j.envres.2012.05.001; Glad JA, 2012, ARCH ENVIRON OCCUP H, V67, P103, DOI 10.1080/19338244.2011.598888; Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035; Globe G, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0217-5; Grineski SE, 2011, ENVIRON RES, V111, P1148, DOI 10.1016/j.envres.2011.06.007; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Im HJ, 2000, KOREAN J OCCUPATIONA, V12, P249; Iskandar A, 2011, EUROPEAN RESP J S55, V38, P1131; Iskandar A, 2012, THORAX, V67, P252, DOI 10.1136/thoraxjnl-2011-200324; Jalaludin B, 2005, EPIDEMIOLOGY, V16, pS57, DOI 10.1097/00001648-200509000-00136; Jiang XQ, 2016, J THORAC DIS, V8, pE31, DOI 10.3978/j.issn.2072-1439.2015.11.50; Kahle D, 2015, PACKAGE GGMAP; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Laurent O, 2008, AM J EPIDEMIOL, V168, P58, DOI 10.1093/aje/kwn087; Lavigne E, 2012, CAN J PUBLIC HEALTH, V103, P4, DOI 10.1007/BF03404060; Lee JT, 2003, KOREAN J PREV MED, V36, P47; Lewin A, 2013, J EXPO SCI ENV EPID, V23, P474, DOI 10.1038/jes.2013.27; Li S, 2011, ENVIRON RES, V111, P1137, DOI 10.1016/j.envres.2011.06.002; Lin M, 2003, J EPIDEMIOL COMMUN H, V57, P50, DOI 10.1136/jech.57.1.50; Lu Y, 2007, BIOSTATISTICS, V8, P337, DOI 10.1093/biostatistics/kxl013; Masiol M, 2014, SCI TOTAL ENVIRON, V494, P84, DOI 10.1016/j.scitotenv.2014.06.122; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mathew J, 2012, ARCH MED SCI, V8, P589, DOI 10.5114/aoms.2012.30280; O'Byrne PM, 2011, J ALLERGY CLIN IMMUN, V128, P257, DOI 10.1016/j.jaci.2011.03.035; Pereira G, 2010, MED J AUSTRALIA, V193, P511, DOI 10.5694/j.1326-5377.2010.tb04034.x; Pollart SM, 2011, AM FAM PHYSICIAN, V84, P40; Romeo Elisa, 2006, Epidemiol Prev, V30, P245; Rothstein H, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, pIX; Sacks JD, 2014, ENVIRON HEALTH PERSP, V122, P506, DOI 10.1289/ehp.1306940; Santus P, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-95; Simoni M, 2015, J THORAC DIS, V7, P34, DOI 10.3978/j.issn.2072-1439.2014.12.10; Smargiassi A, 2009, ENVIRON HEALTH PERSP, V117, P653, DOI 10.1289/ehp.0800010; Spann K, 2016, ANN GLOB HEALTH, V82, P28, DOI 10.1016/j.aogh.2016.01.007; Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Strickland M, 2009, EPIDEMIOLOGY, V20, pS163; Sunyer J, 2002, THORAX, V57, P687, DOI 10.1136/thorax.57.8.687; Tecer LH, 2008, J TOXICOL ENV HEAL A, V71, P512, DOI 10.1080/15287390801907459; Tecer LH, 2011, INT MULTI SCI GEOCO, P1263; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Ueda Kayo, 2010, Environmental Health and Preventive Medicine, V15, P350, DOI 10.1007/s12199-010-0150-5; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; Wells G.A., 2000, VIS COMMUN Q; World Bank, 2016, COUNTR LEND GROUPS; Yamazaki S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005736; Yip S, 2016, PACKAGE WEATHERR; Zhang SQ, 2016, ENVIRON RES, V148, P15, DOI 10.1016/j.envres.2016.03.008; Zheng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117773	72	215	222	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174050	10.1371/journal.pone.0174050	http://dx.doi.org/10.1371/journal.pone.0174050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319180	Green Submitted, gold, Green Published			2022-12-27	WOS:000398945800045
J	Mohanty, B; Rimmer, K; McMahon, RM; Headey, SJ; Vazirani, M; Shouldice, SR; Coincon, M; Tay, S; Morton, CJ; Simpson, JS; Martin, JL; Scanlon, MJ				Mohanty, Biswaranjan; Rimmer, Kieran; McMahon, Roisin M.; Headey, Stephen J.; Vazirani, Mansha; Shouldice, Stephen R.; Coincon, Mathieu; Tay, Stephanie; Morton, Craig J.; Simpson, Jamie S.; Martin, Jennifer L.; Scanlon, Martin J.			Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1	PLOS ONE			English	Article							PROTEIN-LIGAND COMPLEXES; NMR STRUCTURE DETERMINATION; CRYSTAL-STRUCTURE; INTERACTION SITE; LEAD DISCOVERY; IN-VIVO; ASSIGNMENT; REVEALS; SOFTWARE; DESIGN	At a time when the antibiotic drug discovery pipeline has stalled, antibiotic resistance is accelerating with catastrophic implications for our ability to treat bacterial infections. Globally we face the prospect of a future when common infections can once again kill. Anti-virulence approaches that target the capacity of the bacterium to cause disease rather than the growth or survival of the bacterium itself offer a tantalizing prospect of novel antimicrobials. They may also reduce the propensity to induce resistance by removing the strong selection pressure imparted by bactericidal or bacteriostatic agents. In the human pathogen Pseudomonas aeruginosa, disulfide bond protein A (PaDsbA1) plays a central role in the oxidative folding of virulence factors and is therefore an attractive target for the development of new anti-virulence antimicrobials. Using a fragment-based approach we have identified small molecules that bind to PaDsbA1. The fragment hits show selective binding to PaDsbA1 over the DsbA protein from Escherichia coli, suggesting that developing species-specific narrowspectrum inhibitors of DsbA enzymes may be feasible. Structures of a co-complex of PaDsbA1 with the highest affinity fragment identified in the screen reveal that the fragment binds on the non-catalytic surface of the protein at a domain interface. This biophysical and structural data represent a starting point in the development of higher affinity compounds, which will be assessed for their potential as selective PaDsbA1 inhibitors.	[Mohanty, Biswaranjan; Rimmer, Kieran; Headey, Stephen J.; Vazirani, Mansha; Simpson, Jamie S.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [McMahon, Roisin M.; Shouldice, Stephen R.; Coincon, Mathieu; Tay, Stephanie; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Morton, Craig J.] Biota Holdings Ltd, Notting Hill, Vic, Australia; [McMahon, Roisin M.; Martin, Jennifer L.] Griffith Univ, Inst Drug Discovery, Nathan, Qld, Australia; [Coincon, Mathieu] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, Stockholm, Sweden; [Morton, Craig J.] St Vincents Inst Med Res, Australian Canc Res Fdn, Rat Drug Discovery Ctr, Fitzroy, Vic, Australia	Monash University; University of Queensland; Griffith University; Stockholm University; St. Vincent's Institute of Medical Research	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia.	martin.scanlon@monash.edu	Mohanty, Biswaranjan/E-2080-2018; Simpson, Jamie/ABC-7083-2020; Simpson, Jamie S/A-1700-2012; McMahon, Roisin/A-9823-2014; Morton, Craig/GON-8638-2022	Mohanty, Biswaranjan/0000-0002-6921-343X; Simpson, Jamie/0000-0002-8894-422X; Simpson, Jamie S/0000-0002-8894-422X; McMahon, Roisin/0000-0001-5437-0355; Morton, Craig/0000-0001-5452-5193; Headey, Stephen/0000-0001-8015-7064; Scanlon, Martin/0000-0002-9230-7506	Australian Research Council [LP0990166, FL0992138]; Industry Partner - Biota Holdings Ltd.; Laureate Award; National Health and Medical Research Council [1061241]	Australian Research Council(Australian Research Council); Industry Partner - Biota Holdings Ltd.; Laureate Award; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded through a Linkage Grant from the Australian Research Council (arc.gov.au) (LP0990166), which was supported by an Industry Partner - Biota Holdings Ltd. JLM was supported by an Australian Research Council (arc.gov.au) Australian Laureate Fellowship during this research (FL0992138). RMM, MC and ST were supported by the same Laureate Award. RMM and BM were supported in part by a National Health and Medical Research Council (nhmrc.gov.au) Project Grant (1061241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Devine SM, 2015, J MED CHEM, V58, P1205, DOI 10.1021/jm501402x; Doak BC, 2013, AUST J CHEM, V66, P1465, DOI 10.1071/CH13280; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferenczy GG, 2013, J MED CHEM, V56, P2478, DOI 10.1021/jm301851v; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hubbard RE, 2011, METHOD ENZYMOL, V493, P509, DOI 10.1016/B978-0-12-381274-2.00020-0; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Jahnke W, 2010, NAT CHEM BIOL, V6, P660, DOI [10.1038/NCHEMBIO.421, 10.1038/nchembio.421]; Keller R., 2004, COMPUTER AIDED RESON, P33; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon RM, 2014, BIOCH BIOPHYS ACTA; McMahon RM, 2015, ACTA CRYSTALLOGR D, V71, P2386, DOI 10.1107/S1399004715018519; Mohanty B, 2016, J BIOMOL NMR, V66, P195, DOI 10.1007/s10858-016-0067-4; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mortenson PN, 2011, J COMPUT AID MOL DES, V25, P663, DOI 10.1007/s10822-011-9435-z; Murray JB, 2014, J MED CHEM, V57, P2845, DOI 10.1021/jm401848a; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Orts J, 2016, J AM CHEM SOC, V138, P4393, DOI 10.1021/jacs.5b12391; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Premkumar L, 2014, J BIOL CHEM, V289, P19869, DOI 10.1074/jbc.M114.571737; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sethi A, 2015, PROTEIN SCI, V24, P1013, DOI 10.1002/pro.2671; Shah DM, 2012, J MED CHEM, V55, P10786, DOI 10.1021/jm301396d; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Silvestre HL, 2013, P NATL ACAD SCI USA, V110, P12984, DOI 10.1073/pnas.1304045110; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Urban A, 2001, J BACTERIOL, V183, P587, DOI 10.1128/JB.183.2.587-596.2001; Valkov E, 2012, TOP CURR CHEM, V317, P145, DOI 10.1007/128_2011_265; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; Wielens J, 2013, J BIOMOL SCREEN, V18, P147, DOI 10.1177/1087057112465979; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173436	10.1371/journal.pone.0173436	http://dx.doi.org/10.1371/journal.pone.0173436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346540	Green Published, gold			2022-12-27	WOS:000399174300006
J	Park, CK; Ho, CH; Jeong, SJ; Lee, EJ; Kim, J				Park, Chang-Kyun; Ho, Chang-Hoi; Jeong, Su-Jong; Lee, Eun Ju; Kim, Jinwon			Spatial and temporal changes in leaf coloring date of Acer palmatum and Ginkgo biloba in response to temperature increases in South Korea	PLOS ONE			English	Article							GROWING-SEASON LENGTH; CLIMATE-CHANGE; EASTERN CHINA; PHENOLOGY; VEGETATION; EUROPE; FOREST; ECOSYSTEMS; SENESCENCE; PREDICTION	Understanding shifts in autumn phenology associated with climate changes is critical for preserving forest ecosystems. This study examines the changes in the leaf coloring date (LCD) of two temperate deciduous tree species, Acer palmatum (Acer) and Ginkgo biloba (Ginkgo), in response to surface air temperature (Ts) changes at 54 stations of South Korea for the period 1989 - 2007. The variations of Acer and Ginkgo in South Korea are very similar: they show the same mean LCD of 295th day of the year and delays of about 0.45 days year - 1 during the observation period. The delaying trend is closely correlated (correlation coefficient > 0.77) with increases in Ts in mid-autumn by 2.8 days degrees C-1. It is noted that the LCD delaying and temperature sensitivity (days degrees C-1) for both tree species show negligible dependences on latitudes and elevations. Given the significant LCD-Ts relation, we project LCD changes for 2016 - 35 and 2046 - 65 using a process-based model forced by temperature from climate model simulation. The projections indicate that the mean LCD would be further delayed by 3.2 (3.7) days in 2016 - 35 (2046 - 65) due to mid-autumn Ts increases. This study suggests that the mid-autumn warming is largely responsible for the observed LCD changes in South Korea and will intensify the delaying trends in the future.	[Park, Chang-Kyun; Ho, Chang-Hoi] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Jeong, Su-Jong] South Univ Sci & Technol China, Sch Environm Sci & Engn, Shenzhen, Peoples R China; [Lee, Eun Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Kim, Jinwon] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA	Seoul National University (SNU); Southern University of Science & Technology; Seoul National University (SNU); University of California System; University of California Los Angeles	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	hoch@cpl.snu.ac.kr	Ho, Chang-Hoi/H-8354-2015	Park, Chang-Kyun/0000-0001-9485-5007	Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program; MOE under the Climate Change Correspondence Program	Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program; MOE under the Climate Change Correspondence Program	This study was funded by the Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program. The work by JK and CKP were partially supported by salaries from the MOE under the Climate Change Correspondence Program. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Archetti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057373; Bassow SL, 1998, ECOLOGY, V79, P2660, DOI 10.1890/0012-9658(1998)079[2660:HECACL]2.0.CO;2; Bell GD, 1999, B AM METEOROL SOC, V80, pS1, DOI 10.1175/1520-0477-80.5s.S1; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bowers JE, 2007, SOUTHWEST NAT, V52, P347, DOI 10.1894/0038-4909(2007)52[347:HCWASF]2.0.CO;2; Chen XQ, 2012, INT J BIOMETEOROL, V56, P695, DOI 10.1007/s00484-011-0471-0; Chen XQ, 2005, GLOBAL CHANGE BIOL, V11, P1118, DOI 10.1111/j.1365-2486.2005.00974.x; Chmura DJ, 2011, FOREST ECOL MANAG, V261, P1121, DOI 10.1016/j.foreco.2010.12.040; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Dai JH, 2014, INT J BIOMETEOROL, V58, P521, DOI 10.1007/s00484-013-0679-2; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Doi H, 2008, GLOBAL ECOL BIOGEOGR, V17, P556, DOI 10.1111/j.1466-8238.2008.00398.x; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Fu YSH, 2014, P NATL ACAD SCI USA, V111, P7355, DOI 10.1073/pnas.1321727111; Garonna I, 2014, GLOBAL CHANGE BIOL, V20, P3457, DOI 10.1111/gcb.12625; Ge QS, 2011, ECOL RES, V26, P713, DOI 10.1007/s11284-011-0830-7; Ho CH, 2005, TERR ATMOS OCEAN SCI, V16, P1163, DOI 10.3319/TAO.2005.16.5.1163(A); Ho CH, 1988, J KOREAN METEOR SOC, V24, P38; Ho CH, 2006, INT J CLIMATOL, V26, P2117, DOI 10.1002/joc.1356; Hong SY, 2010, ASIA-PAC J ATMOS SCI, V46, P425, DOI 10.1007/s13143-010-0024-1; Iler AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0489; IPCC, 2014, BIOL SCI; Jenerette GD, 2010, J VEG SCI, V21, P16, DOI 10.1111/j.1654-1103.2009.01118.x; Jeong JH, 2011, INT J CLIMATOL, V31, P1488, DOI 10.1002/joc.2178; Jeong SJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P1245, DOI 10.1111/geb.12206; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jung HS, 2002, INT J CLIMATOL, V22, P1327, DOI 10.1002/joc.797; Keenan TF, 2015, GLOBAL CHANGE BIOL, V21, P2634, DOI 10.1111/gcb.12890; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; KOIKE T, 1990, TREE PHYSIOL, V7, P21, DOI 10.1093/treephys/7.1-2-3-4.21; Lebourgeois F, 2010, INT J BIOMETEOROL, V54, P563, DOI 10.1007/s00484-010-0305-5; Lee DW, 2003, ECOL RES, V18, P677, DOI 10.1111/j.1440-1703.2003.00588.x; Matsumoto K, 2003, GLOBAL CHANGE BIOL, V9, P1634, DOI 10.1046/j.1365-2486.2003.00688.x; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Min SK, 2015, ASIA-PAC J ATMOS SCI, V51, P103, DOI 10.1007/s13143-015-0066-5; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nooden L.D., 2004, PLANT CELL DEATH PRO; Olsson C, 2015, ECOL MODEL, V316, P41, DOI 10.1016/j.ecolmodel.2015.08.002; Park CK, 2015, J HYDROL, V526, P221, DOI 10.1016/j.jhydrol.2014.10.043; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Schaber J, 2003, INT J BIOMETEOROL, V47, P193, DOI 10.1007/s00484-003-0171-5; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Shen MG, 2013, P NATL ACAD SCI USA, V110, pE2329, DOI 10.1073/pnas.1304625110; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Xu L, 2013, GLOBAL CHANGE BIOL, V19, P1275, DOI 10.1111/gcb.12095; Yang YT, 2015, GLOBAL CHANGE BIOL, V21, P652, DOI 10.1111/gcb.12778; Yu ET, 2015, CLIM DYNAM, V45, P2013, DOI 10.1007/s00382-014-2452-6; Yu R, 2016, INT J BIOMETEOROL, V60, P335, DOI 10.1007/s00484-015-1031-9; Zhang NN, 2009, CLIMATIC CHANGE, V95, P341, DOI 10.1007/s10584-009-9568-4; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	58	11	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174390	10.1371/journal.pone.0174390	http://dx.doi.org/10.1371/journal.pone.0174390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346534	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300042
J	Shiraya, T; Kato, S; Araki, F; Ueta, T; Miyaji, T; Yamaguchi, T				Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi; Miyaji, Tempei; Yamaguchi, Takuhiro			Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COHERENCE TOMOGRAPHIC FEATURES; TUMOR-NECROSIS-FACTOR; INDUCIBLE PROTEIN-10; VITREOUS LEVELS; HUMOR CYTOKINE; RETINOPATHY; BEVACIZUMAB; THERAPY; INTERLEUKIN-8	Purpose It is controversial whether the administration of anti-vascular endothelial growth factor drugs for diabetic macular edema (DME) affects intraocular inflammatory cytokines. In this study, we measured cytokine concentration in aqueous humor before and after intravitreal injection of ranibizumab (IVR). The aim was to determine changes in cytokine concentration and their effects on DME reduction. Methods Twelve patients (13 eyes) with DME received two IVR (0.5 mg) with a 1 month interval, and a total of 26 aqueous humor samples were obtained. Macular thickness was measured with an optical coherence tomography (OCT) using thickness-map mode with an Early Treatment Diabetic Retinopathy Study (ETDRS) 9-zone grid that was divided into two zones: a central circle with a diameter of 1 mm (zone1); and an outer circle with a diameter of 6 mm (zone2). Results The concentration of eotaxin-1 in aqueous humor samples decreased significantly after IVR. Baseline cytokine concentration was associated with IVR-induced DME reduction. In zone1, higher baseline concentration of interferon-induced protein (IP)-10, and in zone 2, higher baseline concentration of granulocyte-macrophage colony-stimulating factor, IP-10, and tumor necrosis factor (TNF) alpha; and lower baseline concentration of eotaxin-1, interleukin (IL)-5, and IL-8 were associated with improved DME. Cytokine changes were associated with IVR-induced DME reduction. In zone1, lower concentration of IP-10 compared to baseline or higher concentration of macrophage inflammatory protein (MIP) -alpha, and in zone 2, lower concentration of IL-5 compared to baseline, IL-8, and IP-10 or higher concentration of eotaxin-1 and MIP-1 beta were associated with improved DME. Conclusions These findings suggest that ranibizumab affects the concentration of cytokines in aqueous humor. Various cytokines contribute to a decrease in retinal thickness, both in the center of the macula and in a larger area of the retina.	[Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Miyaji, Tempei; Yamaguchi, Takuhiro] Univ Tokyo, Grad Sch Med, Dept Clin Trial Data Management, Tokyo, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Div Biostat, Sendai, Miyagi, Japan	University of Tokyo; University of Tokyo; Tohoku University	Shiraya, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	shiraya01@gmail.com			JSPS KAKENHI [JP 25861617]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number JP 25861617 (https://www.jsps.go.jp/english/e-grants/index.html).	Alkuraya Hisham, 2005, International Ophthalmology, V26, P93, DOI 10.1007/s10792-006-9007-8; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Cheung CMG, 2012, MOL VIS, V18, P830; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Elner SG, 1998, ARCH OPHTHALMOL-CHIC, V116, P1597, DOI 10.1001/archopht.116.12.1597; ELNER SG, 1995, CURR EYE RES, V14, P1045, DOI 10.3109/02713689508998529; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Forooghian F, 2016, CAN J OPHTHALMOL, V51, P87, DOI 10.1016/j.jcjo.2015.11.001; Forooghian F, 2010, INVEST OPHTH VIS SCI, V51, P2388, DOI 10.1167/iovs.09-4065; Funatsu H, 2006, OPHTHALMOLOGY, V113, P294, DOI 10.1016/j.ophtha.2005.10.030; Funatsu H, 2002, AM J OPHTHALMOL, V133, P70, DOI 10.1016/S0002-9394(01)01269-7; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Petrovic MG, 2007, AM J OPHTHALMOL, V143, P175, DOI 10.1016/j.ajo.2006.07.032; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P999, DOI 10.1097/01.iae.0000247165.38655.bf; Hernandez C, 2005, DIABETIC MED, V22, P719, DOI 10.1111/j.1464-5491.2005.01538.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang SW, 2004, AM J OPHTHALMOL, V137, P313, DOI 10.1016/j.ajo.2003.09.016; Kim M, 2015, INDIAN J OPHTHALMOL, V63, P312, DOI 10.4103/0301-4738.158069; Kim M, 2011, OPHTHALMOLOGICA, V226, DOI 10.1159/000330045; Liu GQ, 2015, CURR EYE RES, V40, P891, DOI 10.3109/02713683.2014.968934; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Oh IK, 2010, CURR EYE RES, V35, P1116, DOI 10.3109/02713683.2010.510257; Photocoagulation for diabetic macular edema, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI DOI 10.1001/ARCH0PHT.1985.01050120030015; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Selim KM, 2010, INDIAN J OPHTHALMOL, V58, P375, DOI 10.4103/0301-4738.67042; Shimura M, 2008, AM J OPHTHALMOL, V145, P854, DOI 10.1016/j.ajo.2007.12.031; Shimura M, 2013, RETINA-J RET VIT DIS, V33, P740, DOI 10.1097/IAE.0b013e31826b6763; Shiraya T, 2016, ACTA OPHTHA IN PRESS; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; Takatsu K, 2011, P JPN ACAD B-PHYS, V87, P463, DOI 10.2183/pjab.87.463; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Wang HB, 2011, INVEST OPHTH VIS SCI, V52, P8271, DOI 10.1167/iovs.11-8230	35	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174340	10.1371/journal.pone.0174340	http://dx.doi.org/10.1371/journal.pone.0174340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346545	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300039
J	Brodehl, A; Belke, DD; Garnett, L; Martens, K; Abdelfatah, N; Rodriguez, M; Diao, C; Chen, YX; Gordon, PMK; Nygren, A; Gerull, B				Brodehl, Andreas; Belke, Darrell D.; Garnett, Lauren; Martens, Kristina; Abdelfatah, Nelly; Rodriguez, Marcela; Diao, Catherine; Chen, Yong-Xiang; Gordon, Paul M. K.; Nygren, Anders; Gerull, Brenda			Transgenic mice overexpressing desmocollin-2 (DSC2) develop cardiomyopathy associated with myocardial inflammation and fibrotic remodeling	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; ARRHYTHMOGENIC CARDIOMYOPATHY; JUNCTION FORMATION; HYPER-ADHESION; MUTATIONS; HEART; PLAKOGLOBIN; DESMOPLAKIN; DESMOSOMES; DISEASE	Background Arrhythmogenic cardiomyopathy is an inherited heart muscle disorder leading to ventricular arrhythmias and heart failure, mainly as a result of mutations in cardiac desmosomal genes. Desmosomes are cell-cell junctions mediating adhesion of cardiomyocytes; however, the molecular and cellular mechanisms underlying the disease remain widely unknown. Desmo-collin-2 is a desmosomal cadherin serving as an anchor molecule required to reconstitute homeostatic intercellular adhesion with desmoglein-2. Cardiac specific lack of desmoglein-2 leads to severe cardiomyopathy, whereas overexpression does not. In contrast, the corresponding data for desmocollin-2 are incomplete, in particular from the view of protein overexpression. Therefore, we developed a mouse model overexpressing desmocollin-2 to determine its potential contribution to cardiomyopathy and intercellular adhesion pathology. Methods and results We generated transgenic mice overexpressing DSC2 in cardiac myocytes. Transgenic mice developed a severe cardiac dysfunction over 5 to 13 weeks as indicated by 2D-echocardiography measurements. Corresponding histology and immunohistochemistry demonstrated fibrosis, necrosis and calcification which were mainly localized in patches near the epi- and endocardium of both ventricles. Expressions of endogenous desmosomal proteins were markedly reduced in fibrotic areas but appear to be unchanged in non-fibrotic areas. Furthermore, gene expression data indicate an early up-regulation of inflammatory and fibrotic remodeling pathways between 2 to 3.5 weeks of age. Conclusion Cardiac specific overexpression of desmocollin-2 induces necrosis, acute inflammation and patchy cardiac fibrotic remodeling leading to fulminant biventricular cardiomyopathy.	[Brodehl, Andreas; Belke, Darrell D.; Garnett, Lauren; Martens, Kristina; Abdelfatah, Nelly; Rodriguez, Marcela; Diao, Catherine; Chen, Yong-Xiang; Nygren, Anders; Gerull, Brenda] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada; [Brodehl, Andreas; Belke, Darrell D.; Garnett, Lauren; Martens, Kristina; Abdelfatah, Nelly; Rodriguez, Marcela; Diao, Catherine; Chen, Yong-Xiang; Nygren, Anders; Gerull, Brenda] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Rodriguez, Marcela; Nygren, Anders] Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada; [Gordon, Paul M. K.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Genom & Bioinformat Facil, Calgary, AB, Canada; [Gerull, Brenda] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Gerull, Brenda] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Wurzburg; University of Wurzburg	Gerull, B (corresponding author), Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada.; Gerull, B (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.; Gerull, B (corresponding author), Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany.; Gerull, B (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	gerull_b@ukw.de	Brodehl, Andreas/C-6450-2013	Brodehl, Andreas/0000-0001-9202-2343	Alberta Innovates Health Solutions [201200822]; Candian Institutes of Health Research (FRN) [123351]; Libin Cardiovascular Institute of Alberta; Alberta Innovates [201200822] Funding Source: researchfish	Alberta Innovates Health Solutions; Candian Institutes of Health Research (FRN); Libin Cardiovascular Institute of Alberta; Alberta Innovates	We are greateful for the support of Alberta Innovates Health Solutions (201200822) and the Candian Institutes of Health Research (FRN: 123351). Support was also provided by the Libin Cardiovascular Institute of Alberta.	Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Brodehl A, 2016, HUM MUTAT, V37, P269, DOI 10.1002/humu.22942; Broussard JA, 2015, CELL TISSUE RES, V360, P501, DOI 10.1007/s00441-015-2136-5; Campian ME, 2010, EUR J NUCL MED MOL I, V37, P2079, DOI 10.1007/s00259-010-1525-y; Campian ME, 2010, EUR J HEART FAIL, V12, P653, DOI 10.1093/eurjhf/hfq066; Campuzano O, 2012, J CLIN PATHOL, V65, P1077, DOI 10.1136/jclinpath-2012-201022; Caruso L, 2010, J MOL CELL CARDIOL, V48, P1194, DOI 10.1016/j.yjmcc.2010.01.022; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; Cruz FM, 2015, J AM COLL CARDIOL, V65, P1438, DOI 10.1016/j.jacc.2015.01.045; Deng JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116969; Dubash AD, 2011, CURR BIOL, V21, pR529, DOI 10.1016/j.cub.2011.04.035; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Ferreira-Cornwell MC, 2002, J CELL SCI, V115, P1623; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Garrod D, 2008, BIOCHEM SOC T, V36, P195, DOI 10.1042/BST0360195; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gehmlich K, 2012, CARDIOVASC PATHOL, V21, P275, DOI 10.1016/j.carpath.2011.09.005; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gerull B, 2013, CIRC-CARDIOVASC GENE, V6, P327, DOI 10.1161/CIRCGENETICS.113.000097; Gomes J, 2012, EUR HEART J, V33, P1942, DOI 10.1093/eurheartj/ehr472; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Kant S, 2015, CIRC CARDIOVASC GENE; Kant S, 2012, CELL TISSUE RES, V348, P249, DOI 10.1007/s00441-011-1322-3; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; Klauke B, 2010, HUM MOL GENET, V19, P4595, DOI 10.1093/hmg/ddq387; Kowalczyk AP, 2013, PROG MOL BIOL TRANSL, V116, P95, DOI 10.1016/B978-0-12-394311-8.00005-4; Krusche CA, 2011, BASIC RES CARDIOL, V106, P617, DOI 10.1007/s00395-011-0175-y; Le Quang K, 2015, CIRC-ARRHYTHMIA ELEC, V8, P921, DOI 10.1161/CIRCEP.115.001668; Li DQ, 2011, HUM MOL GENET, V20, P4582, DOI 10.1093/hmg/ddr392; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzon A, 2015, AM J CARDIOL, V116, P1245, DOI 10.1016/j.amjcard.2015.07.037; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Mavroidis M, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0485-6; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Moncayo-Arlandi J., 2016, HUM MOL GENET; Patel DM, 2014, CELL COMMUN ADHES, V21, P109, DOI 10.3109/15419061.2014.906533; Pilichou K, 2009, J EXP MED, V206, P1787, DOI 10.1084/jem.20090641; Prante C, 2007, J BIOL CHEM, V282, P26441, DOI 10.1074/jbc.M702299200; Pratt CH, 2015, EXP MOL PATHOL, V98, P164, DOI 10.1016/j.yexmp.2015.01.015; Rienks M, 2016, J MOL CELL CARDIOL, V91, P172, DOI 10.1016/j.yjmcc.2016.01.008; Rimpler U., 2014, FUNKTIONELLE CHARAKT; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruiz P, 1998, TRENDS CARDIOVAS MED, V8, P97, DOI 10.1016/S1050-1738(97)00141-2; Seffouh A, 2013, FASEB J, V27, P2431, DOI 10.1096/fj.12-226373; Thiene G, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-45; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Zhang ZW, 2015, J CLIN INVEST, V125, P1708, DOI 10.1172/JCI80335	51	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174019	10.1371/journal.pone.0174019	http://dx.doi.org/10.1371/journal.pone.0174019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339476	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700019
J	Kim, SH; Chen, ZY; Yoshida, A; Paldurai, A; Xiao, S; Samal, SK				Kim, Shin-Hee; Chen, Zongyan; Yoshida, Asuka; Paldurai, Anandan; Xiao, Sa; Samal, Siba K.			Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							CHICKEN; VIRULENCE; CANDIDATE; OUTBREAKS; STRAINS; CHINA	Newcastle disease virus (NDV) causes a devastating poultry disease worldwide. Frequent outbreaks of NDV in chickens vaccinated with conventional live vaccines suggest a need to develop new vaccines that are genetically matched against circulating NDV strains, such as the genotype V virulent strains currently circulating in Mexico and Central America. In this study, a reverse genetics system was developed for the virulent NDV strain Mexico/01/10 strain and used to generate highly attenuated vaccine candidates by individually modifying the cleavage site sequence of fusion (F) protein. The cleavage site sequence of parental virus was individually changed to those of the avirulent NDV strain LaSota and other serotypes of avian paramyxoviruses (APMV serotype-2, -3, -4, -6, -7, -8, and -9). In general, these mutations affected cell-to-cell fusion activity in vitro and the efficiency of the F protein cleavage and made recombinant Mexico/01/10 (rMex) virus highly attenuated in chickens. When chickens were immunized with the rMex mutant viruses and challenged with the virulent parent virus, there was reduced challenge virus shedding compared to birds immunized with the heterologous vaccine strain LaSota. Among the vaccine candidates, rMex containing the cleavage site sequence of APMV-2 induced the highest neutralizing antibody titer and completely protected chickens from challenge virus shedding. These results show the role of the F protein cleavage site sequence of each APMV type in generating genotype V-matched vaccines and the efficacy of matched vaccine strains to provide better protection against NDV strains currently circulating in Mexico.	[Kim, Shin-Hee; Chen, Zongyan; Yoshida, Asuka; Paldurai, Anandan; Xiao, Sa; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Greenmead Dr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, Greenmead Dr, College Pk, MD 20742 USA.	ssamal@umd.edu	chen, zongyan/ABG-9170-2021					Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; Cho SH, 2008, CLIN VACCINE IMMUNOL, V15, P1572, DOI 10.1128/CVI.00156-08; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw OS, 2003, J GEN VIROL, V84, P475, DOI 10.1099/vir.0.18714-0; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2012, VET MICROBIOL, V160, P17, DOI 10.1016/j.vetmic.2012.05.003; Hu SL, 2009, VACCINE, V27, P904, DOI 10.1016/j.vaccine.2008.11.091; Hu ZL, 2011, AVIAN DIS, V55, P391, DOI 10.1637/9633-122410-Reg.1; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kim SYH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Perozo F, 2008, AVIAN DIS, V52, P472, DOI 10.1637/8276-022908-Reg.1; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Susta L, 2014, J CLIN MICROBIOL, V52, P1382, DOI 10.1128/JCM.00066-14; Xiao Sa, 2013, Genome Announc, V1, DOI 10.1128/genomeA.00177-12; Xiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052751	24	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173965	10.1371/journal.pone.0173965	http://dx.doi.org/10.1371/journal.pone.0173965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339499	Green Submitted, Green Published, gold			2022-12-27	WOS:000399116700018
J	Rai, U; Najm, F; Tartakoff, AM				Rai, Urvashi; Najm, Fadi; Tartakoff, Alan M.			Nucleolar asymmetry and the importance of septin integrity upon cell cycle arrest	PLOS ONE			English	Article							MOTHER-BUD NECK; BUDDING YEAST; MITOTIC EXIT; CHROMOSOME CONDENSATION; SPINDLE CHECKPOINT; CDC14 PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-ENVELOPE; WILD-TYPE; ANAPHASE	Cell cycle arrest can be imposed by inactivating the anaphase promoting complex (APC). In S. cerevisiae this arrest has been reported to stabilize a metaphase-like intermediate in which the nuclear envelope spans the bud neck, while chromatin repeatedly translocates between the mother and bud domains. The present investigation was undertaken to learn how other features of nuclear organization are affected upon depletion of the APC activator, Cdc20. We observe that the spindle pole bodies and the spindle repeatedly translocate across the narrow orifice at the level of the neck. Nevertheless, we find that the nucleolus (organized around rDNA repeats on the long right arm of chromosome XII) remains in the mother domain, marking the polarity of the nucleus. Accordingly, chromosome XII is polarized: TelXIIR remains in the mother domain and its centromere is predominantly located in the bud domain. In order to learn why the nucleolus remains in the mother domain, we studied the impact of inhibiting rRNA synthesis in arrested cells. We observed that this fragments the nucleolus and that these fragments entered the bud domain. Taken together with earlier observations, the restriction of the nucleolus to the mother domain therefore can be attributed to its massive structure. We also observed that inactivation of septins allowed arrested cells to complete the cell cycle, that the alternative APC activator, Cdh1, was required for completion of the cell cycle and that induction of Cdh1 itself caused arrested cells to progress to the end of the cell cycle.	[Rai, Urvashi] Case Western Reserve Univ, Dept Mol & Microbiol, Cell Biol Program, Cleveland, OH 44106 USA; [Najm, Fadi] Harvard Med Sch, Div Med Sci, Boston, MA USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Harvard University; Harvard Medical School; Case Western Reserve University	Tartakoff, AM (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	amt10@case.edu			NIH [P30CA43703-12, R01GM089872]; Visconsi family	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Visconsi family	This study was supported by NIH grants P30CA43703-12 and R01GM089872 and by the Visconsi family. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Amberg DC, 2005, METHODS IN YEAST GEN; Bermejo R, 2012, TRENDS CELL BIOL, V22, P465, DOI 10.1016/j.tcb.2012.05.007; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Boettcher B, 2012, J CELL BIOL, V197, P921, DOI 10.1083/jcb.201112117; Brito IL, 2010, CELL CYCLE, V9, P3611, DOI 10.4161/cc.9.17.12885; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Caydasi AK, 2012, EXP CELL RES, V318, P1421, DOI 10.1016/j.yexcr.2012.03.031; Caydasi AK, 2009, DEV CELL, V16, P146, DOI 10.1016/j.devcel.2008.10.013; Chan LY, 2010, MOL CELL, V39, P444, DOI 10.1016/j.molcel.2010.07.032; Cheng TMK, 2015, ELIFE, V4, DOI 10.7554/eLife.05565; Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Falk JE, 2011, P NATL ACAD SCI USA, V108, P12584, DOI 10.1073/pnas.1107784108; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Fuchs J, 2004, CHROMOSOME RES, V12, P427, DOI 10.1023/B:CHRO.0000034726.05374.db; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Geymonat M, 2009, J CELL BIOL, V187, P497, DOI 10.1083/jcb.200905114; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guillermond A., 1917, ANN I PASTEUR, V3, P107; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hu Z, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.29355; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Kinoshita M, 2007, CELL, V130, P777, DOI 10.1016/j.cell.2007.08.022; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Loidl J, 2003, INT REV CYTOL, V222, P141; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Melesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103517; Merlini L, 2011, BIOL CHEM, V392, P805, DOI 10.1515/BC.2011.090; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; PALMER RE, 1989, J CELL BIOL, V109, P3355, DOI 10.1083/jcb.109.6.3355; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Rinonos SZ, 2012, JOVE-J VIS EXP, DOI 10.3791/4197; Robbins JA, 2010, MOL BIOL CELL, V21, P914, DOI 10.1091/mbc.E09-10-0901; Schmidt M, 2003, MOL BIOL CELL, V14, P2128, DOI 10.1091/mbc.E02-08-0547; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sloan KE, 2016, J MOL BIOL, V428, P2040, DOI 10.1016/j.jmb.2015.09.023; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Tan ALC, 2005, BIOCHEM J, V386, P1, DOI 10.1042/BJ20041415; Tartakoff AM, 2012, CELL REPORTS; Thrower DA, 2003, J CELL SCI, V116, P561, DOI 10.1242/jcs.00251; Toda K, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-4; Torres-Rosell J, 2004, CELL CYCLE, V3, P496; Toussaint M, 2005, BIOCHEM CELL BIOL, V83, P449, DOI 10.1139/O05-141; Trumtel S, 2000, MOL BIOL CELL, V11, P2175, DOI 10.1091/mbc.11.6.2175; Tully GH, 2009, MOL BIOL CELL, V20, P1201, DOI 10.1091/mbc.E08-08-0822; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vanoosthuyse V, 2009, GENE DEV, V23, P2799, DOI 10.1101/gad.1882109; Varela E, 2009, EMBO J, V28, P1562, DOI 10.1038/emboj.2009.111; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	89	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174306	10.1371/journal.pone.0174306	http://dx.doi.org/10.1371/journal.pone.0174306			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339487	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700027
J	Fletcher, LB; Veenstra, RN; Loo, EY; Hwang, AE; Siddiqi, IN; Visser, L; Hepkema, BG; Nolte, IM; van den Berg, A; Cozen, W; Diepstra, A				Fletcher, Luke B.; Veenstra, Rianne N.; Loo, Eric Y.; Hwang, Amie E.; Siddiqi, Imran N.; Visser, Lydia; Hepkema, Bouke G.; Nolte, Ilja M.; van den Berg, Anke; Cozen, Wendy; Diepstra, Arjan			HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; CLASS-I; DISEASE; RISK; HLA-A-ASTERISK-02; METAANALYSIS; POPULATIONS; PROTEIN	A proportion of classical Hodgkin lymphomas harbor the Epstein Barr virus (EBV). We previously demonstrated that associations between Human Leukocyte Antigen (HLA) alleles and susceptibility to EBV+ classical Hodgkin lymphoma differ between European and Chinese populations. Data on Hispanic populations is missing. Here we examined the association between HLA type, tumor cell HLA expression and other characteristics in Hispanic Hodgkin lymphoma patients. Hispanic Hodgkin lymphoma patients diagnosed at the Los Angeles County-University of Southern California Medical Center from 2000-2012 were included (n = 65). Formalin-fixed paraffin-embedded tumor tissue was analyzed for EBV by in situ hybridization and for HLA class I and class II expression by immunohistochemistry. HLA typing was performed by HLA-A specific quantitative PCR of genomic DNA from tissue. Thirty patients (46%) had EBV+ tumors. Expression of HLA class I (p = 0.0006) was significantly associated with EBV+ tumor status in Hispanic patients, similar to Europeans and Chinese. A positive association between HLA class II expression and EBV+ tumor status, as present in large studies in Europeans, was not found (p = 0.06). The prevalences of the specific European HLA-A*01 risk and European HLA-A*02 protective types were not significantly associated with EBV+ tumors among these Hispanic patients, however numbers were too low to draw firm conclusions. The HLA-A*02: 07 allele, that is associated with EBV+ Hodgkin lymphoma in Chinese, was absent. In conclusion, the association between EBV positivity in tumor cells and HLA class I expression appears to be consistent across different populations. Larger studies in Hispanics are needed to evaluate HLA allele susceptibility associations.	[Fletcher, Luke B.; Hwang, Amie E.; Cozen, Wendy] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Fletcher, Luke B.; Loo, Eric Y.; Hwang, Amie E.; Siddiqi, Imran N.; Cozen, Wendy] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Veenstra, Rianne N.; Visser, Lydia; van den Berg, Anke; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Loo, Eric Y.; Siddiqi, Imran N.; Cozen, Wendy] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Hepkema, Bouke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Southern California; University of Southern California; University of Groningen; University of Southern California; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	van den Berg, Anke/H-1718-2011	van den Berg, Anke/0000-0002-8894-2638; Diepstra, Arjan/0000-0001-9239-1050; Siddiqi, Imran/0000-0001-8083-9639	National Cancer Institute [P30CA014089, 1R01CA206019-01]; Dutch Cancer Society [KWF RUG 2014-6698]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Cancer Society(KWF Kankerbestrijding)	The project described was supported in part by award numbers P30CA014089 and 1R01CA206019-01 from the National Cancer Institute (www.cancer.gov) to Wendy Cozen. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The project was also supported by a grant from the Dutch Cancer Society (KWF RUG 2014-6698;www.kwf.nl/englsh) to Anke van den Berg and Arjan Diepstra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2008, CLIN CANCER RES, V14, P685, DOI 10.1158/1078-0432.CCR-07-1246; Ansell SM, 2012, AM J HEMATOL, V87, P1096, DOI 10.1002/ajh.23348; Barros MHM, 2012, INT J CANCER, V131, P1142, DOI 10.1002/ijc.27314; Bryden H, 1997, INT J CANCER, V72, P614, DOI 10.1002/(SICI)1097-0215(19970807)72:4<614::AID-IJC11>3.0.CO;2-B; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Cozen W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4856; COZEN W, 1992, CANCER EPIDEM BIOMAR, V1, P261; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Gandhi MK, 2004, BRIT J HAEMATOL, V125, P267, DOI 10.1111/j.1365-2141.2004.04902.x; Glaser SL, 2008, INT J CANCER, V123, P1499, DOI 10.1002/ijc.23741; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; HERBST H, 1993, INT J CLIN LAB RES, V23, P13, DOI 10.1007/BF02592274; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Huang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031865; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Jones K, 2016, CLIN EXP IMMUNOL, V183, P206, DOI 10.1111/cei.12716; Kushekhar K, 2014, CANCER EPIDEM BIOMAR, V23, P2737, DOI 10.1158/1055-9965.EPI-14-0683; Lee SP, 1998, BLOOD, V92, P1020, DOI 10.1182/blood.V92.3.1020.415a20_1020_1030; Liu Y, 2014, LEUKEMIA, V28, P2248, DOI 10.1038/leu.2014.201; Liu YX, 2014, SEMIN CANCER BIOL, V24, P15, DOI 10.1016/j.semcancer.2013.07.002; Nakatsuka S, 2006, INT J HEMATOL, V83, P391, DOI 10.1532/IJH97.05184; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Niens M, 2006, CANCER EPIDEM BIOMAR, V15, P2280, DOI 10.1158/1055-9965.EPI-06-0476; Omiya R, 2002, J IMMUNOL, V169, P2172, DOI 10.4049/jimmunol.169.4.2172; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Reichel J, 2015, BLOOD, V125, P1061, DOI 10.1182/blood-2014-11-610436; Urayama K., 2012, JNCI-J NATL CANCER I, V104, P1	31	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174457	10.1371/journal.pone.0174457	http://dx.doi.org/10.1371/journal.pone.0174457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334025	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200101
J	Trevelin, LC; Novaes, RLM; Colas-Rosas, PF; Benathar, TCM; Peres, CA				Trevelin, Leonardo Carreira; Morim Novaes, Roberto Leonan; Colas-Rosas, Paul Francois; Melo Benathar, Thayse Cristhina; Peres, Carlos A.			Enhancing sampling design in mist-net bat surveys by accounting for sample size optimization	PLOS ONE			English	Article							RIO-DE-JANEIRO; ATLANTIC FOREST; VERTICAL STRATIFICATION; PHYLLOSTOMID BATS; TEMPORAL ACTIVITY; ASSEMBLAGES; PATTERNS; COMMUNITIES; CONCORDANCE; LANDSCAPE	The advantages of mist-netting, the main technique used in Neotropical bat community studies to date, include logistical implementation, standardization and sampling representativeness. Nonetheless, study designs still have to deal with issues of detectability related to how different species behave and use the environment. Yet there is considerable sampling heterogeneity across available studies in the literature. Here, we approach the problem of sample size optimization. We evaluated the common sense hypothesis that the first six hours comprise the period of peak night activity for several species, thereby resulting in a representative sample for the whole night. To this end, we combined re-sampling techniques, species accumulation curves, threshold analysis, and community concordance of species compositional data, and applied them to datasets of three different Neotropical biomes (Amazonia, Atlantic Forest and Cerrado). We show that the strategy of restricting sampling to only six hours of the night frequently results in incomplete sampling representation of the entire bat community investigated. From a quantitative standpoint, results corroborated the existence of a major Sample Area effect in all datasets, although for the Amazonia dataset the six-hour strategy was significantly less species-rich after extrapolation, and for the Cerrado dataset it was more efficient. From the qualitative standpoint, however, results demonstrated that, for all three datasets, the identity of species that are effectively sampled will be inherently impacted by choices of sub-sampling schedule. We also propose an alternative six-hour sampling strategy (at the beginning and the end of a sample night) which performed better when resampling Amazonian and Atlantic Forest datasets on bat assemblages. Given the observed magnitude of our results, we propose that sample representativeness has to be carefully weighed against study objectives, and recommend that the trade-off between logistical constraints and additional sampling performance should be carefully evaluated.	[Trevelin, Leonardo Carreira] Univ Fed Para, Programa Posgrad Zool, Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Morim Novaes, Roberto Leonan] Fundacao Oswaldo Cruz, Fiocruz Mata Atlantica, Rio De Janeiro, RJ, Brazil; [Colas-Rosas, Paul Francois] Biophilium Consultoria Ambiental Ltda, Atibaia, SP, Brazil; [Melo Benathar, Thayse Cristhina] Univ Fed Para, Lab Citogenet, CEABIO, ICB, Belem, Para, Brazil; [Peres, Carlos A.] Univ East Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich, Norfolk, England	Museu Paraense Emilio Goeldi; Universidade Federal do Para; Fundacao Oswaldo Cruz; Universidade Federal do Para; University of East Anglia	Trevelin, LC (corresponding author), Univ Fed Para, Programa Posgrad Zool, Museu Paraense Emilio Goeldi, Belem, Para, Brazil.	leotrevelin@hotmail.com	Novaes, Roberto Leonan Morim/AAC-3630-2020; Trevelin, Leonardo/AAX-3233-2021; Peres, Carlos A./ABE-8361-2020; Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019	Novaes, Roberto Leonan Morim/0000-0003-1657-2807; Trevelin, Leonardo/0000-0002-1041-6902; Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Colas-Rosas, Paul Francois/0000-0003-4487-7114	ICNT Project "Uso da Terra e Biodiversidade na Amazonia" Project [384368/2009-3]; Brazilian Ministry of Education (CAPES); Darwin Initiative for the Survival of Species [20-001]	ICNT Project "Uso da Terra e Biodiversidade na Amazonia" Project; Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Darwin Initiative for the Survival of Species	Fieldwork in Amazonia was financed by ICNT Project "Uso da Terra e Biodiversidade na Amazonia" Project (process no. 384368/2009-3). LCT was awarded a PhD studentship from the Brazilian Ministry of Education (CAPES). Fieldwork in Brazil by CAP is funded by the Darwin Initiative for the Survival of Species under project 20-001. These funders had no role in the study design, data collection and data analysis, decision to publish, or preparation of the manuscript. Casa da Floresta Ambiental SS and Fibria provided support by granting access to a portion of the data analyzed in this manuscript. Biophilium Consultoria Ambiental Ltda. provides support in the form of salaries for PFCR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2012, METHODS ECOL EVOL, V3, P992, DOI 10.1111/j.2041-210X.2012.00244.x; Aguiar Ludmilla Moura de Souza, 2004, Rev. Bras. Zool., V21, P385, DOI 10.1590/S0101-81752004000200037; Avma, 2021, AVM DEF ANT US TREAT; Baker M.E., 2015, TITAN2 THRESHOLD IND; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Bernard E, 2001, J TROP ECOL, V17, P115, DOI 10.1017/S0266467401001079; Bernard E, 2011, MAMMAL REV, V41, P23, DOI 10.1111/j.1365-2907.2010.00164.x; Bernard Enrico, 2002, Rev. Bras. Zool., V19, P173, DOI 10.1590/S0101-81752002000100016; Bezerra AMR, 2010, ZOOTAXA, P41; Bini LM, 2008, HYDROBIOLOGIA, V598, P247, DOI 10.1007/s10750-007-9157-3; Bolivar-Cime B, 2013, ACTA CHIROPTEROL, V15, P399, DOI 10.3161/150811013X679026; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cardoso P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063294; Castro-Arellano I, 2009, BIOL CONSERV, V142, P2131, DOI 10.1016/j.biocon.2009.04.013; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cunto GC, 2012, ACTA CHIROPTEROL, V14, P143, DOI 10.3161/150811012X654358; de Almeida A.S., 2010, REV ESTUDOS U, V36, P95, DOI DOI 10.1007/S13398-014-0173-7.2; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Erkert H.G., 1982, P201; Esberard CEL, 2005, REV BRAS ZOOL, V22, P1095, DOI 10.1590/S0101-81752005000400039; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Faria D, 2006, J TROP ECOL, V22, P531, DOI 10.1017/S0266467406003385; GARDNER A. L., 2008, MAMMALS S AM, P1; Gotelli Nicholas J., 2011, P39; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Juen L, 2013, ANN LIMNOL-INT J LIM, V49, P129, DOI 10.1051/limn/2013048; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kingston Tigga, 2009, P195; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; KUNZ TH, 1996, MEASURING MONITORING, P122; Leitao RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0084; Magurran Anne E., 2011, P97; MapBiomas project, 2016, COLL 1 ANN SER BRAZ; Marciente R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129560; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Meyer CFJ, 2011, J APPL ECOL, V48, P777, DOI 10.1111/j.1365-2664.2011.01976.x; Novaes RLM, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e4404; Moura NG, 2014, CONSERV BIOL, V28, P1271, DOI 10.1111/cobi.12300; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Patterson BD, 2003, BAT ECOLOGY, P536; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Peters SL, 2006, CONSERV BIOL, V20, P1410, DOI 10.1111/j.1523-1739.2006.00526.x; Presley SJ, 2009, J MAMMAL, V90, P210, DOI 10.1644/08-MAMM-A-089.1; R Core Team, 2018, R LANGUAGE ENV STAT; Pereira MJR, 2010, CURR ZOOL, V56, P469, DOI 10.1093/czoolo/56.4.469; Pereira MJR, 2009, J ANIM ECOL, V78, P1163, DOI 10.1111/j.1365-2656.2009.01591.x; Saito VS, 2015, BIOTROPICA, V47, P399, DOI 10.1111/btp.12222; Sarkar D, 2008, USE R, P1; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons NB, 1998, B AM MUS NAT HIST, P1; Siqueira T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043626; Souza Renan de Franca, 2015, Neotropical Biology and Conservation, V10, P9, DOI 10.4013/nbc.2015.101.02; Voss Robert S., 1996, Bulletin of the American Museum of Natural History, V230, P1	55	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174067	10.1371/journal.pone.0174067	http://dx.doi.org/10.1371/journal.pone.0174067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334046	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000399102200042
J	Wade, CH; Elliott, KR				Wade, Christopher H.; Elliott, Kailyn R.			Preferences for the provision of whole genome sequencing services among young adults	PLOS ONE			English	Article							LIFE-COURSE PERSPECTIVE; INCIDENTAL FINDINGS; GENETICS PROFESSIONALS; LONGITUDINAL COHORT; DECISION-MAKING; ATTITUDES; EXOME; DISEASE; RETURN; RISK	Objectives As whole genome sequencing (WGS) becomes increasingly available, clinicians will be faced with conveying complex information to individuals at different stages in life. The purpose of this study is to characterize the views of young adults toward obtaining WGS, learning different types of genomic information, and having choice about which results are disclosed. Methods A mixed-methods descriptive study was conducted with a diverse group of 18 and 19-years-olds (N = 145). Participants watched an informational video about WGS and then completed an online survey. Results Participants held a positive attitude toward obtaining WGS and learning about a range of health conditions and traits. Increased interest in learning WGS information was significantly associated with anticipated capacity to handle the emotional consequences if a serious risk was found (beta = 0.13, P =.04). Young adults wanted the ability to choose what types of genomic risk information would be returned and expressed decreased willingness to undergo WGS if clinicians made these decisions (t(138) = -7.14, P <. 01). Qualitative analysis showed that young adults emphasized procedural factors in WGS decision-making and that perceived health benefits of WGS had a substantial role in testing preferences and anticipated usage of WGS results. Conclusions Clinicians are likely to encounter enthusiasm for obtaining WGS results among young adults and may need to develop strategies for ensuring that this preference is adequately informed.	[Wade, Christopher H.] Univ Washington Bothell, Sch Nursing & Hlth Studies, Bothell, WA 98011 USA; [Elliott, Kailyn R.] Univ Washington, Sch Med, Seattle, WA USA	University of Washington; University of Washington Bothell; University of Washington; University of Washington Seattle	Wade, CH (corresponding author), Univ Washington Bothell, Sch Nursing & Hlth Studies, Bothell, WA 98011 USA.	cwade7@uw.edu		Wade, Christopher/0000-0003-1036-5145	School of Nursing Health Studies; School of Nursing and Health Studies at the University of Washington Bothell	School of Nursing Health Studies; School of Nursing and Health Studies at the University of Washington Bothell	The funding for this study was supplied by the first author's (Christopher H. Wade) annual departmental research funds. These funds were supplied by the School of Nursing & Health Studies (www.umb.edu/nhs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the School of Nursing and Health Studies at the University of Washington Bothell for providing the funding for this study.	Alexander D, 2006, PEDIATRICS, V117, pS350, DOI 10.1542/peds.2005-2633O; Anderson JA, 2015, CLIN GENET, V87, P301, DOI 10.1111/cge.12460; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Bodian DL, 2016, GENET MED, V18, P221, DOI 10.1038/gim.2015.111; Borry P, 2006, EUR J HUM GENET, V14, P133, DOI 10.1038/sj.ejhg.5201509; Brockman D, 2003, LATE ADOLESCENCE YOU; Collins J, 2014, J HUM NUTR DIET, V27, P479, DOI 10.1111/jhn.12179; Dodson DS, 2015, PUBLIC HEALTH GENOM, V18, P151, DOI 10.1159/000375115; Driessnack M, 2013, J COMMUN GENET, V4, P435, DOI 10.1007/s12687-013-0145-1; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Facio FM, 2013, EUR J HUM GENET, V21, P261, DOI 10.1038/ejhg.2012.179; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Hall MJ, 2015, J SURG ONCOL, V111, P9, DOI 10.1002/jso.23712; Hamilton RJ, 2016, J GENET COUNS, V25, P44, DOI 10.1007/s10897-015-9878-9; Hamilton RJ, 2016, J GENET COUNS, V25, P49, DOI 10.1007/s10897-015-9877-x; Hein IM, 2015, J GENET COUNS, V24, P971, DOI 10.1007/s10897-015-9835-7; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Kerruish N, 2015, GENET MED; Levenseller BL, 2014, J GENET COUNS, V23, P552, DOI 10.1007/s10897-013-9626-y; Mavroidopoulou V, 2015, J HUM GENET, V60, P515, DOI 10.1038/jhg.2015.58; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Patall EA, 2008, PSYCHOL BULL, V134, P270, DOI 10.1037/0033-2909.134.2.270; Persky S, 2007, GENET MED, V9, P727, DOI 10.1097/GIM.0b013e318159a344; Reyna VF, 2008, MED DECIS MAKING, V28, P850, DOI 10.1177/0272989X08327066; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Sanderson SC, 2016, GENET MED, V18, P501, DOI 10.1038/gim.2015.118; Sanderson SC, 2015, GENET MED, V17, P866, DOI 10.1038/gim.2014.203; Sanderson SC, 2013, GENOME MED, V5, DOI 10.1186/gm518; Tercyak KP, 2011, PEDIATRICS, V127, pE1288, DOI 10.1542/peds.2010-0938; Tluczek Audrey, 2013, J Obstet Gynecol Neonatal Nurs, V42, pE84, DOI 10.1111/1552-6909.12253; Ulm E, 2015, J GENET COUNS, V24, P452, DOI 10.1007/s10897-014-9779-3; Vayena E, 2014, PUBLIC HEALTH GENOM, V17, P158, DOI 10.1159/000360257; Wade CH, 2012, PUBLIC HEALTH GENOM, V15, P322, DOI 10.1159/000338114; Wade CH, 2016, PER MED IN PRESS; Wade CH, 2013, ANNU REV GENOM HUM G, V14, P535, DOI 10.1146/annurev-genom-091212-153425; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004; Yu JH, 2013, GENET MED, V15, P684, DOI 10.1038/gim.2013.35	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174131	10.1371/journal.pone.0174131	http://dx.doi.org/10.1371/journal.pone.0174131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334023	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200052
J	Le Bloa, S; Durand, L; Cueff-Gauchard, V; Le Bars, J; Taupin, L; Marteau, C; Bazire, A; Cambon-Bonavita, MA				Le Bloa, Simon; Durand, Lucile; Cueff-Gauchard, Valerie; Le Bars, Josiane; Taupin, Laure; Marteau, Charlotte; Bazire, Alexis; Cambon-Bonavita, Marie-Anne			Highlighting of quorum sensing lux genes and their expression in the hydrothermal vent shrimp Rimicaris exoculata ectosymbiontic community. Possible use as biogeographic markers	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; TO-CELL COMMUNICATION; HELICOBACTER-PYLORI; BACTERIAL SYMBIONTS; HOMOSERINE LACTONE; MICROBIAL LIFE; GILL CHAMBER; BIOFILMS; FIELD; ALVINOCARIDIDAE	Rimicaris exoculata is a caridean shrimp that dominates the fauna at several hydrothermal vent sites of the Mid-Atlantic Ridge. It has two distinct and stable microbial communities. One of these epibiontic bacterial communities is located in the shrimp gut and has a distribution and role that are poorly understood. The second colonizes its enlarged gill chamber and is involved in host nutrition. It is eliminated after each molt, and has colonization processes reminiscent of those of a biofilm. The presence and expression of genes usually involved in quorum sensing (QS) were then studied. At four sites, Rainbow, TAG, Snake Pit and Logatchev, two lux genes were identified in the R. exoculata epibiontic community at different shrimp molt stages and life stages. RT-PCR experiments highlighted lux gene expression activity at TAG, Snake Pit and Rainbow vent sites. Their potential QS activity and their possible roles in epibiont colonization processes are discussed. Moreover, phylogenetic analysis has shown the presence of three clades for luxS (Epsilonproteobacteria) and four clades for luxR (Gammaproteobacteria) genes, each clade being restricted to a single site. These genes are more divergent than the 16S rRNA one. They could therefore be used as biogeographical genetic markers.	[Le Bloa, Simon; Durand, Lucile; Cueff-Gauchard, Valerie; Le Bars, Josiane; Cambon-Bonavita, Marie-Anne] IFREMER, Lab Microbiol Environm Extremes, UMR Ifremer CNRS UBO 6197, Ctr Bretagne,REM EEP LM2E, Plouzane, France; [Le Bloa, Simon; Cueff-Gauchard, Valerie; Le Bars, Josiane; Cambon-Bonavita, Marie-Anne] Univ Brest, Lab Microbiol Environm Extremes, UMR Ifremer CNRS UBO 6197, Plouzane, France; [Le Bloa, Simon; Cueff-Gauchard, Valerie; Le Bars, Josiane; Cambon-Bonavita, Marie-Anne] CNRS, Lab Microbiol Environm Extremes, UMR Ifremer CNRS UBO 6197, Plouzane, France; [Taupin, Laure; Marteau, Charlotte; Bazire, Alexis] Univ Bretagne Sud, EA 3884, LBCM, Lorient, France	Ifremer; Universite de Bretagne Occidentale; Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Bretagne Occidentale	Cambon-Bonavita, MA (corresponding author), IFREMER, Lab Microbiol Environm Extremes, UMR Ifremer CNRS UBO 6197, Ctr Bretagne,REM EEP LM2E, Plouzane, France.	macambon@ifremer.fr	Cueff, Valerie/AAW-9258-2021	Cueff-Gauchard, Valerie/0000-0001-6969-642X; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472	Ifremer; LabexMer [ANR-10-LABX-19-01]; Carnot Ifremer EDROME 'Reximmu' [ANR CARN-018-01]	Ifremer; LabexMer; Carnot Ifremer EDROME 'Reximmu'	This work was supported by Ifremer, and LabexMer (ANR-10-LABX-19-01) and Carnot Ifremer EDROME 'Reximmu' (ANR CARN-018-01) fundings.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Biswa P, 2013, FEMS MICROBIOL LETT, V343, P34, DOI 10.1111/1574-6968.12123; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Cao YA, 2012, APPL ENVIRON MICROB, V78, P1899, DOI 10.1128/AEM.06139-11; CASANOVA B, 1993, CAH BIOL MAR, V34, P573; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chiba H, 2001, GEOPHYS RES LETT, V28, P2919, DOI 10.1029/2000GL012645; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Corbari L, 2008, BIOGEOSCIENCES, V5, P1295, DOI 10.5194/bg-5-1295-2008; Corbari L, 2008, AQUAT BIOL, V1, P225, DOI 10.3354/ab00024; DeChaine EG, 2006, ENVIRON MICROBIOL, V8, P1902, DOI 10.1111/j.1462-2920.2005.01113.x; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Durand L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv101; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; Eberl L, 2011, PROTEOMICS, V11, P3070, DOI 10.1002/pmic.201000814; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Ferrer M, 2012, ENVIRON MICROBIOL, V14, P268, DOI 10.1111/j.1462-2920.2011.02634.x; Filloux A, 2003, M S-MED SCI, V19, P77, DOI 10.1051/medsci/200319177; Flores GE, 2011, ENV MICROBIOL, V13; Fuqua C, 2006, J BACTERIOL, V188, P3169, DOI 10.1128/JB.188.9.3169-3171.2006; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Gun M, 2012, ISME J, V6, P597; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Irie Y, 2008, CURR TOP MICROBIOL, V322, P67; Jan C, 2014, ENVIRON MICROBIOL, V16, P2723, DOI 10.1111/1462-2920.12406; Joint I, 2002, SCIENCE, V298, P1207, DOI 10.1126/science.1077075; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Komai T, 2008, J SHELLFISH RES, V27, P21, DOI 10.2983/0730-8000(2008)27[21:TROTHV]2.0.CO;2; Letunic L, 2012, NUCL ACIDS RES; Monroe D, 2007, PLOS BIOL, V5, P2458, DOI 10.1371/journal.pbio.0050307; Montgomery Kate, 2013, Life-Basel, V3, P131, DOI 10.3390/life3010131; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Nichols JD, 2009, FEMS MICROBIOL ECOL, V68, P173, DOI 10.1111/j.1574-6941.2009.00662.x; Nye V, 2012, J MAR BIOL ASS; O'Toole PW, 2000, MICROBES INFECT, V2, P1207, DOI 10.1016/S1286-4579(00)01274-0; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Perez-Rodriguez I, 2015, ISME J, V9, P1222, DOI 10.1038/ismej.2014.214; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Plummer P, 2012, INFECT IMMUN, V80, P585, DOI 10.1128/IAI.05766-11; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Rader BA, 2011, MICROBIOL-SGM, V157, P2445, DOI 10.1099/mic.0.049353-0; Ravaux J, 2009, MAR ECOL PROG SER, V396, P153, DOI 10.3354/meps08293; Rosa RD, 2010, ISJ-INVERT SURVIV J, V7, P262; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Schmidt C, 2008, MAR CHEM, V108, P18, DOI 10.1016/j.marchem.2007.09.009; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Szafranski KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00162; Tait K, 2005, ENVIRON MICROBIOL, V7, P229, DOI 10.1111/j.1462-2920.2004.00706.x; Tait K, 2013, MOL ECOL, V22, P2588, DOI 10.1111/mec.12273; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; Wolcott RD, 2008, J WOUND CARE, V8, P333; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	79	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174338	10.1371/journal.pone.0174338	http://dx.doi.org/10.1371/journal.pone.0174338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328982	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700083
J	Suswardany, DL; Sibbritt, DW; Supardi, S; Pardosi, JF; Chang, S; Adams, J				Suswardany, Dwi Linna; Sibbritt, David W.; Supardi, Sudibyo; Pardosi, Jerico F.; Chang, Sungwon; Adams, Jon			A cross-sectional analysis of traditional medicine use for malaria alongside free antimalarial drugs treatment amongst adults in high-risk malaria endemic provinces of Indonesia	PLOS ONE			English	Article							HEALTH-CARE-SEEKING; COMMUNITY PERCEPTIONS; JAVA; ELIMINATION; COUNTRIES; CHILDREN; DISEASE; PATIENT; ACCESS; SYSTEM	Background The level of traditional medicine use, particularly Jamu use, in Indonesia is substantial. Indonesians do not always seek timely treatment for malaria and may seek self-medication via traditional medicine. This paper reports findings from the first focused analyses of traditional medicine use for malaria in Indonesia and the first such analyses worldwide to draw upon a large sample of respondents across high-risk malaria endemic areas. Methods A sub-study of the Indonesia Basic Health Research/Riskesdas Study 2010 focused on 12,226 adults aged 15 years and above residing in high-risk malaria-endemic provinces. Logistic regression was undertaken to determine the significant associations for traditional medicine use for malaria symptoms. Findings Approximately one in five respondents use traditional medicine for malaria symptoms and the vast majority experiencing multiple episodes of malaria use traditional medicine alongside free antimalarial drug treatments. Respondents consuming traditional medicine for general health/common illness purposes every day (odds ratio: 3.75, 95% Confidence Interval: 2.93 4.79), those without a hospital in local vicinity (odds ratio: 1.31, 95% Confidence Interval: 1.10 1.57), and those living in poorer quality housing, were more likely to use traditional medicine for malaria symptoms. Conclusion A substantial percentage of those with malaria symptoms utilize traditional medicine for treating their malaria symptoms. In order to promote safe and effective malaria treatment, all providing malaria care in Indonesia need to enquire with their patients about possible traditional medicine use.	[Suswardany, Dwi Linna; Sibbritt, David W.; Chang, Sungwon; Adams, Jon] Univ Technol Sydney, Fac Hlth, ARCCIM, Sydney, NSW, Australia; [Suswardany, Dwi Linna] Univ Muhammadiyah Surakarta, Cent Java, Indonesia; [Supardi, Sudibyo; Pardosi, Jerico F.] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Pardosi, Jerico F.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Technology Sydney; Universitas Muhammadiyah Surakarta; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; University of New South Wales Sydney	Adams, J (corresponding author), Univ Technol Sydney, Fac Hlth, ARCCIM, Sydney, NSW, Australia.	Jon.Adams@uts.edu.au	Sibbritt, David W/F-8070-2017; Suswardany, Dwi Linna/GQZ-4670-2022; Pardosi, Jerico/L-7873-2019; Chang, Sungwon/ABB-1454-2021	Sibbritt, David W/0000-0003-3561-9447; Suswardany, Dwi Linna/0000-0003-0793-9945; Pardosi, Jerico/0000-0003-3753-5669; Adams, Jon/0000-0002-9901-5717; Chang, Sungwon/0000-0003-0723-3192	Ministry of Research, Technology, and Higher Education, Indonesia; Directorate General for Higher Education (DIKTI)	Ministry of Research, Technology, and Higher Education, Indonesia; Directorate General for Higher Education (DIKTI)	PhD scholarship for DLS was via the Ministry of Research, Technology, and Higher Education, Indonesia. Cost for publication is provided by Australian Research Centre in Complementary and Integrative Medicine (ARCCIM).; We would like to thank: the National Institute of Health Research and Development, Ministry of Health, Indonesia for approving and facilitating access to the data set; the Directorate General for Higher Education (DIKTI), Ministry of Research, Technology, and Higher Education, Indonesia for funding a PhD Scholarship for DLS; Universitas Muhammadiyah Surakarta for supporting DLS' study, and Ki Hariyadi for contributing via early correspondence on this topic.	Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2015, GUIDELINES FOR THE T; Aqil A, 2009, HEALTH POLICY PLANN, V24, P217, DOI 10.1093/heapol/czp010; Asih PBS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-291; Badan Penelitian dan Pengembangan Kesehatan Kemenkes (National Health Research and Develop- ment Ministry of Health Indonesia), 2013, LAPORAN RISKESDAS; Badan Penelitian dan Pengembangan Kesehatan Kemenkes (National Health Research and Development Ministry of Health Indonesia), 2010, LAPORAN RISKESDAS; Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia (National Health Research and Development Ministry of Health Indonesia), 2010, PED PENG KEUS RISK 2; Badan Pusat Statistik (Statistics Indonesia), 2015, PERSENTASE PENDUDUK; Bruxvoort K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084555; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Das A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-39; Delima D, 2012, BULETIN PENELITIAN K, V40; Diaz T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-157; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Elfahmi, 2014, J HERB MED, V4, P51, DOI 10.1016/j.hermed.2014.01.002; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Gazali A. K, 2013, PERILAKU PENCARIAN P; Gyasi R.M., 2011, GLOBAL J HLTH SCI, V3, P2, DOI DOI 10.5539/gjhs.v3n2p40; Handayani L, 2011, BULETIN PENELITIAN S, V14; Harijanto PN, 2010, ACTA MED INDONES, V42, P11; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kusriastuti Rita, 2012, Acta Med Indones, V44, P265; Limpakarnjanarat K., 2011, NATIONAL MALARIA CON; Linn TZ, 2005, J NAT PROD, V68, P706, DOI 10.1021/np0401720; Luthi B, 2015, TRAVEL MED INFECT DI, V13, P48, DOI 10.1016/j.tmaid.2014.04.014; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mardiana M, 2004, MEDIA PENELITIAN DAN, V14; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII16, DOI 10.1093/heapol/czr062; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Moszynski P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5645; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mustofa, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P609; Nimpagaritse M, 2011, HEALTH POLICY PLANN, V26, pII63, DOI 10.1093/heapol/czr061; Nonaka D, 2009, ACTA TROP, V112, P283, DOI 10.1016/j.actatropica.2009.08.013; Orem JN, 2011, HEALTH POLICY PLANN, V26, pII41, DOI 10.1093/heapol/czr065; Pradono J, 2005, SURVEI KESEHATAN RUM; Ramadianto A. S., 2015, J AMSA, V4, P4; Ransford HE, 2010, J HEALTH CARE POOR U, V21, P862, DOI 10.1353/hpu.0.0348; Roosita K, 2008, J ETHNOPHARMACOL, V115, P72, DOI 10.1016/j.jep.2007.09.010; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sanjana P, 2006, AM J TROP MED HYG, V75, P783, DOI 10.4269/ajtmh.2006.75.783; Shah GM, 2014, J ETHNOPHARMACOL, V155, P450, DOI 10.1016/j.jep.2014.05.047; Shinta S, 2005, JURNAL EKOLOGI KESEH, V4; Shirayama Yoshihisa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P622; Sidik NA, 2013, TROP MED INT HEALTH, V18, P407, DOI 10.1111/tmi.12061; Srivastava D, 2015, SOC SCI MED, V133, P21, DOI 10.1016/j.socscimed.2015.03.021; Subeki S, 2012, J TEKNOLOGI DAN IND, V13; Sujarwo W, 2015, J ETHNOPHARMACOL, V169, P34, DOI 10.1016/j.jep.2015.03.079; Supardi S, 2011, HLTH SCI J INDONES, V2, P3; Supardi S, 2011, BULETIN PENELITIAN S, V13; Suswardany DL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0593-7; Tangjang S, 2011, J ETHNOPHARMACOL, V134, P18, DOI 10.1016/j.jep.2010.11.053; Torri MC, 2016, J SMALL BUS MANAGE, V54, P341, DOI 10.1111/jsbm.12148; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; Utarini A, 2003, SOC SCI MED, V56, P701, DOI 10.1016/S0277-9536(02)00066-7; Vijayakumar KN, 2009, ACTA TROP, V112, P137, DOI 10.1016/j.actatropica.2009.07.011; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Widowati L, 2014, MEDIA PENELIT PENGEM, V24, P95; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066; Xu JW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-417	61	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173522	10.1371/journal.pone.0173522	http://dx.doi.org/10.1371/journal.pone.0173522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28329019	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700023
J	Yang, MN; Xiao, XL; Xing, XR; Li, X; Xia, T; Long, HN				Yang, Minnan; Xiao, Xiuli; Xing, Xiaorui; Li, Xin; Xia, Tian; Long, Hanan			KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BINDING-SITE POLYMORPHISM; CELL LUNG-CANCER; BREAST-CANCER; CHINESE POPULATION; SEQUENCE VARIATION; INCREASED RISK; METAANALYSIS; MUTATIONS; ASSOCIATION	Single nucleotide polymorphisms (SNPs) in tumor-related genes have been reported to play important roles in cancer development. Recent studies have shown that 3'-untranslated regions (UTR) polymorphisms are associated with the occurrence and prognosis of cancers. The aim of this study is to analyze the association between KRAS and VEGF gene 3'-UTR SNPs and genetic susceptibility to colorectal cancer (CRC). In this case-control study of 371 CRC cases and 246 healthy controls, we analyzed the association between one SNP (rs1137188G > A) in the KRAS gene and four SNPs (rs3025039C > T, rs3025040C > T, rs3025053G > A and rs10434A > G) in the VEGF gene and CRC susceptibility by the improved multiplex ligase detection reaction (iMLDR) method. We checked the selected SNPs' minor allele frequency and its distribution in the frequency of Chinese people by Hap-map database and Hardy-Weinberg equilibrium, and used multivariate logistic regression models to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs). We found that the rs3025039C variant genotype in the VEGF gene was associated with a significant protection for CRC (AOR = 0.693, 95% CI = 0.485-0.989; P = 0.043 for CC and CT+TT). Nevertheless, the difference was no longer significant after Bonferroni correction (Bonferroni-adjusted P = 0.172). In genetic polymorphisms analysis, we found that the KRAS rs1137188 variant AA genotype had higher portion of tumor size (>= 5 cm) (P = 0.01; Bonferroni-adjusted P = 0.04), which suggested that the rs1137188 variant AA genotype may significantly be associated with increased progression of CRC. In conclusion, our study suggested that these five SNPs in the KRAS gene and the VEGF gene were not associated with CRC susceptibility in Han Chinese in Sichuan province.	[Yang, Minnan; Xing, Xiaorui] Southwest Med Univ, Coll Preclin Med, Luzhou, Sichuan, Peoples R China; [Xiao, Xiuli; Xia, Tian; Long, Hanan] Southwest Med Univ, Affiliated Hosp, Dept Pathol, Luzhou, Sichuan, Peoples R China; [Li, Xin] Chengdu Univ Tradit Chinese Med, Affiliated Hosp, Dept Gastrointestinal Surg, Chengdu, Sichuan, Peoples R China; [Long, Hanan] Southwest Med Univ, Dept Sci & Technol, Luzhou, Sichuan, Peoples R China	Southwest Medical University; Southwest Medical University; Chengdu University of Traditional Chinese Medicine; Southwest Medical University	Long, HN (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Pathol, Luzhou, Sichuan, Peoples R China.; Long, HN (corresponding author), Southwest Med Univ, Dept Sci & Technol, Luzhou, Sichuan, Peoples R China.	hananlly@sina.com			Joint Project of Luzhou government and Luzhou Medical College [2013LZLY-J28]	Joint Project of Luzhou government and Luzhou Medical College	This work was financially supported by the Joint Project of Luzhou government and Luzhou Medical College (No. 2013LZLY-J28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NF, 2012, INT J CANCER, V131, pE636, DOI 10.1002/ijc.27387; Arjaans M, 2016, ONCOTARGET, V7, P21247, DOI 10.18632/oncotarget.6918; Azeem Salman, 2015, Asian Pac J Cancer Prev, V16, P5389; Chen N, 2015, GENET MOL RES, V14, P16006, DOI 10.4238/2015.December.7.13; Costa-Cabral S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149099; Della-Morte D, 2015, PHARMACOGENOMICS, V16, P61, DOI [10.2217/PGS.14.136, 10.2217/pgs.14.136]; Dobre M, 2015, ROM J MORPHOL EMBRYO, V56, P671; Gao XR, 2013, CANCER BIOMARK, V13, P465, DOI 10.3233/CBM-130386; Hansen TF, 2011, PHARMACOGENOMICS J, V11, P53, DOI 10.1038/tpj.2010.4; Hein A, 2015, INT J CANCER, V137, P2981, DOI 10.1002/ijc.29656; Huller CM, 2012, CANCER RES, V72, P2036; Janardhan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131190; Jeon YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-881; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kazmi HR, 2016, J CANCER RES CLIN, V142, P2577, DOI 10.1007/s00432-016-2254-9; Kim HS, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2141-4; Kim M, 2014, CELL CYCLE, V13, P1030, DOI 10.4161/cc.27941; Kimura Y, 2016, MOL MED REP, V13, P1551, DOI 10.3892/mmr.2015.4687; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Langevin SM, 2014, CANCER MED-US, V3, P1385, DOI 10.1002/cam4.279; Li ZH, 2013, TUMOR BIOL, V34, P3159, DOI 10.1007/s13277-013-0885-x; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Rabeneck L, 2015, DIS CONTROL PRIORITI, V3, P101; Rezaei M, 2016, BREAST CANCER-BASIC, V10, P85, DOI 10.4137/BCBCR.S39649; Smits KM, 2011, CLIN CANCER RES, V17, P7723, DOI 10.1158/1078-0432.CCR-11-0990; Sun WJ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-63; Sun ZF, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-32; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang F, 2016, ONCOTARGET, V7, P11724, DOI 10.18632/oncotarget.7352; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126619; Wu T, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.482; Yao KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001884; Yi CH, 2016, ONCOTARGET, V7, P17265, DOI 10.18632/oncotarget.7504; Ying HQ, 2014, TUMOR BIOL, V35, P5895, DOI 10.1007/s13277-014-1780-9; Zhang JN, 2016, MOL NEUROBIOL, V53, P2610, DOI 10.1007/s12035-015-9240-0; Zhang SY, 2016, J CANCER RES THER, V12, P699, DOI 10.4103/0973-1482.147379	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174140	10.1371/journal.pone.0174140	http://dx.doi.org/10.1371/journal.pone.0174140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328959	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700059
J	Abdelbaset, AE; Fox, BA; Karram, MH; Abd Ellah, MR; Bzik, DJ; Igarashi, M				Abdelbaset, E. Abdelbaset; Fox, Barbara A.; Karram, Mohamed H.; Abd Ellah, Mahmoud R.; Bzik, David J.; Igarashi, Makoto			Lactate dehydrogenase in Toxoplasma gondii controls virulence, bradyzoite differentiation, and chronic infection	PLOS ONE			English	Article							SPECIFICALLY EXPRESSED GENE; HEAT-SHOCK PROTEINS; PROTOZOAN PARASITE; GLYCOLYTIC-ENZYMES; STAGE CONVERSION; NITRIC-OXIDE; IDENTIFICATION; CLONING; INDUCTION; ANTIGENS	In the asexual stages, Toxoplasma gondii stage converts between acute phase rapidly replicating tachyzoites and chronic phase slowly dividing bradyzoites. Correspondingly, T. gondii differentially expresses two distinct genes and isoforms of the lactate dehydrogenase enzyme, expressing LDH1 exclusively in the tachyzoite stage and LDH2 preferentially in the bradyzoite stage. LDH catalyzes the interconversion of pyruvate and lactate in anaerobic growth conditions and is utilized for energy supply, however, the precise role of LDH1 and LDH2 in parasite biology in the asexual stages is still unclear. Here, we investigated the biological role of LDH1 and LDH2 in the asexual stages, and the vaccine strain potential of deletion mutants lacking LDH1, LDH2, or both genes (Delta ldh1, Delta ldh2 and Delta ldh1/2). Deletion of LDH1 reduced acute parasite virulence, impaired bradyzoite differentiation in vitro, and markedly reduced chronic stage cyst burdens in vivo. In contrast, deletion of LDH2 impaired chronic stage cyst burdens without affecting virulence or bradyzoite differentiation. Deletion of both LDH1 and LDH2 induced a more severe defect in chronic stage cyst burdens. These LDH mutant phenotypes were not associated with any growth defect. Vaccination of mice with a low dose of mutants deleted for LDH elicited effective protective immunity to lethal challenge infection, demonstrating the vaccine potential of LDH deletion mutants. These results suggest that lactate dehydrogenase in T. gondii controls virulence, bradyzoite differentiation, and chronic infection and reveals the potential of LDH mutants as vaccine strains.	[Abdelbaset, E. Abdelbaset; Igarashi, Makoto] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Abdelbaset, E. Abdelbaset; Karram, Mohamed H.; Abd Ellah, Mahmoud R.] Assiut Univ, Fac Vet Med, Dept Anim Med, Clin Lab Diag, Assiut, Egypt; [Fox, Barbara A.; Bzik, David J.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); Assiut University; Dartmouth College	Igarashi, M (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.	makoto@obihiro.ac.jp	Abdelbaset, Abdelbaset/AAY-5914-2021; Abd Ellah, Mahmoud Rushdi/U-2679-2017	Abdelbaset, Abdelbaset/0000-0002-3992-4417; Abd Ellah, Mahmoud Rushdi/0000-0001-6578-8634	Japan Society for the Promotion of Science (JSPS) [25450419]; Ministry of Higher Education, Egypt	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Higher Education, Egypt(Ministry of Higher Education & Scientific Research (MHESR))	This study was supported by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science (JSPS), http://www.jsps.go. jp/j-grantsinaid/, grant #25450419, MI and the Ministry of Higher Education, Egypt, https://www. b2match.eu/energycall2016%20/participants/406, AEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science (JSPS) and the Ministry of Higher Education, Egypt.	Al-Anouti F, 2004, J BIOL CHEM, V279, P52300, DOI 10.1074/jbc.M409175200; BOHNE W, 1993, INFECT IMMUN, V61, P1141, DOI 10.1128/IAI.61.3.1141-1145.1993; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Dando C, 2001, MOL BIOCHEM PARASIT, V118, P23, DOI 10.1016/S0166-6851(01)00360-7; Dautu G, 2008, PARASITOL RES, V102, P1301, DOI 10.1007/s00436-008-0909-4; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dzierszinski F, 1999, J BIOL CHEM, V274, P24888, DOI 10.1074/jbc.274.35.24888; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Fox BA, 2015, INFECT IMMUN, V83, P2148, DOI 10.1128/IAI.02756-14; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Friesen J, 2008, MOL BIOCHEM PARASIT, V157, P228, DOI 10.1016/j.molbiopara.2007.10.005; Kavanagh KL, 2004, BIOCHEMISTRY-US, V43, P879, DOI 10.1021/bi035108g; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Lekutis C, 2000, EXP PARASITOL, V96, P89, DOI 10.1006/expr.2000.4556; Lunghi M, 2015, MOL MICROBIOL, V96, P1159, DOI 10.1111/mmi.12999; Miller CMD, 1999, PARASITOL TODAY, V15, P418, DOI 10.1016/S0169-4758(99)01515-X; Mouveaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105820; OdbergFerragut C, 1996, MOL BIOCHEM PARASIT, V82, P237, DOI 10.1016/0166-6851(96)02740-5; Okada T, 2013, MOL BIOCHEM PARASIT, V189, P5, DOI 10.1016/j.molbiopara.2013.04.005; PARMLEY SF, 1995, MOL BIOCHEM PARASIT, V73, P253, DOI 10.1016/0166-6851(95)00100-F; Salman D, 2014, J VET MED SCI, V76, P855, DOI 10.1292/jvms.13-0632; Sambrook J., 2001, MOL CLONING LAB MANU; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039; TOMAVO S, 1995, INT J PARASITOL, V25, P1293, DOI 10.1016/0020-7519(95)00066-B; Ueno A, 2009, EXP PARASITOL, V121, P55, DOI 10.1016/j.exppara.2008.09.018; Ueno A, 2011, EXP PARASITOL, V127, P795, DOI 10.1016/j.exppara.2011.01.015; YANG SM, 1995, MOL BIOCHEM PARASIT, V73, P291, DOI 10.1016/0166-6851(95)00124-J; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5	30	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173745	10.1371/journal.pone.0173745	http://dx.doi.org/10.1371/journal.pone.0173745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323833	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000027
J	Debove, S; Baumard, N; Andre, JB				Debove, Stephane; Baumard, Nicolas; Andre, Jean-Baptiste			On the evolutionary origins of equity	PLOS ONE			English	Article							COMPETITIVE ALTRUISM; PARTNER CHOICE; BIOLOGICAL MARKETS; FAIRNESS; MERIT; COOPERATION; RECIPROCITY; BENEFITS; JUSTICE; GAMES	Equity, defined as reward according to contribution, is considered a central aspect of human fairness in both philosophical debates and scientific research. Despite large amounts of research on the evolutionary origins of fairness, the evolutionary rationale behind equity is still unknown. Here, we investigate how equity can be understood in the context of the cooperative environment in which humans evolved. We model a population of individuals who cooperate to produce and divide a resource, and choose their cooperative partners based on how they are willing to divide the resource. Agent-based simulations, an analytical model, and extended simulations using neural networks provide converging evidence that equity is the best evolutionary strategy in such an environment: individuals maximize their fitness by dividing benefits in proportion to their own and their partners' relative contribution. The need to be chosen as a cooperative partner thus creates a selection pressure strong enough to explain the evolution of preferences for equity. We discuss the limitations of our model, the discrepancies between its predictions and empirical data, and how interindividual and intercultural variability fit within this framework.	[Debove, Stephane; Andre, Jean-Baptiste] PSL Res Univ, Ecole Normale Super, IBENS, NSERM 1024,CNRS 8197, Paris, France; [Debove, Stephane; Baumard, Nicolas] PSL Res Univ, Ecole Normale Super, Inst Jean Nicod, CNRS,EHESS,ENS,Dept Etud Cognit, Paris, France; [Andre, Jean-Baptiste] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Debove, S (corresponding author), PSL Res Univ, Ecole Normale Super, IBENS, NSERM 1024,CNRS 8197, Paris, France.; Debove, S (corresponding author), PSL Res Univ, Ecole Normale Super, Inst Jean Nicod, CNRS,EHESS,ENS,Dept Etud Cognit, Paris, France.	sd@stephanedebove.net	Andre, Jean-Baptiste/D-1634-2018	Andre, Jean-Baptiste/0000-0001-9069-447X; Debove, Stephane/0000-0002-5246-6537	Region Ile-de-France; Agence Nationale de la Recherche [ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL]; Institut des systemes complexes; Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt	Region Ile-de-France(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut des systemes complexes; Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt	This work was supported by the Region Ile-de-France (2012 DIM "Problematiques transversales aux systemes complexes"), Agence Nationale de la Recherche (ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL*), the Institut des systemes complexes, and the Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1963, J ABNORM PSYCHOL, V67, P422, DOI 10.1037/h0040968; ADAMS JS, 1964, J ABNORM SOC PSYCH, V69, P19, DOI 10.1037/h0040241; Aktipis CA, 2011, EVOL HUM BEHAV, V32, P263, DOI 10.1016/j.evolhumbehav.2011.01.002; Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Alvard MS, 2002, CARCASS OWNERSHIP ME, V21; Amici F, 2014, P R SOCB; Andre JB, 2011, J THEOR BIOL, V289, P128, DOI 10.1016/j.jtbi.2011.07.031; Aristotle, 1999, NICOMACHEAN ETHICS, V112; Austin W, 1974, REACTIONS CONFIRMATI, P16; Barclay P, 2004, EVOL HUM BEHAV, V25, P209, DOI 10.1016/j.evolhumbehav.2004.04.002; Barclay P., 2013, EVOLUTION HUMAN BEHA; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; Barclay P, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0213; Barclay P, 2011, J THEOR BIOL, V281, P47, DOI 10.1016/j.jtbi.2011.04.023; Baumard N, 2013, TRENDS COGN SCI, V17, P272, DOI 10.1016/j.tics.2013.04.003; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; Binmore K, 2005, NATURAL JUSTICE; Bird RB, 2015, PROSOCIAL SIGNALING; Brauer J, 2012, SOC JUSTICE RES, V25, P256, DOI 10.1007/s11211-012-0159-6; Camerer C., 2003, BEHAV GAME THEORY EX, V32; Cappelen AW, 2007, AM ECON REV, V97, P818, DOI 10.1257/aer.97.3.818; Cappelen AW, 2010, EUR ECON REV, V54, P429, DOI 10.1016/j.euroecorev.2009.08.005; COHEN GA, 2009, WHY NOT SOCIALISM; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Debove S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0392; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Forber P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2439; Frohlich N, 2004, PUBLIC CHOICE, V119, P91, DOI 10.1023/B:PUCH.0000024169.08329.eb; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; GAVRILETS S, 1993, J EVOLUTION BIOL, V6, P31, DOI 10.1046/j.1420-9101.1993.6010031.x; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hoebel EA, 1954, LAW PRIMITIVE MAN ST, P372; HOEL M, 1987, ECON LETT, V24, P5, DOI 10.1016/0165-1765(87)90173-X; HOMANS GC, 1958, AM J SOCIOL, V63, P597, DOI 10.1086/222355; Huck S, 1999, GAME ECON BEHAV, V28, P13, DOI 10.1006/game.1998.0691; Kanngiesser P, 2010, PSYCHOL SCI, V21, P1236, DOI 10.1177/0956797610380701; Kaplan H.S., 2005, MORAL SENTIMENTS MAT, P75; Killingback T, 2001, P ROY SOC B-BIOL SCI, V268, P1797, DOI 10.1098/rspb.2001.1697; Konow J, 2003, J ECON LIT, V41, P1188, DOI 10.1257/002205103771800013; Lienard P, 2013, J COGN CULT, V13, P57, DOI 10.1163/15685373-12342084; Lyle HF, 2014, P NATL ACAD SCI USA, V111, P4820, DOI 10.1073/pnas.1318372111; Marshall G, 1999, EUR SOCIOL REV, V15, P349, DOI 10.1093/oxfordjournals.esr.a018270; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; MELLERS BA, 1982, J EXP PSYCHOL GEN, V111, P242, DOI 10.1037/0096-3445.111.2.242; Nesse Randolph M., 2007, Biology Theory, V2, P143, DOI 10.1162/biot.2007.2.2.143; Nettle D, 2011, CURR ANTHROPOL, V52, P747, DOI 10.1086/661521; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Noe R., 2001, EC NATURE SOCIAL DIL; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Osborne M.J., 1990, BARGAINING MARKETS; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2002, B MATH BIOL, V64, P1101, DOI 10.1006/bulm.2002.0321; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Robinson PH, 2007, MINN LAW REV, V91, P1; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; Sahlins M., 1972, STONE AGE EC; Schafer M, 2015, FAIR IS NOT FAIR EVE; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Skitka LJ, 2012, SOC JUSTICE RES, V25, P327, DOI 10.1007/s11211-012-0161-z; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Sun SW, 2015, APPL MATH COMPUT, V252, P249, DOI 10.1016/j.amc.2014.12.044; Sylwester K, 2013, EVOL HUM BEHAV, V34, P201, DOI 10.1016/j.evolhumbehav.2012.11.009; Takesue H, 2017, J THEOR BIOL, V416, P45, DOI 10.1016/j.jtbi.2016.12.027; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Trivers R, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P67; Turiel E., 2002, CULTURE MORALITY SOC; WALSTER E, 1973, J PERS SOC PSYCHOL, V25, P151, DOI 10.1037/h0033967	77	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173636	10.1371/journal.pone.0173636	http://dx.doi.org/10.1371/journal.pone.0173636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323830	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000023
J	dos Santos, LA; Mendes, MF; Kruger, AP; Blauth, ML; Gottschalk, MS; Garcia, FRM				dos Santos, Luana A.; Mendes, Mayara F.; Kruger, Alexandra P.; Blauth, Monica L.; Gottschalk, Marco S.; Garcia, Flavio R. M.			Global potential distribution of Drosophila suzukii (Diptera, Drosophilidae)	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; SPECIES DISTRIBUTIONS; UNITED-STATES; BRAZIL; INVASION; POPULATION; PREDICTION; TOLERANCE; BLUEBERRY; ACCOUNT	Drosophila suzukii (Matsumura) is a species native to Western Asia that is able to pierce intact fruit during egg laying, causing it to be considered a fruit crop pest in many countries. Drosophila suzukii have a rapid expansion worldwide; occurrences were recorded in North America and Europe in 2008, and South America in 2013. Due to this rapid expansion, we modeled the potential distribution of this species using the Maximum Entropy Modeling (MaxEnt) algorithm and the Genetic Algorithm for Ruleset Production (GARP) using 407 sites with known occurrences worldwide and 11 predictor variables. After 1000 replicates, the value of the average area under the curve (AUC) of the model predictions with 1000 replicates was 0.97 for MaxEnt and 0.87 for GARP, indicating that both models had optimal performances. The environmental variables that most influenced the prediction of the MaxEnt model were the annual mean temperature, the maximum temperature of the warmest month, the mean temperature of the coldest quarter and the annual precipitation. The models indicated high environmental suitability, mainly in temperate and subtropical areas in the continents of Asia, Europe and North and South America, where the species has already been recorded. The potential for further invasions of the African and Australian continents is predicted due to the environmental suitability of these areas for this species.	[dos Santos, Luana A.; Garcia, Flavio R. M.] Univ Fed Pelotas, Inst Biol, Posgrad Entomol, Pelotas, RS, Brazil; [Mendes, Mayara F.; Gottschalk, Marco S.; Garcia, Flavio R. M.] Univ Fed Pelotas, Inst Biol, Posgrad Biol Anim, Pelotas, RS, Brazil; [Kruger, Alexandra P.; Garcia, Flavio R. M.] Univ Fed Pelotas, Fac Agron Eliseu Maciel, Posgrad Fitossanidade, Pelotas, RS, Brazil; [Blauth, Monica L.; Gottschalk, Marco S.; Garcia, Flavio R. M.] Univ Fed Pelotas, Inst Biol, Dept Ecol Zool & Genet, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Garcia, FRM (corresponding author), Univ Fed Pelotas, Inst Biol, Posgrad Entomol, Pelotas, RS, Brazil.; Garcia, FRM (corresponding author), Univ Fed Pelotas, Inst Biol, Posgrad Biol Anim, Pelotas, RS, Brazil.; Garcia, FRM (corresponding author), Univ Fed Pelotas, Fac Agron Eliseu Maciel, Posgrad Fitossanidade, Pelotas, RS, Brazil.; Garcia, FRM (corresponding author), Univ Fed Pelotas, Inst Biol, Dept Ecol Zool & Genet, Pelotas, RS, Brazil.	flaviormg@hotmail.com	Garcia, Flávio/D-5610-2013; Mendes, Mayara/GQP-8863-2022; Gottschalk, Marco Silva/M-7350-2013	Garcia, Flávio/0000-0003-0493-1788; Gottschalk, Marco Silva/0000-0002-9453-4331	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientffico e Tecnologico [455101/2014-0 CNPq]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientffico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (455101/2014-0 CNPq) are acknowledged for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Arriaga J. T., 2011, PHYTOSANITARY ALERT; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Bachli G., 2015, TAXODROS DATA BASE T; Benito NP, 2016, PESQUI AGROPECU BRAS, V51, P571, DOI 10.1590/S0100-204X2016000500018; Bitner-Mathe B.C., 2014, Drosophila Information Service, V97, P136; Burrack HJ, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM12012; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Cini A, 2012, B INSECTOL, V65, P149; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Garcia Ana C.L., 2005, Drosophila Information Service, V88, P28; Geisler F.C.S., 2015, REV CIENC AMB, V9, P125; Giannini Tereza C., 2012, Rodriguésia, V63, P733; Gonzalez Gisell, 2015, Drosophila Information Service, V98, P103; Gutierrez A, 2016, BIOL INVASIONS, V18, P3647, DOI 10.1007/s10530-016-1255-6; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakobs R, 2015, J INSECT PHYSIOL, V79, P1, DOI 10.1016/j.jinsphys.2015.05.003; Kaneshiro KY, 1983, P HAWAIIAN ENTOMOL S, P157; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lasa Rodrigo, 2015, Florida Entomologist, V98, P987, DOI 10.1653/024.098.0332; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Legendre P., 2012, NUMERICAL ECOLOGY; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; loriatti C, 2013, INVASIVE SPECIES COM; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Medina-Munoz M.C., 2015, Drosophila Information Service, V98, P75; Muhammad AUD, 2005, DROSOPH INF SERV, V88, P6; Paula M.A., 2014, Drosophila Information Service, V97, P113; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poppe JL, 2016, ANN ENTOMOL SOC AM, P1; Poyet M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142785; Santadino MV, 2015, REV SOC ENTOMOL ARGE, V74, P183; Shearer PW, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0070-3; SINGH BK, 1988, ORIENT INSECTS, V22, P147, DOI 10.1080/00305316.1988.11835486; Tidon R, 2006, BIOL J LINN SOC, V87, P233, DOI 10.1111/j.1095-8312.2006.00570.x; Tochen S, 2016, J APPL ENTOMOL, V140, P47, DOI 10.1111/jen.12247; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Tonina L, 2016, J PEST SCI, V89, P1; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Vilela CR, 2014, REV BRAS ENTOMOL, V58, P371, DOI 10.1590/S0085-56262014000400004; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Walton VM, 2016, ACTA HORTIC, V1117, P87, DOI 10.17660/ActaHortic.2016.1117.16; Wiman N.G., 2014, PLOS ONE, V9, P1; Zerulla FN, 2015, J BERRY RES, V5, P41, DOI 10.3233/JBR-150089; Zhai YF, 2016, J PEST SCI, V89, P679, DOI 10.1007/s10340-016-0760-9	54	114	118	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174318	10.1371/journal.pone.0174318	http://dx.doi.org/10.1371/journal.pone.0174318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323903	gold, Green Submitted, Green Published			2022-12-27	WOS:000399089000085
J	Egger, J; Gall, M; Wallner, J; Boechat, P; Hann, A; Li, X; Chen, XJ; Schmalstieg, D				Egger, Jan; Gall, Markus; Wallner, Juergen; Boechat, Pedro; Hann, Alexander; Li, Xing; Chen, Xiaojun; Schmalstieg, Dieter			HTC Vive MeVisLab integration via OpenVR for medical applications	PLOS ONE			English	Article							VIRTUAL-REALITY; OCULUS RIFT; OPENIGTLINK; SIMULATION; VOLUMETRY; SOFTWARE; PLATFORM	Virtual Reality, an immersive technology that replicates an environment via computer-simulated reality, gets a lot of attention in the entertainment industry. However, VR has also great potential in other areas, like the medical domain, Examples are intervention planning, training and simulation. This is especially of use in medical operations, where an aesthetic outcome is important, like for facial surgeries. Alas, importing medical data into Virtual Reality devices is not necessarily trivial, in particular, when a direct connection to a proprietary application is desired. Moreover, most researcher do not build their medical applications from scratch, but rather leverage platforms like MeVisLab, MITK, OsiriX or 3D Slicer. These platforms have in common that they use libraries like ITK and VTK, and provide a convenient graphical interface. However, ITK and VTK do not support Virtual Reality directly. In this study, the usage of a Virtual Reality device for medical data under the MeVisLab platform is presented. The OpenVR library is integrated into the MeVisLab platform, allowing a direct and uncomplicated usage of the head mounted display HTC Vive inside the MeVisLab platform. Medical data coming from other MeVisLab modules can directly be connected per drag-and-drop to the Virtual Reality module, rendering the data inside the HTC Vive for immersive virtual reality inspection.	[Egger, Jan; Gall, Markus; Schmalstieg, Dieter] Graz Univ Technol, Inst Comp Graph & Vis, Inffeldgasse 16c-2, Graz, Austria; [Egger, Jan] BioTechMed Graz, Krenngasse 37-1, Graz, Austria; [Wallner, Juergen; Boechat, Pedro] Med Univ Graz, Dept Oral & Maxillofacial Surg, Auenbruggerpl 5-1, Graz, Austria; [Hann, Alexander] Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, Ulm, Germany; [Li, Xing; Chen, Xiaojun] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai, Peoples R China	Graz University of Technology; Medical University of Graz; Ulm University; Shanghai Jiao Tong University	Egger, J (corresponding author), Graz Univ Technol, Inst Comp Graph & Vis, Inffeldgasse 16c-2, Graz, Austria.; Egger, J (corresponding author), BioTechMed Graz, Krenngasse 37-1, Graz, Austria.	egger@tugraz.at		Chen, Xiaojun/0000-0002-0298-4491	BioTechMed-GrazinAustria; Research & Technology House (F&T-Haus) at the Graz University of Technology; "Interactive Planning and Reconstruction of Facial Defects"; TU Graz Open Access Publishing Fund; Natural Science Foundation of China [81511130089]; Foundation of Science and Technology Commission of Shanghai Municipality [14441901002, 15510722200, 16441908400]	BioTechMed-GrazinAustria; Research & Technology House (F&T-Haus) at the Graz University of Technology; "Interactive Planning and Reconstruction of Facial Defects"; TU Graz Open Access Publishing Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The work received funding from BioTechMed-GrazinAustria (https:// biotechmedgraz.at/en/, "Hardwareaccelerated intelligentmedicalimaging"), the 6th Call of the Initial Funding Program from the Research & Technology House (F&T-Haus) at the Graz University of Technology (https://www.tugraz.at/ en/, "Interactive Planning and Reconstruction of Facial Defects", PI: JanEgger)and was supported by TU Graz Open Access Publishing Fund. D r. Xiaojun Chen receives support by the Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. : 81511130089) and the Foundation of Science and Technology Commission of Shanghai Municipality (GrantNo.: 14441901002, 15510722200 and 16441908400).The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; The work received funding from BioTechMed-Graz in Austria (https://biotechmedgraz.at/en/, "Hardware accelerated intelligent medical imaging"), the 6 th Call of the Initial Funding Program from the Research & Technology House (F&T-Haus) at the Graz University of Technology (https://www.tugraz.at/en/, "Interactive Planning and Reconstruction of Facial Defects", PI: Jan Egger) and was supported by TU Graz Open Access Publishing Fund. Dr. Xiaojun Chen receives support by the Natural Science Foundation of China (www.nsfc.gov.cn, Grant No.: 81511130089) and the Foundation of Science and Technology Commission of Shanghai Municipality (Grants No.: 14441901002, 15510722200 and 16441908400). Moreover, the authors want to thank their colleagues Laurenz Theuerkauf, Peter Mohr and Denis Kalkofen for their support. Furthermore, we are planning to provide the module as Open Source to the research community in the future. Until then, the module can be requested from the authors. Finally, a video demonstrating the integration can be found on the following You Tube channel: https://www.youtube.com/c/JanEgger	Ai ZM, 2007, STUD HEALTH TECHNOL, V125, P7; Alcantarilla PF, 2013, IEEE ENG MED BIO, P7346, DOI 10.1109/EMBC.2013.6611255; Bowman DA, 2007, COMPUTER, V40, P36, DOI 10.1109/MC.2007.257; Cha YW, 2016, STUD HEALTH TECHNOL, V220, P55, DOI 10.3233/978-1-61499-625-5-55; Chen XJ, 2015, J BIOMED INFORM, V55, P124, DOI 10.1016/j.jbi.2015.04.003; Egger J, 2007, P ANN INT IEEE EMBS, P6232; Egger J, PLOS ONE, V7; Egger J, PLOS ONE, V7; Egger J, 2007, I S BIOMED IMAGING, P392, DOI 10.1109/ISBI.2007.356871; Egger J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15373; Egger J, 2014, COMPUT MED IMAG GRAP, V38, P285, DOI 10.1016/j.compmedimag.2014.01.006; Egger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076645; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Egger J, 2012, INT J MED ROBOT COMP, V8, P282, DOI 10.1002/rcs.1415; Farahani Navid, 2016, J Pathol Inform, V7, P22, DOI 10.4103/2153-3539.181766; Gall M, IEEE ENG MED BIOL SO; Gall M, 2016, CRANIAL DEFECT DATAS; Gall M, 2016, INT J CARS S1, V11, pS241; Gall M, 2016, IEEE ENG MED BIO, P1179, DOI 10.1109/EMBC.2016.7590915; Gor M, 2003, BJOG-INT J OBSTET GY, V110, P181, DOI 10.1046/j.1471-0528.2003.02016.x; Greiner K., 2008, P BILDV MED BVM BERL, P51; Kim J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00248; King F, 2015, THESIS, P1; Klemm M, 2017, INT J COMPUT ASS RAD, V12, P351, DOI 10.1007/s11548-016-1488-y; Li X, 2016, INT J CARS, V11, pS241; Lu J, 2008, SPIE MED IMAGING; McCloy R, 2001, BRIT MED J, V323, P912, DOI 10.1136/bmj.323.7318.912; Messier E, 2016, STUD HEALTH TECHNOL, V220, P233, DOI 10.3233/978-1-61499-625-5-233; Newbutt N, 2016, J AUTISM DEV DISORD, V46, P3166, DOI 10.1007/s10803-016-2830-5; Nunnerley J., 2016, DISABIL REHABIL ASSI, P1; Reitinger B, 2006, IEEE COMPUT GRAPH, V26, P36, DOI 10.1109/MCG.2006.131; Renapurkar RD, 2012, EUR J RADIOL, V81, pE87, DOI 10.1016/j.ejrad.2011.01.077; Rheingold H., 1991, VIRTUAL REALITY EXPL, P1; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schmitt D., 2016, AUGMENTED REALITY PR, P1, DOI https://doi.org/10.1007/978-3-7091-1880-1_1; Schwarzenberg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093389; Tian J, 2008, IEEE T INF TECHNOL B, V12, P800, DOI 10.1109/TITB.2008.926395; Tong X, 2016, STUD HEALTH TECHNOL, V220, P424, DOI 10.3233/978-1-61499-625-5-424; Vogelreiter P, 2015, GLOBAL ILLUMI NATION; Xu X, 2015, J BIOMECH, V48, P721, DOI 10.1016/j.jbiomech.2015.01.005	40	55	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173972	10.1371/journal.pone.0173972	http://dx.doi.org/10.1371/journal.pone.0173972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323840	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000051
J	Kim, JH; Kang, JH; Jang, JE; Choi, SK; Kim, MJ; Park, SR; Lee, HJ				Kim, Jae Hwan; Kang, Ji Hyoun; Jang, Ji Eun; Choi, Sun Kyeong; Kim, Min Ji; Park, Sang Rul; Lee, Hyuk Je			Population genetic structure of eelgrass (Zostera marina) on the Korean coast: Current status and conservation implications for future management	PLOS ONE			English	Article							SEASONAL GROWTH-RESPONSES; REPRODUCTIVE STRATEGIES; RE-IMPLEMENTATION; SOUTHERN COAST; SEAGRASS; DIVERSITY; RESTORATION; SOFTWARE; BAY; TRANSPLANTS	Seagrasses provide numerous ecosystem services for coastal and estuarine environments, such as nursery functions, erosion protection, pollution filtration, and carbon sequestration. Zostera marina (common name broken vertical bar eelgrass ) is one of the seagrass bed-forming species distributed widely in the northern hemisphere, including the Korean Peninsula. Recently, however, there has been a drastic decline in the population size of Z. marina worldwide, including Korea. We examined the current population genetic status of this species on the southern coast of Korea by estimating the levels of genetic diversity and genetic structure of 10 geographic populations using eight nuclear microsatellite markers. The level of genetic diversity was found to be significantly lower for populations on Jeju Island [mean allelic richness (AR) = 1.92, clonal diversity (R) = 0.51], which is located approximately 155 km off the southernmost region of the Korean Peninsula, than for those in the South Sea (mean AR = 2.69, R = 0.82), which is on the southern coast of the mainland. South Korean eelgrass populations were substantially genetically divergent from one another (F-ST = 0.061 - 0.573), suggesting that limited contemporary gene flow has been taking place among populations. We also found weak but detectable temporal variation in genetic structure within a site over 10 years. In additional depth comparisons, statistically significant genetic differentiation was observed between shallow (or middle) and deep zones in two of three sites tested. Depleted genetic diversity, small effective population sizes (N-e) and limited connectivity for populations on Jeju Island indicate that these populations may be vulnerable to local extinction under changing environmental conditions, especially given that Jeju Island is one of the fastest warming regions around the world. Overall, our work will inform conservation and restoration efforts, including transplantation for eelgrass populations at the southern tip of the Korean Peninsula, for this ecologically important species.	[Kim, Jae Hwan; Jang, Ji Eun; Lee, Hyuk Je] Sangji Univ, Dept Biol Sci, Coll Sci & Engn, Mol Ecol & Evolut Lab, Wonju, South Korea; [Kang, Ji Hyoun] Korea Univ, Korean Entomol Inst, Seoul, South Korea; [Choi, Sun Kyeong; Kim, Min Ji; Park, Sang Rul] Jeju Natl Univ, Dept Marine Life Sci, Estuarine & Costal Ecol Lab, Jeju, South Korea	Sangji University; Korea University; Jeju National University	Lee, HJ (corresponding author), Sangji Univ, Dept Biol Sci, Coll Sci & Engn, Mol Ecol & Evolut Lab, Wonju, South Korea.; Park, SR (corresponding author), Jeju Natl Univ, Dept Marine Life Sci, Estuarine & Costal Ecol Lab, Jeju, South Korea.	srpark@jejunu.ac.kr; hyukjelee@sangji.ac.kr	kim, minji/GRX-9996-2022; Choi, Sun Kyeong/GWV-0273-2022	Choi, Sun Kyeong/0000-0002-0557-501X	Ministry of Oceans and Fisheries of Korea; National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2014R1A1A2059401]; Sangji University Research Fund	Ministry of Oceans and Fisheries of Korea; National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Sangji University Research Fund	This research was supported by the Ministry of Oceans and Fisheries of Korea (Project title: Long-term changes in structure and function in the marine ecosystems of Korea) to SRP and HJL, a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; NRF-2014R1A1A2059401) to HJL and the Sangji University Research Fund, 2014 to HJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F. W., 2007, CONSERV GENET, P642, DOI DOI 10.1515/MAMM.2007.038; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Belkhir K, 2002, LABORATOIRE GE NOME; Boulding Elizabeth Grace, 2008, P199; Campanella JJ, 2013, POPUL ECOL, V55, P121, DOI 10.1007/s10144-012-0351-4; 장승민, 2006, 한국해양환경•에너지학회지, V9, P55; Choi SK, 2016, OCEAN SCI J, V51, P1, DOI 10.1007/s12601-016-0001-4; COLEMAN VL, 1994, J EXP MAR BIOL ECOL, V179, P29, DOI 10.1016/0022-0981(94)90015-9; Cornuet JM, 1996, GENETICS, V144, P2001; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferber S, 2008, MAR ECOL PROG SER, V372, P87, DOI 10.3354/meps07705; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; FONSECA MS, 1989, ESTUAR COAST SHELF S, V29, P501, DOI 10.1016/0272-7714(89)90083-8; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Goudet J, 2002, PROGRAM ESTIMATE TES; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hovel KA, 2002, MAR ECOL PROG SER, V243, P11, DOI 10.3354/meps243011; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Jung SD, 2003, J PLANT BIOL, V46, P255, DOI 10.1007/BF03030372; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; Kim S, 2016, MAR BIODIVERS, V46, P337, DOI 10.1007/s12526-015-0364-2; Kim SH, 2014, MAR ECOL PROG SER, V509, P1, DOI 10.3354/meps10899; Kim YK, 2015, ESTUAR COAST, V38, P558, DOI 10.1007/s12237-014-9833-2; Kurokochi H, 2016, CONSERV GENET, V17, P103, DOI 10.1007/s10592-015-0764-7; Lee KS, 2005, MAR BIOL, V147, P1091, DOI 10.1007/s00227-005-0011-8; Lee KS., 2003, WORLD ATLAS SEAGRASS, P193; Lee KS, 2008, MAR POLLUT BULL, V56, P1015, DOI 10.1016/j.marpolbul.2008.02.010; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Li WT, 2014, ECOL ENG, V71, P56, DOI 10.1016/j.ecoleng.2014.07.020; Li WT, 2013, ESTUAR COAST SHELF S, V118, P72, DOI 10.1016/j.ecss.2012.12.022; Li WT, 2010, ESTUAR COAST SHELF S, V88, P377, DOI 10.1016/j.ecss.2010.04.017; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Meehan AJ, 2000, AQUAT BOT, V67, P161, DOI 10.1016/S0304-3770(99)00097-2; Mijangos JL, 2015, MOL ECOL, V24, P22, DOI 10.1111/mec.12995; Olsen JL, 2013, MAR ECOL PROG SER, V486, P121, DOI 10.3354/meps10373; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Ort BS, 2012, J HERED, V103, P533, DOI 10.1093/jhered/ess022; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Park JI, 2007, MAR POLLUT BULL, V54, P1238, DOI 10.1016/j.marpolbul.2007.03.020; Park SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156214; Park SR, 2010, J EXP MAR BIOL ECOL, V383, P122, DOI 10.1016/j.jembe.2009.12.002; Park SR, 2009, ESTUAR COAST SHELF S, V81, P38, DOI 10.1016/j.ecss.2008.10.003; Park SJ, 2009, MEDIA JEJU      0428; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; PHILLIPS RC, 1983, AQUAT BOT, V16, P1, DOI 10.1016/0304-3770(83)90047-5; Pritchard JK, 2000, GENETICS, V155, P945; Procaccini G, 2001, RESTOR ECOL, V9, P332, DOI 10.1046/j.1526-100x.2001.009003332.x; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Provan J, 2008, CONSERV GENET, V9, P271, DOI 10.1007/s10592-007-9338-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reusch TBH, 2000, MOL ECOL, V9, P371, DOI 10.1046/j.1365-294x.2000.00874-4.x; Reusch TBH, 1999, MOL ECOL, V8, P317, DOI 10.1046/j.1365-294X.1999.00531.x; Reusch TBH, 1999, MAR BIOL, V133, P519, DOI 10.1007/s002270050492; Reusch TBH, 2002, LIMNOL OCEANOGR, V47, P78, DOI 10.4319/lo.2002.47.1.0078; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Reynolds LK, 2012, MAR ECOL PROG SER, V448, P223, DOI 10.3354/meps09386; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shin H, 1998, AQUAT BOT, V60, P49, DOI 10.1016/S0304-3770(97)00066-1; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Talbot SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152701; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	79	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174105	10.1371/journal.pone.0174105	http://dx.doi.org/10.1371/journal.pone.0174105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323864	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000061
J	Rallon, N; Garcia, M; Garcia-Samaniego, J; Rodriguez, N; Cabello, A; Restrepo, C; Alvarez, B; Garcia, R; Gorgolas, M; Benito, JM				Rallon, Norma; Garcia, Marcial; Garcia-Samaniego, Javier; Rodriguez, Noelia; Cabello, Alfonso; Restrepo, Clara; Alvarez, Beatriz; Garcia, Rosa; Gorgolas, Miguel; Benito, Jose M.			HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; HIV-1-INFECTED PATIENTS; ELEVATED FREQUENCIES; HCV/HIV COINFECTION; PROGRAMMED DEATH-1; NATURAL-HISTORY; INFECTION; EXPRESSION	Background There are several contributors to HIV-pathogenesis or insufficient control of the infection. However, whether HIV/HCV-coinfected population exhibits worst evolution of HIV-pathogenesis remains unclear. Recently, some markers of immune exhaustion have been proposed as preferentially upregulated on T-cells during HIV-infection. Herein, we have analyzed T-cell exhaustion together with several other contributors to HIV-pathogenesis that could be affected by HCV-coinfection. Patients and methods Ninety-six patients with chronic HIV-infection (60 HIV-monoinfected and 36 HIV/HCV-coinfected), and 20 healthy controls were included in the study. All patients were untreated for both infections. Several CD4 and CD8 T-cell subsets involved in HIV-pathogenesis were investigated. Non-parametric tests were used to establish differences between groups and associations between variables. Multivariate linear regression was used to ascertain the variables independently associated with CD4 counts. Results HIV-patients presented significant differences compared to healthy controls in most of the parameters analyzed. Both HIV and HIV/HCV groups were comparable in terms of age, CD4 counts and HIV-viremia. Compared to HIV group, HIV/HCV group presented significantly higher levels of exhaustion (Tim3(+)PD1(-) subset) in total CD8(+) T-cells (p = 0.003), and higher levels of exhaustion in CD8(+) HLADR(+) CD38(+) (p = 0.04), CD8(+) HLADR(-)CD38(+) (p = 0.009) and CD8(+) HLADR(-)CD38(-) (P = 0.006) subsets of CD8(+) T-cells. Interestingly these differences were maintained after adjusting by CD4 counts and HIV-viremia. Conclusions We show a significant impact of HCV-coinfection on CD8 T-cells exhaustion, an important parameter associated with CD8 T-cell dysfunction in the setting of chronic HIV-infection. The relevance of this phenomenon on immunological and/or clinical HIV progression prompts HCV treatment to improve management of coinfected patients.	[Rallon, Norma; Garcia, Marcial; Rodriguez, Noelia; Restrepo, Clara; Benito, Jose M.] UAM, IIS Fdn Jimenez Diaz, Madrid, Spain; [Rallon, Norma; Garcia, Marcial; Rodriguez, Noelia; Restrepo, Clara; Benito, Jose M.] Hosp Univ Rey Juan Carlos, Mostoles, Spain; [Garcia-Samaniego, Javier] Hosp Univ Carlos III La Paz, Madrid, Spain; [Cabello, Alfonso; Alvarez, Beatriz; Garcia, Rosa; Gorgolas, Miguel] Univ Hosp Fdn Jimenez Diaz, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz	Rallon, N (corresponding author), UAM, IIS Fdn Jimenez Diaz, Madrid, Spain.; Rallon, N (corresponding author), Hosp Univ Rey Juan Carlos, Mostoles, Spain.	normaibon@yahoo.com	Benito, Jose/AAC-4554-2020; Cabello, Alfonso/ABH-3203-2021	Garcia-Samaniego, Javier/0000-0002-9974-0855; Rallon, Norma/0000-0002-4643-247X; Benito, Jose/0000-0002-7172-049X; Cabello-Ubeda, Alfonso/0000-0001-8429-8358; Garcia, Marcial/0000-0001-7462-1836	Plan Nacional I+0+I [RD12/0017/0031, PI14/00518]; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund (Fondos FEDER); ISCIII, Madrid, Spain [CP14/00198]; Intramural Research Scholarship from IIS-FJD	Plan Nacional I+0+I; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund (Fondos FEDER); ISCIII, Madrid, Spain(Instituto de Salud Carlos III); Intramural Research Scholarship from IIS-FJD	This study has been funded by projects: RD12/0017/0031 and PI14/00518 integrated in the Plan Nacional I+0+I and co-funded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (Fondos FEDER). Norma Rallon is a Miguel Servet investigator from the ISCIII (CP14/00198), Madrid, Spain. M Garcia is a predoctoral student co-funded by CP14/00198 project and Intramural Research Scholarship from IIS-FJD. N Rodriguez and C Restrepo are funded by project RD12/0017/0031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Arends JE, 2015, J HEPATOL, V63, P1254, DOI 10.1016/j.jhep.2015.06.034; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Callendret B, 2011, NAT MED, V17, P252, DOI 10.1038/nm0311-252; Chan ML, 2010, P ROY SOC B-BIOL SCI, V277, P3773, DOI 10.1098/rspb.2010.0972; Cockerham LR, 2014, AIDS, V28, P1749, DOI 10.1097/QAD.0000000000000314; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Feuth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059302; Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Korner C, 2009, CLIN SCI, V116, P861, DOI 10.1042/CS20080532; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Laskus T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075921; Legat A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00455; Marquez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119568; Migueles SA, 2015, NAT IMMUNOL, V16, P563, DOI 10.1038/ni.3161; Monforte AD, 2009, CLIN INFECT DIS, V49, P612, DOI 10.1086/603557; Nunez M, 2006, CLIN INFECT DIS, V43, P1209, DOI 10.1086/508355; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Platt L, 2016, LANCET INFECT DIS; Poonia B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-91; Rider PJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-32; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rosignoli G, 2009, CLIN EXP IMMUNOL, V157, P90, DOI 10.1111/j.1365-2249.2009.03960.x; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Saha B, 2013, AIDS, V27, P2191, DOI 10.1097/QAD.0b013e32836285e4; Sengupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064956; Shmagel KV, 2014, AIDS, V28, P2381, DOI 10.1097/QAD.0000000000000418; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZHANG Z, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1155/2015/825136	42	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173943	10.1371/journal.pone.0173943	http://dx.doi.org/10.1371/journal.pone.0173943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323897	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000046
J	Erives, AJ				Erives, Albert J.			Evolving Notch polyQ tracts reveal possible solenoid interference elements	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; AMEBA DICTYOSTELIUM-DISCOIDEUM; DROSOPHILA GENE MASTERMIND; TATA-BINDING PROTEIN; AGE-OF-ONSET; HUNTINGTONS-DISEASE; COILED COILS; AGGREGATION; REPEATS; LENGTH	Polyglutamine (polyQ) tracts in regulatory proteins are extremely polymorphic. As functional elements under selection for length, triplet repeats are prone to DNA replication slippage and indel mutations. Many polyQ tracts are also embedded within intrinsically disordered domains, which are less constrained, fast evolving, and difficult to characterize. To identify structural principles underlying polyQ tracts in disordered regulatory domains, here I analyze deep evolution of metazoan Notch polyQ tracts, which can generate alleles causing developmental and neurogenic defects. I show that Notch features polyQ tract turnover that is restricted to a discrete number of conserved "polyQ insertion slots". Notch polyQ insertion slots are: (i) identifiable by an amphipathic "slot leader" motif; (ii) conserved as an intact C-terminal array in a 1-to-1 relationship with the N-terminal solenoid-forming ankyrin repeats (ARs); and (iii) enriched in carboxamide residues (Q/N), whose sidechains feature dual hydrogen bond donor and acceptor atoms. Correspondingly, the terminal loop and beta-strand of each AR feature conserved carboxamide residues, which would be susceptible to folding interference by hydrogen bonding with residues outside the ARs. I thus suggest that Notch polyQ insertion slots constitute an array of AR interference elements (ARIEs). Notch ARIEs would dynamically compete with the delicate serial folding induced by adjacent ARs. Huntingtin, which harbors solenoid-forming HEAT repeats, also possesses a similar number of polyQ insertion slots. These results suggest that intrinsically disordered interference arrays featuring carboxamide and polyQ enrichment may constitute coupled proteodynamic modulators of solenoids.	[Erives, Albert J.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Erives, AJ (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu						ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; Brittain A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101177; Chen MC, 2016, P NATL ACAD SCI USA, V113, P5006, DOI 10.1073/pnas.1602702113; Crocker J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1102; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Kelly DF, 2007, P NATL ACAD SCI USA, V104, P9591, DOI 10.1073/pnas.0702887104; Kumar S., 2016, MOL BIOL EVOL; Li Z, 1999, HUM MOL GENET, V8, P1807, DOI 10.1093/hmg/8.9.1807; Myre MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002052; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Neuwald AF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004936; NEWFELD SJ, 1994, J MOL EVOL, V38, P637; NEWFELD SJ, 1991, J MOL EVOL, V32, P415, DOI 10.1007/BF02101281; NEWFELD SJ, 1993, J MOL EVOL, V37, P483, DOI 10.1007/BF00160429; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Pelassa I, 2014, HUM MOL GENET, V23, P3402, DOI 10.1093/hmg/ddu049; Petrakis S, 2013, BIOESSAYS, V35, P503, DOI 10.1002/bies.201300001; Rice C, 2015, G3-GENES GENOM GENET, V5, P2405, DOI 10.1534/g3.115.021659; Rubinsztein DC, 1996, AM J MED GENET, V67, P495, DOI 10.1002/(SICI)1096-8628(19960920)67:5<495::AID-AJMG12>3.0.CO;2-I; Santarriaga S, 2015, J BIOL CHEM, V290, P25571, DOI 10.1074/jbc.M115.676247; Scala C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046150; Schlotterer C, 1997, GENETICS, V146, P309; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vasquez-Del Carpio R, 2011, MOL CELL BIOL, V31, P1396, DOI 10.1128/MCB.00360-10; Vijayvargia R, 2016, ELIFE, V5, DOI 10.7554/eLife.11184; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Zuhlke C, 2001, EUR J HUM GENET, V9, P160, DOI 10.1038/sj.ejhg.5200617	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174253	10.1371/journal.pone.0174253	http://dx.doi.org/10.1371/journal.pone.0174253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319202	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800061
J	Kiviniemi, V; Korhonen, V; Kortelainen, J; Rytky, S; Keinanen, T; Tuovinen, T; Isokangas, M; Sonkajarvi, E; Siniluoto, T; Nikkinen, J; Alahuhta, S; Tervonen, O; Turpeenniemi-Hujanen, T; Myllyla, T; Kuittinen, O; Voipio, J				Kiviniemi, Vesa; Korhonen, Vesa; Kortelainen, Jukka; Rytky, Seppo; Keinanen, Tuija; Tuovinen, Timo; Isokangas, Matti; Sonkajarvi, Eila; Siniluoto, Topi; Nikkinen, Juha; Alahuhta, Seppo; Tervonen, Osmo; Turpeenniemi-Hujanen, Taina; Myllyla, Teemu; Kuittinen, Outi; Voipio, Juha			Real-time monitoring of human blood-brain barrier disruption	PLOS ONE			English	Article							PRIMARY CNS LYMPHOMA; SLOW EEG FLUCTUATIONS; DELIVERY; TUMOR; RATS; OSCILLATIONS; PRESERVATION; TOXICITY; DYNAMICS; RODENT	Chemotherapy aided by opening of the blood-brain barrier with intra-arterial infusion of hyperosmolar mannitol improves the outcome in primary central nervous system lymphoma. Proper opening of the blood-brain barrier is crucial for the treatment, yet there are no means available for its real-time monitoring. The intact blood-brain barrier maintains a mV-level electrical potential difference between blood and brain tissue, giving rise to a measurable electrical signal at the scalp. Therefore, we used direct-current electroencephalography ( DC-EEG) to characterize the spatiotemporal behavior of scalp-recorded slow electrical signals during blood-brain barrier opening. Nine anesthetized patients receiving chemotherapy were monitored continuously during 47 blood-brain barrier openings induced by carotid or vertebral artery mannitol infusion. Left or right carotid artery mannitol infusion generated a strongly lateralized DC-EEG response that began with a 2 min negative shift of up to 2000 mu V followed by a positive shift lasting up to 20 min above the infused carotid artery territory, whereas contralateral responses were of opposite polarity. Vertebral artery mannitol infusion gave rise to a minimally lateralized and more uniformly distributed slow negative response with a posterior-frontal gradient. Simultaneously performed near-infrared spectroscopy detected a multiphasic response beginning with mannitol-bolus induced dilution of blood and ending in a prolonged increase in the oxy/deoxyhemoglobin ratio. The pronounced DC-EEG shifts are readily accounted for by opening and sealing of the blood-brain barrier. These data show that DC-EEG is a promising real-time monitoring tool for bloodbrain barrier disruption augmented drug delivery.	[Kiviniemi, Vesa; Korhonen, Vesa; Tuovinen, Timo; Isokangas, Matti; Siniluoto, Topi; Tervonen, Osmo] Oulu Univ Hosp, Dept Diagnost Radiol, MRC, Oulu, Finland; [Kiviniemi, Vesa; Korhonen, Vesa; Keinanen, Tuija; Tuovinen, Timo; Tervonen, Osmo] Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu Funct NeuroImaging Grp, Oulu, Finland; [Kortelainen, Jukka] Univ Oulu, Ctr Machine Vis & Signal Anal, Physiol Signal Anal Team, MRC Oulu, Oulu, Finland; [Kortelainen, Jukka; Rytky, Seppo; Keinanen, Tuija] Oulu Univ Hosp, Dept Clin Neurophysiol, MRC, Oulu, Finland; [Sonkajarvi, Eila; Alahuhta, Seppo] Oulu Univ Hosp, Dept Anaesthesiol, MRC, Oulu, Finland; [Nikkinen, Juha; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi] Oulu Univ Hosp, Dept Oncol, MRC, Oulu, Finland; [Myllyla, Teemu] Univ Oulu, Hlth & Wellness Measurement Grp, Optoelect & Measurement Tech Unit, Oulu, Finland; [Voipio, Juha] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki	Kiviniemi, V (corresponding author), Oulu Univ Hosp, Dept Diagnost Radiol, MRC, Oulu, Finland.; Kiviniemi, V (corresponding author), Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu Funct NeuroImaging Grp, Oulu, Finland.	vesa.kiviniemi@oulu.fi	; Kortelainen, Jukka/P-5512-2014	Voipio, Juha/0000-0001-7096-1286; Tuovinen, Timo/0000-0001-7079-3673; Kortelainen, Jukka/0000-0003-2585-2376; Korhonen, Vesa/0000-0001-9403-4583; Nikkinen, Juha/0000-0001-6355-3444; Keinanen, Tuija/0000-0002-3300-5022	CSTI/SHOK Salwe [WP302]; JAES; MRC Oulu DP-grant; Oulu University Scholarship Foundation; Tauno Tonning Foundation; Academy of Finland [275352]	CSTI/SHOK Salwe; JAES; MRC Oulu DP-grant; Oulu University Scholarship Foundation; Tauno Tonning Foundation; Academy of Finland(Academy of Finland)	CSTI/SHOK Salwe WP302 grant(VKi), JAES grant(VKi), MRC Oulu DP-grant (VKo), Oulu University Scholarship Foundation (VKo), Tauno Tonning Foundation (VKo) and Academy of Finland grant#275352 (VKi) iscordially acknowledge d in this study	ALADJALOVA NA, 1957, NATURE, V179, P957, DOI 10.1038/179957a0; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Blanchette M, 2014, J CEREBR BLOOD F MET, V34, P820, DOI 10.1038/jcbfm.2014.14; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Doolittle N D, 2001, Neuro Oncol, V3, P46, DOI 10.1093/neuonc/3.1.46; Doolittle ND, 2008, BLOOD, V111, P1085, DOI 10.1182/blood-2007-07-101402; Doolittle Nancy D, 2014, Adv Pharmacol, V71, P203, DOI 10.1016/bs.apha.2014.06.002; Ergin A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057008; Harjama L, 2015, ACTA ONCOL, P1; HELD D, 1964, J NEUROPHYSIOL, V27, P942, DOI 10.1152/jn.1964.27.5.942; Hiltunen T, 2014, J NEUROSCI, V34, P356, DOI 10.1523/JNEUROSCI.0276-13.2014; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Joshi S, 2014, BRAIN RES, V1549, P42, DOI 10.1016/j.brainres.2013.12.036; Kang EJ, 2013, NEUROBIOL DIS, V52, P204, DOI 10.1016/j.nbd.2012.12.007; Kasenda B, 2015, ANN ONCOL, V26, P1305, DOI 10.1093/annonc/mdv076; Kraemer DF, 2001, NEUROSURGERY, V48, P1033, DOI 10.1097/00006123-200105000-00013; Krysl D, 2012, J PHYSIOL PHARMACOL, V63, P127; Kuitunen H, 2016, J NEUROONCOL, P1; Librizzi L, 2001, J NEUROSCI RES, V66, P289, DOI 10.1002/jnr.1223; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-34; Marchi N, 2009, EPILEPSIA, V50, P664, DOI 10.1111/j.1528-1167.2008.01989.x; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Muldoon LL, 2011, CLIN CANCER RES, V17, P2207, DOI 10.1158/1078-0432.CCR-10-2923; Neuwelt E A, 1979, Trans Am Neurol Assoc, V104, P256; NEUWELT EA, 1986, AM J PHYSIOL, V250, pR875, DOI 10.1152/ajpregu.1986.250.5.R875; NEUWELT EA, 1991, J CLIN ONCOL, V9, P1580, DOI 10.1200/JCO.1991.9.9.1580; NEUWELT EA, 1979, J CLIN INVEST, V64, P684, DOI 10.1172/JCI109509; NEUWELT EA, 1982, P NATL ACAD SCI-BIOL, V79, P4420, DOI 10.1073/pnas.79.14.4420; NEUWELT EA, 1981, P NATL ACAD SCI-BIOL, V78, P5838, DOI 10.1073/pnas.78.9.5838; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; NILAVER G, 1995, P NATL ACAD SCI USA, V92, P9829, DOI 10.1073/pnas.92.21.9829; Nita DA, 2004, J NEUROPHYSIOL, V92, P1011, DOI 10.1152/jn.00110.2004; O'Reilly MA, 2012, INT J HYPERTHER, V28, P386, DOI 10.3109/02656736.2012.666709; O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Remsen LG, 1999, ANESTH ANALG, V88, P559, DOI 10.1097/00000539-199903000-00018; REVEST PA, 1994, BRAIN RES, V652, P76, DOI 10.1016/0006-8993(94)90319-0; Revest PA, 1993, ADV EXPT MED BIOL; ROMANGOLDSTEIN S, 1995, AM J NEURORADIOL, V16, P543; ROMANGOLDSTEIN S, 1994, AM J NEURORADIOL, V15, P581; ROMANGOLDSTEIN SM, 1994, J COMPUT ASSIST TOMO, V18, P731, DOI 10.1097/00004728-199409000-00010; SOMJEN GG, 1991, EXP PHYSIOL, V76, P507, DOI 10.1113/expphysiol.1991.sp003516; SORENSEN E, 1978, SCAND J CLIN LAB INV, V38, P203, DOI 10.3109/00365517809108412; Sorvoja HSS, 2010, QUANTUM ELECTRON+, V40, P1067, DOI [10.1070/QE2010v040n12ABE014503, 10.1070/QE2010v040n12ABEH014503]; Tallgren P, 2005, CLIN NEUROPHYSIOL, V116, P799, DOI 10.1016/j.clinph.2004.10.001; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vanhatalo S, 2003, CLIN NEUROPHYSIOL, V114, P1744, DOI 10.1016/S1388-2457(03)00163-9; Vanhatalo S, 2005, CLIN NEUROPHYSIOL, V116, P1, DOI 10.1016/j.clinph.2004.09.015; Vanhatalo S., 2011, NIEDERMEYRS ELECTROE, P741; Voipio J, 2003, J NEUROPHYSIOL, V89, P2208, DOI 10.1152/jn.00915.2002; Voipio J., 2010, HDB PHYS MED BIOL, P211; WILLIAMS PC, 1995, NEUROSURGERY, V37, P17, DOI 10.1227/00006123-199507000-00003; WOODY CD, 1970, AM J PHYSIOL, V218, P275, DOI 10.1152/ajplegacy.1970.218.1.275; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823	56	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174072	10.1371/journal.pone.0174072	http://dx.doi.org/10.1371/journal.pone.0174072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319185	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800047
J	Takada, H; Imadome, KI; Shibayama, H; Yoshimori, M; Wang, LD; Saitoh, Y; Uota, S; Yamaoka, S; Koyama, T; Shimizu, N; Yamamoto, K; Fujiwara, S; Miura, O; Arai, A				Takada, Honami; Imadome, Ken-Ichi; Shibayama, Haruna; Yoshimori, Mayumi; Wang, Ludan; Saitoh, Yasunori; Uota, Shin; Yamaoka, Shoji; Koyama, Takatoshi; Shimizu, Norio; Yamamoto, Kouhei; Fujiwara, Shigeyoshi; Miura, Osamu; Arai, Ayako			EBV induces persistent NF-kappa B activation and contributes to survival of EBV-positive neoplastic T- or NK-cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CD40 LIGAND; INFECTION; KINASE; LINES; MEMBRANE-PROTEIN-1; TRANSCRIPTION; LOCALIZATION; SUPPRESSES; INHIBITOR	Epstein Barr virus (EBV) has been detected in several T- and NK-cell neoplasms such as extranodal NK/T-cell lymphoma nasal type, aggressive NK-cell leukemia, EBV-positive peripheral T-cell lymphoma, systemic EBV-positive T-cell lymphoma of childhood, and chronic active EBV infection (CAEBV). However, how this virus contributes to lymphoma genesis in T or NK cells remains largely unknown. Here, we examined NF-kappa B activation in EBV-positive Tor NK cell lines, SNT8, SNT15, SNT16, SNK6, and primary EBV-positive and clonally proliferating T/NK cells obtained from the peripheral blood of patients with CAEBV. Western blotting, electrophoretic mobility shift assays, and immunofluorescent staining revealed persistent NF-kappa B activation in EBV-infected cell lines and primary cells from patients. Furthermore, we investigated the role of EBV in infected T cells. We performed an in vitro infection assay using MOLT4 cells infected with EBV. The infection directly induced NF-kappa B activation, promoted survival, and inhibited etoposide-induced apoptosis in MOLT4 cells. The luciferase assay suggested that LMP1 mediated NF-kappa B activation in MOLT4 cells. IMD-0354, a specific inhibitor of NF-kappa B that suppresses NF-kappa B activation in cell lines, inhibited cell survival and induced apoptosis. These results indicate that EBV induces NF-kappa B-mediated survival signals in T and NK cells, and therefore, may contribute to the lymphomagenesis of these cells.	[Takada, Honami; Shibayama, Haruna; Yoshimori, Mayumi; Wang, Ludan; Koyama, Takatoshi; Miura, Osamu; Arai, Ayako] Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Takada, Honami; Shibayama, Haruna; Yoshimori, Mayumi; Koyama, Takatoshi] Tokyo Med & Dent Univ, Dept Lab Mol Genet Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Div Adv Med Virus Infect, Setagaya Ku, Tokyo, Japan; [Saitoh, Yasunori; Uota, Shin; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Grad Sch Hlth Care Sci, Bunkyo Ku, Tokyo, Japan; [Shimizu, Norio] Tokyo Med & Dent Univ, Virus Res Unit, Div Med Sci, Med Res Inst,Bunkyo Ku, Tokyo, Japan; [Yamamoto, Kouhei] Tokyo Med & Dent Univ, Dept Comprehens Pathol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan	Arai, A (corresponding author), Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	ara.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15K09468]; Rare/Intractable Diseases from Japan Agency for Medical Research and development, AMED [15ek0109098]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Rare/Intractable Diseases from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (15K09468 http://www.mext.go.jp/english/) as well as a grant from the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and development, AMED (15ek0109098 http://www.amed.go.jp/en/). A.A.K-1.1., and S.F. received them. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai A, 2012, INT J HEMATOL; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Chan J., 2008, WHO CLASSIFICATION T, P276; Chan JC, 2008, WHO CLASSIFICATION T, P285; Chan KK, 2010, J PATHOL, V221, P164, DOI 10.1002/path.2699; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Imadome KI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002326; Imadome KI, 2005, J INFECT DIS, V192, P1340, DOI 10.1086/466530; Imadome KI, 2003, P NATL ACAD SCI USA, V100, P7836, DOI 10.1073/pnas.1231363100; Kanemitsu N, 2012, CLIN CANCER RES, V18, P2164, DOI 10.1158/1078-0432.CCR-11-2395; Kanno H, 2008, CLIN EXP IMMUNOL, V151, P519, DOI 10.1111/j.1365-2249.2007.03584.x; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Ng SB, 2011, J PATHOL, V223, P496, DOI 10.1002/path.2823; Nosaka Y, 1999, J BIOL CHEM, V274, P30154, DOI 10.1074/jbc.274.42.30154; Ohshima K, 2008, PATHOL INT, V58, P209, DOI 10.1111/j.1440-1827.2008.02213.x; Okano M, 2005, AM J HEMATOL, V80, P64, DOI 10.1002/ajh.20398; Quintanilla-Marinez L, 2008, WHO CLASSIFICATION T, P278; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Shirakata M, 2001, J VIROL, V75, P5059, DOI 10.1128/JVI.75.11.5059-5068.2001; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tanaka A, 2005, BLOOD, V105, P2324, DOI 10.1182/blood-2004-08-3247; Uota S, 2012, CANCER SCI, V103, P100, DOI 10.1111/j.1349-7006.2011.02110.x; Yoshimori M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112564; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x	33	30	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174136	10.1371/journal.pone.0174136	http://dx.doi.org/10.1371/journal.pone.0174136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346502	Green Submitted, gold, Green Published			2022-12-27	WOS:000399174300026
J	Batista-Garcia, RA; Sutton, T; Jackson, SA; Tovar-Herrera, OE; Balcazar-Lopez, E; Sanchez-Carbente, MD; Sanchez-Reyes, A; Dobson, ADW; Folch-Mallol, JL				Alberto Batista-Garcia, Ramon; Sutton, Thomas; Jackson, Stephen A.; Eduardo Tovar-Herrera, Omar; Balcazar-Lopez, Edgar; del Rayo Sanchez-Carbente, Maria; Sanchez-Reyes, Ayixon; Dobson, Alan D. W.; Luis Folch-Mallol, Jorge			Characterization of lignocellulolytic activities from fungi isolated from the deep-sea sponge Stelletta normani	PLOS ONE			English	Article							AFFINITY; SPP.	Extreme habitats have usually been regarded as a source of microorganisms that possess robust proteins that help enable them to survive in such harsh conditions. The deep sea can be considered an extreme habitat due to low temperatures (<5 degrees C) and high pressure, however marine sponges survive in these habitats. While bacteria derived from deep-sea marine sponges have been studied, much less information is available on fungal biodiversity associated with these sponges. Following screening of fourteen fungi isolated from the deep-sea sponge Stelletta normanisampled at a depth of 751 metres, three halotolerant strains (TS2, TS11 and TS12) were identified which displayed high CMCase and xylanase activities. Molecular based taxonomic approaches identified these strains as Cadophora sp. TS2, Emericellopsis sp. TS11 and Pseudogymnoascus sp. TS 12. These three fungi displayed psychrotolerance and halotolerant growth on CMC and xylan as sole carbon sources, with optimal growth rates at 20 degrees C. They produced CMCase and xylanase activities, which displayed optimal temperature and pH values of between 50-70 degrees C and pH 5-8 respectively, together with good thermostability and halotolerance. In solid-state fermentations TS2, TS11 and TS12 produced CMCases, xylanases and peroxidase/phenol oxidases when grown on corn stover and wheat straw. This is the first time that CMCase, xylanase and peroxidase/phenol oxidase activities have been reported in these three fungal genera isolated from a marine sponge. Given the biochemical characteristics of these ligninolytic enzymes it is likely that they may prove useful in future biomass conversion strategies involving lignocellulosic materials.	[Alberto Batista-Garcia, Ramon; Balcazar-Lopez, Edgar; Sanchez-Reyes, Ayixon] Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico; [Alberto Batista-Garcia, Ramon; Balcazar-Lopez, Edgar; del Rayo Sanchez-Carbente, Maria; Sanchez-Reyes, Ayixon; Luis Folch-Mallol, Jorge] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico; [Sutton, Thomas; Jackson, Stephen A.; Dobson, Alan D. W.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Jackson, Stephen A.; Dobson, Alan D. W.] Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Cork, Ireland; [Eduardo Tovar-Herrera, Omar] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Inst Biotecnol, San Nicolas De Los Garza, Nuevo Leon, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; University College Cork; University College Cork; Universidad Autonoma de Nuevo Leon	Folch-Mallol, JL (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico.; Dobson, ADW (corresponding author), Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Dobson, ADW (corresponding author), Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Cork, Ireland.	a.dobson@ucc.ie; jordi@uaem.mx	Jackson, Stephen/J-4368-2019; del Rayo Sánchez, Maria/AAG-3615-2020; Sánchez-Reyes, Ayixon/AAI-5948-2020; Dobson, Alan D W/M-7844-2017	Jackson, Stephen/0000-0001-7869-9032; del Rayo Sánchez, Maria/0000-0001-9586-3033; Sánchez-Reyes, Ayixon/0000-0002-6749-5883; Dobson, Alan D W/0000-0002-7713-5574; Batista-Garcia, Ramon Alberto/0000-0002-1032-0767; Balcazar, Edgar/0000-0003-0616-309X; Folch-Mallol, Jorge/0000-0002-1860-8175; Sutton, Thomas/0000-0002-0218-4275	PharmaSea project - EU Seventh Framework Programme [312184]; Beaufort Marine Research Award; Sea Change Strategy; Strategy for Science Technology and Innovation; Marine Institute under the Marine Research Sub Programme of the National Development Plan; Department of Agriculture, Fisheries and Food [DAFF11/F/009]; National Council for Science and Technology (CONACyT)-Mexico [CB-153789]; PRODEP-SEP [UAEMOR-PTC-333]; Europe Molecular Biology Organization (EMBO) [ASTF503-2013]; National Council for Science and Technology (CONACyT) in Mexico	PharmaSea project - EU Seventh Framework Programme; Beaufort Marine Research Award; Sea Change Strategy; Strategy for Science Technology and Innovation; Marine Institute under the Marine Research Sub Programme of the National Development Plan; Department of Agriculture, Fisheries and Food; National Council for Science and Technology (CONACyT)-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PRODEP-SEP; Europe Molecular Biology Organization (EMBO); National Council for Science and Technology (CONACyT) in Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by the PharmaSea project (www.pharma-sea.eu) funded by the EU Seventh Framework Programme (contract no. 312184); by the Beaufort Marine Research Award, part of the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2012), with the support of The Marine Institute under the Marine Research Sub Programme of the National Development Plan 2007-2013; by the Department of Agriculture, Fisheries and Food (DAFF11/F/009 MabS); by the National Council for Science and Technology (CONACyT)-Mexico: Project CB-153789; and PRODEP-SEP Project UAEMOR-PTC-333. RABG acknowledges the support of the Europe Molecular Biology Organization (EMBO: ASTF503-2013) for a research visit to University College Cork (Cork, Ireland). RABG together with OETH, EBL and ASR also received a scholarship from the National Council for Science and Technology (CONACyT) in Mexico.	Batista-Garcia RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105893; Alcaino J, 2015, WORLD J MICROB BIOT, V31, P1467, DOI 10.1007/s11274-015-1900-8; Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Alsheikh-Hussain A, 2014, J BIOTECHNOL TECHNOL, V5, P765; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Annamalai N, 2009, INDIAN J BIOTECHNOL, V8, P291; Arantes V, 2010, ACCESS CELLULOSE LIM, P1; Bach CE, 2013, SOIL BIOL BIOCHEM, V67, P183, DOI 10.1016/j.soilbio.2013.08.022; Baker PW, 2010, J APPL MICROBIOL, V108, P1668, DOI 10.1111/j.1365-2672.2009.04563.x; Baker PW, 2009, MAR BIOTECHNOL, V11, P540, DOI 10.1007/s10126-008-9169-7; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blanchette RA, 2010, MICROB ECOL, V60, P29, DOI 10.1007/s00248-010-9664-z; Bonugli-Santos RC, 2012, WATER AIR SOIL POLL, V223, P2333, DOI 10.1007/s11270-011-1027-y; Bonugli-Santos RC, 2010, FUNGAL BIOL-UK, V114, P863, DOI 10.1016/j.funbio.2010.08.003; Bonugli-Santos RC, 2010, ENZYME MICROB TECH, V46, P32, DOI 10.1016/j.enzmictec.2009.07.014; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bouchotroch S, 2001, INT J SYST EVOL MICR, V51, P1625, DOI 10.1099/00207713-51-5-1625; Bucher VVC, 2004, MICROB ECOL, P331; Burtseva YV, 2003, MAR BIOTECHNOL, V5, P349, DOI 10.1007/s10126-002-0070-2; Carreira C, 2015, ENVIRON MICROBIOL, P1; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Chang PK, 1995, APPL ENVIRON MICROB, P40; Chen HY, 2011, APPL BIOCHEM BIOTECH, V165, P1754, DOI 10.1007/s12010-011-9392-y; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; Del-Cid A, 2014, APPL BIOCHEM BIOTECH, V172, P524, DOI 10.1007/s12010-013-0551-1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dojnov B, 2015, ELECTROPHORESIS; Duncan SM, 2006, ENVIRON MICROBIOL, V8, P1212, DOI 10.1111/j.1462-2920.2006.01013.x; EI-Gendy MMa, 2010, APPL BIOCHEM BIOTECH, P780; El-Bondkly AMA, 2012, APPL BIOCHEM BIOTECH, V167, P2160, DOI 10.1007/s12010-012-9763-z; El-Bondkly AMA, 2012, ANTON LEEUW INT J G, V101, P331, DOI 10.1007/s10482-011-9639-1; Ernst M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-242; Fan X, 1999, EMERICELLA NIDULANS, P1071; Figueroa L, 2015, J NAT PROD; Floch C, 2007, J MICROBIOL METH, V71, P319, DOI 10.1016/j.mimet.2007.09.020; Gage J. D., 1991, DEEP SEA BIOL NATURA, P504, DOI DOI 10.1017/CBO9781139163637; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Godinho VM, 2015, EXTREMOPHILES; Goncalves VN, 2012, FEMS MICROBIOL ECOL, V82, P459, DOI 10.1111/j.1574-6941.2012.01424.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grum-Grzhimaylo AA, 2013, IMA FUNGUS, V4, P213, DOI 10.5598/imafungus.2013.04.02.07; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunny AAN, 2014, BIORESOURCE TECHNOL, V155, P177, DOI 10.1016/j.biortech.2013.12.101; Haber M, 2014, J APPL MICROBIOL, V116, P519, DOI 10.1111/jam.12401; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He LM, 2014, MICROB ECOL, V67, P951, DOI 10.1007/s00248-014-0393-6; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hinrikson HP, 2005, J CLIN MICROBIOL, V43, P2092, DOI 10.1128/JCM.43.5.2092-2103.2005; Hou YH, 2006, ACTA BIOCH BIOPH SIN, V38, P142, DOI 10.1111/j.1745-7270.2006.00135.x; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Jagielski T, 2013, POL J MICROBIOL, V62, P303, DOI 10.33073/pjm-2013-040; Johnson LJAN, 2013, APPL ENVIRON MICROB, V79, P5465, DOI 10.1128/AEM.01429-13; Kamada M, 2015, PLOONE PUBLIC LIB; Kanbe T, 2002, MICROBIOL IMMUNOL, V46, P841, DOI 10.1111/j.1348-0421.2002.tb02771.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kennedy J, 2011, J APPL MICROBIOL, V111, P787, DOI 10.1111/j.1365-2672.2011.05106.x; Kennedy J, 2014, PLOS ONE; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuhad RC, 2004, FOLIA MICROBIOL, V49, P112, DOI 10.1007/BF02931383; Dalmaso GZL, 2015, MAR DRUGS, V13, P1925, DOI 10.3390/md13041925; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lopez-Lopez O, 2014, CURR PROTEIN PEPT SC, V15, P445, DOI 10.2174/1389203715666140228153801; Lowry O.H., 1951, READINGS, V193, P265, DOI [10.1016/0304-3894(92)87011-4, DOI 10.1016/0304-3894(92)87011-4]; Magnet A, 2014, PARASITOL RES, V113, P2845, DOI 10.1007/s00436-014-3945-2; Marcheggiani S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-171; Martinez-Anaya C, 2008, REV LATINOAM MICROBI, P119; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Molina C, 2014, REV MEX ING QUIM, V13, P765; Mota MJ, 2013, BIOTECHNOL ADV, V31, P1426, DOI 10.1016/j.biotechadv.2013.06.007; Moubasher A, 1990, ACTA MYCOL, P65; NAGESWARA S, 2014, BIOMED RES INT, V1, P1; Nong XH, 2014, MAR DRUGS, V12, P6113, DOI 10.3390/md12126113; Pandey A, 1999, CURR SCI INDIA, V77, P149; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Paul NC, 2014, INT J MOL SCI, V15, P15272, DOI 10.3390/ijms150915272; Pensupa N, 2013, BIORESOURCE TECHNOL, V149, P261, DOI 10.1016/j.biortech.2013.09.061; Pointing SB, 1999, MYCOL RES, V103, P696, DOI 10.1017/S0953756298007655; Proksch P, 2008, BOT MAR, V51, P209, DOI 10.1515/BOT.2008.014; Quiroz-Castaneda RE, 2011, BIODEGRADATION, V22, P565, DOI 10.1007/s10532-010-9428-y; Quiroz-Castarieda RE, 2009, ELECT J BIOTECHNOL; Raap J, 2005, J PEPT SCI, V11, P331, DOI 10.1002/psc.621; Rateb ME, 2011, NAT PROD REP, V28, P290, DOI 10.1039/c0np00061b; Raudabaugh DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078300; Reynolds HT, 2014, PLOS ONE, P16; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Rimington WR, 2015, NEW PHYTOL, V205, P1394, DOI 10.1111/nph.13221; Sabu A, 2000, ENZYME, P705; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Saranraj P, 2012, INT J BIOCH BIOTECH, V1, P1; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Shi R, 2013, BIORESOUR TECHNOL EL, P338; Sigler L, 2004, STUD MYCOL, P409; Spicer GS, 2002, ANN ENTOMOL SOC AM, V95, P156, DOI 10.1603/0013-8746(2002)095[0156:MPOTDV]2.0.CO;2; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Sun S, 2015, SCI REP NATURE PUBLI; Suryanarayanan TS, 2012, BOT MAR, V55, P553, DOI 10.1515/bot-2011-0086; Tako M, 2015, ACTA BIOL HUNG, V66, P348, DOI 10.1556/018.66.2015.3.10; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Terahara T, 2016, GENE, V576, P696, DOI 10.1016/j.gene.2015.10.027; Travadon R, 2015, FUNGAL BIOL-UK, V119, P53, DOI 10.1016/j.funbio.2014.11.002; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Viniegra-Gonzalez G, 2003, BIOCHEM ENG J, V13, P157, DOI 10.1016/S1369-703X(02)00128-6; Vogel H.J., 1956, MICROB GENET B, V13, P42; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; Wang G, 2008, ANTON LEEUW INT J G, P163; Wang GY, 2006, J IND MICROBIOL BIOT, V33, P545, DOI 10.1007/s10295-006-0123-2; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; Yang X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-412; Yokoyama K, 2001, FEMS MICROBIOL LETT, V200, P241, DOI 10.1111/j.1574-6968.2001.tb10722.x; Zhang D, 2015, LETT APPL MICROBIOL; Zuccaro A, 2004, STUD MYCOL, P283; Zukal J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097224	120	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173750	10.1371/journal.pone.0173750	http://dx.doi.org/10.1371/journal.pone.0173750			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339473	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399116700009
J	Qiao, K; Chen, J; Wang, LY; Zeng, L; Yan, B				Qiao, Kai; Chen, Jian; Wang, Linyuan; Zeng, Lei; Yan, Bin			A top-down manner-based DCNN architecture for semantic image segmentation	PLOS ONE			English	Article							BOTTOM-UP MECHANISMS; VISUAL-ATTENTION; COMPETITION	Given their powerful feature representation for recognition, deep convolutional neural networks (DCNNs) have been driving rapid advances in high-level computer vision tasks. However, their performance in semantic image segmentation is still not satisfactory. Based on the analysis of visual mechanism, we conclude that DCNNs in a bottom-up manner are not enough, because semantic image segmentation task requires not only recognition but also visual attention capability. In the study, superpixels containing visual attention information are introduced in a top-down manner, and an extensible architecture is proposed to improve the segmentation results of current DCNN-based methods. We employ the current state-of-the-art fully convolutional network (FCN) and FCN with conditional random field (DeepLab-CRF) as baselines to validate our architecture. Experimental results of the PASCAL VOC segmentation task qualitatively show that coarse edges and error segmentation results are well improved. We also quantitatively obtain about 2%-3% intersection over union (IOU) accuracy improvement on the PASCAL VOC 2011 and 2012 test sets.	[Qiao, Kai; Chen, Jian; Wang, Linyuan; Zeng, Lei; Yan, Bin] Natl Digital Switching Syst Engn & Technol Res Ct, Zhengzhou, Peoples R China	PLA Information Engineering University	Yan, B (corresponding author), Natl Digital Switching Syst Engn & Technol Res Ct, Zhengzhou, Peoples R China.	ybspace@hotmail.com		Yan, Bin/0000-0001-8268-559X	National High Technology Research and Development Program of China [2012AA011603]; National Natural Science Foundation of China [61372172, 61601518]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National High Technology Research and Development Program of China (2012AA011603) (http://www.863.gov.cn) and the National Natural Science Foundation of China (61372172 and 61601518) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is partially supported by the National High Technology Research and Development Program of China (2012AA011603) (http://www.863.gov.cn) and the National Natural Science Foundation of China (61372172 and 61601518) (http://www.nsfc.gov.cn). The Authors are also grateful to the anonymous reviewers giving us constructive comments and suggestions to improve this paper.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Carreira J, 2012, LECT NOTES COMPUT SC, V7578, P430, DOI 10.1007/978-3-642-33786-4_32; Carreira J, 2012, IEEE T PATTERN ANAL, V34, P1312, DOI 10.1109/TPAMI.2011.231; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hariharan B, 2014, LECT NOTES COMPUT SC, V8695, P297, DOI 10.1007/978-3-319-10584-0_20; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He KM, 2014, LECT NOTES COMPUT SC, V8691, P346, DOI 10.1007/978-3-319-10578-9_23; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Krahenbuhl P., 2011, ADV NEURAL INFORM PR, P109; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Liang XD, 2017, IEEE T PATTERN ANAL, V39, P115, DOI 10.1109/TPAMI.2016.2537339; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; Mostajahi M, 2015, PROC CVPR IEEE, P3376, DOI 10.1109/CVPR.2015.7298959; Noh H, 2015, IEEE I CONF COMP VIS, P1520, DOI 10.1109/ICCV.2015.178; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Sermanet P., 2013, COMPUT VIS PATTERN R, V1312, P6229; Shen JB, 2016, IEEE T IMAGE PROCESS, V25, P5933, DOI 10.1109/TIP.2016.2616302; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tighe J, 2015, INT J COMPUT VISION, V112, P150, DOI 10.1007/s11263-014-0778-5; Uijlings JRR, 2013, INT J COMPUT VISION, V104, P154, DOI 10.1007/s11263-013-0620-5; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Van Essen David C., 1995, P383; Wei YC, 2017, IEEE T CYBERNETICS, V47, P449, DOI 10.1109/TCYB.2016.2519449; Xie S, 2016, ARXIV151107409V2; Yamins D.L., 2013, ADV NEURAL INFORM PR, V26, P3093, DOI [DOI 10.5555/2999792.2999957, 10.5555/2999792.2999957]; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yang JM, 2014, PROC CVPR IEEE, P3294, DOI 10.1109/CVPR.2014.415; Zhang H, 2016, IEEE T IND INFORM; Zhang Z, 2017, IEEE T IMAGE PROCESS, V26, P1607, DOI 10.1109/TIP.2017.2654163; Zhang Z, 2017, PATTERN RECOGN, V61, P492, DOI 10.1016/j.patcog.2016.07.042; Zhang Z, 2016, IEEE T SIGNAL PROCES, V64, P3790, DOI 10.1109/TSP.2016.2550016	47	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174508	10.1371/journal.pone.0174508	http://dx.doi.org/10.1371/journal.pone.0174508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339486	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700033
J	Becker, S; Kinny-Koster, B; Bartels, M; Scholz, M; Seehofer, D; Berg, T; Engelmann, C; Thiery, J; Ceglarek, U; Kaiser, T				Becker, Susen; Kinny-Koester, Benedict; Bartels, Michael; Scholz, Markus; Seehofer, Daniel; Berg, Thomas; Engelmann, Cornelius; Thiery, Joachim; Ceglarek, Uta; Kaiser, Thorsten			Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; APOLIPOPROTEIN M; FTY720; MODEL	Background & aim The association of circulating sphingosine-1-phosphate (S1P), a bioactive lipid involved in various cellular processes, and related metabolites such as sphinganine-1-phosphate (SA1P) and sphingosine (SPH) with mortality in patients with end-stage liver disease is investigated in the presented study. S1P as a bioactive lipid mediator, is involved in several cellular processes, however, in end-stage liver disease its role is not understood. Methods The study cohort consisted of 95 patients with end-stage liver disease and available information on one-year outcome. The median MELD (Model for end-stage liver disease) score was 12.41 (Range 6.43-39.63). The quantification of sphingolipids in citrated plasma specimen was performed after methanolic protein precipitation followed by hydrophilic interaction liquid chromatography and tandem mass spectrometric detection. Results S1P and SA1P displayed significant correlations with the MELD score. Patients with circulating S1P levels below the lowest tertile (110.68 ng/ml) showed the poorest one-year survival rate of only 57.1%, whereas one-year survival rate in patients with S1P plasma levels above 165.67 ng/ml was 93.8%. In a multivariate cox regression analysis including platelet counts, concentrations of hemoglobin and MELD score, S1P remained a significant predictor for three-month and one-year mortality. Conclusions Low plasma S1P concentrations are highly significantly associated with prognosis in end-stage liver disease. This association is independent of the stage of liver disease. Further studies should be performed to investigate S1P, its role in the pathophysiology of liver diseases and its potential for therapeutic interventions.	[Becker, Susen; Kinny-Koester, Benedict; Thiery, Joachim; Ceglarek, Uta; Kaiser, Thorsten] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diag, Leipzig, Germany; [Bartels, Michael; Seehofer, Daniel] Univ Hosp Leipzig, Dept Visceral Vasc Thorac & Transplant Surg, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Scholz, Markus; Thiery, Joachim; Ceglarek, Uta] Univ Hosp Leipzig, LIFE Leipzig Res Ctr Civilizat, Leipzig, Germany; [Berg, Thomas; Engelmann, Cornelius] Univ Leipzig, Dept Gastroenterol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University	Kaiser, T (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diag, Leipzig, Germany.	thorsten.kaiser@medizin-uni-leipzig.de	Seehofer, Daniel/X-1933-2019; Ceglarek, Uta/GOE-5561-2022	Kaiser, Thorsten/0000-0003-0523-3113				Brunati AM, 2008, BBA-MOL CELL RES, V1783, P347, DOI 10.1016/j.bbamcr.2007.11.008; Ceglarek U, 2014, CLIN CHIM ACTA, V435, P1, DOI 10.1016/j.cca.2014.04.010; DiVito C, 2016, PLATELETS, P1; Frej C, 2015, ANAL BIOANAL CHEM, V407, P8533, DOI 10.1007/s00216-015-9008-4; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Ikeda H, 2010, CLIN CHIM ACTA, V411, P765, DOI 10.1016/j.cca.2010.02.063; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kong YX, 2014, INFLAMMATION, V37, P1326, DOI 10.1007/s10753-014-9877-2; Kumaraswamy SB, 2012, CRIT CARE, V16, DOI 10.1186/cc11305; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; MELD/ PELD, 2009, MELD PELD CALC DOC; Meyer J, 2015, J HEPATOL; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nojima H, 2016, J HEPATOL, V64, P60, DOI 10.1016/j.jhep.2015.07.030; Nojiri T, 2014, J DIABETES INVEST, V5, P639, DOI 10.1111/jdi.12232; Ren K, 2015, CLIN CHIM ACTA, V446, P21, DOI 10.1016/j.cca.2015.03.038; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Yang L, 2012, AM J PATHOL, V181, P85, DOI 10.1016/j.ajpath.2012.03.014; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404	22	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174424	10.1371/journal.pone.0174424	http://dx.doi.org/10.1371/journal.pone.0174424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334008	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200098
J	Pena, JCD; Martello, F; Ribeiro, MC; Armitage, RA; Young, RJ; Rodrigues, M				de Castro Pena, Joao Carlos; Martello, Felipe; Ribeiro, Milton Cezar; Armitage, Richard A.; Young, Robert J.; Rodrigues, Marcos			Street trees reduce the negative effects of urbanization on birds	PLOS ONE			English	Article							URBAN; DIVERSITY; VEGETATION; BRAZIL	The effects of streets on biodiversity is an important aspect of urban ecology, but it has been neglected worldwide. Several vegetation attributes (e.g. street tree density and diversity) have important effects on biodiversity and ecological processes. In this study, we evaluated the influences of urban vegetation-represented by characteristics of street trees (canopy size, proportion of native tree species and tree species richness)-and characteristics of the landscape (distance to parks and vegetation quantity), and human impacts (human population size and exposure to noise) on taxonomic data and functional diversity indices of the bird community inhabiting streets. The study area was the southern region of Belo Horizonte (Minas Gerais, Brazil), a largely urbanized city in the understudied Neotropical region. Bird data were collected on 60 point count locations distributed across the streets of the landscape. We used a series of competing GLM models (using Akaike's information criterion for small sample sizes) to assess the relative contribution of the different sets of variables to explain the observed patterns. Seventy-three bird species were observed exploiting the streets: native species were the most abundant and frequent throughout this landscape. The bird community's functional richness and Rao's Quadratic Entropy presented values lower than 0.5. Therefore, this landscape was favoring few functional traits. Exposure to noise was the most limiting factor for this bird community. However, the average size of arboreal patches and, especially the characteristics of street trees, were able to reduce the negative effects of noise on the bird community. These results show the importance of adequately planning the urban afforestation process: increasing tree species richness, preserving large trees and planting more native trees species in the streets are management practices that will increase bird species richness, abundance and community functional aspects and consequently improve human wellbeing and quality of life.	[de Castro Pena, Joao Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Programa Posgrad Ecol Conservacao & Manejo Vida S, Belo Horizonte, MG, Brazil; [de Castro Pena, Joao Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Ornithol Lab, Belo Horizonte, MG, Brazil; [Martello, Felipe; Ribeiro, Milton Cezar] Univ Estadual Paulista, UNESP, Inst Biosci, Spatial Ecol & Conservat Lab,Dept Ecol, Sao Paulo, Brazil; [Armitage, Richard A.; Young, Robert J.] Univ Salford, Sch Environm & Life Sci, Peel Bldg, Manchester, Lancs, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual Paulista; University of Manchester; University of Salford	Pena, JCD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Programa Posgrad Ecol Conservacao & Manejo Vida S, Belo Horizonte, MG, Brazil.; Pena, JCD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Ornithol Lab, Belo Horizonte, MG, Brazil.	joaocpena@gmail.com	Young, Robert/B-7356-2013; de Castro Pena, João Carlos/S-6798-2016; Martello, Felipe/AAW-1624-2020; Pena, João Carlos Castro/M-3576-2019; Armitage, Richard/B-1639-2010	Young, Robert/0000-0002-8407-2348; de Castro Pena, João Carlos/0000-0003-1368-1805; Martello, Felipe/0000-0003-1243-9750; Pena, João Carlos Castro/0000-0003-1368-1805; Armitage, Richard/0000-0002-7569-425X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [312045/2013-1]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/50421-2]; Fundaao de Amparo a Pesquisa do Estado de Minas Gerais	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundaao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) [MCR (grant number 312045/2013-1) and MR]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (https://www.capes.gov.br/) (JCCP and FM); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant number 2013/50421-2 (http;//www.fapesp.br/) (MCR); and Fundaao de Amparo a Pesquisa do Estado de Minas Gerais (littp://www. fapemig.br/) (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelstam P, 2006, LANDSCAPE URBAN PLAN, V77, P39; [Anonymous], 2019, R LANG ENV STAT COMP; Aronson MFJ, 2014, P ROY SOC B, P281; Arroyo-Solis A, 2013, J AVIAN BIOL, V44, P288, DOI 10.1111/j.1600-048X.2012.05796.x; de Toledo MCB, 2012, URBAN ECOSYST, V15, P111, DOI 10.1007/s11252-011-0195-2; Belo Horizonte, 2015, PREF MUN BEL HOR; Bhullar Simrath, 2000, Pacific Conservation Biology, V6, P171; Bibby C., 2000, EXPEDITION FIELD TEC; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blair RB, 2008, LANDSCAPE ECOL, V23, P1157, DOI 10.1007/s10980-008-9267-y; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Concepcion ED, 2016, ECOGRAPHY IN PRESS; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; del Hoyo J., 2004, HDB BIRDS WORLD; Dray S, 2014, PACKAGE ADE4, P409; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fernandez-Juricic E, 2000, CONSERV BIOL, V14, P513, DOI 10.1046/j.1523-1739.2000.98600.x; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Gatesire T, 2014, SCI WORLD J, DOI 10.1155/2014/157824; Herzog C, 2016, LANDSC ECOL ENG, V12, P141, DOI 10.1007/s11355-013-0233-8; Herzog CP, 2013, CIDADE TODOS RE APRE; Hong SH, 2013, LANDSC ECOL ENG, V9, P165, DOI 10.1007/s11355-012-0194-3; IBGE, 2010, CENS DEM; Ikin K, 2013, DIVERS DISTRIB, V19, P294, DOI 10.1111/j.1472-4642.2012.00937.x; Ikin K, 2013, LANDSCAPE ECOL, V28, P45, DOI 10.1007/s10980-012-9811-7; Jokimaki J, 2016, URBAN ECOSYST, V19, P1565, DOI 10.1007/s11252-014-0423-7; Laliberte A E, 2014, PACKAGE FD, P28; Le Roux DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099403; Lindenmayer DB, 2014, CONSERV LETT, V7, P61, DOI 10.1111/conl.12013; Lindsay AR, 2002, BIOL CONSERV, V107, P1, DOI 10.1016/S0006-3207(01)00260-9; Litteral J, 2012, URBAN ECOSYST, V15, P939, DOI 10.1007/s11252-012-0245-4; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mazerolle MJ, 2016, AICCMODAVG, P158; McDonald Robert I., 2013, P31; McHarg I.L., 1992, DESIGN NATURE; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Meffert PJ, 2013, LANDSCAPE ECOL, V28, P943, DOI 10.1007/s10980-013-9867-z; Meillere A, 2015, BEHAV ECOL, V26, P569, DOI 10.1093/beheco/aru232; Melo-Junior TA, 2013, TAXEUS LISTAS ESPECI; Morante JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128923; Moro MF, 2015, URBAN ECOSYST, V18, P47, DOI 10.1007/s11252-014-0380-1; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Oksanen J, 2016, PACKAGE VEGAN, P291; Ortega-Alvarez R, 2011, AUK, V128, P415, DOI 10.1525/auk.2011.10082; Ortega-Alvarez R, 2009, LANDSCAPE URBAN PLAN, V90, P189, DOI 10.1016/j.landurbplan.2008.11.003; Pauchard Anibal, 2013, P589; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Pena JCC., 2016, REV SOC BRAS ARBORIZ, V11, P66, DOI [10.5380/revsbau.v11i4.63481, DOI 10.5380/REVSBAU.V11I4.63481]; Piacentini VD, 2015, REV BRAS ORNITOL, V23, P91; PONCO J.V., 2013, ATUALIDADES ORNITOLO, V174, P60; Pujol G, 2016, PACKAGE SENSITIVITY, P69; Reis E, 2012, LANDSCAPE URBAN PLAN, V107, P31, DOI 10.1016/j.landurbplan.2012.04.009; Rodrigues M, 2009, CIDADE U UFMG HIST N, P207; Schutz C, 2015, ECOL EVOL; Secretariat of the Convention of Biological Diversity, 2012, CIT BIOD OUTL ACT PO; Shackleton CM, 2016, EVIDENCE USING MISTL, P7; Sick H, 2001, ORNITOLOGIA BRASILEI; Stagoll K, 2012, CONSERV LETT, V5, P115, DOI 10.1111/j.1755-263X.2011.00216.x; Threlfall CG, 2016, LANDSCAPE URBAN PLAN, V153, P28, DOI 10.1016/j.landurbplan.2016.04.011; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tremblay MA, 2009, J APPL ECOL, V46, P1314, DOI 10.1111/j.1365-2664.2009.01717.x; United Nations Department of Economic and Social Affairs Population Division, 2014, WORLD URB PROSP; van der Ree R, 2011, ECOL SOC, V16; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1; Yang F, 2010, J ENVIRON HEALTH, V72, P8; Young KM, 2007, AUSTRAL ECOL, V32, P541, DOI 10.1111/j.1442-9993.2007.01726.x	73	36	39	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174484	10.1371/journal.pone.0174484	http://dx.doi.org/10.1371/journal.pone.0174484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333989	Green Published, gold			2022-12-27	WOS:000399102200104
J	Sun, ML; Xu, QL; Xu, JW; Wu, Y; Wang, YT; Zuo, DY; Guan, Q; Bao, K; Wang, J; Wu, YL; Zhang, WG				Sun, Maolin; Xu, Qile; Xu, Jingwen; Wu, Yue; Wang, Yueting; Zuo, Daiying; Guan, Qi; Bao, Kai; Wang, Jian; Wu, Yingliang; Zhang, Weige			Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity	PLOS ONE			English	Article							ANTICANCER AGENTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL EVALUATION; COMBRETASTATIN A-4; BINDING AGENTS; DISCOVERY; MICROTUBULES; CHEMISTRY; 2-AMINOTHIAZOLES; COLCHICINE	A series of N,4-diaryl-1,3-thiazole-2-amines containing three aromatic rings with an amino linker were designed and synthesized as tubulin inhibitors and evaluated for their antiproliferative activity in three human cancer cell lines. Most of the target compounds displayed moderate antiproliferative activity, and N-(2,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1,3-thiazol-2-amine (10s) was determined to be the most potent compound. Tubulin polymerization and immunostaining experiments revealed that 10s potently inhibited tubulin polymerization and disrupted tubulin microtubule dynamics in a manner similar to CA-4. Moreover, 10s effectively induced SGC-7901 cell cycle arrest at the G2/M phase in both concentration and time-dependent manners. The molecular docking results revealed that 10s could bind to the colchicine binding site of tubulin.	[Sun, Maolin; Xu, Qile; Wu, Yue; Wang, Yueting; Guan, Qi; Bao, Kai; Wang, Jian; Zhang, Weige] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China; [Xu, Jingwen; Zuo, Daiying; Wu, Yingliang] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China; [Bao, Kai] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Div Nucl Med & Mol Imaging, Dept Radiol, Boston, MA USA; [Bao, Kai] Harvard Med Sch, Boston, MA USA	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wang, J; Zhang, WG (corresponding author), Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China.	jianwang@syphu.edu.cn; zhangweige2000@sina.com		Xu, Jingwen/0000-0002-2451-8037; Zhang, Weige/0000-0002-4492-3072; Guan, Qi/0000-0002-5003-8723	Programme for Innovative Research Team of the Ministry of Education; Programme for Liaoning Innovative Research Team in University.; National Natural Science Foundation of China [81502932]; State Key Laboratory of Natural Medicines and Active Substance [GTZK201603]; Programme for Innovative Research Team of the Ministry of Education and the Programme for Liaoning Innovative Research Team in University	Programme for Innovative Research Team of the Ministry of Education; Programme for Liaoning Innovative Research Team in University.; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Natural Medicines and Active Substance; Programme for Innovative Research Team of the Ministry of Education and the Programme for Liaoning Innovative Research Team in University	This work was supported by the the National Natural Science Foundation of China (81502932), State Key Laboratory of Natural Medicines and Active Substance (No. GTZK201603), the Programme for Innovative Research Team of the Ministry of Education and the Programme for Liaoning Innovative Research Team in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Programme for Innovative Research Team of the Ministry of Education and the Programme for Liaoning Innovative Research Team in University.	Attia SM, 2013, J APPL TOXICOL, V33, P426, DOI 10.1002/jat.1753; Carlson RO, 2008, EXPERT OPIN INV DRUG, V17, P707, DOI [10.1517/13543784.17.5.707, 10.1517/13543784.17.5.707 ]; Chaudhary A, 2007, MINI-REV MED CHEM, V7, P1186, DOI 10.2174/138955707782795647; Chen JJ, 2010, J MED CHEM, V53, P7414, DOI 10.1021/jm100884b; Das D, 2016, EUR J MED CHEM, V109, P89, DOI 10.1016/j.ejmech.2015.12.022; Dong MQ, 2016, MOLECULES, V21, DOI 10.3390/molecules21101375; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Graening T, 2004, ANGEW CHEM INT EDIT, V43, P3230, DOI 10.1002/anie.200300615; Guan Q, 2015, MEDCHEMCOMM, V6, P1484, DOI 10.1039/c5md00150a; Guan Q, 2014, EUR J MED CHEM, V87, P1, DOI 10.1016/j.ejmech.2014.09.046; Jiang ZQ, 2009, ORG LETT, V11, P1503, DOI 10.1021/ol9001152; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kabalka GW, 2006, TETRAHEDRON LETT, V47, P5171, DOI 10.1016/j.tetlet.2006.05.053; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim KS, 2002, J MED CHEM, V45, P3905, DOI 10.1021/jm0201520; La Regina G, 2014, J MED CHEM, V57, P6531, DOI 10.1021/jm500561a; Lu Y, 2009, J MED CHEM, V52, P1701, DOI 10.1021/jm801449a; Pettit GR, 1998, J MED CHEM, V41, P1688, DOI 10.1021/jm970644q; PETTIT GR, 1989, EXPERIENTIA, V45, P209, DOI 10.1007/BF01954881; PETTIT GR, 1987, J NAT PROD, V50, P119, DOI 10.1021/np50049a016; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Sato Takashi, 2012, J Med Case Rep, V6, P266, DOI 10.1186/1752-1947-6-266; STEPHENS RE, 1976, PHYSIOL REV, V56, P709, DOI 10.1152/physrev.1976.56.4.709; TAGUCHI M, 1992, J MED CHEM, V35, P94, DOI 10.1021/jm00079a011; Wang XF, 2013, BIOORGAN MED CHEM, V21, P632, DOI 10.1016/j.bmc.2012.11.047; Xiao M, 2013, J MED CHEM, V56, P3318, DOI 10.1021/jm4001117; Xu Q., 2015, IEEE T EMERG TOP COM, V3, P1, DOI DOI 10.1109/ISEC.2015.7383446	28	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174006	10.1371/journal.pone.0174006	http://dx.doi.org/10.1371/journal.pone.0174006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333984	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200037
J	Dennis, EB; Morgan, BJT; Freeman, SN; Ridout, MS; Brereton, TM; Fox, R; Powney, GD; Roy, DB				Dennis, Emily B.; Morgan, Byron J. T.; Freeman, Stephen N.; Ridout, Martin S.; Brereton, Tom M.; Fox, Richard; Powney, Gary D.; Roy, David B.			Efficient occupancy model-fitting for extensive citizen-science data	PLOS ONE			English	Article							SITE-OCCUPANCY; HIERARCHICAL-MODELS; TRENDS; DETECTABILITY; PACKAGE	Appropriate large-scale citizen-science data present important new opportunities for biodiversity modelling, due in part to the wide spatial coverage of information. Recently proposed occupancy modelling approaches naturally incorporate random effects in order to account for annual variation in the composition of sites surveyed. In turn this leads to Bayesian analysis and model fitting, which are typically extremely time consuming. Motivated by presence only records of occurrence from the UK Butterflies for the New Millennium data base, we present an alternative approach, in which site variation is described in a standard way through logistic regression on relevant environmental covariates. This allows efficient occupancy model-fitting using classical inference, which is easily achieved using standard computers. This is especially important when models need to be fitted each year, typically for many different species, as with British butterflies for example. Using both real and simulated data we demonstrate that the two approaches, with and without random effects, can result in similar conclusions regarding trends. There are many advantages to classical model-fitting, including the ability to compare a range of alternative models, identify appropriate covariates and assess model fit, using standard tools of maximum likelihood. In addition, modelling in terms of covariates provides opportunities for understanding the ecological processes that are in operation. We show that there is even greater potential; the classical approach allows us to construct regional indices simply, which indicate how changes in occupancy typically vary over a species' range. In addition we are also able to construct dynamic occupancy maps, which provide a novel, modern tool for examining temporal changes in species distribution. These new developments may be applied to a wide range of taxa, and are valuable at a time of climate change. They also have the potential to motivate citizen scientists.	[Dennis, Emily B.; Morgan, Byron J. T.; Ridout, Martin S.] Univ Kent, Sch Math Stat & Actuarial Sci, Canterbury, Kent, England; [Dennis, Emily B.; Brereton, Tom M.; Fox, Richard] Butterfly Conservat, Wareham, Dorset, England; [Freeman, Stephen N.; Powney, Gary D.; Roy, David B.] Ctr Ecol & Hydrol, Wallingford, Oxon, England	University of Kent; UK Centre for Ecology & Hydrology (UKCEH)	Dennis, EB (corresponding author), Univ Kent, Sch Math Stat & Actuarial Sci, Canterbury, Kent, England.	E.B.Dennis@kent.ac.uk	Roy, David/A-6619-2009	Roy, David/0000-0002-5147-0331; Ridout, Martin/0000-0001-7233-2985; Fox, Richard/0000-0001-6992-3522; Powney, Gary/0000-0003-3313-7786; Dennis, Emily/0000-0003-2692-4415	Engineering and Physical Sciences Research Council [EP/1000917/1, EP/P505577/1]; University of Kent; Butterfly Conservation; EPSRC [EP/I000917/1] Funding Source: UKRI; NERC [ceh020004, ceh020002] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000917/1] Funding Source: researchfish; Natural Environment Research Council [ceh020004, ceh020002] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Kent; Butterfly Conservation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	EBD was funded by the Engineering and Physical Sciences Research Council on grants EP/1000917/1 and EP/P505577/1, as well as Butterfly Conservation and the University of Kent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Asher J, 2011, J INSECT CONSERV, V15, P291, DOI 10.1007/s10841-010-9346-7; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Bishop TR, 2013, METHODS ECOL EVOL, V4, P1024, DOI 10.1111/2041-210X.12112; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Burns F., 2016, STATE OF NATURE 2016; Chambert T, 2015, METHODS ECOL EVOL, V6, P638, DOI 10.1111/2041-210X.12362; Defra, 2016, UK BIOD IND 2015; Dennis EB, 2015, CONSTRUCTION SPATIAL; Dennis Roger L. H., 2005, Journal of Insect Conservation, V9, P187, DOI 10.1007/s10841-005-5660-x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fox R, 2015, STATE UKS BUTTER FLI; Gimenez O, 2006, BIOMETRICS, V62, P691, DOI 10.1111/j.1541-0420.2005.00514.x; Gimenez O, 2014, METHODS ECOL EVOL, V5, P592, DOI 10.1111/2041-210X.12191; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Harrison PJ, 2014, J APPL ECOL, V51, P1650, DOI 10.1111/1365-2664.12316; Hill MO, 2012, METHODS ECOL EVOL, V3, P195, DOI 10.1111/j.2041-210X.2011.00146.x; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Jackson CH, 2011, J STAT SOFTW, V38, P1; Johnson DS, 2013, ECOLOGY, V94, P801, DOI 10.1890/12-0564.1; Kelling S, 2015, AMBIO, V44, pS601, DOI 10.1007/s13280-015-0710-4; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Kery M, 2010, CONSERV BIOL, V24, P1388, DOI 10.1111/j.1523-1739.2010.01479.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Met Office, 2015, UK CLIMATE HISTORIC; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Morton R. D., 2014, LAND COVER MAP 2007, DOI DOI 10.5285/FDF8C8D3-5998-45A5-8431-7F5-6302FC32; Nychka D., FIELDS TOOLS SPATIAL; Pagel J, 2014, METHODS ECOL EVOL, V5, P751, DOI 10.1111/2041-210X.12221; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pocock MJO, 2015, BIOL J LINN SOC, V115, P475, DOI 10.1111/bij.12548; Powney GD, 2015, BIOL J LINN SOC, V115, P532, DOI 10.1111/bij.12517; Roth T, 2014, ECOLOGY, V95, P2144; Schaub M, 2012, ANIM CONSERV, V15, P125, DOI 10.1111/j.1469-1795.2012.00531.x; Schmucki R, 2016, J APPL ECOL, V53, P501, DOI 10.1111/1365-2664.12561; Strebel N, 2014, METHODS ECOL EVOL, V5, P483, DOI 10.1111/2041-210X.12175; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; van Strien AJ, 2010, BASIC APPL ECOL, V11, P495, DOI 10.1016/j.baae.2010.05.003; Winston C, 2016, WEB APPL FRAMEWORK R; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459	47	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174433	10.1371/journal.pone.0174433	http://dx.doi.org/10.1371/journal.pone.0174433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328937	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399094700093
J	Grinnell, F; Dalley, S; Shepherd, K; Reisch, J				Grinnell, Frederick; Dalley, Simon; Shepherd, Karen; Reisch, Joan			High school science fair and research integrity	PLOS ONE			English	Article							PARTICIPATION	Research misconduct has become an important matter of concern in the scientific community. The extent to which such behavior occurs early in science education has received little attention. In the current study, using the web-based data collection program REDCap, we obtained responses to an anonymous and voluntary survey about science fair from 65 high school students who recently competed in the Dallas Regional Science and Engineering Fair and from 237 STEM-track, post-high school students (undergraduates, 1st year medical students, and 1st year biomedical graduate students) doing research at UT Southwestern Medical Center. Of the post-high school students, 24% had competed in science fair during their high school education. Science fair experience was similar overall for the local cohort of Dallas regional students and the more diverse state/national cohort of post-high school students. Only one student out of 122 reported research misconduct, in his case making up the data. Unexpectedly, post-high school students who did not participate in science fair anticipated that carrying out science fair would be much more difficult than actually was the case, and 22% of the post-high school students anticipated that science fair participants would resort to research misconduct to overcome obstacles. No gender-based differences between students' science fair experiences or expectations were evident.	[Grinnell, Frederick] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; [Dalley, Simon] Southern Methodist Univ, Dept Phys, Dallas, TX USA; [Shepherd, Karen] Plano Independent Sch Dist, Plano, TX USA; [Reisch, Joan] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Methodist University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grinnell, F (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	frederick.grinnell@utsouthwestern.edu		grinnell, frederick/0000-0001-5337-3087	Robert McLemore Professorship; Maguire Center for Ethics and Public Responsibility at SMU; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER	Robert McLemore Professorship; Maguire Center for Ethics and Public Responsibility at SMU; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	FG was supported by the Robert McLemore Professorship and SD was supported by the Maguire Center for Ethics and Public Responsibility at SMU.	Allen PJ, 2016, ETHICS BEHAV, V26, P300, DOI 10.1080/10508422.2015.1019070; Anderman E. M., 2011, PSYCHOL ACAD CHEATIN; Davidson EW, 2000, INV RES INT P 1 ORI, P27; Del Carlo D, 2006, BIOCHEM MOL BIOL EDU, V34, P338, DOI 10.1002/bmb.2006.494034052657; Elliott SL., 2015, PERSPECTIVES RES INT; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Flanagan J., 2013, PLOS BLOGS SCI ED; GREENFIELD TA, 1995, J RES SCI TEACH, V32, P735, DOI 10.1002/tea.3660320707; Grinnell F., 2009, EVERYDAY PRACTICE SC; Grinnell F, 2013, SCI ENG ETHICS, V19, P685, DOI 10.1007/s11948-012-9376-5; Jensen LA, 2002, CONTEMP EDUC PSYCHOL, V27, P209, DOI 10.1006/ceps.2001.1088; Manoharan J, 2011, BIOTECHNIQUES; McComas W.F., 2011, SCI TEACH, V78, P34; Moorin MA, 2011, SCI UN FAIR REFORMAT; National Academies-Institute of Medicine, 2002, INT SCI RES CREAT EN; National Institutes of Health, 2011, NOT OD 10 019 UPD RE; National Science Foundation, 2010, RESP COND RES RCR B; National Science Teachers Assocation, 2003, SCI FAIRS PLUS REV O; Rajah-Kanagasabai CJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00535; SCHAB F, 1991, ADOLESCENCE, V26, P839; Schenk H, 2015, ATLANTIC; Sonnert G, 2013, SCHOOL SCI MATH, V113, P135, DOI 10.1111/ssm.12007; Syer C.A., 2001, SCHOOL SCI MATH, V101, P206, DOI [10.1111/j.1949-8594.2001.tb18023.x, DOI 10.1111/J.1949-8594.2001.TB18023.X]; Tarjan LM, 2015, SCI SCOPE, V39, P42; Turrens J, 2001, INV RES INT P 1 ORI, P49	26	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174252	10.1371/journal.pone.0174252	http://dx.doi.org/10.1371/journal.pone.0174252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328976	gold, Green Published			2022-12-27	WOS:000399094700076
J	Hiraoka, T; Miyata, K; Hayashidera, T; Iida, M; Takada, K; Minami, K; Oshika, T				Hiraoka, Takahiro; Miyata, Kazunori; Hayashidera, Takeshi; Iida, Masaharu; Takada, Keita; Minami, Keiichiro; Oshika, Tetsuro			Influence of intraocular lens subsurface nanoglistenings on functional visual acuity	PLOS ONE			English	Article							SURFACE LIGHT-SCATTERING; POSTERIOR CAPSULE OPACIFICATION; DRY EYE PATIENTS; CONTRAST SENSITIVITY; CATARACT-SURGERY; LONG-TERM; SYSTEM; IMPLANTATION; GLISTENINGS; ABERRATIONS	To investigate the influence of intraocular lens subsurface nanoglistenings (SSNGs) on functional visual acuity (FVA), thirty-nine eyes of 29 patients were examined in this study. The SSNG group comprised 19 eyes of 14 patients (75.7 +/- 5.4 years, mean +/- standard deviation), and the control group comprised 20 eyes of 15 patients (7 3.6 +/- 6.5 years). The SSNGs were diagnosed on the basis of the typical whitish IOL appearance upon slit-lamp examination and results of densitometry regarding surface light scattering using Scheimpflug images. The FVA measurement system (AS-28; Kowa, Aichi, Japan) was used to examine changes in continuous visual acuity (VA) over time, and visual function parameters such as FVA, visual maintenance ratio (VMR), maximum VA, minimum VA, standard deviation of VA, and number of blinks were assessed. The results were compared between the SSNG and control groups, and correlations of FVA parameters with the intensity of surface light scattering, time after surgery, and age were also evaluated. There were significant differences in VMR (P = 0.035) and standard deviation of VAs (P = 0.031) between the two groups, although no significant differences were found in baseline VA, FVA, maximum VA, minimum VA, and number of blinks. None of the FVA parameters showed any significant correlations with the intensity of surface light scattering, time after surgery, or age. There is a possibility that VA is unstable during a continuous gazing task in patients with SSNGs.	[Hiraoka, Takahiro; Hayashidera, Takeshi; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan; [Miyata, Kazunori; Iida, Masaharu; Takada, Keita; Minami, Keiichiro] Miyata Eye Hosp, Dept Ophthalmol, Miyazaki, Japan	University of Tsukuba	Hiraoka, T (corresponding author), Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan.	thiraoka@md.tsukuba.ac.jp		Hiraoka, Takahiro/0000-0002-4444-4127				Anal P, 2011, PLOS ONE, V6; ARTAL P, 1993, J OPT SOC AM A, V10, P1656, DOI 10.1364/JOSAA.10.001656; Beheregaray S, 2014, J CATARACT REFR SURG, V40, P1147, DOI 10.1016/j.jcrs.2013.10.047; Franssen L, 2006, INVEST OPHTH VIS SCI, V47, P768, DOI 10.1167/iovs.05-0690; Fujikado T, 2004, J CATARACT REFR SURG, V30, P1198, DOI 10.1016/j.jcrs.2003.12.023; Goto E, 2003, AM J OPHTHALMOL, V135, P704, DOI 10.1016/S0002-9394(02)02147-5; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Hayashi K, 2012, AM J OPHTHALMOL, V154, P240, DOI 10.1016/j.ajo.2012.03.011; Henriksen BS, 2015, J CATARACT REFR SURG, V41, P1190, DOI 10.1016/j.jcrs.2014.09.051; Hiraoka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134505; Hiraoka T, 2013, J OCUL PHARMACOL TH, V29, P770, DOI 10.1089/jop.2013.0024; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Ishioka M, 2009, ACTA OPHTHALMOL, V87, P574, DOI 10.1111/j.1755-3768.2008.01230.x; Kaido M, 2008, OPTOMETRY VISION SCI, V85, P758, DOI 10.1097/OPX.0b013e3181819f0a; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2011, JPN J OPHTHALMOL, V55, P183, DOI 10.1007/s10384-011-0026-2; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Katada Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151094; Lavric A, 2014, OPTOMETRY VISION SCI, V91, P1348, DOI 10.1097/OPX.0000000000000390; Li X, 2016, EYE LOND; Liu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077860; Matsushima H, 2015, SAUDI J OPHTHALMOL, V29, P259, DOI 10.1016/j.sjopt.2015.07.001; Matsushima H, 2009, J CATARACT REFR SURG, V35, P1927, DOI 10.1016/j.jcrs.2009.07.004; Miyata K, 2009, BRIT J OPHTHALMOL, V93, P684, DOI 10.1136/bjo.2008.144691; Miyata K, 2012, J CATARACT REFR SURG, V38, P221, DOI 10.1016/j.jcrs.2011.08.042; Monestam E, 2011, ACTA OPHTHALMOL, V89, P724, DOI 10.1111/j.1755-3768.2009.01833.x; Munoz G, 2006, J CATARACT REFR SURG, V32, P1320, DOI 10.1016/j.jcrs.2006.02.055; Munoz G, 2012, EUR J OPHTHALMOL, V22, P769, DOI 10.5301/ejo.5000112; Munoz G, 2011, EUR J OPHTHALMOL, V21, P723, DOI 10.5301/EJO.2011.6356; Nishi Y, 2013, ACTA OPHTHALMOL, V91, pE353, DOI 10.1111/aos.12060; Nishihara H, 2003, J CATARACT REFR SURG, V29, P1385, DOI 10.1016/S0886-3350(02)01994-6; Ong MD, 2012, J CATARACT REFR SURG, V38, P1833, DOI 10.1016/j.jcrs.2012.05.043; Rodriguez-Galietero A, 2005, J CATARACT REFR SURG, V31, P1736, DOI 10.1016/j.jcrs.2005.02.039; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; Tanaka Y, 2004, AM J OPHTHALMOL, V137, P732, DOI 10.1016/j.ajo.2003.11.011; Tomita Y, 2016, OPTOMETRY VISION SCI, V93, P70, DOI 10.1097/OPX.0000000000000755; Wakamatsu TH, 2011, J CATARACT REFR SURG, V37, P258, DOI 10.1016/j.jcrs.2010.08.048; Wang Lu, 2010, Zhonghua Yan Ke Za Zhi, V46, P254; Watanabe K, 2014, CONTACT LENS ANTERIO, V37, P203, DOI 10.1016/j.clae.2013.11.009; Yamaguchi T, 2009, J REFRACT SURG, V25, P410, DOI 10.3928/1081597X-20090422-02; Yoshida S, 2011, JPN J OPHTHALMOL, V55, P62, DOI 10.1007/s10384-010-0901-2	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173574	10.1371/journal.pone.0173574	http://dx.doi.org/10.1371/journal.pone.0173574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328997	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700025
J	Lopez-Guerrero, P; Maridet, O; Zhang, ZQ; Daxner-Hock, G				Lopez-Guerrero, Paloma; Maridet, Olivier; Zhang, Zhaoqun; Daxner-Hoeck, Gudrun			A new species of Argyromys (Rodentia, Mammalia) from the Oligocene of the Valley of Lakes (Mongolia): Its importance for palaeobiogeographical homogeneity across Mongolia, China and Kazakhstan	PLOS ONE			English	Article							EARLY MIOCENE; CRICETIDAE RODENTIA; MIDDLE OLIGOCENE; EVOLUTION; BASIN; YUNNAN; FAUNA	We describe a new species of Rodentia (Mammalia), Argyromys cicigei sp. nov. from Toglorhoi (fossil bed TGW-A/2a) in Mongolia and Ulantatal (fossil beds UTL 1 and UTL 7) in China. Its tooth morphology differs from the type species Argyromys aralensis from Akespe in Kazakhstan by smaller size and simpler structures. Argyromys has been assigned in different families of Muroidea, such as Tachyoryctoididae and Spalacidae. However, the presence of common characters indicates a closer relationship of Argyromys with the genera of Cricetidae s.l. (subfamilies Eucricetodontinae; Cricetopinae; Cricetodontinae and Gobicricetodontinae among others) from Asia than with the earliest representatives of Spalacidae or the endemic Tachyoryctoididae. Argyromys cicigei sp. nov. possesses a simple anterocone and anteroconid in the upper and lower first molars, respectively, which is characteristic for Cricetidae s.l. It has a flat occlusal surface in worn specimens; weakly-developed posterolophs; an oblique protolophule and metaloph on the upper molars and it lacks a labial anterolophid on the m1. These traits are also typical of the Oligocene genera Aralocricetodon and Plesiodipus, included in the subfamilies Cricetodontinae and Gobicricetodontinae respectively. The cladistic analysis performed here supports this hypothesis. The clade formed by Argyromys species is grouped with other cricetid taxa (s.l). Spalacids, however, form a different clade, as do the tachyoryctoids. Previous authors state that the Aral Formation (Kazakhstan) should be dated to the Oligocene instead of the Miocene, based on the presence of several taxa. The finds of Argyromys in both regions supports the statement that they are closer in age than previously thought. The occurrence of Argyromys in Kazakhstan, Mongolia and China evidences the biogeographic unity of the Central Asian bioprovince during the Oligocene.	[Lopez-Guerrero, Paloma; Daxner-Hoeck, Gudrun] Nat Hist Museum Wien, Geol & Palaontol Abt, Vienna, Austria; [Maridet, Olivier] Jurass Museum, Collect Management Ctr, Porrentruy, Switzerland; [Maridet, Olivier] Univ Fribourg, Dept Geosci, Earth Sci, Fribourg, Switzerland; [Zhang, Zhaoqun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China	University of Fribourg; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Lopez-Guerrero, P (corresponding author), Nat Hist Museum Wien, Geol & Palaontol Abt, Vienna, Austria.	palomalopez1981@gmail.com	Maridet, Olivier/H-5313-2019	Maridet, Olivier/0000-0002-0956-0712; Lopez-Guerrero, Paloma/0000-0002-6017-0656	Austrian Science Fun (FWF);  [P-23061-N19]	Austrian Science Fun (FWF)(Austrian Science Fund (FWF)); 	The authors received specific funding for this work from the Austrian Science Fun (FWF) by a Stand-Alone-Project awarded to Dr. Gudrun Daxner-Hock. The project title: "Impact of Oligo-Miocene climate changes on Mongolian mammals"; Project leader: Gudrun Hock-Daxner; Project number: P-23061-N19; Application accepted: 29.11.2010; Project started: 01.03.2011; Project ended: 31.12.2015; URL: https://www.fwf.ac.at/en/research-funding/fwf-programmes/stand-alone-projects/. The funder Jurassica Museum provided support in the form of salaries for author OM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdul-Aziz H., 2008, INT J EARTH SCI, V97, P115, DOI DOI 10.1007/S00531-006-0166-7; Argyropoulo AI, 1939, DOKL AKAD NAUK SSSR, V23, P206; Bendukidze OG, 2001, DISTRIBUTION MIGRATI, P9; Bendukidze OG, 1993, THESIS; Bendukidze Oleg G., 2009, Palaeodiversity, P343; Bi SD, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3602[1:ANSOMC]2.0.CO;2; Bohlin B., 1937, PALAEONTOLOGICA SI C, V3, P7; CHALINE J, 1977, MAMMALIA, V41, P245, DOI 10.1515/mamm.1977.41.3.245; Cook JA, 2000, LIFE UNDERGROUND, P332; Daams R, 1999, NEWSL STRATIGR, V37, P103; Dashzeveg D., 1971, P JOINT SOVIET MONGO, V3, P68; DAXNER-HOCK G., 1997, MEMOIRES TRAVAUX I M, V21, P163; Daxner-Hock G., 2007, ANN NATURHISTORISC A, V108, P1; Daxner-Hock G, PALAEOBIODI IN PRESS; Daxner-Hock Gudrun, 2000, Palaeontologische Zeitschrift, V74, P215; Daxner-Hoeck Gudrun, 2003, Deinsea (Rotterdam), V10, P127; Daxner-Hoeck Gudrun, 2015, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V117A, P161; Daxner-Hoeck Gudrun, 2014, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V116A, P131; Daxner-Hoeck Gudrun, 2001, Senckenbergiana Lethaea, V81, P359; de Bruijn H, 2015, PALAEOBIO PALAEOENV, V95, P257, DOI 10.1007/s12549-015-0195-y; DEBRUIJN H, 1981, P K NED AKAD B PHYS, V84, P71; Deng Tao, 2013, P243; Emry RJ, 1998, J VERTEBR PALEONTOL, V18, P218, DOI 10.1080/02724634.1998.10011045; Fejfar O., 1972, Neues Jb Geol Paleont Abh, V141, P168; Flynn L.J., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V92, P589; Flynn LJ, 2009, B AM MUS NAT HIST, P128, DOI 10.1206/582-4.1; Freudenthal M., 1994, Scripta Geologica, V104, P57; Freudenthal M., 1992, Revista Espanola de Paleontologia, P49; Garcia-Paredes I, 2016, CR PALEVOL, V15, P781, DOI 10.1016/j.crpv.2015.09.014; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomez-Rodrigues H., 2009, J ZOOLOGICAL SYSTEMA, V48, P259; Gudrun DAXNER-HCK, 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P348; Hock V., 1999, MITT OSTERR GEOL GES, V90, P83; HOFMEIJER GK, 1985, P K NED AKAD B PHYS, V88, P185; HUANG XH, 1985, VERTEBRAT PALASIATIC, V23, P152; HUANG XS, 1984, VERTEBRAT PALASIATIC, V22, P304; HUANG XS, 1982, VERTEBRAT PALASIATIC, V20, P337; HUANG XS, 1985, VERTEBRAT PALASIATIC, V23, P27; Huang Xue-Shi, 2002, Vertebrata Palasiatica, V40, P17; Kalin D, 2009, NEUES JAHRB GEOL P-A, V254, P177, DOI 10.1127/0077-7749/2009/0010; Kordikova Elena G., 2001, Senckenbergiana Lethaea, V81, P391; LI CK, 1980, VERTEBRAT PALASIATIC, V18, P198; Li Qian, 2012, Vertebrata Palasiatica, V50, P237; Lindsay E. H., 1977, Geobios, Lyon, V10, P597, DOI 10.1016/S0016-6995(77)80040-5; Lindsay E, 2016, HIST BIOL, V28, P78, DOI 10.1080/08912963.2015.1050389; Lindsay EH, 2016, HIST BIOL, V28, P215, DOI 10.1080/08912963.2015.1027888; Lindsay Everett H., 1994, National Science Museum Monographs, V8, P131; Lopatin AV, 2004, PALEONTOL J+, V38, P211; Lopez-Guerrero P., 2015, CURRENT TRENDS PALEO, P177; Lopez-Guerrero P, 2014, CR PALEVOL, V13, P647, DOI 10.1016/j.crpv.2014.07.002; Maridet Olivier, 2014, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V116A, P247; Maridet O, 2013, SWISS J GEOSCI, V106, P231, DOI 10.1007/s00015-013-0145-5; Maridet O, 2013, J VERTEBR PALEONTOL, V33, P185, DOI 10.1080/02724634.2012.710283; Maridet O, 2009, AM MUS NOVIT, P1, DOI 10.1206/676.1; Matthew W. D., 1923, American Museum Novitates, VNo. 102, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; Mein P., 1971, Scripta geol, V2, P1; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nevo E, 1995, ACTA THERIOL, P9; Qiu ZD, 2003, B AM MUS NAT HIST, P586, DOI 10.1206/0003-0090(2003)279<0586:C>2.0.CO;2; Qiu ZD., 1996, MIDDLE MIOCENE MICRO; Qiu Zhu-Ding, 2001, Vertebrata Palasiatica, V39, P204; Qiu Zhu-Ding, 2010, Vertebrata Palasiatica, V48, P27; Reichenbacher B, 2013, SWISS J GEOSCI, V106, P309, DOI 10.1007/s00015-013-0142-8; Rodrigues Helder Gomes, 2014, PALAEOVERTEBRATA, V38, pe3, DOI 10.18563/pv.38.1.e3; Rodrigues HG, 2012, J ASIAN EARTH SCI, V56, P160, DOI 10.1016/j.jseaes.2012.05.007; Schaub S, 2015, TRAITE PALEONTOLOGIC, V2, P659; SCHMIDT-KITTLER N., 2007, ANN NATURHISTORISC A, V108, P173; Sen Sevket, 2011, Yerbilimleri, V32, P21; Sen Sevket, 2011, Vertebrata Palasiatica, V49, P257; Shevyreva NS, 1983, RODENTS RODENTIA MAM; Sun JM, 2015, GEOLOGY, V43, P1015, DOI 10.1130/G37165.1; Tong Y.S., 1997, PALEONT SIN NEW SER, V26, P1; Tong Yongsheng, 1992, Vertebrata Palasiatica, V30, P1; Unay E., 1996, P246; UNAY E, 1990, J HUM EVOL, V19, P445, DOI 10.1016/0047-2484(90)90055-G; Unay Engin, 1999, P421; Unay-Bayraktar E., 1989, Utrecht Micropaleontological Bulletins Special Publication, P1; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Vianey-Liaud M, 2010, ZOOL J LINN SOC-LOND, V160, P531, DOI 10.1111/j.1096-3642.2010.00615.x; Vianey-Liaud Monique, 2006, Palaeovertebrata (Montpellier), V34, P111; Wang B. Y., 1991, VERT PALASIAT, V29, P64; Wang Ban-Yue, 2012, Swiss Journal of Palaeontology, V131, P107, DOI 10.1007/s13358-011-0038-z; Wang Ban-Yue, 2010, Vertebrata Palasiatica, V48, P79; Wang Ban-Yue, 2007, Vertebrata Palasiatica, V45, P195; Wang Ban-Yue, 1994, Annals of Carnegie Museum, V63, P239; Wang Banyue, 1997, Journal of Stratigraphy, V21, P183; WANG BY, 1986, VERTEBRAT PALASIATIC, V24, P110; Wang XM, 2003, FOSSIL MAMMALS ASIA, P275; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wu Wen-Yu, 2009, Vertebrata Palasiatica, V47, P208; Young CC, 1927, PALEONTOLOGIA SINI C, V5; Zhang ZQ, 2016, CR PALEVOL, V15, P903, DOI 10.1016/j.crpv.2015.05.012	93	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172733	10.1371/journal.pone.0172733	http://dx.doi.org/10.1371/journal.pone.0172733			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328975	Green Submitted, gold, Green Published			2022-12-27	WOS:000399094700008
J	Granja, AG; Holland, JW; Pignatelli, J; Secombes, CJ; Tafalla, C				Granja, Aitor G.; Holland, Jason W.; Pignatelli, Jaime; Secombes, Christopher J.; Tafalla, Carolina			Characterization of BAFF and APRIL subfamily receptors in rainbow trout (Oncorhynchus mykiss). Potential role of the BAFF/APRIL axis in the pathogenesis of proliferative kidney disease	PLOS ONE			English	Article							B-LYMPHOCYTE STIMULATOR; CELL ACTIVATING FACTOR; TNF RECEPTOR; ONCORHYNCHUS-MYKISS; MOLECULAR-STRUCTURE; FUNCTIONAL-ANALYSIS; EXPRESSION ANALYSIS; CARTILAGINOUS FISH; IMMUNE-RESPONSE; SALMO-GAIRDNERI	Proliferative kidney disease (PKD) is a parasitic infection of salmonid fish characterized by hyper-secretion of immunoglobulins in response to the presence of the myxozoan parasite, Tetracapsuloides bryosalmonae. In this context, we hypothesized that the BAFF/APRIL axis, known to play a major role in B cell differentiation and survival in mammals, could be affected by the parasite and consequently be involved in the apparent shift in normal B cell activity. To regulate B cell activity, BAFF and APRIL bind to transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B cell maturation antigen (BCMA), whereas BAFF also binds to BAFF receptor (BAFF-R). In teleost fish, although some BAFF and APRIL sequences have been reported, their receptors have not been identified. Thus, as a first step in the current work, we have identified homologues to mammalian TACI, BCMA and BAFF-R in rainbow trout (Oncorhynchus mykiss), that constitute the first report of BAFF and APRIL receptor sequences in fish. Subsequently we studied the transcriptional modulation of BAFF, APRIL, and the fish-specific related cytokine, BALM and their putative receptors in fish naturally exposed to T. bryosalmonae. Finally, to gain further insights on the functional role that these cytokines play during the course of PKD, we have studied their effect on the survival of kidney IgM+ B cells and on immunoglobulin transcription. Our results support the premise that the BAFF / APRIL axis could play an important role during PKD, which may open the possibility of new therapeutic treatments against the disease.	[Granja, Aitor G.; Pignatelli, Jaime; Tafalla, Carolina] INIA, CISA, Valdeolmos, Madrid, Spain; [Holland, Jason W.; Secombes, Christopher J.] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland	University of Aberdeen	Tafalla, C (corresponding author), INIA, CISA, Valdeolmos, Madrid, Spain.	tafalla@inia.es	pignatelli, jaime/AAY-8734-2021; Granja, Aitor/K-8102-2014; Tafalla, Carolina/J-8074-2014	pignatelli, jaime/0000-0002-8431-2241; Tafalla, Carolina/0000-0002-0860-2976	European Research Council (ERC) [2011280469]; European Commission under the Horizon H2020 research and innovation programme [311993, H2020-634429]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2014-54456JIN]; Swiss National Science Foundation [CRSI13_147649-1]	European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission under the Horizon H2020 research and innovation programme; Spanish Ministry of Economy and Competitiveness (MINECO); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Research Council (ERC Starting Grant 2011280469) and by the European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union (Grant Agreement 311993 TARGETFISH) and under the Horizon H2020 research and innovation programme (Grant H2020-634429 ParaFishControl). This work was also partially funded by project AGL2014-54456JIN from the Spanish Ministry of Economy and Competitiveness (MINECO). JWH was supported by the Swiss National Science Foundation (grant reference CRSI13_147649-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abos B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30004; Abos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082737; Ai HX, 2011, FISH SHELLFISH IMMUN, V30, P1265, DOI 10.1016/j.fsi.2011.03.020; Basu M, 2016, MOL IMMUNOL, V78, P9, DOI 10.1016/j.molimm.2016.08.010; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chang SK, 2008, J IMMUNOL, V180, P7394, DOI 10.4049/jimmunol.180.11.7394; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Chilmonczyk S, 2002, J FISH DIS, V25, P217, DOI 10.1046/j.1365-2761.2002.00362.x; CLIFTONHADLEY RS, 1987, J FISH DIS, V10, P335, DOI 10.1111/j.1365-2761.1987.tb01081.x; Cuesta A, 2008, MOL IMMUNOL, V45, P2333, DOI 10.1016/j.molimm.2007.11.007; Cui XW, 2012, INT IMMUNOPHARMACOL, V12, P34, DOI 10.1016/j.intimp.2011.10.009; Darce JR, 2007, J IMMUNOL, V178, P5612, DOI 10.4049/jimmunol.178.9.5612; Das S, 2016, J IMMUNOL, V197, P2695, DOI 10.4049/jimmunol.1600799; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; DELUCA D, 1983, EUR J IMMUNOL, V13, P546, DOI 10.1002/eji.1830130706; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; FARRELL AP, 1983, J EXP BIOL, V107, P415; Figgett WA, 2014, SEMIN IMMUNOL, V26, P191, DOI 10.1016/j.smim.2014.06.001; Glenney GW, 2007, J IMMUNOL, V178, P7955, DOI 10.4049/jimmunol.178.12.7955; Godahewa GI, 2016, DEV COMP IMMUNOL, V55, P1, DOI 10.1016/j.dci.2015.10.004; Gorgoglione B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-55; Grabner DS, 2010, DIS AQUAT ORGAN, V90, P197, DOI 10.3354/dao02236; Hedrick R. P., 1993, Annual Review of Fish Diseases, V3, P277, DOI 10.1016/0959-8030(93)90039-E; Huard B, 2004, INT IMMUNOL, V16, P467, DOI 10.1093/intimm/dxh043; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; le Gouvello R, 1999, AQUACULTURE, V171, P27, DOI 10.1016/S0044-8486(98)00430-X; Li RG, 2015, FISH SHELLFISH IMMUN, V47, P381, DOI 10.1016/j.fsi.2015.09.033; Li RG, 2012, DEV COMP IMMUNOL, V36, P707, DOI 10.1016/j.dci.2011.11.010; Liang ZN, 2010, FISH SHELLFISH IMMUN, V29, P233, DOI 10.1016/j.fsi.2010.03.006; Liu HZ, 2016, FISH SHELLFISH IMMUN, V51, P240, DOI 10.1016/j.fsi.2016.02.026; Liu Z, 2011, EXP CELL RES, V317, P1270, DOI 10.1016/j.yexcr.2011.02.005; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Meng FQ, 2015, FISH SHELLFISH IMMUN, V43, P191, DOI 10.1016/j.fsi.2014.12.022; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ni CZ, 2004, J IMMUNOL, V173, P7394, DOI 10.4049/jimmunol.173.12.7394; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Okamura B, 2011, FRESHWATER BIOL, V56, P735, DOI 10.1111/j.1365-2427.2010.02465.x; Pandit NP, 2013, DEV COMP IMMUNOL, V39, P460, DOI 10.1016/j.dci.2013.01.004; Pinto D, 2013, BLOOD, V121, P4110, DOI 10.1182/blood-2012-09-459289; Ren WH, 2011, FISH SHELLFISH IMMUN, V31, P1088, DOI 10.1016/j.fsi.2011.09.013; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Sun Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136015; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wang TH, 2009, J IMMUNOL, V183, P962, DOI 10.4049/jimmunol.0802953; Xiao W, 2014, MOL IMMUNOL, V59, P64, DOI 10.1016/j.molimm.2014.01.005; Yonar ME, 2010, PESTIC BIOCHEM PHYS, V97, P19, DOI 10.1016/j.pestbp.2009.11.009; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zwollo P, 2005, J IMMUNOL, V174, P6608, DOI 10.4049/jimmunol.174.11.6608	57	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174249	10.1371/journal.pone.0174249	http://dx.doi.org/10.1371/journal.pone.0174249			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323891	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000079
J	Guo, XY; Fan, CM; Tian, L; Liu, YL; Wang, HY; Zhao, SH; Duan, FJ; Zhang, XL; Zhao, X; Wang, FQ; Zhu, HG; Lin, AQ; Wu, X; Li, YS				Guo, Xiying; Fan, Chaomei; Tian, Lei; Liu, Yanling; Wang, Hongyue; Zhao, Shihua; Duan, Fujian; Zhang, Xiuling; Zhao, Xing; Wang, Fengqi; Zhu, Hongguang; Lin, Aiqing; Wu, Xia; Li, Yishi			The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy	PLOS ONE			English	Article							ECHOCARDIOGRAPHIC-ASSESSMENT; EUROPEAN-SOCIETY; TASK-FORCE; OBSTRUCTION; CARDIOLOGY; ASSOCIATION; INVOLVEMENT; DYSFUNCTION; PREVALENCE; DEATH	Introduction Severe right ventricular hypertrophy (SRVH) is a rare phenotype in hypertrophic cardiomyopathy (HCM) for which limited information is available. This study was undertaken to investigate the clinical, prognostic and genetic characteristics of HCM patients with SRVH. Methods HCM with SRVH was defined as HCM with a maximum right ventricular wall thickness >= 10 mm. Whole-genome sequencing (WGS) was performed in HCM patients with SRVH. Multivariate Cox proportional hazards regression models were used to identify risk factors for cardiac death and events in HCM with SRVH. Patients with apical hypertrophic cardiomyopathy (ApHCM) were selected as a comparison group. The clinical features and outcomes of 34 HCM patients with SRVH and 273 ApHCM patients were compared. Results Compared with the ApHCM group, the HCM with SRVH group included younger patients and a higher proportion of female patients and also displayed higher cardiovascular morbidity and mortality. The multivariate Cox proportional hazards regression models identified 2 independent predictors of cardiovascular death in HCM patients with SRVH, a New York Heart Association class >= III (hazard ratio [HR] = 8.7, 95% confidence interval (CI): 1.4352.87, p = 0.019) and an age at the time of HCM diagnosis <= 18 (HR = 5.5, 95% CI: 1.24-28.36, p = 0.026). Among the 11 HCM patients with SRVH who underwent WGS, 10 (90.9%) were identified as carriers of at least one specific sarcomere gene mutation. MYH7 and TTN mutations were the most common sarcomere mutations noted in this study. Two or more HCM-related gene mutations were observed in 9 (82%) patients, and mutations in either other cardiomyopathy-related genes or ion-channel disease-related genes were found in 8 (73%) patients. Conclusions HCM patients with SRVH were characterized by poor clinical outcomes and the presentation of multiple gene mutations.	[Guo, Xiying; Fan, Chaomei; Tian, Lei; Li, Yishi] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp, Beijing, Peoples R China; [Guo, Xiying; Fan, Chaomei; Tian, Lei; Li, Yishi] Peking Union Med Coll, Beijing, Peoples R China; [Liu, Yanling; Duan, Fujian] Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China; [Wang, Hongyue] Fuwai Hosp, Dept Pathol, Beijing, Peoples R China; [Zhao, Shihua] Fuwai Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Xiuling] Anqiu Chinese Med Hosp, Dept Cardiol, Anqiu, Peoples R China; [Zhao, Xing] Heze Zone Cent Hosp, Dept Cardiol, Heze, Peoples R China; [Wang, Fengqi] Zhecheng Peoples Hosp, Dept Cardiol, Zhecheng, Peoples R China; [Zhu, Hongguang] Harbor Hosp Yantai, Dept Cardiol, Yantai, Peoples R China; [Lin, Aiqing] Muping Dist Chinese Med Hosp Yantai, Dept Cardiol, Yantai, Peoples R China; [Wu, Xia] Laiwu Cent Hosp, Dept Cardiol, Laiwu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Fan, CM; Tian, L (corresponding author), Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp, Beijing, Peoples R China.; Fan, CM; Tian, L (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	fred_fan2004@126.com; tianlei0807@hotmail.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022; Lu, Minjie/AAF-5091-2020; Zhao, Shihua/A-7553-2019	Lu, Minjie/0000-0001-8696-318X; Zhao, Shihua/0000-0003-1339-7476	National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09303-008-001]; Key Laboratory Construction Project of the Ministry of Health in China; Beijing, China	National Science and Technology Major Project of the Ministry of Science and Technology of China; Key Laboratory Construction Project of the Ministry of Health in China; Beijing, China	This work was supported by the National Science and Technology Major Project (No. 2012ZX09303-008-001) of the Ministry of Science and Technology of China, and the Key Laboratory Construction Project of the Ministry of Health in China; Beijing, China.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bos JM, 2009, J AM COLL CARDIOL, V54, P201, DOI 10.1016/j.jacc.2009.02.075; Cai C, 2014, CAN J CARDIOL, V30, P441, DOI 10.1016/j.cjca.2013.10.005; Ciurzynski M, 2014, CLIN RHEUMATOL, V33, P83, DOI 10.1007/s10067-013-2354-8; Denault AY, 2006, J THORAC CARDIOV SUR, V132, P43, DOI 10.1016/j.jtcvs.2006.03.014; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Finocchiaro G, 2014, AM J CARDIOL, V113, P361, DOI 10.1016/j.amjcard.2013.09.045; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Horton KD, 2009, J AM SOC ECHOCARDIOG, V22, P776, DOI 10.1016/j.echo.2009.04.027; Jan MF, 2016, INT J CARDIOL, V222, P745, DOI 10.1016/j.ijcard.2016.07.154; Katoh H, 2001, CLIN RADIOL, V56, P516, DOI 10.1053/crad.1999.0451; Kebed KY, 2014, AM J CARDIOL, V114, P777, DOI 10.1016/j.amjcard.2014.05.067; Keeling AN, 2010, EUR HEART J, V31, P381, DOI 10.1093/eurheartj/ehp528; Klarich KW, 2013, AM J CARDIOL, V111, P1784, DOI 10.1016/j.amjcard.2013.02.040; Lopes LR, 2013, J MED GENET, V50, P228, DOI 10.1136/jmedgenet-2012-101270; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2000, CIRCULATION, V102, P858; Maron MS, 2007, AM J CARDIOL, V100, P1293, DOI 10.1016/j.amjcard.2007.05.061; Marziliano N, 2012, NEONATOLOGY, V102, P254, DOI 10.1159/000339847; MCKENNA WJ, 1988, J AM COLL CARDIOL, V11, P351, DOI 10.1016/0735-1097(88)90101-5; Mittal S R, 2010, J Assoc Physicians India, V58, P249; Mittal S R, 1998, J Assoc Physicians India, V46, P970; Morner S, 2008, INT J CARDIOL, V124, P57, DOI 10.1016/j.ijcard.2006.12.022; Mozaffarian D, 2001, CLIN CARDIOL, V24, P2, DOI 10.1002/clc.4960240102; Pagourelias ED, 2011, EUR J ECHOCARDIOGR, V12, P809, DOI 10.1093/ejechocard/jer126; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Severino S, 2000, Eur J Echocardiogr, V1, P281, DOI 10.1053/euje.2000.0043; Shimizu M, 2003, CIRC J, V67, P855, DOI 10.1253/circj.67.855; Tian T, 2013, CARDIOLOGY, V126, P258, DOI 10.1159/000354953; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]	33	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174118	10.1371/journal.pone.0174118	http://dx.doi.org/10.1371/journal.pone.0174118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323875	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000064
J	Wang, X; Dalmeijer, GW; den Ruijter, HM; Anderson, TJ; Britton, AR; Dekker, J; Engstrom, G; Evans, GW; de Graaf, J; Grobbee, DE; Hedblad, B; Holewijn, S; Ikeda, A; Kauhanen, J; Kitagawa, K; Kitamura, A; Kurl, S; Lonn, EM; Lorenz, MW; Mathiesen, EB; Nijpels, G; Okazaki, S; Polak, JF; Price, JF; Rembold, CM; Rosvall, M; Rundek, T; Salonen, JT; Sitzer, M; Stehouwer, CDA; Tuomainen, TP; Peters, SAE; Bots, ML				Wang, Xin; Dalmeijer, Geertje W.; den Ruijter, Hester M.; Anderson, Todd J.; Britton, Annie R.; Dekker, Jacqueline; Engstrom, Gunnar; Evans, Greg W.; de Graaf, Jacqueline; Grobbee, Diederick E.; Hedblad, Bo; Holewijn, Suzanne; Ikeda, Ai; Kauhanen, Jussi; Kitagawa, Kazuo; Kitamura, Akihiko; Kurl, Sudhir; Lonn, Eva M.; Lorenz, Matthias W.; Mathiesen, Ellisiv B.; Nijpels, Giel; Okazaki, Shuhei; Polak, Joseph F.; Price, Jacqueline F.; Rembold, Christopher M.; Rosvall, Maria; Rundek, Tatjana; Salonen, Jukka T.; Sitzer, Matthias; Stehouwer, Coen D. A.; Tuomainen, Tomi-Pekka; Peters, Sanne A. E.; Bots, Michiel L.			Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study	PLOS ONE			English	Article							MALMO DIET; ATHEROSCLEROSIS; PROGRESSION; ARTERY; PREDICTION; EVENTS; DETERMINANTS; INDIVIDUALS; COUNTRIES; FUTURE	Background The relation of a single risk factor with atherosclerosis is established. Clinically we know of risk factor clustering within individuals. Yet, studies into the magnitude of the relation of risk factor clusters with atherosclerosis are limited. Here, we assessed that relation. Methods Individual participant data from 14 cohorts, involving 59,025 individuals were used in this cross-sectional analysis. We made 15 clusters of four risk factors (current smoking, overweight, elevated blood pressure, elevated total cholesterol). Multilevel age and sex adjusted linear regression models were applied to estimate mean differences in common carotid intima-media thickness (CIMT) between clusters using those without any of the four risk factors as reference group. Results Compared to the reference, those with 1, 2, 3 or 4 risk factors had a significantly higher common CIMT: mean difference of 0.026 mm, 0.052 mm, 0.074 mm and 0.114 mm, respectively. These findings were the same in men and in women, and across ethnic groups. Within each risk factor cluster (1, 2, 3 risk factors), groups with elevated blood pressure had the largest CIMT and those with elevated cholesterol the lowest CIMT, a pattern similar for men and women. Conclusion Clusters of risk factors relate to increased common CIMT in a graded manner, similar in men, women and across race-ethnic groups. Some clusters seemed more atherogenic than others. Our findings support the notion that cardiovascular prevention should focus on sets of risk factors rather than individual levels alone, but may prioritize within clusters.	[Wang, Xin; Dalmeijer, Geertje W.; Grobbee, Diederick E.; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [den Ruijter, Hester M.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Anderson, Todd J.] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada; [Anderson, Todd J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Britton, Annie R.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Dekker, Jacqueline; Nijpels, Giel] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res, Amsterdam, Netherlands; [Engstrom, Gunnar; Hedblad, Bo; Rosvall, Maria] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Evans, Greg W.] Wake Forest Sch Med, Dept Biostat Sci & Neurol, Winston Salem, NC USA; [de Graaf, Jacqueline; Holewijn, Suzanne] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Div Vasc Med, Nijmegen, Netherlands; [Grobbee, Diederick E.] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Ikeda, Ai; Kitamura, Akihiko] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Kauhanen, Jussi; Kurl, Sudhir; Tuomainen, Tomi-Pekka] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Kitagawa, Kazuo] Tokyo Women Med Univ, Dept Neurol, Tokyo, Japan; [Lonn, Eva M.] McMaster Univ, Div Cardiol, Dept Med, Hamilton, ON, Canada; [Lonn, Eva M.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Lorenz, Matthias W.] Goethe Univ, Univ Hosp, Dept Neurol, Frankfurt, Germany; [Lorenz, Matthias W.] Krankenhaus NW Frankfurt, Dept Neurol, Frankfurt, Germany; [Mathiesen, Ellisiv B.] Univ Tromso, Dept Clin Med, Brain & Circulat Res Grp, Tromso, Norway; [Okazaki, Shuhei] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Osaka, Japan; [Polak, Joseph F.] Tufts Univ, Sch Med, Dept Radiol, Boston, MA 02111 USA; [Price, Jacqueline F.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Rembold, Christopher M.] Univ Virginia, Dept Internal Med, Div Cardiol, Charlottesville, VA USA; [Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Salonen, Jukka T.] Univ Helsinki, Dept Publ Hlth, Fac Med, Helsinki, Finland; [Salonen, Jukka T.] MAS Metab Analyt Serv Oy, Helsinki, Finland; [Sitzer, Matthias] Goethe Univ, Univ Hosp, Dept Neurol, Frankfurt, Germany; [Sitzer, Matthias] Klinikum Herford, Dept Neurol, Herford, Germany; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Peters, Sanne A. E.] Univ Oxford, George Inst Global Hlth, Oxford, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Gothenburg; Wake Forest University; Radboud University Nijmegen; Universiti Malaya; University of Eastern Finland; Tokyo Women's Medical University; McMaster University; McMaster University; Population Health Research Institute; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Krankenhaus Nordwest; UiT The Arctic University of Tromso; National Cerebral & Cardiovascular Center - Japan; Tufts University; University of Edinburgh; University of Virginia; University of Miami; University of Helsinki; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ruhr University Bochum; Maastricht University; Maastricht University; University of Oxford	Dalmeijer, GW (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	G.W.Dalmeijer@umcutrecht.nl	Kauhanen, Jussi/ABC-4064-2021; Rembold, Christopher/K-8359-2013; Stehouwer, Coen/AAB-3435-2021	Price, Jackie/0000-0003-3251-3970; Rembold, Christopher/0000-0003-0819-7488; Stehouwer, Coen/0000-0001-8752-3223; den Ruijter, Hester/0000-0001-9762-014X; Peters, Sanne/0000-0003-0346-5412; Nijpels, Giel/0000-0002-3679-9710	Netherlands Organisation for Health Research and Development [200320003]; NIH [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167]; Chinese Scholarship Council; Dutch Heart Foundation [2013T084]; Medical Research Council [MR/K013351/1, MR/M006638/1] Funding Source: researchfish; MRC [MR/K013351/1, MR/M006638/1] Funding Source: UKRI	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); Dutch Heart Foundation(Netherlands Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The USE-IMT-project is supported by a grant from the Netherlands Organisation for Health Research and Development (ZonMw 200320003). The Multi-Ethnic Study of Atherosclerosis (MESA) was supported by NIH contracts N01-HC-95159 to N01-HC-95167. Dr X Wang has been supported by a grant from the Chinese Scholarship Council. Dr GW Dalmeijer has been supported by a grant by the Dutch Heart Foundation 2013T084: Queen of Hearts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YS, 2006, ATHEROSCLEROSIS, V187, P186, DOI 10.1016/j.atherosclerosis.2005.09.003; Anderson TJ, 2011, CIRCULATION, V123, P163, DOI 10.1161/CIRCULATIONAHA.110.953653; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; [Anonymous], 1995, WHO TECHNICAL REPORT; Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; Bots ML, 2012, J AM COLL CARDIOL, V60, P1599, DOI 10.1016/j.jacc.2011.12.061; Bots ML, 1997, STROKE, V28, P2442, DOI 10.1161/01.STR.28.12.2442; BOTS ML, 1993, ARTERIOSCLER THROMB, V13, P64, DOI 10.1161/01.ATV.13.1.64; Bots ML, 1996, ANN EPIDEMIOL, V6, P147, DOI 10.1016/1047-2797(96)00001-4; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; den Ruijter HM, 2013, DIABETOLOGIA, V56, P1494, DOI 10.1007/s00125-013-2898-9; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Duerden M, 2015, BRIT J GEN PRACT, V65, P378, DOI 10.3399/bjgp15X685933; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gijsberts CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132321; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Holewijn S, 2009, J CLIN ENDOCR METAB, V94, P2893, DOI 10.1210/jc.2009-0084; Huxley RR, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-61; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; LI RL, 1994, STROKE, V25, P2377, DOI 10.1161/01.STR.25.12.2377; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Makris GC, 2010, ATHEROSCLEROSIS, V213, P8, DOI 10.1016/j.atherosclerosis.2010.04.032; Marfella R, 2005, AM J HYPERTENS, V18, P308, DOI 10.1016/j.amjhyper.2004.09.013; Masquio DCL, 2013, CLIN ENDOCRINOL, V79, P55, DOI 10.1111/j.1365-2265.2012.04504.x; McGill HC, 2008, CIRCULATION, V117, P1216, DOI 10.1161/CIRCULATIONAHA.107.717033; Mora S, 2007, ATHEROSCLEROSIS, V192, P211, DOI 10.1016/j.atherosclerosis.2006.05.007; Nair SB, 2012, POSTGRAD MED J, V88, P694, DOI 10.1136/postgradmedj-2011-130214; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Peters SAE, 2012, J INTERN MED, V272, P257, DOI 10.1111/j.1365-2796.2011.02505.x; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Pipe AL, 2010, CURR ATHEROSCLER REP, V12, P145, DOI 10.1007/s11883-010-0105-8; Prabhakaran Shyam, 2007, Atherosclerosis, V195, pe197, DOI 10.1016/j.atherosclerosis.2007.03.044; Price JF, 2007, J CLIN EPIDEMIOL, V60, P1067, DOI 10.1016/j.jclinepi.2007.01.011; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; Rosvall M, 2015, ATHEROSCLEROSIS, V239, P615, DOI 10.1016/j.atherosclerosis.2015.01.030; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; SALONEN R, 1991, J INTERN MED, V229, P225, DOI 10.1111/j.1365-2796.1991.tb00336.x; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Vasan RS, 2016, CIRCULATION, V133, P2626, DOI 10.1161/CIRCULATIONAHA.116.023528; Wang JG, 2006, STROKE, V37, P1933, DOI 10.1161/01.STR.0000227223.90239.13; Wang X, 2016, EUR J PREV CARDIOL; Wiersma Tjerk, 2012, Ned Tijdschr Geneeskd, V156, pA5104; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173393	10.1371/journal.pone.0173393	http://dx.doi.org/10.1371/journal.pone.0173393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323823	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000019
J	Puffer, ES; Annan, J; Sim, AL; Salhi, C; Betancourt, TS				Puffer, Eve S.; Annan, Jeannie; Sim, Amanda L.; Salhi, Carmel; Betancourt, Theresa S.			The impact of a family skills training intervention among Burmese migrant families in Thailand: A randomized controlled trial	PLOS ONE			English	Article							CHILD ADJUSTMENT; MENTAL-HEALTH; PSYCHOSOCIAL SUPPORT; CORPORAL PUNISHMENT; CULTURAL-ADAPTATION; ASSOCIATIONS; DISCIPLINE; RESILIENCE; ACCEPTANCE; CHALLENGES	Objective To conduct a randomized controlled trial assessing the impact of a family-based intervention delivered to Burmese migrant families displaced in Thailand on parenting and family functioning. Participants and procedures Participants included 479 Burmese migrant families from 20 communities in Thailand. Families, including 513 caregivers and 479 children aged 7 to 15 years, were randomized to treatment and waitlist control groups. The treatment group received a 12-session family-based intervention delivered to groups of families by lay facilitators. Adapted standardized and locally derived measures were administered before and after the intervention to assess parent-child relationship quality, discipline practices, and family functioning. Results Compared with controls, intervention families demonstrated improved quality of parent-child interactions on scales of parental warmth and affection (Effect size (ES) = 0.25 caregivers; 0.26 children, both p < 0.05) and negative relationship quality (ES = -0.37, p < 0.001 caregivers; -0.22 children, p < 0.05). Both children and caregivers also reported an effect on relationship quality based on a locally derived measure (ES = 0.40 caregivers, p <.001; 0.43 children, p <.05). Family functioning was improved, including family cohesion ( ES = 0.46 caregivers; 0.36 children; both p < 0.001) and decreased negative interactions (ES = -0.30 caregivers, p < 0.01; -0.24 children, p < 0.05). Family communication also improved according to children only (ES = 0.29, p < 0.01). Caregivers, but not children, reported decreased harsh discipline (ES = -0.39, p < 0.001), and no effects were observed on use of positive discipline strategies. Treatment attendance was high, with participants attending a mean of 9.7 out of 12 sessions. Conclusion The intervention increased protective aspects of family well-being for migrant children and caregivers in a middle-income country. The strongest effects were on parent-child relationship quality and family functioning, while results were mixed on changes in discipline practices. Results suggest that a behavioral family-based approach implemented by lay providers in community settings is a promising intervention approach for strengthening families in highly stressed contexts.	[Puffer, Eve S.] Duke Univ, Dept Psychol & Neurosci, Duke Global Hlth Inst, Durham, NC 27708 USA; [Annan, Jeannie] Int Rescue Comm, Res Evaluat & Learning Tech Unit, New York, NY USA; [Sim, Amanda L.] Univ Oxford, Dept Social Policy & Intervent, Ctr Evidence Based Intervent, Oxford, England; [Salhi, Carmel] Boston Childrens Hosp, Dept Dev Med, Labs Cognit Neurosci, Boston, MA USA; [Betancourt, Theresa S.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Duke University; University of Oxford; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Puffer, ES (corresponding author), Duke Univ, Dept Psychol & Neurosci, Duke Global Hlth Inst, Durham, NC 27708 USA.	eve.puffer@duke.edu	Sim, Amanda/AAI-3784-2021	Sim, Amanda/0000-0001-7995-6299	USAID Displaced Children and Orphans Fund (DCOF)	USAID Displaced Children and Orphans Fund (DCOF)(United States Agency for International Development (USAID))	This work was supported by USAID Displaced Children and Orphans Fund (DCOF); funding was awarded to The International Rescue Committee. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; Barrera M, 2013, J CONSULT CLIN PSYCH, V81, P196, DOI 10.1037/a0027085; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Bernal G, 2009, PROF PSYCHOL-RES PR, V40, P361, DOI 10.1037/a0016401; Betancourt T, 2012, J AM ACAD CHILD PSY, V51, P1284, DOI 10.1016/j.jaac.2012.09.003; Betancourt TS, 2015, J CHILD PSYCHOL PSYC, V56, P1101, DOI 10.1111/jcpp.12389; Betancourt TS, 2013, HARVARD REV PSYCHIAT, V21, P70, DOI 10.1097/HRP.0b013e318283bf8f; Betancourt TS, 2011, SOC SCI MED, V73, P693, DOI 10.1016/j.socscimed.2011.06.053; Biglan A, 2012, AM PSYCHOL, V67, P257, DOI 10.1037/a0026796; Bogels SM, 2006, CLIN PSYCHOL REV, V26, P834, DOI 10.1016/j.cpr.2005.08.001; Bolton P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001757; Boudreault-Bouchard AM, 2013, J ADOLESCENCE, V36, P695, DOI 10.1016/j.adolescence.2013.05.002; Castro FG, 2010, ANNU REV CLIN PSYCHO, V6, P213, DOI 10.1146/annurev-clinpsy-033109-132032; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; CONGER RD, 1994, CHILD DEV, V65, P541, DOI 10.1111/j.1467-8624.1994.tb00768.x; Falb KL, 2013, INT J GYNECOL OBSTET, V120, P279, DOI 10.1016/j.ijgo.2012.10.015; FOXCROFT DR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003024; Furlong M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008225.pub2; Green M., 2008, FORCED MIGRATION REV, V30, P31; Green SB, 2009, PSYCHOMETRIKA, V74, P121, DOI 10.1007/s11336-008-9098-4; Hoeve M, 2009, J ABNORM CHILD PSYCH, V37, P749, DOI 10.1007/s10802-009-9310-8; International Rescue Committee, 2012, SURV THRIV THAI BURM; International Rescue Committee, 2011, CHILDR AR PUPP PAR M; Jordans MJD, 2013, SOC PSYCH PSYCH EPID, V48, P1851, DOI 10.1007/s00127-012-0630-6; Khaleque A, 2012, J CROSS CULT PSYCHOL, V43, P784, DOI 10.1177/0022022111406120; Knerr W, 2013, PREV SCI, V14, P352, DOI 10.1007/s11121-012-0314-1; Kumpfer K. L., 1989, STRENGTHENING FAMILI; Kumpfer KL, 2008, EVAL HEALTH PROF, V31, P226, DOI 10.1177/0163278708315926; Kumpfer KL, 2010, GROUP DYN-THEOR RES, V14, P211, DOI 10.1037/a0020602; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; Lansford JE, 2005, CHILD DEV, V76, P1234, DOI 10.1111/j.1467-8624.2005.00847.x; Lansford JE, 2014, J CLIN CHILD ADOLESC, V43, P670, DOI 10.1080/15374416.2014.893518; Lansford JE, 2014, J PEDIATR-US, V164, P1208, DOI 10.1016/j.jpeds.2013.11.060; Laskey BJ, 2009, CHILD CARE HLTH DEV, V35, P717, DOI 10.1111/j.1365-2214.2009.00977.x; Lundahl BW, 2006, RES SOCIAL WORK PRAC, V16, P251, DOI 10.1177/1049731505284391; Mejia A, 2012, CLIN CHILD FAM PSYCH, V15, P163, DOI 10.1007/s10567-012-0116-9; Meyer S, 2013, GLOB PUBLIC HEALTH, V8, P1027, DOI 10.1080/17441692.2013.811531; Piquero A. R., 2008, EFFECTS EARLY FAMILY; Putnick DL, 2015, J CHILD PSYCHOL PSYC, V56, P923, DOI 10.1111/jcpp.12366; Renzaho AMN, 2011, J FAM STUD, V17, P71, DOI 10.5172/jfs.2011.17.1.71; Rohner R. P., 2005, HDB STUDY PARENTAL A; Rubin DB, 2009, MULTIPLE IMPUTATION; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Smokowski PR, 1998, SOC SERV REV, V72, P337, DOI 10.1086/515762; Sriskandarajah V, 2015, BMC PSYCHIATRY, P15; StataCorp, 2015, STAT SOFTW REL 14; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; Trentacosta CJ, 2008, J CHILD PSYCHOL PSYC; UNICEF, 2005, MULT IND CLUST SURV; UNICEF Division of Policy and Practice, 2010, CHILD DISC PRACT HOM; Wyatt Kaminski J., 2008, J ABNORMAL CHILD PSY, V36, P567, DOI DOI 10.1007/S10802-007-9201-9; Young Rebekah, 2010, 64 ANN C AM ASS PUBL, P6242; Zimet DM, 2001, CLIN CHILD FAM PSYCH, V4, P319, DOI 10.1023/A:1013595304718	54	39	39	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0172611	10.1371/journal.pone.0172611	http://dx.doi.org/10.1371/journal.pone.0172611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350809	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174400003
J	Lajoie, M; Drouin, S; Caron, M; St-Onge, P; Ouimet, M; Gioia, R; Lafond, MH; Vidal, R; Richer, C; Oualkacha, K; Droit, A; Sinnett, D				Lajoie, Mathieu; Drouin, Simon; Caron, Maxime; St-Onge, Pascal; Ouimet, Manon; Gioia, Romain; Lafond, Marie-Helene; Vidal, Ramon; Richer, Chantal; Oualkacha, Karim; Droit, Arnaud; Sinnett, Daniel			Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia	PLOS ONE			English	Article							MOLECULAR SIGNATURES; B-CELL; CANCER; EZH2; CLASSIFICATION; MUTATIONS; LANDSCAPE; PROGNOSIS; DISCOVERY; SURVIVAL	Pre-B cell childhood acute lymphoblastic leukemia (pre-B cALL) is a heterogeneous disease involving many subtypes typically stratified using a combination of cytogenetic and molecular-based assays. These methods, although widely used, rely on the presence of known chromosomal translocations, which is a limiting factor. There is therefore a need for robust, sensitive, and specific molecular biomarkers unaffected by such limitations that would allow better risk stratification and consequently better clinical outcome. In this study we performed a transcriptome analysis of 56 pre-B cALL patients to identify expression signatures in different subtypes. In both protein-coding and long non-coding RNAs (IncRNA), we identified subtype-specific gene signatures distinguishing pre-B cALL subtypes, particularly in t(12;21) and hyperdiploid cases. The genes up-regulated in pre-B cALL subtypes were enriched in bivalent chromatin marks in their promoters. LncRNAs is a new and under-studied class of transcripts. The subtype-specific nature of IncRNAs suggests they may be suitable clinical biomarkers to guide risk stratification and targeted therapies in pre-B cALL patients.	[Lajoie, Mathieu; Drouin, Simon; Caron, Maxime; St-Onge, Pascal; Ouimet, Manon; Gioia, Romain; Vidal, Ramon; Richer, Chantal; Sinnett, Daniel] Hop St Justine, Ctr Hlth, Res Ctr, Div Hematol Oncol, 3175 Chemin Cote St Catherine, Montreal, PQ, Canada; [Lafond, Marie-Helene; Oualkacha, Karim] Univ Quebec, Dept Math & Stat, 201 President Kennedy Ave, Montreal, PQ, Canada; [Droit, Arnaud] Univ Laval, Dept Endocrinol & Nephrol, 2705 Laurier Blvd, Quebec City, PQ, Canada; [Sinnett, Daniel] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada	Universite de Montreal; University of Quebec; University of Quebec Montreal; Laval University; Universite de Montreal	Sinnett, D (corresponding author), Hop St Justine, Ctr Hlth, Res Ctr, Div Hematol Oncol, 3175 Chemin Cote St Catherine, Montreal, PQ, Canada.; Sinnett, D (corresponding author), Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada.	daniel.sinnett@umontreal.ca	Droit, Arnaud/AGZ-6283-2022; sinnett, daniel/S-4589-2017	Droit, Arnaud/0000-0001-7922-790X; sinnett, daniel/0000-0003-3625-6676; Lajoie, Mathieu/0000-0001-9162-086X	Terry Fox Research Institute; Canadian Institutes for Health Research; Canadian Cancer Society Research Institute	Terry Fox Research Institute; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This study was supported by research funds provided by the Terry Fox Research Institute, the Canadian Institutes for Health Research, and the Canadian Cancer Society Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2009, GENE SET ENRICHMENT, V27, P1; Anders S, 2014, BIOINFORMATICS BTU63; Andersson A, 2005, LEUKEMIA, V19, P1042, DOI 10.1038/sj.leu.2403749; Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhojwani D, 2008, J CLIN ONCOL, V26, P4376, DOI 10.1200/JCO.2007.14.4519; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen IM, 2012, BLOOD, V119, P3512, DOI 10.1182/blood-2011-11-394221; de Kok JB, 2002, CANCER RES, V62, P2695; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fernando TR, 2015, MOL CANCER RES, V13, P839, DOI 10.1158/1541-7786.MCR-15-0006-T; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Goff LA, 2015, GENOME RES, V25, P1456, DOI 10.1101/gr.191122.115; Gruszka-Westwood AM, 2004, GENE CHROMOSOME CANC, V41, P191, DOI 10.1002/gcc.20085; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Hock H, 2012, GENE DEV, V26, P751, DOI 10.1101/gad.191163.112; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; KANEKO Y, 1981, CANCER GENET CYTOGEN, V4, P227, DOI 10.1016/0165-4608(81)90016-9; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee ST, 2015, NUCLEIC ACIDS RES, V43, P2590, DOI 10.1093/nar/gkv103; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Paulsson K, 2015, NAT GENET, V47, P672, DOI 10.1038/ng.3301; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Ripley B. D., 2007, PATTERN RECOGNITION, DOI DOI 10.1017/CBO9780511812651; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Schafer V, 2016, J CANCER RES CLIN, V142, P1641, DOI 10.1007/s00432-016-2174-8; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Silveira VS, 2013, LEUKEMIA LYMPHOMA, V54, P310, DOI 10.3109/10428194.2012.710330; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; van Delft FW, 2005, BRIT J HAEMATOL, V130, P26, DOI 10.1111/j.1365-2141.2005.05545.x; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Woo JS, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-16; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37; Zhang J., 2015, ADV MATER SCI ENG, V1, P1; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	55	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174124	10.1371/journal.pone.0174124	http://dx.doi.org/10.1371/journal.pone.0174124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346506	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300025
J	Li, Q; Hu, GP; Jubery, TZ; Ganapathysubramanian, B				Li, Qi; Hu, Guiping; Jubery, Talukder Zaki; Ganapathysubramanian, Baskar			A farm-level precision land management framework based on integer programming	PLOS ONE			English	Article							BIOFUEL PRODUCTION; TECHNOECONOMIC ANALYSIS; OPTIMIZATION MODEL; WATER-RESOURCES; IRRIGATION; UNCERTAINTY; WEATHER	Farmland management involves several planning and decision making tasks including seed selection and irrigation management. A farm-level precision farmland management model based on mixed integer linear programming is proposed in this study. Optimal decisions are designed for pre-season planning of crops and irrigation water allocation. The model captures the effect of size and shape of decision scale as well as special irrigation patterns. The authors illustrate the model with a case study on a farm in the state of California in the U.S. and show the model can capture the impact of precision farm management on profitability. The results show that threefold increase of annual net profit for farmers could be achieved by carefully choosing irrigation and seed selection. Although farmers could increase profits by applying precision management to seed or irrigation alone, profit increase is more significant if farmers apply precision management on seed and irrigation simultaneously. The proposed model can also serve as a risk analysis tool for farmers facing seasonal irrigation water limits as well as a quantitative tool to explore the impact of precision agriculture.	[Li, Qi; Hu, Guiping] Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA; [Jubery, Talukder Zaki; Ganapathysubramanian, Baskar] Iowa State Univ, Dept Mech Engn, Ames, IA USA	Iowa State University; Iowa State University	Hu, GP (corresponding author), Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.	gphu@iastate.edu	Jubery, Zaki/N-6807-2019; Hu, Guiping/AAT-4414-2020	Hu, Guiping/0000-0001-8392-8442; Li, Qi/0000-0002-1406-9127				Barton B, 2014, WATER CLIMATE RISKS; Bongiovanni R., 2004, Precision Agriculture, V5, P359, DOI 10.1023/B:PRAG.0000040806.39604.aa; Brown PD, 2010, AGR WATER MANAGE, V97, P892, DOI 10.1016/j.agwat.2010.01.020; Campbell G.S., 1985, SOIL PHYS BASIC TRAN; Edwards W., 2014, A170 AG DEC MAK LOW; Eswaran H., 2002, SOIL CLASSIFICATION, DOI [10.1201/9781420040364, DOI 10.1201/9781420040364]; Fereres E, 2007, J EXP BOT, V58, P147, DOI 10.1093/jxb/erl165; Ganji A, 2006, IRRIGATION SCI, V25, P63, DOI 10.1007/s00271-006-0035-y; Georgiou PE, 2008, IRRIGATION SCI, V26, P487, DOI 10.1007/s00271-008-0110-7; Gorantiwar SD, 2005, J IRRIG DRAIN ENG, V131, P264, DOI 10.1061/(ASCE)0733-9437(2005)131:3(264); Itoh T, 2003, INT J PROD ECON, V81-2, P555, DOI 10.1016/S0925-5273(02)00283-9; Kumar DN, 2006, J IRRIG DRAIN ENG, V132, P123, DOI 10.1061/(ASCE)0733-9437(2006)132:2(123); Li Q, 2016, BIORESOURCE TECHNOL, V206, P195, DOI 10.1016/j.biortech.2016.01.101; Li Q, 2015, BIORESOURCE TECHNOL, V191, P88, DOI 10.1016/j.biortech.2015.05.002; Li Q, 2014, ENERGY, V74, P576, DOI 10.1016/j.energy.2014.07.023; McBratney Alex, 2005, Precision Agriculture, V6, P7, DOI 10.1007/s11119-005-0681-8; Papendick R.I., 1995, CROP RESIDUE MANAGEM; Plastina A., 2015, ESTIMATED COSTS CROP; Sarker RA, 2002, COMPUT IND ENG, V42, P541, DOI 10.1016/S0360-8352(02)00022-0; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schwankl L, 2015, CORN ET ESTIMATES 20; Seppelt R, 2003, ECOL MODEL, V168, P217, DOI 10.1016/S0304-3800(03)00138-8; Sethi LN, 2002, WATER RESOUR MANAG, V16, P145, DOI 10.1023/A:1016137726131; Singh A, 2014, WATER RESOUR MANAG, V28, P1, DOI 10.1007/s11269-013-0469-y; Spekken M, 2013, PRECIS AGRIC, V14, P224, DOI 10.1007/s11119-012-9290-5; Tao F, 2009, AGR FOREST METEOROL, V149, P831, DOI 10.1016/j.agrformet.2008.11.004; Vekshin A., 2015, CALIFORNIA WATER PRI; Wardlaw R, 2004, IRRIG DRAIN, V53, P397, DOI 10.1002/ird.121; Wright S, 2015, U CALIFORNIA COOPERA; Yamout G, 2005, WATER RESOUR MANAG, V19, P791, DOI 10.1007/s11269-005-3280-6; Zhang NQ, 2002, COMPUT ELECTRON AGR, V36, P113, DOI 10.1016/S0168-1699(02)00096-0	32	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174680	10.1371/journal.pone.0174680	http://dx.doi.org/10.1371/journal.pone.0174680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346499	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300068
J	Borges, PD; Vincent, TL; Marenzana, M				Borges, Patricia Das Neves; Vincent, Tonia L.; Marenzana, Massimo			Automated assessment of bone changes in cross-sectional micro-CT studies of murine experimental osteoarthritis	PLOS ONE			English	Article							SUBCHONDRAL BONE; ARTICULAR-CARTILAGE; STRUCTURAL PATHOLOGY; MOUSE MODELS; RISK-FACTORS; SHAPE MODEL; REPRODUCIBILITY; PROGRESSION; OSTEOPHYTES; PAIN	Objective The degradation of articular cartilage, which characterises osteoarthritis (OA), is usually paired with excessive bone remodelling, including subchondral bone sclerosis, cysts, and osteophyte formation. Experimental models of OA are widely used to investigate pathogenesis, yet few validated methodologies for assessing periarticular bone morphology exist and quantitative measurements are limited by manual segmentation of micro-CT scans. The aim of this work was to chart the temporal changes in periarticular bone in murine OA by novel, automated micro-CT methods. Methods OA was induced by destabilisation of the medial meniscus (DMM) in 10-week old male mice and disease assessed cross-sectionally from 1-to 20-weeks post-surgery. A novel approach was developed to automatically segment subchondral bone compartments into plate and trabecular bone in micro-CT scans of tibial epiphyses. Osteophyte volume, as assessed by shape differences using 3D image registration, and by measuring total epiphyseal volume was performed. Results Significant linear and volumetric structural modifications in subchondral bone compartments and osteophytes were measured from 4-weeks post-surgery and showed progressive changes at all time points; by 20 weeks, medial subchondral bone plate thickness increased by 160 +/- 19.5 mu m and the medial osteophyte grew by 0.124 +/- 0.028 mu m(3). Excellent agreement was found when automated measurements were compared with manual assessments. Conclusion Our automated methods for assessing bone changes in murine periarticular bone are rapid, quantitative, and highly accurate, and promise to be a useful tool in future preclinical studies of OA progression and treatment. The current approaches were developed specifically for cross-sectional micro-CT studies but could be applied to longitudinal studies.	[Borges, Patricia Das Neves; Marenzana, Massimo] Imperial Coll London, Dept Bioengn, London, England; [Borges, Patricia Das Neves; Vincent, Tonia L.; Marenzana, Massimo] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford, England; [Marenzana, Massimo] London South Bank Univ, Sch Hlth & Social Care Allied Hlth Sci, London, England	Imperial College London; University of Oxford; London South Bank University	Borges, PD (corresponding author), Imperial Coll London, Dept Bioengn, London, England.; Borges, PD (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford, England.	patricia.borges@kennedy.ox.ac.uk		Vincent, Tonia/0000-0002-3412-5712; Das Neves Borges, Patricia/0000-0001-5656-273X	Wellcome Trust/Engineering and Physical Sciences Research Council (EPSRC) Centre of Excellence in Engineering Solutions for the Management of Osteoarthritis [088844/Z/09/Z]	Wellcome Trust/Engineering and Physical Sciences Research Council (EPSRC) Centre of Excellence in Engineering Solutions for the Management of Osteoarthritis	This work was supported by the Wellcome Trust/Engineering and Physical Sciences Research Council (EPSRC) Centre of Excellence in Engineering Solutions for the Management of Osteoarthritis (grant number: 088844/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Anderson-MacKenzie JM, 2005, INT J BIOCHEM CELL B, V37, P224, DOI 10.1016/j.biocel.2004.06.016; Barr AJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0735-x; Barr RJ, 2012, RHEUMATOLOGY, V51, P562, DOI 10.1093/rheumatology/ker382; Besler BA, 2015, BONE, V81, P649, DOI 10.1016/j.bone.2015.09.014; Bolbos RI, 2008, OSTEOARTHR CARTILAGE, V16, P1150, DOI 10.1016/j.joca.2008.02.018; Borges PD, 2014, OSTEOARTHR CARTILAGE, V22, P1419, DOI 10.1016/j.joca.2014.07.014; Botter SM, 2006, BIORHEOLOGY, V43, P379; Botter SM, 2011, ARTHRITIS RHEUM-US, V63, P2690, DOI 10.1002/art.30307; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Campbell GM, 2014, CALCIFIED TISSUE INT, V94, P282, DOI 10.1007/s00223-013-9809-4; Chia SL, 2009, ARTHRITIS RHEUM-US, V60, P2019, DOI 10.1002/art.24654; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Goldring SR, 2012, THER ADV MUSCULOSKEL, V4, P249, DOI 10.1177/1759720X12437353; Goldring SR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3135; Gregory JS, 2007, ARTHRITIS RHEUM-US, V56, P3634, DOI 10.1002/art.22982; Guermazi A, 2013, RHEUM DIS CLIN N AM, V39, P567, DOI 10.1016/j.rdc.2013.02.001; Iijima H, 2016, OSTEOARTHR CARTILAGE, V24, P354, DOI 10.1016/j.joca.2015.09.001; Inglis JJ, 2008, ARTHRITIS RHEUM-US, V58, P3110, DOI 10.1002/art.23870; Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004; Jilka RL, 2013, J GERONTOL A-BIOL, V68, P1209, DOI 10.1093/gerona/glt046; Kaukinen P, 2016, OSTEOARTHR CARTILAGE, V24, P1565, DOI 10.1016/j.joca.2016.05.001; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Khorasani MS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0546-0; Koh YH, 2010, RHEUMATOL INT, V30, P1165, DOI 10.1007/s00296-009-1118-x; Lambers FM, 2011, BONE, V49, P1340, DOI 10.1016/j.bone.2011.08.035; Little CB, 2008, CURR RHEUMATOL REV, V4, P175, DOI 10.2174/157339708785133523; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lublinsky S, 2007, CALCIFIED TISSUE INT, V81, P285, DOI 10.1007/s00223-007-9063-8; Maas O, 2015, OSTEOARTHR CARTILAGE, V23, P1713, DOI 10.1016/j.joca.2015.05.014; Merle C, 2014, J ORTHOP RES, V32, P413, DOI 10.1002/jor.22518; Moodie JP, 2011, OSTEOARTHR CARTILAGE, V19, P163, DOI 10.1016/j.joca.2010.11.006; Nishiyama KK, 2010, BONE, V46, P155, DOI 10.1016/j.bone.2009.09.023; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Poulet B, 2015, OSTEOARTHR CARTILAGE, V23, P940, DOI 10.1016/j.joca.2015.01.012; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Roemer FW, 2014, BEST PRACT RES CL RH, V28, P31, DOI 10.1016/j.berh.2014.02.002; Saha PK, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2129519; Siebelt M, 2014, BONE, V66, P163, DOI 10.1016/j.bone.2014.06.009; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; Vincent TL, 2012, RHEUMATOLOGY, V51, P1931, DOI 10.1093/rheumatology/kes035; Weinans Harrie, 2012, HSS J, V8, P10, DOI 10.1007/s11420-011-9257-5	56	24	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174294	10.1371/journal.pone.0174294	http://dx.doi.org/10.1371/journal.pone.0174294			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334010	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200073
J	Jaramillo, E; Melnick, D; Baez, JC; Montecino, H; Lagos, NA; Acuna, E; Manzano, M; Camus, PA				Jaramillo, Eduardo; Melnick, Daniel; Carlos Baez, Juan; Montecino, Henry; Lagos, Nelson A.; Acuna, Emilio; Manzano, Mario; Camus, Patricio A.			Calibrating coseismic coastal land-level changes during the 2014 Iquique (M-w=8.2) earthquake (northern Chile) with leveling, GPS and intertidal biota	PLOS ONE			English	Article							DEFORMATION; RECRUITMENT; UPLIFT; ORGANISMS; DIVERSITY; PACIFIC; ECOLOGY	The April 1st 2014 Iquique earthquake (M-W 8.1) occurred along the northern Chile margin where the Nazca plate is subducted below the South American continent. The last great megathrust earthquake here, in 1877 of M-w similar to 8.8 opened a seismic gap, which was only partly closed by the 2014 earthquake. Prior to the earthquake in 2013, and shortly after it we compared data from leveled benchmarks, deployed campaign GPS instruments, continuous GPS stations and estimated sea levels using the upper vertical level of rocky shore benthic organisms including algae, barnacles, and mussels. Land-level changes estimated from mean elevations of benchmarks indicate subsidence along a similar to 100-km stretch of coast, ranging from 3 to 9 cm at Corazones (18 degrees 30'S) to between 30 and 50 cm at Pisagua (19 degrees 30'S). About 15 cm of uplift was measured along the southern part of the rupture at Chanabaya (20 degrees 50'S). Land-level changes obtained from benchmarks and campaign GPS were similar at most sites (mean difference 3.7 +/- 3.2 cm). Higher differences however, were found between benchmarks and continuous GPS (mean difference 8.5 +/- 3.6 cm), possibly because sites were not collocated and separated by several kilometers. Subsidence estimated from the upper limits of intertidal fauna at Pisagua ranged between 40 to 60 cm, in general agreement with benchmarks and GPS. At Chanavaya, the magnitude and sense of displacement of the upper marine limit was variable across species, possibly due to species-dependent differences in ecology. Among the studied species, measurements on lithothamnioid calcareous algae most closely matched those made with benchmarks and GPS. When properly calibrated, rocky shore benthic species may be used to accurately measure land-level changes along coasts affected by subduction earthquakes. Our calibration of those methods will improve their accuracy when applied to coasts lacking pre-earthquake data and in estimating deformation during pre instrumental earthquakes.	[Jaramillo, Eduardo; Melnick, Daniel; Acuna, Emilio] Univ Austral Chile, ICT, Fac Ciencias, Valdivia, Chile; [Jaramillo, Eduardo; Melnick, Daniel; Acuna, Emilio] Univ Austral Chile, TAQUACH Transdisciplinary Ctr Quaternary Res, Valdivia, Chile; [Carlos Baez, Juan] Univ Chile, Ctr Sismol Nacl, Santiago, Chile; [Montecino, Henry] Univ Concepcion, Dept Ciencias Geodes, Los Angeles, Chile; [Lagos, Nelson A.] Univ Santo Tomas, Fac Ciencias, Ctr Invest & Innovac Cambio Climat CIICC UST, Santiago, Chile; [Manzano, Mario] Univ Austral Chile, Biol Marina, Valdivia, Chile; [Camus, Patricio A.] Univ Catolica Santsima Concepcion, CIBAS, Dept Ecol, Fac Ciencias, Concepcion, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad de Chile; Universidad de Concepcion; Universidad Santo Tomas; Universidad Austral de Chile; Universidad Catolica de la Santisima Concepcion	Jaramillo, E (corresponding author), Univ Austral Chile, ICT, Fac Ciencias, Valdivia, Chile.; Jaramillo, E (corresponding author), Univ Austral Chile, TAQUACH Transdisciplinary Ctr Quaternary Res, Valdivia, Chile.	edojaramillo@gmail.com	Manzano, Mario/AAI-8065-2021; Montecino, Henry/AAG-1872-2019; Melnick, Daniel/G-8484-2011	Montecino, Henry/0000-0002-1795-8720; Melnick, Daniel/0000-0001-8397-7391; Baez, Juan Carlos/0000-0002-7265-7402	CONICYT Chile (Proyecto Fondecyt) [1121043]; Direccion de Investigacion y Desarrollo; Universidad Australde Chile; German Science Foundation (DFG) grant [ME3157/4-2]; Project FONDECYT [1121043, 150321, 1140938]	CONICYT Chile (Proyecto Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo; Universidad Australde Chile; German Science Foundation (DFG) grant(German Research Foundation (DFG)); Project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by funds granted to EJ from CONICYT Chile (Proyecto Fondecyt 1121043) and Direccion de Investigacion y Desarrollo, Universidad Australde Chile. DM was supported by German Science Foundation (DFG) grant ME3157/4-2, Project FONDECYT 1121043 (international cooperation) and Project FONDECYT 150321. During the final edition of this manuscript, NAL was under the tenure of Project FONDECYT 1140938.	Albert JH, 1996, BAYESIAN COMPUTATION; ATWATER BF, 1987, SCIENCE, V236, P942, DOI 10.1126/science.236.4804.942; Bedford J, 2013, EARTH PLANET SC LETT, V383, P26, DOI 10.1016/j.epsl.2013.09.020; Bevis M, 2014, J GEODESY, V88, P283, DOI 10.1007/s00190-013-0685-5; BODIN P, 1986, SCIENCE, V233, P1071, DOI 10.1126/science.233.4768.1071; BRATTSTROM H, 1983, SARSIA, V68, P289, DOI 10.1080/00364827.1983.10420583; BRATTSTROM H, 1990, SARSIA, V75, P107, DOI 10.1080/00364827.1990.10413444; BURT Stephen D., 1988, WEATHER, V43, P90, DOI [10.1002/j.1477-8696.1988.tb03885.x, DOI 10.1002/J.1477-8696.1988.TB03885.X]; Cale P, 2008, NEW MODEL ECOSYST DY, P295; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; CAMUS PA, 1994, J EXP MAR BIOL ECOL, V184, P171, DOI 10.1016/0022-0981(94)90003-5; Camus PA, 1996, REV CHIL HIST NAT, V69, P193; CAMUS PA, 1990, REV CHIL HIST NAT, V63, P11; Camus PA, 2008, REV BIOL MAR OCEANOG, V43, P615; Camus Patricio A., 2008, International Journal of Environment and Health, V2, P5, DOI 10.1504/IJENVH.2008.018668; Castilla J.C., 1992, AFR J MAR SCI, V12, P703; Castilla JC, 1988, SCIENCE, V24, P2; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; Comte D., 1991, Natural Hazards, V4, P23, DOI 10.1007/BF00126557; Dach R, 2007, BERNESE GPS SOFTWARE, V640, P114; Duputel Z, 2015, GEOPHYS RES LETT, V42, P7949, DOI 10.1002/2015GL065402; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Farias M, 2011, TECTONICS, V30, DOI 10.1029/2011TC002888; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Franklin JF, 2000, SCIENCE, V288, P1183, DOI 10.1126/science.288.5469.1183; Grandin R, 2016, GEOPHYS RES LETT, V43, P2552, DOI 10.1002/2016GL067954; Haeussler PJ, 2015, B SEISMOL SOC AM, V105, P1265, DOI 10.1785/0120140197; Herrera NC, 2014, PLOS ONE, V9; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; King PP, 1839, P 2 EXP 1831 1836 CO; Lagos NA, 2008, ECOL MONOGR, V78, P245, DOI 10.1890/07-0041.1; Lay T., 2012, J GEOPHYS RES SOLID, V117; Lewis J. R., 1964, ECOLOGY ROCKY SHORES; LEWIS JR, 1955, J ECOL, V43, P270, DOI 10.2307/2257134; Li SY, 2015, J GEOPHYS RES-SOL EA, V120, P4522, DOI 10.1002/2015JB011903; Lomnitz C, 2004, SEISMOL RES LETT, V75, P368, DOI 10.1785/gssrl.75.3.368; Loveless JP, 2010, TECTONOPHYSICS, V495, P15, DOI 10.1016/j.tecto.2009.05.008; Melnick D, 2016, NAT GEOSCI, V9, P401, DOI [10.1038/ngeo2683, 10.1038/NGEO2683]; Melnick D, 2012, QUATERNARY SCI REV, V42, P29, DOI 10.1016/j.quascirev.2012.03.012; Meltzner AJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007499; MOORE PG, 1985, ECOLOGY ROCKY COASTS; Moreno M., 2012, EARTH PLANET SC LETT, V321, P152, DOI DOI 10.1016/J.EPSL.2012.01.006; Munoz JLP, 2005, COMP BIOCHEM PHYS A, V142, P92, DOI 10.1016/j.cbpa.2005.08.002; Nelson A.R., 1992, QUATERN INT, V15, P61, DOI [10.1016/1040-6182(92)90036-2, DOI 10.1016/1040-6182(92)90036-2]; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P949, DOI 10.1016/S0277-3791(96)00056-X; Ortlieb L., 2003, GEOPHYS MONOGR SER, V137, P157, DOI [10.1029/137GM12, DOI 10.1029/137GM12]; Ortlieb L., 1995, PALEOCLIMAS CUATERNA; Pirazzoli P.A., 1996, SEA LEVEL CHANGES LA; PLAFKER G, 1972, J GEOPHYS RES, V77, P901, DOI 10.1029/JB077i005p00901; Plafker G, GEOL SOC AM; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rovere A, 2015, HANDBOOK OF SEA-LEVEL RESEARCH, P268; Schurr B, 2014, NATURE, V512, P299, DOI 10.1038/nature13681; Sibaja-Cordero JA, 2011, THALASSAS, V27, P81; Smart SM, 2014, J ECOL, V102, P1273, DOI 10.1111/1365-2745.12291; Stephenson T.A., 1972, LIFE TIDEMARKS ROCKY; Takesue RK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001856; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Udo K, 2016, COAST ENG J, V58, DOI 10.1142/S0578563416400167; Villagra P, 2012, LANDSC REV, V14; Wang KL, 2012, NATURE, V484, P327, DOI 10.1038/nature11032; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wesson RL, 2015, NAT GEOSCI, V8, P547, DOI [10.1038/NGEO2468, 10.1038/ngeo2468]; Willig Michael R., 1999, V16, P747; [No title captured], DOI DOI 10.2307/279082	69	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174348	10.1371/journal.pone.0174348	http://dx.doi.org/10.1371/journal.pone.0174348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333998	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200083
J	Kawata, M; Taniguchi, Y; Mori, D; Yano, F; Ohba, S; Chung, UI; Shimogori, T; Mills, AA; Tanaka, S; Saito, T				Kawata, Manabu; Taniguchi, Yuki; Mori, Daisuke; Yano, Fumiko; Ohba, Shinsuke; Chung, Ung-il; Shimogori, Tomomi; Mills, Alea A.; Tanaka, Sakae; Saito, Taku			Different regulation of limb development by p63 transcript variants	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; CONDITIONAL INACTIVATION; BUD; EXPRESSION; OUTGROWTH; FGF4; MICE; PLURIPOTENCY; MAINTENANCE; R-SPONDIN2	The apical ectodermal ridge (AER), located at the distal end of each limb bud, is a key signaling center which controls outgrowth and patterning of the proximal-distal axis of the limb through secretion of various molecules. Fibroblast growth factors (FGFs), particularly Fgf8 and Fgf4, are representative molecules produced by AER cells, and essential to maintain the AER and cell proliferation in the underlying mesenchyme, meanwhile Jag2-Notch pathway negatively regulates the AER and limb development. p63, a transcription factor of the p53 family, is expressed in the AER and indispensable for limb formation. However, the underlying mechanisms and specific roles of p63 variants are unknown. Here, we quantified the expression of p63 variants in mouse limbs from embryonic day (E) 10.5 to E12.5, and found that Delta Np63 gamma was strongly expressed in limbs at all stages, while TAp63 gamma expression was rapidly increased in the later stages. Fluorescence-activated cell sorting analysis of limb bud cells from reporter mouse embryos at E11.5 revealed that all variants were abundantly expressed in AER cells, and their expression was very low in mesenchymal cells. We then generated AER-specific p63 knockout mice by mating mice with a null and a flox allele of p63, and Msx2-Cre mice (Msx2-Cre; p63(Delta/fl)). Msx2-Cre; p63(Delta/fl) neonates showed limb malformation that was more obvious in distal elements. Expression of various AER-related genes was decreased in Msx2-Cre; p63(Delta/fl) limb buds and embryoid bodies formed by p63-knockdown induced pluripotent stem cells. Promoter analyses and chromatin immunoprecipitation assays demonstrated Fgf8 and Fgf4 as transcriptional targets of Delta Np63 gamma, and Jag2 as that of TAp63 gamma. Furthermore, TAp63. overexpression exacerbated the phenotype of Msx2-Cre; p63./fl mice. These data indicate that Delta Np63 and TAp63 control limb development through transcriptional regulation of different target molecules with different roles in the AER. Our findings contribute to further understanding of the molecular network of limb development.	[Kawata, Manabu; Taniguchi, Yuki; Mori, Daisuke; Tanaka, Sakae; Saito, Taku] Univ Tokyo, Sensory & Motor Syst Med, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Mori, Daisuke; Yano, Fumiko; Saito, Taku] Univ Tokyo, Bone & Cartilage Regenerat Med, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Yano, Fumiko; Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Shimogori, Tomomi] RIKEN Brain Sci Inst, Shimogori Res Unit, 2-1 Hirosawa, Wako, Saitama, Japan; [Mills, Alea A.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	University of Tokyo; University of Tokyo; University of Tokyo; RIKEN; Cold Spring Harbor Laboratory	Saito, T (corresponding author), Univ Tokyo, Sensory & Motor Syst Med, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.; Saito, T (corresponding author), Univ Tokyo, Bone & Cartilage Regenerat Med, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	tasaitou-tky@umin.ac.jp	Shimogori, Tomomi/L-2893-2013; Tanaka, Sakae/Y-3061-2019	Shimogori, Tomomi/0000-0002-6931-5401; Tanaka, Sakae/0000-0001-9210-9414; Ohba, Shinsuke/0000-0002-6874-8539	Japan Society for the Promotion of Science [26293330, 26253075]; Grants-in-Aid for Scientific Research [15K15536] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from Japan Society for the Promotion of Science (26293330, 26253075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Bergholz J, 2012, CANCER MICROENVIRON, V5, P311, DOI 10.1007/s12307-012-0116-9; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Cheng HC, 2004, DEV BIOL, V270, P513, DOI 10.1016/j.ydbio.2004.03.005; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Duijf PHG, 2002, HUM MOL GENET, V11, P799, DOI 10.1093/hmg/11.7.799; Francis JC, 2005, DEV DYNAM, V234, P1006, DOI 10.1002/dvdy.20590; Hara K, 1997, DEV GROWTH DIFFER, V39, P705; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kaufman MH, 1992, ALTAS MOUSE DEV, P59; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2002, GENESIS, V32, P138, DOI 10.1002/gene.10067; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Sato T, 2008, P NATL ACAD SCI USA, V105, P18806, DOI 10.1073/pnas.0807345105; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Taniguchi Y, 2017, ARTHRITIS RHEUMATOL, V69, P598, DOI 10.1002/art.39976; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Vieux-Rochas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051700; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang XX, 2013, STEM CELLS, V31, P2667, DOI 10.1002/stem.1371	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174122	10.1371/journal.pone.0174122	http://dx.doi.org/10.1371/journal.pone.0174122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333962	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200049
J	Marigomez, I; Mugica, M; Izagirre, U; Sokolova, IM				Marigomez, Ionan; Mugica, Maria; Izagirre, Urtzi; Sokolova, Inna M.			Chronic environmental stress enhances tolerance to seasonal gradual warming in marine mussels	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA GMELIN; TISSUE-LEVEL BIOMARKERS; MYTILUS-GALLOPROVINCIALIS; DIGESTIVE CELLS; QUANTITATIVE ALTERATIONS; ELEVATED-TEMPERATURE; MEMBRANE STABILITY; LITTORINA-LITTOREA; BASQUE ESTUARIES; CADMIUM EXPOSURE	In global climate change scenarios, seawater warming acts in concert with multiple stress sources, which may enhance the susceptibility of marine biota to thermal stress. Here, the responsiveness to seasonal gradual warming was investigated in temperate mussels from a chronically stressed population in comparison with a healthy one. Stressed and healthy mussels were subjected to gradual temperature elevation for 8 days (1 degrees C per day; fall: 16- 24 degrees C, winter: 12-20 degrees C, summer: 20-28 degrees C) and kept at elevated temperature for 3 weeks. Healthy mussels experienced thermal stress and entered the time-limited survival period in the fall, became acclimated in winter and exhibited sublethal damage in summer. In stressed mussels, thermal stress and subsequent health deterioration were elicited in the fall but no transition into the critical period of time-limited survival was observed. Stressed mussels did not become acclimated to 20 degrees C in winter, when they experienced low-to-moderate thermal stress, and did not experience sublethal damage at 28 degrees C in summer, showing instead signs of metabolic rate depression. Overall, although the thermal threshold was lowered in chronically stressed mussels, they exhibited enhanced tolerance to seasonal gradual warming, especially in summer. These results challenge current assumptions on the susceptibility of marine biota to the interactive effects of seawater warming and pollution.	[Marigomez, Ionan; Mugica, Maria; Izagirre, Urtzi] PiE UPV EHU, Res Ctr Expt Marine Biol & Biotechnol, CBET Res Grp, Plentzia Bizkaia, Basque Country, Spain; [Sokolova, Inna M.] Univ Rostock, Marine Biol, Inst Biosci, Rostock, Germany	University of Basque Country; University of Rostock	Marigomez, I (corresponding author), PiE UPV EHU, Res Ctr Expt Marine Biol & Biotechnol, CBET Res Grp, Plentzia Bizkaia, Basque Country, Spain.	ionan.marigomez@ehu.eus	Sokolova, Inna M./B-4955-2009; MARIGOMEZ, Ionan/C-3909-2017; Sokolova, Inna/AAE-4150-2019; Izagirre, Urtzi/C-3848-2017	Sokolova, Inna M./0000-0002-2068-4302; MARIGOMEZ, Ionan/0000-0001-6274-541X; Sokolova, Inna/0000-0002-2068-4302; Izagirre, Urtzi/0000-0002-3477-4974	ETORTEK research strategic actions "K-Egokitzen I & II" (Basque Government); MINECO [CTM2012-40203-C02-01]; Consolidated Research Group in Cell Biology in Environmental Toxicology [GIC07/26-IT-393-07]; UPV/EHU Research & Formation Unit in "Ecosystem Health Protection" [UFI11/37]; MINECO (DIAGNOseas-BMW)	ETORTEK research strategic actions "K-Egokitzen I & II" (Basque Government)(Basque Government); MINECO(Spanish Government); Consolidated Research Group in Cell Biology in Environmental Toxicology; UPV/EHU Research & Formation Unit in "Ecosystem Health Protection"; MINECO (DIAGNOseas-BMW)	This work was supported by funds from ETORTEK research strategic actions "K-Egokitzen I & II" (Basque Government 2007-2011), by MINECO (CTM2012-40203-C02-01; DIAGNOseas-BMW), grants to the Consolidated Research Group in Cell Biology in Environmental Toxicology (GIC07/26-IT-393-07) and the UPV/EHU Research & Formation Unit in "Ecosystem Health Protection" (UFI11/37).	Anestis A, 2007, AM J PHYSIOL-REG I, V293, pR911, DOI 10.1152/ajpregu.00124.2007; Anestis A, 2010, COMP BIOCHEM PHYS A, V156, P57, DOI 10.1016/j.cbpa.2009.12.018; [Anonymous], 1979, STEREOLOGICAL METHOD; AZKONA A, 1984, WATER SCI TECHNOL, V16, P95, DOI 10.2166/wst.1984.0125; Bagwe R, 2015, AQUAT TOXICOL, V167, P77, DOI 10.1016/j.aquatox.2015.07.012; Belzunce MJ, 2004, ELSEV OCEANOGR SERIE, V70, P233; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bocchetti R, 2006, CHEMOSPHERE, V65, P913, DOI 10.1016/j.chemosphere.2006.03.049; Brooks S, 2011, MAR POLLUT BULL, V62, P327, DOI 10.1016/j.marpolbul.2010.10.007; CAJARAVILLE MP, 1991, ARCH ENVIRON CON TOX, V21, P395, DOI 10.1007/BF01060362; CAJARAVILLE MP, 1992, COMP BIOCHEM PHYS C, V102, P113; Cancio I, 1999, COMP BIOCHEM PHYS C, V123, P135, DOI 10.1016/S0742-8413(99)00019-5; Carmichael RH, 2012, J SHELLFISH RES, V31, P1, DOI 10.2983/035.031.0101; Cherkasov AS, 2006, J EXP BIOL, V209, P1274, DOI 10.1242/jeb.02093; Diaz E, 2003, J EXP MAR BIOL ECOL, V292, P213, DOI 10.1016/S0022-0981(03)00179-5; Dimitriadis VK, 2012, MAR ENVIRON RES, V73, P70, DOI 10.1016/j.marenvres.2011.11.004; Fabricius KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054399; Fearman J, 2010, AQUACULTURE, V305, P20, DOI 10.1016/j.aquaculture.2010.04.003; Garcia-Barcina JM, 2006, WATER RES, V40, P951, DOI 10.1016/j.watres.2006.01.004; Garmendia L, 2011, J ENVIRON MONITOR, V13, P915, DOI 10.1039/c0em00410c; Garmendia L, 2011, J ENVIRON MONITOR, V13, P901, DOI 10.1039/c0em00409j; Garmendia L, 2010, AQUAT BIOL, V9, P203, DOI 10.3354/ab00245; Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0; ICES, 2004, REP WORK GROUP BIOL; ICES, 2011, REP STUD GROUP INT M; Izagirre U, 2014, AQUAT TOXICOL, V149, P145, DOI 10.1016/j.aquatox.2014.01.013; Izagirre U, 2009, ENVIRON POLLUT, V157, P1544, DOI 10.1016/j.envpol.2009.01.011; Izagirre U, 2008, MAR ECOL PROG SER, V372, P105, DOI 10.3354/meps07656; Izagirre U, 2009, COMP BIOCHEM PHYS C, V149, P587, DOI 10.1016/j.cbpc.2009.01.004; Jansen JM, 2007, OECOLOGIA, V154, P23, DOI 10.1007/s00442-007-0808-x; Kaloyianni M, 2009, COMP BIOCHEM PHYS C, V149, P631, DOI 10.1016/j.cbpc.2009.01.006; Kim Y., 2006, NOAA TECHNICAL MEMOR, V27, P1; LANGTON RW, 1977, MAR BIOL, V41, P53, DOI 10.1007/BF00390581; Lannig G, 2006, AQUAT TOXICOL, V79, P278, DOI 10.1016/j.aquatox.2006.06.017; Le Pennec GL, 2002, COMP BIOCHEM PHYS B, V133, P417, DOI 10.1016/S1096-4959(02)00169-0; Leinio S, 2005, COMP BIOCHEM PHYS C, V140, P408, DOI 10.1016/j.cca.2005.04.005; Lekube X, 2014, SCI TOTAL ENVIRON, V472, P36, DOI 10.1016/j.scitotenv.2013.10.075; LOWE DM, 1981, AQUAT TOXICOL, V1, P213, DOI 10.1016/0166-445X(81)90016-3; Marigomez I, 1996, COMP BIOCHEM PHYS C, V113, P291, DOI 10.1016/0742-8413(95)02100-0; Marigomez I, 2003, AQUAT TOXICOL, V64, P235, DOI 10.1016/S0166-445X(03)00056-0; Marigomez I, 2013, ECOTOXICOLOGY, V22, P486, DOI 10.1007/s10646-013-1042-4; Matoo OB, 2013, COMP BIOCHEM PHYS A, V164, P545, DOI 10.1016/j.cbpa.2012.12.025; Menge BA, 2008, ECOL LETT, V11, P151, DOI 10.1111/j.1461-0248.2007.01135.x; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; MOORE MN, 1976, CELL TISSUE RES, V175, P279; Mugica M, 2015, MAR ENVIRON RES, V103, P1, DOI 10.1016/j.marenvres.2014.10.005; Orbea A, 1999, ARCH ENVIRON CON TOX, V36, P158, DOI 10.1007/s002449900456; Orbea A, 2006, ENVIRON TOXICOL CHEM, V25, P1616, DOI 10.1897/04-520R2.1; Ortiz-Zarragoitia M, 2006, ARCH ENVIRON CON TOX, V50, P361, DOI 10.1007/s00244-005-1082-8; Ortiz-Zarragoitia M, 2011, J ENVIRON MONITOR, V13, P84, DOI 10.1039/c0em00102c; Ortiz-Zarragoitia M, 2010, ECOTOX ENVIRON SAFE, V73, P693, DOI 10.1016/j.ecoenv.2010.04.002; Patra RW, 2007, ENVIRON TOXICOL CHEM, V26, P1454, DOI 10.1897/06-156R1.1; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171, DOI 10.4319/lo.2003.48.6.2171; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reid PC, 2009, ADV MAR BIOL, V56, P1, DOI 10.1016/S0065-2881(09)56001-4; Schiedek D, 2007, MAR POLLUT BULL, V54, P1845, DOI 10.1016/j.marpolbul.2007.09.020; SCHULTE EH, 1975, MAR BIOL, V30, P331, DOI 10.1007/BF00390638; SEED R, 1969, OECOLOGIA, V3, P277, DOI 10.1007/BF00390380; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; Sokolova IM, 2004, J EXP BIOL, V207, P2639, DOI 10.1242/jeb.01054; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Soto M., 1996, Polish Journal of Environmental Studies, V5, P59; SOTO M, 1995, MAR ECOL PROG SER, V125, P127, DOI 10.3354/meps125127; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; VEGA MM, 1989, MAR BIOL, V103, P547, DOI 10.1007/BF00399587; Viarengo A, 2000, MAR ENVIRON RES, V49, P1, DOI 10.1016/S0141-1136(99)00045-8; Viarengo A, 1989, AQUAT SCI, V46, P45; VILLALBA A, 1995, AQUACULTURE, V130, P269, DOI 10.1016/0044-8486(94)00213-8; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WIDDOWS J, 1973, MAR BIOL, V20, P269, DOI 10.1007/BF00354270; Zaldibar B, 2008, HISTOL HISTOPATHOL, V23, P281, DOI 10.14670/HH-23.281; Zaldibar B, 2007, AQUAT TOXICOL, V81, P183, DOI 10.1016/j.aquatox.2006.12.007; Zhang ZH, 2006, AQUACULTURE, V256, P502, DOI 10.1016/j.aquaculture.2006.02.003	78	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174359	10.1371/journal.pone.0174359	http://dx.doi.org/10.1371/journal.pone.0174359			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333994	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200086
J	Maxwell, MJ; de Carvalho, MHF; Hoet, AE; Vigilato, MAN; Pompei, JC; Cosivi, O; Vilas, VJD				Maxwell, Melody J.; Freire de Carvalho, Mary H.; Hoet, Armando E.; Vigilato, Marco A. N.; Pompei, Julio C.; Cosivi, Ottorino; del Rio Vilas, Victor J.			Building the road to a regional zoonoses strategy: A survey of zoonoses programmes in the Americas	PLOS ONE			English	Article								Background In recent years, global public health security has been threatened by zoonotic disease emergence as exemplified by outbreaks of H5N1 and H1N1 influenza, SARS, and most recently Ebola and Zika. Additionally, endemic zoonoses, such as rabies, burden countries year after year, placing demands on limited finances and personnel. To survey the baseline status of the emerging and endemic zoonoses programmes of the Latin American and the Caribbean (LAC) countries, the Pan American Health Organization (PAHO) conducted a survey of priority emerging and endemic zoonoses, countries A prioritization criteria and methodologies, and suggestions to strengthen countries capacities and regional approaches to zoonoses control. Methods A fillable online questionnaire was sent to the zoonoses programme managers of the Ministries of Health (MOH) and Ministries of Agriculture (MAg) of 33 LAC countries from January to April of 2015. The questionnaire comprised 36 single, multiple choice and open-ended questions to inform the objectives of the survey. A descriptive exploratory analysis was completed. Results Fifty-four ministries (26 MOH, 25 MAg, and 3 combined responses) in 31 LAC countries responded to the survey. Within the ministries, 22 (85%) MOH, 5 (20%) MAg, and 2 (67%) combined entities indicated they had specialized zoonoses units. For endemic zoonoses, 32 of 54 ministries responded that they conduct formal prioritization exercises, most of them annually (69%). The three priority endemic zoonoses for the MOHs were leptospirosis, rabies, and brucellosis while the three priorities for the MAgs were brucellosis, rabies, and tuberculosis. Diagnosis for rabies and leptospirosis were cited as the capacities most in need of development. The most needed cross-cutting capacity was coordination between stakeholders. For emerging zoonoses, 28 ministries performed formal prioritization exercises. The top prioritization criteria were probability of introduction into the country and impact. The three priority emerging zoonoses for the MOHs were Ebola viral disease, avian influenza, and Chikungunya while for the MAgs were avian influenza, bovine spongiform encephalopathy and West Nile virus disease. Surveillance for avian influenza and Ebola, and diagnosis for BSE were quoted as the capacities most needed. For all zoonoses, the majority of respondents (69%) ranked their relationship with the other Ministry as productive or very productive, and 31% minimally productive. Many countries requested a formal regional network, better regional communication and collaboration, and integrated surveillance. Conclusions The survey is the first comprehensive effort to date to inform the status of zoonoses programmes in LAC. The information collected here will be used to develop a regional strategy for zoonoses (both endemic and emerging), increase efforts, advocacy, and promote prompt identification and management of EIDs and improvement of endemic programmes.	[Maxwell, Melody J.; Freire de Carvalho, Mary H.; Vigilato, Marco A. N.; Pompei, Julio C.; Cosivi, Ottorino; del Rio Vilas, Victor J.] PANAFTOSA PAHO WHO, Rio De Janeiro, Brazil; [Hoet, Armando E.] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Vet Publ Hlth Program, Columbus, OH 43210 USA; [Hoet, Armando E.] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA; [Maxwell, Melody J.] APHIS, Int Serv, USDA, Riverdale, MD USA; [del Rio Vilas, Victor J.] Univ Surrey, Sch Vet Med, Guildford, Surrey, England	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Agriculture (USDA); University of Surrey	Vilas, VJD (corresponding author), PANAFTOSA PAHO WHO, Rio De Janeiro, Brazil.; Vilas, VJD (corresponding author), Univ Surrey, Sch Vet Med, Guildford, Surrey, England.	vdelriovilas@yahoo.co.uk	Vigilato, Marco Antonio Natal/G-3848-2012	Vigilato, Marco Antonio Natal/0000-0003-3920-0766; del rio vilas, victor/0000-0002-1674-9951; Maxwell, Melody/0000-0003-2475-781X	National Security Education Program	National Security Education Program	We would like to acknowledge the David L. Boren Fellowship, sponsored by the National Security Education Program, for their support of the lead author (MJM) during her research.	[Anonymous], 2014, IHR CORE CAPACITY MO; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2008, INT HLTH REG; Clavijo A, 2013, AM J TROP MED HYG, V89, P1040, DOI 10.4269/ajtmh.13-0229; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; FAO/WHO, 2014, MICR RISK ASS SER, V23; Gibbs E., 2014, EVOLUTION ONE HLTH D, P85; Grace D., 2012, MAPPING POVERTY LIKE; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Msellati L, 2012, REV SCI TECH OIE, V31, P413; Pan American Health Organization (PAHO), 2015, INF EP REG AM 2009 2; Pan American Health Organization (PAHO), 2016, 17 INT MIN M HLTH AG; SAS Institute, 2013, US JMP 11; Schneider MC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000964; Steele K, 2009, RISK ANAL, V29, P26, DOI 10.1111/j.1539-6924.2008.01130.x; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; United Nations (UN), 2015, TRANSF OUR WORLD 203; Vilas VJD, 2011, EUROSURVEILLANCE, V16, P24; Vilas VJD, 2013, PREV VET MED, V108, P94, DOI 10.1016/j.prevetmed.2012.08.007; Vrbova L, 2010, TRANSBOUND EMERG DIS, V57, P154, DOI 10.1111/j.1865-1682.2010.01100.x; Wang LF, 2014, REV SCI TECH OIE, V33, P569, DOI 10.20506/rst.33.2.2311; World Bank, 2015, WORK END POV LAT AM; World Health Organization, NEGL ZOON DIS; World Health Organization, 2010, FAO OIE WHO COLL SHA; World Health Organization, 2014, INT HLTH REG 2005 SU, P64	27	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174175	10.1371/journal.pone.0174175	http://dx.doi.org/10.1371/journal.pone.0174175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333986	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200058
J	Valaee, S; Yaghoobi, MM; Shamsara, M				Valaee, Shiva; Yaghoobi, Mohammad Mehdi; Shamsara, Mehdi			Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner	PLOS ONE			English	Article							E-CADHERIN; CLINICAL-SIGNIFICANCE; VIMENTIN; PROLIFERATION; CARCINOMA; INVASION; CATENIN; EMT	Epithelial-mesenchymal transition (EMT), which is mainly recognized by upregulation of mesenchymal markers and movement of cells, is a critical stage occurred during embryo development and spreading cancerous cells. Metformin is an antidiabetic drug used in treatment of type 2 diabetes. EMT inhibitory effect of metformin has been studied in several cancers; however, it remains unknown in gastric cancer. The aim of the present study was to investigate the metformin effects on inhibition of EMT-related genes as well as migration and invasion of AGS gastric cancer cell line. Moreover, to study the effect of glucose on metformin-mediated EMT inhibition, all experiments were performed in two glucose levels, similar to non-fasting blood sugar (7.8 mM) and hyperglycemic (17.5 mM) conditions. The results showed reduction of mesenchymal markers, including vimentin and beta-catenin, and induction of epithelial marker, E-cadherin, by metformin in both glucose concentrations. Furthermore, wound-healing and invasion assays showed a significant decrease in cell migration and invasion after metformin treatment in both glucose levels. In conclusion, our results indicated that metformin strongly inhibited EMT of gastric cancer cells in conditions mimicking normo and hyperglycemic blood sugar.	[Valaee, Shiva; Yaghoobi, Mohammad Mehdi] Grad Univ Adv Technol, Dept Biotechnol Res, Inst Sci & High Technol & Environm Sci, Kerman, Iran; [Shamsara, Mehdi] Natl Inst Genet Engn & Biotechnol, Dept Anim Biotechnol, Tehran, Iran	Graduate University of Advanced Technology	Shamsara, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Anim Biotechnol, Tehran, Iran.	shamsa@nigeb.ac.ir	Yaghoobi, Mohammad Mehdi/AAL-6319-2020	Yaghoobi, Mohammad Mehdi/0000-0003-1434-6224				Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Chen GX, 2015, AM J CANCER RES, V5, P1423; Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903; Correia S, 2008, MINI-REV MED CHEM, V8, P1343, DOI 10.2174/138955708786369546; Du R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030771; Fuyuhiro Y, 2010, ANTICANCER RES, V30, P5239; Gilles C, 2003, CANCER RES, V63, P2658; Habibollahi P, 2013, J NUCL MED, V54, P252, DOI 10.2967/jnumed.112.107011; Han L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027074; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iwatsuki M, 2010, ANN SURG ONCOL, V17, P2526, DOI 10.1245/s10434-010-1041-0; Kasznicki J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.01; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Lazarova DL, 2016, J CELL MOL MED, V20, P989, DOI 10.1111/jcmm.12850; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Liu X, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/637308; Matveeva EA, 2015, BIOL OPEN, V4, P1290, DOI 10.1242/bio.011874; Morgillo F, 2013, EXPERT OPIN INV DRUG, V22, P1401, DOI 10.1517/13543784.2013.828691; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peng Z, 2014, WORLD J GASTROENTERO, V20, P5403, DOI 10.3748/wjg.v20.i18.5403; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Poli G, 2016, ONCOTARGET, V7, P49636, DOI 10.18632/oncotarget.10421; Rattan R, 2012, J ONCOL, V2012, P12; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Rodriguez FJ, 2008, CANCER, V113, P2779, DOI 10.1002/cncr.23899; Sandulache VC, 2011, CANCER-AM CANCER SOC, V117, P2926, DOI 10.1002/cncr.25868; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schwarz N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030030; Smieszek A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/769402; Smith TAD, 2013, NUCL MED BIOL, V40, P858, DOI 10.1016/j.nucmedbio.2013.05.006; Suissa S, 2014, DIABETES CARE, V37, P1786, DOI 10.2337/dc14-0500; Tanabe S, 2015, TRANSL GASTROIN CANC, V4, P258, DOI 10.3978/j.issn.2224-4778.2015.07.04; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang YR, 2014, INT J MOL MED, V33, P1514, DOI 10.3892/ijmm.2014.1707; Wei JC, 2008, ANTICANCER RES, V28, P327; Zhang H, 2013, J CANCER RES CLIN, V139, P1033, DOI 10.1007/s00432-012-1363-3; Zhang Q, 2013, CARCINOGENESIS, V34, P962, DOI 10.1093/carcin/bgt027; Zhang T, 2013, INT J MOL SCI, V14, P24603, DOI 10.3390/ijms141224603; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444	43	34	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174486	10.1371/journal.pone.0174486	http://dx.doi.org/10.1371/journal.pone.0174486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334027	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200105
J	Chauvigne, F; Olle, J; Gonzalez, W; Duncan, N; Gimenez, I; Cerda, J				Chauvigne, Francois; Olle, Judith; Gonzalez, Wendy; Duncan, Neil; Gimenez, Ignacio; Cerda, Joan			Toward developing recombinant gonadotropin-based hormone therapies for increasing fertility in the flatfish Senegalese sole	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ATLANTIC HALIBUT; JAPANESE EEL; ARTIFICIAL FERTILIZATION; ADMINISTRATION METHODS; ANGUILLA-JAPONICA; LEYDIG-CELLS; SEA-BASS; SPERM; FSH	Captive flatfishes, such as the Senegalese sole, typically produce very low volumes of sperm. This situation is particularly prevalent in the first generation (F1) of reared sole males, which limits the development of artificial fertilization methods and the implementation of selective breeding programs. In this study, we investigated whether combined treatments with homologous recombinant follicle-stimulating (rFsh) and luteinizing (rLh) hormones, produced in a mammalian host system, could stimulate spermatogenesis and enhance sperm production in Senegalese sole F1 males. In an initial autumn/winter experiment, weekly intramuscular injections with increasing doses of rFsh over 9 weeks resulted in the stimulation of gonad weight, androgen release, germ cell proliferation and entry into meiosis, and the expression of different spermatogenesis-related genes, whereas a subsequent single rLh injection potentiated spermatozoa differentiation. In a second late winter/spring trial corresponding to the sole's natural prespawning and spawning periods, we tested the effect of repeated rLh injections on the amount and quality of sperm produced by males previously treated with rFsh for 4, 6, 8 or 10 weeks. These latter results showed that the combination of rFsh and rLh treatments could increase sperm production up to 7 times, and slightly improve the motility of the spermatozoa, although a high variability in the response was found. However, sustained administration of rFsh during spawning markedly diminished Leydig cell survival and the steroidogenic potential of the testis. These data suggest that in vivo application of rFsh and rLh is effective at stimulating spermatogenesis and sperm production in Senegalese sole F1 males, setting the basis for the future establishment of recombinant gonado-tropin-based hormone therapies to ameliorate reproductive dysfunctions of this species.	[Chauvigne, Francois; Olle, Judith; Cerda, Joan] CSIC, Inst Ciencies Mar, IRTA, Barcelona, Spain; [Gonzalez, Wendy; Duncan, Neil] IRTA, Tarragona, Spain; [Gimenez, Ignacio] Rara Avis Biotec SL, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA; IRTA	Chauvigne, F; Cerda, J (corresponding author), CSIC, Inst Ciencies Mar, IRTA, Barcelona, Spain.; Gimenez, I (corresponding author), Rara Avis Biotec SL, Valencia, Spain.	chauvigne@cmima.csic.es; igimenez@raraavis-bio.com; joan.cerda@irta.cat	Duncan, Neil/B-8906-2013; Cerdà, Joan/M-1099-2016; Chauvigne, Francois/D-6854-2017	Duncan, Neil/0000-0001-5456-9217; Cerdà, Joan/0000-0003-2568-6398; Chauvigne, Francois/0000-0001-5571-7517; Gonzalez Lopez, Wendy Angela/0000-0002-4378-9123; Olle Vilanova, Judith/0000-0002-6431-4127	CERCA Programme (Government of Catalonia); Spanish Ministry of Economy and Competitivity (MINECO) [AGL2013-41196-R]; Spanish National Institute for Agronomic Research (INIA) European Fund for Economic and Regional Development (FEDER) [RTA2014-00048]; Ramon y Cajal contract (MINECO); National Board of Science and Technology (CONACYT, Mexico)	CERCA Programme (Government of Catalonia); Spanish Ministry of Economy and Competitivity (MINECO); Spanish National Institute for Agronomic Research (INIA) European Fund for Economic and Regional Development (FEDER); Ramon y Cajal contract (MINECO); National Board of Science and Technology (CONACYT, Mexico)	This work was supported by the CERCA Programme (Government of Catalonia), and partially funded by the Spanish Ministry of Economy and Competitivity (MINECO) (Grant no. AGL2013-41196-R to JC), and the Spanish National Institute for Agronomic Research (INIA) European Fund for Economic and Regional Development (FEDER) (Grant no. RTA2014-00048 to ND). Participation of FC and WG was funded, respectively, by a "Ramon y Cajal" contract (MINECO) and a predoctoral grant from the National Board of Science and Technology (CONACYT, Mexico).	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Agulleiro MJ, 2007, COMP BIOCHEM PHYS A, V147, P885, DOI 10.1016/j.cbpa.2007.02.008; Agulleiro MJ, 2006, AQUACULTURE, V257, P511, DOI 10.1016/j.aquaculture.2006.02.001; Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Beirao J, 2011, ANIM REPROD SCI, V126, P122, DOI 10.1016/j.anireprosci.2011.04.009; Beirao J, 2015, AQUACULTURE, V435, P187, DOI 10.1016/j.aquaculture.2014.09.025; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Cabrita E, 2006, AQUACULTURE, V261, P967, DOI 10.1016/j.aquaculture.2006.08.020; Cabrita E, 2011, THERIOGENOLOGY, V75, P1, DOI 10.1016/j.theriogenology.2010.07.003; Carazo I., 2011, INDIAN J SCI TECHNOL, V4, P96; Cerda J, 2008, GEN COMP ENDOCR, V156, P470, DOI 10.1016/j.ygcen.2008.02.006; Chauvigne F, 2016, COMP BIOCHEM PHYS A, V191, P35, DOI 10.1016/j.cbpa.2015.09.015; Chauvigne F, 2015, GEN COMP ENDOCR, V221, P75, DOI 10.1016/j.ygcen.2014.10.009; Chauvigne F, 2014, J MOL ENDOCRINOL, V53, P175, DOI 10.1530/JME-14-0087; Chauvigne F, 2014, P NATL ACAD SCI USA, V111, P1427, DOI 10.1073/pnas.1317838111; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Chauvigne F, 2010, BIOL REPROD, V82, P1088, DOI 10.1095/biolreprod.109.082289; Chen SX, 2013, GEN COMP ENDOCR, V185, P1, DOI 10.1016/j.ygcen.2013.01.005; Chereguini O, 2006, P AQ 2006 FLOR IT MA, P164; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501; Fauvel C, 1999, J FISH BIOL, V54, P356, DOI 10.1111/j.1095-8649.1999.tb00835.x; Garcia-Lopez A, 2006, GEN COMP ENDOCR, V147, P343, DOI 10.1016/j.ygcen.2006.02.003; Garcia-Lopez A, 2005, HISTOL HISTOPATHOL, V20, P1179, DOI 10.14670/HH-20.1179; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; GarciaCampayo V, 1997, NAT BIOTECHNOL, V15, P663, DOI 10.1038/nbt0797-663; Guzman JM, 2011, AQUACULTURE, V316, P121, DOI 10.1016/j.aquaculture.2011.03.014; Guzman JM, 2011, COMP BIOCHEM PHYS A, V158, P235, DOI 10.1016/j.cbpa.2010.11.016; Mazon MJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.110569; Kamei H, 2003, GEN COMP ENDOCR, V134, P244, DOI 10.1016/S0016-6480(03)00259-4; Kasuto H, 2005, GEN COMP ENDOCR, V140, P222, DOI 10.1016/j.ygcen.2004.10.016; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; Khan UW, 2007, J ENDOCRINOL, V194, P441, DOI 10.1677/JOE-06-0225; King HR, 2001, AQUACULTURE, V193, P179, DOI 10.1016/S0044-8486(00)00472-5; Ko H, 2007, J MOL ENDOCRINOL, V38, P99, DOI 10.1677/jme.1.02163; Kobayashi M, 2010, GEN COMP ENDOCR, V167, P379, DOI 10.1016/j.ygcen.2010.01.003; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krishnamurthy H, 2001, BIOL REPROD, V65, P1201, DOI 10.1095/biolreprod65.4.1201; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; [刘新富 LIU Xinfu], 2008, [海洋水产研究, Marine Fisheries Research], V29, P10; Marin-Juez R, 2011, GEN COMP ENDOCR, V172, P130, DOI 10.1016/j.ygcen.2011.02.003; Martinez-Pastor F, 2008, REPRODUCTION, V135, P449, DOI 10.1530/REP-07-0376; Miura C, 2009, P NATL ACAD SCI USA, V106, P20972, DOI 10.1073/pnas.0907631106; Miura T, 1999, BIOCHEM BIOPH RES CO, V264, P230, DOI 10.1006/bbrc.1999.1494; Moles G, 2011, BIOL REPROD, V84, P1171, DOI 10.1095/biolreprod.110.086470; Morais S, 2016, REV AQUACULT, V8, P227, DOI 10.1111/raq.12091; Munoz-Velasco I, 2013, J HISTOCHEM CYTOCHEM, V61, P680, DOI 10.1369/0022155413496639; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nader MR, 1999, BIOL REPROD, V61, P944, DOI 10.1095/biolreprod61.4.944; Nobrega RH, 2015, ENDOCRINOLOGY, V156, P3804, DOI 10.1210/en.2015-1157; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; Ozaki Y, 2006, ENDOCRINOLOGY, V147, P5139, DOI 10.1210/en.2006-0391; Rasines I, 2013, AQUACULTURE, V392, P94, DOI 10.1016/j.aquaculture.2013.02.011; Rasines I, 2012, AQUACULTURE, V326, P129, DOI 10.1016/j.aquaculture.2011.11.021; Rolland AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053302; Sanchis-Benlloch PJ, 2017, GEN COMP ENDOCR, V241, P41, DOI 10.1016/j.ygcen.2016.03.001; Schulz RW, 2008, GEN COMP ENDOCR, V156, P154, DOI 10.1016/j.ygcen.2008.01.002; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Scott AP, 2010, J FISH BIOL, V76, P183, DOI 10.1111/j.1095-8649.2009.02483.x; TAPANAINEN JS, 1993, MOL ENDOCRINOL, V7, P643, DOI 10.1210/me.7.5.643; Tvedt HB, 2001, AQUACULTURE, V194, P191, DOI 10.1016/S0044-8486(00)00516-0; Vermeirssen ELM, 2004, AQUACULTURE, V230, P547, DOI 10.1016/S0044-8486(03)00414-9; Vermeirssen ELM, 2000, FISH PHYSIOL BIOCHEM, V22, P77, DOI 10.1023/A:1007820913009; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Wootton RJ, 2014, REPROD BIOL TELEOST; Xu YR, 2016, GENE, V582, P97, DOI 10.1016/j.gene.2016.02.007; Yom-Din S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162344; Yu XB, 2010, FISH PHYSIOL BIOCHEM, V36, P273, DOI 10.1007/s10695-008-9244-z; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1	72	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174387	10.1371/journal.pone.0174387	http://dx.doi.org/10.1371/journal.pone.0174387			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329024	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700087
J	Hanif, A; Edin, ML; Zeldin, DC; Morisseau, C; Falck, JR; Nayeem, MA				Hanif, Ahmad; Edin, Matthew L.; Zeldin, Darryl C.; Morisseau, Christophe; Falck, John R.; Nayeem, Mohammed A.			Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE; EXPRESSION; RECEPTORS; METABOLITES; ISCHEMIA; INJURY; ROLES; HYPERTENSION	Arachidonic acid is metabolized to epoxyeicosatrienoic acids (EETs) by cytochrome (CYP) P450 epoxygenases, and to omega-terminal hydroxyeicosatetraenoic acids (HETEs) by omega-hydroxylases. EETs and HETEs often have opposite biologic effects; EETs are vasodilatory and protect against ischemia/reperfusion injury, while omega-terminal HETEs are vasoconstrictive and cause vascular dysfunction. Other oxylipins, such as epoxyoctadecaenoic acids (EpOMEs), hydroxyoctadecadienoic acids (HODEs), and prostanoids also have varied vascular effects. Post-ischemic vasodilation in the heart, known as coronary reactive hyperemia (CRH), protects against potential damage to the heart muscle caused by ischemia. The relationship among CRH response to ischemia, in mice with altered levels of CYP2J epoxygenases has not yet been investigated. Therefore, we evaluated the effect of endothelial overexpression of the human cytochrome P450 epoxygenase CYP2J2 in mice (Tie2-CYP2J2 Tr) on oxylipin profiles and CRH. Additionally, we evaluated the effect of pharmacologic inhibition of CYP-epoxygenases and inhibition of omega-hydroxylases on CRH. We hypothesized that CRH would be enhanced in isolated mouse hearts with vascular endothelial overexpression of human CYP2J2 through modulation of oxylipin profiles. Similarly, we expected that inhibition of CYP-epoxygenases would reduce CRH, whereas inhibition of omega-hydroxylases would enhance CRH. Compared to WT mice, Tie2-CYP2J2 Tr mice had enhanced CRH, including repayment volume, repayment duration, and repayment/debt ratio (P < 0.05). Similarly, inhibition of omega-hydroxylases increased repayment volume and repayment duration, in Tie2-CYP2J2 Tr compared to WT mice (P < 0.05). Endothelial overexpression of CYP2J2 significantly changed oxylipin profiles, including increased EETs (P < 0.05), increased EpOMEs (P < 0.05), and decreased 8-iso-PGF(2 alpha) (P < 0.05). Inhibition of CYP epoxygenases with MS-PPOH attenuated CRH (P < 0.05). Ischemia caused a decrease in mid-chain HETEs (5-, 11-, 12-, 15-HETEs P < 0.05) and HODEs (P < 0.05). These data demonstrate that vascular endothelial overexpression of CYP2J2, through changing the oxylipin profiles, enhances CRH. Inhibition of CYP epoxygenases decreases CRH, whereas inhibition of omega-hydroxylases enhances CRH.	[Hanif, Ahmad; Nayeem, Mohammed A.] West Virginia Univ, Sch Pharm, Ctr Basic & Translat Stroke Research, Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Morisseau, Christophe] Univ Calif Davis, Davis, CA 95616 USA; [Falck, John R.] Univ Texas Southwestern Med Ctr Dallas, Biochem, Dallas, TX 75390 USA	West Virginia University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nayeem, MA (corresponding author), West Virginia Univ, Sch Pharm, Ctr Basic & Translat Stroke Research, Basic Pharmaceut Sci, Morgantown, WV 26506 USA.	mnayeem@hsc.wvu.edu	Nayeem, Mohammed A/A-3949-2017; Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019	Nayeem, Mohammed A/0000-0002-7827-4760; Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	National Institutes of Health [HL-114559, GM-31278]; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences [Z01 ES025034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (HL-114559) to M. A. Nayeem, National Institutes of Health (GM-31278) to J. R. Falck, and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034 to D. C. Zeldin).	Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Askari A, 2013, PROSTAG OTH LIPID M, V107, P56, DOI 10.1016/j.prostaglandins.2013.02.003; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Berwick ZC, 2010, MICROCIRCULATION, V17, P600, DOI 10.1111/j.1549-8719.2010.00054.x; Borbouse L, 2010, AM J PHYSIOL-HEART C, V298, P29; BURHOP KE, 1988, CIRC RES, V62, P687, DOI 10.1161/01.RES.62.4.687; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; CATELLA F, 1990, P NATL ACAD SCI USA, V87, P5893, DOI 10.1073/pnas.87.15.5893; Chen WS, 2015, CELL PHYSIOL BIOCHEM, V35, P2043, DOI 10.1159/000374011; Cheng J, 2008, AM J PHYSIOL-HEART C, V294, P21; COFFMAN JD, 1960, AM J PHYSIOL, V199, P1143, DOI 10.1152/ajplegacy.1960.199.6.1143; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Ellinsworth DC, 2014, CARDIOVASC RES, V102, P9, DOI 10.1093/cvr/cvu015; Emerson MR, 2004, BRAIN RES, V1021, P140, DOI 10.1016/j.brainres.2004.06.045; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fang X, 2004, AM J PHYSIOL-HEART C, V287, P29; Fritsche KL, 2008, PROSTAG LEUKOTR ESS, V79, P173, DOI 10.1016/j.plefa.2008.09.019; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; Graves JP, 2015, DRUG METAB DISPOS, V43, P1169, DOI 10.1124/dmd.115.064139; Hanif A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162147; Hanif AM, 2016, AM J PHYSL REGUL INT, V3; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Hellmann M, 2015, FUND CLIN PHARMACOL, V29, P510, DOI 10.1111/fcp.12135; Hoopes SL, 2015, PROSTAG OTH LIPID M, V120, P9, DOI 10.1016/j.prostaglandins.2015.03.002; Hou HH, 2012, CARDIOVASC RES, V93, P120, DOI 10.1093/cvr/cvr267; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Jia J, 2016, EXP NEUROL, V279, P75, DOI 10.1016/j.expneurol.2016.02.016; Kingsbury MP, 2000, J MOL CELL CARDIOL, V32, P527, DOI 10.1006/jmcc.1999.1097; KITAKAZE M, 1992, CIRC RES, V71, P558, DOI 10.1161/01.RES.71.3.558; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kunduri SS, 2013, J CARDIOVASC PHARM, V62, P78, DOI 10.1097/FJC.0b013e3182919591; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, P28; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Li R, 2012, PROSTAG OTH LIPID M, V99, P68, DOI 10.1016/j.prostaglandins.2012.09.004; Lukaszewicz KM, 2016, MICROCIRCULATION, V18, P12304; Maayah ZH, 2016, ARCH TOXICOL, V90, P119, DOI 10.1007/s00204-015-1620-8; Maayah ZH, 2015, CELL BIOL TOXICOL, V31, P241, DOI 10.1007/s10565-015-9308-7; Marciante KD, 2008, PHARMACOGENET GENOM, V18, P535, DOI 10.1097/FPC.0b013e3282fd1287; Mobert J, 1997, J CARDIOVASC PHARM, V29, P789, DOI 10.1097/00005344-199706000-00012; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Moran JH, 2000, TOXICOL APPL PHARM, V168, P268, DOI 10.1006/taap.2000.9053; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Nowak G, 2004, TOXICOL LETT, V147, P161, DOI 10.1016/j.toxlet.2003.11.002; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; PROCTOR KG, 1987, CIRC RES, V60, P50, DOI 10.1161/01.RES.60.1.50; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Sha WX, 2012, IMMUNOBIOLOGY, V217, P1225, DOI 10.1016/j.imbio.2012.05.001; Shim CY, 2014, AM J PHYSIOL-ENDOC M, V307, P21; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; STERN N, 1993, ENDOCRINOLOGY, V133, P843, DOI 10.1210/en.133.2.843; STOLL LL, 1994, AM J PHYSIOL, V266, pC990, DOI 10.1152/ajpcell.1994.266.4.C990; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; Wen Y, 1996, AM J PHYSL, V271	59	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174137	10.1371/journal.pone.0174137	http://dx.doi.org/10.1371/journal.pone.0174137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328948	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700058
J	Perez, T; Diaz, MC; Ruiz, C; Condor-Lujan, B; Klautau, M; Hajdu, E; Lobo-Hajdu, G; Zea, S; Pomponi, SA; Thacker, RW; Carteron, S; Tollu, G; Pouget-Cuvelier, A; Thelamon, P; Marechal, JP; Thomas, OP; Ereskovsky, AV; Vacelet, J; Boury-Esnault, N				Perez, Thierry; Diaz, Maria-Cristina; Ruiz, Cesar; Condor-Lujan, Baslavi; Klautau, Michelle; Hajdu, Eduardo; Lobo-Hajdu, Gisele; Zea, Sven; Pomponi, Shirley A.; Thacker, Robert W.; Carteron, Sophie; Tollu, Guillaume; Pouget-Cuvelier, Adeline; Thelamon, Philippe; Marechal, Jean-Philippe; Thomas, Olivier P.; Ereskovsky, Alexander V.; Vacelet, Jean; Boury-Esnault, Nicole			How a collaborative integrated taxonomic effort has trained new spongiologists and improved knowledge of Martinique Island (French Antilles, eastern Caribbean Sea) marine biodiversity	PLOS ONE			English	Article							SPONGES PORIFERA; CORAL-REEF; MANGROVE; DEMOSPONGIAE; COMMUNITIES; DIVERSITY; ABUNDANCE; BONAIRE; CURACAO	Although sponges are important components of benthic ecosystems of the Caribbean Sea, their diversity remained poorly investigated in the Lesser Antilles. By organizing a training course in Martinique, we wanted both to promote taxonomy and to provide a first inventory of the sponge diversity on this island. The course was like a naturalist expedition, with a field laboratory and a classroom nearby. Early-career scientists and environmental managers were trained in sponge taxonomy. We gathered unpublished data and conducted an inventory at 13 coastal sites. We explored only shallow water habitats (0-30 m), such as mangroves, reefs or rocky bottoms and underwater caves. According to this study, the sponge fauna of Martinique is currently represented by a minimum of 191 species, 134 of which we could assign species names. One third of the remaining non-identified sponge species we consider to be new to science. Martinique appears very remarkable because of its littoral marine fauna harboring sponge aggregations with high biomass and species diversity dominating over coral species. In mangroves, sponges cover about 10% of the surface of subtidal roots. Several submarine caves are true reservoirs of hidden and insufficiently described sponge diversity. Thanks to this new collaborative effort, the Eastern Caribbean has gained a significant increase of knowledge, with sponge diversity of this area potentially representing 40% of the total in the Caribbean Sea. We thus demonstrated the importance of developing exploratory and educational research in areas historically devoid of biodiversity inventories and systematics studies. Finally, we believe in the necessity to consider not only the number of species but their distribution in space to evaluate their putative contribution to ecosystem services and our willingness to preserve them.	[Perez, Thierry; Ruiz, Cesar; Ereskovsky, Alexander V.; Vacelet, Jean; Boury-Esnault, Nicole] Avignon Univ Stn Marine Endoume, Aix Marseille Univ, CNRS,IRD, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Chemin Batterie Lions, Marseille, France; [Diaz, Maria-Cristina; Pomponi, Shirley A.] Florida Atlantic Univ, Harbor Branch, Oceanog Inst, Ft Pierce, FL USA; [Condor-Lujan, Baslavi; Klautau, Michelle] Univ Fed Rio de Janeiro, Dept Zool, Inst Biol, Rio De Janeiro, RJ, Brazil; [Hajdu, Eduardo] Univ Fed Rio de Janeiro, Dept Invertebrados, Museu Nacl, Rio De Janeiro, RJ, Brazil; [Lobo-Hajdu, Gisele] Univ Estado Rio de Janeiro, Dept Genet, Inst Biol Roberto Alcantara Gomes, Rua Sao Francisco Xavier, Rio De Janeiro, RJ, Brazil; [Zea, Sven] Univ Nacl Colombia, INVEMAR, Inst Estudios Ciencias Mar, Calle 25 2-55, Playa Salguero, Santa Marta, Colombia; [Thacker, Robert W.] SUNY Stony Brook, Dept Ecol & Evolut, 650 Life Sci Bldg, Stony Brook, NY 11794 USA; [Carteron, Sophie] OTEIS, 370 Rue Rene Descartes, Aix En Provence, France; [Tollu, Guillaume; Pouget-Cuvelier, Adeline] IMPACT MER, 90 Rue Prof Raymond Garcin,Route Didier, Fort De France, Martinique, France; [Thelamon, Philippe] Abyss Plongee, 1 Rue Cototiers, Grande Anse, Anses Darlet, France; [Marechal, Jean-Philippe] Nova Blue Environm, 14 Rue Chery Rosette, Fond Lahaye, Schoelcher, France; [Thomas, Olivier P.] Natl Univ Ireland Galway, Sch Chem, Coll Sci, Marine Biodiscovery, Galway, Ireland; [Ereskovsky, Alexander V.] St Petersburg State Univ, Fac Biol, 7-9 Univ Skaya Emb, St Petersburg, Russia	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidad Nacional de Colombia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Ollscoil na Gaillimhe-University of Galway; Saint Petersburg State University	Perez, T (corresponding author), Avignon Univ Stn Marine Endoume, Aix Marseille Univ, CNRS,IRD, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Chemin Batterie Lions, Marseille, France.	thierry.perez@imbe.fr	Ereskovsky, Alexander/B-3136-2013; Ereskovsky, Alexander/W-1504-2019; Lobo-Hajdu, Gisele/A-6709-2008	Ereskovsky, Alexander/0000-0003-1079-7204; Lobo-Hajdu, Gisele/0000-0001-7792-9609; CONDOR LUJAN, BASLAVI/0000-0001-7832-7319; THOMAS, Olivier/0000-0002-5708-1409; Ruiz Pinzon, Cesar Augusto/0000-0002-4862-6032	CNRS LIA MARRIO project; TOTAL Foundation; Region La Martinique; DEAL La Martinique; CAR/SPAW Guadeloupe; COFECUB; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council of Technological and Scientific Development (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	CNRS LIA MARRIO project; TOTAL Foundation(Total SA); Region La Martinique; DEAL La Martinique; CAR/SPAW Guadeloupe; COFECUB; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Support was provided by the CNRS LIA MARRIO project, TOTAL Foundation, Region La Martinique, DEAL La Martinique, CAR/SPAW Guadeloupe, COFECUB, Coordination for the Improvement of Higher Education Personnel (CAPES), National Council of Technological and Scientific Development (CNPq), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the following agencies and programs for funding and various forms of support: CNRS LIA MARRIO project, TOTAL Foundation, Region La Martinique, DEAL La Martinique, CAR/SPAW Guadeloupe, COFECUB, Coordination for the Improvement of Higher Education Personnel (CAPES), National Council of Technological and Scientific Development (CNPq), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). For logistic scientific support and microscopes we would like to thank the IRD, especially Dr. Patrick Queneherve and Mr. Yoan Labrousse, Universite des Antilles, particularly Dr. Juliette Smith-Ravin and Dr. Maximilian Hassler, and the City of Les Anses d'Arlet. The involvement of our friend Jean Claude Erin, from La Sucrerie Motel, was essential for the success of the Sponge Training Course, respectively in organizing the diving and the housing of the "sponge camp". Thanks to Joelle Massei, helped by Dania Tokina, for coordinating all the travelling and general logistics before and during the STC. We especially acknowledge Marie Grenier for designing the illustrated underwater fieldguides. Finally, we would like to thank all the people of Les Anses d'Arlet, and all the participants of the course.	Alcolado P, 2012, SERIE OCEANOLOGICA, V10, P1; Alcolado Pedro M., 2002, Avicennia, V15, P53; Bouchon C, 1986, ANN I OCEANOGRAPHIQU, V62, P251; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Diaz MC, 2012, HYDROBIOLOGIA, V687, P179, DOI 10.1007/s10750-011-0952-5; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; de Lamarck J-B., 1814, ANN MUSEUM NATL HIST, V20, P432; de Voogd NJ, 2013, CORAL REEFS, V32, P755, DOI 10.1007/s00338-013-1030-4; De Weerdt Wallie H., 1999, Beaufortia, V49, P47; Diaz M.C., 1990, P367; Diaz Maria Cristina, 2009, Smithsonian Contributions to the Marine Sciences, P151; Diaz MC, 2001, B MAR SCI, V69, P535; Diaz MC, 2011, SPECIES COMPOSITION; Duchassaing de Fonbresin EP, 1850, ANIMAUX RADIAIRES AN; Duchassaing P., 1864, NATUURKUNDIGE VERHAN, V21, P1; Ereskovsky AV, 2014, J MAR BIOL ASSOC UK, V94, P285, DOI 10.1017/S0025315413000295; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Hajdu E, 1998, P BIOL SOC WASH, V111, P737; HARMELIN JG, 1985, TETHYS, V11, P214; Hartman W. D., 1969, Postilla, V137, P1; Hechtel G. J., 1969, Postilla, V132, P1; KOBLUK DR, 1989, B MAR SCI, V44, P1207; LABOREL J, 1986, ANN I OCEANOGR PARIS, V62, P193; Lamarck JB de, 1814, ANN MUSEUM NATL HIST, V20, P294; Lamarck JBPA de M de, 1814, ANN MUSEUM NATL HIST, P370; Lehnert Helmut, 1996, Beaufortia, V46, P53; Loh TL, 2014, P NATL ACAD SCI USA, V111, P4151, DOI 10.1073/pnas.1321626111; Madduppa H, 2015, MAR BIODIVERS; Maldonado M., 2017, MARINE ANIMAL FOREST, P145, DOI [DOI 10.1007/978-3-319-17001-5_24-1, 10.1007/978-3-319-17001-5_24-1]; MEESTERS E, 1991, CORAL REEFS, V10, P189, DOI 10.1007/BF00336773; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Perez T, 2003, ENVIRON SCI TECHNOL, V37, P2152, DOI 10.1021/es026234v; Perez T, 2002, HYDROBIOLOGIA, V489, P225, DOI 10.1023/A:1023217218585; Ruiz C, 2017, ZOOL J LINN IN PRESS; Rutzler K, 2014, ZOOTAXA, V3805, P1, DOI 10.11646/zootaxa.3805.1.1; TOFFART JL, 1983, B ECOL, V14, P227; Topcu NE, 2010, J EXP MAR BIOL ECOL, V389, P61, DOI 10.1016/j.jembe.2010.03.017; VACELET J, 1994, DEEP-SEA RES PT I, V41, P965, DOI 10.1016/0967-0637(94)90013-2; Vacelet J., 1990, GRANDE ENCY CARAIBE, P16; Vacelet J., 1998, FRUITS MER PLANTES M, P49; Vacelet J, 2000, SPONGIAIRES DEP FRAN; Van Soest R. W. M., 2001, Beaufortia, V51, P109; van Soest R.W.M., 1980, Uitgaven Natuurwetenschappelijke Studiekring voor Suriname en de Nederlandse Antillen, P1; Van Soest R.W.M, 1978, STUD FAUNA CURACAO, V56, P1; van Soest R.W.M., 1984, UITGAVEN NATUURWETEN, V66, P1; Van Soest RWM, 2014, ZOOTAXA, V3878, P401, DOI 10.11646/zootaxa.3878.5.1; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Van Soest RWM, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.68.729; Van Soest RWM, 2009, ZOOTAXA, P1; Van Soest RWM, 2016, WORLD PORIFERA DATAB; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WIEDENMAYER F, 1977, SHALLOW WATER SPONGE; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Zea S., 1987, ESPONJAS CARIBE COLO	56	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173859	10.1371/journal.pone.0173859	http://dx.doi.org/10.1371/journal.pone.0173859			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329020	gold, Green Submitted, Green Published			2022-12-27	WOS:000399094700033
J	Rentoumi, V; Peters, T; Conlin, J; Garrard, P				Rentoumi, Vassiliki; Peters, Timothy; Conlin, Jonathan; Garrard, Peter			The acute mania of King George III: A computational linguistic analysis	PLOS ONE			English	Article							BIPOLAR DISORDER; LEXICAL RICHNESS; PORPHYRIA; DIVERSITY; SCHIZOPHRENIA; IMPAIRMENT; DEMENTIA; LANGUAGE; ENTROPY; SPEECH	We used a computational linguistic approach, exploiting machine learning techniques, to examine the letters written by King George III during mentally healthy and apparently mentally ill periods of his life. The aims of the study were: first, to establish the existence of alterations in the King's written language at the onset of his first manic episode; and secondly to identify salient sources of variation contributing to the changes. Effects on language were sought in two control conditions (politically stressful vs. politically tranquil periods and seasonal variation). We found clear differences in the letter corpus, across a range of different features, in association with the onset of mental derangement, which were driven by a combination of linguistic and information theory features that appeared to be specific to the contrast between acute mania and mental stability. The paucity of existing data relevant to changes in written language in the presence of acute mania suggests that lexical, syntactic and stylometric descriptions of written discourse produced by a cohort of patients with a diagnosis of acute mania will be necessary to support the diagnosis independently and to look for other periods of mental illness of the course of the King's life, and in other historically significant figures with similarly large archives of handwritten documents.	[Rentoumi, Vassiliki; Garrard, Peter] SGUL, Mol & Clin Sci Res Inst, Neurosci Res Ctr, London, England; [Peters, Timothy] Univ Birmingham, Inst Archaeol & Antiqu, Birmingham, W Midlands, England; [Conlin, Jonathan] Univ Southampton, Sch Humanities, Southampton, Hants, England	St Georges University London; University of London; King's College London; University of Birmingham; University of Southampton	Garrard, P (corresponding author), SGUL, Mol & Clin Sci Res Inst, Neurosci Res Ctr, London, England.	pgarrard@sgul.ac.uk		Garrard, Peter/0000-0001-8268-9718	Leverhulme Trust [RPG-2012-484]	Leverhulme Trust(Leverhulme Trust)	This work was funded by a project grant (Ref RPG-2012-484) from the Leverhulme Trust (http://www.leverhu;me.ac.uk/funding/funding.cfm) to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NJC, 1976, ARCH GEN PSYCHIAT, V33, P1361; Aspinall A, 1962, LATER CORRES GEORGE, V3; Aspinall A, 1962, LATER CORRES GEORGE, V2; Aspinall A., 1962, LATER CORRES GEORGE; Aspinall A, 1962, LATER CORRES GEORGE, V5, P1808; Aspinall Anthony, 1962, LATER CORRES GEORGE, V4; Barrett SL, 2009, BRIT J PSYCHIAT, V195, P67, DOI 10.1192/bjp.bp.108.054874; Behr F, 2003, IEEE DATA COMPR CONF, P416; Black Jeremy., 2006, GEORGE 3 AM LAST KIN; Brooke J, 1972, KING GEORGE 3 CONSTA; Burrows J., 2007, Literary & Linguistic Computing, V22. no 1, P27, DOI 10.1093/llc/fqi067; Burrows J., 2002, Literary & Linguistic Computing, V17, P267, DOI 10.1093/llc/17.3.267; Campbell RS, 2003, PSYCHOL SCI, V14, P60, DOI 10.1111/1467-9280.01419; Cannon J, 2004, GEORGE 3 1738 1820; Covington MA, 2005, SCHIZOPHR RES, V77, P85, DOI 10.1016/j.schres.2005.01.016; Cox TM, 2005, LANCET, V366, P332, DOI 10.1016/S0140-6736(05)66991-7; Delashmit WH, 2002, CONF REC ASILOMAR C, P1029; DENT CE, 1968, BRIT MED J, V1, P311, DOI 10.1136/bmj.1.5587.311-b; Dobree B, 1935, LETT KING GEORGE 3 C; Duran P, 2004, APPL LINGUIST, V25, P220, DOI 10.1093/applin/25.2.220; Elvevag B, 2010, J NEUROLINGUIST, V23, P270, DOI 10.1016/j.jneuroling.2009.05.002; Engber C.A., 1995, J SECOND LANG WRIT, V4, P139, DOI [10.1016/1060-3743(95)90004-7, DOI 10.1016/1060-3743(95)90004-7]; Fjordbak BS, 2006, THESIS; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Fortescue JS, 1927, CORRES KING GEORGE 3, VI-VI; Fraser KC, 2014, CORTEX, V55, P43, DOI 10.1016/j.cortex.2012.12.006; Garrard P, 2005, BRAIN, V128, P250, DOI 10.1093/brain/awh341; Garrard P, 2014, CORTEX, V55, P122, DOI 10.1016/j.cortex.2013.05.008; Gomez PC, 2012, REV ESPANOLA LINGUIS, P51; Guttmacher MS, 1941, AM LAST KING INTERPR; Hague W., 2005, W PITT YOUNGER; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hawthorne N, 1994, MADNESS KING GEORGE; Herdan G., 1960, QUANTITATIVE LINGUIS; Leader D., 2013, STRICTLY BIPOLAR; Lu X, INT J CORPUS LINGUIS, V15, P474; Lu XF, 2012, MOD LANG J, V96, P190, DOI 10.1111/j.1540-4781.2011.01232.x; MACALPINE I, 1966, BMJ-BRIT MED J, V1, P65, DOI 10.1136/bmj.1.5479.65; MACALPINE I, 1968, BMJ-BRIT MED J, V1, P7, DOI 10.1136/bmj.1.5583.7; McCallum A., 1998, AAAI 98 WORKSHOP LEA, P41; McClure E., 1991, PRAGMATICS LANGUAGE, V2, P141; Mitchell TM, 1997, MACH LEARN, P45; Namier LB, 1937, ADDITIONS CORRECTION; Noriega L., 2005, MULTILAYER PERCEPTRO; Ortega L, 2003, APPL LINGUIST, V24, P492, DOI 10.1093/applin/24.4.492; Peters T, 2009, HIST TODAY, P59; Peters TJ, 2010, J ROY COLL PHYS EDIN, V40, P81, DOI 10.4997/JRCPE.2010.116; Peters TJ, 2010, HIST PSYCHIATR, V21, P20, DOI 10.1177/0957154X09343825; Peters TJ, 2010, HIST PSYCHIATR, V21, P3, DOI 10.1177/0957154X09102616; Radanovic M, 2008, INT PSYCHOGERIATR, V20, P687, DOI 10.1017/S1041610208007084; Salomon David, HDB DATA COMPRESSION; Shannon C. E., 1959, IRE NAT CONV REC, V4; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; THOIRON P, 1986, COMPUT HUMANITIES, V20, P197, DOI 10.1007/BF02404461; Yu G., APPL LINGUISTICS, V31, P236	57	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0171626	10.1371/journal.pone.0171626	http://dx.doi.org/10.1371/journal.pone.0171626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328964	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000399094700002
J	Yuen, AHL; Tsui, HCL; Kot, BCW				Yuen, Adams Hei Long; Tsui, Henry Chun Lok; Kot, Brian Chin Wing			Accuracy and reliability of cetacean cranial measurements using computed tomography three dimensional volume rendered images	PLOS ONE			English	Article							DELPHINUS; ANATOMY; DOLPHIN; CT	Computed tomography (CT) has become more readily available for post-mortem examination, offering an alternative to cetacean cranial measurements obtained manually. Measurement error may result in possible variation in cranial morphometric analysis. This study aimed to evaluate the accuracy and reliability of cetacean cranial measurements obtained by CT three-dimensional volume rendered images (3DVRI). CT scans of 9 stranded cetaceans were performed. The acquired images were reconstructed using bone reconstruction algorithms. The reconstructed crania obtained by 3DVRI were visualized after excluding other body structures. Accuracy of cranial measurements obtained by CT 3DVRI was evaluated by comparing with that obtained by manual approach as standard of reference. Reproducibility and repeatability of cranial measurements obtained by CT 3DVRI were evaluated using intraclass correlation coefficient (ICC). The results demonstrated that cranial measurements obtained by CT 3DVRI yielded high accuracy (88.05%-99.64%). High reproducibility (ICC ranged from 0.897 to 1.000) and repeatability (ICC ranged from 0.919 to 1.000 for operator 1 and ICC range from 0.768 to 1.000 for operator 2) were observed in cranial measurements obtained by CT 3DVRI. Therefore, cranial measurements obtained by CT 3DVRI could be considered as virtual alternative to conventional manual approach. This may help the development of a normative reference for current cranial maturity and discriminant analysis studies in cetaceans.	[Yuen, Adams Hei Long; Tsui, Henry Chun Lok; Kot, Brian Chin Wing] Tung Wah Coll, Sch Med & Hlth Sci, Kowloon, Hong Kong, Peoples R China; [Kot, Brian Chin Wing] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Kot, BCW (corresponding author), Tung Wah Coll, Sch Med & Hlth Sci, Kowloon, Hong Kong, Peoples R China.; Kot, BCW (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	briankot@yahoo.co.uk	YUEN, Adams Hei Long/X-1008-2019	YUEN, Adams Hei Long/0000-0001-9326-0247; Kot, Brian Chin Wing/0000-0002-8932-1884	Hong Kong Research Grants Council [UGC/FDS17/M07/14]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This project was financially supported by the Hong Kong Research Grants Council [Grant number: UGC/FDS17/M07/14] and received by BK.	Brough AL, 2013, J FORENSIC SCI, V58, P946, DOI 10.1111/1556-4029.12126; Cavalcanti M, 2014, DENTOMAXILLOFAC RAD, V33, P170; Chien PFW, 2001, BRIT J OBSTET GYNAEC, V108, P568, DOI 10.1111/j.1471-0528.2001.00128.x; Fatterpekar GM, 2006, RADIOGRAPHICS, V26, pS117, DOI 10.1148/rg.26si065502; Ford JM, 2016, J FORENSIC RADIOL IM, V4, P43, DOI 10.1016/j.jofri.2015.10.004; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; Grabherr S, 2009, EUR RADIOL, V19, P419, DOI 10.1007/s00330-008-1155-y; Jordan FFJ, 2015, MAR MAMMAL SCI, V31, P1077, DOI 10.1111/mms.12229; Khan KS, 2001, BRIT J OBSTET GYNAEC, V108, P562; Lauridsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017879; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lopes PML, 2008, ORAL SURG ORAL MED O, V105, P224, DOI 10.1016/j.tripleo.2007.08.036; Montie EW, 2011, J EXP BIOL, V214, P945, DOI 10.1242/jeb.051599; Murphy S, 2006, MAR MAMMAL SCI, V22, P573, DOI 10.1111/j.1748-7692.2006.00037.x; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; Rommel S., 1990, BOTTLENOSE DOLPHIN, P309; Stull KE, 2014, FORENSIC SCI INT, V238, P133, DOI 10.1016/j.forsciint.2014.03.005; Thompson KF, 2014, J ZOOL, V294, P13, DOI 10.1111/jzo.12151; van de Kamp T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102355; Wang JY, 2000, J ZOOL, V252, P147, DOI 10.1017/S0952836900009894; Whyms BJ, 2013, OR SURG OR MED OR PA, V115, P682, DOI 10.1016/j.oooo.2013.02.008; Yao CJ, 2008, ZOOL SCI, V25, P1234, DOI 10.2108/zsj.25.1234	22	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174215	10.1371/journal.pone.0174215	http://dx.doi.org/10.1371/journal.pone.0174215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329016	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700071
J	Chen, F; Zhang, Y; Daugherty, AB; Yang, ZY; Shaw, R; Dong, MX; Lutz, S; Benner, SA				Chen, Fei; Zhang, Yuan; Daugherty, Ashley B.; Yang, Zunyi; Shaw, Ryan; Dong, Mengxing; Lutz, Stefan; Benner, Steven A.			Biological phosphorylation of an Unnatural Base Pair (UBP) using a Drosophila melanogaster deoxynucleoside kinase (DmdNK) mutant	PLOS ONE			English	Article							MULTISUBSTRATE DEOXYRIBONUCLEOSIDE KINASE; EXPANDED GENETIC ALPHABET; ACTIVE-SITE MUTANTS; NUCLEOSIDE ANALOGS; STRUCTURAL BASIS; SUBSTRATE-SPECIFICITY; PCR AMPLIFICATION; REPLICATION; DNA; EFFICIENT	One research goal for unnatural base pair (UBP) is to replicate, transcribe and translate them in vivo. Accordingly, the corresponding unnatural nucleoside triphosphates must be available at sufficient concentrations within the cell. To achieve this goal, the unnatural nucleoside analogues must be phosphorylated to the corresponding nucleoside triphosphates by a cascade of three kinases. The first step is the monophosphorylation of unnatural deoxynucleoside catalyzed by deoxynucleoside kinases (dNK), which is generally considered the rate limiting step because of the high specificity of dNKs. Here, we applied a Drosophila melanogaster deoxyribonucleoside kinase (DmdNK) to the phosphorylation of an UBP (a pyrimidine analogue (6-amino-5-nitro-3-(1'-b-d-2'-deoxyribofuranosyl)-2(1H)-pyridone, Z) and its complementary purine analogue (2-amino-8-(1'-b-d-2'-deoxyribofuranosyl)imidazo[1,2-a]-1,3,5-triazin-4(8H)-one, P). The results showed that DmdNK could efficiently phosphorylate only the dP nucleoside. To improve the catalytic efficiency, a DmdNK-Q81E mutant was created based on rational design and structural analyses. This mutant could efficiently phosphorylate both dZ and dP nucleoside. Structural modeling indicated that the increased efficiency of dZ phosphorylation by the DmdNK-Q81E mutant might be related to the three additional hydrogen bonds formed between E81 and the dZ base. Overall, this study provides a groundwork for the biological phosphorylation and synthesis of unnatural base pair in vivo.	[Chen, Fei; Dong, Mengxing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Fei; Dong, Mengxing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Fei; Yang, Zunyi; Shaw, Ryan; Benner, Steven A.] Fdn Appl Mol Evolut FfAME, Alachua, FL 32615 USA; [Zhang, Yuan] Beijing Normal Univ, Coll Chem, Beijing, Peoples R China; [Daugherty, Ashley B.; Lutz, Stefan] Emory Univ, Dept Chem, Sch Med, 1515 Pierce Dr, Atlanta, GA 30322 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University; Emory University	Chen, F (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.; Chen, F (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, F; Benner, SA (corresponding author), Fdn Appl Mol Evolut FfAME, Alachua, FL 32615 USA.	chenfei@big.ac.cn; sbenner@ffame.org		chen, fei/0000-0003-3895-6318	NSF [1412869]; Defense Advanced Research Projects Agency Microsystems Technology (DSO) [CLIO: N66001-12C-4019]; ARPA [8657\00]; National Natural Science Foundation of China [31270846, 21472182]; '100-Talent Program' of the Chinese Academy of Sciences [Y3CAS81554]; Div Of Molecular and Cellular Bioscience [1412869] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Microsystems Technology (DSO); ARPA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '100-Talent Program' of the Chinese Academy of Sciences(Chinese Academy of Sciences); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is based on work supported by the NSF under Grant No. 1412869. This work was also sponsored in part by the Defense Advanced Research Projects Agency Microsystems Technology (DSO) under contract CLIO: N66001-12C-4019, ARPA Order No. 8657\00. This research was also funded by the National Natural Science Foundation of China (No. 31270846, 21472182) and the '100-Talent Program' of the Chinese Academy of Sciences (No. Y3CAS81554).; This research was funded by the National Natural Science Foundation of China (No. 21472182, 31270846) and the '100-Talent Program' of the Chinese Academy of Sciences (No. Y3CAS81554). This research was also based on work supported by the NSF under Grant No. 1412869, and the Defense Advanced Research Projects Agency Microsystems Technology (DSO) under contract CLIO: N66001-12C-4019, ARPA Order No. 8657\00.	Al-Madhoun AS, 2004, MINI-REV MED CHEM, V4, P341; Benner SA, 2011, CR CHIM, V14, P372, DOI 10.1016/j.crci.2010.06.013; Chen F, 2011, NUCLEIC ACIDS RES, V39, P3949, DOI 10.1093/nar/gkq1274; De Clercq E, 2006, BRIT J PHARMACOL, V147, P1, DOI 10.1038/sj.bjp.0706446; Egeblad-Welin L, 2007, FEBS J, V274, P1542, DOI 10.1111/j.1742-4658.2007.05701.x; Faderl S, 2008, CURR OPIN HEMATOL, V15, P101, DOI 10.1097/MOH.0b013e3282f46e94; Gerth ML, 2007, J MOL BIOL, V370, P742, DOI 10.1016/j.jmb.2007.05.021; Havemann SA, 2008, NUCLEOS NUCLEOT NUCL, V27, P261, DOI 10.1080/15257770701853679; Hirao I, 2007, J AM CHEM SOC, V129, P15549, DOI 10.1021/ja073830m; Hirao I, 2006, NAT METHODS, V3, P729, DOI 10.1038/nmeth915; Jarchow-Choy SK, 2009, J AM CHEM SOC, V131, P5488, DOI 10.1021/ja808244t; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Kimoto M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn956; Knecht W, 2002, EMBO J, V21, P1873, DOI 10.1093/emboj/21.7.1873; Knecht W, 2009, BIOCHEM BIOPH RES CO, V382, P430, DOI 10.1016/j.bbrc.2009.03.041; Li LJ, 2014, J AM CHEM SOC, V136, P826, DOI 10.1021/ja408814g; Liu LF, 2010, CHEM COMMUN, V46, P8803, DOI 10.1039/c0cc02961k; Liu LF, 2009, NUCLEIC ACIDS RES, V37, P4472, DOI 10.1093/nar/gkp400; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; Malyshev DA, 2010, CHEM-EUR J, V16, P12650, DOI 10.1002/chem.201000959; Malyshev DA, 2009, J AM CHEM SOC, V131, P14620, DOI 10.1021/ja906186f; Matsuura MF, 2016, ACS SYNTH BIOL, V5, P234, DOI 10.1021/acssynbio.5b00172; Mikkelsen NE, 2003, BIOCHEMISTRY-US, V42, P5706, DOI 10.1021/bi0340043; Mikkelsen NE, 2008, FEBS J, V275, P2151, DOI 10.1111/j.1742-4658.2008.06369.x; Munch-Petersen B, 2000, J BIOL CHEM, V275, P6673, DOI 10.1074/jbc.275.9.6673; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Sefah K, 2014, P NATL ACAD SCI USA, V111, P1449, DOI 10.1073/pnas.1311778111; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Solaroli N, 2003, EUR J BIOCHEM, V270, P2879, DOI 10.1046/j.1432-1033.2003.03666.x; Valentin-Hansen P, 1978, Methods Enzymol, V51, P308; Welin M, 2005, FEBS J, V272, P3733, DOI 10.1111/j.1742-4658.2005.04803.x; Wu YQ, 2002, J AM CHEM SOC, V124, P14626, DOI 10.1021/ja028050m; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yang ZY, 2013, ANAL CHEM, V85, P4705, DOI 10.1021/ac400422r; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n; Yang ZY, 2010, ANGEW CHEM INT EDIT, V49, P177, DOI 10.1002/anie.200905173	38	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174163	10.1371/journal.pone.0174163	http://dx.doi.org/10.1371/journal.pone.0174163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323896	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000069
J	Rudas, C; Suranyi, O; Yasseri, T; Torok, J				Rudas, Csilla; Suranyi, Oliver; Yasseri, Taha; Torok, Janos			Understanding and coping with extremism in an online collaborative environment: A data-driven modeling	PLOS ONE			English	Article								The Internet has provided us with great opportunities for large scale collaborative public good projects. Wikipedia is a predominant example of such projects where conflicts emerge and get resolved through bottom-up mechanisms leading to the emergence of the largest encyclopedia in human history. Disaccord arises whenever editors with different opinions try to produce an article reflecting a consensual view. The debates are mainly heated by editors with extreme views. Using a model of common value production, we show that the consensus can only be reached if groups with extreme views can actively take part in the discussion and if their views are also represented in the common outcome, at least temporarily. We show that banning problematic editors mostly hinders the consensus as it delays discussion and thus the whole consensus building process. To validate the model, relevant quantities are measured both in simulations and Wikipedia, which show satisfactory agreement. We also consider the role of direct communication between editors both in the model and in Wikipedia data (by analyzing the Wikipedia talkpages). While the model suggests that in certain conditions there is an optimal rate of "talking" vs "editing", it correctly predicts that in the current settings of Wikipedia, more activity in talk pages is associated with more controversy.	[Rudas, Csilla; Torok, Janos] Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary; [Suranyi, Oliver; Torok, Janos] Eotvos Lorand Univ, Inst Phys, Budapest, Hungary; [Yasseri, Taha] Univ Oxford, Oxford Internet Inst, Oxford, England; [Yasseri, Taha] Alan Turing Inst, London, England	Budapest University of Technology & Economics; Eotvos Lorand University; University of Oxford	Torok, J (corresponding author), Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary.; Torok, J (corresponding author), Eotvos Lorand Univ, Inst Phys, Budapest, Hungary.	torok@phy.bme.hu	Yasseri, Taha/AAK-9213-2021; Török, János/A-9944-2012	Yasseri, Taha/0000-0002-1800-6094; Török, János/0000-0002-4275-2396	European Union's Horizon research and innovation program [645043]; Alan Turing Institute [TU/B/000045] Funding Source: researchfish	European Union's Horizon research and innovation program; Alan Turing Institute	TY has received funding from the European Union's Horizon2020 research and innovation program under grant agreement No 645043; "HUMANE: a typology, method and roadmap for HUman-MAchine NEtworks".	Beaudouin-Lafon, 1999, COMPUTER SUPPORTED C; Ben Segal, 1995, SHORT HIST INTERNET; Borra E, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P193, DOI 10.1145/2702123.2702436; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Ciampaglia GL, 2011, LECT NOTES COMPUT SC, V6984, P269, DOI 10.1007/978-3-642-24704-0_29; DeDeo S., 2016, FUTURE INTERNET, V8; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Eide AW, 2016, HUMAN MACHINE NETWOR, P11; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Iniguez G, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0007-z; Iosub D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104880; Kittur A, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1509; Laniado D., 2011, P ICWSM, P177; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leiner BM, 2009, ACM SIGCOMM COMP COM, V39, P22, DOI 10.1145/1629607.1629613; Potthast M, 2008, LECT NOTES COMPUT SC, V4956, P663; Smets K., 2008, AAAI WORKSH WIK ART, P43; Sobkowicz P, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.2015.00017; Sumi R., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P724, DOI 10.1109/PASSAT/SocialCom.2011.47; Sumi R., 2011, P ACM WEBSCI 11 KOBL, P1; Torok J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.088701; Tsvetkova M, 2016, ARXIV160201652; Tsvetkova M, 2015, ARXIV151105324; Viegas F. B., 2007, P 40 ANN HAW INT C S, P78, DOI DOI 10.1109/HICSS.2007.511; Vuong B.-Q., 2008, MODELS AND WSDM, V2008, P171, DOI DOI 10.1145/1341531.1341556; Watts D., 2013, BRIDGE FRONTIERS ENG, V2013, P5; Wu Q., 2010, P 19 ACM INT C INF K, P1797; Yasseri T., 2014, GLOBAL WIKIPEDIA INT; Yasseri T, 2013, J STAT PHYS, V151, P414, DOI 10.1007/s10955-013-0728-6; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048386; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038869	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173561	10.1371/journal.pone.0173561	http://dx.doi.org/10.1371/journal.pone.0173561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323867	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000020
J	Skovsted, GF; Kruse, LS; Berchtold, LA; Grell, AS; Warfvinge, K; Edvinsson, L				Skovsted, Gry Freja; Kruse, Lars Schack; Berchtold, Lukas Adrian; Grell, Anne-Sofie; Warfvinge, Karin; Edvinsson, Lars			Myocardial ischemia-reperfusion enhances transcriptional expression of endothelin-1 and vasoconstrictor ETB receptors via the protein kinase MEK-ERK1/2 signaling pathway in rat	PLOS ONE			English	Article							INCREASED PLASMA-LEVEL; CORONARY SPASM; DISEASE; IMMUNOREACTIVITY; CONTRACTILE; MECHANISMS; CELLS; TONE	Background Coronary artery remodelling and vasospasm is a complication of acute myocardial ischemia and reperfusion. The underlying mechanisms are complex, but the vasoconstrictor peptide endothelin-1 is suggested to have an important role. This study aimed to determine whether the expression of endothelin-1 and its receptors are regulated in the myocardium and in coronary arteries after experimental ischemia-reperfusion. Furthermore, we evaluated whether treatment with a specific MEK1/2 inhibitor, U0126, modified the expression and function of these proteins. Methods and findings Sprague-Dawley rats were randomly divided into three groups: sham-operated, ischemiareperfusion with vehicle treatment and ischemia-reperfusion with U0126 treatment. Ischemia was induced by ligating the left anterior descending coronary artery for 30 minutes followed by reperfusion. U0126 was administered before ischemia and repeated 6 hours after start of reperfusion. The contractile properties of isolated coronary arteries to endothelin-1 and sarafotoxin 6c were evaluated using wire-myography. The gene expression of endothelin- 1 and endothelin receptors were measured using qPCR. Distribution and localization of proteins (pERK1/2, prepro-endothelin-1, endothelin-1, and endothelin ETA and ETB receptors) were analysed by Western blot and immunohistochemistry. We found that pERK1/2 was significantly augmented in the ischemic area 3 hours after ischemia-reperfusion; this correlated with increased ETB receptor and ET-1 gene expressions in ischemic myocardium and in coronary arteries. ETB receptor-mediated vasoconstriction was observed to be increased in coronary arteries 24 hours after ischemia-reperfusion. Treatment with U0126 reduced pERK1/2, expression of ET-1 and ETB receptor, and ETB receptor-mediated vasoconstriction. Conclusions These findings suggest that the MEK-ERK1/2 signaling pathway is important for regulating endothelin-1 and ETB receptors in myocardium and coronary arteries after ischemia-reperfusion in the ischemic region. Inhibition of the MEK-ERK1/2 pathway may provide a novel target for reducing ischemia-reperfusion damage in the heart.	[Skovsted, Gry Freja; Kruse, Lars Schack; Grell, Anne-Sofie; Warfvinge, Karin; Edvinsson, Lars] Univ Copenhagen, Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Berchtold, Lukas Adrian] Univ Copenhagen, Dept Biomed Sci, Cellular & Metab Res Sect, Copenhagen, Denmark; [Edvinsson, Lars] Lund Univ, Inst Clin Sci Lund, Dept Med, Lund, Sweden; [Skovsted, Gry Freja] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet & Anim Sci, Frederiksberg C, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Lund University; University of Copenhagen	Skovsted, GF (corresponding author), Univ Copenhagen, Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.; Skovsted, GF (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet & Anim Sci, Frederiksberg C, Denmark.	gryfreja@sund.ku.dk		Skovsted, Gry Freja/0000-0002-3652-8507; Edvinsson, Lars/0000-0002-1805-1346	Lundbeckfonden Grant of Excellence, DK; Swedish Research Council [5958, 20130271]; Lundbeck Foundation; Heart and Lung Foundation; Swedish Heart and Lung Foundation	Lundbeckfonden Grant of Excellence, DK; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	Funded by Lundbeckfonden Grant of Excellence, DK http://www.lundbeckfoundation.com/applications-and-deadlines/previous-grants/grants-of-excellence/lars-edvinsson and Swedish Research Council http://www.vr.se/inenglish/shortcutsareas/researchfunding.4.39ba98d215396c67f6e894c6.html (grant no 5958) Hjart-Lungfonden award number 20130271 (www.hjart-lungforiden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Trine Jensen and Flemming Holland, Department of Clinical Biochemistry, Copenhagen University Hospital, Amager Hospital, for technical assistance with serum Troponin T measurements. The work was supported by Lundbeck Foundation and the Heart and Lung Foundation, and the Swedish Heart and Lung Foundation.	Abe Y, 2000, J BIOL CHEM, V275, P8664, DOI 10.1074/jbc.275.12.8664; Adner M, 1996, BRIT J PHARMACOL, V119, P1159, DOI 10.1111/j.1476-5381.1996.tb16018.x; Bourgeois C, 1997, J CLIN ENDOCR METAB, V82; Chao HH, 2007, EUR J PHARMACOL, V573, P49, DOI 10.1016/j.ejphar.2007.06.051; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; de Beer VJ, 2010, AM J PHYSIOL-HEART C, V298, pH1976, DOI 10.1152/ajpheart.00459.2009; Doi Y, 2004, J CARDIOVASC PHARM, V44, pS207, DOI 10.1097/01.fjc.0000166235.18959.2a; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Garcia-Dorado D, 2009, CARDIOVASC RES, V83, P165, DOI 10.1093/cvr/cvp185; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goodwin AT, 1999, CARDIOVASC RES, V41, P554, DOI 10.1016/S0008-6363(98)00253-3; HARRISON VJ, 1992, BRIT J PHARMACOL, V105, P511, DOI 10.1111/j.1476-5381.1992.tb09009.x; Hatae N, 2007, MOL ENDOCRINOL, V21, P1192, DOI 10.1210/me.2006-0343; HAYNES WG, 1994, LANCET, V344, P852, DOI 10.1016/S0140-6736(94)92827-4; Honore JC, 2000, J CARDIOVASC PHAR S1, V36; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kolettis TM, 2013, CARDIOL REV, V21, P249, DOI 10.1097/CRD.0b013e318283f65a; LERMAN A, 1991, NEW ENGL J MED, V325, P997, DOI 10.1056/NEJM199110033251404; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; MacCarthy PA, 2001, J AM COLL CARDIOL, V37, P137, DOI 10.1016/S0735-1097(00)01042-1; MATSUYAMA K, 1991, AM J CARDIOL, V68, P991, DOI 10.1016/0002-9149(91)90484-3; Merkus D, 2005, AM J PHYSIOL-HEART C, V288, pH871, DOI 10.1152/ajpheart.00429.2004; Miyamoto Y, 1996, BIOCH J 3, V313; Nambi P, 1996, J PHARMACOL EXP THER, V277, P1567; OMLAND T, 1994, CIRCULATION, V89, P1573, DOI 10.1161/01.CIR.89.4.1573; Opgaard OS, 2001, MOL CELL BIOCHEM, V224, P151, DOI 10.1023/A:1011952504093; OPGAARD OS, 1994, J CARDIOVASC PHARM, V23, P576, DOI 10.1097/00005344-199404000-00009; Pieske B, 1999, CIRCULATION, V99, P1802, DOI 10.1161/01.CIR.99.14.1802; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Quehenberger P, 2002, CIRC RES, V90, P711, DOI 10.1161/01.RES.0000014226.74709.90; Skovsted GF, 2014, BRIT J PHARMACOL; Skovsted GF, 2012, LIFE SCI; STEWART DJ, 1991, J AM COLL CARDIOL, V18, P38, DOI 10.1016/S0735-1097(10)80214-1; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V191, P823, DOI 10.1006/bbrc.1993.1291; Takamura M, 2000, J APPL PHYSIOL, V89, P2041, DOI 10.1152/jappl.2000.89.5.2041; Takanashi M, 2004, J CARDIOVASC PHARM, V44, pS268, DOI 10.1097/01.fjc.0000166282.01034.8f; TOYOOKA T, 1991, CIRCULATION, V83, P476, DOI 10.1161/01.CIR.83.2.476; Wackenfors A, 2004, EUR J PHARMACOL, V484, P103, DOI 10.1016/j.ejphar.2003.11.001; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; WEI CM, 1994, CIRCULATION, V89, P1580, DOI 10.1161/01.CIR.89.4.1580; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang YF, 1998, BRIT J CANCER, V78; Zhao ZQ, 2000, J SURG RES, V94, P133, DOI 10.1006/jsre.2000.6029	44	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174119	10.1371/journal.pone.0174119	http://dx.doi.org/10.1371/journal.pone.0174119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323857	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000065
J	Chen, FG; Xie, F; Yang, BL; Wang, CC; Liu, SG; Zhang, YL				Chen, Fuguang; Xie, Fang; Yang, Baoling; Wang, Chengcheng; Liu, Siguo; Zhang, Yueling			Streptococcus suis sortase A is Ca2+ independent and is inhibited by acteoside, isoquercitrin and baicalin	PLOS ONE			English	Article							SORTING SIGNAL; TRANSPEPTIDASE; PATHOGENESIS; PROTEINS; BINDING; EVASION; TARGET; AGENTS; SRTA	Sortase A (SrtA) has long been recognized as an ideal drug target for therapeutic agents against Gram-positive pathogens. However, the SrtA of Streptococcus suis (Ss-SrtA), an important zoonotic agent, has not been studied. In this study, the enzymatic properties of Ss-SrtA were investigated, and inhibition of Ss-SrtA by natural products was evaluated. SsSrtA was expressed and purified. The purified recombinant Ss-SrtA had maximal activity at pH 6.0-7.5, 45 degrees C, and showed a Km of 6.7 mu M for the hydrolysis of substrate abz-LPATGdnp. Different from Staphylococcus aureus SrtA (Sa-SrtA) which is stimulated by Ca2+, SsSrtA was observed to be Ca2+ independent. Structural analysis showed that salt bridges formed between K111 and D180 in Ss-SrtA replaced the function of Ca2+ in Sa-SrtA to stabilize the substrate-binding cleft. Site-directed mutagenesis identified H126, C192 and R200 as the key residues of Ss-SrtA active site. To discover potential inhibitors, the percent inhibition of sortase activity by natural products was measured. Among these selected natural products, acteoside, isoquercitrin and baicalin were discovered as novel SrtA inhibitors, with IC50 values of 36.3 +/- 1.3 mu M, 100.0 +/- 1.3 mu M and 85.4 +/- 1.5 mu M, respectively. The inhibitory effects of these three natural products were further confirmed on endogenous Sa-SrtA. Using a previously established S. aureus model with a fluorescent-labeled Sa-SrtA substrate, acteoside, isoquercitrin, and baicalin showed 86%, 28% and 45% inhibition on endogenous Sa-SrtA activity, respectively. Overall, these findings shed new light on enzymatic properties, Ca2+-independent catalytic mechanism and potential inhibitors of Ss-SrtA.	[Chen, Fuguang; Xie, Fang; Liu, Siguo; Zhang, Yueling] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Yang, Baoling] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang, Peoples R China; [Wang, Chengcheng] Northeast Agr Univ, Coll Vet Med, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Shenyang Agricultural University; Northeast Agricultural University - China	Liu, SG; Zhang, YL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	siguo_liu@hvri.ac.cn; zhangyueling@caas.cn		Xie, Fang/0000-0003-2041-2208; Zhang, Yueling/0000-0002-5619-8410	National Nature Science Foundation of China [31602094, 31500112]; Natural Science Foundation of Heilongjiang Province of China [QC2016044]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This work supported by 1) National Nature Science Foundation of China (No. 31602094); 2) National Natural Science Foundation of China (No. 31500112); and 3) Natural Science Foundation of Heilongjiang Province of China (QC2016044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cascioferro S, 2015, J MED CHEM, V58, P9108, DOI 10.1021/acs.jmedchem.5b00779; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Cascioferro S, 2014, FUTURE MICROBIOL, V9, P1209, DOI [10.2217/FMB.14.56, 10.2217/fmb.14.56]; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chen FG, 2014, FEMS MICROBIOL LETT, V351, P95, DOI 10.1111/1574-6968.12354; de Buhr N, 2014, MICROBIOL-SGM, V160, P385, DOI 10.1099/mic.0.072199-0; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Gurung M, 2015, J CLIN MICROBIOL, V53, P2332, DOI 10.1128/JCM.00123-15; Hu P, 2013, APPL BIOCHEM BIOTECH, V171, P396, DOI 10.1007/s12010-013-0378-9; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kang SS, 2006, BIOL PHARM BULL, V29, P1751, DOI 10.1248/bpb.29.1751; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu P, 2014, J INFECT DIS, V210, P35, DOI 10.1093/infdis/jiu050; Manaskova SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147401; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; Park BS, 2005, J AGR FOOD CHEM, V53, P9005, DOI 10.1021/jf051765z; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Segura M, 2015, EXPERT REV VACCINES, V14, P1587, DOI 10.1586/14760584.2015.1101349; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Wang CJ, 2009, ARCH MICROBIOL, V191, P23, DOI 10.1007/s00203-008-0425-z; Zhang J, 2014, P NATL ACAD SCI USA, V111, P13517, DOI 10.1073/pnas.1408601111; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	32	10	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173767	10.1371/journal.pone.0173767	http://dx.doi.org/10.1371/journal.pone.0173767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319184	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800029
J	Ciller, C; De Zanet, S; Kamnitsas, K; Maeder, P; Glocker, B; Munier, FL; Rueckert, D; Thiran, JP; Cuadra, MB; Sznitman, R				Ciller, Carlos; De Zanet, Sandro; Kamnitsas, Konstantinos; Maeder, Philippe; Glocker, Ben; Munier, Francis L.; Rueckert, Daniel; Thiran, Jean-Philippe; Cuadra, Meritxell Bach; Sznitman, Raphael			Multi-channel MRI segmentation of eye structures and tumors using patient-specific features	PLOS ONE			English	Article							INTRAOCULAR TUMORS; SHAPE MODELS; RETINOBLASTOMA; DIAGNOSIS; THERAPY; BRAIN	Retinoblastoma and uveal melanoma are fast spreading eye tumors usually diagnosed by using 2D Fundus Image Photography (Fundus) and 2D Ultrasound (US). Diagnosis and treatment planning of such diseases often require additional complementary imaging to confirm the tumor extend via 3D Magnetic Resonance Imaging (MRI). In this context, having automatic segmentations to estimate the size and the distribution of the pathological tissue would be advantageous towards tumor characterization. Until now, the alternative has been the manual delineation of eye structures, a rather time consuming and error-prone task, to be conducted in multiple MRI sequences simultaneously. This situation, and the lack of tools for accurate eye MRI analysis, reduces the interest in MRI beyond the qualitative evaluation of the optic nerve invasion and the confirmation of recurrent malignancies below calcified tumors. In this manuscript, we propose a new framework for the automatic segmentation of eye structures and ocular tumors in multi-sequence MRI. Our key contribution is the introduction of a pathological eye model from which Eye Patient-Specific Features (EPSF)can be computed. These features combine intensity and shape information of pathological tissue while embedded in healthy structures of the eye. We assess our work on a dataset of pathological patient eyes by computing the Dice Similarity Coefficient (DSC) of the sclera, the cornea, the vitreous humor, the lens and the tumor. In addition, we quantitatively show the superior performance of our pathological eye model as compared to the segmentation obtained by using a healthy model (over 4% DSC) and demonstrate the relevance of our EPSF, which improve the final segmentation regardless of the classifier employed.	[Ciller, Carlos; Maeder, Philippe; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Univ Lausanne, CIBM, Radiol Dept, Lausanne, Switzerland; [Ciller, Carlos; Maeder, Philippe; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Univ Hosp, Lausanne, Switzerland; [Ciller, Carlos; De Zanet, Sandro; Sznitman, Raphael] Univ Bern, ARTORG Ctr, Ophthalm Technol Grp, Bern, Switzerland; [Kamnitsas, Konstantinos; Glocker, Ben; Rueckert, Daniel] Imperial Coll London, Biomed Image Anal Grp, London, England; [Munier, Francis L.] Jules Gonin Eye Hosp, Unit Pediat Ocular Oncol, Lausanne, Switzerland; [Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Ecole Polytech Fed Lausanne, Signal Proc Lab, Lausanne, Switzerland; [Ciller, Carlos] CIBM, CHUV, Rue Bugnon 46, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; Imperial College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ciller, C (corresponding author), Univ Lausanne, CIBM, Radiol Dept, Lausanne, Switzerland.; Ciller, C (corresponding author), Univ Hosp, Lausanne, Switzerland.; Ciller, C (corresponding author), Univ Bern, ARTORG Ctr, Ophthalm Technol Grp, Bern, Switzerland.; Ciller, C (corresponding author), CIBM, CHUV, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	carlos.cillerruiz@unil.ch		Bach Cuadra, Meritxell/0000-0003-2730-4285	Swiss Cancer League [KFS-2937-02-2012]; Doc.Mobility grant from the Swiss National Science Foundation (SNF) [P1LAP3-161995]; Hasler Stiftung [15041]; Centre d'Imagerie BioMedcale (CIBM) of the University of Lausanne (UNIL); Ecole Polytechnique Federale de Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); University of Bern (UniBe); Leenaards Foundation; Jeantet Foundation	Swiss Cancer League; Doc.Mobility grant from the Swiss National Science Foundation (SNF); Hasler Stiftung; Centre d'Imagerie BioMedcale (CIBM) of the University of Lausanne (UNIL); Ecole Polytechnique Federale de Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); University of Bern (UniBe); Leenaards Foundation; Jeantet Foundation	This work is supported by a grant from the Swiss Cancer League (KFS-2937-02-2012). This work is supported by a Doc.Mobility grant from the Swiss National Science Foundation (SNF) with number P1LAP3-161995. This work is supported by a grant from the Hasler Stiftung (15041 ). This work is also supported by the Centre d'Imagerie BioMedcale (CIBM) of the University of Lausanne (UNIL), the Ecole Polytechnique Federale de Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG), the University of Bern (UniBe) and the Leenaards and the Jeantet Foundations.; This work is also supported by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Ecole Polytechnique Federale de Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards and the Jeantet Foundations. This work is also supported by Swiss Cancer League (KFS-2937-02-2012), Hasler Stiftung (15041) and Doc.Mobility (P1LAP3-161995) from the Swiss National Science Foundation (SNF)	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Balmer A, 2006, ONCOGENE, V25, P5341, DOI 10.1038/sj.onc.1209622; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Beenakker JWM, 2013, NMR BIOMED, V26, P1864, DOI 10.1002/nbm.3041; Beenakker JWM, 2016, MAGN RESON MATER PHY, V29, P571, DOI 10.1007/s10334-016-0529-4; Beenakker JWM, 2015, INVEST OPHTH VIS SCI, V56, P1033, DOI 10.1167/iovs.14-15161; Ben Salah M, 2013, LECT NOTES COMPUT SC, V8033, P30, DOI 10.1007/978-3-642-41914-0_4; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Ciller C, 2015, INT J RADIAT ONCOL, V92, P794, DOI 10.1016/j.ijrobp.2015.02.056; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; de Graaf P, 2012, AM J NEURORADIOL, V33, P110, DOI 10.3174/ajnr.A2729; de Graaf P, 2012, PEDIATR RADIOL, V42, P2, DOI 10.1007/s00247-011-2201-5; de Jong MC, 2015, SURV OPHTHALMOL, V60, P346, DOI 10.1016/j.survophthal.2015.01.002; De Zanet SI, 2015, IEEE T BIO-MED ENG, V62, P532, DOI 10.1109/TBME.2014.2359676; Dobler B, 2002, PHYS MED BIOL, V47, P593, DOI 10.1088/0031-9155/47/4/304; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Harati V, 2011, COMPUT BIOL MED, V41, P483, DOI 10.1016/j.compbiomed.2011.04.010; Ioffe S, 2015, ARXIV 1502 03167, V32, P448; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kohli P, 2007, IEEE T PATTERN ANAL, V29, P2079, DOI 10.1109/TPAMI.2007.1128; Lucchi A, 2012, IEEE T MED IMAGING, V31, P474, DOI 10.1109/TMI.2011.2171705; Makropoulos A, 2014, IEEE T MED IMAGING, V33, P1818, DOI 10.1109/TMI.2014.2322280; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Munier FL, 2008, CLIN EXP OPHTHALMOL, V36, P78, DOI 10.1111/j.1442-9071.2007.01602.x; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Ruegsegger MB, 2012, INT J RADIAT ONCOL, V84, pE541, DOI 10.1016/j.ijrobp.2012.05.040; Srivastava N, 2014, J MACH LEARN RES, V15, P1929	28	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173900	10.1371/journal.pone.0173900	http://dx.doi.org/10.1371/journal.pone.0173900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350816	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174400009
J	Martin, EB; Williams, A; Wooliver, C; Heidel, RE; Adams, S; Dunlap, J; Ramirez-Alvarado, M; Blancas-Mejia, LM; Lands, RH; Kennel, SJ; Wall, JS				Martin, Emily B.; Williams, Angela; Wooliver, Craig; Heidel, R. Eric; Adams, Sarah; Dunlap, John; Ramirez-Alvarado, Marina; Blancas-Mejia, Luis M.; Lands, Ronald H.; Kennel, Stephen J.; Wall, Jonathan S.			Differential recruitment efficacy of patient derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity	PLOS ONE			English	Article							BENCE-JONES PROTEINS; THERMAL-STABILITY; MULTIPLE-MYELOMA; VARIABLE DOMAINS; PEPTIDE P5; SERUM; ANTIBODIES; DEPOSITS; DISEASE; IMMUNOGLOBULINS	Background Monoclonal free light chain (LC) proteins are present in the circulation of patients with immunoproliferative disorders such as light chain (AL) amyloidosis and multiple myeloma (MM). Light chain-associated amyloid is a complex pathology composed of proteinaceous fibrils and extracellular matrix proteins found in all patients with AL and in-10-30% of patients who presented with MM. Amyloid deposits systemically in multiple organs and tissues leading to dysfunction and ultimately death. The overall survival of patients with amyloidosis is worse than for those with early stage MM. Methods and findings We have developed a sensitive binding assay quantifying the recruitment of full length, patient-derived LC proteins by synthetic amyloid fibrils, as a method for studying their amyloidogenic potential. In a survey of eight urinary LC, both AL and MM-associated proteins were recruited by synthetic amyloid fibrils; however, AL-associated LC bound significantly more efficiently (p < 0.05) than did MM LCs. The LC proteins used in this study were isolated from urine and presumed to represent a surrogate of serum free light chains. Conclusion The binding of LC to synthetic fibrils in this assay accurately differentiated LC with amyloidogenic propensity from MM LC that were not associated with clinical amyloid disease. Notably, the LC from a MM patient who subsequently developed amyloid behaved as an AL-associated protein in the assay, indicating the possibility for identifying MM patients at risk for developing amyloidosis based on the light chain recruitment efficacy. With this information, at risk patients can be monitored more closely for the development of amyloidosis, allowing timely administration of novel, amyloid-directed immunotherapies this approach may improve the prognosis for these patients.	[Martin, Emily B.; Williams, Angela; Wooliver, Craig; Lands, Ronald H.; Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Med Ctr, Dept Med, Knoxville, TN 37996 USA; [Heidel, R. Eric; Adams, Sarah] Univ Tennessee, Med Ctr, Dept Surg, Knoxville, TN 37920 USA; [Dunlap, John] Univ Tennessee, Microscopy Facil, Knoxville, TN USA; [Ramirez-Alvarado, Marina; Blancas-Mejia, Luis M.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Ramirez-Alvarado, Marina; Blancas-Mejia, Luis M.] Mayo Clin, Immunol, Rochester, MN USA; [Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Med Ctr, Dept Radiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center	Wall, JS (corresponding author), Univ Tennessee, Med Ctr, Dept Med, Knoxville, TN 37996 USA.; Wall, JS (corresponding author), Univ Tennessee, Med Ctr, Dept Radiol, Knoxville, TN 37996 USA.	jwall@utmck.edu	Heidel, Robert Eric/GSE-4942-2022	Heidel, Robert Eric/0000-0002-1518-8072; Wall, Jonathan/0000-0002-5516-8578; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Martin, Emily/0000-0003-4993-5782	National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) [R01DK079984]; National Institute of General Medical Sciences (MR-A) [R01GM071514]; University of TN MC, Department of Medicine; Mayo Foundation	National Institute of Diabetes and Digestive Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences (MR-A); University of TN MC, Department of Medicine; Mayo Foundation	This work was supported in part by PHS grants R01DK079984 (JSW) from the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), and R01GM071514 from the National Institute of General Medical Sciences (MR-A) as well as funds from the University of TN MC, Department of Medicine and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2016, NATURE, V531, P294, DOI 10.1038/531294a; ABE M, 1993, AM J CLIN PATHOL, V100, P67, DOI 10.1093/ajcp/100.1.67; Blancas-Mejia LM, 2016, BIOCHEMISTRY-US, V55, P2967, DOI 10.1021/acs.biochem.6b00090; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Comenzo RL, 2014, J CLIN ONCOL, V32, P2679, DOI 10.1200/JCO.2014.56.2892; del Pozo-Yauner L, 2014, BIOCHEM BIOPH RES CO, V443, P495, DOI 10.1016/j.bbrc.2013.11.123; Dhodapkar MV, 1997, HEMATOL ONCOL CLIN N, V11, P89, DOI 10.1016/S0889-8588(05)70417-2; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dispenzieri A, 2010, LANCET, V375, P1721, DOI 10.1016/S0140-6736(10)60482-5; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; EULITZ M, 1991, J IMMUNOL, V146, P3091; FRANGIONE B, 1983, J IMMUNOL, V131, P2490; Gertz MA, 2016, J CLIN ONCOL, V34, P1097, DOI 10.1200/JCO.2015.63.6530; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Helms LR, 1996, J MOL BIOL, V257, P77, DOI 10.1006/jmbi.1996.0148; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Jelinek T, 2016, CRIT REV ONCOL HEMAT, V99, P249, DOI 10.1016/j.critrevonc.2016.01.004; Kaplan B, 2001, AMYLOID, V8, P22, DOI 10.3109/13506120108993811; Khurana R, 2003, AMYLOID, V10, P97, DOI 10.3109/13506120309041731; Kim YS, 2002, J BIOL CHEM, V277, P27240, DOI 10.1074/jbc.M202492200; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Langer A., 2015, BLOOD, V126, P188; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Marin-Argany M, 2015, PROTEIN SCI, V24, P1829, DOI 10.1002/pro.2790; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; Martin EB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22695; Martin EB, 2013, BIOCHEM BIOPH RES CO, V436, P85, DOI 10.1016/j.bbrc.2013.05.063; McWilliams-Koeppen HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137716; Merlini G, 2014, EXPERT REV HEMATOL, V7, P143, DOI 10.1586/17474086.2014.858594; Merlini G, 2012, HEMATOL-AM SOC HEMAT, P595, DOI 10.1182/asheducation-2012.1.595; Murphy CL, 2006, METHOD ENZYMOL, V412, P48, DOI 10.1016/S0076-6879(06)12004-2; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P1240, DOI 10.1021/bi0616605; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; Rajkumar SV, 2013, AM J HEMATOL, V88, P225, DOI 10.1002/ajh.23390; Ramirez-Alvarado M, 2012, CURR TOP MED CHEM, V12, P2523; Richards DB, 2015, NEW ENGL J MED, V373, P1106, DOI 10.1056/NEJMoa1504942; Rios-Tamayo R, 2015, CANCER EPIDEMIOL, V39, P693, DOI 10.1016/j.canep.2015.08.002; Rocken C, 2006, J PATHOL, V210, P478, DOI 10.1002/path.2076; Sharma N, 2013, CURR OPIN CARDIOL, V28, P242, DOI 10.1097/HCO.0b013e32835dd165; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Solomon A, 1998, P NATL ACAD SCI USA, V95, P9547, DOI 10.1073/pnas.95.16.9547; Solomon A, 1995, AMYLOID, V2, P269, DOI 10.3109/13506129508999010; SOLOMON A, 1982, J CLIN INVEST, V70, P453, DOI 10.1172/JCI110635; SOLOMON A, 1994, J IMMUNOL, V153, P1658; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; STEVENS FJ, 1981, J MOL BIOL, V147, P185, DOI 10.1016/0022-2836(81)90086-3; Stevens FJ, 1999, ANTIBODIES, V5, P175; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; Tjernberg LO, 2016, J INTERN MED; Usnarska-Zubkiewicz L, 2014, ADV CLIN EXP MED, V23, P531, DOI 10.17219/acem/23169; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052686; Wall JS, 2010, BLOOD, V116, P2241, DOI 10.1182/blood-2010-03-273797; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wechalekar AD, 2015, LANCET; Weiss BM, 2014, J CLIN ONCOL, V32, P2699, DOI 10.1200/JCO.2013.50.0892; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030	68	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174152	10.1371/journal.pone.0174152	http://dx.doi.org/10.1371/journal.pone.0174152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350808	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174400018
J	Vidovic, MMC; Kloft, M; Muller, KR; Gornitz, N				Vidovic, Marina M. -C.; Kloft, Marius; Mueller, Klaus-Robert; Goernitz, Nico			ML2Motif-Reliable extraction of discriminative sequence motifs from learning machines	PLOS ONE			English	Article							DNA; VECTORS; MODES; RNA	High prediction accuracies are not the only objective to consider when solving problems using machine learning. Instead, particular scientific applications require some explanation of the learned prediction function. For computational biology, positional oligomer importance matrices (POIMs) have been successfully applied to explain the decision of support vector machines (SVMs) using weighted-degree (WD) kernels. To extract relevant biological motifs from POIMs, the motifPOIM method has been devised and showed promising results on real-world data. Our contribution in this paper is twofold: as an extension to POIMs, we propose gPOIM, a general measure of feature importance for arbitrary learning machines and feature sets (including, but not limited to, SVMs and CNNs) and devise a sampling strategy for efficient computation. As a second contribution, we derive a convex formulation of motif-POIMs that leads to more reliable motif extraction from gPOIMs. Empirical evaluations confirm the usefulness of our approach on artificially generated data as well as on real-world datasets.	[Vidovic, Marina M. -C.; Mueller, Klaus-Robert; Goernitz, Nico] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany; [Kloft, Marius] Humboldt Univ, Dept Comp Sci, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea	Technical University of Berlin; Humboldt University of Berlin; Korea University	Vidovic, MMC; Muller, KR; Gornitz, N (corresponding author), Tech Univ Berlin, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea.	marina.vidovic@tu-berlin.de; klaus-robert.mueller@tu-berlin.de; nico.goernitz@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Hohne, Marina/0000-0003-3090-6279	BMBF ALICE II [01IB15001B]; German Research Foundation [DFG KL2698/2-1, MU 987/6-1, RA 1894/1-1]; National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program; German Ministry for Education and Research [031L0023A, 031B0187B]; Berlin Big Data Center BBDC [01IS14013A]	BMBF ALICE II(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Berlin Big Data Center BBDC	MMCV and NG were supported by BMBF ALICE II grant 01IB15001B. We also acknowledge the support by the German Research Foundation through the grant DFG KL2698/2-1, MU 987/6-1, and RA 1894/1-1. KRM thanks for partial funding by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology in the BK21 program. MK and KRM were supported by the German Ministry for Education and Research through the awards 031L0023A and 031B0187B and the Berlin Big Data Center BBDC (01IS14013A).; We thank Raphael Pelessof for stimulating discussions. MMCV and NG were supported by BMBF ALICE II grant 01IB15001B. We also acknowledge the support by the German Research Foundation through the grant DFG KL2698/2-1, MU 987/6-1, and RA 1894/1-1. KRM thanks for partial funding by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology in the BK21 program. MK and KRM were supported by the German Ministry for Education and Research through the awards 031L0023A and 031B0187B and the Berlin Big Data Center BBDC (01IS14013A).	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Azar A. T., 2015, CHAOS MODELING CONTR; Bach S., 2015, PLOS ONE, V10; Baehrens D, 2010, J MACH LEARN RES, V11, P1803; Bailey TL, 2015, NOBLE WS; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bishop C.M., 2006, MACH LEARN, V128; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Bessa IV, 2016, RENEW ENERG, V87, P634, DOI 10.1016/j.renene.2015.10.061; Gornitz N, 2014, P 17 INT C ART INT S, V33; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Mathelier A., 2015, NUCL ACIDS RES; Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nasir JA, 2014, COLING; Nico G, 2015, P 32 INT C MACH LEAR; Porbadnigk AK, 2015, NEUROIMAGE, V120, P225, DOI 10.1016/j.neuroimage.2015.05.078; Rao C. R., 2013, HDB STAT MACHINE LEA, V31; Ratsch G, 2007, PLOS COMPUTATIONAL B, V3; Sandelin Albin, 2003, Functional & Integrative Genomics, V3, P125, DOI 10.1007/s10142-003-0086-6; Schutt KT, 2016, ARXIV160908259; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Sonnenburg Soren, 2010, ICML; Vidovic MMC, 2016, IEEE T NEUR SYS REH, V24, P961, DOI 10.1109/TNSRE.2015.2492619; Vidovic MM, 2015, PLOS ONE, P1; Vidovic MMC, 2015, ECML PKDD, V6913, P175; Zien A, 2009, FEATURE IMPORTANCE R, P1	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174392	10.1371/journal.pone.0174392	http://dx.doi.org/10.1371/journal.pone.0174392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346487	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300043
J	Lee, J; Choi, HL				Lee, Joonhee; Choi, Hong L.			The dynamics of nitrogen derived from a chemical nitrogen fertilizer with treated swine slurry in paddy soil-plant systems	PLOS ONE			English	Article							LONG-TERM APPLICATION; NITRIFICATION-DENITRIFICATION; AMMONIA VOLATILIZATION; ORGANIC-CARBON; RICE; MANURE; MINERALIZATION; RHIZOSPHERE; UPLAND; ACCUMULATION	A well-managed chemical nitrogen (N) fertilization practice combined with treated swine slurry (TSS) is necessary to improve sustainability and N use efficiency in rice farming. However, little is known about the fate of N derived from chemical N fertilizer with and without TSS in paddy soil-plant systems. The objectives of this study were (1) to estimate the contribution of applied N fertilizer to N turnover in rice paddy soil with different N fertilization practices that were manipulated by the quantity of treated swine slurry and chemical N fertilizer (i.e., HTSS+LAS, a high amount of TSS with a low amount of ammonium sulfate; LTSS+HAS, a low amount of TSS with a high amount of ammonium sulfate; AS, ammonium sulfate with phosphorus and potassium; C, the control) and (2) to compare the rice response to applied N derived from each N fertilization practice. Rice biomass yield, (15) N recovery in both rice grain and stems, soil total N (TN), soil inorganic N, and soil (15) N recovery were analyzed. Similar amounts of (15) N uptake by rice in the TSS+AS plots were obtained, indicating that the effects of the different quantities of TSS on chemical fertilizer N recovery in rice during the experimental period were not significant. The soil (15) N recoveries of HTSS+LAS, LTSS+HAS, and AS in each soil layer were not significantly different. For the HTSS+LAS, LTSS+HAS and AS applications, total (15) N recoveries were 42%, 43% and 54%, respectively. Because the effects of reducing the use of chemical N fertilizer were attributed to enhancing soil quality and cost-effectiveness, HTSS+LAS could be an appropriate N fertilization practice for improving the long-term sustainability of paddy soil-plant systems. However, N losses, especially through the coupled nitrification-denitrification process, can diminish the benefits that HTSS+LAS offers.	[Lee, Joonhee; Choi, Hong L.] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Choi, Hong L.] Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU)	Choi, HL (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Choi, HL (corresponding author), Res Inst Agr & Life Sci, Seoul, South Korea.	ulsoo8@snu.ac.kr			Korea Environmental Industry & Technology Institute (KEITI) [2013001470005]	Korea Environmental Industry & Technology Institute (KEITI)(Korea Environmental Industry & Technology Institute (KEITI))	This study was funded by project (no. 2013001470005) from the Korea Environmental Industry & Technology Institute (KEITI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by project (no. 2013001470005) from the Korea Environmental Industry & Technology Institute (KEITI). The authors thank Andi Febrisiantosa for his assistance in field during this study.	AKUNNA J, 1994, WATER SCI TECHNOL, V30, P297, DOI 10.2166/wst.1994.0629; Amon B, 2006, AGR ECOSYST ENVIRON, V112, P153, DOI 10.1016/j.agee.2005.08.030; Arth I, 2000, BIOL FERT SOILS, V31, P427, DOI 10.1007/s003749900190; Aulakh MS, 2000, BIOL FERT SOILS, V31, P162, DOI 10.1007/s003740050640; BEEGLE DB, 1994, J SOIL WATER CONSERV, V49, P23; BERNAL MP, 1992, BIOL FERT SOILS, V13, P135; Bernet N, 2000, WATER RES, V34, P611, DOI 10.1016/S0043-1354(99)00170-0; Chen DJ, 2013, BIOL FERT SOILS, V49, P647, DOI 10.1007/s00374-012-0752-8; Choi WJ, 2003, SOIL BIOL BIOCHEM, V35, P483, DOI 10.1016/S0038-0717(02)00299-7; Cox MS, 2001, SOIL SCI, V166, P484, DOI 10.1097/00010694-200107000-00006; Curtis CJ, 2005, J APPL ECOL, V42, P507, DOI 10.1111/j.1365-2664.2005.01029.x; Gu JF, 2015, CROP J, V3, P285, DOI 10.1016/j.cj.2015.03.007; JENKINSON DS, 1985, J SOIL SCI, V36, P425, DOI 10.1111/j.1365-2389.1985.tb00348.x; JENSEN K, 1993, APPL ENVIRON MICROB, V59, P3287, DOI 10.1128/AEM.59.10.3287-3296.1993; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; Lee C, 2014, J ENVIRON QUAL, V43, P398, DOI 10.2134/jeq2013.03.0083; Li ZP, 2010, SOIL TILL RES, V106, P268, DOI 10.1016/j.still.2009.12.008; Lim SS, 2015, BIOL FERT SOILS, V51, P231, DOI 10.1007/s00374-014-0967-y; Liu MQ, 2009, APPL SOIL ECOL, V42, P166, DOI 10.1016/j.apsoil.2009.03.006; Liu M, 2011, AGR SCI CHINA, V10, P259, DOI 10.1016/S1671-2927(11)60003-5; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mohanty S, 2013, EUR J SOIL BIOL, V58, P113, DOI 10.1016/j.ejsobi.2013.07.004; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Penton CR, 2013, SOIL BIOL BIOCHEM, V57, P362, DOI 10.1016/j.soilbio.2012.10.018; Powell JM, 2005, AGRON J, V97, P333, DOI 10.2134/agronj2005.0333; RAO ACS, 1991, SOIL SCI SOC AM J, V55, P1616, DOI 10.2136/sssaj1991.03615995005500060019x; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Revsbech NP, 1999, BIOL FERT SOILS, V29, P379, DOI 10.1007/s003740050568; Saleque MA, 2004, FIELD CROP RES, V86, P53, DOI 10.1016/S0378-4290(03)00119-9; SCHNIER HF, 1987, BIOL FERT SOILS, V4, P171, DOI 10.1007/BF00270937; Song YJ, 2012, PLANT PROD SCI, V15, P253, DOI 10.1626/pps.15.253; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Wagner WC, 1999, INT J PARASITOL, V29, P1, DOI 10.1016/S0020-7519(98)00173-8; Zhang QX, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-37; Zhao X, 2009, PLANT SOIL, V319, P225, DOI 10.1007/s11104-008-9865-0	37	2	3	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174747	10.1371/journal.pone.0174747	http://dx.doi.org/10.1371/journal.pone.0174747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339491	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700038
J	Neganova, AY; Postnov, DD; Sosnovtseva, O; Jacobsen, JCB				Neganova, Anastasiia Y.; Postnov, Dmitry D.; Sosnovtseva, Olga; Jacobsen, Jens Christian B.			Rat retinal vasomotion assessed by laser speckle imaging	PLOS ONE			English	Article							BLOOD-FLOW; ARTERIOLES; DIAMETER; OSCILLATIONS	Vasomotion is spontaneous or induced rhythmic changes in vascular tone or vessel diameter that lead to rhythmic changes in flow. While the vascular research community debates the physiological and pathophysiological consequence of vasomotion, there is a great need for experimental techniques that can address the role and dynamical properties of vasomotion in vivo. We apply laser speckle imaging to study spontaneous and drug induced vasomotion in retinal network of anesthetized rats. The results reveal a wide variety of dynamical patterns. Wavelet-based analysis shows that (i) spontaneous vasomotion occurs in anesthetized animals and (ii) vasomotion can be initiated by systemic administration of the thromboxane analogue U-46619 and the nitric-oxide donor S-nitroso-acetylDL-penicillamine (SNAP). Although these drugs activate different cellular pathways responsible for vasomotion, our approach can track the dynamical changes they cause.	[Neganova, Anastasiia Y.; Postnov, Dmitry D.; Sosnovtseva, Olga; Jacobsen, Jens Christian B.] Univ Copenhagen, Dept Biomed Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Neganova, AY (corresponding author), Univ Copenhagen, Dept Biomed Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	anastasiia@sund.ku.dk	Sosnovtseva, Olga/H-5115-2016	Sosnovtseva, Olga/0000-0001-7334-9869; Postnov, Dmitry D/0000-0002-9708-8453	European Commission [316990]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was made possible by a Marie Curie grant from the European Commission in the framework of the Retinal Vascular Modeling, Measurement and Diagnosis Initial Training Research Network, Project number 316990, http:// cordis europa euiprojectircn/105459_en html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; Addison P. S., 2002, ILLUSTRATED WAVELET; Basak K, 2012, MED BIOL ENG COMPUT, V50, P547, DOI 10.1007/s11517-012-0902-z; Bek T, 1999, ACTA OPHTHALMOL SCAN, V77, P376, DOI 10.1034/j.1600-0420.1999.770402.x; Bek T, 2013, INVEST OPHTH VIS SCI, V54, P636, DOI 10.1167/iovs.12-11182; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Briers D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066018; BURROWS ME, 1981, AM J PHYSIOL, V241, pH829, DOI 10.1152/ajpheart.1981.241.6.H829; Cheng HY, 2008, OPT EXPRESS, V16, P10214, DOI 10.1364/OE.16.010214; COLANTUONI A, 1984, INT J MICROCIRC, V3, P13; DIRNAGL U, 1993, MICROVASC RES, V45, P318, DOI 10.1006/mvre.1993.1028; Durduran T, 2004, J CEREBR BLOOD F MET, V24, P518, DOI 10.1097/00004647-200405000-00005; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Haddock RE, 2002, J PHYSIOL-LONDON, V540, P219, DOI 10.1113/jphysiol.2001.013698; Hessellund A, 2006, ACTA OPHTHALMOL SCAN, V84, P228, DOI 10.1111/j.1600-0420.2006.00633.x; Hessellund A, 2003, ACTA OPHTHALMOL SCAN, V81, P278, DOI 10.1034/j.1600-0420.2003.00063.x; HOM GJ, 1992, J CARDIOVASC PHARM, V19, P194; HUNDLEY WG, 1988, AM J PHYSIOL, V254, pH67, DOI 10.1152/ajpheart.1988.254.1.H67; Jacobsen JCB, 2007, AM J PHYSIOL-HEART C, V293, pH229, DOI 10.1152/ajpheart.00727.2006; Jeppesen P, 2007, INVEST OPHTH VIS SCI, V48, P328, DOI 10.1167/iovs.06-0360; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; KOHNER EM, 1995, DIABETES, V44, P603, DOI 10.2337/diabetes.44.6.603; Logan JFJ, 2004, BRIT J OPHTHALMOL, V88, P1049, DOI 10.1136/bjo.2003.034884; Mayer S., 1876, AKAD WISS WIEN MATH, V74, P281; Nadort A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25258; Neganova AY, 2016, BIOMED OPT EXPRESS, V7, P1375, DOI 10.1364/BOE.7.001375; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Ponticorvo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.090501; Postnov DD, 2016, BIOMED OPT EXPRESS, V7, P2759, DOI 10.1364/BOE.7.002759; Postnov DD, 2015, BIOMED OPT EXPRESS, V6, P5055, DOI 10.1364/BOE.6.005055; Srienc A. I., 2010, FRONT NEUROENERG, P1; Stansberry KB, 1996, DIABETES CARE, V19, P715, DOI 10.2337/diacare.19.7.715; Stucker M, 2003, J VASC SURG, V38, P522, DOI 10.1016/S0741-5214(03)00335-5; VONDERWEID PY, 1993, J PHYSIOL-LONDON, V471, P13, DOI 10.1113/jphysiol.1993.sp019888; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173805	10.1371/journal.pone.0173805	http://dx.doi.org/10.1371/journal.pone.0173805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339503	gold, Green Published, Green Submitted			2022-12-27	WOS:000399116700012
J	Cha, MJ; Kim, HS; Kim, SH; Park, JH; Cho, GY				Cha, Myung-Jin; Kim, Hyun-Sook; Kim, Seong Hwan; Park, Jae-Hyeong; Cho, Goo-Yeong			Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; LONGITUDINAL STRAIN; 2-DIMENSIONAL SPECKLE; HEART-FAILURE; DYSFUNCTION; VALIDATION; DOPPLER; RISK; LIMITATIONS; PREDICTION	Backgrounds We aimed to evaluate the predictive power of longitudinal and circumferential fibers according to left ventricular ejection fraction (LVEF) in successfully reperfused acute ST elevation myocardial infarction (STEMI) patients. Methods Total 691 patients (age 59 +/- 13, 20% female) underwent clinical evaluation and conventional and strain echocardiography (Global longitudinal strain (GLS), global circumferential strain (GCS)). The clinical outcome was defined as the composite of death, hospitalization for heart failure, non-fatal myocardial infarction, and ventricular arrhythmia. Results During a follow-up of 39 +/- 19 months, there were 47 (6.8%) clinical events. In multivariate Cox models adjusted clinical risk factors, age (HR 1.08, p = 0.001) and GLS (HR 1.37, p = 0.001) were independent predictors. The addition of GLS resulted in significant incremental improvement in the predictive value on LVEF (chi(2) = 31.8 -> 45.8, p<0.001), although GCS offers no additional benefit. In the subgroup analysis according to LVEF, adjusted with clinical factors, GLS was significant predictive for outcome for the patients with mildly depressed (LVEF 40-50%, HR 2.25, p<0.001) and significantly depressed (LVEF<40%, HR 1.28, p = 0.016) systolic function, although GCS and LVEF lost their power with LVEF<40%. For the patients with preserved LVEF (>50%), GLS, GCS and LVEF did not show significant predictive power. Conclusions GLS is a most powerful predictor of outcome in successfully reperfused STEMI patients, especially with depressed LV dysfunction, although GCS and LVEF lost their predictive power for the patients with significantly depressed LV function. However, GLS did not predict outcome for the patients with preserved LVEF (>50%).	[Cha, Myung-Jin] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol,Cardiovasc Ctr,Coll Med, Seoul, South Korea; [Kim, Hyun-Sook] Hallym Univ, Med Ctr, Dept Internal Med, Cardiovasc Div, Anyang, South Korea; [Kim, Seong Hwan] Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, Anam, South Korea; [Park, Jae-Hyeong] Chungnam Natl Univ Hosp, Dept Internal Med, Cardiovasc Div, Daejeon, South Korea; [Cho, Goo-Yeong] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Div Cardiol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hallym University; Korea University; Korea University Medicine (KU Medicine); Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU)	Cho, GY (corresponding author), Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Div Cardiol, Seongnam, South Korea.	cardioch@snu.ac.kr	Park, Jae-Hyeong/AAD-9015-2021	Park, Jae-Hyeong/0000-0001-7035-286X; Cho, Goo-Yeong/0000-0002-7067-5535				AHNVE S, 1986, AM J CARDIOL, V58, P872, DOI 10.1016/S0002-9149(86)80002-9; BATTLER A, 1980, AM J CARDIOL, V45, P197, DOI 10.1016/0002-9149(80)90635-9; Biere L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086959; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Buxton AE, 2007, J AM COLL CARDIOL, V50, P1150, DOI 10.1016/j.jacc.2007.04.095; Cho GY, 2006, AM J CARDIOL, V97, P1661, DOI 10.1016/j.amjcard.2005.12.063; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Cimino S, 2013, EUR HEART J-CARD IMG, V14, P805, DOI 10.1093/ehjci/jes295; CORRAO S, 1995, CARDIOLOGY, V86, P503, DOI 10.1159/000176930; Edvardsen T, 2002, CIRCULATION, V106, P50, DOI 10.1161/01.CIR.0000019907.77526.75; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Gjesdal O, 2008, CIRC-CARDIOVASC IMAG, V1, P189, DOI 10.1161/CIRCIMAGING.108.784900; Hoshi H, 2014, HEART VESSELS, V29, P300, DOI 10.1007/s00380-013-0361-y; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Hurlburt HM, 2007, ECHOCARDIOGR-J CARD, V24, P723, DOI 10.1111/j.1540-8175.2007.00460.x; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kovacs A, 2015, AM J PHYSIOL-HEART C, V308, pH743, DOI 10.1152/ajpheart.00828.2014; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee JH, 2009, AM J CARDIOL, V104, P182, DOI 10.1016/j.amjcard.2009.03.010; Lumens J, 2015, JACC-CARDIOVASC IMAG, V8, P1360, DOI 10.1016/j.jcmg.2015.08.014; Oh JK, 2012, J AM SOC ECHOCARDIOG, V25, P327, DOI 10.1016/j.echo.2011.12.002; Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Solomon SD, 2001, ANN INTERN MED, V134, P451, DOI 10.7326/0003-4819-134-6-200103200-00009; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Urheim S, 2000, CIRCULATION, V102, P1158, DOI 10.1161/01.CIR.102.10.1158; Woo JS, 2011, AM J CARDIOL, V108, P340, DOI 10.1016/j.amjcard.2011.03.052	28	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174160	10.1371/journal.pone.0174160	http://dx.doi.org/10.1371/journal.pone.0174160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334029	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200055
J	Huang, WY; Ho, CL; Lee, CC; Hsiao, CW; Wu, CC; Jao, SW; Yang, JF; Lo, CH; Chen, JH				Huang, Wen-Yen; Ho, Ching-Liang; Lee, Chia-Cheng; Hsiao, Cheng-Wen; Wu, Chang-Chieh; Jao, Shu-Wen; Yang, Jen-Fu; Lo, Cheng-Hsiang; Chen, Jia-Hong			Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; ADVANCED HEPATOCELLULAR-CARCINOMA; RECURRENT MALIGNANT GLIOMA; RENAL-CELL CARCINOMA; PHASE-II; ADJUVANT TREATMENT; PROSTATE-CANCER; OVARIAN-CANCER; CHEMOTHERAPY; TRIAL	The purpose of this study was to estimate the impact of metronomic therapy with oral tegafur-uracil (UFUR) following an intravenous FOLFOX regimen as surgical adjuvant chemotherapy on the overall survival (OS) and disease-free survival (DFS) of stage I I I colon cancer patients. From the retrospective database of patients who underwent a surgical resection for colorectal cancer at the Tri-Service General Hospital from October 2008 through December 2014, stage I I I colon carcinomas treated with radical RO resection were reviewed. One hundred thirty two patients were treated with a FOLFOX regimen (comparison group), and 113 patients were treated with the same regimen followed by additional oral UFUR (UFUR group). The clinical characteristics and mean age of the comparison and UFUR groups were similar. Furthermore, for all study patients, DFS was not significantly different between the two groups. However, 5-year OS rates were 86.8% and 68.5% in the UFUR and comparison groups, respectively (p = 0.0107). Adding UFUR to a FOLFOX regimen was found to significantly improve the OS in patients with stage III colon cancer. UFUR as a maintenance therapy following FOLFOX regimen as an alternative therapeutic option for the treatment of stage I I I colon cancer patients.	[Huang, Wen-Yen; Yang, Jen-Fu; Lo, Cheng-Hsiang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Ho, Ching-Liang; Chen, Jia-Hong] Natl Def Med Ctr, Triserv Gen Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan; [Lee, Chia-Cheng; Hsiao, Cheng-Wen; Wu, Chang-Chieh; Jao, Shu-Wen] Natl Def Med Ctr, Triserv Gen Hosp, Div Colon & Rectal Surg, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University	Chen, JH (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan.; Chen, JH (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	ndmc_tw.tw@yahoo.com.tw	huang, wen/GXW-0661-2022	Lo, Cheng-Hsiang/0000-0001-5002-587X	 [TSGH-C104-053];  [TSGH-C105-049]	; 	The study was supported in part by the study projects of TSGH-C104-053 & TSGH-C105-049. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bellmunt J, 2010, LANCET ONCOL, V11, P350, DOI 10.1016/S1470-2045(09)70383-3; Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Carmichael J, 2002, J CLIN ONCOL, V20, P3617, DOI 10.1200/JCO.2002.10.129; Chan TS, 2016, J EXP MED, V213, P2967, DOI 10.1084/jem.20151665; Douillard JY, 2002, J CLIN ONCOL, V20, P3605, DOI 10.1200/JCO.2002.04.123; Fontana A, 2009, CLIN CANCER RES, V15, P4954, DOI 10.1158/1078-0432.CCR-08-3317; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; GonzalezBaron M, 1995, EUR J CANCER, V31A, P2215, DOI 10.1016/0959-8049(95)00487-4; Hsu CH, 2010, J HEPATOL, V53, P126, DOI 10.1016/j.jhep.2010.01.035; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Lin PC, 2007, CANCER CHEMOTH PHARM, V60, P351, DOI 10.1007/s00280-006-0377-4; Lord R, 2007, J UROLOGY, V177, P2136, DOI 10.1016/j.juro.2007.01.143; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Ogata Y, 2007, ANTICANCER RES, V27, P2605; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; PAZDUR R, 1994, J CLIN ONCOL, V12, P2296, DOI 10.1200/JCO.1994.12.11.2296; Perry JR, 2010, J CLIN ONCOL, V28, P2051, DOI 10.1200/JCO.2009.26.5520; Reardon DA, 2009, BRIT J CANCER, V101, P1986, DOI 10.1038/sj.bjc.6605412; Rosati G, 2005, ONCOLOGY-BASEL, V69, P122, DOI 10.1159/000087814; Sadahiro S, 2015, ANN ONCOL, V26, P2274, DOI 10.1093/annonc/mdv358; Shaked Y, 2016, CANCER RES, V76, P5983, DOI 10.1158/0008-5472.CAN-16-0136; Shao YY, 2012, ONCOLOGY-BASEL, V82, P59, DOI 10.1159/000336126; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Watanabe T, 2009, J CLIN ONCOL, V27, P1368, DOI 10.1200/JCO.2008.18.3939	29	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174280	10.1371/journal.pone.0174280	http://dx.doi.org/10.1371/journal.pone.0174280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328969	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700078
J	Kaverina, NV; Kadoya, H; Eng, DG; Rusiniak, ME; Sequeira-Lopez, MLS; Gomez, RA; Pippin, JW; Gross, KW; Peti-Peterdi, J; Shankland, SJ				Kaverina, Natalya V.; Kadoya, Hiroyuki; Eng, Diana G.; Rusiniak, Michael E.; Sequeira-Lopez, Maria Luisa S.; Gomez, R. Ariel; Pippin, Jeffrey W.; Gross, Kenneth W.; Peti-Peterdi, Janos; Shankland, Stuart J.			Tracking the stochastic fate of cells of the renin lineage after podocyte depletion using multicolor reporters and intravital imaging	PLOS ONE			English	Article							PARIETAL EPITHELIAL-CELLS; PROGENITOR CELLS; REGENERATION; GLOMERULOSCLEROSIS; APOPTOSIS; INJURY; MOUSE; ONSET	Podocyte depletion plays a major role in focal segmental glomerular sclerosis (FSGS). Because cells of the renin lineage (CoRL) serve as adult podocyte and parietal epithelial cell (PEC) progenitor candidates, we generated Ren1cCre/R26R-ConfettiTG/WT and Ren1dCre/R26R-ConfettiTG/WT mice to determine CoRL clonality during podocyte replacement. Four CoRL reporters (GFP, YFP, RFP, CFP) were restricted to cells in the juxtaglomerular compartment (JGC) at baseline. Following abrupt podocyte depletion in experimental FSGS, all four CoRL reporters were detected in a subset of glomeruli at day 28, where they co-expressed de novo four podocyte proteins (podocin, nephrin, WT-1 and p57) and two glomerular parietal epithelial cell (PEC) proteins (claudin-1, PAX8). To monitor the precise migration of a subset of CoRL over a 2w period following podocyte depletion, intravital multiphoton microscopy was used. Our findings demonstrate direct visual support for the migration of single CoRL from the JGC to the parietal Bowman's capsule, early proximal tubule, mesangium and glomerular tuft. In summary, these results suggest that following podocyte depletion, multi-clonal CoRL migrate to the glomerulus and replace podocyte and PECs in experimental FSGS.	[Kaverina, Natalya V.; Eng, Diana G.; Pippin, Jeffrey W.; Shankland, Stuart J.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Kadoya, Hiroyuki; Peti-Peterdi, Janos] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Kadoya, Hiroyuki] Kawasaki Med Sch, Dept Hypertens & Nephrol, Kurashiki, Okayama, Japan; [Rusiniak, Michael E.; Gross, Kenneth W.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Sequeira-Lopez, Maria Luisa S.; Gomez, R. Ariel] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA	University of Washington; University of Washington Seattle; University of Southern California; Kawasaki Medical School; Roswell Park Cancer Institute; University of Virginia	Shankland, SJ (corresponding author), Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA.; Peti-Peterdi, J (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.	petipete@med.usc.edu; stuartjs@uw.edu			US National Institutes of Health [5 R01 DK 056799-10, 5 R01 DK 056799-12, 1 R01 DK097598-01A1, DK64324, DK100944]; American Diabetes Association grant [4-15-CKD-56]; American Heart Association grant [15GRNT23040039]; CCSG Core Grant [5P30CA016056-39, R37 HL066242, RO1 DK091330, P50 DK096373];  [RO1 HL048459-17]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097598, R01DK064324, R01DK100944] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association grant(American Diabetes Association); American Heart Association grant(American Heart Association); CCSG Core Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	US National Institutes of Health grants 5 R01 DK 056799-10, 5 R01 DK 056799-12, 1 R01 DK097598-01A1, DK64324 and DK100944, American Diabetes Association grant 4-15-CKD-56, and American Heart Association grant 15GRNT23040039. RO1 HL048459-17; 5P30CA016056-39(CCSG Core Grant) R37 HL066242, RO1 DK091330, P50 DK096373.	Asanuma K, 2007, NEPHROLOGY, V12, pS15, DOI 10.1111/j.1440-1797.2007.00876.x; Berg Alison C, 2013, World J Nephrol, V2, P11, DOI 10.5527/wjn.v2.i1.11; Castellanos-Rivera RM, 2015, J AM SOC NEPHROL, V26, P67, DOI 10.1681/ASN.2013101045; D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df; Di Girolamo N, 2015, STEM CELLS, V33, P157, DOI 10.1002/stem.1769; Eng DG, 2015, KIDNEY INT, V88, P999, DOI 10.1038/ki.2015.152; Gharib SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105289; Grahammer F, 2013, AM J PATHOL, V183, P333, DOI 10.1016/j.ajpath.2013.04.009; Hackl MJ, 2013, NAT MED, V19, P1661, DOI 10.1038/nm.3405; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, pF495, DOI 10.1152/ajprenal.00521.2005; Kaverina NV, 2016, AM J PHYSIOL-RENAL, V310, pF1397, DOI 10.1152/ajprenal.00369.2015; Lichtnekert J, 2016, JOURNAL OF THE AMERI; Lin EE, 2014, AM J PHYSIOL-RENAL, V306, pF249, DOI 10.1152/ajprenal.00313.2013; Lopez MLSS, 2004, DEV CELL, V6, P719; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Moeller MJ, 2014, NEPHRON EXP NEPHROL, V126, P97, DOI 10.1159/000360677; Nezu Masahiro, 2014, Nihon Rinsho, V72, P1691; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Peired A, 2014, NEPHRON EXP NEPHROL, V126, P70, DOI 10.1159/000360669; Pichaiwong W, 2013, J AM SOC NEPHROL, V24, P1088, DOI 10.1681/ASN.2012050445; Pippin JW, 2013, AM J PATHOL, V183, P542, DOI 10.1016/j.ajpath.2013.04.024; Pippin JW, 2015, AM J PHYSL RENAL PHY; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Rivera RMC, 2011, PHYSIOL GENOMICS, V43, P1021, DOI 10.1152/physiolgenomics.00061.2011; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Starke C, 2015, J AM SOC NEPHROL, V26, P48, DOI 10.1681/ASN.2014030265; Stefanska AM, 2013, PFLUG ARCH EUR J PHY, V465, P767, DOI 10.1007/s00424-013-1263-7; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Thoma Clemens, 2014, Nat Rev Nephrol, V10, P424, DOI 10.1038/nrneph.2014.115; Venkatareddy M, 2014, J AM SOC NEPHROL, V25, P1118, DOI 10.1681/ASN.2013080859; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Zhang J, 2015, J RENIN-ANGIO-ALDO S, V16, P234, DOI 10.1177/1470320314543910; Zhang J, 2013, AM J PHYSIOL-RENAL, V304, pF1375, DOI 10.1152/ajprenal.00020.2013; Zhang J, 2012, NEPHRON EXP NEPHROL, V121, pE23, DOI 10.1159/000342808	36	39	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173891	10.1371/journal.pone.0173891	http://dx.doi.org/10.1371/journal.pone.0173891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329012	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700036
J	Mumtaz, S; Khan, L				Mumtaz, Sidra; Khan, Laiq			Adaptive control paradigm for photovoltaic and solid oxide fuel cell in a grid-integrated hybrid renewable energy system	PLOS ONE			English	Article							PREDICTIVE CONTROL; GENERATION SYSTEM; MPPT ALGORITHM; POWER; MODEL; PERFORMANCE; MANAGEMENT; EQUATION; STRATEGY; CHARGE	The hybrid power system (HPS) is an emerging power generation scheme due to the plentiful availability of renewable energy sources. Renewable energy sources are characterized as highly intermittent in nature due to meteorological conditions, while the domestic load also behaves in a quite uncertain manner. In this scenario, to maintain the balance between generation and load, the development of an intelligent and adaptive control algorithm has preoccupied power engineers and researchers. This paper proposes a Hermite wavelet embedded NeuroFuzzy indirect adaptive MPPT (maximum power point tracking) control of photovoltaic (PV) systems to extract maximum power and a Hermite wavelet incorporated NeuroFuzzy indirect adaptive control of Solid Oxide Fuel Cells (SOFC) to obtain a swift response in a grid-connected hybrid power system. A comprehensive simulation testbed for a grid-connected hybrid power system (wind turbine, PV cells, SOFC, electrolyzer, battery storage system, supercapacitor (SC), micro-turbine (MT) and domestic load) is developed in Matlab/Simulink. The robustness and superiority of the proposed indirect adaptive control paradigm are evaluated through simulation results in a grid-connected hybrid power system testbed by comparison with a conventional PI (proportional and integral) control system. The simulation results verify the effectiveness of the proposed control paradigm.	[Mumtaz, Sidra; Khan, Laiq] COMSATS Inst Informat Technol, Dept Elect Engn, Abbottabad, Khyber Pakhtunk, Pakistan	COMSATS University Islamabad (CUI)	Mumtaz, S (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Abbottabad, Khyber Pakhtunk, Pakistan.	sidramumtaz@ciit.net.pk						Abu-Rub H, 2013, IEEE T SUSTAIN ENERG, V4, P11, DOI 10.1109/TSTE.2012.2196059; Aguiar P, 2005, J POWER SOURCES, V147, P136, DOI 10.1016/j.jpowsour.2005.01.017; Ahmed J, 2015, APPL ENERG, V150, P97, DOI 10.1016/j.apenergy.2015.04.006; [Anonymous], 15472003 IEEE, P1; Badar R, 2013, P 2013 11 INT C FRON, P95; Badar R, 2014, ELECTR POW COMPO SYS, V42, P818, DOI 10.1080/15325008.2014.896430; Badar R, 2013, ELECTR POW COMPO SYS, V41, P845, DOI 10.1080/15325008.2013.792882; Conti J., 2011, DOEEIA0484; Entchev E, 2007, J POWER SOURCES, V170, P122, DOI 10.1016/j.jpowsour.2007.04.015; Gokmen N, 2013, SOL ENERGY, V98, P322, DOI 10.1016/j.solener.2013.09.025; Gong WY, 2014, ENG APPL ARTIF INTEL, V27, P28, DOI 10.1016/j.engappai.2013.07.016; Grujicic M, 2004, P I MECH ENG A-J POW, V218, P487, DOI 10.1243/0957650042456999; Gupta AK, 2015, APPL MATH COMPUT, V270, P458, DOI 10.1016/j.amc.2015.08.058; Haque ME, 2010, IEEE T IND APPL, V46, P331, DOI 10.1109/TIA.2009.2036550; Harrag A, 2015, RENEW SUST ENERG REV, V49, P1247, DOI 10.1016/j.rser.2015.05.003; Hosseini M, 2013, J POWER SOURCES, V221, P372, DOI 10.1016/j.jpowsour.2012.08.047; Khan L, 2006, COMPEL, V25, P841, DOI 10.1108/03321640610684033; Khan L, 2015, TURK J ELECTR ENG CO, V23, P395, DOI 10.3906/elk-1212-31; Lei Z., 2014, IFAC P, V47, P3899, DOI DOI 10.3182/20140824-6-ZA-1003.00657; Mellit A, 2011, RENEW ENERG, V36, P250, DOI 10.1016/j.renene.2010.06.028; Mohammed YS, 2014, RENEW SUST ENERG REV, V35, P527, DOI 10.1016/j.rser.2014.04.022; Mutoh N, 2007, IEEE T IND ELECTRON, V54, P374, DOI 10.1109/TIE.2006.885149; Nelson DB, 2006, RENEW ENERG, V31, P1641, DOI 10.1016/j.renene.2005.08.031; Oh SR, 2014, IEEE T CONTR SYST T, V22, P911, DOI 10.1109/TCST.2013.2271902; Ou TC, 2014, ENERGY, V66, P314, DOI 10.1016/j.energy.2014.01.042; Pukrushpan JT, 2002, P AMER CONTR CONF, V1-6, P3117, DOI 10.1109/ACC.2002.1025268; Ray SS, 2015, APPL MATH COMPUT, V266, P135, DOI 10.1016/j.amc.2015.05.045; Rezk H, 2015, SOL ENERGY, V112, P1, DOI 10.1016/j.solener.2014.11.010; Sastry S., 2011, ADAPTIVE CONTROL STA; Sivakumar P, 2015, RENEW ENERG, V81, P543, DOI 10.1016/j.renene.2015.03.062; Stiller C, 2006, J POWER SOURCES, V158, P303, DOI 10.1016/j.jpowsour.2005.09.010; Tao G., 2003, ADAPTIVE CONTROL DES; Tarek Boutabba, 2013, 8 INT C EXH EC VEH R, P1; Uzunoglu M, 2009, RENEW ENERG, V34, P509, DOI 10.1016/j.renene.2008.06.009; Wang CS, 2008, IEEE T ENERGY CONVER, V23, P957, DOI 10.1109/TEC.2007.914200; Wang RR, 2008, J POWER SOURCES, V185, P1201, DOI 10.1016/j.jpowsour.2008.06.090; Wu XJ, 2008, J POWER SOURCES, V179, P232, DOI 10.1016/j.jpowsour.2007.12.036; Wu XJ, 2008, SIMUL MODEL PRACT TH, V16, P399, DOI 10.1016/j.simpat.2008.01.004; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2013, IEEE IND ELEC, P7331, DOI 10.1109/IECON.2013.6700352; Zheng LF, 2016, APPL ENERG, V180, P424, DOI 10.1016/j.apenergy.2016.08.016	43	11	11	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173966	10.1371/journal.pone.0173966	http://dx.doi.org/10.1371/journal.pone.0173966			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329015	gold, Green Submitted, Green Published			2022-12-27	WOS:000399094700039
J	Radhakrishnan, S; Erbis, S; Isaacs, JA; Kamarthi, S				Radhakrishnan, Srinivasan; Erbis, Serkan; Isaacs, Jacqueline A.; Kamarthi, Sagar			Novel keyword co-occurrence network-based methods to foster systematic reviews of scientific literature	PLOS ONE			English	Review							CO-WORD ANALYSIS; SCIENTOMETRICS; ACIDIFICATION; TRENDS	Systematic reviews of scientific literature are important for mapping the existing state of research and highlighting further growth channels in a field of study, but systematic reviews are inherently tedious, time consuming, and manual in nature. In recent years, keyword cooccurrence networks (KCNs) are exploited for knowledge mapping. In a KCN, each keyword is represented as a node and each co-occurrence of a pair of words is represented as a link. The number of times that a pair of words co-occurs in multiple articles constitutes the weight of the link connecting the pair. The network constructed in this manner represents cumulative knowledge of a domain and helps to uncover meaningful knowledge components and insights based on the patterns and strength of links between keywords that appear in the literature. In this work, we propose a KCN-based approach that can be implemented prior to undertaking a systematic review to guide and accelerate the review process. The novelty of this method lies in the new metrics used for statistical analysis of a KCN that differ from those typically used for KCN analysis. The approach is demonstrated through its application to nano-related Environmental, Health, and Safety (EHS) risk literature. The KCN approach identified the knowledge components, knowledge structure, and research trends that match with those discovered through a traditional systematic review of the nanoEHS field. Because KCN-based analyses can be conducted more quickly to explore a vast amount of literature, this method can provide a knowledge map and insights prior to undertaking a rigorous traditional systematic review. This two-step approach can significantly reduce the effort and time required for a traditional systematic literature review. The proposed KCN-based pre-systematic review method is universal. It can be applied to any scientific field of study to prepare a knowledge map.	[Radhakrishnan, Srinivasan; Erbis, Serkan; Isaacs, Jacqueline A.; Kamarthi, Sagar] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA	Northeastern University	Kamarthi, S (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	Sagar@coe.neu.edu	Isaacs, Jacqueline/I-7558-2015; Kamarthi, Sagar/P-7226-2014	Isaacs, Jacqueline/0000-0001-8406-0083; Kamarthi, Sagar/0000-0001-5845-7714	NSF; NSF Scalable Nanomanufacturing Award [CMMI-1120329]; NSEC [EEC-0832785]; National Institute of Standards and Technology [70NANB15H028]; Directorate For Engineering [1120329] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF Scalable Nanomanufacturing Award; NSEC; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by NSF Scalable Nanomanufacturing Award CMMI-1120329 and in part by NSEC Award EEC 0832785. We also thank the National Institute of Standards and Technology for providing funding for this research under sponsor award number 70NANB15H028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the NSF-funded Nanoscale Science and Engineering Center for Highrate Nanomanufacturing at Northeastern University for their technical insights. S. Abbasi, C. Bosso, M. Eckelman, L. Pourzahedi, W. Walker and P. Zhai at Northeastern contributed to discussions. This work was supported by NSF Scalable Nanomanufacturing Award CMMI-1120329 and in part by NSEC Award EEC-0832785. We also thank the National Institute of Standards and Technology for providing funding for this research under sponsor award number 70NANB15H028.	Amez L., 2010, 16 INT C CULT EC ACE; An XY, 2011, SCIENTOMETRICS, V88, P133, DOI 10.1007/s11192-011-0374-1; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; CAMBROSIO A, 1993, SCIENTOMETRICS, V27, P119, DOI 10.1007/BF02016546; Cattuto C, 2006, EUR PHYS J C, V46, P33, DOI 10.1140/epjcd/s2006-03-004-4; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COURTIAL JP, 1994, SCIENTOMETRICS, V31, P251, DOI 10.1007/BF02016875; Ding Y, 2001, INFORM PROCESS MANAG, V37, P817, DOI 10.1016/S0306-4573(00)00051-0; Duvvuru A, 2013, PROCEDIA COMPUT SCI, V20, P439, DOI 10.1016/j.procs.2013.09.300; Erbis S, 2016, RISK ANAL; Halpin H., 2006, P 1 SEM AUTH ANN WOR, V209; Jacob EK, 2004, LIBR TRENDS, V52, P515; Ke Jinyun, 2002, Complexity, V7, P41, DOI 10.1002/cplx.10030; LAW J, 1992, SCIENTOMETRICS, V23, P417, DOI 10.1007/BF02029807; LAW J, 1988, SCIENTOMETRICS, V14, P251, DOI 10.1007/BF02020078; [刘则渊 LIU Zeyuan], 2007, [科学学研究, Studies in Science of Science], V25, P193; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; NWB Team, 2006, NETW BENCH TOOL; PETERS HPF, 1993, RES POLICY, V22, P23, DOI 10.1016/0048-7333(93)90031-C; Shirky Clay, 2005, ONTOLOGY IS OVER RAT; SPENCE DP, 1990, J PSYCHOLINGUIST RES, V19, P317, DOI 10.1007/BF01074363; Steels L, 1999, LECT NOTES ARTIF INT, V1674, P679; Su HN, 2010, SCIENTOMETRICS, V85, P65, DOI 10.1007/s11192-010-0259-8; Xie CX, 2005, J INFORM, V24, P69; Zhang JH, 2012, ADV BIOM ENG, V7, P7; Zhang ZK, 2008, EUR PHYS J B, V66, P557, DOI 10.1140/epjb/e2008-00453-9	28	89	91	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172778	10.1371/journal.pone.0172778	http://dx.doi.org/10.1371/journal.pone.0172778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28328983	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700010
J	Usarek, E; Baranczyk-Kuzma, A; Kazmierczak, B; Gajewska, B; Kuzma-Kozakiewicz, M				Usarek, Ewa; Baranczyk-Kuzma, Anna; Kazmierczak, Beata; Gajewska, Beata; Kuzma-Kozakiewicz, Magdalena			Validation of qPCR reference genes in lymphocytes from patients with amyotrophic lateral sclerosis	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; LYMPHOBLASTOID CELL-LINES; MESSENGER-RNA EXPRESSION; TRANSCRIPTION-PCR DATA; 28S RIBOSOMAL-RNA; HOUSEKEEPING GENES; BETA-ACTIN; INTERNAL STANDARDS; NORMALIZATION; GAPDH	Quantitative polymerase chain reaction (qPCR) is the most specific and reliable method for determination of mRNA gene expression. Crucial point for its accurate normalization is the choice of appropriate internal control genes (ICGs). In the present work we determined and compare the expression of eight commonly used ICGs in lymphocytes from 26 patients with amyotrophic lateral sclerosis (ALS) and 30 control subjects. Peripheral blood mononuclear cells (PBMCs) before and after immortalization by EBV transfection (lymphoblast cell lines-LCLs) were used for qPCR analysis. LCLs were studied before and after liquid nitrogen cryopreservation and culturing (groups LCL1 and LCL2, respectively). qPCR data of 8 ICGs expression was analyzed by BestKeeper, NormFinder and geNorm methods. All studied genes (18SRNA, ACTB, B2M, GUSB, GAPDH, HPRT1, MT-ATP6 and RPS17) were expressed in PBMCs, whereas only first four in LCLs. LCLs cryopreservation had no effect on ICGs expression. Comprehensive ranking indicated RPS17 with MT-ATP6 as the best ICGs for qPCR in PBMCs of control and ALS subjects, and RPS17 with 18RNA or MT-ATP6 in LCLs from ALS. In PBMCs 18RNA shouldn't be used as ICG.	[Usarek, Ewa; Baranczyk-Kuzma, Anna; Kazmierczak, Beata; Gajewska, Beata] Med Univ Warsaw, Dept Biochem, Warsaw, Poland; [Baranczyk-Kuzma, Anna; Kazmierczak, Beata; Gajewska, Beata; Kuzma-Kozakiewicz, Magdalena] Med Univ Warsaw, Neurodegenerat Dis Res Grp, Warsaw, Poland; [Kuzma-Kozakiewicz, Magdalena] Med Univ Warsaw, Dept Neurol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Kuzma-Kozakiewicz, M (corresponding author), Med Univ Warsaw, Neurodegenerat Dis Res Grp, Warsaw, Poland.; Kuzma-Kozakiewicz, M (corresponding author), Med Univ Warsaw, Dept Neurol, Warsaw, Poland.	magdalena.kuzma@wum.edu.pl	Usarek, Ewa/X-1699-2018	Usarek, Ewa/0000-0003-1913-2954; Kazmierczak, Beata/0000-0002-5575-8623; Gajewska, Beata/0000-0003-4105-0306	EU Joint Programme Neurodegenerative Disease Research Project; Medical University of Warsaw, Poland [1WK/N/2015];  [5/JPND/2011]	EU Joint Programme Neurodegenerative Disease Research Project; Medical University of Warsaw, Poland; 	This work was supported by grant 5/JPND/2011 (MK-K, AB-K), SOPHIA from the EU Joint Programme Neurodegenerative Disease Research Project and 1WK/N/2015 from the Medical University of Warsaw, Poland (AB-K).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; BHATIA P, 1994, ANAL BIOCHEM, V216, P223, DOI 10.1006/abio.1994.1028; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DELEEUW WJF, 1989, NUCLEIC ACIDS RES, V17, P10137, DOI 10.1093/nar/17.23.10137; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dupuis L, 2009, EXP NEUROL, V215, P146, DOI 10.1016/j.expneurol.2008.09.019; Ersahin T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093341; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gajewska B, 2015, CNS NEUROL DISORD-DR, V14, P1328, DOI 10.2174/1871527314666150821104019; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Gordon PH, 2011, CNS DRUGS, V25, P1, DOI 10.2165/11586000-000000000-00000; Gupta PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038382; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-114; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Henn D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054132; Jones NR, 2014, DRUG METAB DISPOS, V42, P529, DOI 10.1124/dmd.113.054718; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Kuzma-Kozakiewicz M., 2011, BIOMED REV, V22, P7; Kuzma-Kozakiewicz M, 2013, NEURODEGENER DIS, V12, P71, DOI 10.1159/000339529; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Lin ZW, 2015, INT J MED SCI, V12, P7, DOI 10.7150/ijms.8352; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oturai DB, 2016, SCAND J IMMUNOL, V83, P72, DOI 10.1111/sji.12391; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinto N, 2014, CLIN PHARMACOL THER, V95, P644, DOI 10.1038/clpt.2014.37; Pradat PF, 2009, MOL DIAGN THER, V13, P115, DOI 10.2165/01250444-200913020-00005; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Segundo-Val IS, 2016, METHODS MOL BIOL, V1434, P57, DOI 10.1007/978-1-4939-3652-6_5; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V246, P287, DOI 10.1006/bbrc.1998.8600; Shlapatska L. M., 2014, Experimental Oncology, V36, P2; Tarasiuk J, 2012, J NEURAL TRANSM, V119, P747, DOI 10.1007/s00702-012-0806-y; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vaiphei ST, 2015, J RADIAT RES, V56, P177, DOI 10.1093/jrr/rru074; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang H, 2016, CLIN LAB, V62, P227, DOI 10.7754/Clin.Lab.2015.150805; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174317	10.1371/journal.pone.0174317	http://dx.doi.org/10.1371/journal.pone.0174317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328930	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700082
J	Yoshioka, T; Tatsumi, T; Miyagi, T; Mukai, K; Nishio, K; Nishio, A; Yokoyama, Y; Suda, T; Kegasawa, T; Shigekawa, M; Hikita, H; Sakamori, R; Takehara, T				Yoshioka, Teppei; Tatsumi, Tomohide; Miyagi, Takuya; Mukai, Kaori; Nishio, Kumiko; Nishio, Akira; Yokoyama, Yoshinobu; Suda, Takahiro; Kegasawa, Tadashi; Shigekawa, Minoru; Hikita, Hayato; Sakamori, Ryotaro; Takehara, Tetsuo			Frequency and role of NKp46 and NKG2A in hepatitis B virus infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CYTOTOXICITY RECEPTORS; FUNCTIONAL DICHOTOMY; NK CELLS; RECOGNITION; EXPRESSION; REPLICATION; MODULATION; INNATE; CANCER	Background and Aim Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Patients/Method Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-gamma production in NK cells were evaluated using RT-PCR and flow cytometry. Results CHB patients were classified into treatment-naive patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t) ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-gamma production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46 (high)NKG2A(high) subset). The frequencies of NKp46(high)NKG2A(high) subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naive CHB patients, the frequencies of NKp46(high)NKG2A(high) subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher IFN-gamma expression was lower in the NKp46(high)NKG2A(high) subset than in the other subsets. Conclusion The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46(high)NKG2A(high) subset, may be associated with liver injury and HBV replication.	[Yoshioka, Teppei; Tatsumi, Tomohide; Miyagi, Takuya; Mukai, Kaori; Nishio, Kumiko; Nishio, Akira; Yokoyama, Yoshinobu; Suda, Takahiro; Kegasawa, Tadashi; Shigekawa, Minoru; Hikita, Hayato; Sakamori, Ryotaro; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan	Osaka University	Takehara, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	takehara@gh.med.osaka-u.ac.jp	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X	Japan Agency for Medical Research and Development	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid for Research on Hepatitis from the Japan Agency for Medical Research and Development.	Achdout H, 2010, J VIROL, V84, P3993, DOI 10.1128/JVI.02289-09; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Golden-Mason L, 2012, HEPATOLOGY, V56, P1214, DOI 10.1002/hep.25771; Golden-Mason L, 2011, HEPATOLOGY, V54, P1559, DOI 10.1002/hep.24556; Jinushi M, 2004, J IMMUNOL, V173, P6072, DOI 10.4049/jimmunol.173.10.6072; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Kruse PH, 2014, IMMUNOL CELL BIOL, V92, P221, DOI 10.1038/icb.2013.98; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Li WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135874; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086927; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Miyagi T, 2010, J HEPATOL, V53, P424, DOI 10.1016/j.jhep.2010.03.018; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nishio A, 2016, HEPATOLOGY; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Organiztion WH.. Department of Communicable Disease Surveillance and Response, 2002, WHOCDSCSRLY020022; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Tatsumi T, 2016, HEPATOL RES, V46, P416, DOI 10.1111/hepr.12619; Tjwa ETTL, 2011, J HEPATOL, V54, P209, DOI 10.1016/j.jhep.2010.07.009; TSURIMOTO T, 1987, P NATL ACAD SCI USA, V84, P444, DOI 10.1073/pnas.84.2.444; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049135; Zhao R, 2011, WORLD J GASTROENTERO, V17, P1152, DOI 10.3748/wjg.v17.i9.1152	42	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174103	10.1371/journal.pone.0174103	http://dx.doi.org/10.1371/journal.pone.0174103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328926	gold, Green Submitted, Green Published			2022-12-27	WOS:000399094700052
J	Yuan, L; Wang, MF; Zhang, XT; Wang, ZX				Yuan, Lin; Wang, Mingfa; Zhang, Xiaotu; Wang, Zhixiang			Effects of protease and non-starch polysaccharide enzyme on performance, digestive function, activity and gene expression of endogenous enzyme of broilers	PLOS ONE			English	Article							WHEAT-BASED DIETS; ILEAL NUTRIENT DIGESTIBILITIES; HULLESS BARLEY VARIETIES; GASTROINTESTINAL-TRACT; GROWTH-PERFORMANCE; XYLANASE SUPPLEMENTATION; EXOGENOUS ENZYMES; GUT MICROFLORA; MESSENGER-RNA; FOOD-INTAKE	Three hundred one-day-old male broiler chickens (Ross-308) were fed corn-soybean basal diets containing non-starch polysaccharide (NSP) enzyme and different levels of acid protease from 1 to 42 days of age to investigate the effects of exogenous enzymes on growth performance, digestive function, activity of endogenous digestive enzymes in the pancreas and mRNA expression of pancreatic digestive enzymes. For days 1-42, compared to the control chickens, average daily feed intake (ADFI) and average daily gain (ADG) were significantly enhanced by the addition of NSP enzyme in combination with protease supplementation at 40 or 80 mg/kg (p<0.05). Feed-to-gain ratio (FGR) was significantly improved by supplementation with NSP enzymes or NSP enzyme combined with 40 or 80 mg/kg protease compared to the control diet (p<0.05). Apparent digestibility of crude protein (ADCP) was significantly enhanced by the addition of NSP enzyme or NSP enzyme combined with 40 or 80 mg/kg protease (p<0.05). Cholecystokinin (CCK) level in serum was reduced by 31.39% with NSP enzyme combined with protease supplementation at 160 mg/kg (p< 0.05), but the CCK level in serum was increased by 26.51% with NSP enzyme supplementation alone. After 21 days, supplementation with NSP enzyme and NSP enzyme combined with 40 or 80 mg/kg protease increased the activity of pancreatic trypsin by 74.13%, 70.66% and 42.59% (p< 0.05), respectively. After 42 days, supplementation with NSP enzyme and NSP enzyme combined with 40 mg/kg protease increased the activity of pancreatic trypsin by 32.45% and 27.41%, respectively (p< 0.05). However, supplementation with NSP enzyme and 80 or 160 mg/kg protease decreased the activity of pancreatic trypsin by 10.75% and 25.88%, respectively (p< 0.05). The activities of pancreatic lipase and amylase were significantly higher in treated animals than they were in the control group (p< 0.05). Supplementation with NSP enzyme, NSP enzyme combined with 40 or 80 mg/kg protease increased pancreatic trypsin mRNA levels by 40%, 44% and 28%, respectively. Supplementation with NSP enzyme and 160 mg/kg protease decreased pancreatic trypsin mRNA levels by 13%. Pancreatic lipase and amylase mRNA expression were significantly elevated in treated animals compared to the control group (p< 0.05). These results suggest that the amount of NSP enzyme and acid protease in the diet significantly affects digestive function, endogenous digestive-enzyme activity and mRNA expression in broilers.	[Yuan, Lin; Zhang, Xiaotu; Wang, Zhixiang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Yuan, Lin; Wang, Mingfa] Henan Acad Agr Sci, Inst Anim Husb & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Academy of Agricultural Sciences	Wang, ZX (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wzxhau@aliyun.com						Acamovic T, 2001, WORLD POULTRY SCI J, V57, P225, DOI 10.1079/WPS20010016; ALMIRALL M, 1995, J NUTR, V125, P947; AOAC, 2000, OFFICIAL METHODS ANA; Bedford M. R., 1993, Journal of Applied Poultry Research, V2, P85, DOI 10.1093/japr/2.1.85; BEDFORD MR, 1992, J NUTR, V122, P560, DOI 10.1093/jn/122.3.560; Bedford MR, 2000, ANIM FEED SCI TECH, V86, P1, DOI 10.1016/S0377-8401(00)00155-3; Choct M, 1996, BRIT POULTRY SCI, V37, P609, DOI 10.1080/00071669608417891; CHOCT M, 1992, BRIT POULTRY SCI, V33, P821, DOI 10.1080/00071669208417524; Cowieson AJ, 2008, BRIT POULTRY SCI, V49, P37, DOI 10.1080/00071660701812989; Cowieson AJ, 2006, ANIM FEED SCI TECH, V129, P149, DOI 10.1016/j.anifeedsci.2005.12.008; Cowieson AJ, 2005, ANIM FEED SCI TECH, V119, P293, DOI 10.1016/j.anifeedsci.2004.12.017; Engberg RM, 2004, POULTRY SCI, V83, P925, DOI 10.1093/ps/83.6.925; Esmaeilipour O, 2011, POULTRY SCI, V90, P1975, DOI 10.3382/ps.2010-01264; Freitas DM, 2011, J APPL POULTRY RES, V20, P322, DOI 10.3382/japr.2010-00295; Gao F, 2008, ANIM FEED SCI TECH, V142, P173, DOI 10.1016/j.anifeedsci.2007.07.008; Gao F, 2007, BRIT POULTRY SCI, V48, P480, DOI 10.1080/00071660701477320; Ghazi S, 2002, BRIT POULTRY SCI, V43, P70, DOI 10.1080/00071660120109935; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GIORGI D, 1985, BIOCHEM BIOPH RES CO, V127, P937, DOI 10.1016/S0006-291X(85)80034-6; GIORGI D, 1984, EMBO J, V3, P1521, DOI 10.1002/j.1460-2075.1984.tb02005.x; Gracia MI, 2009, ANIM FEED SCI TECH, V150, P303, DOI 10.1016/j.anifeedsci.2008.10.005; IKEGAMI S, 1990, J NUTR, V120, P353, DOI 10.1093/jn/120.4.353; Iwamori M, 1997, BIOCHEM BIOPH RES CO, V237, P262, DOI 10.1006/bbrc.1997.7128; Konturek PC, 2003, J PHYSIOL PHARMACOL, V54, P17; KROGDAHL A, 1989, POULTRY SCI, V68, P1561, DOI 10.3382/ps.0681561; Lemme A, 2004, WORLD POULTRY SCI J, V60, P423, DOI 10.1079/WPS200426; Li JJ, 2005, MICROPOR MESOPOR MAT, V79, P79, DOI 10.1016/j.micromeso.2004.10.023; LUKASZEWSKI L, 1988, AM J PHYSIOL, V254, pR17, DOI 10.1152/ajpregu.1988.254.1.R17; MAHAGNA M, 1995, REPROD NUTR DEV, V35, P201, DOI 10.1051/rnd:19950208; Marsman GJP, 1997, POULTRY SCI, V76, P864, DOI 10.1093/ps/76.6.864; Meng X, 2005, POULTRY SCI, V84, P37, DOI 10.1093/ps/84.1.37; NITSAN Z, 1991, BRIT POULTRY SCI, V32, P515, DOI 10.1080/00071669108417376; NOY Y, 1995, POULTRY SCI, V74, P366, DOI 10.3382/ps.0740366; Olukosi OA, 2007, POULTRY SCI, V86, P77, DOI 10.1093/ps/86.1.77; Parsons CM, 1997, POULTRY SCI, V76, P361, DOI 10.1093/ps/76.2.361; PEKAS JC, 1991, J NUTR, V121, P563, DOI 10.1093/jn/121.4.563; Pinheiro DF, 2004, POULTRY SCI, V83, P1544, DOI 10.1093/ps/83.9.1544; Reddy VR, 1997, BRIT POULTRY SCI, V38, P263, DOI 10.1080/00071669708417984; REHFELD JF, 1980, CLIN GASTROENTEROL, V9, P593; Scheideler SE, 2005, J APPL POULTRY RES, V14, P77, DOI 10.1093/japr/14.1.77; SOMOGYI M, 1960, CLIN CHEM, V6, P23; Takiguchi S, 2002, PANCREAS, V24, P276, DOI 10.1097/00006676-200204000-00011; VERDUIN PA, 1973, CLIN CHIM ACTA, V46, P11, DOI 10.1016/0009-8981(73)90096-X; Walk CL, 2011, POULTRY SCI, V90, P91, DOI 10.3382/ps.2010-00760; Wang Y, 2002, AM J PHYSIOL-GASTR L, V282, pG16, DOI 10.1152/ajpgi.2002.282.1.G16; WARD AT, 1983, POULTRY SCI, V62, P1054, DOI 10.3382/ps.0621054; WICKER C, 1988, BIOCHIMIE, V70, P1277, DOI 10.1016/0300-9084(88)90195-2; Yin YL, 2004, J ANIM FEED SCI, V13, P445, DOI 10.22358/jafs/67611/2004; Yin YL, 2001, LIVEST PROD SCI, V71, P109, DOI 10.1016/S0301-6226(01)00215-9; Yin YL, 2001, LIVEST PROD SCI, V71, P97, DOI 10.1016/S0301-6226(01)00214-7; Zanella I, 1999, POULTRY SCI, V78, P561, DOI 10.1093/ps/78.4.561; Zhang L, 2014, ASIAN AUSTRAL J ANIM, V27, P855, DOI 10.5713/ajas.2014.14006	52	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173941	10.1371/journal.pone.0173941	http://dx.doi.org/10.1371/journal.pone.0173941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323908	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000045
J	Hegen, H; Auer, M; Bsteh, G; Di Pauli, F; Plavina, T; Walde, J; Deisenhammer, F; Berger, T				Hegen, Harald; Auer, Michael; Bsteh, Gabriel; Di Pauli, Franziska; Plavina, Tatiana; Walde, Janette; Deisenhammer, Florian; Berger, Thomas			Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIRUS SEROPREVALENCE; RISK STRATIFICATION; HUMAN SERUM; NATALIZUMAB; COHORT; PLASMA; SEROCONVERSION; PREVALENCE	Background Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies. Objective To investigate the longitudinal evolution of anti-JCV antibody index and to determine the predictive value of baseline anti-JCV antibody index for long-term stability of anti-JCV antibody status. Methods MS patients from the MS centre of Medical University of Innsbruck, who had serum sampling for a time period of 4 - 6 years at intervals of 6 +/- 3 months, were included in this retrospective, longitudinal study. Anti-JCV antibody serological status and index were determined by 2-step second-generation anti-JCV antibody assay. Results 154 patients were included in this study. Median follow-up time was 63.7 months, with median 11 samples available per patient. At baseline, 111 (72.1%) patients were anti-JCV antibody positive. Baseline anti-JCV antibody index significantly correlated with age (R = 0.22, p = 0.005); there was no difference with respect to sex, disease duration or previously used disease-modifying treatment. During follow-up anti-JCV antibody status changed from negative to positive or vice versa in 17% of patients. In seronegative patients at baseline, baseline anti-JCV antibody index was significantly lower in those remaining seronegative at follow-up compared to those converting to seropositivity (median 0.16 vs. 0.24, p = 0.002). In seropositive patients at baseline, index was higher in those remaining seropositive compared to those reverting to seronegativity (2.6 vs. 0.45, p< 10(-7)). Baseline anti-JCV antibody index >0.90 predicted stable positive serostatus (sensitivity 88.7%, specificity 96.5%) and < 0.20 stable negative serostatus (sensitivity 61.3%, specificity 97.6%). Conclusions Anti-JCV antibody index remained relatively stable over 6-year follow-up with annual serostatus change of similar to 3%. Baseline anti-JCV antibody index predicted stable negative and stable positive JCV serostatus.	[Hegen, Harald; Auer, Michael; Bsteh, Gabriel; Di Pauli, Franziska; Deisenhammer, Florian; Berger, Thomas] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Plavina, Tatiana] Biogen, Cambridge, MA USA; [Walde, Janette] Univ Innsbruck, Fac Econ & Stat, Dept Stat, Innsbruck, Austria	Medical University of Innsbruck; Biogen; University of Innsbruck	Hegen, H (corresponding author), Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.	harald.hegen@i-med.ac.at	Walde, Janette/HCH-4003-2022	Walde, Janette/0000-0002-1241-5292; Berger, Thomas/0000-0001-5626-1144	Biogen	Biogen(Biogen)	The funder (Biogen) provided financial support (recipient TB) for the laboratory work (determination of anti-JCVantibody status and index). TP as an employee of the funder contributed to the analysis and interpretation of the data and revision of the manuscript for its intellectual content. The funder did not play a role in study design, data collection, decision to publish and preparation of the original draft. The specific roles of the authors are articulated in the author contributions section.	Aladro Y, 2016, J NEUROL SCI, V365, P16, DOI 10.1016/j.jns.2016.03.050; Alroughani R, 2016, J NEUROL SCI, V360, P61, DOI 10.1016/j.jns.2015.11.044; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Bozic C, 2011, ANN NEUROL, V70, P713, DOI 10.1002/ana.22606; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Kister I, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000029; Kolasa M, 2016, ACTA NEUROL SCAND, V133, P391, DOI 10.1111/ane.12475; Lee P, 2013, J CLIN VIROL, V57, P141, DOI 10.1016/j.jcv.2013.02.002; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Olsson T, 2013, MULT SCLER J, V19, P1533, DOI 10.1177/1352458513477925; Outteryck O., 2013, MULT SCLER; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Plavina T, 2012, J CLIN VIROL, V53, P65, DOI 10.1016/j.jcv.2011.10.003; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Raffel J, 2015, MULT SCLER J, V21, P1833, DOI 10.1177/1352458515599681; Schwab N, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000195; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Trampe AK, 2012, NEUROLOGY, V78, P1736, DOI 10.1212/WNL.0b013e3182583022; Vennegoor A, 2016, EUR J NEUROL, V23, P1079, DOI 10.1111/ene.12988	21	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174005	10.1371/journal.pone.0174005	http://dx.doi.org/10.1371/journal.pone.0174005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319193	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800041
J	Maman, S; Murray, KR; Mavedzenge, SN; Oluoch, L; Sijenje, F; Agot, K; Thirumurthy, H				Maman, Suzanne; Murray, Katherine R.; Mavedzenge, Sue Napierala; Oluoch, Lennah; Sijenje, Florence; Agot, Kawango; Thirumurthy, Harsha			A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CARE; TRANSMISSION; CLIENTS; TRIAL	Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approach that is gaining ground in sub-Saharan Africa as a strategy to increase knowledge of HIV status and promote safer sexual decisions. However, little is known about self-test distribution strategies that are optimal for increasing testing access among hard-toreach and high risk individuals. We conducted a qualitative study with 18 FSW who participated in a larger study that provided them with five oral fluid-based self-tests, training on how to use the tests, and encouragement to offer the self-tests to their sexual partners using their discretion. Women demonstrated agency in the strategies they used to introduce self-tests to their partners and to avoid conflict with partners. They carefully considered with whom to share self-tests, often assessing the possibility for negative reactions from partners as part of their decision making process. When women faced negative reactions from partners, they drew on strategies they had used before to avoid conflict and physical harm from partners, such as not responding to angry partners and forgoing payment to leave angry partners quickly. Some women also used self-tests to make more informed sexual decisions with their partners.	[Maman, Suzanne] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Murray, Katherine R.] FHI360, Durham, NC USA; [Mavedzenge, Sue Napierala] Res Triangle Int, San Francisco, CA USA; [Oluoch, Lennah; Sijenje, Florence; Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Thirumurthy, Harsha] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Maman, S (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA.	smaman@unc.edu		Murray, Katherine/0000-0002-5990-0594; Napierala, Sue/0000-0003-1146-8154; Thirumurthy, Harsha/0000-0002-3308-7603	Bill and Melinda Gates Foundation [OPP1069673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, K01HD061605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH110316] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Bill and Melinda Gates Foundation (grant no. OPP1069673).; This study was funded by the Bill and Melinda Gates Foundation (grant no. OPP1107923). We thank all study participants for sharing their experience and giving their time. We also thank Immaculate Akello for assistance in implementing the study, Manali Nekkanti for help coding the qualitative data, the research assistants who conducted enrollment and follow-up, as well as staff at the health facility and drop-in center.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; [Anonymous], 2014, 909090 UNAIDS; ATLAS.ti, 2016, SCI SOFTWARE DEV; Balan IC, 2013, AIDS BEHAV; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Jakubowski A, 2015, JAIDS J ACQUIRED IMM; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; National AIDS and STI Control Programme Ministry of Health, 2015, GUID HIV TEST SERV K; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Osoti AO, 2014, AIDS, V28, P95, DOI 10.1097/QAD.0000000000000023; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Shand T, 2014, IDS BULL-I DEV STUD, V45, P53, DOI 10.1111/1759-5436.12068; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; Vandenhoudt HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054953; Voeten HACM, 2002, SEX TRANSM DIS, V29, P444, DOI 10.1097/00007435-200208000-00003; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, GUID HIV SELF TEST P; WHO, 2011, PREV HIV SEX WORK SE	27	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174629	10.1371/journal.pone.0174629	http://dx.doi.org/10.1371/journal.pone.0174629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346527	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300065
J	Maxwell, DJ; Partridge, JC; Roberts, NW; Boonham, N; Foster, GD				Maxwell, D. J.; Partridge, J. C.; Roberts, N. W.; Boonham, N.; Foster, G. D.			The effects of surface structure mutations in Arabidopsis thaliana on the polarization of reflections from virus-infected leaves	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; ECERIFERUM MUTANTS; ANTIVIRAL DEFENSE; MYZUS-PERSICAE; POTATO PLANTS; WAX; BIOSYNTHESIS; REFLECTANCE; EXPRESSION; VECTORS	The way in which light is polarized when reflected from leaves can be affected by infection with plant viruses. This has the potential to influence viral transmission by insect vectors due to altered visual attractiveness of infected plants. The optical and topological properties of cuticular waxes and trichomes are important determinants of how light is polarized upon reflection. Changes in expression of genes involved in the formation of surface structures have also been reported following viral infection. This paper investigates the role of altered surface structures in virus-induced changes to polarization reflection from leaves. The percentage polarization of reflections from Arabidopsis thaliana cer5, cer6 and cer8 wax synthesis mutants, and the gll leaf hair mutant, was compared to those from wild-type (WT) leaves. The cer5 mutant leaves were less polarizing than WT on the adaxial and abaxial surfaces; gll leaves were more polarizing than WT on the adaxial surfaces. The cer6 and cer8 mutations did not significantly affect polarization reflection. The impacts of Turnip vein clearing virus (TVCV) infection on the polarization of reflected light were significantly affected by cer5 mutation, with the reflections from cer5 mutants being higher than those from WT leaves, suggesting that changes in CER5 expression following infection could influence the polarization of the reflections. There was, however, no significant effect of the gll mutation on polarization following TVCV infection. The cer5 and gll mutations did not affect the changes in polarization following Cucumber mosaic virus (CMV) infection. The accumulation of TVCV and CMV did not differ significantly between mutant and WT leaves, suggesting that altered expression of surface structure genes does not significantly affect viral titres, raising the possibility that if such regulatory changes have any adaptive value it may possibly be through impacts on viral transmission.	[Maxwell, D. J.; Roberts, N. W.; Foster, G. D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Partridge, J. C.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Partridge, J. C.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Boonham, N.] Food & Environm Res Agcy, York, N Yorkshire, England	University of Bristol; University of Western Australia; University of Western Australia; Food & Environment Research Agency	Foster, GD (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	gary.foster@bristol.ac.uk	Foster, Gary D/A-7985-2011; Partridge, Julian C/F-2097-2014	Foster, Gary D/0000-0002-1979-1397; Partridge, Julian C/0000-0003-3788-2900; Boonham, Neil/0000-0002-8886-5708; Roberts, Nicholas/0000-0002-4540-6683	NERC; BBSRC [BB/G022917/1] Funding Source: UKRI; EPSRC [EP/M000885/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by NERC, http://ww.nerc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2007, ENTOMOL EXP APPL, V125, P135, DOI 10.1111/j.1570-7458.2007.00607.x; Deng P, 2013, ACTA ENTOMOL SINICA, V56, P644; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Garbay B, 2007, PLANT SCI, V172, P299, DOI 10.1016/j.plantsci.2006.09.001; GRANT L, 1987, REMOTE SENS ENVIRON, V22, P309, DOI 10.1016/0034-4257(87)90064-2; GRANT L, 1987, ENVIRON EXP BOT, V27, P139, DOI 10.1016/0098-8472(87)90064-5; GRANT L, 1993, PHYSIOL PLANTARUM, V88, P1, DOI 10.1111/j.1399-3054.1993.tb01753.x; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mauck KE, 2014, PLANT CELL ENVIRON, V37, P1427, DOI 10.1111/pce.12249; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Maxwell DJ, 2016, PLOS ONE, V11, P1; McMenemy LS, 2012, ENTOMOL EXP APPL, V144, P56, DOI 10.1111/j.1570-7458.2012.01248.x; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Powell G, 1999, ENTOMOL EXP APPL, V91, P115, DOI 10.1023/A:1003639225674; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; VANDERBILT VC, 1985, P IEEE, V73, P1012, DOI 10.1109/PROC.1985.13232; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206	23	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174014	10.1371/journal.pone.0174014	http://dx.doi.org/10.1371/journal.pone.0174014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346494	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300018
J	Hallajzadeh, J; Safiri, S; Mansournia, MA; Khoramdad, M; Izadi, N; Almasi-Hashiani, A; Pakzad, R; Ayubi, E; Sullman, MJM; Karamzad, N				Hallajzadeh, Jamal; Safiri, Saeid; Mansournia, Mohammad Ali; Khoramdad, Maliheh; Izadi, Neda; Almasi-Hashiani, Amir; Pakzad, Reza; Ayubi, Erfan; Sullman, Mark J. M.; Karamzad, Nahid			Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis	PLOS ONE			English	Review							DISEASE-ACTIVITY; CARDIOMETABOLIC RISK; PREVALENCE; FREQUENCY; ASSOCIATION; WOMEN; COHORT	Background Estimating the current global prevalence of metabolic syndrome (MetS), and its components, among rheumatoid arthritis (RA) patients is necessary in order to formulate preventative strategies and to ensure there are adequate community resources available for these patients. Furthermore, the association between RA and MetS is controversial and has not previously been comprehensively assessed. Therefore, the present study aimed to: 1) determine the prevalence of MetS, and its components, among RA patients across the world 2) update the odds ratio of MetS in RA patients, compared to healthy controls, using a comprehensive systematic review and meta-analysis. Methods International databases, including: the Web of Science, PubMed, Scopus, Embase, CINAHL and other relevant databases were searched to identify English language articles which reported the prevalence and risk of MetS in RA patients between January 2000 and August 2016. The meta-analysis only included studies which clearly described the time and location of the study, utilised adequate sampling strategies, and appropriate statistical analyses. Results The meta-analyses of prevalence (70 studies [n = 12612]) and risk (43 studies [n = 35220]) of MetS in RA patients were undertaken separately. The overall pooled prevalence of MetS was 30.65% (95% CI: 27.87-33.43), but this varied from 14.32% (95% CI: 10.59-18.05) to 37.83% (95% CI: 31.05-44.61), based upon the diagnostic criteria used. The prevalence of MetS also varied slightly between males (31.94%, 95% CI: 24.37-39.51) and females (33.03%, 95% CI: 28.09-37.97), but this was not statistically significant. The overall pooled odds ratio (OR) of MetS in RA patients, compared to healthy controls, was 1.44 (95% CI: 1.20-1.74), but this ranged from 0.70 (95% CI: 0.27-1.76) to 4.09 (95% CI: 2.03-8.25), depending on the criteria used. The mean age and diagnostic criteria of MetS were identified as sources of heterogeneity in the estimated odds ratios between studies (P<0.05). Conclusions According to the high prevalence of MetS in RA patients, and high risk of MetS, measuring metabolic syndrome in RA patients is strongly recommended. Furthermore, as high waist circumference (WC) is the most common metabolic syndrome component, more attention must be paid to nutrition and weight loss among those with RA.	[Hallajzadeh, Jamal] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Community Nutr, Tehran, Iran; [Hallajzadeh, Jamal; Safiri, Saeid] Maragheh Univ Med Sci, Sch Nursing & Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran; [Safiri, Saeid; Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Khoramdad, Maliheh] Kermanshah Univ Med Sci, Dept Epidemiol & Biostat, Fac Hlth, Kermanshah, Iran; [Izadi, Neda] Shahid Beheshti Univ Med Sci, Dept Epidemiol, Sch Publ Hlth, Tehran, Iran; [Almasi-Hashiani, Amir] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Dept Epidemiol & Reprod Hlth, Tehran, Iran; [Pakzad, Reza] Ilam Univ Med Sci, Fac Hlth, Dept Epidemiol, Ilam, Iran; [Ayubi, Erfan] Zabol Univ Med Sci, Dept Publ Hlth, Sch Publ Hlth, Zabol, Iran; [Sullman, Mark J. M.] Cranfield Univ, Driving Res Grp, Cranfield, Beds, England; [Karamzad, Nahid] Maragheh Univ Med Sci, Food & Drug, Maragheh, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Kermanshah University of Medical Sciences; Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Cranfield University	Safiri, S (corresponding author), Maragheh Univ Med Sci, Sch Nursing & Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran.; Safiri, S (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.; Karamzad, N (corresponding author), Maragheh Univ Med Sci, Food & Drug, Maragheh, Iran.	saeidsafiri@gmail.com; nahidkaramzad@gmail.com	Safiri, Saeid/A-1678-2017; Almasi-Hashiani, Amir/P-3356-2018; Ayubi, Erfan/AAD-3213-2019; Pakzad, Reza/X-7386-2018	Safiri, Saeid/0000-0001-7986-9072; Almasi-Hashiani, Amir/0000-0003-4434-561X; Pakzad, Reza/0000-0001-8133-3664; Izadi, Neda/0000-0002-6373-1113; Sullman, Mark/0000-0001-7920-6818				Abdul-Qaharr Z, IOSR J DENT MED SCI, V1, p69 ; Abourazzak FE, 2014, CLIN RHEUMATOL, V33, P1549, DOI 10.1007/s10067-014-2570-x; Baker JF, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.01.025; Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004; Craciun L., 2014, ACTA MED MARISIEN, V60, DOI [10.2478/amma-2014-0041, DOI 10.2478/AMMA-2014-0041]; Crowson CS, 2011, J RHEUMATOL, V38, P29, DOI 10.3899/jrheum.100346; da Cunha VR, 2012, SCAND J RHEUMATOL, V41, P186, DOI 10.3109/03009742.2011.626443; Dabrowski Piotr, 2015, Wiad Lek, V68, P235; Dao H- H, 2010, ARTHRITIS RES THER, V12, P1; Dao HH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3203; Dessein PH, 2006, J RHEUMATOL, V33, P2425; Dihingia P, INCREASE FREQUENCY M, V41, p56 9; Ferraz-Amaro I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/710928; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Ghazaly AHAH, 2016, EGYPT RHEUMATOL, V38, P9, DOI 10.1016/j.ejr.2015.03.001; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P3173, DOI 10.1002/art.27629; Goshayeshi L, 2012, CLIN RHEUMATOL, V31, P1197, DOI 10.1007/s10067-012-1995-3; de Oliveira BMGB, 2016, REV BRAS REUMATOL, V56, P117, DOI 10.1016/j.rbre.2015.08.016; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Salinas MJH, 2013, JCR-J CLIN RHEUMATOL, V19, P439, DOI 10.1097/RHU.0000000000000039; Hugo M, 2016, RHEUMATOLOGY; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Karakoc Mehmet, 2012, J Clin Med Res, V4, P279, DOI 10.4021/jocmr1001w; Karimi M, 2011, INT J RHEUM DIS, V14, P248, DOI 10.1111/j.1756-185X.2011.01595.x; Karvounaris SA, 2007, ANN RHEUM DIS, V66, P28, DOI 10.1136/ard.2006.053488; Kerekes G, 2014, NAT REV RHEUMATOL, V10, P691, DOI 10.1038/nrrheum.2014.121; Kojima M, 2009, J PSYCHOSOM RES, V67, P425, DOI 10.1016/j.jpsychores.2009.01.001; Kumar BS, PREVALENCE THYROID D; La Montagna G, 2006, SCAND J RHEUMATOL; La Montagna Giovanni, 2007, Diab Vasc Dis Res, V4, P130; Lee SH, 2016, KOREAN J FAM MED, V37, P44, DOI 10.4082/kjfm.2016.37.1.44; Lee SG, 2013, KOREAN J INTERN MED, V28, P206, DOI 10.3904/kjim.2013.28.2.206; Manka V, 2012, ACTA MEDICA MARTINIA, V12, P19; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mok CC, 2011, ARTHRIT CARE RES, V63, P195, DOI 10.1002/acr.20363; Muller R, 2016, RHEUMATOL INT, P1; Nguyen VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132557; Ormseth MJ, 2013, ARTHRIT CARE RES, V65, P1410, DOI 10.1002/acr.22027; Ozmen M, 2014, EUR J RHEUMATOL, V1, P1, DOI 10.5152/eurjrheum.2014.001; Parra-Salcedo F, 2015, ARTHRITIS RESEARCH T, P17; Parra-Salcedo F, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0549-x; Rai D, 2015, RHEUMATOL INT, V35, P2047; Raterman HG, 2010, ANN RHEUM DIS, V69, P39, DOI 10.1136/ard.2008.100776; Rostom S, 2013, BMC MUSCULOSKEL DIS, V14, P1; Rostom S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-147; Sahebari M, 2011, THESCIENTIFICWORLDJO, V11, P1195, DOI 10.1100/tsw.2011.111; Santos MJ, 2010, ACTA REUMATOL PORT, V35, P325; Sidiropoulos PI, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2397; Solomon A, 2010, J RHEUMATOL, V37, P953, DOI 10.3899/jrheum.091032; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Tantayakom P, 2016, JOINT BONE SPINE; Tierney M, 2012, J PHYS ACT HEALTH, V9, P1036, DOI 10.1123/jpah.9.7.1036; Tillin T, 2005, DIABETOLOGIA, V48, P649, DOI 10.1007/s00125-005-1689-3; Toms TE, 2009, ARTHRITIS RES THER, V11, P1; Tuna S, INT J CLIN EXPT MED; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Zafar ZA, FREQUENCY METABOLIC; Zafar ZA, 2016, J PAK MED ASSOC, V66, P671; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078151; Zonana-Nacach A, 2008, JCR-J CLIN RHEUMATOL, V14, P74, DOI 10.1097/RHU.0b013e31816b2faa	61	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0170361	10.1371/journal.pone.0170361	http://dx.doi.org/10.1371/journal.pone.0170361			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333949	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200002
J	Krzyzanski, W; Rao, GG				Krzyzanski, Wojciech; Rao, Gauri G.			Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B	PLOS ONE			English	Article							PHARMACODYNAMIC MODEL; ESCHERICHIA-COLI; ANTIBIOTICS; SYSTEMS	The purpose of this report is to apply multi-scale modeling using the theory of physiologically structured populations (PSP) to develop a mathematical model for antimicrobial resistance based on a heterogeneous distribution of receptors and affinities among bacterial cells. The theory has been tested on data obtained from an in vitro static time-kill infection model analyzing the pharmacodynamics of polymyxin B against Gram-negative bacteria. The drug binding parameter K-D (dissociation equilibrium constant) is assumed to vary between the bacterial cells. The PSP model describes the time course of the density distribution of K-D upon exposure to cytotoxic drug concentrations. The drug increases the hazard of cell death as a function of receptor occupancy. The initial distribution of K-D is described by the Weibull function. Time-kill data were used for model qualification. In vitro static time-kill experiments to evaluate the rate and extent of killing due to polymyxin B against two Klebsiella pneumoniae clinical isolates with differing susceptibilities to polymyxin B were performed over 48 h. The time-kill kinetics data of bacterial load cfu (colony forming units)/mL was used for model qualification. The resistant bacterial population is determined by the balance between growth rate and hazard of cell death controlled by polymyxin B concentrations. There exists a critical K-D value below which cells continue to grow. Estimates of shape parameters for distributions of K-D yielded unimodal distributions with the modes at 0 nM and the right tails containing approximately 25% of the bacteria. Our findings support a hypothesis that resistance of Klebsiella pneumoniae to polymyxin B can be at least partially attributed to a drug-induced selection of a subpopulation due to heterogeneity of polymyxin B receptor binding in the bacterial population.	[Krzyzanski, Wojciech; Rao, Gauri G.] Univ Buffalo, Dept Pharmaceut Sci, Sch Pharm Practice & Pharmaceut Sci, Buffalo, NY 14228 USA; [Rao, Gauri G.] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill	Rao, GG (corresponding author), Univ Buffalo, Dept Pharmaceut Sci, Sch Pharm Practice & Pharmaceut Sci, Buffalo, NY 14228 USA.; Rao, GG (corresponding author), Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.	gaurirao@live.unc.edu						BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bulitta JB, 2010, ANTIMICROB AGENTS CH, V54, P2051, DOI 10.1128/AAC.00881-09; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; De Roos A. M., 1997, POPULATION COMMUNITY, V18; de Trixhe XW, 2015, J THEOR BIOL, V378, P1, DOI 10.1016/j.jtbi.2015.04.017; Diekmann O, 2007, MATH ECOLOGY ENV SCI; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Gehring R, 2010, J THEOR BIOL, V262, P97, DOI 10.1016/j.jtbi.2009.09.002; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; Luzyanina T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-26; Ly NS, 2015, J ANTIMICROB CHEMOTH, V70, P1434, DOI 10.1093/jac/dku567; Meagher AK, 2004, ANTIMICROB AGENTS CH, V48, P2061, DOI 10.1128/AAC.48.6.2061-2068.2004; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Sandoval-Motta S, 2016, WIRES SYST BIOL MED, V8, P253, DOI 10.1002/wsbm.1335; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200	19	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0171834	10.1371/journal.pone.0171834	http://dx.doi.org/10.1371/journal.pone.0171834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334005	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200003
J	Tan, SY; Baig, N; Hansapinyo, L; Jhanji, V; Wei, SH; Tham, CC				Tan, Shaoying; Baig, Nafees; Hansapinyo, Linda; Jhanji, Vishal; Wei, Shihui; Tham, Clement C.			Comparison of self-measured diurnal intraocular pressure profiles using rebound tonometry between primary angle closure glaucoma and primary open angle glaucoma patients	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETER; VISUAL-FIELD PROGRESSION; RISK-FACTOR; MANAGEMENT; CHILDREN; INTERVENTION; FLUCTUATION; PERIMETRY; EYES	Purpose To document the diurnal intraocular pressure (IOP) profile with rebound tonometry performed by primary glaucoma patients in non-clinic environment. Patients and methods Fifty-three medically-treated eyes of 31 primary angle closure glaucoma (PACG) and 22 primary open angle glaucoma (POAG) patients with no previous eye surgery were recruited. Diurnal IOP was measured 5 times per day at four-hourly intervals from 08: 00 to 24: 00 for 1 week in patients' study eye using rebound tonometry in a non-clinic environment. The diurnal IOP profiles were compared between PACG and POAG eyes. Results For both PACG and POAG eyes, mean patient-measured IOP was highest in the morning, gradually decreased over the course of a day, and was lowest by midnight (p < 0.001). The diurnal IOP fluctuation +/- 1 standard deviation (SD), as documented by SD in daily IOP values, was lower in PACG group (1.6 +/- 1.1 mmHg) than in POAG group (2.0 +/- 1.2 mmHg; p = 0.049). The mean trough IOP +/- 1 SD was higher in PACG group (12.9 +/- 2.8 mmHg), compared to POAG group (11.5 +/- 3.8 mmHg; p = 0.041). The mean IOP level at midnight +/- 1 SD in PACG group (14.0 +/- 3.2 mmHg) was higher than that in POAG group (12.1 +/- 3.7 mmHg; p = 0.013). Conclusions IOP in primary glaucoma patients was highest in the morning, and decreased over the course of a day in non-clinic environment. Treated diurnal IOP fluctuation seemed to be greater in POAG than PACG eyes.	[Tan, Shaoying; Baig, Nafees; Hansapinyo, Linda; Jhanji, Vishal; Tham, Clement C.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China; [Tan, Shaoying; Wei, Shihui] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Baig, Nafees; Hansapinyo, Linda; Jhanji, Vishal; Tham, Clement C.] Hong Kong Eye Hosp, Kowloon, Hong Kong, Peoples R China; [Hansapinyo, Linda] Chiang Mai Univ, Dept Ophthalmol, Fac Med, Chiang Mai, Thailand; [Jhanji, Vishal; Tham, Clement C.] Prince Wales Hosp, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese People's Liberation Army General Hospital; Chiang Mai University; Chinese University of Hong Kong; Prince of Wales Hospital	Tham, CC (corresponding author), Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China.; Tham, CC (corresponding author), Hong Kong Eye Hosp, Kowloon, Hong Kong, Peoples R China.; Tham, CC (corresponding author), Prince Wales Hosp, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China.	clemtham@cuhk.edu.hk	Tan, Shaoying/T-6816-2019; Tham, Chee Yung Clement/AAD-6528-2020	Tham, Chee Yung Clement/0000-0003-4407-6907; Hansapinyo, Linda/0000-0002-4718-798X; Tan, Shaoying/0000-0001-9997-7396	Chinese University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong)	This project is supported by Direct Grant for Research from the Chinese University of Hong Kong 2011-2012. The funding organization had no role in the design or conduct of this research	Anderson DR, 2000, AM J OPHTHALMOL, V130, P827, DOI 10.1016/S0002-9394(00)00665-6; Asrani S, 2000, J GLAUCOMA, V9, P134; Asrani S, 2011, J GLAUCOMA, V20, P74, DOI 10.1097/IJG.0b013e3181d78811; Baskaran M, 2009, OPHTHALMOLOGY, V116, P2300, DOI 10.1016/j.ophtha.2009.06.010; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Choudhari NS, 2009, OPHTHALMOLOGY, V116, P3, DOI 10.1016/j.ophtha.2008.06.020; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Dabasia PL, 2016, BRIT J OPHTHALMOL, V100, P1139, DOI 10.1136/bjophthalmol-2015-307674; DAVID R, 1992, BRIT J OPHTHALMOL, V76, P280, DOI 10.1136/bjo.76.5.280; DRANCE SM, 1963, ARCH OPHTHALMOL-CHIC, V70, P302, DOI 10.1001/archopht.1963.00960050304004; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Fischer N, 2013, OPHTHALMOLOGE, V110, P755, DOI 10.1007/s00347-012-2774-x; Flemmons MS, 2011, AM J OPHTHALMOL, V152, P470, DOI 10.1016/j.ajo.2011.03.001; Gandhi NG, 2012, AM J OPHTHALMOL, V154, P843, DOI 10.1016/j.ajo.2012.05.003; Grigorian F, 2012, J AAPOS, V16, P508, DOI 10.1016/j.jaapos.2012.07.004; Halkiadakis I, 2012, GRAEF ARCH CLIN EXP, V250, P1207, DOI 10.1007/s00417-011-1875-6; Heijl A, 2011, ACTA OPHTHALMOL, V89, P309, DOI 10.1111/j.1755-3768.2011.02169.x; Hsiao YC, 2012, J AAPOS, V16, P58, DOI 10.1016/j.jaapos.2011.10.005; Hughes E, 2003, J GLAUCOMA, V12, P232, DOI 10.1097/00061198-200306000-00009; Katavisto M, 1964, ACTA OPHTHALMOL S78, P71; Kim KN, 2013, ACTA OPHTHALMOL, V91, pE392, DOI 10.1111/aos.12109; KITAZAWA Y, 1975, AM J OPHTHALMOL, V79, P557, DOI 10.1016/0002-9394(75)90792-8; Kontiola AI, 2000, ACTA OPHTHALMOL SCAN, V78, P142, DOI 10.1034/j.1600-0420.2000.078002142.x; Lazzaro EC, 2013, J GLAUCOMA; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; NEWELL FW, 1965, AM J OPHTHALMOL, V59, P840, DOI 10.1016/0002-9394(65)93016-3; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Poostchi A, 2009, CLIN EXP OPHTHALMOL, V37, P687, DOI 10.1111/j.1442-9071.2009.02109.x; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sigle KJ, 2011, VET OPHTHALMOL, V14, P48, DOI 10.1111/j.1463-5224.2011.00913.x; Sihota R., 2005, Indian Journal of Ophthalmology, V53, P243; SMITH J, 1985, OPHTHALMOLOGY, V92, P858; Tan SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42067; Tan SY, 2015, INVEST OPHTH VIS SCI, V56, P4994, DOI 10.1167/iovs.15-17245; Wilensky Jacob T, 2004, Curr Opin Ophthalmol, V15, P90, DOI 10.1097/00055735-200404000-00005; WILENSKY JT, 1993, OPHTHALMOLOGY, V100, P940; YAMAGAMI J, 1993, OPHTHALMOLOGY, V100, P643; ZARETSKAYA RB, 1948, AM J OPHTHALMOL, V31, P721, DOI 10.1016/S0002-9394(48)91920-5	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173905	10.1371/journal.pone.0173905	http://dx.doi.org/10.1371/journal.pone.0173905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333942	Green Published, gold			2022-12-27	WOS:000399102200028
J	Tao, CY; Li, J; Chen, BB; Chi, DM; Zeng, YQ; Liu, HL				Tao, Chenyu; Li, Juan; Chen, Baobao; Chi, Daming; Zeng, Yaqiong; Liu, Honglin			Genome-scale identification of nucleosome organization by using 1000 porcine oocytes at different developmental stages	PLOS ONE			English	Article							OVARIAN FOLLICULAR DEVELOPMENT; IN-VITRO MATURATION; SECONDARY FOLLICLES; GROWTH; OCCUPANCY; POSITIONS; YEAST; DNA	The nucleosome is the basic structural unit of chromosomes, and its occupancy and distribution in promoters are crucial for the regulation of gene expression. During the growth process of porcine oocytes, the "growing" oocytes (SF) have a much higher transcriptional activity than the "fully grown" oocytes (BF). However, the chromosome status of the two kinds of oocytes remains poorly understood. In this study, we profiled the nucleosome distributions of SF and BF with as few as 1000 oocytes. By comparing the altered regions, we found that SF tended toward nucleosome loss and more open chromosome architecture than BF did. BF had decreased nucleosome occupancy in the coding region and increased nucleosome occupancy in the promoter compared to SF. The nucleosome occupancy of SF was higher than that of BF in the GC-poor regions, but lower than that of BF in the GC-rich regions. The nucleosome distribution around the transcriptional start site (TSS) of all the genes of the two samples was basically the same, but the nucleosome occupancy around the TSS of SF was lower than that of BF. GO functional annotation of genes with different nucleosome occupancy in promoter showed the genes were mainly involved in cell, cellular process, and metabolic process biological process. The results of this study revealed the dynamic reorganization of porcine oocytes in different developmental stages and the critical role of nucleosome arrangement during the oocyte growth process.	[Tao, Chenyu; Li, Juan; Chen, Baobao; Chi, Daming; Zeng, Yaqiong; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [31472073, 31501920]; 973 Program [2014CB138502]; State Key Program of National Natural Science Foundation of China [31630072]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (31472073), the 973 Program (2014CB138502), the State Key Program of National Natural Science Foundation of China (31630072), the National Natural Science Foundation of China (31501920), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittomaki K, 1996, J CLIN ENDOCR METAB, V81, P3722, DOI 10.1210/jc.81.10.3722; Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; [Anonymous], 2009, BIOL REPROD, V80, P1072; Aparicio IM, 2011, BIOL REPROD, V84, P910, DOI 10.1095/biolreprod.110.087411; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Blondin P, 2002, BIOL REPROD, V66, P38, DOI 10.1095/biolreprod66.1.38; Borman SM, 2004, BIOL REPROD, V71, P366, DOI 10.1095/biolreprod.103.023390; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Druliner BR, 2016, ONCOTARGET, V7, P13429, DOI 10.18632/oncotarget.6811; Dunning KR, 2007, HUM REPROD, V22, P2842, DOI 10.1093/humrep/dem277; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225; GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Huang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep17691; Hunter MG, 2000, REV REPROD, V5, P122, DOI 10.1530/revreprod/5.2.122; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kind KL, 2013, REPROD FERT DEVELOP, V25, P426, DOI 10.1071/RD11305; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MORBECK DE, 1992, BIOL REPROD, V47, P485, DOI 10.1095/biolreprod47.3.485; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reynaud K, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130955; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Tao Y, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0109-x; Ting AY, 2011, HUM REPROD, V26, P2461, DOI 10.1093/humrep/der196; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Xu J, 2010, REPRODUCTION, V140, P685, DOI 10.1530/REP-10-0284; Yeo CX, DISRUPTION BIDIRECTI; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174225	10.1371/journal.pone.0174225	http://dx.doi.org/10.1371/journal.pone.0174225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333987	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200066
J	Zhou, Y; van den Hof, S; Wang, SF; Pang, Y; Zhao, B; Xia, H; Anthony, R; Ou, XC; Li, Q; Zheng, Y; Song, YY; Zhao, YL; van Soolingen, D				Zhou, Yang; van den Hof, Susan; Wang, Shengfen; Pang, Yu; Zhao, Bing; Xia, Hui; Anthony, Richard; Ou, Xichao; Li, Qiang; Zheng, Yang; Song, Yuanyuan; Zhao, Yanlin; van Soolingen, Dick			Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey	PLOS ONE			English	Article							LARGE SEQUENCE POLYMORPHISMS; BEIJING GENOTYPE; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; EAST-ASIA; EVOLUTION; ORIGIN; FAMILY; CLONE; SPOLIGOTYPES	We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p < 0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p < 0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.	[Zhou, Yang; Wang, Shengfen; Pang, Yu; Zhao, Bing; Xia, Hui; Ou, Xichao; Li, Qiang; Zheng, Yang; Song, Yuanyuan; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [van den Hof, Susan] Amsterdam Med Ctr, Dept Global Hlth, Pietersbergweg 17, Amsterdam, Netherlands; [Anthony, Richard; van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands	Chinese Center for Disease Control & Prevention; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	Zhao, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.; van Soolingen, D (corresponding author), Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.	zhaoyanlin@chinatb.org; dick.van.soolingen@rivm.nl	Anthony, Richard/AAP-3406-2020	Anthony, Richard/0000-0002-0550-5273	National Science and Technology Key Program China [2014ZX10003002]	National Science and Technology Key Program China	This work was supported by the National Science and Technology Key Program (2014ZX10003002), China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL; Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; [Anonymous], 1979, Am Rev Respir Dis, V119, P579; Bespyatykh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28985; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Boeree MJ, 2015, AM J RESP CRIT CARE, V191, P1058, DOI 10.1164/rccm.201407-1264OC; Bouklata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135695; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; de Keijzer J., 2016, J PROTEOME RES, DOI 10.1021/acs.jproteome.5b01073; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; den Hertog AL, 2014, EMERG INFECT DIS, V20, P1932, DOI 10.3201/eid2011.130560; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; He L, 2011, THESIS; Jiao WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084315; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Kremer K, 2002, SPOLIGOTYPING PCR BA; Liu ML, 2014, INFECT GENET EVOL, V22, P23, DOI 10.1016/j.meegid.2013.12.023; Luo T, 2015, P NATL ACAD SCI USA, V112, P8136, DOI 10.1073/pnas.1424063112; Merker M, 2015, NAT GENET; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Rindi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107150; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; Rindi L, 2009, INFECT GENET EVOL, V9, P48, DOI 10.1016/j.meegid.2008.09.006; Streptomycin-in-Tuberculosis-Trials-Committee, 1948, BMJ-BRIT MED J, V2, P769, DOI [DOI 10.1136/BMJ.2.4582.769, 10.1136/bmj.2.4582.769]; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thoracic British and Association Tuberculosis, 1976, LANCET, V308, P1102; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Toit K, 2014, PUBLIC HEALTH ACTION, V4, pS34, DOI 10.5588/pha.14.0045; Urska Bidovec-Stojkovic, 2011, RESPIR MED S, V105, pS67; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Vyazovaya A, 2015, ANTIMICROB AGENTS CH, V59, P2349, DOI 10.1128/AAC.04221-14; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Witney AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0598-2; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Yin QQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34353; Yin QQ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0699-2; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	50	17	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174197	10.1371/journal.pone.0174197	http://dx.doi.org/10.1371/journal.pone.0174197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333978	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200060
J	Eliasdottir, TS; Bragason, D; Hardarson, SH; Vacchiano, C; Gislason, T; Kristjansdottir, JV; Kristjansdottir, G; Stefansson, E				Eliasdottir, Thorunn Scheving; Bragason, David; Hardarson, Sveinn Hakon; Vacchiano, Charles; Gislason, Thorarinn; Kristjansdottir, Jona Valgerdur; Kristjansdottir, Gudrun; Stefansson, Einar			Retinal oximetry measures systemic hypoxia in central nervous system vessels in chronic obstructive pulmonary disease	PLOS ONE			English	Article							VENOUS OXYGEN-SATURATION; BLOOD-FLOW; PERFUSION; RISK	Background Determination of the blood oxyhemoglobin saturation in the retinal vessels of the eye can be achieved through spectrophotometric retinal oximetry which provides access to the state of oxyhemoglobin saturation in the central nervous system circulation. The purpose of this study was to test the capability of the Oxymap T1 oximeter to detect systemic hypoxemia and the effect of supplemental oxygen on retinal vessel oxyhemoglobin saturation. Methods Oxygen saturation of hemoglobin in retinal arterioles and venules was measured in 11 subjects with severe chronic obstructive pulmonary disease (COPD) on long term oxygen therapy. Measurements were made with and without their daily supplemental oxygen. Eleven healthy age and gender matched subjects were measured during ambient air breathing for comparison of oxyhemoglobin saturation in retinal arterioles and venules. Retinal arteriolar oxyhemoglobin saturation in COPD subjects inspiring ambient air was compared with finger pulse oximetry and blood samples from radial artery. Results COPD subjects had significantly lower oxyhemoglobin saturation during ambient air breathing than healthy controls in both retinal arterioles (87.2%+/- 4.9% vs. 93.4%+/- 4.3%, p = 0.02; n = 11) and venules (45.0%+/- 10.3% vs. 55.2%+/- 5.5%, p = 0.01). Administration of their prescribed supplemental oxygen increased oxyhemoglobin saturation in retinal arterioles (87.2%+/- 4.9% to 89.5%+/- 6.0%, p = 0.02) but not in venules (45.0%+/- 10.3% to 46.7%+/- 12.8%, p = 0.3). Retinal oximetry values were slightly lower than radial artery blood values ( mean percentage points difference = -5.0 +/- 5.4, 95% CI: -15.68 to 5.67) and finger pulse oximetry values (-3.1 +/- 5.5, 95% CI: -14.05 to 7.84). Conclusions The noninvasive Oxymap T1 retinal oximetry detects hypoxemia in central nervous system vessels in patients with severe COPD compared with healthy controls. The instrument is sensitive to changes in oxygen breathing but displays slightly lower measures than finger pulse oximetry or radial artery measures. With further technological improvement, retinal oximetry may offer noninvasive "on-line" measurement of oxygen levels in central circulation in general anesthesia and critically ill patients.	[Eliasdottir, Thorunn Scheving; Hardarson, Sveinn Hakon; Kristjansdottir, Gudrun; Stefansson, Einar] Univ Iceland, Reykjavik, Iceland; [Eliasdottir, Thorunn Scheving; Bragason, David; Kristjansdottir, Jona Valgerdur; Stefansson, Einar] Natl Univ Hosp Iceland, Dept Ophthalmol, Reykjavik, Iceland; [Eliasdottir, Thorunn Scheving] Landspitali Natl Univ Hosp Iceland, Dept Anesthesiol, Reykjavik, Iceland; [Vacchiano, Charles] Duke Univ, Sch Nursing, Durham, NC USA; [Gislason, Thorarinn] Landspitali Natl Univ Hosp Iceland, Dept Resp Med & Sleep E7, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; Duke University	Eliasdottir, TS (corresponding author), Univ Iceland, Reykjavik, Iceland.; Eliasdottir, TS (corresponding author), Natl Univ Hosp Iceland, Dept Ophthalmol, Reykjavik, Iceland.; Eliasdottir, TS (corresponding author), Landspitali Natl Univ Hosp Iceland, Dept Anesthesiol, Reykjavik, Iceland.	tse@hi.is	Kristjansdottir, Gudrun/A-1737-2008	Kristjansdottir, Gudrun/0000-0002-1616-7687; Eliasdottir, Thorunn/0000-0003-4217-7050; Hardarson, Sveinn Hakon/0000-0001-5865-6756	Icelandic Fund for Prevention of Blindness; Icelandic Center for Research (Rannis); Landspitali-University Hospital Research Fund [A-2013-041, A-2014-033]; Memorial Fund of Helga Jonsdottir; Sigurlidi Kristjansson; University of Iceland	Icelandic Fund for Prevention of Blindness; Icelandic Center for Research (Rannis); Landspitali-University Hospital Research Fund; Memorial Fund of Helga Jonsdottir; Sigurlidi Kristjansson; University of Iceland	This study was funded by the Icelandic Fund for Prevention of Blindness, The Icelandic Center for Research (Rannis), University of Iceland, Landspitali-University Hospital Research Fund A-2013-041 & A-2014-033, Memorial Fund of Helga Jonsdottir and Sigurlidi Kristjansson.	Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Denninghoff KR, 2003, J APPL PHYSIOL, V94, P891, DOI 10.1152/japplphysiol.01197.2001; Dutton Richard P, 2007, Anesthesiol Clin, V25, P23, DOI 10.1016/j.atc.2006.11.007; Eliasdottir TS, 2015, GRAEF ARCH CLIN EXP, V253, P1653, DOI 10.1007/s00417-014-2849-2; FLENLEY DC, 1981, LANCET, V1, P681; Geirsdottir A, 2012, INVEST OPHTH VIS SCI, V53, P5433, DOI 10.1167/iovs.12-9912; Guyton A.C., 2006, TXB MED PHYSL; Habib J, 2012, VASC MED, V17, P352, DOI 10.1177/1358863X12451514; Hammer M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976032; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Harris A, 2003, OPHTHAL SURG LAS IM, V34, P152, DOI 10.3928/1542-8877-20030301-16; HAYREH S S, 1963, Br J Ophthalmol, V47, P651, DOI 10.1136/bjo.47.11.651; HEISTAD DD, 1980, CIRCULATION, V61, P463, DOI 10.1161/01.CIR.61.3.463; Jorgensen CM, 2014, ACTA OPHTHALMOL, V92, P34, DOI 10.1111/aos.12283; Olafsdottir OB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128780; Palkovits S, 2014, AM J PHYSIOL-HEART C, V307, pH1412, DOI 10.1152/ajpheart.00479.2014; Palkovits S, 2013, INVEST OPHTH VIS SCI, V54, P1008, DOI 10.1167/iovs.12-10504; Palsson O, 2012, INVEST OPHTH VIS SCI, V53, P1729, DOI 10.1167/iovs.11-8621; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; Riva CE, 2011, ADLERS PHYSL EYE, P243, DOI [10.1016/b978-0-323-05714-1.00010-8, DOI 10.1016/B978-0-323-05714-1.00010-8]; Schallom L, 2007, HEART LUNG, V36, P188, DOI 10.1016/j.hrtlng.2006.07.007; Schweitzer D, 1999, IEEE T BIO-MED ENG, V46, P1454, DOI 10.1109/10.804573; Traustason S, 2013, INVEST OPHTH VIS SCI, V54, P2746, DOI 10.1167/iovs.12-11284; Traustason S, 2011, INVEST OPHTH VIS SCI, V52, P5064, DOI 10.1167/iovs.11-7275; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43	27	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174026	10.1371/journal.pone.0174026	http://dx.doi.org/10.1371/journal.pone.0174026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328974	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700044
J	Guerra, PA; Reppert, SM				Guerra, Patrick A.; Reppert, Steven M.			Dimorphic cocoons of the cecropia moth (Hyalophora cecropia): Morphological, behavioral, and biophysical differences	PLOS ONE			English	Article							INSECT DIAPAUSE; LEPIDOPTERA; PHYSIOLOGY; SILKWORM; EVOLUTION; STRATEGY; COMPACT; BAGGY	The larvae of the giant silk moth (Hyalophora cecropia) spin strikingly dimorphic, multilayered cocoons that are either large and fluffy (baggy) or significantly smaller and tightly woven (compact). Although these cocoon-morphs share the same function (i.e., housing for pupal to adult development during overwintering), previous work has been unable to determine why cocoon dimorphism exists. We addressed this issue in cecropia moth cocoons collected along power line right-of-way habitats in Massachusetts. We first characterized the architectural differences between cocoon-morphs for all three cocoon sections (outer and inner envelopes, and the intermediate layer separating the two). We show that outer envelope structural and ultrastructural differences are what underlie dimorphism. Using a common spinning arena, we next show that the behavioral suites used to construct the outer envelopes of the two morphs are significantly different in behavioral time investment and patterning, as well as in the location of silk placement in the common spinning arena. Finally, we compared the cocoon-morphs in response to various environmental stressors to ask whether dimorphism is an adaptive response to such pressures. In contrast to compact cocoons, we find that baggy cocoons act as heat sinks and allow greater moisture permeability; differences in outer envelope architecture underlie these characteristics. These two biophysical properties could be advantageous for pupae in baggy cocoons, during unseasonably cold or dry conditions encountered during development prior to adult emergence. Our results suggest that cocoon dimorphism in the cecropia moth may provide a bet-hedging strategy for dealing with varying environmental conditions in Massachusetts and perhaps over its entire habitat range, during pupal to adult development.	[Guerra, Patrick A.; Reppert, Steven M.] Univ Massachusetts, Med Sch, Dept Neurobiol, Worcester, MA 01605 USA; [Guerra, Patrick A.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Cincinnati	Guerra, PA; Reppert, SM (corresponding author), Univ Massachusetts, Med Sch, Dept Neurobiol, Worcester, MA 01605 USA.; Guerra, PA (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA.	patrick.guerra@uc.edu; steven.reppert@umassmed.edu						ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; Boettner GH, 2000, CONSERV BIOL, V14, P1798, DOI 10.1046/j.1523-1739.2000.99193.x; Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062; Danks HV, 2002, OIKOS, V99, P10, DOI 10.1034/j.1600-0706.2002.990102.x; Dawkins, 1999, EXTENDED PHENOTYPE L, P327; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Fitzgerald TD, 2012, J THERM BIOL, V37, P615, DOI 10.1016/j.jtherbio.2012.07.010; Gene Stratton -Porter, 1912, MOTHS LIMBERLOST; Guerra PA, 2010, BIOL REV, V86, P831; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Rehnberg BG, 2002, J THERM BIOL, V27, P525, DOI 10.1016/S0306-4565(02)00026-8; Rhim JW, 2006, LWT-FOOD SCI TECHNOL, V39, P806, DOI 10.1016/j.lwt.2005.05.008; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Saether BE, 2015, TRENDS ECOL EVOL, V30, P273, DOI 10.1016/j.tree.2015.03.007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; STERNBURG J G, 1981, Journal of the Lepidopterists' Society, V35, P304; Tammaru T, 1999, ECOLOGY, V80, P1666, DOI 10.1890/0012-9658(1999)080[1666:WSVOPP]2.0.CO;2; TRUMAN JW, 1972, J EXP BIOL, V57, P805; TRUMAN JW, 1976, PHOTOCHEM PHOTOBIOL, V23, P215, DOI 10.1111/j.1751-1097.1976.tb07246.x; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; Tuskes PM, 1996, WILD SILK MOTHS N AM; van der Vinne V, 2015, J EXP BIOL, V218, P2585, DOI 10.1242/jeb.119354; VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P157, DOI 10.1163/156853953X00096; VANDERKLOOT WG, 1956, SCI AM, V194, P131, DOI 10.1038/scientificamerican0456-131; VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P141, DOI 10.1163/156853953X00087; WALDBAUE.GP, 1967, ANN ENTOMOL SOC AM, V60, P97, DOI 10.1093/aesa/60.1.97; WALDBAUER GP, 1982, ENTOMOL EXP APPL, V31, P191, DOI 10.1111/j.1570-7458.1982.tb03134.x; WALDBAUER GP, 1970, ANN ENTOMOL SOC AM, V63, P1366, DOI 10.1093/aesa/63.5.1366; Waldbauer GP, 2005, INSIGHTS INSECTS WHA; WILLIAMS CM, 1956, BIOL BULL, V110, P201, DOI 10.2307/1538982; WILLIAMS CM, 1965, BIOL BULL, V128, P497, DOI 10.2307/1539909; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhang J, 2013, MATER DESIGN, V49, P842, DOI 10.1016/j.matdes.2013.02.006	36	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e174023	10.1371/journal.pone.0174023	http://dx.doi.org/10.1371/journal.pone.0174023			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329006	Green Published, gold			2022-12-27	WOS:000399094700043
J	Hong, ZW; Yang, YC; Pan, T; Tzeng, HF; Fu, HW				Hong, Zhi-Wei; Yang, Yu-Chi; Pan, Timothy; Tzeng, Huey-Fen; Fu, Hua-Wen			Differential effects of DEAE negative mode chromatography and gel-filtration chromatography on the charge status of Helicobacter pylori neutrophil-activating protein	PLOS ONE			English	Article							ION-EXCHANGE CHROMATOGRAPHY; ESCHERICHIA-COLI DPS; HP-NAP; IMMUNE-RESPONSES; BINDING; CELLS; DNA; PATHOGENESIS; RETENTION; RELEASE	Helicobacter pylori neutrophil-activating protein (HP-NAP) is involved in H. pylori-associated gastric inflammation. HP-NAP is also a vaccine candidate, a possible drug target, and a potential diagnostic marker for H. pylori-associated diseases. Previously, we purified recombinant HP-NAP by one-step diethylaminoethyl (DEAE) negative mode chromatography by collecting the unbound fraction at pH 8.0 at 4 degrees C. It remains unclear why HP-NAP does not bind to DEAE resins at the pH above its isoelectric point during the purification. To investigate how pH affects the surface net charge of HP-NAP and its binding to DEAE resins during the purification, recombinant HP-NAP expressed in Escherichia coli was subjected to DEAE negative mode chromatography at pH ranging from 7.0 to 9.0 at 25 degrees C and the surface charge of purified HP-NAP was determined by capillary electrophoresis. A minimal amount of HP-NAP was detected in the elution fraction of DEAE Sepharose resin at pH 8.5, whereas recombinant HP-NAP was detected in the elution fraction of DEAE Sephadex resin only at pH 7.0 and 8.0. The purified recombinant HP-NAP obtained from the unbound fractions was not able to bind to DEAE resins at pH 7.0 to 9.0. In addition, the surface charge of the purified HP-NAP was neutral at pH 7.0 to 8.0 and was either neutral or slightly negative at pH 8.5 and 9.0. However, recombinant HP-NAP purified from gel-filtration chromatography was able to bind to DEAE Sepharose resin at pH 7.0 to 9.0 and DEAE Sephadex resin at pH 7.0. At pH 8.5 and 9.0, only the negatively charged species of HP-NAP were found. Thus, recombinant HP-NAP with different charge status can be differentially purified by DEAE negative mode chromatography and gel-filtration chromatography. Furthermore, the charge distribution on the surface of HP-NAP, the presence of impure proteins, and the overall net charge of the resins all affect the binding of HP-NAP to DEAE resins during the negative purification.	[Hong, Zhi-Wei; Yang, Yu-Chi; Fu, Hua-Wen] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Pan, Timothy; Fu, Hua-Wen] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Tzeng, Huey-Fen] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Pan, Timothy] Univ Illinois, Dept Biochem, Urbana, IL USA	National Tsing Hua University; National Tsing Hua University; National Chi Nan University; University of Illinois System; University of Illinois Urbana-Champaign	Fu, HW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.; Fu, HW (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.; Tzeng, HF (corresponding author), Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan.	hftzeng@ncnu.edu.tw; hwfu@life.nthu.edu.tw		Fu, Hua-Wen/0000-0002-6346-2785	Ministry of Science and Technology of Taiwan [MOST 104-2311-B-007-003, NSC101-2311-B-007-007, NSC 100-2113-M-260-002]; research program of National Tsing Hua University [104N2052E1, 105N528CE1]; Joint Research Program of National Tsing Hua University and Mackay Memorial Hospital [101N2727E1, 103N2773E1]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); research program of National Tsing Hua University; Joint Research Program of National Tsing Hua University and Mackay Memorial Hospital	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 104-2311-B-007-003 and NSC101-2311-B-007-007 to H-W. Fu, and NSC 100-2113-M-260-002 to H-F. Tzeng), www.most.gov.tw, the research program of National Tsing Hua University (104N2052E1 and 105N528CE1 to H-W. Fu), and the Joint Research Program of National Tsing Hua University and Mackay Memorial Hospital (101N2727E1 and 103N2773E1 to H-W. Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2007, NUCLEIC ACIDS RES, V35, P2247, DOI 10.1093/nar/gkm077; EVANS DJ, 1995, INFECT IMMUN, V63, P2213, DOI 10.1128/IAI.63.6.2213-2220.1995; Fu HW, 2014, WORLD J GASTROENTERO, V20, P5294, DOI 10.3748/wjg.v20.i18.5294; Hallgren E, 2000, J CHROMATOGR A, V877, P13, DOI 10.1016/S0021-9673(00)00190-4; KAZI JI, 1989, J PATHOL, V159, P231, DOI 10.1002/path.1711590310; KOPACIEWICZ W, 1983, J CHROMATOGR, V266, P3, DOI 10.1016/S0021-9673(01)90875-1; Kottakis F, 2008, FEBS J, V275, P302, DOI 10.1111/j.1742-4658.2007.06201.x; Kuo TY, 2016, JOVE-J VIS EXP, DOI 10.3791/54043; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; lankov ID, 2011, VACCINE, V29, P1710; Laurence JS, 2001, BIOCHEMISTRY-US, V40, P4990, DOI 10.1021/bi002593w; MARSHALL BJ, 1984, LANCET, V1, P1311; Montemurro P, 2002, EUR J IMMUNOL, V32, P671, DOI 10.1002/1521-4141(200203)32:3<671::AID-IMMU671>3.3.CO;2-X; Polenghi A, 2007, J IMMUNOL, V178, P1312, DOI 10.4049/jimmunol.178.3.1312; Ramachandran M, 2014, J IMMUNOL, V193, P2287, DOI 10.4049/jimmunol.1400339; Satin B, 2000, J EXP MED, V191, P1467, DOI 10.1084/jem.191.9.1467; Shih KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060786; Thoreson ACE, 2000, J CLIN MICROBIOL, V38, P3436, DOI 10.1128/JCM.38.9.3436-3441.2000; Tonello F, 1999, MOL MICROBIOL, V34, P238, DOI 10.1046/j.1365-2958.1999.01584.x; Tsai CC, 2015, VIRULENCE, V6, P755, DOI 10.1080/21505594.2015.1043505; Tsuruta O, 2012, ACTA CRYSTALLOGR F, V68, P134, DOI 10.1107/S1744309111052675; Wang CA, 2008, BIOCHEM BIOPH RES CO, V377, P52, DOI 10.1016/j.bbrc.2008.09.072; YANG YQ, 1994, J BIOL CHEM, V269, P20110; Yang YC, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0136-x; Yokoyama H, 2014, BIOMOLECULES, V4, P600, DOI 10.3390/biom4030600; Yokoyama H, 2012, BIOCHEM BIOPH RES CO, V422, P745, DOI 10.1016/j.bbrc.2012.05.073; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173632	10.1371/journal.pone.0173632	http://dx.doi.org/10.1371/journal.pone.0173632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328957	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700027
J	Kim, HS; Shin, MS; Cheon, MS; Kim, JW; Lee, C; Kim, WH; Kim, YS; Jang, BG				Kim, Hye Sung; Shin, Myung Soo; Cheon, Min Seok; Kim, Jae Wang; Lee, Cheol; Kim, Woo Ho; Kim, Young Sill; Jang, Bo Gun			GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas	PLOS ONE			English	Article							STEM-CELL; TUMOR MICROENVIRONMENT; COLORECTAL-CANCER; BONE; NICHE; TRICHOEPITHELIOMA; ANTAGONISTS; PATTERNS; MARKERS; TISSUE	Cancer-associated fibroblasts (CAFs) play important roles in cancer progression through their complex interactions with cancer cells. The secreted bone morphogenetic protein antagonist, gremlin1 (GREM1) is expressed by the CAFs of basal cell carcinomas (BCCs), and promotes the growth of cancer cells. In this study, we investigated the expression of GREM1 mRNAs in various benign and malignant skin tumors, including various BCC subtypes. Analysis by RNA in situ hybridization (ISH) revealed that fibroblasts in the scar tissue expressed GREM1 and a-smooth muscle actin (a-SMA), whereas resident fibroblasts in the dermis of the normal skin did not express GREM1. Real-time polymerase chain reaction analysis showed significantly higher GREM1 expression in skin cancers and pilomatricomas (PMCs) than in other benign skin tumors. Tissue microarrays analyzed by RNA ISH for GREM1 expression also demonstrated that 23% of BCCs, 42% of squamous cell carcinomas, 20% of melanomas, and 90% of PMCs were positive for GREM1 expression, whereas trichoepitheliomas, eccrine poromas, hidradenomas, and spiradenomas were negative for GREM1 expression. Most BCCs that were GREM1 expression positive were of desmoplastic or mixed subtypes, and GREM1 expression was localized to activated myofibroblasts at the tumoral-stromal interface. Interestingly, most PMCs harbored GREM1-expressing fibroblasts, probably because of the inflammatory responses caused by foreign body reactions to keratin. Additionally, in BCCs, stromal GREM1 expression had a strong correlation with CD10 expression. In conclusion, GREM1 is frequently expressed by myofibroblasts in scars or in the stroma of basal cell carcinomas, suggesting that GREM1 expression can be a marker for activated myofibroblasts in the cancer stroma or in scar tissue.	[Kim, Hye Sung; Kim, Young Sill; Jang, Bo Gun] Jeju Natl Univ, Sch Med, Dept Pathol, Jeju, South Korea; [Kim, Hye Sung; Shin, Myung Soo; Cheon, Min Seok; Kim, Jae Wang; Kim, Young Sill; Jang, Bo Gun] Jeju Natl Univ Hosp, Jeju, South Korea; [Shin, Myung Soo] Jeju Natl Univ, Sch Med, Dept Plast Surg, Jeju, South Korea; [Cheon, Min Seok; Kim, Jae Wang] Jeju Natl Univ, Sch Med, Dept Dermatol, Jeju, South Korea; [Lee, Cheol; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea	Jeju National University; Jeju National University; Jeju National University; Jeju National University; Seoul National University (SNU)	Kim, YS; Jang, BG (corresponding author), Jeju Natl Univ, Sch Med, Dept Pathol, Jeju, South Korea.; Kim, YS; Jang, BG (corresponding author), Jeju Natl Univ Hosp, Jeju, South Korea.	Sill@jejunu.ac.kr; bgjang9633@gmail.com		Jang, Bogun/0000-0003-4683-8338	Jeju National University Hospital development fund	Jeju National University Hospital development fund	This work was supported by a research grant from Jeju National University Hospital development fund in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Davis H, 2015, NAT MED, V21, P62, DOI 10.1038/nm.3750; Huber MA, 2006, J CUTAN PATHOL, V33, P145, DOI 10.1111/j.0303-6987.2006.00446.x; Jang BG, 2015, HISTOPATHOLOGY; Jang BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082390; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Kan S, 2014, J CUTAN PATHOL, V41, P561, DOI 10.1111/cup.12322; Karagiannis GS, 2015, BIOL CHEM, V396, P163, DOI 10.1515/hsz-2014-0221; Karagiannis GS, 2014, MOL ONCOL, V8, P1240, DOI 10.1016/j.molonc.2014.04.004; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rupp C, 2015, ONCOGENE, V34, P815, DOI 10.1038/onc.2014.18; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Sellheyer K, 2011, J CUTAN PATHOL, V38, P542, DOI 10.1111/j.1600-0560.2011.01693.x; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Tebcherani AJ, 2012, MODERN PATHOL, V25, P1345, DOI 10.1038/modpathol.2012.96; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Wang DJ, 2012, ONCOL REP, V27, P58, DOI 10.3892/or.2011.1463; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042	23	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174565	10.1371/journal.pone.0174565	http://dx.doi.org/10.1371/journal.pone.0174565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346486	Green Submitted, Green Published, gold			2022-12-27	WOS:000399174300056
J	Talreja, H; Ryan, SE; Graham, J; Sood, MM; Hadziomerovic, A; Clark, E; Hiremath, S				Talreja, Hari; Ryan, Stephen Edward; Graham, Janet; Sood, Manish M.; Hadziomerovic, Adnan; Clark, Edward; Hiremath, Swapnil			Endoluminal dilatation for embedded hemodialysis catheters: A case-control study of factors associated with embedding and clinical outcomes	PLOS ONE			English	Article							CENTRAL VEIN; REMOVAL; STUCK	Background With the increasing frequency of tunneled hemodialysis catheter use there is a parallel increase in the need for removal and/or exchange. A small but significant minority of catheters become embedded or 'stuck' and cannot be removed by traditional means. Management of embedded catheters involves cutting the catheter, burying the retained fragment with a subsequent increased risk of infections and thrombosis. Endoluminal dilatation may provide a potential safe and effective technique for removing embedded catheters, however, to date, there is a paucity of data. Objectives 1) To determine factors associated with catheters becoming embedded and 2) to determine outcomes associated with endoluminal dilatation Methods All patients with endoluminal dilatation for embedded catheters at our institution since Jan. 2010 were included. Patients who had an embedded catheter were matched 1:3 with patients with uncomplicated catheter removal. Baseline patient and catheter characteristics were compared. Outcomes included procedural success and procedure-related infection. Logistic regression models were used to determine factors associated with embedded catheters. Results We matched 15 cases of embedded tunneled catheters with 45 controls. Among patients with embedded catheters, there were no complications with endoluminal dilatation. Factors independently associated with embedded catheters included catheter dwell time (> 2 years) and history of central venous stenosis. Conclusion Embedded catheters can be successfully managed by endoluminal dilatation with minimal complications and factors associated with embedding include dwell times > 2 years and/or with a history of central venous stenosis.	[Talreja, Hari; Graham, Janet; Sood, Manish M.; Clark, Edward; Hiremath, Swapnil] Univ Ottawa, Div Nephrol, Fac Med, Ottawa, ON, Canada; [Ryan, Stephen Edward; Hadziomerovic, Adnan] Univ Ottawa, Dept Med Imaging, Fac Med, Ottawa, ON, Canada; [Sood, Manish M.; Clark, Edward; Hiremath, Swapnil] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Hiremath, S (corresponding author), Univ Ottawa, Div Nephrol, Fac Med, Ottawa, ON, Canada.; Hiremath, S (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	shiremath@toh.on.ca	Sood, Manish M/H-3134-2019; Hiremath, Swapnil/H-3492-2019	Sood, Manish M/0000-0002-9146-2344; Hiremath, Swapnil/0000-0003-0010-3416; Clark, Edward/0000-0002-6767-1197				Akgun S, 2008, VASA-J VASCULAR DIS, V37, P293, DOI 10.1024/0301-1526.37.3.293; Beigi AA, 2013, ARCH IRAN MED, V16, P243, DOI 013164/AIM.0011; Besarab Anatole, 2004, Hemodial Int, V8, P199, DOI 10.1111/j.1492-7535.2004.01096.x; Carrillo RG, 2009, SEMIN DIALYSIS, V22, P688, DOI 10.1111/j.1525-139X.2009.00646.x; Farooq A, 2012, CARDIOVASC INTER RAD, V35, P1528, DOI 10.1007/s00270-012-0365-5; Field M, 2008, J VASC ACCESS, V9, P301, DOI 10.1177/112972980800900415; Foley PT, 2007, CARDIOVASC INTER RAD, V30, P1079, DOI 10.1007/s00270-007-9018-5; Forauer AR, 2006, RADIOLOGY, V240, P427, DOI 10.1148/radiol.2402031129; Forauer AR, 2003, J VASC INTERV RADIOL, V14, P1163, DOI 10.1097/01.RVI.0000086531.86489.4C; Hassan A, 2006, NEPHROL DIAL TRANSPL, V21, P2005, DOI 10.1093/ndt/gfl123; Hong JH, 2010, J VASC ACCESS, V11, P59, DOI 10.1177/112972981001100112; Hong JH, 2011, J VASC ACCESS, V12, P381, DOI 10.5301/JVA.2011.8415; Liu T, 2007, NEPHROL DIAL TRANSPL, V22, P960, DOI 10.1093/ndt/gfl730; Lopes K, 2011, PORT J NEPHROL HYPER, V25, P51; MacRae JM., 2016, CAN J KIDNEY HEALTH, V3, DOI [10.1177/2054358116669125, DOI 10.1177/2054358116669125]; Miller Lisa M, 2016, Can J Kidney Health Dis, V3, p2054358116669130, DOI 10.1177/2054358116669130; QUINTON W, 1960, T AM SOC ART INT ORG, V6, P104; Ryan SE, 2012, J VASC INTERV RADIOL, V23, P1089, DOI 10.1016/j.jvir.2012.04.013; Thein H, 2005, AM J KIDNEY DIS, V46, DOI 10.1053/j.ajkd.2005.05.030	19	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174061	10.1371/journal.pone.0174061	http://dx.doi.org/10.1371/journal.pone.0174061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346468	gold, Green Submitted, Green Published			2022-12-27	WOS:000399174300020
J	Huo, AL; Chen, ZY; Wang, PK; Yang, LM; Wang, GP; Wang, DD; Liao, SC; Cheng, TL; Chen, JH; Shi, JS				Huo, Ailing; Chen, Zhenyu; Wang, Pengkai; Yang, Liming; Wang, Guangping; Wang, Dandan; Liao, Suchan; Cheng, Tielong; Chen, Jinhui; Shi, Jisen			Establishment of transient gene expression systems in protoplasts from Liriodendron hybrid mesophyll cells	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; ANGIOSPERM PHYLOGENY; SIGNAL-TRANSDUCTION; NUCLEAR GENES; TRANSFORMATION; MAIZE	Liriodendron is a genus of the magnolia family comprised of two flowering tree species that produce hardwoods of great ecological and economic value. However, only a limited amount of genetic research has been performed on the Liriodendron genus partly because transient or stable transgenic trees have been difficult to produce. In general, transient expression systems are indispensable for rapid, high-throughput screening and systematic characterization of gene functions at a low cost; therefore, development of such a system for Liriodendron would provide a necessary step forward for research on Magnoliaceae and other woody trees. Herein, we describe an efficient and rapid protocol for preparing protoplasts from the leaf mesophyll tissue of a Liriodendron hybrid and an optimized system for polyethylene glycol-mediated transient transfection of the protoplasts. Because the leaves of the Liriodendron hybrid are waxy, we formulated an enzyme mix containing 1.5% (w/v) Cellulase R-10, 0.5% (w/v) Macerozyme R-10, and 0.1% (w/v) Pectolyase Y-23 to efficiently isolate protoplasts from the Liriodendron hybrid leaf mesophyll tissue in 3 h. We optimized Liriodendron protoplast transfection efficiency by including 20 mu g plasmid DNA per 10(4) protoplasts, a transformation time of 20 min, and inclusion of 20% (w/v) polyethylene glycol 4000. After integrating the Liriodendron WOX1 gene into pJIT166-GFP to produce a WOX1-GFP fusion product and transfecting it into isolated protoplasts, LhWOX1-GFP was found to localize to the nucleus according to its green fluorescence.	[Huo, Ailing; Chen, Zhenyu; Wang, Pengkai; Wang, Guangping; Wang, Dandan; Liao, Suchan; Cheng, Tielong; Chen, Jinhui; Shi, Jisen] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Huo, Ailing; Yang, Liming] Huaiyin Normal Univ, Sch Life Sci, Huaian, Peoples R China; [Chen, Zhenyu; Wang, Pengkai; Wang, Guangping; Wang, Dandan; Chen, Jinhui; Shi, Jisen] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Cheng, Tielong] Nanjing Forestry Univ, Coll Biol & Environm, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Huaiyin Normal University; Nanjing Forestry University; Nanjing Forestry University	Chen, JH; Shi, JS (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Chen, JH; Shi, JS (corresponding author), Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China.	chenjh@njfu.edu.cn; jshi@njfu.edu.cn	Chen, Zhenyu/GRR-9677-2022	Chen, Zhenyu/0000-0001-6694-0319	National High technology Research and Development Program of China (863 Program) [2013AA102705]; Specialized Research Fund for Doctoral Program of Higher Education [SRFDP 20113204130002]; Qinglan Project; Ministry of Science and Technology; New Century Excellent Talents Support Program; Co-Innovation Center for Sustainable Forestry in Southern China; Nanjing Foresty University; Priority Academic Program Development of Jiangsu Higher Education institutions	National High technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Qinglan Project(Jiangsu Polytech Institute); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); New Century Excellent Talents Support Program(Program for New Century Excellent Talents in University (NCET)); Co-Innovation Center for Sustainable Forestry in Southern China; Nanjing Foresty University; Priority Academic Program Development of Jiangsu Higher Education institutions	This work was supported by National High technology Research and Development Program of China (863 Program, 2013AA102705), Specialized Research Fund for Doctoral Program of Higher Education (SRFDP 20113204130002), Qinglan Project, Talent project by Ministry of Science and Technology, New Century Excellent Talents Support Program, Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Foresty University, and Priority Academic Program Development of Jiangsu Higher Education institutions.	Bai Y, 2014, PLANT CELL TISS ORG, V119, P211, DOI 10.1007/s11240-014-0527-z; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Cao JM, 2014, ACTA PHYSIOL PLANT, V36, P1271, DOI 10.1007/s11738-014-1508-x; Chen JinHui, 2003, Scientia Silvae Sinicae, V39, P49; [程占超 Cheng Zhanchao], 2013, [生物技术通报, Biotechnology Bulletin], P69; COCKING EC, 1960, NATURE, V187, P962, DOI 10.1038/187962a0; Costanzo E, 2014, ANN BOT-LONDON, V114, P1545, DOI 10.1093/aob/mcu123; Davey MR, 2005, BIOTECHNOL ADV, V23, P131, DOI 10.1016/j.biotechadv.2004.09.008; Dolan MC, 2014, PROCESS BIOCHEM, V49, P490, DOI 10.1016/j.procbio.2013.12.010; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; GULZ PG, 1992, Z NATURFORSCH C, V47, P516; Guo JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044908; Guo Y, 2015, ACTA PHYSIOL PLANT, V37, P1; Hensel G, 2011, J PLANT PHYSIOL, V168, P30, DOI 10.1016/j.jplph.2010.07.007; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jung HI, 2015, METHODS MOL BIOL, V1284, P433, DOI 10.1007/978-1-4939-2444-8_22; LARKIN PJ, 1976, PLANTA, V128, P213, DOI 10.1007/BF00393231; Li J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025777, 10.1371/journal.pone.0028840, 10.1371/journal.pone.0027198]; Li NiNa, 2014, Acta Agronomica Sinica, V40, P231; Locatelli F, 2003, PLANT CELL REP, V21, P865, DOI 10.1007/s00299-003-0593-x; Lung SC, 2011, PLANT CELL REP, V30, P473, DOI 10.1007/s00299-010-0953-2; Manavella PA, 2009, NAT PROTOC, V4, P1699, DOI 10.1038/nprot.2009.178; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Matsumoto TK, 2013, PLANT CELL REP, V32, P443, DOI 10.1007/s00299-012-1376-z; MERKLE SA, 1987, AM J BOT, V74, P1317, DOI 10.2307/2444166; Pitzschke A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-14; Qiu YL, 2006, TAXON, V55, P837, DOI 10.2307/25065680; RASMUSSEN JO, 1993, PLANT SCI, V89, P199, DOI 10.1016/0168-9452(93)90128-M; Shang YJ, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-1; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Tan BY, 2013, PLANT CELL TISS ORG, V114, P11, DOI 10.1007/s11240-013-0299-x; Tulipifera L., 2003, SCI SILVAE SINICAE, V39, P49; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Wang HL, 2015, SCI HORTIC-AMSTERDAM, V191, P82, DOI 10.1016/j.scienta.2015.04.039; Wang Pengkai, 2013, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V33, P254; Wang Z., 1997, FOREST SCI TECHNOLOG, p8 ; Wang ZY, 2014, ACTA PHYSIOL PLANT, V36, P621, DOI 10.1007/s11738-013-1440-5; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	42	17	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0172475	10.1371/journal.pone.0172475	http://dx.doi.org/10.1371/journal.pone.0172475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323890	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000014
J	Urlacher, E; Devaud, JM; Mercer, AR				Urlacher, Elodie; Devaud, Jean-Marc; Mercer, Alison R.			C-type allatostatins mimic stress-related effects of alarm pheromone on honey bee learning and memory recall	PLOS ONE			English	Article							DIVISION-OF-LABOR; PROBOSCIS EXTENSION RESPONSE; JUVENILE-HORMONE TITERS; SUCROSE RESPONSIVENESS; APIS-MELLIFERA; NEUROPEPTIDES; BRAIN; BEHAVIOR; PROTEIN; INHIBITION	As honey bee populations worldwide are declining there is an urgent need for a deeper understanding of stress reactivity in these important insects. Our data indicate that stress responses in bees (Apis mellifera L.) may be mediated by neuropeptides identified, on the basis of sequence similarities, as allatostatins (ASTA, ASTC and ASTCC). Effects of allatostatin injection are compared with stress-related changes in learning performance induced by the honeybee alarm pheromone, isopentylacetate (IPA). We find that bees can exhibit two markedly different responses to IPA, with opposing effects on learning behaviour and memory generalisation, and that strikingly similar responses can be elicited by allatostatins, in particular ASTCC. These findings lend support to the hypothesis that allatostatins mediate stress reactivity in honey bees and suggest responses to stress in these insects are state dependent.	[Urlacher, Elodie; Mercer, Alison R.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Devaud, Jean-Marc] CNRS, Ctr Rech Cognit Anim, UMR 5169, Toulouse, France; [Devaud, Jean-Marc] Univ Toulouse, UPS Ctr Rech Cognit Anim, UMR 5169, Toulouse, France	University of Otago; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Urlacher, E (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.	elodie.urlacher@otago.ac.nz		Urlacher, Elodie/0000-0002-0544-831X; Mercer, Alison/0000-0001-8110-4247	Royal Society of New Zealand Marsden fund [U0012017]	Royal Society of New Zealand Marsden fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Royal Society of New Zealand Marsden fund U0012017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audsley N, 2006, PEPTIDES, V27, P512, DOI 10.1016/j.peptides.2005.08.022; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Balderrama N, 2002, J COMP PHYSIOL A, V188, P485, DOI 10.1007/s00359-002-0321-y; Billimoria CP, 2006, J NEUROSCI, V26, P5910, DOI 10.1523/JNEUROSCI.4659-05.2006; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Borbely E, 2013, NEUROPEPTIDES, V47, P439, DOI 10.1016/j.npep.2013.10.012; Chen YM, 2014, J INSECT BEHAV, V27, P791, DOI 10.1007/s10905-014-9468-y; Coast GM, 2011, PEPTIDES, V32, P620, DOI 10.1016/j.peptides.2010.11.006; COLLINS AM, 1983, J CHEM ECOL, V9, P57, DOI 10.1007/BF00987770; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; FREE JB, 1968, Z VERGL PHYSIOL, V61, P361, DOI 10.1007/BF00428008; Fu Y, 2013, NEUROSCI BULL, V29, P270, DOI 10.1007/s12264-013-1308-0; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Gruntenko NE, 2012, J INSECT PHYSIOL, V58, P49, DOI 10.1016/j.jinsphys.2011.09.015; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Hammer M, 1998, LEARN MEMORY, V5, P146; Harris JW, 1999, PHYSIOL ENTOMOL, V24, P285, DOI 10.1046/j.1365-3032.1999.00141.x; Hentze JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11680; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Kreienkamp HJ, 2002, J BIOL CHEM, V277, P39937, DOI 10.1074/jbc.M206931200; Kreissl S, 2010, J COMP NEUROL, V518, P1391, DOI 10.1002/cne.22343; Lin HR, 2004, APIDOLOGIE, V35, P319, DOI 10.1051/apido:2004018; Lin LC, 2015, MOL PSYCHIATR, V20, P377, DOI 10.1038/mp.2014.184; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nassel DR, 2009, INVERTEBR NEUROSCI, V9, P57, DOI 10.1007/s10158-009-0090-1; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; Pamir E, 2011, LEARN MEMORY, V18, P733, DOI 10.1101/lm.2232711; Pearce AN, 2001, J INSECT PHYSIOL, V47, P1243, DOI 10.1016/S0022-1910(01)00109-3; Rachinsky A, 2000, J INSECT PHYSL; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; RUTZ W, 1976, J INSECT PHYSIOL, V22, P1485, DOI 10.1016/0022-1910(76)90214-6; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sandoz JC, 2007, FRONT BEHAV NEUROSCI, V1, DOI 10.3389/neuro.08.005.2007; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 2014, CURR OPIN INSECT SCI, V6, P99, DOI 10.1016/j.cois.2014.10.009; Sullivan JP, 2003, J EXP BIOL, V206, P2287, DOI 10.1242/jeb.00432; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Tauchman SJ, 2007, INSECT BIOCHEM MOLEC, V37, P847, DOI 10.1016/j.ibmb.2007.05.015; Urlacher E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146248; Urlacher E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113630; Urlacher E, 2013, HBK BEHAV NEUROSCI, V22, P442, DOI 10.1016/B978-0-12-415823-8.00032-0; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P161, DOI 10.1016/j.ibmb.2008.10.014; Verlinden H, 2015, J INSECT PHYSIOL, V80, P2, DOI 10.1016/j.jinsphys.2015.04.004; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Wang ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150399; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Yamagata N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002586	64	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174321	10.1371/journal.pone.0174321	http://dx.doi.org/10.1371/journal.pone.0174321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8RG	28323874	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000086
J	Ajibola, G; Zash, R; Shapiro, RL; Batlang, O; Botebele, K; Bennett, K; Chilisa, F; von Widenfelt, E; Makhema, J; Lockman, S; Holmes, LB; Powis, KM				Ajibola, Gbolahan; Zash, Rebecca; Shapiro, Roger L.; Batlang, Oganne; Botebele, Kerapetse; Bennett, Kara; Chilisa, Florence; von Widenfelt, Erik; Makhema, Joseph; Lockman, Shahin; Holmes, Lewis B.; Powis, Kathleen M.			Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana	PLOS ONE			English	Article								Introduction A large and increasing number of HIV-infected women are conceiving on antiretroviral treatment (ART). While most antiretrovirals are considered safe in pregnancy, monitoring for rare pregnancy and infant adverse outcomes is warranted. Methods We conducted a retrospective secondary analysis nested within a clinical trial of infant cotrimoxazole vs. placebo prophylaxis in Botswana (the Mpepu Study). Infants were examined at birth, and at least every 3 months through 18 months of age. Abnormal physical findings and diagnostic testing revealing malformations were documented. Post hoc, a geneticist classified all reported malformations based on available documentation. Structural malformations with surgical, medical or cosmetic importance were classified as major malformations. We present a descriptive analysis of identified malformations. Results Between 2011 and 2014, 2,933 HIV-infected women who enrolled in the Mpepu study delivered 2,971 live-born infants. Study staff conducted 2,944 (99%) newborn exams. One thousand eighty-eight (38%) women were taking ART at conception; 1,147 (40%) started ART during pregnancy; 442 (15%) received zidovudine monotherapy; and 223 (7%) received no antiretroviral during pregnancy. Of 33 reported anomalies, 25 (76%) met congenital malformations criteria, 10 (30%) were classified as major malformations, 4 (40%) of which were identified after the birth exam. Discussion Our results highlight the importance of staff training on identification of congenital malformations, programmatic monitoring beyond the birth examination and the value of geneticist involvement in the malformations classification process in resource-limited settings. These elements will be important to fully define antiretroviral drug safety in pregnancy. Significance Surveillance systems for monitoring the safety of antiretroviral use during pregnancy among HIV-infected women in resource-limited setting are lacking. The World Health Organization's published programmatic recommendations for such surveillance systems represents the gold standard. We employed data from a clinical trial in Botswana, a country with a generalized HIV epidemic and high antiretroviral uptake by HIV-infected women, to highlight practical opportunities to strengthen congenital malformation surveillance systems in these settings where over 1 million HIV infected pregnant women reside.	[Ajibola, Gbolahan; Zash, Rebecca; Shapiro, Roger L.; Batlang, Oganne; Botebele, Kerapetse; Chilisa, Florence; von Widenfelt, Erik; Makhema, Joseph; Lockman, Shahin; Powis, Kathleen M.] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Zash, Rebecca] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Zash, Rebecca; Shapiro, Roger L.; Lockman, Shahin; Powis, Kathleen M.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Bennett, Kara] Bennett Stat Consulting Inc, Ballston Lake, NY USA; [Lockman, Shahin] Brigham & Womens Hosp, Infect Dis Unit, 75 Francis St, Boston, MA 02115 USA; [Holmes, Lewis B.] MassGen Hosp Children, Genet Unit, Boston, MA USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Powis, Kathleen M.] MassGen Hosp Children, Global Hlth, Boston, MA USA	Botswana-Harvard AIDS Institute Partnership; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ajibola, G (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.	gajibola@bhp.org.bw	Powis, Kathleen/AAU-5123-2021	Ajibola, Gbolahan/0000-0002-5408-4823; Zash, Rebecca/0000-0001-5707-421X	National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases [R01 HD061265]; National Institute of Child Health and Human Development [K23 HD070774]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD070774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI131928] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Mpepu study was supported by funding from the National Institute of Child Health and Human Development and the National Institute of Allergy and Infectious Diseases (R01 HD061265). The funder only provided support for the conduct of the study and in the form of salaries for authors [GA, RLS, OB, KB, FC, EvW, JM, SL, and KMP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KMP also received salary support from the National Institute of Child Health and Human Development (K23 HD070774). KB, of Bennett Statistical Consulting, was contracted by the study to provide statistical support and assisted with data analysis and manuscript preparation, but did not contribute to study design or data collection.	[Anonymous], 2014, WORLD AIDS DAY 2014; Busby A, 2005, BMJ-BRIT MED J, V331, P140, DOI 10.1136/bmj.331.7509.140; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Gulley ML, 2014, J MOL DIAGN, V16, P601, DOI 10.1016/j.jmoldx.2014.07.002; Holmes LB, 2011, BIRTH DEFECTS RES A, V91, P807, DOI 10.1002/bdra.20842; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Marazzi MC, 2009, PEDIATR INFECT DIS J, V28, P483, DOI 10.1097/INF.0b013e3181950c56; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Meow-Keong Thang, 2014, FRONTIERS PEDIAT; Mofenson LM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001636; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sitkin NA, 2015, WORLD J SURG, V39, P36, DOI 10.1007/s00268-014-2714-9; Smith SE, 2013, TELEMED E-HEALTH, V19, P166, DOI 10.1089/tmj.2012.0085; US Department of Health and Human Services Food and Drug Administration, 2002, GUID IND EST PREGN E; WHO, 2020, BIRTH DEF SURV MAN P, V2nd; World Health Organization, 2013, SURV ANT TOX HIV AID; World health organization(WHO), 2014, BIRTH DEF SURV ATL S, P1	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173800	10.1371/journal.pone.07173800	http://dx.doi.org/10.1371/journal.pone.07173800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339500				2022-12-27	WOS:000399116700010
J	Schmidt, J; Bohner, J; Brandl, R; Opgenoorth, L				Schmidt, Joachim; Boehner, Juergen; Brandl, Roland; Opgenoorth, Lars			Mass elevation and lee effects markedly lift the elevational distribution of ground beetles in the Himalaya-Tibet orogen	PLOS ONE			English	Article								Mass elevation and lee effects markedly influence snow lines and tree lines in high mountain systems. However, their impact on other phenomena or groups of organisms has not yet been quantified. Here we quantitatively studied their influence in the Himalaya Tibet orogen on the distribution of ground beetles as model organisms, specifically whether the ground beetle distribution increases from the outer to the inner parts of the orogen, against latitudinal effects. We also tested whether July temperature and solar radiation are predictors of the beetle's elevational distribution ranges. Finally, we discussed the general importance of these effects for the distributional and evolutionary history of the biota of High Asia. We modelled spatially explicit estimates of variables characterizing temperature and solar radiation and correlated the variables with the respective lower elevational range of 118 species of ground beetles from 76 high-alpine locations. Both July temperature and solar radiation significantly positively correlated with the elevational ranges of high-alpine beetles. Against the latitudinal trend, the median elevation of the respective species distributions increased by 800 m from the Himalayan south face north to the Transhimalaya. Our results indicate that an increase in seasonal temperature due to mass elevation and lee effects substantially impact the regional distribution patterns of alpine ground beetles of the Himalaya Tibet orogen and are likely to affect also other soil biota there and in mountain ranges worldwide. Since these effects must have changed during orogenesis, their potential impact must be considered when biogeographic scenarios based on geological models are derived. As this has not been the practice, we believe that large biases likely exist in many paleoecological and evolutionary studies dealing with the biota from the Himalaya-Tibet orogen and mountain ranges worldwide.	[Schmidt, Joachim] Univ Rostock, Inst Biowissensch Allgemeine & Spezielle Zool, Univ Pl 2, Rostock, Germany; [Schmidt, Joachim; Brandl, Roland; Opgenoorth, Lars] Philipps Univ Marburg, Dept Ecol, Karl von Frisch Str, Marburg, Germany; [Boehner, Juergen] Univ Hamburg, Inst Geog, Bundesstr, Hamburg, Germany	University of Rostock; Philipps University Marburg; University of Hamburg	Schmidt, J (corresponding author), Univ Rostock, Inst Biowissensch Allgemeine & Spezielle Zool, Univ Pl 2, Rostock, Germany.; Schmidt, J; Opgenoorth, L (corresponding author), Philipps Univ Marburg, Dept Ecol, Karl von Frisch Str, Marburg, Germany.	Schmidt@agonum.de; Opgenoorth@uni-marburg.de	Boehner, Juergen/I-9844-2014; Opgenoorth, Lars/C-9624-2018	Boehner, Juergen/0000-0002-0842-0152; Opgenoorth, Lars/0000-0003-0737-047X	German Research Council (DFG [3005/2-1, 219/3-1]	German Research Council (DFG(German Research Foundation (DFG))	The study was supported by the German Research Council (DFG grants SCHM 3005/2-1, OP 219/3-1).	[Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; [Anonymous], 2014, R LANG ENV STAT COMP; Asar O, 2017, COMMUN STAT-SIMUL C, V46, P91, DOI 10.1080/03610918.2014.957839; Bates D, IME4 LINEAR MIXED EF; Bluthgen J, 1980, ALLGEMEINE KLIMAGEOG; Bohner J, 2009, DEV SOIL SCI, V33, P195, DOI 10.1016/S0166-2481(08)00008-1; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; Brancucci M, 2008, ZOOTAXA, P51, DOI 10.11646/zootaxa.1825.1.5; Coope G.R., 1986, P703; Deuve T., 2013, CALOSOMA CARABUS CHI; Flohn H., 1968, CONTRIBUTIONS METEOR; Gerlitz L, 2015, EARTH SYST DYNAM, V6, P61, DOI 10.5194/esd-6-61-2015; Gerlitz L., 2015, THEORETICAL APPL CLI, P337; Gerlitz L, 2014, CLIM RES, V58, P235, DOI 10.3354/cr01193; Han F, 2012, J GEOGR SCI, V22, P609, DOI 10.1007/s11442-012-0950-1; Han F, 2011, ARCT ANTARCT ALP RES, V43, P207, DOI 10.1657/1938-4246-43.2.207; Hieke F., 1894, BIODIVERSITAT NATURA, P107; Hochasien Haffner W., 1997, GEOGRAPHISCHE RUNDSC, P307; Hodges KV, 2001, TECTONICS, V20, P799, DOI 10.1029/2001TC001281; Humboldt A von, 1807, IDEEN GEOGRAFIE PFLA; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Kearney MR, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.6; Korner C, 2007, ERDKUNDE, V61, P316, DOI 10.3112/erdkunde.2007.04.02; Ledoux G, 2005, NEBRIA LYON MUSEUM C; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Lindroth CH, 1949, ALLGEMEINER TEIL; Miehe G., 1991, OKOLOGIE ERDE, P181; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Miehe G, 2004, GEBIRGE DER ERDE, P31; Miehe G, 2007, MT RES DEV, V27, P169, DOI 10.1659/mrd.0792; Mulch A, 2006, NATURE, V439, P670, DOI 10.1038/439670a; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Quervain AD, 1904, GERLANDS BEITRAGE GE, P481; Schickhoff U, 2005, MOUNTAIN ECOSYSTEMS: STUDIES IN TREELINE ECOLOGY, P275; Schmidt J., 2016, TRECHINI GROUND BEET, P301; SCHMIDT J, 2013, ANGEW CARABIDOLOGIE, V10, P41; Schmidt J, 2009, ZOOTAXA, P1; Schmidt J, 2011, QUATERNARY SCI REV, V30, P1918, DOI 10.1016/j.quascirev.2011.04.014; Thiele HU, 1973, VERHANDLUNGEN GESELL, P38; Toledano L., 2008, MEMOIRE MUSEO CIVICO, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zamotajlov, 2005, GEOGRAPHIC ECOLOGICA	42	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0172939	10.1371/journal.pone.0172939	http://dx.doi.org/10.1371/journal.pone.0172939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339461	Green Published, Green Submitted, gold			2022-12-27	WOS:000399116700005
J	Meng, QH; Cooney, M; Yepuri, N; Cooney, RN				Meng, Qinghe; Cooney, Mitchell; Yepuri, Natesh; Cooney, Robert N.			L-arginine attenuates Interleukin-1 beta (IL-1 beta) induced Nuclear Factor Kappa-Beta (NF-B-k) activation in Caco-2 cells	PLOS ONE			English	Article							NITRIC-OXIDE; TRANSPORT; SUPPLEMENTATION; INFANTS; MODEL; LINE	Background Specific nutrients like L-arginine (L-Arg) ameliorate intestinal inflammation, however the exact mechanisms of this effect are unclear. We hypothesized the anti-inflammatory effects of L-Arg require active transport and metabolism by inducible nitric oxide synthase (iNOS) to generate nitric oxide (NO). To test this hypothesis we examined the effects of L-Arg, L-Arg transport activity, NO production and iNOS inhibitor on IL-1 beta-mediated NF-B-k-activation in Caco-2 cells. Methods Caco-2 cells were cultured, transfected with a NF-B-k promoter luciferase vector, incubated +/- L-Arg, +/- IL-1 beta and luciferase activity was measured. Using siRNA we inhibited the L-Arg cationic amino acid transporter system y(+) (CAT1) expression and examined its effects on L-Arg transport activity and IL-1 beta-mediated NF-B-k-activation. Finally, the effects of sodium nitroprusside (SNP, a NO donor) and N omega-nitro-L-arginine (NNA, an iNOS inhibitor) on IL-1 beta-mediated NF-B-k-activation were examined. Results IL-1 beta increased NF-B-k luciferase activity (8-fold) and NF-B-k expression (mRNA and protein), both of these were significantly decreased by L-Arg. System y(+) CAT1 siRNA decreased CAT1 expression, L-Arg transport activity and attenuated the inhibitory effects of L-Arg on NF-B-k activity. SNP attenuated the IL-1 beta-induced increase in NF-B-k luciferase activity and expression, whereas NNA diminished the inhibitory effects of L-Arg on IL-1 beta-inducible NF-B-k luciferase activity. Conclusion The inhibitory effects of L-Arg on IL-1 beta-mediated NF-B-k-activation in Caco-2 cells involve L-Arg transport activity by CAT1, regulation of IL-1 beta-mediated increases in NF-B-k expression, L-Arg on NF-B-k activation are mediated in part by iNOS since SNP preserves and NNA attenuates the effects of L-Arg on IL-1 beta-mediated NF-B-k-activation and expression.	[Meng, Qinghe; Cooney, Mitchell; Yepuri, Natesh; Cooney, Robert N.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cooney, RN (corresponding author), SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA.	cooneyr@upstate.edu						Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Brasse-Lagnel C, 2005, BIOCHIMIE, V87, P403, DOI 10.1016/j.biochi.2005.01.009; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; de Jong NSH, 2007, DIGEST DIS SCI, V52, P2029, DOI 10.1007/s10620-006-9449-x; delaTorre A, 1999, J IMMUNOL, V162, P4101; DILORENZO M, 1995, J PEDIATR SURG, V30, P235, DOI 10.1016/0022-3468(95)90567-7; Duque J, 2006, CELL SIGNAL, V18, P1262, DOI 10.1016/j.cellsig.2005.10.009; Hartman C, 2009, WORLD J GASTROENTERO, V15, P2570, DOI 10.3748/wjg.15.2570; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lecleire S, 2008, J NUTR, V138, P2481, DOI 10.3945/jn.108.099127; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Marion R, 2005, BIOCHIMIE, V87, P1048, DOI 10.1016/j.biochi.2005.06.009; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; McCord N, 2006, HYPERTENSION, V47, P109, DOI 10.1161/01.HYP.0000197952.22711.c4; Mcrae MP, 2016, J CHIROPR MED, V15, P184, DOI 10.1016/j.jcm.2016.06.002; Meng QH, 2005, J GASTROINTEST SURG, V9, P1276, DOI 10.1016/j.gassur.2005.08.008; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pan M, 2004, J NUTR, V134, p2826S, DOI 10.1093/jn/134.10.2826S; PAN M, 1995, AM J PHYSIOL-GASTR L, V268, pG578, DOI 10.1152/ajpgi.1995.268.4.G578; Ren WK, 2014, J NUTR, V144, P988, DOI 10.3945/jn.114.192120; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Rosenthal MD, 2016, J NUTR, V146, P2594, DOI 10.3945/jn.115.228544; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Shah P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004339.pub3; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Viladomiu M, 2013, J NUTR BIOCHEM, V24, P929, DOI 10.1016/j.jnutbio.2013.01.006; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Yuan C, 2015, MOL CELL BIOCHEM, V399, P229, DOI 10.1007/s11010-014-2249-2; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	32	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174441	10.1371/journal.pone.0174441	http://dx.doi.org/10.1371/journal.pone.0174441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334039	Green Submitted, gold, Green Published			2022-12-27	WOS:000399102200099
J	Mohite, S; Yang, F; Amin, PA; Zunta-Soares, G; Colpo, GD; Stertz, L; Sharma, AN; Fries, GR; Walss-Bass, C; Soares, JC; Okusaga, OO				Mohite, Satyajit; Yang, Fang; Amin, Pooja A.; Zunta-Soares, Giovana; Colpo, Gabriela D.; Stertz, Laura; Sharma, Ajaykumar N.; Fries, Gabriel R.; Walss-Bass, Consuelo; Soares, Jair C.; Okusaga, Olaoluwa O.			Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls	PLOS ONE			English	Article							SERUM-LEVELS; INFLAMMATION; ACTIVATION; EXPRESSION; ENDOTHELIUM; LEUKOCYTES	Immune dysfunction has been implicated in the pathophysiology of schizophrenia. Leukocyte migration to the site of inflammation is a fundamental step of immune response which involves P-, E-, and L-selectins. Elevated selectin levels have been reported in un-medicated first-episode patients with schizophrenia but not in medicated patients with multi-episode schizophrenia. We measured fasting plasma soluble P-, E-, and L-selectin in 39 medicated patients with multi-episode schizophrenia and 19 healthy controls. In patients, psychotic symptom severity and cognitive function were assessed with the Positive and Negative Syndrome Scale (PANSS) and the NIH Toolbox Cognitive Test Battery respectively. C-reactive protein (CRP) and Body Mass Index (BMI) were measured in patients and controls. Comparison of selectin levels between patients and controls was done with t-tests and linear regression. Pearson correlation coefficients between plasma selectins and PANSS and cognitive measures were calculated. Geometric mean plasma soluble L-selectin level was lower in patients compared to controls from unadjusted (606.7 +/- 1.2 ng/ml vs. 937.7 +/- 1.15 ng/ml, p < 0.001) and adjusted analyses (beta = 0.59; CI 0.41 to 0.88, p = 0.011). There was a trend towards higher plasma soluble P- selectin in patients compared to controls (90.4 +/- 1.2ng/ml vs. 71.8 +/- 1.2ng/ml, p = 0.059) in the unadjusted analysis. There was no association between the selectins and psychotic symptoms or cognitive function in the patients. In addition, the selectins were not significantly associated with CRP or BMI. The limitations of this study include small sample size and unavailability of information on medications and blood cell counts. The potential utility of soluble L-selectin as a biomarker of antipsychotic exposure in patients with schizophrenia and the concomitant change in immune response with the use of antipsychotics should be further evaluated.	[Mohite, Satyajit; Yang, Fang; Amin, Pooja A.; Soares, Jair C.; Okusaga, Olaoluwa O.] UT Harris Cty Psychiat Ctr, 2800 S MacGregor Way, Houston, TX 77021 USA; [Mohite, Satyajit; Yang, Fang; Zunta-Soares, Giovana; Colpo, Gabriela D.; Stertz, Laura; Sharma, Ajaykumar N.; Fries, Gabriel R.; Walss-Bass, Consuelo; Soares, Jair C.; Okusaga, Olaoluwa O.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Okusaga, OO (corresponding author), UT Harris Cty Psychiat Ctr, 2800 S MacGregor Way, Houston, TX 77021 USA.; Okusaga, OO (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	Olaoluwa.O.Okusaga@uth.tmc.edu	Mohite, Satyajit/AAS-4132-2021; Walss-Bass, Consuelo/K-5702-2015; Fries, Gabriel R/C-1521-2009; Fries, Gabriel R/P-8810-2014; Stertz, Laura/AAC-7384-2019	Mohite, Satyajit/0000-0002-2873-3025; Walss-Bass, Consuelo/0000-0003-2474-5448; Fries, Gabriel R/0000-0002-5468-2612; Fries, Gabriel R/0000-0002-5468-2612; Stertz, Laura/0000-0002-1426-6796; Okusaga, Olaoluwa O/0000-0002-4263-9086; Soares, Jair C./0000-0002-5466-5628; Delevati Colpo, Gabriela/0000-0003-2023-6902	Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston	Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston	The Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston provided funds for plasma selectin analyses.	Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Bloomfield P. S., 2015, AM J PSYCHIAT; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cella G, 2006, LEUKEMIA, V20, P1430, DOI 10.1038/sj.leu.2404271; Choudhary D, 2015, INCREASED EXPRESSION; D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Ferri LE, 2002, CRIT CARE MED, V30, P1842, DOI 10.1097/00003246-200208000-00028; Hirose M, 2011, BIOCHEM BIOPH RES CO, V414, P437, DOI 10.1016/j.bbrc.2011.09.123; Impellizzeri D, 2014, EXPERT OPIN THER TAR, V18, P55, DOI 10.1517/14728222.2013.841140; Iwata Y, 2008, BRIT J PSYCHIAT, V193, P338, DOI 10.1192/bjp.bp.107.043497; Iwata Y, 2007, SCHIZOPHR RES, V89, P154, DOI 10.1016/j.schres.2006.08.026; Jackson LA, 2005, J INFECT DIS, V191, P1361, DOI 10.1086/428949; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141; Lai CY, 2016, WORLD J PSYCHIATR, V6, P102, DOI 10.5498/wjp.v6.i1.102; Librizzi L, 2006, NEUROSCIENCE, V137, P1211, DOI 10.1016/j.neuroscience.2005.10.041; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MacKinnon JR, 2004, BRIT J OPHTHALMOL, V88, P1137, DOI 10.1136/bjo.2003.040329; Marki A, 2015, J LEUKOCYTE BIOL, V98, P503, DOI 10.1189/jlb.3MR0115-011R; Masopust J, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-2; Matsumoto A, 2015, ANESTH ANALG, V120, P895, DOI 10.1213/ANE.0000000000000606; McEver RP, 2015, CARDIOVASC RES; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Noto C, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu042; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Patterson P., 2011, INFECT BEHAV; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Shimada Y, 1999, J ALLERGY CLIN IMMUN, V104, P163, DOI 10.1016/S0091-6749(99)70128-4; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174073	10.1371/journal.pone.0174073	http://dx.doi.org/10.1371/journal.pone.0174073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334045	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200043
J	Nielsen, TRH; Appel, EVR; Svendstrup, M; Ohrt, JD; Dahl, M; Fonvig, CE; Hollensted, M; Have, CT; Kadarmideen, HN; Pedersen, O; Hansen, T; Holm, JC; Grarup, N				Nielsen, Tenna Ruest Haarmark; Appel, Emil Vincent Rosenbaum; Svendstrup, Mathilde; Ohrt, Johanne Dam; Dahl, Maria; Fonvig, Cilius Esmann; Hollensted, Mette; Have, Christian Theil; Kadarmideen, Haja N.; Pedersen, Oluf; Hansen, Torben; Holm, Jens-Christian; Grarup, Niels			A genome-wide association study of thyroid stimulating hormone and free thyroxine in Danish children and adolescents	PLOS ONE			English	Article							OBESE CHILDREN; REFERENCE INTERVALS; COMMON VARIANTS; TSH LEVELS; LOCI; GENE; METAANALYSIS; POPULATION; PREVALENCE; TRIIODOTHYRONINE	Background Hypothyroidism is associated with obesity, and thyroid hormones are involved in the regulation of body composition, including fat mass. Genome-wide association studies (GWAS) in adults have identified 19 and 6 loci associated with plasma concentrations of thyroid stimulating hormone (TSH) and free thyroxine (fT4), respectively. Objective This study aimed to identify and characterize genetic variants associated with circulating TSH and fT4 in Danish children and adolescents and to examine whether these variants associate with obesity. Methods Genome-wide association analyses of imputed genotype data with fasting plasma concentrations of TSH and fT4 from a population-based sample of Danish children, adolescents, and young adults, and a group of children, adolescents, and young adults with overweight and obesity were performed (N = 1,764, mean age = 12.0 years [range 2.5-24.7]). Replication was performed in additional comparable samples (N = 2,097, mean age = 11.8 years [1.2-22.8]). Meta-analyses, using linear additive fixed-effect models, were performed on the results of the discovery and replication analyses. Results No novel loci associated with TSH or fT4 were identified. Four loci previously associated with TSH in adults were confirmed in this study population (PDE10A (rs2983511: beta = 0.112SD, p = 4.8.10(-16)), FOXE1 (rs7847663: beta = 0.223SD, p = 1.5 . 10(-20)), NR3C2 (rs9968300: beta = 0.194SD), p = 2.4 . 10(-11)), VEGFA (rs2396083: beta = 0.088SD, p = 2.2 . 10(-10))). Effect sizes of variants known to associate with TSH or fT4 in adults showed a similar direction of effect in our cohort of children and adolescents, 11 of which were associated with TSH or fT4 in our study (p<0.0002). None of the TSH or fT4 associated SNPs were associated with obesity in our cohort, indicating no pleiotropic effects of these variants on obesity. Conclusion In a group of Danish children and adolescents, four loci previously associated with plasma TSH concentrations in adults, were associated with plasma TSH concentrations in children, suggesting comparable genetic determinants of thyroid function in adults and children.	[Nielsen, Tenna Ruest Haarmark; Ohrt, Johanne Dam; Dahl, Maria; Fonvig, Cilius Esmann; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark; [Nielsen, Tenna Ruest Haarmark; Appel, Emil Vincent Rosenbaum; Svendstrup, Mathilde; Fonvig, Cilius Esmann; Hollensted, Mette; Have, Christian Theil; Pedersen, Oluf; Hansen, Torben; Holm, Jens-Christian; Grarup, Niels] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, Copenhagen, Denmark; [Svendstrup, Mathilde] Danish Diabet Acad, Odense, Denmark; [Kadarmideen, Haja N.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Frederiksberg C, Denmark; [Kadarmideen, Haja N.] Tech Univ Denmark, Dept Bio & Hlth Informat, Lyngby, Denmark; [Holm, Jens-Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Technical University of Denmark; University of Copenhagen	Holm, JC (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark.; Hansen, T; Holm, JC; Grarup, N (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, Copenhagen, Denmark.; Holm, JC (corresponding author), Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.	torben.hansen@sund.ku.dk; jhom@regionsjaelland.dk; niels.grarup@sund.ku.dk	Holm, Jens-Christian/T-4594-2017; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Fonvig, Cilius/I-1234-2013; Pedersen, Oluf/AAG-8015-2020	Holm, Jens-Christian/0000-0003-4653-342X; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Fonvig, Cilius/0000-0002-5031-0125; Hollensted, Mette/0000-0001-5572-3183; Hansen, Torben/0000-0001-8748-3831; Kadarmideen, Haja/0000-0001-6294-382X	Innovation Fund Denmark [0603-00484B, 0603-00457B]; Novo Nordisk Foundation [NNF15OC0016544]; Region Zealand Health and Medical Research Foundation	Innovation Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Region Zealand Health and Medical Research Foundation	The study was supported by the Innovation Fund Denmark, www.innovationsfonden.dk (TH: grant 0603-00484B and HNK: grant 0603-00457B), the Novo Nordisk Foundation, www.novonordiskfonden.dk (JCH: grant NNF15OC0016544), and the Region Zealand Health and Medical Research Foundation, www.regionsjaelland.dk (JCH, TRHN, CEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alul FY, 2013, PEDIATR RES, V73, P484, DOI 10.1038/pr.2013.18; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; [Anonymous], 2021, LANG ENV STAT COMP; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Aypak C, 2013, J PEDIATR ENDOCR MET, V26, P703, DOI 10.1515/jpem-2012-0384; Borch-Johnsen K, 2003, EUR J CARDIOV PREV R, V10, P377; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Dekelbab BH, 2010, ENDOCR PRACT, V16, P187, DOI 10.4158/EP09176.OR; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dong BJ, 2000, WESTERN J MED, V172, P102, DOI 10.1136/ewjm.172.2.102; Elmlinger MW, 2001, CLIN CHEM LAB MED, V39, P973, DOI 10.1515/CCLM.2001.158; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Fox J., 2019, R COMPANION APPL REG, V.; Grandone A, 2012, EUR J ENDOCRINOL, V166, P255, DOI 10.1530/EJE-11-0703; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hansen PS, 2007, AM J PHYSIOL-ENDOC M, V292, pE765, DOI 10.1152/ajpendo.00321.2006; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hollowell JG, 2002, J CLIN ENDOCRINOLOGY, P87; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; Hutchinqs B, 2001, INT J OBESITY, V25, P177; Juul A, 1997, J CLIN ENDOCR METAB, V82, P2497, DOI 10.1210/jc.82.8.2497; Korevaar TIM, 2016, J CLIN ENDOCR METAB, V101, P205, DOI 10.1210/jc.2015-3559; Krause AJ, 2016, PEDIAT OBES; Kyvik KO, 2004, J CLIN ENDOCRINOLOGY, V89, P1181; La'ulu SL, 2016, J CLIN RES PEDIATR E, V8, P26, DOI 10.4274/jcrpe.2152; Lasky-Su J, 2012, HUM GENET, V131, P1495, DOI 10.1007/s00439-012-1185-z; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Malinowski JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111301; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marras V, 2010, HORM RES PAEDIAT, V73, P193, DOI 10.1159/000284361; Medici M, 2015, ENDOCR REV, V36, P214, DOI 10.1210/er.2014-1081; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2016, R FDN STAT COMP; Rawal R, 2012, HUM MOL GENET, V21, P3275, DOI 10.1093/hmg/dds136; Roef G, 2012, EUR J ENDOCRINOL, V167, P719, DOI 10.1530/EJE-12-0447; Shalitin S, 2009, HORM RES, V71, P155, DOI 10.1159/000197872; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Taylor PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6681; Taylor PN, 2011, EUR J ENDOCRINOL, V164, P773, DOI 10.1530/EJE-10-0938; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174204	10.1371/journal.pone.0174204	http://dx.doi.org/10.1371/journal.pone.0174204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333968	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200062
J	Bauer, CM; Hirsch, GV; Zajac, L; Koo, BB; Collignon, O; Merabet, LB				Bauer, Corinna M.; Hirsch, Gabriella V.; Zajac, Lauren; Koo, Bang-Bon; Collignon, Olivier; Merabet, Lotfi B.			Multimodal MR-imaging reveals large-scale structural and functional connectivity changes in profound early blindness	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; PRIMARY VISUAL-CORTEX; WHITE-MATTER; HUMAN BRAIN; NEUROANATOMICAL STRUCTURES; RETINOTOPIC ORGANIZATION; COMPENSATORY PLASTICITY; SENSORY SUBSTITUTION; PREDICTS PERFORMANCE; INTRACRANIAL VOLUME	In the setting of profound ocular blindness, numerous lines of evidence demonstrate the existence of dramatic anatomical and functional changes within the brain. However, previous studies based on a variety of distinct measures have often provided inconsistent findings. To help reconcile this issue, we used a multimodal magnetic resonance (MR)-based imaging approach to provide complementary structural and functional information regarding this neuroplastic reorganization. This included gray matter structural morphometry, high angular resolution diffusion imaging (HARDI) of white matter connectivity and integrity, and resting state functional connectivity MRI (rsfcMRI) analysis. When comparing the brains of early blind individuals to sighted controls, we found evidence of co-occurring decreases in cortical volume and cortical thickness within visual processing areas of the occipital and temporal cortices respectively. Increases in cortical volume in the early blind were evident within regions of parietal cortex. Investigating white matter connections using HARDI revealed patterns of increased and decreased connectivity when comparing both groups. In the blind, increased white matter connectivity (indexed by increased fiber number) was predominantly left-lateralized, including between frontal and temporal areas implicated with language processing. Decreases in structural connectivity were evident involving frontal and somatosensory regions as well as between occipital and cingulate cortices. Differences in white matter integrity (as indexed by quantitative anisotropy, or QA) were also in general agreement with observed pattern changes in the number of white matter fibers. Analysis of resting state sequences showed evidence of both increased and decreased functional connectivity in the blind compared to sighted controls. Specifically, increased connectivity was evident between temporal and inferior frontal areas. Decreases in functional connectivity were observed between occipital and frontal and somatosensory-motor areas and between temporal (mainly fusiform and parahippocampus) and parietal, frontal, and other temporal areas. Correlations in white matter connectivity and functional connectivity observed between early blind and sighted controls showed an overall high degree of association. However, comparing the relative changes in white matter and functional connectivity between early blind and sighted controls did not show a significant correlation. In summary, these findings provide complimentary evidence, as well as highlight potential contradictions, regarding the nature of regional and large scale neuroplastic reorganization resulting from early onset blindness.	[Bauer, Corinna M.; Hirsch, Gabriella V.; Merabet, Lotfi B.] Harvard Med Sch, Lab Visual Neuroplast, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA; [Zajac, Lauren; Koo, Bang-Bon] Boston Univ, Sch Med, Ctr Biomed Imaging, Boston, MA 02118 USA; [Collignon, Olivier] Univ Trento, Crossmodal Percept & Plast Lab, Trento, Italy	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Boston University; University of Trento	Merabet, LB (corresponding author), Harvard Med Sch, Lab Visual Neuroplast, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA.	lotfi_merabet@meei.harvard.edu	merabet, lotfi/AAU-8259-2020; Merabet, Lotfi B./V-2735-2017	merabet, lotfi/0000-0002-8094-9536; Merabet, Lotfi B./0000-0002-8094-9536; Bauer, Corinna/0000-0001-9407-4657	NIH/NEI [R01 EY019924]; Low Vision Research Award from Research; Lions Clubs International Foundation (LCIF); NATIONAL EYE INSTITUTE [R01EY019924] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Low Vision Research Award from Research; Lions Clubs International Foundation (LCIF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the NIH/NEI (R01 EY019924), the Low Vision Research Award from Research to Prevent Blindness (RPB), and the Lions Clubs International Foundation (LCIF) to LBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Anurova I, 2015, CEREB CORTEX, V25, P2035, DOI 10.1093/cercor/bhu009; Bauer C, 2015, CORTEX, V63, P104, DOI 10.1016/j.cortex.2014.08.003; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi YC, 2016, TRENDS COGN SCI, V20, P282, DOI 10.1016/j.tics.2016.02.002; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bock AS, 2015, J NEUROSCI, V35, P12366, DOI 10.1523/JNEUROSCI.4715-14.2015; Bottini R, 2016, CORTEX, V83, P271, DOI 10.1016/j.cortex.2016.08.007; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Burton H, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00051; Butt OH, 2013, J NEUROSCI, V33, P16209, DOI 10.1523/JNEUROSCI.0363-13.2013; Cecchetti L, 2015, BRAIN STRUCT FUNCT; Cetin MS, 2014, NEUROIMAGE, V97, P117, DOI 10.1016/j.neuroimage.2014.04.009; Collignon O, 2013, BRAIN, V136, P2769, DOI 10.1093/brain/awt176; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de la Iglesia-Vaya M, 2011, RADIOLOGIA-MADRID, V53, P236, DOI 10.1016/j.rx.2010.11.007; Deen B, 2015, J COGNITIVE NEUROSCI, V27, P1633, DOI 10.1162/jocn_a_00807; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dormal G, 2016, NEUROIMAGE, V134, P630, DOI 10.1016/j.neuroimage.2016.04.027; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gomez J, 2015, NEURON, V85, P216, DOI 10.1016/j.neuron.2014.12.027; Goodale MA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0337; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton RH, 2004, NEUROREPORT, V15, P803, DOI 10.1097/00001756-200404090-00012; Heine L, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00086; Hubbard CS, 2014, NEURO E, Ve1, P1; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kupers R, 2011, NEUROPSYCHOLOGIA, V49, P2037, DOI 10.1016/j.neuropsychologia.2011.03.033; Kupers R, 2014, NEUROSCI BIOBEHAV R, V41, P36, DOI 10.1016/j.neubiorev.2013.08.001; Lao Y, 2015, NEUROREPORT, V26, P1151, DOI 10.1097/WNR.0000000000000488; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Lepore N, 2009, NEUROIMAGE, V46, P949, DOI 10.1016/j.neuroimage.2009.01.071; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Nair A, 2014, HUM BRAIN MAPP, V35, P4035, DOI 10.1002/hbm.22456; Noppeney U, 2003, BRAIN, V126, P1620, DOI 10.1093/brain/awg152; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pelland M OP, 2014, NEUROIMAGE; Pintzka CWS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00238; Poppenk J, 2011, NEURON, V72, P931, DOI 10.1016/j.neuron.2011.10.014; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Qin W, 2015, CEREB CORTEX, V25, P2507, DOI 10.1093/cercor/bhu051; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Reislev NL, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6029241; Renier L, 2014, NEUROSCI BIOBEHAV R, V41, P53, DOI 10.1016/j.neubiorev.2013.01.025; Rombaux P, 2010, NEUROREPORT, V21, P1069, DOI 10.1097/WNR.0b013e32833fcb8a; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sanfilipo MP, 2004, NEUROIMAGE, V22, P1732, DOI 10.1016/j.neuroimage.2004.03.037; Sathian K, 2014, TXB NEURAL REPAIR RE, P140; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Soares JM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00330; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sterr A, 1998, J NEUROSCI, V18, P4417; Striem-Amit E, 2015, BRAIN, V138, P1679, DOI 10.1093/brain/awv083; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026; Striem-Amit E, 2012, CEREB CORTEX, V22, P1698, DOI 10.1093/cercor/bhr253; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tomaiuolo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107871; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Voss P, 2014, BRAIN, V137, P1224, DOI 10.1093/brain/awu030; Voss P, 2012, CEREB CORTEX, V22, P2455, DOI 10.1093/cercor/bhr311; Voss P, 2012, CURR BIOL, V22, pR168, DOI 10.1016/j.cub.2012.01.030; Wang DW, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/128236; Watkins KE, 2012, BRAIN, V135, P1566, DOI 10.1093/brain/aws067; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yoh FC, 2013, PLOS ONE, V8; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Yu CS, 2007, NEUROIMAGE, V36, P411, DOI 10.1016/j.neuroimage.2007.03.003	108	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173064	10.1371/journal.pone.0173064	http://dx.doi.org/10.1371/journal.pone.0173064			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328939	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700015
J	Homma, Y; Yamauchi, S; Mizobe, M; Nakashima, Y; Takahashi, J; Funakoshi, H; Urayama, KY; Ohde, S; Takahashi, O; Shiga, T				Homma, Yosuke; Yamauchi, Sunao; Mizobe, Michiko; Nakashima, Yoshiyuki; Takahashi, Jin; Funakoshi, Hiraku; Urayama, Kevin Y.; Ohde, Sachiko; Takahashi, Osamu; Shiga, Takashi			Emergency department outpatient treatment of alcohol-intoxicated bicyclists increases the cost of medical care in Japan	PLOS ONE			English	Article							INJURY SEVERITY; RISK; CYCLISTS; TRAUMA; HEAD	Riding a bicycle under the influence of alcohol is illegal in Japan. Nevertheless, intoxicated bicyclists are frequently treated at hospital emergency departments for bicycle-related injuries. This patient population usually requires more hospital resources, even for relatively minor injuries. Therefore, we hypothesized that bicycle-related crashes involving bicyclists under the influence of alcohol cost more to treat than those that do not involve alcohol intoxication. The aim of the present study was to examine the costs associated with bicycle-related minor injuries and alcohol intoxication of the bicyclist. The study was conducted at the Tokyo Bay Urayasu Ichikawa Medical Center Emergency Department, Japan. All minor bicycle crashes involving 217 individuals aged >= 20 years treated from September 1, 2012 to August 31, 2013 were included in the analysis of data obtained from medical records. Variables included alcohol intoxication, sex, age, collision with a motor vehicle, Glasgow Coma Scale, injury severity score (ISS), laboratory tests, treatment of wounds, number of X-ray images, number of computed tomography scans, and medical costs. Multiple linear regression analysis was performed to evaluate the association between alcohol intoxication and medical costs. Seventy (32%) patients consumed alcohol, and the median medical cost was 253 USD (interquartile range [IQR], 164-330). Multivariable analysis showed that alcohol intoxication was independently associated with higher medical costs (p = 0.030, adjusted R-square value = 0.55). These findings support our hypothesis and should encourage authorities to implement comprehensive measures to prohibit bicycling under the influence of alcohol to prevent injuries and to reduce medical costs.	[Homma, Yosuke; Mizobe, Michiko; Nakashima, Yoshiyuki; Takahashi, Jin; Funakoshi, Hiraku; Shiga, Takashi] Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency Med & Crit Care, Chiba, Japan; [Yamauchi, Sunao] Univ Iowa Hosp & Clin, Dept Emergency Med, Iowa City, IA 52242 USA; [Urayama, Kevin Y.; Ohde, Sachiko; Takahashi, Osamu] St Lukes Int Univ, Ctr Clin Epidemiol, Tokyo, Japan	University of Iowa; St. Luke's International Hospital	Homma, Y (corresponding author), Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency Med & Crit Care, Chiba, Japan.	jazz.dr.homma@gmail.com	Ohde, Sachiko/AAC-6496-2019; Funakoshi, Hiraku/R-4400-2019	Ohde, Sachiko/0000-0001-9137-0047; Homma, Yosuke/0000-0002-0473-9617; Takahashi, Jin/0000-0001-5396-0054				Asbridge M, 2014, PREV MED, V66, P80, DOI 10.1016/j.ypmed.2014.06.006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brick J, 2009, ALCOHOL CLIN EXP RES, V33, P1489, DOI 10.1111/j.1530-0277.2009.00979.x; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Crocker P, 2010, AM J EMERG MED, V28, P68, DOI 10.1016/j.ajem.2008.09.011; Hakucho Ayako, 2014, Nihon Arukoru Yakubutsu Igakkai Zasshi, V49, P177; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Li GH, 2001, JAMA-J AM MED ASSOC, V285, P893, DOI 10.1001/jama.285.7.893; Martinez-Ruiz V, 2013, ACCIDENT ANAL PREV, V51, P228, DOI 10.1016/j.aap.2012.11.023; Morgan AS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-699; Olson KN, 2013, ALCOHOL ALCOHOLISM, V48, P386, DOI 10.1093/alcalc/agt042; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; SPAITE DW, 1995, J TRAUMA, V38, P287, DOI 10.1097/00005373-199502000-00028; Twisk DAM, 2013, ACCIDENT ANAL PREV, V60, P134, DOI 10.1016/j.aap.2013.08.015	15	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174408	10.1371/journal.pone.0174408	http://dx.doi.org/10.1371/journal.pone.0174408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8SZ	28329002	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700089
J	Rickbeil, GJM; Hermosilla, T; Coops, NC; White, JC; Wulder, MA				Rickbeil, Gregory J. M.; Hermosilla, Txomin; Coops, Nicholas C.; White, Joanne C.; Wulder, Michael A.			Estimating changes in lichen mat volume through time and related effects on barren ground caribou (Rangifer tarandus groenlandicus) movement	PLOS ONE			English	Article							SPATIAL ASSOCIATION; PRODUCTIVITY; HABITAT; CANADA; VEGETATION; DYNAMICS; QUALITY; TUNDRA; FIRE	Lichens form a critical portion of barren ground caribou (Rangifer tarandus groenlandicus) diets, especially during winter months. Here, we assess lichen mat volume across five herd ranges in the Northwest Territories and Nunavut, Canada, using newly developed composite Landsat imagery. The lichen volume estimator (LVE) was adapted for use across 700 000 km 2 of barren ground caribou habitat annually from 1984-2012. We subsequently assessed how LVE changed temporally throughout the time series for each pixel using Theil-Sen's slopes, and spatially by assessing whether slope values were centered in local clusters of similar values. Additionally, we assessed how LVE estimates resulted in changes in barren ground caribou movement rates using an extensive telemetry data set from 2006-2011. The Ahiak/Beverly herd had the largest overall increase in LVE (median = 0.033), while the more western herds had the least (median slopes below zero in all cases). LVE slope pixels were arranged in significant clusters across the study area, with the Cape Bathurst, Bathurst, and Bluenose East herds having the most significant clusters of negative slopes (more than 20% of vegetated land in each case). The Ahiak/Beverly and Bluenose West had the most significant positive clusters (16.3% and 18.5% of vegetated land respectively). Barren ground caribou displayed complex reactions to changing lichen conditions depending on season; the majority of detected associations with movement data agreed with current understanding of barren ground caribou foraging behavior (the exception was an increase in movement velocity at high lichen volume estimates in Fall). The temporal assessment of LVE identified areas where shifts in ecological conditions may have resulted in changing lichen mat conditions, while assessing the slope estimates for clustering identified zones beyond the pixel scale where forage conditions may be changing. Lichen volume estimates associated with barren ground caribou movement metrics in an expected manner and, as such, show value for future habitat assessments.	[Rickbeil, Gregory J. M.; Hermosilla, Txomin; Coops, Nicholas C.] Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [White, Joanne C.; Wulder, Michael A.] Canadian Forest Serv, Nat Resources Canada, Pacific Forestry Ctr, Victoria, BC, Canada	University of British Columbia; Natural Resources Canada; Canadian Forest Service	Rickbeil, GJM (corresponding author), Univ British Columbia, Fac Forestry, Vancouver, BC, Canada.	gregory.rickbeil@alumni.ubc.ca	Wulder, Michael A/J-5597-2016; White, Joanne C./Z-1981-2019; Coops, Nicholas/L-3652-2019; Coops, Nicholas C/J-1543-2012; Hermosilla, Txomin/K-6206-2014	Wulder, Michael A/0000-0002-6942-1896; White, Joanne C./0000-0003-4674-0373; Coops, Nicholas/0000-0002-0151-9037; Coops, Nicholas C/0000-0002-0151-9037; Hermosilla, Txomin/0000-0002-5445-0360	National Science and Engineering Council of Canada [PGS M - 427425-2012, PGS M-427425-2012]; NCC [RGPIN 311926-13]; Government of the Northwest Territories; Canadian Space Agency (CSA); Government Related Initiatives Program (GRIP); Canadian Forest Service (CFS) of Natural Resources Canada	National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NCC; Government of the Northwest Territories; Canadian Space Agency (CSA)(Canadian Space Agency); Government Related Initiatives Program (GRIP)(Canadian Space Agency); Canadian Forest Service (CFS) of Natural Resources Canada(Natural Resources CanadaCanadian Forest Service)	This work was funded by National Science and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) grants to GR (award number: PGS M - 427425-2012) and NCC (RGPIN 311926-13), and the Government of the Northwest Territories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by National Science and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) grants to GR (award number: PGS M-427425-2012) and NCC (RGPIN 31192613), and the Government of the Northwest Territories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data used in this study is an outcome of the National Terrestrial Ecosystem Monitoring System (NTEMS): Timely and detailed national cross-sector monitoring for Canada project jointly funded by the Canadian Space Agency (CSA), Government Related Initiatives Program (GRIP), and the Canadian Forest Service (CFS) of Natural Resources Canada.	Adamczewski J, 2015, ARCTIC, V68, P407, DOI 10.14430/arctic4523; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bergerud A.T., 2000, ECOLOGY MANAGEMENT L, P658; Boulanger J., 2014, 142 GOV NW TERR ENV; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Campbell M, 2012, TECHNICAL REPORT SER; Cebrian MR, 2008, ARCT ANTARCT ALP RES, V40, P48, DOI 10.1657/1523-0430(06-073)[CEBRIAN]2.0.CO;2; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Colpaert A, 2003, ARCTIC, V56, P147; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Dodge S, 2008, INFORM VISUAL, V7, P240, DOI 10.1057/palgrave.ivs.9500182; Euskirchen ES, 2006, GLOBAL CHANGE BIOL, V12, P731, DOI 10.1111/j.1365-2486.2006.01113.x; Falldorf T, 2014, REMOTE SENS ENVIRON, V140, P573, DOI 10.1016/j.rse.2013.09.027; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Fraser RH, 2014, ECOSYSTEMS, V17, P1151, DOI 10.1007/s10021-014-9783-3; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Getis A., 1994, SPATIAL ANAL GIS, P105; Gordon Bryan, 2003, Rangifer, P15; Gunn A, 1986, RANGIFER, V6, P151, DOI 10.7557/2.6.2.640; Hagemoen RIM, 2002, J ANIM ECOL, V71, P883, DOI 10.1046/j.1365-2656.2002.00654.x; Heard Douglas C., 1996, Rangifer, V16, P37; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hermosilla T, 2016, INT J DIGIT EARTH, V9, P1035, DOI 10.1080/17538947.2016.1187673; Hermosilla T, 2015, REMOTE SENS ENVIRON, V158, P220, DOI 10.1016/j.rse.2014.11.005; Jandt R, 2008, ARCT ANTARCT ALP RES, V40, P89, DOI 10.1657/1523-0430(06-122)[JANDT]2.0.CO;2; Joly K, 2010, ECOSCIENCE, V17, P321, DOI 10.2980/17-3-3337; Ju JC, 2016, REMOTE SENS ENVIRON, V176, P1, DOI 10.1016/j.rse.2016.01.001; Kelly R, 2013, P NATL ACAD SCI USA, V110, P13055, DOI 10.1073/pnas.1305069110; Kendall M. G., 1975, RANK CORRELATION MET; Kimball JS, 2006, EARTH INTERACT, V10; Lantz TC, 2013, ECOSYSTEMS, V16, P47, DOI 10.1007/s10021-012-9595-2; Lantz TC, 2010, J BIOGEOGR, V37, P1597, DOI 10.1111/j.1365-2699.2010.02317.x; Manseau M, 1996, J ECOL, P503; Michaud JS, 2012, ECOL INDIC, V18, P303, DOI 10.1016/j.ecolind.2011.11.027; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Nagy JA., 2011, USE SPACE CARIBOU NO; Nagy JA, 2011, ECOL APPL, V21, P2334, DOI 10.1890/10-1410.1; Nordberg ML, 1998, 27TH INTERNATIONAL SYMPOSIUM ON REMOTE SENSING OF ENVIRONMENT, PROCEEDINGS, P431; Parlee B, 2005, ARCTIC, V58, P26; Pinheiro J, 2020, R PACKAGE VERSION 31; Pouliot D, 2014, REMOTE SENS ENVIRON, V140, P731, DOI 10.1016/j.rse.2013.10.004; R Core Team, 2013, R LANG ENV STAT COMP; Rickbeil GJ, 2016, GLOBAL CHANGE BIOL; Rickbeil GJM, 2015, REMOTE SENS ENVIRON, V164, P314, DOI 10.1016/j.rse.2015.04.006; Roy DP, 2010, REMOTE SENS ENVIRON, V114, P35, DOI 10.1016/j.rse.2009.08.011; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Theau J, 2005, REMOTE SENS ENVIRON, V94, P232, DOI 10.1016/j.rse.2004.10.008; Tveraa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056450; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weladji RB, 2003, J ZOOL, V260, P79, DOI 10.1017/S0952836903003510; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Wulder M, 2001, CAN J REMOTE SENS, V27, P69; Wulder M, 1998, INT J REMOTE SENS, V19, P2223, DOI 10.1080/014311698214983; Wulder MA, 2014, NATURE, V513, P30, DOI 10.1038/513030a; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zuur A. F., 2004, MIXED EFFECTS MODELS	66	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172669	10.1371/journal.pone.0172669	http://dx.doi.org/10.1371/journal.pone.0172669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328953	Green Published, Green Submitted, gold			2022-12-27	WOS:000399094700006
J	Sung, NW; Pham, NT; Huynh, T; Hwang, WJ; You, I; Choo, KKR				Sung, Nak Woon; Pham, Ngoc-Thai; Huynh, Thong; Hwang, Won-Joo; You, Ilsun; Choo, Kim-Kwang Raymond			Prediction-based association control scheme in dense femtocell networks	PLOS ONE			English	Article							WLAN ASSOCIATIONS; HANDOVER; OPTIMIZATION; AVOIDANCE; DELAY	The deployment of large number of femtocell base stations allows us to extend the coverage and efficiently utilize resources in a low cost manner. However, the small cell size of femtocell networks can result in frequent handovers to the mobile user, and consequently throughput degradation. Thus, in this paper, we propose predictive association control schemes to improve the system's effective throughput. Our design focuses on reducing handover frequency without impacting on throughput. The proposed schemes determine handover decisions that contribute most to the network throughput and are proper for distributed implementations. The simulation results show significant gains compared with existing methods in terms of handover frequency and network throughput perspective.	[Sung, Nak Woon] Elect & Telecommun Res Inst, Daejeon 34129, South Korea; [Pham, Ngoc-Thai; Hwang, Won-Joo] Inje Univ, Dept Informat & Commun Engn, Gimhae 50834, South Korea; [Huynh, Thong] Tokyo Univ Sci, Dept Elect Engn, Tokyo 1258585, Japan; [You, Ilsun] Soonchunhyang Univ, Dept Informat Secur Engn, Asan 31538, South Korea; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA; [Choo, Kim-Kwang Raymond] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia	Electronics & Telecommunications Research Institute - Korea (ETRI); Inje University; Tokyo University of Science; Soonchunhyang University; University of Texas System; University of Texas at San Antonio (UTSA); University of South Australia	Sung, NW (corresponding author), Elect & Telecommun Res Inst, Daejeon 34129, South Korea.	nwsung@etri.re.kr	Choo, Kim-Kwang Raymond/A-3634-2009; You, Ilsun/AAR-7793-2021	Choo, Kim-Kwang Raymond/0000-0001-9208-5336; 	Cross Ministry Giga KOREA Project' of the Ministry of Science, ICT and Future Planning, Korea [GK15N0100]	Cross Ministry Giga KOREA Project' of the Ministry of Science, ICT and Future Planning, Korea	This research is funded by 'The Cross Ministry Giga KOREA Project' [GK15N0100, 5G mobile communication system development based on mmWave] of the Ministry of Science, ICT and Future Planning, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulova V, 2011, WIREL NETW, V17, P149, DOI 10.1007/s11276-010-0270-2; Avil?s JMR., 2015, EURASIP J WIREL COMM, V2015, P1; Balakrishnan R, 2015, IEEE T, P1; Becvar Zdenek, 2010, Proceedings 2010 6th International Conference on Wireless and Mobile Communications (ICWMC 2010), P256, DOI 10.1109/ICWMC.2010.17; Chandrasekhar V, 2008, IEEE COMMUN MAG, V46, P59, DOI 10.1109/MCOM.2008.4623708; Chen MM, 2014, IEEE VTS VEH TECHNOL; Cheng M, 2014, 2014 POW SYST COMP C, P1; Coucheney P, 2013, 2013 IEEE 24TH INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATIONS (PIMRC), P3129, DOI 10.1109/PIMRC.2013.6666684; Dely P, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-255; Kalbkhani H, 2014, IET COMMUN, V8, P3061, DOI 10.1049/iet-com.2014.0230; Lal S, 2007, 10 INT C INF TECHN I, P133; Lee CH, 2015, IEEE COMMUN LETT, V19, P1596, DOI 10.1109/LCOMM.2015.2422823; Li Y, 2016, IEEE WIREL COMMUN, V23, P112, DOI 10.1109/MWC.2016.7462492; Liu F, 2014, IEEE ICC, P4875, DOI 10.1109/ICC.2014.6884092; Luo Z, 2015, IEEE T COMMUN, V63, P2273, DOI 10.1109/TCOMM.2015.2427167; Peng W, 2012, 2012 EIGHTH INTERNATIONAL CONFERENCE ON MOBILE AD HOC AND SENSOR NETWORKS (MSN 2012), P140, DOI 10.1109/MSN.2012.25; Powell WB, 2007, APPROXIMATE DYNAMIC PROGRAMMING: SOLVING THE CURSES OF DIMENSIONALITY, P1, DOI 10.1002/9780470182963; Ray SK, 2010, IEEE COMMUN SURV TUT, V12, P376, DOI 10.1109/SURV.2010.032210.00064; Rodriguez J, 2015, Fundamentals of 5G Mobile Networks, P1, DOI 10.1002/9781118867464; Son K, 2009, IEEE T WIREL COMMUN, V8, P3566, DOI 10.1109/TWC.2009.071140; Sung NW, 2013, WIREL NETW, V19, P741, DOI 10.1007/s11276-012-0498-0; Sung NW, 2013, IEEE COMMUN LETT, V17, P924, DOI 10.1109/LCOMM.2013.031913.130127; Tseng PH, 2014, IEEE COMMUN LETT, V18, P797, DOI 10.1109/LCOMM.2014.031414.132731; Wang YL, 2015, J LIGHTWAVE TECHNOL, V33, P4671, DOI 10.1109/JLT.2015.2480969; Xenakis D, 2014, IEEE COMMUN SURV TUT, V16, P64, DOI 10.1109/SURV.2013.060313.00152; Yan XH, 2010, COMPUT NETW, V54, P1848, DOI 10.1016/j.comnet.2010.02.006; Zhang HC, 2015, IEEE COMMUN LETT, V19, P1873, DOI 10.1109/LCOMM.2015.2459048; Zhu YM, 2013, COMPUT COMMUN, V36, P203, DOI 10.1016/j.comcom.2012.08.016; Zola E, 2014, IEEE COMMUN LETT, V18, P2007, DOI 10.1109/LCOMM.2014.2359456	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174220	10.1371/journal.pone.0174220	http://dx.doi.org/10.1371/journal.pone.0174220			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328992	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399094700073
J	Xiu, LL; Zhong, GS; Ma, XM				Xiu, Linlin; Zhong, Gansheng; Ma, Xueman			Urinary iodine concentration (UIC) could be a promising biomarker for predicting goiter among school-age children: A systematic review and meta-analysis	PLOS ONE			English	Review							DEFICIENCY DISORDERS; PREVALENCE; WORLD; SALT	Objectives To evaluate whether urinary iodine concentration (UIC) can predict goiter among schoolage children, and to assess the association between UIC and goiter prevalence. Methods We searched the MEDLINE, EMBASE, Cochrane Library (Cochrane Database of Systematic Reviews), Web of Science, CNKI, VIP, and Wan Fang databases for relevant reports in both English and Chinese up to August 25, 2016. The mean differences (MD) and 95% confidence intervals (CI) were calculated for the UIC and goiter prevalence assessments. Pooled odds ratios and 95% CIs were used to compare the prevalences of goiter in the different UIC groups. Results We identified 11 case-control studies, and found that children with goiter had lower UIC values, compared to children without goiter (MD: -1.82, 95% CI: -3.24, -0.40, p < 0.05). An increased risk of goiter was associated with UIC values of < 20 mu g/L or > 200 mu g/L. Conclusion The results of our meta-analysis suggest that lower UIC values were associated with an increased risk of goiter, and that iodine deficiency may lead to an increased risk of goiter. Furthermore, we observed U-shaped relationships between UIC and the prevalence of goiter, which suggests that both severe iodine deficiency and excessive iodine intake may lead to increased risks of goiter.	[Xiu, Linlin; Zhong, Gansheng; Ma, Xueman] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China	Beijing University of Chinese Medicine	Zhong, GS (corresponding author), Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China.	zhonggansheng@126.com		ma, xueman/0000-0003-1442-6064				Aminorroaya A, 2001, Endocr Pract, V7, P95; [Anonymous], WHONMHNHDEPG145; [Anonymous], 2007, ASS IOD DEF DIS MON; Azizi F, 2008, J ENDOCRINOL INVEST, V31, P422, DOI 10.1007/BF03346386; Burgi H, 2010, BEST PRACT RES CL EN, V24, P107, DOI 10.1016/j.beem.2009.08.010; Cetin H, 2006, J ENDOCRINOL INVEST, V29, P714, DOI 10.1007/BF03344181; Cinaz P, 2004, BIOL TRACE ELEM RES, V100, P185, DOI 10.1385/BTER:100:3:185; Clar C, 2002, ENDOCRIN METAB CLIN, V31, P681, DOI 10.1016/S0889-8529(02)00011-7; Delange F, 2002, THYROID, V12, P915, DOI 10.1089/105072502761016557; Delange F, 2001, THYROID, V11, P437, DOI 10.1089/105072501300176390; Delshad Hossein, 2010, Acta Med Iran, V48, P361; Dodd Nina S., 1993, National Medical Journal of India, V6, P110; Egri M, 2006, TURKISH J PEDIATR, V48, P119; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Hurrell RF, 1997, EUR J CLIN NUTR, V51, pS9; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; Liu P, 2010, J ENDOCRINOL INVEST, V33, P26, DOI 10.1007/BF03346545; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Niedziela M, 2006, ENDOCR-RELAT CANCER, V13, P427, DOI 10.1677/erc.1.00882; Ozkan B, 2004, TURKISH J PEDIATR, V46, P16; Rezvanfar MR, 2007, J ENDOCRINOL INVEST, V30, P274, DOI 10.1007/BF03346293; Sanjari M, 2014, ENDOCRINOL METAB, V29, P307, DOI 10.3803/EnM.2014.29.3.307; Sethy PGS, 2007, INDIAN J PEDIATR, V74, P917, DOI 10.1007/s12098-007-0169-9; Stanbury JB, 1998, THYROID, V8, P83, DOI 10.1089/thy.1998.8.83; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; TODD CH, 1995, LANCET, V346, P1563, DOI 10.1016/S0140-6736(95)92095-1; van den Briel T, 2001, J NUTR, V131, P2701, DOI 10.1093/jn/131.10.2701; Venturi S, 2009, NUTRITION, V25, P977, DOI 10.1016/j.nut.2009.06.002; Vitti P, 2003, LANCET, V361, P1226, DOI 10.1016/S0140-6736(03)12935-2; Wells G., 2013, OTTAWA HOSP RES I; Xiao DL, 2007, CHINA NATL IODINE DE, P43; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3	33	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174095	10.1371/journal.pone.0174095	http://dx.doi.org/10.1371/journal.pone.0174095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328929	Green Submitted, gold, Green Published			2022-12-27	WOS:000399094700050
J	Freyd, T; Warszycki, D; Mordalski, S; Bojarski, AJ; Sylte, I; Gabrielsen, M				Freyd, Thibaud; Warszycki, Dawid; Mordalski, Stefan; Bojarski, Andrzej J.; Sylte, Ingebrigt; Gabrielsen, Mari			Ligand-guided homology modelling of the GABA(B2) subunit of the GABAB receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; NEGATIVE ALLOSTERIC MODULATOR; N,N'-DICYCLOPENTYL-2-METHYLSULFANYL-5-NITRO-PYRIMIDINE-4,6-DIAMINE GS39783; HEPTAHELICAL DOMAIN; POINT MUTATIONS; BINDING-SITE; CLASS-A; DISCOVERY; ACTIVATION; GPCRS	gamma- aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, and disturbances in the GABAergic system have been implicated in numerous neurological and neuropsychiatric diseases. The GABAB receptor is a heterodimeric class C G protein-coupled receptor (GPCR) consisting of GABA(B1a/b) and GABA(B2) subunits. Two GABAB receptor ligand binding sites have been described, namely the orthosteric GABA binding site located in the extracellular GABA(B1) Venus fly trap domain and the allosteric binding site found in the GABAB2 transmembrane domain. To date, the only experimentally solved three-dimensional structures of the GABAB receptor are of the Venus fly trap domain. GABAB receptor allosteric modulators, however, show great therapeutic potential, and elucidating the structure of the GABAB2 transmembrane domain may lead to development of novel drugs and increased understanding of the allosteric mechanism of action. Despite the lack of x-ray crystal structures of the GABAB2 transmembrane domain, multiple crystal structures belonging to other classes of GPCRs than class A have been released within the last years. More closely related template structures are now available for homology modelling of the GABAB receptor. Here, multiple homology models of the GABAB2 subunit of the GABAB receptor have been constructed using templates from class A, B and C GPCRs, and docking of five clusters of positive allosteric modulators and decoys has been undertaken to select models that enrich the active compounds. Using this ligand-guided approach, eight GABAB2 homology models have been chosen as possible structural representatives of the transmembrane domain of the GABAB2 subunit. To the best of our knowledge, the present study is the first to describe homology modelling of the transmembrane domain of the GABAB2 subunit and the docking of positive allosteric modulators in the receptor.	[Freyd, Thibaud; Sylte, Ingebrigt; Gabrielsen, Mari] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway; [Warszycki, Dawid; Mordalski, Stefan; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland	UiT The Arctic University of Tromso; Polish Academy of Sciences	Sylte, I (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway.	ingebrigt.sylte@uit.no	Bojarski, Andrzej/GSO-0213-2022; Warszycki, Dawid/T-9712-2017	Bojarski, Andrzej/0000-0003-1417-6333; Gabrielsen, Mari/0000-0003-3898-1193; Sylte, Ingebrigt/0000-0002-3290-3736; Warszycki, Dawid/0000-0002-2393-4709	Polish-Norwegian Research Program [Pol-Nor/198887/73/2013]; UiT The Arctic University of Norway; Polish Academy of Science; Notur (the Norwegian metacentre for computational studies) [nn2978k]	Polish-Norwegian Research Program; UiT The Arctic University of Norway; Polish Academy of Science; Notur (the Norwegian metacentre for computational studies)	The study was partially supported by the Polish-Norwegian Research Program operated by the Polish National Centre for Research and Development under the Norwegian Financial Mechanism 2009-2014 in the frame of Project PLATFORMex (Pol-Nor/198887/73/2013). UiT The Arctic University of Norway contributed With PhD scholarship for TF and salary for MG and IS. The Polish Academy of Science funded DW, SM and AJB. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.; This work was partly supported by computational resources provided by Notur (the Norwegian metacentre for computational studies), project nn2978k.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; [Anonymous], 2014, SCHROD REL 2014 1 MA; [Anonymous], 2014, SCHROD REL 2014 1 EP; [Anonymous], 2013, ADDEX RECEIVES APPRO; [Anonymous], 2014, SMALL MOL DRUG DISC; [Anonymous], 2014, SCHROD REL 2014 1 LI; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Brown KM, 2015, J MED CHEM, V58, P6336, DOI 10.1021/jm5018913; Castelli MP, 2012, J PHARMACOL EXP THER, V340, P529, DOI 10.1124/jpet.111.186460; Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m; Cavasotto CN, 2015, CHEM COMMUN, V51, P13576, DOI 10.1039/c5cc05050b; Chen LH, 2014, ACS MED CHEM LETT, V5, P742, DOI 10.1021/ml500162z; Christopher JA, 2015, J MED CHEM, V58, P6653, DOI 10.1021/acs.jmedchem.5b00892; Civelli O, 2013, ANNU REV PHARMACOL, V53, P127, DOI 10.1146/annurev-pharmtox-010611-134548; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cryan JF, 2004, J PHARMACOL EXP THER, V310, P952, DOI 10.1124/jpet.104.066753; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Dupuis DS, 2006, MOL PHARMACOL, V70, P2027, DOI 10.1124/mol.106.028183; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Gregory KJ, 2013, MOL PHARMACOL, V83, P991, DOI 10.1124/mol.112.083949; Guery S, 2007, BIOORG MED CHEM LETT, V17, P6206, DOI 10.1016/j.bmcl.2007.09.023; Guglietti CL, 2013, BRAIN STIMUL, V6, P397, DOI 10.1016/j.brs.2012.08.005; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Kalinichev M, 2014, BRIT J PHARMACOL, V171, P4941, DOI 10.1111/bph.12812; Kalinichev M, 2017, NEUROPHARMACOLOGY, V114, P34, DOI 10.1016/j.neuropharm.2016.11.016; KELLY JL, 1956, IRE T INFORM THEOR, V2, P185, DOI 10.1109/TIT.1956.1056803; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kufareva I, 2014, STRUCTURE, V22, P1120, DOI 10.1016/j.str.2014.06.012; Lehmann K, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/892784; McRobb FM, 2010, J CHEM INF MODEL, V50, P626, DOI 10.1021/ci900444q; Mordalski S, 2011, BIOORG MED CHEM LETT, V21, P6816, DOI 10.1016/j.bmcl.2011.09.027; Mugnaini C, 2013, J MED CHEM, V56, P3620, DOI 10.1021/jm400144w; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Phatak SS, 2010, J CHEM INF MODEL, V50, P2119, DOI 10.1021/ci100285f; Porcu A, EUR J PHARM; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rodriguez D, 2014, STRUCTURE, V22, P1140, DOI 10.1016/j.str.2014.05.017; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sun B, 2016, BIOCHEM J, V473, P779, DOI 10.1042/BJ20150979; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Urwyler S, 2003, J PHARMACOL EXP THER, V307, P322, DOI 10.1124/jpet.103.053074; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	63	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173889	10.1371/journal.pone.0173889	http://dx.doi.org/10.1371/journal.pone.0173889			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323850	Green Published, Green Submitted, gold			2022-12-27	WOS:000399089000041
J	Guan, JZ; Yuan, SF; Wu, HQMG; Na, RS; Wu, XQ; Wang, X; Bao, S				Guan, Jingzhi; Yuan, Shaofei; Wu, Hanqimuge; Na, Risu; Wu, Xueqin; Wang, Xin; Bao, Shan			Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review								Background and objective To systematically evaluate the clinical effects and safety of traditional Chinese medical bath therapy (TCMBT) combined with ultraviolet irradiation in the treatment of psoriasis. Methods Electronic database retrieval was utilized. The foreign retrieval databases consulted included those of the Cochrane Library, PubMed and EMBASE; the domestic retrieval databases included the Chinese Biomedical Literature Database (Sino-Med), the China National Knowledge Infrastructure (CNKI), VIP and the WangFang Database. Clinical randomized controlled trials were conducted to evaluate the effects of TCMBT combined with ultraviolet irradiation in the treatment of psoriasis; the language of the retrieved articles was Chinese or English. Each database was searched from its inception to August 1, 2015. Two researchers independently collected the data and analyzed the methodology of the documented literature. The researchers conducted a meta-analysis with RevMan 5.2.3 software. Results According to the available literature, 25 RCTs (randomized controlled trials) of low research quality were conducted. According to the meta-analysis, the total effective rate of TCMBT combined with ultraviolet irradiation was relatively higher than that of ultraviolet irradiation alone. The recurrence rate, incidence of adverse reactions and Psoriasis Area and Severity Index (PASI) for the combined therapy was lower than that of ultraviolet irradiation (P<0.05). Conclusion For the treatment of psoriasis, the clinical effects and safety of TCMBT combined with ultraviolet irradiation are generally better than those of ultraviolet irradiation alone. However, the original literature was written in Chinese, and the quality of the studies was not high. Thus, it is difficult to confirm the clinical effects and safety of TCMBT combined with ultraviolet irradiation. It is necessary to conduct a scientific, normalized and high-quality RCT with multiple large samples and centers.	[Guan, Jingzhi; Wu, Xueqin; Wang, Xin; Bao, Shan] Inner Mongolia Int Mongolian Hosp, Dept Pharmaceut, Hohhot, Inner Mongolia, Peoples R China; [Yuan, Shaofei] Baotou Med Coll, Dept Pharmaceut, Affiliated Hosp 2, Baotou, Inner Mongolia, Peoples R China; [Wu, Hanqimuge] Inner Mongolia Int Mongolian Hosp, Pharmaceut Lab, Hohhot, Inner Mongolia, Peoples R China; [Na, Risu] Inner Mongolia Int Mongolian Hosp, Dept Psychosomat Med, Hohhot, Inner Mongolia, Peoples R China	Baotou Medical College	Bao, S (corresponding author), Inner Mongolia Int Mongolian Hosp, Dept Pharmaceut, Hohhot, Inner Mongolia, Peoples R China.	shanbao_IMIMH@163.com		bao, shan/0000-0002-1996-2280				Bandow GD, 2004, INT J DERMATOL, V43, P555, DOI 10.1111/j.1365-4632.2004.02032.x; Cui Bing-Nan, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P355; Declercq SD, 2013, SCI WORLD J, DOI 10.1155/2013/980419; Dong X, 2016, CONTINUING MED ED, V2, P115; Duan X, 2013, CHINESE J DERMATOVEN, V27, P192; Feng XG, 2009, MODERN J INTEGRATED, V8, P932; Han L., 2013, J GUIYANG U CHIN MED, V35, P149; Hu SJ, 2006, CHINA J LEPROSY SKIN, V9, P779; Kang DY, 2003, J EVIDENCE BASED MED, V1, P46; Kimball AB, 2014, BRIT J DERMATOL, V170, P366, DOI 10.1111/bjd.12744; Lan HR, 2015, JIANGXI J TRADITIONA, V10, P7; Li LZ, 2016, MODERN J INTEGRATED, V1, P680; Li N., 2014, CHINA HLTH IND, P190; Lin GS, 2010, ACTA U MED ANHUI, V3, P404; Liu B, 2005, J CLIN DERMATOLOGY, V8, P552; Liu HQ, 2005, N J TRADIT CHIN MED, V2, P53; Liu HX, 2008, OBSERVED CLIN CURATI; LIU XW, 2010, J DALIAN MED U, V32, P551; Luo GP, 2014, HUBEI J TRADITIONAL, V8, P12; Luo SM, 2010, CHINESE J DERMATOLOG, V4, P284; Mehta D, 2016, AM J CLIN DERMATOL, V17, P125, DOI 10.1007/s40257-016-0176-6; MU Z, 2009, CHINA MED ABSTRACT D, V3, P156; Peter Juni, 2001, CHINESE J EVIDENCE B, V4, P250; Qu YY, 2011, XINJIANG MED J, V4, P28; Racz E, 2015, DERMATOL CLIN, V33, P79, DOI 10.1016/j.det.2014.09.007; Re YEHGL WXE, 2012, SHAANXI J TRADITIONA, V7, P860; [师秀利 Shi Xiuli], 2011, [中国激光医学杂志, Chinese Journal of Laser Medicine and Surgery], V20, P314; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C., 2016, PHOTOCHEM PHOTOBIOL; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A., 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2015, PHOTODERMATOL PHOTO, V31, P121, DOI 10.1111/phpp.12165; Song LJ, 2011, CHINESE J DERMATOLOG, V44, P60; SUN ZJ, 2010, CONT MED, V30, P152; Tan YQ, 2011, CHIN J INTEGR MED, V17, P150, DOI 10.1007/s11655-011-0645-y; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH9; Wang FE, 2013, CLIN MED, V9, P112; Wang GC, 2002, DERMATOLOGY VENEREAL, P538; Wang LX, 2012, NEI MONGOL J TRADITI, V7, P115; Wang XG, 2015, CLIN J MED OFFICERS, V3, P300; Wang XN, 2015, PHARM BIOTECHNOLOGY, V3, P259; Wang XS, 2005, YANG GUOLIANG DERMAT, P508; Wang YQ, 2013, MED J NATL DEFENDING, V3, P260; Wang YS, 2014, WIT TRANS ENG SCI, V84, P85, DOI 10.2495/MEEE20130121; Wang ZX, 2011, HENAN XUE XUE BAO, V30, P226; Wu ZH, 2004, MODERN DERMATOLOGY, P450; Xuan ML, 2015, CHIN J INTEGR MED, V21, P108, DOI 10.1007/s11655-014-1792-0; Yan YH, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/719641; YE CG, 2009, CHINA TROPICAL MED, V4, P636; Yu JJ, 2013, TOPICA CHINESE HERBA; YUAN LL, 2014, CHINA J LEPROSY SKIN, V8, P473; Zhang CS, 2016, COMPLEMENT THER MED, V25, P55, DOI 10.1016/j.ctim.2015.12.014; Zhang Y, 2014, HUNAN CHINESE MED J, V30, P184; Zhang YH, 2014, J HUBEI U CHINESE ME, V2, P95; Zhang YS, 2010, ZHONG GUO MA FENG PI, V26, P815; Zhao B, 2009, CHINA CLIN DERMATOLO, P1011; Zhao D, 2015, CLIN J TRADITIONAL C, V5, P695; Zhao XN, 2002, CLIN DERMATOL, P1034; Zhou M, 2005, LIAONING J TRADITION, V10, P1025; Zhou ML, 2014, MED INFORM, V4, P166; Zhou XY, 2002, J EVIDENCE BASED MED, V4, P216	64	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173276	10.1371/journal.pone.0173276	http://dx.doi.org/10.1371/journal.pone.0173276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323822	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000016
J	Raja, Z; Andre, S; Abbassi, F; Humblot, V; Lequin, O; Bouceba, T; Correia, I; Casale, S; Foulon, T; Sereno, D; Oury, B; Ladram, A				Raja, Zahid; Andre, Sonia; Abbassi, Feten; Humblot, Vincent; Lequin, Olivier; Bouceba, Tahar; Correia, Isabelle; Casale, Sandra; Foulon, Thierry; Sereno, Denis; Oury, Bruno; Ladram, Ali			Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent	PLOS ONE			English	Article							HELICAL ANTIMICROBIAL PEPTIDES; DIFFERENTIAL SCANNING CALORIMETRY; MODEL MEMBRANE SYSTEMS; HOST-DEFENSE PEPTIDES; LEISHMANIA-DONOVANI; FROG-SKIN; HEMOLYTIC-ACTIVITY; DRUG-RESISTANCE; AMPHIBIAN SKIN; DERMASEPTIN B2	Antimicrobial peptides (AMPs) are promising drugs to kill resistant pathogens. In contrast to bacteria, protozoan parasites, such as Leishmania, were little studied. Therefore, the antiparasitic mechanism of AMPs is still unclear. In this study, we sought to get further insight into this mechanism by focusing our attention on temporin-SHa (SHa), a small broad-spectrum AMP previously shown to be active against Leishmania infantum. To improve activity, we designed analogs of SHa and compared the antibacterial and antiparasitic mechanisms. [K-3] SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum. Multipassage resistance selection demonstrated that temporins-SH, particularly [K-3] SHa, are not prone to induce resistance in Escherichia coli. Analysis of the mode of action revealed that bacterial and parasite killing occur through a similar membranolytic mechanism involving rapid membrane permeabilization and depolarization. This was confirmed by high-resolution imaging (atomic force microscopy and field emission gun-scanning electron microscopy). Multiple combined techniques (nuclear magnetic resonance, surface plasmon resonance, differential scanning calorimetry) allowed us to detail peptide-membrane interactions. [K-3] SHa was shown to interact selectively with anionic model membranes with a 4-fold higher affinity (K-D = 3 x 10(-8) M) than SHa. The amphipathic a-helical peptide inserts in-plane in the hydrophobic lipid bilayer and disrupts the acyl chain packing via a detergent-like effect. Interestingly, cellular events, such as mitochondrial membrane depolarization or DNA fragmentation, were observed in L. infantum promastigotes after exposure to SHa and [K-3] SHa at concentrations above IC50. Our results indicate that these temporins exert leishmanicidal activity via a primary membranolytic mechanism but can also trigger apoptotis-like death. The many assets demonstrated for [K-3] SHa make this small analog an attractive template to develop new antibacterial/antiparasitic drugs.	[Raja, Zahid; Andre, Sonia; Abbassi, Feten; Foulon, Thierry; Ladram, Ali] UPMC Univ Paris 06, Sorbonne Univ, CNRS, IBPS,Biogenese Signaux Peptid BIOSIPE, Paris, France; [Humblot, Vincent; Casale, Sandra] UPMC Univ Paris 06, Sorbonne Univ, CNRS, LRS, Paris, France; [Lequin, Olivier; Correia, Isabelle] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Ecole Normale Super,Lab Biomol, Paris, France; [Lequin, Olivier; Correia, Isabelle] UPMC Univ Paris 06, PSL Res Univ, CNRS, Dept Chem,Ecole Normale Super,Lab Biomol, Paris, France; [Bouceba, Tahar] UPMC Univ Paris 06, Sorbonne Univ, CNRS, IBPS,Plate Forme Interact Mol, Paris, France; [Sereno, Denis; Oury, Bruno] Univ Montpellier I, IRD, CNRS, UMR 224, Montpellier, France; [Sereno, Denis; Oury, Bruno] Univ Montpellier 2, MiVegec, Montpellier, France; [Sereno, Denis; Oury, Bruno] CIRAD, IRD, Interact Hotes Vecteurs Parasites Environm Malad, UMR 177, Montpellier, France; [Abbassi, Feten] Univ Monastir, ESSTSM, Monastir, Tunisia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Monastir	Ladram, A (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, IBPS,Biogenese Signaux Peptid BIOSIPE, Paris, France.	ali.ladram@upmc.fr	denis, Sereno/I-7242-2019	denis, Sereno/0000-0002-0034-9291; LEQUIN, Olivier/0000-0001-5307-3068	University Pierre and Marie Curie (UPMC); Institute of Research for Development; French state funds [ANR-11-IDEX-0004-02]; Convergence MECV program of UPMC; French Ministere de l'Enseignement Superieur et de la Recherche	University Pierre and Marie Curie (UPMC); Institute of Research for Development; French state funds; Convergence MECV program of UPMC; French Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by the University Pierre and Marie Curie (UPMC), Institute of Research for Development (IRD-AAP Leishmed 2010), French state funds managed by the ANR (Investissements d'Avenir program, reference ANR-11-IDEX-0004-02, within the framework of the Cluster of Excellence MATISSE), and by funds from the Convergence MECV 2011 program of UPMC. ZR and SA were supported by a fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche, allocated by the Ecole Doctorale iViv (ED 387, UPMC, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi F, 2008, PEPTIDES, V29, P1526, DOI 10.1016/j.peptides.2008.05.008; Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Abbassi F, 2013, BIOCHIMIE, V95, P388, DOI 10.1016/j.biochi.2012.10.015; Abbassi F, 2010, J BIOL CHEM, V285, P16880, DOI 10.1074/jbc.M109.097204; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amiche M, 2008, PEPTIDES, V29, P2074, DOI 10.1016/j.peptides.2008.06.017; Andre S, 2015, ACS CHEM BIOL, V10, P2257, DOI 10.1021/acschembio.5b00495; Avitabile C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04293; Belokoneva OS, 2003, BBA-BIOMEMBRANES, V1617, P22, DOI 10.1016/j.bbamem.2003.08.010; BESSALLE R, 1992, ANTIMICROB AGENTS CH, V36, P313, DOI 10.1128/AAC.36.2.313; Carlier L, 2015, BIOPHYS CHEM, V196, P40, DOI 10.1016/j.bpc.2014.09.004; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Cobb SL, 2010, CURR OPIN INVEST DR, V11, P868; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Conlon JM, 2007, METHODS, V42, P349, DOI 10.1016/j.ymeth.2007.01.004; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Eggimann GA, 2015, MOLECULES, V20, P2775, DOI 10.3390/molecules20022775; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hein-Kristensen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073620; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; HERNANDEZ C, 1992, EUR J CELL BIOL, V59, P414; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; Kosowska-Shick K, 2009, ANTIMICROB AGENTS CH, V53, P4217, DOI 10.1128/AAC.00742-09; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Lequin O, 2003, BIOCHEMISTRY-US, V42, P10311, DOI 10.1021/bi034401d; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; Lombana A, 2014, J PEPT SCI, V20, P563, DOI 10.1002/psc.2654; Mahalka AK, 2009, BBA-BIOMEMBRANES, V1788, P1600, DOI 10.1016/j.bbamem.2009.04.012; Maler L, 2013, ADV DRUG DELIVER REV, V65, P1002, DOI 10.1016/j.addr.2012.10.011; Malgieri G, 2015, ACS CHEM BIOL, V10, P965, DOI 10.1021/cb501057d; MANGONI LM, 2009, BIOCHIM BIOPHYS ACTA, V1788, P1610; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Mangoni ML, 2006, BIOCHEMISTRY-US, V45, P4266, DOI 10.1021/bi052150y; Mangoni ML, 2000, EUR J BIOCHEM, V267, P1447, DOI 10.1046/j.1432-1327.2000.01143.x; MCELHANEY RN, 1986, BIOCHIM BIOPHYS ACTA, V864, P361, DOI 10.1016/0304-4157(86)90004-3; Moradin N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00121; Nicolas P., 2013, HDB BIOL ACTIVE PEPT, P350; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Pal T, 2005, REGUL PEPTIDES, V129, P85, DOI 10.1016/j.regpep.2005.01.015; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Raina P, 2006, MOL CELL BIOCHEM, V289, P83, DOI 10.1007/s11010-006-9151-5; Raja Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070782; Rex S, 1996, BIOPHYS CHEM, V58, P75, DOI 10.1016/0301-4622(95)00087-9; Rinaldi A.C., 2013, HDB BIOL ACTIVE PEPT, V2nd ed., P400, DOI [10.1016/B978-0-12-385095-9.00056-7, DOI 10.1016/B978-0-12-385095-9.00056-7]; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rivas L, 2009, BBA-BIOMEMBRANES, V1788, P1570, DOI 10.1016/j.bbamem.2008.11.002; Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; Santa-Rita RM, 2004, J ANTIMICROB CHEMOTH, V54, P704, DOI 10.1093/jac/dkh380; Sereno D, 1998, ANTIMICROB AGENTS CH, V42, P3097, DOI 10.1128/AAC.42.12.3097; Shireen T, 2013, ANTIMICROB AGENTS CH, V57, P5134, DOI 10.1128/AAC.00780-13; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; SIMPSON L, 1970, J PROTOZOOL, V17, P511, DOI 10.1111/j.1550-7408.1970.tb04719.x; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Torrent M, 2012, CURR DRUG TARGETS, V13, P1138, DOI 10.2174/138945012802002393; Tossi A, 2000, BIOPOLYMERS, V55, P4; Urban E, 2007, INT J ANTIMICROB AG, V29, P317, DOI 10.1016/j.ijantimicag.2006.09.007; Verma NK, 2007, EXP PARASITOL, V116, P1, DOI 10.1016/j.exppara.2006.10.007; Vizioli J, 2002, TRENDS PARASITOL, V18, P475, DOI 10.1016/S1471-4922(02)02428-5; Wade D, 2000, FEBS LETT, V479, P6, DOI 10.1016/S0014-5793(00)01754-3; WHO/Department of control of neglected tropical diseases, 2015, 3 WHO DEP CONTR NEGL; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; World Health Organization, 2014, ANT RES GLOB REP SUR; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5	82	42	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174024	10.1371/journal.pone.0174024	http://dx.doi.org/10.1371/journal.pone.0174024			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319176	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800043
J	Caini, S; Alonso, WJ; Balmaseda, A; Bruno, A; Bustos, P; Castillo, L; de Lozano, C; de Mora, D; Fasce, RA; de Almeida, WAF; Kusznierz, GF; Lara, J; Matute, ML; Moreno, B; Henriques, CMP; Rudi, JM; Seblain, CE; Schellevis, F; Paget, J				Caini, Saverio; Alonso, Wladimir J.; Balmaseda, Angel; Bruno, Alfredo; Bustos, Patricia; Castillo, Leticia; de Lozano, Celina; de Mora, Domenica; Fasce, Rodrigo A.; Ferreira de Almeida, Walquiria Aparecida; Kusznierz, Gabriela F.; Lara, Jenny; Luisa Matute, Maria; Moreno, Brechla; Pessanha Henriques, Claudio Maierovitch; Manuel Rudi, Juan; Seblain, Clotilde El-Guerche; Schellevis, Francois; Paget, John		Global Influenza B Study Grp Latin	Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countries	PLOS ONE			English	Article							CIRCULATION; CHILDREN; ILLNESS; TROPICS; AFRICA; BURDEN	Introduction The increased availability of influenza surveillance data in recent years justifies an actual and more complete overview of influenza epidemiology in Latin America. We compared the influenza surveillance systems and assessed the epidemiology of influenza A and B, including the spatio-temporal patterns of influenza epidemics, in ten countries and sub-national regions in Latin America. Methods We aggregated the data by year and country and characteristics of eighty-two years were analysed. We calculated the median proportion of laboratory-confirmed influenza cases caused by each virus strain, and compared the timing and amplitude of the primary and secondary peaks between countries. Results 37,087 influenza cases were reported during 2004-2012. Influenza A and B accounted for a median of 79% and, respectively, 21% of cases in a year. The percentage of influenza A cases that were subtyped was 82.5%; for influenza B, 15.6% of cases were characterized. Influenza A and B were dominant in seventy-five (91%) and seven (9%) years, respectively. In half (51%) of the influenza A years, influenza A(H3N2) was dominant, followed by influenza A(H1N1) pdm2009 (41%) and pre-pandemic A(H1N1) (8%). The primary peak of influenza activity was in June-September in temperate climate countries, with little or no secondary peak. Tropical climate countries had smaller primary peaks taking place in different months and frequently detectable secondary peaks. Conclusions We found that good influenza surveillance data exists in Latin America, although improvements can still be made (e.g. a better characterization of influenza B specimens); that influenza B plays a considerable role in the seasonal influenza burden; and that there is substantial heterogeneity of spatio-temporal patterns of influenza epidemics. To improve the effectiveness of influenza control measures in Latin America, tropical climate countries may need to develop innovative prevention strategies specifically tailored to the spatio-temporal patterns of influenza in this region.	[Caini, Saverio; Schellevis, Francois; Paget, John] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Alonso, Wladimir J.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Balmaseda, Angel] Minist Hlth, Natl Influenza Ctr, Managua, Nicaragua; [Bruno, Alfredo; de Mora, Domenica] Ctr Referencia Nacl Influenza & Otros Virus Resp, Inst Nacl Invest Salud Publ INSPI, Guayaquil, Ecuador; [Bustos, Patricia; Fasce, Rodrigo A.] Inst Salud Publ Chile, Secc Virus Resp, Santiago, Chile; [Castillo, Leticia] Minist Hlth, Natl Influenza Ctr, Guatemala City, Guatemala; [de Lozano, Celina] Minist Hlth, Natl Influenza Ctr, San Salvador, El Salvador; [Ferreira de Almeida, Walquiria Aparecida; Pessanha Henriques, Claudio Maierovitch] Minist Hlth, Brasilia, DF, Brazil; [Kusznierz, Gabriela F.; Manuel Rudi, Juan] ANLIS C Malbran, Inst Nacl Enfermedades Resp Dr Emilio Coni, Santa Fe, Argentina; [Lara, Jenny] Minist Hlth, Natl Influenza Ctr, San Jose, Costa Rica; [Luisa Matute, Maria] Minist Hlth, Natl Influenza Ctr, Tegucigalpa, Honduras; [Moreno, Brechla] IC Gorges, Natl Influenza Ctr, Panama City, Panama; [Seblain, Clotilde El-Guerche] Sanofi Pasteur, Lyon, France; [Schellevis, Francois] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth Care Res, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Vrije Universiteit Amsterdam	Caini, S (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	s.caini@nivel.nl	Caini, Saverio/AAI-3788-2020; Henriques, Claudio/AAW-8044-2021; Alonso, Wladimir J./N-9223-2017; BRUNO, ALFREDO/AAW-8354-2020	Caini, Saverio/0000-0002-2262-1102; Alonso, Wladimir J./0000-0001-7038-0801; BRUNO, ALFREDO/0000-0002-9678-4203	Sanofi Pasteur	Sanofi Pasteur	The Global Influenza B Study is supported by an unrestricted research grant by Sanofi Pasteur. The funder provided support in the form of salaries for Clotilde EI-Guerche Seblain, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contribution" section.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Alonso WJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-982; Belongia EA, 2015, VACCINE, V33, P246, DOI 10.1016/j.vaccine.2014.06.052; Budgell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120226; Caini S, 2016, PLOS ONE, V11, DOI DOI 10.1371/journal.pone.0155089; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Chadha MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124122; Comach G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044511; Lange MMA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-881; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Delangue J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-35; Durand LO, 2016, INFLUENZA OTHER RESP, V10, P170, DOI 10.1111/irv.12371; Arango AE, 2015, INFLUENZA OTHER RESP, V9, P1, DOI 10.1111/irv.12271; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Mosnier A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1056-z; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; World Health Organization, INFL TRANSM ZON; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	26	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174592	10.1371/journal.pone.0174592	http://dx.doi.org/10.1371/journal.pone.0174592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346498	gold, Green Published, Green Submitted			2022-12-27	WOS:000399174300059
J	Chen, JQ; Papp, G; Poliska, S; Szabo, K; Tarr, T; Balint, BL; Szodoray, P; Zeher, M				Chen, Ji-Qing; Papp, Gabor; Poliska, Szilard; Szabo, Krisztina; Tarr, Tunde; Balint, Balint Laszlo; Szodoray, Peter; Zeher, Margit			MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren's syndrome	PLOS ONE			English	Article							B-CELL SUBSETS; CLASSIFICATION CRITERIA; SIGNALING PROTEINS; MIRNAS; RNA; AUTOIMMUNITY; BIOGENESIS; COMPONENT; SIRNAS; GENE	The discovery of microRNAs (miRNAs) and their critical role in genetic control opened new avenues in understanding of various biological processes including immune cell lineage commitment, differentiation, proliferation and apoptosis. However, a given miRNA may have hundreds of different mRNA targets and a target might be regulated by multiple miRNAs, thus the characterisation of dysregulated miRNA expression profiles could give a better insight into the development of immunological disturbances in autoimmune diseases. The aim of our study was to examine the changes in miRNA expression profiles in patients with systemic lupus erythematosus (SLE) and primary Sjogren's syndrome (pSS). Eight SLE patients, 8 pSS patients and 7 healthy subjects were enrolled in the investigation. MiRNAs were isolated from peripheral blood mononuclear cells, and expression patterns were determined with Illumina next-generation sequencing technology. Since the immunopathogenesis of pSS and SLE encompasses pronounced B cell hyperactivity along with specific autoantibody production, we paid a special attention on the association between miRNA expression levels and altered peripheral B cell distribution. In SLE patients 135, while in pSS patients 26 miRNAs showed altered expression. Interestingly, the 25 miRNAs including miR-146a, miR-16 and miR-21, which were over-expressed in pSS patients, were found to be elevated in SLE group, as well. On the contrary, we observed the down-regulation of miR-1505p, which is a novel and unique finding in pSS. Levels of several miRNAs over-expressed in SLE, were not changed in pSS, such as miR-148a-3p, miR-152, miR-155, miR-223, miR-224, miR-326 and miR-342. Expression levels of miR-223-5p, miR-150-5p, miR-155-5p and miR-342-3p, which miRNAs are potentially linked to B cell functions, showed associations with the B cell proportions within peripheral blood mononuclear cells. The observed differences in miRNA expression profiles and the better understanding of immune regulatory mechanisms of miRNAs may help to elucidate the pathogenesis of SLE and pSS.	[Chen, Ji-Qing; Papp, Gabor; Szabo, Krisztina; Tarr, Tunde; Zeher, Margit] Univ Debrecen, Fac Med, Div Clin Immunol, Debrecen, Hungary; [Poliska, Szilard; Balint, Balint Laszlo] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Debrecen, Hungary; [Szodoray, Peter] Univ Oslo, Oslo Univ Hosp, Rikshosp, Ctr Immune Regulat, Oslo, Norway; [Szodoray, Peter] Univ Oslo, Oslo Univ Hosp, Rikshosp, Dept Immunol, Oslo, Norway	University of Debrecen; University of Debrecen; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Zeher, M (corresponding author), Univ Debrecen, Fac Med, Div Clin Immunol, Debrecen, Hungary.	zeher@iiibel.dote.hu	Szabó, Krisztina/AAK-3483-2021; Szodoray, Peter/P-3694-2018	Balint, Balint/0000-0002-6163-7190; Szabo, Krisztina/0000-0002-0079-3659; Szodoray, Peter/0000-0003-4443-6159	UNKP-16-4-III New Excellence Program of the Ministry of Human Capacities; Hungarian National Scientific Research Fund (OTKA) [K101470]; Szodoray Scholrship of the University of Debrecen, Medical Faculty	UNKP-16-4-III New Excellence Program of the Ministry of Human Capacities; Hungarian National Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Szodoray Scholrship of the University of Debrecen, Medical Faculty	This work was supported by the UNKP-16-4-III New Excellence Program of the Ministry of Human Capacities (http://www.kormany.nu/en/ministry-of-human-resource to GP), and the Hungarian National Scientific Research Fund (OTKA Grant No. K101470 to MZ) (http://nktin.gov.nu/english). BLB was financially supported by the Szodoray Scholrship of the University of Debrecen, Medical Faculty (https://aok.unideb.nu/en). The funders had no role in study design. data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the UNKP-16-4-III New National Excellence Program of the Ministry of Human Capacities ( GP), and the Hungarian National Scientific Research Fund (OTKA Grant No. K101470 to MZ). BLB was financially supported by the Szodoray Scholarship of the University of Debrecen, Faculty of Medicine.	Alevizos I, 2010, AUTOIMMUN REV, V9, P618, DOI 10.1016/j.autrev.2010.05.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Chen J-Q, 2016, AUTOIMMUN REV; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Chung J-W, 2017, GUT LIVER; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Gonzalez-Martin A, 2016, NAT IMMUNOL, V17, P433, DOI 10.1038/ni.3385; Hamada S, 2015, DIGESTION, V91, P263, DOI 10.1159/000381283; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hrdlickova R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086990; Huang X. L., 2015, AUTOIMMUNITY, P1; Husakova M, 2016, BIOMED PAP, V160, P327, DOI 10.5507/bp.2016.004; Iqbal J, 2012, BLOOD, V119, P4939, DOI 10.1182/blood-2011-07-370122; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Kapsogeorgou EK, 2011, J AUTOIMMUN, V37, P129, DOI 10.1016/j.jaut.2011.05.003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Lu MC, 2013, CLIN EXP IMMUNOL, V171, P91, DOI 10.1111/j.1365-2249.2012.04676.x; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Palmer JD, 2014, AGEING RES REV, V17, P16, DOI 10.1016/j.arr.2014.04.005; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; ROTHFIELD N, 1989, Current Opinion in Rheumatology, V1, P327; Sebastiani G, 2011, DIABETES-METAB RES, V27, P862, DOI 10.1002/dmrr.1262; Szabo K, 2016, CLIN EXP IMMUNOL, V183, P76, DOI 10.1111/cei.12703; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zeher M, 2009, SJOGRENS SYNDROME AS; Zhou R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030772; Zilahi E, 2012, IMMUNOL LETT, V141, P165, DOI 10.1016/j.imlet.2011.09.006	39	82	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174585	10.1371/journal.pone.0174585	http://dx.doi.org/10.1371/journal.pone.0174585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339495	Green Submitted, Green Published, gold			2022-12-27	WOS:000399116700034
J	Ivanova, EA; Korvigo, IO; Aparin, BF; Chirak, EL; Pershina, EV; Romaschenko, NS; Provorov, NA; Andronov, EE				Ivanova, Ekaterina A.; Korvigo, Ilia O.; Aparin, Boris F.; Chirak, Evgenii L.; Pershina, Elizaveta V.; Romaschenko, Nikolay S.; Provorov, Nikolai A.; Andronov, Evgeny E.			The preservation of microbial DNA in archived soils of various genetic types	PLOS ONE			English	Article							SEQUENCES; SURVIVAL; BACTERIA	This study is a comparative analysis of samples of archived (stored for over 70-90 years) and modern soils of two different genetic types-chernozem and sod-podzolic soils. We revealed a reduction in biodiversity of archived soils relative to their modern state. Particularly, long-term storage in the museum exerted a greater impact on the microbiomes of sodpodzolic soils, while chernozem samples better preserved the native community. Thus, the persistence of microbial DNA in soil is largely determined by the physico-chemical characteristics that differ across soil types. Chernozems create better conditions for the long-term DNA preservation than sod-podzolic soils. This results in supposedly higher levels of biodiversity conservation in the microbiomes of chernozem with preservation of major microbial taxa dominant in the modern (control) soil samples, which makes archived chernozems a promising object for paleosoil studies.	[Ivanova, Ekaterina A.; Korvigo, Ilia O.; Chirak, Evgenii L.; Pershina, Elizaveta V.; Romaschenko, Nikolay S.; Provorov, Nikolai A.; Andronov, Evgeny E.] All Russia Res Inst Agr Microbiol, Lab Microbiol Monitoring & Bioremediat Soils, St Petersburg, Russia; [Ivanova, Ekaterina A.; Andronov, Evgeny E.] VV Dokuchaev Soil Sci Inst, Lab Biol & Biochem Soils, Moscow, Russia; [Korvigo, Ilia O.] Moscow Inst Phys & Technol, Lab Funct Anal Genome, Moscow, Russia; [Korvigo, Ilia O.] ITMO Univ, St Petersburg, Russia; [Aparin, Boris F.] St Petersburg State Univ, Dept Soil Sci & Soil Ecol, St Petersburg, Russia; [Pershina, Elizaveta V.; Andronov, Evgeny E.] St Petersburg State Univ, Dept Microbiol & Genet, St Petersburg, Russia	Dokuchaev Soil Science Institute; Moscow Institute of Physics & Technology; ITMO University; Saint Petersburg State University; Saint Petersburg State University	Ivanova, EA (corresponding author), All Russia Res Inst Agr Microbiol, Lab Microbiol Monitoring & Bioremediat Soils, St Petersburg, Russia.; Ivanova, EA (corresponding author), VV Dokuchaev Soil Sci Inst, Lab Biol & Biochem Soils, Moscow, Russia.	ektrnivanova@gmail.com	Andronov, Evgeny/AAE-4235-2021; Aparin, Boris/K-7558-2015; Provorov, Nikolay/AAB-3908-2021; Ivanova, Ekaterina/F-9279-2017; Andronov, Evgeny Evgeny/S-1688-2016; Pershina, Elizaveta/N-2985-2015; Ivanova, Ekaterina/AAN-7257-2020; Chirak, Evgenii/AAZ-4151-2021	Andronov, Evgeny/0000-0002-5204-262X; Aparin, Boris/0000-0001-6012-0168; Ivanova, Ekaterina/0000-0003-1589-9875; Andronov, Evgeny Evgeny/0000-0002-5204-262X; Pershina, Elizaveta/0000-0003-0834-3211; Ivanova, Ekaterina/0000-0003-1589-9875; Romashchenko, Nikolai/0000-0002-2264-5219; Provorov, Nikolai/0000-0001-9091-9384; Chirak, Evgenii/0000-0001-9167-5000	Program of basic research of Presidium of the Russian Academy of Sciences [10115-54]; Russian Science Foundation (RSF) [14-26-00094]; research scientists participating in Russian Science Foundation (RSF) [14-26-00079]; Russian Science Foundation [17-26-00003] Funding Source: Russian Science Foundation	Program of basic research of Presidium of the Russian Academy of Sciences; Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); research scientists participating in Russian Science Foundation (RSF); Russian Science Foundation(Russian Science Foundation (RSF))	DNA isolation and sequencing were carried out with the support of the Program of basic research of Presidium of the Russian Academy of Sciences "Depositary functions, indication technology of the state and risks of soil degradation in the system of planning and rational environment conservation in Russia", no. 10115-54, (authors: Evgenii L. Chirak, Elizaveta V. Pershina, http://www.ras.ruipresidiumidocuments/ directionsp.aspx?ID=43af00e8-ddf4-4524-a745ea0d32075ee0), bioinformatic data analysis was performed with support of Russian Science Foundation (RSF) grant 14-26-00094 (authors: Ilia 0. Korvigo, Nikolai A. Provorov, http://rsctru/en/ enpricard9rid=14-26-00094), discussion chapter was prepared together with the research scientists participating in Russian Science Foundation (RSF) grant 14-26-00079 (Ekaterina A. Ivanova, Evgeny E. And ronov, httplirsctruien/enpricard?rid-1 4-2600079).	Aparin BF, 2012, POCHVOVEDENIE; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Belobrov VP, 2004, GEOGRAPHIYA OSNOVAMI; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cary SC, 2014, NAT REV MICROBIOL, V12, P789, DOI 10.1038/nrmicro3382; Clark IM, 2008, SOIL BIOL BIOCHEM, V40, P1090, DOI 10.1016/j.soilbio.2007.11.021; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; De Nobili M, 2006, SOIL BIOL BIOCHEM, V38, P2871, DOI 10.1016/j.soilbio.2006.04.044; Demkina TS, 2010, EURASIAN SOIL SCI+, V43, P194, DOI 10.1134/S1064229310020092; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3382-c1; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drenovsky RE, 2010, GLOBAL ECOL BIOGEOGR, V19, P27, DOI 10.1111/j.1466-8238.2009.00486.x; Feng YZ, 2015, SOIL BIOL BIOCHEM, V81, P186, DOI 10.1016/j.soilbio.2014.11.021; Freidman El, 1993, ANTARCTIC MICROBIOLO; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Krupennikov IA, 1992, POCHVENNYI POKROV MO; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Oksanen J., 2016, R PACKAG, P23; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Rawlence NJ, 2014, J QUATERNARY SCI, V29, P610, DOI 10.1002/jqs.2740; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Shishov LL, 2004, CLASSIFICATSIA DIAGN; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warinner C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0376; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012; Zaccone C, 2015, GEOPH RES ABSTR	33	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173901	10.1371/journal.pone.0173901	http://dx.doi.org/10.1371/journal.pone.0173901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339464	Green Published, gold, Green Submitted			2022-12-27	WOS:000399116700016
J	Villa-Bellosta, R; Rodriguez-Osorio, L; Mas, S; Abadi, Y; Rubert, M; de la Piedra, C; Gracia-Iguacel, C; Mahillo, I; Ortiz, A; Egido, J; Gonzalez-Parra, E				Villa-Bellosta, Ricardo; Rodriguez-Osorio, Laura; Mas, Sebastian; Abadi, Younes; Rubert, Mercedes; de la Piedra, Concepcion; Gracia-Iguacel, Carolina; Mahillo, Ignacio; Ortiz, Alberto; Egido, Jesus; Gonzalez-Parra, Emilio			A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SECONDARY HYPERPARATHYROIDISM; SURVIVAL PREDICTABILITY; MINERAL METABOLISM; DIALYSIS PATIENTS; VITAMIN-D; CALCIUM; PHOSPHORUS; PHOSPHATE; MEN	Background The mortality of dialysis patients is 10- to 100-fold higher than in the general population. Baseline serum PTH levels, and more recently, changes in serum PTH levels (Delta PTH) over time, have been associated to mortality in dialysis patients. Methods We explored the relationship between.PTH over 1 year with mortality over the next year in a prospective cohort of 115 prevalent hemodialysis patients from a single center that had median baseline iPTH levels within guideline recommendations. Results Median baseline iPTH levels were 205 (116.5, 400) pg/ml. Delta iPTH between baseline and 1 year was 85.2 +/- 57.1 pg/ml. During the second year of follow-up, 27 patients died. Delta iPTH was significantly higher in patients who survived (+ 157.30 +/- 25.82 pg/ml) than in those who died (+39.03 +/- 60.95 pg/ml), while baseline iPTH values were not significantly different. The highest mortality (48%) was observed in patients with a decrease in Delta iPTH (Delta iPTH quartile 1, negative Delta iPTH) and the lowest (12%) mortality in quartile 3 Delta iPTH (Delta iPTH increase 101-300 pg/ml). In a logistic regression model,Delta iPTH was associated with mortality with an odds ratio (OR) of 0.998 (95% CI 0.996-0999, p = 0.038). In multivariable analysis, mortality risk was 73% and 88% lower for patients with Delta iPTH 0-100 pg/ml and 101-300 pg/ml, respectively, than for those with a decrease in Delta iPTH. In patients with a decrease in Delta iPTH, the OR for death was 4.131 (1.515-11.27)(p = 0.006). Conclusions In prevalent hemodialysis patients with median baseline iPTH values within the guideline recommended range, a decrease in Delta iPTH was associated with higher mortality. Further studies are required to understand the mechanisms and therapeutic implications of this observation that challenges current clinical practice.	[Villa-Bellosta, Ricardo; Rodriguez-Osorio, Laura; Mas, Sebastian; Abadi, Younes; Gracia-Iguacel, Carolina; Ortiz, Alberto; Egido, Jesus; Gonzalez-Parra, Emilio] Fdn Jimenez Diaz, Serv Nefrol, Madrid, Spain; [Villa-Bellosta, Ricardo; Rodriguez-Osorio, Laura; Mas, Sebastian; Gracia-Iguacel, Carolina; Mahillo, Ignacio; Ortiz, Alberto; Egido, Jesus; Gonzalez-Parra, Emilio] Fdn Jimenez Diaz IIS FJD, Fdn Inst Invest Sanitaria, Madrid, Spain; [Villa-Bellosta, Ricardo; Mas, Sebastian; Egido, Jesus] Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain; [Rodriguez-Osorio, Laura; Ortiz, Alberto; Gonzalez-Parra, Emilio] Spanish Kidney Res Network REDINREN, Madrid, Spain; [Rubert, Mercedes; de la Piedra, Concepcion] Fdn Jimenez Diaz, Serv Lab Bioquim, Madrid, Spain; [Ortiz, Alberto; Egido, Jesus; Gonzalez-Parra, Emilio] Univ Autonoma Madrid, Madrid, Spain	Fundacion Jimenez Diaz; Autonomous University of Madrid	Villa-Bellosta, R; Gonzalez-Parra, E (corresponding author), Fdn Jimenez Diaz, Serv Nefrol, Madrid, Spain.; Villa-Bellosta, R; Gonzalez-Parra, E (corresponding author), Fdn Jimenez Diaz IIS FJD, Fdn Inst Invest Sanitaria, Madrid, Spain.; Villa-Bellosta, R (corresponding author), Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain.; Gonzalez-Parra, E (corresponding author), Spanish Kidney Res Network REDINREN, Madrid, Spain.; Gonzalez-Parra, E (corresponding author), Univ Autonoma Madrid, Madrid, Spain.	ricardo.villa@fjd.es; egparra@fjd.es	Mas, S/T-1489-2018; ortiz, alberto/Y-7582-2018; Mahillo-Fernandez, Ignacio/T-2042-2018	Mas, S/0000-0001-6604-3327; ortiz, alberto/0000-0002-9805-9523; Villa-Bellosta, Ricardo/0000-0002-1680-552X; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541	FIS [PI16/01298, PI13/00047, PI16/02057]; FEDER funds ISCIII-RETIC REDinREN [RD12/0021, RD16/0009]; FRIAT; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); Spanish Ministerio de Economia y Competitividad [SAF-2014-60699-JIN]; Institute de Salud Carlos III [CD14/00198]	FIS(Instituto de Salud Carlos III); FEDER funds ISCIII-RETIC REDinREN; FRIAT; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); Spanish Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by FIS PI16/01298, PI13/00047, PI16/02057, FEDER funds ISCIII-RETIC REDinREN RD12/0021, RD16/0009, FRIAT and Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to A.O. The Spanish Ministerio de Economia y Competitividad (SAF-2014-60699-JIN) and Institute de Salud Carlos III ("Sara borrell" CD14/00198 postdoctoral contract) supports R.V-B.	Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Cozzolino M, 2012, NEPHROL DIAL TRANSPL, V27, P3588, DOI 10.1093/ndt/gfs108; de La Piedra C, 2008, NEFROLOGIA, V28, P123; Drechsler C, 2011, NEPHROL DIAL TRANSPL, V26, P1340, DOI 10.1093/ndt/gfq541; Drechsler C, 2009, NEPHROL DIAL TRANSPL, V24, P3151, DOI 10.1093/ndt/gfp260; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kovesdy CP, 2008, KIDNEY INT, V73, P1296, DOI 10.1038/ki.2008.64; Kovesdy CP, 2007, CLIN J AM SOC NEPHRO, V2, P1024, DOI 10.2215/CJN.01970507; Lertdumrongluk P, 2013, NEPHROL DIAL TRANSPL, V28, P2535, DOI 10.1093/ndt/gft290; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Fernandez-Martin JL, 2015, NEPHROL DIAL TRANSPL, V30, P1542, DOI 10.1093/ndt/gfv099; Merle E, 2016, KIDNEY INT, V89, P666, DOI 10.1016/j.kint.2015.12.001; Messa P, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0006-8; Moradi H, 2013, AM J NEPHROL, V38, P136, DOI 10.1159/000351758; Natoli JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-88; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; Palmer SC, 2015, AM J KIDNEY DIS, V66, P962, DOI 10.1053/j.ajkd.2015.03.036; Parra EG, 2008, NEFROLOGIA, V28, P1; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Stevens LA, 2004, J AM SOC NEPHROL, V15, P770, DOI 10.1097/01.ASN.0000113243.24155.2F; Streja E, 2014, BONE, V61, P201, DOI 10.1016/j.bone.2014.01.016	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0173831	10.1371/journal.pone.0173831	http://dx.doi.org/10.1371/journal.pone.0173831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339474	gold, Green Submitted, Green Published			2022-12-27	WOS:000399116700014
J	Zhang, BB; Liu, GY; Li, X; Guo, LP; Zhang, XX; Qi, TX; Wang, HL; Tang, HN; Qiao, XQ; Zhang, JF; Xing, CZ; Wu, JY				Zhang, Bingbing; Liu, Guoyuan; Li, Xue; Guo, Liping; Zhang, Xuexian; Qi, Tingxiang; Wang, Hailin; Tang, Huini; Qiao, Xiuqin; Zhang, Jinfa; Xing, Chaozhu; Wu, Jianyong			A genome-wide identification and analysis of the DYW-deaminase genes in the pentatricopeptide repeat gene family in cotton (Gossypium spp.)	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; SINGLE-STRANDED RNA; POLYPLOID GOSSYPIUM; STRUCTURAL BASIS; RESTORER GENE; PPR PROTEINS; MITOCHONDRIAL; DOMAIN; RECOGNITION; SITE	The RNA editing occurring in plant organellar genomes mainly involves the change of cytidine to uridine. This process involves a deamination reaction, with cytidine deaminase as the catalyst. Pentatricopeptide repeat (PPR) proteins with a C-terminal DYW domain are reportedly associated with cytidine deamination, similar to members of the deaminase superfamily. PPR genes are involved in many cellular functions and biological processes including fertility restoration to cytoplasmic male sterility (CMS) in plants. In this study, we identified 227 and 211 DYW deaminase-coding PPR genes for the cultivated tetraploid cotton species G. hirsutum and G. barbadense (2n = 4x = 52), respectively, as well as 126 and 97 DYW deaminase-coding PPR genes in the ancestral diploid species G. raimondii and G. arboreum (2n = 26), respectively. The 227 G. hirsutum PPR genes were predicted to encode 52-2016 amino acids, 203 of which were mapped onto 26 chromosomes. Most DYW deaminase genes lacked introns, and their proteins were predicted to target the mitochondria or chloroplasts. Additionally, the DYW domain differed from the complete DYW deaminase domain, which contained part of the E domain and the entire E+ domain. The types and number of DYW tripeptides may have been influenced by evolutionary processes, with some tripeptides being lost. Furthermore, a gene ontology analysis revealed that DYW deaminase functions were mainly related to binding as well as hydrolase and transferase activities. The G. hirsutum DYW deaminase expression profiles varied among different cotton tissues and developmental stages, and no differentially expressed DYW deaminasecoding PPRs were directly associated with the male sterility and restoration in the CMS-D2 system. Our current study provides an important piece of information regarding the structural and evolutionary characteristics of Gossypium DYW-containing PPR genes coding for deaminases and will be useful for characterizing the DYW deaminase gene family in cotton biology and breeding.	[Zhang, Bingbing; Liu, Guoyuan; Li, Xue; Guo, Liping; Zhang, Xuexian; Qi, Tingxiang; Wang, Hailin; Tang, Huini; Qiao, Xiuqin; Xing, Chaozhu; Wu, Jianyong] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol China, Anyang, Henan, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; New Mexico State University	Xing, CZ; Wu, JY (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol China, Anyang, Henan, Peoples R China.	xingcz@cricaas.com.cn; dr.wujianyong@live.cn		Xing, Chaozhu/0000-0001-5099-6094; Wu, Jianyong/0000-0003-1392-4790	National Key Research and Development program of China [2016YFD0101400]; Cotton Germplasm Innovation; Molecular breeding of High yield varieties in National Natural Science Foundation of China [31621005]	National Key Research and Development program of China; Cotton Germplasm Innovation; Molecular breeding of High yield varieties in National Natural Science Foundation of China	This research was financed by funds from the National Key Research and Development program of China (2016YFD0101400) and Cotton Germplasm Innovation and the Molecular breeding of High yield varieties in National Natural Science Foundation of China (31621005).	Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Chakraborty A, 2015, PLANTA, V241, P1463, DOI 10.1007/s00425-015-2269-5; Dahan J, 2013, RNA BIOL, V10, P1469, DOI 10.4161/rna.25568; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hu GJ, 2010, GENOME, V53, P599, DOI [10.1139/g10-038, 10.1139/G10-038]; Huang WC, 2015, P NATL ACAD SCI USA, V112, P14984, DOI 10.1073/pnas.1511748112; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI DOI 10.1093/NAR/GKR691; Jordan DR, 2010, THEOR APPL GENET, V120, P1279, DOI 10.1007/s00122-009-1255-3; Kazama T, 2014, RICE, V7, DOI 10.1186/s12284-014-0028-z; Klein RR, 2005, THEOR APPL GENET, V111, P994, DOI 10.1007/s00122-005-2011-y; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Shikanai T, 2015, BBA-BIOENERGETICS, V1847, P779, DOI 10.1016/j.bbabio.2014.12.010; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sugita M, 2013, RNA BIOL, V10, P1439, DOI 10.4161/rna.24772; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Suzuki H, 2013, MOL GENET GENOMICS, V288, P445, DOI 10.1007/s00438-013-0764-6; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wang F, 2007, GENOME, V50, P818, DOI 10.1139/G07-061; Wang J, 2009, MITOCHONDRION, V9, P364, DOI 10.1016/j.mito.2009.07.005; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wei L, 2008, ACTA PHYSIOL PLANT, V30, P657, DOI 10.1007/s11738-008-0162-6; Wu JY, 2014, MOL BREEDING, V34, P231, DOI 10.1007/s11032-014-0032-4; Wu JY, 2011, EUPHYTICA, V181, P17, DOI 10.1007/s10681-011-0357-6; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; You Q, 2017, NUCLEIC ACIDS RES, V45, pD1090, DOI 10.1093/nar/gkw910	40	14	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174201	10.1371/journal.pone.0174201	http://dx.doi.org/10.1371/journal.pone.0174201			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9AZ	28339482	Green Submitted, gold, Green Published			2022-12-27	WOS:000399116700021
J	Botta, F; del Genio, CI				Botta, Federico; del Genio, Charo I.			Analysis of the communities of an urban mobile phone network	PLOS ONE			English	Article							COMPLEX NETWORKS; IDENTIFICATION; MODULARITY; MULTISCALE; BEHAVIOR	Being able to characterise the patterns of communications between individuals across different time scales is of great importance in understanding people's social interactions. Here, we present a detailed analysis of the community structure of the network of mobile phone calls in the metropolitan area of Milan revealing temporal patterns of communications between people. We show that circadian and weekly patterns can be found in the evolution of communities, presenting evidence that these cycles arise not only at the individual level but also at that of social groups. Our findings suggest that these trends are present across a range of time scales, from hours to days and weeks, and can be used to detect socially relevant events.	[Botta, Federico] Univ Warwick, Ctr Complex Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England; [del Genio, Charo I.] Univ Warwick, Sch Life Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Botta, F (corresponding author), Univ Warwick, Ctr Complex Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.; del Genio, CI (corresponding author), Univ Warwick, Sch Life Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	federico.botta@wbs.ac.uk; C.I.del-Genio@warwick.ac.uk	Botta, Federico/I-3688-2019; del Genio, Charo I/F-7249-2010	Botta, Federico/0000-0002-5681-4535; del Genio, Charo I/0000-0001-9958-017X	UK EPSRC [EP/E501311/1]; EINS; Network of Excellence in Internet Science; European Commissions FP7 under Communications Networks; Content and Technologies [288021]; QMUL Research-IT; EPSRC [EP/K000128/1]; Engineering and Physical Sciences Research Council [1231220] Funding Source: researchfish	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EINS; Network of Excellence in Internet Science; European Commissions FP7 under Communications Networks; Content and Technologies; QMUL Research-IT; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	FB acknowledges the support of UK EPSRC EP/E501311/1. CIDG acknowledges support by EINS, Network of Excellence in Internet Science, via the European Commissions FP7 under Communications Networks, Content and Technologies, grant No. 288021. This research utilised Queen Marys MidPlus computational facilities, supported by QMUL Research-IT and funded by EPSRC grant EP/K000128/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FB acknowledges the support of UK EPSRC EP/E501311/1. CIDG acknowledges support by EINS, Network of Excellence in Internet Science, via the European Commission's FP7 under Communications Networks, Content and Technologies, grant No. 288021. This research utilised Queen Mary's MidPlus computational facilities, supported by QMUL Research-IT and funded by EPSRC grant EP/K000128/1.	Ale T, 2015, PLOS ONE, V10; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Barlacchi G, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.55; Blondel VD, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0046-0; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Botta F, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150162; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Del Genio CI, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103038; Del Genio CI, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.040801; Eriksen KA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148701; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fred A, 2003, P IEEE COMP SOC C CO; Garnett GP, 1996, SEX TRANSM DIS, V23, P248, DOI 10.1097/00007435-199605000-00015; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Irevino S, 2012, PLOS COMPUT BIOL, V8; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuncheva LI, 2004, IEEE SYS MAN CYBERN, P1214; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Saramaki J, 2015, EUR PHYS J B, V88, DOI [10.1140/epjb/e2015-60106-6, 10.1140/epjb/e2015-60660-9]; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Trevino S, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/02/P02003; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wang Q, 2013, DYNAMICS COMPLEX NET, V2, P159, DOI DOI 10.1007/978-1-4614-6729-8_9; Weppner J, 2013, INT CONF PERVAS COMP, P193, DOI 10.1109/PerCom.2013.6526732	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174198	10.1371/journal.pone.0174198	http://dx.doi.org/10.1371/journal.pone.0174198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334003	gold, Green Submitted, Green Published			2022-12-27	WOS:000399102200061
J	Lindberg, C				Lindberg, Carl			A note on contracts on quadratic variation	PLOS ONE			English	Article							RISK PREMIA; VARIANCE	Given a Black stochastic volatility model for a future F, and a function g, we show that the price of 1/2 integral(T)(0) g(t, F(t))F-2(t) sigma(2)(t)dt can be represented by portfolios of put and call options. This generalizes the classical representation result for the variance swap. Further, in a local volatility model, we give an example based on Dupire's formula which shows how the theorem can be used to design variance related contracts with desirable characteristics.	[Lindberg, Carl] Second Swedish Natl Pens Fund, Gothenburg, Sweden; [Lindberg, Carl] Chalmers, Math Sci, Gothenburg, Sweden	Chalmers University of Technology	Lindberg, C (corresponding author), Second Swedish Natl Pens Fund, Gothenburg, Sweden.; Lindberg, C (corresponding author), Chalmers, Math Sci, Gothenburg, Sweden.	h.carl.n.lindberg@gmail.com		Lindberg, Carl/0000-0001-9053-8311				Bekaert G, 2014, J ECONOMETRICS, V183, P181, DOI 10.1016/j.jeconom.2014.05.008; Bollerslev T, 2011, J FINANC, V66, P2165, DOI 10.1111/j.1540-6261.2011.01695.x; Bollerslev T, 2009, REV FINANC STUD, V22, P4463, DOI 10.1093/rfs/hhp008; Carr P, 2007, J DERIV, V13, P13; Carr P, 2009, REV FINANC STUD, V22, P1311, DOI 10.1093/rfs/hhn038; Drechsler I, 2011, REV FINANC STUD, V24, P1, DOI 10.1093/rfs/hhq085; Egloff D, 2010, J FINANC QUANT ANAL, V45, P1279, DOI 10.1017/S0022109010000463; Filipovic D, 2016, J FINANC ECON, V119, P44, DOI 10.1016/j.jfineco.2015.08.015; Jiang GJ, 2005, REV FINANC STUD, V18, P1305, DOI 10.1093/rfs/hhi027; Lindberg C, 2013, ANN APPL PROBAB, V23, P834, DOI 10.1214/12-AAP858; Todorov V, 2010, REV FINANC STUD, V23, P345, DOI 10.1093/rfs/hhp035	11	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174133	10.1371/journal.pone.0174133	http://dx.doi.org/10.1371/journal.pone.0174133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333971	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200053
J	Ludvigsson, J; Jones, MP; Faresjo, A				Ludvigsson, Johnny; Jones, Michael P.; Faresjo, Ashild			Worm infestations and development of autoimmunity in children - The ABIS study	PLOS ONE			English	Article							TYPE-1; INFECTION; HYGIENE; RISK	Worm infestations influence the immune system and may therefore decrease the risk for autoimmune diseases. The aim of the study was to determine whether children who have developed autoimmune disease were less likely to have had worm infestations in childhood. The ABIS-study is a prospective population-based cohort study of children born in southeast Sweden 1997/99. 17.055 children participated. As of June 2014 116 individuals had developed Type 1 diabetes, 181 celiac disease, and 53 Juvenile Rheumatoid Arthritis. The parents answered questions on worm infestations when the children were 1, 5 and 8 years of age. The ABIS registry was connected to the National Registry of Drug Prescriptions, and national registries for diagnosis of the studied diseases. We found no differences in incidence of worm infestations at 1, 5 or 8 years of age between children who developed autoimmune disease(s) or healthy controls. At 8 years in total 20.0% of the general child population had experienced a worm infestation; children who developed Type 1 diabetes, 21,3%, celiac disease 19,5% and JRA 18,8%. There was no difference in prescriptions of drugs for treatment of worm infestations between those who had and who had not developed Type 1 diabetes, celiac disease, Juvenile Rheumatoid Arthritis. We found no associations indicating that worm infestations in childhood does not play a role in the development of autoimmune diseases in Sweden.	[Ludvigsson, Johnny] Linkoping Univ, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Jones, Michael P.] Macquarie Univ, Fac Human Sci, Sydney, NSW, Australia; [Faresjo, Ashild] Linkoping Univ, Dept Med & Hlth, Linkoping, Sweden	Linkoping University; Macquarie University; Linkoping University	Ludvigsson, J (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden.	Johnny.Ludvigsson@liu.se	Ludvigsson, Johnny/AAI-2051-2020; Jones, Michael/A-9013-2013	Ludvigsson, Johnny/0000-0003-1695-5234; Jones, Michael/0000-0003-0565-4938	Swedish Child Diabetes Foundaion (Barndiabetesfonden); Research Council of South-east Sweden (FORSS); Swedish Research Council [K2005-72X-11242-11A]; ALF/County Council of Ostergotland	Swedish Child Diabetes Foundaion (Barndiabetesfonden); Research Council of South-east Sweden (FORSS); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF/County Council of Ostergotland	The ABIS-study was supported by the Swedish Child Diabetes Foundaion (Barndiabetesfonden), The Research Council of South-east Sweden (FORSS), Swedish Research Council K2005-72X-11242-11A, and ALF/County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, LANCET, V387, P2331; Cooke A, 2001, NAT IMMUNOL, V2, P810, DOI 10.1038/ni0901-810; Cooke A, 2009, IMMUNOLOGY, V126, P12, DOI 10.1111/j.1365-2567.2008.03009.x; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Hamid F, 2015, CURR TOP MICROBIOL, V388, P91, DOI 10.1007/978-3-319-13725-4_5; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; KOLB H, 1994, DIABETOLOGIA, V37, P729, DOI 10.1007/BF00417700; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Ludvigsson J, 2013, DIABETES-METAB RES, V29, P161, DOI 10.1002/dmrr.2377; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Nygren M, 2015, DIABETOLOGIA, V58, P1188, DOI 10.1007/s00125-015-3555-2; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Sepa A, 2004, SCAND J PSYCHOL, V45, P169, DOI 10.1111/j.1467-9450.2004.00392.x; Viskari H, 2005, DIABETOLOGIA, V48, P1280, DOI 10.1007/s00125-005-1780-9; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e173988	10.1371/journal.pone.0173988	http://dx.doi.org/10.1371/journal.pone.0173988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333965	Green Submitted, Green Published, gold			2022-12-27	WOS:000399102200034
J	Neumann, JT; Sorensen, NA; Ojeda, F; Renne, T; Schnabel, RB; Zeller, T; Karakas, M; Blankenberg, S; Westermann, D				Neumann, Johannes Tobias; Soerensen, Nils Arne; Ojeda, Francisco; Renne, Thomas; Schnabel, Renate B.; Zeller, Tanja; Karakas, Mahir; Blankenberg, Stefan; Westermann, Dirk			Early diagnosis of acute myocardial infarction using high-sensitivity troponin I	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; DELAYED INVASIVE INTERVENTION; 99TH PERCENTILE; ABSOLUTE	Objective There is a clinical need for early and accurate diagnosis of acute myocardial infarction (AMI). Current European Society of Cardiology (ESC) guidelines recommend diagnosis of non-ST-elevation AMI based on serial troponin measurements. We aimed to challenge the ESC guidelines using 1) a high-sensitivity troponin I (hs-TnI) baseline cutoff, 2) an absolute hs-TnI change after 1 hour and 3) additional application of an ischemic ECG. Methods 1,516 patients with suspected AMI presenting to the emergency department were included. Hs-TnI was measured directly at admission, after 1 and 3 hours. We investigated baseline concentrations, absolute changes of hs-TnI and additional application of an ischemic ECG to diagnose AMI. A positive predictive value (PPV) of more than 85% was targeted. Results The median age of the study population was 65 years; 291 patients were diagnosed with AMI. The PPV of the 3-hours ESC algorithm was 85.5% (CI 79.7, 90.1) and 65.8% (CI 60.5,70.8) for the 1-hour algorithm. Using a high baseline hs-TnI concentration of 150 ng/L resulted in a PPV of 87.8% (CI 80.9,92.9). Alternatively, a hs-TnI change of 20 ng/L after 1 hour, resulted in a PPV of 86.5% (80.9,91.0), respectively for the diagnosis of AMI. Additional use of an ischemic ECG increased the PPV to 90.5% (CI 83.2,95.3), while reducing the efficacy. Conclusion The diagnosis of AMI based on hs-TnI is challenging. The application of absolute hs-TnI changes after 1 hour may facilitate rapid rule-in of patients.	[Neumann, Johannes Tobias; Soerensen, Nils Arne; Ojeda, Francisco; Schnabel, Renate B.; Zeller, Tanja; Karakas, Mahir; Blankenberg, Stefan; Westermann, Dirk] Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Neumann, Johannes Tobias; Schnabel, Renate B.; Zeller, Tanja; Karakas, Mahir; Blankenberg, Stefan; Westermann, Dirk] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Gottingen, Germany; [Renne, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Hamburg, Germany; [Renne, Thomas] Karolinska Inst, Dept Mol Med & Surg, Clin Chem, Stockholm, Sweden	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet	Neumann, JT (corresponding author), Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany.; Neumann, JT (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Gottingen, Germany.	j.neumann@uke.de	Westermann, Dirk/D-1344-2011; Neumann, Johannes/AAW-6131-2020; Schnabel, Renate B/ABE-6668-2021; Sörensen, Nils A./AAJ-8504-2020	Neumann, Johannes/0000-0002-9478-2757; Schnabel, Renate B/0000-0001-7170-9509; Sörensen, Nils A./0000-0002-7571-4847; Westermann, Dirk/0000-0002-7542-1956; Renne, Thomas/0000-0003-4594-5975; Ojeda, Francisco/0000-0003-4037-144X; Zeller, Tanja/0000-0003-3379-2641	Abbott Diagnostics	Abbott Diagnostics(Abbott Laboratories)	The BACC study was supported by an unrestricted grant by Abbott Diagnostics. Abbott Diagnostics also provided test reagents for high-sensitivity troponin I measurements. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Milosevic A, 2016, JACC-CARDIOVASC INTE, V9, P541, DOI 10.1016/j.jcin.2015.11.018; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; Nawar Eric W, 2007, Adv Data, P1; Neumann JT, 2016, JAMA CARDIOL, V1, P397, DOI 10.1001/jamacardio.2016.0695; Neumann JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090063; Neumann JT, 2016, CLIN CHEM; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Pickering JW, 2016, HEART, V102, P1270, DOI 10.1136/heartjnl-2015-308505; Pickering JW, 2016, CIRCULATION; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; RICHARDSON SG, 1990, BRIT MED J, V300, P355, DOI 10.1136/bmj.300.6721.355; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Gimenez MR, 2015, AM J MED, V128, P861, DOI 10.1016/j.amjmed.2015.01.046; Sorensen NA, 2016, INT J CARDIOLOGY; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Zeller T, 2015, CLIN CHEM LAB MED, V53, P699, DOI 10.1515/cclm-2014-0619	21	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174288	10.1371/journal.pone.0174288	http://dx.doi.org/10.1371/journal.pone.0174288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333976	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200072
J	Rajicic, M; Romanenko, SA; Karamysheva, TV; Blagojevic, J; Adnadevic, T; Budinski, I; Bogdanov, AS; Trifonov, VA; Rubtsov, NB; Vujosevic, M				Rajicic, M.; Romanenko, S. A.; Karamysheva, T. V.; Blagojevic, J.; Adnadevic, T.; Budinski, I.; Bogdanov, A. S.; Trifonov, V. A.; Rubtsov, N. B.; Vujosevic, M.			The origin of B chromosomes in yellow-necked mice (Apodemus flavicollis)-Break rules but keep playing the game	PLOS ONE			English	Article							APODEMUS-FLAVICOLLIS RODENTIA; WOOD MICE; FIELD MICE; RIBOSOMAL CISTRONS; SEX-CHROMOSOMES; MOUSE; MAMMALIA; POPULATION; MEIOSIS; POLYMORPHISM	B chromosomes (Bs) are known for more than hundred years but their origin, structure and pattern of evolution are not well understood. In the past few years new methodological approaches, involving isolation of Bs followed by whole DNA amplification, DNA probe generation, and fluorescent in situ hybridization (FISH) or the B chromosome DNA sequencing, has allowed detailed analysis of their origin and molecular structure in different species. In this study we explored the origin of Bs in the yellow-necked wood mouse, Apodemus flavicollis, using generation of microdissected DNA probes followed by FISH on metaphase chromosomes. Bs of A. flavicollis were successfully isolated and DNA was used as the template for B-specific probes for the first time. We revealed homology of DNA derived from the analyzed B chromosomes to the pericentromeric region (PR) of sex chromosomes and subtelomeric region of two pairs of small autosomes, but lower homology to the rest of the Y chromosome. Moreover, all analysed Bs had the same structure regardless of their number per individual or the great geographic distance between examined populations from the Balkan Peninsula (Serbia) and Eastern Europe (south region of Russia and central Belarus). Therefore, it was suggested that B chromosomes in A. flavicollis have a unique common origin from the PR of sex chromosomes, and/or similar evolutionary pattern.	[Rajicic, M.; Blagojevic, J.; Adnadevic, T.; Budinski, I.; Vujosevic, M.] Univ Belgrade, Dept Genet Res, Inst Biol Res Sinisa Stankovic, Belgrade, Serbia; [Romanenko, S. A.; Trifonov, V. A.] RAS, SB, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Karamysheva, T. V.; Rubtsov, N. B.] RAS, SB, Inst Cytol & Genet, Novosibirsk, Russia; [Bogdanov, A. S.] RAS, Koltzov Inst Dev Biol, Moscow, Russia	University of Belgrade; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Rajicic, M (corresponding author), Univ Belgrade, Dept Genet Res, Inst Biol Res Sinisa Stankovic, Belgrade, Serbia.	marija.rajicic@ibiss.bg.ac.rs	Karamysheva, Tatyana/AAD-4913-2020; Rubtsov, Nikolay/L-2365-2017; Budinski, Ivana/L-5470-2019; Bogdanov, Aleksey/T-8440-2017; Trifonov, Vladimir/E-4907-2012; Blagojević, Jelena/B-4593-2008; Romanenko, Svetlana/N-2500-2015; Vujosevic, Mladen/C-3707-2016	Rubtsov, Nikolay/0000-0001-7406-8057; Budinski, Ivana/0000-0001-8834-4200; Bogdanov, Aleksey/0000-0002-2106-3989; Trifonov, Vladimir/0000-0003-0454-8359; Blagojević, Jelena/0000-0001-7102-5510; Romanenko, Svetlana/0000-0002-0951-5209; Vujosevic, Mladen/0000-0002-5577-4455; Rajicic, Marija/0000-0002-2470-9888; Adnadevic, Tanja/0000-0002-6665-861X	Federal Agency of Scientific Organisations [ICG 0324-2016-0003]; Russian Foundation for Basic Research [14-04-00785]; Russian Science Foundation [16-14-10009]; Ministry of Education, Science and Technological Development of the Republic of Serbia [OI173003]; RSF [16-14-10009]; RFBR [14-04-00785, 14-04-00086a]	Federal Agency of Scientific Organisations; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Education, Science and Technological Development of the Republic of Serbia; RSF(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR))	This study was supported by the Federal Agency of Scientific Organisations no. ICG 0324-2016-0003, T. V. Karamysheva and N. B. Rubtsov. This funder had a role in study design, resources. This study was also supported by the Russian Foundation for Basic Research no. 14-04-00785. This funder had a role in sample collection. This study was also supported by the Russian Science Foundation no. 16-14-10009, V. A. Trifonov. This funder had a role in study design, data collection and analysis, resources. This study was also supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia, grant OI173003, M. Vujosevic. This funder had a role in study design, data collection and analysis, resources.; This research was supported by: RSF No. 16-14-10009 grant, RFBR No. 14-04-00086a research project, RFBR No. 14-04-00785 project and Ministry of Education, Science and Technological Development of the Republic of Serbia, grant OI173003.	Adnadevic T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112260; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Banaei-Moghaddam AM, 2015, BBA-GENE REGUL MECH, V1849, P64, DOI 10.1016/j.bbagrm.2014.11.007; Banaei-Moghaddam AM, 2012, PLANT CELL, V24, P4124, DOI 10.1105/tpc.112.105270; Banaszek A, 2006, FOLIA ZOOL, V55, P113; Basheva EA, 2010, CHROMOSOME RES, V18, P689, DOI 10.1007/s10577-010-9149-4; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; BLAGOJEVIC J, 1995, GENOME, V38, P472, DOI 10.1139/g95-062; Blagojevic J, 2005, BELG J ZOOL, V135, P79; Blagojevic J, 2004, HEREDITY, V93, P249, DOI 10.1038/sj.hdy.6800460; Blagojevic J, 2009, ITAL J ZOOL, V76, P250, DOI 10.1080/11250000802647044; Blagojevic J, 2000, ACTA THERIOL, V45, P129, DOI 10.4098/AT.arch.00-14; Blagojevic J, 1991, GENETICA, V83, P167; Bugarski-Stanojevic V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160946; Burgov AG, 2004, CYTOGENET GENOME RES, V106, P284; Burt A, 2006, GENES CONFLICT BIOL; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Carchilan M, 2007, PLANT CELL, V19, P1738, DOI 10.1105/tpc.106.046946; Charlesworth D., 2008, V4, P83, DOI 10.1159/000126008; Cheng YM, 2016, CHROMOSOME RES, V24, P183, DOI 10.1007/s10577-015-9516-2; Fantinatti BEA, 2011, GENETICA, V139, P1273, DOI 10.1007/s10709-012-9629-x; Flaquer A, 2009, HUM HERED, V68, P192, DOI 10.1159/000224639; Ford CE, 1966, COMP MAMMALIAN CYTOG, P461; Gornung E, 2009, ACTA THERIOL, V54, P267, DOI 10.4098/j.at.0001-7051.081.2008; Graphodatsky AS, 2007, MOL BIOL+, V41, P361, DOI 10.1134/S002689330703003X; Graphodatsky A.S., 1988, CHROMOSOMES AGR LAB; Graphodatsky AS, 2005, CHROMOSOME RES, V13, P113, DOI 10.1007/s10577-005-7474-9; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; Hsu TC, 1969, COMP MAMMALIAN CYTOG, P454; Jojic V, 2007, J MAMMAL, V88, P689, DOI 10.1644/06-MAMM-A-019R1.1; Jojic V, 2011, J MAMMAL, V92, P396, DOI 10.1644/10-MAMM-A-158.1; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Jones RN, 1982, B CHROMOSOMES; Karamysheva TV, 2002, CYTOGENET GENOME RES, V96, P154, DOI 10.1159/000063027; KARTAVTSEVA IV, 2002, KARYOSYSTEMATICS WOO; Khurana E, 2016, NATURE; Makunin AI, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0099-y; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Palazzo AF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00002; Palestis BG, 2004, P ROY SOC B-BIOL SCI, V271, pS22, DOI 10.1098/rsbl.2003.0084; PATTON JL, 1977, CHROMOSOMA, V60, P1, DOI 10.1007/BF00330406; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poletto AB, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-1, 10.1186/1471-2156-11-50]; Rajicic M, 2015, GENETIKA-BELGRADE, V47, P311, DOI 10.2298/GENSR1501311R; Ramalhinho MG, 2002, MAMMALIA, V66, P300; Raudsepp T, 2012, SEX DEV, V6, P72, DOI 10.1159/000330627; Romanenko SA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0194-8; Rovatsos MT, 2008, ACTA THERIOL, V53, P157, DOI 10.1007/BF03194248; Rubtsov NB, 2015, RUSS J GENET+, V51, P1233, DOI 10.1134/S1022795415120091; Rubtsov NB, 2015, RUSS J GENET+, V51, P278, DOI 10.1134/S1022795415030114; Rubtsov NB, 2011, RUSS J GENET+, V47, P1096, DOI 10.1134/S1022795411090158; Rubtzov NB, 2009, RUSS J GENET+, V45, P389, DOI 10.1134/S1022795409040024; Safronova LD, 2007, RUSS J GENET+, V43, P658, DOI 10.1134/S1022795407060099; Sharbel TF, 1998, GENOME, V41, P14, DOI 10.1139/gen-41-1-14; Silva DMZD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094896; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; Stitou S, 2001, HEREDITY, V86, P128, DOI 10.1046/j.1365-2540.2001.00771.x; Stitou S, 2000, CHROMOSOME RES, V8, P305, DOI 10.1023/A:1009227427575; Tanic N, 2005, CHROMOSOMA, V113, P418, DOI 10.1007/s00412-004-0327-z; Tanic N, 2000, GENOME RES, V10, P55; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Trifonov VA, 2010, RUSS J GENET+, V46, P1094, DOI 10.1134/S1022795410090206; Trifonov VA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-90; Trifonov Vladimir A., 2009, P99, DOI 10.1007/978-3-540-70581-9_9; Valente GT, 2014, MOL BIOL EVOL, V31, P2061, DOI 10.1093/molbev/msu148; Ventura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136663; VUJOSEVIC M, 1995, ACTA THERIOL, V40, P131, DOI 10.4098/AT.arch.95-14; VUJOSEVIC M, 1992, CARYOLOGIA, V45, P347, DOI 10.1080/00087114.1992.10797237; Vujosevic M, 2000, Z SAUGETIERKD, V65, P313; Vujosevic M, 2007, ITAL J ZOOL, V74, P313, DOI 10.1080/11250000701508578; VUJOSEVIC M, 1987, ACTA VET-BEOGRAD, V37, P115; Vujosevic M, 1990, ARCH BIOL SCI, V42, P39; Wojcik JM, 2004, CYTOGENET GENOME RES, V106, P264, DOI 10.1159/000079297; WURSTERHILL DH, 1988, CYTOGENET CELL GENET, V49, P278, DOI 10.1159/000132677; Yang Fengtang, 2009, P35, DOI 10.1007/978-3-540-70581-9_3; Zhou Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-109; Zima J, 2003, CAN J ZOOL, V81, P1312, DOI 10.1139/Z03-128; ZIMA J, 1984, FOLIA ZOOL, V33, P133	81	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0172704	10.1371/journal.pone.0172704	http://dx.doi.org/10.1371/journal.pone.0172704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329013	Green Published, gold, Green Submitted			2022-12-27	WOS:000399094700007
J	Sgandurra, G; Lorentzen, J; Inguaggiato, E; Bartalena, L; Beani, E; Cecchi, F; Dario, P; Giampietri, M; Greisen, G; Herskind, A; Nielsen, JB; Rossi, G; Cioni, G				Sgandurra, Giuseppina; Lorentzen, Jakob; Inguaggiato, Emanuela; Bartalena, Laura; Beani, Elena; Cecchi, Francesca; Dario, Paolo; Giampietri, Matteo; Greisen, Gorm; Herskind, Anna; Nielsen, Jens Bo; Rossi, Giuseppe; Cioni, Giovanni		CareToy Consortium	A randomized clinical trial in preterm infants on the effects of a home-based early intervention with the 'CareToy System'	PLOS ONE			English	Article							BIRTH-WEIGHT CHILDREN; MOTOR DEVELOPMENT; CEREBRAL-PALSY; RISK; RELIABILITY; PLASTICITY; RECOVERY; VALIDITY; OUTCOMES; PROFILE	CareToy system is an innovative tele-rehabilitative tool, useful in providing intensive, individualized, home-based, family-centred Early Intervention (EI) in infants. Our aim was to evaluate, through a Randomized Clinical Trial (RCT) study, the effects of CareToy intervention on early motor and visual development in preterm infants. 41 preterm infants (range age: 3.0-5.9 months of corrected age) were enrolled and randomized into two groups, CareToy and Standard Care. 19 infants randomized in CareToy group performed a 4-week CareToy program, while 22 allocated to control group completed 4 weeks of Standard Care. Infant Motor Profile (IMP) was primary outcome measure, Alberta Infant Motor Scale (AIMS) and Teller Acuity Cards were secondary ones. Assessments were carried out at baseline (T0) and at the end of CareToy training or Standard Care period (T1). T1 was the primary endpoint. After RCT phase, 17 infants from control group carried out a 4-week CareToy program, while 18 infants from the CareToy group continued with Standard Care. At the end of this phase, infants were re-assessed at T2. In RCT phase, delta IMP total score and variation and performance sub-domains were significantly higher (P<0.050) in CareToy group if compared to Standard Care group. Similar results were found for Teller Acuity Cards, while no differences between groups were found for AIMS. No differences were found in any outcome measure results (T2-T0), between infants who started CareToy training before or after one month of standard care. This RCT study confirms the results of a previous pilot study, indicating that CareToy system can provide effective home-based EI.	[Sgandurra, Giuseppina; Inguaggiato, Emanuela; Beani, Elena; Cioni, Giovanni] IRCCS Fdn Stella Maris, Dept Dev Neurosci, Pisa, Italy; [Sgandurra, Giuseppina; Cioni, Giovanni] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Lorentzen, Jakob; Herskind, Anna] Helene Elsass Ctr, Charlottenlund, Denmark; [Lorentzen, Jakob; Nielsen, Jens Bo] Univ Copenhagen, Dept Nutr Exercise & Sport, Copenhagen, Denmark; [Inguaggiato, Emanuela] Inst Life Sci, Scuola Super St Anna, Pisa, Italy; [Bartalena, Laura; Giampietri, Matteo] Pisa Univ Hosp Santa Chiara, Neonatal Intens Care Unit, Pisa, Italy; [Cecchi, Francesca; Dario, Paolo] BioRobot Inst, Polo St Anna Valdera, Pisa, Italy; [Greisen, Gorm; Herskind, Anna] Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark; [Herskind, Anna; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, Pisa, Italy	IRCCS Fondazione Stella Maris; University of Pisa; University of Copenhagen; Scuola Superiore Sant'Anna; Rigshospitalet; University of Copenhagen; University of Copenhagen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Sgandurra, G (corresponding author), IRCCS Fdn Stella Maris, Dept Dev Neurosci, Pisa, Italy.; Sgandurra, G (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	gsgandurra@fsm.unipi.it	Cioni, Giovanni/A-4178-2015; Greisen, Gorm/AAA-6463-2022; Beani, Elena/AAJ-6740-2021; Inguaggiato, Emanuela/AAL-7004-2021; Sgandurra, Giuseppina/B-9961-2018; Nielsen, Jens Bo/C-7632-2015; Beani, Elena/K-3121-2018; Inguaggiato, Emanuela/K-3617-2018; Giampietri, Matteo/K-8862-2016	Cioni, Giovanni/0000-0002-6526-5566; Greisen, Gorm/0000-0001-8042-3262; Beani, Elena/0000-0001-6931-7813; Inguaggiato, Emanuela/0000-0002-0224-0628; Sgandurra, Giuseppina/0000-0003-1081-1766; Nielsen, Jens Bo/0000-0001-5568-2916; Beani, Elena/0000-0001-6931-7813; Inguaggiato, Emanuela/0000-0002-0224-0628; Giampietri, Matteo/0000-0003-1878-7668; Lorentzen, Jakob/0000-0002-7634-0218; CECCHI, FRANCESCA/0000-0001-5483-6354	European Union under the Seventh Framework Program; theme Information and Communications Technology "Personal Health Systems (PHS)" [(ICT)-2011.5.1, ICT-2011.5.1-287932]	European Union under the Seventh Framework Program; theme Information and Communications Technology "Personal Health Systems (PHS)"	CareToy (http://www.caretoy.eu) was funded by the European Union under the Seventh Framework Program (https://ec.europa.eu/ research/fp7/index en.cfm), theme Information and Communications Technology (ICT)-2011.5.1 "Personal Health Systems (PHS)", Grant ICT-2011.5.1-287932 to PD, GC and JBN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824; Byblow W, 2016, ANN NEUROL, V80, P339, DOI 10.1002/ana.24735; Campbell SK, 2012, J PEDIATR REHAB MED, V5, P15, DOI 10.3233/PRM-2011-0185; Cecchi F, IEEE ROBOTI IN PRESS; Chakrabarty S, 2009, J NEUROPHYSIOL, V101, P1283, DOI 10.1152/jn.91026.2008; Cioni G, 2016, DEV MED CHILD NEUROL, V58, P61, DOI 10.1111/dmcn.13050; Cioni G, 2013, HAND CLINIC, V111, P3, DOI 10.1016/B978-0-444-52891-9.00001-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darrah J, 1998, DEV MED CHILD NEUROL, V40, P485; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Eyre JA, 2001, NEUROLOGY, V57, P1543, DOI 10.1212/WNL.57.9.1543; Geldof CJA, 2012, RES DEV DISABIL, V33, P726, DOI 10.1016/j.ridd.2011.08.025; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Hadders-Algra M, 2010, PHYS THER, V90, P1823, DOI 10.2522/ptj.20100006; Hecker E, 2016, PEDIATR PHYS THER, V28, P217, DOI 10.1097/PEP.0000000000000244; Heineman KR, 2008, DEV MED CHILD NEUROL, V50, P275, DOI 10.1111/j.1469-8749.2008.02035.x; Heineman KR, 2013, DEV MED CHILD NEUROL, V55, P539, DOI 10.1111/dmcn.12100; Kolb B, 2007, DEV PSYCHOBIOL, V49, P107, DOI 10.1002/dev.20199; Lang CE, 2016, ANN NEUROL, V80, P342, DOI 10.1002/ana.24734; Madan A, 2005, DEV MED CHILD NEUROL, V47, P276, DOI 10.1017/S0012162205000514; Manetti S, 2015, VALUE HEALTH, V18, pA358, DOI 10.1016/j.jval.2015.09.683; Martin JH, 2012, CLIN NEUROL NEUROSUR, V114, P515, DOI 10.1016/j.clineuro.2012.01.011; MCDONALD M, 1985, INVEST OPHTH VIS SCI, V26, P1158; Mitchell DE, 2009, PHILOS T R SOC B, V364, P383, DOI 10.1098/rstb.2008.0192; Morgan C, 2016, DEV MED CHILD NEUROL, V58, P900, DOI 10.1111/dmcn.13105; Morgan C, 2013, PEDIATRICS, V132, pE735, DOI 10.1542/peds.2012-3985; Orton J, 2009, DEV MED CHILD NEUROL, V51, P851, DOI 10.1111/j.1469-8749.2009.03414.x; Piper M., 1994, MOTOR ASSESSMENT DEV; Pratesi A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0076-7; Purpura G, 2014, EARLY HUM DEV, V90, P809, DOI 10.1016/j.earlhumdev.2014.08.016; Rihar A, 2016, ANN BIOMED ENG; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sgandurra G, 2016, RES DEV DISABIL, V53-54, P32, DOI 10.1016/j.ridd.2016.01.013; Sgandurra G, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-268; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Squires J., 2009, AGES STAGES QUESTION, VThird, DOI DOI 10.1146/ANNUREV-BIOENG-071910-124654; van Hof-van Duin J, 1998, DEV MED CHILD NEUROL, V40, P302; Weller C, 2010, J WOUND CARE, V19, P347, DOI 10.12968/jowc.2010.19.8.77713	38	40	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173521	10.1371/journal.pone.0173521	http://dx.doi.org/10.1371/journal.pone.0173521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328946	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700022
J	Han, J; Lee, HB; Lee, ES; Kang, YJ; Kim, Y; Choi, J; Rhu, J; Shin, HC; Han, W; Noh, DY; Moon, HG				Han, Jaihong; Lee, Han-Byoel; Lee, Eun-Shin; Kang, Young Joon; Kim, Yumi; Choi, Jihye; Rhu, Jiyoung; Shin, Hee-Chul; Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon			The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities	PLOS ONE			English	Article							OLDER WOMEN; COMORBIDITY; IMPACT; CHEMOTHERAPY; MORTALITY; COHORT	Purpose Studies have suggested a potential role of patient's co-morbidity in determining the survival outcomes of breast cancer. In this study, we examined the long-term oncologic outcomes in breast cancer patients who underwent curative surgery according to their pre-existing comorbid conditions and analyzed the association between the co-morbidity and the use of adjuvant therapies. Methods The medical records of 2,501 patients who underwent surgery for primary breast cancer from June 2006 to June 2010 were reviewed retrospectively. The patients were classified into three groups according to preoperative ASA status determined by the anesthesiologists. Clinico-pathologic characteristics and survival outcomes of the patients were compared among the different co-morbidity groups. Results There were 1,792 (71.6%), 665 (26.6%), and 44 (1.8%) patients in ASA I, II, and III, respectively. Total 95 (3.8%) deaths and 269 (10.8%) recurrences (loco-regional and distant) occurred during the median follow-up period of 71 months. Patients with high comorbidity showed significantly higher rate of deaths (51 (2.8%), 38 (5.7%) and 6 (13.6%) deaths in ASA I, II and III group, respectively, p<0.001). The ASA 3 patients also showed significantly higher rate of breast cancer recurrence when compared to other groups (180 (10.0%), 80 (12.0%) and 9 (20.5%) in ASA I, II, and III, respectively, p = 0.041). Significantly fewer patients in the high co-morbidity group received adjuvant therapies (77 (4.3%), 44 (6.6%) and 8 (18.2%) in ASA I, II, and III, respectively, p<0.001). The increased recurrence of breast cancer in the high morbidity group was mostly seen in patients who did not receive adjuvant therapies. The incidence of serious adverse effect during the adjuvant therapy did not differ according to the co-morbidity conditions. Conclusions In this study, high comorbidity was related to increased risk of death and recurrence in breast cancer. The increased risk of recurrence in high co-morbidity group was mostly seen in patients who did not receive adjuvant therapies. Considering the relatively low rates of serious adverse effects in high co-morbidity patients who received adjuvant therapies, active use of adjuvant therapies in selected patients may improve survival outcomes in breast cancer patients with severe co-morbidities.	[Han, Jaihong; Lee, Han-Byoel; Lee, Eun-Shin; Kang, Young Joon; Kim, Yumi; Choi, Jihye; Rhu, Jiyoung; Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Shin, Hee-Chul] Chung Ang Univ, Coll Med, Dept Surg, Seoul, South Korea; [Han, Wonshik; Noh, Dong-Young; Moon, Hyeong-Gon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU)	Noh, DY; Moon, HG (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.; Noh, DY; Moon, HG (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	dynoh@snu.ac.kr; moonhg74@snu.ac.kr	Kim, Sung Jae/K-5012-2012; Han, Wonshik/B-3699-2008	Han, Wonshik/0000-0001-7310-0764; Moon, Hyeong-Gon/0000-0002-9981-0286	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1D1A1A02061904]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [A1520250]; Korea Health Industry Development Institute (KHIDI), - Ministry of Health & Welfare, Republic of Korea [H114C1277, HI13C2148]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Korea Health Industry Development Institute (KHIDI), - Ministry of Health & Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1D1A1A02061904), by the grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (A1520250), and by the grant of the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H114C1277 and HI13C2148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2009, MED CARE, V47, P73, DOI 10.1097/MLR.0b013e318180913c; Berglund A, 2012, BREAST CANCER RES TR, V135, P281, DOI 10.1007/s10549-012-2176-4; Chao C, 2014, ANN ONCOL, V25, P1821, DOI 10.1093/annonc/mdu203; Dehal A, 2013, BREAST CANCER RES TR, V139, P469, DOI 10.1007/s10549-013-2543-9; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; Gold HT, 2008, CANCER-AM CANCER SOC, V113, P3108, DOI 10.1002/cncr.23923; Houterman S, 2004, BRIT J CANCER, V90, P2332, DOI 10.1038/sj.bjc.6601844; Hurria A, 2007, CRIT REV ONCOL HEMAT, V61, P255, DOI 10.1016/j.critrevonc.2006.09.002; Kiderlen M, 2014, BREAST CANCER RES TR, V145, P185, DOI 10.1007/s10549-014-2917-7; Klepin HD, 2014, J ONCOL PRACT, V10, pE285, DOI 10.1200/JOP.2014.001388; Land LH, 2012, BREAST CANCER RES TR, V131, P1013, DOI 10.1007/s10549-011-1819-1; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Sankar A, 2014, BRIT J ANAESTH, V113, P424, DOI 10.1093/bja/aeu100; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Yancik R, 2001, J CLIN ONCOL, V19, P1147, DOI 10.1200/JCO.2001.19.4.1147	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173721	10.1371/journal.pone.0173721	http://dx.doi.org/10.1371/journal.pone.0173721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323842	gold, Green Published, Green Submitted			2022-12-27	WOS:000399089000025
J	Betti, S; Castiello, U; Guerra, S; Sartori, L				Betti, Sonia; Castiello, Umberto; Guerra, Silvia; Sartori, Luisa			Overt orienting of spatial attention and corticospinal excitability during action observation are unrelated	PLOS ONE			English	Article							ACTION OBSERVATION NETWORK; HUMAN MOTOR CORTEX; SELECTIVE ATTENTION; DIVIDED ATTENTION; ACTION PERCEPTION; VIRTUAL LESIONS; VISUAL-SEARCH; JOINT ACTION; BODY ACTIONS; MODULATION	Observing moving body parts can automatically activate topographically corresponding motor representations in the primary motor cortex (M1), the so-called direct matching. Novel neurophysiological findings from social contexts are nonetheless proving that this process is not automatic as previously thought. The motor system can flexibly shift from imitative to incongruent motor preparation, when requested by a social gesture. In the present study we aim to bring an increase in the literature by assessing whether and how diverting overt spatial attention might affect motor preparation in contexts requiring interactive responses from the onlooker. Experiment 1 shows that overt attention-although anchored to an observed biological movement-can be captured by a target object as soon as a social request for it becomes evident. Experiment 2 reveals that the appearance of a short-lasting red dot in the contralateral space can divert attention from the target, but not from the biological movement. Nevertheless, transcranial magnetic stimulation (TMS) over M1 combined with electromyography (EMG) recordings (Experiment 3) indicates that attentional interference reduces corticospinal excitability related to the observed movement, but not motor preparation for a complementary action on the target. This work provides evidence that social motor preparation is impermeable to attentional interference and that a double dissociation is present between overt orienting of spatial attention and neurophysiological markers of action observation.	[Betti, Sonia; Castiello, Umberto; Guerra, Silvia; Sartori, Luisa] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Castiello, Umberto; Sartori, Luisa] Univ Padua, Ctr Cognit Neurosci, Padua, Italy; [Castiello, Umberto] Accademia Nazl Lincei, Ctr Beniamino Segre, Rome, Italy	University of Padua; University of Padua	Sartori, L (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.; Sartori, L (corresponding author), Univ Padua, Ctr Cognit Neurosci, Padua, Italy.	luisa.sartori@unipd.it	Betti, Sonia/AAB-2644-2019	Betti, Sonia/0000-0001-7698-3259; Sartori, Luisa/0000-0002-3838-8958; Castiello, Umberto/0000-0003-0629-1286	Progetto Strategico, Universita di Padova [2010XPMFW4]; SIR [RBSI141QKX]	Progetto Strategico, Universita di Padova; SIR	This work was supported by Progetto Strategico, Universita di Padova (N. 2010XPMFW4) to UC and by SIR grant (Scientific Independence of Young Researchers-N. RBSI141QKX) to LS. The authors would like to thank Sarah De Meo, Rossana Calzolari and Giulia Panozzo for their help in conducting the experiment.	Amoruso L, 2016, NEUROIMAGE, V134, P74, DOI 10.1016/j.neuroimage.2016.03.060; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00185; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; Bach P, 2007, EXP BRAIN RES, V178, P509, DOI 10.1007/s00221-006-0756-4; Bortoletto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053248; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; BRIGGS G G, 1975, Cortex, V11, P230; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Candidi M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0644; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Catmur C, 2016, J EXP PSYCHOL HUMAN, V42, P530, DOI 10.1037/xhp0000166; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Cattaneo L, 2010, CEREB CORTEX, V20, P2252, DOI 10.1093/cercor/bhp291; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Davare M, 2010, CURR BIOL, V20, P176, DOI 10.1016/j.cub.2009.11.063; De Stefani E, 2014, EXP BRAIN RES, V232, P2431, DOI 10.1007/s00221-014-3943-8; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Eimer M, 2014, CURR BIOL, V24, P193, DOI 10.1016/j.cub.2013.12.001; Elsner C, 2013, NEUROPSYCHOLOGIA, V51, P488, DOI 10.1016/j.neuropsychologia.2012.12.007; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fagioli S, 2016, J COGNITIVE NEUROSCI, V28, P1392, DOI 10.1162/jocn_a_00980; Fiori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep38396; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Frey HP, 2014, EUR J NEUROSCI, V39, P1499, DOI 10.1111/ejn.12523; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gobell JL, 2004, VISION RES, V44, P1273, DOI 10.1016/j.visres.2004.01.012; Hamilton AFD, 2013, CORTEX, V49, P2957, DOI 10.1016/j.cortex.2013.08.012; Hetu S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00458; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hogeveen J, 2012, J NEUROSCI, V32, P5984, DOI 10.1523/JNEUROSCI.5938-11.2012; Jacquet PO, 2015, CEREB CORTEX, V25, P598, DOI 10.1093/cercor/bht242; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Joyce K, 2016, COGN NEUROSCI-UK, V7, P74, DOI 10.1080/17588928.2015.1053443; Kamke MR, 2014, J NEUROSCI, V34, P1475, DOI 10.1523/JNEUROSCI.1595-13.2014; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Kourtis D, 2014, J COGNITIVE NEUROSCI, V26, P2275, DOI 10.1162/jocn_a_00634; Langton SRH, 2006, Q J EXP PSYCHOL, V59, P2056, DOI 10.1080/17470210600917884; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Lavie N, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P175; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Leonetti A, 2015, EXP BRAIN RES, V233, P3013, DOI 10.1007/s00221-015-4371-0; Letesson C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00569; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Liepelt R, 2010, EXP PSYCHOL, V57, P221, DOI 10.1027/1618-3169/a000028; Marquez CMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027292; Mattiassi ADA, 2014, J COGNITIVE NEUROSCI, V26, P2028, DOI 10.1162/jocn_a_00619; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Mele S, 2014, J EXP PSYCHOL HUMAN, V40, P1940, DOI 10.1037/a0036215; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Naish KR, 2014, NEUROPSYCHOLOGIA, V64, P331, DOI 10.1016/j.neuropsychologia.2014.09.034; Newman-Norlund RD, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.005.2010; Pavlova M, 2006, CEREB CORTEX, V16, P321, DOI 10.1093/cercorbhi108; Peelena MV, 2011, P NATL ACAD SCI USA, V108, P12125, DOI 10.1073/pnas.1101042108; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Sacheli LM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01034; Sartori L, 2015, FRONT PSYCHOL, V6; Sartori L, 2013, JOVE-J VIS EXP, DOI 10.3791/51001; Sartori L, 2013, SOC COGN AFFECT NEUR, V8, P662, DOI 10.1093/scan/nss044; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Sartori L, 2011, EXP BRAIN RES, V211, P557, DOI 10.1007/s00221-011-2650-y; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schuch S, 2010, EXP BRAIN RES, V205, P235, DOI 10.1007/s00221-010-2358-4; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Teufel C, 2010, ATTEN PERCEPT PSYCHO, V72, P695, DOI 10.3758/APP.72.3.695; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tidoni E, 2013, J NEUROSCI, V33, P611, DOI 10.1523/JNEUROSCI.2228-11.2013; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; Vossel S, 2015, J NEUROSCI, V35, P11532, DOI 10.1523/JNEUROSCI.1382-15.2015; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wiggett AJ, 2015, PSYCHON B REV, V22, P1678, DOI 10.3758/s13423-015-0823-6; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017; Wolfe JM, 2011, ATTEN PERCEPT PSYCHO, V73, P1650, DOI 10.3758/s13414-011-0153-3; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	101	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173114	10.1371/journal.pone.0173114	http://dx.doi.org/10.1371/journal.pone.0173114			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319191	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800009
J	Shaver, DJ; Hart, KM; Fujisaki, I; Bucklin, D; Iverson, AR; Rubio, C; Backof, TF; Burchfield, PM; Miron, RDGD; Dutton, PH; Frey, A; Pena, J; Gamez, DG; Martinez, HJ; Ortiz, J				Shaver, Donna J.; Hart, Kristen M.; Fujisaki, Ikuko; Bucklin, David; Iverson, Autumn R.; Rubio, Cynthia; Backof, Thomas F.; Burchfield, Patrick M.; Gonzales Diaz Miron, Raul de Jesus; Dutton, Peter H.; Frey, Amy; Pena, Jaime; Gamez, Daniel Gomez; Martinez, Hector J.; Ortiz, Jaime			Inter-nesting movements and habitat-use of adult female Kemp's ridley turtles in the Gulf of Mexico	PLOS ONE			English	Article							STATE-SPACE MODELS; LEATHERBACK TURTLES; SEA-TURTLES; DERMOCHELYS-CORIACEA; LEPIDOCHELYS-KEMPII; CHELONIA-MYDAS; SATELLITE TRACKING; LOGGERHEAD TURTLES; CARETTA-CARETTA; BEHAVIORAL PLASTICITY	Species vulnerability is increased when individuals congregate in restricted areas for breeding; yet, breeding habitats are not well defined for many marine species. Identification and quantification of these breeding habitats are essential to effective conservation. Satellite telemetry and switching state-space modeling (SSM) were used to define inter-nesting habitat of endangered Kemp's ridley turtles (Lepidochelys kempil) in the Gulf of Mexico. Turtles were outfitted with satellite transmitters after nesting at Padre Island National Seashore, Texas, USA, from 1998 through 2013 (n = 60); Rancho Nuevo, Tamaulipas, Mexico, during 2010 and 2011 (n = 11); and Tecolutla, Veracruz, Mexico, during 2012 and 2013 (n = 11). These sites span the range of nearly all nesting by this species. Inter-nesting habitat lies in a narrow band of nearshore western Gulf of Mexico waters in the USA and Mexico, with mean water depth of 14 to 19 m within a mean distance to shore of 6 to 11 km as estimated by 50% kernel density estimate, a-Hull, and minimum convex polygon methodologies. Turtles tracked during the inter-nesting period moved, on average, 17.5 km/day and a mean total distance of 398 km. Mean home ranges occupied were 725 to 2948 km(2). Our results indicate that these nearshore western Gulf waters represent critical inter-nesting habitat for this species, where threats such as shrimp trawling and oil and gas platforms also occur. Up to half of all adult female Kemp's ridleys occupy this habitat for weeks to months during each nesting season. Because inter-nesting habitat for this species is concentrated in nearshore waters of the western Gulf of Mexico in both Mexico and the USA, international collaboration is needed to protect this essential habitat and the turtles occurring within it.	[Shaver, Donna J.; Rubio, Cynthia; Backof, Thomas F.] Padre Isl Natl Seashore, Natl Pk Serv, Corpus Christi, TX 78418 USA; [Hart, Kristen M.] US Geol Survey, Wetland & Aquat Res Ctr, Davie, FL USA; [Fujisaki, Ikuko; Bucklin, David] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Iverson, Autumn R.] US Geol Survey, Cherokee Nation Technol, Wetland & Aquat Res Ctr, Davie, FL USA; [Burchfield, Patrick M.; Pena, Jaime; Gamez, Daniel Gomez; Martinez, Hector J.; Ortiz, Jaime] Gladys Porter Zoo, Brownsville, TX USA; [Gonzales Diaz Miron, Raul de Jesus] Acuario Veracruz AC, Veracruz, Veracruz, Mexico; [Dutton, Peter H.; Frey, Amy] NOAA, Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, La Jolla, CA USA	United States Department of the Interior; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Shaver, DJ (corresponding author), Padre Isl Natl Seashore, Natl Pk Serv, Corpus Christi, TX 78418 USA.	donna_shaver@nps.gov	Shaver, Donna J/D-6227-2013	Shaver, Donna J/0000-0003-1379-8974	National Park Service; USGS Priority Ecosystem Studies program; USGS Ecosystems Program; USGS Natural Resources Protection Program; Deepwater Horizon Natural Resource Damage Assessment (NRDA); National Fish and Wildlife Foundation	National Park Service; USGS Priority Ecosystem Studies program; USGS Ecosystems Program; USGS Natural Resources Protection Program; Deepwater Horizon Natural Resource Damage Assessment (NRDA); National Fish and Wildlife Foundation	Funding for this work was provided by the National Park Service, USGS Priority Ecosystem Studies program, USGS Ecosystems Program, USGS Natural Resources Protection Program, Deepwater Horizon Natural Resource Damage Assessment (NRDA), and National Fish and Wildlife Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cherokee Nation Technologies is a commercial affiliation that employs contract workers for the U.S. Geological Survey. ARI aided with data analysis and writing of the manuscript. The funders provided support in the form of salaries for authors [DJS KMH IF DB ARI CR TB PMB RGDM PHD AF JP DGG HJM JO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, R LANG ENV STAT COMP; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Bevan E, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1244; Bevan Elizabeth, 2016, Herpetological Review, V47, P27; Blanco GS, 2012, IEEE PES GEN M 2012, P1; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; BOWEN BW, 1991, NATURE, V352, P709, DOI 10.1038/352709a0; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; Collecte Localisation Satellites (CLS), 2015, ARG US MAN WORLDW TR; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; ESRI, 2010, ARCGIS DESKT REL 10; ESRI, 2007, ARCGIS 9 3 GIS; Esteban N, 2015, MAR BIOL, V162, P1153, DOI 10.1007/s00227-015-2656-2; Figgener C, 2016, J EXP MAR BIOL ECOL, V475, P114, DOI 10.1016/j.jembe.2015.11.014; Fitzsimmons NN, 1998, MOL ECOL, V7, P575, DOI 10.1046/j.1365-294x.1998.00355.x; Foley AM, 2014, MAR BIOL, V161, P1251, DOI 10.1007/s00227-014-2415-9; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Frey A, 2014, ENDANGER SPECIES RES, V23, P63, DOI 10.3354/esr00565; Fuller WJ, 2009, MAR TECHNOL SOC J, V43, P51, DOI 10.4031/MTSJ.43.3.4; Gallaway Benny J., 2016, Gulf of Mexico Science, V33, P138; Georges JY, 2007, MAR ECOL PROG SER, V338, P225, DOI 10.3354/meps338225; GRASSMAN M, 1993, BRAIN BEHAV EVOLUT, V41, P224, DOI 10.1159/000113842; Gredzens C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098944; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hardy RF, 2014, CAN J FISH AQUAT SCI, V71, P1924, DOI 10.1139/cjfas-2014-0128; Hart CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116225; Hart KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103453; Hart KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066921; Hart KM, 2010, AQUAT BIOL, V11, P77, DOI 10.3354/ab00296; Hart Rick A., 2013, U S National Marine Fisheries Service Marine Fisheries Review, V75, P43; Hart Rick A., 2012, U S National Marine Fisheries Service Marine Fisheries Review, V74, P1; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Hays GC, 1999, MAR ECOL PROG SER, V189, P263, DOI 10.3354/meps189263; HILDEBRAND HENRY H., 1963, CIENCIA [MEXICO], V22, P105; Hitipeuw C, 2007, CHELONIAN CONSERV BI, V6, P28, DOI 10.2744/1071-8443(2007)6[28:PSAIMO]2.0.CO;2; Hochscheid S, 1999, MAR ECOL PROG SER, V185, P101, DOI 10.3354/meps185101; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; I-Jiunn C, 2009, J EXP MAR BIOL ECOL, V381, P18, DOI 10.1016/j.jembe.2009.08.021; Jimenez-Quiroz MD, 2005, CHELONIAN CONSERV BI, V4, P774; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kichler K, 1999, MOL ECOL, V8, P819; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lee PLM, 2004, P NATL ACAD SCI USA, V101, P6530, DOI 10.1073/pnas.0307982101; LENHARDT M L, 1983, Journal of Auditory Research, V23, P119; Lewison RL, 2003, CONSERV BIOL, V17, P1089, DOI 10.1046/j.1523-1739.2003.02057.x; Lowther AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124754; Malarde J, 2011, IMPROVING ARGOS DOPP; Marquez M R, 1994, SINOPSIS DATOS BIOL; Marquez R, 2005, CHELONIAN CONSERV BI, V4, P761; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; MENDONCA MT, 1986, HERPETOLOGICA, V42, P373; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Narazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066043; National Marine Fisheries Service Southeast Fisheries Science Center, 2008, SEFSC579 NOAA NAT MA; National Marine Fisheries Service U.S. Fish and Wildlife Service and SEMARNAT, 2011, BIN REC PLAN KEMPS R; National Research Council, 1990, DECL SEA TURTL CAUS; NMFS USFWS (National Marine Fisheries Service United States Fish and Wildlife Service), 2015, KEMPS RIDL SEA TURTL; OWENS DW, 1985, COPEIA, P723, DOI 10.2307/1444766; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Putman NF, 2013, CURR BIOL, V23, P312, DOI 10.1016/j.cub.2012.12.041; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Renaud Maurice L., 1996, Chelonian Conservation and Biology, V2, P108; Renka RJ, 1996, ACM T MATH SOFTWARE, V22, P1, DOI 10.1145/225545.225546; Rostal David C., 1997, Chelonian Conservation and Biology, V2, P538; Rostal DC, 2005, CHELONIAN CONSERV BI, V4, P788; Rostal DC, 1991, THESIS; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Schofield G, 2013, BIOL CONSERV, V161, P101, DOI 10.1016/j.biocon.2013.03.004; Scott R, 2012, GLOBAL ECOL BIOGEOG; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seney EE, 2011, MAR ECOL PROG SER, V440, P241, DOI 10.3354/meps09380; Seney Erin E., 2008, Endangered Species Research, V4, P73, DOI 10.3354/esr00077; Shaver DJ, 2005, CHELONIAN CONSERV BI, V4, P817; SHAVER DJ, 1991, J HERPETOL, V25, P327, DOI 10.2307/1564592; Shaver DJ, 2016, BIOL CONSERV, V194, P158, DOI 10.1016/j.biocon.2015.12.014; Shaver DJ, 2015, HERPETOL CONSERV BIO, V10, P378; Shaver DJ, 2013, ECOL EVOL, V3, P2002, DOI 10.1002/ece3.594; Shaver Donna J., 2008, Endangered Species Research, V4, P43, DOI 10.3354/esr00061; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Silva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092277; Silva MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076507; Stokes K, 2015, DIVERS DISTRIB, P1; Systat Software, 2012, SIGMAPLOT 13 0; Tripathy B, 2008, HERPETOL CONSERV BIO, V3, P40; Tucker AD, 2001, J HERPETOL, V35, P500, DOI 10.2307/1565970; Tucker AD, 2010, J EXP MAR BIOL ECOL, V383, P48, DOI 10.1016/j.jembe.2009.11.009; VANBUSKIRK J, 1994, COPEIA, P66; Waayers D. A., 2011, Journal of the Royal Society of Western Australia, V94, P359; Walcott J, 2012, MAR BIOL; Walcott J, 2014, B MAR SCI, V90, P969, DOI 10.5343/bms.2014.1033; Wallace BP, 2008, J APPL ECOL, V45, P1076, DOI 10.1111/j.1365-2664.2008.01507.x; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; White G. C., 1990, ANAL WILDLIFE RADIOT; Wilson SG, 2015, CAN J FISH AQUAT SCI, V72, P1700, DOI 10.1139/cjfas-2015-0110; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Witzell WN, 2005, CHELONIAN CONSERV BI, V4, P781; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zbinden JA, 2007, BIOL CONSERV, V137, P157, DOI 10.1016/j.biocon.2007.01.022; Zerbini Alexandre N., 2004, Journal of Cetacean Research and Management, V6, P101	122	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174248	10.1371/journal.pone.0174248	http://dx.doi.org/10.1371/journal.pone.0174248			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319178	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800060
J	Chappell, CP; Draves, KE; Clark, EA				Chappell, Craig P.; Draves, Kevin E.; Clark, Edward A.			CD22 is required for formation of memory B cell precursors within germinal centers	PLOS ONE			English	Article							RECEPTOR SIGNAL-TRANSDUCTION; CD22-DEFICIENT MICE; ANTIBODY-RESPONSES; NEGATIVE REGULATOR; EXPRESSION; SURVIVAL; ADHESION; AFFINITY; SUBSETS; LIGANDS	CD22 is a BCR co-receptor that regulates B cell signaling, proliferation and survival and is required for T cell-independent Ab responses. To investigate the role of CD22 during T cell-dependent (TD) Ab responses and memory B cell formation, we analyzed Ag-specific B cell responses generated by wild-type (WT) or CD22(-/-) B cells following immunization with a TD Ag. CD22(-/-) B cells mounted normal early Ab responses yet failed to generate either memory B cells or long-lived plasma cells, whereas WT B cells formed both populations. Surprisingly, B cell expansion and germinal center (GC) differentiation were comparable between WT and CD22(-/-) B cells. CD22(-/-) B cells, however, were significantly less capable of generating a population of CXCR4(hi)CD38(hi) GC B cells, which we propose represent memory B cell precursors within GCs. These results demonstrate a novel role for CD22 during TD humoral responses evident during primary GC formation and underscore that CD22 functions not only during B cell maturation but also during responses to both TD and T cell-independent antigens.	[Chappell, Craig P.; Draves, Kevin E.; Clark, Edward A.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Clark, Edward A.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Chappell, Craig P.] Merck Res Labs, Immunol Discovery, Boston, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Merck & Company	Clark, EA (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.; Clark, EA (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	eaclark@uw.edu		Clark, Edward A/0000-0001-8061-5475	National Institute of Allergy and Infectious Diseases [AI52203, AI44257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052203, R01AI044257] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) AI52203 and AI44257 (EAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; CLARK EA, 1993, J IMMUNOL, V150, P4715; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Goins CL, 2010, J IMMUNOL, V184, P6293, DOI 10.4049/jimmunol.0902530; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Lajaunias F, 2003, ARTHRITIS RHEUM, V48, P1612, DOI 10.1002/art.11021; LAW CL, 1995, J IMMUNOL, V155, P3368; Li YF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5273; Macauley MS, 2015, J BIOL CHEM, V290, P30066, DOI 10.1074/jbc.M115.691337; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Onodera T, 2008, J IMMUNOL, V180, P907, DOI 10.4049/jimmunol.180.2.907; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tedder TF, 2005, ADV IMMUNOL, V88, P1, DOI 10.1016/S0065-2776(05)88001-0; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Zeng JW, 2009, J IMMUNOL, V182, P4721, DOI 10.4049/jimmunol.0802833	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174661	10.1371/journal.pone.0174661	http://dx.doi.org/10.1371/journal.pone.0174661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346517	Green Published, gold, Green Submitted			2022-12-27	WOS:000399174300067
J	Lamei, S; Hu, YOO; Olofsson, TC; Andersson, AF; Forsgren, E; Vasquez, A				Lamei, Sepideh; Hu, Yue O. O.; Olofsson, Tobias C.; Andersson, Anders F.; Forsgren, Eva; Vasquez, Alejandra			Improvement of identification methods for honeybee specific Lactic Acid Bacteria; future approaches	PLOS ONE			English	Article							APIS-MELLIFERA; LACTOBACILLUS-KUNKEEI; COMPARATIVE GENOMICS; SP NOV.; STOMACH; DIVERSITY; REVEALS; POLLEN; FLORA; BEES	Honeybees face many parasites and pathogens and consequently rely on a diverse set of individual and group-level defenses to prevent disease. The crop microbiota of Apis mellifera, composed of 13 Lactic Acid Bacterial (LAB) species within the genera Lactobacillus and Bifidobacterium, form a beneficial symbiotic relationship with each other and the honeybee to protect their niche and their host. Possibly playing a vital role in honeybee health, it is important that these honeybee specific Lactic Acid Bacterial (hbs-LAB) symbionts can be correctly identified, isolated and cultured, to further investigate their health promoting properties. We have previously reported successful identification to the strain level by culture-dependent methods and we recently sequenced and annotated the genomes of the 13 hbs-LAB. However, the hitherto applied techniques are unfortunately very time consuming, expensive and not ideal when analyzing a vast quantity of samples. In addition, other researchers have constantly failed to identify the 13 hbs-LAB from honeybee samples by using inadequate media and/or molecular techniques based on 16S rRNA gene sequencing with insufficient discriminatory power. The aim of this study was to develop better and more suitable methods for the identification and cultivation of hbs-LAB. We compared currently used bacterial cultivation media and could for the first time demonstrate a significant variation in the hbs-LAB basic requirements for optimal growth. We also present a new bacterial identification approach based on amplicon sequencing of a region of the 16S rRNA gene using the Illumina platform and an error correction software that can be used to successfully differentiate and rapidly identify the 13 hbs-LAB to the strain level.	[Lamei, Sepideh; Olofsson, Tobias C.; Vasquez, Alejandra] Lund Univ, Dept Lab Med Lund, Sect Med Microbiol, Lund, Sweden; [Lamei, Sepideh; Forsgren, Eva] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Hu, Yue O. O.; Andersson, Anders F.] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden	Lund University; Swedish University of Agricultural Sciences; Royal Institute of Technology	Vasquez, A (corresponding author), Lund Univ, Dept Lab Med Lund, Sect Med Microbiol, Lund, Sweden.	Alejandra.vasquez@med.lu.se	Andersson, Anders/J-9310-2019; Hu, Yue/AHB-2985-2022	Andersson, Anders/0000-0002-3627-6899; Hu, Yue/0000-0002-2025-2198	Swedish Research Council FORMAS [2012-822, 2013-423]; China Scholarship Council (CSC) [201206950024]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); China Scholarship Council (CSC)(China Scholarship Council)	This work was funded by grants from The Swedish Research Council FORMAS (grants: 2012-822 and 2013-423) and Y.O.O.H. was supported by a scholarship from the China Scholarship Council (CSC#201206950024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Arskold E, 2008, J BACTERIOL, V190, P206, DOI 10.1128/JB.01227-07; Butler E., 2014, INT WOUND J, V2014, P1; Butler E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-235; Callahan BJ, 2015, NAT METHODS, V13; Audisio MC, 2011, MICROBIOL RES, V166, P1, DOI 10.1016/j.micres.2010.01.003; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards CG, 1998, J APPL MICROBIOL, V84, P698, DOI 10.1046/j.1365-2672.1998.00399.x; Ellegaard KM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1476-6; Endo A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2339-x; Endo A, 2013, SYST APPL MICROBIOL, V36, P444, DOI 10.1016/j.syapm.2013.06.002; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Hu YOO, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00679, 10.5589/fmicb.2016.00679]; Kalia A, 1999, ANAL BIOCHEM, V275, P1, DOI 10.1006/abio.1999.4259; Killer J, 2014, INT J SYST EVOL MICR, V64, P152, DOI 10.1099/ijs.0.053033-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kwong WK, 2014, GENOME ANNOUNC, V2; Maggi M, 2013, VET MICROBIOL, V167, P474, DOI 10.1016/j.vetmic.2013.07.030; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Meixner MD, 2014, J APICULT RES, V53, P215, DOI 10.3896/IBRA.1.53.2.04; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; MORISHITA T, 1981, J BACTERIOL, V148, P64, DOI 10.1128/JB.148.1.64-71.1981; Mudronova D, 2011, J APICULT RES, V50, P323, DOI 10.3896/IBRA.1.50.4.11; Neveling DP, 2012, CURR MICROBIOL, V65, P507, DOI 10.1007/s00284-012-0186-4; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Olofsson TC, 2014, INT WOUND J, P1; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2014, INT J SYST EVOL MICR, V64, P3109, DOI 10.1099/ijs.0.059600-0; Olofsson TC, 2011, APIDOLOGIE, V42, P696, DOI 10.1007/s13592-011-0064-2; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ragout A, 1996, BIOTECHNOL LETT, V18, P1105, DOI 10.1007/BF00129740; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Stanley R. G., 1974, POLLEN BIOL BIOCH MA, P117; Tamarit D, 2015, GENOME BIOL EVOL, V7, P1455, DOI 10.1093/gbe/evv079; Temmerman R, 2004, TRENDS FOOD SCI TECH, V15, P348, DOI 10.1016/j.tifs.2003.12.007; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Vasquez A, 2001, LETT APPL MICROBIOL, V32, P215, DOI 10.1046/j.1472-765X.2001.00901.x; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Vasquez A, 2009, APIDOLOGIE, V40, P26, DOI 10.1051/apido:2008063; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106	57	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174614	10.1371/journal.pone.0174614	http://dx.doi.org/10.1371/journal.pone.0174614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346815	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000399174300061
J	Schumann, U; Jenkinson, CP; Alt, A; Zugel, M; Steinacker, JM; Flechtner-Mors, M				Schumann, Uwe; Jenkinson, Christopher P.; Alt, Andreas; Zuegel, Martina; Steinacker, Juergen M.; Flechtner-Mors, Marion			Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects	PLOS ONE			English	Article							BLOOD-FLOW; IN-VIVO; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MICRODIALYSIS; HUMANS; STIMULATION; METABOLISM; LACTATE; ETHANOL	The study aim was to investigate the effect of endogenous insulin release on lipolysis in subcutaneous adipose tissue after adrenergic stimulation in obese subjects diagnosed with type 2 diabetes (T2D). In 14 obese female T2D subjects, or 14 obese non-T2D controls, glycerol concentration was measured in response to the alpha(1,2),beta-agonist norepinephrine, the alpha(1)-agonist norfenefrine and the beta(2)-agonist terbutaline (each 10(-4) M), using the microdialysis technique. After 60 minutes of stimulation, an intravenous glucose load (0.5 g/kg lean body mass) was given. Local blood flow was monitored by means of the ethanol technique. Norepinephrine and norfenefrine induced a four and three fold rise in glycerol dialysate concentration (p<0.001, each), with a similar pattern in adipose tissue. Following agonist stimulation and glucose infusion, endogenous insulin release inhibited lipolysis in the presence of norepinephrine, which was more rapid and pronounced in healthy obese controls than in T2D subjects (p = 0.024 obese vs T2D subjects). Insulin-induced inhibition of lipolysis in the presence of norfenefrine was similar in all study participants. In the presence of terbutaline the lipolysis rate increased two fold until the effect of endogenous insulin (p<0.001). A similar insulin-induced decrease in lipolysis was observed for each of the norfenefrine groups and the terbutaline groups, respectively. Adipose tissue blood flow remained unchanged after the iv-glucose load. Both norepinephrine and norfenefrine diminished blood flow slightly, but insulin reversed this response (p<0.001 over the entire time). Terbutaline alone and terbutaline plus increased endogenous insulin augmented local blood flow (p<0.001 over the entire time). In conclusion, a difference in insulin-induced inhibition of lipolysis was observed in obese T2D subjects compared to obese healthy controls following modulation of sympathetic nervous system activity and is assumed to be due to beta 1-adrenoceptor mediated stimulation by norepinephrine.	[Schumann, Uwe; Zuegel, Martina; Steinacker, Juergen M.; Flechtner-Mors, Marion] Univ Ulm, Med Ctr, Div Sports & Rehabil Med, Ulm, Germany; [Jenkinson, Christopher P.] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Harlingen, TX USA; [Alt, Andreas] Univ Ulm, Inst Legal Med, Ulm, Germany	Ulm University; University of Texas System; University of Texas Rio Grande Valley; Ulm University	Flechtner-Mors, M (corresponding author), Univ Ulm, Med Ctr, Div Sports & Rehabil Med, Ulm, Germany.	marion.flechtner-mors@uni-ulm.de	Steinacker, Juergen M. M/E-6876-2015	Steinacker, Juergen M. M/0000-0001-8901-9450				Ardilouze JL, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000105681.70455.73; ARNER P, 1993, CLIN SCI, V85, P247, DOI 10.1042/cs0850247; Arner P, 1987, RECENT ADV OBESITY R, P204; ARNER P, 1996, DIABETES REV, V4, P450; Barbe P, 1996, BRIT J PHARMACOL, V117, P907, DOI 10.1111/j.1476-5381.1996.tb15279.x; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157; Bjorkhelm J, 1981, J LIPID RES, V67, P467; Bjorntorp P, 1971, Adv Metab Disord, V5, P277; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boschmann M, 2002, OBES RES, V10, P555, DOI 10.1038/oby.2002.75; COPPACK SW, 1994, J LIPID RES, V35, P177; CURRY AS, 1966, ANALYST, V91, P742, DOI 10.1039/an9669100742; DELPRATO S, 1990, DIABETOLOGIA, V33, P228, DOI 10.1007/BF00404801; Divertie GD, 1997, AM J PHYSIOL-ENDOC M, V272, pE1130, DOI 10.1152/ajpendo.1997.272.6.E1130; ENGFELDT P, 1988, J BIOL CHEM, V263, P15553; ENOCKSSON S, 1995, J CLIN INVEST, V95, P2239, DOI 10.1172/JCI117914; Fellander G, 1996, INT J OBESITY, V20, P220; Flechtner-Mors M, 2002, J PHARMACOL EXP THER, V301, P229, DOI 10.1124/jpet.301.1.229; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; HagstromToft E, 1997, AM J PHYSIOL-ENDOC M, V273, pE584, DOI 10.1152/ajpendo.1997.273.3.E584; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Heptulla RA, 2003, PEDIATR RES, V53, P830, DOI 10.1203/01.PDR.0000059552.08913.B7; JENSEN MD, 1989, DIABETES, V38, P1595, DOI 10.2337/diabetes.38.12.1595; Karpe F, 2002, DIABETES, V51, P2467, DOI 10.2337/diabetes.51.8.2467; Karpe F, 2002, J PHYSIOL-LONDON, V540, P1087, DOI 10.1113/jphysiol.2001.013358; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; LONNROTH P, 1990, J INTERN MED, V227, P295; MACDONALD IA, 1995, INT J OBESITY, V19, pS2; Masuo K, 1997, AM J HYPERTENS, V10, P77, DOI 10.1016/S0895-7061(96)00303-2; Morigny P, 2015, BIOCHIMIE; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; REYNISDOTTIR S, 1994, J CLIN INVEST, V93, P2590, DOI 10.1172/JCI117271; Shulman GI, 1999, AM J CARDIOL, V84, p3J; SKOWRONSKI R, 1991, DIABETIC MED, V8, P330, DOI 10.1111/j.1464-5491.1991.tb01605.x; Sotornik R, 2012, AM J PHYSIOL-ENDOC M, V302, pE1157, DOI 10.1152/ajpendo.00351.2011; van Baak M A, 2001, Obes Rev, V2, P3; Wilding J, 1998, CLINICAL OBESITY-BOOK, P308	39	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173803	10.1371/journal.pone.0173803	http://dx.doi.org/10.1371/journal.pone.0173803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346464	Green Published, Green Submitted, gold			2022-12-27	WOS:000399174300013
J	Meller, FO; Assuncao, MCF; Schafer, AA; de Mola, CL; Dahly, DL; Vaz, JS; Barros, FC				Meller, F. O.; Assuncao, M. C. F.; Schafer, A. A.; Loret de Mola, C.; Dahly, D. L.; Vaz, J. S.; Barros, F. C.			Is the number of siblings associated with dietary patterns in adolescents? The 1993 birth cohort of Pelotas (Brazil)	PLOS ONE			English	Article							NUTRIENT INTAKE; NUTRITION TRANSITION; LIFE-STYLE; CHILDREN; FOOD; DETERMINANTS	Our study aimed to estimate the association between number of siblings and dietary patterns in adolescents. Prospective longitudinal study was developed using data from the birth cohort of the city of Pelotas, Brazil, which included 5249 participants. At the 18-year-old follow-up, from 4563 individuals located, 4106 were interviewed (follow-up rate 81.3%). Of these, 3751 were included in our principal component analysis of dietary patterns. Regular dietary intake of 45 food groups over the previous year was measured with a food frequency questionnaire. We identified four patterns, which accounted for 40% of the total variance in food group consumption. These were labeled "Protein and fast food", "Fruit and vegetables", "Common Brazilian", and "Sweets, soft drinks, and dairy products". Crude and adjusted analyses of the association between number of siblings and dietary patterns were performed using linear regression. The number of siblings was positively associated with a higher adherence to each dietary pattern, with the exception of the "Common Brazilian" patterns, for which there was no apparent relationship with number of siblings. The findings showed that a greater number of siblings is related to a more diverse diet in the later adolescence, which may predict better nutrient adequacy and health outcomes.	[Meller, F. O.; Assuncao, M. C. F.; Schafer, A. A.; Loret de Mola, C.; Vaz, J. S.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Dahly, D. L.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Barros, F. C.] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, Brazil	Universidade Federal de Pelotas; University College Cork; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Meller, FO (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	mellerfernanda@gmail.com	de Mola, Christian Loret/C-9534-2012; Vaz, Juliana/A-5645-2012	de Mola, Christian Loret/0000-0002-5264-5914; Barros, Fernando/0000-0001-5973-1746; Dahly, Darren/0000-0003-0110-324X; Vaz, Juliana/0000-0002-2880-767X	Wellcome Trust; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian Ministry of Health	All colleagues and workers who contributed to the study included since its 1 st year. This article is based on data from the study "Pelotas Birth Cohort, 1993" conducted by Postgraduate Program in Epidemiology at Universidade Federal de Pelotas with the collaboration of the Brazilian Public Health Association (ABRASCO) and the Brazilian National Research Council (CNPq). From 2004 to 2013, the Wellcome Trust supported the 1993 birth cohort study. The European Union, National Support Program for Centers of Excellence (PRONEX), and the Brazilian Ministry of Health supported previous phases of the study.	Ambrosini GL, 2009, PUBLIC HEALTH NUTR, V12, P1807, DOI 10.1017/S1368980008004618; Bates CJ, 2000, NATL DIET NUTR SURVE; Chen AY, 2010, PREV CHRONIC DIS, V7; Collins CE, 2010, INT J OBESITY, V34, P1103, DOI 10.1038/ijo.2009.241; COOK J, 1973, BRIT J PREV SOC MED, V27, P91; Cutler GJ, 2012, BRIT J NUTR, V108, P349, DOI 10.1017/S0007114511005435; de Oliveira EP, 2012, ARQ BRAS CARDIOL, V98, P338, DOI 10.1590/S0066-782X2012005000024; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Fernandez-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78; Foote JA, 2004, J NUTR, V134, P1779; Goncalves H, 2014, INT J EPIDEMIOL, V43, P1082, DOI 10.1093/ije/dyu077; Hanna KL, 2015, NUTR REV, V73, P594, DOI 10.1093/nutrit/nuv024; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; JACOBY A, 1975, BRIT J PREV SOC MED, V29, P116; Kag G, 2007, EPIDEMIOLOGIA NUTR, P213; Lake AA, 2006, J PUBLIC HEALTH-UK, V28, P10, DOI 10.1093/pubmed/fdi082; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; McCrory MA, 2002, PUBLIC HEALTH NUTR, V5, P873, DOI 10.1079/PHN2002387; Meller FD, 2015, BRIT J NUTR, V114, P118, DOI 10.1017/S0007114515001488; Nascimento Sileia, 2011, Nutr J, V10, P79, DOI 10.1186/1475-2891-10-79; Northstone K, 2005, EUR J CLIN NUTR, V59, P751, DOI 10.1038/sj.ejcn.1602136; Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Richter A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-35; Santos LP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3725-2; Schneider BC, REV BRASILEIRA EPIDE; Serra-Majem L, 2002, ANN NUTR METAB, V46, P31, DOI 10.1159/000066398; Sichieri R, 1998, NUTR RES, V18, P1649, DOI 10.1016/S0271-5317(98)00151-1; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008	29	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174087	10.1371/journal.pone.0174087	http://dx.doi.org/10.1371/journal.pone.0174087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28333975	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200045
J	Na, W; Yi, K; Song, YS; Park, MH				Na, Woong; Yi, Kijong; Song, Young Soo; Park, Moon Hyang			Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; IGG4-RELATED DISEASE; ANTIBODY-RESPONSES; MUTUAL INFORMATION; GLOMERULONEPHRITIS; RECEPTOR; IDENTIFICATION; IMMUNOGLOBULIN; ERYTHEMATOSUS; MALIGNANCY	Membranous lupus nephritis (MLN) and idiopathic membranous nephropathy (IMN) are kidney diseases with similar morphology, but distinct etiologies, both producing glomeruli with immune deposits. Immunoglobulins and complements, the main components of the deposits, can be detected by immunofluorescence (IF) microscopy. Previous researches characterized the immune deposits only individually, but not the interactions between them. To study these relationships we analyzed an IF profile of IgG subclasses and complements (IgG1, IgG2, IgG3, IgG4, C3, C1q, and C4) in 53 and 95 cases of biopsy-confirmed MLNs and IMNs, respectively, mainly using information theory and Bayesian networks. We identified significant entropy differences between MLN and IMN for all markers except C3 and IgG1, but mutual information (a measure of mutual dependence) were not significantly different for all the pairs of markers. The entropy differences between MLN and IMN, therefore, were not attributable to the mutual information. These findings suggest that disease type directly and/or indirectly influences the glomerular deposits of most of IgG subclasses and complements, and that the interactions between any pair of the markers were similar between the two diseases. A Markov chain of IgG subclasses was derived from the mutual information about each pair of IgG subclass. Finally we developed an integrated disease model, consistent with the previous findings, describing the glomerular immune deposits of the IgG subclasses and complements based on a Bayesian network using the Markov chain of IgG subclasses as seed. The relationships between the markers were effectively explored by information theory and Bayesian network. Although deposits of IgG subclasses and complements depended on both disease type and the other markers, the interaction between the markers appears conserved, independent from the disease type. The disease model provided an integrated and intuitive representation of the relationships of the IgG subclasses and complements in MLN and IMN.	[Na, Woong; Yi, Kijong; Song, Young Soo; Park, Moon Hyang] Hanyang Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Park, Moon Hyang] Konyang Univ Hosp, Dept Pathol, Daejeon, South Korea	Hanyang University; Konyang University; Konyang University Hospital	Song, YS; Park, MH (corresponding author), Hanyang Univ, Dept Pathol, Coll Med, Seoul, South Korea.; Park, MH (corresponding author), Konyang Univ Hosp, Dept Pathol, Daejeon, South Korea.	lifen@hanyang.ac.kr; parkmh@hanyang.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2010-0028631]; Hanyang University	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Hanyang University	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2010-0028631) and the research fund of Hanyang University (HY-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2010-0028631) and the research fund of Hanyang University (HY-2012).	Beck LH, 2010, SEMIN NEPHROL, V30, P635, DOI 10.1016/j.semnephrol.2010.09.011; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Culver EL, 2016, NAT REV GASTRO HEPAT, V13, P601, DOI 10.1038/nrgastro.2016.132; De Moor G, 2015, J BIOMED INFORM, V53, P162, DOI 10.1016/j.jbi.2014.10.006; Deshpande V, 2015, ARCH PATHOL LAB MED, V139, P742, DOI 10.5858/arpa.2014-0181-RA; DONADIO JV, 1988, KIDNEY INT, V33, P708, DOI 10.1038/ki.1988.56; DONADIO JV, 1977, MEDICINE, V56, P527, DOI 10.1097/00005792-197711000-00007; Duering M, 2013, NEUROIMAGE, V66, P177, DOI 10.1016/j.neuroimage.2012.10.084; FRANKLIN WA, 1973, KIDNEY INT, V4, P36, DOI 10.1038/ki.1973.78; FRIEND PS, 1977, BRIT MED J, V1, P25, DOI 10.1136/bmj.1.6052.25; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; JENNETTE JC, 1983, KIDNEY INT, V24, P377, DOI 10.1038/ki.1983.170; Jeong HH, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0171-1; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Riemekasten G, 2005, RHEUMATOLOGY, V44, P975, DOI 10.1093/rheumatology/keh688; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roper RL, 2002, IMMUNOL LETT, V84, P191, DOI 10.1016/S0165-2478(02)00185-2; Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x; Scutari M., 2009, ARXIV09083817; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Shlush LI, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-47; Song YS, 2012, CLIN J AM SOC NEPHRO, V7, P1947, DOI 10.2215/CJN.04800511; Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2; Umemura T, 2007, GUT, V56, P1471, DOI 10.1136/gut.2007.122283; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wernersson S, 2000, SCAND J IMMUNOL, V52, P563, DOI 10.1046/j.1365-3083.2000.00813.x; Zuniga R, 2003, ARTHRITIS RHEUM, V48, P460, DOI 10.1002/art.10930	36	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174501	10.1371/journal.pone.0174501	http://dx.doi.org/10.1371/journal.pone.0174501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28334051	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200107
J	Premji, SS; Currie, G; Reilly, S; Dosani, A; Oliver, LM; Lodha, AK; Young, M				Premji, Shahirose S.; Currie, Genevieve; Reilly, Sandra; Dosani, Aliyah; Oliver, Lynnette May; Lodha, Abhay K.; Young, Marilyn			A qualitative study: Mothers of late preterm infants relate their experiences of community-based care	PLOS ONE			English	Article							RISK-FACTORS; NEAR-TERM; CONFIDENCE; BIRTH	Purpose In Alberta, the high occurrence of late preterm infants and early hospital discharge of mother-infant dyads has implications for postpartum care in the community. Shortened hospital stay and complexities surrounding the care of biologically and developmentally immature late preterm infants heighten anxiety and fears. Our descriptive phenomenological study explores mothers' experience of caring for their late preterm infants in the community. Methods Eleven mothers were interviewed using a semi-structured interview guide. Interview transcripts were analysed using an interpretive thematic approach. Findings The mothers' hospital experience informed their perspective that being a late preterm infant was not a ''big deal,'' and they tended to treat their infant as normal. ''Feeding was really problem,'' especially the variability in feeding effectiveness, which was not anticipated. Failing to recognize late preterm infants' feeding distress exemplified lack of knowledge of feeding cues and tendencies to either rationalize or minimize feeding concerns. Public health nurses represent a source of informational support for managing neonatal morbidities associated with being late preterm; however, maternal experiences with public health nurses varied. Some nurses used a directive style that overwhelmed certain mothers. Seeing multiple public health nurses and care providers was not always effective, given inconsistent and contradictory guidance to care. These new and changing situations increased maternal anxiety and stress and influenced maternal confidence in care. Fathers, family, and friends were important sources of emotional support. Conclusion After discharge, mothers report their lack of preparation to meet the special needs of their late preterm infants. Current approaches to community-based care can threaten maternal confidence in care. New models and pathways of care for late preterm infants and their families need to be responsive to the spectrum of feeding issues encountered, limit duplication of services, and ensure consistent and effective care that parents will accept.	[Premji, Shahirose S.; Reilly, Sandra; Oliver, Lynnette May] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Premji, Shahirose S.; Lodha, Abhay K.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Premji, Shahirose S.; Reilly, Sandra; Dosani, Aliyah] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Premji, Shahirose S.; Lodha, Abhay K.] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Currie, Genevieve; Dosani, Aliyah] Mt Royal Univ, Sch Nursing & Midwifery, Calgary, AB, Canada; [Lodha, Abhay K.] Alberta Hlth Serv, Div Neonatol, Dept Paediat, Calgary, AB, Canada; [Young, Marilyn] Alberta Hlth Serv, Publ Hlth Calgary Zone, Prenatal & Postpartum Serv, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Mount Royal University; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary	Premji, SS (corresponding author), Univ Calgary, Fac Nursing, Calgary, AB, Canada.; Premji, SS (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.; Premji, SS (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada.; Premji, SS (corresponding author), Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.	premjis@ucalgary.ca		Sadrudin Premji, Shahirose/0000-0003-0323-8009; Dosani, Aliyah/0000-0001-6817-3571	Alberta Centre for Child, Family & Community Research	Alberta Centre for Child, Family & Community Research	The study was funded by the Alberta Centre for Child, Family & Community Research (http://research4children.com/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Bakewell-Sachs S, 2007, NEWBORN INFANT NURS, V7, P67, DOI 10.1053/j.nainr.2007.05.001; Bunik M, 2011, BREASTFEED MED, V6, P151, DOI 10.1089/bfm.2011.9990; Canadian Institute for Health Information, 2014, NEWB BORN HOSP CAN I; Creswell J. W., 2007, QUALITATIVE INQUIRY; DeMauro SB, 2011, CLIN PEDIATR, V50, P957, DOI 10.1177/0009922811409028; Demirci JR, 2015, MATERN CHILD NUTR, V11, P59, DOI 10.1111/j.1740-8709.2012.00463.x; Gagliardi AR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0399-1; Golec L, 2009, J PERINATOL, V29, P600, DOI 10.1038/jp.2009.98; Howe TH, 2014, RES DEV DISABIL, V35, P1748, DOI 10.1016/j.ridd.2014.02.015; Hummel P., 2003, NEWBORN INFANT NURS, V3, P88; Kugelman A, 2013, PEDIATRICS, V132, P741, DOI 10.1542/peds.2013-1131; Kuzniewicz MW, 2013, CLIN PERINATOL, V40, P753, DOI [10.1016/j.c1p.2013.07.008, 10.1016/j.clp.2013.07.008]; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Mally PV, 2010, CURR PROB PEDIATR AD, V40, P218, DOI 10.1016/j.cppeds.2010.07.005; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; Olafsen KS, 2007, SCAND J PSYCHOL, V48, P499, DOI 10.1111/j.1467-9450.2007.00619.x; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Premji SS, 2015, CARING LATE PRETERM; Shapiro-Mendoza, 2009, NEOREVIEWS, V10, P287; Shapiro-Mendoza CK, 2006, SEMIN PERINATOL, V30, P54, DOI 10.1053/j.semperi.2006.02.002; Singer LT, 2003, J DEV BEHAV PEDIATR, V24, P233, DOI 10.1097/00004703-200308000-00003; Solomon J., 2015, HDB ATTACHMENT THEOR; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Tu MT, 2007, DEV PSYCHOBIOL, V49, P150, DOI 10.1002/dev.20204; Voegtline KM, 2010, INFANT BEHAV DEV, V33, P545, DOI 10.1016/j.infbeh.2010.07.006; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Warren PL, 2005, J ADV NURS, V50, P479; Young PC, 2013, PEDIATRICS, V131, pE1538, DOI 10.1542/peds.2012-2634; Zanardo V, 2011, EARLY HUM DEV, V87, P321, DOI 10.1016/j.earlhumdev.2011.01.035	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174419	10.1371/journal.pone.0174419	http://dx.doi.org/10.1371/journal.pone.0174419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER8VS	28334033	Green Published, gold, Green Submitted			2022-12-27	WOS:000399102200096
J	Riester, M; Wu, HJ; Zehir, A; Gonen, M; Moreira, AL; Downey, RJ; Michor, F				Riester, Markus; Wu, Hua-Jun; Zehir, Ahmet; Gonen, Mithat; Moreira, Andre L.; Downey, Robert J.; Michor, Franziska			Distance in cancer gene expression from stem cells predicts patient survival	PLOS ONE			English	Article							EMBRYONIC STEM; BREAST-CANCER; SIGNATURE; MARKER; MYC; CLASSIFICATION; SIMILARITIES; EVOLUTION; SUBTYPE; SOX2	The degree of histologic cellular differentiation of a cancer has been associated with prognosis but is subjectively assessed. We hypothesized that information about tumor differentiation of individual cancers could be derived objectively from cancer gene expression data, and would allow creation of a cancer phylogenetic framework that would correlate with clinical, histologic and molecular characteristics of the cancers, as well as predict prognosis. Here we utilized mRNA expression data from 4,413 patient samples with 7 diverse cancer histologies to explore the utility of ordering samples by their distance in gene expression from that of stem cells. A differentiation baseline was obtained by including expression data of human embryonic stem cells (hESC) and human mesenchymal stem cells (hMSC) for solid tumors, and of hESC and CD34+ cells for liquid tumors. We found that the correlation distance (the degree of similarity) between the gene expression profile of a tumor sample and that of stem cells orients cancers in a clinically coherent fashion. For all histologies analyzed (including carcinomas, sarcomas, and hematologic malignancies), patients with cancers with gene expression patterns most similar to that of stem cells had poorer overall survival. We also found that the genes in all undifferentiated cancers of diverse histologies that were most differentially expressed were associated with up-regulation of specific oncogenes and down-regulation of specific tumor suppressor genes. Thus, a stem cell-oriented phylogeny of cancers allows for the derivation of a novel cancer gene expression signature found in all undifferentiated forms of diverse cancer histologies, that is competitive in predicting overall survival in cancer patients compared to previously published prediction models, and is coherent in that gene expression was associated with up-regulation of specific oncogenes and down-regulation of specific tumor suppressor genes associated with regulation of the multicellular state.	[Riester, Markus; Wu, Hua-Jun; Michor, Franziska] Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Riester, Markus; Wu, Hua-Jun; Michor, Franziska] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Zehir, Ahmet] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Moreira, Andre L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Downey, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Michor, F (corresponding author), Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Michor, F (corresponding author), Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Downey, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA.	downeyr@mskcc.org; michor@jimmy.harvard.edu	Gonen, Mithat/E-4826-2012; Zehir, Ahmet/ABE-7155-2020	Gonen, Mithat/0000-0001-8683-8477; Zehir, Ahmet/0000-0001-5406-4104	UDana-Farber Cancer Institute Physical Sciences-Oncology Center [U54CA143798]; NIH/NCI Cancer Center Support Grants [P30 CA008748, U54CA193461-01]; NATIONAL CANCER INSTITUTE [U54CA193461, R01CA185137, P30CA008748] Funding Source: NIH RePORTER	UDana-Farber Cancer Institute Physical Sciences-Oncology Center; NIH/NCI Cancer Center Support Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the UDana-Farber Cancer Institute Physical Sciences-Oncology Center (U54CA143798 to FM) and by the NIH/NCI Cancer Center Support Grants (P30 CA008748 to RJD; U54CA193461-01 to FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Chang SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-613; Cheung PFY, 2016, ONCOTARGET, V7, P21644, DOI 10.18632/oncotarget.7803; Chiang JH, 2014, OMICS, V18, P310, DOI 10.1089/omi.2013.0084; Desper R, 2004, J THEOR BIOL, V228, P477, DOI 10.1016/j.jtbi.2004.02.021; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Finicelli M, 2014, ONCOTARGET, V5, P9678, DOI 10.18632/oncotarget.1936; Forn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123263; Gentles AJ, 2009, BLOOD, V114, P3158, DOI 10.1182/blood-2009-02-202465; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Guo Nancy Lan, 2011, International Journal of Computational Biology and Drug Design, V4, P19, DOI 10.1504/IJCBDD.2011.038655; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r18; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassan KA, 2009, CLIN CANCER RES, V15, P6386, DOI 10.1158/1078-0432.CCR-09-1105; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Larson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031414; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miyazawa K, 2014, ONCOL LETT, V8, P985, DOI 10.3892/ol.2014.2274; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Moreira AL, 2010, MODERN PATHOL, V23, P889, DOI 10.1038/modpathol.2010.68; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Organista-Nava J, 2014, TUMOR BIOL, V35, P1727, DOI 10.1007/s13277-013-1321-y; Palmer NP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r71; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Rangel MC, 2016, BREAST CANCER RES TR, V156, P211, DOI 10.1007/s10549-016-3746-7; Riester M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000777; Robles AI, 2015, J THORAC ONCOL, V10, P1037, DOI 10.1097/JTO.0000000000000560; Rye MB, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-50; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Schwede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057799; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Shaykhiev R, 2013, STEM CELLS, V31, P1992, DOI 10.1002/stem.1459; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Toraih EA, 2016, MOL MED, V22, P653, DOI 10.2119/molmed.2016.00096; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waldron L, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju049; Wang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072435; Wang Xiaosheng, 2011, BMC Res Notes, V4, P471, DOI 10.1186/1756-0500-4-471; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Williams C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2256; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Yan XW, 2011, P NATL ACAD SCI USA, V108, P1591, DOI 10.1073/pnas.1018696108; Zhao XZ, 2016, ONCOL LETT, V11, P442, DOI 10.3892/ol.2015.3884; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	65	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0173589	10.1371/journal.pone.0173589	http://dx.doi.org/10.1371/journal.pone.0173589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333954	gold, Green Published, Green Submitted			2022-12-27	WOS:000399102200019
J	Su, YW; Liu, PH; Hsu, CY; Lee, YH; Hsia, CY; Ho, SY; Hou, MC; Chen, HS; Huo, TI				Su, Yu-Wen; Liu, Po-Hong; Hsu, Chia-Yang; Lee, Yun-Hsuan; Hsia, Cheng-Yuan; Ho, Shu-Yein; Hou, Ming-Chih; Chen, Harn-Shen; Huo, Teh-Ia			Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective	PLOS ONE			English	Article							INSULIN-RESISTANCE; HEPATIC STEATOSIS; LIVER-DISEASE; RISK; ASSOCIATION; INCREASES; RESECTION; FIBROSIS; THERAPY; WORSENS	Background Diabetes mellitus (DM) is associated with higher incidence and poorer prognosis of hepatocellular carcinoma (HCC). The influence of DM on patient survival in different HCC stages is not known. Methods A prospective dataset of 3,182 HCC patients was collected between 2002 and 2014. Patients were divided into three groups according to BCLC stages (BCLC stage 0 and stage A, BCLC stage B, BCLC stage C and stage D). We compared the cumulative survival rate of diabetic and non-diabetic patients in different BCLC groups. The correlation between DM and overall survival was also analyzed by multivariate Cox regression model within each group. Results DM is present in 25.2% of all patients. Diabetic patients had lower cumulative survival in BCLC stage 0 plus BCLC stage A group (log rank p< 0.001), and BCLC stage B group (log rank p = 0.012), but not in BCLC stage C plus BCLC stage D group (log rank p = 0.132). Statistically significant differences in overall survival are found between diabetic and non-diabetic patients in BCLC stage 0 plus stage A group (adjusted hazard ratio [HR] = 1.45, 95% confidence interval [CI] 1.08-1.93, p = 0.013), and BCLC stage B (adjusted HR = 1.77, 95% CI 1.24-2.51, p = 0.002). In contrast, the survival difference is not seen in BCLC stage C plus stage D group (adjusted HR = 1.09, 95% CI 0.90-1.30, p = 0.387). Conclusions DM is prevalent in HCC, and is associated with lower survival rate in HCC patients with BCLC stage 0 plus stage A and B, but not in those with BCLC stage C plus stage D.	[Su, Yu-Wen; Liu, Po-Hong; Lee, Yun-Hsuan; Ho, Shu-Yein; Hou, Ming-Chih; Chen, Harn-Shen; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Su, Yu-Wen; Liu, Po-Hong; Hsu, Chia-Yang; Lee, Yun-Hsuan; Hsia, Cheng-Yuan; Hou, Ming-Chih; Chen, Harn-Shen; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Nevada, Sch Med, Dept Internal Med, Reno, NV 89557 USA; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Huo, TI (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Liu, Po-Hong/0000-0001-6205-3704	Taipei Veterans General Hospital, Taipei, Taiwan [V105C-009, VN106-11]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This study was supported by the grants from Taipei Veterans General Hospital (V105C-009, VN106-11), Taipei, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chau GY, 2014, WORLD J GASTROENTERO, V20, P12473, DOI 10.3748/wjg.v20.i35.12473; Chu CJ, 2008, HEPATO-GASTROENTEROL, V55, P2157; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Feng YH, 2011, MED ONCOL, V28, P1080, DOI 10.1007/s12032-010-9650-9; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Huang YH, 2005, ALIMENT PHARM THER, V21, P687, DOI 10.1111/j.1365-2036.2005.02404.x; Huo TI, 2010, LIVER INT, V30, P198, DOI 10.1111/j.1478-3231.2009.02143.x; Huo TI, 2004, AM J GASTROENTEROL, V99, P1479, DOI 10.1111/j.1572-0241.2004.30024.x; Huo TI, 2003, EUR J GASTROEN HEPAT, V15, P1203, DOI 10.1097/00042737-200311000-00009; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Jinjuvadia R, 2014, J CLIN GASTROENTEROL, V48, P172, DOI 10.1097/MCG.0b013e3182a030c4; Kamkar MMA, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-57; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2011, WORLD J HEPATOL, V3, P99, DOI 10.4254/wjh.v3.i5.99; Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x; Ko WH, 2012, HEPATOL RES, V42, P774, DOI 10.1111/j.1872-034X.2012.00979.x; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Liu PH, ANN SURG; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Perumpail RB, 2015, WORLD J HEPATOL, V7, P2384, DOI 10.4254/wjh.v7.i22.2384; Petta S, 2011, LIVER INT, V31, P507, DOI 10.1111/j.1478-3231.2011.02453.x; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Raffetti E, 2015, DIGEST LIVER DIS, V47, P950, DOI 10.1016/j.dld.2015.07.010; Ting CT, 2012, TOHOKU J EXP MED, V227, P73, DOI 10.1620/tjem.227.73; Toyoda H, 2001, CANCER-AM CANCER SOC, V91, P957; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267	34	11	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2017	12	3							e0174333	10.1371/journal.pone.0174333	http://dx.doi.org/10.1371/journal.pone.0174333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8VS	28333991	Green Published, Green Submitted, gold			2022-12-27	WOS:000399102200080
J	Feng, YM; Yang, Y; Han, XL; Zhang, F; Wan, D; Guo, R				Feng, Yan-mei; Yang, Yuan; Han, Xiao-li; Zhang, Fan; Wan, Dong; Guo, Rui			The effect of early versus late initiation of renal replacement therapy in patients with acute kidney injury: A meta-analysis with trial sequential analysis of randomized controlled trials	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; CARDIAC-SURGERY; CARE PATIENTS; FAILURE; DIALYSIS; MORTALITY; SURVIVAL; STANDARD; IMPACT	Background The optimal timing for initiating renal replacement therapy (RRT) in patients with acute kidney injury (AKI) remains controversial. Methods We conducted a meta-analysis with trial sequential analysis (TSA) of randomized controlled trials (RCTs) using PUBMED, Cochrane Library databases, and Web of Science (from January 1, 1985, to August 21, 2016). Adult patients with AKI who received RRT with different timing were included. The primary outcome was mortality. The secondary outcomes were intensive care unit (ICU) length of stay (LOS) and hospital LOS. Results We included 9 RCTs with a total of 1636 participants. No differences between the early RRT group and the late RRT group were found with respect to mortality (38% vs 41.4%; relative risk, 0.93; 95% confidence interval [CI], 0.74-1.18). However, TSA showed that the cumulative Z-curve did not cross either the conventional boundary for benefit or the trial sequential monitoring boundary, indicating insufficient evidence. Similarity, there were no findings of benefits in terms of reduction in the ICU LOS (standard difference in the means, -0.32 days; 95% CI, -0.71 to 0.07 days) and hospital LOS (standard difference in the means, -1.11 days; 95% CI, -2.28 to 0.06 days). Meanwhile, the results of TSA did not confirm this conclusion. Conclusions Although conventional meta-analysis showed that early initiation of RRT in patients with AKI was not associated with decreased mortality, ICU LOS and hospital LOS, TSA indicated that the data were far too sparse to make any conclusions. Therefore, well-designed, large RCTs are needed.	[Feng, Yan-mei; Han, Xiao-li] Chongqing Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Chongqing, Peoples R China; [Yang, Yuan] Chongqing Med Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Chongqing, Peoples R China; [Zhang, Fan] Chongqing Med Univ, Sch Publ Hlth & Hlth Management, Chongqing, Peoples R China; [Wan, Dong; Guo, Rui] Chongqing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Guo, R (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Chongqing, Peoples R China.	guo-rui5@163.com	Feng, Yanmei/GQB-1685-2022		national natural science foundation of China [81201173]	national natural science foundation of China(National Natural Science Foundation of China (NSFC))	Rui Guo received national natural science foundation of China (81201173) for this work.	Bagshaw SM, 2016, NAT REV NEPHROL; Bihorac A, 2010, JAMA-J AM MED ASSOC, V303, P229, DOI 10.1001/jama.2009.1878; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Boussekey N, 2012, INT J ARTIF ORGANS, V35, P1039, DOI 10.5301/ijao.5000133; Carl DE, 2010, HEMODIAL INT, V14, P11, DOI 10.1111/j.1542-4758.2009.00407.x; Chertow GM, 2016, JAMA-J AM MED ASSOC, V315, P2171, DOI 10.1001/jama.2016.6210; Combes A, 2015, AM J RESP CRIT CARE, V192, P1179, DOI 10.1164/rccm.201503-0516OC; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; Durmaz I, 2003, ANN THORAC SURG, V75, P859, DOI 10.1016/S0003-4975(02)04635-0; Gallagher M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001601; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Gettings LG, 1999, INTENS CARE MED, V25, P805, DOI 10.1007/s001340050956; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Iyem H, 2009, HEMODIAL INT, V13, P55, DOI 10.1111/j.1542-4758.2009.00347.x; Jamale TE, 2013, AM J KIDNEY DIS, V62, P1116, DOI 10.1053/j.ajkd.2013.06.012; Ji QA, 2011, HEART VESSELS, V26, P183, DOI 10.1007/s00380-010-0045-9; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Liu Y, 2014, J CARDIOTHOR VASC AN, V28, P557, DOI 10.1053/j.jvca.2013.12.030; Mehta RL, 2016, NEW ENGL J MED, V375, P175, DOI 10.1056/NEJMe1606125; Mehta RL, 2016, LANCET, V387, P2017, DOI 10.1016/S0140-6736(16)30240-9; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Ostermann M, 2016, CONTRIB NEPHROL, V187, P106, DOI 10.1159/000442369; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Shiao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042952; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Sugahara Souichi, 2004, Hemodial Int, V8, P320, DOI 10.1111/j.1492-7535.2004.80404.x; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Vats HS, 2011, RENAL FAILURE, V33, P698, DOI 10.3109/0886022X.2011.589945; Wald R, 2015, KIDNEY INT, V88, P897, DOI 10.1038/ki.2015.184; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wierstra BT, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1291-8; Xu Y, 2016, CLIN EXP NEPHROL; Zarbock A, 2016, JAMA-J AM MED ASSOC, V315, P2190, DOI 10.1001/jama.2016.5828	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174158	10.1371/journal.pone.0174158	http://dx.doi.org/10.1371/journal.pone.0174158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28329026	gold, Green Published, Green Submitted			2022-12-27	WOS:000399094700062
J	Hakenbeck, SE; Evans, J; Chapman, H; Fothi, E				Hakenbeck, Susanne E.; Evans, Jane; Chapman, Hazel; Fothi, Erzsebet			Practising pastoralism in an agricultural environment: An isotopic analysis of the impact of the Hunnic incursions on Pannonian populations	PLOS ONE			English	Article							BONE-COLLAGEN; STABLE CARBON; TECHNICAL NOTE; TROPHIC LEVEL; STRONTIUM; NITROGEN; DIET; CEMETERY; AGE; RECONSTRUCTION	We conducted a multi-isotope study of five fifth-century AD cemeteries in modern-day Hungary to determine relationships between nomadic-pastoralist incomers-D the historically documented Huns and other nomadic groups-and the sedentary agricultural population of the late Roman province of Pannonia. Contemporary historical sources describe this relationship as adversarial and destructive for the late Roman population, but archaeological evidence indicates high levels of hybridity between different groups. We undertook carbon, nitrogen, strontium and oxygen isotope analyses of bone collagen, dentine and tooth enamel at Keszthely-Fenekpuszta,Hacs-Bendekpuszta,Gyor-Szechenyi Square, Mozs and Szolnok-Szanda to examine these relationships through past subsistence practices. The patterns at all sites indicate medium to high animal protein consumption with little evidence for a significant contribution of aquatic resources. All populations relied to a great extent on C4 plants, most likely millet. Within each population, diet was heterogeneous, with significant variations in terms of animal protein and C3 and C4 plant consumption. High levels of intra-population and individual variability suggest that populations made use of a range of subsistence strategies, with many individuals exhibiting significant changes over their lifetimes. Rather than being characterised only by violence, the historically-documented influx of nomadic populations appears to have led to widespread changes in subsistence strategies of populations in the Carpathian basin. Nomadic-pastoralist groups may have switched to smaller herds and more farming, and, conversely, local populations may have integrated with a new economic system based on animal herding.	[Hakenbeck, Susanne E.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Evans, Jane] NERC, Isotope Geosci Lab, Keyworth, Notts, England; [Chapman, Hazel] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Fothi, Erzsebet] Hungarian Nat Hist Museum, Budapest, Hungary	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Cambridge	Hakenbeck, SE (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England.	seh43@cam.ac.uk	Evans, Jane A/G-3673-2010		McDonald Institute for Archaeological Research, University of Cambridge; SYNTHESYS travel grant; NERC [nigl010001] Funding Source: UKRI; Natural Environment Research Council [nigl010001] Funding Source: researchfish	McDonald Institute for Archaeological Research, University of Cambridge(University of Cambridge); SYNTHESYS travel grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The analytical costs were funded by a research grant from the McDonald Institute for Archaeological Research, University of Cambridge. A study visit to Hungary was supported by a SYNTHESYS travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110793; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Anke B., 1995, JH ETNOGRAPHISCH ARC, V36, P144; [Anonymous], 2011, GMTED2010; Barth Fredrik, 1964, NOMADS S PERSIA BASS; Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Beaumont J, 2015, AM J PHYS ANTHROPOL, P1; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bierbrauer V, 2006, MISCELLANEA ROMANOBA, P167; Biro S, 2009, EX OFFICINA STUDIA H, P49; Biro S, 2013, SZENT MOR BENCES PER, P521; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bola A, 2016, ZWISCHEN BYZANZ STEP, P31; Bona I, 2002, GEPIDISCHE GRABERFEL, P197; Bona I, 2002, GEPIDISCHE GRABERFEL; Brettell R, 2012, J ANAL ATOM SPECTROM, V27, P778, DOI 10.1039/c2ja10335d; Brio S, 2009, REGESZETI KUTATASOK, V2010, P39; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; COMAR CL, 1957, SCIENCE, V126, P485, DOI 10.1126/science.126.3272.485; COPLEN TB, 1983, NATURE, V302, P236, DOI 10.1038/302236a0; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; De La Vaissiere E, 2014, CAMBRIDGE COMPANION, P175; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; DICOSMO N, 1994, J ASIAN STUD, V53, P1092, DOI 10.2307/2059235; Dufour E, 1999, J ARCHAEOL SCI, V26, P617, DOI 10.1006/jasc.1998.0379; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Fenner JN, 2014, J ARCHAEOL SCI, V46, P231, DOI 10.1016/j.jas.2014.03.017; Fitzsimmons KE, 2012, QUATERNARY SCI REV, V41, P104, DOI 10.1016/j.quascirev.2012.03.002; France CAM, 2015, INT J OSTEOARCHAEOL, V25, P299, DOI 10.1002/oa.2300; Giblin JI, 2009, J ARCHAEOL SCI, V36, P491, DOI 10.1016/j.jas.2008.09.034; Global Network of Isotopes in Precipitation, 2006, THE GNIP DATABASE; Gyulai F., 2014, Columella - Journal of Agricultural and Environmental Sciences, V1, P39, DOI 10.18380/szie.colum.2014.1.1.39; Gyulai F., 2010, ARCHAEOBOTANY HUNGAR; Gyulai F, 2013, KESZTHELY FENEKPUSZT, P635; Gyulai F., 2006, ARCHAEOLOGICAL CULTU, P63; Hakenbeck SE, OXFORD HDB ARCHAEOLO; Hakenbeck S, 2010, AM J PHYS ANTHROPOL, V143, P235, DOI 10.1002/ajpa.21309; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; HEATHER P, 1995, ENGL HIST REV, V110, P4; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Hedges REM, 2003, INT J OSTEOARCHAEOL, V13, P66, DOI 10.1002/oa.660; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Heinrich-Tamaska O, 2013, KESZTHELY FENEKPUSZT, P513; Heinrich-Tamaska O, 2015, FRONTIER WORLD ROMAN, P617; Heinrich-Tamaska O, 2011, KESZTHELY FENEKPUSZT, P653; Heinrich-Tamaska Orsolya, 2011, KESZTHELY FENEKPUSZT, P457; Heinrich-Tarnaska O, 2013, KESZTHELY FENEKPUSZT, P25; Hull BD, 2012, OXFORD HDB ANGLOSAXO, P667; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Khazanov Anatoly, 1994, NOMADS OUTSIDE WORLD; Kiss A, 1995, ACTA ANTIQUAE ACAD S, P275; Knipper C, 2013, ARCHAEOL ANTHROP SCI, V5, P17, DOI 10.1007/s12520-012-0106-3; Korosi A, 2013, KESZTHELY FENEK PUSZ, P653; Lambers H., 2008, PLANT PHYSL ECOLOGY; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Lightfoot E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153850; Liptak P, 1961, ACTA ARCHAEOL-HUNG, V33, P231; Liu XY, 2014, WORLD ARCHAEOL, V46, P661, DOI 10.1080/00438243.2014.953706; Loftus E, 2012, AM J PHYS ANTHROPOL, V147, P499, DOI 10.1002/ajpa.22012; Magyari EK, 2010, J BIOGEOGR, V37, P915, DOI 10.1111/j.1365-2699.2009.02261.x; Marano YA, 2011, KESZTHELY FENEKPUSZT, P173; Matuzeviciute GM, 2015, J ARCHAEOL SCI, V59, P23, DOI 10.1016/j.jas.2015.03.029; Miller NF, 2016, HOLOCENE, V26, P1566, DOI 10.1177/0959683616641742; Molnar Z., 2012, EURASIAN STEPPES ECO, V6, P209; Muller R, 2010, GRABERFELDER VOR SIT; Murphy EM, 2013, J ARCHAEOL SCI, V40, P2547, DOI 10.1016/j.jas.2012.09.038; Nafradi K., 2014, American Journal of Plant Sciences, V5, P1557, DOI 10.4236/ajps.2014.511170; Noche-Dowdy L., 2015, MULTIISOTOPE ANAL RE; O'Connell Tamsin, 2003, PREHISTORIC STEPPE A, P253; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; Odor JG, 2011, KESZTHELY FENEKPUSZT, P347; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; PAP I, 1984, Annales Historico-Naturales Musei Nationalis Hungarici, V76, P335; PAP I, 1985, Annales Historico-Naturales Musei Nationalis Hungarici, V77, P281; PAP I, 1983, Annales Historico-Naturales Musei Nationalis Hungarici, V75, P339; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Pollard AM, 2011, AM J PHYS ANTHROPOL, V145, P499, DOI 10.1002/ajpa.21524; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Privat K. L., 2005, EURASIA ANTIQUA, V11, P419; Privat KL, 2002, J ARCHAEOL SCI, V29, P779, DOI 10.1006/jasc.2001.0785; SALAMON A, 1980, WORLD ARCHAEOL, V12, P93, DOI 10.1080/00438243.1980.9979783; Salesse K, 2013, AM J PHYS ANTHROPOL, V151, P202, DOI 10.1002/ajpa.22267; Scheeres M, 2014, AM J PHYS ANTHROPOL, V155, P496, DOI 10.1002/ajpa.22597; Schroeder H, 2009, AM J PHYS ANTHROPOL, V139, P547, DOI 10.1002/ajpa.21019; Schutkowski H, 1999, J ARCHAEOL SCI, V26, P675, DOI 10.1006/jasc.1998.0384; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; Shishlina N, 2012, POPULATION DYNAMICS, P177; Sos AC, 1961, ACTA ARCHAEOL-HUNG, V33, P247; Straub P, 2011, KESZTHELY FENEKPUSZT, P325; Straub P, 2001, ACTA ARCHAEOL-HUNG, V52, P303; Sumegi P, 2015, OPEN GEOSCI, V7, P40, DOI 10.1515/geo-2015-0003; Svyatko SV, 2013, J ARCHAEOL SCI, V40, P3936, DOI 10.1016/j.jas.2013.05.005; Tejral J., 2007, SPISY ARCHEOLOGICKEH, V26, P55; Tomka P, 2004, ZENTRUM PERIPHERIE G, P389; TOOTS H, 1965, SCIENCE, V149, P854, DOI 10.1126/science.149.3686.854; Turner BL, 2012, J ARCHAEOL SCI, V39, P3125, DOI 10.1016/j.jas.2012.04.053; von Bulow G., 2007, TRANSITION LATE ANTI, P459; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Willis KJ, 1998, ANTIQUITY, V72, P101, DOI 10.1017/S0003598X00086312; Woelfel JB, 2012, DENT ANATOMY ITS REL	103	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0173079	10.1371/journal.pone.0173079	http://dx.doi.org/10.1371/journal.pone.0173079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ER8SZ	28328951	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399094700017
J	Harada, K; Shimizu, T; Mukai, Y; Kuwajima, K; Sato, T; Kajino, A; Usui, M; Tamura, Y; Kimura, Y; Miyamoto, T; Tsuyuki, Y; Ohki, A; Kataoka, Y				Harada, Kazuki; Shimizu, Takae; Mukai, Yujiro; Kuwajima, Ken; Sato, Tomomi; Kajino, Akari; Usui, Masaru; Tamura, Yutaka; Kimura, Yui; Miyamoto, Tadashi; Tsuyuki, Yuzo; Ohki, Asami; Kataoka, Yasushi			Phenotypic and molecular characterization of antimicrobial resistance in Enterobacter spp. isolates from companion animals in Japan	PLOS ONE			English	Article							AMPC BETA-LACTAMASES; EXTENDED-SPECTRUM; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; CTX-M; CLOACAE; IDENTIFICATION; INFECTIONS; PREVALENCE; CATS	The emergence of antimicrobial resistance among Enterobacter spp., including resistance to extended-spectrum cephalosporins (ESC), is of great concern in both human and veterinary medicine. In this study, we investigated the prevalence of antimicrobial resistance among 60 isolates of Enterobacter spp., including E. cloacae (n = 44), E. aerogenes (n = 10), and E. asburiae (n = 6), from clinical specimens of dogs and cats from 15 prefectures in Japan. Furthermore, we characterized the resistance mechanisms harbored by these isolates, including extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated quinolone resistance (PMQR); and assessed the genetic relatedness of ESC-resistant Enterobacter spp. strains by multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE). Antimicrobial susceptibility testing demonstrated the resistance rates to ampicillin (93.3%), amoxicillin-clavulanic acid (93.3%), cefmetazole (93.3%), chloramphenicol (46.7%), ciprofloxacin (43.3%), tetracycline (40.0%), ceftazidime (33.3%), cefotaxime (33.3%), trimethoprim/sulfamethoxazole (28.3%), gentamicin (23.3%), and meropenem (0%). Phenotypic testing detected ESBLs in 16 of 18 ESC-resistant E. cloacae isolates but not in the other species. The most frequent ESBL was CTX-M-15 (n = 8), followed by SHV-12 (n = 7), and CTX-M-3 (n = 1). As for AmpC beta-lactamases, CMY-2 (n = 2) and DHA-1 (n = 2) were identified in ESC-resistant E. cloacae strains with or without ESBLs. All of the ESC-resistant E. cloacae strains also harbored one or two PMQRs, including qnrB (n = 15), aac (6')-Ib-cr (n = 8), and qnrS (n = 2). Based on MLST and PFGE analysis, E. cloacae clones of ST591-SHV-12, ST171-CTX-M-15, and ST121-CTX-M-15 were detected in one or several hospitals. These results suggested intra-and inter-hospital dissemination of E. cloacae clones co-harboring ESBLs and PMQRs among companion animals. This is the first report on the large-scale monitoring of antimicrobial-resistant isolates of Enterobacter spp. from companion animals in Japan.	[Harada, Kazuki; Shimizu, Takae] Tottori Univ, Dept Vet Internal Med, Tottori, Japan; [Mukai, Yujiro; Kuwajima, Ken; Kataoka, Yasushi] Nippon Vet & Life Sci Univ, Lab Vet Microbiol, Tokyo, Japan; [Sato, Tomomi; Kajino, Akari; Usui, Masaru; Tamura, Yutaka] Rakuno Gakuen Univ, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido, Japan; [Kimura, Yui; Miyamoto, Tadashi] Miyamoto Anim Hosp, Yamaguchi, Japan; [Tsuyuki, Yuzo] Sanritsu Zelkova Vet Lab, Kawasaki, Kanagawa, Japan; [Ohki, Asami] Fujifilm Monoris Co Ltd, Tokyo, Japan	Tottori University; Nippon Veterinary & Life Science University; Rakuno Gakuen University	Harada, K (corresponding author), Tottori Univ, Dept Vet Internal Med, Tottori, Japan.	k-harada@muses.tottori-u.ac.jp			JSPS KAKENHI [24780299]; Fujifilm Monoris Co., Ltd	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fujifilm Monoris Co., Ltd	This work was financially supported by JSPS KAKENHI Grant Number 24780299. The Fujifilm Monoris Co., Ltd. provided support in the form of salaries for A.O., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Ciesielczuk H, 2013, J MED MICROBIOL, V62, P1823, DOI 10.1099/jmm.0.064428-0; Clinical and Laboratory Standards Institute, 2013, VET01A CLSI, V2nd; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Clinical and Laboratory Standards Institute, 2013, VET01A CLSI; Conceicao T, 2004, FEMS MICROBIOL LETT, V230, P197, DOI 10.1016/S0378-1097(03)00891-7; Dalben M, 2008, J HOSP INFECT, V70, P7, DOI 10.1016/j.jhin.2008.05.003; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; Delgado-Valverde M, 2013, THER ADV INFECT DIS, V1, P49, DOI 10.1177/2049936113476284; Dierig A, 2015, PEDIATR INFECT DIS J, V34, P97, DOI 10.1097/INF.0000000000000601; EUCAST, 2013, EUCAST GUID DET RES; Gibson JS, 2010, VET MICROBIOL, V143, P329, DOI 10.1016/j.vetmic.2009.11.031; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Haenni M, 2016, J ANTIMICROB CHEMOTH, V71, P1497, DOI 10.1093/jac/dkw006; Harada K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01021; Harada K, 2014, J MED MICROBIOL, V63, P1561, DOI 10.1099/jmm.0.081539-0; Harada K, 2012, MICROBIOL IMMUNOL, V56, P480, DOI 10.1111/j.1348-0421.2012.00463.x; Harada K, 2012, MICROBIOL IMMUNOL, V56, P123, DOI 10.1111/j.1348-0421.2011.00416.x; Harada K, 2012, AM J VET RES, V73, P409, DOI 10.2460/ajvr.73.3.409; Hayakawa K, 2014, ANTIMICROB AGENTS CH, V58, P3441, DOI 10.1128/AAC.02652-13; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Hrabak J, 2014, CLIN MICROBIOL INFEC, V20, P839, DOI 10.1111/1469-0691.12678; Huang SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047636; Izdebski R, 2015, J ANTIMICROB CHEMOTH, V70, P48, DOI 10.1093/jac/dku359; Kanamori Hajime, 2012, PLoS One, V7, pe37967, DOI 10.1371/journal.pone.0037967; Khari FIM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150643; Kim ES, 2009, ANTIMICROB AGENTS CH, V53, P2643, DOI 10.1128/AAC.01534-08; Kim J, 2005, FEMS MICROBIOL LETT, V245, P93, DOI 10.1016/j.femsle.2005.02.029; Lloyd DH, 2007, CLIN INFECT DIS, V45, pS148, DOI 10.1086/519254; Mezzatesta ML, 2012, FUTURE MICROBIOL, V7, P887, DOI [10.2217/FMB.12.61, 10.2217/fmb.12.61]; Miyoshi-Akiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066358; Ohkusu K, 2000, J CLIN MICROBIOL, V38, P4586, DOI 10.1128/JCM.38.12.4586-4592.2000; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Schmiedel J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-187; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Sidjabat HE, 2007, J MED MICROBIOL, V56, P426, DOI 10.1099/jmm.0.46888-0; Souna D, 2014, MED MALADIES INFECT, V44, P146, DOI 10.1016/j.medmal.2014.01.008; Steward CD, 2001, J CLIN MICROBIOL, V39, P2864, DOI 10.1128/JCM.39.8.2864-2872.2001; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Weese JS, 2008, VET MICROBIOL, V130, P426, DOI 10.1016/j.vetmic.2008.02.009; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0; Yamaguchi Keizo, 2012, Jpn J Antibiot, V65, P181; Yan JJ, 2002, J CLIN MICROBIOL, V40, P3121, DOI 10.1128/JCM.40.9.3121-3126.2002	44	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2017	12	3							e0174178	10.1371/journal.pone.0174178	http://dx.doi.org/10.1371/journal.pone.0174178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8SZ	28328967	Green Submitted, Green Published, gold			2022-12-27	WOS:000399094700066
J	Fan, YF; Garcia-Rodriguez, C; Lou, JL; Wen, WH; Conrad, F; Zhai, WW; Smith, TJ; Smith, LA; Marks, JD				Fan, Yongfeng; Garcia-Rodriguez, Consuelo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Zhai, Wenwu; Smith, Theresa J.; Smith, Leonard A.; Marks, James D.			A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes	PLOS ONE			English	Article							DOMAIN-BASED ASSAYS; CLOSTRIDIUM-BOTULINUM; MOLECULAR EVOLUTION; GENETIC DIVERSITY; BINDING; TOXIN	Human botulism is primarily caused by botulinum neurotoxin (BoNT) serotypes A, B and E, with around 1% caused by serotype F (BoNT/F). BoNT/F comprises at least seven different subtypes with the amino acid sequence difference between subtypes as high as 36%. The sequence differences present a significant challenge for generating monoclonal antibodies (mAbs) that can bind, detect and neutralize all BoNT/F subtypes. We used repertoire cloning of immune mouse antibody variable (V) regions and yeast display to generate a panel of 33 lead single chain Fv (scFv) mAbs that bound one or more BoNT/F subtypes with a median equilibrium dissociation constant (K-D) of 4.06 x 10(-9) M. By diversifying the V-regions of the lead mAbs and selecting for cross reactivity we generated five mAbs that bound each of the seven subtypes. Three scFv binding non-overlapping epitopes were converted to IgG that had KD for the different BoNT/F subtypes ranging from 2.2x10(-8) M to 1.47x10(-12) pM. An equimolar combination of the mAbs was able to potently neutralize BoNT/F1, F2, F4 and F7 in the mouse neutralization assay. The mAbs have potential utility as diagnostics capable of recognizing the known BoNT/F subtypes and could be developed as antitoxins to prevent and treat type F botulism.	[Fan, Yongfeng; Garcia-Rodriguez, Consuelo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Zhai, Wenwu; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Fan, Yongfeng; Garcia-Rodriguez, Consuelo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Zhai, Wenwu; Marks, James D.] Trauma Ctr, San Francisco, CA 94143 USA; [Smith, Theresa J.] US Army, Med Inst Infect Dis USAMRIID, Mol & Translat Sci Div, Ft Detrick, MD USA; [Smith, Leonard A.] US Army, Med Res Inst Infect Dis, Med Countermeasures Technol, Ft Detrick, MD 21702 USA	University of California System; University of California San Francisco	Marks, JD (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA.; Marks, JD (corresponding author), Trauma Ctr, San Francisco, CA 94143 USA.	jim.marks@ucsf.edu			National Institute of Allergy and Infectious Diseases [R01 AI04579, U01 AI056493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104579] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding support for this work was from the National Institute of Allergy and Infectious Diseases numbers R01 AI04579 and U01 AI056493 to JDM (https://www.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, interpretations	Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; ARNON SS, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P477; Arnon SS, 2007, PEDIATRICS, V119, P785, DOI 10.1542/peds.2006-0646; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Burke GS, 1919, J BACTERIOL, V4, P541, DOI 10.1128/JB.4.5.541-553.1919; Control CfD, 1998, BOTULISM US 1899 199; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Fagan RP, 2011, CLIN INFECT DIS, V53, pE125, DOI 10.1093/cid/cir550; Fan YF, 2016, J INFECT DIS, V213, P1606, DOI 10.1093/infdis/jiv770; Fan YF, 2015, TOXINS, V7, P3405, DOI 10.3390/toxins7093405; Fan YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135306; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Grossman I, 2016, PROTEIN ENG DES SEL, V29, P135, DOI 10.1093/protein/gzv067; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Kalb SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012237; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Maslanka S.E., 2015, J INFECT DIS; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Meng Q, 2012, ANAL BIOCHEM, V421, P351, DOI 10.1016/j.ab.2011.09.030; MOLLER VAGN, 1960, ACTA PATHOL ET MICROBIOL SCAND, V48, P80; Nayak SU, 2014, ANTIMICROB AGENTS CH, V58, P5047, DOI 10.1128/AAC.02830-14; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raphael BH, 2010, APPL ENVIRON MICROB, V76, P4805, DOI 10.1128/AEM.03109-09; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005	35	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0174187	10.1371/journal.pone.0174187	http://dx.doi.org/10.1371/journal.pone.0174187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323873	Green Published, gold, Green Submitted			2022-12-27	WOS:000399089000073
J	Zhang, ZR; Liang, ZX; Li, HD; Li, CS; Yang, Z; Li, YQ; She, DY; Cao, L; Wang, WJ; Liu, CL; Chen, LA				Zhang, Zhaorui; Liang, Zhixin; Li, Huaidong; Li, Chunsun; Yang, Zhen; Li, Yanqin; She, Danyang; Cao, Lu; Wang, Wenjie; Liu, Changlin; Chen, Liangan			Perfluorocarbon reduces cell damage from blast injury by inhibiting signal paths of NF-kappa B, MAPK and Bcl-2/Bax signaling pathway in A549 cells	PLOS ONE			English	Article							PARTIAL LIQUID VENTILATION; LUNG INJURY; INFLAMMATORY RESPONSE; ICAM-1 EXPRESSION; OXIDATIVE STRESS; MODEL; EXPOSURE	Background and objective Blast lung injury is a common type of blast injury and has very high mortality. Therefore, research to identify medical therapies for blast injury is important. Perfluorocarbon (PFC) is used to improve gas exchange in diseased lungs and has antiinflammatory functions in vitro and in vivo. The aim of this study was to determine whether PFC reduces damage to A549 cells caused by blast injury and to elucidate its possible mechanisms of action. Study design and methods A549 alveolar epithelial cells exposed to blast waves were treated with and without PFC. Morphological changes and apoptosis of A549 cells were recorded. PCR and enzymelinked immunosorbent assay (ELISA) were used to measure the mRNA or protein levels of IL-1 beta, IL-6 and TNF-alpha. Malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity levels were detected. Western blot was used to quantify the expression of NF-kappa B, Bax, Bcl-2, cleaved caspase-3 and MAPK cell signaling proteins. Results A549 cells exposed to blast wave shrank, with less cell-cell contact. The morphological change of A549 cells exposed to blast waves were alleviated by PFC. PFC significantly inhibited the apoptosis of A549 cells exposed to blast waves. IL-1 beta, IL-6 and TNF-alpha cytokine and mRNA expression levels were significantly inhibited by PFC. PFC significantly increased MDA levels and decreased SOD activity levels. Further studies indicated that NF-kappa B, Bax, caspase-3, phospho-p38, phosphor-ERK and phosphor-JNK proteins were also suppressed by PFC. The quantity of Bcl-2 protein was increased by PFC.	[Zhang, Zhaorui; Liang, Zhixin; Li, Chunsun; Yang, Zhen; Li, Yanqin; She, Danyang; Cao, Lu; Chen, Liangan] Chinese Peoples Liberat Army Gen Hosp, Dept Respirat, Beijing, Peoples R China; [Li, Huaidong] 88th Hosp Chinese PLA, Dept Resp Dis, Tai An, Shandong, Peoples R China; [Wang, Wenjie; Liu, Changlin] Beijing Univ Technol, Dept State Key Lab Explos Sci & Technol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Beijing University of Technology	Chen, LA (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Respirat, Beijing, Peoples R China.	chenliangan301@163.com		Liang, Zhixin/0000-0001-5208-7505; Liang, Zhixin/0000-0003-3520-2297; Chen, Liang-an/0000-0002-1829-3134	military twelfth five-year key project of China [BWS11J057]	military twelfth five-year key project of China	This study was supported by the military twelfth five-year key project of China (BWS11J057).	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Forgiarini LA, 2013, J SURG RES, V183, P835, DOI 10.1016/j.jss.2013.01.035; Argyros GJ, 1997, TOXICOLOGY, V121, P105, DOI 10.1016/S0300-483X(97)03659-7; Arnold Jeffrey L, 2003, Prehosp Disaster Med, V18, P220; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bass CR, 2010, J TRAUMA, V69, P179, DOI 10.1097/TA.0b013e3181c42649; Cao L, 2016, MOL MED REP, V13, P3700, DOI 10.3892/mmr.2016.4952; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chu PY, 2010, FOOD CHEM TOXICOL, V48, P1821, DOI 10.1016/j.fct.2010.04.014; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fan Chong-Xi, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P243; Folch E, 1999, ANN SURG, V230, P792, DOI 10.1097/00000658-199912000-00008; Frank JA, 2005, CRIT CARE MED, V33, P181, DOI 10.1097/01.CCM.0000150663.45778.C4; Gorbunov NV, 2004, CRIT CARE MED, V32, P1028, DOI 10.1097/01.CCM.0000120051.79520.B6; Hirschl RB, 1996, CRIT CARE MED, V24, P1001, DOI 10.1097/00003246-199606000-00021; Huang WC, 2015, FOOD FUNCT, V6, P1960, DOI 10.1039/c5fo00149h; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kumar M, 2010, Med J Armed Forces India, V66, P309, DOI 10.1016/S0377-1237(10)80005-X; Lange M, 2012, SHOCK, V37, P468, DOI 10.1097/SHK.0b013e31824b1793; Lehmler Hans-Joachim, 2008, Expert Rev Respir Med, V2, P273, DOI 10.1586/17476348.2.2.273; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Liener UC, 2003, SHOCK, V20, P511, DOI 10.1097/01.shk.0000095057.62263.fb; Max M, 1999, ANESTHESIOLOGY, V91, P796, DOI 10.1097/00000542-199909000-00032; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Muggia-Sullam M, 2007, ANN SURG, V245, P502, DOI 10.1097/01.sla.0000256107.84051.23; Perl M, 2012, SHOCK, V38, P98, DOI 10.1097/SHK.0b013e318254be6a; Qin Xin, 2007, Zhonghua Yi Xue Za Zhi, V87, P493; Rotta Alexandre T, 2003, Pediatr Crit Care Med, V4, P233, DOI 10.1097/01.PCC.0000059729.21375.D0; Seitz DH, 2008, SHOCK, V30, P537, DOI 10.1097/SHK.0b013e31816a394b; Smith Jason E, 2011, J R Nav Med Serv, V97, P99; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xu SF, 2013, INFLAMMATION, V36, P512, DOI 10.1007/s10753-012-9572-0; Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9	40	16	20	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2017	12	3							e0173884	10.1371/journal.pone.0173884	http://dx.doi.org/10.1371/journal.pone.0173884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER8RG	28323898	Green Submitted, Green Published, gold			2022-12-27	WOS:000399089000039
J	Bitar, A; De, R; Melgar, S; Aung, KM; Rahman, A; Qadri, F; Wai, SN; Shirin, T; Hammarstrom, ML				Bitar, Aziz; De, Rituparna; Melgar, Silvia; Aung, Kyaw Min; Rahman, Arman; Qadri, Firdausi; Wai, Sun Nyunt; Shirin, Tahmina; Hammarstrom, Marie-Louise			Induction of immunomodulatory miR-146a and miR-155 in small intestinal epithelium of Vibrio cholerae infected patients at acute stage of cholera	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; HELICOBACTER-PYLORI; ANTIMICROBIAL PEPTIDES; INFLAMMATORY RESPONSE; GENE-EXPRESSION; T-CELLS; MICRORNAS; EPIDEMIOLOGY; ACTIVATION; IMMUNITY	The potential immunomodulatory role of microRNAs in small intestine of patients with acute watery diarrhea caused by Vibrio cholerae O1 or enterotoxigenic Escherichia coli (ETEC) infection was investigated. Duodenal biopsies were obtained from study participants at the acute (day 2) and convalescent (day 21) stages of disease and from healthy individuals. Levels of miR 146a miR 155 and miR 375 and target gene (IRAK1 TRAF6 CARD10) and 11 cytokine mRNAs were determined by qRT PCR. The cellular source of microRNAs in biopsies was analyzed by in situ hybridization. The ability of V. cholerae bacteria and their secreted products to cause changes in microRNA and mRNA levels in polarized tight monolayers of intestinal epithelial cells was investigated. miR 146a and miR 155 were expressed at significantly elevated levels at acute stage of V. cholerae infection and declined to normal at convalescent stage (P< 0.009 versus controls P = 0.03 versus convalescent stage pairwise). Both microRNAs were mainly expressed in the epithelium. Only marginal down regulation of target genes IRAK1 and CARD10 was seen and a weak cytokine profile was identified in the acute infected mucosa. No elevation of microRNA levels was seen in ETEC infection. Challenge of tight monolayers with the wild type V. cholerae O1 strain C6706 and clinical isolates from two study participants caused significant increase in miR 155 and miR 146a by the strain C6706 (P< 0.01). One clinical isolate caused reduction in IRAK1 levels (P< 0.05) and none of the strains induced inflammatory cytokines. In contrast secreted factors from these strains caused markedly increased levels of IL 8 IL 1a and CARD10 (P< 0.001) without inducing microRNA expression. Thus miR 146a and miR155 are expressed in the duodenal epithelium at the acute stage of cholera. The inducer is probably the V. cholerae bacterium. By inducing microRNAs the bacterium can limit the Innate immune response of the host,including inflamation evoked by its own secreted factors,there by decreasing the riskof being eliminated	[Bitar, Aziz; De, Rituparna; Aung, Kyaw Min; Hammarstrom, Marie-Louise] Umea Univ, Dept Clin Microbiol, Immunol, Umea, Sweden; [De, Rituparna; Aung, Kyaw Min; Wai, Sun Nyunt] Umea Univ, Lab Mol Infect Med Sweden MIMS, Dept Mol Biol, Umea, Sweden; [Melgar, Silvia] Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [Rahman, Arman] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Qadri, Firdausi] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Shirin, Tahmina] Natl Influenza Ctr, Inst Epidemiol Dis Control & Res, Dept Virol, Dhaka, Bangladesh	Umea University; Umea University; University College Cork; University College Dublin; International Centre for Diarrhoeal Disease Research (ICDDR)	Hammarstrom, ML (corresponding author), Umea Univ, Dept Clin Microbiol, Immunol, Umea, Sweden.; Shirin, T (corresponding author), Natl Influenza Ctr, Inst Epidemiol Dis Control & Res, Dept Virol, Dhaka, Bangladesh.	tahmina.shirin14@gmail.com; marie-louise.hammarstrom@umu.se	Qadri, Firdausi/AAF-4583-2019; Rahman, Arman/K-8539-2017; Al, Mamun M./AAF-5850-2019	Rahman, Arman/0000-0003-4648-156X; melgar, silvia/0000-0001-7463-3343; De, Dr.Rituparna/0000-0002-8573-7276; Shirin, Tahmina/0000-0002-5061-3783; Hammarstrom, Marie-Louise/0000-0001-6182-4423; Wai, Sun Nyunt/0000-0003-4793-4671	icddr; Swedish International Development Cooperation Agency (SIDA) [INT-ICDDR, B-HN-01-AV]; Swedish Research Council-Natural and Engineering Sciences [2013-4522]; Umea University; Kempe Foundations [SMK-1454]; Science Foundation Ireland(SFI) [SFI/12/RC/2273]; Found of Donations to the Medical Faculty; County of VaEsterbotten; Government of Bangladesh; Canada; Swedenand; UK	icddr; Swedish International Development Cooperation Agency (SIDA); Swedish Research Council-Natural and Engineering Sciences(Swedish Research Council); Umea University; Kempe Foundations; Science Foundation Ireland(SFI)(Science Foundation Ireland); Found of Donations to the Medical Faculty; County of VaEsterbotten; Government of Bangladesh; Canada; Swedenand; UK	This research was supported by the icddr,b and by grants from the Swedish International Development Cooperation Agency (SIDA) grant INT-ICDDR,B-HN-01-AV to F.Q.,the Swedish Research Council-Natural and Engineering Sciences grant no. 2013-4522 to M-L.H. and grant no.2014-4401 to S.N.W.,the TORNADO-project within the 7th framework program theme,grant agreement no.222720-2 to M-L.H.,the Fund for Biotechnology-oriented Basic Science at Umea University to M-L.H.,the Kempe Foundations grant no.SMK-1454 to S.N.W.,the Science Foundation Ireland(SFI) to S.M. under grant no.SFI/12/RC/2273 to APC Microbiome Institute,the Found of Donations to the Medical Faculty ,Umea University to M-L.H., and a combined medical practice-and research fellowship from the County of VaEsterbotten to A.Z..icddr,b is thankful to the donors for their support to its research efforts. icddr,b is also grateful to the Government of Bangladesh,Canada,Swedenand the UK for providing core/unrestricted support.The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript	Belair C, 2009, CLIN MICROBIOL INFEC, V15, P806, DOI 10.1111/j.1469-0691.2009.02960.x; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bhaumik D, 2009, CELL CYCLE, V8, P1822; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bielig H, 2011, INFECT IMMUN, V79, P1418, DOI 10.1128/IAI.00754-10; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Cheng Y, 2012, INFLAMMATION, V35, P1308, DOI 10.1007/s10753-012-9443-8; Cowan C, 2014, INVEST OPHTH VIS SCI, V55, P4944, DOI 10.1167/iovs.13-13631; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Guo Z, 2015, J GASTROEN HEPATOL, V30, P109, DOI 10.1111/jgh.12644; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; KAHN MU, 1988, T R SOC TROP MED HYG, V82, P485; Kuchta A, 2011, CLIN VACCINE IMMUNOL, V111, P1001; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDQVIST C, 1994, J IMMUNOL, V153, P2302; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Ou GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007806; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Qadri F, 2004, GUT, V53, P62, DOI 10.1136/gut.53.1.62; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Queen J, 2015, INFECT IMMUN, V83, P2496, DOI 10.1128/IAI.02461-14; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Sack RB, 2003, J INFECT DIS, V187, P96, DOI 10.1086/345865; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Sheikh A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000908; Shirin T, 2011, MICROBES INFECT, V13, P1111, DOI 10.1016/j.micinf.2011.06.014; Sjoberg V, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.9; Sjoberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053414; Sjoling A, 2006, MICROBES INFECT, V8, P2797, DOI 10.1016/j.micinf.2006.08.011; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; West CE, 2012, CLIN EXP ALLERGY, V42, P540, DOI 10.1111/j.1365-2222.2011.03941.x; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443	41	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							0173817	10.1371/journal.pone.0173817	http://dx.doi.org/10.1371/journal.pone.0173817			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319200	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800031
